PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Frattalone, AR; Ling, GSF				Frattalone, Anthony R.; Ling, Geoffrey S. F.			Moderate and Severe Traumatic Brain Injury: Pathophysiology and Management	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Clinical practice guidelines; Head injury; Concussion; Coma; ICP (intracranial pressure); OPP (cerebral perfusion pressure)	RAPID-SEQUENCE INTUBATION; SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; GLASGOW COMA SCALE; INTRACRANIAL-PRESSURE; INTENSIVE-CARE; BLOOD-PRESSURE; IMPACT; TISSUE; HYPOTENSION	Traumatic brain injury (TBI) is a serious disorder that is all too common. TBI ranges in severity from mild concussion to a severe life-threatening state. Across this spectrum, rational therapeutic approaches exist. Early identification that TBI has occurred in a patient is paramount to optimal outcome. Proper clinical management should be instituted as soon as possible by appropriately trained medical providers. More seriously injured patients must be triaged to advanced care centers. It is only through this rational approach to TBI that patients may expect to achieve optimal clinical and functional outcome.	[Frattalone, Anthony R.; Ling, Geoffrey S. F.] Johns Hopkins Med Inst, Div Neurocrit Care, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Frattalone, Anthony R.; Ling, Geoffrey S. F.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA		Ling, GSF (corresponding author), US Army, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	geoffrey.ling@usuhs.edu					Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Arienta C, 1997, SURG NEUROL, V48, P213, DOI 10.1016/S0090-3019(97)00019-0; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bochicchio GV, 2006, JPEN-PARENTER ENTER, V30, P503, DOI 10.1177/0148607106030006503; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bulger E., 2010, JAMA-J AM MED ASSOC, V304, P1445; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butler J, 2002, EMERG MED J, V19, P554, DOI 10.1136/emj.19.6.554; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; DOCZI T, 1993, ACTA NEUROCHIR, V121, P1, DOI 10.1007/BF01405174; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Eken C, 2009, EUR J EMERG MED, V16, P29, DOI 10.1097/MEJ.0b013e32830346ab; Eriksson EA, 2012, CLIN NEUROPHYSIOL, V123, P1255, DOI 10.1016/j.clinph.2011.08.035; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Fernandez-Ortega JF, 2012, J NEUROTRAUM, V29, P1364, DOI 10.1089/neu.2011.2033; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gjerris F, 2000, PATHOPHYSIOLOGY CERE; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Johnston AJ, 2003, BRIT J ANAESTH, V91, P781, DOI 10.1093/bja/aeg256; Meirelles CMJ, 2011, NUTR HOSP, V26, P1120, DOI [10.1590/S0212-16112011000500030, 10.3305/nh.2011.26.5.5133]; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kubal WS, 2012, RADIOL CLIN N AM, V50, P15, DOI 10.1016/j.rcl.2011.08.010; Ley EJ, 2011, J TRAUMA, V71, P1689, DOI 10.1097/TA.0b013e31823cc5df; LYONS MK, 1990, MAYO CLIN PROC, V65, P684, DOI 10.1016/S0025-6196(12)65131-3; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Manz H J, 1979, Pathobiol Annu, V9, P359; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; MCCOMB JG, 1983, J NEUROSURG, V59, P369, DOI 10.3171/jns.1983.59.3.0369; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; RAPHAEL JH, 1994, ANAESTHESIA, V49, P437; Robinson N, 2001, EMERG MED J, V18, P453, DOI 10.1136/emj.18.6.453; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; Scalfani MT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.008; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; SHRIBMAN AJ, 1987, BRIT J ANAESTH, V59, P295, DOI 10.1093/bja/59.3.295; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; Stein NR, 2011, NEUROCRIT CARE, V32, P1639; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; STOELTING RK, 1977, ANESTHESIOLOGY, V47, P381, DOI 10.1097/00000542-197710000-00012; Stone MB, 2010, ACAD EMERG MED, V17, P100, DOI 10.1111/j.1553-2712.2009.00624.x; Suarez JI, 2004, CRIT CARE MED, V32, P2311, DOI 10.1097/01.CCM.0000146132.29042.4c; Sydenham E., 2009, COCHRANE DATABASE SY; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Thillai M, 2000, BRIT MED J, V320, P399, DOI 10.1136/bmj.320.7232.399; Varelas PN, 2004, CRIT CARE MED, V32, P2191, DOI 10.1097/01.CCM.0000146131.03578.21; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wijdicks EF, 2010, PRACTICE EMERGENCY C; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Zhang XY, 2011, AM J EMERG MED, V29, P699, DOI 10.1016/j.ajem.2010.01.042	78	28	30	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	2013	24	3					309	+		10.1016/j.nec.2013.03.006			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	191NY	WOS:000322421100002	23809027				2022-02-06	
J	Gonda, DD; Meltzer, HS; Crawford, JR; Hilfiker, ML; Shellington, DK; Peterson, BM; Levy, ML				Gonda, David D.; Meltzer, Hal S.; Crawford, John R.; Hilfiker, Mary L.; Shellington, David K.; Peterson, Bradley M.; Levy, Michael L.			Complications Associated With Prolonged Hypertonic Saline Therapy in Children With Elevated Intracranial Pressure	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						acute kidney injury; acute respiratory distress syndrome; anemia; hypertonic saline solution; intracranial hypertension; neutropenia; thrombocytopenia	TRAUMATIC BRAIN-INJURY; ACUTE KIDNEY INJURY; SEVERE HEAD-INJURY; CONSENSUS CONFERENCE; BARBITURATE COMA; CEREBRAL EDEMA; RENAL-FAILURE; RESUSCITATION; MANNITOL; FLUID	Objectives: Safe upper limits for therapeutic hypernatremia in the treatment of intracranial hypertension have not been well established. We investigated complications associated with hypernatremia in children who were treated with prolonged infusions of hypertonic saline. Design: Retrospective chart analysis. Setting: PICU in university-affiliated children's hospital. Patients: All children from 2004 to 2009 requiring intracranial pressure monitoring (external ventricular drain or fiberoptic intraparenchymal monitor) for at least 4 days who were treated with hypertonic saline infusion for elevated intracranial pressure and did not meet exclusion criteria. Intervention: Continuous hypertonic saline infusion on a sliding scale was used to achieve target sodium levels that would keep intracranial pressure less than 20 mm Hg once the conventional therapies failed. Measurements and Main Results: Eighty-eight children met inclusion criteria. Etiologies of elevated intracranial pressure included trauma (n = 48), ischemic or hemorrhagic stroke (n = 20), infection (n = 8), acute disseminated encephalomyelitis (n = 5), neoplasm (n = 2), and others (n = 5). The mean peak serum sodium was 171.3 mEq/L (range, 150-202). The mean Glasgow Outcome Score was 2.8 (+/- 1.1) at time of discharge from the hospital. Overall mortality was 15.9%. Children with sustained (> 72 hr) serum sodium levels above 170 mEq/L had a significantly higher occurrence of thrombocytopenia (p < 0.001), renal failure (p < 0.001), neutropenia (p = 0.006), and acute respiratory distress syndrome (p = 0.029) after controlling for variables of age, gender, Pediatric Risk of Mortality score, duration of barbiturate-induced coma, duration of intracranial pressure monitoring, vasopressor requirements, and underlying pathology. Children with sustained serum sodium levels greater than 165 mEq/L had a significantly higher prevalence of anemia (p < 0.001). Conclusions: Children treated by continuous hypertonic saline infusion for intracranial hypertension whose serum sodium levels exceeded certain thresholds experienced significantly more events of acute renal failure, thrombocytopenia, neutropenia, anemia, and acute respiratory distress syndrome than those whose sodium level was maintained below these thresholds.	[Gonda, David D.; Meltzer, Hal S.; Levy, Michael L.] Univ Calif San Diego, San Diego Med Ctr, Div Neurosurg, San Diego, CA 92103 USA; [Meltzer, Hal S.; Levy, Michael L.] Rady Childrens Hosp, Div Neurosurg, San Diego, CA USA; [Crawford, John R.] Rady Childrens Hosp, Dept Neurol, San Diego, CA USA; [Hilfiker, Mary L.] Rady Childrens Hosp, Div Pediat Surg, San Diego, CA USA; [Shellington, David K.; Peterson, Bradley M.] Rady Childrens Hosp, Dept Crit Care Med, San Diego, CA USA		Gonda, DD (corresponding author), Univ Calif San Diego, San Diego Med Ctr, Div Neurosurg, San Diego, CA 92103 USA.	dgonda@ucsd.edu	Crawford, John/ABH-2134-2021; Levy, Michael/AAL-4647-2020	Shellington, David/0000-0001-6708-6978			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BINGHAM WF, 1986, SURG NEUROL, V25, P340, DOI 10.1016/0090-3019(86)90207-7; Ciesla DJ, 2000, J TRAUMA, V48, P388, DOI 10.1097/00005373-200003000-00004; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; DuBose JJ, 2010, J TRAUMA, V68, P1172, DOI 10.1097/TA.0b013e3181d76d40; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; GERBER JG, 1979, AM J PHYSIOL, V237, pF441, DOI 10.1152/ajprenal.1979.237.6.F441; Greinacher A, 2010, HEMATOL-AM SOC HEMAT, P135, DOI 10.1182/asheducation-2010.1.135; Hanke AA, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-12; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Liumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P132, DOI 10.2450/2009.0005-09; Liumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P49, DOI 10.2450/2008.0020-08; Llompart-Pou JA, 2007, J ENDOCRINOL INVEST, V30, P393, DOI 10.1007/BF03346316; Lozance K, 1998, J CLIN NEUROSCI, V5, P394, DOI 10.1016/S0967-5868(98)90269-7; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Murao Y, 2000, SHOCK, V14, P18, DOI 10.1097/00024382-200014010-00004; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; R Development Core Team, 2011, R LANG ENV STAT COMP; Sakellaridis N, 2011, J NEUROSURG, V114, P545, DOI 10.3171/2010.5.JNS091685; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Therneau TM, PACKAGE SURVIVAL ANA; TODD MM, 1985, ANESTH ANALG, V64, P681; Yildizdas D, 2006, INDIAN PEDIATR, V43, P771	42	28	31	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2013	14	6					610	620		10.1097/PCC.0b013e318291772b			11	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	AL4IF	WOS:000339095600012	23823197				2022-02-06	
J	Liu, HD; Li, W; Chen, ZR; Zhou, ML; Zhuang, Z; Zhang, DD; Zhu, L; Hang, CH				Liu, Huan-Dong; Li, Wei; Chen, Zhen-Rui; Zhou, Meng-Liang; Zhuang, Zong; Zhang, Ding-Ding; Zhu, Lin; Hang, Chun-Hua			Increased expression of ferritin in cerebral cortex after human traumatic brain injury	NEUROLOGICAL SCIENCES			English	Article						Ferritin; Iron; Traumatic brain injury; Inflammation	HEME OXYGENASE-1 HO-1; INTRACEREBRAL HEMORRHAGE; OXIDATIVE STRESS; IRON; DEFEROXAMINE; HEMOGLOBIN; CYTOKINES; PROTEINS; EDEMA	Despite numerous researches and improvements in the past few years, the precise mechanisms underlying secondary brain injury after trauma remain obscure. Iron is essential for almost all types of cells, including nerve cells. However, excess of iron has been proved to contribute to the brain injury following trauma in animal models. As a key iron-handling protein in the brain, ferritin might be involved in iron-induced pathophysiological process of various brain disorders. Therefore, the current study was aimed to investigate the expression of ferritin in the human contused brain. Nineteen contused brain samples were obtained from 19 patients undergoing surgery for brain contusions 3 h-17 d after trauma, and three normal temporal pole samples from 3 patients with petroclival meningioma were collected as controls. Expression of ferritin-H-chain was measured by quantitative real-time polymerase chain reaction (PCR), western blot and immunohistochemistry, respectively. Perl's reaction was taken for iron staining. The results showed that human traumatic brain injury (TBI) could up-regulate ferritin-H-chain in pericontusional cortex. A marked increase of ferritin was detected in the early group (a parts per thousand currency sign12 h), and remained elevated for a long time till after 48 h post-injury. The location of ferritin-H-chain was found mainly at the neuron-like cells and seldom at glia-like cells. Perl's reaction showed that most of the iron-positive cells were glia-like cells. These findings suggested that iron and ferritin might be involved in the secondary brain injury and could be therapeutic targets for patients with TBI.	[Liu, Huan-Dong; Chen, Zhen-Rui; Hang, Chun-Hua] Southern Med Univ Guangzhou, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Li, Wei; Zhou, Meng-Liang; Zhuang, Zong; Zhang, Ding-Ding; Zhu, Lin; Hang, Chun-Hua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com	Li, Wei/ABE-4301-2021	Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation, ChinaNational Natural Science Foundation of China (NSFC) [81171170, 8100053, 81271377]; Nature Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]	This study was supported by grants from National Natural Science Foundation, China (No. 81171170 for C.-H. Hang, No. 8100053 for M.-L. Zhou and No. 81271377 for L. Zhu) and Nature Science Foundation of Jiangsu Province, China (BK2010459).	Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Carbonell T, 2007, CURR MED CHEM, V14, P857, DOI 10.2174/092986707780363014; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chen Z, 2011, STROKE, V42, P465, DOI 10.1161/STROKEAHA.110.602755; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; Dennery PA, 2003, FREE RADICAL BIO MED, V34, P124, DOI 10.1016/S0891-5849(02)01295-9; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Khoshyomn Sami, 2004, Semin Pediatr Surg, V13, P80, DOI 10.1053/j.sempedsurg.2004.01.003; Koeppen AH, 1995, J NEUROL SCI, V134, P102, DOI 10.1016/0022-510X(95)00215-N; Lee JY, 2010, J CEREBR BLOOD F MET, V30, P1793, DOI 10.1038/jcbfm.2010.137; LEVI S, 1992, BIOCHEM J, V288, P591, DOI 10.1042/bj2880591; Li W, 2012, NEUROL SCI; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; Okauchi M, 2009, STROKE, V40, P1858, DOI 10.1161/STROKEAHA.108.535765; Roth P, 2000, Crit Care Nurs Q, V23, P14; Selim M, 2009, STROKE, V40, pS90, DOI 10.1161/STROKEAHA.108.533125; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; YOUDIM MBH, 1991, EUR NEUROL, V31, P34, DOI 10.1159/000116719; Zhang L, 2012, NEUROL SCI; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	33	28	30	0	8	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	JUL	2013	34	7					1173	1180		10.1007/s10072-012-1214-7			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	187SS	WOS:000322140400020	23079850				2022-02-06	
J	Sanganahalli, BG; Herman, P; Hyder, F; Kannurpatti, SS				Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed; Kannurpatti, Sridhar S.			Mitochondrial calcium uptake capacity modulates neocortical excitability	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						aging; brain injury; BOLD; calcium uniporter; CBF; mitochondria	RAT SOMATOSENSORY CORTEX; ACTIVITY-DEPENDENT INCREASES; HIPPOCAMPAL SLICE CULTURES; TRAUMATIC BRAIN-INJURY; SPONTANEOUS CA2+ WAVES; NEURONAL-ACTIVITY; BLOOD-FLOW; ALZHEIMERS-DISEASE; INTERSTITIAL-CELLS; ENERGY-METABOLISM	Local calcium (Ca2+) changes regulate central nervous system metabolism and communication integrated by subcellular processes including mitochondrial Ca2+ uptake. Mitochondria take up Ca2+ through the calcium uniporter (mCU) aided by cytoplasmic microdomains of high Ca2+. Known only in vitro, the in vivo impact of mCU activity may reveal Ca2+-mediated roles of mitochondria in brain signaling and metabolism. From in vitro studies of mitochondrial Ca2+ sequestration and cycling in various cell types of the central nervous system, we evaluated ranges of spontaneous and activity-induced Ca2+ distributions in multiple subcellular compartments in vivo. We hypothesized that inhibiting (or enhancing) mCU activity would attenuate (or augment) cortical neuronal activity as well as activity-induced hemodynamic responses in an overall cytoplasmic and mitochondrial Ca2+-dependent manner. Spontaneous and sensory-evoked cortical activities were measured by extracellular electrophysiology complemented with dynamic mapping of blood oxygen level dependence and cerebral blood flow. Calcium uniporter activity was inhibited and enhanced pharmacologically, and its impact on the multimodal measures were analyzed in an integrated manner. Ru360, an mCU inhibitor, reduced all stimulus-evoked responses, whereas Kaempferol, an mCU enhancer, augmented all evoked responses. Collectively, the results confirm aforementioned hypotheses and support the Ca2+ uptake-mediated integrative role of in vivo mitochondria on neocortical activity.	[Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Dept Diagnost Radiol, Sch Med, New Haven, CT 06510 USA; [Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, MRRC, Sch Med, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Core Ctr, QNMR, New Haven, CT USA; [Hyder, Fahmeed] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Kannurpatti, Sridhar S.] UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ 07103 USA		Kannurpatti, SS (corresponding author), UMDNJ New Jersey Med Sch, Dept Radiol, ADMC Bldg 5,Suite 575,Bergen St, Newark, NJ 07103 USA.	kannursr@umdnj.edu	Sanganahalli, Basavaraju G/C-3296-2008; Hyder, Fahmeed/A-2644-2015	Sanganahalli, Basavaraju G/0000-0002-0851-6621; Hyder, Fahmeed/0000-0001-7822-4002; Herman, Peter/0000-0003-2218-9652	American Heart AssociationAmerican Heart Association [0930132N]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30NS052519]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH067528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS052519] Funding Source: NIH RePORTER	This work was supported by grants from the American Heart Association 0930132N (SK) and National Institute of Health P30NS052519 (FH).	Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Azarias G, 2011, J NEUROSCI, V31, P3550, DOI 10.1523/JNEUROSCI.4378-10.2011; Barve A, 2009, BIOPHARM DRUG DISPOS, V30, P356, DOI 10.1002/bdd.677; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Bindokas VP, 1998, J NEUROSCI, V18, P4570; Boumezbeur F, 2010, J CEREBR BLOOD F MET, V30, P211, DOI 10.1038/jcbfm.2009.197; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Burkeen JF, 2011, J NEUROSCI, V31, P8432, DOI 10.1523/JNEUROSCI.6576-10.2011; Busche MA, 2012, P NATL ACAD SCI USA, V109, P8740, DOI 10.1073/pnas.1206171109; de la Fuente S, 2012, CELL CALCIUM, V51, P65, DOI 10.1016/j.ceca.2011.10.007; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Fluegge D, 2012, NAT NEUROSCI, V15, P754, DOI 10.1038/nn.3074; Garcia-Rivas GD, 2005, FEBS J, V272, P3477, DOI 10.1111/j.1742-4658.2005.04771.x; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hashiatni H, 2010, BRIT J PHARMACOL, V161, P680, DOI 10.1111/j.1476-5381.2010.00902.x; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Huchzermeyer C, 2008, J NEUROSCI, V28, P1153, DOI 10.1523/JNEUROSCI.4105-07.2008; Huttunen JK, 2008, NEUROIMAGE, V39, P775, DOI 10.1016/j.neuroimage.2007.06.042; HYDER F, 1995, MAGN RESON IMAGING, V13, P97, DOI 10.1016/0730-725X(94)00068-E; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Hyder F, 2013, P NATL ACAD SCI USA, V110, P3549, DOI 10.1073/pnas.1214912110; Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5; Kannurpatti SS, 2008, J CEREBR BLOOD F MET, V28, P772, DOI 10.1038/sj.jcbfm.9600574; Kannurpatti SS, 2011, BRAIN RES, V1417, P16, DOI 10.1016/j.brainres.2011.08.026; Kannurpatti SS, 2000, NEUROCHEM RES, V25, P1527, DOI 10.1023/A:1026602100160; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kovacs R, 2005, J NEUROSCI, V25, P4260, DOI 10.1523/JNEUROSCI.4000-04.2005; Kreiner L, 2006, J BIOL CHEM, V281, P4691, DOI 10.1074/jbc.M511971200; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223, DOI 10.1152/ajpheart.1993.264.4.H1223; Liu RN, 2006, BIOMED CHROMATOGR, V20, P1178, DOI 10.1002/bmc.675; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lopez-Sanchez C, 2007, BRAIN RES, V1182, P123, DOI 10.1016/j.brainres.2007.08.087; Mann ZF, 2009, CELL CALCIUM, V46, P136, DOI 10.1016/j.ceca.2009.06.005; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; Masamoto K, 2009, EUR J NEUROSCI, V30, P242, DOI 10.1111/j.1460-9568.2009.06812.x; Mathiesen C, 2011, J NEUROSCI, V31, P18327, DOI 10.1523/JNEUROSCI.4526-11.2011; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Moreira PI, 2006, J ALZHEIMERS DIS, V9, P101; Nemoto EM, 2005, ADV EXP MED BIOL, V566, P83; Nemoto M, 2012, NEUROIMAGE, V59, P3325, DOI 10.1016/j.neuroimage.2011.11.067; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Nir Y, 2007, CURR BIOL, V17, P1275, DOI 10.1016/j.cub.2007.06.066; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Pivovarova NB, 2010, FEBS J, V277, P3622, DOI 10.1111/j.1742-4658.2010.07754.x; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; Restom K, 2007, NEUROIMAGE, V37, P430, DOI 10.1016/j.neuroimage.2007.05.024; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Sanganahalli BG, 2009, J NEUROSCI, V29, P1707, DOI 10.1523/JNEUROSCI.5549-08.2009; Sanganahalli Basavaraju G., 2009, V489, P213, DOI 10.1007/978-1-59745-543-5_10; Sarnat HB, 2011, CAN J NEUROL SCI, V38, P909, DOI 10.1017/S0317167100012518; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/nmeth.2013, 10.1038/NMETH.2013]; Sergeant GP, 2008, J PHYSIOL-LONDON, V586, P4631, DOI 10.1113/jphysiol.2008.159194; Simpson PB, 2000, J BIOENERG BIOMEMBR, V32, P5, DOI 10.1023/A:1005552126516; Simpson PB, 1998, BRAIN RES REV, V26, P72, DOI 10.1016/S0165-0173(97)00056-8; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Tsytsarev V, 2012, J NEUROSCI METH, V203, P136, DOI 10.1016/j.jneumeth.2011.09.005; Ueki M, 1992, ACTA ANAESTH SCAND, V36, P5; Vay L, 2007, J PHYSIOL-LONDON, V580, P39, DOI 10.1113/jphysiol.2006.126391; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; YAMAGUCHI T, 1986, STROKE, V17, P1220, DOI 10.1161/01.STR.17.6.1220; Zazueta C, 1999, J BIOENERG BIOMEMBR, V31, P551, DOI 10.1023/A:1005464927366; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73	72	28	28	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	2013	33	7					1115	1126		10.1038/jcbfm.2013.61			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	174VW	WOS:000321185800018	23591650	Green Published, Bronze			2022-02-06	
J	Stubberud, J; Langenbahn, D; Levine, B; Stanghelle, J; Schanke, AK				Stubberud, Jan; Langenbahn, Donna; Levine, Brian; Stanghelle, Johan; Schanke, Anne-Kristine			Goal Management Training of Executive Functions in Patients with Spina Bifida: A Randomized Controlled Trial	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Executive functioning; Brain injury; Cognitive rehabilitation; Myelomeningocele; Goal management; Evidence-based	TRAUMATIC BRAIN-INJURY; OF-THE-LITERATURE; COGNITIVE REHABILITATION; SUSTAINED ATTENTION; FRONTAL-LOBE; CLINICAL NEUROPSYCHOLOGY; DYSFUNCTION; HYDROCEPHALUS; DEFICITS; PLASTICITY	Executive dysfunction causes significant real-life disability for patients with spina bifida (SB). However, no previous research has been directed toward the amelioration of executive functioning deficits amongst persons with SB. Goal Management Training (GMT) is a compensatory cognitive rehabilitation approach, addressing underlying deficits in sustained attention to improve executive function. GMT has received empirical support in studies of other patient groups. The purpose of the present study was to determine the efficacy of GMT in treating subjects with SB, using inpatient intervention periods. We hypothesized post-intervention changes in scores on neuropsychological measures to reflect improved attentional control, including sustained attention and inhibitory control. Thirty-eight adult subjects with SB were included in this randomized controlled trial. Inclusion was based upon the presence of executive functioning complaints. Experimental subjects (n = 24) received 21 hr of GMT, with efficacy of GMT being compared to results of subjects in a wait-list condition (n = 14). All subjects were assessed at baseline, post-intervention, and at 6-month follow-up. Findings indicated superior effects of GMT on domain-specific neuropsychological measures and on a functional "real-life" measure, all lasting at least 6 months post-treatment. These results show that deficits in executive functioning can be ameliorated in patients with congenital brain dysfunction.	[Stubberud, Jan; Stanghelle, Johan; Schanke, Anne-Kristine] Sunnaas Rehabil Hosp, N-1450 Nesoddtangen, Norway; [Langenbahn, Donna] NYU, Sch Med, Rusk Inst Rehabil Med, New York, NY USA; [Levine, Brian] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Levine, Brian] Univ Toronto, Dept Med, Toronto, ON, Canada; [Stanghelle, Johan] Univ Oslo, Dept Med, Oslo, Norway; [Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, Oslo, Norway		Stubberud, J (corresponding author), Sunnaas Rehabil Hosp, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway.	jan.stubberud@sunnaas.no	Levine, Brian/O-2725-2019; Stubberud, Jan/ABE-6922-2021; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Stubberud, Jan/0000-0001-9592-8589	South-Eastern Norway Regional Health Authority [2011041]	This work was supported by The South-Eastern Norway Regional Health Authority (grant number 2011041). The authors thank all patients, caregivers, and staff, especially Astri Andersen, Lisbeth Brondberg, Gunnar Riemer, Lena Haugen, Karen Grimsrud, Brede Dammann, Pal-Erik Plaum, Helene Barder, Per Frydenborg, and Solveig Skou who helped to carry out the study. We also thank Marianne Lovstad and Jan Egil Nordvik for the discussions concerning this study. The authors report no conflict of interest.	Alfonso JP, 2011, DRUG ALCOHOL DEPEN, V117, P78, DOI 10.1016/j.drugalcdep.2010.12.025; Andres P, 2003, CORTEX, V39, P871, DOI 10.1016/S0010-9452(08)70868-2; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Barkovich A.J., 2000, PAEDIAT NEUROIMAGING; Benedict R., 1997, BRIEF VISUOSPATIAL M; Blake DT, 2006, NEURON, V52, P371, DOI 10.1016/j.neuron.2006.08.009; Boelen DHE, 2011, J NEUROPSYCHOL, V5, P73, DOI 10.1348/174866410X516434; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Burmeister R, 2005, CHILD NEUROPSYCHOL, V11, P265, DOI 10.1080/092970490911324; Charney Edward B., 1992, P471; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 2013, STAT POWER ANAL BEHA; Conners CK, 2000, CONNERS CPT 2 CONTIN; Coull J. T., 1995, THESIS CAMBRIDGE U; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2006, J INT NEUROPSYCH SOC, V12, P285, DOI 10.1017/S1355617706060371; Dennis M, 2010, DEV DISABIL RES REV, V16, P31, DOI 10.1002/ddrr.89; Dumville JC, 2006, CONTEMP CLIN TRIALS, V27, P1, DOI 10.1016/j.cct.2005.08.003; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; Evans J, 2005, EFFECTIVENESS REHABI, P247; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fletcher JM, 2005, J NEUROSURG, V102, P268, DOI 10.3171/ped.2005.102.3.0268; Fletcher JM, 1996, DEV NEUROPSYCHOL, V12, P53, DOI 10.1080/87565649609540640; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gleichgerrcht E, 2010, J INT NEUROPSYCH SOC, V16, P687, DOI 10.1017/S1355617710000482; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Greene CM, 2009, NEUROPSYCHOLOGIA, V47, P591, DOI 10.1016/j.neuropsychologia.2008.10.003; Hampton LE, 2011, J NEUROSURG-PEDIATR, V8, P289, DOI 10.3171/2011.6.PEDS10584; Jackson JC, 2012, CRIT CARE MED, V40, P1088, DOI 10.1097/CCM.0b013e3182373115; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kelly NC, 2012, CHILD NEUROPSYCHOL, V18, P417, DOI 10.1080/09297049.2011.613814; Levaux M. N., 2012, CASE REPORTS PSYCHIA, V2012; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B., 2008, COGNITIVE NEUROREHAB, V2nd, P464, DOI [10.1017/CBO9781316529898.033, DOI 10.1017/CBO9781316529898.033]; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P258, DOI 10.1076/chin.8.4.258.13510; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; McDonnell GV, 2000, CHILD NERV SYST, V16, P222, DOI 10.1007/s003810050502; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Metzler-Baddeley C, 2010, APPL NEUROPSYCHOL, V17, P299, DOI 10.1080/09084282.2010.523394; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Norman D.A., 1986, CONSCIOUSNESS SELF R; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; O'Connell RG, 2009, J COGNITIVE NEUROSCI, V21, P93, DOI 10.1162/jocn.2009.21008; O'Connor C, 2011, NEUROPSYCHOLOGY, V25, P535, DOI 10.1037/a0022767; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Raz N, 2009, NEUROPSYCHOL REV, V19, P411, DOI 10.1007/s11065-009-9122-1; Reason J., 1990, HUMAN ERROR INTERNET, DOI DOI 10.1017/CBO9781139062367; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Robertson I., 1996, GOAL MANAGEMENT TRAI; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Roca M, 2008, MULT SCLER, V14, P364, DOI 10.1177/1352458507084270; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rose BM, 2007, J PEDIATR PSYCHOL, V32, P983, DOI 10.1093/jpepsy/jsm042; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Smith A, 1996, NATURE, V380, P291, DOI 10.1038/380291a0; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stubberud J, 2012, DISABIL REHABIL, V34, P740, DOI 10.3109/09638288.2011.619617; Stuss DT, 2007, J INT NEUROPSYCH SOC, V13, P120, DOI 10.1017/S1355617707070154; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Torralva T, 2013, J ATTEN DISORD, V17, P11, DOI 10.1177/1087054710389988; Tuminello ER, 2012, CHILD NEUROPSYCHOL, V18, P105, DOI 10.1080/09297049.2011.590470; van Hooren SAH, 2007, PATIENT EDUC COUNS, V65, P205, DOI 10.1016/j.pec.2006.07.010; Wechsler D., 1999, MANUAL WECHSLER ABBR; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilson BA, 2009, NEUROPSYCHOLOGICAL REHABILITATION: THEORY, MODELS, THERAPY AND OUTCOME, P1, DOI 10.1017/CBO9780511581083; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012	95	28	28	1	19	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2013	19	6					672	685		10.1017/S1355617713000209			14	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	170QY	WOS:000320869700006	23575309				2022-02-06	
J	Szymanski, CR; Chiha, W; Morellini, N; Cummins, N; Bartlett, CA; Doig, RLO; Savigni, DL; Payne, SC; Harvey, AR; Dunlop, SA; Fitzgerald, M				Szymanski, Charis R.; Chiha, Wissam; Morellini, Natalie; Cummins, Nadia; Bartlett, Carole A.; Doig, Ryan L. O'Hare; Savigni, Donna L.; Payne, Sophie C.; Harvey, Alan R.; Dunlop, Sarah A.; Fitzgerald, Melinda			Paranode Abnormalities and Oxidative Stress in Optic Nerve Vulnerable to Secondary Degeneration: Modulation by 670 nm Light Treatment	PLOS ONE			English	Article							SPINAL-CORD-INJURY; RETINAL GANGLION-CELLS; TRAUMATIC BRAIN-INJURY; CYTOCHROME-C-OXIDASE; NEAR-INFRARED LIGHT; REACTIVE OXYGEN; ABSORPTION-MEASUREMENTS; OLIGODENDROCYTES; CALCIUM; DEATH	Secondary degeneration of nerve tissue adjacent to a traumatic injury results in further loss of neurons, glia and function, via mechanisms that may involve oxidative stress. However, changes in indicators of oxidative stress have not yet been demonstrated in oligodendrocytes vulnerable to secondary degeneration in vivo. We show increases in the oxidative stress indicator carboxymethyl lysine at days 1 and 3 after injury in oligodendrocytes vulnerable to secondary degeneration. Dihydroethidium staining for superoxide is reduced, indicating endogenous control of this particular reactive species after injury. Concurrently, node of Ranvier/paranode complexes are altered, with significant lengthening of the paranodal gap and paranode as well as paranode disorganisation. Therapeutic administration of 670 nm light is thought to improve oxidative metabolism via mechanisms that may include increased activity of cytochrome c oxidase. Here, we show that light at 670 nm, delivered for 30 minutes per day, results in in vivo increases in cytochrome c oxidase activity co-localised with oligodendrocytes. Short term (1 day) 670 nm light treatment is associated with reductions in reactive species at the injury site. In optic nerve vulnerable to secondary degeneration superoxide in oligodendrocytes is reduced relative to handling controls, and is associated with reduced paranode abnormalities. Long term (3 month) administration of 670 nm light preserves retinal ganglion cells vulnerable to secondary degeneration and maintains visual function, as assessed by the optokinetic nystagmus visual reflex. Light at a wavelength of 670 nm may serve as a therapeutic intervention for treatment of secondary degeneration following neurotrauma.	[Szymanski, Charis R.; Chiha, Wissam; Morellini, Natalie; Cummins, Nadia; Bartlett, Carole A.; Doig, Ryan L. O'Hare; Savigni, Donna L.; Payne, Sophie C.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Harvey, Alan R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	lindy.fitzgerald@uwa.edu.au	Doig, Ryan O'Hare/AAG-7585-2019; Fitzgerald, Melinda/C-4235-2011; Dunlop, Sarah A/G-9357-2013	Fitzgerald, Melinda/0000-0002-4823-8179; Cummins, Nadia/0000-0002-4494-2345; Dunlop, Sarah/0000-0002-1306-3962; , Alan/0000-0002-2590-831X	Neurotrauma Research Program (Western Australia); National Health and Medical Research Council (NHMRC), AustraliaNational Health and Medical Research Council of Australia [572550]; NHMRC, AustraliaNational Health and Medical Research Council of Australia [APP1002347]	This work was supported by the Neurotrauma Research Program (Western Australia) and National Health and Medical Research Council (NH&MRC), Australia (Grant ID: 572550). Prof. Dunlop is a Principal Research Fellow of the NH&MRC, Australia (Grant ID: APP1002347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Back SA, 1998, J NEUROSCI, V18, P6241; Balabanov R, 2005, NAT NEUROSCI, V8, P262, DOI 10.1038/nn0305-262; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buttermore ED, 2011, J NEUROSCI, V31, P8013, DOI 10.1523/JNEUROSCI.1015-11.2011; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Chan YC, 2009, J PHARMACOL EXP THER, V329, P450, DOI 10.1124/jpet.108.148353; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; DANNENBERG AM, 1994, J LEUKOCYTE BIOL, V56, P436, DOI 10.1002/jlb.56.4.436; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Griselda CM, 2011, NEUROSCI BIOBEHAV R, V35, P1353, DOI 10.1016/j.neubiorev.2011.02.009; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Karu TI, 2008, PHOTOMED LASER SURG, V26, P593, DOI 10.1089/pho.2008.2246; Kitada M, 2006, GLIA, V54, P35, DOI 10.1002/glia.20354; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Komel'kova L V, 2004, Patol Fiziol Eksp Ter, P15; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li ZS, 2010, FEBS LETT, V584, P2291, DOI 10.1016/j.febslet.2010.03.040; McLellan ME, 2003, J NEUROSCI, V23, P2212; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nickells RW, 2004, BRAIN RES BULL, V62, P439, DOI 10.1016/j.brainresbull.2003.07.007; Othman A, 2011, GLIA, V59, P914, DOI 10.1002/glia.21163; Owusu-Ansah E, 2008, PROTOCOL IN VIVO DET; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Payne SC, 2012, INVEST OPHTHALMOL VI; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Reyes RC, 2012, J NEUROSCI, V32, P12973, DOI 10.1523/JNEUROSCI.1597-12.2012; Rinholm JE, 2012, NATURE, V487, P435, DOI 10.1038/487435a; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Rosenbluth J, 2009, J NEUROSCI RES, V87, P3250, DOI 10.1002/jnr.22013; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257; Saggu SK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-97; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Schlieve CR, 2006, INVEST OPHTH VIS SCI, V47, P3878, DOI 10.1167/iovs.05-1010; Sharikabad MN, 2001, AM J PHYSIOL-HEART C, V280, pH344, DOI 10.1152/ajpheart.2001.280.1.H344; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; Stemer Andrew B, 2010, Curr Cardiol Rep, V12, P29, DOI 10.1007/s11886-009-0071-3; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tretter L, 2007, J NEUROSCI RES, V85, P3471, DOI 10.1002/jnr.21405; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Wong-Riley MTT, 2001, NEUROREPORT, V12, P3033, DOI 10.1097/00001756-200110080-00011; Ziabreva I, 2010, GLIA, V58, P1827, DOI 10.1002/glia.21052	65	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66448	10.1371/journal.pone.0066448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	WOS:000322361200080	23840470	Green Published, gold, Green Submitted			2022-02-06	
J	Larimer, EL; Fallon, SC; Westfall, J; Frost, M; Wesson, DE; Naik-Mathuria, BJ				Larimer, Emily L.; Fallon, Sara C.; Westfall, Jaimee; Frost, Mary; Wesson, David E.; Naik-Mathuria, Bindi J.			The importance of surgeon involvement in the evaluation of non-accidental trauma patients	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pediatrics; Child Abuse; Non-accidental Trauma	CHILD-ABUSE; ABDOMINAL-TRAUMA; INJURIES	Introduction: Non-Accidental Trauma (NAT) is a significant cause of childhood morbidity and mortality, causing 50% of trauma-related deaths at our institution. Our purpose was to evaluate the necessity of primary surgical evaluation and admission to the trauma service for children presenting with NAT. Methods: We reviewed all NAT patients from 2007-2011. Injury types, demographic data, and hospitalization information were collected. Comparisons to accidental trauma (AT) patients were made using Wilcoxon rank sum and Student's t tests. Results: We identified 267 NAT patients presenting with 473 acute injuries. Injuries in NAT patients were more severe than in AT patients, and Injury Severity Scores, ICU admission rates, and mortality were all significantly (p < 0.001) higher. The majority suffered from polytrauma. Multiple areas of injury were seen in patients with closed head injuries (72%), extremity fractures (51%), rib fractures (82%), and abdominal/thoracic trauma (80%). Despite these complex injury patterns, only 56% received surgical consults, resulting in potential delays in diagnosis, as 24% of abdominal CT scans were obtained > 12 hours after hospitalization. Conclusion: Given the high incidence of polytrauma in NAT patients, prompt surgical evaluation is necessary to determine the scope of injury. Admission to the trauma service and a thorough tertiary survey should be considered for all patients. (c) 2013 Elsevier Inc. All rights reserved.	[Larimer, Emily L.; Fallon, Sara C.; Westfall, Jaimee; Frost, Mary; Wesson, David E.; Naik-Mathuria, Bindi J.] Baylor Coll Med, Div Pediat Surg, Texas Childrens Hosp Trauma Program, Michael E DeBakey Dept Surg, Houston, TX 77030 USA		Naik-Mathuria, BJ (corresponding author), Baylor Coll Med, Div Pediat Surg, Texas Childrens Hosp Trauma Program, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	bnaik@texaschildrens.org					Barnes PM, 2005, LANCET, V366, P234, DOI 10.1016/S0140-6736(05)66913-9; Berdon WE, 2012, CHILD ABUSE NEGLECT, V36, P200, DOI 10.1016/j.chiabu.2011.07.010; Bowkett B, 1998, AUST NZ J SURG, V68, P380, DOI 10.1111/j.1445-2197.1998.tb04779.x; Champion MP, 2002, ARCH DIS CHILD, V87, P432, DOI 10.1136/adc.87.5.432; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Forjuoh SN, 2000, CHILD ABUSE NEGLECT, V24, P1019, DOI 10.1016/S0145-2134(00)00163-0; Gipson CL, 2006, SOUTH MED J, V99, P536, DOI 10.1097/01.smj.0000216471.54786.e5; Lane WG, 2012, CHILD ABUSE NEGLECT, V36, P142, DOI 10.1016/j.chiabu.2011.09.010; Lane WG, 2011, PEDIATRICS, V127; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; Roaten JB, 2005, AM J SURG, V190, P827, DOI 10.1016/j.amjsurg.2005.05.049; Sagar M, 2012, PEDIATR EMERG CARE, V28, P61, DOI 10.1097/PEC.0b013e3182417a77; TRACY T, 1993, AM SURGEON, V59, P342; Trokel M, 2006, PEDIATR EMERG CARE, V22, P700, DOI 10.1097/01.pec.0000238734.76413.d0	16	28	28	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468			J PEDIATR SURG	J. Pediatr. Surg.	JUN	2013	48	6					1357	1362		10.1016/j.jpedsurg.2013.03.035			6	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Surgery	187YW	WOS:000322158600038	23845630				2022-02-06	
J	Al-Ali, H; Schurer, SC; Lemmon, VP; Bixby, JL				Al-Ali, Hassan; Schuerer, Stephan C.; Lemmon, Vance P.; Bixby, John L.			Chemical Interrogation of the Neuronal Kinome Using a Primary Cell-Based Screening Assay	ACS CHEMICAL BIOLOGY			English	Article							CHONDROITIN SULFATE PROTEOGLYCANS; NEURITE OUTGROWTH; AXONAL GROWTH; KINASE INHIBITORS; RHOA-KINASE; MYOSIN-II; REGENERATION; RETRACTION; CNS; PHOSPHORYLATION	A fundamental impediment to functional recovery from spinal cord injury (SCI) and traumatic brain injury is the lack of sufficient axonal regeneration in the adult central nervous system. There is thus a need to develop agents that can stimulate axon growth to re-establish severed connections. Given the critical role played by protein kinases in regulating axon growth and the potential for pharmacological intervention, small molecule protein kinase inhibitors present a promising therapeutic strategy. Here, we report a robust cell-based phenotypic assay, utilizing primary rat hippocampal neurons, for identifying small molecule kinase inhibitors that promote neurite growth. The assay is highly reliable and suitable for medium-throughput screening, as indicated by its Z'-factor of 0.73. A focused structurally diverse library of protein kinase inhibitors was screened, revealing several compound groups with the ability to strongly and consistently promote neurite growth. The best performing bioassay hit robustly and consistently promoted axon growth in a postnatal cortical slice culture assay. This study can serve as a jumping-off point for structure activity relationship (SAR) and other drug discovery approaches toward the development of drugs for treating SCI and related neurological pathologies.	[Al-Ali, Hassan; Lemmon, Vance P.; Bixby, John L.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Schuerer, Stephan C.; Lemmon, Vance P.; Bixby, John L.] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA; [Lemmon, Vance P.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; [Schuerer, Stephan C.; Bixby, John L.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA		Lemmon, VP (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	vlemmon@med.miami.edu; jbixby@med.miami.edu	Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576; Bixby, John/0000-0003-1633-5318; Al-Ali, Hassan/0000-0002-8899-3443	James and Esther King Biomedical Research Program [JEK09KW-05]; U.S ArmyUnited States Department of Defense [W81XWH-05-1-0061]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD057521, NS059866]; Buoniconti Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS059866] Funding Source: NIH RePORTER	We thank current and former members of the LemBix laboratory for assisting with several steps of this project, especially Y. Shi with the HCA, A. Oliva and T. Slepak with the primary cell culture, and Y. Martinez with the slice cultures. We acknowledge resources from the Center for Computational Science. V.P.L. holds the Walter G Ross Distinguished Chair in Developmental Neuroscience. We thank P. Hong at Brandeis University for providing guidance and executables for the neurite extraction software. This work was supported by grants from the James and Esther King Biomedical Research Program JEK09KW-05 (JLB), the U.S Army W81XWH-05-1-0061 (V.P.L., J.L.B.), the National Institutes of Health [HD057521 (V.P.L.), NS059866 (J.L.B.)], and the Buoniconti Fund.	Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Alabed YZ, 2010, J NEUROSCI, V30, P5635, DOI 10.1523/JNEUROSCI.6154-09.2010; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BIXBY JL, 1992, J NEUROBIOL, V23, P468, DOI 10.1002/neu.480230503; BIXBY JL, 1989, NEURON, V3, P287, DOI 10.1016/0896-6273(89)90253-5; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Buchser WJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.52; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Diez H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032715; Dimitropoulou A, 2005, MOL CELL NEUROSCI, V28, P292, DOI 10.1016/j.mcn.2004.09.013; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Duffy P, 2009, J NEUROSCI, V29, P15266, DOI 10.1523/JNEUROSCI.4650-09.2009; Feng YB, 2008, J MED CHEM, V51, P6642, DOI 10.1021/jm800986w; Fischer M, 2009, MOL CELL NEUROSCI, V42, P134, DOI 10.1016/j.mcn.2009.06.006; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Gallo G, 2002, J CELL BIOL, V158, P1219, DOI 10.1083/jcb.200204140; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Gopalakrishnan SM, 2008, J NEUROSCI RES, V86, P2214, DOI 10.1002/jnr.21671; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Klebl BM, 2005, EXPERT OPIN THER TAR, V9, P975, DOI 10.1517/14728222.9.5.975; Lee Jae-Hyuk, 2011, Chonnam Med J, V47, P27, DOI 10.4068/cmj.2011.47.1.27; Lerch JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030417; Lie M, 2010, NEUROSCIENCE, V169, P855, DOI 10.1016/j.neuroscience.2010.05.020; Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Loudon RR, 2006, J NEUROBIOL, V66, P847, DOI 10.1002/neu.20258; Michaelevski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000952; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pettus LH, 2008, CURR TOP MED CHEM, V8, P1452, DOI 10.2174/156802608786264245; Samara C, 2010, P NATL ACAD SCI USA, V107, P18342, DOI 10.1073/pnas.1005372107; Sato K, 1997, BIOCHEM BIOPH RES CO, V240, P329, DOI 10.1006/bbrc.1997.7666; Schmidt JT, 2002, J NEUROBIOL, V52, P175, DOI 10.1002/neu.10083; Schurer SC, 2013, J CHEM INF MODEL, V53, P27, DOI 10.1021/ci300403k; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Wang PY, 2001, AM J PHYSIOL-LUNG C, V281, pL1472, DOI 10.1152/ajplung.2001.281.6.L1472; Wu CH, 2010, NEUROINFORMATICS, V8, P83, DOI 10.1007/s12021-010-9067-9; Yoshimura K, 2011, NEUROSCI RES, V71, P266, DOI 10.1016/j.neures.2011.07.1830; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	47	28	29	0	14	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1554-8929	1554-8937		ACS CHEM BIOL	ACS Chem. Biol.	MAY	2013	8	5					1027	1036		10.1021/cb300584e			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	155BP	WOS:000319720700022	23480631	Green Accepted, Green Published			2022-02-06	
J	Gerretsen, P; Chakravarty, MM; Mamo, D; Menon, M; Pollock, BG; Rajji, TK; Graff-Guerrero, A				Gerretsen, Philip; Chakravarty, M. Mallar; Mamo, David; Menon, Mahesh; Pollock, Bruce G.; Rajji, Tarek K.; Graff-Guerrero, Ariel			Frontotemporoparietal asymmetry and lack of illness awareness in schizophrenia	HUMAN BRAIN MAPPING			English	Article						schizophrenia; insight; anosognosia; illness awareness; VBM; deformation-based analysis	VOXEL-BASED MORPHOMETRY; PREFRONTAL CORTEX; HUMAN-BRAIN; INSIGHT; PSYCHOSIS; MATTER; LATERALIZATION; SEGMENTATION; REGISTRATION; UNAWARENESS	Introduction: Lack of illness awareness or anosognosia occurs in both schizophrenia and right hemisphere lesions due to stroke, dementia, and traumatic brain injury. In the latter conditions, anosognosia is thought to arise from unilateral hemispheric dysfunction or interhemispheric disequilibrium, which provides an anatomical model for exploring illness unawareness in other neuropsychiatric disorders, such as schizophrenia. Methods: Both voxel-based morphometry using Diffeomorphic Anatomical Registration through Exponentiated Lie Algebra (DARTEL) and a deformation-based morphology analysis of hemispheric asymmetry were performed on 52 treated schizophrenia subjects, exploring the relationship between illness awareness and gray matter volume. Analyses included age, gender, and total intracranial volume as covariates. Results: Hemispheric asymmetry analyses revealed illness unawareness was significantly associated with right < left hemisphere volumes in the anteroinferior temporal lobe (t = 4.83, P = 0.051) using DARTEL, and the dorsolateral prefrontal cortex (t = 5.80, P = 0.003) and parietal lobe (t = 4.3, P = 0.050) using the deformation-based approach. Trend level associations were identified in the right medial prefrontal cortex (t = 4.49, P = 0.127) using DARTEL. Lack of illness awareness was also strongly associated with reduced total white matter volume (r = 0.401, P < 0.01) and illness severity (r = 0.559, P < 0.01). Conclusion: These results suggest a relationship between anosognosia and hemispheric asymmetry in schizophrenia, supporting previous volume-based MRI studies in schizophrenia that found a relationship between illness unawareness and reduced right hemisphere gray matter volume. Functional imaging studies are required to examine the neural mechanisms contributing to these structural observations. Hum Brain Mapp, 2013. (c) 2012 Wiley Periodicals, Inc.	[Gerretsen, Philip; Mamo, David; Menon, Mahesh; Graff-Guerrero, Ariel] Ctr Addict & Mental Hlth, Multimodal Imaging Grp, Toronto, ON, Canada; [Gerretsen, Philip; Mamo, David; Pollock, Bruce G.; Rajji, Tarek K.] Ctr Addict & Mental Hlth, Geriatr Mental Hlth Program, Toronto, ON, Canada; [Gerretsen, Philip; Mamo, David; Menon, Mahesh; Pollock, Bruce G.; Rajji, Tarek K.; Graff-Guerrero, Ariel] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Chakravarty, M. Mallar] Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Chakravarty, M. Mallar] Hosp Sick Children, Mouse Imaging Ctr MICe, Toronto, ON M5G 1X8, Canada; [Menon, Mahesh; Graff-Guerrero, Ariel] Ctr Addict & Mental Hlth, Schizophrenia Program, Toronto, ON, Canada		Graff-Guerrero, A (corresponding author), PET Ctr, CAMH Multimodal Imaging Grp, 250 Coll St, Toronto, ON M5T 1R8, Canada.	ariel_graff@camh.net	Rajji, Tarek K/K-1543-2015	Gerretsen, Philip/0000-0003-4053-6814	Bristol-Myers SquibbBristol-Myers Squibb; Grants Health Research, Clinician Scientist Program; Department of Psychiatry, University of Toronto	Contract grant sponsors: Bristol-Myers Squibb (DM); Grants Health Research, Clinician Scientist Program; Department of Psychiatry, University of Toronto.	AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826; APM, 2000, DIAGN STAT MAN MENT; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Babinski J.F.F., 1914, REV NEUROL, DOI [DOI 10.1016/J.CORTEX.2014.04.019, 10.1016/j.cortex.2014.04.019]; Basch M., 1988, UNDERSTANDING PSYCHO; Bassitt DP, 2007, EUR ARCH PSY CLIN N, V257, P58, DOI 10.1007/s00406-006-0685-z; Berge D, 2011, ACTA PSYCHIAT SCAND, V123, P431, DOI 10.1111/j.1600-0447.2010.01635.x; BIRCHWOOD M, 1994, ACTA PSYCHIAT SCAND, V89, P62, DOI 10.1111/j.1600-0447.1994.tb01487.x; Buckley PF, 2007, CNS DRUGS, V21, P129, DOI 10.2165/00023210-200721020-00004; Chakravarty MM, 2009, HUM BRAIN MAPP, V30, P3574, DOI 10.1002/hbm.20780; Chung MK, 2001, NEUROIMAGE, V14, P595, DOI 10.1006/nimg.2001.0862; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Cooke MA, 2008, SCHIZOPHR RES, V103, P40, DOI 10.1016/j.schres.2008.04.022; Cuesta MJ, 2000, BRIT J PSYCHIAT, V177, P233, DOI 10.1192/bjp.177.3.233; DAVID AS, 1990, BRIT J PSYCHIAT, V156, P798, DOI 10.1192/bjp.156.6.798; Drake RJ, 2007, J CLIN PSYCHIAT, V68, P81, DOI 10.4088/JCP.v68n0111; Flashman LA, 2001, J NEUROPSYCH CLIN N, V13, P255, DOI 10.1176/appi.neuropsych.13.2.255; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; GLICK SD, 1982, BRAIN RES, V234, P53, DOI 10.1016/0006-8993(82)90472-3; Grabner G, 2006, LECT NOTES COMPUT SC, V4191, P58; Henley SMD, 2010, AM J NEURORADIOL, V31, P711, DOI 10.3174/ajnr.A1939; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Hugdahl K, 2000, ACTA PSYCHOL, V105, P211, DOI 10.1016/S0001-6918(00)00062-7; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kemp R, 1996, BRIT J PSYCHIAT, V169, P444, DOI 10.1192/bjp.169.4.444; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; MCEVOY JP, 1989, J NERV MENT DIS, V177, P43, DOI 10.1097/00005053-198901000-00007; Mohamed S, 2009, SCHIZOPHRENIA BULL, V35, P336, DOI 10.1093/schbul/sbn067; Morgan KD, 2010, BRIT J PSYCHIAT, V197, P141, DOI 10.1192/bjp.bp.109.070888; Oertel-Knochel V, 2011, NEUROSCIENTIST; OKE A, 1978, SCIENCE, V200, P1411, DOI 10.1126/science.663623; Olfson M, 2006, PSYCHIAT SERV, V57, P205, DOI 10.1176/appi.ps.57.2.205; Orfei MD, 2008, NEUROSCIENTIST, V14, P203, DOI 10.1177/1073858407309995; Pallanti S, 1999, PSYCHIAT RES, V86, P239, DOI 10.1016/S0165-1781(99)00033-5; Parellada M, 2011, SCHIZOPHRENIA BULL, V37, P38, DOI 10.1093/schbul/sbq109; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Ramachandran VS, 2007, MED HYPOTHESES, V69, P486, DOI 10.1016/j.mehy.2006.12.036; RAMACHANDRAN VS, 1995, CONSCIOUS COGN, V4, P22, DOI 10.1006/ccog.1995.1002; Robbins S, 2004, MED IMAGE ANAL, V8, P311, DOI 10.1016/j.media.2004.06.009; Sanz M, 1998, PSYCHOL MED, V28, P437, DOI 10.1017/S0033291797006296; Sapara A, 2007, SCHIZOPHR RES, V89, P22, DOI 10.1016/j.schres.2006.09.016; Shad MU, 2006, PSYCHIAT RES-NEUROIM, V146, P35, DOI 10.1016/j.pscychresns.2005.11.001; Shad MU, 2004, NEUROIMAGE, V22, P1315, DOI 10.1016/j.neuroimage.2004.03.016; Shad MU, 2007, INT REV PSYCHIATR, V19, P439, DOI 10.1080/09540260701486324; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spalletta G, 2003, SCHIZOPHR RES, V64, P15, DOI 10.1016/S0920-9964(03)00010-0; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tsang O, 2008, IEEE ENG MED BIO, P3924, DOI 10.1109/IEMBS.2008.4650068; TUCKER DM, 1984, PSYCHOL REV, V91, P185, DOI 10.1037/0033-295X.91.2.185; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; WAGNER HN, 1983, SCIENCE, V221, P1264, DOI 10.1126/science.6604315; White T, 2001, NEUROIMAGE, V13, P577, DOI 10.1006/nimg.2000.0716; Wilke M, 2003, NEUROIMAGE, V20, P330, DOI 10.1016/S1053-8119(03)00296-9; Worsley KJ, 2002, NEUROIMAGE, V15, P1, DOI 10.1006/nimg.2001.0933	58	28	29	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	MAY	2013	34	5					1035	1043		10.1002/hbm.21490			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	122DT	WOS:000317297500004	22213454	Green Published			2022-02-06	
J	Marcano, DC; Bitner, BR; Berlin, JM; Jarjour, J; Lee, JM; Jacob, A; Fabian, RH; Kent, TA; Tour, JM				Marcano, Daniela C.; Bitner, Brittany R.; Berlin, Jacob M.; Jarjour, Jane; Lee, Juhye M.; Jacob, Aakash; Fabian, Roderic H.; Kent, Thomas A.; Tour, James M.			Design of Poly(ethylene Glycol)-Functionalized Hydrophilic Carbon Clusters for Targeted Therapy of Cerebrovascular Dysfunction in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						antioxidants; in vitro; mildTBI; P-selectin; targeted drug delivery; vascular dysfunction	ABSORBENCY CAPACITY ASSAY; HYDROGEN-PEROXIDE; DRUG-DELIVERY; HEAD-INJURY; ANTIOXIDANT CAPACITY; ENDOTHELIAL-CELLS; HYDROXYL RADICALS; OXIDATIVE STRESS; CATALYTIC METALS; IRON COMPLEXES	Traumatic brain injury (TBI) involves the elaboration of oxidative stress that causes cerebrovascular dysfunction, including impairment of autoregulation of cerebral blood flow. Currently, there is no clinically effective antioxidant treatment for these pathologies. Most currently available antioxidants act through mechanisms in which the antioxidant either transfers the radical or requires regeneration, both of which are impaired in the toxic post-TBI environment. We previously reported that single-walled carbon nanotubes (SWCNTs) and ultrashort SWCNTs possess antioxidant activity, and their characteristics suggest that radical annihilation is the major mechanism. We have now developed a biologically compatible class of carbon-based nanovectors, poly(ethylene glycol)-functionalized hydrophilic carbon clusters (PEG-HCCs) that can be further functionalized with antibodies, and hence show promise as targeted drug delivery platforms. Here we report that PEG-HCCs possess innate antioxidant activity and can be rapidly targeted via an antibody to the P-selectin antigen in a model of injured cultured brain endothelial cells. One immediate application of this therapy is to vascular dysfunction that accompanies TBI and worsens outcome in the face of systemic hypotension. These in vitro results support the need for further investigation in animal models.	[Marcano, Daniela C.; Berlin, Jacob M.; Jarjour, Jane; Lee, Juhye M.; Jacob, Aakash; Tour, James M.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Marcano, Daniela C.; Berlin, Jacob M.; Tour, James M.] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA; [Bitner, Brittany R.; Kent, Thomas A.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Bitner, Brittany R.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Fabian, Roderic H.; Kent, Thomas A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Fabian, Roderic H.; Kent, Thomas A.] Michael E DeBakey VA Med Ctr, Houston, TX USA		Tour, JM (corresponding author), Rice Univ, Dept Chem, 6100 Main St MS222, Houston, TX 77005 USA.	tkent@bcm.edu; tour@rice.edu	Nanozymes, Nanozymes/D-8197-2019	Lee, Juhye/0000-0002-8133-2562; Kent, Thomas/0000-0002-9877-7584; Marcano, Daniela C./0000-0002-3446-8010; Tour, James/0000-0002-8479-9328	Alliance for NanoHealth through University of Texas Health Science Center, Houston (Department of Defense) [W8XWH-09-2-0139]; Traumatic Brain Injury Consortium; United States ArmyUnited States Department of Defense [W81XWH-08-2-0141, W81XWH-08-2-0143]; Nanoscale Science and Engineering Initiative of the National Science Foundation (NSF) through the NSF Center for Biological and Environmental NanotechnologyNational Science Foundation (NSF) [EEC-0647452]	Funding came from the Alliance for NanoHealth through a subcontract from the University of Texas Health Science Center, Houston (Department of Defense, W8XWH-09-2-0139); the Traumatic Brain Injury Consortium, funded by the United States Army (W81XWH-08-2-0141 and W81XWH-08-2-0143); and the Nanoscale Science and Engineering Initiative of the National Science Foundation (NSF) under NSF Award EEC-0647452 for funding through the NSF Center for Biological and Environmental Nanotechnology.	Alconcel SNS, 2011, POLYM CHEM-UK, V2, P1442, DOI 10.1039/c1py00034a; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; BAKER MS, 1984, ARCH BIOCHEM BIOPHYS, V234, P258, DOI 10.1016/0003-9861(84)90348-5; Barz M, 2011, POLYM CHEM-UK, V2, P1900, DOI 10.1039/c0py00406e; Berlin JM, 2011, ACS NANO, V5, P6643, DOI 10.1021/nn2021293; Berlin JM, 2010, ACS NANO, V4, P4621, DOI 10.1021/nn100975c; Bernhardt PV, 2003, J BIOL INORG CHEM, V8, P866, DOI 10.1007/s00775-003-0486-z; Buettner G.R., 1985, FREE RADICAL RES COM, V1, P349; BUETTNER GR, 1988, J BIOCHEM BIOPH METH, V16, P27, DOI 10.1016/0165-022X(88)90100-5; Buettner GR, 1996, RADIAT RES, V145, P532, DOI 10.2307/3579271; CAO GH, 1993, FREE RADICAL BIO MED, V14, P303, DOI 10.1016/0891-5849(93)90027-R; Chen ZY, 2006, J AM CHEM SOC, V128, P10568, DOI 10.1021/ja063283p; DEAN RT, 1994, FREE RADICAL RES, V20, P83, DOI 10.3109/10715769409147506; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Duncan R, 2011, CURR OPIN BIOTECH, V22, P492, DOI 10.1016/j.copbio.2011.05.507; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; Freeman LR, 2012, BBA-MOL BASIS DIS, V1822, P822, DOI 10.1016/j.bbadis.2011.12.009; Gillespie KM, 2007, NAT PROTOC, V2, P867, DOI 10.1038/nprot.2007.100; GLAZER AN, 1990, METHOD ENZYMOL, V186, P161; Golding EA, 2003, J CEREBR BLOOD F MET, V23, P210, DOI 10.1097/01.WCB.0000044739.64940.B5; Grady MS, 1999, J NEUROTRAUM, V16, P13, DOI 10.1089/neu.1999.16.13; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Han YH, 2008, ONCOL REP, V20, P689, DOI 10.3892/or_00000061; Haseneder R, 2007, WATER SCI TECHNOL, V55, P83, DOI 10.2166/wst.2007.391; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]; Kent T.A., 2011, 25 INT S CER BLOOD F; Kerem Z, 1998, P NATL ACAD SCI USA, V95, P10373, DOI 10.1073/pnas.95.18.10373; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Kocha T, 1997, BBA-PROTEIN STRUCT M, V1337, P319, DOI 10.1016/S0167-4838(96)00180-X; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Koob AO, 2005, J NEUROTRAUM, V22, P1092, DOI 10.1089/neu.2005.22.1092; Liu-Snyder P, 2007, J EXP BIOL, V210, P1455, DOI 10.1242/jeb.02756; Lucas-Abellan C, 2011, FOOD CHEM TOXICOL, V49, P1255, DOI 10.1016/j.fct.2011.03.004; Lucente-Schultz RM, 2009, J AM CHEM SOC, V131, P3934, DOI 10.1021/ja805721p; Malhotra R, 2011, AM J PHYSIOL-HEART C, V300, pH1733, DOI 10.1152/ajpheart.01054.2010; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Potts Mathew B, 2006, NeuroRx, V3, P143; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Price BK, 2009, CHEM MATER, V21, P3917, DOI 10.1021/cm9021613; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Rigg JL, 2005, J HEAD TRAUMA REHAB, V20, P389, DOI 10.1097/00001199-200507000-00010; Robertson CS, 2012, J NEUROTRAUM, V29, P1156, DOI 10.1089/neu.2011.1827; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Wei Y, 2007, ANGEW CHEM INT EDIT, V46, P4722, DOI 10.1002/anie.200604859; Whalen MJ, 2000, J LEUKOCYTE BIOL, V67, P160, DOI 10.1002/jlb.67.2.160; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zulueta A, 2009, FOOD CHEM, V114, P310, DOI 10.1016/j.foodchem.2008.09.033	57	28	28	0	28	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2013	30	9			SI		789	796		10.1089/neu.2011.2301			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	145BJ	WOS:000318987600010	22928502				2022-02-06	
J	Ferguson, M; Bianchi, MT; Sutter, R; Rosenthal, ES; Cash, SS; Kaplan, PW; Westover, MB				Ferguson, Matthew; Bianchi, Matt T.; Sutter, Raoul; Rosenthal, Eric S.; Cash, Sydney S.; Kaplan, Peter W.; Westover, M. Brandon			Calculating the Risk Benefit Equation for Aggressive Treatment of Non-convulsive Status Epilepticus	NEUROCRITICAL CARE			English	Article						Non-convulsive status epilepticus; Risk benefit analysis; NCSE; Decision analysis	REFRACTORY STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; CONVULSIVE STATUS EPILEPTICUS; QUALITY-OF-LIFE; INTRACEREBRAL HEMORRHAGE; ABSENCE STATUS; ELECTROGRAPHIC SEIZURES; HOSPITAL MORTALITY; CRITICALLY-ILL	To address the question: does non-convulsive status epilepticus warrant the same aggressive treatment as convulsive status epilepticus? We used a decision model to evaluate the risks and benefits of treating non-convulsive status epilepticus with intravenous anesthetics and ICU-level aggressive care. We investigated how the decision to use aggressive versus non-aggressive management for non-convulsive status epilepticus impacts expected patient outcome for four etiologies: absence epilepsy, discontinued antiepileptic drugs, intraparenchymal hemorrhage, and hypoxic ischemic encephalopathy. Each etiology was defined by distinct values for five key parameters: baseline mortality rate of the inciting etiology; efficacy of non-aggressive treatment in gaining control of seizures; the relative contribution of seizures to overall mortality; the degree of excess disability expected in the case of delayed seizure control; and the mortality risk of aggressive treatment. Non-aggressive treatment was favored for etiologies with low morbidity and mortality such as absence epilepsy and discontinued antiepileptic drugs. The risk of aggressive treatment was only warranted in etiologies where there was significant risk of seizure-induced neurologic damage. In the case of post-anoxic status epilepticus, expected outcomes were poor regardless of the treatment chosen. The favored strategy in each case was determined by strong interactions of all five model parameters. Determination of the optimal management approach to non-convulsive status epilepticus is complex and is ultimately determined by the inciting etiology.	[Ferguson, Matthew; Bianchi, Matt T.; Rosenthal, Eric S.; Cash, Sydney S.; Westover, M. Brandon] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sutter, Raoul] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Div Neurosci Crit Care, Baltimore, MD 21205 USA; [Sutter, Raoul; Kaplan, Peter W.] Johns Hopkins Bayview Med Ctr, Dept Neurol, Baltimore, MD USA; [Westover, M. Brandon] Massachusetts Gen Hosp, Boston, MA 02114 USA		Westover, MB (corresponding author), Massachusetts Gen Hosp, Wang 7 Neurol,55 Fruit St, Boston, MA 02114 USA.	gferguson1212@gmail.com; mtbianchi@partners.org; rsutter3@jhmi.edu; erosenthal@partners.org; pkaplan@jhmi.edu; mb.westover@gmail.com	Rosenthal, Eric Scott/A-2085-2017; Raoul Christian Sutter/J-7747-2019	Rosenthal, Eric Scott/0000-0003-3900-356X; Raoul Christian Sutter/0000-0002-6575-356X	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS062092]; American Brain Foundation; National Center for Research Resources: Harvard Clinical and Translational Science CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); Center for Integration of Medicine and Innovative Technology (CIMIT); NIH/NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [5U54EB007954-04]; Department of DefenseUnited States Department of Defense [W81XWH-08-2-0154]; Andrew David Heitman Neuroendovascular Research Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB007954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS062092] Funding Source: NIH RePORTER	MBW receives research support from the NIH/NINDS (NS062092) and American Brain Foundation. MTB receives research support from the National Center for Research Resources: Harvard Clinical and Translational Science Center and the Center for Integration of Medicine and Innovative Technology (CIMIT). ESR receives research support from the Center for Integration of Medicine and Innovative Technology (CIMIT), the NIH/NIBIB (5U54EB007954-04), the Department of Defense (W81XWH-08-2-0154), and the Andrew David Heitman Neuroendovascular Research Foundation.	Agathonikou A, 1998, EPILEPSIA, V39, P1265, DOI 10.1111/j.1528-1157.1998.tb01324.x; Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; Alvarez V, 2012, EPILEPSIA, V53, pe89, DOI 10.1111/j.1528-1167.2012.03451.x; Aminoff MJ, 1998, ARCH NEUROL-CHICAGO, V55, P119, DOI 10.1001/archneur.55.1.119; ANDERMANN F, 1972, EPILEPSIA, V13, P177, DOI 10.1111/j.1528-1157.1972.tb04565.x; Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Anon JM, 2012, MED INTENSIVA; BAYLIFF CD, 1985, CLIN PHARMACOL THER, V38, P457, DOI 10.1038/clpt.1985.204; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2002, EPILEPSIA, V43, P146, DOI 10.1046/j.1528-1157.2002.28501.x; Claassen J, 2002, NEUROLOGY, V58, P139, DOI 10.1212/WNL.58.1.139; Cooper AD, 2009, ARCH NEUROL-CHICAGO, V66, P1505, DOI 10.1001/archneurol.2009.273; Cordato DJ, 1999, ANESTHESIOLOGY, V91, P1693, DOI 10.1097/00000542-199912000-00022; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; DeGiorgio CM, 1999, NEUROLOGY, V52, P746, DOI 10.1212/WNL.52.4.746; Delanty N, 2001, SEIZURE-EUR J EPILEP, V10, P116, DOI 10.1053/seiz.2000.0482; DeLorenzo RJ, 1999, EPILEPSIA, V40, P164, DOI 10.1111/j.1528-1157.1999.tb02070.x; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Dennis LJ, 2002, NEUROSURGERY, V51, P1136, DOI 10.1097/00006123-200211000-00006; Drislane FW, 2008, J CLIN NEUROPHYSIOL, V25, P181, DOI 10.1097/WNP.0b013e31817be70e; Drislane FW, 2009, EPILEPSIA, V50, P1566, DOI 10.1111/j.1528-1167.2008.01993.x; Eckman MH, 2003, STROKE, V34, P1710, DOI 10.1161/01.STR.0000078311.18928.16; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Foreman B, 2012, NEUROL CLIN, V30, P11, DOI 10.1016/j.ncl.2011.09.005; Forster AJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-259; Fuchs L, 2012, INTENSIVE CARE MED; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Garrouste-Orgeas M, 2010, AM J RESP CRIT CARE, V181, P134, DOI 10.1164/rccm.200812-1820OC; GOKYIGIT A, 1995, EPILEPSIA, V36, P210, DOI 10.1111/j.1528-1157.1995.tb00982.x; Grundmann H, 2005, CRIT CARE MED, V33, P946, DOI 10.1097/01.CCM.0000163223.26234.56; Guerrini R, 2004, AICARDIS EPILEPSY CH; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Jordan KG, 2006, EPILEPSIA, V47, P41, DOI 10.1111/j.1528-1167.2006.00659.x; Kaplan PW, 1999, J CLIN NEUROPHYSIOL, V16, P341, DOI 10.1097/00004691-199907000-00006; Kaplan PW, 2000, NEUROPHYSIOL CLIN, V30, P377, DOI 10.1016/S0987-7053(00)00238-0; Kosty J, 2012, J NEUROTRAUM, V29, P1322, DOI 10.1089/neu.2011.2222; Koubeissi M, 2007, NEUROLOGY, V69, P886, DOI 10.1212/01.wnl.0000269791.96189.70; KRESS HG, 1987, ANAESTHESIST, V36, P356; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; Mayer SA, 2002, ARCH NEUROL-CHICAGO, V59, P205, DOI 10.1001/archneur.59.2.205; Meierkord H, 2006, EUR J NEUROL, V13, P445, DOI 10.1111/j.1468-1331.2006.01397.x; Meldrum BS, 2002, PROG BRAIN RES, V135, P3; Naidech AM, 2009, NEUROCRIT CARE, V10, P11, DOI 10.1007/s12028-008-9148-x; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; Novy J, 2010, EPILEPSIA, V51, P251, DOI 10.1111/j.1528-1167.2009.02323.x; Oddo M, 2011, CURR OPIN CRIT CARE, V17, P254, DOI 10.1097/MCC.0b013e328344f2ae; Oddo M, 2009, CRIT CARE MED, V37, P2051, DOI 10.1097/CCM.0b013e3181a00604; Panayiotopoulos C., 2005, EPILEPSIES SEIZURES; Rossetti AO, 2007, NEUROLOGY, V69, P255, DOI 10.1212/01.wnl.0000265819.36639.e0; Rossetti AO, 2007, EPILEPSIA, V48, P52, DOI 10.1111/j.1528-1167.2007.01350.x; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Rossetti AO, 2008, J NEUROL, V255, P1561, DOI 10.1007/s00415-008-0989-1; Rossetti AO, 2005, ARCH NEUROL-CHICAGO, V62, P1698, DOI 10.1001/archneur.62.11.1698; Rost NS, 2008, STROKE, V39, P2304, DOI 10.1161/STROKEAHA.107.512202; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Shirasaka Y, 2002, EPILEPSIA, V43, P1498, DOI 10.1046/j.1528-1157.2002.10502.x; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; Shorvon S, 2005, EPILEPSIA, V46, P73, DOI 10.1111/j.1528-1167.2005.00316.x; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Vignatelli L, 2008, J NEUROL, V255, P197, DOI 10.1007/s00415-008-0635-y; Waterhouse EJ, 1998, EPILEPSY RES, V29, P175, DOI 10.1016/S0920-1211(97)00071-5; Waterhouse EJ, 1999, EPILEPSIA, V40, P752, DOI 10.1111/j.1528-1157.1999.tb00774.x; Westover MB, 2011, ARCH NEUROL-CHICAGO, V68, P573, DOI 10.1001/archneurol.2010.356; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wunsch H, 2012, CHEST, V141, P1393, DOI 10.1378/chest.11-2819; Young GB, 2010, NEUROLOGY, V75, P760, DOI 10.1212/WNL.0b013e3181f32141; Young GB, 1998, ARCH NEUROL-CHICAGO, V55, P117, DOI 10.1001/archneur.55.1.117; Young GB, 1996, NEUROLOGY, V47, P83	78	28	29	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2013	18	2					216	227		10.1007/s12028-012-9785-y			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	105PR	WOS:000316084700009	23065689	Green Accepted			2022-02-06	
J	Guyette, FX; Farrell, K; Carlson, JN; Callaway, CW; Phrampus, P				Guyette, Francis X.; Farrell, Kathryn; Carlson, Jestin N.; Callaway, Clifton W.; Phrampus, Paul			COMPARISON OF VIDEO LARYNGOSCOPY AND DIRECT LARYNGOSCOPY IN A CRITICAL CARE TRANSPORT SERVICE	PREHOSPITAL EMERGENCY CARE			English	Article						prehospital; intubation; video laryngocopy; HEMS	HOSPITAL ENDOTRACHEAL INTUBATION; TRAUMATIC BRAIN-INJURY; TRACHEAL INTUBATION; AIRWAY MANAGEMENT; VIDEOLARYNGOSCOPE; GLIDESCOPE(R); METAANALYSIS; PREDICTORS; SUCCESS	Objective. We evaluated video laryngoscopy (VL) (C-MAC, Karl Storz, Tuttlingen, Germany) for use in a critical care transport system. We hypothesized that the total number of airway attempts would decrease when using a video laryngoscope versus use of direct laryngoscopy (DL). Methods. We performed a nonrandomized group-controlled trial where six aircraft were outfitted with VL and the remainder utilized DL responding to a mix of scene runs and interfacility transports. Our primary outcome measure was the number of intubation attempts. We also compared the first-pass success (FPS) rates, laryngoscopic grades, and frequencies of rescue device use (including utilization of surgical airways) between VL and DL. Results. Crews intubated 348 patients with VL and 510 with DL. Successful endotracheal intubation within three attempts occurred 97.6% (confidence interval [CI] 96.5-98.6) of the time. The FPS rate was 85.8% (CI 83.4-88.1). In this cohort of patients, VL did not differ from DL with respect to total number of airway attempts (1.17 [CI 1.11-1.22] vs. 1.16 [CI 1.12-1.20]), FPS rate (85.6% [CI 82-89%] vs. 86.1% [CI 83-89]), or use of rescue airways (2.6% vs. 2.2%). The laryngoscopic view was superior in the VL group relative to the DL group (median Cormack-Lehane grade 1 [interquartile range (IQR) 1, 2] vs. 2 [IQR 1, 2]). Conclusion. VL using the C-MAC video laryngoscope did not reduce the total number of airway attempts or improve intubation compared with DL in a system of highly trained providers.	[Guyette, Francis X.; Farrell, Kathryn; Carlson, Jestin N.; Callaway, Clifton W.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA 15261 USA; [Guyette, Francis X.] STAT MedEvac, Dept Med, W Mifflin, PA USA; [Phrampus, Paul] Univ Pittsburgh, WISER Ctr, Pittsburgh, PA 15261 USA		Guyette, FX (corresponding author), Univ Pittsburgh, Dept Emergency Med, 3600 Forbes Ave,Iroquois Bldg, Pittsburgh, PA 15261 USA.	fguyette@statmedevac.com		Guyette, Francis/0000-0002-9151-4896; Callaway, Clifton/0000-0002-3309-1573			Aziz MF, 2012, ANESTHESIOLOGY, V116, P629, DOI 10.1097/ALN.0b013e318246ea34; Berg BW, 2009, STUD HEALTH TECHNOL, V142, P34, DOI 10.3233/978-1-58603-964-6-34; Carlson JN, 2012, PREHOSP EMERG CARE, V16, P293, DOI 10.3109/10903127.2011.640764; Cavus E, 2011, EMERG MED J, V28, P650, DOI 10.1136/emj.2010.098707; Cooper RM, 2005, CAN J ANAESTH, V52, P191, DOI 10.1007/BF03027728; Davis DP, 2006, PREHOSP EMERG CARE, V10, P356, DOI 10.1080/10903120600725751; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Griesdale DEG, 2012, CAN J ANESTH, V59, P41, DOI 10.1007/s12630-011-9620-5; Kim YM, 2011, PREHOSP EMERG CARE, V15, P98, DOI 10.3109/10903127.2010.514087; Low D, 2008, ANAESTHESIA, V63, P195, DOI 10.1111/j.1365-2044.2007.05323.x; Nakstad AR, 2009, ACTA ANAESTH SCAND, V53, P1257, DOI 10.1111/j.1399-6576.2009.02094.x; Nouruzi-Sedeh P, 2009, ANESTHESIOLOGY, V110, P32, DOI 10.1097/ALN.0b013e318190b6a7; Su YC, 2011, EUR J ANAESTH, V28, P788, DOI 10.1097/EJA.0b013e32834a34f3; Tremblay MH, 2008, ANESTH ANALG, V106, P1495, DOI 10.1213/ane.0b013e318168b38f; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang Henry E, 2005, Prehosp Emerg Care, V9, P156; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Wang HE, 2009, ANN EMERG MED, V54, P645, DOI 10.1016/j.annemergmed.2009.05.024; Wayne MA, 2010, PREHOSP EMERG CARE, V14, P278, DOI 10.3109/10903120903537189	20	28	29	0	4	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1090-3127			PREHOSP EMERG CARE	Prehosp. Emerg. Care	APR-JUN	2013	17	2					149	154		10.3109/10903127.2012.729128			6	Emergency Medicine; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	099PU	WOS:000315634500002	23231426				2022-02-06	
J	Cuberos-Urbano, G; Caracuel, A; Vilar-Lopez, R; Valls-Serrano, C; Bateman, A; Verdejo-Garcia, A				Cuberos-Urbano, Gustavo; Caracuel, Alfonso; Vilar-Lopez, Raquel; Valls-Serrano, Carlos; Bateman, Andrew; Verdejo-Garcia, Antonio			Ecological validity of the Multiple Errands Test using predictive models of dysexecutive problems in everyday life	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Neuropsychology; Dysexecutive syndrome; Ecological validity	TRAUMATIC BRAIN-INJURY; SIMPLIFIED VERSION; SYMPTOMS; IMPAIRMENTS; BEHAVIOR; SAMPLE	Thedysexecutive syndrome is composed of a range of cognitive, emotional, and behavioral deficits that are difficult to evaluate using traditional neuropsychological tests. The Multiple Errands Test (MET) was originally developed to systematize the assessment of the more elusive manifestations of the dysexecutive syndrome. The aims of this study were to examining the reliability of the MET and to investigate the predictive ability of its indices to explain a range of dysexecutive-related symptoms in everyday life. Thirty patients with acquired brain injury participated in this study. The MET showed an adequate inter-rater reliability and ecological validity. The main performance indices from the MET were able to significantly predict severity of everyday life executive problems, with different indices predicting particular manifestations of different components of executive functions.	[Cuberos-Urbano, Gustavo; Vilar-Lopez, Raquel; Valls-Serrano, Carlos; Verdejo-Garcia, Antonio] Univ Granada, Dept Clin Psychol, E-18071 Granada, Spain; [Caracuel, Alfonso] Univ Granada, Dept Dev Psychol, E-18071 Granada, Spain; [Caracuel, Alfonso; Vilar-Lopez, Raquel; Verdejo-Garcia, Antonio] Univ Granada, Inst Neurosci F Oloriz, E-18071 Granada, Spain; [Bateman, Andrew] Princess Wales Hosp, Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, Wales; [Bateman, Andrew] NIHR CLAHRC Cambridgeshire & Peterborough, Cambridge, England		Vilar-Lopez, R (corresponding author), Univ Granada, Dept Personalidad Evaluac & Tratamiento Psicol, Fac Psychol, Campus La Cartuja S-N, E-18071 Granada, Spain.	rvilar@ugr.es	Caracuel, Alfonso/V-3695-2019; Vilar-Lopez, Raquel/I-7847-2016; Verdejo-Garcia, Antonio/AAV-1147-2021	Caracuel, Alfonso/0000-0002-9738-8456; Vilar-Lopez, Raquel/0000-0001-9639-0143; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Bateman, Andrew/0000-0002-2547-5921	Spanish Ministry of Health, Instituto de Salud Carlos III, Fondo de Investigacion SanitariaInstituto de Salud Carlos IIISpanish Government [PI09/91008]; National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC C-P)	This study was funded by Grant PI09/91008 from the Spanish Ministry of Health, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (PI: A. V. G). A. B. was funded by the National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care (CLAHRC C-P).	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Alexander M, 2006, J INT NEUROPSYCH SOC, V12, P192, DOI 10.1017/S1355617706060292; Amieva H, 2003, BRAIN COGNITION, V53, P129, DOI 10.1016/S0278-2626(03)00094-0; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Caracuel A, 2008, ARCH CLIN NEUROPSYCH, V23, P447, DOI 10.1016/j.acn.2008.03.004; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Chaytor N, 2007, BRAIN INJURY, V21, P615, DOI 10.1080/02699050701426949; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Hair JF., 2006, MULTIVARIATE DATA AN, V6; Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119; Knight C, 2002, NEUROPSYCHOL REHABIL, V12, P231, DOI 10.1080/09602010244000039; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Simpson A, 2002, BRAIN INJURY, V16, P1075, DOI 10.1080/02699050210155249; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220	23	28	28	0	17	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAR 1	2013	35	3					329	336		10.1080/13803395.2013.776011			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	104IM	WOS:000315985900010	23458357				2022-02-06	
J	Boonstra, AM; Reneman, MF; Stewart, RE; Post, MW; Preuper, HRS				Boonstra, Anne M.; Reneman, Michiel F.; Stewart, Roy E.; Post, Marcel W.; Preuper, Henrica R. Schiphorst			Life satisfaction in patients with chronic musculoskeletal pain and its predictors	QUALITY OF LIFE RESEARCH			English	Article						Life satisfaction; Musculoskeletal pain; Quality of life	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; FOLLOW-UP; DETERMINANTS; IMPACT; COHORT	Purpose To determine the life satisfaction of patients with chronic non-malignant musculoskeletal pain (CMP) compared to the general population (GP) and to identify predictors of life satisfaction. Methods Subjects were patients with CMP (n = 1,082) admitted to multidisciplinary rehabilitation and a general population sample (n = 506). Lisat-9 measures satisfaction with life as a whole and eight life domains. Physical, emotional and social functioning and pain intensity were assessed using the SF-36. Ordinal logistic regression was used to analyse differences between patients with CMP and the GP, and predictors of life satisfaction in patients with CMP. Results Compared to the general population, patients with CMP reported lower satisfaction with 'life as a whole', and with six life domains: self-care, leisure, vocational and financial situation, sex life and contacts with friends. In the CMP group, pain was associated with satisfaction with self-care, vocational situation, partnership, family life and contacts with friends. Marital status, age and mental health were associated with most satisfaction scores. Conclusions Compared to the general population, patients with CMP reported lower satisfaction with 'life as a whole' and most life domains. The most consistent predictors of life satisfaction were marital status, mental health, vitality and pain.	[Boonstra, Anne M.] Revalidatie Friesland, Ctr Rehabil, NL-9244 ZN Beetsterzwaag, Netherlands; [Reneman, Michiel F.; Preuper, Henrica R. Schiphorst] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil, Ctr Rehabil, Groningen, Netherlands; [Stewart, Roy E.] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands; [Post, Marcel W.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Post, Marcel W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands		Boonstra, AM (corresponding author), Revalidatie Friesland, Ctr Rehabil, POB 2, NL-9244 ZN Beetsterzwaag, Netherlands.	a.m.boonstra@revalidatie-friesland.nl	Post, Marcel/AAS-2502-2021	Stewart, Roy/0000-0001-9227-433X			Anke AGW, 2003, CLIN REHABIL, V17, P431, DOI 10.1191/0269215503cr629oa; Berges IM, 2007, ARCH PHYS MED REHAB, V88, P413, DOI 10.1016/j.apmr.2006.12.022; Boonstra AM, 2008, INT J REHABIL RES, V31, P181, DOI 10.1097/MRR.0b013e3282fc0fdf; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Brox JI, 2005, J REHABIL MED, V37, P95, DOI 10.1080/16501970410017738; Budh CN, 2007, CLIN REHABIL, V21, P89, DOI 10.1177/0269215506070313; Chen YY, 2008, ARCH PHYS MED REHAB, V89, P2285, DOI 10.1016/j.apmr.2008.06.008; Cummins RA, 1998, SOC INDIC RES, V43, P307, DOI 10.1023/A:1006831107052; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Heikkila H, 1998, CLIN REHABIL, V12, P487, DOI 10.1191/026921598670569564; Hicken BL, 2002, J REHABIL RES DEV, V39, P359; Leonard MT, 2006, J PAIN, V7, P377, DOI 10.1016/j.jpain.2006.01.442; Lund ML, 2007, DISABIL REHABIL, V29, P1417, DOI 10.1080/09638280601029068; NEAR JP, 1993, SOC INDIC RES, V29, P109, DOI 10.1007/BF01136199; PETRIE K, 1994, AUST NZ J SURG, V64, P115, DOI 10.1111/j.1445-2197.1994.tb02155.x; Post Marcel, 2005, J Neurol Phys Ther, V29, P139; Post MWM, 1998, SCAND J REHABIL MED, V30, P23; Post MWM, 1998, ARCH PHYS MED REHAB, V79, P395, DOI 10.1016/S0003-9993(98)90139-3; POST MWM, 1996, TIJDSCHR SOC GEZONDH, V74, P204; Putzke JD, 2002, ARCH PHYS MED REHAB, V83, P555, DOI 10.1053/apmr.2002.31173; Silvemark AJ, 2008, DISABIL REHABIL, V30, P1929, DOI 10.1080/09638280701748773; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; TENNANT A, 1995, BRIT J RHEUMATOL, V34, P899; Tonack M, 2008, SPINAL CORD, V46, P380, DOI 10.1038/sj.sc.3102088; van Koppenhagen CF, 2008, ARCH PHYS MED REHAB, V89, P1733, DOI 10.1016/j.apmr.2007.12.042; Veenhoven R., WORLD DATABASE HAPPI; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; World Health Organization, 1997, PROGR MENT HLTH MEAS; World Health Organization (WHO), 1958, 1 10 YEARS WHO; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	28	29	1	12	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343			QUAL LIFE RES	Qual. Life Res.	FEB	2013	22	1					93	101		10.1007/s11136-012-0132-8			9	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	094QQ	WOS:000315279300010	22350589	Green Submitted			2022-02-06	
J	Kuhlmei, A; Walther, B; Becker, T; Muller, U; Nikolaus, T				Kuhlmei, A.; Walther, B.; Becker, T.; Mueller, U.; Nikolaus, T.			Actigraphic daytime activity is reduced in patients with cognitive impairment and apathy	EUROPEAN PSYCHIATRY			English	Article						Alzheimer's disease; Actigraphy; Apathy; Dementia; Mild cognitive impairment/MCI	TRAUMATIC BRAIN-INJURY; NURSING-HOME RESIDENTS; EVALUATION SCALE; ALZHEIMERS-DISEASE; CIRCADIAN-RHYTHMS; DISORDERS; SCHIZOPHRENIA; SLEEP/WAKE; DEMENTIA	Objectives: Apathy is a neuropsychiatric symptom in mild cognitive impairment (MCI) and dementia. This study examines correlations between Apathy Evaluation Scale (AES) ratings and actigraphic measures of daytime activity. The aim of this study is to determine the value of ambulatory actigraphy in the assessment of locomotor deficits as a correlate of apathy in geriatric patients with cognitive impairment. Patients and methods: In this cross-sectional study a total of 82 participants were recruited, 32 patients with dementia, 21 patients with MCI and 23 elderly controls. Rating scales for apathy (AES) and depression (Beck Depression Inventory, BDI) were completed. To measure daytime activity a wrist-worn actigraph and an established protocol were used. A single measure of mean daytime activity per participant was calculated for further statistical analysis. Results: In the two groups of patients with MCI and dementia, apathy is associated with reduced daytime activity, independent of diagnosis (no group by apathy interaction). AES scores correlate significantly with daytime activity. Cognitive impairment reduces daytime activity (effect greater in dementia than in MCI). Daytime activity is negatively correlated with memory deficits. Conclusion: Ambulatory actigraphy is a promising method to evaluate self-initiated action as a correlate of apathy in patients with cognitive impairment. (C) 2011 Elsevier Masson SAS. All rights reserved.	[Kuhlmei, A.] Bethesda Geriatr Klin Ulm, D-89073 Ulm, Germany; [Kuhlmei, A.; Walther, B.; Becker, T.; Nikolaus, T.] Univ Ulm, Bezirkskrankenhaus Gunzburg, Dept Psychiat 2, D-89312 Gunzburg, Germany; [Mueller, U.] Cambridge Behav & Clin Neurosci Inst BCNI, Dept Expt Psychol, Cambridge CB2 3EB, England; [Mueller, U.] Cambridge Behav & Clin Neurosci Inst BCNI, Dept Psychiat, Cambridge CB2 3EB, England		Kuhlmei, A (corresponding author), Bethesda Geriatr Klin Ulm, Zollernring 26, D-89073 Ulm, Germany.	a.kuhlmei@gmx.de	Becker, Thomas/O-9769-2014	Becker, Thomas/0000-0001-8179-1219	Forschungskolleg Geriatrie, Robert Bosch Foundation, Stuttgart, Germany	Funded by a grant of the Forschungskolleg Geriatrie, Robert Bosch Foundation, Stuttgart, Germany. We thank all patients and healthy volunteers for their participation.	Alessi CA, 2005, J AM GERIATR SOC, V53, P803, DOI 10.1111/j.1532-5415.2005.53251.x; Andersson S, 1999, BRAIN INJURY, V13, P393, DOI 10.1080/026990599121458; Borod JC, 2000, NEUROPSYCHOLOGY EMOT, P340; Bruck D, 2005, HUM PSYCHOPHARM CLIN, V20, P105, DOI 10.1002/hup.666; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dane AV, 2000, J AM ACAD CHILD PSY, V39, P752, DOI 10.1097/00004583-200006000-00014; Deb S, 2004, BRAIN INJURY, V18, P1, DOI 10.1080/0269905031000110463; Glenn MB, 2002, BRAIN INJURY, V16, P509, DOI 10.1080/02699050110119132; Harper DG, 2001, ARCH GEN PSYCHIAT, V58, P353, DOI 10.1001/archpsyc.58.4.353; Hatfield CF, 2004, BRAIN, V127, P1061, DOI 10.1093/brain/awh129; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kiang M, 2003, SCHIZOPHR RES, V63, P79, DOI 10.1016/S0920-9964(02)00433-4; Lemke MR, 1999, J PSYCHIAT RES, V33, P215, DOI 10.1016/S0022-3956(98)00067-3; Lueken U, 2006, FORTSCHR NEUROL PSYC, V74, P714, DOI 10.1055/s-2006-932164; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Martin J, 2001, SCHIZOPHR RES, V47, P77, DOI 10.1016/S0920-9964(00)00029-3; McAllister T W, 2000, Semin Clin Neuropsychiatry, V5, P275, DOI 10.1053/scnp.2000.9557; Muller U, 2006, BRAIN INJURY, V20, P157, DOI 10.1080/02699050500443467; Paavilainen P, 2005, J SLEEP RES, V14, P61, DOI 10.1111/j.1365-2869.2004.00433.x; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Robert P, 2009, EUR PSYCHIAT, V24, P98, DOI 10.1016/j.eurpsy.2008.09.001; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; Volicer L, 2001, AM J PSYCHIAT, V158, P704, DOI 10.1176/appi.ajp.158.5.704; Winkler D, 2005, BIOL PSYCHIAT, V58, P331, DOI 10.1016/j.biopsych.2005.01.031	25	28	28	0	17	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0924-9338			EUR PSYCHIAT	Eur. Psychiat.	FEB	2013	28	2					94	97		10.1016/j.eurpsy.2011.04.006			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	088XK	WOS:000314871000005	21696925				2022-02-06	
J	Maerlender, A; Flashman, L; Kessler, A; Kumbhani, S; Greenwald, R; Tosteson, T; McAllister, T				Maerlender, A.; Flashman, L.; Kessler, A.; Kumbhani, S.; Greenwald, R.; Tosteson, T.; McAllister, T.			Discriminant Construct Validity of ImPACT (TM): A Companion Study	CLINICAL NEUROPSYCHOLOGIST			English	Article						Sports concussion; ImPACT; Contruct validity; Discriminant validity; Neuropsychological testing	NEUROPSYCHOLOGICAL MEASURES; CONCUSSION; VALIDATION	In a previous analysis of ImPACT scores relative to traditional neuropsychological tests (NP) and experimental tasks (Maerlender et al., 2010) we demonstrated convergent construct validity for the primary ImPACT test-score composites. A complete analysis of discriminant validity was not undertaken at that time. Here, test scores from the 54 collegiate football and hockey players were re-analyzed to specifically address the discriminant validity of the ImPACT composite scores using a multiply operationalized correlation matrix of multi-trait multi-method data. In the method used here, discriminant validity is determined by obtaining non-significant correlations between a target score when correlated with the average of the other trait measurements (multiply-operationalized multi-trait-mono-method analysis). Results showed that the ImPACT Verbal Memory (p=.044), Visual Memory (p=.006), and Visual Motor Speed (p=.000) scores were highly correlated with composites of the other scores, while the Reaction Time composite demonstrated adequate discriminant validity (p=.145). In comparison all of the NP composites showed good discrimination (all p-values >.05, except for Reaction Time p=.05). Thus the apparent lack of discriminability between three of four composite scores in this sample raises questions about using ImPACT composite scores to support specific construct-oriented interpretations. Taken together, the discriminant and convergent construct validity properties of ImPACT indicate construct sensitivity, but limited construct specificity.	[Maerlender, A.; Flashman, L.; McAllister, T.] Geisel Sch Med Dartmouth, Dept Psychiat, Lebanon, NH USA; [Kessler, A.] Univ Wisconsin, Sch Med, Dept Psychiat, Madison, WI 53706 USA; [Greenwald, R.] Simbex LLC, Hanover, NH USA; [Greenwald, R.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Tosteson, T.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Lebanon, NH USA		Maerlender, A (corresponding author), Dartmouth Hitchcock Med Ctr, Dept Psychiat, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Art.Maerlender@dartmouth.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [BRP R01HD048638, RO1NS055020]; National Center for Medical Rehabilitation Research; National Institute of Child Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Health/National Institute of Neurological Disease and Stroke; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055020] Funding Source: NIH RePORTER	This work was supported by National Institute of Health BRP R01HD048638 National Center for Medical Rehabilitation Research, National Institute of Child Health and Development, and National Institute of Health RO1NS055020 National Institute of Health/National Institute of Neurological Disease and Stroke.	Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benedict R., 1997, BRIEF VISUOSPATIAL M; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Cole D., 1981, J COUNSELING CLIN PS, V34, P315; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Green P, 1995, MANUAL ORAL WORD MEM; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HOWARD GS, 1992, J COUNS PSYCHOL, V39, P398, DOI 10.1037/0022-0167.39.3.398; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson G. L., 2003, NAT AC NEUR ANN M HO; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Smith A., 1991, SYMBOL DIGIT MODALIT; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd	19	28	28	0	24	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 1	2013	27	2					290	299		10.1080/13854046.2012.744098			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	146MH	WOS:000319094700007	23317033	Green Accepted, Green Published			2022-02-06	
J	Rieger, BP; Lewandowski, LJ; Callahan, JM; Spenceley, L; Truckenmiller, A; Gathje, R; Miller, LA				Rieger, Brian P.; Lewandowski, Lawrence J.; Callahan, James M.; Spenceley, Laura; Truckenmiller, Adrea; Gathje, Rebecca; Miller, Laura A.			A prospective study of symptoms and neurocognitive outcomes in youth with concussion vs orthopaedic injuries	BRAIN INJURY			English	Article						concussion; mild traumatic brain injury; post-concussion; paediatric; outcome	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; POSTCONCUSSIVE SYMPTOMS; STANDARDIZED ASSESSMENT; HEAD-INJURIES; MILD; CHILDREN; MANAGEMENT; VALIDITY; IMPACT	Background: This study examined symptom reports and neurocognitive outcomes in children (8-17 years) with mild traumatic brain injury (mTBI) or orthopaedic injury (OI). Method: Children and parents were initially assessed upon presentation in the Emergency Department of a local hospital and again at 3 months. Children completed the Immediate Post-Concussion Assessment and Cognitive Testing battery (ImPACT) and parents completed the Behavior Rating Inventory of Executive Function (BRIEF). The Peabody Picture Vocabulary Test, 3rd edition (PPVT-III) was completed by the children at the 3-month assessment. Results: Children with mTBI reported more symptoms than the OI group initially, but did not differ from the OI group at 3 months. Both groups reported a higher than expected number of symptoms at 3 months. On the ImPACT, children with mTBI performed significantly worse than the OI on a visual memory test at both assessments. The OI group had higher levels of parent-reported executive dysfunction on the BRIEF at initial and 3-month assessments. Discussion: As expected, more post-concussion symptoms were initially reported by children and adolescents with mTBI vs orthopaedic injury, but there was no difference at 3 months. The BRIEF and ImPACT cognitive measures did not differentiate concussed subjects from controls, with the exception of concussed subjects' lower performance on a visual memory test at both initial assessment and at 3 months.	[Rieger, Brian P.] SUNY Upstate Med Univ, Dept Phys Med & Rehabil, Syracuse, NY 13210 USA; [Lewandowski, Lawrence J.] Syracuse Univ, Dept Psychol, Syracuse, NY USA; [Callahan, James M.] Childrens Hosp Philadelphia, Div Emergency Med, Dept Pediat, Philadelphia, PA USA; [Callahan, James M.] Univ Penn, Perelman Sch Med, Philadelphia, PA USA; [Spenceley, Laura; Truckenmiller, Adrea; Miller, Laura A.] Syracuse Univ, Dept Psychol, Syracuse, NY USA; [Gathje, Rebecca] Univ Nebraska Med Ctr, Omaha, NE USA		Rieger, BP (corresponding author), Univ Hosp Room 2104,750 E Adams St, Syracuse, NY 13210 USA.	riegerb@upstate.edu	Truckenmiller, Adrea/AAM-1840-2021; Meijer, Anna/K-5118-2016	Truckenmiller, Adrea/0000-0002-6101-6175; 	Hendricks Fund for Medical Research, SUNY Upstate Medical University	Dr Rieger is the Director of the Concussion Management Programme and Upstate Sports Concussion Centre at SUNY Upstate Medical University, Syracuse, NY. He earns occasional honoraria for speaking about concussion at medical, sports, and community forums. This study was funded by the Hendricks Fund for Medical Research, SUNY Upstate Medical University.	Alloway TP, 2009, CHILD PSYCHIAT HUM D, V40, P353, DOI 10.1007/s10578-009-0131-3; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Gioia G. A., 2005, BRIEF BEHAV RATING I; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Iverson G, 2007, BRAIN INJURY MED PRI; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2003, NAT AC NEUR ANN M DA; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rees RJ, 2007, NEUROREHABILITATION, V22, P229; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	44	28	28	0	28	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2013	27	2					169	178		10.3109/02699052.2012.729290			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500005	23384214				2022-02-06	
J	Wang, ZT; Yao, WF; Deng, QJ; Zhang, XH; Zhang, JN				Wang, Zhitao; Yao, Weifeng; Deng, Quanjun; Zhang, Xiaohui; Zhang, Jianning			Protective Effects of BDNF Overexpression Bone Marrow Stromal Cell Transplantation in Rat Models of Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Marrow stromal cells; Brain-derived neurotrophic factor; Traumatic brain injury	MESENCHYMAL STEM-CELLS; NEUROTROPHIC FACTOR; INTRACEREBRAL TRANSPLANTATION; FUNCTIONAL RECOVERY; EXPRESSION; ENHANCEMENT; PHENOTYPE; INFUSION; CHILDREN; DEFICITS	Bone marrow stromal cells (MSCs) were used as cell therapy for various diseases in recent years. Some reports showed that transplanted MSCs promote functional recovery in animal models of brain trauma. But other studies indicate that tissue replacement by this method may not be the main source of therapeutic benefit. Neurotrophic factors such as brain-derived neurotrophic factor (BDNF) therapeutic potential may contribute to the recovery of function after trauma. Our previous study showed that BDNF-MSCs could promote the survival of neurons in neuronal injured models in vitro. The present study was undertaken to explore the therapeutic effects of MSCs transfected with BDNF in vivo. After intraventricular injection of MSCs-BDNF, BDNF levels were increased significantly in cerebrospinal fluid by ELISA. Further studies showed that treatment of traumatic brain injury with MSCs-BDNF could attenuate neuronal injury as measurement of biological behavior assessment. These studies demonstrate that by increasing the brain concentration of BDNF, intraventricularly transplanted MSCs-BDNF might play an important role in the treatment of traumatic brain injury and might be an optional therapeutic strategy.	[Wang, Zhitao; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Wang, Zhitao; Zhang, Jianning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Wang, Zhitao; Zhang, Jianning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Wang, Zhitao; Zhang, Jianning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Yao, Weifeng] Tianjin Acad Tradit Chinese Med, Affiliated Hosp, Tianjin 300052, Peoples R China; [Deng, Quanjun] Tianjin Huanghe Rd Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Zhang, Xiaohui] Tianjin Med Univ, Canc Inst & Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com					Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.0299.x, 10.1111/j.1582-4934.2008.00299.x]; Bolton MM, 2000, J NEUROSCI, V20, P3221, DOI 10.1523/JNEUROSCI.20-09-03221.2000; Borlongan CV, 1996, NEUROL RES, V18, P297; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Clark BR, 1995, ANN NY ACAD SCI, V770, P70, DOI 10.1111/j.1749-6632.1995.tb31044.x; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Diogenes MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P1823, DOI 10.1038/npp.2011.64; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; FLEMING JO, 1983, J NEUROIMMUNOL, V4, P129, DOI 10.1016/0165-5728(83)90017-6; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Jendelova P, 2003, MAGNET RESON MED, V50, P767, DOI 10.1002/mrm.10585; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lipsky RH, 2007, ANN NY ACAD SCI, V1122, P130, DOI 10.1196/annals.1403.009; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; McIntosh TK, 1996, LAB INVEST, V74, P315; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mori T, 2005, MOL CELL BIOL, V25, P5183, DOI 10.1128/MCB.25.12.5183-5195.2005; Mu JS, 1999, BRAIN RES, V835, P259, DOI 10.1016/S0006-8993(99)01592-9; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Wang ZT, 2009, J MOL NEUROSCI, V38, P265, DOI 10.1007/s12031-009-9208-5; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C	42	28	32	0	16	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	FEB	2013	49	2					409	416		10.1007/s12031-012-9908-0			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	070OW	WOS:000313519900019	23143881				2022-02-06	
J	Ge, YF; Sun, J; Jin, CJ; Cao, BQ; Jiang, ZF; Shao, JF				Ge, Yun-Fei; Sun, Jun; Jin, Chun-Jie; Cao, Bo-Qiang; Jiang, Zhi-Feng; Shao, Jun-Fei			AntagomiR-27a Targets FOXO3a in Glioblastoma and Suppresses U87 Cell Growth in Vitro and in Vivo	ASIAN PACIFIC JOURNAL OF CANCER PREVENTION			English	Article						MiR-27a; antagomiR-27a; glioblastoma; target gene FOXO3a	TUMOR SUPPRESSION; SPROUTY; PROLIFERATION; ACTIVATION; MIGRATION; MICRORNAS; PATHWAYS	Objective: To study the effect of the antagomiR-27a inhibitor on glioblastoma cells. Methods: The miR-27a expression level in specimens of human glioblastoma and normal human brain tissues excised during decompression for traumatic brain injury was assessed using qRT-PCR; The predicted target gene of miR-27a was screened out through bioinformatics databases, and the predicted gene was verified using genetic report assays; the effect of antagomiR-27a on the invasion and proliferation of glioma cells was analyzed using MTT assays and 5-ethynyl-2'-deoxyuridine (EdU) labeling. A xenograft glioblastoma model in BALB-c nude mice was established to detect the effect of antagomiR-27a on tumour growth. Results: qRT-PCR results showed that miR-27a significantly increased in specimens from glioblastoma comparing with normal human brain tissues. Th miR-27a inhibitor significantly suppressed invasion and proliferation of glioblastoma cells. FOXO3a was verified as a new target of miR-27a by Western blotting and reporter analyzes. Tumor growth in vivo was suppressed by administration of the miR-27a inhibitor. Conclusion: MiR-27a may be up-regulated in human glioblastoma, and antagomiR-27a could inhibit the proliferation and invasion ability of glioblastoma cells.	[Ge, Yun-Fei; Sun, Jun; Cao, Bo-Qiang; Shao, Jun-Fei] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Neurosurg, Wuxi, Peoples R China; [Jin, Chun-Jie] Beichen Hosp Tianjin, Dept Neurosurg, Tianjin, Peoples R China; [Jiang, Zhi-Feng] Southeast Univ, Jiangyin Peoples Hosp, Dept Neurosurg, Jiangyin, Peoples R China		Shao, JF (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Neurosurg, Wuxi, Peoples R China.	wxbrain@163.com			National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [812272791]	This study was supported by the grants from the National Natural Science Foundation (812272791).	Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Burgess R, 2008, CANCER BIOL THER, V7, P1326, DOI 10.4161/cbt.7.9.6992; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Li XR, 2010, ENDOCRINOLOGY, V151, P2462, DOI 10.1210/en.2009-1150; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sevignani C, 2006, MAMM GENOME, V17, P189, DOI 10.1007/s00335-005-0066-3; Wang Q, 2011, ONCOGENE, V30, P3875, DOI 10.1038/onc.2011.103; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200	20	28	29	0	3	ASIAN PACIFIC ORGANIZATION CANCER PREVENTION	GYEONGGI-DO	APJCP HEAD OFFICE, KOREAN NATL CANCER CENTER, 323 ILAN -RO, ILSANDONG-GU, GOYANG-SI, GYEONGGI-DO, 410-769, SOUTH KOREA	1513-7368			ASIAN PAC J CANCER P	Asian Pac. J. Cancer Prev.		2013	14	2					963	968		10.7314/APJCP.2013.14.2.963			6	Oncology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology	224VU	WOS:000324920000063	23621269	gold			2022-02-06	
J	Meng, X; Browne, KD; Huang, SM; Mietus, C; Cullen, DK; Tofighi, MR; Rosen, A				Meng, Xu; Browne, Kevin D.; Huang, Shi-Min; Mietus, Constance; Cullen, D. Kacy; Tofighi, Mohammad-Reza; Rosen, Arye			Dynamic Evaluation of a Digital Wireless Intracranial Pressure Sensor for the Assessment of Traumatic Brain Injury in a Swine Model	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Digital wireless implants; intracranial pressure (ICP); rotational head injury; slot antenna; traumatic brain injury (TBI)	CLINICAL-PRACTICE; HEAD-INJURY; DEVICE; TRANSMISSION; IMPLANT; PIG	The monitoring and control of increased intracranial pressure (ICP) are the major requirements for the diagnosis and treatment of patients suffering from traumatic brain injury (TBI) or hydrocephalus. Widely used commercially available ICP measuring devices require the use of a tethered fiber optic probe, which can cause complications, such as infection and hemorrhage. The use of a probe also prohibits immediate (at the time of induced injury) and long-term measurements of ICP. Therefore, we have developed and tested a small fully embedded wireless ICP sensor, incorporating a novel antenna and packaging arrangement. Evaluations were performed in-vitro and in-vivo to demonstrate the robustness of this microwave pressure-monitoring system. This is the first report of in-vivo tests in a dynamic study of continuous (every 6 s) wireless ICP measurements in a swine model of closed-head rotational-acceleration induced TBI using a digital device. In particular, our device measured extreme changes in ICP immediately upon rapid head rotation that persisted for hours after the injury. The readings matched well those obtained from a commercially available tethered monitor. Our device can be utilized in the future as a tool to diagnose and track long-term ICP changes.	[Meng, Xu; Rosen, Arye] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Browne, Kevin D.; Mietus, Constance; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Huang, Shi-Min] Drexel Univ, Dept Elect Engn, Philadelphia, PA 19104 USA; [Tofighi, Mohammad-Reza] Penn State Univ, Capital Coll, Middletown, PA 17057 USA		Meng, X (corresponding author), Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA.	xm26@drexel.edu; kbrowne@mail.med.upenn.edu; sh592@drexel.edu; mi-etus@mail.med.upenn.edu; dkacy@mail.med.upenn.edu; mtofighi@psu.edu; ar86@drexel.edu	Huang, Shimin/X-6369-2019		Department of Neurosurgery, University of Pennsylvania; University Research Foundation, University of Pennsylvania; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050598]	This work was supported in part by the Department of Neurosurgery and University Research Foundation, University of Pennsylvania, and the National Institutes of Health (NIH) under Grant NS050598.	[Anonymous], 2009, HYDR STAT; Bashirullah R, 2010, IEEE MICROW MAG, V11, pS14, DOI 10.1109/MMM.2010.938579; CHAMBERS IR, 1990, NEUROSURGERY, V26, P421, DOI 10.1227/00006123-199003000-00007; CHAMBERS IR, 1993, NEUROSURGERY, V33, P866; Chen PJ, 2010, J MICROELECTROMECH S, V19, P721, DOI 10.1109/JMEMS.2010.2049825; Chow EY, 2010, IEEE T BIO-MED ENG, V57, P1487, DOI 10.1109/TBME.2010.2041058; Chow EY, 2008, IEEE T MICROW THEORY, V56, P3200, DOI 10.1109/TMTT.2008.2007338; Faul M, 2010, TRAUMATIC BRAIN INJU; Figaji AA, 2009, SURG NEUROL, V72, P389, DOI 10.1016/j.surneu.2009.02.012; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Kawoos U., 2009, THESIS DREXEL U PHIL; Kawoos U, 2008, IEEE T MICROW THEORY, V56, P2356, DOI 10.1109/TMTT.2008.2004253; Mahfouz MR, 2009, IEEE T MICROW THEORY, V57, P2550, DOI 10.1109/TMTT.2009.2029721; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; Majerus SJA, 2011, IEEE T BIO-MED ENG, V58, P763, DOI 10.1109/TBME.2010.2085002; March K, 2005, AACN ADV CRIT CARE, V16, P456, DOI 10.1097/00044067-200510000-00004; Meng X, 2012, ELECTRON LETT, V48, P363, DOI 10.1049/el.2012.0281; Meng X., 2011, IEEE MTT S INT MICR, P1; Munch E, 1998, ACTA NEUROCHIR, V140, P1113, DOI 10.1007/s007010050224; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Schepps J, 2002, IEEE T MICROW THEORY, V50, P1044, DOI 10.1109/22.989992; SCHICKNER DJ, 1992, SURG NEUROL, V37, P251, DOI 10.1016/0090-3019(92)90147-F; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Sodagar AM, 2009, IEEE J SOLID-ST CIRC, V44, P2591, DOI 10.1109/JSSC.2009.2023159; Tofighi M. R, 2011, 12 ANN IEEE WIR MICR, P1; Vorst A, 2006, RF MICROWAVE INTERAC; Warty R, 2008, IEEE T MICROW THEORY, V56, P2366, DOI 10.1109/TMTT.2008.2004254; Yakovlev A, 2012, IEEE COMMUN MAG, V50, P152, DOI 10.1109/MCOM.2012.6178849	29	28	28	1	19	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	JAN	2013	61	1	1				316	325		10.1109/TMTT.2012.2224361			10	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	076EW	WOS:000313940300034					2022-02-06	
J	Sandel, NK; Lovell, MR; Kegel, NE; Collins, MW; Kontos, AP				Sandel, Natalie K.; Lovell, Mark R.; Kegel, Nathan E.; Collins, Michael W.; Kontos, Anthony P.			The Relationship of Symptoms and Neurocognitive Performance to Perceived Recovery From Sports-Related Concussion Among Adolescent Athletes	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						adolescent; athletes; concussion; neurocognitive; perceptions; recovery	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; IMPACT	Sports medicine practitioners often consider athletes' self-reports of recovery for the management of concussion, and it is not clear which factors (i.e., neurocognitive performance and symptoms) athletes consider when forming perceptions of recovery from concussion. The current study assessed the relationship of perceptions of recovery to neurocognitive performance on the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery and to symptoms using the Post-Concussion Symptom Scale (PCSS). A total of 101 concussed athletes (62 males, 39 females) aged 12 to 18 years old were included in the study (M-age = 14.75, SD = 1.76). Athletes were asked to rate their "percent back to normal" (i.e., perception of recovery) at the time of evaluation. A multiple regression for neurocognitive performance and symptoms revealed a significant model that accounted for 58% of the variance in perceptions of recovery. Adolescent athletes base their perceptions primarily on somatic symptoms (e. g., headache, nausea, vomiting, etc.), and these perceptions may be incongruent with objective neurocognitive measures. Athletes' tendency to overlook several factors when forming their perceptions of recovery should caution the sports medicine practitioner from relying on self-reported symptoms as their primary criterion for return-to-play decisions. These data further support the need for valid and reliable measures for concussion management.	[Sandel, Natalie K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15203 USA; [Sandel, Natalie K.] Univ Pittsburgh, Sch Med Sports Med, Ctr Sports Med, Concuss Program, Pittsburgh, PA 15203 USA; [Lovell, Mark R.] Univ Pittsburgh, Dept Orthoped Surg, Pittsburgh, PA 15203 USA; [Kegel, Nathan E.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Sch Med, Ctr Sports Med, Dept Orthoped Surg, Pittsburgh, PA 15203 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Sch Med Sports Med, Ctr Sports Med, Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.	akontos@pitt.edu	Meijer, Anna/K-5118-2016	Kontos, Anthony/0000-0002-3749-4310			CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	16	28	28	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2013	2	1					64	69		10.1080/21622965.2012.670580			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AD0SV	WOS:000332945300009	23427778				2022-02-06	
J	Walker, JJ; Cleveland, LM; Davis, JL; Seales, JS				Walker, Jennifer Junnila; Cleveland, Leanne M.; Davis, Jenny L.; Seales, Jennifer S.			Audiometry Screening and Interpretation	AMERICAN FAMILY PHYSICIAN			English	Article							TRAUMATIC BRAIN-INJURY; HEARING-LOSS; PREVALENCE; HEALTH; CARE	The prevalence of hearing loss varies with age, affecting at least 25 percent of patients older than 50 years and more than 50 percent of those older than 80 years. Adolescents and young adults represent groups in which the prevalence of hearing loss is increasing and may therefore benefit from screening. If offered, screening can be performed periodically by asking the patient or family if there are perceived hearing problems, or by using clinical office tests such as whispered voice, finger rub, or audiometry. Audiometry in the family medicine clinic setting is a relatively simple procedure that can be interpreted by a trained health care professional. Pure-tone testing presents tones across the speech spectrum (500 to 4,000 Hz) to determine if the patient's hearing levels fall within normal limits. A quiet testing environment, calibrated audiometric equipment, and appropriately trained personnel are required for in-office testing. Pure-tone audiometry may help physicians appropriately refer patients to an audiologist or otolaryngologist. Unilateral or asymmetrical hearing loss can be symptomatic of a central nervous system lesion and requires additional evaluation. (Am Fam Physician. 2013;87(1) :41-47. Copyright (C) 2013 American Academy of Family Physicians.)	[Walker, Jennifer Junnila] USA, Hlth Clin, Schofield Barracks, HI 96857 USA; [Cleveland, Leanne M.] Ft Richardson Troop Hlth Clin, Joint Base Elmendorf Ric, AK USA; [Davis, Jenny L.] Landstuhl Reg Med Ctr, Landstuhl, Germany; [Seales, Jennifer S.] Gen Leonard Wood Army Community Hosp, Ft Leonard Wood, MO USA		Walker, JJ (corresponding author), USA, Hlth Clin, Bldg 683, Schofield Barracks, HI 96857 USA.						Abraham M, 2011, CPT 2012 CURRENT PRO; Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; American Academy of Audiology, 1997, POS STAT GUID CONS P; American Academy of Otolaryngology-Head and Neck Surgery, FAQS CMS AUD TRANSM; American Academy of Pediatrics Bright Futures Steering Committee, BRIGHT FUT GUID HLTH; American National Standards Institute, 2008, S311999 ANSIASA; American National Standards Institute, S362010 ANSI; American Speech-Language-Hearing Association, 2004, SUPP PERS ISS ETH; Army Publishing Directorate, 1998, DEP ARM PAMPHL 40 50, pDecember; Barnett S, 2002, AM FAM PHYSICIAN, V66, P911; Bogardus ST, 2003, JAMA-J AM MED ASSOC, V289, P1986, DOI 10.1001/jama.289.15.1986; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Centers for Medicare Medicaid Services, PHYS FEE SCHED SEARC; Chung JH, 2005, PEDIATRICS, V115, P861, DOI 10.1542/peds.2004-0173; Council for Accreditation in Occupational Hearing Conservation, COURS LEAD CERT REC; Cunningham M, 2003, PEDIATRICS, V111, P436, DOI 10.1542/peds.111.2.436; Durmaz A, 2009, J LARYNGOL OTOL, V123, P840, DOI 10.1017/S0022215109004769; Elsawy B, 2011, AM FAM PHYSICIAN, V83, P48; Fausti SA, 2005, J REHABIL RES DEV, V42, P45, DOI 10.1682/JRRD.2005.02.0039; Forzley GJ, 2003, PFENNINGER FOWLERS P, P409; FRANK T, 1987, EAR HEARING, V8, P180, DOI 10.1097/00003446-198706000-00009; Halloran DR, 2009, ARCH PEDIAT ADOL MED, V163, P158, DOI 10.1001/archpediatrics.2008.526; Harrell RW., 2002, HDB CLIN AUDIOLOGY, V5, P71; *I CLIN SYST IMPR, HLTH CAR GUID PREV S; Jupiter T, 2009, AM J AUDIOL, V18, P99, DOI 10.1044/1059-0889(2009/08-0020); Katz J, 2002, HDB CLIN AUDIOLOGY, P124; KLOCKHOFF I, 1986, SCAND AUDIOL, V15, P217, DOI 10.3109/01050398609042146; Moore KJ, 2003, FAM PRACT MANAG, V10, P17; MULROW CD, 1991, J GEN INTERN MED, V6, P249, DOI 10.1007/BF02598971; Rabinowitz PM, 2000, AM FAM PHYSICIAN, V61, P2749; RAPPO PD, 1995, PEDIATRICS, V96, P373; Saliba I, 2009, OTOL NEUROTOL, V30, P515, DOI 10.1097/MAO.0b013e3181a5297a; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Torres-Russotto D, 2009, NEUROLOGY, V72, P1595, DOI 10.1212/WNL.0b013e3181a41280; U. S. Department of Health and Human Services Centers for Disease Control and Prevention Centers for Medicare & Medicaid Services, 2007, ICD 9 CM INT CLASS D; U. S. Preventive Services Task Force, SCREEN HEAR IMP OLD; Vogel I, 2008, J PEDIATR-US, V152, P400, DOI 10.1016/j.jpeds.2007.07.009	39	28	29	1	13	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	JAN 1	2013	87	1					41	47					7	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	068QN	WOS:000313381400007	23317024				2022-02-06	
J	Zheng, B; Wang, CY; He, LH; Xu, XJ; Qu, J; Hu, J; Zhang, HX				Zheng, Bing; Wang, Chunyan; He, Lihong; Xu, Xiaojing; Qu, Jing; Hu, Jun; Zhang, Huanxiang			Neural differentiation of mesenchymal stem cells influences chemotactic responses to HGF	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article							MARROW STROMAL CELLS; GROWTH FACTOR/SCATTER FACTOR; UMBILICAL-CORD BLOOD; MAGNETIC-RESONANCE TRACKING; FACTOR-INDUCED MIGRATION; TRAUMATIC BRAIN-INJURY; BONE-MARROW; IN-VITRO; FUNCTIONAL RECOVERY; PROGENITOR CELLS	Recently, mesenchymal stem cells (MSCs) have been extensively used for cell-based therapies in neuronal degenerative disease. Although much effort has been devoted to the delineation of factors involved in the migration of MSCs, the relationship between the chemotactic responses and the differentiation status of these cells remains elusive. Here, we report that MSCs in varying neural differentiation states display different chemotactic responses to hepatocyte growth factor (HGF): first, the number of chemotaxing MSCs and the optimal concentrations of HGF that induced the peak migration varied greatly; second, time-lapse video analysis showed that MSCs in certain differentiation state migrated more efficiently toward HGF; third, the phosphorylation levels of Akt, ERK1/2, SAPK/JNK, and p38MAPK were closely related to the differentiation levels of MSCs subjected to HGF; and finally, although inhibition of ERK1/2 signaling significantly attenuated HGF-stimulated transfilter migration of both undifferentiated and differentiating MSCs, abolishment of PI3K/Akt, p38MAPK, or SAPK/JNK signaling only decreased the number of migrated cells in certain differentiation state(s). Blocking of PI3K/Akt or MAPK signaling impaired the migration efficiency and/or speed, the extent of which depends on the cell differentiation states. Meanwhile, F-actin rearrangement, which is essential for MSCs chemotaxis, was induced by HGF, and the time points of cytoskeletal reorganization were different among these cells. Collectively, these results demonstrate that neural differentiation of MSCs influences their chemotactic responses to HGF: MSCs in varying differentiation states possess different migratory capacities, thereby shedding light on optimization of the therapeutic potential of MSCs to be employed for neural regeneration after injury. J. Cell. Physiol. 228: 149162, 2013. (c) 2012 Wiley Periodicals, Inc.	[Zheng, Bing; Wang, Chunyan; He, Lihong; Xu, Xiaojing; Qu, Jing; Hu, Jun; Zhang, Huanxiang] Soochow Univ, Coll Med, Dept Cell Biol, Jiangsu Key Lab Stem Cell Res, Suzhou 215123, Peoples R China		Zhang, HX (corresponding author), Soochow Univ, Coll Med, Dept Cell Biol, Jiangsu Key Lab Stem Cell Res, Ren Ai Rd 199,Suzhou Ind Pk, Suzhou 215123, Peoples R China.	hzhang@suda.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31071220, 30870642]; China Project 211 (Reconstruction of Spinal Functions and Bone Tissue Engineering After Minimal Invasive Surgery)	Contract grant sponsor: National Natural Science Foundation of China;; Contract grant numbers: 31071220, 30870642.; Contract grant sponsor: China Project 211 (Reconstruction of Spinal Functions and Bone Tissue Engineering After Minimal Invasive Surgery).	Alexanian AR, 2008, STEM CELLS DEV, V17, P1123, DOI 10.1089/scd.2007.0212; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI15392; Corti S, 2004, J CELL MOL MED, V8, P329, DOI 10.1111/j.1582-4934.2004.tb00322.x; Cova L, 2010, BRAIN RES, V1311, P12, DOI 10.1016/j.brainres.2009.11.041; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Delcroix GJR, 2009, BRAIN RES, V1255, P18, DOI 10.1016/j.brainres.2008.12.013; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Doucette T, 2011, NEOPLASIA, V13, P716, DOI 10.1593/neo.101680; Duan HF, 2004, EXP CELL RES, V298, P593, DOI 10.1016/j.yexcr.2004.04.049; Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116; Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Gagari E, 2006, EUR J ORAL SCI, V114, P409, DOI 10.1111/j.1600-0722.2006.00388.x; Garzotto D, 2008, J NEUROSCI, V28, P5901, DOI 10.1523/JNEUROSCI.1083-08.2008; Giacobini P, 2002, ENDOCRINOLOGY, V143, P3306, DOI 10.1210/en.2002-220146; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huttenlocher A, 2005, NAT CELL BIOL, V7, P336, DOI 10.1038/ncb0405-336; Isakova IA, 2007, STEM CELLS, V25, P3261, DOI 10.1634/stemcells.2007-0543; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Jin HK, 2002, J CLIN INVEST, V109, P1183, DOI 10.1072/JCI200214862; Kao AP, 2011, FERTIL STERIL, V95, P1308, DOI 10.1016/j.fertnstert.2010.09.064; Kim SM, 2008, CANCER RES, V68, P9614, DOI 10.1158/0008-5472.CAN-08-0451; Kitada Masaaki, 2008, Nihon Rinsho, V66, P921; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lee WJ, 2006, CHEM-BIOL INTERACT, V160, P123, DOI 10.1016/j.cbi.2006.01.002; Lepski G, 2010, TISSUE ENG PT A, V16, P2769, DOI [10.1089/ten.tea.2009.0686, 10.1089/ten.TEA.2009.0686]; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668; Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Pisati F, 2007, CELL TRANSPLANT, V16, P41, DOI 10.3727/000000007783464443; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Ryu CH, 2010, BIOCHEM BIOPH RES CO, V398, P105, DOI 10.1016/j.bbrc.2010.06.043; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Segarra J, 2006, J BIOL CHEM, V281, P4771, DOI 10.1074/jbc.M508298200; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Shyu WC, 2007, STROKE, V38, P367, DOI 10.1161/01.STR.0000254463.24655.14; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Stephens P, 2001, WOUND REPAIR REGEN, V9, P34, DOI 10.1046/j.1524-475x.2001.00034.x; Sykova E, 2006, NEURODEGENER DIS, V3, P62, DOI 10.1159/000092095; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Tfilin M, 2010, MOL PSYCHIATR, V15, P1164, DOI 10.1038/mp.2009.110; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Vande Woude GF, 1997, CIBA F SYMP, V212, P119; VANDEWOUDE GF, 1997, CIBA F SYMP, V212, P130; VANDEWOUDE GF, 1997, CIBA FOUND S, V212, P148; Veit C, 2004, CANCER RES, V64, P5291, DOI 10.1158/0008-5472.CAN-04-1112; Wang JF, 2000, BLOOD, V95, P2505, DOI 10.1182/blood.V95.8.2505.008k24_2505_2513; Wang Lei, 2002, Hematology, V7, P113; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu GD, 2003, TRANSPLANTATION, V75, P679, DOI 10.1097/01.TP.0000048488.35010.95; Xu F, 2010, ONCOL REP, V23, P1561, DOI 10.3892/or_00000796; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Zhao Zhiqiang, 2011, Eur Cell Mater, V22, P344; ZICHA D, 1991, J CELL SCI, V99, P769; Zou CY, 2011, IN VITRO CELL DEV-AN, V47, P241, DOI 10.1007/s11626-010-9377-0	68	28	31	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	JAN	2013	228	1					149	162		10.1002/jcp.24114			14	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	018QW	WOS:000309678000019	22570218				2022-02-06	
J	Weisbrod, AB; Rodriguez, C; Bell, R; Neal, C; Armonda, R; Dorlac, W; Schreiber, M; Dunne, JR				Weisbrod, Allison B.; Rodriguez, Carlos; Bell, Randy; Neal, Christopher; Armonda, Rocco; Dorlac, Warren; Schreiber, Martin; Dunne, James R.			Long-term outcomes of combat casualties sustaining penetrating traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	42nd Annual Meeting of the Western-Trauma-Association	FEB 26-MAR 03, 2012	Vail, CO	Western Trauma Assoc		Trauma; head injury; traumatic brain injury; military; blast injury	CIVILIAN GUNSHOT WOUNDS; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; CRANIOCEREBRAL INJURIES; PREDICTION; MANAGEMENT; MORTALITY; REHABILITATION	BACKGROUND: Previous studies have documented short-term functional outcomes for patients sustaining penetrating brain injuries (PBIs). However, little is known regarding the long-term functional outcome in this patient population. Therefore, we sought to describe the long-term functional outcomes of combat casualties sustaining PBI. METHODS: Prospective data were collected from 2,443 patients. admitted to a single military institution during an 8-year period from 2003 to 2011. PBI was identified in 137 patients and constitute the study cohort. Patients were stratified by age, Injury Severity Score (ISS) and admission Glasgow Coma Scale (aGCS) score. Glasgow Outcome Scale (GOS) scores were calculated at discharge, 6 months, 1 year and 2 years. Patients with a GOS score of 4 or greater were considered to have attained functional independence (FI). RESULTS: The mean (SD) age of the cohort was 25 (7) years, mean (SD) ISS was 28 (9), and mean (SD) aGCS score was 8.8 (4.0). PBI mechanisms included gunshot wounds (31%) and blast injuries (69%). Invasive intracranial monitoring was used in 80% of patients, and 86.9% of the study cohort underwent neurosurgical intervention. Complications included cerebrospinal fluid leak (8.3%), venous thromboembolic events (15.3%), meningitis (24.8%), systemic infection (27.0%), and mortality (5.8%). The cohort was stratified by aGCS score and showed significant improvement in functional status when mean discharge GOS score was compared with mean GOS score at 2 years. For those with aGCS score of 3 to 5 (2.3 [0.9] vs. 2.9 [1.4], p < 0.01), 32% progressed to FI. For those with aGCS score of 6 to 8 (3.1 [0.7] vs. 4.0 [1.2], p < 0.0001), 63% progressed to FI. For those with aGCS score of 9 to 11(3.3 [0.5] vs. 4.3 [0.8], p < 0.0001), 74% progressed to FI. For those with aGCS score of 12 to 15 (3.9 [0.7] vs. 4.8 [0.4], p < 0.00001), 100% progressed to FI. CONCLUSION: Combat casualties with PBI demonstrated significant improvement in functional status up to 2 years from discharge, and a large proportion of patients sustaining severe PBI attained FI. (J Trauma Acute Care Surg. 2012;73: 1525-1530. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Weisbrod, Allison B.; Rodriguez, Carlos; Dunne, James R.] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD 20889 USA; [Bell, Randy; Neal, Christopher; Armonda, Rocco] Walter Reed Natl Mil Med Ctr, Dept Neurosurg, Bethesda, MD 20889 USA; [Dorlac, Warren] Univ Cincinnati, Dept Surg, Div Trauma Crit Care, Cincinnati, OH 45267 USA; [Schreiber, Martin] Oregon Hlth & Sci Univ, Dept Surg, Div Trauma Crit Care & Acute Care Surg, Portland, OR 97201 USA		Dunne, JR (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Gen Surg, 8901 Rockville Pike, Bethesda, MD 20889 USA.	Twobdun@aol.com					AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; Ahmadi SA, 2010, BRAIN INJURY, V24, P1539, DOI 10.3109/02699052.2010.523049; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Atabey C, 2012, BRIT J NEUROSURG, V26, P208, DOI 10.3109/02688697.2011.626875; BARLOW P, 1986, NEUROSURGERY, V19, P989, DOI 10.1227/00006123-198612000-00014; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cripps MW, 2009, AM SURGEON, V75, P44; Dosoglu M, 1999, NEUROCHIRURGIE, V45, P201; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; LEVI L, 1990, ISRAEL J MED SCI, V26, P548; LEVI L, 1990, ISRAEL J MED SCI, V26, P555; LEVI L, 1991, British Journal of Neurosurgery, V5, P241, DOI 10.3109/02688699109005183; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Ma JP, 2011, CRIT CARE, V15, DOI 10.1186/cc10358; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; POLIN RS, 1995, NEUROSURG CLIN N AM, V6, P689; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Rosenthal G, 2011, CRIT CARE MED, V39, P2575, DOI 10.1097/CCM.0b013e31822e56c7; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Yatsushige H, 2010, ACTA NEUROCHIR SUPPL, V106, P265, DOI 10.1007/978-3-211-98811-4_50; Zafonte RD, 1997, BRAIN INJURY, V11, P403; Zafonte RD, 2001, ARCH PHYS MED REHAB, V82, P306, DOI 10.1053/apmr.2001.18226	39	28	28	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2012	73	6					1525	1530		10.1097/TA.0b013e318270e179			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	058FV	WOS:000312620400026	23188247				2022-02-06	
J	Brady, KM; Easley, RB; Kibler, K; Kaczka, DW; Andropoulos, D; Fraser, CD; Smielewski, P; Czosnyka, M; Adams, GJ; Rhee, CJ; Rusin, CG				Brady, Ken M.; Easley, R. Blaine; Kibler, Kathleen; Kaczka, David W.; Andropoulos, Dean; Fraser, Charles D., III; Smielewski, Peter; Czosnyka, Marek; Adams, Gerald J.; Rhee, Christopher J.; Rusin, Craig G.			Positive end-expiratory pressure oscillation facilitates brain vascular reactivity monitoring	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						cerebrovascular autoregulation; pressure reactivity; positive end-expiratory pressure; neonatal	CEREBRAL PERFUSION-PRESSURE; NEAR-INFRARED SPECTROSCOPY; BLOOD-FLOW VELOCITY; CEREBROVASCULAR REACTIVITY; INTRACRANIAL-PRESSURE; PHASE RELATIONSHIP; AUTOREGULATION; INJURY; HUMANS	Brady KM, Easley RB, Kibler K, Kaczka DW, Andropoulos D, Fraser CD 3rd, Smielewski P, Czosnyka M, Adams GJ, Rhee CJ, Rusin CG. Positive end-expiratory pressure oscillation facilitates brain vascular reactivity monitoring. J Appl Physiol 113: 1362-1368, 2012. First published September 13, 2012; doi:10.1152/japplphysiol.00853.2012.-The pressure reactivity index (PRx) identifies optimal cerebral perfusion pressure after traumatic brain injury. We describe a method to improve PRx precision by induced variations in arterial blood pressure (ABP) using positive end-expiratory pressure (PEEP) modulation (iPRx). Neonatal swine (n = 10) were ventilated with static PEEP and then with PEEP oscillated between 5 and 10 cmH(2)O at a frequency of 1/min. PRx was recorded as a moving correlation coefficient between ABP and intracranial pressure (ICP) from spontaneous ABP activity (0.05-0.003 Hz) during static PEEP. iPRx was similarly recorded with PEEP oscillation-induced ABP waves. The lower limit of autoregulation (LLA) was delineated with continuous cortical laser Doppler flux monitoring. PEEP oscillation increased autoregulation-monitoring precision. The ratios of median absolute deviations to range of possible values for the PRx and iPRx were 9.5% (8.3-13.7%) and 6.2% (4.2-8.7%), respectively (P = 0.006; median, interquartile range). The phase-angle difference between ABP and ICP above LLA was 161 degrees (150 degrees-166 degrees) and below LLA, -31 degrees (-42 degrees to 12 degrees, P < 0.0001). iPRx above LLA was -0.42 (-0.67 to -0.29) and below LLA, 0.32 (0.22-0.43, P = 0.0004). A positive iPRx was 97% specific and 91% sensitive for perfusion pressure below LLA. PEEP oscillation caused stable, low-frequency ABP oscillations that reduced noise in the PRx. Safe translation of these findings to clinical settings is expected to yield more accurate and rapid delineation of individualized optimal perfusion-pressure goals for patients.	[Brady, Ken M.; Easley, R. Blaine; Kibler, Kathleen; Andropoulos, Dean; Adams, Gerald J.; Rhee, Christopher J.; Rusin, Craig G.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Kaczka, David W.] Harvard Univ, Sch Med, Boston, MA USA; [Fraser, Charles D., III] Univ Texas Houston, Sch Med, Houston, TX USA; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Neurosurg Unit, Cambridge CB2 2QQ, England		Brady, KM (corresponding author), Texas Childrens Hosp, Baylor Coll Med, 6621 Fannin,WT 17-417B, Houston, TX 77030 USA.	kbrady@texaschildrens.org	Kaczka, David W./U-2580-2018; Kaczka, David W./A-2984-2008	Kaczka, David W./0000-0003-4378-5242; Kaczka, David W./0000-0003-4378-5242; Smielewski, Peter/0000-0001-5096-3938; Rusin, Craig/0000-0003-3812-8133			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2010, ANESTH ANALG, V111, P191, DOI 10.1213/ANE.0b013e3181e054ba; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Diedler J, 2011, ANESTH ANALG, V113, P849, DOI 10.1213/ANE.0b013e3182285dc0; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lewis PM, 2008, ACTA NEUROCHIR, V150, P139, DOI 10.1007/s00701-007-1447-z; Pedersen TF, 2003, AM J PHYSIOL-HEART C, V285, pH1097, DOI 10.1152/ajpheart.00098.2003; Ragauskas A, 2005, ACTA NEUROCHIR SUPPL, V95, P367; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236	19	28	28	0	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587			J APPL PHYSIOL	J. Appl. Physiol.	NOV	2012	113	9					1362	1368		10.1152/japplphysiol.00853.2012			7	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	031NQ	WOS:000310649200003	22984248				2022-02-06	
J	Cuthbert, JP; Corrigan, JD; Whiteneck, GG; Harrison-Felix, C; Graham, JE; Bell, JM; Coronado, VG				Cuthbert, Jeffrey P.; Corrigan, John D.; Whiteneck, Gale G.; Harrison-Felix, Cynthia; Graham, James E.; Bell, Jeneita M.; Coronado, Victor G.			Extension of the Representativeness of the Traumatic Brain Injury Model Systems National Database: 2001 to 2010	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						methodology; rehabilitation; traumatic brain injury		Objective: To extend the representativeness of the Traumatic Brain Injury Model Systems National Database (TBIMS-NDB) for individuals 16 years and older, admitted for acute, inpatient rehabilitation in the United States with a primary diagnosis of traumatic brain injury (TBI) analyses completed by Corrigan and colleagues by comparing this data set to national data for patients admitted to inpatient rehabilitation with identical inclusion criteria that included 3 additional years of data and 2 new demographic variables. Design: Secondary analysis of existing data sets and extension of previously published analyses. Setting: Acute inpatient rehabilitation facilities. Participants: Patients 16 years and older with a primary rehabilitation diagnosis of TBI; the US TBI Rehabilitation population, n = 156 447; and the TBIMS-NDB population, n = 7373. Interventions: None. Main Outcome Measures: Demographics, functional status, and length of stay in hospital. Results: The TBIMS-NDB was largely representative of patients 16 years and older, admitted for rehabilitation in the United States with a primary diagnosis of TBI on or after October 1, 2001, and discharged as of December 31, 2010. The results of the extended analyses were similar to those reported by Corrigan and colleagues. Age accounted for the largest difference between the samples, with the TBIMS-NDB including a smaller proportion of patients 65 years and older than all those admitted for rehabilitation with a primary diagnosis of TBI in the United States. After partitioning each data set at age 65, most distributional differences found between samples were markedly reduced; however, differences in the preinjury vocational status of the employed and rehabilitation lengths of stay between 1 and 9 days remained robust. The subsamples of patients 64 years and younger were found to differ only slightly on all remaining variables, whereas those 65 years and older were found to have meaningful differences in insurance type and age distribution. Conclusions: These results reconfirm that the TBIMS-NDB is largely representative of patients with TBI receiving inpatient rehabilitation in the United States. Differences between the 2 data sets were found to be stable across the 3 additional years of data, and new differences were limited to those involving newly introduced variables. To use these data for population-based research, it is strongly recommended that statistical adjustment be conducted to account for the lower percentage of patients older than 65 years, inpatient rehabilitation stays less than 10 days, and preinjury vocational status in the TBIMS-NDB.	[Cuthbert, Jeffrey P.; Whiteneck, Gale G.; Harrison-Felix, Cynthia] Craig Hosp, Dept Res, Englewood, CO 80113 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Graham, James E.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX USA; [Bell, Jeneita M.; Coronado, Victor G.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Cuthbert, JP (corresponding author), Craig Hosp, Dept Res, 3425 S Clarkson St, Englewood, CO 80113 USA.	JCuthbert@Craighospital.org	Corrigan, John D./E-2921-2011		US Department of Health and Human Services (HHS); Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA; National Institute on Disability and Rehabilitation Research (NIDRR) [H133A110006]; US Department of EducationUS Department of Education; Office of Special Education and Rehabilitative Services; TBI Model System Centers grant from NIDRR [H133A070029]; National Institutes of Health National Center for Medical Rehabilitation Research within the National Institute of Child Health and Human Development [R24 HD065702]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065702, P2CHD065702] Funding Source: NIH RePORTER	This research was supported by an intra-agency agreement between the US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), and the National Institute on Disability and Rehabilitation Research (NIDRR), US Department of Education, Office of Special Education and Rehabilitative Services, with supplemental funding to the NIDRR-funded Traumatic Brain Injury (TBI) Model Systems National Data and Statistical Center (grant H133A110006). It was also supported by a TBI Model System Centers grant (H133A070029) from the NIDRR to Ohio State University and by a grant (R24 HD065702) from the National Institutes of Health National Center for Medical Rehabilitation Research within the National Institute of Child Health and Human Development. This article does not reflect the official policy or opinions of the CDC or the US Department of HHS and does not constitute an endorsement of the individuals or their programs-by CDC, HHS, or other components of the federal government-and none should be inferred. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated. The TBI Model Systems National Database is supported by the NIDRR and created and maintained by the TBI Model Systems Centers Program. However, these contents do not necessarily reflect the opinions or views of the TBI Model Systems Centers, the NIDRR, or the US Department of Education.	Center for Medicare & Medicaid Services, INP REH FAC PAT ASS; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Marr A., 2004, CENTRAL NERVOUS SYST; Stineman MG, 2002, ARCH PHYS MED REHAB, V83, P1802, DOI 10.1053/apmr.2002.36067; TBI Model Systems National Data and Statistical Center, TRAUM BRAIN INJ MOD	6	28	28	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					E15	E27		10.1097/HTR.0b013e31826da983			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200002	23131967	Green Accepted			2022-02-06	
J	Nishijima, DK; Shahlaie, K; Echeverri, A; Holmes, JF				Nishijima, Daniel K.; Shahlaie, Kiarash; Echeverri, Angela; Holmes, James F.			A clinical decision rule to predict adult patients with traumatic intracranial haemorrhage who do not require intensive care unit admission	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Intensive care; Clinical decision rule	COMPUTED AXIAL-TOMOGRAPHY; INJURY SEVERITY SCORE; BRAIN-INJURY; HEAD-INJURY; LOGISTIC-REGRESSION; EMERGENCY-MEDICINE; TREE ANALYSIS; GUIDELINES; STATES; CLASSIFICATION	Objective: To derive a clinical decision rule to identify adult emergency department (ED) patients with traumatic intracranial haemorrhage (tICH) who are at low risk for requiring critical care resources during hospitalization. Methods: This is a retrospective cohort study of patients (>= 18 years) with tICH presenting to the ED. The need for intensive care unit (ICU) admission was defined as the presence of a critical care intervention including: intubation, neurosurgical intervention, blood product transfusion, vasopressor or inotrope administration, invasive monitoring for haemodynamic instability, emergent treatment for arrhythmia, therapeutic angiography, and cardiopulmonary resuscitation. The decision rule was derived using binary recursive partitioning. Results: A total of 432 patients were identified (median age 48 years) of which 174 patients (40%) had a critical care intervention. We performed binary recursive partitioning with Classification and Regression Trees (CART) software to develop the clinical decision rule. Patients with a normal mental status (Glasgow Coma Score = 15), isolated head injury, and age < 65 were considered low risk for a critical care intervention. The derived rule had a sensitivity of 98% (95% confidence interval [CI] 94-99), a specificity of 50% (95% CI 44-56), a positive predictive value of 57% (95% CI 51-62), and a negative predictive value of 97% (95% CI 93-99). The area under the curve for the decision rule was 0.74 (95% CI 0.70-0.77). Conclusions: This clinical decision rule identifies low risk adult ED patients with tICH who do not need ICU admission. Further validation and refinement of these findings would allow for more appropriate ICU resource utilisation. (C) 2011 Elsevier Ltd. All rights reserved.	[Nishijima, Daniel K.; Echeverri, Angela; Holmes, James F.] Univ Calif Davis, Sch Med, Dept Emergency Med, Davis, CA USA; [Shahlaie, Kiarash] Univ Calif Davis, Sch Med, Dept Neurosurg, Davis, CA USA		Nishijima, DK (corresponding author), Univ Calif Davis, Med Ctr, Dept Emergency Med, 2315 Stockton Blvd,PSSB 2100, Sacramento, CA 95817 USA.	daniel.nishijima@ucdmc.ucdavis.edu		Nishijima, Daniel/0000-0003-4952-8212	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000002] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000002] Funding Source: NIH RePORTER		Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; [Anonymous], 1999, CRIT CARE MED, V27, P633; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Breiman L., 1984, CLASSIFICATION REGRE; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Bullock MR, 2006, NEUROSURGERY, V58, pS25; Bullock MR, 2006, NEUROSURGERY, V58, pS16; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; Escher M, 2004, BRIT MED J, V329, P425, DOI 10.1136/bmj.329.7463.425; Frost SA, 2009, RESUSCITATION, V80, P224, DOI 10.1016/j.resuscitation.2008.10.030; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-00017; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; HECKERLING PS, 1990, ANN INTERN MED, V113, P664, DOI 10.7326/0003-4819-113-9-664; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Hesdorffer DC, 2007, J TRAUMA, V63, P7; Hillman KM, 2002, INTENS CARE MED, V28, P1629, DOI 10.1007/s00134-002-1496-y; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2005, INTENS CARE MED, V31, P799, DOI 10.1007/s00134-005-2628-y; Huynh T, 2006, AM SURGEON, V72, P6; Huynh T, 2006, AM SURGEON, V72, P1162; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; SAX FL, 1987, CRIT CARE MED, V15, P510, DOI 10.1097/00003246-198705000-00012; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Worster A, 2005, ANN EMERG MED, V45, P448, DOI 10.1016/j.annemergmed.2004.11.021	41	28	28	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	NOV	2012	43	11					1827	1832		10.1016/j.injury.2011.07.020			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	014VR	WOS:000309404300009	21839444	Green Accepted			2022-02-06	
J	Squarcina, L; Bertoldo, A; Ham, TE; Heckemann, R; Sharp, DJ				Squarcina, Letizia; Bertoldo, Alessandra; Ham, Timothy E.; Heckemann, Rolf; Sharp, David J.			A robust method for investigating thalamic white matter tracts after traumatic brain injury	NEUROIMAGE			English	Article						Diffusion tensor imaging; Tractography; Thalamus; Traumatic axonal injury	DIFFUSE AXONAL INJURY; PROBABILISTIC TRACTOGRAPHY; STRUCTURAL CONNECTIVITY; MULTIPLE-SCLEROSIS; HEAD TRAUMA; TENSOR MRI; MILD; SEGMENTATION; NEUROPATHOLOGY; RECONSTRUCTION	Damage to the structural connections of the thalamus is a frequent feature of traumatic brain injury (TBI) and can be a key factor in determining clinical outcome. Until recently it has been difficult to quantify the extent of this damage in vivo. Diffusion tensor imaging (DTI) provides a validated method to investigate traumatic axonal injury, and can be applied to quantify damage to thalamic connections. DTI can also be used to assess white matter tract structure using tractography, and this technique has been used to study thalamo-cortical connections in the healthy brain. However, the presence of white matter injury can cause failure of tractography algorithms. Here, we report a method for investigating thalamo-cortical connectivity that bypasses the need for individual tractography. We first created a template for a number of thalamo-cortical connections using probabilistic tractography performed in ten healthy subjects. This template for investigating white matter structure was validated by comparison with individual tractography in the same group, as well as in an independent control group (N = 11). We also evaluated two methods of masking tract location using the tract skeleton generated by tract based spatial statistics, and a cerebrospinal fluid mask Voxel-wise estimates of fractional anisotropy derived from the template were more strongly correlated with individual tractography when both types of masking were used. The tract templates were then used to sample DTI measures from a group of TBI patients (N = 22), with direct comparison performed against probabilistic tractography in individual patients. Probabilistic tractography often failed to produce anatomically plausible tracts in TBI patients. Importantly, we show that this problem increases as tracts become more damaged, and leads to underestimation of the amount of traumatic axonal injury. In contrast, the tract template can be used in these cases, allowing a more accurate assessment of white matter damage. In summary, we propose a method suitable for assessing specific thalamo-cortical white matter connections after TBI that is robust to the presence of varying amounts of traumatic axonal injury, as well as highlighting the potential problems of applying tractography algorithms in patient populations. (C) 2012 Elsevier Inc. All rights reserved.	[Squarcina, Letizia; Bertoldo, Alessandra] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy; [Ham, Timothy E.; Sharp, David J.] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London W12 0NN, England; [Heckemann, Rolf] CERMEP Imagerie Vivant, Neurodis Fdn, F-69003 Lyon, France; [Heckemann, Rolf] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London W12 0NN, England		Sharp, DJ (corresponding author), Hammersmith Hosp, Computat Cognit & Clin Neuroimaging Lab, 3rd Floor,Burlington Danes Bldg,Du Cane Rd, London W12 0NN, England.	david.sharp@imperial.ac.uk	Sharp, David J/A-2119-2013; Heckemann, Rolf Andreas/H-9022-2019; Squarcina, Letizia/J-9869-2016	Heckemann, Rolf Andreas/0000-0003-3582-3683; Squarcina, Letizia/0000-0001-6209-4629; Bertoldo, Alessandra/0000-0002-6262-6354	Medical Research Council (UK)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); Imperial College Healthcare Charity; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701951] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0701951] Funding Source: UKRI	This work was supported by grants from The Medical Research Council (UK) to DJS and The Imperial College Healthcare Charity to DJS. We would like to thank all the subjects who took part in this study.	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Alkonyi B, 2011, AM J NEURORADIOL, V32, P962, DOI 10.3174/ajnr.A2417; Alkonyi B, 2010, EUR J PAEDIATR NEURO, V14, P425, DOI 10.1016/j.ejpn.2010.03.012; Andersson J, 2008, 14 ANN M ORG HUM BRA; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bruns J. Jr., 2003, EPILEPSIA, V10, P2, DOI DOI 10.1046/J.1528-1157.44.S10.3.X; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Glenn OA, 2003, J MAGN RESON IMAGING, V18, P641, DOI 10.1002/jmri.10420; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hashimoto K, 2007, J REHABIL MED, V39, P418, DOI 10.2340/16501977-0065; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kanaan RA, 2006, PSYCHIAT RES-NEUROIM, V146, P73, DOI 10.1016/j.pscychresns.2005.11.002; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reich DS, 2010, NEUROIMAGE, V49, P3047, DOI 10.1016/j.neuroimage.2009.11.043; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tozer DJ, 2012, NEUROIMAGE, V59, P3094, DOI 10.1016/j.neuroimage.2011.10.088; Traynor C, 2010, NEUROIMAGE, V52, P69, DOI 10.1016/j.neuroimage.2010.04.024; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	53	28	28	0	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119			NEUROIMAGE	Neuroimage	NOV 1	2012	63	2					779	788		10.1016/j.neuroimage.2012.07.016			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	013VY	WOS:000309335200015	22813952	hybrid, Green Published			2022-02-06	
J	Uthaikhup, S; Jull, G; Sungkarat, S; Treleaven, J				Uthaikhup, Sureeporn; Jull, Gwendolen; Sungkarat, Somporn; Treleaven, Julia			The influence of neck pain on sensorimotor function in the elderly	ARCHIVES OF GERONTOLOGY AND GERIATRICS			English	Article						Neck pain; Elderly; Sensorimotor; Postural control	CERVICOCEPHALIC KINESTHETIC SENSIBILITY; POSTURAL STABILITY; OLDER-ADULTS; WHIPLASH INJURY; VERTICALITY PERCEPTION; PERSISTENT WHIPLASH; BALANCE CONFIDENCE; STANDING BALANCE; GAIT PARAMETERS; CERVICAL-SPINE	Greater disturbances in sensorimotor control have been demonstrated in younger to middle aged groups. However, it is unknown whether or not the impairments documented in these populations can be extrapolated to elders with neck pain. The aim of this study was to investigate the influence of neck pain on sensorimotor function in elders. Twenty elders with neck pain (12 women and 8 men) and 20 healthy elder controls (14 women and 6 men) aged 65 years and over were recruited from the general community. Tests for sensorimotor function included; cervical joint position sense (JPS); computerised rod-and-frame test (RFT); smooth pursuit neck torsion test (SPNT); standing balance (under conditions of eyes open, eyes closed on firm and soft surfaces in comfortable stance); step test and ten-meter walk test with and without head movement. Elders with neck pain had greater deficits in the majority of sensorimotor function tests after controlling for effects of age and comorbidities. Significant differences were found in the SPNT (p < 0.01), error in the RFT (frame angled at 10 degrees and 15 degrees anticlockwise) (p < 0.05), standing balance (amplitude of sway) - eyes open on a firm surface in the medio-lateral (ML) direction (p = 0.03), and total number of steps on the step test, both left and right sides (p < 0.01). Elders with neck pain have greater sensorimotor disturbances than elders without neck pain, supporting a contribution of altered afferent information originating from the cervical spine to such disturbances. The findings may inform falls prevention and management programs. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Uthaikhup, Sureeporn; Sungkarat, Somporn] Chiang Mai Univ, Dept Phys Therapy, Fac Associated Med Sci, Chiang Mai 50200, Thailand; [Jull, Gwendolen; Treleaven, Julia] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld 4072, Australia; [Jull, Gwendolen; Treleaven, Julia] Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld 4072, Australia		Uthaikhup, S (corresponding author), Chiang Mai Univ, Dept Phys Therapy, Fac Associated Med Sci, Chiang Mai 50200, Thailand.	sureeporn.uthaikhup@cmu.ac.th	Treleaven, Julia M/F-8734-2010; Jull, Gwendolen/F-4233-2010; SUNGKARAT, SOMPORN/AAU-3448-2020; Treleaven, Julia/N-1379-2019	Treleaven, Julia M/0000-0002-6258-3972; Jull, Gwendolen/0000-0003-2670-1318; SUNGKARAT, SOMPORN/0000-0003-4283-7469; Treleaven, Julia/0000-0002-6258-3972	Chiang Mai University	This work has been funded by Chiang Mai University.	Ahmed Mohamed S, 2005, Phys Med Rehabil Clin N Am, V16, P19, DOI 10.1016/j.pmr.2004.06.017; Akdal G, 2009, HEADACHE, V49, P419, DOI 10.1111/j.1526-4610.2008.01256.x; Bagust J, 2005, ARCH PHYS MED REHAB, V86, P1062, DOI 10.1016/j.apmr.2004.05.022; Berkovits, 1996, PHYSIOTHER CAN, V48, P257, DOI [10.3138/ptc.48.4.257, DOI 10.3138/PTC.48.4.257]; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Bolton PS, 1998, J MANIP PHYSIOL THER, V21, P553; Bove M, 2002, J NEUROPHYSIOL, V88, P2232, DOI 10.1152/jn.00198.2002; Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Chamberlin ME, 2005, J GERONTOL A-BIOL, V60, P1163, DOI 10.1093/gerona/60.9.1163; Choy NL, 2003, J GERONTOL A-BIOL, V58, P525; Courtine G, 2003, NEUROREPORT, V14, P2365, DOI 10.1097/00001756-200312190-00015; CRESS ME, 1995, J AM GERIATR SOC, V43, P93, DOI 10.1111/j.1532-5415.1995.tb06372.x; della Volpe R, 2006, GAIT POSTURE, V24, P349, DOI 10.1016/j.gaitpost.2005.10.009; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Gill J, 2001, J GERONTOL A-BIOL, V56, pM438, DOI 10.1093/gerona/56.7.M438; Grod JP, 2002, ARCH PHYS MED REHAB, V83, P412, DOI 10.1053/apmr.2002.29660; Hatch J, 2003, PHYS THER, V83, P1072, DOI 10.1093/ptj/83.12.1072; Hawk Cheryl, 2006, Chiropr Osteopat, V14, P3, DOI 10.1186/1746-1340-14-3; Humphreys BK, 2008, J MANIP PHYSIOL THER, V31, P540, DOI 10.1016/j.jmpt.2008.08.007; Jacobson GP, 2008, J AM ACAD AUDIOL, V19, P799, DOI 10.3766/jaaa.19.10.7; Jull G, 2008, WHIPLASH HEADACHE NE; Kelders WPA, 2003, J PHYSIOL-LONDON, V553, P311, DOI 10.1113/jphysiol.2003.049338; Kogler A, 2000, ACTA OTO-LARYNGOL, V120, P151; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Liaw Mei-Yun, 2009, Chang Gung Med J, V32, P297; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; March LM, 1998, MED J AUSTRALIA, V168, P439, DOI 10.5694/j.1326-5377.1998.tb139023.x; Montfoort I, 2008, J NEUROTRAUM, V25, P687, DOI 10.1089/neu.2007.0314; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Poole E, 2008, MANUAL THER, V13, P317, DOI 10.1016/j.math.2007.02.002; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; Rix GD, 2001, ARCH PHYS MED REHAB, V82, P911, DOI 10.1053/apmr.2001.23300; Salzman B, 2010, AM FAM PHYSICIAN, V82, P61; Schrager MA, 2008, GAIT POSTURE, V28, P466, DOI 10.1016/j.gaitpost.2008.02.009; Shumway-Cook A, 2000, PHYS THER, V80, P896, DOI 10.1093/ptj/80.9.896; Storaci R, 2006, EUR SPINE J, V15, P1811, DOI 10.1007/s00586-006-0085-0; Tjell C, 1998, AM J OTOL, V19, P76; Tjell C., 2002, J WHIPLASH RELAT DIS, V1, P9, DOI [10.3109/J180v01n02_02, DOI 10.3109/J180V01N02_02]; Treleaven J, 2005, J REHABIL MED, V37, P219, DOI 10.1080/16501970410024299; Treleaven J, 2005, GAIT POSTURE, V21, P395, DOI 10.1016/j.gaitpost.2004.04.008; Treleaven J, 2003, J REHABIL MED, V35, P36, DOI 10.1080/16501970306109; Treleaven J, 2008, ARCH PHYS MED REHAB, V89, P522, DOI 10.1016/j.apmr.2007.11.002; Treleaven J, 2008, MANUAL THER, V13, P2, DOI 10.1016/j.math.2007.06.003; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vuillerme N, 2008, AGING CLIN EXP RES, V20, P355; Vuillerme N, 2009, EXP BRAIN RES, V192, P723, DOI 10.1007/s00221-008-1639-7; Woollacott MH, 1997, PHYS THER, V77, P646, DOI 10.1093/ptj/77.6.646	49	28	29	0	22	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0167-4943			ARCH GERONTOL GERIAT	Arch. Gerontol. Geriatr.	NOV-DEC	2012	55	3					667	672		10.1016/j.archger.2012.01.013			6	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology	004GC	WOS:000308667900023	22349008				2022-02-06	
J	Kim, JH; Jang, BG; Choi, BY; Kwon, LM; Sohn, M; Song, HK; Suh, SW				Kim, Jin Hee; Jang, Bong Geom; Choi, Bo Young; Kwon, Lyo Min; Sohn, Min; Song, Hong Ki; Suh, Sang Won			Zinc Chelation Reduces Hippocampal Neurogenesis after Pilocarpine-Induced Seizure	PLOS ONE			English	Article							HYPOGLYCEMIC NEURONAL DEATH; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; ADULT-RAT; DENTATE GYRUS; CELL-PROLIFERATION; CEREBRAL-ISCHEMIA; CHELATABLE ZINC; LIMBIC SEIZURES; GRANULE CELLS	Several studies have shown that epileptic seizures increase hippocampal neurogenesis in the adult. However, the mechanism underlying increased neurogenesis after seizures remains largely unknown. Neurogenesis occurs in the subgranular zone (SGZ) of the hippocampus in the adult brain, although an understanding of why it actively occurs in this region has remained elusive. A high level of vesicular zinc is localized in the presynaptic terminals of the SGZ. Previously, we demonstrated that a possible correlation may exist between synaptic zinc localization and high rates of neurogenesis in this area after hypoglycemia. Using a lithium-pilocarpine model, we tested our hypothesis that zinc plays a key role in modulating hippocampal neurogenesis after seizure. Then, we injected the zinc chelator, clioquinol (CQ, 30 mg/kg), into the intraperitoneal space to reduce brain zinc availability. Neuronal death was detected with Fluoro Jade-B and NeuN staining to determine whether CQ has neuroprotective effects after seizure. The total number of degenerating and live neurons was similar in vehicle and in CQ treated rats at 1 week after seizure. Neurogenesis was evaluated using BrdU, Ki67 and doublecortin (DCX) immunostaining 1 week after seizure. The number of BrdU, Ki67 and DCX positive cell was increased after seizure. However, the number of BrdU, Ki67 and DCX positive cells was significantly decreased by CQ treatment. Intracellular zinc chelator, N,N,N0,N-Tetrakis (2-pyridylmethyl) ethylenediamine (TPEN), also reduced seizure-induced neurogenesis in the hippocampus. The present study shows that zinc chelation does not prevent neurodegeneration but does reduce seizure-induced progenitor cell proliferation and neurogenesis. Therefore, this study suggests that zinc has an essential role for modulating hippocampal neurogenesis after seizure.	[Song, Hong Ki] Hallym Univ, Coll Med, Dept Neurol, Chunchon, South Korea; [Kim, Jin Hee; Jang, Bong Geom; Choi, Bo Young; Kwon, Lyo Min; Suh, Sang Won] Hallym Univ, Coll Med, Dept Physiol, Chunchon, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon, South Korea		Song, HK (corresponding author), Hallym Univ, Coll Med, Dept Neurol, Chunchon, South Korea.	hksong0@paran.com; swsuh@hallym.ac.kr	Kwon, Lyo Min/ABC-5338-2020	Kwon, Lyo Min/0000-0001-5611-2480; Choi, Bo Young/0000-0002-9579-3503; SOHN, MIN/0000-0003-4021-2051	Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A120202]	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120202).	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Corniola RS, 2008, BRAIN RES, V1237, P52, DOI 10.1016/j.brainres.2008.08.040; DANSCHER G, 1985, J HISTOCHEM CYTOCHEM, V33, P706, DOI 10.1177/33.7.4008918; DVERGSTEN CL, 1983, BRAIN RES, V271, P217, DOI 10.1016/0006-8993(83)90284-6; ECKENHOFF MF, 1988, J NEUROSCI, V8, P2729; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; GOLUB MS, 1994, AM J CLIN NUTR, V60, P238, DOI 10.1093/ajcn/60.2.238; GUENEAU G, 1982, DEV NEUROSCI-BASEL, V5, P345, DOI 10.1159/000112694; HALAS ES, 1983, PHYSIOL BEHAV, V30, P371, DOI 10.1016/0031-9384(83)90140-3; HOUSER CR, 1990, J NEUROSCI, V10, P267; Jo SM, 2000, BRAIN RES, V870, P163, DOI 10.1016/S0006-8993(00)02418-5; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kuhn HG, 1996, J NEUROSCI, V16, P2027; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; MANFORD M, 1992, NEUROLOGY, V42, P1911; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; OKANO HJ, 1993, J NEUROSCI, V13, P2930; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Park MH, 2011, NEUROBIOL DIS; PEREZCLAUSELL J, 1985, BRAIN RES, V337, P91, DOI 10.1016/0006-8993(85)91612-9; PERSINGER MA, 1988, PHYSIOL BEHAV, V44, P27, DOI 10.1016/0031-9384(88)90342-3; PRASAD AS, 1963, AM J CLIN NUTR, V12, P437, DOI 10.1093/ajcn/12.6.437; Sandstead HH, 2000, J NUTR, V130, p496S, DOI 10.1093/jn/130.2.496S; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; SEKI T, 1993, J NEUROSCI, V13, P2351, DOI 10.1523/JNEUROSCI.13-06-02351.1993; STEWART GR, 1984, BRAIN RES, V290, P43, DOI 10.1016/0006-8993(84)90734-0; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2005, DIABETES, V54, P500, DOI 10.2337/diabetes.54.2.500; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2003, J NEUROSCI, V23, P10681; Suh SW, 2001, NEUROREPORT, V12, P1523, DOI 10.1097/00001756-200105250-00044; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q	50	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48543	10.1371/journal.pone.0048543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	WOS:000310600500167	23119054	Green Submitted, gold, Green Published			2022-02-06	
J	Bagnato, S; Boccagni, C; Sant'Angelo, A; Prestandrea, C; Rizzo, S; Galardi, G				Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Prestandrea, Caterina; Rizzo, Silvia; Galardi, Giuseppe			Patients in a vegetative state following traumatic brain injury display a reduced intracortical modulation	CLINICAL NEUROPHYSIOLOGY			English	Article						Consciousness disorders; Cortical excitability; Cortical functions; Intracortical inhibition (ICI); Minimally conscious state; Transcranial magnetic stimulation (TMS)	HUMAN MOTOR CORTEX; MINIMALLY CONSCIOUS STATES; HEAD-INJURY; EXCITABILITY; STIMULATION; INHIBITION; DEFINITION; DISORDERS; NEURONS; SINGLE	Objective: Patients in coma who fail to wake develop a condition known as a vegetative state (VS). While we know that some cortical activities exist in patients in VS, it remains unclear whether interneuronal modulation can be abnormal in the cerebral cortex of these patients. The aim of the study was to evaluate the inhibitory and excitatory interneuronal circuits in patients in VS following a traumatic brain injury. Methods: Cortical excitability was studied in 5 VS patients and in 10 healthy subjects using paired pulses transcranial magnetic stimulation (TMS). Resting motor threshold and intracortical inhibition and facilitation at short intervals (2 and 10 ms, respectively) were evaluated. Two patients were studied again after their level of consciousness transitioned into a minimally conscious state (MCS). Results: Both intracortical inhibition and facilitation were significantly reduced in patients compared to healthy subjects (p < 0.05). In addition, these results did not significantly change in the 2 patients who evolved into a MCS. Conclusions: This is the first report showing an abnormal cortical excitability in patients in VS. Significance: Our findings suggest a pathophysiological base for future work aiming to restore the lack of interneuronal transmission in patients in VS. (C) 2012 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Prestandrea, Caterina; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Neurophysiol, I-90015 Cefalu, PA, Italy; [Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Rizzo, Silvia; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Unit Severe Acquired Brain Injuries, Rehabil Dept, I-90015 Cefalu, PA, Italy		Bagnato, S (corresponding author), Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Neurophysiol, Viale G Giardina, I-90015 Cefalu, PA, Italy.	sergiobagnato@gmail.com	Bagnato, Sergio/H-6842-2013	Bagnato, Sergio/0000-0002-6289-1887; Boccagni, Cristina/0000-0002-6317-015X			Abbruzzese G, 2002, J CLIN NEUROPHYSIOL, V19, P307, DOI 10.1097/00004691-200208000-00005; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Avesani M, 2008, EXP BRAIN RES, V187, P17, DOI 10.1007/s00221-008-1274-3; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Boccagni C, 2011, J CLIN NEUROPHYSIOL, V28, P489, DOI 10.1097/WNP.0b013e318231c8c8; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Clauss RP, 2010, MED HYPOTHESES, V75, P287, DOI 10.1016/j.mehy.2010.03.005; Deschenes M, 1996, NEUROSCIENCE, V72, P679, DOI 10.1016/0306-4522(96)00001-2; Fingelkurts AA, COGNIT PROC IN PRESS; Fingelkurts AA, 2012, CONSCIOUS COGN, V21, P149, DOI 10.1016/j.concog.2011.10.004; Fingelkurts AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025967; FONSECA M, 1993, NEUROSCIENCE, V55, P1107, DOI 10.1016/0306-4522(93)90324-9; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Molnar GF, 2006, NEUROLOGY, V66, P566, DOI 10.1212/01.wnl.0000198254.08581.6b; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Monti MM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3765; Muller-Dahlhaus JFM, 2008, J PHYSIOL-LONDON, V586, P495, DOI 10.1113/jphysiol.2007.142059; O'Connor RM, 2010, EUR J PHARMACOL, V639, P123, DOI 10.1016/j.ejphar.2010.02.059; Royal College of Physicians, 2003, PERM VEG STAT GUID D; Schabus M, 2011, FUNCT NEUROL, V26, P31; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schwenkreis P, 1999, NEUROSCI LETT, V270, P137, DOI 10.1016/S0304-3940(99)00492-9; Soddu A, 2011, FUNCT NEUROL, V26, P37; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	35	28	28	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2012	123	10					1937	1941		10.1016/j.clinph.2012.03.014			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	005GU	WOS:000308739700010	22560638				2022-02-06	
J	Macciocchi, S; Seel, RT; Warshowsky, A; Thompson, N; Barlow, K				Macciocchi, Stephen; Seel, Ronald T.; Warshowsky, Adam; Thompson, Nicole; Barlow, Kimether			Co-Occurring Traumatic Brain Injury and Acute Spinal Cord Injury Rehabilitation Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Cognition; Prognosis; Rehabilitation; Spinal cord injuries; Traumatic brain injuries	FUNCTIONAL INDEPENDENCE MEASURE; CLOSED HEAD-INJURY; COGNITIVE DYSFUNCTION; VALIDITY	Macciocchi S, Seel RT, Warshowsky A, Thompson N, Barlow K. Co-occurring traumatic brain injury and acute spinal cord injury rehabilitation outcomes. Arch Phys Med Rehabil 2012;93:1788-94. Objective: To determine the impact of co-occurring traumatic brain injury (TBI) on functional motor outcome and cognition during acute spinal cord injury (SCI) rehabilitation. Design: Prospective, longitudinal cohort. Setting: Single-center National Institute of Disability and Rehabilitation Research SCI Model System. Participants: Persons aged 16 to 59 years (N = 189) admitted for acute SCI rehabilitation during the 18-month recruitment window who met inclusion criteria. Interventions: Not applicable. Main Outcome Measures: FIM Motor Scale (Rasch transformed) and acute rehabilitation length of stay (LOS). Results: In the tetraplegia sample, co-occurring TBI was not related to FIM Motor Scale scores or acute rehabilitation LOS despite having negative impacts on memory and problem solving. Persons with paraplegia who sustained co-occurring severe TBI had lower admission and discharge FIM Motor Scale scores and longer acute rehabilitation LOS than did persons with paraplegia and either no TBI or mild TBI. Persons with paraplegia and severe TBI had lower functional comprehension, problem solving, and memory and impairments on tests of processing speed compared with persons with paraplegia and no TBI, mild TBI, and moderate TBI. Persons with paraplegia and co-occurring mild and moderate TBI had equivalent acute rehabilitation motor outcomes and cognitive functioning compared with persons with paraplegia and no TBI. Conclusions: This study provides evidence that persons aged 16 to 59 years with paraplegia and co-occurring severe TBI had worse motor outcomes and longer acute rehabilitation LOS than did persons with paraplegia and no TBI. Impairments in processing speed, comprehension, memory, and problem solving may explain suboptimal motor skill acquisition. Research with larger samples is required to determine whether mild and moderate TBI impact acute rehabilitation motor outcomes and LOS.	[Macciocchi, Stephen; Seel, Ronald T.; Warshowsky, Adam; Thompson, Nicole; Barlow, Kimether] Shepherd Ctr, Atlanta, GA 30309 USA; [Macciocchi, Stephen] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Macciocchi, S (corresponding author), Shepherd Ctr, 2020 Peachtree Rd, Atlanta, GA 30309 USA.	stephen_macciocchi@shepherd.org			National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H113G030004]	Supported by the National Institute on Disability and Rehabilitation Research, US Department of Education (grant no. H113G030004).	Benedict, 2001, HOPKINS VERBAL LEARN; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; Graves DE, 2006, J SPINAL CORD MED, V29, P39, DOI 10.1080/10790268.2006.11753855; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Marino RJ, 2003, J SPINAL CORD MED S1, V26, pS50; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; RICHARDS JS, 1991, ARCH PHYS MED REHAB, V72, P275; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Smith A, 1995, SYMBOL DIGIT MODALIT; STUTTS M, 1991, NEUROREHABILITATION, V3, P79; Trahan DE, 1988, CONTINUOUS VISUAL ME; Wechsler D., 1997, ADM SCORING MANUAL W; Wetzel L., 2000, SHORT CATEGORY TEST; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	25	28	29	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2012	93	10					1788	1794		10.1016/j.apmr.2012.01.022			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	018FP	WOS:000309645800014	22480549				2022-02-06	
J	Tu, Y; Chen, C; Sun, HT; Cheng, SX; Liu, XZ; Qu, Y; Li, XH; Zhang, S				Tu, Yue; Chen, Chong; Sun, Hong-Tao; Cheng, Shi-Xiang; Liu, Xiao-Zhi; Qu, Yang; Li, Xiao-hong; Zhang, Sai			Combination of Temperature-Sensitive Stem Cells and Mild Hypothermia: A New Potential Therapy for Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						mild hypothermia; stem cell; temperature-sensitive; transplantation; traumatic brain injury	LARGE-T-ANTIGEN; MARROW STROMAL CELLS; IN-VITRO MODEL; NONPERMISSIVE TEMPERATURE; NEURONAL DIFFERENTIATION; TRANSPLANTATION; LINES; GENE; TRANSFORMATION; EXPRESSION	Stem cell transplantation holds great potential for the treatment of traumatic brain injury (TBI). However, the micro-environment of reduced oxygen and accumulated toxins leads to low survival rates of grafted cells, which dramatically limits their clinical application. Mild hypothermia has been demonstrated to improve the micro-environment after severe TBI. Thus, we speculate that combinational therapy of mild hypothermia may promote survival of grafted cells, especially temperature-sensitive stem cells, which show the most activity in mild temperatures. In this study, we first isolated mesenchymal stem cells from umbilical cord (UCSMCs) and generated the temperature-sensitive UCSMCs (tsUCSMCs) by infection with a retrovirus carrying the temperature-sensitive tsA58 SV40 LT antigen gene. We demonstrated that tsUCSMCs grew and proliferated with more activity at 33 degrees C than at 37 degrees C by counting cell numbers with a hematocytometer, measuring the cell cycle with flow cytometry, and detecting proliferating cell nuclear antigen (PCNA) with immunofluorescence staining. Thereafter, we established the rat severe TBI model by fluid percussion, and injected PBS, UCSMCs, or tsUCSMCs into the injured region, and subject the animals to normothermia or mild hypothermia (33 degrees C). We found that, compared with UCSMC or tsUCSMC treatment alone, their combination with hypothermia could significantly improve motor and cognitive function with more survival of the grafted cells. Furthermore, we observed that combined therapy with hypothermia and tsUCSMCs exerted the most protective effect on the recovery of neurological function of all the tested treatments, with the highest survival and proliferation rates, and the lowest apoptosis rate. Thus this may represent a new therapeutic strategy for the treatment of severe TBI.	[Tu, Yue; Chen, Chong; Sun, Hong-Tao; Cheng, Shi-Xiang; Liu, Xiao-Zhi; Qu, Yang; Li, Xiao-hong; Zhang, Sai] Chinese Peoples Armed Police Forces, Logist Coll, Pingjin Hosp, Inst Traumat Brain Injury & Neurol, Tianjin 300162, Peoples R China		Zhang, S (corresponding author), Chinese Peoples Armed Police Forces, Logist Coll, Pingjin Hosp, Inst Traumat Brain Injury & Neurol, Tianjin 300162, Peoples R China.	Zhangsai718@yahoo.com			National Nature Scientific Fund of China [30872668]	This work was supported by the National Nature Scientific Fund of China (grant no. 30872668).	Bacher A, 1998, ANESTHESIOLOGY, V88, P403, DOI 10.1097/00000542-199802000-00019; Brinkkoetter PT, 2008, CELL PHYSIOL BIOCHEM, V22, P195, DOI 10.1159/000149797; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Chen LM, 2012, J NEUROCHEM, V120, P157, DOI 10.1111/j.1471-4159.2011.07275.x; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Ebihara S, 2004, J BIOCHEM, V136, P321, DOI 10.1093/jb/mvh120; Fu YS, 2004, J BIOMED SCI, V11, P652, DOI 10.1159/000079678; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GLOBUS MYT, 1987, NEUROLOGY, V37, P1712, DOI 10.1212/WNL.37.11.1712; Hasan SM, 2010, CELL TRANSPLANT, V19, P1291, DOI 10.3727/096368910X505477; Hernandez TD, 2006, J NEUROTRAUM, V23, P1211, DOI 10.1089/neu.2006.23.1211; Hsieh JK, 2000, ARTERIOSCL THROM VAS, V20, P973, DOI 10.1161/01.ATV.20.4.973; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; Kanehira M, 2006, J BIOCHEM, V140, P211, DOI 10.1093/jb/mvj140; Karlsson J, 2005, CELL TRANSPLANT, V14, P301, DOI 10.3727/000000005783983089; Karlsson J, 2000, NEUROREPORT, V11, P1665, DOI 10.1097/00001756-200006050-00014; Kawai N, 2000, J NEUROTRAUM, V17, P193, DOI 10.1089/neu.2000.17.193; Kohno S, 2011, CELL BIOL INT, V35, P325, DOI 10.1042/CBI20090344; Koizumi M, 2004, BIOCHEM BIOPH RES CO, V319, P612, DOI 10.1016/j.bbrc.2004.04.196; Larsson O, 2004, CANCER RES, V64, P482, DOI 10.1158/0008-5472.CAN-03-1872; Li XH, 2012, NEUROBIOL AGING, V33, P1400, DOI 10.1016/j.neurobiolaging.2011.02.003; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Obinata M, 1997, GENES CELLS, V2, P235, DOI 10.1046/j.1365-2443.1997.1160314.x; Oostendorp RAJ, 2002, J CELL SCI, V115, P2099; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Shindo T, 2006, J MED INVESTIG, V53, P42, DOI 10.2152/jmi.53.42; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Tabuchi Y, 2005, BIOCHEM BIOPH RES CO, V329, P947, DOI 10.1016/j.bbrc.2005.02.065; TEGTMEYER P, 1975, J VIROL, V15, P613, DOI 10.1128/JVI.15.3.613-618.1975; Tran LD, 2006, J NEUROTRAUM, V23, P1330, DOI 10.1089/neu.2006.23.1330; Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Yan Y, 2010, J CLIN NEUROSCI, V17, P196, DOI 10.1016/j.jocn.2009.05.022; YANAI N, 1994, EXP CELL RES, V211, P296, DOI 10.1006/excr.1994.1090; Yano S, 2005, BRAIN RES, V1065, P60, DOI 10.1016/j.brainres.2005.10.031; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang F, 2009, J CEREBR BLOOD F MET, V29, P1022, DOI 10.1038/jcbfm.2009.28	52	28	36	2	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2012	29	14					2393	2403		10.1089/neu.2012.2374			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	004SM	WOS:000308701400003	22655683	Green Published			2022-02-06	
J	Van Calster, B; Van Belle, V; Vergouwe, Y; Steyerberg, EW				Van Calster, Ben; Van Belle, Vanya; Vergouwe, Yvonne; Steyerberg, Ewout W.			Discrimination ability of prediction models for ordinal outcomes: Relationships between existing measures and a new measure	BIOMETRICAL JOURNAL			English	Article						c-Index; Discrimination; Model performance; Ordinal outcomes; Prediction models	TRAUMATIC BRAIN-INJURY; CONFIDENCE-INTERVALS; EXTERNAL VALIDATION; ROC ANALYSIS; RISK; AREA; ACCURACY; CURVE; ASSOCIATION; PERFORMANCE	In this paper, we focus on measures to evaluate discrimination of prediction models for ordinal outcomes. We review existing extensions of the dichotomous c-indexwhich is equivalent to the area under the receiver operating characteristic (ROC) curvesuggest a new measure, and study their relationships. The volume under the ROC surface (VUS) scores sets of cases including one case from each outcome category. VUS considers sets as either correctly or incorrectly ordered by the model. All other existing measures assess pairs of cases. We propose an ordinal c-index (ORC) that is set-based but, contrary to VUS, scores sets more gradually by indicating the closeness of the model-based ordering to the perfect ordering. As a result, the ORC does not decrease rapidly as the number of outcome categories increases. It turns out that the ORC can be rewritten as the average of pairwise c-indexes. Hence, the ORC has both a set- and pair-based interpretation. There are several relationships between the existing measures, leading to only two types of existing measures: a prevalence-weighted average of pairwise c-indexes and the VUS. Our suggested measure ORC positions itself in between as it is set-based but turns out to equal an unweighted average of pairwise c-indexes. The measures are demonstrated through a case study on the prediction of six-month outcome after traumatic brain injury. In conclusion, the set-based nature and graded scoring system make the ORC an attractive measure with a simple interpretation, together with its prevalence-independence that is a natural property of a discrimination measure.	[Van Calster, Ben] Univ Louvain, KU Leuven, Dept Dev, B-3000 Louvain, Belgium; [Van Belle, Vanya] Univ Louvain, KU Leuven, Dept Elect Engn ESAT SCD, B-3001 Louvain, Belgium; [Van Belle, Vanya] Univ Louvain, KU Leuven, IBBT Future Hlth Dept, B-3001 Louvain, Belgium; [Vergouwe, Yvonne; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands		Van Calster, B (corresponding author), Univ Louvain, KU Leuven, Dept Dev, Herestr 49,Box 7003, B-3000 Louvain, Belgium.	ben.vancalster@med.kuleuven.be	Steyerberg, Ewout W/C-1509-2018; Van Calster, Ben/F-9150-2010	Steyerberg, Ewout W/0000-0002-7787-0122; Van Calster, Ben/0000-0003-1613-7450	Research Foundation - Flanders (FWO)FWO [1.2516.09 N, 1.2516.12 N, G.0493.12 N]; Katholieke Universiteit LeuvenKU Leuven; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-042691]; Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [9120.8004]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042691] Funding Source: NIH RePORTER	Ben Van Calster was supported by the Research Foundation - Flanders (FWO) (grants 1.2516.09 N, 1.2516.12 N, G.0493.12 N). Vanya Van Belle was supported by a BOF-PDM postdoctoral fellowship from the Katholieke Universiteit Leuven. Ewout Steyerberg was supported by NIH (NS-042691). Yvonne Vergouwe was supported by the Netherlands Organization for Scientific Research (grant 9120.8004).	Adams NM, 2000, COMPUT BIOL MED, V30, P89, DOI 10.1016/S0010-4825(99)00025-6; Alonzo TA, 2009, STAT MED, V28, P1144, DOI 10.1002/sim.3536; Baker SG, 2009, J R STAT SOC A STAT, V172, P729, DOI 10.1111/j.1467-985X.2009.00592.x; BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P109, DOI 10.1016/0895-4356(90)90064-V; Flandre P, 2007, STAT MED, V26, P4441, DOI 10.1002/sim.2871; Gerds TA, 2008, BIOMETRICAL J, V50, P457, DOI 10.1002/bimj.200810443; Gerds TA, 2011, BIOMETRICAL J, V53, P259, DOI 10.1002/bimj.201000157; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1998, STAT MED, V17, P909, DOI 10.1002/(SICI)1097-0258(19980430)17:8<909::AID-SIM753>3.0.CO;2-O; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE Jr, 2017, REGRESSION MODELING; Herbrich R, 2000, ADV NEUR IN, P115; HILDEN J, 1991, MED DECIS MAKING, V11, P95, DOI 10.1177/0272989X9101100204; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; JENNETT B, 1975, LANCET, V1, P480; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; KIM JO, 1971, AM J SOCIOL, V76, P891, DOI 10.1086/225004; Mossman D, 1999, MED DECIS MAKING, V19, P78, DOI 10.1177/0272989X9901900110; Nakas CT, 2004, STAT MED, V23, P3437, DOI 10.1002/sim.1917; Newcombe RG, 2006, STAT MED, V25, P559, DOI 10.1002/sim.2324; Newcombe RG, 2006, STAT MED, V25, P543, DOI 10.1002/sim.2323; Obuchowski NA, 2005, ACAD RADIOL, V12, P1198, DOI 10.1016/j.acra.2005.05.013; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Scurfield BK, 1996, J MATH PSYCHOL, V40, P253, DOI 10.1006/jmps.1996.0024; Smith WD, 1996, STAT MED, V15, P1199, DOI 10.1002/(SICI)1097-0258(19960615)15:11<1199::AID-SIM218>3.0.CO;2-Y; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Terpstra JT, 2003, J NONPARAMETR STAT, V15, P289, DOI 10.1080/1048525031000078349; Timmerman D, 2010, ULTRASOUND OBST GYN, V36, P226, DOI 10.1002/uog.7636; Van Calster B, 2010, STAT MED, V29, P318, DOI 10.1002/sim.3761; Van Holsbeke C, 2012, CLIN CANCER RES, V18, P815, DOI 10.1158/1078-0432.CCR-11-0879; Vergouwe Yvonne, 2002, Semin Urol Oncol, V20, P96, DOI 10.1053/suro.2002.32521; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Waegeman W, 2008, PATTERN RECOGN LETT, V29, P1, DOI 10.1016/j.patrec.2007.07.019; Xiong CJ, 2006, STAT MED, V25, P1251, DOI 10.1002/sim.2433	41	28	28	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0323-3847	1521-4036		BIOMETRICAL J	Biom. J.	SEP	2012	54	5					674	685		10.1002/bimj.201200026			12	Mathematical & Computational Biology; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Mathematics	995TQ	WOS:000308036200006	22711459				2022-02-06	
J	Tsai, J; Whealin, JM; Scott, JC; Harpaz-Rotem, I; Pietrzak, RH				Tsai, Jack; Whealin, Julia M.; Scott, J. Cobb; Harpaz-Rotem, Ilan; Pietrzak, Robert H.			Examining the Relation Between Combat-Related Concussion, a Novel 5-Factor Model of Posttraumatic Stress Symptoms, and Health-Related Quality of Life in Iraq and Afghanistan Veterans	JOURNAL OF CLINICAL PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; OPERATIONS ENDURING FREEDOM; DYSPHORIC AROUSAL; DISORDER; PTSD; DIMENSIONALITY; CHALLENGES; CHECKLIST; HOSTILITY; SLEEP	Objective: This study examined demographic, military, and clinical characteristics associated with combat-related concussion and persistent postconcussive symptoms; and how combat-related concussion and persistent postconcussive symptoms and a novel 5-factor model of posttraumatic stress disorder (PTSD) symptoms are related to physical and mental health-related quality of life in veterans who served in Iraq and Afghanistan. Method: 233 veterans recruited from the Veterans Affairs Hawaii Program Registry who served in Iraq and Afghanistan completed a survey in 2010 that assessed combat-related concussion and persistent postconcussive symptoms, PTSD (DSM-IV criteria), alcohol use problems, and physical and mental health-related quality of life. The primary measure was physical and mental health-related quality of life as assessed by the 12-item Short-Form Health Survey, version 2. Results: Veterans who screened positive for combat-related concussion and persistent postconcussive symptoms were more likely than those who did not to report direct combat exposure (x(2) = 15.46, P < .001), living in a rural area (x(2) = 6.86, P < .01), and screening positive for PTSD (x(2) = 37.67, P < .001) and alcohol use problems (x(2) = 11.62, P < .01); 57.3% of veterans who screened positive for combat-related concussion and persistent postconcussive symptoms screened positive for PTSD. In bivariate analyses, combat-related concussion and persistent postconcussive symptoms were associated with lower scores on measures of physical and mental health-related quality of life (r=-0.27 to -0.45, P < .001). In multivariate analyses, combat-related concussion and persistent postconcussive symptoms were no longer related to these outcomes, with PTSD-related dysphoric arousal symptoms as the strongest predictor of physical health-related quality of life (beta=-0.55, P < .001) and PTSD-related emotional numbing symptoms (beta=-0.56, P < .001) as the strongest predictor of mental health-related quality of life. Conclusions: Results of this study suggest that a 5-factor model of PTSD symptoms may provide greater specificity in understanding the relation between combat-related concussion and persistent postconcussive symptoms, PTSD symptoms, and health-related physical and mental quality of life in Iraq/Afghanistan veterans. Psychiatric clinicians should consider this heterogeneity of PTSD symptoms when assessing and treating symptomatic veterans. J Clin Psychiatry 2012;73(8):1110-1118 (c) Copyright 2012 Physicians Postgraduate Press, Inc.	[Tsai, Jack; Harpaz-Rotem, Ilan] VA New England Mental Illness Res Educ & Clin Ctr, West Haven, CT USA; [Scott, J. Cobb; Harpaz-Rotem, Ilan; Pietrzak, Robert H.] VA Connecticut Healthcare Syst, Clin Neurosci Div, Natl Ctr Posttraumat Stress Disorder, West Haven, CT USA; [Tsai, Jack; Scott, J. Cobb; Harpaz-Rotem, Ilan; Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Whealin, Julia M.] VA Pacific Isl Hlth Care Syst, Honolulu, HI USA		Tsai, J (corresponding author), Yale Univ, Dept Psychiat, 950 Campbell Ave,151D, West Haven, CT 06516 USA.	Jack.Tsai@yale.edu	Tsai, Jack/D-3889-2013; Whealin, Julia/J-8819-2015	Tsai, Jack/0000-0002-0329-648X; Scott, J. Cobb/0000-0001-6538-9043; Whealin, Julia/0000-0002-2876-6783; harpaz-rotem, ilan/0000-0002-6066-9406	Health Services Research and Development; US Department of Veterans AffairsUS Department of Veterans Affairs; Clinical Neurosciences Division of the National Center for Posttraumatic Stress Disorder; Veterans Affairs Pacific Islands Health Care System	This work was funded by a Health Services Research and Development grant from the US Department of Veterans Affairs and was supported by the Clinical Neurosciences Division of the National Center for Posttraumatic Stress Disorder, the Veterans Affairs Pacific Islands Health Care System, and a private donation.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2008, STAT PACK SOC SCI SP; [Anonymous], 2008, MILD TRAUM BRAIN INJ; Armed Forces Health Surveillance Center (AFHSC), 2011, MSMR, V18, P2; Armour C, 2012, J ANXIETY DISORD, V26, P368, DOI 10.1016/j.janxdis.2011.12.002; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; Beckham JC, 2009, BIOL PSYCHIAT, V65, P268, DOI 10.1016/j.biopsych.2008.06.024; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Bentler P.M., 2001, EQS 6 STRUCTURAL EQU; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Clum GA, 2001, J NERV MENT DIS, V189, P618, DOI 10.1097/00005053-200109000-00008; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Dhalla S, 2007, CLIN INVEST MED, V30, P33, DOI 10.25011/cim.v30i1.447; DSM-5 Development, DSM 5 DEV G 05 POSTT; Elhai JD, 2011, J ANXIETY DISORD, V25, P340, DOI 10.1016/j.janxdis.2010.10.007; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Feeny NC, 2000, J TRAUMA STRESS, V13, P489, DOI 10.1023/A:1007789409330; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Han SD, 2009, J HEAD TRAUMA REHAB, V24, P57, DOI 10.1097/HTR.0b013e3181957055; Harder LH, 2011, J NERV MENT DIS, V199, P940, DOI 10.1097/NMD.0b013e3182392bfb; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; KUBANY ES, 1994, J TRAUMA STRESS, V7, P21, DOI 10.1002/jts.2490070104; LITZ BT, 1992, CLIN PSYCHOL REV, V12, P417, DOI 10.1016/0272-7358(92)90125-R; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mohr D, 2003, PSYCHOSOM MED, V65, P485, DOI 10.1097/01.PSY.0000041404.96597.38; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pietrzak RH, 2012, J PSYCHIATR RES, V46, P317, DOI 10.1016/j.jpsychires.2011.11.013; Pietrzak RH, 2010, PSYCHIAT RES, V178, P323, DOI 10.1016/j.psychres.2010.04.039; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Riviere LA, 2011, J NERV MENT DIS, V199, P199, DOI 10.1097/NMD.0b013e31820caee4; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tabachnick B, 2001, USING MULTIVARIATE A; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Tsai J, 2011, J AFFECT DISORDERS, V135, P310, DOI 10.1016/j.jad.2011.06.057; Wang L, 2011, DEPRESS ANXIETY, V28, P1097, DOI 10.1002/da.20823; Wang L, 2011, J ANXIETY DISORD, V25, P771, DOI 10.1016/j.janxdis.2011.03.011; Wang L, 2011, J ABNORM CHILD PSYCH, V39, P749, DOI 10.1007/s10802-011-9508-4; Ware J. E., 2002, VERSION 2 SF 12 HLTH; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Weathers FW, 1991, PCL C DSM 4	56	28	28	0	13	PHYSICIANS POSTGRADUATE PRESS	MEMPHIS	P O BOX 752870, MEMPHIS, TN 38175-2870 USA	0160-6689	1555-2101		J CLIN PSYCHIAT	J. Clin. Psychiatry	AUG	2012	73	8					1110	1118		10.4088/JCP.11m07587			9	Psychology, Clinical; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	090SM	WOS:000315000300006	22781019				2022-02-06	
J	Kaneko, T; Kibayashi, K				Kaneko, Tomomi; Kibayashi, Kazuhiko			Mild hypothermia facilitates the expression of cold-inducible RNA-binding protein and heat shock protein 70.1 in mouse brain	BRAIN RESEARCH			English	Article						Mild hypothermia; Cold ambience; CIRP; hsp70.1; Cytokine; Cell survival	MAMMALIAN HIBERNATION; CEREBRAL-ISCHEMIA; CIRP EXPRESSION; GENE-EXPRESSION; MICE; TEMPERATURE; RESUSCITATION; ACCLIMATION; ACTIVATION; MECHANISM	An appropriate thermal control system is essential for maintaining brain homeostasis. Hypothermia is a decrease in core body temperature that occurs when the thermoregulatory responses of homeotherrnic animals are impaired by environmental and situational influences, such as cold ambience and anesthesia. In recent years, hypothermia has been used for medical treatment, i.e., therapeutic hypothermia, for patients with stroke, traumatic brain injury, and heart surgery. However, the target molecules acting during hypothermia have not been identified. To understand the molecular mechanisms, we generated a mouse model of mild hypothermia (1 degrees C-2 degrees C below normal), and analyzed the expression of several genes. After mice were exposed to cold for 24 and 48 h, their rectal temperature reached 33 degrees C-35 degrees C. Then, using real-time quantitative PCR, we analyzed the mRNA expression levels of c-fos, cold-inducible RNAbinding protein (CIRP), heat shock protein (hsp) 70.1, oxytocin, and representative inflammatory cytokines, i.e., tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 in target organs. Importantly, we found that the expression levels of CIRP and hsp70.1 were elevated in the olfactory bulb within 48 h. In the hypothalamus, CIRP expression levels increased and were followed by an increase in hsp70.1 expression. Meanwhile, TNF-alpha and IL-6 expression decreased gradually over 24 and 48 h in the olfactory bulb and hypothalamus. These specific expression profiles, i.e., enhanced CIRP and hsp70.1 expression and depressed cytokine expression, suggest that they could regulate apoptosis related to the cytokine signaling. (c) 2012 Elsevier B.V. All rights reserved.	[Kaneko, Tomomi; Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, Tokyo 1628666, Japan		Kaneko, T (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	kaneko@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [23790730, 21659177]	This research was supported by a Grant-in-Aid for Young Scientists (B) (No. 23790730) to Dr. T. Kaneko and a Grant-inAid for Challenging Exploratory Research (No. 21659177) to Dr. K. Kibayashi from the Japan Society for the Promotion of Science.	Al-Fageeh MB, 2009, RNA, V15, P1164, DOI 10.1261/rna.1179109; Belsham DD, 2004, ENDOCRINOLOGY, V145, P393, DOI 10.1210/en.2003-0946; Bischoff F, 1942, CANCER RES, V2, P370; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Carlson NG, 1999, J IMMUNOL, V163, P3963; CARTER N, 1995, INT J LEGAL MED, V108, P116, DOI 10.1007/BF01369918; Furuse M, 2007, NEUROL RES, V29, P53, DOI 10.1179/174313206X152537; Garrido C, 2001, BIOCHEM BIOPH RES CO, V286, P433, DOI 10.1006/bbrc.2001.5427; Hagioka S, 2003, CRIT CARE MED, V31, P2502, DOI 10.1097/01.CCM.0000084845.76762.F4; Ji Y, 2002, COMPUT BIOL MED, V32, P495, DOI 10.1016/S0010-4825(02)00030-6; Kasahara Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3122, DOI 10.1271/bbb.70498; Kibayashi K, 2009, INT J LEGAL MED, V123, P371, DOI 10.1007/s00414-008-0278-7; Lapiz-Bluhm MDS, 2009, PSYCHOPHARMACOLOGY, V202, P329, DOI 10.1007/s00213-008-1224-6; Lapo IB, 2003, PHYSIOL BEHAV, V78, P345, DOI 10.1016/S0031-9384(02)01004-1; Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604; LIU AYC, 1994, J BIOL CHEM, V269, P14768; Matsui T, 2006, J NEUROSURG ANESTH, V18, P189, DOI 10.1097/01.ana.0000188639.39844.f6; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; McPherson CA, 2011, BRAIN BEHAV IMMUN, V25, P850, DOI 10.1016/j.bbi.2010.09.003; Meng XZ, 2002, SHOCK, V17, P345, DOI 10.1097/00024382-200205000-00001; Morin P, 2009, INT J DEV BIOL, V53, P433, DOI 10.1387/ijdb.082643pm; Nishimura M, 1999, PHARMACOLOGY, V59, P149, DOI 10.1159/000028315; Nishiyama H, 1998, BIOCHEM BIOPH RES CO, V245, P534, DOI 10.1006/bbrc.1998.8482; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Nishiyama H, 1998, AM J PATHOL, V152, P289; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Sakurai T, 2006, BBA-MOL CELL RES, V1763, P290, DOI 10.1016/j.bbamcr.2006.02.007; SATO K, 1994, CLIN SCI, V86, P133, DOI 10.1042/cs0860133; Shintani Y, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/809874; Takata T, 1997, NEUROSCI LETT, V227, P41, DOI 10.1016/S0304-3940(97)00296-6; Tatar CL, 2010, ASN NEURO, V2, DOI 10.1042/AN20100016; Terao Y, 2009, NEUROREPORT, V20, P745, DOI 10.1097/WNR.0b013e32832a2f32; Wirth D, 2002, CELL STRESS CHAPERON, V7, P387, DOI 10.1379/1466-1268(2002)007<0387:DHSGHR>2.0.CO;2; Wolfson MR, 2008, NEUROCRIT CARE, V8, P437, DOI 10.1007/s12028-008-9064-0; Zeiner A, 2000, STROKE, V31, P86, DOI 10.1161/01.STR.31.1.86	37	28	35	1	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 23	2012	1466						128	136		10.1016/j.brainres.2012.05.001			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	989ZH	WOS:000307600300013	22609236				2022-02-06	
J	Gibson, TJ; Ridler, AL; Lamb, CR; Williams, A; Giles, S; Gregory, NG				Gibson, T. J.; Ridler, A. L.; Lamb, C. R.; Williams, A.; Giles, S.; Gregory, N. G.			Preliminary evaluation of the effectiveness of captive-bolt guns as a killing method without exsanguination for horned and unhorned sheep	ANIMAL WELFARE			English	Article						animal welfare; captive bolt; disease control; ewes; rams; sheep horned and polled	BRAIN-FUNCTION; CONCUSSIVE METHODS; SLAUGHTER; CATTLE; CALVES; RESPONSES; INJURY	The current study aims to make welfare-based recommendations for gun/cartridge combinations and shooting positions that will ensure death of the sheep (horned, unhorned, rams and ewes), without the need for either sticking or pithing. The study examined the pathophysiology of captive-bolt gun (CBG) injuries that result in incomplete concussion leading to death. Behavioural, brainstem and cranial/spinal responses were examined along with gross pathology in 489 animals (116 polled ewes, 134 horned ewes, 117 polled rams and 122 horned rams) following a variety of CBG-cartridge combinations. Shooting horned rams was more challenging than unhorned sheep, partly because minor movements of the head at the time of shooting can result in deflection of the gun by the horns. Marksmanship was the definitive factor: 100% of animals that showed signs of incomplete concussion were found to have been shot incorrectly. The findings will have application when it is necessary to kill sheep on farms for disease control or euthanasia purposes.	[Gibson, T. J.; Lamb, C. R.; Gregory, N. G.] Univ London Royal Vet Coll, Dept Vet Clin Sci, Hatfield AL9 7TA, Herts, England; [Ridler, A. L.] Massey Univ, Inst Vet Anim & Biomed Sci, Pamerston North 4442, New Zealand; [Williams, A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Giles, S.] Univ Bristol, Sch Clin Vet Sci, Anim Welf & Behav Grp, Bristol BS8 1TH, Avon, England		Gibson, TJ (corresponding author), Univ London Royal Vet Coll, Dept Vet Clin Sci, Hatfield AL9 7TA, Herts, England.	tgibson@rvc.ac.uk	Gibson, Troy/AAA-8687-2019; Lamb, Christopher R./G-3963-2014	Gibson, Troy/0000-0002-1242-2695; 	Department for Environment Food and Rural Affairs UKDepartment for Environment, Food & Rural Affairs (DEFRA)	The authors thank Accles & Shelvoke and the Humane Slaughter Association for assistance during the study. We also wish to thank Richard Prior, Gwen Fraser, Gilly Ansell, Chris Davies, Karin Klinglmair, Gabriela Olmos Antillon, Mick Kirby and David Manners. This work was funded by a research grant from the Department for Environment Food and Rural Affairs UK.	Aarabi B, 2005, HEAD INJURY PATHOPHY, P384; Adams JH, 1995, MUIRS TXB PATHOLOGY, V12, P2121; ADAS, 2007, MH0133 ADAS DEFR, P1; BLACKMORE DK, 1982, MEAT SCI, V7, P19, DOI 10.1016/0309-1740(82)90094-8; BLACKMORE DK, 1979, VET REC, V105, P372, DOI 10.1136/vr.105.16.372; BLACKMORE DK, 1984, RES VET SCI, V37, P223, DOI 10.1016/S0034-5288(18)31909-X; DALY CC, 1986, RES VET SCI, V41, P349, DOI 10.1016/S0034-5288(18)30628-3; DALY CC, 1986, RES VET SCI, V41, P353, DOI 10.1016/S0034-5288(18)30629-5; DALY CC, 1987, BRIT VET J, V143, P574, DOI 10.1016/0007-1935(87)90049-2; Finnie JW, 1997, AUST VET J, V75, P204, DOI 10.1111/j.1751-0813.1997.tb10067.x; FRICKER C, 1981, FLEISCHWIRTSCHAFT, V61, P124; Gibson TJ, 2009, NEW ZEAL VET J, V57, P96, DOI 10.1080/00480169.2009.36885; Gouveia KG, 2009, ANIM WELFARE, V18, P171; Gregory NG, 2009, MEAT SCI, V81, P178, DOI 10.1016/j.meatsci.2008.07.016; Gregory NG, 2005, MEAT SCI, V70, P481, DOI 10.1016/j.meatsci.2004.06.026; Grosse Perdekamp M, 2010, INT J LEGAL MED, V124, P605, DOI 10.1007/s00414-010-0450-8; Nikolic S, 2011, J FORENSIC SCI, V56, P248, DOI 10.1111/j.1556-4029.2010.01507.x; Owen R, 2005, HEAD INJURY PATHOPHY, V2, P472; Teasdale E, 2005, HEAD INJURY PATHOPHY, V2, P169; Viel G, 2009, FORENSIC SCI INT, V187, pE7, DOI 10.1016/j.forsciint.2009.01.022; Wei G, 2010, J NEUROTRAUM, V27, P1635, DOI 10.1089/neu.2010.1378	21	28	29	0	35	UNIV FEDERATION ANIMAL WELFARE	WHEATHAMPSTEAD	OLD SCHOOL, BREWHOUSE HILL, WHEATHAMPSTEAD AL4 8AN, HERTS, ENGLAND	0962-7286			ANIM WELFARE	Anim. Welf.	JUN	2012	21			2			35	42		10.7120/096272812X13353700593446			8	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	952JA	WOS:000304787600007					2022-02-06	
J	Lopez, NE; Krzyzaniak, MJ; Costantini, TW; Putnam, J; Hageny, AM; Eliceiri, B; Coimbra, R; Bansal, V				Lopez, Nicole E.; Krzyzaniak, Michael J.; Costantini, Todd W.; Putnam, James; Hageny, Ann-Marie; Eliceiri, Brian; Coimbra, Raul; Bansal, Vishal			Vagal nerve stimulation decreases blood-brain barrier disruption after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						TBI; VNS; BBB; AQP-4	INTESTINAL DYSFUNCTION; RECOVERY; GHRELIN	BACKGROUND: Traumatic brain injury (TBI) may alter sympathetic tone causing autonomic abnormalities and organ dysfunction. Vagal nerve stimulation (VNS) has been shown to decrease inflammation and distant organ injury after TBI. It is unknown whether VNS may reduce blood-brain barrier (BBB) dysfunction after TBI. We hypothesize that VNS prevents TBI-induced breakdown of the BBB, subsequent brain edema, and neuronal injury. METHODS: A weight-drop model was used to create severe TBI in balb/c mice. Animals were divided into three groups: TBI-TBI only; TBI or VNS-animals that were treated with 10 minutes of VNS immediately before TBI; and sham-animals with opening of the skull but no TBI and VNS treatment. Brain vascular permeability to injected (M-r 70,000) FITC-dextran was measured by radiated fluorescence 6 hours after injury. Injured tissue sections were stained for perivascular aquaporin 4 (AQP-4), an important protein causing BBB-mediated brain edema. Fluorescence was quantified under laser scanning by confocal microscopy. RESULTS: Six hours after TBI, cerebral vascular permeability was increased fourfold compared with sham (mean [SD], 6.6(E+08) [5.5(E+07)] arbitrary fluorescence units [afu] vs. 1.5(E+08) [2.9(E+07)] afu; p < 0.001). VNS prevented the increase in permeability when compared with TBI alone (mean [SD], 3.5(E+08) [8.3(E+07)] afu vs. 6.6(E+08) [5.5(E+07)] afu; p < 0.05). Perivascular expression of AQP-4 was increased twofold in TBI animals compared with sham (mean [SD], 0.96 [0.12] afu vs. 1.79 [0.37] afu; p < 0.05). Similarly, VNS decreased post-TBI expression of AQP-4 to levels similar to sham (mean [SD], 1.15 [0.12] afu; p < 0.05). CONCLUSION: VNS attenuates cerebral vascular permeability and decreases the up-regulation of AQP-4 after TBI. Future studies are needed to assess the mechanisms by which VNS maintains the BBB. (J Trauma Acute Care Surg. 2012;72: 1562-1566. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Lopez, Nicole E.; Krzyzaniak, Michael J.; Costantini, Todd W.; Putnam, James; Hageny, Ann-Marie; Eliceiri, Brian; Coimbra, Raul; Bansal, Vishal] Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA		Bansal, V (corresponding author), Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care & Burns, 200 W Arbor Dr 8896, San Diego, CA 92103 USA.	v3bansal@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Lopez, Nicole/0000-0002-4807-7360; Eliceiri, Brian/0000-0003-1811-1916	Division of Trauma, University of California, San Diego; American Surgical Association Foundation	Nicole E. Lopez, MD, Michael J. Krzyzaniak, MD, Todd W. Costantini, James Putnam, BS, Ann-Marie Hageny, BS, Brian Eliceiri, PhD, and Raul Coimbra, MD, received funding from the Division of Trauma, University of California, San Diego. Vishal Bansal MD, received funding from the American Surgical Association Foundation.	Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Clough RW, 2007, NEUROSCIENCE, V147, P286, DOI 10.1016/j.neuroscience.2007.04.043; Cobbs CS, 1997, BRAIN RES, V751, P336, DOI 10.1016/S0006-8993(96)01429-1; Davies DC, 2002, J ANAT, V200, P639, DOI 10.1046/j.1469-7580.2002.00065.x; De Herdt V, 2009, J NEUROIMMUNOL, V214, P104, DOI 10.1016/j.jneuroim.2009.06.008; Ersahin M, 2010, J NEUROTRAUM, V27, P1143, DOI 10.1089/neu.2009.1210; Fazzina G, 2010, J NEUROTRAUM, V27, P453, DOI 10.1089/neu.2008.0782; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Li G, SEIZURE, V20, P249; Li L, FASEB J, V25, P1556; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; NARITOKU DK, 1995, EPILEPSY RES, V22, P53, DOI 10.1016/0920-1211(95)00035-9; Pan WH, 2011, CURR PHARM DESIGN, V17, P3729, DOI 10.2174/138161211798220918; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DC, 2006, J NEUROTRAUM, V23, P1549, DOI 10.1089/neu.2006.23.1549; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555	24	28	32	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2012	72	6					1562	1566		10.1097/TA.0b013e3182569875			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	960WH	WOS:000305422900025	22695423				2022-02-06	
J	Matthews, S; Spadoni, A; Knox, K; Strigo, I; Simmons, A				Matthews, Scott; Spadoni, Andrea; Knox, Kerry; Strigo, Irina; Simmons, Alan			Combat-Exposed War Veterans at Risk for Suicide Show Hyperactivation of Prefrontal Cortex and Anterior Cingulate During Error Processing	PSYCHOSOMATIC MEDICINE			English	Article						OEF-OIF veterans; functional magnetic resonance imaging; suicide; self-monitoring; error processing; anterior cingulate	TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; INHIBITION; DEPRESSION; PREVALENCE; MODEL; IRAQ	Objective: Suicide is a significant public health problem. Suicidal ideation (SI) increases the risk for completed suicide. However, the brain basis of SI is unknown. The objective of this study was to examine the neural correlates of self-monitoring in individuals at risk for suicide. We hypothesized that combat veterans with a history of SI relative to those without such a history would show altered activation in the anterior cingulate cortex and related circuitry during self-monitoring. Methods: Two groups of combat-exposed war veterans (13 men with and 13 men without history of SI) were studied. Both the SI and non-SI participants had two or more of the following: a) current major depressive disorder, b) current posttraumatic stress disorder, and c) history of mild traumatic brain injury, and each subject performed a validated stop task during functional magnetic resonance imaging Error-related activation was compared between the Si and non-SI groups. Results: The SI group demonstrated more error-related activation of the anterior cingulate (8256 mm(3), t = 2.51) and prefrontal cortex (i.e., clusters >2048 mm(3), voxelwise p < .05). The SI and non-SI participants showed similar behavioral task performance (i.e., mean error rate, F values < 0.63, p values > .43; and mean reaction times, F = 0.27, p = .61). Conclusions: These findings suggest neural correlates of altered self-monitoring in individuals with a history of SI and may further suggest that functional magnetic resonance imaging could be used to identify individuals at risk for suicide before they engage in suicidal behavior.	[Matthews, Scott; Spadoni, Andrea; Strigo, Irina; Simmons, Alan] VA San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Matthews, Scott; Spadoni, Andrea; Strigo, Irina; Simmons, Alan] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Matthews, Scott; Strigo, Irina; Simmons, Alan] VASDHS Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Matthews, Scott] VASDHS Mental Illness Educ Res & Clin Ctr, San Diego, CA USA; [Knox, Kerry] VA VISN 2 Ctr Excellence Suicide Prevent, Albany, NY USA; [Knox, Kerry] Univ Rochester, Dept Psychiat, Rochester, NY USA		Matthews, S (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr,Mail Code 116-A, La Jolla, CA 92093 USA.	scmatthews@ucsd.edu	Simmons, Alan N/A-9815-2008; strigo, irina A/L-9882-2016	Simmons, Alan N/0000-0003-3963-2112; strigo, irina A/0000-0002-8799-716X; Spadoni, Andrea/0000-0002-8367-6406	Veterans AdministrationUS Department of Veterans Affairs; Congressionally Directed Medical Research ProgramUnited States Department of Defense; VA Mental Illness Research, Education and Clinical Center; VA Center of Excellence for Stress and Mental Health; CDA-2 from VA Clinical Science Research and Development; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R00MH080003, T32MH018399] Funding Source: NIH RePORTER	This work was funded by grants from the Veterans Administration and the Congressionally Directed Medical Research Program and was supported by the VA Mental Illness Research, Education and Clinical Center and the VA Center of Excellence for Stress and Mental Health. Dr. Matthews' VA salary is supported by a CDA-2 from VA Clinical Science Research and Development.	Amen DG, 2009, J NEUROPSYCH CLIN N, V21, P430, DOI 10.1176/appi.neuropsych.21.4.430; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Courtet P, 2010, EUR PSYCHIAT, V25, P294, DOI 10.1016/j.eurpsy.2009.12.010; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; FAWCETT J, 1990, AM J PSYCHIAT, V147, P1189; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jollant F, 2008, AM J PSYCHIAT, V165, P740, DOI 10.1176/appi.ajp.2008.07081239; Jollant F, 2010, NEUROIMAGE, V51, P1275, DOI 10.1016/j.neuroimage.2010.03.027; Kang HK, 2009, ANN EPIDEMIOL, V19, P757, DOI 10.1016/j.annepidem.2009.05.004; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Matthews SC, 2005, NEUROREPORT, V16, P755, DOI 10.1097/00001756-200505120-00020; Matthews S, 2009, PSYCHIAT RES-NEUROIM, V172, P1, DOI 10.1016/j.pscychresns.2008.08.006; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Oquendo MA, 2003, ARCH GEN PSYCHIAT, V60, P14, DOI 10.1001/archpsyc.60.1.14; Pan LA, 2011, J AM ACAD CHILD PSY, V50, P602, DOI 10.1016/j.jaac.2011.03.018; Rudd MD, 2000, SUICIDE LIFE-THREAT, V30, P18; Schwab K, 2006, NEUROLOGY, V22, P377; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Talairach J, 1998, COPLANAR STEREOTAXIC; Weissman MM, 1999, PSYCHOL MED, V29, P9, DOI 10.1017/S0033291798007867	29	28	28	1	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0033-3174	1534-7796		PSYCHOSOM MED	Psychosom. Med.	JUN	2012	74	5					471	475		10.1097/PSY.0b013e31824f888f			5	Psychiatry; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	959GB	WOS:000305299800006	22511726	Green Accepted			2022-02-06	
J	Boggild, M; Tator, CH				Boggild, Miranda; Tator, Charles H.			Concussion Knowledge among Medical Students and Neurology/Neurosurgery Residents	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							BRAIN-INJURY; SPORT; MANAGEMENT; TBI	Background and Objectives: Concussion is a prevalent brain injury in the community. While primary prevention strategies need to be enhanced, it is also important to diagnose and treat concussions expertly and expeditiously to prevent serious complications that may be life-threatening or long lasting. Therefore, physicians should be knowledgeable about the diagnosis and management of concussions. The present study assesses Ontario medical students' and residents' knowledge of concussion management. Methods: A survey to assess the knowledge and awareness of the diagnosis and treatment of concussions was developed and administered to graduating medical students (n = 222) and neurology and neurosurgery residents (n = 80) at the University of Toronto. Results: Residents answered correctly significantly more of the questions regarding the diagnosis and management of concussions than the medical students (mean = 5.8 vs 4.1, t = 4.48, p<0.01). Gender, participation in sports, and personal concussion history were not predictive of the number of questions answered correctly. Several knowledge ups were identified in the sample population as a whole. Approximately half of the medical students and residents did not recognize chronic traumatic encephalopathy (n = 36) or the second impact syndrome (n = 44) as possible consequences of repetitive concussions. Twenty-four percent of the medical students (n = 18) did not think that "every concussed individual should see a physician" as part of management. Conclusions: A significant number of medical students and residents have incomplete knowledge about concussion diagnosis and management. This should be addressed by targeting this population during undergraduate medical education.	[Tator, Charles H.] Toronto Western Hosp, Toronto, ON M5T 2S8, Canada; [Tator, Charles H.] Div Neurosurg, Toronto, ON, Canada; [Boggild, Miranda] Univ Toronto, Toronto, ON, Canada		Tator, CH (corresponding author), Toronto Western Hosp, 399 Bathurst St,Ste 4W-433, Toronto, ON M5T 2S8, Canada.	charles.tator@uhn.ca					Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Centers for Disease Control and Prevention, 2003, NAT CTR INJ PREV CON; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Delaney J, THINKFIRST CONCUSSIO; Demorest RA, 2005, PEDIATRICS, V115, P28, DOI 10.1542/peds.2004-0266; Ferrara Michael S., 2001, J Athl Train, V36, P145; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Government of Canada, 2000, CAN COMM HLTH SURV Q; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Kelly JP, 1997, NEUROLOGY, V48, P581; King NS, 2001, BRAIN INJURY, V25, P462; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Tator CH, 2010, CAN J NEUROL SCI, V37, P714, DOI 10.1017/S0317167100051337; Tator CH, 2009, CAN J NEUROL SCI, V36, P405, DOI 10.1017/S031716710000771X; Tator CH, 2009, CAN J NEUROL SCI, V36, P269, DOI 10.1017/S0317167100006922; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Zafonte R, 2011, JAMA-J AM MED ASSOC, V306, P79, DOI 10.1001/jama.2011.819	25	28	28	0	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2012	39	3					361	368		10.1017/S0317167100013524			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	946VR	WOS:000304386100018	22547519	Bronze			2022-02-06	
J	Fulton, JB; Yeates, KO; Taylor, HG; Walz, NC; Wade, SL				Fulton, John B.; Yeates, Keith Owen; Taylor, H. Gerry; Walz, Nicolay C.; Wade, Shari L.			Cognitive Predictors of Academic Achievement in Young Children 1 Year After Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; preschool children; academic achievement; memory; executive function	CLOSED-HEAD-INJURY; EARLY-CHILDHOOD; PRESCHOOL-CHILDREN; SHAPE SCHOOL; SHORT-TERM; FUNCTIONAL RECOVERY; EXECUTIVE CONTROL; BEHAVIOR PROBLEMS; AGE; SKILLS	Objective: To examine cognitive predictors of academic achievement in young children with traumatic brain injury (TBI) and orthopedic injury (OI) shortly after injury and I year postinjury. Methods: Participants included 3- to 6-year-old children, 63 with TBI (46 with moderate TBI and 17 with severe TBI) and a comparison group of 80 children with OI. Academic achievement was assessed approximately 1 and 12 months postinjury using three subtests from the Woodcock-Johnson Tests of Achievement-Third Edition and the School Readiness Composite from the Bracken Basic Concepts Scale-Revised. General intellectual functioning, memory, and executive functions were measured at the initial assessment using standardized tests. Results: Hierarchical linear regression was used to predict academic achievement at the initial and 1-year follow-up assessments. Memory and executive functions were significant predictors of academic achievement at both assessments after controlling for group membership and demographic variables. Executive function remained a significant predictor of some outcomes after taking general intellectual functioning into account. Predictive relationships did not vary across the TBI and 01 groups. Similar results were obtained when regression analyses were completed with only TBI participants using the Glasgow Coma Scale score as a predictor, although memory and executive functioning were somewhat less robust in predicting academic achievement than before. Conclusion: Memory and executive function predict academic achievement after TBI in preschool children, although some of the associations may be accounted for by general intellectual functioning.	[Fulton, John B.] Phoenix Childrens Hosp, Dept Psychol, Barrow Neurol Inst, Phoenix, AZ 85016 USA; [Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Walz, Nicolay C.; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Walz, Nicolay C.; Wade, Shari L.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA		Fulton, JB (corresponding author), Phoenix Childrens Hosp, Dept Psychol, Barrow Neurol Inst, 1919 E Thomas Rd, Phoenix, AZ 85016 USA.	jfulton@phoenixchildrens.com	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institutes of Health (NIH)/National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1UL1RR026314]; National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; State of Ohio Emergency Medical Services; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K02 HD44099]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K02HD044099] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER	This publication was supported by an Institutional Clinical and Translational Science Award, National Institutes of Health (NIH)/National Center for Research Resources grant number 1UL1RR026314. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH. Additional support provided to Dr. Wade included grant R01 HD42729 from the National Institute of Child Health and Human Development (NICHD) and Trauma Research grants from the State of Ohio Emergency Medical Services. Dr. Yeates received support from career development grant K02 HD44099 from NICHD during the conduct of the research. The authors wish to acknowledge the contributions of Christine Abraham, Andrea Beebe, Lori Bernard, Anne Birnbaum, Beth Bishop, Tammy Matecun, Karen Oberjohn, Elizabeth Roth, and Elizabeth Shaver in data collection and coding. The authors also thank Nori Minich for her assistance in data analysis. The Cincinnati Children's Medical Center Trauma Registry, Rainbow Pediatric Trauma Center, Rainbow Babies & Children's Hospital, Nationwide Children's Hospital Trauma Program, and the Metro Health Center Department of Pediatrics and Trauma Registry provided assistance with recruitment.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Beres K.A., 2000, HDB PSYCHOL ASSESSME, V3rd edn, P65, DOI DOI 10.1016/B978-008043645-6/50082-3; Bracken, 2006, BRACKEN BASIC CONCEP; Bruce D. A., 1995, TRAUMATIC HEAD INJUR, P40; Bull R, 2008, DEV NEUROPSYCHOL, V33, P205, DOI 10.1080/87565640801982312; Catroppa C, 1999, Pediatr Rehabil, V3, P167; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Clark CAC, 2010, DEV PSYCHOL, V46, P1176, DOI 10.1037/a0019672; Elliott C. D., 1990, DIFFERENTIAL ABILITY; Espy KA, 1997, DEV NEUROPSYCHOL, V13, P495, DOI 10.1080/87565649709540690; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Espy KA, 1999, BRAIN COGNITION, V41, P178, DOI 10.1006/brcg.1999.1117; Espy KA, 2006, PSYCHOL ASSESSMENT, V18, P373, DOI 10.1037/1040-3590.18.4.373; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Goldstein G., 2000, HDB PSYCHOL ASSESSME; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; McClelland MM, 2007, DEV PSYCHOL, V43, P947, DOI 10.1037/0012-1649.43.4.947; MCGREW KS, 2001, TECHNICAL MANUAL W J; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Pritchard VE, 2011, PSYCHOL ASSESSMENT, V23, P31, DOI 10.1037/a0021095; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Verger K, 2000, BRAIN INJURY, V14, P495; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	46	28	29	1	17	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2012	26	3					314	322		10.1037/a0027973			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	937AG	WOS:000303630800005	22563873	Green Accepted			2022-02-06	
J	Corrigan, F; Vink, R; Blumbergs, PC; Masters, CL; Cappai, R; van den Heuvel, C				Corrigan, Frances; Vink, Robert; Blumbergs, Peter C.; Masters, Colin L.; Cappai, Roberto; van den Heuvel, Corinna			Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury	BRAIN RESEARCH			English	Article						Amyloid precursor protein; Caspase-3; GAP-43; sAPP alpha; Synaptophysin; Traumatic brain injury	CLOSED-HEAD INJURY; LONG-TERM ACCUMULATION; SECRETED FORMS; BETA-PROTEIN; HIPPOCAMPAL-NEURONS; CEREBROSPINAL-FLUID; NEURITE OUTGROWTH; AXONAL DAMAGE; UP-REGULATION; MICE LACKING	The amyloid precursor protein (APP) increases following traumatic brain injury (TBI), although the functional significance of this remains unclear largely because the functions of the subsequent APP metabolites are so different: A beta is neurotoxic whilst sAPP alpha is neuroprotective. To investigate this further, APP wildtype and knockout mice were subjected to mild diffuse TBI and their outcomes compared. APP knockout mice displayed significantly worse cognitive and motor deficits, as demonstrated by the Barnes Maze and rotarod respectively, than APP wildtype mice. This was associated with a significant increase in hippocampal and cortical cell loss, as well as axonal injury, in APP knockout mice and an impaired neuroreparative response as indicated by diminished GAP-43 immunoreactivity when compared to APP wildtype mice. This study is the first to demonstrate that endogenous APP is beneficial following mild TBI, suggesting that the upregulation of APP observed following injury is an acute protective response. (C) 2012 Elsevier B.V. All rights reserved.	[Corrigan, Frances; Vink, Robert; Blumbergs, Peter C.; van den Heuvel, Corinna] Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia; [Corrigan, Frances; Vink, Robert; Blumbergs, Peter C.; van den Heuvel, Corinna] Hanson Inst, Ctr Neurol Dis, Adelaide, SA, Australia; [Masters, Colin L.] Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Cappai, Roberto] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Cappai, Roberto] Univ Melbourne, Mol Sci & BioTechnol Inst Bio21, Melbourne, Vic 3010, Australia		van den Heuvel, C (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.	corinna.vandenheuvel@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012; Cappai, Roberto/B-3347-2010	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Cappai, Roberto/0000-0002-9505-8496; , Corinna/0000-0003-0664-8935; Corrigan, Frances/0000-0001-6150-8893	Brain Foundation; Neurological Research Foundation	We thank Prof. Hui Zheng for providing the APP knockout mice and Dr Stephen Helps, Dr Emma Thornton, Dr Jenna Zeibell and Jim Manavis for expert technical assistance. We also thank the staff within the IMVS animal care facility. This work was funded in part by grants from the Brain Foundation and the Neurological Research Foundation. RC is a National Health and Medical Research Council Senior Research Fellow.	ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Bendotti C, 1997, EUR J NEUROSCI, V9, P93, DOI 10.1111/j.1460-9568.1997.tb01357.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; BHASIN R, 1991, P NATL ACAD SCI USA, V88, P10307, DOI 10.1073/pnas.88.22.10307; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Boyd-Kimball D, 2004, J ALZHEIMERS DIS, V6, P515; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Emery DL, 2000, J COMP NEUROL, V424, P521; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; FRASER PE, 1992, J NEUROCHEM, V59, P1531, DOI 10.1111/j.1471-4159.1992.tb08470.x; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Gordon-Krajcer W, 2001, FOLIA NEUROPATHOL, V39, P163; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Johnson V. E., 2010, NAT REV NEUROSCI; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kim HS, 2004, J NEUROSCI RES, V75, P117, DOI 10.1002/jnr.10845; Koo EH, 1996, J CELL SCI, V109, P991; Koopmans G, 2003, PHYSIOL BEHAV, V79, P683, DOI 10.1016/S0031-9384(03)00171-9; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; LIN LH, 1992, MOL BRAIN RES, V14, P147, DOI 10.1016/0169-328X(92)90024-6; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McKinney RA, 1999, P NATL ACAD SCI USA, V96, P11631, DOI 10.1073/pnas.96.20.11631; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nihashi T, 2001, ACTA NEUROCHIR, V143, P287, DOI 10.1007/s007010170109; Ohsawa I, 1997, BIOCHEM BIOPH RES CO, V236, P59, DOI 10.1006/bbrc.1997.6903; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Opazo C, 2000, BIOL RES, V33, P125; Phinney AL, 1999, NEUROSCIENCE, V90, P1207, DOI 10.1016/S0306-4522(98)00645-9; Popa-Wagner A, 1998, STROKE, V29, P2196, DOI 10.1161/01.STR.29.10.2196; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Raby CA, 1998, J NEUROCHEM, V71, P2505; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; SMITHSWINTOSKY VL, 1994, J NEUROCHEM, V63, P781, DOI 10.1046/j.1471-4159.1994.63020781.x; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; TEASDALE G, 1974, LANCET, V2, P81; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Wallace WC, 1997, MOL BRAIN RES, V52, P201, DOI 10.1016/S0169-328X(97)00258-1; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	74	28	32	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 27	2012	1451						87	99		10.1016/j.brainres.2012.02.045			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	943MQ	WOS:000304128100010	22424792				2022-02-06	
J	Baker, KS; Piriyapunyaporn, T; Cunnington, R				Baker, Katharine S. y; Piriyapunyaporn, Teerut; Cunnington, Ross			Neural activity in readiness for incidental and explicitly timed actions	NEUROPSYCHOLOGIA			English	Article						Motor preparation; Time reproduction; Readiness potential; Attention; ERP	MOVEMENT-RELATED POTENTIALS; SUPPLEMENTARY MOTOR AREA; EXTERNALLY TRIGGERED MOVEMENTS; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; VOLUNTARY MOVEMENT; TEMPORAL REPRODUCTION; PARKINSONS-DISEASE; PREFRONTAL CORTEX; TOURETTE-SYNDROME	Voluntary, self-initiated actions are preceded by slowly increasing neural activity in pre-motor regions of the brain, beginning up to 2s before the onset of muscle movement. This activity is commonly seen in the scalp-recorded readiness potential, and is an index of movement preparation involving both motor programming and non-motor or cognitive processes such as attention. The specific contribution of cognitive processes, thought to occur during the earliest stage of planning, remains somewhat unclear. We suggest that attention to the timing of movement is a key voluntary process contributing to early-stage cortical activity. As a novel approach to examining this, we recorded EEG throughout a time reproduction task in which participants replicated the interval between two tones with two button-press actions. The first action, i.e. the beginning of the reproduced interval, was somewhat incidental to the task of time reproduction and required minimal attention to the time of initiation, while the second action required explicit attention to the time of initiation. Pre-movement neural activity preceding the first, relatively unattended movement was greatly reduced in amplitude and almost absent in the early stage, in contrast with readiness potentials typically seen prior to voluntary movement. Neural activity preceding explicitly timed movements was significantly larger, with effects emerging in the early component of pre-movement activity over frontal and right frontal scalp regions. We propose that attention to movement timing, i.e. the process of orienting attention in time towards the moment of movement initiation, is a key component of voluntary action preparation that is reflected in the early-stage neural activity we typically see prior to voluntary movement. (C) 2012 Elsevier Ltd. All rights reserved.	[Baker, Katharine S. y; Piriyapunyaporn, Teerut; Cunnington, Ross] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia; [Baker, Katharine S. y; Cunnington, Ross] Univ Queensland, Sch Psychol, St Lucia, Qld 4072, Australia		Cunnington, R (corresponding author), Univ Queensland, Queensland Brain Inst, QBI Bldg 79, St Lucia, Qld 4072, Australia.	r.cunnington@uq.edu.au		Cunnington, Ross/0000-0002-7423-4809	Australian Research CouncilAustralian Research Council [FT0991468]; Mahidol University, Thailand	This study was supported by funding from the Australian Research Council (FT0991468) and travel funding to TP from Mahidol University, Thailand.	Baker KS, 2011, NEUROPSYCHOLOGIA, V49, P3303, DOI 10.1016/j.neuropsychologia.2011.08.003; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Bortoletto M, 2011, BRAIN COGNITION, V75, P196, DOI 10.1016/j.bandc.2010.11.016; Bortoletto M, 2010, NEUROIMAGE, V49, P3338, DOI 10.1016/j.neuroimage.2009.11.048; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; DEECKE L, 1969, EXP BRAIN RES, V7, P158; Haggard P., 1999, EXPT BRAIN RES, V126; Jahanshahi M, 1998, COGN NEUROPSYCHOL, V15, P483, DOI 10.1080/026432998381005; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Jones CRG, 2004, EXP BRAIN RES, V158, P366, DOI 10.1007/s00221-004-1912-3; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; Kagerer FA, 2002, NEUROPSYCHOLOGIA, V40, P357, DOI 10.1016/S0028-3932(01)00111-7; Karp BI, 1996, J NEUROL NEUROSUR PS, V61, P103, DOI 10.1136/jnnp.61.1.103; KELLER I, 1990, ELECTROEN CLIN NEURO, V76, P351, DOI 10.1016/0013-4694(90)90036-J; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Lee KM, 1999, NEUROIMAGE, V9, P117, DOI 10.1006/nimg.1998.0393; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; LIBET B, 1982, ELECTROEN CLIN NEURO, V54, P322, DOI 10.1016/0013-4694(82)90181-X; Macar F, 2003, PSYCHOPHYSIOLOGY, V40, P950, DOI 10.1111/1469-8986.00113; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; OBESO JA, 1981, J NEUROL NEUROSUR PS, V44, P735, DOI 10.1136/jnnp.44.8.735; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; Pfeuty M, 2003, EXP BRAIN RES, V151, P372, DOI 10.1007/s00221-003-1505-6; Praamstra P, 2006, J NEUROSCI, V26, P5448, DOI 10.1523/JNEUROSCI.0440-06.2006; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rowe J, 2002, NEUROIMAGE, V17, P988, DOI 10.1006/nimg.2002.1156; SHIBASAKI H, 1980, ELECTROEN CLIN NEURO, V49, P213, DOI 10.1016/0013-4694(80)90216-3; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; SINGH J, 1990, BRAIN RES, V531, P45, DOI 10.1016/0006-8993(90)90756-2; Stephan KM, 2002, NEUROIMAGE, V15, P345, DOI 10.1006/nimg.2001.0929; Stern E, 2000, ARCH GEN PSYCHIAT, V57, P741, DOI 10.1001/archpsyc.57.8.741; Trevena J, 2010, CONSCIOUS COGN, V19, P447, DOI 10.1016/j.concog.2009.08.006; Ulbrich P, 2007, ACTA PSYCHOL, V125, P51, DOI 10.1016/j.actpsy.2006.06.004; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Wildgruber D, 1997, NEUROSCI LETT, V227, P161, DOI 10.1016/S0304-3940(97)00329-7	45	28	28	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	APR	2012	50	5					715	722		10.1016/j.neuropsychologia.2011.12.026			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	941HS	WOS:000303954900017	22245011				2022-02-06	
J	Feng, JF; Zhao, XR; Gurkoff, GG; Van, KC; Shahlaie, K; Lyeth, BG				Feng, Jun-feng; Zhao, Xueren; Gurkoff, Gene G.; Van, Ken C.; Shahlaie, Kiarash; Lyeth, Bruce G.			Post-Traumatic Hypoxia Exacerbates Neuronal Cell Death in the Hippocampus	JOURNAL OF NEUROTRAUMA			English	Article						hippocampal fields; hippocampus; hypoxia; neuronal degeneration; neuronal survival; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; LATERAL FLUID-PERCUSSION; FLUORO-JADE-B; HEAD-INJURY; SELECTIVE VULNERABILITY; RAT HIPPOCAMPUS; AMINO-ACIDS; AUTOREGULATION; GLUTAMATE	Hypoxia frequently occurs in patients with traumatic brain injury (TBI) and is associated with increased morbidity and mortality. This study examined the effects of immediate or delayed post-traumatic hypoxia (fraction of inspired oxygen [FiO(2)] 11%) on acute neuronal degeneration and long-term neuronal survival in hippocampal fields after moderate fluid percussion injury in rats. In Experiment 1, hypoxia was induced for 15 or 30 min alone or immediately following TBI. In Experiments 2 and 3, 30 min of hypoxia was induced immediately after TBI or delayed until 60 min after TBI. In Experiment 1, acute neurodegeneration was evaluated in the hippocampal fields 24 h after insults using Fluoro-Jade staining and stereological quantification. During hypoxia alone, or in combination with TBI, mean arterial blood pressure was significantly reduced by approximately 30%, followed by a rapid return to normal values upon return to pre-injury FiO(2). Hypoxia alone failed to cause hippocampal neuronal degeneration when measured at 24 h after insult. TBI alone resulted in neuronal degeneration in each ipsilateral hippocampal field, predominantly in CA2-CA3 and the dentate gyrus. Compared to TBI alone, TBI plus immediate hypoxia for either 15 or 30 min significantly increased neuronal loss in most ipsilateral hippocampal fields and in the contralateral hilus and dentate gyrus. In Experiment 2, TBI plus hypoxia delayed 30 min significantly increased degeneration only in ipsilateral CA2-CA3. In Experiment 3, 30 min of immediate hypoxia significantly reduced the numbers of surviving neurons in the CA3 at 14 days after TBI. The greatly increased vulnerability in all hippocampal fields by immediate 30 min post-traumatic hypoxia provides a relevant model of TBI complicated with hypoxia/hypotension. These data underscore the significance of the secondary insult, the necessity to better characterize the range of injuries experienced by the TBI patient, and the importance of strictly avoiding hypoxia in the early management of TBI patients.	[Feng, Jun-feng; Zhao, Xueren; Gurkoff, Gene G.; Van, Ken C.; Shahlaie, Kiarash; Lyeth, Bruce G.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Feng, Jun-feng] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200030, Peoples R China; [Gurkoff, Gene G.] Univ Calif Davis, NSF Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA		Lyeth, BG (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1 Shields Ave, Davis, CA 95616 USA.	bglyeth@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS29995]; Center for Biophotonics Science and Technology, a designated NSF Science and Technology Center [PHY 0120999]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke grant NS29995, and the Center for Biophotonics Science and Technology, a designated NSF Science and Technology Center, managed by the University of California at Davis, under cooperative agreement number PHY 0120999. Expert technical assistance was provided by Rahil Ghiasvand and Darrin Lee.	Amaral David G., 1995, P443; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Anderson RE, 2003, J TRAUMA, V54, P550, DOI 10.1097/01.TA.0000047049.64695.69; Aoyama N, 2008, BRAIN RES, V1230, P310, DOI 10.1016/j.brainres.2008.07.006; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; Bauman RA, 2000, J NEUROTRAUM, V17, P679, DOI 10.1089/089771500415427; Bedell EA, 2004, J NEUROTRAUM, V21, P1212; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goodman M.D., 2010, J SURG RES; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hellewell S.C., 2010, J NEUROTRAUMA; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Kirkness C J, 2001, Biol Res Nurs, V2, P175, DOI 10.1177/109980040100200303; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McSwain NE, 2004, J TRAUMA, V57, P8; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Mikrogianakis A, 2007, J NEUROTRAUM, V24, P338, DOI 10.1089/neu.2006.003615; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Okada K, 2009, BEHAV BRAIN RES, V200, P181, DOI 10.1016/j.bbr.2009.01.011; Owens J, 1997, ANN NEUROL, V41, P187, DOI 10.1002/ana.410410210; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Ract C, 2001, J NEUROTRAUM, V18, P1247, DOI 10.1089/089771501317095287; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	61	28	30	2	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2012	29	6					1167	1179		10.1089/neu.2011.1867			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	927ZL	WOS:000302949100017	22191636	Green Published			2022-02-06	
J	Guresir, E; Schuss, P; Seifert, V; Vatter, H				Gueresir, Erdem; Schuss, Patrick; Seifert, Volker; Vatter, Hartmut			Decompressive Craniectomy in Children: Single-Center Series and Systematic Review	NEUROSURGERY			English	Article						Brain swelling; Decompressive craniectomy; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; REFRACTORY INTRACRANIAL HYPERTENSION; OF-THE-LITERATURE; HEAD-INJURY; MALIGNANT INFARCTION; OXYGENATION CHANGES; CENTER EXPERIENCE; CLINICAL ARTICLE; HEMICRANIECTOMY	BACKGROUND: Decompressive craniectomy (DC) is performed as a life-saving procedure in patients with intractably increased intracranial pressure after traumatic brain injury, bleeding, cerebral infarction, or brain swelling of other causes. However, the application of DC is as controversial in the pediatric population as it is in adults. OBJECTIVE: To find factors influencing the outcome in pediatric patients who underwent DC because of sustained high intracranial pressure. METHODS: Between April 2000 and December 2009, 34 pediatric patients (age 0-18 years) underwent DC. Patients were stratified according to the indication for DC. Outcome was assessed according to the modified Rankin Scale score at 6 months. MEDLINE was searched for published studies or reports of DC in pediatric patients to gain a larger population. Two reviewers independently extracted data. RESULTS: Literature data, including the current series, revealed a total of 172 pediatric patients. Overall, a favorable outcome was achieved in 106 of 172 patients (62%). A favorable outcome was achieved in 25 of 36 patients without traumatic brain injury vs 81 of 136 patients with traumatic brain injury (69% vs 60%). Patients without signs of cerebral herniation had a better outcome than patients with unilateral or bilateral dilated pupils (73% vs 60% vs 45%, respectively). CONCLUSION: The current data indicate that DC in children with traumatic or non-traumatic brain swelling might be warranted, regardless of the underlying cause. Despite mydriasis, a favorable outcome might be achieved in a significant number of pediatric patients. Nevertheless, careful individual decision making is needed for each patient, especially when signs of cerebral herniation have persisted for a long time.	[Gueresir, Erdem; Schuss, Patrick; Seifert, Volker; Vatter, Hartmut] Goethe Univ Frankfurt, Dept Neurosurg, D-60528 Frankfurt, Germany		Guresir, E (corresponding author), Goethe Univ Frankfurt, Dept Neurosurg, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	Gueresir@em.uni-frankfurt.de	Guresir, Erdem/AAV-7224-2021; Schuss, Patrick/ABC-6469-2020; Guresir, Erdem/AAL-4484-2020	Guresir, Erdem/0000-0001-8319-0847; Schuss, Patrick/0000-0002-5806-2576; 			Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Aghakhani N, 2009, J NEUROS-PEDIATR, V3, P66, DOI 10.3171/2008.10.PEDS08116; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Ausman J I, 1976, Surg Neurol, V6, P97; Berger S, 2002, J TRAUMA, V53, P558, DOI 10.1097/00005373-200209000-00027; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; COOK DJ, 1992, CHEST, V102, pS305; Coutinho JM, 2009, STROKE, V40, P2233, DOI 10.1161/STROKEAHA.108.543421; Csokay A, 2001, ACTA NEUROCHIR, V143, P173, DOI 10.1007/s007010170125; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Figaji AA, 2007, CHILD NERV SYST, V23, P1331, DOI 10.1007/s00381-007-0388-4; Figaji AA, 2006, SAMJ S AFR MED J, V96, P969; Fukai J, 2009, NEUROL MED-CHIR, V49, P22, DOI 10.2176/nmc.49.22; Guresir E, 2009, J NEUROL NEUROSUR PS, V80, P799, DOI 10.1136/jnnp.2008.155630; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hejazi N, 2002, EUR J PEDIATR, V161, P99, DOI 10.1007/s00431-001-0864-x; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Lee MC, 2003, PEDIATR NEUROSURG, V38, P181, DOI 10.1159/000069096; Marion DW, 2006, NEUROSURGERY, V58, P655; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Rabelino GAG, 2008, PEDIATR NEUROL, V39, P201, DOI 10.1016/j.pediatrneurol.2008.06.006; Ramaswamy V, 2008, J CHILD NEUROL, V23, P889, DOI 10.1177/0883073808314960; Ranger A, 2009, PEDIATR NEUROSURG, V45, P390, DOI 10.1159/000260910; Reithmeier T, 2005, CHILD NERV SYST, V21, P249, DOI 10.1007/s00381-004-1044-x; RENGACHARY SS, 1981, NEUROSURGERY, V8, P321, DOI 10.1227/00006123-198103000-00004; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Ruggiero A, 2009, INT J HEMATOL, V90, P87, DOI 10.1007/s12185-009-0333-2; Rutigliano D, 2006, J PEDIATR SURG, V41, P83, DOI 10.1016/j.jpedsurg.2005.10.010; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Schwab S, 1997, NEUROLOGY, V48, P412, DOI 10.1212/WNL.48.2.412; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; Taferner E, 2001, INTENS CARE MED, V27, P1426, DOI 10.1007/s001340101027; Tan MA, 2006, CHILD NERV SYST, V22, P523, DOI 10.1007/s00381-005-0001-7; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Ushewokunze S, 2009, CHILD NERV SYST, V25, P341, DOI 10.1007/s00381-008-0752-z; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; Visocchi M, 2007, ACTA NEUROCHIR, V149, P347, DOI 10.1007/s00701-006-1102-0; Walz B, 2002, J NEUROL, V249, P1183, DOI 10.1007/s00415-002-0798-x; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	61	28	28	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2012	70	4					881	888		10.1227/NEU.0b013e318237a6a6			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	914FF	WOS:000301934000044	21946506				2022-02-06	
J	Medaglia, JD; Chiou, KS; Slocomb, J; Fitzpatrick, NM; Wardecker, BM; Ramanathan, D; Vesek, J; Good, DC; Hillary, FG				Medaglia, John D.; Chiou, Kathy S.; Slocomb, Julia; Fitzpatrick, Neal M.; Wardecker, Britney M.; Ramanathan, Deepa; Vesek, Jeffrey; Good, David C.; Hillary, Frank G.			The Less BOLD, the Wiser: Support for the latent resource hypothesis after traumatic brain injury	HUMAN BRAIN MAPPING			English	Article						reorganization; traumatic brain injury; working memory; functional MRI; cognitive control	DIFFUSE AXONAL INJURY; ADULT AGE-DIFFERENCES; WORKING-MEMORY TASK; MULTIPLE-SCLEROSIS; PREFRONTAL CORTEX; PROCESSING-SPEED; FUNCTIONAL MRI; NEUROPSYCHOLOGICAL DEFICITS; ANTERIOR CINGULATE; COGNITIVE-CONTROL	Previous studies of the BOLD response in the injured brain have revealed neural recruitment relative to controls during working memory tasks in several brain regions, most consistently the right prefrontal cortex and anterior cingulate cortices. We previously proposed that the recruitment observed in this literature represents auxiliary support resources, and that recruitment of PFC is not abnormal or injury specific and should reduce as novelty and challenge decrease. The current study directly tests this hypothesis in the context of practice of a working memory task. It was hypothesized that individuals with brain injury would demonstrate recruitment of previously indicated regions, behavioral improvement following task practice, and a reduction in the BOLD signal in recruited regions after practice. Individuals with traumatic brain injury and healthy controls performed the n-back during fMRI acquisition, practiced each task out of the scanner, and returned to the scanner for additional fMRI n-back acquisition. Statistical parametric maps demonstrated a number of regions of recruitment in the 1-back in individuals with brain injury and a number of corresponding regions of reduced activation in individuals with brain injury following practice in both the 1-back and 2-back. Regions of interest demonstrated reduced activation following practice, including the anterior cingulate and right prefrontal cortices. Individuals with brain injury demonstrated modest behavioral improvements following practice. These findings suggest that neural recruitment in brain injury does not represent reorganization but a natural extension of latent mechanisms that engage transiently and are contingent upon cerebral challenge. Hum Brain Mapp, 2012. (c) 2011 Wiley Periodicals, Inc.	[Medaglia, John D.; Chiou, Kathy S.; Wardecker, Britney M.; Ramanathan, Deepa; Hillary, Frank G.] Penn State Univ, Dept Psychol, State Coll, PA USA; [Slocomb, Julia; Fitzpatrick, Neal M.; Good, David C.; Hillary, Frank G.] Hershey Med Ctr, Dept Neurol, Hershey, PA USA; [Vesek, Jeffrey] Hershey Med Ctr, Dept Radiol, Hershey, PA USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 223 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021	Wardecker, Britney/0000-0003-2168-538X; Ramanathan-Elion, Deepa/0000-0001-7723-7346	Pennsylvania Tobacco Funds [4100031293]; New Jersey Commission on Brain Injury Research [0120090178]; Social Sciences Research Institute, PSU	Contract grant sponsor: Pennsylvania Tobacco Funds; Contract grant number: 4100031293; Contract grant sponsor: New Jersey Commission on Brain Injury Research; Contract grant number: 0120090178; Contract grant sponsor: Social Sciences Research Institute, PSU.	ALEXANDER JE, 1995, PSYCHOPHYSIOLOGY, V32, P467, DOI 10.1111/j.1469-8986.1995.tb02098.x; Army Individual Test Battery, 1990, MAN DIR SCOR; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; BADDELEY A, 1992, J COGNITIVE NEUROSCI, V4, P281, DOI 10.1162/jocn.1992.4.3.281; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; BRADLEY VA, 1989, J NEUROL NEUROSUR PS, V52, P1228, DOI 10.1136/jnnp.52.11.1228; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Chang L, 2001, NEUROLOGY, V57, P1001, DOI 10.1212/WNL.57.6.1001; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Collette F, 1999, NEUROPSYCHOLOGIA, V37, P905, DOI 10.1016/S0028-3932(98)00148-1; Courtney Susan M., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P501, DOI 10.3758/CABN.4.4.501; Daffner KR, 2000, BRAIN, V123, P927, DOI 10.1093/brain/123.5.927; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.0.CO;2-J; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Jaeggi SM, 2003, NEUROIMAGE, V19, P210, DOI 10.1016/S1053-8119(03)00098-3; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Knight RT, 1998, J CLIN NEUROPHYSIOL, V15, P3, DOI 10.1097/00004691-199801000-00003; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Landau SM, 2004, NEUROIMAGE, V22, P211, DOI 10.1016/j.neuroimage.2004.01.003; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORRIS RG, 1988, J CLIN EXP NEUROPSYC, V10, P279, DOI 10.1080/01688638808408242; Mostofsky SH, 2003, COGNITIVE BRAIN RES, V17, P419, DOI 10.1016/S0926-6410(03)00144-7; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Ramsey NF, 2004, BRAIN, V127, P517, DOI 10.1093/brain/awh060; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P471, DOI 10.1080/01688638908400907; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P699, DOI 10.1080/01688638908400926; Reitan R, 1985, HALSTEAD REITAN NEUR; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Rypma B, 2006, NEUROIMAGE, V33, P969, DOI 10.1016/j.neuroimage.2006.05.065; Salthouse T. A., 1993, J GERONTOL B-PSYCHOL, V48, P245; SALTHOUSE TA, 1992, MEM COGNITION, V20, P413, DOI 10.3758/BF03210925; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Sweet LH, 2006, HUM BRAIN MAPP, V27, P28, DOI 10.1002/hbm.20163; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	72	28	28	0	13	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1065-9471			HUM BRAIN MAPP	Hum. Brain Mapp.	APR	2012	33	4					979	993		10.1002/hbm.21264			15	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	906JI	WOS:000301341000018	21591026	Green Published			2022-02-06	
J	Gerring, JP; Wade, S				Gerring, Joan P.; Wade, Shari			The Essential Role of Psychosocial Risk and Protective Factors in Pediatric Traumatic Brain Injury Research	JOURNAL OF NEUROTRAUMA			English	Article						additive model; moderation model; psychosocial protective factors; psychosocial risk factors; TBI research	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; BEHAVIOR PROBLEMS; SHORT-TERM; PSYCHIATRIC-DISORDER; YOUNG-CHILDREN; HEAD-INJURIES; OUTCOMES; ADOLESCENTS; PREDICTORS; COMPETENCE	This article builds upon Traumatic Brain Injury Common Data Elements (TBI CDE) version 1.0 and the pediatric CDE Initiative by emphasizing the essential role of psychosocial risk and protective factors in pediatric TBI research. The goals are to provide a compelling rationale for including psychosocial risk and protective factors in addition to socioeconomic status (SES), age, and sex in the study design and analyses of pediatric TBI research and to describe recommendations for core common data elements in this domain. Risk and protective factor research is based on the ecological theory of child development in which children develop through a series of interactions with their immediate and more distant environments. Home, school, religious, and social influences are conceptualized as risk and/or protective factors. Child development and TBI researchers have interpreted risk and protective variables as main effects or as interactions and have used cumulative risk indices and moderation models to describe the relationship among these variables and outcomes that have to do with development and with recovery from TBI. It is likely that the number, type, and interaction among risk and protective factors each contribute unique variance to study outcomes. Longitudinal designs in TBI research will be essential to understanding the reciprocal relationships between risk/protective factors and the recovery/outcome made by the child. The search for effective interventions to hasten TBI recovery mandates the need to target modifiable risks and to promote protective factors in the child's environment.	[Gerring, Joan P.] Johns Hopkins Univ, Sch Med, Kennedy Krieger Res Inst, Dept Psychiat & Pediat, Baltimore, MD USA; [Wade, Shari] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Wade, Shari] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA		Gerring, JP (corresponding author), Johns Hopkins Bayview Med Ctr, Dept Psychiat, 4840 Eastern Ave D2 E, Baltimore, MD 21224 USA.	jgerring@jhmi.edu			National Institutes of Health (National Institute of Neurological Disorders and Stroke; NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); United States Department of Education/National Institute on Disability and Rehabilitation Research (DOE/NIDRR) including NIDRR Rehabilitation Research and Training Center [H133B090010]	This project was jointly supported by the National Institutes of Health (National Institute of Neurological Disorders and Stroke; NIH/NINDS) and the United States Department of Education/National Institute on Disability and Rehabilitation Research (DOE/NIDRR) including NIDRR Rehabilitation Research and Training Center grant H133B090010.	Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; BOYLE MH, 1987, ARCH GEN PSYCHIAT, V44, P826; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Byrne B., 2001, STRUCTURAL EQUATION; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Copeland-Linder N, 2010, J CLIN CHILD ADOLESC, V39, P176, DOI 10.1080/15374410903532601; GARMEZY N, 1984, CHILD DEV, V55, P97, DOI 10.2307/1129837; Gerrard-Morris A., 2009, J INT NEUROPSYCH SOC, V16, P1; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Green JG, 2010, ARCH GEN PSYCHIAT, V67, P113, DOI 10.1001/archgenpsychiatry.2009.186; Halle T, 2009, DISPARITIES EARLY LE; Kessler RC, 1997, PSYCHOL MED, V27, P1101, DOI 10.1017/S0033291797005588; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; MASTEN AS, 1988, J CHILD PSYCHOL PSYC, V29, P745, DOI 10.1111/j.1469-7610.1988.tb00751.x; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCauley S.R., 2011, J NEUROTRAUMA; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; PRINZ RJ, 1979, J APPL BEHAV ANAL, V12, P691, DOI 10.1901/jaba.1979.12-691; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Stouthamer-Loeber M, 2002, J CONSULT CLIN PSYCH, V70, P111, DOI 10.1037//0022-006X.70.1.111; SZATMARI P, 1994, INT J METHOD PSYCH, V4, P231; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wade SL, 2009, J HEAD TRAUMA REHAB, V24, P239, DOI 10.1097/HTR.0b013e3181ad6680; Wallander JL, 1998, J CHILD PSYCHOL PSYC, V39, P29, DOI 10.1017/S0021963097001741; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	49	28	28	0	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2012	29	4					621	628		10.1089/neu.2011.2234			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	901SQ	WOS:000300987500001	22091875	Green Published			2022-02-06	
J	Hudak, AM; Hynan, LS; Harper, CR; Diaz-Arrastia, R				Hudak, A. M.; Hynan, L. S.; Harper, C. R.; Diaz-Arrastia, R.			Association of Depressive Symptoms With Functional Outcome After Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						BDI-II; depression; function; FSE; outcomes; Traumatic brain injury	COMORBIDITY SURVEY REPLICATION; MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; SIGNIFICANT OTHERS; MASS VIOLENCE; INVENTORY-II; HEAD TRAUMA; BDI-II; MILD; MODERATE	Objective: To test whether improved functional status correlates with more depressive symptoms after traumatic brain injury (TBI). This is based on the concept that increasing awareness of deficits may exacerbate depression, even while survivors are making functional improvements. Participants: A total of 471 individuals with TBI (72% white; 71% men; median Glasgow Coma Scale (GCS) score = 11) enrolled during acute care or inpatient rehabilitation and followed up at a median of 6 months. Main Measure: Beck Depression Inventory-II (BDI-II), Glasgow Outcome Scale-Extended, and Functional Status Examination (FSE). Results: We found significant Spearman rank order correlations between BDI-II scores and the total FSE as well as all domains of the FSE. Lower functional levels correlated with more depressive symptoms. Modeling of predictive factors, including subject characteristics, injury-related characteristics, and outcome measures, resulted in 2 models, both containing age and GCS along with other factors. Conclusion: The relation between depressive symptoms and functional outcomes is complex and a fertile area for further research. The authors would encourage clinicians to monitor patients for depressive symptoms to help to prevent the detrimental impact on recovery.	[Hudak, A. M.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Hynan, L. S.] Univ Texas SW Med Ctr Dallas, Div Biostat, Dept Clin Sci, Dallas, TX 75390 USA; [Hynan, L. S.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Harper, C. R.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Diaz-Arrastia, R.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Rockville, MD USA		Hudak, AM (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 730 E Broad St,Box 843038, Richmond, VA 23298 USA.	Ahudak@vcu.edu	Hynan, Linda S/P-6473-2016	Hynan, Linda/0000-0002-4642-7769; Diaz-Arrastia, Ramon/0000-0001-6051-3594	 [NIH 5 KL2 RR024983-02];  [NIH R01 HD48179];  [NIH U01 HD42652];  [NIDRR H133AO252604]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042652] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048179] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003138] Funding Source: NIH RePORTER	This work was supported in part by grants NIH 5 KL2 RR024983-02, NIH R01 HD48179, NIH U01 HD42652, and NIDRR H133AO252604.	[Anonymous], 2000, DIAGNOSTIC STAT MANU; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Dozois DJA, 1998, PSYCHOL ASSESSMENT, V10, P83, DOI 10.1037/1040-3590.10.2.83; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Henry JD, 2005, J CLIN EXP NEUROPSYC, V27, P78, DOI 10.1080/138033990513654; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Homaifar BY, 2009, ARCH PHYS MED REHAB, V90, P652, DOI 10.1016/j.apmr.2008.10.028; HOSMER DW, 1989, APPL LOGISTIC REGRES, P86; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Kirkness Catherine J, 2002, J Neurosci Nurs, V34, P134; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Mollica RF, 2002, BRIT J PSYCHIAT, V181, P339, DOI 10.1192/bjp.181.4.339; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; Prigatano GP, 1997, PERSP PSYCH, V6, P341; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rowland SM, 2005, BRAIN INJURY, V19, P77, DOI 10.1080/02699050410001719988; SAS, 2008, SAS WIND VERS 9 2; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; TEASDALE G, 1974, LANCET, V2, P81; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wallace CA, 2000, BRAIN INJURY, V14, P549; Weinstein CS, 2001, NEUROPSYCHOL REV, V11, P131, DOI 10.1023/A:1016650623996; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whisman MA, 2000, J CLIN PSYCHOL, V56, P545, DOI 10.1002/(SICI)1097-4679(200004)56:4<545::AID-JCLP7>3.0.CO;2-U; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 1993, INT CLASS IMP DIS HA; [No title captured]	66	28	28	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2012	27	2					87	98		10.1097/HTR.0b013e3182114efd			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	912LI	WOS:000301799100001	22411107	Green Accepted			2022-02-06	
J	Marshall, S; Bayley, M; McCullagh, S; Velikonja, D; Berrigan, L				Marshall, Shawn; Bayley, Mark; McCullagh, Scott; Velikonja, Diana; Berrigan, Lindsay			Clinical practice guide for traumatic light cerebral lesions and persistent symptoms	CANADIAN FAMILY PHYSICIAN			French	Article							WESTMEAD PTA SCALE; BRAIN-INJURY; TASK-FORCE; INTERNATIONAL-CONFERENCE; EARLY IDENTIFICATION; HEAD-INJURY; CONCUSSION; STATEMENT; VALIDITY; FATIGUE		[Marshall, Shawn] Ctr Readaptat Hop Ottawa, Programme Les Cerebrales Acquises, Ottawa, ON K1H 8M2, Canada; [Marshall, Shawn] Univ Ottawa, Fac Med, Ottawa, ON K1N 6N5, Canada; [Bayley, Mark] Toronto Rehabil Inst, Programme Neuroreadaptat, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Fac Med, Toronto, ON M5S 1A1, Canada; [McCullagh, Scott] Sunnybrook Hlth Sci Ctr, Programme Neuropsychiat, Toronto, ON M4N 3M5, Canada; [McCullagh, Scott] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Velikonja, Diana] Hamilton Hlth Sci Ctr, Programme Les Cerebrales Acquises, Hamilton, Vic, Australia; [Velikonja, Diana] McMaster Univ, Dept Psychiat & Neurosci Comportementales, Hamilton, ON, Canada; [Berrigan, Lindsay] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada		Marshall, S (corresponding author), Ctr Readaptat Hop Ottawa, Programme Les Cerebrales Acquises, 505 Chemin Smyth, Ottawa, ON K1H 8M2, Canada.	smarshall@lho.on.ca		Bayley, Mark/0000-0001-7860-9463			American Academy of Sleep Medicine, 2006, PRACT PAR PSYCH BEH; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 2006, OPT PRACT GUID AD IN; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Cappa SF, 2005, EUR J NEUROL, V12, P665; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; *CDCP, 2007, HEADS FACTS PHYS MIL; Centers for Disease Control and Prevention, 2007, HEADS TOOL KIT; Commission de la securite professionnelle et de l'assurance contre les accidents de travail de l'Ontario, 2006, PROGR CAR MILD TRAUM; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; Defense and Veterans Brain Injury Center, 2008, UPD MTBI CLIN GUID; Department of Labor and Employment, 2005, TRAUM BRAIN INJ MED; Department of Veterans Affairs/Department of Defense, 2009, VA DOD CLIN PRACT GU; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Graham Ian D, 2005, Evid Based Nurs, V8, P68, DOI 10.1136/ebn.8.3.68; Guidelines and Protocols Advisory Committee, 2004, PRIM CAR MAN SLEEP C; Hillier SL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005397.pub2; HILTON M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003162.PUB2; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Lemonick MD., 2008, TIME            0131; Marteau, 1998, HEALTH TECHNOL ASSES, V2, pI, DOI DOI 10.3310/hta2030; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; MTBI Guidelines Development Team, 2010, GUID MILD TRAUM BRAI; Multiple Sclerosis Council for Clinical Practice Guidelines, 1998, FAT MULT SCLER EV BA; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I, V56; New South Wales Motor Accident Authority, 2008, GUID MILD TRAUM BRAI; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Organisation mondiale de la Sante, 1992, INT STAT CLASS DIS R; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Shores EA, 2008, J NEUROL NEUROSUR PS, V79, P1100, DOI 10.1136/jnnp.2007.132571; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	44	28	28	0	3	COLL FAMILY PHYSICIANS CANADA	MISSISSAUGA	2630 SKYMARK AVE, MISSISSAUGA, ONTARIO L4W 5A4, CANADA	0008-350X	1715-5258		CAN FAM PHYSICIAN	Can. Fam. Phys.	MAR	2012	58	3					E128	E140					13	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	909DO	WOS:000301542700002					2022-02-06	
J	Saraiva, ALL; Ferreira, APO; Silva, LFA; Hoffmann, MS; Dutra, FD; Furian, AF; Oliveira, MS; Fighera, MR; Royes, LFF				Lopes Saraiva, Andre Luis; Oliveira Ferreira, Ana Paula; Almeida Silva, Luiz Fernando; Hoffmann, Mauricio Scopel; Dutra, Fabricio Diniz; Furian, Ana Flavia; Oliveira, Mauro Schneider; Fighera, Michele Rechia; Freire Royes, Luiz Fernando			Creatine reduces oxidative stress markers but does not protect against seizure susceptibility after severe traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						Creatine; Traumatic brain injury; Post-traumatic epilepsy; TBARS; Carbonyl; Na+,K+-ATPase	PENTYLENETETRAZOL-INDUCED SEIZURES; POSTTRAUMATIC EPILEPSY; NA+,K+-ATPASE ACTIVITY; TIME-COURSE; K+-ATPASE; RAT; HYPEREXCITABILITY; SUPPLEMENTATION; EPILEPTOGENESIS; CONVULSIONS	Achievements made over the last years have highlighted the important role of creatine in health and disease. However, its effects on hyperexcitable circuit and oxidative damage induced by traumatic brain injury (TBI) are not well understood. In the present study we revealed that severe TBI elicited by fluid percussion brain injury induced oxidative damage characterized by protein carbonylation, thiobarbituric acid reactive species (TBARS) increase and Na+,K+-ATPase activity inhibition 4 and 8 days after neuronal injury. Statistical analysis showed that after TBI creatine supplementation (300 mg/kg, p.o.) decreased the levels of protein carbonyl and TBARS but did not protect against TBI-induced Na+,K+-ATPase activity inhibition. Electroencephalography (EEG) analysis revealed that the injection of a subconvulsant dose of PTZ (35 mg/kg, i.p.), 4 but not 8 days after neuronal injury, decreased latency for the first clonic seizures and increased the time of spent generalized tonic-clonic seizures compared with the sham group. In addition, creatine supplementation had no effect on convulsive parameters induced by a subconvulsant dose of PTZ. Current experiments provide evidence that lipid and protein oxidation represents a separate pathway in the early post-traumatic seizures susceptibility. Furthermore, the lack of consistent anticonvulsant effect exerted by creatine in this early phase suggests that its apparent antioxidant effect does not protect against excitatory input generation induced by TBI. (C) 2011 Elsevier Inc. All rights reserved.	[Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Dept Metodos & Tecnicas Desport, Ctr Educ Fis & Desportos, BR-97119900 Santa Maria, RS, Brazil; [Lopes Saraiva, Andre Luis; Oliveira Ferreira, Ana Paula; Almeida Silva, Luiz Fernando; Furian, Ana Flavia; Oliveira, Mauro Schneider; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Programa Posgrad Ciencias Biol Bioquim Toxicologi, Ctr Ciencias Nat & Exatas, BR-97119900 Santa Maria, RS, Brazil; [Lopes Saraiva, Andre Luis; Oliveira Ferreira, Ana Paula; Almeida Silva, Luiz Fernando; Hoffmann, Mauricio Scopel; Dutra, Fabricio Diniz; Furian, Ana Flavia; Fighera, Michele Rechia; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Lab Bioquim Exercicio, Ctr Educ Fis & Desportos, BR-97119900 Santa Maria, RS, Brazil; [Oliveira, Mauro Schneider] Univ Fed Santa Maria, Dept Fisiol & Farmacol, Ctr Ciencias Saude, BR-97119900 Santa Maria, RS, Brazil		Royes, LFF (corresponding author), Univ Fed Santa Maria, Dept Metodos & Tecnicas Desport, Ctr Educ Fis & Desportos, BR-97105900 Anta Maria, RS, Brazil.	nandoroyes@yahoo.com.br	Fighera, Michele R/J-9576-2014; royes, luiz/T-3581-2019; Oliveira, Mauro Schneider/G-3437-2012; Hoffmann, Mauricio/AAM-9899-2020	Oliveira, Mauro Schneider/0000-0002-5381-1208; Hoffmann, Mauricio/0000-0003-4232-3169; Saraiva, Andre Lopes/0000-0001-9612-3846; Almeida Silva, Luiz Fernando/0000-0002-7621-4836; Fighera, Michele/0000-0002-3111-7530; royes, luiz/0000-0003-4045-4827			Adhihetty PJ, 2008, NEUROMOL MED, V10, P275, DOI 10.1007/s12017-008-8053-y; Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bertorello AM, 2003, MOL BIOL CELL, V14, P1149, DOI 10.1091/mbc.E02-06-0367; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng SXJ, 1999, J PHYSIOL-LONDON, V518, P37, DOI 10.1111/j.1469-7793.1999.0037r.x; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Fiske CH, 1925, J BIOL CHEM, V66, P375; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Furian AF, 2007, NEUROCHEM INT, V50, P164, DOI 10.1016/j.neuint.2006.07.012; Garga Nina, 2006, Epilepsy Curr, V6, P1, DOI 10.1111/j.1535-7511.2005.00083.x; Glaser V, 2010, NEUROTOXICOLOGY, V31, P454, DOI 10.1016/j.neuro.2010.05.012; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Gurkoff GG, 2009, NEUROSCIENCE, V164, P862, DOI 10.1016/j.neuroscience.2009.08.021; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2010, CURR OPIN NEUROL, V23, P183, DOI 10.1097/WCO.0b013e32833749e4; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Lima FD, 2009, BRAIN RES, V1279, P147, DOI 10.1016/j.brainres.2009.04.052; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; LOSCHER W, 1991, EPILEPSY RES, V8, P171, DOI 10.1016/0920-1211(91)90062-K; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Maciejak P, 2010, BRAIN RES, V1342, P150, DOI 10.1016/j.brainres.2010.04.045; Magni DV, 2007, BRAIN RES, V1185, P336, DOI 10.1016/j.brainres.2007.09.023; McColl CD, 2003, NEUROPHARMACOLOGY, V44, P234, DOI 10.1016/S0028-3908(02)00369-6; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Mujika I, 1997, INT J SPORTS MED, V18, P491, DOI 10.1055/s-2007-972670; Nishi A, 1999, J NEUROCHEM, V73, P1492, DOI 10.1046/j.1471-4159.1999.0731492.x; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oliveira MS, 2004, NEUROSCIENCE, V128, P721, DOI 10.1016/j.neuroscience.2004.07.012; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Sakellaris G, 2006, J TRAUMA, V61, P322, DOI 10.1097/01.ta.0000230269.46108.d5; Scheff SW, 2004, NEUROCHEM RES, V29, P469, DOI 10.1023/B:NERE.0000013753.22615.59; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wyse ATS, 2000, NEUROREPORT, V11, P2331, DOI 10.1097/00001756-200007140-00052; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362	46	28	28	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230			BRAIN RES BULL	Brain Res. Bull.	FEB 10	2012	87	2-3					180	186		10.1016/j.brainresbull.2011.10.010			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	909FP	WOS:000301548300005	22051612				2022-02-06	
J	Livingston, SC; Goodkin, HP; Hertel, JN; Saliba, EN; Barth, JT; Ingersoll, CD				Livingston, Scott C.; Goodkin, Howard P.; Hertel, Jay N.; Saliba, Ethan N.; Barth, Jeffrey T.; Ingersoll, Christopher D.			Differential Rates of Recovery After Acute Sport-Related Concussion: Electrophysiologic, Symptomatic, and Neurocognitive Indices	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						Mild traumatic brain injury; Cerebral concussion; Transcranial magnetic stimulation; Motor evoked potentials; Postconcussion signs/symptoms; Neuropsychological test performance	TRANSCRANIAL MAGNETIC STIMULATION; INDUCED AXONAL INJURY; BRAIN-INJURY; POSTCONCUSSION SYMPTOMS; FOOTBALL PLAYERS; MILD; RETURN; PATHOPHYSIOLOGY; PATHOBIOLOGY; ASSOCIATION	Purpose: To determine if motor evoked potentials (MEPs), postconcussion signs and symptoms, and neurocognitive functions follow a similar recovery pattern after concussion. Methods: Nine collegiate athletes with acute concussion (>24 hours after injury) participated in this retrospective time series design. Transcranial magnetic stimulation was applied over the motor cortex, and MEPs were recorded from the contralateral upper extremity. Self-reported symptoms were evaluated using the Head Injury Scale, and the Concussion Resolution Index was used to assess neurocognitive function. All measures were repeated on days 3, 5, and 10 after injury. Results: Composite scores on the Head Injury Scale were significantly higher on day 1 after injury (F-3,F-51 = 15.3; P = 0.0001). Processing speed on the Concussion Resolution Index was slower on days 1, 3, and 5 compared with that on day 10 (F-3,F-24 = 6.75; P = 0.0002). Median MEP latencies were significantly longer on day 10 compared with day 1 after concussion (t(8) = -2.69; P = 0.03). Ulnar MEP amplitudes were significantly smaller on day 3 after concussion compared with day 5 (t(8) = -3.48; P = 0.008). Conclusions: Acutely concussed collegiate athletes demonstrate changes in MEPs, which persist for up to 10 days after injury and do not follow the same recovery pattern as symptoms and neuropsychological test performance. The apparent differential rates of recovery most likely indicate different pathophysiological processes occurring in the immediate postconcussion period.	[Livingston, Scott C.] Univ Kentucky, Div Phys Therapy, Concuss Assessment Res Lab, Lexington, KY 40536 USA; [Goodkin, Howard P.] Univ Virginia, Curry Sch Educ, Dept Neurol, Charlottesville, VA 22903 USA; [Hertel, Jay N.; Saliba, Ethan N.] Univ Virginia, Curry Sch Educ, Div Kinesiol, Dept Human Serv, Charlottesville, VA 22903 USA; [Barth, Jeffrey T.] Univ Virginia, Dept Neuropsychol, Charlottesville, VA USA; [Ingersoll, Christopher D.] Cent Michigan Univ, Coll Hlth Profess, Mt Pleasant, MI 48859 USA		Livingston, SC (corresponding author), Univ Kentucky, Div Phys Therapy, Concuss Assessment Res Lab, 900 S Limestone, Lexington, KY 40536 USA.	scott.livingston@uky.edu	Ingersoll, Christopher/H-6474-2015	Ingersoll, Christopher/0000-0001-9157-6846; Goodkin, Howard/0000-0003-0528-4949	National Operating Committee on the Standards of Athletic Equipment [13-06]; National Athletic Trainers' Association Research and Education Foundation [305DGP002]	Supported by the National Operating Committee on the Standards of Athletic Equipment (grant 13-06) and the National Athletic Trainers' Association Research and Education Foundation (grant 305DGP002).	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chistyakov AV, 1999, CLIN NEUROPHYSIOL, V110, P1080, DOI 10.1016/S1388-2457(99)00029-2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Conforto AB, 2004, CLIN NEUROPHYSIOL, V115, P812, DOI 10.1016/j.clinph.2003.11.010; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GHEZZI A, 1991, ACTA NEUROL SCAND, V84, P503, DOI 10.1111/j.1600-0404.1991.tb05003.x; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2000, NEUROLOGIC ATHLETIC, P80; Grindel Scott H, 2003, Curr Sports Med Rep, V2, P18, DOI 10.1249/00149619-200302000-00005; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; HeadMinder, 2002, HEADMINDER CONC RES; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; Hugon M, 1973, NEW DEVELOPMENTS ELE, P277; Hurley RA, 2004, J NEUROPSYCH CLIN N, V16, P1, DOI 10.1176/appi.neuropsych.16.1.1; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Kimura J, 1989, ELECTRODIAGNOSIS DIS; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lefebvre R, 2004, J MANIP PHYSIOL THER, V27, P97, DOI 10.1016/j.jmpt.2003.12.004; Livingston S, 2007, RELATIONSHIP TRANSCR; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Mills KR, 1997, MUSCLE NERVE, V20, P570, DOI 10.1002/(SICI)1097-4598(199705)20:5<570::AID-MUS5>3.0.CO;2-6; Mills KR, 1999, MAGNETIC STIMULATION; Misulis K, 2001, BASIC SCI EVOKED POT, P26; MURRAY NMF, 1999, ELECTRODIAGNOSIS CLI, P549; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Pridmore S, 1998, J ECT, V14, P25; Rossini PM, 2007, NEUROLOGY, V68, P484, DOI 10.1212/01.wnl.0000250268.13789.b2; Sosin DM, 1996, BRAIN INJURY, V10, P47; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8	58	28	28	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	FEB	2012	29	1					23	32		10.1097/WNP.0b013e318246ae46			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	897GF	WOS:000300634700003	22353982				2022-02-06	
J	Tian, ZR; Sharma, A; Nozari, A; Subramaniam, R; Lundstedt, T; Sharma, HS				Tian, Z. Ryan; Sharma, Aruna; Nozari, Ala; Subramaniam, Raman; Lundstedt, Torbjorn; Sharma, Hari Shanker			Nanowired Drug Delivery to Enhance Neuroprotection in Spinal Cord Injury	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Nanowired drug delivery; spinal cord injury; blood-spinal cord barrier; spinal cord edema; TiO2 nanowires; silica nanowires; neuronal injury; stem cells; functional recovery; astrocytes; myelin; ultrastructure; nanoparticles	CENTRAL-NERVOUS-SYSTEM; TITANIUM-DIOXIDE NANOPARTICLES; SEROTONIN SYNTHESIS INHIBITOR; IN-VIVO; ELECTRON-MICROSCOPY; PARTICULATE MATTER; OXIDATIVE STRESS; TRAUMATIC INJURY; EDEMA FORMATION; BRAIN DELIVERY	Spinal cord injury (SCI) is a serious clinical situation for which no suitable drug therapy exists. SCI often results in paraplegia or quadriplegia and, apart from the personal trauma leads to huge costs to society for rehabilitation or day-to-day life support. Sensory motor dysfunction following SCI is mainly a consequence of the slowly progressing cord pathology after primary injury that worsens over tine. Thus, almost all sensory and motor nerve control and pathways passing through spinal cord and reflexes are compromised in SCI patients. As a result their peripheral nervous system, autonomic nervous function and central nervous system regulations are adversely affected. Experiments carried out in our laboratory show that various therapeutic agents, if given within 10 to 30 minutes after primary SCI could correct morphological changes to a certain extent. In these rat models of SCI reduction in cord pathology, e.g., blood-spinal cord barrier (BSCB) breakdown, edema formation and cell injury by the neuroprotective agents that also limited sensory motor dysfunction and improved functional behavior. However, these drugs if given beyond 30 minutes after SCI showed a markedly reduced neuroprotective efficacy. Thus, new strategies are needed to enhance neuroprotection in SCI to prevent structural and functional changes over longer periods of time. To that end our laboratory has initiated a series of investigations in which nanowired delivery of various neurotherapeutic agents are applied after different time periods of SCI, that resulted in a much better outcome than with the parent compounds under identical conditions. The superior neuroprotective activity of nanowired compound delivery could be due to a reduced metabolism of active compounds in the central nervous system (CNS) or by sustained release of the drug for longer times. In addition, nanowired drugs may penetrate the CNS faster and could reach widespread areas once entering the spinal cord. Thus, nanowired drug delivery to treat SCI may have potential therapeutic value. These aspects of nanowired drug delivery to enhance neuroprotection in SCI are discussed in this review based on our own investigations.	[Sharma, Aruna; Sharma, Hari Shanker] Uppsala Univ, Univ Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, Lab Cerebrovasc Res, SE-75185 Uppsala, Sweden; [Tian, Z. Ryan; Subramaniam, Raman] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA; [Nozari, Ala] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Lundstedt, Torbjorn] AcurePharma AB, Uppsala, Sweden; [Lundstedt, Torbjorn] Uppsala Univ, Div Organ Chem, Dept Med Chem, SE-75185 Uppsala, Sweden		Sharma, HS (corresponding author), Uppsala Univ, Univ Hosp, Dept Surg Sci Anesthesiol & Intens Care Med, Lab Cerebrovasc Res, SE-75185 Uppsala, Sweden.	Sharma@surgsci.uu.se	Nozari, Ala/AAH-6070-2021; Tian, Z. Ryan/R-6671-2016	Tian, Z. Ryan/0000-0002-5644-8483	Air Force Office of Scientific Research (London), Air Force Material Command, USAFUnited States Department of DefenseAir Force Office of Scientific Research (AFOSR) [FA8655-05-1-3065]; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [2710]; Astra-Zeneca, Molndal, SwedenAstraZeneca; Alexander von Humboldt Foundation, GermanyAlexander von Humboldt Foundation; IPSEN Medical, FranceIpsen; University Grants Commission, New Delhi, IndiaUniversity Grants Commission, India; Indian Council of Medical Research, New Delhi, IndiaIndian Council of Medical Research (ICMR)	This investigation was partially supported by the Air Force Office of Scientific Research (London), Air Force Material Command, USAF, under grant number FA8655-05-1-3065. The U.S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the U.S. Government. We express sincere gratitude to several laboratories where a part of the work was done or some data recorded and evaluated. Financial support Swedish Medical Research Council (Grant Nr. 2710, HSS); Astra-Zeneca, Molndal, Sweden (HSS), Alexander von Humboldt Foundation, Germany (HSS); IPSEN Medical, France (HSS); and University Grants Commission, New Delhi, India (HSS); Indian Council of Medical Research, New Delhi, India (HSS) is gratefully acknowledged. The authors have no conflict of interest with any financial agencies mentioned above.	Assie MB, 2007, N-S ARCH PHARMACOL, V375, P241, DOI 10.1007/s00210-007-0162-x; Bechara S, 2011, ACTA BIOMATER, V7, P2892, DOI 10.1016/j.actbio.2011.04.009; Beck-Broichsitter M., 2011, J CONTROL RELEASE; Betbeder D., 2002, PHARM RES, V17, P743; Boffetta P, 2004, CANCER CAUSE CONTROL, V15, P697, DOI 10.1023/B:CACO.0000036188.23970.22; Brewer M, 2007, MED CLIN N AM, V91, P963, DOI 10.1016/j.mcna.2007.05.006; Brigger I, 2002, J PHARMACOL EXP THER, V303, P928, DOI 10.1124/jpet.102.039669; Brokx RD, 2002, J CONTROL RELEASE, V78, P115, DOI 10.1016/S0168-3659(01)00491-6; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Carty CL, 2003, J ENVIRON MONITOR, V5, P953, DOI 10.1039/b308488d; CHEN JL, 1988, J OCCUP ENVIRON MED, V30, P937, DOI 10.1097/00043764-198812000-00011; Chi B, 2007, J NANOSCI NANOTECHNO, V7, P668, DOI 10.1166/jnn.2007.147; Cho Y, 2012, EXP NEUROL, V233, P126, DOI 10.1016/j.expneurol.2011.09.028; Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002; Costigan S., 2006, TOXICOLOGY NANOPARTI; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Dong W, 2006, NANOMED-NANOTECHNOL, V2, P248, DOI 10.1016/j.nano.2006.10.005; Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Dyer AM, 2002, PHARM RES-DORDR, V19, P998, DOI 10.1023/A:1016418523014; ECETOC, 2006, WORKSH TEST STRAT ES; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122, DOI 10.1152/ajplegacy.1949.157.1.122; *EUR SCI FDN, 2005, POL BRIEF ESF ESF SC; Fabian E, 2008, ARCH TOXICOL, V82, P151, DOI 10.1007/s00204-007-0253-y; Fang C, 2006, EUR J PHARM SCI, V27, P27, DOI 10.1016/j.ejps.2005.08.002; Fernandes C, 2010, PHARMACOL RES, V62, P166, DOI 10.1016/j.phrs.2010.02.004; Gao XL, 2006, BIOMATERIALS, V27, P3482, DOI 10.1016/j.biomaterials.2006.01.038; Gibaud S, 1996, J PHARM SCI, V85, P944, DOI 10.1021/js960032d; Gomes AJ, 2006, PHOTOMED LASER SURG, V24, P514, DOI 10.1089/pho.2006.24.514; Gommersall L, 2007, EUR UROL, V52, P368, DOI 10.1016/j.eururo.2007.04.065; Grassian VH, 2007, ENVIRON HEALTH PERSP, V115, P397, DOI 10.1289/ehp.9469; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Kane RS, 2007, BIOTECHNOL PROGR, V23, P316, DOI 10.1021/bp060388n; Kipp JE, 2004, INT J PHARMACEUT, V284, P109, DOI 10.1016/j.ijpharm.2004.07.019; Kreuter J, 2004, J NANOSCI NANOTECHNO, V4, P484, DOI 10.1166/jnn.2003.077; Kreuter J, 2003, PHARM RES-DORDR, V20, P409, DOI 10.1023/A:1022604120952; Kreuter J, 2001, ADV DRUG DELIVER REV, V47, P65, DOI 10.1016/S0169-409X(00)00122-8; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; Lockman PR, 2003, PHARM RES-DORDR, V20, P705, DOI 10.1023/A:1023492015851; Michaelis K, 2006, J PHARMACOL EXP THER, V317, P1246, DOI 10.1124/jpet.105.097139; Modi G, 2009, PROG NEUROBIOL, V88, P272, DOI 10.1016/j.pneurobio.2009.05.002; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Mouritsen OG, 2011, EUR J LIPID SCI TECH, V113, P1174, DOI 10.1002/ejlt.201100050; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Na K, 2006, EUR J PHARM SCI, V27, P115, DOI 10.1016/j.ejps.2005.08.012; Nair BG, 2011, MED CHEM, V7, P488; Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017; Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021; Olivier JC, 1999, PHARMACEUT RES, V16, P1836, DOI 10.1023/A:1018947208597; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Peracchia MT, 1999, J CONTROL RELEASE, V60, P121, DOI 10.1016/S0168-3659(99)00063-2; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Ricci-Junior E, 2006, J MICROENCAPSUL, V23, P523, DOI 10.1080/02652040600775525; Ross R., 2007, TOWN CTRY MAG    APR, P68; Saez A, 2000, EUR J PHARM BIOPHARM, V50, P379, DOI 10.1016/S0939-6411(00)00125-9; SCENIHR. EU Scientific Committee on Emerging and Newly Identified Health Risks, 2006, EU SCI COMM EM NEWL; Schins RPF, 2004, TOXICOL APPL PHARM, V195, P1, DOI 10.1016/j.taap.2003.10.002; Schins RPF, 2002, CHEM RES TOXICOL, V15, P1166, DOI 10.1021/tx025558u; Seki J, 2004, INT J PHARM, V273, P75, DOI 10.1016/j.ijpharm.2003.12.022; SENIOR J, 1991, BIOCHIM BIOPHYS ACTA, V1062, P77, DOI 10.1016/0005-2736(91)90337-8; SENIOR J, 1982, FEBS LETT, V145, P109, DOI 10.1016/0014-5793(82)81216-7; Sharma A, 2012, EXPERT OPIN DRUG MET, V8, P47, DOI 10.1517/17425255.2012.637916; Sharma HS, 2007, CURR PHARM DESIGN, V13, P1929; Sharma H.S., 2012, NEUROTROPHIC FACTOR, V846, P1; Sharma H. S., 2004, BLOOD SPINAL CORD BR, P437; Sharma HS, 2011, J NEURAL TRANSM, V118, P3, DOI 10.1007/s00702-010-0542-0; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5014, DOI 10.1166/jnn.2009.GR04; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5055, DOI 10.1166/jnn.2009.GR09; Sharma HS, 2008, EXPERT OPIN PHARMACO, V9, P2773, DOI 10.1517/14656566.9.16.2773 ; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P197, DOI 10.1196/annals.1403.014; Sharma HS, 2007, NANOMEDICINE-UK, V2, P753, DOI 10.2217/17435889.2.6.753; Sharma HS, 2007, PROG BRAIN RES, V162, P245, DOI 10.1016/S0079-6123(06)62013-X; Sharma HS, 2007, CURR PHARM DESIGN, V13, P1841; Sharma HS, 2012, WIRES NANOMED NANOBI, V4, P184, DOI 10.1002/wnan.172; Sharma HS, 2011, J NANOSCI NANOTECHNO, V11, P7549, DOI 10.1166/jnn.2011.5114; Sharma Hari Shanker, 2011, Expert Rev Neurother, V11, P1121, DOI 10.1586/ern.11.100; Sharma HS, 2011, J NEURAL TRANSM, V118, P87, DOI 10.1007/s00702-010-0486-4; Sharma HS, 2009, PROG BRAIN RES, V180, P155, DOI 10.1016/S0079-6123(08)80009-X; Sharma HS, 2009, J NANOSCI NANOTECHNO, V9, P5073, DOI 10.1166/jnn.2009.GR10; Sharma Hari Shanker, 2008, Central Nervous System Agents in Medicinal Chemistry, V8, P143; SHARMA HS, 1995, NEUROSCI RES, V21, P241, DOI 10.1016/0168-0102(94)00855-A; Sharma HS, 2005, ANN NY ACAD SCI, V1053, P407, DOI 10.1196/annals.1344.036; Sharma HS, 2006, J NEURAL TRANSM, V113, P497, DOI 10.1007/s00702-005-0406-1; Sharma HS, 2006, J NEURAL TRANSM, V113, P521, DOI 10.1007/s00702-005-0405-2; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; Sharma HS, 1995, PROG BRAIN RES, V104, P401; Sharma HS, 2000, ACTA NEUROCHIR SUPPL, V76, P297; SHARMA HS, 1995, RESTOR NEUROL NEUROS, V7, P207, DOI 10.3233/RNN-1994-7403; Sharma HS, 1996, NEUROSCI RES, V24, P373, DOI 10.1016/0168-0102(95)01015-7; SHARMA HS, 1991, J NEUROL SCI, V102, P150, DOI 10.1016/0022-510X(91)90063-D; SHARMA HS, 1993, ACTA NEUROPATHOL, V85, P145; SHARMA HS, 1990, ACTA NEUROPATHOL, V79, P604, DOI 10.1007/BF00294237; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Stratmeyer M.E., 2007, SOC TOX 46 ANN M TOX; Tomazic-Jezic VJ, 2001, J BIOMED MATER RES, V55, P523, DOI 10.1002/1097-4636(20010615)55:4<523::AID-JBM1045>3.0.CO;2-G; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Warheit DB, 2007, TOXICOLOGY, V230, P90, DOI 10.1016/j.tox.2006.11.002; Winkler T, 1998, SPINAL CORD MONITORING, P283; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Yao CP, 2006, EPILEPSIA, V47, P1822, DOI 10.1111/j.1528-1167.2006.00814.x; Zhao DB, 2006, SMALL, V2, P879, DOI 10.1002/smll.200500317; Zhao LZ, 2010, BIOMATERIALS, V31, P8341, DOI 10.1016/j.biomaterials.2010.07.036	103	28	30	0	15	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	FEB	2012	11	1					86	95					10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	934MW	WOS:000303449400010	22385571				2022-02-06	
J	Bennett, TD; Statler, KD; Korgenski, EK; Bratton, SL				Bennett, Tellen D.; Statler, Kimberly D.; Korgenski, E. Kent; Bratton, Susan L.			Osmolar therapy in pediatric traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						brain edema; craniocerebral trauma; hypertonic saline solution; intracranial hypertension; mannitol; pediatrics	INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; HEAD-INJURY; FOLLOW-UP; CHILDREN; MANNITOL; HOSPITALIZATIONS; EPIDEMIOLOGY; DISCHARGE; OUTCOMES	Objectives: To describe patterns of use for mannitol and hypertonic saline in children with traumatic brain injury, to evaluate any potential associations between hypertonic saline and mannitol use and patient demographic, injury, and treatment hospital characteristics, and to determine whether the 2003 guidelines for severe pediatric traumatic brain injury impacted clinical practice regarding osmolar therapy. Design: Retrospective cohort study. Setting: Pediatric Health Information System database, January, 2001 to December, 2008. Patients: Children (age <18 yrs) with traumatic brain injury and head/neck Abbreviated Injury Scale score >= 3 who received mechanical ventilation and intensive care. Interventions: None. Measurements and Main Results: The primary outcome was hospital billing for parenteral hypertonic saline and mannitol use, by day of service. Overall, 33% (2,069 of 6,238) of the patients received hypertonic saline, and 40% (2,500 of 6,238) received mannitol. Of the 1,854 patients who received hypertonic saline or mannitol for >= 2 days in the first week of therapy, 29% did not have intracranial pressure monitoring. After adjustment for hospital-level variation, primary insurance payer, and overall injury severity, use of both drugs was independently associated with older patient age, intracranial hemorrhage (other than epidural), skull fracture, and higher head/neck injury severity. Hypertonic saline use increased and mannitol use decreased with publication of the 2003 guidelines, and these trends continued through 2008. Conclusions: Hypertonic saline and mannitol are used less in infants than in older children. The patient-level and hospital-level variation in osmolar therapy use and the substantial amount of sustained osmolar therapy without intracranial pressure monitoring suggest opportunities to improve the quality of pediatric traumatic brain injury care. With limited high-quality evidence available, published expert guidelines appear to significantly impact clinical practice in this area. (Crit Care Med 2012; 40: 208-215)	[Bennett, Tellen D.; Korgenski, E. Kent] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84112 USA		Bennett, TD (corresponding author), Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84112 USA.	tell.bennett@hsc.utah.edu	Bratton, Susan L./O-2353-2013	Bratton, Susan L./0000-0002-4605-8078; Bennett, Tellen/0000-0003-1483-4236	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH/NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1KM1CA156723]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [KM1CA156723] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001067] Funding Source: NIH RePORTER	Supported, in part, by the National Institutes of Health. Dr. Bennett is partially supported by the Mentored Scholars Program for Translational Comparative Effectiveness Research, NIH/NCI Grant Number 1KM1CA156723.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; *CHILD HLTH CORP A, CTC 2010 COD STRUCT; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; Dawson L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000111; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Durbin D R, 2001, Inj Prev, V7, P96, DOI 10.1136/ip.7.2.96; *EXP GROUP INJ SEV, DISC DOC INJ SEV MEA; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Goldin AB, 2007, PEDIATRICS, V119, P905, DOI 10.1542/peds.2006-2040; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kochanek PM, 2006, PEDIAT CRITICAL CARE, P1596; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Madden JM, 2002, NEW ENGL J MED, V347, P2031, DOI 10.1056/NEJMsa020408; Meara E, 2004, PEDIATRICS, V113, P1619, DOI 10.1542/peds.113.6.1619; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P831, DOI 10.1001/jama.263.6.831; Tasker RC, 2011, BRIT J NEUROSURG, V25, P68, DOI 10.3109/02688697.2010.538770; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; *TRIAN, 1997, ICDMAP 90 SOFTW US G; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Weiss PF, 2009, J PEDIATR-US, V155, P812, DOI 10.1016/j.jpeds.2009.05.030; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	44	28	30	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2012	40	1					208	215		10.1097/CCM.0b013e31822e9d31			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	866KO	WOS:000298379800030	21926592	Green Accepted			2022-02-06	
J	Kubal, WS				Kubal, Wayne S.			Updated Imaging of Traumatic Brain Injury	RADIOLOGIC CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Computed tomography; Magnetic resonance imaging; Diffusion tensor imaging; Magnetic resonance spectroscopy	DIFFUSE AXONAL INJURY; ACUTE SUBDURAL-HEMATOMA; CLOSED-HEAD-INJURY; GUNSHOT INJURIES; CORPUS-CALLOSUM; CT FINDINGS; PREVALENCE; RECOVERY; SPECTROSCOPY; TOMOGRAPHY	Computed tomography (CT) and magnetic resonance (MR) play important roles in the evaluation of traumatic brain injury. Modern CT scanners allow for rapid and accurate diagnosis of intracranial hemorrhage and mass effect and allow the efficient implementation of emergent CT angiography. Newer sequences, such as gradient recalled echo, susceptibility-weighted imaging, and diffusion-weighted imaging, can provide greater sensitivity for specific types of diffuse posttraumatic brain injury. MR spectroscopy can provide additional chemical information, and diffusion tensor imaging can provide information about white matter injury. Patient treatment can be optimized using the diagnostic and prognostic information derived from current imaging techniques.	Univ Arizona, Hlth Sci Ctr, Dept Radiol, Tucson, AZ 85724 USA		Kubal, WS (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Radiol, Room 1369,1501 N Campbell Ave,POB 245067, Tucson, AZ 85724 USA.	wkubal@email.arizona.edu					ALEXANDER E, 1982, SURG NEUROL, V17, P107, DOI 10.1016/S0090-3019(82)80031-1; Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; Arrangoiz R, 2010, AM SURGEON, V76, P1255; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; Brocker B, 1991, NEUROIMAG CLIN N AM, V1, P387; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; GEAN AD, 1994, IMAGING HEAD TRAUMA, P207; GEAN AD, 1994, IMAGING HEAD TRAUMA, P75; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GOODWIN JR, 1994, J TRAUMA, V37, P119, DOI 10.1097/00005373-199407000-00021; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hofbauer M, 2010, J TRAUMA, V69, P770, DOI 10.1097/TA.0b013e3181c81d7d; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson Michele H., 1995, V134, P98; Kim TW, 2007, J TRAUMA, V62, P1446, DOI 10.1097/01.ta.0000222909.31666.db; KUBAL WS, 2000, ARRS, P1; Lee Kyeong-Seok, 1997, Journal of Korean Medical Science, V12, P353; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Nakabayashi M, 2007, J NEUROSURG, V106, P370, DOI 10.3171/jns.2007.106.3.370; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; NOGUCHI K, 1995, RADIOLOGY, V196, P773, DOI 10.1148/radiology.196.3.7644642; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; POPP JA, 1985, NEUROSURGERY, P1536; Provenzale J, 2007, EMERG RADIOL, V14, P1, DOI 10.1007/s10140-007-0587-z; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; REED D, 1986, AM J NEURORADIOL, V7, P417; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; ROTHFUS WE, 1987, AM J NEURORADIOL, V8, P1073; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Tate DF, 2011, J INT NEUROPSYCH SOC, V17, P308, DOI 10.1017/S1355617710001670; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; WERNICK S, 1989, J COMPUT ASSIST TOMO, V13, P323, DOI 10.1097/00004728-198903000-00027; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	62	28	30	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0033-8389			RADIOL CLIN N AM	Radiol. Clin. N. Am.	JAN	2012	50	1					15	+		10.1016/j.rcl.2011.08.010			28	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	865LE	WOS:000298311600003	22099485				2022-02-06	
J	Lebowitz, MS; Dams-O'Connor, K; Cantor, JB				Lebowitz, Matthew S.; Dams-O'Connor, Kristen; Cantor, Joshua B.			Feasibility of computerized brain plasticity-based cognitive training after traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						attention; brain injury; cognitive symptoms; computer-assisted therapy; feasibility; human information processing; neuronal plasticity; neuropsychology; rehabilitation; self-report	OLDER-ADULTS; REHABILITATION; RECOVERY; MEMORY; NEUROPLASTICITY; REMEDIATION; EXERCISE; FAILURES; PROGRAM; SPEED	The present study investigates the feasibility and utility of using a computerized brain plasticity-based cognitive training (BPCT) program as an intervention for community-dwelling individuals with traumatic brain injury (TBI). In a pre-post pilot study, 10 individuals with mild to severe TBI who were 6 mo to 22 yr postinjury were asked to use a computerized BPCT intervention designed to improve cognitive functioning through a graduated series of structured exercises at their homes in an urban community. Outcome measures included objective neuropsychological and self-report measures of cognitive functioning. All participants were able to use the software in their homes. Some mild fatigue was reported, which tended to dissipate over time. Few technical difficulties were reported. Remote support was sufficient for what technical assistance was needed. Participants reported subjective improvement in cognitive functioning, and small to large effect sizes on self-report and neuropsychological measures are reported. We conclude that BPCT may be a viable intervention for TBI outpatients as an adjunct to comprehensive neurorehabilitation. The intervention can be delivered in patients' homes with support provided remotely. Results of this study demonstrate the potential for treatment-related improvements many years after injury. Further study in controlled trials is warranted.	[Lebowitz, Matthew S.; Dams-O'Connor, Kristen; Cantor, Joshua B.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA		Lebowitz, MS (corresponding author), Yale Univ, Dept Psychol, 2 Hillhouse Ave, New Haven, CT 06520 USA.	Matthew.Lebowitz@yale.edu			National Institute on Disability and Rehabilitation Research, U.S. Department of EducationUS Department of Education [H133P050004]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1R49CE001171-01]	This material was based on work supported by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education (grant H133P050004), and the Centers for Disease Control and Prevention (grant 1R49CE001171-01). Computer software was provided by Posit Science Corporation, San Francisco, California.	Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Barnes DE, 2009, ALZ DIS ASSOC DIS, V23, P205, DOI 10.1097/WAD.0b013e31819c6137; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Bergquist T, 2008, BRAIN INJURY, V22, P891, DOI 10.1080/02699050802405487; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Diamond MC, 2001, AN ACAD BRAS CIENC, V73, P211, DOI 10.1590/S0001-37652001000200006; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Etchells E, 1996, CAN MED ASSOC J, V155, P657; Fisher M, 2010, SCHIZOPHRENIA BULL, V36, P869, DOI 10.1093/schbul/sbn170; Fisher M, 2009, AM J PSYCHIAT, V166, P805, DOI 10.1176/appi.ajp.2009.08050757; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keefe R, 2010, SCHIZOPHR RES, V117, P394, DOI 10.1016/j.schres.2010.02.712; Levin HS, 2006, ARCH PHYS MED REHAB, V87, pS1, DOI 10.1016/j.apmr.2006.09.010; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; REASON J, 1984, BRIT J CLIN PSYCHOL, V23, P121, DOI 10.1111/j.2044-8260.1984.tb00635.x; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Vom Hofe A, 1998, EUR REV APPL PSYCHOL, V48, P49; Wexler BE, 2005, SCHIZOPHRENIA BULL, V31, P931, DOI 10.1093/schbul/sbi038; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; YATES GCR, 1985, BRIT J EDUC PSYCHOL, V55, P28, DOI 10.1111/j.2044-8279.1985.tb02603.x	35	28	29	1	37	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	10					1547	1556		10.1682/JRRD.2011.07.0133			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149FD	WOS:000319303500012	23516058	Bronze			2022-02-06	
J	Hearst, SM; Walker, LR; Shao, Q; Lopez, M; Raucher, D; Vig, PJS				Hearst, S. M.; Walker, L. R.; Shao, Q.; Lopez, M.; Raucher, D.; Vig, P. J. S.			THE DESIGN AND DELIVERY OF A THERMALLY RESPONSIVE PEPTIDE TO INHIBIT S100B-MEDIATED NEURODEGENERATION	NEUROSCIENCE			English	Article						S100B; spinocerebellar ataxia type 1; cerebellum; neurodegeneration; elastin-like polypeptide; thermal targeting	ELASTIN-LIKE POLYPEPTIDE; INTENSITY FOCUSED ULTRASOUND; BLOOD-BRAIN-BARRIER; TRYPTOPHAN FLUORESCENCE; OXIDATIVE STRESS; TRANSGENIC MICE; S100 PROTEINS; CELL-SURVIVAL; BINDING; TARGET	S100B, a glial-secreted protein, is believed to play a major role in neurodegeneration in Alzheimer's disease, Down syndrome, traumatic brain injury, and spinocerebellar ataxia type 1 (SCA1). SCA1 is a trinucleotide repeat disorder in which the expanded polyglutamine mutation in the protein ataxin-1 primarily targets Purkinje cells of the cerebellum. Currently, the exact mechanism of S100B-mediated Purkinje cell damage in SCA1 is not clear. However, here we show that S100B may act via the activation of the receptor for advanced glycation end product (RAGE) signaling pathway, resulting in oxidative stress-mediated injury to mutant ataxin-1-expressing neurons. To combat S100B-mediated neurodegeneration, we have designed a selective thermally responsive S100B inhibitory peptide, Synb1-ELP-TRTK. Our therapeutic polypeptide was developed using three key elements: (1) the elastin-like polypeptide (ELP), a thermally responsive polypeptide, (2) the TRTK12 peptide, a known S100B inhibitory peptide, and (3) a cell-penetrating peptide, Synb1, to enhance intracellular delivery. Binding studies revealed that our peptide, Synb1-ELP-TRTK, interacts with its molecular target S100B and maintains a high S100B binding affinity as comparable with the TRTK12 peptide alone. In addition, in vitro studies revealed that Synb1-ELP-TRTK treatment reduces S100B uptake in SHSY5Y cells. Furthermore, the Synb1-ELP-TRTK peptide decreased S100B-induced oxidative damage to mutant ataxin-1-expressing neurons. To test the delivery capabilities of ELP-based therapeutic peptides to the cerebellum, we treated mice with fluorescently labeled Synb1-ELP and observed that thermal targeting enhanced peptide delivery to the cerebellum. Here, we have laid the framework for thermal-based therapeutic targeting to regions of the brain, particularly the cerebellum. Overall, our data suggest that thermal targeting of ELP-based therapeutic peptides to the cerebellum is a novel treatment strategy for cerebellar neurodegenerative disorders. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.	[Hearst, S. M.; Shao, Q.; Lopez, M.; Vig, P. J. S.] Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA; [Hearst, S. M.; Walker, L. R.; Raucher, D.; Vig, P. J. S.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA		Vig, PJS (corresponding author), Univ Mississippi, Med Ctr, Dept Neurol, 2500 N State St, Jackson, MS 39216 USA.	pvig@umc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03 NS070065-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS070065] Funding Source: NIH RePORTER	This work was supported by R03 NS070065-01 grant from the NIH. We would like to thank Dr. Gene Bidwell III, for his help with ELP protein labeling and animal studies; and Henry Murphy II, for his help with binding studies, cell culture and protein purification experiments.	Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; BARGER SW, 1995, BRAIN RES, V677, P167, DOI 10.1016/0006-8993(95)00160-R; Bianchi R, 1996, BBA-MOL CELL RES, V1313, P258, DOI 10.1016/0167-4889(96)00098-5; Bidwell GL, 2007, BIOCHEM PHARMACOL, V73, P620, DOI 10.1016/j.bcp.2006.10.028; Bidwell GL, 2010, ADV DRUG DELIVER REV, V62, P1486, DOI 10.1016/j.addr.2010.05.003; Bidwell GL, 2010, PEPTIDES, V31, P834, DOI 10.1016/j.peptides.2010.02.007; Bidwell GL, 2009, EXPERT OPIN DRUG DEL, V6, P1033, DOI 10.1517/17425240903143745; Bidwell GL, 2009, J CONTROL RELEASE, V135, P2, DOI 10.1016/j.jconrel.2008.11.015; Bidwell GL, 2005, MOL CANCER THER, V4, P1076, DOI 10.1158/1535-7163.MCT-04-0253; Bocedi A, 2004, IUBMB LIFE, V56, P609, DOI 10.1080/15216540400016286; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Charpentier TH, 2010, J MOL BIOL, V396, P1227, DOI 10.1016/j.jmb.2009.12.057; Chen THH, 2008, PHARM RES, V25, P683, DOI 10.1007/s11095-007-9382-5; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; DONATO R, 1991, CELL CALCIUM, V12, P713, DOI 10.1016/0143-4160(91)90040-L; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Dreher MR, 2007, CANCER RES, V67, P4418, DOI 10.1158/0008-5472.CAN-06-4444; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; Frizzo JK, 2004, NEUROCHEM RES, V29, P735, DOI 10.1023/B:NERE.0000018844.51009.40; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Hearst SM, 2010, J NEUROCHEM, V114, P706, DOI 10.1111/j.1471-4159.2010.06791.x; Hertzberg Y, 2010, MED PHYS, V37, P2934, DOI 10.1118/1.3395553; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; IVANENKOV VV, 1995, J BIOL CHEM, V270, P14651, DOI 10.1074/jbc.270.24.14651; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; KATO K, 1990, J MOL NEUROSCI, V2, P109, DOI 10.1007/BF02876918; Kim SJ, 2003, NEUROSCI LETT, V348, P21, DOI 10.1016/S0304-3940(03)00657-8; Kim SJ, 2003, BIOCHEM BIOPH RES CO, V307, P660, DOI 10.1016/S0006-291X(03)01241-5; Koeppen AH, 2005, CEREBELLUM, V4, P62, DOI 10.1080/14734220510007950; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Li B, 2001, J AM CHEM SOC, V123, P11991, DOI 10.1021/ja010363e; Liu WE, 2006, J CONTROL RELEASE, V116, P170, DOI 10.1016/j.jconrel.2006.06.026; MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/NMAT2569, 10.1038/nmat2569]; Martin E, 2009, ANN NEUROL, V66, P858, DOI 10.1002/ana.21801; Massodi I, 2009, MOLECULES, V14, P1999, DOI 10.3390/molecules14061999; Matilla-Duenas A, 2008, CEREBELLUM, V7, P106, DOI 10.1007/s12311-008-0009-0; McClintock KA, 2000, PROTEIN SCI, V9, P2043, DOI 10.1110/ps.9.10.2043; Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100; Meyer DE, 2001, CANCER RES, V61, P1548; Moktan S, INVEST NEW IN PRESS; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; Ram Z, 2006, NEUROSURGERY, V59, P949; Raucher D, 2009, EXPERT OPIN DRUG DEL, V6, P1049, DOI 10.1517/17425240903158909; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Roltsch E, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-78; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rousselle C, 2000, MOL PHARMACOL, V57, P679, DOI 10.1124/mol.57.4.679; Ryu J, 2010, BIOCHEM BIOPH RES CO, V393, P280, DOI 10.1016/j.bbrc.2010.01.122; Sarantseva S. V., 2009, Biomeditsinskaya Khimiya, V55, P41; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Skinner PJ, 2001, AM J PATHOL, V159, P905, DOI 10.1016/S0002-9440(10)61766-X; Sorci G, CARDIOVASC IN PRESS; Takano K, 2007, AM J PHYSIOL-CELL PH, V293, pC1884, DOI 10.1152/ajpcell.00305.2007; Vig PJS, 2011, CEREBELLUM, V10, P254, DOI 10.1007/s12311-011-0262-5; Vig Parminder J S, 2006, J Neurol Sci Turk, V23, P166; Vig PJS, 2009, CEREBELLUM, V8, P231, DOI 10.1007/s12311-009-0125-5; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Weljie AM, 2000, PROTEIN ENG, V13, P59, DOI 10.1093/protein/13.1.59; Whitaker-Azmitia PM, 1997, BRAIN RES, V776, P51, DOI 10.1016/S0006-8993(97)01002-0; Wilder PT, 2006, BBA-MOL CELL RES, V1763, P1284, DOI 10.1016/j.bbamcr.2006.08.024; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Wright Nathan T, 2009, Curr Chem Biol, V3, P138; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620; Zimmer DB, CARDIOVASC IN PRESS	70	28	28	1	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 1	2011	197						369	380		10.1016/j.neuroscience.2011.09.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849QR	WOS:000297140700035	21958864	Green Accepted			2022-02-06	
J	Ishigami, Y; Klein, RM				Ishigami, Yoko; Klein, Raymond M.			Repeated measurement of the components of attention of older adults using the two versions of the Attention Network Test: stability, isolability, robustness, and reliability	FRONTIERS IN AGING NEUROSCIENCE			English	Article						attention; alerting; orienting; executive control; older adults; attention network test; aging	ANTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; AGE-RELATED-CHANGES; ALZHEIMERS-DISEASE; VISUAL-ATTENTION; LIFE-SPAN; SUSTAINED ATTENTION; YOUNGER ADULTS; ALERTNESS; REHABILITATION	Ishigami and Klein (2010) showed that scores of the three attention networks (alerting, orienting, and executive control) measured with the two versions of the Attention Network Test (ANT; Fan et al., 2002; Callejas et al., 2005) were robust over 10 sessions of repeated testing even though practice effects were consistently observed especially in the executive network when young adults were tested. The current study replicated their method to examine robustness, stability, reliability, and isolability of the networks scores when older adults were tested with these ANTs. Ten test sessions, each containing two versions of the ANT, were administered to 10 older adults. Participants were asked to indicate the direction of a target arrow, flanked by distractors, presented either above or below the fixation following auditory signals or/and visual cue. Network scores were calculated using orthogonal subtractions of performance in selected conditions. All network scores remained highly significant even after nine previous sessions despite some practice effects in the executive and the alerting networks. Some lack of independence among the networks was found. The relatively poor reliability of network scores with one session of data rises to respectable levels as more data is added.	[Ishigami, Yoko] Dalhousie Univ, Dept Psychol, Life Sci Ctr, Halifax, NS B3H 4R2, Canada		Ishigami, Y (corresponding author), Dalhousie Univ, Dept Psychol, Life Sci Ctr, 1355 Oxford St, Halifax, NS B3H 4R2, Canada.	ishigami@dal.ca			Natural Sciences and Engineering Research Council Discovery grantNatural Sciences and Engineering Research Council of Canada (NSERC); Killam Trust and Multiple Sclerosis Society of Canada	This research was made possible by a Natural Sciences and Engineering Research Council Discovery grant to Raymond M. Klein and scholarship support to Yoko Ishigami from the Killam Trust and Multiple Sclerosis Society of Canada. The research reported here is drawn from a thesis by Yoko Ishigami in partialful fillment of requirements for a PhD degree at the Dalhousie University.	Bherer L, 2008, EXP AGING RES, V34, P188, DOI 10.1080/03610730802070068; Brodeur DA, 1997, CAN J EXP PSYCHOL, V51, P20, DOI 10.1037/1196-1961.51.1.20; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Callejas A, 2005, EXP BRAIN RES, V167, P27, DOI 10.1007/s00221-005-2365-z; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; D'Aloisio A, 1990, DEV ATTENTION RES TH, P447, DOI DOI 10.1016/S0166-4115(08)60470-7; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fernandez-Duque D, 2006, NEUROPSYCHOLOGY, V20, P133, DOI 10.1037/0894-4105.20.2.133; Festa-Martino E, 2004, NEUROPSYCHOLOGY, V18, P258, DOI 10.1037/0894-4105.18.2.258; FOLK CL, 1992, PSYCHOL AGING, V7, P453, DOI 10.1037/0882-7974.7.3.453; Funes MJ, 2007, J EXP PSYCHOL HUMAN, V33, P348, DOI 10.1037/0096-1523.33.2.348; GREENWOOD PM, 1993, NEUROPSYCHOLOGIA, V31, P471, DOI 10.1016/0028-3932(93)90061-4; Groth KE, 2000, FRONT BIOSCI-LANDMRK, V5, pD284, DOI 10.2741/Groth; HARTLEY AA, 1990, J EXP PSYCHOL HUMAN, V16, P523, DOI 10.1037/0096-1523.16.3.523; Ishigami Y, 2010, J NEUROSCI METH, V190, P117, DOI 10.1016/j.jneumeth.2010.04.019; Ishigami Y, 2009, J INDIVID DIF, V30, P220, DOI 10.1027/1614-0001.30.4.220; Jennings JM, 2007, AGING NEUROPSYCHOL C, V14, P353, DOI 10.1080/13825580600788837; Jha AP, 2007, COGN AFFECT BEHAV NE, V7, P109, DOI 10.3758/CABN.7.2.109; Klein R, 2009, CAN J EXP PSYCHOL, V63, P240, DOI 10.1037/a0015807; Kok A, 2000, BIOL PSYCHOL, V54, P107, DOI 10.1016/S0301-0511(00)00054-5; Kok A, 1999, ACTA PSYCHOL, V101, P129, DOI 10.1016/S0001-6918(99)00003-7; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Lincourt AE, 1997, AGING NEUROPSYCHOL C, V4, P290, DOI 10.1080/13825589708256654; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Madden DJ, 1997, AGING NEUROPSYCHOL C, V4, P185, DOI 10.1080/13825589708256647; Marrocco RT, 1998, ATTENTIVE BRAIN, P35; NEBES RD, 1993, CORTEX, V29, P77, DOI 10.1016/S0010-9452(13)80213-4; NISSEN MJ, 1985, J GERONTOL, V40, P185, DOI 10.1093/geronj/40.2.185; Norman D., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; Pero S, 2006, BRAIN INJURY, V20, P1207, DOI 10.1080/02699050600983271; Posner, 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; RABBITT P, 1984, ATTENTION PERFORM, V10, P515; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Rogers W. A., 2000, COGNITIVE AGING PRIM, P57; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Sturm W, 2006, RESTOR NEUROL NEUROS, V24, P371; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Tales A, 2002, NEUROREPORT, V13, P2557, DOI 10.1097/00001756-200212200-00035; Tales A, 2002, NEUROPSYCHOLOGIA, V40, P2000, DOI 10.1016/S0028-3932(02)00057-X; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Thimm M, 2006, NEUROPSYCHOLOGIA, V44, P1230, DOI 10.1016/j.neuropsychologia.2005.09.008; Waszak F, 2010, DEV PSYCHOL, V46, P337, DOI 10.1037/a0018541; WRIGHT LL, 1979, J GERONTOL, V34, P704, DOI 10.1093/geronj/34.5.704; Zeef EJ, 1996, PSYCHOPHYSIOLOGY, V33, P555, DOI 10.1111/j.1469-8986.1996.tb02432.x	52	28	29	2	17	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	NOV 15	2011	3								17	10.3389/fnagi.2011.00017			13	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	054KA	WOS:000312341200001	22110440	Green Published, gold			2022-02-06	
J	McColgan, P; Sharma, P; Bentley, P				McColgan, Peter; Sharma, Pankaj; Bentley, Paul			Stem Cell Tracking in Human Trials: A Meta-Regression	STEM CELL REVIEWS AND REPORTS			English	Article							MARROW MONONUCLEAR-CELLS; MAGNETIC-RESONANCE TRACKING; PROGENITOR CELLS; MYOCARDIAL-INFARCTION; CD34(+) CELLS; INTRACORONARY INJECTION; TISSUE DISTRIBUTION; STROKE; TRANSPLANTATION; MIGRATION	The potential effectiveness of cell therapies is dependent upon homing of transplanted cells to relevant target organs. In this study we firstly characterise the range of methods employed in all human therapeutic-cell studies published to date investigated with cell-tracking. Secondly, we determine factors that predict target-organ cell uptake efficiency by meta-regression. Following a comprehensive literature search, we identified 19 relevant trials, representing 145 patients over the following 7 diseases: myocardial infarction; Chagasic cardiomyopathy; ischemic stroke; traumatic injury of brain or spinal cord; diabetes and cirrhosis. Cell-labelling strategies employed were: 18-fluorodeoxyglucose-PET, 111-indium-SPECT; 99-technetium-SPECT, and iron oxide-MRI. The following methodological parameters were extracted: label type; label dose; labelling efficiency; stability; cell dose; percentage labelled cells; disease type and chronicity; cell purity; cell type; and cell uptake efficiency. Meta-regression techniques were used to identify predictors of cell-labelling efficiency; viability and cell uptake efficiency. These analyses found that labelling efficiency is proportionate to cell dose, while cell viability is lowest with indium and long label incubation times. Uptake efficiency of cells is predicted by stem cell purity (positive association) and cell infusion number (negative association), although these two variables are themselves strongly negatively correlated between studies. In summary the methodological factors associated with enhanced therapeutic-cell homing from both our own analysis, and within-trial comparisons, are: acute (versus chronic) disease, selective stem cells (versus unselected cells), and intra-arterial (versus intravenous) delivery. However, future trials need to keep cell doses and imaging times constant so as to enable meaningful comparisons in uptake efficiency.	[Bentley, Paul] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Cerebrovasc Res Unit ICCRU, London W6 8RF, England; [McColgan, Peter; Sharma, Pankaj] Imperial Coll Hosp, Imperial Coll Cerebrovasc Res Unit ICCRU, London W6 8RF, England		Bentley, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Coll Cerebrovasc Res Unit ICCRU, Fulham Palace Rd, London W6 8RF, England.	p.bentley@imperial.ac.uk		Bentley, Paul/0000-0001-8036-7010	UK Department of Health Senior	PS and PB supported by UK Department of Health Senior Fellowships.	Alexandrescu DT, 2010, J IMMUNOTHER, V33, P570, DOI 10.1097/CJI.0b013e3181e032e8; Arminan A, 2010, J AM COLL CARDIOL, V55, P2244, DOI 10.1016/j.jacc.2009.08.092; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Ballios BG, 2010, CAN J OPHTHALMOL, V45, P342, DOI 10.3129/i10-070; da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010; da Fonseca LMB, 2009, CIRCULATION, V120, P539, DOI 10.1161/CIRCULATIONAHA.109.863084; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bersano A, 2010, CURR VASC PHARMACOL, V8, P29, DOI 10.2174/157016110790226570; Blocklet D, 2006, STEM CELLS, V24, P333, DOI 10.1634/stemcells.2005-0201; Bonavita AG, 2010, XENOTRANSPLANTATION, V17, P181, DOI 10.1111/j.1399-3089.2010.00588.x; Brenner W, 2004, J NUCL MED, V45, P512; Callera F, 2007, STEM CELLS DEV, V16, P461, DOI 10.1089/scd.2007.0083; Caveliers V, 2007, Q J NUCL MED MOL IM, V51, P61; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Correa PL, 2007, CLIN NUCL MED, V32, P839, DOI 10.1097/RLU.0b013e318156b980; DAFONSECA LMB, 2010, INT J CARDIOLOGY MAR; Dedobbeleer C, 2009, J CARDIOVASC PHARM, V53, P480, DOI 10.1097/FJC.0b013e3181a7b572; Gera A, 2010, REGEN MED, V5, P73, DOI 10.2217/RME.09.79; Goussetis E, 2006, STEM CELLS, V24, P2279, DOI 10.1634/stemcells.2005-0589; Grogaard HK, 2007, CARDIOVASC REVASCULA, V8, P21, DOI 10.1016/j.carrev.2006.09.001; Halban PA, 2010, J CLIN ENDOCR METAB, V95, P1034, DOI 10.1210/jc.2009-1819; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; ISHIWATA K, 1993, J NUCL MED, V34, P1936; Jacob José Luiz Balthazar, 2007, Arq. Bras. Cardiol., V89, pe10, DOI 10.1590/S0066-782X2007001400014; Jendelova P, 2005, CELL TRANSPLANT, V14, P173, DOI 10.3727/000000005783983124; Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017; Kang WJ, 2006, J NUCL MED, V47, P1295; Khan AA, 2010, CELL TRANSPLANT, V19, P409, DOI 10.3727/096368910X498241; Kurisaki A, 2010, HUM CELL, V23, P1, DOI 10.1111/j.1749-0774.2010.00080.x; Kurpisz M, 2007, INT J CARDIOL, V121, P194, DOI 10.1016/j.ijcard.2006.08.062; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; Ly HQ, 2008, NAT CLIN PRACT CARD, V5, pS96, DOI 10.1038/ncpcardio1159; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; Mesquita CT, 2005, J NUCL CARDIOL, V12, P610, DOI 10.1016/j.nuclcard.2005.05.010; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Pajtasz-Piasecka E, 2010, IMMUNOTHERAPY-UK, V2, P257, DOI 10.2217/IMT.10.7; Palestro CJ, 2009, Q J NUCL MED MOL IM, V53, P105; Park DH, 2011, STEM CELL REV REP, V7, P181, DOI 10.1007/s12015-010-9163-0; Penicka M, 2007, HEART, V93, P837, DOI 10.1136/hrt.2006.091934; Politi LS, 2007, NEURORADIOLOGY, V49, P523, DOI 10.1007/s00234-007-0219-z; Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102; Singh S, 2009, CLIN CARDIOL, V32, P176, DOI 10.1002/clc.20470; SRIVASTAVA SC, 1984, SEMIN NUCL MED, V14, P68, DOI 10.1016/S0001-2998(84)80022-7; Steinman RM, 2001, INT J CANCER, V94, P459, DOI 10.1002/ijc.1503; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; TENBERGE RJM, 1983, J NUCL MED, V24, P615; Toso C, 2008, AM J TRANSPLANT, V8, P701, DOI 10.1111/j.1600-6143.2007.02120.x; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	51	28	29	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1550-8943	1558-6804		STEM CELL REV REP	Stem Cell Rev. Rep.	NOV	2011	7	4					1031	1040		10.1007/s12015-011-9260-8			10	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	855WU	WOS:000297597800024	21475954				2022-02-06	
J	Thompson, DO; Hurtado, TR; Liao, MM; Byyny, RL; Gravitz, C; Haukoos, JS				Thompson, David O.; Hurtado, Timothy R.; Liao, Michael M.; Byyny, Richard L.; Gravitz, Craig; Haukoos, Jason S.			Validation of the Simplified Motor Score in the Out-of-Hospital Setting for the Prediction of Outcomes After Traumatic Brain Injury	ANNALS OF EMERGENCY MEDICINE			English	Article							GLASGOW COMA SCALE; EMERGENCY-DEPARTMENT; INTERRATER RELIABILITY; ADVANCED STATISTICS; CLINICAL-RESEARCH; MISSING DATA	Study objective: The Glasgow Coma Scale (GCS) score is widely used to assess patients with head injury but has been criticized for its complexity and poor interrater reliability. A 3-point Simplified Motor Score (SMS) (defined as obeys commands=2, localizes pain=1, and withdraws to pain or worse=0) was created to address these limitations. Our goal is to validate the SMS in the out-of-hospital setting, with the hypothesis that it is equivalent to the GCS score for discriminating brain injury outcomes. Methods: This was a secondary analysis of an urban Level I trauma registry. Four outcomes and their composite were studied: emergency tracheal intubation, clinically meaningful brain injury, need for neurosurgical intervention, and mortality. The out-of-hospital GCS score and SMS were evaluated by comparing areas under the receiver operating characteristic curve with a paired nonparametric approach. Multiple imputation was used for missing data. A clinically significant difference in areas under the receiver operating characteristic curve was defined as greater than or equal to 0.05, according to previous literature. Results: We included 19,408 patients, of whom 18% were tracheally intubated, 18% had brain injuries, 8% required neurosurgical intervention, and 6% died. The difference between the area under the receiver operating characteristic curve for the out-of-hospital GCS score and SMS was 0.05 (95% confidence interval [CI] 0.01 to 0.11) for emergency tracheal intubation, 0.05 (95% CI 0 to 0.09) for brain injury, 0.04 (95% CI -0.01 to 0.09) for neurosurgical intervention, 0.08 (95% CI 0.02 to 0.15) for mortality, and 0.05 (95% CI 0 to 0.10) for the composite outcome. Conclusion: In this external validation, SMS was similar to the GCS score for predicting outcomes in traumatic brain injury in the out-of-hospital setting. [Ann Emerg Med. 2011;58:417-425.]	[Thompson, David O.; Hurtado, Timothy R.; Liao, Michael M.; Byyny, Richard L.; Haukoos, Jason S.] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO 80204 USA; [Gravitz, Craig] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Thompson, David O.; Liao, Michael M.; Byyny, Richard L.; Haukoos, Jason S.] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO USA; [Hurtado, Timothy R.] Front Range Emergency Specialists PC, Colorado Springs, CO USA; [Haukoos, Jason S.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA		Thompson, DO (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO 80204 USA.	davidothompson@gmail.com		Byyny, Richard/0000-0002-9145-7457	Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [F32 HS018123, K02 HS017526]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [F32HS018123, K02HS017526] Funding Source: NIH RePORTER	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). Dr. Liao was supported by the Agency for Healthcare Research and Quality (AHRQ) (F32 HS018123), as was Dr. Haukoos (K02 HS017526).	Al-Salamah MA, 2004, ACAD EMERG MED, V11, P834, DOI 10.1197/j.aem.2004.03.008; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gill M, 2007, ANN EMERG MED, V49, P403, DOI 10.1016/j.annemergmed.2006.03.031; Gill M, 2006, ACAD EMERG MED, V13, P968, DOI 10.1197/j.aem.2006.05.019; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Haukoos JS, 2007, ACAD EMERG MED, V14, P662, DOI 10.1197/j.aem.2006.11.037; Haukoos JS, 2007, ANN EMERG MED, V50, P18, DOI 10.1016/j.annemergmed.2006.10.004; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heard K, 2004, HUM EXP TOXICOL, V23, P197, DOI 10.1191/0960327104ht436oa; Holdgate Anna, 2006, Emerg Med Australas, V18, P379, DOI 10.1111/j.1742-6723.2006.00867.x; Kornbluth J, 2011, NEUROCRIT CARE, V14, P134, DOI 10.1007/s12028-010-9409-3; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; Newgard CD, 2006, ACAD EMERG MED, V13, P314, DOI 10.1197/j.aem.2005.09.011; Newgard CD, 2007, ACAD EMERG MED, V14, P669, DOI 10.1197/j.aem.2006.11.038; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Rubin D.B., 1987, MULTIPLE IMPUTATION; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81	24	28	28	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	NOV	2011	58	5					417	425		10.1016/j.annemergmed.2011.05.033			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	846ZU	WOS:000296942500003	21803448				2022-02-06	
J	de Souza, A; Nalini, A; Kovoor, JME; Yeshraj, G; Siddalingaiah, HS; Thennarasu, K				de Souza, Aaron; Nalini, Atchayaram; Kovoor, Jerry M. E.; Yeshraj, Gangappa; Siddalingaiah, Hanumanthaiah S.; Thennarasu, Kandavel			Perilesional gliosis around solitary cerebral parenchymal cysticerci and long-term seizure outcome: A prospective study using serial magnetization transfer imaging	EPILEPSIA			English	Article						Solitary cerebral cysticercal lesion; Neurocysticercosis; Perilesional gliosis; Magnetic resonance imaging; Magnetization transfer imaging	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; DIAGNOSTIC-CRITERIA; AXONAL INJURY; NEUROCYSTICERCOSIS; EPILEPSY; GRANULOMA; QUANTITATION; PROPOSAL; MATTER	Purpose: Epilepsy following solitary cerebral cysticercosis (SCC) is possibly caused by perilesional gliosis, best visualized on magnetization transfer imaging (MTI). This study aims to describe development of gliosis around SCC by prospective serial MTI and to correlate this gliosis with long-term seizure outcome. Methods: We randomized 123 patients with SCC and new-onset seizures to treatment with albendazole plus antiepileptics (treatment), or antiepileptics only (control), and performed magnetic resonance imaging (MRI) scans at 0, 3, 6, 12, and 24 months. Prospective follow-up data regarding seizure outcome up to 5 years later were collected. MRI studies were analyzed for lesion characteristics and perilesional magnetization transfer (MT) hyperintensity. Key Findings: Clinical and radiologic data of 77 patients were analyzed. Demographic and seizure characteristics were similar in treatment and control groups. Clinical data were available up to 64 months after enrollment. At 12 months, 89.5% patients were seizure-free. MTI is more sensitive than routine imaging for detection of perilesional gliosis. Albendazole treatment did not affect imaging or clinical outcome, including development of gliosis. Independent of duration of follow-up, gliosis was associated with more seizures, and with seizure recurrence at 12 months; duration of seizures and antiepileptic therapy was longer. Gliosis was not dependent on seizure type or stage of degeneration at enrollment or persistence/calcification of the lesion. Significance: Perilesional gliosis around SCC helps prognosticate seizure outcome. Poorer outcome in patients with persistent lesions is likely to be related to mechanisms other than gliosis. The lack of effect of albendazole on seizure outcome may be due to its inability to decrease formation of gliosis.	[de Souza, Aaron; Nalini, Atchayaram; Yeshraj, Gangappa; Siddalingaiah, Hanumanthaiah S.] Natl Inst Mental Hlth & Neurosci, Dept Neurol, Bangalore 560029, Karnataka, India; [Kovoor, Jerry M. E.] Natl Inst Mental Hlth & Neurosci, Dept Neuroimaging & Intervent Radiol, Bangalore 560029, Karnataka, India; [Thennarasu, Kandavel] Natl Inst Mental Hlth & Neurosci, Dept Biostat, Bangalore 560029, Karnataka, India		Nalini, A (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurol, Neurosci Fac Block, Bangalore 560029, Karnataka, India.	nalini@nimhans.kar.nic.in	Nalini, Atchayaram/AAT-2469-2021; H.S., Siddalingaiah/U-4322-2017	Nalini, Atchayaram/0000-0001-9791-3639; de Souza, Aaron/0000-0001-6941-5683; H.S., Siddalingaiah/0000-0002-4771-8285	Indian Council of Medical Research (ICMR)Indian Council of Medical Research (ICMR) [SWG/Neuro/7/2001-NCD-I]	We are grateful to the Indian Council of Medical Research (ICMR) for funding this study (ICMR grant no. SWG/Neuro/7/2001-NCD-I). We thank all the participants of the study and in particular the radiographers of the department of Neuroimaging and Interventional Radiology, NIMHANS for their constant support.	Agarwal A, 2004, NEUROL INDIA, V52, P197; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Carpio A, 1998, EPILEPSIA, V39, P1025, DOI 10.1111/j.1528-1157.1998.tb01287.x; Chatterjee KD, 1973, PARASITOLOGY PROTOZO; Chawla S, 2004, J MAGN RESON IMAGING, V20, P208, DOI 10.1002/jmri.20105; Chung C K, 1998, J Korean Med Sci, V13, P445; De Souza A, 2010, NEURORADIOL J, V23, P574, DOI 10.1177/197140091002300506; de Souza A, 2010, J NEUROL SCI, V288, P135, DOI 10.1016/j.jns.2009.09.018; de Souza A, 2009, J NEUROL SCI, V276, P108, DOI 10.1016/j.jns.2008.09.010; deBittencourt PRM, 1996, EPILEPSIA, V37, P1121, DOI 10.1111/j.1528-1157.1996.tb01035.x; DELBRUTTO OH, 1992, NEUROLOGY, V42, P389, DOI 10.1212/WNL.42.2.389; DELBRUTTO OH, 1994, NEUROLOGY, V44, P1706, DOI 10.1212/WNL.44.9.1706; DelBrutto OH, 1996, J NEUROL SCI, V142, P1, DOI 10.1016/0022-510X(96)00130-X; Fazekas F, 2005, BRAIN, V128, P2926, DOI 10.1093/brain/awh567; Ferreira LS, 2001, EPILEPSIA, V42, P1438, DOI 10.1046/j.1528-1157.2001.11101.x; Filippi M, 2004, J NEUROIMAGING, V14, P303, DOI 10.1177/1051228404265708; Filippi M, 2007, NEUROTHERAPEUTICS, V4, P401, DOI 10.1016/j.nurt.2007.03.002; GARCIA HH, 1993, LANCET, V341, P197, DOI 10.1016/0140-6736(93)90064-N; Gupta R. K., 2000, MAGNETIZATION TRANSF; Gupta RK, 1999, LANCET, V354, P44, DOI 10.1016/S0140-6736(99)00881-8; Kathuria MK, 1998, J MAGN RESON IMAGING, V8, P473, DOI 10.1002/jmri.1880080231; Kimura H, 1996, J COMPUT ASSIST TOMO, V20, P540, DOI 10.1097/00004728-199607000-00007; KRAMER LD, 1989, RADIOLOGY, V171, P459, DOI 10.1148/radiology.171.2.2704811; Kumar CSS, 2004, NEUROL INDIA, V52, P265; Kumar R, 2003, MAGN RESON IMAGING, V21, P893, DOI 10.1016/S0730-725X(03)00189-9; Kumar R, 2002, NEUROIMAGE, V15, P1015, DOI 10.1006/nimg.2001.1036; Kuruvilla A., 2001, SMJ Singapore Medical Journal, V42, P297; Lino RD, 2007, ARQ NEURO-PSIQUIAT, V65, P87, DOI 10.1590/S0004-282X2007000100019; McGowan JC, 1999, NEUROLOGY, V53, pS3; Murthy JMK, 1998, SEIZURE-EUR J EPILEP, V7, P153, DOI 10.1016/S1059-1311(98)80072-1; Pradhan S, 2000, ANN NEUROL, V48, P181, DOI 10.1002/1531-8249(200008)48:2&lt;181::AID-ANA7&gt;3.0.CO;2-C; Pradhan S, 2003, ACTA NEUROL SCAND, V107, P260, DOI 10.1034/j.1600-0404.2003.01380.x; Proano JV, 2001, NEW ENGL J MED, V345, P879, DOI 10.1056/NEJMoa010212; Rajshekhar V, 1997, ACTA NEUROL SCAND, V96, P76; RAJSHEKHAR V, 1993, J NEUROSURG, V78, P402, DOI 10.3171/jns.1993.78.3.0402; Rajshekhar V, 2004, NEUROLOGY, V62, P2236, DOI 10.1212/01.WNL.0000130471.19171.D8; Roman G, 2000, B WORLD HEALTH ORGAN, V78, P399; Rosicky, 1983, GUIDELINES SURVEILLA; SARTI E, 1992, AM J TROP MED HYG, V46, P677, DOI 10.4269/ajtmh.1992.46.677; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Udani Vrajesh, 2005, Indian Journal of Pediatrics, V72, P309, DOI 10.1007/BF02724012; Wallin MT, 2004, NEUROLOGY, V63, P1559, DOI 10.1212/01.WNL.0000142979.98182.FF	42	28	28	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia	OCT	2011	52	10					1918	1927		10.1111/j.1528-1167.2011.03189.x			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	835WH	WOS:000296067000029	21777233	hybrid			2022-02-06	
J	Pitkanen, A; Lukasiuk, K				Pitkanen, Asla; Lukasiuk, Katarzyna			Molecular biomarkers of epileptogenesis	BIOMARKERS IN MEDICINE			English	Article						cerebrospinal fluid; microRNA; proteomics; serum; traumatic brain injury	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; COMPUTED-TOMOGRAPHY FINDINGS; SPECTRIN BREAKDOWN PRODUCTS; FIBRILLARY ACIDIC PROTEIN; CEREBROSPINAL-FLUID; OUTCOME PREDICTION; HEAD TRAUMA; SERUM; S100B	The heterogeneity of epilepsy syndromes and pathologies creates a great challenge for the search for biomarkers. Not surprisingly, identification of a marker that is specific and sensitive for a given epileptogenic pathology remains an unmet need. There have, however, been several studies of major epileptogenic etiologies like traumatic brain injury that aimed to identify molecular markers in blood and cerebrospinal fluid that predict outcome, by using proteomics and metabolomics. Unfortunately, epileptogenesis has not been analyzed as an outcome measure. Another question to be explored is whether a palette of molecular markers is needed, rather than a single molecule, with each marker probing a different component of epileptogenic pathology. Further, perhaps multiple biomarker platforms (e.g., imaging, proteomics, electrophysiology) should be used in combination and/or in a defined temporal sequence.	[Pitkanen, Asla] Univ Eastern Finland, Virtanen Inst Mol Sci, Dept Neurobiol, FIN-70211 Kuopio, Finland; [Lukasiuk, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland; [Pitkanen, Asla] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FIN-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Lukasiuk, Katarzyna/F-4636-2010	Lukasiuk, Katarzyna/0000-0002-1582-0920	Academy of FinlandAcademy of FinlandEuropean Commission; Sigrid Juselius FoundationSigrid Juselius Foundation; CURE; Nencki Institute	The authors were supported by the Academy of Finland (A Pitkanen), The Sigrid Juselius Foundation (A Pitkanen), CURE (A Pitkanen), and statutory funds of the Nencki Institute (K Lukasiuk). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cardali S, 2006, J Neurosurg Sci, V50, P25; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; McKeating EG, 1998, ACT NEUR S, V71, P200; McKeating EG, 1998, ACT NEUR S, V71, P117; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Raabe A, 1998, ACTA NEUROCHIR, V140, P787, DOI 10.1007/s007010050180; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schuff N, 2006, ADV EXP MED BIOL, V576, P241; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Tang Y, 2005, ARCH NEUROL-CHICAGO, V62, P210, DOI 10.1001/archneur.62.2.210; Tang Y, 2001, ANN NEUROL, V50, P699, DOI 10.1002/ana.10042; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Ucar T, 2004, J TRAUMA, V57, P95, DOI 10.1097/01.TA.0000071352.95491.75; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wang L, 2010, CLIN CHIM ACTA, V411, P581, DOI 10.1016/j.cca.2010.01.022; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Xiao F, 2009, BRAIN RES, V1255, P180, DOI 10.1016/j.brainres.2008.12.008; Xiao Z, 2010, CLIN BIOCHEM, V43, P1129, DOI 10.1016/j.clinbiochem.2010.06.015; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7	50	28	31	0	20	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1752-0363	1752-0371		BIOMARK MED	Biomark. Med.	OCT	2011	5	5					629	633		10.2217/BMM.11.67			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	857TW	WOS:000297744900012	22003911	Green Published			2022-02-06	
J	Viswanathan, V; Eugster, EA				Viswanathan, Vidhya; Eugster, Erica A.			Etiology and Treatment of Hypogonadism in Adolescents	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Hypergonadotropic hypogonadism; Hypogonadotropic hypogonadism; Adolescents; Delayed puberty; Treatment	ADRENAL HYPOPLASIA CONGENITA; FOLLICLE-STIMULATING-HORMONE; TRAUMATIC BRAIN-INJURY; PRADER-WILLI-SYNDROME; IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; COMPLETE ANDROGEN INSENSITIVITY; GENOTYPE-PHENOTYPE CORRELATIONS; TESTICULAR REGRESSION SYNDROME; ACUTE LYMPHOBLASTIC-LEUKEMIA; VAGINAL LENGTH MEASUREMENT	Adequate functioning at all levels of the hypothalamic-pituitary-gonadal axis is necessary for normal gonadal development and subsequent sex steroid production. Deficiencies at any level of the axis can lead to a hypogonadal state. The causes of hypogonadism are heterogeneous and may involve any level of the reproductive system. This review discusses various causes of hypogonadism, describes the evaluation of hypogonadal states, and outlines treatment options for the induction of puberty in affected adolescents. Whereas some conditions are clearly delineated, the exact etiology and underlying pathogenesis of many disorders is unknown.	[Viswanathan, Vidhya; Eugster, Erica A.] Indiana Univ Sch Med, Sect Pediat Endocrinol, Dept Pediat, Riley Hosp Children, Indianapolis, IN 46202 USA		Viswanathan, V (corresponding author), Indiana Univ Sch Med, Sect Pediat Endocrinol, Dept Pediat, Riley Hosp Children, Room 5960,702 Barnhill Dr, Indianapolis, IN 46202 USA.	vviswana@iupui.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32DK065549] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T32 DK065549] Funding Source: Medline		Abulhasan SJ, 1999, ANN HUM GENET, V63, P199, DOI 10.1046/j.1469-1809.1999.6330199.x; Achermann JC, 2001, MOL CELL ENDOCRINOL, V179, P89, DOI 10.1016/S0303-7207(01)00474-9; AHONEN P, 1987, J CLIN ENDOCR METAB, V64, P494, DOI 10.1210/jcem-64-3-494; AITTOMAKI K, 1994, AM J HUM GENET, V54, P844; Akefeldt A, 1999, DEV MED CHILD NEUROL, V41, P789, DOI 10.1017/S0012162299221573; al Kandari Hessa, 2006, J Clin Endocrinol Metab, V91, P2821, DOI 10.1210/jc.2005-2230; Andreu JAL, 2000, PEDIATR HEMAT ONCOL, V17, P21, DOI 10.1080/088800100276631; Ankarberg-Lindgren C, 2001, J CLIN ENDOCR METAB, V86, P3039, DOI 10.1210/jc.86.7.3039; APTER D, 1993, J CLIN ENDOCR METAB, V76, P940, DOI 10.1210/jc.76.4.940; Arnhold IJP, 1999, CLIN ENDOCRINOL, V51, P701, DOI 10.1046/j.1365-2265.1999.00863.x; Arslanian S, 1997, J CLIN ENDOCR METAB, V82, P3213, DOI 10.1210/jc.82.10.3213; Baker BY, 2006, J CLIN ENDOCR METAB, V91, P4781, DOI 10.1210/jc.2006-1565; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BERGADA I, 1995, J PEDIATR ENDOCR MET, V8, P117; Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; Bondy CA, 2007, J CLIN ENDOCR METAB, V92, P10, DOI 10.1210/jc.2006-1374; BOYAR R, 1972, NEW ENGL J MED, V287, P582, DOI 10.1056/NEJM197209212871203; Buzi F, 2003, J CLIN ENDOCR METAB, V88, P3146, DOI 10.1210/jc.2002-021495; Chan JL, 2005, LANCET, V366, P74, DOI 10.1016/S0140-6736(05)66830-4; CHETKOWSKI RJ, 1986, NEW ENGL J MED, V314, P1615, DOI 10.1056/NEJM198606193142505; CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203; Costa-Santos M, 2004, J CLIN ENDOCR METAB, V89, P49, DOI 10.1210/jc.2003-031021; Crino A, 2003, EUR J PEDIATR, V162, P327, DOI 10.1007/s00431-002-1132-4; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; de Roux N, 2001, MOL CELL ENDOCRINOL, V179, P83, DOI 10.1016/S0303-7207(01)00471-3; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; DEZEGHER F, 1995, PEDIATR RES, V37, P395; Donaldson MDC, 2006, ARCH DIS CHILD, V91, P513, DOI 10.1136/adc.2003.035907; Eiholzer U, 2007, HORM RES, V68, P178, DOI 10.1159/000100925; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fechner PY, 2006, J CLIN ENDOCR METAB, V91, P4896, DOI 10.1210/jc.2006-1157; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Fujieda K, 1997, J CLIN INVEST, V99, P1265, DOI 10.1172/JCI119284; FURUI K, 1994, J CLIN ENDOCR METAB, V78, P107, DOI 10.1210/jc.78.1.107; Gelfand IM, 2006, J PEDIATR-US, V149, P877, DOI 10.1016/j.jpeds.2006.08.050; Gonc EN, 2004, PEDIATR NEUROSURG, V40, P112, DOI 10.1159/000079852; GOODPASTURE JC, 1993, CLIN OBSTET GYNECOL, V36, P773, DOI 10.1097/00003081-199309000-00034; Habiby RL, 1996, J CLIN INVEST, V98, P1055, DOI 10.1172/JCI118866; Haddad NG, 2005, J PEDIATR ENDOCR MET, V18, P853; Hoek A, 1997, ENDOCR REV, V18, P107, DOI 10.1210/er.18.1.107; Holland C M, 2001, J Pediatr Adolesc Gynecol, V14, P77, DOI 10.1016/S1083-3188(01)00075-4; Hovatta O, 1999, ANN MED, V31, P106, DOI 10.3109/07853899708998785; IMBEAUD S, 1995, EUR J PEDIATR, V154, P187, DOI 10.1007/BF01954268; JEFFCOATE WJ, 1980, CLIN ENDOCRINOL, V12, P81, DOI 10.1111/j.1365-2265.1980.tb03136.x; KASSMANN K, 1992, CLIN NEPHROL, V37, P148; KAUFMAN FR, 1981, NEW ENGL J MED, V304, P994, DOI 10.1056/NEJM198104233041702; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kohler B, 2008, HUM MUTAT, V29, P59, DOI 10.1002/humu.20588; KREMER H, 1995, NAT GENET, V9, P160, DOI 10.1038/ng0295-160; Larsen EC, 2003, J CLIN ENDOCR METAB, V88, P5307, DOI 10.1210/jc.2003-030352; Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805; Law H, 2006, FETAL PEDIATR PATHOL, V25, P119, DOI 10.1080/15513810600788806; Layman LC, 1997, NEW ENGL J MED, V337, P607, DOI 10.1056/NEJM199708283370905; Lazar L, 2003, HORM RES, V60, P227, DOI 10.1159/000074036; Lee PA, 2006, PEDIATRICS, V118, pE488, DOI 10.1542/peds.2006-0738; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LIN HJ, 1993, AM J MED GENET, V45, P761, DOI 10.1002/ajmg.1320450619; LINDEN MG, 1988, PEDIATRICS, V82, P619; Lindstedt G, 1998, CLIN CHEM LAB MED, V36, P663, DOI 10.1515/CCLM.1998.118; Mantovani G, 2006, EUR J ENDOCRINOL, V154, P685, DOI 10.1530/eje.1.02132; MATTHEWS CH, 1993, NAT GENET, V5, P83, DOI 10.1038/ng0993-83; Mauras N, 2007, J CLIN ENDOCR METAB, V92, P4154, DOI 10.1210/jc.2007-0671; Mayo A, 2004, J CLIN ENDOCR METAB, V89, P681, DOI 10.1210/jc.2003-031086; Meacham LR, 1997, MED PEDIATR ONCOL, V29, P86, DOI 10.1002/(SICI)1096-911X(199708)29:2<86::AID-MPO4>3.0.CO;2-N; Merchant TE, 2002, INT J RADIAT ONCOL, V54, P45, DOI 10.1016/S0360-3016(02)02888-2; Michala L, 2008, BJOG-INT J OBSTET GY, V115, P737, DOI 10.1111/j.1471-0528.2008.01703.x; Mills JL, 1997, J PEDIATR-US, V131, P598, DOI 10.1016/S0022-3476(97)70069-6; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Nabhan ZM, 2009, J CLIN ENDOCR METAB, V94, P2009, DOI 10.1210/jc.2008-2123; Nandagopal R, 2008, HORM RES, V69, P65, DOI 10.1159/000111809; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Oakes MB, 2008, J PEDIATR ADOL GYNEC, V21, P305, DOI 10.1016/j.jpag.2007.09.006; Oliveira LMB, 2001, J CLIN ENDOCR METAB, V86, P1532, DOI 10.1210/jc.86.4.1532; Pasquino AM, 1997, J CLIN ENDOCR METAB, V82, P1810, DOI 10.1210/jc.82.6.1810; Perniola R, 2000, EUR J ENDOCRINOL, V143, P497, DOI 10.1530/eje.0.1430497; Pfaeffle RW, 2008, J CLIN ENDOCR METAB, V93, P1062, DOI 10.1210/jc.2007-1525; Pfaffle RW, 1999, ACTA PAEDIATR, V88, P33, DOI 10.1111/j.1651-2227.1999.tb14401.x; Piippo S, 2004, J CLIN ENDOCR METAB, V89, P3241, DOI 10.1210/jc.2003-032069; Pitteloud N, 2007, P NATL ACAD SCI USA, V104, P17447, DOI 10.1073/pnas.0707173104; Prestoz LLC, 1997, EUR J PEDIATR, V156, P116, DOI 10.1007/s004310050568; Priebe C, 2005, J PEDIATR SURG, V40, P136; Rahhal SN, 2008, J PEDIATR-US, V152, P289, DOI 10.1016/j.jpeds.2007.10.052; Raivio T, 2007, NEW ENGL J MED, V357, P863, DOI 10.1056/NEJMoa066494; RAPPAPORT R, 1982, J CLIN ENDOCR METAB, V54, P1164, DOI 10.1210/jcem-54-6-1164; RICHMAN RA, 1988, NEW ENGL J MED, V319, P1563, DOI 10.1056/NEJM198812153192402; Rizzolio F, 2006, HUM REPROD, V21, P1477, DOI 10.1093/humrep/dei495; Rogol Alan D, 2005, Pediatr Endocrinol Rev, V2, P383; Rosenfield RL, 1998, PEDIATRICS, V102, P486; Sarpel U, 2005, J PEDIATR SURG, V40, P133, DOI 10.1016/j.jpedsurg.2004.09.012; Sato N, 2004, J CLIN ENDOCR METAB, V89, P1079, DOI 10.1210/jc.2003-030476; Schatz DA, 2002, ENDOCRIN METAB CLIN, V31, P339, DOI 10.1016/S0889-8529(01)00012-3; Schulze A, 2001, ACTA PAEDIATR, V90, P455, DOI 10.1080/080352501750126474; Sedlmeyer IL, 2002, J CLIN ENDOCR METAB, V87, P1613, DOI 10.1210/jc.87.4.1613; SHALET SM, 1989, J ENDOCRINOL, V120, P161, DOI 10.1677/joe.0.1200161; Sinisi AA, 1997, INT J ANDROL, V20, P23, DOI 10.1046/j.1365-2605.1997.00101.x; SMITH NM, 1991, HISTOPATHOLOGY, V19, P269, DOI 10.1111/j.1365-2559.1991.tb00033.x; SOLIMAN AT, 1995, METABOLISM, V44, P1013, DOI 10.1016/0026-0495(95)90098-5; Steffens M, 2008, CLIN ENDOCRINOL, V69, P819, DOI 10.1111/j.1365-2265.2008.03283.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; UIBO R, 1994, J CLIN ENDOCR METAB, V78, P323, DOI 10.1210/jc.78.2.323; Vinci G, 2004, J CLIN ENDOCR METAB, V89, P6282, DOI 10.1210/jc.2004-0891; VOGL TJ, 1994, RADIOLOGY, V191, P53, DOI 10.1148/radiology.191.1.8134597; VONKALCKREUTH G, 1991, HORM RES, V35, P222; Wallace WHB, 2003, HUM REPROD, V18, P117, DOI 10.1093/humrep/deg016; WEISS J, 1992, NEW ENGL J MED, V326, P179, DOI 10.1056/NEJM199201163260306; Welt CK, 2004, NEW ENGL J MED, V351, P987, DOI 10.1056/NEJMoa040388; Wharton Robert H., 1996, Current Opinion in Pediatrics, V8, P618, DOI 10.1097/00008480-199612000-00013; Wolff ASB, 2007, J CLIN ENDOCR METAB, V92, P595, DOI 10.1210/jc.2006-1873; Yang F, 2009, EUR J PEDIATR, V168, P329, DOI 10.1007/s00431-008-0779-x; Yang J, 2006, J CLIN ENDOCR METAB, V91, P3619, DOI 10.1210/jc.2005-2283; Zielinska D, 2007, J PEDIATR SURG, V42, P1721, DOI 10.1016/j.jpedsurg.2007.05.029	117	28	32	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	OCT	2011	58	5					1181	+		10.1016/j.pcl.2011.07.009			21	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	843NM	WOS:000296678700008	21981955	Green Accepted			2022-02-06	
J	Kuceyeski, A; Maruta, J; Niogi, SN; Ghajar, J; Raj, A				Kuceyeski, Amy; Maruta, Jun; Niogi, Sumit N.; Ghajar, Jamshid; Raj, Ashish			The generation and validation of white matter connectivity importance maps	NEUROIMAGE			English	Article						white matter importance map; brain connectivity networks; graph theory; tractography; prediction of impairment; traumatic brain injury	DIFFUSION-WEIGHTED MRI; MULTIPLE-SCLEROSIS; BRAIN; TENSOR; ORGANIZATION; TRACTOGRAPHY; DISABILITY; NETWORKS; TRACKING; FEATURES	Both the size and location of injury in the brain influences the type and severity of cognitive or sensorimotor dysfunction. However, even with advances in MR imaging and analysis, the correspondence between lesion location and clinical deficit remains poorly understood. Here, structural and diffusion images from 14 healthy subjects are used to create spatially unbiased white matter connectivity importance maps that quantify the amount of disruption to the overall brain network that would be incurred if that region were compromised. Some regions in the white matter that were identified as highly important by such maps have been implicated in strategic infarct dementia and linked to various attention tasks in previous studies. Validation of the maps is performed by investigating the correlations of the importance maps' predicted cognitive deficits in a group of 15 traumatic brain injury patients with their cognitive test scores measuring attention and memory. While no correlation was found between amount of white matter injury and cognitive test scores, significant correlations (r>0.68, p <0.006) were found when including location information contained in the importance maps. These tools could be used by physicians to improve surgical planning, diagnosis, and assessment of disease severity in a variety of pathologies like multiple sclerosis, trauma, and stroke. (C) 2011 Elsevier Inc. All Fights reserved.	[Kuceyeski, Amy; Raj, Ashish] Weill Cornell Med Coll, IDEAL, Dept Radiol, New York, NY 10065 USA; [Maruta, Jun; Ghajar, Jamshid] Brain Trauma Fdn, World Trade Ctr 7, New York, NY 10007 USA; [Ghajar, Jamshid] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY 10065 USA		Kuceyeski, A (corresponding author), Weill Cornell Med Coll, IDEAL, Dept Radiol, 515 E 71st St,S-125, New York, NY 10065 USA.	amk2012@med.cornell.edu; jmartuta@braintrauma.org; sun2003@nyp.org; ghajar@braintrauma.org; asi2004@med.cornell.edu	Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F32 EB012404-01, P41 RR023953-02, P41 RR023953-02S1, R21 EB008138-02]; Department of DefenseUnited States Department of Defense [W81XWH-08-1-0646, W81XWH-08-2-0177]; James S. McDonnell Foundation; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR023953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [F32EB012404, R21EB008138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS075425] Funding Source: NIH RePORTER	The data processing, analysis, importance map creation and validation were supported by the following National Institutes of Health grants: F32 EB012404-01, P41 RR023953-02, P41 RR023953-02S1 and R21 EB008138-02. The data were collected and maintained with support from the Department of Defense grants W81XWH-08-1-0646 and W81XWH-08-2-0177, and a James S. McDonnell Foundation grant for the Cognitive Neurobiological Research Consortium in Traumatic Brain Injury. Rachel Roister and Ranjeeta Sarkar provided assistance with subject enrollment and cognitive testing.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Aleman-Gomez Y, 2005, 12 ANN M ORG HUM BRA; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BOWMAN FD, 2009, NEUROIMAGE, V47, pS147; Charil A, 2003, NEUROIMAGE, V19, P532, DOI 10.1016/S1053-8119(03)00117-4; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; FRISTON KJ, 2006, STAT PARAMETRIC MAPP, P656; Gondran M, 1984, DISCREET MATH SERIES, V1484; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; ITURRIAMEDINA Y, 2005, NEUROIMAGE, V26; IVKOVICH M, PLOS ONE IN PRESS; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; KUCEYESKI A, 2010, JOINT ANN M ISMRM ES, P1676; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Lu YG, 2006, NEUROIMAGE, V31, P1061, DOI 10.1016/j.neuroimage.2006.01.043; Mainero C, 2001, NEUROLOGY, V56, P1331, DOI 10.1212/WNL.56.10.1331; Mammi S, 1996, ACTA NEUROL SCAND, V94, P93, DOI 10.1111/j.1600-0404.1996.tb07036.x; Menezes NM, 2007, STROKE, V38, P194, DOI 10.1161/01.STR.0000251792.76080.45; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nazzal ME, 2009, DISABIL REHABIL, V31, P1501, DOI 10.1080/09638280802627702; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Oishi K, 2009, NEUROIMAGE, V46, P486, DOI 10.1016/j.neuroimage.2009.01.002; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pereira JMS, 2010, NEUROIMAGE, V49, P2205, DOI 10.1016/j.neuroimage.2009.10.068; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schmahmann J.D., 2006, FIBER PATHWAYS BRAIN; Singh M, 2010, MAGN RESON IMAGING, V28, P22, DOI 10.1016/j.mri.2009.05.049; Sotero RC, 2007, NEURAL COMPUT, V19, P478, DOI 10.1162/neco.2007.19.2.478; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; TATEMICHI TK, 1995, ARZNEIMITTEL-FORSCH, V45-1, P371; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; Vellinga MM, 2009, J MAGN RESON IMAGING, V29, P768, DOI 10.1002/jmri.21679; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Wilson M, 2003, J NEUROL NEUROSUR PS, V74, P203, DOI 10.1136/jnnp.74.2.203; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zhang F, 2009, MED IMAGE ANAL, V13, P5, DOI 10.1016/j.media.2008.05.001	50	28	29	1	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	SEP 1	2011	58	1					109	121		10.1016/j.neuroimage.2011.05.087			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	802ZC	WOS:000293548500014	21722739	Green Accepted			2022-02-06	
J	Turgeon, C; Champoux, F; Lepore, F; Leclerc, S; Ellemberg, D				Turgeon, Christine; Champoux, Francois; Lepore, Franco; Leclerc, Suzanne; Ellemberg, Dave			Auditory Processing After Sport-Related Concussions	EAR AND HEARING			English	Article								Objective: The aim of the study is to investigate whether sport-related concussions disrupt auditory processes. Design: Sixteen university athletes participated in the study: eight had one or more sport-related concussions, and eight never experienced a concussion. The Frequency Pattern Sequence test, the Duration Pattern Sequence test, the Synthetic Sentence Identification test, and the Staggered Spondaic Word test were used to assess auditory processing. Results: All nonconcussed athletes have normal auditory processing. In contrast, more than half of the concussed athletes had deficits for one or more of the auditory processing tests. Conclusions: The pattern of results suggests that sport-related concussions can disrupt the neurological mechanisms implicated in several auditory processes, including monaural low-redundancy speech recognition, tone pattern recognition, and dichotic listening.	[Leclerc, Suzanne; Ellemberg, Dave] Univ Montreal, Dept Kinesiol, Montreal, PQ H3T 1C5, Canada; [Turgeon, Christine; Champoux, Francois; Lepore, Franco; Ellemberg, Dave] Univ Montreal, Ctr Rech Neuropsychol & Cognit, Montreal, PQ H3T 1C5, Canada; [Champoux, Francois] Inst Raymond Dewar, Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada		Ellemberg, D (corresponding author), Univ Montreal, Dept Kinesiol, 2100 Edouard Montpetit, Montreal, PQ H3T 1C5, Canada.	dave.ellemberg@umontreal.ca			Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	This work was supported by grants from the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Council of Canada (to D. E.).	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bellis T. J., 2003, ASSESSMENT MANAGEMEN; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Champoux F, 2007, EUR J NEUROSCI, V25, P291, DOI 10.1111/j.1460-9568.2006.05260.x; Cockrell J. L., 1992, BRAIN INJURY, V6, P216; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; JERGER J, 1974, ARCH OTOLARYNGOL, V99, P342; KATZ J, 1968, J SPEECH HEAR DISORD, V33, P132, DOI 10.1044/jshd.3302.132; Kelly JP, 1997, NEUROLOGY, V48, P581; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Musiek Frank E, 2004, J Am Acad Audiol, V15, P117, DOI 10.3766/jaaa.15.2.3; Pinheiro M. L., 1995, ASSESSMENT CENTRAL A; PINHEIRO ML, 1971, J ACOUST SOC AM, V49, P1778, DOI 10.1121/1.1912581	15	28	32	2	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-0202	1538-4667		EAR HEARING	Ear Hear.	SEP-OCT	2011	32	5					667	670		10.1097/AUD.0b013e31821209d6			4	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	812HI	WOS:000294281400016	21399499				2022-02-06	
J	Rojo, DR; Prough, DS; Falduto, MT; Boone, DR; Micci, MA; Kahrig, KM; Crookshanks, JM; Jimenez, A; Uchida, T; Cowart, JC; Hawkins, BE; Avila, M; DeWitt, DS; Hellmich, HL				Rojo, Daniel R.; Prough, Donald S.; Falduto, Michael T.; Boone, Deborah R.; Micci, Maria-Adelaide; Kahrig, Kristen M.; Crookshanks, Jeanna M.; Jimenez, Arnaldo; Uchida, Tatsuo; Cowart, Jeremy C.; Hawkins, Bridget E.; Avila, Marcela; DeWitt, Douglas S.; Hellmich, Helen L.			Influence of Stochastic Gene Expression on the Cell Survival Rheostat after Traumatic Brain Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FLUORO-JADE; HIPPOCAMPAL NEUROGENESIS; SYNAPTIC PLASTICITY; MOLECULAR NETWORKS; MOUSE MODEL; HEAD-INJURY; DISEASE; DEATH; NEURONS	Experimental evidence suggests that random, spontaneous (stochastic) fluctuations in gene expression have important biological consequences, including determination of cell fate and phenotypic variation within isogenic populations. We propose that fluctuations in gene expression represent a valuable tool to explore therapeutic strategies for patients who have suffered traumatic brain injury (TBI), for which there is no effective drug therapy. We have studied the effects of TBI on the hippocampus because TBI survivors commonly suffer cognitive problems that are associated with hippocampal damage. In our previous studies we separated dying and surviving hippocampal neurons by laser capture microdissection and observed unexplainable variations in post-TBI gene expression, even though dying and surviving neurons were adjacent and morphologically identical. We hypothesized that, in hippocampal neurons that subsequently are subjected to TBI, randomly increased pre-TBI expression of genes that are associated with neuroprotection predisposes neurons to survival; conversely, randomly decreased expression of these genes predisposes neurons to death. Thus, to identify genes that are associated with endogenous neuroprotection, we performed a comparative, high-resolution transcriptome analysis of dying and surviving hippocampal neurons in rats subjected to TBI. We found that surviving hippocampal neurons express a distinct molecular signature - increased expression of networks of genes that are associated with regeneration, cellular reprogramming, development, and synaptic plasticity. In dying neurons we found decreased expression of genes in those networks. Based on these data, we propose a hypothetical model in which hippocampal neuronal survival is determined by a rheostat that adds injury-induced genomic signals to expression of pro-survival genes, which pre-TBI varies randomly and spontaneously from neuron to neuron. We suggest that pharmacotherapeutic strategies that co-activate multiple survival signals and enhance self-repair mechanisms have the potential to shift the cell survival rheostat to favor survival and therefore improve functional outcome after TBI.	[Rojo, Daniel R.; Prough, Donald S.; Boone, Deborah R.; Micci, Maria-Adelaide; Kahrig, Kristen M.; Crookshanks, Jeanna M.; Uchida, Tatsuo; Cowart, Jeremy C.; Hawkins, Bridget E.; Avila, Marcela; DeWitt, Douglas S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Falduto, Michael T.] GenUs BioSyst, Northbrook, IL USA; [Jimenez, Arnaldo] Vel Lab Res, Missouri City, TX USA		Rojo, DR (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013; Hawkins, Bridget/H-4933-2015	Prough, Donald S/0000-0001-7994-532X; Hawkins, Bridget/0000-0002-1887-3657	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS052532]; Moody Foundation; Department of Anesthesiology, University of Texas Medical Branch; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052532] Funding Source: NIH RePORTER	This work was supported by a grant from the National Institutes of Health, RO1 NS052532 (to H.L.H), by a grant from the Moody Foundation and the Department of Anesthesiology, University of Texas Medical Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts P, 2006, MOL BIOL CELL, V17, P1194, DOI 10.1091/mbc.E05-07-0643; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Armstrong JS, 2004, BIOESSAYS, V26, P894, DOI 10.1002/bies.20071; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bast T, 2007, REV NEUROSCIENCE, V18, P253; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Benekareddy M, 2008, SYNAPSE, V62, P590, DOI 10.1002/syn.20529; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fontan- Lozano A, 2008, MOL NEUROBIOL, V27; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fraser D, 2009, MOL MICROBIOL, V71, P1333, DOI 10.1111/j.1365-2958.2009.06605.x; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Grimaldi B, 2009, INT J BIOCHEM CELL B, V41, P81, DOI 10.1016/j.biocel.2008.08.035; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; HERRUP K, 1995, DEVELOPMENT, V121, P2385; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kotani S, 2006, NEUROSCIENCE, V142, P505, DOI 10.1016/j.neuroscience.2006.06.035; Ladurner AG, 2006, MOL CELL, V24, P1, DOI 10.1016/j.molcel.2006.09.002; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lim CM, 2009, J NEUROSCI RES, V87, P1037, DOI 10.1002/jnr.21899; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lynch G, 2007, J NEUROSCI, V27, P4424, DOI 10.1523/JNEUROSCI.5113-06.2007; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McLaughlin B, 2003, P NATL ACAD SCI USA, V100, P715, DOI 10.1073/pnas.0232966100; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Nagy Z, 2000, NEUROBIOL AGING, V21, P761, DOI 10.1016/S0197-4580(00)00223-2; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; Paizanis E, 2007, NEUROCHEM RES, V32, P1762, DOI 10.1007/s11064-007-9330-0; Palacios-Pelaez R, 2010, MOL NEUROBIOL, V41, P367, DOI 10.1007/s12035-010-8139-z; Papa L, 2009, CRIT CARE MED; Pirity MK, 2005, MOL CELL BIOL, V25, P7193, DOI 10.1128/MCB.25.16.7193-7202.2005; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Roberge MC, 2008, NEUROSCIENCE, V156, P11, DOI 10.1016/j.neuroscience.2008.05.062; SAS Institute Inc, 2004, SAS STAT US GUID VER; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Seo SY, 2004, J BIOL CHEM, V279, P42240, DOI 10.1074/jbc.M406775200; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wada A, 2009, J PHARMACOL SCI, V110, P14, DOI 10.1254/jphs.09R02CR; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weinreb O, 2009, NEUROTHERAPEUTICS, V6, P163, DOI 10.1016/j.nurt.2008.10.030; Winship IR, 2008, J NEUROSCI, V28, P6592, DOI 10.1523/JNEUROSCI.0622-08.2008; Ye XM, 2001, BRAIN RES PROTOC, V8, P104, DOI 10.1016/S1385-299X(01)00086-1; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	86	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e23111	10.1371/journal.pone.0023111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	WOS:000293953400028	21853077	gold, Green Published, Green Submitted			2022-02-06	
J	Assaf, F; Fishbein, M; Gafni, M; Keren, O; Sarne, Y				Assaf, Fadi; Fishbein, Miriam; Gafni, Mikhal; Keren, Ora; Sarne, Yosef			Pre- and post-conditioning treatment with an ultra-low dose of Delta(9)-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage	BEHAVIOURAL BRAIN RESEARCH			English	Article						Neuroprotection; Cannabinoid; Epileptic seizures; Preconditioning; Postconditioning; Cognitive deficit	TRAUMATIC BRAIN-INJURY; FOCAL CEREBRAL-ISCHEMIA; IN-VIVO; NEUROGENIC NEUROPROTECTION; ENDOCANNABINOID SYSTEM; STATUS EPILEPTICUS; NEURONAL INJURY; SPATIAL MEMORY; TIME-COURSE; EPILEPSY	Preconditioning, a phenomenon where a minor noxious stimulus protects from a subsequent more severe insult, and post-conditioning, where the protective intervention is applied following the insult, offer new insight into the neuronal mechanism(s) of neuroprotection and may provide new strategies for the prevention and treatment of brain damage. We have previously reported that a single administration of an extremely low dose of Delta(9)-tetrahydrocannabinol (THC; the psychoactive ingredient of marijuana) to mice induced minor long-lasting cognitive deficits. In the present study we examined the possibility that such a low dose of THC will protect the mice from more severe cognitive deficits induced by the epileptogenic drug pentylenetetrazole (PTZ). THC (0.002 mg/kg, a dose that is 3-4 orders of magnitude lower than the doses that induce the conventional effects of THC) was administered 1-7 days before, or 1-3 days after the injection of PTZ (60 mg/kg). The consequences of this treatment were studied 3-7 weeks later by various behavioral tests that evaluated different aspects of memory and learning. We found that a single administration of THC either before or after PTZ abolished the PTZ-induced long-lasting cognitive deficits. Biochemical studies indicated a concomitant reduction in phosphorylated-ERK (extracellular signal-regulated kinase) in the cerebella of mice 7 weeks following the injection of THC. Our results suggest that a pre- or post-conditioning treatment with extremely low doses of THC, several days before or after brain injury, may provide safe and effective long-term neuroprotection. (C) 2011 Elsevier B.V. All rights reserved.	[Sarne, Yosef] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Adelson Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, Mauerberger Chair Neuropharmacol, IL-69978 Tel Aviv, Israel		Sarne, Y (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Adelson Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel.	sarney@post.tau.ac.il			Israel Anti Drug Authority	Tetrahydrocannabinol was kindly donated by Prof. R. Mechoulam of The Hebrew University of Jerusalem, Israel and by The National Institute on Drug Abuse (NIDA), USA. This study was supported by a grant of the Israel Anti Drug Authority.	Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Amal H, 2010, BEHAV BRAIN RES, V206, P245, DOI 10.1016/j.bbr.2009.09.021; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Braida D, 2000, NEUROSCI LETT, V296, P69, DOI 10.1016/S0304-3940(00)01634-7; CharriautMarlangue C, 1996, TRENDS NEUROSCI, V19, P109, DOI 10.1016/S0166-2236(96)80039-7; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Clark RE, 2005, HIPPOCAMPUS, V15, P260, DOI 10.1002/hipo.20056; Clement AB, 2003, J NEUROSCI, V23, P3916; De Reuck J, 2006, EUR J NEUROL, V13, P402; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Derkinderen P, 2003, J NEUROSCI, V23, P2371; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Fowler CJ, 2010, EXP NEUROL, V224, P37, DOI 10.1016/j.expneurol.2010.03.021; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Golanov EV, 2003, CELL MOL NEUROBIOL, V23, P651, DOI 10.1023/A:1025088516742; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hayakawa K, 2007, LIFE SCI, V80, P1466, DOI 10.1016/j.lfs.2007.01.014; Huang LT, 2002, EPILEPSIA, V43, P567, DOI 10.1046/j.1528-1157.2002.29101.x; KITAGAWA K, 1991, BRAIN RES, V561, P203, DOI 10.1016/0006-8993(91)91596-S; Lamberty Y, 2000, EPILEPSY BEHAV, V1, P256, DOI 10.1006/ebeh.2000.0085; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Mitchell AJ, 2010, ACTA NEUROPSYCHIATR, V22, P2, DOI 10.1111/j.1601-5215.2009.00439.x; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nagayama T, 1999, J NEUROSCI, V19, P2987; Obrenovitch TP, 2008, PHYSIOL REV, V88, P211, DOI 10.1152/physrev.00039.2006; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pertwee RG, 2009, BRIT J PHARMACOL, V156, P397, DOI 10.1111/j.1476-5381.2008.00048.x; Pignataro G, 2008, J CEREBR BLOOD F MET, V28, P232, DOI 10.1038/sj.jcbfm.9600559; Pignataro G, 2009, FEBS J, V276, P46, DOI 10.1111/j.1742-4658.2008.06769.x; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Reis DJ, 1998, BRAIN RES, V780, P161, DOI 10.1016/S0006-8993(97)01017-2; Rubino T, 2004, MOL CELL NEUROSCI, V25, P355, DOI 10.1016/j.mcn.2003.11.003; Rutten A, 2002, EUR J NEUROSCI, V16, P501, DOI 10.1046/j.1460-9568.2002.02103.x; Sankar R, 1998, J NEUROSCI, V18, P8382; Senn R, 2008, PHARMACOL BIOCHEM BE, V88, P230, DOI 10.1016/j.pbb.2007.08.005; Shouman B, 2006, BRIT J PHARMACOL, V148, P442, DOI 10.1038/sj.bjp.0706755; Sommer C, 2009, ACTA NEUROPATHOL, V117, P511, DOI 10.1007/s00401-008-0473-0; Tanay E, 2006, BRAIN RES, V1112, P222, DOI 10.1016/j.brainres.2006.07.004; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Tselnicker I, 2007, NEUROSCI LETT, V411, P108, DOI 10.1016/j.neulet.2006.10.033; van der Stelt M, 2001, J NEUROSCI, V21, P6475, DOI 10.1523/JNEUROSCI.21-17-06475.2001; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Viscomi MT, 2010, EXP NEUROL, V224, P56, DOI 10.1016/j.expneurol.2010.03.023; Wang P, 2008, BRAIN RES, V1238, P108, DOI 10.1016/j.brainres.2008.07.103; Zaleska MM, 2009, NEUROPHARMACOLOGY, V56, P329, DOI 10.1016/j.neuropharm.2008.10.006; Zemke D, 2004, NEUROTOXICOLOGY, V25, P895, DOI 10.1016/j.neuro.2004.03.009; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13; Zhao ZQ, 2006, CARDIOVASC RES, V70, P200, DOI 10.1016/j.cardiores.2006.01.024	52	28	28	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUN 20	2011	220	1					194	201		10.1016/j.bbr.2011.02.005			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	752PC	WOS:000289703600024	21315768				2022-02-06	
J	O'Callaghan, AM; McAllister, L; Wilson, L				O'Callaghan, Anna M.; McAllister, Lindy; Wilson, Linda			Experiences of care: Perspectives of carers of adults with traumatic brain injury	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						Traumatic brain injury; family members; survey methodology; healthcare journey; experiences; carers; continuum of care	FAMILY CAREGIVERS; NEEDS; BURDEN; INDIVIDUALS; PREDICTORS; DISTRESS	This paper describes the results of a survey that explored the experiences of carers when accessing rehabilitative services alongside their family member with a moderate-severe TBI. The 184 carers who completed these surveys reflected retrospectively on the care they received. The results of this study indicated that 61% of the carer respondents recollected accessing inpatient rehabilitation following their acute care. However, following inpatient discharge only 33% of carers reported receiving ongoing services. One quarter of carers stated they received inadequate information while transitioning through their healthcare journey and fewer than 20% of carers recollected receiving any formal support service. The results of this study showed that as carers transitioned through the healthcare journey with their family member with TBI, health services progressively declined. As this occurred, carers' satisfaction with services reduced, while their responsibilities for caring increased. This trend is concerning given the needs of carers have been shown to change over time and increase if not addressed. This paper describes both carer experience following TBI in Australia and encourages clinicians to advocate for carers needs when planning and providing rehabilitation services.	[O'Callaghan, Anna M.; Wilson, Linda] Charles Sturt Univ, Albury, NSW, Australia; [McAllister, Lindy] Univ Queensland, Brisbane, Qld, Australia		O'Callaghan, AM (corresponding author), Charles Sturt Univ, POB 789, Albury, NSW, Australia.	aocallaghan@csu.edu.au	Wilson, Linda/P-8523-2015; McAllister, Lindy/C-8027-2009; Copley, Anna/D-1067-2011	Wilson, Linda/0000-0003-4175-7125; Copley, Anna/0000-0003-1784-9070			Albert SM, 2002, J HEAD TRAUMA REHAB, V17, P175, DOI 10.1097/00001199-200204000-00007; British Society of Rehabilitation Medicine Royal College of Physicians, 2003, REH FOLL ACQ BRAIN I; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; *DEP HUM SERV, 1995, PUBL HOSP PAT CHART; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fyffe C, 1996, Aust J Rural Health, V4, P232, DOI 10.1111/j.1440-1584.1996.tb00216.x; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; O'Callaghan AM, 2010, INT J SPEECH-LANG PA, V12, P107, DOI 10.3109/17549500903431774; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Smith J E, 2000, Care Manag J, V2, P27; Stebbins P, 1998, J REHABIL, V64, P15; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062	25	28	28	0	6	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	1754-9507			INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	JUN	2011	13	3					218	226		10.3109/17549507.2011.549240			9	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	763CU	WOS:000290532400005	21563896				2022-02-06	
J	Rossi, JL; Ranaivo, HR; Patel, F; Chrzaszcz, M; Venkatesan, C; Wainwright, MS				Rossi, Janet L.; Ranaivo, Hantamalala Ralay; Patel, Fatima; Chrzaszcz, MaryAnn; Venkatesan, Charu; Wainwright, Mark S.			Albumin Causes Increased Myosin Light Chain Kinase Expression in Astrocytes Via p38 Mitogen-Activated Protein Kinase	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						myosin light chain kinase; blood-brain barrier; astrocyte; traumatic brain injury; transforming growth factor	EPITHELIAL BARRIER DYSFUNCTION; LUNG INJURY; RHO-KINASE; INHIBITION; PHOSPHORYLATION; SUSCEPTIBILITY; INVOLVEMENT; KNOCKOUT; ISOFORM; MODEL	Myosin light chain kinase (MLCK) plays an important role in the reorganization of the cytoskeleton, leading to disruption of vascular barrier integrity in multiple organs, including the blood-brain barrier (BBB), after traumatic brain injury (TBI). MLCK has been linked to transforming growth factor (TGF) and rho kinase signaling pathways, but the mechanisms regulating MLCK expression following TBI are not well understood. Albumin leaks into the brain parenchyma following TBI, activates glia, and has been linked to TGF-beta receptor signaling. We investigated the role of albumin in the increase of MLCK in astrocytes and the signaling pathways involved in this increase. After midline closed-skull TBI in mice, there was a significant increase in MLCK-immunoreactive (IR) cells and albumin extravasation, which was prevented by treatment with the MLCK inhibitor ML-7. Using immunohistochemical methods, we identified the MLCK-IR cells as astrocytes. In primary astrocytes, exposure to albumin increased both isoforms of MLCK, 130 and 210. Inhibition of the TGF-b receptor partially prevented the albumin-induced increase in both isoforms, which was not prevented by inhibition of smad3. Inhibition of p38 MAPK, but not ERK, JNK, or rho kinase, also prevented this increase. These results are further evidence of a role of MLCK in the mechanisms of BBB compromise following TBI and identify astrocytes as a cell type, in addition to endothelium in the BBB, that expresses MLCK. These findings implicate albumin, acting through p38 MAPK, in a novel mechanism by which activation of MLCK following TBI may lead to compromise of the BBB. (C) 2011 Wiley-Liss, Inc.	[Rossi, Janet L.; Wainwright, Mark S.] Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Div Crit Care,Dept Pediat, Chicago, IL 60614 USA; [Ranaivo, Hantamalala Ralay; Patel, Fatima; Chrzaszcz, MaryAnn; Venkatesan, Charu; Wainwright, Mark S.] Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Div Neurol,Dept Pediat, Chicago, IL 60614 USA; [Rossi, Janet L.; Ranaivo, Hantamalala Ralay; Patel, Fatima; Chrzaszcz, MaryAnn; Venkatesan, Charu; Wainwright, Mark S.] Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Ctr Interdisciplinary Res Pediat Crit Illness & I, Chicago, IL 60614 USA		Wainwright, MS (corresponding author), Childrens Mem Hosp, Div Neurol 51, 2300 Childrens Plaza, Chicago, IL 60614 USA.	m-wainwright@northwestern.edu	Venkatesan, Charu/D-5944-2016		Department of Pediatrics Faculty Research Development Award; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12 HD052902]; Medical Research Junior Board Foundation; Lyndsey Whittingham Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD052902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS044998] Funding Source: NIH RePORTER	Contract grant sponsor: Department of Pediatrics Faculty Research Development Award (to J.L.R.); Contract grant sponsor: NIH; Contract grant number: K12 HD052902 (to C. V.); Contract grant sponsor: Medical Research Junior Board Foundation (to M. S. W.); Contract grant sponsor: Lyndsey Whittingham Foundation (to M.S.W.).	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Afonso PV, 2007, J IMMUNOL, V179, P2576, DOI 10.4049/jimmunol.179.4.2576; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; BAORTO DM, 1992, J CELL BIOL, V117, P357, DOI 10.1083/jcb.117.2.357; Bazzoni G, 1999, CURR OPIN CELL BIOL, V11, P573, DOI 10.1016/S0955-0674(99)00023-X; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004; Drexler H, 1999, J MOL CELL CARDIOL, V31, P51, DOI 10.1006/jmcc.1998.0843; EDELMAN AM, 1992, MOL BRAIN RES, V14, P27, DOI 10.1016/0169-328X(92)90006-W; Eiznhamer DA, 2004, PULM PHARMACOL THER, V17, P105, DOI 10.1016/j.pupt.2003.11.003; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Haorah J, 2005, ALCOHOL CLIN EXP RES, V29, P999, DOI 10.1097/01.ALC.0000166944.79914.0A; Hooper C, 2009, J NEUROCHEM, V109, P694, DOI 10.1111/j.1471-4159.2009.05953.x; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Kudryashov DS, 2004, EXP CELL RES, V298, P407, DOI 10.1016/j.yexcr.2004.04.025; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Kuhlmann CRW, 2006, NEUROPHARMACOLOGY, V51, P907, DOI 10.1016/j.neuropharm.2006.06.004; Kuhlmann CRW, 2009, STROKE, V40, P1458, DOI 10.1161/STROKEAHA.108.535930; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Mihaescu A, 2010, BRIT J SURG, V97, P226, DOI 10.1002/bjs.6811; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Padmanabhan J, 1998, NEUROCHEM RES, V23, P377, DOI 10.1023/A:1022413718447; Park SY, 2010, KOREAN J PHYSIOL PHA, V14, P29, DOI 10.4196/kjpp.2010.14.1.29; Parker JC, 2000, J APPL PHYSIOL, V89, P2241, DOI 10.1152/jappl.2000.89.6.2241; Ranaivo HR, 2010, EXP NEUROL, V226, P310, DOI 10.1016/j.expneurol.2010.09.005; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Reynoso R, 2007, SHOCK, V28, P589, DOI 10.1097/SHK.0b013c31804d415f; Rossi JL, 2007, AM J PHYSIOL-LUNG C, V292, pL1327, DOI 10.1152/ajplung.00380.2006; Schmidt O.I., 2004, EUR J TRAUMA, V30, P135, DOI DOI 10.1007/S00068-004-1394-9; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Sinpitaksakul SN, 2008, BIOCHEM BIOPH RES CO, V371, P713, DOI 10.1016/j.bbrc.2008.04.128; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Yu CG, 2010, J NEUROCHEM, V113, P131, DOI 10.1111/j.1471-4159.2010.06579.x; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767	38	28	30	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2011	89	6					852	861		10.1002/jnr.22600			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	749OI	WOS:000289477500008	21360574	Green Accepted			2022-02-06	
J	Tazarourte, K; Atchabahian, A; Tourtier, JP; David, JS; Ract, C; Savary, D; Monchi, M; Vigue, B				Tazarourte, K.; Atchabahian, A.; Tourtier, J. -P.; David, J. -S.; Ract, C.; Savary, D.; Monchi, M.; Vigue, B.			Pre-hospital transcranial Doppler in severe traumatic brain injury: a pilot study	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							SEVERE HEAD-INJURY; BLOOD-FLOW; HYPOTENSION; ULTRASOUND; MODERATE; MANAGEMENT; ADMISSION; DIAGNOSIS	Background Investigation of the feasibility and usefulness of pre-hospital transcranial Doppler (TCD) to guide early goal-directed therapy following severe traumatic brain injury (TBI). Methods Prospective, observational study of 18 severe TBI patients during pre-hospital medical care. TCD was performed to estimate cerebral perfusion in the field and upon arrival at the Level 1 trauma centre. Specific therapy (mannitol, noradrenaline) aimed at improving cerebral perfusion was initiated if the initial TCD was abnormal (defined by a pulsatility index > 1.4 and low diastolic velocity). Results Nine patients had a normal initial TCD and nine an abnormal one, without a significant difference between groups in terms of the Glasgow Coma Scale or the mean arterial pressure. Among patients with an abnormal TCD, four presented with an initial areactive bilateral mydriasis. Therapy normalized TCD in five patients, with reversal of the initial mydriasis in two cases. Among these five patients for whom TCD was corrected, only two died within the first 48 h. All four patients for whom the TCD could not be corrected during transport died within 48 h. Only patients with an initial abnormal TCD required emergent neurosurgery (3/9). Mortality at 48 h was significantly higher for patients with an initial abnormal TCD. Conclusions Our preliminary study suggests that TCD could be used in pre-hospital care to detect patients whose cerebral perfusion may be impaired.	[Tazarourte, K.; Tourtier, J. -P.; David, J. -S.; Savary, D.; Monchi, M.] Hop Marc Jacquet, Serv Aide Med Urgente SAMU 77, F-77000 Melun, France; [Tazarourte, K.; Ract, C.; Vigue, B.] Univ Paris 11, Hop Bicetre, AP HP, Dept Anesthesie Reanimat, Le Kremlin Bicetre, France; [Atchabahian, A.] NYU, Med Ctr, Dept Anesthesiol, New York, NY 10016 USA		Tazarourte, K (corresponding author), Hop Marc Jacquet, Serv Aide Med Urgente SAMU 77, F-77000 Melun, France.	karim.tazarourte@ch-melun.fr	David, Jean Stephane/H-9399-2019	David, Jean Stephane/0000-0001-6274-7044; Hertling, Arthur/0000-0002-1634-6538; tazarourte, karim/0000-0002-3376-1258			Bouhours G, 2008, ANN FR ANESTH, V27, P397, DOI 10.1016/j.annfar.2008.02.015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BRATTON SL, 2007, J NEUROTRAUM, V27, pS1; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; CZOSNYKA M, 1994, NEUROSURGERY, V35, P287, DOI 10.1227/00006123-199408000-00015; DeWitt D S, 1995, New Horiz, V3, P376; Ducrocq X, 1998, J NEUROL SCI, V159, P145, DOI 10.1016/S0022-510X(98)00158-0; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Holscher T, 2008, CEREBROVASC DIS, V26, P659, DOI 10.1159/000166844; Hukkelhoven CWPM, 2005, INTENS CARE MED, V31, P799, DOI 10.1007/s00134-005-2628-y; Jaffres P, 2005, INTENS CARE MED, V31, P785, DOI 10.1007/s00134-005-2630-4; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kirkpatrick PJ, 2007, HEAD INJURY, P243; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Lapostolle F, 2006, AM J EMERG MED, V24, P237, DOI 10.1016/j.ajem.2005.07.010; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Ract C, 2007, INTENS CARE MED, V33, P645, DOI 10.1007/s00134-007-0558-6; Rouxel JPM, 2004, ANN FR ANESTH, V23, P6, DOI 10.1016/j.annfar.2003.09.021; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Svenson J, 2008, AM J EMERG MED, V26, P465, DOI 10.1016/j.ajem.2007.05.013; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878	24	28	28	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	APR	2011	55	4					422	428		10.1111/j.1399-6576.2010.02372.x			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	733FS	WOS:000288249200008	21288224				2022-02-06	
J	Berthet, C; Lei, HX; Gruetter, R; Hirt, L				Berthet, Carole; Lei, Hongxia; Gruetter, Rolf; Hirt, Lorenz			Early Predictive Biomarkers for Lesion After Transient Cerebral Ischemia	STROKE			English	Article						biological markers; magnetic resonance spectroscopy; middle cerebral artery occlusion; transient ischemic attack; stroke	MAGNETIC-RESONANCE-SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; N-ACETYL ASPARTATE; MR SPECTROSCOPY; ARTERY OCCLUSION; MOUSE-BRAIN; BLOOD-FLOW; ECHO-TIME; STROKE; TAURINE	Background and Purpose-Despite the improving imaging techniques, it remains challenging to predict the outcome early after transient cerebral ischemia. The aim of this study was thus to identify early metabolic biomarkers for outcome prediction. Methods-We modeled transient ischemic attacks and strokes in mice. Using high-field MR spectroscopy, we correlated early changes in the neurochemical profile of the ischemic striatum with histopathologic alterations at a later time point. Results-A significant increase in glutamine was measured between 3 hours and 8 hours after all ischemic events followed by reperfusion independently of the outcome and can thus be considered as an indicator of recent transient ischemia. On the other hand, a reduction of the score obtained by summing the concentrations of N-acetyl aspartate, glutamate, and taurine was a good predictor of an irreversible lesion as early as 3 hours after ischemia. Conclusions-We identified biomarkers of reversible and irreversible ischemic damage, which can be used in an early predictive evaluation of stroke outcome. (Stroke. 2011;42:799-805.)	[Lei, Hongxia; Gruetter, Rolf] Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging, CH-1015 Lausanne, Switzerland; [Berthet, Carole; Hirt, Lorenz] CHU Vaudois, Dept Clin Neurosci, CH-1011 Lausanne, Switzerland; [Lei, Hongxia; Gruetter, Rolf] Univ Lausanne, Dept Radiol, Lausanne, Switzerland; [Gruetter, Rolf] Univ Geneva, Dept Radiol, Geneva, Switzerland		Lei, HX (corresponding author), Ecole Polytech Fed Lausanne, Lab Funct & Metab Imaging, CH-1015 Lausanne, Switzerland.	hongxia.lei@epfl.ch	Gruetter, Rolf/H-6260-2011; Hirt, Lorenz/G-3553-2010	Gruetter, Rolf/0000-0003-1870-4025; Hirt, Lorenz/0000-0002-2921-5000; Lei, Hongxia/0000-0002-4065-9331	Centre d'Imagerie BioMedicale of the University of Lausanne (UNIL); University of Geneva (UNIGE); Hopital universitaire de Geneve (HUG); Centre Hospitalier Universtaire Vaudois (CHUV); Ecole Polytechnique Federale de Lausanne (EPFL); Leenaards, Jeantet and Gianni Biaggi de Blasys Foundations	This work was supported by the Centre d'Imagerie BioMedicale of the University of Lausanne (UNIL), University of Geneva (UNIGE), Hopital universitaire de Geneve (HUG), Centre Hospitalier Universtaire Vaudois (CHUV), and Ecole Polytechnique Federale de Lausanne (EPFL); and the Leenaards, Jeantet and Gianni Biaggi de Blasys Foundations.	Bisschops RHC, 2002, STROKE, V33, P110, DOI 10.1161/hs0102.100879; Brouns R, 2008, CLIN CHIM ACTA, V397, P27, DOI 10.1016/j.cca.2008.07.016; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Cvoro V, 2009, STROKE, V40, P767, DOI 10.1161/STROKEAHA.108.525626; DECAVEL C, 1995, J COMP NEUROL, V354, P13, DOI 10.1002/cne.903540103; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Federico F, 1998, ARCH NEUROL-CHICAGO, V55, P489, DOI 10.1001/archneur.55.4.489; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Frykholm P, 2005, J NEUROSURG, V102, P1076, DOI 10.3171/jns.2005.102.6.1076; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Giroud M, 1999, NEUROL RES, V21, P563, DOI 10.1080/01616412.1999.11740976; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; HENNIG J, 1988, J MAGN RESON, V78, P397, DOI 10.1016/0022-2364(88)90128-X; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Higuchi T, 1996, NEUROSURGERY, V38, P121, DOI 10.1097/00006123-199601000-00030; Hirt L, 2004, STROKE, V35, P1738, DOI 10.1161/01.STR.0000131480.03994.b1; Kidwell CS, 2000, ANN NEUROL, V47, P462, DOI 10.1002/1531-8249(200004)47:4<462::AID-ANA9>3.3.CO;2-P; KUNZ N, 2009, P INT SOC MAG RESON, P1378; Lei HX, 2009, J CEREBR BLOOD F MET, V29, P811, DOI 10.1038/jcbfm.2009.8; Liebeskind DS, 2009, ANN NEUROL, V66, P574, DOI 10.1002/ana.21787; Mekle R, 2009, MAGN RESON MED, V61, P1279, DOI 10.1002/mrm.21961; Mlynarik V, 2006, MAGN RESON MED, V56, P965, DOI 10.1002/mrm.21043; Mlynash M, 2009, NEUROLOGY, V72, P1127, DOI 10.1212/01.wnl.0000340983.00152.69; NAGELHUS EA, 1993, NEUROSCIENCE, V54, P615, DOI 10.1016/0306-4522(93)90233-6; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Pereira AC, 1999, STROKE, V30, P1577, DOI 10.1161/01.STR.30.8.1577; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Saenger AK, 2010, CLIN CHEM, V56, P21, DOI 10.1373/clinchem.2009.133801; Sager TN, 2000, J CEREBR BLOOD F MET, V20, P780, DOI 10.1097/00004647-200005000-00004; Sanak D, 2009, BIOMED PAP, V153, P181, DOI 10.5507/bp.2009.030; Saransaari P, 2010, AMINO ACIDS, V38, P739, DOI 10.1007/s00726-009-0278-z; Sicard KM, 2006, J CEREBR BLOOD F MET, V26, P1451, DOI 10.1038/sj.jcbfm.9600299; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; van der Zwaag W, 2009, J MAGN RESON IMAGING, V30, P1171, DOI 10.1002/jmri.21951; Weber R, 2006, J CEREBR BLOOD F MET, V26, P591, DOI 10.1038/sj.jcbfm.9600241; Wintermark M, 2002, ANN NEUROL, V51, P417, DOI 10.1002/ana.10136	36	28	28	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	MAR	2011	42	3					799	805		10.1161/STROKEAHA.110.603647			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	723AW	WOS:000287479402019	21293024	Green Published, Bronze			2022-02-06	
J	Rughani, AI; Lin, CT; Ares, WJ; Cushing, DA; Horgan, MA; Tranmer, BI; Jewell, RP; Florman, JE				Rughani, Anand I.; Lin, Chih-Ta; Ares, William J.; Cushing, Deborah A.; Horgan, Michael A.; Tranmer, Bruce I.; Jewell, Ryan P.; Florman, Jeffrey E.			Helmet use and reduction in skull fractures in skiers and snowboarders admitted to the hospital Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						helmet use; skiing; skull fracture; snowboarding; traumatic brain injury	HEAD-INJURIES; SKIING INJURIES; SAFETY HELMETS; RISK; CHILDREN; SLOPES; WEAR	Object. Helmet use has been associated with fewer hospital visits among injured skiers and snowboarders, but there remains no evidence that helmets alter the intracranial injury patterns. The authors hypothesized that helmet use among skiers and snowboarders reduces the incidence of head injury as defined by findings on head CT scans. Methods. The authors performed a retrospective review of head-injured skiers and snowboarders at 2 Level I trauma centers in New England over a 6-year period. The primary outcome of interest was intracranial injury evident on CT scans. Secondary outcomes included the following: need for a neurosurgical procedure, presence of spine injury, need for ICU admission, length of stay, discharge location, and death. Results. Of the 57 children identified who sustained a head injury while skiing or snowboarding, 33.3% were wearing a helmet at the time of injury. Of the helmeted patients, 5.3% sustained a calvarial fracture compared with 36.8% of the unhelmeted patients (p = 0.009). Although there was a favorable trend, there was no significant difference in the incidence of epidural hematoma, subdural hematoma, intraparenchymal hemorrhage, subarachnoid hemorrhage, or contusion in helmeted and unhelmeted patients. With regard to secondary outcomes, there were no significant differences between the 2 groups in percentage of patients requiring neurosurgical intervention, percentage requiring admission to an ICU, total length of stay, or percentage discharged home. There was no difference in the incidence of cervical spine injury. There was 1 death in an unhelmeted patient, and there were no deaths among helmeted patients. Conclusions. Among hospitalized children who sustained a head injury while skiing or snowboarding, a significantly lower number of patients suffered a skull fracture if they were wearing helmets at the time of the injury. (DOI: 10.3171/2010.12.PEDS10415)	[Rughani, Anand I.; Lin, Chih-Ta; Horgan, Michael A.; Tranmer, Bruce I.; Jewell, Ryan P.] Univ Vermont, Div Neurosurg, Burlington, VT 05401 USA; [Ares, William J.] Univ Vermont, Coll Med, Burlington, VT 05401 USA; [Cushing, Deborah A.; Florman, Jeffrey E.] Maine Med Ctr, Inst Neurosci, Portland, ME 04102 USA		Rughani, AI (corresponding author), Univ Vermont, Div Neurosurg, 111 Colchester Ave,Fletcher 507, Burlington, VT 05401 USA.	anand.rughani@mail.mcgill.ca					Buller DB, 2003, J TRAUMA, V55, P939, DOI 10.1097/01.TA.0000078694.53320.CA; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Cusimano MD, 2010, JAMA-J AM MED ASSOC, V303, P661, DOI 10.1001/jama.2010.147; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; FURRER M, 1995, J TRAUMA, V39, P737, DOI 10.1097/00005373-199510000-00024; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Lawrence L, 2008, PEDIATR EMERG CARE, V24, P219, DOI 10.1097/PEC.0b013e31816a9f0a; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Machold W, 2000, J TRAUMA, V48, P1109, DOI 10.1097/00005373-200006000-00018; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; MORROW PL, 1988, J TRAUMA, V28, P95, DOI 10.1097/00005373-198801000-00014; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Nakaguchi H, 2002, J NEUROSURG, V97, P542, DOI 10.3171/jns.2002.97.3.0542; Ruedl G, 2010, BRIT J SPORT MED, V44, P204, DOI 10.1136/bjsm.2009.066779; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Scott MD, 2007, INJURY PREV, V13, P173, DOI 10.1136/ip.2006.014142; Shorter NA, 1996, J TRAUMA, V40, P997, DOI 10.1097/00005373-199606000-00024; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559	20	28	28	0	12	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2011	7	3					268	271		10.3171/2010.12.PEDS10415			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	725WE	WOS:000287676800011	21361765				2022-02-06	
J	Brakenridge, SC; Toomay, SM; Sheng, JL; Gentilello, LM; Shafi, S				Brakenridge, Scott C.; Toomay, Seth M.; Sheng, Jean L.; Gentilello, Larry M.; Shafi, Shahid			Predictors of early versus late timing of pulmonary embolus after traumatic injury	AMERICAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	National Meeting of the American-College-of-Surgeons-Committee-on-Trauma	MAR 20, 2009	Chicago, IL	Amer Coll Surg Comm Trauma		Pulmonary embolus; Trauma; Injury	VENA-CAVA FILTERS; RESOLUTION CT FINDINGS; VENOUS THROMBOEMBOLISM; BRAIN-INJURY; MAJOR TRAUMA; HYPERCOAGULABILITY; PROPHYLAXIS; COAGULATION; PREVENTION; HEPARIN	OBJECTIVE: To identify risk factors predictive of pulmonary embolus (PE) timing after a traumatic injury. METHODS: One hundred eight traumatic injury patients with a confirmed diagnosis of PE were classified as early PE (<= 4 days, n = 54) or late PE (>4 days, n = 54). Independent predictors of early versus late PE were identified using multivariate logistic regression. RESULTS: Half the PEs were diagnosed <= 4 days of injury. Only long bone fractures independently predicted early PE (odds ratio 2.8; 95% confidence interval, 1.1-7.1). Severe head injuries were associated with late PE (odds ratio 11.1; 95% confidence interval, 3.9-31). Established risk factors such as age did not affect timing. CONCLUSIONS: Half the PEs were diagnosed 4 days after injury. The risk of early PE appeared highest in patients with long bone fractures, and the benefits of immediate prophylaxis may outweigh risks. Patients with severe head injuries appear to have later PE events. Prospective interventional trials in these injury populations are needed. (C) 2011 Published by Elsevier Inc.	[Brakenridge, Scott C.; Gentilello, Larry M.; Shafi, Shahid] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Toomay, Seth M.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Sheng, Jean L.] Univ Texas SW Med Sch, Dallas, TX USA; [Shafi, Shahid] Baylor Hlth Care Syst, Inst Hlth Care Res & Improvement, Dallas, TX USA		Shafi, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA.	rhcmd@uab.edu	; Brakenridge, Scott/AAD-6691-2019	Toomay, Seth/0000-0002-3962-9653; Brakenridge, Scott/0000-0002-7327-3718	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024982] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024982, UL1 RR024982] Funding Source: Medline		Adair JD, 2008, J TRAUMA, V64, P509, DOI 10.1097/TA.0b013e318058251c; Antevil JL, 2006, J TRAUMA, V60, P35, DOI 10.1097/01.ta.0000197607.23019.ab; Arakawa H, 2003, CHEST, V123, P1096, DOI 10.1378/chest.123.4.1096; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; FERRARO FJ, 1992, AM SURGEON, V58, P355; Friis E, 2004, WORLD J SURG, V28, P540, DOI 10.1007/s00268-004-723-9; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ginzburg E, 2003, BRIT J SURG, V90, P1338, DOI 10.1002/bjs.4309; GREEN D, 1988, JAMA-J AM MED ASSOC, V260, P1255, DOI 10.1001/jama.260.9.1255; Hermsen JL, 2008, WORLD J SURG, V32, P1444, DOI 10.1007/s00268-007-9462-z; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Karmy-Jones R, 2007, J TRAUMA, V62, P17, DOI 10.1097/TA.0b013e31802dd72a; Kim KI, 1999, RADIOLOGY, V210, P693, DOI 10.1148/radiology.210.3.r99mr01693; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Kovac M, 2010, CLIN APPL THROMB-HEM, V16, P66, DOI 10.1177/1076029608320721; Mahrer A, 2008, CARDIOVASC INTER RAD, V31, P785, DOI 10.1007/s00270-008-9294-8; Malagari K, 2003, CHEST, V123, P1196, DOI 10.1378/chest.123.4.1196; Meissner MH, 2003, J TRAUMA, V54, P224, DOI 10.1097/01.TA.0000046253.33495.70; Menaker J, 2007, J TRAUMA, V63, P620, DOI 10.1097/TA.0b013e31812f60aa; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Owings JT, 1997, ARCH SURG-CHICAGO, V132, P862; Pasquier E, 2001, THROMB HAEMOSTASIS, V86, P538; Rodeghiero F, 1999, ANN INTERN MED, V130, P643, DOI 10.7326/0003-4819-130-8-199904200-00004; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Schreiber MA, 2005, J TRAUMA, V58, P475, DOI 10.1097/01.TA.0000153938.77777.26; Schultz DJ, 2004, J TRAUMA, V56, P727, DOI 10.1097/01.TA.0000119687.23542.EC; Sing RF, 2006, J TRAUMA, V60, P732, DOI 10.1097/01.ta.0000210285.22571.66; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Velmahos GC, 2009, ARCH SURG-CHICAGO, V144, P928, DOI 10.1001/archsurg.2009.97; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	33	28	28	0	3	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	FEB	2011	201	2					209	215		10.1016/j.amjsurg.2009.12.005			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	722KE	WOS:000287430300012	20385370	Green Accepted			2022-02-06	
J	O'Reilly, RC; Greywoode, J; Morlet, T; Miller, F; Henley, J; Church, C; Campbell, J; Beaman, J; Cox, AM; Zwicky, E; Bean, C; Falcheck, S				O'Reilly, Robert C.; Greywoode, Jewell; Morlet, Thierry; Miller, Freeman; Henley, John; Church, Chris; Campbell, Jeffrey; Beaman, Jason; Cox, Anne Marie; Zwicky, Emily; Bean, Charles; Falcheck, Stephen			Comprehensive Vestibular and Balance Testing in the Dizzy Pediatric Population	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article; Proceedings Paper	23rd Annual Meeting of the American-Society-of-Pediatric-Otolaryngology	MAY 02-04, 2008	Orlando, FL	Amer Soc Pediat Otolaryngol		balance; pediatric; vertigo; vestibular disorders	BENIGN PAROXYSMAL VERTIGO; EVOKED MYOGENIC POTENTIALS; CHILDREN; CHILDHOOD; MIGRAINE; DIZZINESS; INFANTS	Objective. To describe the spectrum of balance disease in a large population of children presenting to a tertiary care vestibular and balance laboratory. Study Design. Case series with chart review. Setting. Tertiary care pediatric hospital. Main Outcome Measures. Results of audiometric, vestibular, and balance tests and final diagnosis. Subjects and Methods. Retrospective review of audiometric, vestibular, balance testing, and final diagnosis from a patient database. Results. Between September 2003 and September 2007, 132 children were evaluated at the Alfred I. duPont Hospital for Children Vestibular Disorders Program. Sixty-nine of the patients were boys and 63 were girls. The average age was 9.7 +/- 5.0 years (range, 1-17 years). Although not all were able to complete the entire test battery (99 children completed at least 50% of the tests in the protocol), a diagnosis was achieved in most cases. The most common diagnoses were peripheral vestibulopathy (29.5%), migraine/benign recurrent vertigo of childhood (24.2%), motor/developmental delay (10.6%), traumatic brain injury (9.8%), and central nervous system structural lesion (9.1%). Conclusions. Peripheral vestibular deficits and migraine disease account for most of the pathology in the pediatric population. With a multidisciplinary approach, diagnosis of the source of vertigo and imbalance is possible in most children.	[O'Reilly, Robert C.] Alfred I duPont Hosp Children, Div Pediat Otolaryngol, Wilmington, DE 19899 USA; [Greywoode, Jewell] Thomas Jefferson Univ Hosp, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19107 USA; [Morlet, Thierry] Alfred I duPont Hosp Children, Ctr Pediat Auditory & Speech Sci, Wilmington, DE 19899 USA; [Miller, Freeman; Henley, John; Church, Chris] Alfred I duPont Hosp Children, Gait Lab, Wilmington, DE 19899 USA; [Campbell, Jeffrey] Alfred I duPont Hosp Children, Div Pediat Neurosurg, Wilmington, DE 19899 USA; [Beaman, Jason] Alfred I duPont Hosp Children, Dept Phys Therapy, Wilmington, DE 19899 USA; [Cox, Anne Marie; Zwicky, Emily] Alfred I duPont Hosp Children, Dept Audiol, Wilmington, DE 19899 USA; [Bean, Charles] Neurol Associates PA, Newark, DE USA; [Falcheck, Stephen] Alfred I duPont Hosp Children, Dept Neurol, Wilmington, DE 19899 USA		O'Reilly, RC (corresponding author), Alfred I duPont Hosp Children, Div Pediat Otolaryngol, POB 269, Wilmington, DE 19899 USA.	roreilly@nemours.org	Morlet, Thierry/AAL-8442-2021				Al-Twaijri WA, 2002, PEDIATR NEUROL, V26, P365, DOI 10.1016/S0887-8994(01)00416-7; ANDRIEUGUITRANCOURT J, 1981, INT J PEDIATR OTORHI, V3, P245, DOI 10.1016/0165-5876(81)90007-0; Bachor E, 2002, LARYNGOSCOPE, V112, P147, DOI 10.1097/00005537-200201000-00026; Balatsouras DG, 2007, INT J PEDIATR OTORHI, V71, P487, DOI 10.1016/j.ijporl.2006.11.024; BASSER LS, 1964, BRAIN, V87, P141, DOI 10.1093/brain/87.1.141; BOWER CM, 1995, ARCH OTOLARYNGOL, V121, P911; Choung YH, 2003, INT J PEDIATR OTORHI, V67, P889, DOI 10.1016/S0165-5876(03)00136-8; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Drigo P, 2001, BRAIN DEV-JPN, V23, P38, DOI 10.1016/S0387-7604(01)00175-9; EEGOLOFSSON O, 1982, ACTA OTO-LARYNGOL, V93, P283, DOI 10.3109/00016488209130884; Erbek SH, 2006, INT J PEDIATR OTORHI, V70, P1547, DOI 10.1016/j.ijporl.2006.04.001; Eviatar L, 1978, Adv Otorhinolaryngol, V23, P169; EVIATAR L, 1979, LARYNGOSCOPE, V89, P1036; FILIPO R, 1985, J LARYNGOL OTOL, V99, P193, DOI 10.1017/S0022215100096523; Horlings CGC, 2008, NAT CLIN PRACT NEURO, V4, P504, DOI 10.1038/ncpneuro0886; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kelsch TA, 2006, LARYNGOSCOPE, V116, P895, DOI 10.1097/01.mlg.0000214664.97049.3e; KENYON GS, 1988, J ROY SOC MED, V81, P644, DOI 10.1177/014107688808101111; Kumar A, 2002, OTOL NEUROTOL, V23, P727, DOI 10.1097/00129492-200209000-00021; Lindskog U, 1999, HEADACHE, V39, P33, DOI 10.1046/j.1526-4610.1999.3901033.x; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; MULCH G, 1979, ANN OTO RHINOL LARYN, V88, P1, DOI 10.1177/00034894790880S201; NEDZELSKI JM, 1986, J OTOLARYNGOL, V15, P101; Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432; Oh AK, 2001, J NEUROL, V248, P971, DOI 10.1007/s004150170050; Pakalnis A, 2001, FAM PRACT, V18, P101, DOI 10.1093/fampra/18.1.101; Purdy RA, 2008, NEUROL SCI, V29, pS44, DOI 10.1007/s10072-008-0885-6; Ravid S, 2003, PEDIATR NEUROL, V29, P317, DOI 10.1016/S0887-8994(03)00278-9; Riina N, 2005, ARCH OTOLARYNGOL, V131, P996, DOI 10.1001/archotol.131.11.996; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; TELISCHI FF, 2005, NEUROTOLOGY, P553; Valente M, 2007, J AM ACAD AUDIOL, V18, P461, DOI 10.3766/jaaa.18.6.2	32	28	31	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	FEB	2011	144	2					142	148		10.1177/0194599810393679			7	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Otorhinolaryngology; Surgery	808RV	WOS:000293997000002	21493408				2022-02-06	
J	Qu, CS; Mahmood, A; Liu, XS; Xiong, Y; Wang, L; Wu, HT; Li, B; Zhang, ZG; Kaplan, DL; Chopp, M				Qu, Changsheng; Mahmood, Asim; Liu, Xian Shuang; Xiong, Ye; Wang, Lei; Wu, Hongtao; Li, Bo; Zhang, Zheng Gang; Kaplan, David L.; Chopp, Michael			The treatment of TBI with human marrow stromal cells impregnated into collagen scaffold: Functional outcome and gene expression profile	BRAIN RESEARCH			English	Article						Endothelial vascular growth factor (VEGF); Traumatic brain injury (TBI); Marrow stromal cell; Collagen scaffold; Restorative therapy	TRAUMATIC BRAIN-INJURY; ENDOTHELIAL GROWTH-FACTOR; UP-REGULATION; ADULT RATS; NEUROGENESIS; ANGIOGENESIS; TRANSPLANTATION; NEUROPROTECTION; INCREASES; SURVIVIN	We have previously demonstrated that human marrow stromal cells (hMSCs) embedded in collagen I scaffolds significantly enhance the restorative therapeutic effect of hMSCs after traumatic brain injury (TBI). In this study, we test the hypothesis that the collagen scaffold alters gene expression in hMSCs and that hMSCs impregnated into scaffolds increase the astrocytic expression of vascular endothelial growth factor (VEGF) in the injured brain. Following TBI induced by controlled cortical impact injury, scaffold with hMSCs (3.0 x 10(6)), hMSCs-only and saline were implanted into the lesion cavity one week after brain injury (n = 8/each group). Morris water maze and modified neurological severity scores were performed to evaluate the spatial learning and sensorimotor functions, respectively. Lesion volume and expression of VEGF were measured one week after different treatments. In vitro, total RNA from hMSCs was extracted one week after culture with or without collagen I scaffold for evaluation of gene microarrays. Furthermore, an RT-PCR study on a select subgroup of genes was performed to identify the changes of expression between the culturing hMSCs with collagen scaffolds and hMSCs only. The treatment of TBI with collagen scaffold impregnated with hMSCs significantly decreases the functional deficits from TB! within 7 days after treatment, and significantly enhances the VEGF expression of astrocytes in the injured brain compared to the hMSCs-only group. In vitro data indicate that collagen scaffolds stimulate hMSCs to express multiple factors which may contribute to hMSC survival, tissue repair and functional recovery after TBI. (C) 2010 Elsevier B.V. All rights reserved.	[Qu, Changsheng; Mahmood, Asim; Xiong, Ye; Wu, Hongtao; Li, Bo] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Liu, Xian Shuang; Wang, Lei; Zhang, Zheng Gang; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Mahmood, A (corresponding author), Henry Ford Hosp, Dept Neurosurg, 2799 W Grand Blvd, Detroit, MI 48202 USA.	nsaam@neuro.hfh.edu		Xiong, Ye/0000-0001-9770-6031	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [PO1 NS42345, RO1 NS042259, P41 EB002520]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042259, P01NS042345] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health grants PO1 NS42345, RO1 NS042259 and P41 EB002520.	Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Day LB, 1996, BEHAV NEUROSCI, V110, P998; DIXON CE, 1991, J NEUROSCI METH, V39, P253; During Matthew J., 2006, Current Alzheimer Research, V3, P29, DOI 10.2174/156720506775697133; Gao F, 2007, CAN J CARDIOL, V23, P891; Horiba M, 2006, CIRCULATION, V114, P1713, DOI 10.1161/CIRCULATIONAHA.106.632273; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Johnson EA, 2004, J NEUROTRAUM, V21, P1183, DOI 10.1089/neu.2004.21.1183; Kawamura K, 2005, BIOL REPROD, V73, P1094, DOI 10.1095/biolreprod.105.042754; Krieglstein K, 2002, J PHYSIOLOGY-PARIS, V96, P25, DOI 10.1016/S0928-4257(01)00077-8; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Liu XS, 2007, J CEREBR BLOOD F MET, V27, P564, DOI 10.1038/sj.jcbfm.9600371; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010; Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pati S, 2009, BRAIN RES, V1256, P85, DOI 10.1016/j.brainres.2008.11.086; Polazzi E, 2009, J NEUROCHEM, V110, P545, DOI 10.1111/j.1471-4159.2009.06117.x; Qu CS, 2009, J NEUROSURG, V111, P658, DOI 10.3171/2009.4.JNS081681; REH T, 1982, J COMP NEUROL, V211, P276, DOI 10.1002/cne.902110306; Salerno A, 2009, J MATER SCI-MATER M, V20, P2043, DOI 10.1007/s10856-009-3767-4; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321; Sun JQ, 2010, BIOCHEM BIOPH RES CO, V394, P146, DOI 10.1016/j.bbrc.2010.02.132; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yamada K, 1999, BRIT J PHARMACOL, V126, P235, DOI 10.1038/sj.bjp.0702309; Zen AA, 2010, CIRC RES, V107, P283, DOI 10.1161/CIRCRESAHA.110.221663; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	56	28	30	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 31	2011	1371						129	139		10.1016/j.brainres.2010.10.088			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	720JV	WOS:000287277900014	21062621	Green Accepted			2022-02-06	
J	Kobori, N; Hu, B; Dash, PK				Kobori, N.; Hu, B.; Dash, P. K.			ALTERED ADRENERGIC RECEPTOR SIGNALING FOLLOWING TRAUMATIC BRAIN INJURY CONTRIBUTES TO WORKING MEMORY DYSFUNCTION	NEUROSCIENCE			English	Article						catecholamines; neurotransmitter signaling; protein kinase A; CREB-mediated gene expression; chromatin immunoprecipitation	CONTROLLED CORTICAL IMPACT; HUMAN ALPHA(1A)-ADRENERGIC RECEPTOR; SUBTYPE MESSENGER-RNAS; PREFRONTAL CORTEX; CARDIAC MYOCYTES; PROTEIN-KINASE; RAT; DEFICITS; GENE; PROMOTER	The prefrontal cortex is highly vulnerable to traumatic brain injury (TBI) and its structural and/or functional alterations as a result of TBI can give rise to persistent working memory (WM) dysfunction. Using a rodent model of TBI, we have described profound WM deficits following TBI that are associated with increases in prefrontal catecholamine (both dopamine and norepinephrine) content. In this study, we examined if enhanced norepinephrine signaling contributes to TBI-associated WM dysfunction. We demonstrate that administration of alpha 1 adrenoceptor antagonists, but not alpha 2A agonist, at 14 days post-injury significantly improved WM performance. mRNA analysis revealed increased levels of alpha 1A, but not alpha 1B or alpha 1D, adrenoceptor in the medial prefrontal cortex (mPFC) of brain-injured rats. As alpha 1A and 1B adrenoceptor promoters contain putative cAMP response element (CRE) sequences, we therefore examined if CRE-binding protein (CREB) actively engages these sequences in order to increase receptor gene transcription following TBI. Our results show that the phosphorylation of CREB is enhanced in the mPFC at time points during which increased alpha 1A mRNA expression was observed. Chromatin immuno-precipitation (ChIP) assays using mPFC tissue from injured animals indicated increased phospho-CREB binding to the CRE sites of alpha 1A, but not alpha 1B, promoter compared to that observed in uninjured controls. To address the translatability of our findings, we tested the efficacy of the FDA-approved alpha 1 antagonist Prazosin and observed that this drug improves WM in injured animals. Taken together, these studies suggest that enhanced CREB-mediated expression of alpha 1 adrenoceptor contributes to TBI-associated WM dysfunction, and therapies aimed at reducing alpha 1 signaling may be useful in the treatment of TBI-associated WM deficits in humans. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.	[Kobori, N.; Hu, B.; Dash, P. K.] Univ Texas Med Sch Houston, Vivian L Smith Dept Neurosurg, Dept Neurobiol & Anat, Houston, TX 77225 USA		Kobori, N (corresponding author), Univ Texas Med Sch Houston, Vivian L Smith Dept Neurosurg, Dept Neurobiol & Anat, POB 20708, Houston, TX 77225 USA.	Nobuhide.Kobori@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS052313, NS49160, MH072933]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH072933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049160, R01NS052313] Funding Source: NIH RePORTER	The authors would like to thank Anthony Moore and John Redell for critical review of the manuscript. This work was supported by grants [NS052313, NS49160, MH072933] from National Institutes of Health.	Arnsten AFT, 2000, NEURAL PLAST, V7, P133, DOI 10.1155/NP.2000.133; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; ARNSTEN AFT, 1985, SCIENCE, V230, P1273, DOI 10.1126/science.2999977; Autelitano DJ, 1998, J MOL CELL CARDIOL, V30, P1515, DOI 10.1006/jmcc.1998.0717; Bergles DE, 1996, J NEUROSCI, V16, P572; Birnbaum S, 1999, BIOL PSYCHIAT, V46, P1266, DOI 10.1016/S0006-3223(99)00138-9; Birnbaum SG, 2000, PHARMACOL BIOCHEM BE, V67, P397, DOI 10.1016/S0091-3057(00)00306-3; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Franowicz JS, 1999, NEUROPSYCHOPHARMACOL, V21, P611, DOI 10.1016/S0893-133X(99)00060-3; Gao B, 1997, MOL PHARMACOL, V52, P1019, DOI 10.1124/mol.52.6.1019; GAO B, 1993, GENE, V131, P243, DOI 10.1016/0378-1119(93)90300-R; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Kawaguchi Y, 1998, J NEUROSCI, V18, P6963; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kobayashi M, 2009, SYNAPSE, V63, P269, DOI 10.1002/syn.20604; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kobori N, 2004, J BIOL CHEM, V279, P2182, DOI 10.1074/jbc.M310734200; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Lee K, 1998, DNA SEQUENCE, V8, P271, DOI 10.3109/10425179809008464; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Liang M, 1998, MOL PHARMACOL, V54, P44, DOI 10.1124/mol.54.1.44; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marti D, 2005, AM J PHYSIOL-HEART C, V289, pH1923, DOI 10.1152/ajpheart.00288.2005; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Michelotti GA, 2003, J BIOL CHEM, V278, P8693, DOI 10.1074/jbc.M211986200; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moghaddam B, 2008, NEUROPSYCHOPHARMACOL, V33, P42, DOI 10.1038/sj.npp.1301554; MOHELL N, 1983, EUR J PHARMACOL, V92, P15, DOI 10.1016/0014-2999(83)90103-6; O'Connell TD, 2001, MOL PHARMACOL, V59, P1225, DOI 10.1124/mol.59.5.1225; Rama P, 1996, PHARMACOL BIOCHEM BE, V55, P415, DOI 10.1016/S0091-3057(96)00111-6; Raskind MA, 2003, AM J PSYCHIAT, V160, P371, DOI 10.1176/appi.ajp.160.2.371; Razik MA, 1997, J BIOL CHEM, V272, P28237, DOI 10.1074/jbc.272.45.28237; Rokosh DG, 1996, J BIOL CHEM, V271, P5839, DOI 10.1074/jbc.271.10.5839; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Stibick DL, 2001, J NEUROTRAUM, V18, P303, DOI 10.1089/08977150151070955; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Yuan WX, 2009, NEUROSCIENCE, V158, P1616, DOI 10.1016/j.neuroscience.2008.11.022	44	28	28	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	JAN 13	2011	172						293	302		10.1016/j.neuroscience.2010.10.048			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705RC	WOS:000286154600029	20974230	Green Accepted			2022-02-06	
J	Chen, ZY; Lu, XCM; Shear, DA; Dave, JR; Davis, AR; Evangelista, CA; Duffy, D; Tortella, FC				Chen, Zhiyong; Lu, X. -C. May; Shear, Deborah A.; Dave, Jitendra R.; Davis, Angela R.; Evangelista, Clifford A.; Duffy, Danelle; Tortella, Frank C.			Synergism of human amnion-derived multipotent progenitor (AMP) cells and a collagen scaffold in promoting brain wound recovery: Pre-clinical studies in an experimental model of penetrating ballistic-like brain injury	BRAIN RESEARCH			English	Article						Human amnion; Progenitor cells; Traumatic brain injury; Penetrating ballistic-like brain injury; Axon degeneration; Collagen scaffold	TRAUMATIC BRAIN; RAT MODEL; NEURAL DIFFERENTIATION; TRANSPLANTATION; IMPLANTATION; DOPAMINE; SURVIVE; DISEASE; GROWTH	One of the histopathological consequences of a penetrating ballistic brain injury is the formation of a permanent cavity. In a previous study using the penetrating ballistic-like brain injury (PBBI) model, engrafted human amnion-derived multipotent progenitor (AMP) cells failed to survive when injected directly in the injury tract, suggesting that the cell survival requires a supportive matrix. In this study, we seated AMP cells in a collagen-based scaffold, injected into the injury core, and investigated cell survival and neuroprotection following PBBI. AMP cells suspended in AMP cell conditioned medium (ACCS) or in a liquefied collagen matrix were injected immediately after a PBBI along the penetrating injury tract. Injured control rats received only liquefied collagen matrix. All animals were allowed to survive two weeks. Consistent with our previous results, AMP cells suspended in ACCS failed to survive; likewise, no collagen was identified at the injury site when injected alone. In contrast, both AMP cells and the collagen were preserved in the injury cavity when injected together. In addition, AMP cells/collagen treatment preserved some apparent brain tissue in the injury cavity, and there was measurable infiltration of endogenous neural progenitor cells and astrocytes into the preserved brain tissue. AMP cells were also found to, have migrated into the subventricular zone and the corpus callosum. Moreover, the AMP cell/collagen treatment significantly attenuated the PBBI-induced axonal degeneration in the corpus callosum and ipsilateral thalamus and improved motor impairment on rotarod performance. Overall, collagen-based scaffold provided a supportive matrix for AMP cell survival, migration, and neuroprotection. Published by Elsevier B.V.	[Chen, Zhiyong; Lu, X. -C. May; Shear, Deborah A.; Dave, Jitendra R.; Davis, Angela R.; Evangelista, Clifford A.; Tortella, Frank C.] Walter Reed Army Inst Res, Dept Appl Neurobiol, Div Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Duffy, Danelle] Stemnion Inc, Pittsburgh, PA USA		Chen, ZY (corresponding author), Walter Reed Army Inst Res, Dept Appl Neurobiol, Div Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Zhiyong.chen@amedd.army.mil	Shear, Deborah/B-3607-2011; Dave, Jitendra R/A-8940-2011		DODUnited States Department of Defense [W81XWH-08-2-0127]	Funding for this project was provided by DOD CDMRP Grant W81XWH-08-2-0127. The material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting true views of the Department of the Army or Department of Defense. The authors have no conflict of interest.	Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Banas RA, 2008, HUM IMMUNOL, V69, P321, DOI 10.1016/j.humimm.2008.04.007; Bantubungi K, 2008, MOL CELL NEUROSCI, V37, P454, DOI 10.1016/j.mcn.2007.11.001; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Chen ZY, 2009, J NEUROTRAUM, V26, P1987, DOI 10.1089/neu.2008.0863; DeFina P, 2009, CLIN NEUROPSYCHOL, V23, P1391, DOI 10.1080/13854040903058978; DUNNETT SB, 1994, J NEUROL, V242, pS43, DOI 10.1007/BF00939242; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Fulop ZL, 1997, INT J NEUROSCI, V90, P203, DOI 10.3109/00207459709000639; Hermanns S, 2001, RESTOR NEUROL NEUROS, V19, P139; HOOVLER DW, 1991, ACTA NEUROPATHOL, V81, P303, DOI 10.1007/BF00305872; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Kakishita K, 2000, EXP NEUROL, V165, P27, DOI 10.1006/exnr.2000.7449; Kakishita K, 2003, BRAIN RES, V980, P48, DOI 10.1016/S0006-8993(03)02875-0; Kong XY, 2008, BRAIN RES, V1205, P108, DOI 10.1016/j.brainres.2008.02.040; Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1; Lin HJ, 2004, DEV BRAIN RES, V153, P163, DOI 10.1016/j.devbrainres.2004.08.010; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood U, 2004, RADIOLOGY, V233, P625, DOI 10.1148/radiol.2333041190; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Meng XT, 2007, CELL BIOL INT, V31, P691, DOI 10.1016/j.cellbi.2006.11.038; Niknejad H, 2010, EUR CELLS MATER, V19, P22, DOI 10.22203/eCM.v019a03; O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shinya M, 2010, FETAL PEDIATR PATHOL, V29, P133, DOI 10.3109/15513811003777292; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Steed David L, 2008, Eplasty, V8, pe18; STEIN DG, 1988, BEHAV NEUROSCI, V102, P260, DOI 10.1037/0735-7044.102.2.260; VANDERWOLF CH, 1990, EXP BRAIN RES, V81, P426; Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17	36	28	28	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 12	2011	1368						71	81		10.1016/j.brainres.2010.10.028			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	714ZJ	WOS:000286849900009	20951684				2022-02-06	
J	Gatson, JW; Simpkins, JW; Yi, KD; Idris, AH; Minei, JP; Wigginton, JG				Gatson, J. W.; Simpkins, J. W.; Yi, K. D.; Idris, A. H.; Minei, J. P.; Wigginton, J. G.			Aromatase Is Increased in Astrocytes in the Presence of Elevated Pressure	ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBROSPINAL-FLUID; IN-VITRO; NEUROBLASTOMA-CELLS; EXPERIMENTAL STROKE; ESTRADIOL TREATMENT; GENDER-DIFFERENCES; MESSENGER-RNA; ANIMAL-MODELS	After traumatic brain injury (TBI), a progressive injury and death of neurons and glia leads to decreased brain function. Endogenous and exogenous estrogens may protect these vulnerable cells. In this study, we hypothesized that increased pressure leads to an increase in aromatase expression and estrogen production in astrocytes. In this study, we subjected rat glioma (C6) cells and primary cortical astrocytes to increased pressure (25 mm Hg) for 1, 3, 6, 12, 24, 48, and 72 h. Total aromatase protein and RNA levels were measured using Western analysis and RT-PCR, respectively. In addition, we measured aromatase activity by assaying estrone levels after administration of its precursor, androstenedione. We found that increased pressure applied to the C6 cells and primary cortical astrocytes resulted in a significant increase in both aromatase RNA and protein. To extend these findings, we also analyzed aromatase activity in the primary astrocytes during increased pressure. We found that increased pressure resulted in a significant (P < 0.01) increase in the conversion of androstenedione to estrone. In conclusion, we propose that after TBI, astrocytes sense increased pressure, leading to an increase in aromatase production and activity in the brain. These results may suggest mechanisms of brain estrogen production after increases in pressure as seen in TBI patients. (Endocrinology 152: 207-213, 2011)	[Gatson, J. W.; Idris, A. H.; Minei, J. P.; Wigginton, J. G.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Simpkins, J. W.; Yi, K. D.] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Gatson, J. W.; Idris, A. H.; Wigginton, J. G.] Dallas Ft Worth Ctr Resuscitat Res, Dallas, TX 75390 USA		Gatson, JW (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joshua.gatson@utsw.edu		Wigginton, Jane/0000-0002-8561-3492	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH 5 T32 GM08593-14, NIH 5 P50 GM21681-44]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM021681, T32GM008593] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health (NIH) T32 Training Grant (NIH 5 T32 GM08593-14) and NIH P50 Burn Center Grant (NIH 5 P50 GM21681-44).	Ali MA, 2009, INT J ONCOL, V34, P1051, DOI 10.3892/ijo_00000231; [Anonymous], 2000, COCHRANE DATABASE SY, DOI DOI 10.1002/14651858.CD000033; Azcoitia I, 2003, ANN NY ACAD SCI, V1007, P298, DOI 10.1196/annals.1286.028; Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535; BISHOP J, 1994, MOL CELL NEUROSCI, V5, P303, DOI 10.1006/mcne.1994.1036; Brown CM, 2009, SEMIN REPROD MED, V27, P240, DOI 10.1055/s-0029-1216277; Carswell HVO, 2005, J STEROID BIOCHEM, V96, P89, DOI 10.1016/j.jsbmb.2005.02.016; Chen G, 2007, GLIA, V55, P1509, DOI 10.1002/glia.20563; COLD G, 1975, ACTA NEUROL SCAND, V52, P187, DOI 10.1111/j.1600-0404.1975.tb05773.x; Darwish RS, 2010, NEUROCRIT CARE, V12, P337, DOI 10.1007/s12028-009-9328-3; ENEVOLDSEN EM, 1977, CLIN NEUROL NEUROSUR, V80, P213; Freking F, 1998, J NEUROBIOL, V36, P30, DOI 10.1002/(SICI)1097-4695(199807)36:1<30::AID-NEU3>3.0.CO;2-B; FUJISHIMA M, 1975, STROKE, V6, P707, DOI 10.1161/01.STR.6.6.707; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Green PS, 1996, NEUROSCI LETT, V218, P165, DOI 10.1016/S0304-3940(96)13148-7; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Knoferl MW, 2000, ARCH SURG-CHICAGO, V135, P425, DOI 10.1001/archsurg.135.4.425; Kondo Y, 1997, NEUROSCI LETT, V238, P45, DOI 10.1016/S0304-3940(97)00847-1; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; MICHAEL MD, 1995, J BIOL CHEM, V270, P13561, DOI 10.1074/jbc.270.22.13561; NAFTOLIN F, 1971, J ENDOCRINOL, V51, P795, DOI 10.1677/joe.0.0510795; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; O'Phelan KH, 2009, NEUROCRIT CARE, V10, P280, DOI 10.1007/s12028-008-9183-7; Pastor-Soler N, 2003, J BIOL CHEM, V278, P49523, DOI 10.1074/jbc.M309543200; Peterson RS, 2001, J NEUROENDOCRINOL, V13, P317, DOI 10.1046/j.1365-2826.2001.00647.x; Roberts EL, 2000, BRAIN RES, V875, P171, DOI 10.1016/S0006-8993(00)02587-7; Roof RL, 1999, PHYSIOL BEHAV, V68, P81, DOI 10.1016/S0031-9384(99)00162-6; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Satoh K, 2008, BIOL PHARM BULL, V31, P357, DOI 10.1248/bpb.31.357; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Simpson ER, 2000, J MOL ENDOCRINOL, V25, P149, DOI 10.1677/jme.0.0250149; Singer CA, 1996, NEUROSCI LETT, V212, P13, DOI 10.1016/0304-3940(96)12760-9; Sudo S, 1997, NEUROSCI RES, V29, P345, DOI 10.1016/S0168-0102(97)00106-5; Suzuki S, 2007, J COMP NEUROL, V500, P1064, DOI 10.1002/cne.21240; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7; Zwain IH, 1997, BBA-GEN SUBJECTS, V1334, P338, DOI 10.1016/S0304-4165(96)00115-8	50	28	29	0	4	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	JAN	2011	152	1					207	213		10.1210/en.2010-0724			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	698DT	WOS:000285573000021	21047944	Green Published, Bronze			2022-02-06	
J	Jones, A; Ingram, MV				Jones, Alvin; Ingram, M. Victoria			A Comparison of Selected MMPI-2 and MMPI-2-RF Validity Scales in Assessing Effort on Cognitive Tests in a Military Sample	CLINICAL NEUROPSYCHOLOGIST			English	Article						MMPI-2; Optimal Data analysis; MMPI-2-RF; Symptom validity tests	FAKE-BAD-SCALE; HENRY-HEILBRONNER INDEX; TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TESTS; FORENSIC SETTINGS; LEES-HALEY; METAANALYSIS; VALIDATION; DISABILITY; DISORDERS	Using a relatively new statistical paradigm, Optimal Data Analysis (ODA; Yarnold & Soltysik, 2005), this research demonstrated that newly developed scales for the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) and MMPI-2 Restructured Form (MMPI-2-RF) specifically designed to assess over-reporting of cognitive and/or somatic symptoms were more effective than the MMPI-2 F-family of scales in predicting effort status on tests of cognitive functioning in a sample of 288 military members. ODA demonstrated that when all scales were performing at their theoretical maximum possible level of classification accuracy, the Henry Heilbronner Index (HHI), Response Bias Scale (RBS), Fake Bad Scale (FBS), and the Symptom Validity Scale (FBS-r) outperformed the F-family of scales on a variety of ODA indexes of classification accuracy, including an omnibus measure (effect strength total, EST) of the descriptive and prognostic utility of ODA models developed for each scale. Based on the guidelines suggested by Yarnold and Soltysik for evaluating effect strengths for ODA models, the newly developed scales had effects sizes that were moderate in size (37.66 to 45.68), whereas the F-family scales had effects strengths that ranged from weak to moderate (15.42 to 32.80). In addition, traditional analysis demonstrated that HHI, RBS, FBS, and FBS-R had large effect sizes (0.98 to 1.16) based on Cohen's (1988) suggested categorization of effect size when comparing mean scores for adequate versus inadequate effort groups, whereas F-family of scales had small to medium effect sizes (0.25 to 0.76). The MMPI-2-RF Infrequent Somatic Responses Scale (F-S) tended to perform in a fashion similar to F, the best performing F-family scale.	[Ingram, M. Victoria] Womack Army Med Ctr, Dept Behav Hlth, Ft Bragg, NC 28310 USA; [Jones, Alvin] Landstuhl Reg Med Ctr, Dept Behav Hlth, Landstuhl, Germany		Ingram, MV (corresponding author), Womack Army Med Ctr, Dept Behav Hlth, 2817 Riley Rd,Bldg 4-2817, Ft Bragg, NC 28310 USA.	victoria.ingram@amedd.army.mil					Arbisi P. A., 1995, PSYCHOL ASSESSMENT, V7, P425; Arbisi PA, 2004, ARCH CLIN NEUROPSYCH, V19, P341, DOI 10.1016/j.acn.2003.12.003; Bagby RM, 2000, ASSESSMENT, V7, P55, DOI 10.1177/107319110000700104; Ben-Porath, 2008, MINNESOTA MULTIPHASI; Cohen J., 2013, STAT POWER ANAL BEHA; GERVAIS R, 2005, ANN MMPI 2 S WORKSH; Gervais R. O., 2008, CLIN NEUROPSYCHOL, V3, P1; Gervais R. O., J PERSONALI IN PRESS; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; GREEN P, 1997, MEMORY COMPLAINTS IN; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P919, DOI 10.1080/13854040701625853; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kaemmer, 1989, MINNESOTA MULTIPHASI; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lees-Haley PR, 2002, J FORENSIC NEUROPSYC, V3, P167, DOI DOI 10.1300/J151V03N01_01; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nelson NW, 2007, J CLIN EXP NEUROPSYC, V29, P67, DOI 10.1080/13803390500488546; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Nelson NW, 2006, CLIN NEUROPSYCHOL, V20, P39, DOI 10.1080/13854040500459322; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ostrander R, 1998, J CONSULT CLIN PSYCH, V66, P660, DOI 10.1037/0022-006X.66.4.660; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Smart CM, 2008, J INT NEUROPSYCH SOC, V14, P842, DOI 10.1017/S1355617708081034; Stump N., 2007, NEUROLOGY TODAY, V7, P15; Tellegen, 2008, MINNESOTA MULTIPHASI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Whitney K. A., 2008, ARCH CLIN NEUROPSYCH, V2, P8; Wygant DB, 2011, PSYCHOL INJ LAW, V4, P13, DOI 10.1007/s12207-011-9098-z; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073; Yarnold PR, 2005, OPTIMAL DATA ANAL GU; Youngjohn, 1995, ASSESSMENT, V2, DOI [https://doi.org/10.1177/1073191195002003007, DOI 10.1177/1073191195002003007]; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]	38	28	29	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	7					1207	1227		10.1080/13854046.2011.600726			21	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882JJ	WOS:000299559600008	21902565				2022-02-06	
J	Lu, XCM; Hartings, JA; Si, YZ; Balbir, A; Cao, Y; Tortella, FC				Lu, Xi-Chun May; Hartings, Jed A.; Si, Yuanzheng; Balbir, Alexander; Cao, Ying; Tortella, Frank C.			Electrocortical Pathology in a Rat Model of Penetrating Ballistic-Like Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; penetrating ballistic-like brain injury; rat	LATERALIZED EPILEPTIFORM DISCHARGES; NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN; CONTINUOUS EEG; ELECTROGRAPHIC SEIZURES; POSTTRAUMATIC EPILEPSY; QUANTITATIVE ELECTROENCEPHALOGRAPHY; INTRACEREBRAL HEMORRHAGE; CLINICAL-FEATURES; SPECTRAL-ANALYSIS	Traumatic brain injury (TBI) causes severe disruption of cerebral electrical activity and electroencephalography (EEG) is emerging as a standard tool to monitor TBI patients in the acute period of risk for secondary injuries. However, animal studies of EEG pathology in the context of TBI are surprisingly sparse, largely because of the lack of real-time continuous EEG (cEEG) monitoring in animal TBI models. Here, we performed long-term EEG monitoring to study nonconvulsive seizures (NCS), periodic epileptiform discharges (FED), and EEG power spectra following three injury severity levels in a rat model of penetrating ballistic-like brain injury (PBBI). EEG signals were recorded continuously from bilateral hemispheres of freely behaving rats for 72 h and for 2 h on days 7 and 14 after the injury. We report that the incidence of NCS and FED positively correlated with the injury severity, where 13%, 39%, and 59% of the animals exhibited NCS, and 0%, 30%, and 65% of the animals exhibited PED following 5%, 10% and 12.5% PBBI, respectively. Similar correlations existed for the number of NCS and FED events and their duration. NCS and FED occurred either independently or in tandem. Longer NCS durations were associated with larger lesion volumes. Significant EEG slowing evidenced by the EEG power shift toward the frequency band (0.5-4 Hz) occurred within 2 h after PBBI, which resolved over time but persisted longer after greater injury severity. In contrast, decreases in higher frequency power (i.e., 30-35 Hz) remained depressed throughout 14 days. This is the first long-term cEEG study of the acute injury phase in a rat model of severe TBI, demonstrating common occurrences of clinically observed electrocortical pathology, such as NCS, FED, and cortical slowing. These EEG pathologies may serve as critical care biomarkers of brain injury, and offer clinically relevant metrics for studying acute therapeutic interventions.	[Lu, Xi-Chun May; Hartings, Jed A.; Si, Yuanzheng; Balbir, Alexander; Cao, Ying; Tortella, Frank C.] Walter Reed Army Inst Res, Div Psychiat & Neurosci, Dept Appl Neurobiol, Silver Spring, MD 20910 USA		Lu, XCM (corresponding author), Walter Reed Army Inst Res, Div Psychiat & Neurosci, Dept Appl Neurobiol, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	may.lu@us.army.mil		Hartings, Jed/0000-0001-8583-3471			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Alster Jason, 1993, Brain Injury, V7, P191, DOI 10.3109/02699059309029672; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Baayen JC, 2003, BRAIN TOPOGR, V16, P85, DOI 10.1023/B:BRAT.0000006332.71345.b7; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Baykan B, 2000, SEIZURE-EUR J EPILEP, V9, P402, DOI 10.1053/seiz.2000.0435; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; CHATRIAN GE, 1964, ELECTROEN CLIN NEURO, V17, P177, DOI 10.1016/0013-4694(64)90149-X; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; COBB W, 1950, BRAIN, V73, P392, DOI 10.1093/brain/73.3.392; de Jongh A, 2003, NEUROIMAGE, V20, P2291, DOI 10.1016/j.neuroimage.2003.07.030; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; DECKER DA, 1972, ELECTROEN CLIN NEURO, V33, P303, DOI 10.1016/0013-4694(72)90157-5; DELAPAZ D, 1981, ARCH NEUROL-CHICAGO, V38, P713, DOI 10.1001/archneur.1981.00510110073012; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Fabene PF, 2008, NAT MED, V14, P1377, DOI 10.1038/nm.1878; Fishman O, 2010, CLIN EEG NEUROSCI, V41, P11, DOI 10.1177/155005941004100104; Fitzpatrick W, 2007, CAN J NEUROL SCI, V34, P443, DOI 10.1017/S0317167100007332; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Garcia-Morales I, 2002, J CLIN NEUROPHYSIOL, V19, P172, DOI 10.1097/00004691-200203000-00009; Garzon E, 2001, NEUROLOGY, V57, P1175, DOI 10.1212/WNL.57.7.1175; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hirsch Lawrence J, 2008, Epilepsy Curr, V8, P97, DOI 10.1111/j.1535-7511.2008.00254.x; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Husain AM, 1999, J CLIN NEUROPHYSIOL, V16, P51, DOI 10.1097/00004691-199901000-00005; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P332, DOI 10.1097/00004691-199907000-00005; JORDAN KG, 1995, NEUROL CLIN, V13, pR9, DOI 10.1016/S0733-8619(18)30029-X; KARNAZE DS, 1982, NEUROLOGY, V32, P289, DOI 10.1212/WNL.32.3.289; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; KUROIWA Y, 1980, ARCH NEUROL-CHICAGO, V37, P15, DOI 10.1001/archneur.1980.00500500045005; Lawn ND, 2000, CLIN NEUROPHYSIOL, V111, P2125, DOI 10.1016/S1388-2457(00)00466-1; Lowenstein D H, 1996, Epilepsy Res Suppl, V11, P45; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; MARKAND ON, 1971, NEUROLOGY, V21, P975, DOI 10.1212/WNL.21.10.975; MEYER K, 2008, J TRAUMA NURS, V15, P190; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; MOULTON RJ, 1988, CAN J NEUROL SCI, V15, P82, DOI 10.1017/S0317167100027244; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Olson S, 2004, J CLIN NEUROSCI, V11, P1, DOI 10.1016/j.jocn.2003.03.002; Orta DS, 2009, ARCH NEUROL-CHICAGO, V66, P985, DOI 10.1001/archneurol.2009.137; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; Paul Danie B, 2006, J Clin Monit Comput, V20, P399, DOI 10.1007/s10877-006-9045-9; Privitera Michael D., 1994, Emergency Medicine Clinics of North America, V12, P1089; RAROQUE HG, 1995, EPILEPSIA, V36, P58, DOI 10.1111/j.1528-1157.1995.tb01666.x; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SALAZAR AM, 1995, NEUROSURG CLIN N AM, V6, P715; SCHEAR HE, 1984, CLIN ELECTROENCEPHAL, V15, P32, DOI 10.1177/155005948401500105; SCHRAEDER PL, 1980, EPILEPSIA, V21, P647, DOI 10.1111/j.1528-1157.1980.tb04318.x; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; SHEAR DA, 2010, NAT NEUR S; Statler KD, 2009, EPILEPSY RES, V86, P221, DOI 10.1016/j.eplepsyres.2009.05.006; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Verma A, 2006, J CLIN NEUROPHYSIOL, V23, P333, DOI 10.1097/01.wnp.0000228497.89734.7a; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Vieth JB, 1996, BRAIN TOPOGR, V8, P215, DOI 10.1007/BF01184772; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Williams AJ, 2001, J PHARMACOL EXP THER, V299, P48; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2008, NEUROSCI LETT, V430, P7, DOI 10.1016/j.neulet.2007.09.052; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Yemisci M, 2003, SEIZURE-EUR J EPILEP, V12, P465, DOI 10.1016/S1059-1311(02)00351-5; Young GB, 1998, ARCH NEUROL-CHICAGO, V55, P117, DOI 10.1001/archneur.55.1.117	86	28	28	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2011	28	1					71	83		10.1089/neu.2010.1471			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	710DT	WOS:000286491800007	20964535				2022-02-06	
J	Morin, A				Morin, Alain			Self-recognition, theory-of-mind, and self-awareness: What side are you on?	LATERALITY			English	Article						Self-awareness; Self-recognition; Theory-of-mind; Right hemisphere; Inner speech	CORTICAL MIDLINE STRUCTURES; TRAUMATIC BRAIN-INJURY; LEFT-HAND ADVANTAGE; INNER SPEECH; SOCIAL COGNITION; PREFRONTAL CORTEX; FACE RECOGNITION; RIGHT-HEMISPHERE; DEFAULT MODE; CONSCIOUSNESS	A fashionable view in comparative psychology states that primates possess self-awareness because they exhibit mirror self-recognition (MSR), which in turn makes it possible to infer mental states in others (otheory-of-mindo; ToM). In cognitive neuroscience, an increasingly popular position holds that the right hemisphere represents the centre of self-awareness because MSR and ToM tasks presumably increase activity in that hemisphere. These two claims are critically assessed here as follows: (1) MSR should not be equated with full-blown self-awareness, as it most probably only requires kinaesthetic self-knowledge and does not involve access to one's mental events; (2) ToM and self-awareness are fairly independent and should also not be taken as equivalent notions; (3) MSR and ToM tasks engage medial and left brain areas; (4) other self-awareness tasks besides MSR and ToM tasks (e.g., self-description, autobiography) mostly recruit medial and left brain areas; (5) and recent neuropsychological evidence implies that inner speech (produced by the left hemisphere) plays a significant role in self-referential activity. The main conclusions reached based on this analysis are that (a) organisms that display MSR most probably do not possess introspective self-awareness, and (b) self-related processes most likely engage a distributed network of brain regions situated in both hemispheres.	Mt Royal Univ, Dept Psychol, Calgary, AB T3E 6K6, Canada		Morin, A (corresponding author), Mt Royal Univ, Dept Psychol, 4825 Mt Royal Gate SW, Calgary, AB T3E 6K6, Canada.	amorin@mtroyal.ca					Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Bard KA, 2006, INFANCY, V9, P191, DOI 10.1207/s15327078in0902_6; Barnacz AL, 2004, SCHIZOPHR RES, V70, P115, DOI 10.1016/j.schres.2003.12.006; Baron-Cohen S, 2001, PRISME, V34, P74; Birch SAJ, 2004, TRENDS COGN SCI, V8, P255, DOI 10.1016/j.tics.2004.04.011; BIRINGER F, 1992, J GERONTOL, V47, pP385, DOI 10.1093/geronj/47.6.P385; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Calarge C, 2003, AM J PSYCHIAT, V160, P1954, DOI 10.1176/appi.ajp.160.11.1954; CAMERON PA, 1988, INFANT BEHAV DEV, V11, P465, DOI 10.1016/0163-6383(88)90006-9; Carpendale JIM, 2004, BEHAV BRAIN SCI, V27, P79; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Cocchini G, 2009, NEUROPSYCHOLOGY, V23, P223, DOI 10.1037/a0014266; Cunningham C., 2004, INT J DISABIL DEV ED, V51, P335, DOI [10.1080/1034912042000295017., DOI 10.1080/1034912042000295017, 10.1080/1034912042000295017]; D'Argembeau A, 2008, SOC COGN AFFECT NEUR, V3, P244, DOI 10.1093/scan/nsn020; DAWSON G, 1984, J AUTISM DEV DISORD, V14, P383, DOI 10.1007/BF02409829; de Veer MW, 1999, ANIM BEHAV, V58, P459, DOI 10.1006/anbe.1999.1166; Dimaggio G, 2008, CONSCIOUS COGN, V17, P778, DOI 10.1016/j.concog.2008.02.005; Dimaggio G, 2009, CONSCIOUS COGN, V18, P653, DOI 10.1016/j.concog.2009.06.003; Duval TS., 1972, THEORY OBJECTIVE SEL; EPSTEIN R, 1981, SCIENCE, V212, P695, DOI 10.1126/science.212.4495.695; Feinberg TE, 2005, CONSCIOUS COGN, V14, P661, DOI 10.1016/j.concog.2005.01.002; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; FENIGSTEIN A, 1986, J PERS, V55, P543; Fink GR, 1996, J NEUROSCI, V16, P4275; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallup G.G. Jr., 1975, P309; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; GALLUP GG, 1985, NEUROSCI BIOBEHAV R, V9, P631, DOI 10.1016/0149-7634(85)90010-7; Gallup GG, 2002, COGNITIVE ANIMAL, P325; GALLUP GG, 1979, AM SCI, V67, P417; Gallup GG, 1997, ANN NY ACAD SCI, V818, P73, DOI 10.1111/j.1749-6632.1997.tb48247.x; GALLUP GG, 1977, AM PSYCHOL, V32, P329, DOI 10.1037/0003-066X.32.5.329; GALLUP GG, 1968, PSYCHOL BULL, V70, P782, DOI 10.1037/h0026777; GALLUP GG, 1998, SCI AM           NOV; Garfield JL, 2001, MIND LANG, V16, P494, DOI 10.1111/1468-0017.00180; Gillihan SJ, 2005, PSYCHOL BULL, V131, P76, DOI 10.1037/0033-2909.131.1.76; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Guise K, 2007, HUM NATURE-INT BIOS, V18, P132, DOI 10.1007/s12110-007-9009-x; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gutchess AH, 2007, SOC NEUROSCI-UK, V2, P117, DOI 10.1080/17470910701399029; Heyes CM, 1998, BEHAV BRAIN SCI, V21, P101, DOI 10.1017/S0140525X98000703; Joireman J, 2004, SELF IDENTITY, V3, P225, DOI 10.1080/13576500444000038; Joireman JA, 2002, SELF IDENTITY, V1, P53, DOI 10.1080/152988602317232803; Kaplan JT, 2008, SOC COGN AFFECT NEUR, V3, P218, DOI 10.1093/scan/nsn014; Keenan J.P., 2003, FACE MIRROR SEARCH O; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2005, CORTEX, V41, P695, DOI 10.1016/S0010-9452(08)70286-7; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Keenan JP, 2001, BRAIN COGNITION, V47, P87; Keenan JP, 2007, CORTEX, V43, P1074, DOI 10.1016/S0010-9452(08)70705-6; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kircher T., 2003, SELF NEUROSCIENCE PS; Klein SB, 2008, SOC COGNITION, V26, P766, DOI 10.1521/soco.2008.26.6.766; Langdon R, 2009, PSYCHOL MED, V39, P655, DOI 10.1017/S0033291708003978; Leary M.R., 2004, CURSE SELF SELF AWAR; Lee J, 2007, SCHIZOPHR RES, V94, P215, DOI 10.1016/j.schres.2007.03.032; McGuire PK, 1996, PSYCHOL MED, V26, P29, DOI 10.1017/S0033291700033699; Mead GeorgeHerbert., 1934, MIND SELF SOC; Milligan K, 2007, CHILD DEV, V78, P622, DOI 10.1111/j.1467-8624.2007.01018.x; MITCHELL RW, 1993, NEW IDEAS PSYCHOL, V11, P295, DOI 10.1016/0732-118X(93)90002-U; Mitchell RW, 1997, J THEOR SOC BEHAV, V27, P17, DOI 10.1111/1468-5914.00024; Mitchell RW, 2002, COGNITIVE ANIMAL, P345; Mitchell RW, 1997, ANN NY ACAD SCI, V818, P39, DOI 10.1111/j.1749-6632.1997.tb48245.x; MITCHELL RW, 2002, HDB SELF IDENTITY, P3; Morin A, 2005, J CONSCIOUSNESS STUD, V12, P115; Morin A, 2004, GENET SOC GEN PSYCH, V130, P197, DOI 10.3200/MONO.130.3.197-224; Morin A, 2002, CONSCIOUS COGN, V11, P396, DOI 10.1016/S1053-8100(02)00009-0; MORIN A, 1990, NEW IDEAS PSYCHOL, V8, P337, DOI 10.1016/0732-118X(94)90020-5; MORIN A, 1993, J MIND BEHAV, V14, P223; Morin A., 1993, REV QUEBECOISE PSYCH, V14, P3; Morin A., 2003, EVOL PSYCHOL-US, V1, P161, DOI [DOI 10.1177/147470490300100113, 10.1177/147470490300100113]; Morin A, 2007, BRAIN RES BULL, V74, P387, DOI 10.1016/j.brainresbull.2007.06.013; Morin A, 2007, CORTEX, V43, P1068, DOI 10.1016/S0010-9452(08)70704-4; Morin A, 2006, CONSCIOUS COGN, V15, P358, DOI 10.1016/j.concog.2005.09.006; Morin A, 2009, CONSCIOUS COGN, V18, P524, DOI 10.1016/j.concog.2008.09.008; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; OJEMANN G, 1986, CAN PSYCHOL, V27, P158; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196; Platek SM, 2003, SCHIZOPHR RES, V65, P147, DOI 10.1016/S0920-9964(02)00494-2; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Platek SM, 2004, CONSCIOUS COGN, V13, P197, DOI 10.1016/j.concog.2003.10.001; Platek SM, 2008, BRAIN RES, V1232, P173, DOI 10.1016/j.brainres.2008.07.010; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Povinelli D.J., 1995, SELF EARLY INFANCY, P161, DOI DOI 10.1016/S0166-4115(05)80011-1; Povinelli DJ, 1996, CHILD DEV, V67, P1540, DOI 10.1111/j.1467-8624.1996.tb01813.x; Preilowski B, 1977, Act Nerv Super (Praha), V19 Suppl 2, P343; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prior H, 2008, PLOS BIOL, V6, P1642, DOI 10.1371/journal.pbio.0060202; RAMACHANDRAN VS, 2007, EDGE 3 CULTURE  0108; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; Rosa C, 2008, BRAIN COGNITION, V68, P204, DOI 10.1016/j.bandc.2008.04.007; Rusalova M N, 2005, Neurosci Behav Physiol, V35, P821, DOI 10.1007/s11055-005-0131-0; Salzen EA, 1998, APPL ANIM BEHAV SCI, V57, P299, DOI 10.1016/S0168-1591(98)00104-X; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schilhab TSS, 2004, BIOL PHILOS, V19, P111, DOI 10.1023/B:BIPH.0000013249.23475.1f; Schneider JF, 2005, PSYCHOL REP, V96, P387; Seger CA, 2004, NEUROPSYCHOLOGIA, V42, P1168, DOI 10.1016/j.neuropsychologia.2004.02.003; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; SIEGRIST M, 1995, PSYCHOL REP, V76, P259, DOI 10.2466/pr0.1995.76.1.259; Silani G, 2008, SOC NEUROSCI-UK, V3, P97, DOI 10.1080/17470910701577020; SPERRY RW, 1979, NEUROPSYCHOLOGIA, V17, P153, DOI 10.1016/0028-3932(79)90006-X; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; SUAREZ SD, 1981, J HUM EVOL, V10, P175, DOI 10.1016/S0047-2484(81)80016-4; Sugiura M, 2006, NEUROIMAGE, V32, P1905, DOI 10.1016/j.neuroimage.2006.05.026; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Taylor, 2006, MY STROKE INSIGHT BR; Trapnell PD, 1999, J PERS SOC PSYCHOL, V76, P284, DOI 10.1037/0022-3514.76.2.284; Turk DJ, 2002, NAT NEUROSCI, V5, P841, DOI 10.1038/nn907; Uddin LQ, 2005, CONSCIOUS COGN, V14, P633, DOI 10.1016/j.concog.2005.01.008; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	118	28	29	0	67	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1357-650X	1464-0678		LATERALITY	Laterality		2011	16	3					367	383	PII 929082268	10.1080/13576501003702648			17	Psychology, Multidisciplinary; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	753PL	WOS:000289791900008	21049317	Green Submitted			2022-02-06	
J	Panczykowski, DM; Okonkwo, DO				Panczykowski, David M.; Okonkwo, David O.			Premorbid oral antithrombotic therapy and risk for reaccumulation, reoperation, and mortality in acute subdural hematomas Clinical article	JOURNAL OF NEUROSURGERY			English	Article						acute subdural hematoma; oral antithrombotic therapy; traumatic brain injury; neurological outcome	TRAUMATIC INTRACRANIAL HEMORRHAGE; ANTICOAGULANT-THERAPY; HEAD-INJURY; WARFARIN; OUTCOMES; COAGULOPATHY; ANTIPLATELET; PREDICTION; MANAGEMENT	Object. Acute subdural hematomas (SDHs) impart serious morbidity and mortality on the elderly population, with only 5% of those older than 65 years of age attaining functional independence. Despite its widespread use, oral antithrombotic therapy (OAT) in the context of acute SDH has not been extensively studied. The authors sought to evaluate the impact of premorbid OAT on recurrence of SDH, radiographic outcome, and mortality in patients undergoing surgical evacuation of an acute SDH. Methods. The authors conducted a retrospective comparative cohort study reviewing all surgically treated cases of acute SDH at their institution between September 2005 and December 2008. They assessed baseline demographics, coagulation parameters, surgical management, and clinical course. Study end points included additional craniotomy for SDH reaccumulation, follow-up Rotterdam score, recurrent SDH volumetric analysis, Glasgow Outcome Score, and death. Results. A total of 300 patients with acute SDH treated by craniotomy were assessed. Of these patients, 49% (148 patients) were receiving OAT. Of those who were on a regimen of OAT, 49% were taking warfarin (mean international normalized ratio 3.1 +/- 1.8), 31% were receiving antiplatelet therapy, and 20% were on a regimen of a combination of agents. On presentation, 72% of those using OAT received reversal agents. Recurrence of SDH necessitating additional evacuation was not significantly different with respect to premorbid OAT status (13% vs 14%). Patients with a history of OAT did not demonstrate a significant difference in Rotterdam score (2 vs 2), recurrent SDH volume (24.1 vs 19.6 cm(3)), GOS score (4 vs 3), or mortality (21% vs 24%). These findings remained stable after controlling for age, injury mechanism, and injury severity. Conclusions. Premorbid OAT was not a significant risk factor for recurrence of SDH necessitating additional evacuation following acute SDH. Additionally, postoperative Rotterdam score, volume of SDH reaccumulation, and overall mortality were not predicted by antithrombotic history. While prernorbid use may predispose the patient to an SDH, OAT does not increase the risk of morbidity or mortality following surgical intervention. (DOI: 10.3171/2010.7.JNS10446)	[Panczykowski, David M.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15213 USA		Okonkwo, DO (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Med Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	okonkwodo@upmc.edu					Aiyagari V, 2009, CURR OPIN CRIT CARE, V15, P87, DOI 10.1097/MCC.0b013e3283269e4d; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Larson BJG, 2005, CHEST, V127, P922, DOI 10.1378/chest.127.3.922; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marion DW, 2006, NEUROSURGERY, V58, P655; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Oake N, 2008, CAN MED ASSOC J, V179, P235, DOI 10.1503/cmaj.080171; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Torn M, 2009, ARCH INTERN MED, V169, P1203, DOI 10.1001/archinternmed.2009.176; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	17	28	28	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2011	114	1					47	52		10.3171/2010.7.JNS10446			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	699NG	WOS:000285669500013	20722610				2022-02-06	
J	Prabhu, SP				Prabhu, Sanjay P.			The Role of Neuroimaging in Sport-Related Concussion	CLINICS IN SPORTS MEDICINE			English	Article						Concussion; Neuroimaging; Sport-related	TRAUMATIC BRAIN-INJURY; PROTON MR SPECTROSCOPY; WHITE-MATTER; OUTCOME PREDICTION; MILD; ABNORMALITIES; IMPAIRMENT; PERFUSION; ISCHEMIA; ATLAS	This article describes some of the newer techniques that are being used in the clinical assessment of patients following mild to moderate TBI, addresses their use in the acute setting, and explores their potential role in long-term follow-up. Also addressed are the challenges faced before some of these newer techniques can be incorporated into routine clinical management. Large studies are needed with a special emphasis on the effects of repeated head trauma in the young athlete. This is especially relevant where conventional imaging does not demonstrate a macroscopic abnormality. The emphasis has to shift from identifying structural abnormalities on imaging studies to understanding the functional changes in the brain that may explain the long-term neuropsychological effects of concussion and mTBI.	[Prabhu, Sanjay P.] Childrens Hosp Boston, Dept Radiol, Div Neuroradiol, Boston, MA 02115 USA; [Prabhu, Sanjay P.] Harvard Univ, Sch Med, Boston, MA 02115 USA		Prabhu, SP (corresponding author), Childrens Hosp, Dept Radiol, 300 Longwood Ave, Boston, MA 02115 USA.	sanjay.prabhu@childrens.harvard.edu	PRABHU, SANJAY/A-9947-2013	PRABHU, SANJAY/0000-0003-0871-115X			Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Barnes SRS, 2009, MAGN RESON IMAGING C, V17, P47, DOI 10.1016/j.mric.2008.12.002; Bigler ED, 2001, INVEST RADIOL, V36, P539, DOI 10.1097/00004424-200109000-00006; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Easdon C, 2004, BRAIN COGNITION, V54, P136; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Greer DM, 2009, CRIT CARE MED, V37, P1523, DOI 10.1097/CCM.0b013e31819d2df2; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hofmann M, 2008, J NUCL MED, V49, P1875, DOI 10.2967/jnumed.107.049353; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Kawai N, 2008, ACTA NEUROCHIR SUPPL, V102, P241, DOI 10.1007/978-3-211-85578-2_46; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Mader I, 2008, EUR J RADIOL, V67, P250, DOI 10.1016/j.ejrad.2008.02.033; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Ziegler A, 2002, MAGN RESON MATER PHY, V14, P45, DOI 10.1007/BF02668186; [No title captured]	42	28	28	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2011	30	1					103	+		10.1016/j.csm.2010.09.003			13	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	691XR	WOS:000285114800010	21074085				2022-02-06	
J	Resnik, L; Gray, M; Borgia, M				Resnik, Linda; Gray, Melissa; Borgia, Matthew			Measurement of community reintegration in sample of severely wounded servicemembers	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						community reintegration; disability; measurement; military healthcare; outcomes assessment; participation; psychometric testing; reliability; traumatic brain injury; veterans	TRAUMATIC-BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; VIETNAM VETERANS; DISABILITY; COMBAT; AFGHANISTAN; INTEGRATION; DEPLOYMENT; HANDICAP	The Community Reintegration of Servicemembers (CRIS) is a new measure of community reintegration. The purpose of this study was to test the CRIS with seriously injured combat veterans. Subjects were 68 patients at the Center for the Intrepid. Each patient completed three CRIS subscales, the 3-6Item Short Form Health Survey for Veterans (SF-36V), the Quality of Life Scale (QOLS), and two Craig Handicap Assessment and Reporting Technique subscales at visit 1 and the 3-month follow-up. Of the patients, 11 also completed the measures within 2 weeks of visit 1. We abstracted diagnoses and activities of daily living from the medical record. We evaluated test-retest reliability using intraclass correlation coefficients (ICCs). We evaluated concurrent validity with Pearson product moment correlations. We used multivariate analyses of variance to compare scores for subjects with and without posttraumatic stress disorder (PTSD), traumatic brain injury (TBI), and depression. Responsiveness analyses evaluated floor and ceiling effects, percent achieving minimal detectable change (MDC), effect size (ES), and the standardized response mean (SRM). CRIS subscale ICCs were 0.90 to 0.91. All subscales were moderately or strongly correlated with QOLS and SF-36V subscales. CRIS subscale scores were lower in PTSD and TBI groups (p < 0.05). CRIS Extent of Participation and Satisfaction with Participation subscales were lower for subjects with depression (p < 0.05). Of the sample, 17.4% to 23.2% had change greater than MDC. The ES ranged from 0.227 to 0.273 (SRM = 0.277-0.370), showing a small effect between visit 1 and the 3-month follow-up. Results suggest that the CRIS is a psychometrically sound choice for community reintegration measurement in severely wounded servicemembers.	[Resnik, Linda] Providence Dept Vet Affairs Med Ctr, Providence, RI USA; [Resnik, Linda; Borgia, Matthew] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; [Gray, Melissa] Brooke Army Med Ctr, San Antonio, TX USA		Resnik, L (corresponding author), Providence VA Med Ctr, 830 Chalkstone Ave, Providence, RI 02908 USA.	Linda_Resnik@brown.edu			VA, Veterans Health Administration, Office of Research and Development, Health Services Research and Development [SDR-07-327]	This material was based on work supported by the VA, Veterans Health Administration, Office of Research and Development, Health Services Research and Development (grant SDR-07-327).	Bellack AS, 2007, SCHIZOPHRENIA BULL, V33, P805, DOI 10.1093/schbul/sbl035; *BROOK, 2010, IR IND; BRUSTEIN J, 2006, GOTHAM GAZETTE   MAR, P4; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P60, DOI 10.1186/1477-7525-1-60; Cohen J, 1977, STAT POWER ANAL BEHA; Committee on the Initial Assessment of Readjustment Needs of Military Personnel Veterans and Their Families, 2010, RET HOM IR AFGH PREL; Dekel R, 2004, ISRAEL J PSYCHIAT, V41, P237; Doyle ME, 2005, PSYCHIAT QUART, V76, P361, DOI 10.1007/s11126-005-4972-z; Fischer Hannah, 2009, US MILITARY CASUALTY; Freeman TW, 2001, J NERV MENT DIS, V189, P317, DOI 10.1097/00005053-200105000-00008; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hooper TI, 2006, ACCIDENT ANAL PREV, V38, P518, DOI 10.1016/j.aap.2005.11.009; Jette DU, 1996, PHYS THER, V76, P930, DOI 10.1093/ptj/76.9.930; Johnson DR, 2004, J NERV MENT DIS, V192, P35, DOI 10.1097/01.nmd.0000105998.90425.6a; Kazis LE, 1999, AM J MED QUAL, V14, P28, DOI 10.1177/106286069901400105; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Linden MA, 2005, DISABIL REHABIL, V27, P1353, DOI 10.1080/09638280500164180; Litz B., 2004, IRAQ WAR CLIN GUIDE; Luty SE, 2002, J AFFECT DISORDERS, V70, P143, DOI 10.1016/S0165-0327(01)00331-7; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Neal LA, 2004, BRIT J PSYCHIAT, V184, P247, DOI 10.1192/bjp.184.3.247; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; ROSENHECK R, 1994, AM J PUBLIC HEALTH, V84, P466, DOI 10.2105/AJPH.84.3.466; ROSENHECK R, 1994, AM J PSYCHIAT, V151, P421; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; Stratford PW, 1996, PHYS THER, V76, P1109, DOI 10.1093/ptj/76.10.1109; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Ware J.E., 1993, SF 36 HLTH SURVEY MA; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Yancosek K, 2008, J HAND THER, V21, P189, DOI 10.1197/j.jht.2007.12.002	35	28	30	0	12	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2011	48	2					89	101		10.1682/JRRD.2010.04.0070			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	733BQ	WOS:000288235800002	21480084	Bronze			2022-02-06	
J	Ahmed, AI; Eynon, CA; Kinton, L; Nicoll, JAR; Belli, A				Ahmed, A. I.; Eynon, C. A.; Kinton, L.; Nicoll, J. A. R.; Belli, A.			Decompressive Craniectomy for Acute Disseminated Encephalomyelitis	NEUROCRITICAL CARE			English	Article						Decompressive craniectomy; Acute disseminated encephalomyelitis	TRAUMATIC BRAIN-INJURY; HEMICRANIECTOMY; MULTICENTER	Acute disseminated encephalomyelitis (ADEM) is a rare, acute demyelinating condition. Although it usually presents in an acute or subacute manner over days, its clinical course may be rapid with symptoms and signs of severe intracerebral mass effect secondary to cerebral oedema. Case report and literature review. We report a case of a patient presenting with a hyperacute course manifested by rapid loss of consciousness and focal neurological signs. Management with emergency hemicraniectomy and steroids resulted in rapid neurological improvement and minimal long-term deficit. We believe that only surgical decompression is likely to be life saving in similar cases of hyperacute cerebral oedema due to ADEM. The wide decompression performed was concordant with that indicated for traumatic brain swelling. Such aggressive management is vindicated by the rapid recovery shown by our patient within days of surgery and the finding of minimal neurological sequelae at 3 months.	[Ahmed, A. I.; Nicoll, J. A. R.; Belli, A.] Univ Southampton, Div Clin Neurosci, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; [Ahmed, A. I.; Eynon, C. A.; Kinton, L.; Nicoll, J. A. R.; Belli, A.] Southampton Univ Hosp NHS Trust, Wessex Neurol Ctr, Southampton SO16 6YD, Hants, England		Ahmed, AI (corresponding author), Univ Southampton, Div Clin Neurosci, Southampton Gen Hosp, LD83,Level D,S Acad Block,Tremona Rd, Southampton SO16 6YD, Hants, England.	a.ahmed@soton.ac.uk	Belli, Antonio/I-3799-2015; Nicoll, James/I-9253-2017	Belli, Antonio/0000-0002-3211-9933; Nicoll, James/0000-0002-9444-7246; Ahmed, Aminul/0000-0001-6670-0438			Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Marchioni E, 2008, NEUROL SCI, V29, pS286, DOI [10.1007/s10072-008-0966-6, 10.1007/s11908-008-0050-7]; Menge T, 2007, CURR OPIN NEUROL, V20, P247, DOI 10.1097/WCO.0b013e3280f31b45; Nilsson P, 2009, EUR J NEUROL, V16, P639, DOI 10.1111/j.1468-1331.2009.02547.x; Ragel BT, 2006, SURG NEUROL, V65, P582, DOI 10.1016/j.surneu.2005.08.015; Refai D, 2005, NEUROSURGERY, V56, P872, DOI 10.1227/01.NEU.0000156201.46473.A8; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Sonneville R, 2009, J INFECTION, V58, P321, DOI 10.1016/j.jinf.2009.02.011; Takata T, 1999, J NEUROL SCI, V165, P94, DOI 10.1016/S0022-510X(99)00089-1; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; von Stuckrad-Barre S, 2003, NEUROLOGY, V61, P420, DOI 10.1212/01.WNL.0000073540.35919.AE	13	28	28	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	DEC	2010	13	3					393	395		10.1007/s12028-010-9420-8			3	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	685UO	WOS:000284653800017	20711687				2022-02-06	
J	Ball, CG; Navsaria, P; Kirkpatrick, AW; Vercler, C; Dixon, E; Zink, J; Laupland, KB; Lowe, M; Salomone, JP; Dente, CJ; Wyrzykowski, AD; Hameed, SM; Widder, S; Inaba, K; Ball, JE; Rozycki, GS; Montgomery, SP; Hayward, T; Feliciano, DV				Ball, Chad G.; Navsaria, Pradeep; Kirkpatrick, Andrew W.; Vercler, Christian; Dixon, Elijah; Zink, John; Laupland, Kevin B.; Lowe, Michael; Salomone, Jeffrey P.; Dente, Christopher J.; Wyrzykowski, Amy D.; Hameed, S. Morad; Widder, Sandy; Inaba, Kenji; Ball, Jill E.; Rozycki, Grace S.; Montgomery, Sean P.; Hayward, Thomas; Feliciano, David V.			The Impact of Country and Culture on End-of-Life Care for Injured Patients: Results From an International Survey	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	Annual Scientific Meeting of the Trauma-Association-of-Canada	MAY 06-07, 2010	Halifax, CANADA	Trauma Assoc Canada		Trauma; End-of-life; Withdrawal of treatment	INTENSIVE-CARE; SUSTAINING TREATMENTS; CRITICALLY-ILL; CARDIAC DEATH; UNITED-STATES; DECISION-MAKING; TRAUMA PATIENTS; FAMILY-MEMBERS; ORGAN DONATION; PHYSICIANS	Background: Up to 20% of all trauma patients admitted to an intensive care unit die from their injuries. End-of-life decision making is a variable process that involves prognosis, predicted functional outcomes, personal beliefs, institutional resources, societal norms, and clinician experience. The goal of this study was to better understand end-of-life processes after major injury by comparing clinician viewpoints from various countries and cultures. Methods: A clinician-based, 38-question international survey was used to characterize the impacts of medical, religious, social, and system factors on end-of-life care after trauma. Results: A total of 419 clinicians from the United States (49%), Canada (19%), South Africa (11%), Europe (9%), Asia (8%), and Australasia (4%) completed the survey. In America, the admitting surgeon guided most end-of-life decisions (51%), when compared with all other countries (0-27%). The practice structure of American respondents also varied from other regions. Formal medical futility laws are rarely available (14-38%). Ethical consultation services are often accessible (29-98%), but rarely used (0-29%), and typically unhelpful (<30%). End-of-life decision making for patients with traumatic brain injuries varied extensively across regions with regard to the impact of patient age, Glasgow Coma Scale score, and clinician philosophy. Similar differences were observed for spinal cord injuries (age and functional level). The avail-ability and use of "donation after cardiac death" also varied substantially between countries. Conclusions: In this unique study, geographic differences in religion, practice composition, decision-maker viewpoint, and institutional resources resulted in significant variation in end-of-life care after injury. These disparities reflect competing concepts (patient autonomy, distributive justice, and religion).	[Ball, Chad G.; Vercler, Christian; Zink, John; Lowe, Michael; Salomone, Jeffrey P.; Dente, Christopher J.; Wyrzykowski, Amy D.; Ball, Jill E.; Rozycki, Grace S.; Feliciano, David V.] Emory Univ, Grady Mem Hosp, Dept Surg, Atlanta, GA 30322 USA; [Navsaria, Pradeep] Univ Cape Town, Dept Surg, Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Kirkpatrick, Andrew W.; Dixon, Elijah; Laupland, Kevin B.] Univ Calgary, Dept Surg, Calgary, AB, Canada; [Hameed, S. Morad] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1W5, Canada; [Widder, Sandy] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Inaba, Kenji] Univ So Calif, Dept Surg, Los Angeles, CA USA; [Montgomery, Sean P.] Walter Reed Army Med Ctr, Dept Surg, Washington, DC 20307 USA; [Hayward, Thomas] Wishard Mem Hosp, Dept Surg, Indianapolis, IN USA		Ball, CG (corresponding author), Emory Univ, Grady Mem Hosp, Dept Surg, Grady Mem Hosp Campus,Glenn Mem Bldg,Room 302,69, Atlanta, GA 30322 USA.	ball.chad@gmail.com	Laupland, Kevin/AAG-3656-2020; Laupland, kevin/AAJ-6339-2020; INABA, KENJI/AAC-8532-2020; Navsaria, Pradeep/AAS-1807-2020	Laupland, kevin/0000-0002-1205-5354; Navsaria, Pradeep/0000-0002-5152-3317			ALEMAYEHU E, 1991, CAN MED ASSOC J, V144, P1133; Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; [Anonymous], 1995, JAMA, V274, P1591; ASCH DA, 1995, AM J RESP CRIT CARE, V151, P288, DOI 10.1164/ajrccm.151.2.7842181; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; BEDELL SE, 1984, NEW ENGL J MED, V310, P1089, DOI 10.1056/NEJM198404263101706; Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x; BLACKHALL LJ, 1987, NEW ENGL J MED, V317, P1281, DOI 10.1056/NEJM198711123172009; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2658, DOI 10.1001/jama.267.19.2658; Carlet J, 2004, INTENS CARE MED, V30, P770, DOI 10.1007/s00134-004-2241-5; Cassel, 1997, APPROACHING DEATH IM; Cohen S, 2005, INTENS CARE MED, V31, P1215, DOI 10.1007/s00134-005-2742-x; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; Curtis JR, 2004, CRIT CARE CLIN, V20, P363, DOI 10.1016/j.ccc.2004.03.001; DANIS M, 1988, CRIT CARE MED, V16, P594, DOI 10.1097/00003246-198806000-00006; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; DEWACHTER MAM, 1989, JAMA-J AM MED ASSOC, V262, P3316, DOI 10.1001/jama.262.23.3316; Ethics Section of the European Society of Intensive Care Medicine, 2009, WELPICUS PROJ CONS G; FaberLangendoen K, 1996, ARCH INTERN MED, V156, P2130, DOI 10.1001/archinte.156.18.2130; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Giannini A, 2003, INTENS CARE MED, V29, P1902, DOI 10.1007/s00134-003-1919-4; Grossman E, 2009, WORLD J SURG, V33, P1338, DOI 10.1007/s00268-009-9997-2; Heyland DK, 2003, INTENS CARE MED, V29, P75, DOI 10.1007/s00134-002-1569-y; HIGH DM, 1988, GERONTOLOGIST, V28, P46, DOI 10.1093/geront/28.Suppl.46; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jones JW, 2002, J VASC SURG, V35, P1305, DOI 10.1067/mva.2002.124492; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; Lynn J, 2000, J AM GERIATR SOC, V48, pS214, DOI 10.1111/j.1532-5415.2000.tb03135.x; Mandell MS, 2006, CRIT CARE MED, V34, P2952, DOI 10.1097/01.CCM.0000247718.27324.65; MORRIS JA, 1990, J TRAUMA, V30, P1476, DOI 10.1097/00005373-199012000-00006; Mosenthal AC, 2008, J TRAUMA, V64, P1587, DOI 10.1097/TA.0b013e318174f112; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Norris P., 2004, SACRED SECULAR RELIG; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2101, DOI 10.1001/jama.267.15.2101; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Pochard F, 2001, CRIT CARE MED, V29, P1887, DOI 10.1097/00003246-200110000-00006; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; President ' Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, DEC FOR LIF SUST TRE, P73; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; Sjokvist P, 1998, CLIN INTENSIVE CARE, V9, P81; SMEDIRA NG, 1990, NEW ENGL J MED, V322, P309, DOI 10.1056/NEJM199002013220506; Sprung CL, 2007, INTENS CARE MED, V33, P104, DOI 10.1007/s00134-006-0405-1; Sprung CL, 2007, INTENS CARE MED, V33, P1732, DOI 10.1007/s00134-007-0693-0; SPRUNG CL, 1992, CRIT CARE MED, V20, P320; Sprung CL, 1996, INTENS CARE MED, V22, P1003; Sprung CL, 1996, MAYO CLIN PROC, V71, P512, DOI 10.4065/71.5.512; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Steinberg A, 2006, INTENS CARE MED, V32, P1234, DOI 10.1007/s00134-006-0186-6; Steinbrook R, 2007, NEW ENGL J MED, V357, P209, DOI 10.1056/NEJMp078066; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; WEBSTER GC, 1991, CAN J ANAESTH, V38, P553, DOI 10.1007/BF03008184; WEIR RF, 1990, JAMA-J AM MED ASSOC, V264, P1846, DOI 10.1001/jama.264.14.1846	56	28	28	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2010	69	6					1323	1333		10.1097/TA.0b013e3181f66878			11	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	695RT	WOS:000285391000012	21045742				2022-02-06	
J	Riggio, S				Riggio, Silvana			Traumatic Brain Injury and Its Neurobehavioral Sequelae	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Postconcussive syndrome; Neuropsychiatric disorders; Frontal lobe seizures	POSTTRAUMATIC-STRESS-DISORDER; HEAD-INJURY; CHRONIC PAIN; PSYCHIATRIC-DISORDERS; SYMPTOMS; FATIGUE; ASSOCIATION; PREVALENCE; CONCUSSION; DISABILITY	The neurobehavioral sequelae (NBS) of traumatic brain injury (TBI) consist of a spectrum of somatic neurological and psychiatric symptoms The challenge for clinicians lies in understanding the interface of the various symptoms and how they interrelate with other entities Specifically, the challenge is differentiating post-TBI-related symptoms from pre-existing or de novo psychiatric neurological and/or systemic disorders A comprehensive evaluation and a multidisciplinary approach to evaluating patients are essential to be able to develop the differential diagnosis needed to design a management plan that maximizes recovery	[Riggio, Silvana] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Riggio, Silvana] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Riggio, Silvana] James J Peters VAMC, Dept Psychiat, Bronx, NY USA		Riggio, S (corresponding author), Mt Sinai Sch Med, Dept Psychiat, 1 Gustave L Levy Pl,Box 1230, New York, NY 10029 USA.						Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Greve KW, 2001, BRAIN INJURY, V15, P255; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Harvey AG, 1998, BRAIN INJURY, V12, P147, DOI 10.1080/026990598122773; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Quesney LF, 1986, RECENT ADV EPILEPSY, V3, P81; Rao Vani, 2002, Curr Treat Options Neurol, V4, P77, DOI 10.1007/s11940-002-0006-4; RIGGIO S, 1995, ADV NEUROL, V66, P153; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruff RM, 1996, BRAIN INJURY, V8, P61; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Turnbull SJ, 2001, BRAIN INJURY, V15, P775, DOI 10.1080/02699050110034334; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316	46	28	28	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					807	+		10.1016/j.psc.2010.08.004			14	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	694TA	WOS:000285320700006	21093680				2022-02-06	
J	Khadr, SN; Crofton, PM; Jones, PA; Wardhaugh, B; Roach, J; Drake, AJ; Minns, RA; Kelnar, CJH				Khadr, Sophie N.; Crofton, Patricia M.; Jones, Patricia A.; Wardhaugh, Barbara; Roach, Jennifer; Drake, Amanda J.; Minns, Robert A.; Kelnar, Christopher J. H.			Evaluation of pituitary function after traumatic brain injury in childhood	CLINICAL ENDOCRINOLOGY			English	Article							GROWTH-HORMONE; CONSENSUS GUIDELINES; CORTISOL RESPONSE; PROVOCATIVE TESTS; REFERENCE CURVES; DYSFUNCTION; DIAGNOSIS; UK; HYPOGLYCEMIA; DEFICIENCY	Objectives Post-traumatic hypopituitarism is well described amongst adult traumatic brain injury (TBI) survivors. We aimed to determine the prevalence and clinical significance of pituitary dysfunction after head injury in childhood. Design Retrospective exploratory study. Patients: 33 survivors of accidental head injury (27 boys). Mean (range) age at study was 13.4 years (5.4-21.7 years) and median (range) interval since injury 4.3 years (1.4-7.8 years). Functional outcome at study: 15 good recovery, 16 moderate disability, two severe disability. Measurements Early morning urine osmolality and basal hormone evaluation were followed by the gonadotrophin releasing hormone (GnRH) and insulin tolerance (n = 25) or glucagon tests (if previous seizures, n = 8). Subjects were not primed. Head injury details were extracted from patient records. Results No subject had short stature (mean height SD score +0.50, range -1.57 to +3.00). Suboptimal GH responses (<5 mu g/l) occurred in six peri-pubertal boys (one with slow growth on follow-up) and one postpubertal adolescent (peak GH 3.2 mu g/l). Median peak cortisol responses to insulin tolerance or glucagon tests were 538 and 562 nm. Nine of twenty-five and two of eight subjects had suboptimal responses, respectively, two with high basal cortisol levels. None required routine glucocorticoid replacement. In three, steroid cover was recommended for moderate/severe illness or injury. One boy was prolactin deficient. Other basal endocrine results and GnRH-stimulated LH and FSH were appropriate for age, sex and pubertal stage. Abnormal endocrine findings were unrelated to the severity or other characteristics of TBI or functional outcome. Conclusions No clinically significant endocrinopathy was identified amongst survivors of accidental childhood TBI, although minor pituitary hormone abnormalities were observed.	[Khadr, Sophie N.; Jones, Patricia A.; Drake, Amanda J.; Minns, Robert A.; Kelnar, Christopher J. H.] Univ Edinburgh, Sect Child Life & Hlth, Edinburgh, Midlothian, Scotland; [Crofton, Patricia M.; Wardhaugh, Barbara; Roach, Jennifer] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; Univ Edinburgh, Dept Child Life & Hlth, Edinburgh, Midlothian, Scotland		Khadr, SN (corresponding author), UCL Inst Child Hlth, Gen & Adolescent Paediat Unit, 30 Guilford St, London WC1N 3EH, England.	s.khadr@ich.ucl.ac.uk			Novo NordiskNovo Nordisk	The research was supported by a grant from Novo Nordisk.	Acerini CL, 2008, J PEDIATR ENDOCR MET, V21, P611; Agha A, 2004, CLIN ENDOCRINOL, V60, P688, DOI 10.1111/j.1365-2265.2004.02035.x; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2000, EUR J ENDOCRINOL, V142, P347, DOI 10.1530/eje.0.1420347; Amed S, 2008, HORM RES, V69, P290, DOI 10.1159/000114860; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Crofton PM, 2004, HORM RES, V61, P92, DOI 10.1159/000075339; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Ghigo E, 1996, J CLIN ENDOCR METAB, V81, P3323, DOI 10.1210/jc.81.9.3323; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Lazar L, 2010, HORM RES PAEDIAT, V73, P299, DOI 10.1159/000284396; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martinez AS, 2000, J CLIN ENDOCR METAB, V85, P4168, DOI 10.1210/jc.85.11.4168; *NAT I HLTH CLIN E, 2003, 64 NAT I HLTH CLIN E; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Paisley AN, 2009, J CLIN ENDOCR METAB, V94, P1757, DOI 10.1210/jc.2008-2392; Pfeifer M, 2001, CLIN ENDOCRINOL, V54, P17, DOI 10.1046/j.1365-2265.2001.01179.x; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Reynolds RM, 2006, CLIN ENDOCRINOL, V64, P82, DOI 10.1111/j.1365-2265.2005.02421.x; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sizonenko PC, 2001, GROWTH HORM IGF RES, V11, P137, DOI 10.1054/ghir.2001.0203; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; TEASDALE G, 1974, LANCET, V2, P81; Yeste D, 2007, HORM RES, V67, P42, DOI 10.1159/000096055; Zevenhuijzena H, 2004, HORM RES, V62, P168, DOI 10.1159/000080324	35	28	28	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	NOV	2010	73	5					637	644		10.1111/j.1365-2265.2010.03857.x			8	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	660IY	WOS:000282635000012	20681995	Green Submitted			2022-02-06	
J	Ottens, AK; Bustamante, L; Golden, EC; Yao, CP; Hayes, RL; Wang, KKW; Tortella, FC; Dave, JR				Ottens, Andrew K.; Bustamante, Liliana; Golden, Erin C.; Yao, Changping; Hayes, Ronald L.; Wang, Kevin K. W.; Tortella, Frank C.; Dave, Jitendra R.			Neuroproteomics: A Biochemical Means To Discriminate the Extent and Modality of Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; middle cerebral artery occlusion; ischemia; proteomics; traumatic brain injury	NEURON-SPECIFIC ENOLASE; CYTOSKELETON-ASSOCIATED PROTEIN; SERUM BIOMARKER CONCENTRATIONS; CONTROLLED CORTICAL IMPACT; CEREBROSPINAL-FLUID; PROTEOMIC ANALYSIS; CEREBRAL-ISCHEMIA; DIAGNOSTIC-TEST; FOCAL ISCHEMIA; CARDIAC-ARREST	Diagnosis and treatment of stroke and traumatic brain injury remain significant health care challenges to society. Patient care stands to benefit from an improved understanding of the interactive biochemistry underlying neurotrauma pathobiology. In this study, we assessed the power of neuroproteomics to contrast biochemical responses following ischemic and traumatic brain injuries in the rat. A middle cerebral artery occlusion (MCAO) model was employed in groups of 30-min and 2-h focal neocortical ischemia with reperfusion. Neuroproteomes were assessed via tandem cation-anion exchange chromatography-gel electrophoresis, followed by reversed-phase liquid chromatography-tandem mass spectrometry. MCAO results were compared with those from a previous study of focal contusional brain injury employing the same methodology to characterize homologous neocortical tissues at 2 days post-injury. The 30-min MCAO neuroproteome depicted abridged energy production involving pentose phosphate, modulated synaptic function and plasticity, and increased chaperone activity and cell survival factors. The 2-h MCAO data indicated near complete loss of ATP production, synaptic dysfunction with degraded cytoarchitecture, more conservative chaperone activity, and additional cell survival factors than those seen in the 30-min MCAO model. The TBI group exhibited disrupted metabolism, but with retained malate shuttle functionality. Synaptic dysfunction and cytoarchitectural degradation resembled the 2-h MCAO group; however, chaperone and cell survival factors were more depressed following TBI. These results underscore the utility of neuroproteomics for characterizing interactive biochemistry for profiling and contrasting the molecular aspects underlying the pathobiological differences between types of brain injuries.	[Ottens, Andrew K.] Virginia Commonwealth Univ, Dept Anat, Med Coll Virginia, Richmond, VA 23298 USA; [Ottens, Andrew K.] Virginia Commonwealth Univ, Dept Neurobiol, Med Coll Virginia, Richmond, VA 23298 USA; [Ottens, Andrew K.] Virginia Commonwealth Univ, Dept Biochem, Med Coll Virginia, Richmond, VA 23298 USA; [Bustamante, Liliana; Golden, Erin C.; Wang, Kevin K. W.] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Yao, Changping; Tortella, Frank C.; Dave, Jitendra R.] Walter Reed Army Inst Res, Dept Appl Neurobiol, Div Psychiat & Neurosci, Silver Spring, MD USA; [Hayes, Ronald L.; Wang, Kevin K. W.] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL USA		Ottens, AK (corresponding author), Virginia Commonwealth Univ, Dept Anat, Med Coll Virginia, POB 980709, Richmond, VA 23298 USA.	akottens@vcu.edu	Ottens, Andrew/K-3352-2012; Dave, Jitendra R/A-8940-2011	Ottens, Andrew/0000-0002-2118-3796; Wang, Kevin/0000-0002-9343-6473	Department of DefenseUnited States Department of Defense [DAMD1703-1-0066]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS055012]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K25NS055012] Funding Source: NIH RePORTER	Our thanks go to Drs. Povlishock and McGinn Greer for their thoughtful feedback. This work was supported by Department of Defense grant DAMD1703-1-0066, and the National Institute of Neurological Disorders and Stroke grant NS055012. This article was reviewed by the Walter Reed Army Institute of Research, and there was no objection to its presentation and publication. The opinions and assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting the views of the Department of the Army or the Department of Defense.	Agoston DV, 2009, J NEUROTRAUM, V26, P901, DOI 10.1089/neu.2008.0724; Angeletti PC, 2002, CELL STRESS CHAPERON, V7, P258, DOI 10.1379/1466-1268(2002)007<0258:SGRPVP>2.0.CO;2; Baird Alison E, 2006, Curr Atheroscler Rep, V8, P267, DOI 10.1007/s11883-006-0003-2; Baron JC, 2001, CEREBROVASC DIS, V11, P2, DOI 10.1159/000049119; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Britton P, 1997, LIFE SCI, V60, P1729, DOI 10.1016/S0024-3205(97)00132-X; Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; Chen A, 2007, NEUROCHEM INT, V50, P1078, DOI 10.1016/j.neuint.2006.11.008; Chen DM, 2006, J PHARMACOL EXP THER, V319, P165, DOI 10.1124/jpet.106.104380; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Cid C, 2007, PROTEOMICS, V7, P3207, DOI 10.1002/pmic.200700214; Cunningham RT, 1996, EUR J CLIN INVEST, V26, P298, DOI 10.1046/j.1365-2362.1996.129282.x; CUNNINGHAM RT, 1991, EUR J CLIN INVEST, V21, P497, DOI 10.1111/j.1365-2362.1991.tb01401.x; Daniel S, 2008, BBA-MOL CELL RES, V1783, P1003, DOI 10.1016/j.bbamcr.2008.01.014; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DAUBERSCHMIDT R, 1991, MOL CHEM NEUROPATHOL, V14, P237, DOI 10.1007/BF03159939; Depaz IM, 2006, BRAIN RES, V1081, P59, DOI 10.1016/j.brainres.2006.01.126; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; Dubaquie Y, 1997, P NATL ACAD SCI USA, V94, P9011, DOI 10.1073/pnas.94.17.9011; Ekegren T, 2008, J MASS SPECTROM, V43, P559, DOI 10.1002/jms.1409; Focking M, 2006, ACTA NEUROBIOL EXP, V66, P273; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Ito M, 2005, NEUROSCI LETT, V378, P125, DOI 10.1016/j.neulet.2004.12.079; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Junker H, 2007, GLIA, V55, P1630, DOI 10.1002/glia.20581; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kent DM, 2003, STROKE, V34, P464, DOI 10.1161/01.STR.0000051506.43212.8B; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Koh PO, 2010, J VET MED SCI, V72, P181, DOI 10.1292/jvms.09-0364; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Laskowitz DT, 2009, STROKE, V40, P77, DOI 10.1161/STROKEAHA.108.516377; Lee JE, 2001, EXP NEUROL, V170, P129, DOI 10.1006/exnr.2000.7614; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Lynch JR, 2004, STROKE, V35, P57, DOI 10.1161/01.STR.0000105927.62344.4C; Macleod MR, 2005, J CEREBR BLOOD F MET, V25, P713, DOI 10.1038/sj.jcbfm.9600064; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Montaner J, 2006, DRUG NEWS PERSPECT, V19, P523, DOI 10.1358/dnp.2006.19.9.1050422; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Ottens AK, 2005, ANAL CHEM, V77, P4836, DOI 10.1021/ac050478r; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Pak JH, 2000, P NATL ACAD SCI USA, V97, P11232, DOI 10.1073/pnas.210184697; Pettigrew LC, 1996, J CEREBR BLOOD F MET, V16, P1189, DOI 10.1097/00004647-199611000-00013; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Prieto DA, 2008, EXPERT REV PROTEOMIC, V5, P283, DOI 10.1586/14789450.5.2.283; Rajdev S, 2000, TOXICOL PATHOL, V28, P105, DOI 10.1177/019262330002800113; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; ROINE RO, 1989, ARCH NEUROL-CHICAGO, V46, P753, DOI 10.1001/archneur.1989.00520430047015; Schellinger PD, 2003, STROKE, V34, P575, DOI 10.1161/01.STR.0000051504.10095.9C; Shibasaki F, 1997, NATURE, V386, P728, DOI 10.1038/386728a0; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sung JH, 2009, J PINEAL RES, V46, P300, DOI 10.1111/j.1600-079X.2008.00661.x; Terada K, 2001, CEREBROVASC DIS, V11, P9, DOI 10.1159/000047606; Tsuchiya D, 2003, NEUROSURGERY, V53, P1179, DOI 10.1227/01.NEU.0000090341.38659.CF; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; Tzoulaki I, 2007, EUR HEART J, V28, P354, DOI 10.1093/eurheartj/ehl441; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Williams AJ, 2000, J PHARMACOL EXP THER, V294, P378; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Yao C, 2003, NEUROTOX RES, V5, P245, DOI 10.1007/BF03033382; Yao CP, 2008, BRAIN INJURY, V22, P723, DOI 10.1080/02699050802304706; Yao CP, 2009, J NEUROTRAUM, V26, P1295, DOI [10.1089/neu.2008.0811, 10.1089/neu.2008-0811]; Yao H, 2009, NEUROCHEM RES, V34, P1999, DOI 10.1007/s11064-009-9988-6; Zetterberg H, 2008, ACTA NEUROL SCAND, V118, P1, DOI 10.1111/j.1600-0404.2007.00985.x; Zhang J, 2008, J NEUROPATH EXP NEUR, V67, P923, DOI 10.1097/NEN.0b013e318187a832; Zhang ZJ, 2009, NEUROCHEM INT, V54, P488, DOI 10.1016/j.neuint.2009.02.005	89	28	28	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2010	27	10					1837	1852		10.1089/neu.2010.1374			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	665OZ	WOS:000283046600008	20698760	Green Published			2022-02-06	
J	Douglas, JM				Douglas, Jacinta M.			Using the La Trobe Communication Questionnaire to Measure Perceived Social Communication Ability in Adolescents With Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						social communication; adolescents; brain injury; assessment		Introduction: The La Trobe Communication Questionnaire (LCQ) was developed to measure perceived social communication ability from various sources including the self-perceptions of individuals as well as those of others with whom they converse regularly (e. g., family members, friends and clinicians). It has been psychometrically evaluated with healthy young adults and adults with traumatic brain injury (TBI) and found to have acceptable reliability and validity. The present study was conducted to gauge the ability of the LCQ to distinguish between a group of adolescents who had sustained TBI and a control group of neurologically normal adolescents matched on the variables of socio-economic status (SES), age, gender and level of education completed. Method: Participants were 19 TBI dyads (TBI adolescents and close relatives) and 19 control dyads. All TBI adolescents had sustained severe injury (mean posttraumatic amnesia duration 33.76 days, SD 18.13) due to moving vehicle-related trauma. Mean age at the time of injury was 16.33 years (SD 1.67) and at the time of assessment 17.11 years (SD 1.90). The LCQ was administered to all participants at home. Results: Perceptions of TBI adolescents and their relatives were significantly different from those of control dyads and consistent with a higher frequency of social communication difficulties in the TBI group. Difficulties reflected reduced conversational fluency and problems with managing the multiple demands of social discourse. Conclusions: The LCQ is a clinical tool that has sound potential to contribute to the multifaceted assessment of social communication in adolescents with TBI.	La Trobe Univ, Sch Human Commun Sci, Bundoora, Vic 3086, Australia		Douglas, JM (corresponding author), La Trobe Univ, Sch Human Commun Sci, Bundoora, Vic 3086, Australia.	J.Douglas@latrobe.edu.au		Douglas, Jacinta/0000-0003-0940-6624			ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; [Anonymous], 2009, MOSBYS MED DICT, V8th; Barnes MA, 2001, BRAIN LANG, V76, P253, DOI 10.1006/brln.2000.2385; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Body R., 1999, BRAIN DAM B; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chelune GJ, 1986, ADV CLIN NEUROPSYCHO, V3, P95, DOI [10.1007/978-1-4613-2211-5_4, DOI 10.1007/978-1-4613-2211-5_4]; Ciccia AH, 2009, TOP LANG DISORD, V29, P249, DOI 10.1097/TLD.0b013e3181b53211; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Dahl RE, 2004, ANN NY ACAD SCI, V1021, P1, DOI 10.1196/annals.1308.001; Damico J. S., 1985, COMMUNICATION SKILLS, P165; Damico J.S., 1991, ASSESSMENT THERAPY M, P125; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Douglas JM, 2007, APHASIOLOGY, V21, P1181, DOI 10.1080/02687030600980950; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; Eisenberg N, 2004, HDB ADOLESCENT PSYCH, V2, P155, DOI DOI 10.1002/9780471726746; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Fyrberg A, 2007, INT J REHABIL RES, V30, P153; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Godfrey H.P.D., 1993, J CLIN EXP PSYCHOL, V15, P530; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; Kim J, 2005, J INT NEUROPSYCH SOC, V11, P434, DOI 10.1017/S1355617705050563; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Larson RW, 2002, J RES ADOLESCENCE, V12, P159, DOI 10.1111/1532-7795.00029; Larson RW, 2002, J RES ADOLESCENCE, V12, P31, DOI 10.1111/1532-7795.00024; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; MCNEILLBROWN D, 1997, INT PERSPECTIVES TRA, P247; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; OFlaherty CA, 1997, APHASIOLOGY, V11, P889, DOI 10.1080/02687039708250463; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Pink B.N., 2006, AUSTR NZ STANDARD CL; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Snow PC, 2000, BRAIN INJURY, V14, P397; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Turkstra L, 2003, LANG SPEECH HEAR SER, V34, P117, DOI 10.1044/0161-1461(2003/010); Turkstra L., 1995, BRAIN INJURY, V10, P319; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; [No title captured]; [No title captured]	75	28	28	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646			BRAIN IMPAIR	Brain Impair.	SEP	2010	11	2			SI		171	182		10.1375/brim.11.2.171			12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	V24IS	WOS:000208404700008					2022-02-06	
J	Egeland, J; Johansen, SN; Ueland, T				Egeland, Jens; Johansen, Susanne Nordby; Ueland, Torill			Do Low-Effort Learning Strategies Mediate Impaired Memory in ADHD?	JOURNAL OF LEARNING DISABILITIES			English	Article						ADHD; memory; effort; elaborative encoding; semantic organization; proactive and retroactive interference; serial position effect	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; CHILDREN; MODEL; PERFORMANCE; DEFICITS; BOYS; SCHIZOPHRENIA; HYPERACTIVITY	As a group, participants with attention-deficit/hyperactivity disorder (ADHD) are impaired in academic performance and learning. This may be due to a mild intellectual impairment, impaired attention, or inability to allocate sufficient effort. If the latter is the case, this should be evident in the learning strategies applied. Four indices of learning strategy, considered to measure degree of effort, were analyzed from 67 participants with ADHD and 67 age-matched normal controls between 9 and 16 years of age. The participants with ADHD were impaired with regard to semantic clustering, retroactive interference, and percentage items reported from the middle section of the list even when controlling for IQ and comorbid conduct or oppositional defiant disorders symptoms. In addition, participants with combined ADHD (ADHD-C) did not display the normal proactive interference effect. The four effort indices explained 39% and 35% of the variance in free recall among participants with inattentive ADHD (ADHD-I) and ADHD-C, respectively. IQ was still significant when the effect of strategy measures were accounted for, whereas diagnosis was no longer significant when entered into the regression analysis after the effort indices. The study shows that participants with ADHD employ less effortful learning strategies than healthy controls and that low effort to a large degree can account for diagnosis related variance in memory performance.	[Egeland, Jens] Vestfold Mental Hlth Care Trust, Dept Res, N-3103 Tonsberg, Norway		Egeland, J (corresponding author), Vestfold Mental Hlth Care Trust, Dept Res, Box 2267, N-3103 Tonsberg, Norway.	jens.egeland@piv.no	Ueland, Torill/AAO-1277-2021	Ueland, Torill/0000-0002-8638-1152			Achenbach TM, 1991, MANUAL CHILD BEHAV C; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Barkley R.A., 1997, ADHD NATURE SELF CON; BENEZRA E, 1988, J ABNORM CHILD PSYCH, V16, P511, DOI 10.1007/BF00914263; Blanchet S, 2001, NEUROPSYCHOLOGIA, V39, P502, DOI 10.1016/S0028-3932(00)00119-6; Carlson CL, 2002, J LEARN DISABIL-US, V35, P104, DOI 10.1177/002221940203500202; Cornoldi C, 1999, DEV NEUROPSYCHOL, V15, P53; Cutting LE, 2003, J LEARN DISABIL-US, V36, P259, DOI 10.1177/002221940303600305; Delis D.C., 2000, CALIFORNIA VERBAL LE; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Delis DC., 1994, CALIFORNIA VERBAL LE; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; DuPaul G.J., 1998, ADHD RATING SCALE 4; Egeland J., 2005, TIDSSKRIFT NORSK PSY, V42, P99; Egeland J, 2007, ARCH CLIN NEUROPSYCH, V22, P763, DOI 10.1016/j.acn.2007.06.004; Egeland J, 2006, NORD PSYCHOL, V58, P136, DOI 10.1027/1901-2276.58.2.136; ELLIS HC, 1984, J EXP PSYCHOL LEARN, V10, P470, DOI 10.1037/0278-7393.10.3.470; Elwood RW, 1995, NEUROPSYCHOL REV, V5, P173, DOI 10.1007/BF02214761; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; GUALTIERI CT, 1982, J AM ACAD CHILD PSY, V21, P19, DOI 10.1097/00004583-198201000-00005; Hallowell E. D., 2005, DELIVERED DISTRACTIO; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Hazell PL, 1999, J CHILD PSYCHOL PSYC, V40, P275, DOI 10.1017/S002196309800331X; HILDEBRAND DK, 2001, HDB PSYCHOEDUCATIONA, P13; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P77, DOI 10.1016/j.acn.2005.07.007; Jensen PS, 2001, J DEV BEHAV PEDIATR, V22, P60, DOI 10.1097/00004703-200102000-00008; Kaplan BJ, 1998, J CLIN EXP NEUROPSYC, V20, P518, DOI 10.1076/jcen.20.4.518.1477; Kareken D A, 1996, J Int Neuropsychol Soc, V2, P486; KATARIA S, 1992, J CLIN PSYCHOL, V48, P371, DOI 10.1002/1097-4679(199205)48:3<371::AID-JCLP2270480316>3.0.CO;2-F; Levin HS, 2000, J CLIN EXP NEUROPSYC, V22, P1, DOI 10.1076/1380-3395(200002)22:1;1-8;FT001; Lockwood KA, 2001, J CLIN EXP NEUROPSYC, V23, P317, DOI 10.1076/jcen.23.3.317.1179; LOGE DV, 1990, J AM ACAD CHILD PSY, V29, P540, DOI 10.1097/00004583-199007000-00006; LORSBACH TC, 1985, J LEARN DISABIL-US, V18, P222, DOI 10.1177/002221948501800408; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Muir-Broaddus JE, 2002, ARCH CLIN NEUROPSYCH, V17, P671, DOI 10.1016/S0887-6177(01)00170-6; Novik TS, 2000, EUR CHILD ADOLES PSY, V9, P54, DOI 10.1007/s007870050116; O'Donnell L., 2005, DISS ABSTR INT B, V65, P4843; Perry W, 2001, SCHIZOPHRENIA BULL, V27, P157, DOI 10.1093/oxfordjournals.schbul.a006854; *PSYCH CORP, 1999, WECHLS ABBR SCAL INT; Sahakyan L, 2003, J MEM LANG, V48, P195, DOI 10.1016/S0749-596X(02)00524-7; Seidman LJ, 2001, NEUROPSYCHOLOGY, V15, P544, DOI 10.1037/0894-4105.15.4.544; Sergeant J. A., 1999, P75, DOI [10.1007/978-1-4615-4881-2_4, DOI 10.1007/978-1-4615-4881-2_4]; Sergeant JA, 2005, BIOL PSYCHIAT, V57, P1248, DOI 10.1016/j.biopsych.2004.09.010; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P387, DOI 10.1111/j.1469-7610.1992.tb00874.x; Talley J., 1993, CHILDRENS AUDTORY VE CHILDRENS AUDITORY V; Van Der Meere J, 2002, HYPERACTIVITY ATTENT, P162; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wechsler D., 1997, WECHSLER INTELLIGENC; Weiss L. G., 1999, CANADIAN J SCH PSYCH, V14, P1, DOI [10.1177/082957359901400202, DOI 10.1177/082957359901400202]; White Holly A, 2007, J Atten Disord, V11, P141, DOI 10.1177/1087054706295604	51	28	29	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-2194			J LEARN DISABIL-US	J. Learn. Disabil.	SEP-OCT	2010	43	5					430	440		10.1177/0022219409355473			11	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	646QQ	WOS:000281557500004	20445203				2022-02-06	
J	Elhammali, N; Bremerich, A; Rustemeyer, J				Elhammali, N.; Bremerich, A.; Rustemeyer, J.			Demographical and clinical aspects of sports-related maxillofacial and skull base fractures in hospitalized patients	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						maxillofacial fracture; skull base fracture; sports-related injury; concomitant injury; midface fracture; mandible fracture	FACIAL FRACTURES; INJURIES; SOCCER; PREVENTION; PROTECTION; ETIOLOGY	As many as 30% of all maxillofacial fractures (MFFs) and skull base fractures (SBFs) are reported to be sports-related. Participation in sporting activities has grown worldwide and the number of cases of sports-related injuries has also increased. The aim of this study was to evaluate the data of 3596 patients hospitalized by MFF or SBF over a 6-year period; 147 (4%) of these cases were sports-related (mean age 29.7 +/- 12.8 years). The highest incidence was found in patients aged 20-29 years (35%), and the fractures resulted mostly from ball sports (74%), especially soccer (59%) and handball (8%). The injuries involved different areas, with a significant prevalence of the midface complex (67%) compared with the mandible region (29%) and the skull base (4%). The commonest diagnoses associated with MFF and SBF were brain concussion (19%), laceration of the skin and soft tissue (16%), and dental injury (8%). Surgery was required for 88% of midface fractures. In cases of mandible fractures 52% were supplied with osteosynthesis. This study identified the significant number of severe sports-related injuries that occur each year, suggesting that changes of rules and safety standards are needed for the prevention of such injuries.	[Elhammali, N.; Bremerich, A.; Rustemeyer, J.] Ctr Hosp, Dept Cranio & Maxillofacial Surg, Bremen, Germany; [Elhammali, N.] Altahadi Univ, Sirte, Libya		Rustemeyer, J (corresponding author), Klinikum Bremen Mitte, Dept Cranio & Maxillofacial Surg, D-28177 Bremen, Germany.	janrustem@gmx.de					Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Antoun JS, 2008, J ORAL MAXIL SURG, V66, P504, DOI 10.1016/j.joms.2007.08.018; Bak MJ, 2004, J ORAL MAXIL SURG, V62, P1209, DOI 10.1016/j.joms.2004.06.034; Carroll SM, 1996, IRISH MED J, V89, P188; Cascone P, 2008, J CRANIOFAC SURG, V19, P772, DOI 10.1097/SCS.0b013e31816b1ad4; Cerulli G, 2002, J CRANIOFAC SURG, V13, P627, DOI 10.1097/00001665-200209000-00006; Chalmers DJ, 1998, SPORTS MED, V25, P339, DOI 10.2165/00007256-199825050-00006; Chalmers DJ, 2002, INJURY PREV, V8, pIV22, DOI 10.1136/ip.8.suppl_4.iv22; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; De Gioanni P P, 2000, Minerva Stomatol, V49, P21; Delilbasi C, 2004, ORAL SURG ORAL MED O, V97, P23, DOI 10.1016/j.tripleo.2003.10.008; DELOES M, 1995, INT J SPORTS MED, V16, P134, DOI 10.1055/s-2007-972980; Dempsey RL, 2005, INJURY PREV, V11, P91, DOI 10.1136/ip.2004.006205; Exadaktylos AK, 2004, BRIT J SPORT MED, V38, P750, DOI 10.1136/bjsm.2003.008581; Fasola A O, 2000, Afr J Med Med Sci, V29, P215; Gassner R, 1999, J ORAL MAXIL SURG, V57, P1068, DOI 10.1016/S0278-2391(99)90327-0; Hill CM, 1998, BRIT J ORAL MAX SURG, V36, P44, DOI 10.1016/S0266-4356(98)90747-1; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; LIM LH, 1993, AUST NZ J SURG, V63, P784, DOI 10.1111/j.1445-2197.1993.tb00341.x; MacAfee K A 2nd, 1994, Penn Dent J (Phila), V93, P16; Maladiere E, 2001, INT J ORAL MAX SURG, V30, P291, DOI 10.1054/ijom.2001.0059; Marshall SW, 2003, JAMA-J AM MED ASSOC, V289, P568, DOI 10.1001/jama.289.5.568; Motamedi MHK, 2003, J ORAL MAXIL SURG, V61, P61, DOI 10.1053/joms.2003.50049; Mourouzis C, 2005, INT J ORAL MAX SURG, V34, P635, DOI 10.1016/j.ijom.2005.01.008; Papakosta V, 2008, DENT TRAUMATOL, V24, P193, DOI 10.1111/j.1600-9657.2007.00536.x; Roccia F, 2008, J CRANIOFAC SURG, V19, P377, DOI 10.1097/SCS.0b013e318163e3d7; SANE J, 1988, INT J ORAL MAX SURG, V17, P122, DOI 10.1016/S0901-5027(88)80165-6; SMITH AM, 1993, MAYO CLIN PROC, V68, P939, DOI 10.1016/S0025-6196(12)62265-4; Tanaka N, 1996, J ORAL MAXIL SURG, V54, P715, DOI 10.1016/S0278-2391(96)90688-6; Ueeck BA, 2004, J ORAL MAXIL SURG, V62, P693, DOI 10.1016/j.joms.2003.12.010	30	28	30	0	4	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	SEP	2010	39	9					857	862		10.1016/j.ijom.2010.04.006			6	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	674QE	WOS:000283761500004	20462740				2022-02-06	
J	Mitchell, EJ; Canter, J; Norris, P; Jenkins, J; Morris, J				Mitchell, Erika J.; Canter, Jeffrey; Norris, Patrick; Jenkins, Judith; Morris, John			The Genetics of Heterotopic Ossification: Insight Into the Bone Remodeling Pathway	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						Heterotopic Ossification; fracture healing; genetics; bone remodeling	TRAUMATIC BRAIN-INJURY; NERVOUS-SYSTEM; MORTALITY; RISK	Objectives: Heterotopic Ossification (HO) is a significant complication after trauma occurring in 12% to 25% of fractures Although clinical predictors have been studied to determine the likelihood of developing HO, the results have been inconsistent This study examines genetic predictors of the HO phenotype to identify the "at-risk" patient and increase the understanding of the genetic contribution to the formation of HO Methods: We examined the frequency of 61 single nucleotide polymorphisms (SNPs) in 1095 consecutive trauma patients with fractures Radiographic studies of these patients were examined for HO in follow-up Ten percent of the patients in the study demonstrated radiographic evidence of HO Multivariate logistic regression was used to analyze each SNP independently while adjusting for severity of injury (as measured by the Trauma and Injury Severity Score) Results: Three SNPs (beta(2)-adrenergic receptor, toll-like receptor 4. complement factor H) were identified that were associated with an increased or decreased frequency of HO The less common polymorphism of the beta(2)-adrenergic receptor gene was associated with increased risk of HO For toll-like receptor 4 and complement factor H, the less common polymorphism was associated with a decreased risk of HO Conclusions: The SNPs identified as predictors of HO formation are representative of the adrenergic system, immune system. and the alternative complement system This represents the interplay of multiple pathways that affect bone remodeling, aberrations of which may be found in the genome	[Mitchell, Erika J.] Vanderbilt Univ, Med Ctr, Dept Orthopaed, Div Orthopaed Trauma,Med Ctr E, Nashville, TN 37232 USA; [Canter, Jeffrey] Vanderbilt Univ, Med Ctr, Ctr Human Genet, Nashville, TN 37232 USA; [Norris, Patrick; Jenkins, Judith; Morris, John] Vanderbilt Univ, Med Ctr, Div Trauma, Nashville, TN 37232 USA		Mitchell, EJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Orthopaed, Div Orthopaed Trauma,Med Ctr E, South Tower,Suite 4200, Nashville, TN 37232 USA.				US Army Medical ResearchUnited States Department of DefenseUS Army Research Laboratory (ARL);  [W81XWH-08-1-0384]	This work was supported by the US Army Medical Research and Material Command. Orthopaedic Extremity Trauma Research Program. under Award No W81XWH-08-1-0384	[Anonymous], 2007, NATURE, V447, P661; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; CANTER JA, 2009, J AM COLL SURGEONS, V66, P1270; CANTER JA, 2009, J AM COLL SURGEONS, V66, P1265; DOVICHI N, 2010, J PROTEOME RES  0303; Elefteriou F, 2005, CELL MOL LIFE SCI, V62, P2339, DOI 10.1007/s00018-005-5175-3; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Johnson GB, 2004, FASEB J, V18, P1282, DOI 10.1096/fj.04-1572fje; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Morris JA, 2009, J AM COLL SURGEONS, V208, P663, DOI 10.1016/j.jamcollsurg.2008.12.017; Morris JA, 2009, J TRAUMA, V66, P1265, DOI 10.1097/TA.0b013e31819ea61a; NORRIS PR, 2009, ANN SURG        0827; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Rigaux P, 2005, JOINT BONE SPINE, V72, P146, DOI 10.1016/j.jbspin.2004.05.012; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8	16	28	31	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	SEP	2010	24	9					530	533		10.1097/BOT.0b013e3181ed147b			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	647FL	WOS:000281603100004	20736788				2022-02-06	
J	Harford-Wright, E; Thornton, E; Vink, R				Harford-Wright, Elizabeth; Thornton, Emma; Vink, Robert			Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						Captopril; Angiotensin-converting enzyme; Neurogenic inflammation; Substance P; Neurotrauma	SUBSTANCE-P; FUNCTIONAL DEFICITS; HEAD-INJURY; RATS; INFLAMMATION; EDEMA; MODEL	Angiotensin-converting enzyme (ACE) inhibitors are widely used as blood pressure medications in hypertensive individuals. However, ACE inhibitors also play an integral role in the breakdown of neuronal substance P. which has been recently implicated in the development of functional deficits following traumatic brain injury (TBI) The present study therefore examined the effects of ACE inhibitors on histological and motor outcome following TBI. Male Sprague-Dawley rats were treated with Captopril. Enalapril or equal volume saline for 7 days prior to the induction of diffuse TBI using the impact acceleration model. At 5 h post-injury, animals administered Captopril demonstrated significantly increased substance P immunoreactivity compared to vehicle controls (p < 0.01), and Increased dark cell change that persisted to 7 days post-trauma. Captopril also resulted in exacerbated motor deficits compared to vehicle treated animals (p < 0 05) as assessed by the rotarod test over a 7-day post-traumatic period. Administration of the alternative ACE inhibitor, Enalapril, likewise exacerbated motor deficits, confirming a class effect of ACE inhibitors rather than a compound effect specific to Captopril We conclude that ACE inhibitors are deleterious to outcome following TBI, presumably by impairing the degradation of substance P and increasing substance P mediated neuronal injury (C) 2010 Elsevier Ireland Ltd. All rights reserved	[Harford-Wright, Elizabeth; Thornton, Emma; Vink, Robert] Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia		Vink, R (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.		Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	Supported, in part, by a grant from the National Health and Medical Research Council of Australia. We thank Dr Stephen Helps for the substance P semi-quantitation by colour deconvolution.	Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Campos MM, 2000, NEUROPEPTIDES, V34, P314, DOI 10.1054/npep.2000.0823; Castro-Obregon S, 2002, CELL DEATH DIFFER, V9, P807, DOI 10.1038/sj.cdd.4401035; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Emanueli C, 1998, HYPERTENSION, V31, P1299, DOI 10.1161/01.HYP.31.6.1299; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; GAUMANN DM, 1990, NEUROSCIENCE, V39, P761, DOI 10.1016/0306-4522(90)90259-7; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; HAFSTROM I, 1989, J RHEUMATOL, V16, P1033; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; LANDINI G, 2009, COLOUR DECONVOLUTION; Leong PKK, 2006, AM J PHYSIOL-RENAL, V290, pF854, DOI 10.1152/ajprenal.00353.2005; Lin RCS, 1995, NEUROREPORT, V7, P310, DOI 10.1097/00001756-199512290-00074; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; PERSSON MG, 1991, EUR J PHARMACOL, V205, P295, DOI 10.1016/0014-2999(91)90913-B; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Scholzen TE, 2003, J IMMUNOL, V170, P3866, DOI 10.4049/jimmunol.170.7.3866; VALDEMARSSON S, 1991, J INTERN MED, V230, P325, DOI 10.1111/j.1365-2796.1991.tb00452.x; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; WERNER C, 1991, STROKE, V22, P910, DOI 10.1161/01.STR.22.7.910; WILLIAMS TA, 1991, J NEUROCHEM, V57, P193, DOI 10.1111/j.1471-4159.1991.tb02115.x	28	28	28	0	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 30	2010	481	1					26	29		10.1016/j.neulet.2010.06.044			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	639VW	WOS:000281005100006	20600611				2022-02-06	
J	Li, XY; Li, J; Feng, DF; Gu, L				Li, X. Y.; Li, J.; Feng, D. F.; Gu, L.			DIFFUSE AXONAL INJURY INDUCED BY SIMULTANEOUS MODERATE LINEAR AND ANGULAR HEAD ACCELERATIONS IN RATS	NEUROSCIENCE			English	Article						traumatic brain injury; animal model; amyloid protein precursor; neurological severity score	TRAUMATIC BRAIN-INJURY; COGNITIVE DEFICITS; EXPERIMENTAL-MODEL; AMYLOID-BETA; IMPACT; DAMAGE; ACCUMULATION; DIAGNOSIS; PATHOPHYSIOLOGY; MOTOR	Diffuse axonal injury (DAI) is one of the most common and important pathologic features of human traumatic brain injury (TBI), accounting for high mortality and development of persistent post-traumatic neurologic sequelae. Although a relatively high number of therapies have been shown to be effective in experimental models, there are currently few treatments that are effective for improving the prognosis of clinical DAI. A major reason is the failure of current models to validly reproduce the pathophysiological characteristics observed after clinical DAI. In the present study, we employed a specially designed, highly controllable model to induce a sudden rotation in the coronal plane (75 degrees rotation at 1.6 x 10(4) degrees/s) combined with lateral translation (1.57 cm displacement at 3.4 x 10(2) cm/s) to the rat's head. We were interested in discovering whether the combined accelerations could reproduce the pathophysiological changes analogous to those seen in human DAI. The axonal injury as assessed with amyloid protein precursor (APP) as a marker was consistently present in all injured rats. The commonly injured brain regions included the subcortical regions, deep white matter, corpus callosum and brain stem. The evolution of APP accumulations in brain sections depicted the detailed progression of axonal pathology. Ultrastructural studies gave further insights into the presence and progression of axonal injury. All injured rats exhibited transient physiological dysfunction, as well as immediate and dramatic neurological impairment that still persisted at 14 days after injury. These results suggest that this model reproduced the major pathophysiological changes analogous to those observed after severe clinical TBI and provides an attractive vehicle for experimental brain injury research. (C) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.	[Feng, D. F.] Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Dept Neurosurg,Peoples Hosp 3, Shanghai 201900, Peoples R China; [Feng, D. F.] Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Shanghai 201900, Peoples R China		Feng, DF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Traumat Med, Dept Neurosurg,Peoples Hosp 3, 280 Mo He Rd, Shanghai 201900, Peoples R China.	feng_df@yahoo.com			Shanghai committee of Science and TechnologyShanghai Science & Technology Committee [064119639]; Shanghai Jiao Tong University School of Medicine [09XJ21072]; Shanghai Jiao Tong University [YG08PETMS19]	This study was supported by grants from the Shanghai committee of Science and Technology (NO. 064119639), Shanghai Jiao Tong University School of Medicine (NO. 09XJ21072) and the Medical Engineering Project of Shanghai Jiao Tong University (NO. YG08PETMS19). Transmission electron microscopy was carried out at the Department of EM, Shanghai School of Medicine, Fudan University.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; DEKOSKY ST, 1998, SEMIN CLIN NEUROPSYC, V3, P176; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; Fijalkowski RJ, 2007, J NEUROTRAUM, V24, P1387, DOI 10.1089/neu.2007.0268; Fijalkowski RJ, 2006, BIOMED SCI INSTRUM, V42, P108; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Goldsmith W, 2001, CRIT REV BIOMED ENG, V29, P441, DOI 10.1615/CritRevBiomedEng.v29.i56.10; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Gutierrez E, 2001, J NEUROTRAUM, V18, P247, DOI 10.1089/08977150151070874; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; KAO CC, 1983, SPINAL CORD RECONSTR, P41; King A. I., 2003, IRCOBI C LISB PORT; Lammie GA, 1999, J NEUROTRAUM, V16, P603, DOI 10.1089/neu.1999.16.603; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Mahoney EJ, 2003, J TRAUMA, V55, P1065, DOI 10.1097/01.TA.0000100381.89107.93; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maruichi K, 2009, NEUROPATHOLOGY, V29, P132, DOI 10.1111/j.1440-1789.2008.00956.x; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; PAXIOS G, 2001, MOUSE BRAIN STEREOTA; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Sahuquillo J, 2002, ADV TECH STAND NEUR, V27, P23; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schmidt RH, 2000, J NEUROTRAUM, V17, P1129, DOI 10.1089/neu.2000.17.1129; Schroeter ML, 2007, NEUROPSYCHOLOGIA, V45, P3149, DOI 10.1016/j.neuropsychologia.2007.07.004; Schroeter ML, 2010, NEUROPSYCHOLOGIA, V48, P185, DOI 10.1016/j.neuropsychologia.2009.09.004; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SKANDSEN T, 2009, J NEUROSURG, V23, P1; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; STALHAMMAR D, 1990, HDB CLIN NEUROLOGY, V13, P17; STALHAMMAR DA, 1991, ADV NEUROTRAUMATOLOG, V3, P1; VANEZIS P, 1987, FORENSIC SCI INT, V35, P1, DOI 10.1016/0379-0738(87)90018-1; Yuan XQ, 1991, J NEUROTRAUM, V8, P219, DOI 10.1089/neu.1991.8.219; Zhao M, 2003, NEUROBIOL DIS, V14, P391, DOI 10.1016/j.nbd.2003.07.006; Zwahlen RA, 2007, J CRANIO MAXILL SURG, V35, P142, DOI 10.1016/j.jcms.2007.01.006	54	28	34	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 11	2010	169	1					357	369		10.1016/j.neuroscience.2010.04.075			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	621LB	WOS:000279579200035	20451584				2022-02-06	
J	Williams, G; Morris, ME; Schache, A; McCrory, PR				Williams, Gavin; Morris, Meg E.; Schache, Anthony; McCrory, Paul R.			People Preferentially Increase Hip Joint Power Generation to Walk Faster Following Traumatic Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						brain injury; gait; assessment; rehabilitation; postural balance	MOBILITY ASSESSMENT-TOOL; GAIT; LEVEL; SPEED; PLANTARFLEXORS; HEMIPARESIS; MANAGEMENT; EXTENSORS; CAPACITY; VALIDITY	Background. Reduced gait speed is common following traumatic brain injury (TBI). Several studies have found that people with TBI display increased lateral movement in their center of mass while walking. It has been hypothesized that reduced gait speed following TBI is a consequence of increased caution and postural instability, but reduced ankle power generation at push-off may also play a contributing role. Objective. To determine whether postural instability or reduced muscle power were associated with reduced gait speed following TBI. Methods . A convenience sample of 55 people with TBI receiving physiotherapy for gait disorders were assessed using 3D gait analysis at self-selected and fast walking speeds. A comparison group of 10 healthy controls performed walking trials at a speed matched to the mean TBI self-selected speed and at a fast walking speed. Results. When matched for speed, people with TBI walked with similar cadence and step length but with reduced ankle power generation at push-off and increased hip power generation both in early stance and in preswing compared with healthy controls. Width of base of support and postural instability were also significantly increased for people with TBI. The differences between the 2 groups at the matched speed remained for the fast speed condition. Postural stability did not deteriorate with increasing gait speed in either group. Conclusion. Reduced gait speed following TBI appears to be attributable to biomechanical deficiencies such as reduced ankle power generation rather than reduced postural stability and increased caution.	[Williams, Gavin] Epworth Med Fdn, Melbourne, Vic, Australia; [Williams, Gavin; Morris, Meg E.; Schache, Anthony; McCrory, Paul R.] Univ Melbourne, Melbourne, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	gavin.williams@epworth.org.au	McCrory, Paul/Q-8688-2019; Schache, Anthony G/F-4482-2016	Schache, Anthony G/0000-0002-1041-5213; Williams, Gavin/0000-0003-2758-7473; McCrory, Paul/0000-0003-4850-0568; Morris, Meg/0000-0002-0114-4175	Victorian Neurotrauma Initiative	This project was funded by the Victorian Neurotrauma Initiative as part of a postdoctoral fellowship.	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Esquenazi A, 2004, J HEAD TRAUMA REHAB, V19, P109, DOI 10.1097/00001199-200403000-00004; Goldberg SR, 2004, J BIOMECH, V37, P1189, DOI 10.1016/j.jbiomech.2003.12.005; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Hosalkar H, 2008, CLIN ORTHOP RELAT R, V466, P2500, DOI 10.1007/s11999-008-0395-0; Jonkers I, 2009, GAIT POSTURE, V29, P129, DOI 10.1016/j.gaitpost.2008.07.010; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Keenan M A, 1988, Orthop Rev, V17, P1185; LAWRENCE SJ, 1994, FOOT ANKLE INT, V15, P340, DOI 10.1177/107110079401500610; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Milot MH, 2008, CLIN BIOMECH, V23, P415, DOI 10.1016/j.clinbiomech.2007.11.003; Milot MH, 2007, J ELECTROMYOGR KINES, V17, P184, DOI 10.1016/j.jelekin.2006.01.001; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; Neptune RR, 2008, GAIT POSTURE, V28, P135, DOI 10.1016/j.gaitpost.2007.11.004; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Perry J, 1999, J HEAD TRAUMA REHAB, V14, P116, DOI 10.1097/00001199-199904000-00003; Requiao LF, 2005, J ELECTROMYOGR KINES, V15, P393, DOI 10.1016/j.jelekin.2004.12.004; Schache AG, 2007, GAIT POSTURE, V25, P440, DOI 10.1016/j.gaitpost.2006.05.018; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, J HEAD TRAU IN PRESS; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	26	28	28	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683			NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUL	2010	24	6					550	558		10.1177/1545968309357925			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	616RB	WOS:000279225400006	20086196	Green Submitted			2022-02-06	
J	Bombardier, CH; Ehde, DM; Stoelb, B; Molton, IR				Bombardier, Charles H.; Ehde, Dawn M.; Stoelb, Brenda; Molton, Ivan R.			The Relationship of Age-Related Factors to Psychological Functioning Among People With Disabilities	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Multiple sclerosis; Growth; Aging; Depression	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; SELF-RATED HEALTH; MULTIPLE-SCLEROSIS; POSTTRAUMATIC GROWTH; MAJOR DEPRESSION; PERCEIVED BENEFIT; POSITIVE CHANGE; BREAST-CANCER; LIFE	The potential influence of age and aging on the psychological functioning of people with disabilities is surprisingly complex. In people with spinal cord injury or multiple sclerosis, depression is highly prevalent. The limited research in this area indicates that older age and greater time span since disability onset may be associated with less self-reported depressive symptoms. Posttraumatic growth (PTG) and benefit finding (BF) are also common in people with disabilities. Older age tends to be associated with less BF and PTG. Studies that use longitudinal designs and examine multiple age-related factors simultaneously are needed. Potential mediators of age-related effects, such as historical trends, life-cycle events, maturity, and declining health, also need to be examined. There are many interesting theoretic and empiric concepts from aging research that can inform future research on the psychological aspects of aging with disability.	[Bombardier, Charles H.; Ehde, Dawn M.; Molton, Ivan R.] Univ Washington, Harborview Med Ctr, Sch Med, Dept Rehabil Med, Seattle, WA 98104 USA; [Stoelb, Brenda] Talaria Inc, Seattle, WA 98122 USA; [Molton, Ivan R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Bombardier, CH (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, Dept Rehabil Med, 325 9th Ave,Box 359612, Seattle, WA 98104 USA.	chb@uw.edu	Ehde, Dawn/K-1883-2016; Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283; Ehde, Dawn/0000-0002-9555-2347	Department of Education, National Institute on Disability and Rehabilitation Research [H133B080024]	This research was supported, in part, by a grant from the Department of Education, National Institute on Disability and Rehabilitation Research (H133B080024). The contents of this article do not necessarily represent the policy of the Department of Education and the reader should not assume endorsement by the Federal Government.	Albright KJ, 2008, REHABIL PSYCHOL, V53, P400, DOI 10.1037/a0013040; Alexopoulos GS, 2008, INT J GERIATR PSYCH, V23, P782, DOI 10.1002/gps.1988; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arnett P, 2005, MULT SCLER J, V11, P328, DOI 10.1191/1352458505ms1162oa; Arnett PA, 2006, J NEUROL NEUROSUR PS, V77, P606, DOI 10.1136/jnnp.2004.047712; Bamer AM, 2008, GEN HOSP PSYCHIAT, V30, P311, DOI 10.1016/j.genhosppsych.2008.04.006; Beal CC, 2007, ARCH PSYCHIAT NURS, V21, P181, DOI 10.1016/j.apnu.2007.02.008; Beiske AG, 2008, EUR J NEUROL, V15, P239, DOI 10.1111/j.1468-1331.2007.02041.x; Bellizzi KM, 2004, INT J AGING HUM DEV, V58, P267, DOI 10.2190/DC07-CPVW-4UVE-5GK0; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; BLAND RC, 1988, ACTA PSYCHIAT SCAND, V77, P33, DOI 10.1111/j.1600-0447.1988.tb08545.x; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Caine ED, 1994, DIAGNOSIS TREATMENT, P21; Calhoun L. G., 1998, POSTTRAUMATIC GROWTH; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Cetin K, 2007, MULT SCLER, V13, P1046, DOI 10.1177/1352458507077864; Charlifue S, 2004, ARCH PHYS MED REHAB, V85, P1848, DOI 10.1016/j.apmr.2004.03.017; Charlifue S, 2004, NEUROREHABILITATION, V19, P15; Charlifue SW, 1999, ARCH PHYS MED REHAB, V80, P1429, DOI 10.1016/S0003-9993(99)90254-X; Chwalisz K, 2008, REHABIL PSYCHOL, V53, P387, DOI 10.1037/a0012998; Chwastiak L, 2002, AM J PSYCHIAT, V159, P1862, DOI 10.1176/appi.ajp.159.11.1862; Chwastiak LA, 2007, PSYCHIAT CLIN N AM, V30, P803, DOI 10.1016/j.psc.2007.07.003; Cole MG, 1996, INT J GERIATR PSYCH, V11, P157, DOI 10.1002/(SICI)1099-1166(199602)11:2<157::AID-GPS304>3.0.CO;2-S; Cole MG, 1999, AM J PSYCHIAT, V156, P1182; Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176; Dalton EJ, 2005, NEUROPSYCHOLOGY, V19, P152, DOI 10.1037/0894-4105.19.2.152; Davis CG, 1998, J PERS SOC PSYCHOL, V75, P561, DOI 10.1037/0022-3514.75.2.561; Diener E, 1997, ANN REV GERONTOLOGY; Ehde DM, 2006, TRAUMA REHABILITATION, P245; Ehde Dawn M, 2005, Phys Med Rehabil Clin N Am, V16, P437, DOI 10.1016/j.pmr.2005.01.010; Ehde DM., 2009, HDB REHABILITATION P, P417; Elliott TR, 1996, ARCH PHYS MED REHAB, V77, P816, DOI 10.1016/S0003-9993(96)90263-4; ELLIOTT TR, 2002, HDB POSITIVE PSYCHOL, P00687; Evers AWM, 2001, J CONSULT CLIN PSYCH, V69, P1026, DOI 10.1037//0022-006X.69.6.1026; First M.B., 1996, STRUCTURED CLIN INTE; Fiske A, 1998, COMPREHENSIVE CLIN P, P193; Frazier P, 2001, J CONSULT CLIN PSYCH, V69, P1048, DOI 10.1037//0022-006X.69.6.1048; FRIEDHOFF AJ, 1992, JAMA-J AM MED ASSOC, V268, P1018, DOI 10.1001/jama.1992.03490080092032; Galeazzi GM, 2005, NEUROL SCI, V26, P255, DOI 10.1007/s10072-005-0468-8; Glass CA, 1997, SPINAL CORD, V35, P349, DOI 10.1038/sj.sc.3100448; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Hitzig SL, 2008, AM J PHYS MED REHAB, V87, P545, DOI 10.1097/PHM.0b013e31817c16d6; Holicky R, 1999, DISABIL REHABIL, V21, P250; Idler EL, 2003, GERONTOLOGIST, V43, P372, DOI 10.1093/geront/43.3.372; Joseph S, 2006, CLIN PSYCHOL REV, V26, P1041, DOI 10.1016/j.cpr.2005.12.006; Kalpakjian CZ, 2009, J SPINAL CORD MED, V32, P6, DOI 10.1080/10790268.2009.11760748; Kasl-Godley JE, 1998, CLINICAL GEROPSYCHOLOGY, P211, DOI 10.1037/10295-019; Kemp BJ, 1999, DISABIL REHABIL, V21, P241; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; Krause JS, 2008, ARCH PHYS MED REHAB, V89, P1482, DOI 10.1016/j.apmr.2007.11.062; Krause JS, 2000, ARCH PHYS MED REHAB, V81, P1099, DOI 10.1053/apmr.2000.7167; Kwok OM, 2008, REHABIL PSYCHOL, V53, P370, DOI 10.1037/a0012765; Laidlaw K, 2008, INT J GERIATR PSYCH, V23, P843, DOI 10.1002/gps.1993; Lechner SC, 2008, TRAUMA RECOVERY GROW, P207; Lenze Eric J, 2008, Dialogues Clin Neurosci, V10, P419; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; LYONS JA, 2008, TRAUMA RECOVERY GROW, P233; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; MCMILLEN C, 1995, J CONSULT CLIN PSYCH, V63, P1037, DOI 10.1037/0022-006X.63.6.1037; McMillen JC, 1997, J CONSULT CLIN PSYCH, V65, P733, DOI 10.1037/0022-006X.65.5.733; McMillen JC, 2003, REHABIL PSYCHOL, V48, P77, DOI 10.1037/0090-5550.48.2.77; Milam J, 2005, TRAUMATOLOGY, V11, P233, DOI DOI 10.1177/153476560501100404; Milam JE, 2004, J ADOLESCENT RES, V19, P192, DOI 10.1177/0743558403258273; Mohr DC, 2007, MULT SCLER J, V13, P215, DOI 10.1177/1352458506070926; NEWMANN JP, 1991, PSYCHOL AGING, V6, P212, DOI 10.1037/0882-7974.6.2.212; Oaksford K, 2005, REHABIL PSYCHOL, V50, P266, DOI 10.1037/0090-5550.50.3.266; Pakenham KI, 2005, HEALTH PSYCHOL, V24, P123, DOI 10.1037/0278-6133.24.2.123; Pargament KI, 1998, J SCI STUD RELIG, V37, P710, DOI 10.2307/1388152; Park C. L., 2005, TRAUMATOLOGY, V11, P297, DOI [10.1177/153476560501100408, DOI 10.1177/153476560501100408]; Park CL, 1996, J PERS, V64, P71, DOI 10.1111/j.1467-6494.1996.tb00815.x; Patten SB, 2003, NEUROLOGY, V61, P1524, DOI 10.1212/01.WNL.0000095964.34294.B4; Patten SB, 2000, MULT SCLER, V6, P115, DOI 10.1177/135245850000600210; Phillips LJ, 2008, J HOLIST NURS, V26, P41, DOI 10.1177/0898010107301870; Pollard C, 2007, BRIT J HEALTH PSYCH, V12, P347, DOI 10.1348/135910707X197046; Powell S, 2003, J CLIN PSYCHOL, V59, P71, DOI 10.1002/jclp.10117; Powell T, 2007, BRAIN INJURY, V21, P31, DOI 10.1080/02699050601106245; PROHASKA TR, 1987, HEALTH PSYCHOL, V6, P495, DOI 10.1037/0278-6133.6.6.495; Richardson EJ, 2008, REHABIL PSYCHOL, V53, P243, DOI 10.1037/0090-5550.53.2.243; Rosenbach C, 2008, J BURN CARE RES, V29, P638, DOI 10.1097/BCR.0b013e31817de275; Saikkonen J, 2004, SPINAL CORD, V42, P459, DOI 10.1038/sj.sc.3101618; Schroots JJF, 1996, GERONTOLOGIST, V36, P742, DOI 10.1093/geront/36.6.742; SCHULZ R, 1985, J PERS SOC PSYCHOL, V48, P1162, DOI 10.1037/0022-3514.48.5.1162; Siegel K, 2000, SOC SCI MED, V51, P1543, DOI 10.1016/S0277-9536(00)00144-1; Tashakkori A, 2009, FDN MIXED METHODS RE; TATE D, 1994, AM J PHYS MED REHAB, V73, P175, DOI 10.1097/00002060-199406000-00006; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tennen H., 2002, HDB POSITIVE PSYCHOL, P584; Tsivgoulis G, 2007, ACTA NEUROL SCAND, V115, P67, DOI 10.1111/j.1600-0404.2006.00736.x; VANMARWIJK H, 1994, FAM PRACT, V11, P80; Weiss T, 2002, J PSYCHOSOC ONCOL, V20, P65, DOI 10.1300/J077v20n02_04; Wells K B, 1991, Psychiatr Med, V9, P503; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Wilhelm K, 2003, J AFFECT DISORDERS, V75, P155, DOI 10.1016/S0165-0327(02)00040-X; Williams RM, 2005, NEUROLOGY, V64, P75, DOI 10.1212/01.WNL.0000148480.31424.2A; WILLIAMSON GM, 1995, PSYCHOL AGING, V10, P369, DOI 10.1037/0882-7974.10.3.369; Yang Y, 2007, J HEALTH SOC BEHAV, V48, P16, DOI 10.1177/002214650704800102	98	28	29	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2010	21	2					281	+		10.1016/j.pmr.2009.12.005			19	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	613GC	WOS:000278966400005	20494277				2022-02-06	
J	Mealings, M; Douglas, J				Mealings, Margaret; Douglas, Jacinta			'School's a big part of your life ... ': Adolescent Perspectives of Their School Participation Following Traumatic Brain Injury	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; adolescent; student	STUDENTS; CHILDREN; REHABILITATION; EDUCATION; PREDICTORS; CHILDHOOD; SERVICES; OUTCOMES; TBI	Sustaining a traumatic brain injury (TBI) as an adolescent has a significant impact on life roles and most notably on that of school participation. In the literature there is a wide range of studies that provide clinicians with information regarding recommendations for assisting students in their return to school. However this information has predominantly been provided from the perspectives of educators and rehabilitation staff. The aim of this preliminary project was to hear the stories of three male adolescent students as they reflected on their own experiences of what it was like to go back to school after sustaining a severe TBI. Using a qualitative research design and in-depth interviews, the students' stories were transcribed and coded using grounded theory principles. Despite persisting communication difficulties, the students were able to provide rich stories indicative of their personal experiences. Three key themes emerged from the interviews: the adolescent student's sense of self, changes the students noted; and supports the students identified. A tentative model illustrating the relationship between these areas was developed. It is anticipated that this model will assist clinicians and educators to develop a holistic picture of a student's school participation from transition to ongoing school life.	[Mealings, Margaret] Epworth Healthcare, Melbourne, Vic, Australia; [Mealings, Margaret; Douglas, Jacinta] La Trobe Univ, Bundoora, Vic 3086, Australia		Mealings, M (corresponding author), Epworth Rehabil, Community Integrat Team, 89 Bridge Rd, Richmond, Vic 3121, Australia.	margaret.mealings@epworth.org.au		Douglas, Jacinta/0000-0003-0940-6624			Access Economics , 2009, EC COST SPIN CORD IN; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Backhouse M, 1999, AUST OCCUP THER J, V46, P99, DOI DOI 10.1046/J.1440-1630.1999.00183.X; Beaulieu CL, 2002, SURG CLIN N AM, V82, P393, DOI 10.1016/S0039-6109(02)00009-9; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P220, DOI 10.1097/01.HTR.0000327254.61751.e7; Blosser J, 1997, J HEAD TRAUMA REHAB, V12, P21, DOI 10.1097/00001199-199704000-00004; Blosser JL, 2003, PEDIAT TRAUMATIC BRA; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; BROWNE J, 2004, HDB RES METHODS NURS; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; Corbin J.M., 1998, BASICS QUALITATIVE R; DAmato RC, 1996, J LEARN DISABIL, V29, P670, DOI 10.1177/002221949602900611; Farmer J., 1996, 5 C INT ASS STUD BRA; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Feeney T., 1997, STUDENTS ACQUIRED BR; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Glang A, 2004, NEUROREHABILITATION, V19, P219; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Heiman T, 2003, J LEARN DISABIL-US, V36, P248, DOI 10.1177/002221940303600304; Helps Y, 2008, INJURY RES STAT SERI, V45; Johnson P, 2006, BRAIN COGNITION, V60, P205; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Kao Hsueh-Fen S, 2004, J Neurosci Nurs, V36, P73; Kennedy M, 2008, NEUROREHABILITATION, V23, P219; King Gillian, 2002, Physical and Occupational Therapy in Pediatrics, V22, P53, DOI 10.1300/J006v22n02_04; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Lloyd V, 2006, QUAL HEALTH RES, V16, P1386, DOI 10.1177/1049732306293846; Maddren E.K., 1996, 5 C INT ASS STUD TRA; McGavin Heather, 1998, Physical and Occupational Therapy in Pediatrics, V18, P69, DOI 10.1300/J006v18n01_05; McMahon MA, 2001, J HEAD TRAUMA REHAB, V16, P587, DOI 10.1097/00001199-200112000-00006; Miller LJ, 2003, REHABIL PSYCHOL, V48, P237, DOI 10.1037/0090-5550.48.4.237; Minichiello V., 2004, HDB RES METHODS NURS, P59; Morse J.M., 2002, READ ME 1 USERS GUID; Parkin AE., 1996, AUSTR OCCUPATIONAL T, V43, P133; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, PEDIATR ANN, V23, P38, DOI 10.3928/0090-4481-19940101-09; Savage RC, 1997, J HEAD TRAUMA REHAB, V12, P11, DOI 10.1097/00001199-199704000-00003; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Todis B., 1997, STUDENTS ACQUIRED BR; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Vaidya AA, 2002, COGNITIVE TECHNOLOGY, V7, P38; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2003, J HEAD TRAUMA REHAB, V18, P164, DOI 10.1097/00001199-200303000-00007; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; WHO, 2014, INT CLASS FUNCT; Yates L., 2008, KEEP CONN YOUNG PEOP; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	52	28	28	0	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2010	11	1					1	16		10.1375/brim.11.1.1			16	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	V24IR	WOS:000208404600001					2022-02-06	
J	Dimoska, A; McDonald, S; Pell, MC; Tate, RL; James, CM				Dimoska, A.; McDonald, S.; Pell, M. C.; Tate, R. L.; James, C. M.			Recognizing vocal expressions of emotion in patients with social skills deficits following traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Emotion perception; Prosody; Semantic; Inhibitory control; Filtered; Nonsense	BLUNT HEAD-INJURY; AFFECTIVE PROSODY; FACIAL EXPRESSION; NEURAL RESPONSE; RECOGNITION; PERCEPTION; SPEECH; LATERALIZATION; LANGUAGE; FMRI	Perception of emotion in voice is impaired following traumatic brain injury (TBI). This Study examined whether an inability to concurrently process semantic information (the "what") and emotional prosody (the "how") of spoken speech contributes to impaired recognition of emotional prosody and whether impairment is ameliorated when little or no semantic information is provided. Eighteen individuals with mod crate-to-severe TBI showing social skills deficits during inpatient rehabilitation were compared with 18 demographically matched controls. Participants completed two discrimination tasks using spoken sentences that varied in the amount of semantic information: that is, (I) well-formed English, (2) a nonsense language, and (3) low-pass filtered speech producing "muffled" voices. Reducing semantic processing demands did not improve perception of emotional prosody. The TBI group were significantly less accurate than controls. Impairment was greater within the TB I group when accessing semantic memory to label the emotion of sentences, compared with simply making "same/different" judgments. Findings suggest an impairment of processing emotional prosody itself rather than semantic processing demands which leads to an over-reliance oil the "what" rather than the "how," in conversational remarks. Emotional recognition accuracy was significantly related to the ability to inhibit prepotent responses, consistent with neuroanatomical research suggesting similar ventrofrontal systems subserve both functions. (JINS, 2010, 16, 369-382.)	[Dimoska, A.; McDonald, S.; James, C. M.] Univ New S Wales, Sch Psychol, Kensington, NSW 2052, Australia; [Pell, M. C.] McGill Univ, Sch Commun Sci & Disorders, Montreal, PQ H3G 1A8, Canada; [Tate, R. L.] Univ Sydney, Rehabil Studies Unit, No Cent Clin Sch, Sydney, NSW 2006, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Kensington, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014; Pell, Marc D./AAL-3121-2021	McDonald, Skye/0000-0003-0723-6094; Pell, Marc D./0000-0002-9947-1552	National Health & Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	This research was supported by a project grant from the National Health & Medical Research Council of Australia. We express our gratitude to people with traumatic brain injuries who participated in the Studies reported here as well as to our community control participants who gave willingly of' their time. The authors have no competing or conflicts of interest to report.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Baum SR, 1999, APHASIOLOGY, V13, P581, DOI 10.1080/026870399401957; Beaucousin V, 2007, CEREB CORTEX, V17, P339, DOI 10.1093/cercor/bhj151; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BEHRENS SJ, 1985, BRAIN LANG, V26, P332, DOI 10.1016/0093-934X(85)90047-1; Besle J, 2004, EUR J NEUROSCI, V20, P2225, DOI 10.1111/j.1460-9568.2004.03670.x; Besson M, 2002, TRENDS COGN SCI, V6, P405, DOI 10.1016/S1364-6613(02)01975-7; Boersma P, 2007, PRAAT MANUAL VERSION; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; BOWERS D, 1987, NEUROPSYCHOLOGIA, V25, P317, DOI 10.1016/0028-3932(87)90021-2; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Creusere M, 2004, J COMMUN DISORD, V37, P5, DOI 10.1016/S0021-9924(03)00036-4; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAMASIO AR, 1994, SCI AM, V271, P144, DOI 10.1038/scientificamerican1094-144; de Gelder B, 2000, COGNITION EMOTION, V14, P289, DOI 10.1080/026999300378824; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Dujardin K, 2004, NEUROPSYCHOLOGIA, V42, P239, DOI 10.1016/S0028-3932(03)00154-4; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; Ekman P, 1976, PICTURES FACIAL EFFE; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Freedman M, 1998, CEREB CORTEX, V8, P18, DOI 10.1093/cercor/8.1.18; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Grimshaw GM, 1998, BRAIN COGNITION, V36, P108, DOI 10.1006/brcg.1997.0949; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HEILMAN KM, 1984, NEUROLOGY, V34, P917, DOI 10.1212/WNL.34.7.917; Hess U., 1988, FACETS EMOTION RECEN, P161; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; JERGER S, 1993, PERCEPT PSYCHOPHYS, V54, P310, DOI 10.3758/BF03205266; Johnstone T, 2006, SOC COGN AFFECT NEUR, V1, P242, DOI 10.1093/scan/nsl027; Kaganovich N, 2006, BRAIN RES, V1114, P161, DOI 10.1016/j.brainres.2006.07.049; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Koff E, 1999, J INT NEUROPSYCH SOC, V5, P32, DOI 10.1017/S1355617799511053; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; LALANDE S, 1992, BRAIN LANG, V42, P165, DOI 10.1016/0093-934X(92)90123-V; Langenecker SA, 2005, J CLIN EXP NEUROPSYC, V27, P320, DOI 10.1080/13803390490490515720; Leinonen L, 1997, J ACOUST SOC AM, V102, P1853, DOI 10.1121/1.420109; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lew H, 1997, J Am Acad Audiol, V8, P104; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Marquardt TP, 2001, APHASIOLOGY, V15, P1091, DOI 10.1080/02687040143000429; Martin I, 2004, J AUTISM DEV DISORD, V34, P311, DOI 10.1023/B:JADD.0000029553.52889.15; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mitchell RLC, 2008, NEUROPSYCHOLOGIA, V46, P2880, DOI 10.1016/j.neuropsychologia.2008.05.024; Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4; MORGAN ALR, 1989, BRAIN LANG, V36, P592, DOI 10.1016/0093-934X(89)90088-6; OSCHNER KN, 2001, EMOTIONS CURRENT ISS, P38; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pell MD, 2003, COGN AFFECT BEHAV NE, V3, P275, DOI 10.3758/CABN.3.4.275; Pell MD, 2009, J PHONETICS, V37, P417, DOI 10.1016/j.wocn.2009.07.005; Pell MD, 1997, BRAIN LANG, V57, P80, DOI 10.1006/brln.1997.1638; Pell MD, 2006, BRAIN LANG, V96, P221, DOI 10.1016/j.bandl.2005.04.007; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Ross ED, 1997, BRAIN LANG, V56, P27, DOI 10.1006/brln.1997.1731; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; Roth PL, 1999, ORGAN RES METHODS, V2, P211, DOI 10.1177/109442819923001; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; SCHLANGER BB, 1976, BRAIN LANG, V3, P396, DOI 10.1016/0093-934X(76)90035-3; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Starkstein SE, 1997, J NERV MENT DIS, V185, P108, DOI 10.1097/00005053-199702000-00007; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TOMPKING CA, 1985, J SPEECH HEAR RES, V28, P527, DOI 10.1044/jshr.2804.527; Uekermann J, 2005, CORTEX, V41, P189, DOI 10.1016/S0010-9452(08)70893-1; VOGT BA, 1986, CEREB CORTEX, V4, P89; Votruba KL, 2008, J HEAD TRAUMA REHAB, V23, P65, DOI 10.1097/01.HTR.0000314525.93381.69; Wambacq IJA, 2004, COGNITIVE BRAIN RES, V20, P427, DOI 10.1016/j.cogbrainres.2004.03.015; Zupan B, 2009, J COMMUN DISORD, V42, P1, DOI 10.1016/j.jcomdis.2008.06.001	93	28	30	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2010	16	2					369	382		10.1017/S1355617709991445			14	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	562DZ	WOS:000275030900018	20128951				2022-02-06	
J	Kosch, Y; Browne, S; King, C; Fitzgerald, J; Cameron, I				Kosch, Y.; Browne, S.; King, C.; Fitzgerald, J.; Cameron, I.			Post-traumatic amnesia and its relationship to the functional outcome of people with severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; post-traumatic amnesia; outcome; length of stay	CLOSED-HEAD INJURY; INDEPENDENCE MEASURE; MEDICAL REHABILITATION; RELIABILITY; VALIDATION; SYSTEM	Objective: To investigate the relationship between Post-Traumatic Amnesia (PTA) duration, length of stay and functional outcomes in Australian in-patients with severe traumatic brain injury (TBI). Design: Retrospective, descriptive study using prospectively collected data from the Uniform Data Set for Medical Rehabilitation (UDSMR). Methods: Prospective collection of Westmead PTA scores and analysis of database for admissions for primary TBI rehabilitation from 1993-2003. Functional Independence Measure (FIM) was used to measure functional outcome. Statistical analysis using SPSS Version 13. Results: Six hundred and thirty-eight consecutive admissions; 611 patients had PTA classified by ranges, 436 of whom had an exact number of PTA days. Mean age 37.6 years; more than 90% had a PTA duration greater than 1 week. Significant predictors of discharge FIM scores and total length of hospitalization were PTA duration, admission FIM scores and acute length of hospitalization. Conclusions: PTA duration correlates with length of hospitalization and discharge function. PTA duration affects recovery rate. Implications include use of PTA duration for prognosticating, discharge planning and funding systems.	[Kosch, Y.; Browne, S.; King, C.; Fitzgerald, J.; Cameron, I.] Royal Rehabil Ctr Sydney, Brain Injury Unit, Ryde, NSW, Australia		Kosch, Y (corresponding author), Liverpool Hosp, Brain Injury Unit, Locked Bag 7103, Bc, NSW 1871, Australia.	yvette.kosch@sswahs.nsw.gov.au					Ahmed S, 2000, BRAIN INJURY, V14, P765; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; GRANGER CV, 1992, AM J PHYS MED REHAB, V71, P108, DOI 10.1097/00002060-199204000-00009; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; GRANGER CV, 1997, GUIDE UNIFORM DATA M; Gurka JA, 1999, J HEAD TRAUMA REHAB, V14, P247, DOI 10.1097/00001199-199906000-00005; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Marosszeky NEV, 1998, PTA PROTOCOL GUIDELI; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; RUSSEL WR, 1935, LANCET           OCT, P762; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; STINEMAN MG, 1994, MED CARE, V32, P366, DOI 10.1097/00005650-199404000-00005; STINEMAN MG, 1994, ARCH PHYS MED REHAB, V75, P1277; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; TATE R, BRAIN INJURY OUTCOME; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	31	28	29	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2010	24	3					479	485		10.3109/02699051003610417			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	574JR	WOS:000275985800004	20184405				2022-02-06	
J	Umschwief, G; Shein, NA; Alexandrovich, AG; Trembovler, V; Horowitz, M; Shohami, E				Umschwief, Gali; Shein, Na'ama A.; Alexandrovich, Alexander G.; Trembovler, Victoria; Horowitz, Michal; Shohami, Esther			Heat acclimation provides sustained improvement in functional recovery and attenuates apoptosis after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Bad; Bcl-xL; caspase-3; cytochrome c; neuroprotection	MIDDLE CEREBRAL-ARTERY; CENTRAL-NERVOUS-SYSTEM; NEURONAL CELL-DEATH; TRANSGENIC MICE; CHANNEL ACTIVITY; CROSS-TOLERANCE; CNS INJURY; BCL-X; ISCHEMIA; BAD	Heat acclimation (HA) offers functional neuroprotection in mice after traumatic brain injury (TBI). This study further characterizes endogenous neuroprotection acquired by HA (34 +/- 1 degrees C, 30 d) after TBI. We establish here the ability of HA to induce sustained functional benefits and to reduce activation of apoptotic pathways. Neurobehavioral recovery, assessed by the Neurological Severity Score, was greater in HA mice up to 8 days after injury as compared with normothermic controls (P < 0.05) and lesion volume was also smaller in the HA group (P < 0.05). Reduced apoptotic cell death in HA mice was confirmed using caspase-3 activity measurements and immunohistochemistry. To investigate the underlying molecular pathways, expression levels of intrinsic apoptotic pathway-related proteins were examined. HA mice displayed higher mitochondrial levels of antiapoptotic Bcl-xL, accompanied by lower proapoptotic Bad levels and decreased cytochrome c release, suggesting a higher apoptotic threshold. Taken together with our previous reports, indicating increased Akt phosphorylation and antioxidative capacity, alongside with reduced tumor necrosis alpha levels after TBI in HA animals, the current results support the involvement of an antiapoptotic effect in HA-induced neuroprotection. Current results warrant further study as TBI-induced apoptosis may persist over weeks after injury, possibly providing a target for belated therapeutic intervention. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 616-627; doi: 10.1038/jcbfm.2009.234; published online 11 November 2009	[Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; [Umschwief, Gali; Shein, Na'ama A.; Horowitz, Michal] Hebrew Univ Jerusalem, Dept Physiol, IL-91120 Jerusalem, Israel		Shohami, E (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel.	horowitz@cc.huji.ac.il; esty@cc.huji.ac.il			ISFIsrael Science Foundation [241/04]	This work was supported in part by a grant (# 241/04) from the ISF. ES is a member in the Brettler Center for Research in Molecular Pharmacology and Therapeutics, and the incumbent of the Dr Leon and Mina Deutch Chair in psychopharmacology at the Hebrew University.	Arieli Y, 2003, BRAIN RES, V962, P15, DOI 10.1016/S0006-8993(02)03681-8; ASSAYAG MG, 2007, 15 EUR AP 4 TRAIN CO; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bonanni L, 2006, J NEUROSCI, V26, P6851, DOI 10.1523/JNEUROSCI.5444-05.2006; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chong ZZ, 2004, ANTIOXID REDOX SIGN, V6, P277, DOI 10.1089/152308604322899341; Condorelli F, 2001, MOL CELL BIOL, V21, P3025, DOI 10.1128/MCB.21.9.3025-3036.2001; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Fukunaga K, 2003, J PHARMACOL SCI, V92, P317; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; Graham SH, 2000, J NEUROTRAUM, V17, P831, DOI 10.1089/neu.2000.17.831; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Horowitz M, 2007, PROG BRAIN RES, V162, P373, DOI 10.1016/S0079-6123(06)62018-9; Kamada H, 2007, J CEREBR BLOOD F MET, V27, P521, DOI 10.1038/sj.jcbfm.9600367; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; LEVI E, 1993, J APPL PHYSIOL, V75, P833, DOI 10.1152/jappl.1993.75.2.833; Miyawaki T, 2008, P NATL ACAD SCI USA, V105, P4892, DOI 10.1073/pnas.0800628105; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reshef A, 2008, J NEUROTRAUM, V25, P569, DOI 10.1089/neu.2007.0341; SCHMIDTNIELSEN K, 1964, ANIMAL PHYSL, P13; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shein NA, 2008, J NEUROTRAUM, V25, P112, DOI 10.1089/neu.2007.0358; Shein NA, 2007, BRAIN RES, V1185, P313, DOI 10.1016/j.brainres.2007.09.024; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Sugawara T, 2003, ANTIOXID REDOX SIGN, V5, P597, DOI 10.1089/152308603770310266; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Tehranian R, 2006, BRAIN RES, V1101, P126, DOI 10.1016/j.brainres.2006.05.049; Tetievsky A, 2008, PHYSIOL GENOMICS, V34, P78, DOI 10.1152/physiolgenomics.00215.2007; Wang FR, 2008, J HUAZHONG U SCI-MED, V28, P56, DOI 10.1007/s11596-008-0114-9; Wiessner C, 1999, NEUROSCI LETT, V268, P119, DOI 10.1016/S0304-3940(99)00392-4; Xilouri M, 2006, EUR J NEUROSCI, V23, P43, DOI 10.1111/j.1460-9568.2005.04548.x; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	41	28	31	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2010	30	3					616	627		10.1038/jcbfm.2009.234			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	563DV	WOS:000275108900016	19904288	Bronze, Green Published			2022-02-06	
J	Agudo-Lopez, A; Miguel, BG; Fernandez, I; Martinez, AM				Agudo-Lopez, Alba; Miguel, Begona G.; Fernandez, Inmaculada; Martinez, Ana M.			Involvement of mitochondria on neuroprotective effect of sphingosine-1-phosphate in cell death in an in vitro model of brain ischemia	NEUROSCIENCE LETTERS			English	Article						Sphingosine-1-phosphate; Ischemia; Mitochondria; Neuroprotection	PROTEIN-KINASE-C; PERMEABILITY TRANSITION; PKC-EPSILON; REPERFUSION INJURY; PORE; CARDIOPROTECTION; PROTECTION; CALCIUM; ANOXIA; RAT	Sphingosine-1-phosphate (S1P) has been demonstrated to be an important regulator of cell death and survival. Although it has been suggested that the sphingolipid may act as a neuroprotector in the cell apoptosis induced by traumatic brain injury, the mechanisms involved in this action are unknown. In this study, the relationship between SIP and neuroprotective effect was studied in an in vitro model of ischemia, maintaining SH-SY5Y human neuroblastoma cells under oxygen-glucose deprivation (OGD). When cells were treated with 1 mu M S1P simultaneously with OGD and recovery, cell viability increases in a dose-response manner. SI P treatment reduces significantly both necrosis and apoptosis cell death. On the other hand, the treatment with specific PKC epsilon (V1-2), prevents S1P protective effect of OGD/recovery-induced necrosis. Moreover, SIP treatment provokes the translocation of PKC epsilon to the mitochondria. From these results, it is reasonable to assume that SIP protection from necrosis is mediated by PKC epsilon. We also studied the action of SIP on mitochondrial inner membrane potential and mitochondrial Ca2+ levels during ischemia. In this regard, we must point out that S1P treatment reduces the OGD-induced membrane depolarization and also reduces the increase of Ca2+ in mitochondria during OGD. Results also indicate that mitochondria from OGD treated cells have significantly less ability to resist swelling on Ca2+ loading than those obtained in presence of oxygen and glucose. Nevertheless, when SI P was added, this resistance increases considerably. These findings suggest that SIP may have a potential role as a neuroprotective agent in brain injury. (C) 2009 Elsevier Ireland Ltd. All rights reserved.	[Agudo-Lopez, Alba; Miguel, Begona G.; Fernandez, Inmaculada; Martinez, Ana M.] Univ Complutense Madrid, Fac Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain		Martinez, AM (corresponding author), Univ Complutense Madrid, Fac Quim, Dept Bioquim & Biol Mol 1, E-28040 Madrid, Spain.	anamart@bbm1.ucm.es			Ministerio de Educacion (Spain)	We are extremely grateful to Dr. R.E. Catalan for helpful discussions and for reading of the manuscript. A. Agudo-Lopez was supported by a fellowship from Ministerio de Educacion (Spain).	ALLEY MC, 1988, CANCER RES, V48, P589; Barnett ME, 2007, CELL SIGNAL, V19, P1820, DOI 10.1016/j.cellsig.2007.05.014; Budas GR, 2007, BIOCHEM SOC T, V35, P1052, DOI 10.1042/BST0351052; Budas GR, 2007, PHARMACOL RES, V55, P523, DOI 10.1016/j.phrs.2007.04.005; Calcerrada MC, 2002, FEBS LETT, V514, P361, DOI 10.1016/S0014-5793(02)02401-8; Costa ADT, 2008, AM J PHYSIOL-HEART C, V295, pH874, DOI 10.1152/ajpheart.01189.2007; Costa ADT, 2006, J BIOL CHEM, V281, P20801, DOI 10.1074/jbc.M600959200; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; Iijima T, 2006, NEUROSCI RES, V55, P234, DOI 10.1016/j.neures.2006.04.005; Jaburek M, 2006, CIRC RES, V99, P878, DOI 10.1161/01.RES.0000245106.80628.d3; Javadov S, 2007, CELL PHYSIOL BIOCHEM, V20, P1, DOI 10.1159/000103747; Kametsu Y, 2003, J CEREBR BLOOD F MET, V23, P416, DOI 10.1097/01.WCB.0000052281.23292.7C; Khaliulin I, 2004, FREE RADICAL BIO MED, V37, P1, DOI 10.1016/j.freeradbiomed.2004.04.017; Kim MY, 2006, BRIT J PHARMACOL, V149, P1059, DOI 10.1038/sj.bjp.0706922; Miglio G, 2004, EUR J PHARMACOL, V489, P157, DOI 10.1016/j.ejphar.2004.03.006; MIYATA H, 1992, CIRC RES, V71, P605, DOI 10.1161/01.RES.71.3.605; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Ruiz-Meana M, 2006, CARDIOVASC RES, V71, P715, DOI 10.1016/j.cardiores.2006.06.019; Singh IN, 2008, J NEUROSCI RES, V86, P1419, DOI 10.1002/jnr.21586; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103	26	28	34	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	FEB 12	2010	470	2					130	133		10.1016/j.neulet.2009.12.070			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	561AJ	WOS:000274946900009	20045720				2022-02-06	
J	Covey, MV; Jiang, YH; Alli, VV; Yang, ZG; Levison, SW				Covey, Matthew V.; Jiang, Yuhui; Alli, Vamsi V.; Yang, Zhengang; Levison, Steven W.			Defining the Critical Period for Neocortical Neurogenesis after Pediatric Brain Injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						Subventricular zone; Stem cells; Neurons; Regenerative medicine; Traumatic brain injury; Brain damage	NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; FRONTAL LESIONS; CEREBRAL-CORTEX; ADULT RATS; PERSISTENT PRODUCTION; MIGRATORY PATHWAY; CORTICAL-LESIONS; NERVOUS-SYSTEM; COLD-INJURY	Pediatric traumatic brain injury (TBI) is a significant and underappreciated societal problem. Whereas many TBI studies have evaluated the mechanisms of cell death after TBI, fewer studies have evaluated the extent to which regeneration is occurring. Here we used a cryoinjury model to damage the somatosensory cortex of rats at postnatal day 6 (P6), P10 and P21. We evaluated the production of new neocortical neurons using a combination of 5-bromo-2-deoxyuridine (BrdU) labeling combined with staining for doublecortin (DCX). BrdU+/DCX+ bipolar cells were observed adjacent to the neocortical lesion, with their processes oriented perpendicular to the pial surface. As the animals aged, both the overall proliferative response as well as the production of neocortical neuroblasts diminished, with P6 animals responding most robustly, P10 animals less strongly, and P21 animals showing a very modest proliferative response and virtually no evidence of neocortical neurogenesis. When BrdU was administered at increasingly delayed intervals after the injury at P6, there was a clear difference in the number of new neuroblasts produced as a function of age, with the greatest number of new neocortical neurons produced between 4 and 7 days after the injury. These studies demonstrate that the immature brain has the capacity to produce neocortical neurons after traumatic injury, but this capacity diminishes as the brain continues to develop. Furthermore, in contrast to moderate hypoxic/ischemic brain damage in the P6 rat, where neurogenesis persists for at least 2 months, the response to cryoinjury is quite different as the neurogenic response diminishes over time. Copyright (C) 2010 S. Karger AG, Basel	[Levison, Steven W.] Univ Med & Dent New Jersey, New Jersey Med Sch, Lab Regenerat Neurobiol, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Covey, Matthew V.; Jiang, Yuhui; Alli, Vamsi V.; Yang, Zhengang; Levison, Steven W.] Univ Med & Dent New Jersey, New Jersey Med Sch, Univ Hosp Canc Ctr, Newark, NJ 07103 USA		Levison, SW (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Lab Regenerat Neurobiol, Dept Neurol & Neurosci, 205 S Orange Ave,H-1226, Newark, NJ 07103 USA.	steve.levison@umdnj.edu	Levison, Steven W./Q-6903-2019	Levison, Steven W./0000-0002-1264-7309; Covey, Matthew/0000-0002-0160-6712; Alli, Vamsi/0000-0002-6569-4272	New Jersey Commission on Brain Injury Research [08.001.BIR2]	These studies were supported by a grant from the New Jersey Commission on Brain Injury Research awarded to S.W.L. (No. 08.001.BIR2).	Alagappan D, 2009, ASN NEURO, V1, DOI 10.1042/AN20090002; Alonso G, 1999, J COMP NEUROL, V405, P508, DOI 10.1002/(SICI)1096-9861(19990322)405:4<508::AID-CNE5>3.0.CO;2-5; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Felling RJ, 2006, J NEUROSCI, V26, P4359, DOI 10.1523/JNEUROSCI.1898-05.2006; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Gorlach C, 2000, PFLUG ARCH EUR J PHY, V440, P309; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Jankovski A, 1996, J COMP NEUROL, V371, P376; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Kolb B, 1998, BEHAV BRAIN RES, V91, P127, DOI 10.1016/S0166-4328(97)00112-5; KOLB B, 1987, BEHAV BRAIN RES, V25, P205, DOI 10.1016/0166-4328(87)90069-6; Kolb B, 1996, BEHAV NEUROSCI, V110, P1271, DOI 10.1037/0735-7044.110.6.1271; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Miller JT, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-63; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Romanko MJ, 2004, J CEREBR BLOOD F MET, V24, P814, DOI 10.1097/01.WCB.0000123906.17746.00; ROMIJN HJ, 1991, EARLY HUM DEV, V26, P61, DOI 10.1016/0378-3782(91)90044-4; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Smith KS, 2007, BEHAV NEUROSCI, V121, P449, DOI 10.1037/0735-7044.121.3.449; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Szele FG, 1996, J COMP NEUROL, V368, P439, DOI 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; WILLIS P, 1976, NEUROPATH APPL NEURO, V2, P377, DOI 10.1111/j.1365-2990.1976.tb00511.x; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang ZG, 2007, DEV NEUROSCI-BASEL, V29, P331, DOI 10.1159/000105474; Yang ZG, 2007, ANN NEUROL, V61, P199, DOI 10.1002/ana.21068; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008	33	28	28	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2010	32	5-6					488	498		10.1159/000321607			11	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	725RO	WOS:000287663900017	21160158				2022-02-06	
J	Helmick, K				Helmick, Katherine		Consensus Conf	Cognitive rehabilitation for military personnel with mild traumatic brain injury and chronic post-concussional disorder: Results of April 2009 consensus conference	NEUROREHABILITATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; NEUROPSYCHOLOGIC REHABILITATION; MEMORY REMEDIATION; SELF-AWARENESS; PROGRAM; MANAGEMENT; INTERVENTION; ATTENTION; DEFICITS	A consensus conference on cognitive rehabilitation for mild traumatic brain injury was conducted by the Defense Centers of Excellence for Psychological Health and Traumatic Brain Injury and the Defense and Veterans Brain Injury Center. Fifty military and civilian subject matter experts from a broad range of clinical and scientific disciplines developed clinical guidance for the care of Service Members with persistent post-concussion cognitive symptoms three or more months post injury. "Cognitive rehabilitation" was identified to be a broad group of diverse services. Specific services within this rubric were identified as effective or not, and were evaluated both as single-services and as combined integrated cognitive rehabilitation programs. Co-morbidities were acknowledged and addressed, but the conference and ensuing guidance focused primarily upon treatment of cognitive impairment. Guidance regarding effective services addressed the areas of assessment, intervention, outcome measurement, and treatment program implementation.	[Helmick, Katherine; Consensus Conf] Def Ctr Excellence Psychol Hlth & Traumat Brain I, Silver Spring, MD 20910 USA		Helmick, K (corresponding author), Def Ctr Excellence Psychol Hlth & Traumat Brain I, 1335 East West Highway,9th Floor,Suite 400, Silver Spring, MD 20910 USA.	Katherine.Helmick@tma.osd.mil					Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; DePompei R, 2008, NEUROREHABILITATION, V23, P487; Ehlhardt LA, 2005, BRAIN INJURY, V19, P569, DOI 10.1080/002699050400013550; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Glisky EL, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P137; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Gordon WA, 2006, J HEAD TRAUMA REHAB, V21, P156, DOI 10.1097/00001199-200603000-00008; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IVERSON GL, 2006, POSTCONCUSSIVE DISOR, P373; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; KIM Y, 2009, NEUROREHABILITATION, V23, P1; Kime SK, 1996, BRAIN INJURY, V10, P17; Levin, 1997, Semin Clin Neuropsychiatry, V2, P207; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lew HL, 2009, AM J PHYS MED REHAB, V88, P1, DOI 10.1097/PHM.0b013e3181911102; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; McCrea M., 2008, MILD TRAUMATIC BRAIN; McKerracher G, 2005, NEUROPSYCHOL REHABIL, V15, P115, DOI 10.1080/09602010443000056; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; *NIH CONS DEV PAN, 1999, JAMA-J AM MED ASSOC, V282, P947; Novack TA, 1996, J HEAD TRAUMA REHAB, V11, P52, DOI 10.1097/00001199-199606000-00008; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; Schutz LE, 2007, BRAIN INJURY, V21, P545, DOI 10.1080/02699050701426923; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; SINOTTE M, 2003, J MED SPEECH PATHOLO, V11, P19; SOHLBERG M, 2007, J MED SPEECH PATHOLO, V15; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M. M., 2003, J MED SPEECH LANGUAG, V11; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; SOHLBERG MM, 2002, J CLIN EXPT NEUROPSY, V22, P656; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thickpenny-Davis KL, 2007, J HEAD TRAUMA REHAB, V22, P303, DOI 10.1097/01.HTR.0000290975.09496.93; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Weathers F.W., 1993, ANN CONV INT SOC TRA; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726	72	28	29	1	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	26	3					239	255		10.3233/NRE-2010-0560			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	603OQ	WOS:000278218300008	20448314				2022-02-06	
J	Park, DH; Eve, DJ; Chung, YG; Sanberg, PR				Park, Dong-Hyuk; Eve, David J.; Chung, Yong-Gu; Sanberg, Paul R.			Regenerative Medicine for Neurological Disorders	THESCIENTIFICWORLDJOURNAL			English	Article						alternative medicine; ASNTR; neuroscience; regenerative medicine; stem cell; transplantation	UMBILICAL-CORD BLOOD; NEURAL STEM-CELLS; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; G93A SOD1 MICE; SPINAL-CORD; ALZHEIMERS-DISEASE; MOUSE MODEL; STEM/PROGENITOR CELLS; PRECURSOR CELLS	The annual meeting of the American Society for Neural Therapy and Repair (ASNTR) has always introduced us to top-notch and up-to-date approaches for regenerative medicine related to neuroscience, ranging from stem cell-based therapy to novel drugs. The 16th ASNTR meeting focused on a variety of different topics, including the unknown pathogenesis or mechanisms of specific neurodegenerative diseases, stem cell biology, and development of novel alternative medicines or devices. Newly developed stem cells, such as amniotic epithelial stem cells and induced pluripotent stem cells, as well as well-known traditional stem cells, such as neural, embryonic, bone marrow mesenchymal, and human umbilical cord blood-derived stem cells, were reported. A number of commercialized stem cells were also covered at this meeting. Fetal neural tissues, such as ventral mesencephalon, striatum, and Schwann cells, were investigated for neurodegenerative diseases or spinal cord injury. A number of studies focused on novel methods for drug monitoring or graft tracking, and combination therapy with stem cells and medicine, such as cytokines or trophic factors. Finally, the National Institutes of Health guidelines for human stem cell research, clinical trials of commercialized stem cells without larger animal testing, and prohibition of medical tourism were big controversial issues that led to heated discussion.	[Park, Dong-Hyuk; Eve, David J.; Sanberg, Paul R.] Univ S Florida, Coll Med, Dept Neurosurg, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Park, Dong-Hyuk; Chung, Yong-Gu] Korea Univ, Coll Med, Dept Neurosurg, Med Ctr, Seoul 136705, South Korea		Eve, DJ (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	doctorns@korea.com; deve@health.usf.edu; yongku9@chol.com; psanberg@health.usf.edu					Acosta SA, 2009, CELL TRANSPLANT, V18, P207; Airavaara M, 2009, CELL TRANSPLANT, V18, P207; Andres RH, 2009, CELL TRANSPLANT, V18, P208; Bachstetter AD, 2009, CELL TRANSPLANT, V18, P208; Bacigaluppi M, 2008, THESCIENTIFICWORLDJO, V8, P698, DOI 10.1100/tsw.2008.94; Baek SH, 2009, CELL TRANSPLANT, V18, P209; Behrouz B, 2009, CELL TRANSPLANT, V18, P209; Bergamaschini L, 2009, THESCIENTIFICWORLDJO, V9, P891, DOI 10.1100/tsw.2009.100; Berk MA, 2009, CELL TRANSPLANT, V18, P209; Bernal GM, 2009, CELL TRANSPLANT, V18, P210; BJUGSTAD KB, 2009, TISSUE CELL, V18, P210; Bobek V, 2009, CELL TRANSPLANT, V18, P211; Boger HA, 2009, CELL TRANSPLANT, V18, P211; Brown DR, 2009, THESCIENTIFICWORLDJO, V9, P1061, DOI 10.1100/tsw.2009.111; Chermenina M, 2009, CELL TRANSPLANT, V18, P211; Cicchetti F, 2009, CELL TRANSPLANT, V18, P211; Collado LM, 2009, CELL TRANSPLANT, V18, P212; Daadi MM, 2009, CELL TRANSPLANT, V18, P212; Deb KD, 2009, THESCIENTIFICWORLDJO, V9, P236, DOI 10.1100/tsw.2009.25; Dentelli P, 2008, THESCIENTIFICWORLDJO, V8, P1111, DOI 10.1100/tsw.2008.142; Devi SA, 2009, THESCIENTIFICWORLDJO, V9, P366, DOI 10.1100/tsw.2009.46; Dodiya HB, 2009, CELL TRANSPLANT, V18, P212; Emborg EM, 2009, CELL TRANSPLANT, V18, P213; Eve DJ, 2009, CELL TRANSPLANT, V18, P213; Federici T, 2009, CELL TRANSPLANT, V18, P213; Fortress AM, 2009, CELL TRANSPLANT, V18, P214; Freeman L, 2009, CELL TRANSPLANT, V18, P214; Garbuzova-Davis S, 2009, CELL TRANSPLANT, V18, P214; GARCIARODRIGUEZ JC, 2009, SCI WORLD J, V9, P970, DOI DOI 10.1100/TSW.2009.103; Ghosh M, 2009, CELL TRANSPLANT, V18, P215; Golshani R, 2009, CELL TRANSPLANT, V18, P215; Gombash SE, 2009, CELL TRANSPLANT, V18, P216; Gorenkova N, 2009, CELL TRANSPLANT, V18, P216; Granholm AC, 2009, CELL TRANSPLANT, V18, P216; Guglielmotto M, 2009, THESCIENTIFICWORLDJO, V9, P781, DOI 10.1100/tsw.2009.93; Hallett PJ, 2009, CELL TRANSPLANT, V18, P217; Harvey BK, 2009, CELL TRANSPLANT, V18, P217; Hayashi T, 2009, CELL TRANSPLANT, V18, P217; Hermann DM, 2009, THESCIENTIFICWORLDJO, V9, P967, DOI 10.1100/tsw.2009.104; Hess DC, 2009, CELL TRANSPLANT, V18, P218; Jain A, 2009, CELL TRANSPLANT, V18, P218; JENSEN P, 2009, CELL TRANSPLANT, V18, P218; Jergova S, 2009, CELL TRANSPLANT, V18, P219; Jinwal UK, 2009, CELL TRANSPLANT, V18, P219; Johansson S, 2009, CELL TRANSPLANT, V18, P219; Kelly L, 2009, CELL TRANSPLANT, V18, P220; KHAING ZZ, 2009, CELL TRANSPLANT, V18, P220; Kulkarni SK, 2009, THESCIENTIFICWORLDJO, V9, P1233, DOI 10.1100/tsw.2009.137; Kuruba R, 2009, CELL TRANSPLANT, V18, P221; Lanari A, 2009, THESCIENTIFICWORLDJO, V9, P961, DOI 10.1100/tsw.2009.106; Lee CT, 2009, CELL TRANSPLANT, V18, P221; Lee DC, 2009, CELL TRANSPLANT, V18, P222; Li Q, 2009, CELL TRANSPLANT, V18, P222; Lieu CA, 2009, CELL TRANSPLANT, V18, P222; Luo Y, 2009, CELL TRANSPLANT, V18, P223; Ma BF, 2009, CELL TRANSPLANT, V18, P223; Macklis JD, 2009, CELL TRANSPLANT, V18, P223; Madhavan L, 2009, CELL TRANSPLANT, V18, P224; Maiese K, 2009, THESCIENTIFICWORLDJO, V9, P1072, DOI 10.1100/tsw.2009.121; Maksoud YA, 2009, CELL TRANSPLANT, V18, P224; Manfredsson FP, 2009, CELL TRANSPLANT, V18, P225; Manfredsson FP, 2009, CELL TRANSPLANT, V18, P224; Marschinke F, 2009, CELL TRANSPLANT, V18, P225; Marupudi NI, 2009, CELL TRANSPLANT, V18, P225; Mervis RF, 2009, CELL TRANSPLANT, V18, P226; Miller C, 2009, CELL TRANSPLANT, V18, P226; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Monahan AJ, 2009, CELL TRANSPLANT, V18, P226; Moradian S, 2009, CELL TRANSPLANT, V18, P227; Musso J, 2009, CELL TRANSPLANT, V18, P227; Nagata T, 2008, THESCIENTIFICWORLDJO, V8, P683, DOI 10.1100/tsw.2008.93; Neckel ND, 2009, CELL TRANSPLANT, V18, P227; Nevalainen N, 2009, CELL TRANSPLANT, V18, P228; Newman MB, 2009, CELL TRANSPLANT, V18, P228; Nguyen T, 2009, CELL TRANSPLANT, V18, P228; Nikas JB, 2009, CELL TRANSPLANT, V18, P229; Pabon MM, 2009, CELL TRANSPLANT, V18, P229; Panza F, 2009, THESCIENTIFICWORLDJO, V9, P373, DOI 10.1100/tsw.2009.48; Parihar VK, 2009, CELL TRANSPLANT, V18, P229; Park DH, 2009, CELL TRANSPLANT, V18, P230; Park JS, 2009, OZONE-SCI ENG, V31, P15, DOI 10.1080/01919510802587143; Pendharkar AV, 2009, CELL TRANSPLANT, V18, P230; Petrovic V, 2009, THESCIENTIFICWORLDJO, V9, P1167, DOI 10.1100/tsw.2009.125; Piao CS, 2009, CELL TRANSPLANT, V18, P231; Priest C, 2009, CELL TRANSPLANT, V18, P231; Quiroz C, 2009, THESCIENTIFICWORLDJO, V9, P1321, DOI 10.1100/tsw.2009.143; Rachubinski A, 2009, CELL TRANSPLANT, V18, P231; Rehnmark A, 2009, CELL TRANSPLANT, V18, P232; Reiss AB, 2009, THESCIENTIFICWORLDJO, V9, P1242, DOI 10.1100/tsw.2009.141; Ross JM, 2009, CELL TRANSPLANT, V18, P232; Rossignol J, 2009, CELL TRANSPLANT, V18, P233; Sanchez-Ramos J, 2009, CELL TRANSPLANT, V18, P233; Scheckhuber CQ, 2009, THESCIENTIFICWORLDJO, V9, P250, DOI 10.1100/tsw.2009.33; Schmitz T, 2008, THESCIENTIFICWORLDJO, V8, P1119, DOI 10.1100/tsw.2008.140; Selenica MLB, 2009, CELL TRANSPLANT, V18, P233; Shahaduzzaman SD, 2009, CELL TRANSPLANT, V18, P234; Sinden J, 2009, CELL TRANSPLANT, V18, P234; Singec I, 2009, CELL TRANSPLANT, V18, P234; Sladek JR, 2009, CELL TRANSPLANT, V18, P234; Smith AJ, 2009, CELL TRANSPLANT, V18, P235; Snyder EY, 2009, CELL TRANSPLANT, V18, P207, DOI 10.3727/096368909788341315; Solfrizzi V, 2009, THESCIENTIFICWORLDJO, V9, P792, DOI 10.1100/tsw.2009.82; Solomon B, 2009, THESCIENTIFICWORLDJO, V9, P909, DOI 10.1100/tsw.2009.99; Soo ETL, 2008, THESCIENTIFICWORLDJO, V8, P270, DOI 10.1100/tsw.2008.48; Spieles-Engemann AL, 2009, CELL TRANSPLANT, V18, P235; Stahl K, 2009, THESCIENTIFICWORLDJO, V9, P811, DOI 10.1100/tsw.2009.68; Steece-Collier K, 2009, CELL TRANSPLANT, V18, P236; Steuer I, 2009, THESCIENTIFICWORLDJO, V9, P490, DOI 10.1100/tsw.2009.63; Stoner S, 2009, CELL TRANSPLANT, V18, P236; Stromberg I, 2009, CELL TRANSPLANT, V18, P237; Teng YD, 2009, CELL TRANSPLANT, V18, P237; Thal DR, 2009, THESCIENTIFICWORLDJO, V9, P557, DOI 10.1100/tsw.2009.72; Thompson VB, 2009, CELL TRANSPLANT, V18, P237; Timmer M, 2009, CELL TRANSPLANT, V18, P238; Vazin T, 2009, CELL TRANSPLANT, V18, P238; Vorobyeva TM, 2009, CELL TRANSPLANT, V18, P239; Wakeman DR, 2009, CELL TRANSPLANT, V18, P239; Walczak P, 2009, CELL TRANSPLANT, V18, P239; Wang L, 2009, CELL TRANSPLANT, V18, P240; Womble TA, 2009, CELL TRANSPLANT, V18, P240; Woods RL, 2009, CELL TRANSPLANT, V18, P241; Worden LT, 2009, CELL TRANSPLANT, V18, P241; Yu S, 2009, CELL TRANSPLANT, V18, P241; Zhu Y, 2009, CELL TRANSPLANT, V18, P242	124	28	28	0	32	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1537-744X			THESCIENTIFICWORLDJO	TheScientificWorldJOURNAL		2010	10						470	489		10.1100/tsw.2010.39			20	Environmental Sciences; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Science & Technology - Other Topics	573BB	WOS:000275882300006	20305989	Green Published, Green Submitted, gold			2022-02-06	
J	Liossi, C; Wood, RL				Liossi, Christina; Wood, Rodger Ll			Gender as a Moderator of Cognitive and Affective Outcome After Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							MINOR HEAD-INJURY; SEX-DIFFERENCES; EXECUTIVE TESTS; DEPRESSION; SAMPLE; MILD; HIPPOCAMPUS; IMPAIRMENT; PREDICTORS; ADJUSTMENT	The aim of this investigation was to compare cognitive and affective functions in men and women who had suffered comparable brain injuries. In a prospective matched cohort design, 150 community-dwelling patients were individually matched on the basis of age, severity of injury, premorbid IQ, and time since injury. Women were significantly more impaired in verbal and visual memory compared with men. The degree of cognitive decline was significantly positively correlated with age in women, but not in men. Women had marginally higher scores compared with men on measures of anxiety and depression. It is concluded that gender is a moderator of cognitive and affective outcome after brain injury.	[Liossi, Christina] Univ Southampton, Sch Psychol, Southampton SO17 1BJ, Hants, England; [Wood, Rodger Ll] Swansea Univ, Dept Psychol, Sch Human Sci, Brain Injury Res Grp, Swansea, W Glam, Wales		Liossi, C (corresponding author), Univ Southampton, Sch Psychol, Southampton SO17 1BJ, Hants, England.	cliossi@soton.ac.uk		Liossi, Christina/0000-0003-0627-6377			Baddeley A., 1992, SPEED CAPACITY LANGU; Barnes EF, 2005, J MED SPEECH-LANG PA, V13, P69; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bounds TA, 2003, NEUROREHABILITATION, V18, P189; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; Cummings P, 2003, EPIDEMIOL REV, V25, P43, DOI 10.1093/epirev/mxg002; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farace E., 1996, NEUROIMAGING HDB BRA, P127; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gujral IB, 2006, BRAIN INJURY, V20, P283, DOI 10.1080/02699050500488058; HART RP, 1987, PSYCHOL AGING, V2, P111, DOI 10.1037/0882-7974.2.2.111; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; HORTNAGL H, 1993, BRAIN RES BULL, V31, P129, DOI 10.1016/0361-9230(93)90019-8; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KOZNIEWSKA E, 1995, CIRC RES, V76, P551, DOI 10.1161/01.RES.76.4.551; Kraus J F, 2000, Neurosurg Focus, V8, pe5; KRAUS JF, 1998, REHABILITATION ADULT, P3; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; LITTLE RJA, 1995, HAND BOOK STAT MODEL, P39; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Nelson HE., 1991, NATL ADULT READING R; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reitan RM, 1985, HALSTEADREITAN NEURO; Ritchie K, 2000, LANCET, V355, P225, DOI 10.1016/S0140-6736(99)06155-3; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; RUTHERFORD WH, 1978, BRAIN INJURY, V10, P225; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Shors TJ, 2001, J NEUROSCI, V21, P6292, DOI 10.1523/JNEUROSCI.21-16-06292.2001; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D., 1997, WECHSLER ADULT MEMOR; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WHWLAN EA, 1990, AM J EPIDEMIOL, V131, P625; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Wood RL, 2006, J NEUROPSYCH CLIN N, V18, P333, DOI 10.1176/appi.neuropsych.18.3.333; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P90, DOI 10.1017/S1355617707070129	59	28	29	0	5	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	2009	21	1					43	51		10.1176/appi.neuropsych.21.1.43			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	431ES	WOS:000265044700007	19359451				2022-02-06	
J	Matschke, J; Voss, J; Obi, N; Gorndt, J; Sperhake, JP; Puschel, K; Glatzel, M				Matschke, Jakob; Voss, Janina; Obi, Nadia; Goerndt, Jennifer; Sperhake, Jan-Peter; Pueschel, Klaus; Glatzel, Markus			Nonaccidental Head Injury Is the Most Common Cause of Subdural Bleeding in Infants < 1 Year of Age	PEDIATRICS			English	Article						abusive head trauma; subdural bleeding; nonaccidental head injury; infant; forensic neuropathology	SHAKEN BABY SYNDROME; DURAL HEMORRHAGE; HEMATOMA; DEATHS; DIAGNOSIS; CHILDREN; EXPLAIN	OBJECTIVE: Subdural bleeding (SDB) in infants is considered an essential symptom of nonaccidental head injury (NAHI). Recently, this view has been challenged by the "unified hypothesis," which claims that SDB in infants is related to hypoxia and brain swelling rather than to traumatic shearing of bridging veins. We analyzed a large series of infants' autopsies for the presence and causes of SDB, which should be a common event according to the unified hypothesis. METHODS: Autopsy, clinical, and legal information for infants <1 year of age from a single institution over 50 years were analyzed regarding cause of death, presence, morphology, and cause of SDB, and brain weight. RESULTS: From a total of 16 661 autopsies during the study period, 715 (4.3%) involved infants <1 year of age. Fifty (7.0%) of those had SDB. NAHI was identified in 17 patients. The most common cause of SDB was trauma (15 cases [30.0%]), with NAHI accounting for 14 cases. SDB was present in 82.4% of patients with NAHI but only 5.2% of infants with other causes of death. Four patients (8.0%) had unexplained SDB with no discernible cause of bleeding. Statistical analysis did not reveal any correlation between the presence of SDB and brain weight. CONCLUSIONS: In the study population, unexplained SDB in infants was an extreme rarity. Moreover, a correlation between brain swelling and the presence of SDB could not be drawn. Our data argue strongly against the unified hypothesis and strengthen the association between SDB and NAHI in infancy. Pediatrics 2009;124:1587-1594	[Matschke, Jakob; Voss, Janina; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Voss, Janina; Goerndt, Jennifer; Sperhake, Jan-Peter; Pueschel, Klaus] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, D-20246 Hamburg, Germany; [Obi, Nadia] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, D-20246 Hamburg, Germany		Matschke, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Martinistr 52, D-20246 Hamburg, Germany.	matschke@uke.de	Glatzel, Markus/V-8844-2019; Glatzel, Markus/G-3356-2011; Matschke, Jakob/F-6641-2013	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Matschke, Jakob/0000-0001-6080-0198			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Block RW, 2004, PEDIATRICS, V113, P432, DOI 10.1542/peds.113.2.432; Byard RW, 2007, PEDIATR DEVEL PATHOL, V10, P348, DOI 10.2350/06-08-0154.1; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Dawson T. P., 2003, NEUROPATHOLOGY TECHN; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Geddes JF, 2004, BMJ-BRIT MED J, V328, P719, DOI 10.1136/bmj.328.7442.719; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Harding B, 2004, BMJ-BRIT MED J, V328, P720, DOI 10.1136/bmj.328.7442.720; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Hoskote A, 2002, CHILD NERV SYST, V18, P311, DOI 10.1007/s00381-002-0616-x; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Kemp AM, 2002, ARCH DIS CHILD, V86, P98, DOI 10.1136/adc.86.2.98; King WJ, 2003, CAN MED ASSOC J, V168, P155; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Matschke J, 2007, PEDIATR NEUROSURG, V43, P330, DOI 10.1159/000103317; Matschke J, 2009, INT J LEGAL MED, V123, P189, DOI 10.1007/s00414-008-0293-8; Miller M, 2004, PEDIATRICS, V114, P326, DOI 10.1542/peds.114.1.326; Morris MW, 2000, PEDIATRICS, V105, P549, DOI 10.1542/peds.105.3.549; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Punt J, 2006, ARCH DIS CHILD, V91, P714; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Richards PG, 2006, ARCH DIS CHILD, V91, P205, DOI 10.1136/adc.2005.090761; SKULLERUD K, 1985, ACTA NEUROL SCAND, V71, P5; Smith C, 2003, NEUROPATH APPL NEURO, V29, P411, DOI 10.1046/j.1365-2990.2003.00500.x; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; Uscinski R, 2002, BRIT J NEUROSURG, V16, P217, DOI 10.1080/02688690220148978; Uscinski RH, 2006, NEUROL MED-CHIR, V46, P57, DOI 10.2176/nmc.46.57; Uscinski RH, 2004, J NEUROSURG, V100, P574; Wilkins B, 1997, ARCH DIS CHILD, V76, P393, DOI 10.1136/adc.76.5.393	38	28	30	0	8	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	DEC	2009	124	6					1587	1594		10.1542/peds.2008-3734			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	524SE	WOS:000272162400011	19948629				2022-02-06	
J	Castillo, LG; Caver, KA				Castillo, Linda G.; Caver, Kelly A.			Expanding the Concept of Acculturation in Mexican American Rehabilitation Psychology Research and Practice	REHABILITATION PSYCHOLOGY			English	Article						Mexican American; acculturation; enculturation; rehabilitation	TRAUMATIC BRAIN-INJURY; FAMILY SUPPORT; HEALTH; PREDICTORS; HISPANICS; IDENTITY; MACHISMO; BELIEFS; CANCER; ISSUES	The acculturation process is increasingly being viewed as an important variable that provides a context for understanding Mexican American health disparities. Although rehabilitation psychologists have noted the importance of utilizing acculturation in research and practice, scholars continue to use out-dated conceptualizations and models of acculturation. Objectives: The authors provide a brief overview of current trends in acculturation theory and research. Limitations of current rehabilitation research and how acculturation theory can help explain Mexican American health outcomes are discussed. Finally, recommendations for rehabilitation research and practice are provided. Conclusions: The authors recommend that rehabilitation scholars develop and test theoretical models that incorporates multiple dimensions of acculturation in order to understand how it influences Mexican American health outcomes. Rehabilitation professionals should incorporate acculturation theory and culturally informed interventions into rehabilitation practice with Mexican Americans.	[Castillo, Linda G.; Caver, Kelly A.] Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA		Castillo, LG (corresponding author), Texas A&M Univ, Dept Educ Psychol, College Stn, TX 77843 USA.	lcastillo@tamu.edu	Castillo, Linda/A-5208-2010	Castillo, Linda/0000-0001-7634-7973			Abraido-Lanza AF, 2007, ETHNIC DIS, V17, P153; Abraido-Lanza AF, 2006, AM J PUBLIC HEALTH, V96, P1342, DOI 10.2105/AJPH.2005.064980; Aguirre-Molina M., 2001, HLTH ISSUES LATINO C; Alexander, 2001, HDB MULTICULTURAL CO, P394; *AM PSYCH ASS, 2002, AM PSYCHOL, V57, P1060, DOI DOI 10.1037/0003-066X.57.12.1060; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Arciniega GM, 2008, J COUNS PSYCHOL, V55, P19, DOI 10.1037/0022-0167.55.1.19; Arends-Toth J, 2006, MON PARENT, P33; Baron, 2009, HISP HEAL CARE INT, V7, DOI [10.1891/1540-4153.7.3.145, DOI 10.1891/1540-4153.7.3.145]; Berry J.W., 2003, ACCULTURATION ADV TH, P17, DOI DOI 10.1037/10472-004; BERRY JW, 1989, APPL PSYCHOL-INT REV, V38, P185, DOI 10.1111/j.1464-0597.1989.tb01208.x; Berry JW, 1986, FIELD METHODS CROSS, P291; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Bourhis RY, 1997, INT J PSYCHOL, V32, P369, DOI 10.1080/002075997400629; BUNDEK NI, 1993, HEALTH PSYCHOL, V12, P193, DOI 10.1037/0278-6133.12.3.193; Caballero AE, 2006, ETHNIC DIS, V16, P559; CANUL GD, 1994, J CLIN PSYCHOL, V50, P736, DOI 10.1002/1097-4679(199409)50:5<736::AID-JCLP2270500511>3.0.CO;2-Z; Carter-Pokras O., 2001, HLTH ISSUES LATINO C; Castillo L. G., 2008, INT J STRESS MANAGE, V15, P43, DOI DOI 10.1037/1072-5245.15.1.43; Castillo LG, 2004, J COUNS PSYCHOL, V51, P151, DOI 10.1037/0022-0167.51.2.151; CASTILLO LG, 2007, CROSS CULTURAL PSYCH, P85; CASTILLO LG, 2009, CONSTRUCTION V UNPUB; Castillo Linda G, 2007, Cultur Divers Ethnic Minor Psychol, V13, P232, DOI 10.1037/1099-9809.13.3.232; CAVALLO MM, 1995, J HEAD TRAUMA REHAB, V10, P66, DOI 10.1097/00001199-199504000-00008; Cianelli R, 2008, CULT HEALTH SEX, V10, P297, DOI 10.1080/13691050701861439; CUELLAR I, 1995, HISPANIC J BEHAV SCI, V17, P275, DOI 10.1177/07399863950173001; Cuellar I., 2004, HDB CHICANA PSYCHOL, P23; Dunn DS, 2008, REHABIL PSYCHOL, V53, P254, DOI 10.1037/a0012962; Edwards LM, 2006, J COUNS PSYCHOL, V53, P279, DOI 10.1037/0022-0167.53.3.279; ELLIOTT TR, 2007, PSYCHOL MANAGEMENT P, P16; FALICOV CJ, 2003, SPIRITUAL RESOURCES, P104; Getrich C, 2007, SOC SCI MED, V65, P319, DOI 10.1016/j.socscimed.2007.03.004; Gordon Milton Myron, 1964, ASSIMILATION AM LIFE; GRAVES TD, 1967, SOUTHWEST J ANTHROP, V23, P337, DOI 10.1086/soutjanth.23.4.3629450; Hanson SL, 2007, REHABIL PSYCHOL, V52, P409, DOI 10.1037/0090-5550.52.4.409; Helms JE, 2005, AM PSYCHOL, V60, P27, DOI 10.1037/0003-066X.60.1.27; Hogg M. A., 2005, SOCIAL OUTCAST OSTRA, P243; Hovell M, 2003, SOC SCI MED, V56, P1789, DOI 10.1016/S0277-9536(02)00176-4; Hubbell FA, 1996, ARCH INTERN MED, V156, P2353, DOI 10.1001/archinte.156.20.2353; Jetten J, 2004, J PERS SOC PSYCHOL, V86, P862, DOI 10.1037/0022-3514.86.6.862; Johnson JL, 1999, RESILIENCE DEV POSIT, P179, DOI [10.1007/0-306-47167-1_9, DOI 10.1007/B108350]; KIM BSK, 2007, HDB ASIAN AM PSYCHOL, P141; Kochhar R, 2005, OCCUPATIONAL STATUS; KOHATSU EL, 2005, HDB RACIAL CULTURAL, V1, P207; LAFROMBOISE T, 1993, PSYCHOL BULL, V114, P395, DOI 10.1037/0033-2909.114.3.395; Livingston G., 2008, HISPANICS HLTH CARE; Losada A, 2006, AGING MENT HEALTH, V10, P69, DOI 10.1080/13607860500307647; MARIN G, 2003, ACCULTURATION ADV TH, P17; Moreno CL, 2007, QUAL HEALTH RES, V17, P340, DOI 10.1177/1049732306297387; *NAT ALL HISP HLTH, 2001, PRIM CULT PROF QUAL; NEFF JA, 1993, J COMMUNITY PSYCHOL, V21, P3, DOI 10.1002/1520-6629(199301)21:1<3::AID-JCOP2290210102>3.0.CO;2-9; Neville HA, 2000, REHABIL PSYCHOL, V45, P89, DOI 10.1037/0090-5550.45.1.89; Niemeier J, 2007, J HEAD TRAUMA REHAB, V22, P75, DOI 10.1097/01.HTR.0000265095.06565.7b; Niemeier JP, 2003, ARCH PHYS MED REHAB, V84, P1240, DOI 10.1016/S0003-9993(03)00295-8; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Oquendo MA, 2005, J NERV MENT DIS, V193, P438, DOI 10.1097/01.nmd.0000168262.06163.31; Padilla, 1980, ACCULTURATION THEORY, P9, DOI DOI 10.1525/AE.1981.8.4.02A00200; PANIAGUA FA, 2005, ASSESSING TREATING C; Parra EO, 2001, AIDS PATIENT CARE ST, V15, P83, DOI 10.1089/108729101300003681; Passel JS, 2008, US POPULATION PROJEC; PEREZSTABLE EJ, 1992, JAMA-J AM MED ASSOC, V268, P3219, DOI 10.1001/jama.268.22.3219; Phinney JS, 2007, J COUNS PSYCHOL, V54, P271, DOI 10.1037/0022-0167.54.3.271; Phinney JS, 1997, J YOUTH ADOLESCENCE, V26, P165, DOI 10.1023/A:1024500514834; Quintana SM, 1999, COUNS PSYCHOL, V27, P485, DOI 10.1177/0011000099274002; QUINTANA SM, 2001, HDB MULTICULTURAL CO, P604; Razani J, 2007, ARCH CLIN NEUROPSYCH, V22, P333, DOI 10.1016/j.acn.2007.01.008; Redfield R., 1936, AM ANTHROPOL, V38, P149, DOI DOI 10.1525/AA.1936.38.1.02A00330; ROGLER LH, 1991, AM PSYCHOL, V46, P585, DOI 10.1037/0003-066X.46.6.585; Ryder AG, 2000, J PERS SOC PSYCHOL, V79, P49, DOI 10.1037//0022-3514.79.1.49; Shah M, 2006, CANCER DETECT PREV, V30, P306, DOI 10.1016/j.cdp.2006.04.003; Sharma P, 2002, REHABIL PSYCHOL, V47, P230, DOI 10.1037//0090-5550.47.2.230; Singelis T., 1995, CROSS-CULT RES, V29, P240, DOI DOI 10.1177/106939719502900302; SLAVIN LA, 1991, J COUNS DEV, V70, P156, DOI 10.1002/j.1556-6676.1991.tb01578.x; SMART JF, 1992, J REHABIL, V58, P29; Smedley BD, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Sobralske M, 2006, J AM ACAD NURSE PRAC, V18, P348, DOI 10.1111/j.1745-7599.2006.00144.x; Sobralske MC, 2006, J TRANSCULT NURS, V17, P129, DOI 10.1177/1043659606286767; SUNDQUIST J, 2000, INT J EPIDEMIOL, V29, P723; Szapocznik J., 1980, INT J INTERCULT REL, V4, P353; TAJFEL H., 1986, PSYCHOL INTERGROUP R, P7, DOI DOI 10.4324/9780203505984-16; Triandis H.C., 2001, BLACKWELL HDB SOCIAL, V4, P367; Urizar GG, 2006, J BEHAV MED, V29, P255, DOI 10.1007/s10865-006-9050-y; Uswatte G, 1997, REHABIL PSYCHOL, V42, P61, DOI 10.1037/0090-5550.42.1.61; Vaeth PAC, 2005, ANN EPIDEMIOL, V15, P373, DOI 10.1016/j.annepidem.2004.11.003; Vega WA, 1999, AM J PSYCHIAT, V156, P928, DOI 10.1176/ajp.156.6.928; VILLAGRAN M, 2008, EMERGING PERSPECTIVE, P203; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345; Zane N, 2003, ACCULTURATION ADV TH, P39, DOI DOI 10.1037/10472-005	89	28	28	0	5	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2009	54	4					351	362		10.1037/a0017801			12	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	526YF	WOS:000272331600001	19929116				2022-02-06	
J	Larson, MJ; Kaufman, DAS; Perlstein, WM				Larson, Michael J.; Kaufman, David A. S.; Perlstein, William M.			Conflict adaptation and cognitive control adjustments following traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Event-related potentials (ERPs); Conflict; Adaptation; Sequential trial; N450; Conflict SP; Cognitive control; Anterior cingulate cortex (ACC); Gratton; Traumatic brain injury; TBI; Stroop	ANTERIOR CINGULATE CORTEX; WORKING-MEMORY LOAD; CLOSED-HEAD INJURY; SEVERE TBI; NEURAL ACTIVITY; STROOP; TASK; INTERFERENCE; ACTIVATION; ATTENTION	Survivors of severe traumatic brain injury (TBI) often demonstrate impairments in the cognitive control functions of detecting response conflict and signaling for recruitment of cognitive resources to appropriately adjust performance. These cognitive control functions can be measured using conflict adaptation effects, wherein manifestations of conflict detection and processing are reduced following high-relative to low-conflict trials. Event-related potentials (ERPs) were collected while 18 survivors of severe traumatic brain injury (TBI) and 21 demographically matched control participants performed it modified Stroop task. The incongruent-minus-congruent trial Stroop effect for trials preceded by incongruent (high conflict) and congruent (low conflict) trials were compared for behavioral (response time [RT] and error rate) and ERP reflections of cognitive control. Behavioral data showed a reduction in the Stroop effect for both control and TBI participant Us when preceded by incongruent trials. The magnitude of these effects did not differentiate control and TBI participants. ERP data revealed a centro-parietal conflict slow potential (conflict SP) that differentiated incongruent from congruent trials. Planned comparisons showed it decreased amplitude conflict SP when ERPs were preceded by incongruent trials in control, but not TBI participants. Results indicate subtle TBI-related impairments in conflict resolution mechanisms in the context of intact RT-related conflict adaptation. (JINS, 2009, 15, 927-937.)	[Larson, Michael J.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Larson, Michael J.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Kaufman, David A. S.; Perlstein, William M.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; [Perlstein, William M.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Perlstein, William M.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA		Larson, MJ (corresponding author), Brigham Young Univ, Dept Psychol, 244 TLRB, Provo, UT 84602 USA.	michael_larson@byu.edu	Larson, Michael J/C-8543-2012	Larson, Michael J/0000-0002-8199-8065	National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 NS053335, K01 MH01857, R21 MH073076]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K01MH001857, R21MH073076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS053335] Funding Source: NIH RePORTER	This original research has not been published elsewhere and was supported by a pre-doctoral National Institute of Health (NIH) Fellowship to MJL(F31 NS053335) and grants K01 MH01857 and R21 MH073076 from the NIH to WMP. We thank Cortney Mauer, Megan Mclntyre, Drew Nagle, Allen Sirizi, and Raechel Steckley for their assistance in data collection. The authors report no conflicts of interest.	Benedict, 2001, HOPKINS VERBAL LEARN; Benton A., 1976, MULTILINGUAL APHASIA; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carroll JFX., 2001, MENTAL HLTH SCREENIN; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hommel B, 1998, VIS COGN, V5, P183, DOI 10.1080/713756773; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Ille N., 1997, BIOMED TECHNOL, V42, P80; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P961, DOI 10.1017/S1355617707071305; Larson MJ, 2006, J CLIN EXP NEUROPSYC, V28, P968, DOI 10.1080/13803390600646860; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; MAYR U, PSYCHOL RES IN PRESS; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Neter J., 1985, APPL LINEAR STAT MOD; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Notebaert W, 2001, PSYCHOL RES-PSYCH FO, V65, P170, DOI 10.1007/s004260000054; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Rasmussen IA, 2008, J NEUROTRAUM, V25, P1057, DOI 10.1089/neu.2008.0520; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ridderinkhof KR, 2002, ATTENTION PERFORM, V19, P494; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Scheibel RS, 2003, BRAIN INJURY, V17, P919, DOI 10.1080/0269905031000110472; Scherg M., 1990, AUDITORY EVOKED MAGN, V6, P65; Seignourel PJ, 2005, NEUROPSYCHOLOGY, V19, P578, DOI 10.1037/0894-4105.19.5.578; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TEASDALE G, 1974, LANCET, V2, P81; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wendt M, 2006, J EXP PSYCHOL HUMAN, V32, P644, DOI 10.1037/0096-1523.32.3.644; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2000, BRAIN RES, V873, P102, DOI 10.1016/S0006-8993(00)02530-0; West R, 2005, CORTEX, V41, P570, DOI 10.1016/S0010-9452(08)70197-7; West R, 2004, J COGNITIVE NEUROSCI, V16, P103, DOI 10.1162/089892904322755593; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X	64	28	31	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2009	15	6					927	937		10.1017/S1355617709990701			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	523ZV	WOS:000272114500015	19765356				2022-02-06	
J	Yamaguchi, S; Tanabe, K; Takai, S; Matsushima-Nishiwaki, R; Adachi, S; Iida, H; Kozawa, O; Dohi, S				Yamaguchi, Shinobu; Tanabe, Kumiko; Takai, Shinji; Matsushima-Nishiwaki, Rie; Adachi, Seiji; Iida, Hiroki; Kozawa, Osamu; Dohi, Shuji			Involvement of Rho-kinase in tumor necrosis factor-alpha-induced interleukin-6 release from C6 glioma cells	NEUROCHEMISTRY INTERNATIONAL			English	Article						Rho-kinase inhibitor; Intrleukin-6; TNF-alpha; MAP kinase; CNS	ACTIVATED PROTEIN-KINASE; SUBARACHNOID HEMORRHAGE; INTRATHECAL APPLICATION; CYTOKINE EXPRESSION; NEUROPATHIC PAIN; IN-VITRO; INHIBITOR; FASUDIL; BRAIN; PHOSPHORYLATION	Tumor necrosis factor (TNF)-alpha stimulated interleukin (IL)-6 release and induced the phosphorylation of myosin phosphatase targeting subunit (MYPT)-1, a Rho-kinase substrate. The IL-6 release was significantly suppressed by Y-27632 and fasudil, Rho-kinase inhibitors. Although I kappa B inhibitor suppressed the TNF-alpha-induced IL-6 release, the Rho-kinase inhibitors did not affect the TNF-alpha-induced I kappa B phosphorylation. TNF-alpha induced the phosphorylation of p38 mitogen-activated protein (MAP) kinase, stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK), and p44/p42 MAP kinase. The TNF-alpha-induced IL-6 release was suppressed by SB203580, a p38 MAPK inhibitor, or SP600125, a SAPK/JNK inhibitor, but not by PD98059, a MAP kinase/extracellular signal-regulated kinase kinase inhibitor. The Rho-kinase inhibitors attenuated the TNF-alpha-induced phosphorylation of both p38 MAP kinase and SAPK/JNK. Rho-kinase, which has been used for the clinical treatment of cerebral vasospasms, may be involved in other central nervous system (CNS) disorders such as traumatic injury, stroke, neurodegenerative disease and neuropathic pain. TNF-alpha, a proinflammatory cytokine that affects the CNS through cytokines, such as IL-6, release from neurons, astrocytes and microglia. Therefore, we investigated the involvement of Rho-kinase in the TNF-alpha-induced IL-6 release from rat C6 glioma cells. These results strongly suggest that Rho-kinase regulates the TNF-alpha-induced IL-6 release at a point upstream from p38 MAPK and SAPK/JNK in C6 glioma cells. Therefore, Rho-kinase inhibitor may be considered to be a new clinical candidate for the treatment of CNS disorders in addition to cerebral vasospasms. (C) 2009 Elsevier Ltd. All rights reserved.	[Yamaguchi, Shinobu; Tanabe, Kumiko; Iida, Hiroki; Dohi, Shuji] Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Gifu 5011194, Japan; [Takai, Shinji; Matsushima-Nishiwaki, Rie; Adachi, Seiji; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu 5011194, Japan		Tanabe, K (corresponding author), Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Gifu 5011194, Japan.	kumiko-t@m2.gyao.ne.jp			Ministry of Education, Science, Sports and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19209050, 20591798]	We are very grateful to Yoko Kawamura (Secretary, Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu, Japan) for her skillful technical assistance.; This work was supported in part by a Grant-in-Aid for Scientific Research (Nos. 19209050 and 20591798) from the Ministry of Education, Science, Sports and Culture of Japan.	AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Buyukafsar K, 2006, EUR J PHARMACOL, V541, P49, DOI 10.1016/j.ejphar.2006.04.042; Chang JY, 2007, NEUROSCI LETT, V416, P217, DOI 10.1016/j.neulet.2007.01.076; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Clark WM, 2001, EXPERT OPIN BIOL TH, V1, P227, DOI 10.1517/14712598.1.2.227; Covey WC, 2002, REGION ANESTH PAIN M, V27, P357, DOI 10.1053/rapm.2002.31930; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Fan YY, 2005, J SURG RES, V129, P196, DOI 10.1016/j.jss.2005.07.041; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Gahring LC, 1996, NEUROIMMUNOMODULAT, V3, P289, DOI 10.1159/000097283; Gosselin D, 2007, BRAIN BEHAV IMMUN, V21, P281, DOI 10.1016/j.bbi.2006.12.004; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heymann D, 2000, CYTOKINE, V12, P1455, DOI 10.1006/cyto.2000.0747; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishida T, 2006, BIOL PHARM BULL, V29, P397, DOI 10.1248/bpb.29.397; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kishi T, 2005, CIRCULATION, V111, P2741, DOI 10.1161/CIRCULATIONAHA.104.510248; Klein MA, 1997, GLIA, V19, P227, DOI 10.1002/(SICI)1098-1136(199703)19:3<227::AID-GLIA5>3.0.CO;2-W; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Madura T, 2007, PLAST RECONSTR SURG, V119, P526, DOI 10.1097/01.prs.0000246380.40596.29; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006; Ramer LM, 2004, J NEUROSCI, V24, P10796, DOI 10.1523/JNEUROSCI.3337-04.2004; Roach JD, 2008, NEUROIMMUNOMODULAT, V15, P117, DOI 10.1159/000148194; Samland H, 2003, J NEUROSCI RES, V73, P176, DOI 10.1002/jnr.10635; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; SHIBUYA M, 1992, J NEUROSURG, V76, P571, DOI 10.3171/jns.1992.76.4.0571; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Spangelo BL, 2004, NEUROIMMUNOMODULAT, V11, P332, DOI 10.1159/000079414; Spangelo BL, 2000, ANN NY ACAD SCI, V917, P597; Suzuki Y, 2008, NEUROL MED-CHIR, V48, P241, DOI 10.2176/nmc.48.241; Takanashi Y, 2001, NEUROL MED-CHIR, V41, P107, DOI 10.2176/nmc.41.107; Tatsumi S, 2005, NEUROSCIENCE, V131, P491, DOI 10.1016/j.neuroscience.2004.10.022; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WILLINGHAM MC, 1976, INT REV CYTOL, V44, P319, DOI 10.1016/S0074-7696(08)61652-6; Zhang Z, 2006, CELL MOL BIOL LETT, V11, P12, DOI 10.2478/s11658-006-0002-x; Zumwalt JW, 1999, ENDOCRINOLOGY, V140, P888, DOI 10.1210/en.140.2.888	49	28	32	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	NOV	2009	55	6					438	445		10.1016/j.neuint.2009.04.016			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	502WT	WOS:000270491800012	19427347				2022-02-06	
J	Figaji, AA; Zwane, E; Thompson, C; Fieggen, AG; Argent, AC; Le Roux, PD; Peter, JC				Figaji, Anthony A.; Zwane, Eugene; Thompson, Crispin; Fieggen, A. Graham; Argent, Andrew C.; Le Roux, Peter D.; Peter, Jonathan C.			Brain tissue oxygen tension monitoring in pediatric severe traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Brain oxygen; Children; Traumatic brain injury; Intracranial pressure; Cerebral perfusion pressure; Monitoring	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; TARGETED THERAPY; CHILDREN; DELIVERY; METABOLISM; HYPEROXIA; SATURATION; REDUCTION	Introduction Brain tissue oxygen tension (PbtO(2)) monitoring is used increasingly in adult severe traumatic brain injury (TBI) management. Several factors are known to influence PbtO(2) in adults, but the variables that affect PbtO(2) in pediatric TBI are not well described. This study examines the relationships between PbtO(2) and (1) physiological markers of potential secondary insults commonly used in pediatric TBI, in particular intracranial pressure (ICP), cerebral perfusion pressure (CPP), and systemic hypoxia, and (2) other clinical factors and treatment received that may influence PbtO(2). Materials and methods In this prospective observational study, 52 children (mean age, 6.5 +/- 3.4 years; range, 9 months to 14 years old) with severe TBI and a median post-resuscitation Glasgow Coma Score (GCS) of 5 were managed with continuous PbtO(2) monitoring. The relationships between PbtO(2) parameters (PbtO(2low), PbtO(2) < 5, PbtO(2) < 10, and mPbtO(224)) and clinical, physiological, and treatment factors were explored using time-linked data and Spearman's correlation coefficients. Results No clinical, physiological, or treatment variable was significantly associated with all PbtO(2) parameters, but individual associations were found with initial GCS (PbtO(2) < 5, p = 0.0113), admission Pediatric Trauma Score (PbtO(2) < 10, 0.0175), mICP > 20 (mPbtO(224), p = 0.0377), CPPlow (PbtO(2low), p = 0.0065), CPP < 40 (PbtO(2low), p = 0.0269; PbtO(2) < 5, p = 0.0212), PaO2 < 60 (mPbtO(224), p = 0.0037), SaO2 < 90 (PbtO(2low), p = 0.0438), and use of inotropes during ICU care (PbtO(2low), p = 0.0276; PbtO(2) < 10, p = 0.0277; p = mPbtO(224)). Conclusion Delivery of oxygen to the brain is important to limit secondary neuronal injury after severe TBI. Our data show that PbtO(2) is poorly predicted by clinical and physiological factors commonly measured in the pediatric ICU. Multimodality monitoring may be needed to detect all secondary cerebral insults in pediatric TBI.	[Figaji, Anthony A.] Red Cross War Mem Childrens Hosp, Inst Child Hlth, ZA-7700 Rondebosch, Cape Town, South Africa; [Figaji, Anthony A.; Thompson, Crispin; Fieggen, A. Graham; Peter, Jonathan C.] Univ Cape Town, Div Neurosurg, Sch Child & Adolescent Hlth, Red Cross Childrens Hosp, ZA-7925 Cape Town, South Africa; [Zwane, Eugene] Univ Cape Town, Infect Dis Epidemiol Unit Biostat, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [Le Roux, Peter D.] Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19107 USA		Figaji, AA (corresponding author), Red Cross War Mem Childrens Hosp, Inst Child Hlth, Room 617,Klipfontein Rd, ZA-7700 Rondebosch, Cape Town, South Africa.	Anthony.Figaji@uct.ac.za	Fieggen, Anthony Graham/AAT-6510-2021; Argent, Andrew/J-1605-2019	Fieggen, Anthony Graham/0000-0001-6541-8377; Argent, Andrew/0000-0001-9333-2036; Figaji, Anthony/0000-0002-3357-6490	Integra Foundation	Dr Figaji has received a grant from the South African- Swedish Links Programme (SIDA, National Research Foundation). Drs Figaji and Le Roux have also received a grant from the Integra Foundation for the study of cerebral perfusion pressure thresholds in children.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Akopian G, 2007, AM SURGEON, V73, P447; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cremer OL, 2008, EUR J ANAESTH, V25, P87, DOI 10.1017/S0265021507003237; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Flynn EP, 2002, ANN NEUROL, V52, P566, DOI 10.1002/ana.10322; Gracias VH, 2004, J TRAUMA, V56, P469, DOI 10.1097/01.TA.0000114274.95423.C0; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Mileski WJ, 2004, J TRAUMA, V56, P472; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Prabhakaran P, 2004, J NEUROSURG, V100, P454, DOI 10.3171/ped.2004.100.5.0454; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P199; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299; van den Brink WA, 1998, J NEUROTRAUM, V15, P813, DOI 10.1089/neu.1998.15.813; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	52	28	29	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2009	25	10					1335	1343		10.1007/s00381-009-0821-y			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	494TE	WOS:000269838900022	19214533				2022-02-06	
J	Nott, MT; Chapparo, C; Heard, R				Nott, Melissa T.; Chapparo, Christine; Heard, Robert			Reliability of the Perceive, Recall, Plan and Perform System of Task Analysis: A criterion-referenced assessment	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						agitation; assessment; brain injuries; occupational performance; reliability	BRAIN-INJURY; REHABILITATION	Objective: To conduct preliminary examination of the rater and test-reliability of the Perceive, Recall, Plan and Perform (PRPP) System of Task Analysis, an ecological measure designed to assess task-embedded information processing capacity during occupational therapy assessment of confused and agitated adults following traumatic brain injury. Methods: Occupational therapists observed and scored client performance using the PRPP System of Task Analysis. Correlational analysis and measures of agreement were performed to determine interrater and intrarater reliability. Test procedures were examined for reliability and internal consistency. Results: Interrater and test reliability considered three factors: therapists, clients and tasks. A moderate level of interrater reliability was achieved between trained therapists (intraclass correlation coefficient (ICC) = 0.60). Test procedures were highly reliable (ICC = 0.88). Across two measurement occasions, therapists showed a tendency towards harder rating on the second test occasion ((d) over bar -4.5%; 95% confidence interval for (d) over bar: -10.67% -> 3.17%). Conclusion: The findings of this study support the use of criterion-referenced tests in the area of occupational performance measurement. Occupational therapists achieved moderate interrater reliability when measuring the performance of adults with brain injury on various activities of daily living. Test procedures were found to be highly reliable in measuring the occupational performance of adults demonstrating confusion and agitation typical to the stage of post-traumatic amnesia following head injury.	[Nott, Melissa T.; Chapparo, Christine; Heard, Robert] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia		Nott, MT (corresponding author), J Block,Rm J126,POB 170, Lidcombe, NSW 1825, Australia.	mnot2529@mail.usyd.edu.au	Nott, Melissa T/M-6778-2018	Nott, Melissa T/0000-0001-7088-5826			Anastasi A., 1988, PSYCHOL TESTING; ARNADOTTIR G, 1990, BRAIN BEHAV ASSESSIN; BAUM C, 1993, AM J OCCUP THER, V47, P431, DOI 10.5014/ajot.47.5.431; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; CARLSON T, 2000, HIGHER ED RES DEV, V19, P103, DOI DOI 10.1080/07294360050020507; Chapparo C., 1997, OCCUPATIONAL PERFORM, V1, P189; CHAPPARO C, 1997, OCCUPATIONAL PERFORM, V1; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; EISNER EW, 1993, J CURRICULUM STUD, V25, P219, DOI 10.1080/0022027930250302; Fry K, 2002, AUSTR OCCUPATIONAL T, V49, P182, DOI 10.1046/j.1440-1630.2002.00337.x; GLASER R, 1981, AM PSYCHOL, V36, P923, DOI 10.1037/0003-066X.36.9.923; Griffin P., 1995, AUSTR NZ J VOCATIONA, V3, P34; HAGEN C, 2001, RELEARNING TIMES, V8, P1; LANDIS JR, 1977, BIOMETRICS, V33, P174; LOHRI J, 2005, INFORM SENSORY PROCE; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; MUNKHETVIT P, 2005, THESIS U SYDNEY SYDN; NOTT MT, 2007, AUSTR OCCUPATIONAL T, V55, P188; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Rockwood K, 1997, J CLIN EPIDEMIOL, V50, P581, DOI 10.1016/S0895-4356(97)00014-0; Romiszowski A, 1984, DESIGNING INSTRUCTIO; Schraagen Jan Maarten, 2000, COGNITIVE TASK ANAL; Slifer KJ, 1997, BRAIN INJURY, V11, P877; Sudsawad P, 2005, AM J OCCUP THER, V59, P351, DOI 10.5014/ajot.59.3.351; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; Whiting S., 1985, RIVERMEAD PERCEPTUAL; WILSON BA, 2003, RIVERMEAD BEHAVIOURA, V2; Wong SP, 1999, EDUC PSYCHOL MEAS, V59, P270, DOI 10.1177/00131649921969848; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; [No title captured]	32	28	28	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	OCT	2009	56	5					307	314		10.1111/j.1440-1630.2008.00763.x			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	504JB	WOS:000270611100003	20854536				2022-02-06	
J	Ruan, S; Noyes, K; Bazarian, JJ				Ruan, Shuolun; Noyes, Katia; Bazarian, Jeffrey J.			The Economic Impact of S-100B as a Pre-Head CT Screening Test on Emergency Department Management of Adult Patients with Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						computed tomography; cost minimization; S-100B; mild traumatic brain injury	COMPUTED-TOMOGRAPHY SCAN; NEW-ORLEANS CRITERIA; PULMONARY-EMBOLISM; PROTEIN MEASUREMENTS; DECISION-MAKING; CLINICAL POLICY; S100B LEVELS; RULE; ADMISSION; MULTICENTER	Recent research suggests that serum S-100B may serve as a good pre-head computed tomography (CT) screening test because of its high sensitivity for abnormal head CT scans. The potential economic impact of using S-100B in the emergency department setting for management of adult patients with isolated mild traumatic brain injury (mTBI) has not been evaluated despite its clinical implementation in Europe. Using evidence from the literature, we constructed a decision tree to compare the average cost per patient of using S-100B as a pre-head CT screening test to the current practice of ordering CT scans based on patients' presenting symptoms without the aid of S-100B. When compared to scanning 45-77% of isolated mTBI patients based upon their presenting symptoms, using S-100B as a pre-head CT screen does not lower hospital costs ($281 versus $160), primarily due to its low specificity for abnormal head CT scans. Sensitivity analyses showed, however, that S-100B becomes cost-lowering when the proportion of mTBI patients being scanned exceeds 78%, or when final CT scan results require 96 min or more than the wait for blood test results. Generally speaking, if blood test results require less time than imaging, and if head CT scan rates for patients with isolated mTBI are relatively high, using S-100B will lower costs. Recommendations for using S-100B as a screening tool should account for setting-specific characteristics and their consequent economic impacts. Despite its high sensitivity and excellent negative predictive value, serum S-100B has low specificity and low positive predictive value, limiting its ability to reduce numbers of CT scans and hospital costs.	[Ruan, Shuolun; Noyes, Katia] Univ Rochester, Sch Med & Dent, Dept Community & Prevent Med, Rochester, NY 14642 USA; [Bazarian, Jeffrey J.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY 14642 USA		Ruan, S (corresponding author), Univ Rochester, Sch Med & Dent, Dept Community & Prevent Med, 601 Elmwood Ave,Box 189, Rochester, NY 14642 USA.	shuolun.ruan@aya.yale.edu			National Center for Research Resources (NCRR)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1 UL1 RR024160-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD051865] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG020980] Funding Source: NIH RePORTER	This research was partially supported by grant 1 UL1 RR024160-01 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. Information on the NCRR is available at http://www.ncrr.nih.gov/.	af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; af Geijerstam JL, 2004, EMERG MED J, V21, P54, DOI 10.1136/emj.2003.003178; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Bayley MD, 2005, ANN EMERG MED, V45, P110, DOI 10.1016/j.annemergmed.2004.09.010; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Duriseti RS, 2006, ACAD EMERG MED, V13, P755, DOI 10.1197/j.aem.2006.02.011; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Falvo T, 2007, ACAD EMERG MED, V14, P332, DOI 10.1197/j.aem.2006.11.011; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hemphill RR, 1999, ACAD EMERG MED, V6, P957, DOI 10.1111/j.1553-2712.1999.tb01248.x; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Konstantinides S, 2008, NEW ENGL J MED, V359, P2804, DOI 10.1056/NEJMcp0804570; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; National Center for Injury Prevention and Control, 2007, MOM NOT SURG CAP TER; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Poli-de-Figueiredo Luiz F, 2006, Clinics, V61, P41, DOI 10.1590/S1807-59322006000100008; Righini M, 2007, J THROMB HAEMOST, V5, P1869, DOI 10.1111/j.1538-7836.2007.02667.x; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; Thiessen ML, 2006, PEDIATR CLIN N AM, V53, P1, DOI 10.1016/j.pcl.2005.09.004; Townend W, 2006, INJURY, V37, P1098, DOI 10.1016/j.injury.2006.07.014; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395	40	28	29	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2009	26	10					1655	1664		10.1089/neu.2009.0928			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	507CT	WOS:000270829200004	19413465	Green Published			2022-02-06	
J	Arun, P; Moffett, JR; Namboodiri, AMA				Arun, Peethambaran; Moffett, John R.; Namboodiri, Aryan M. A.			Evidence for mitochondrial and cytoplasmic N-acetylaspartate synthesis in SH-SY5Y neuroblastoma cells	NEUROCHEMISTRY INTERNATIONAL			English	Article						NAA; Aspartate-N-acetyltransferase; Aspartate aminotransferase; Aminooxyacetic acid; Mitochondria; Cytoplasm; Microsomes	L-ASPARTIC ACID; MAGNETIC-RESONANCE SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; RAT-BRAIN; ACETYL-ASPARTATE; IN-VIVO; DIFFERENTIAL DISTRIBUTION; ENZYMATIC SYNTHESIS; ACETYLASPARTYLGLUTAMATE; OLIGODENDROCYTES	N-acetylaspartate (NAA) is synthesized predominantly in neurons, and brain homogenate subfractionation studies suggest that biosynthesis occurs at both microsomal (cytoplasmic) and mitochondrial sites. We investigated NAA synthesis in SH-SY5Y human neuroblastoma cells using distinct metabolic precursors that are preferentially metabolized in mitochondria and cytoplasm. Incorporation of C-14-aspartate and C-14-malate into NAA was examined in the presence and absence of an inhibitor (aminooxyacetic acid, AOAA) of aspartate aminotransferase (AAT), a central enzyme involved in the biosynthesis of aspartate in mitochondria, and degradation of aspartate in the cytoplasm. AOAA increased the incorporation of C-14-aspartate into NAA, reflecting direct aspartate -> NAA synthesis in an extramitochondrial location. As expected, AOAA decreased incorporation of C-14-malate into NAA, reflecting NAA synthesis in mitochondria via the malate -> oxaloacetate -> aspartate -> NAA pathway. When C-14-malate was used as substrate, the C-14-NAA/C-14-aspartate ratio was over 20-fold higher than the ratio obtained with C-14-aspartate. Because NAA can only be synthesized from aspartate, the higher C-14-NAA/C-14-aspartate (product/substrate) ratio obtained with C-14-malate suggests greater NAA biosynthetic activity. We conclude that NAA biosynthesis occurs in both the cytoplasm and mitochondria of SH-SY5Y cells, and that the contribution from the mitochondrial compartment is quantitatively larger than that in the extramitochondrial compartment. Published by Elsevier Ltd.	[Arun, Peethambaran; Moffett, John R.; Namboodiri, Aryan M. A.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Moffett, JR (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	jmoffett@usuhs.mil			USUHS [C070PB, R070WG]	The work was supported by USUHS internal grants C070PB and R070WG to M.A.A.N.	Ariyannur PS, 2008, BRAIN RES, V1227, P34, DOI 10.1016/j.brainres.2008.06.040; Arun P, 2008, J NEUROCHEM, V106, P1669, DOI 10.1111/j.1471-4159.2008.05524.x; Arun P, 2006, J NEUROCHEM, V98, P2034, DOI 10.1111/j.1471-4159.2006.04068.x; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; BENUCK M, 1968, BIOCHIM BIOPHYS ACTA, V152, P611, DOI 10.1016/0005-2760(68)90101-X; Bhakoo KK, 2000, J NEUROCHEM, V74, P254, DOI 10.1046/j.1471-4159.2000.0740254.x; Blum S, 1999, J MAGN RESON, V136, P219, DOI 10.1006/jmre.1998.1618; CHEESEMAN AJ, 1988, J NEUROCHEM, V50, P1559, DOI 10.1111/j.1471-4159.1988.tb03044.x; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; del Arco A, 1998, J BIOL CHEM, V273, P23327, DOI 10.1074/jbc.273.36.23327; GOLDSTEIN FB, 1959, BIOCHIM BIOPHYS ACTA, V33, P583, DOI 10.1016/0006-3002(59)90161-1; GOLDSTEIN FB, 1969, J BIOL CHEM, V244, P4257; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; KNIZLEY H, 1967, J BIOL CHEM, V242, P4619; Lu ZH, 2004, MOL BRAIN RES, V122, P71, DOI 10.1016/j.molbrainres.2003.12.002; Madhavarao CN, 2003, J NEUROCHEM, V86, P824, DOI 10.1046/j.1471-4159.2003.01905.x; Madhavarao CN, 2002, ANAL BIOCHEM, V308, P314, DOI 10.1016/S0003-2697(02)00225-7; MATALON R, 1995, J PEDIATR-US, V127, P511, DOI 10.1016/S0022-3476(95)70105-2; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; McKenna MC, 2000, NEUROCHEM INT, V36, P451, DOI 10.1016/S0197-0186(99)00148-5; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; MOFFETT JR, 1995, J NEUROCYTOL, V24, P409, DOI 10.1007/BF01181604; MOFFETT JR, 1991, NEUROREPORT, V2, P131, DOI 10.1097/00001756-199103000-00005; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; Sherry AD, 1998, AM J PHYSIOL-HEART C, V274, pH591, DOI 10.1152/ajpheart.1998.274.2.H591; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; TRUCKENMILLER ME, 1985, J NEUROCHEM, V45, P1658, DOI 10.1111/j.1471-4159.1985.tb07240.x	29	28	29	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	SEP	2009	55	4					219	225		10.1016/j.neuint.2009.03.003			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	468SC	WOS:000267839600007	19524112				2022-02-06	
J	Beacher, FDCC; Gray, MA; Mathias, CJ; Critchley, HD				Beacher, Felix D. C. C.; Gray, Marcus A.; Mathias, Christopher J.; Critchley, Hugo D.			Vulnerability to simple faints is predicted by regional differences in brain anatomy	NEUROIMAGE			English	Article						Neurocardiogenic syncope; Vasovagal syncope; Blood pressure; Brain anatomy; Magnetic Resonance Imaging; Voxel-based morphometry	OBSESSIVE-COMPULSIVE DISORDER; VOXEL-BASED MORPHOMETRY; HEART-RATE-VARIABILITY; NEURALLY-MEDIATED SYNCOPE; CEREBRAL-BLOOD-FLOW; VENTROLATERAL PERIAQUEDUCTAL GRAY; MULTIPLE SYSTEM ATROPHY; CAUDAL MIDLINE MEDULLA; UP TILT TEST; VASOVAGAL SYNCOPE	Neurocardiogenic syncope (NCS, simple fainting) is a common and typically benign familial condition, which rarely may result in traumatic injury or hypoxic convulsions. NCS is associated with emotional triggers, anxiety states and stress. However, the etiology of NCS, as a psychophysiological process, is poorly understood. We therefore investigated the relationship between NCS and brain anatomy. We studied a non-clinical sample of eighteen individuals with histories characteristic of NCS, and nineteen matched controls who had never fainted. We recorded fainting frequency, testing heart rate variability measures and anxiety levels. Structural T1-weighted magnetic resonance images (MRI) were acquired at 1.5 T. Associations between brain morphometry (regional gray and white matter Volumes) and NCS, testing physiology and anxiety were tested using voxel-based morphometry (VBM). Compared to controls, NCS participants had lower regional brain volume within medulla and midbrain (a priori regions of interest). Moreover, across NCS individuals, lower gray matter Volume in contiguous regions of left caudate nucleus predicted enhanced parasympathetic cardiac tone, fainting frequency and anxiety levels. Our findings provide preliminary evidence for a hierarchical anatomical basis to NCS. First, differences in the volume of brainstem centers supporting cardiovascular homeostasis may relate to constitutional predisposition to NCS. Second, differences in the Structural organization of the caudate nucleus in NCS individuals may relate to fainting frequency via interactions between emotional state and Parasympathetic control of the heart. These observations highlight the application of VBM to the identification of neurovisceral mechanisms relevant to psychosomatic medicine and the neuroscience of emotion. Crown Copyright (C) 2009 Published by Elsevier Inc. All rights reserved.	[Beacher, Felix D. C. C.; Gray, Marcus A.; Critchley, Hugo D.] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Brighton BN1 9RY, E Sussex, England; [Mathias, Christopher J.] Univ London Imperial Coll Sci Technol & Med, Div Neurosci & Mental Hlth, London SW7 2AZ, England			f.beacher@bsms.ac.uk	critchley, hugo d/G-9267-2011; Gray, Marcus/F-6521-2013	critchley, hugo d/0000-0002-2445-9284; Gray, Marcus/0000-0001-8671-6939; beacher, felix/0000-0002-4130-4073	Wellcome TrustWellcome TrustEuropean Commission	This study was supported by a Wellcome Trust Programme Grant to HDC. Neuroimaging was undertaken at the Clinical Imaging Sciences Centre, Brighton and Sussex Medical School.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bergouignan L, 2009, NEUROIMAGE, V45, P29, DOI 10.1016/j.neuroimage.2008.11.006; Brignole M, 2004, EUR HEART J, V25, P2054, DOI 10.1016/j.ehj.2004.09.004; Brodal P, 2004, CENTRAL NERVOUS SYST; Cavun S, 2001, AM J PHYSIOL-REG I, V281, pR747, DOI 10.1152/ajpregu.2001.281.3.R747; Cohen TJ, 2000, PACE, V23, P837, DOI 10.1111/j.1540-8159.2000.tb00852.x; Della Nave R, 2008, J NEUROL NEUROSUR PS, V79, P82, DOI 10.1136/jnnp.2007.124297; Donadio V, 2007, BRAIN, V130, P1653, DOI 10.1093/brain/awm037; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ellenbogen KA, 1997, PACE, V20, P788, DOI 10.1111/j.1540-8159.1997.tb03905.x; FRIEDMAN BH, 1993, BIOL PSYCHIAT, V34, P298, DOI 10.1016/0006-3223(93)90087-T; Furlan R, 1998, CIRCULATION, V98, P1756, DOI 10.1161/01.CIR.98.17.1756; Ginestroni A, 2008, J NEUROL, V255, P1153, DOI 10.1007/s00415-008-0860-4; Golanov EV, 2001, BRAIN RES, V892, P1, DOI 10.1016/S0006-8993(00)02949-8; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gracie J, 2006, EUROPACE, V8, P636, DOI 10.1093/europace/eul073; Gray MA, 2009, J NEUROSCI, V29, P1817, DOI 10.1523/JNEUROSCI.3363-08.2009; Grubb BP, 2005, NEW ENGL J MED, V352, P1004, DOI 10.1056/NEJMcp042601; GRUBB BP, 1991, CIRCULATION, V84, P1157, DOI 10.1161/01.CIR.84.3.1157; Hainsworth R, 2004, CLIN AUTON RES, V14, P18, DOI 10.1007/s10286-004-1004-2; Hauser TK, 2006, MOVEMENT DISORD, V21, P1674, DOI 10.1002/mds.21032; Henderson LA, 2000, NEUROSCIENCE, V98, P779, DOI 10.1016/S0306-4522(00)00117-2; Heslop DJ, 2002, NEUROSCIENCE, V113, P555, DOI 10.1016/S0306-4522(02)00161-6; Jardine DL, 1998, AM J PHYSIOL-HEART C, V274, pH2110, DOI 10.1152/ajpheart.1998.274.6.H2110; Kapoor WN, 2000, NEW ENGL J MED, V343, P1856, DOI 10.1056/NEJM200012213432507; Kochiadakis GE, 1998, INT J CARDIOL, V64, P185, DOI 10.1016/S0167-5273(98)00039-4; Kochiadakis GE, 1997, PACE, V20, P1332, DOI 10.1111/j.1540-8159.1997.tb06788.x; Kouakam C, 1999, HEART, V82, P312, DOI 10.1136/hrt.82.3.312; Kouakam C, 2002, AM J CARDIOL, V89, P530, DOI 10.1016/S0002-9149(01)02292-5; Lee TM, 1996, CLIN CARDIOL, V19, P137, DOI 10.1002/clc.4960190212; LIPSITZ LA, 1990, CIRCULATION, V81, P1803, DOI 10.1161/01.CIR.81.6.1803; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MARK AL, 1983, J AM COLL CARDIOL, V1, P90, DOI 10.1016/S0735-1097(83)80014-X; Mathias CJ, 2001, LANCET, V357, P348, DOI 10.1016/S0140-6736(00)03642-4; Mathias CJ, 1998, LANCET, V352, P33, DOI 10.1016/S0140-6736(05)79513-1; Minnerop M, 2007, NEUROIMAGE, V36, P1086, DOI 10.1016/j.neuroimage.2007.04.028; Morillo CA, 1997, CIRCULATION, V96, P2509, DOI 10.1161/01.CIR.96.8.2509; MORILLO CA, 1994, AM J CARDIOL, V74, P1258, DOI 10.1016/0002-9149(94)90559-2; MORINO M, 1994, J AUTONOM NERV SYST, V49, P159, DOI 10.1016/0165-1838(94)90135-X; MosquedaGarcia R, 1997, J CLIN INVEST, V99, P2736, DOI 10.1172/JCI119463; OBERG B, 1972, ACTA PHYSIOL SCAND, V85, P164, DOI 10.1111/j.1748-1716.1972.tb05247.x; OST LG, 1984, BEHAV RES THER, V22, P109, DOI 10.1016/0005-7967(84)90099-8; Piccirillo G, 2004, CLIN SCI, V107, P55, DOI 10.1042/CS20030327; Porges S. W., 1993, BODY PERCEPTION QUES; Robertson RM, 1999, AM J MED SCI, V317, P102, DOI 10.1097/00000441-199902000-00004; ROBINSON D, 1995, ARCH GEN PSYCHIAT, V52, P393; RUBIN RT, 1992, ARCH GEN PSYCHIAT, V49, P695; Sarasin FP, 2001, AM J MED, V111, P177, DOI 10.1016/S0002-9343(01)00797-5; Saxena S, 2001, BIOL PSYCHIAT, V50, P159, DOI 10.1016/S0006-3223(01)01123-4; SCHADT JC, 1991, AM J PHYSIOL, V260, pH305; Serletis A, 2006, EUR HEART J, V27, P1965, DOI 10.1093/eurheartj/ehl147; SHALEV Y, 1991, J AM COLL CARDIOL, V18, P746, DOI 10.1016/0735-1097(91)90798-E; SHARPEYSCHAFER EP, 1956, BRIT MED J, V1, P506, DOI 10.1136/bmj.1.4965.506; SILVERSTEIN MD, 1982, JAMA-J AM MED ASSOC, V248, P1185, DOI 10.1001/jama.248.10.1185; SPRENGELMEYER R, 1995, MOVEMENT DISORD, V10, P51, DOI 10.1002/mds.870100110; STEPTOE A, 1988, PSYCHOSOM MED, V50, P402, DOI 10.1097/00006842-198807000-00008; Sutton R, 1992, EUR J CARD PACING EL, V2, P180; SWEDO SE, 1992, ARCH GEN PSYCHIAT, V49, P690; Troy BP, 2003, AUTON NEUROSCI-BASIC, V108, P1, DOI 10.1016/S1566-0702(03)00152-8; Uchida RR, 2008, PSYCHIAT RES-NEUROIM, V163, P21, DOI 10.1016/j.pscychresns.2007.04.015; Vagg DJ, 2008, NEUROSCIENCE, V152, P1099, DOI 10.1016/j.neuroscience.2007.10.070; Verner TA, 2008, BRAIN RES, V1208, P128, DOI 10.1016/j.brainres.2008.02.028; Woermann FG, 1999, NEUROIMAGE, V10, P373, DOI 10.1006/nimg.1999.0481; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016	65	28	28	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119			NEUROIMAGE	Neuroimage	SEP	2009	47	3					937	945		10.1016/j.neuroimage.2009.05.038			9	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	482YI	WOS:000268926200019	19464376	Green Published, hybrid			2022-02-06	
J	Kendall, E; Terry, D				Kendall, Elizabeth; Terry, Deborah			Predicting emotional well-being following traumatic brain injury: A test of mediated and moderated models	SOCIAL SCIENCE & MEDICINE			English	Article						Traumatic brain injury; Moderating role of appraisal; Mediating role of appraisal; Emotional well-being; Adjustment outcomes; Australia	SOCIAL SUPPORT; COPING STRATEGIES; STRESS; ADJUSTMENT; INDIVIDUALS; EXAMPLES; HEALTH; SAMPLE; BUFFER	This study examined two models for predicting emotional well-being following traumatic brain injury (TBI), namely the Lazarus and Folkman (1984) mediated model of stress and coping and the stress-buffer hypothesis (Cohen & Edwards, 1988). The mediated model suggests that antecedent variables (i.e., personal and environmental resources) will predict emotional well-being, but their effect will be mediated through cognitive variables, such as appraisal and coping. In contrast, the moderated (buffer) hypothesis suggests that resources will protect individuals from the effects of stress, so will have different relationships with outcome at different levels of perceived stress. Ninety individuals with TBI were recruited from a major hospital in Brisbane, Australia. They and their relatives completed questionnaires at three time intervals: discharge, one month and nine months post-discharge, discharge being in 1998. Hierarchical regression was used to examine the relationships among the proposed predictors, mediators and outcomes. Support was found for some aspects of both models in the short-term. In the long-term, stress-buffer effects were no longer apparent. However, with the exception of family support, the predictors all influenced long-term adjustment through their impact on short-term adjustment. The role of family support as a direct predictor of emotional well-being in the long-term is highlighted. The findings have the potential to enable the identification of "at risk" individuals prior to discharge and can highlight important foci for rehabilitation. Specifically, the study has identified the importance of early psychological intervention to address appraisal and the need to engage families in rehabilitation. (C) 2009 Elsevier Ltd. All rights reserved.	[Kendall, Elizabeth] Griffith Univ, Ctr Natl Res Disabil & Rehabil Med, Logan, Qld 4131, Australia; [Terry, Deborah] Univ Queensland, Brisbane, Qld 4072, Australia		Kendall, E (corresponding author), Griffith Univ, Ctr Natl Res Disabil & Rehabil Med, Logan Campus,Univ Dr Meadowbrook, Logan, Qld 4131, Australia.	e.kendall@griffith.edu.au	kendall, elizabeth/F-5065-2013	Kendall, Elizabeth/0000-0003-2399-1460			ALDWIN CM, 1987, J PERS SOC PSYCHOL, V53, P337, DOI 10.1037/0022-3514.53.2.337; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beck A.T, 1976, COGNITIVE THERAPY EM; Bedford A, 1997, PERS INDIV DIFFER, V22, P493, DOI 10.1016/S0191-8869(96)00242-5; BEDFORD A, 1976, BRIT J SOC CLIN PSYC, V15, P387, DOI 10.1111/j.2044-8260.1976.tb00050.x; Carte TA, 2003, MIS QUART, V27, P479; Cast AD, 2002, SOC FORCES, V80, P1041, DOI 10.1353/sof.2002.0003; CHAN F, 2008, REHABILITATION COUNS, V2009, P114; Chin W. W., 1998, MIS Q, V22, P7, DOI [DOI 10.2307/249674, DOI 10.2307/249676]; Chwalisz K, 1996, REHABIL PSYCHOL, V41, P91, DOI 10.1037/0090-5550.41.2.91; CICERONE KD, 1991, J HEAD TRAUMA REHAB, V6, P30, DOI DOI 10.1097/00001199-199112000-00007; Cohen J., 1983, APPL MULTIPLE REGRES; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cohen S., 1988, ADV INVESTIGATION PS, P235; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Ellis A., 1987, J COGNITIVE PSYCHOTH, V1, P73; ELLSWORTH E, 1995, J INSTRUCTIONAL PSYC, V22, P19; FELTON BJ, 1984, J CONSULT CLIN PSYCH, V52, P343, DOI 10.1037/0022-006X.52.3.343; FINNEY JW, 1984, J HEALTH SOC BEHAV, V25, P85, DOI 10.2307/2136706; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Folkman S., 1984, STRESS; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Gignac MAM, 1996, PSYCHOL AGING, V11, P214, DOI 10.1037//0882-7974.11.2.214; GUO B, 2008, BRIT J SOCIAL WO JUL, P1; HOLAHAN CJ, 1985, J PERS SOC PSYCHOL, V49, P739, DOI 10.1037/0022-3514.49.3.739; Holmbeck GN, 1997, J CONSULT CLIN PSYCH, V65, P599, DOI 10.1037/0022-006X.65.4.599; Jennett B, 1981, MANAGEMENT HEAD INJU; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Kendall E, 2003, J VOCAT REHABIL, V19, P31; Kendall E, 2007, SOC SCI MED, V64, P735, DOI 10.1016/j.socscimed.2006.09.012; KESSLER RC, 1985, ANNU REV PSYCHOL, V36, P531, DOI 10.1146/annurev.ps.36.020185.002531; Krause N, 1995, PSYCHOL AGING, V10, P518, DOI 10.1037/0882-7974.10.4.518; Larson R, 1996, J SOC PSYCHOL, V136, P5, DOI 10.1080/00224545.1996.9923024; Lazarus R.S., 1990, PSYCHOL INQ, V1, P3, DOI [10.1207/s15327965pli0101_1, DOI 10.1207/S15327965PLI0101_1]; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Marshall Stephen W, 2007, Epidemiol Perspect Innov, V4, P4, DOI 10.1186/1742-5573-4-4; MCCOLL MA, 1995, SOC SCI MED, V41, P395, DOI 10.1016/0277-9536(94)00338-T; MENAGHAN EG, 1983, INDIVIDUAL COPING EF, P157; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; MOORE AD, 1994, CANADIAN J REHABILIT, V7, P193; Muller D, 2005, J PERS SOC PSYCHOL, V89, P852, DOI 10.1037/0022-3514.89.6.852; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Penninx BWJH, 1997, SOC SCI MED, V44, P393, DOI 10.1016/S0277-9536(96)00156-6; Prawitz AD., 2006, FINANCIAL COUNSELING, V17, P34, DOI DOI 10.1037/T60365-000; Rahim MA, 1996, J SOC PSYCHOL, V136, P69, DOI 10.1080/00224545.1996.9923030; Rosenberg M., 1965, SOC ADOLESCENT SELF; Rutterford NA, 2006, J INT NEUROPSYCH SOC, V12, P359, DOI 10.1017/S1355617706060450; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; SARASON IG, 1978, J CONSULT CLIN PSYCH, V46, P932, DOI 10.1037/0022-006X.46.5.932; Stroebe W, 1996, J PERS SOC PSYCHOL, V70, P1241, DOI 10.1037/0022-3514.70.6.1241; TERRY DJ, 1991, AUST J PSYCHOL, V43, P29, DOI 10.1080/00049539108259093; West S. G., 1991, MULTIPLE REGRESSION	56	28	30	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536			SOC SCI MED	Soc. Sci. Med.	SEP	2009	69	6					947	954		10.1016/j.socscimed.2009.06.021			8	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	504UJ	WOS:000270642900019	19616354				2022-02-06	
J	Lee, SW; Hong, YS; Han, C; Kin, SJ; Moon, SW; Shin, JH; Baek, KJ				Lee, Sung-Woo; Hong, Yun-Sik; Han, Chul; Kin, Su-Jin; Moon, Sung-Woo; Shin, Jung-Ho; Baek, Kwang-Je			Concordance of End-Tidal Carbon Dioxide and Arterial Carbon Dioxide in Severe Traumatic Brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						End-tidal carbon dioxide; Arterial carbon dioxide; Tratumatic brain injury	RAPID-SEQUENCE INTUBATION; HEAD-INJURY; HYPERVENTILATION; VENTILATION; CO2	Objective: It is important for preventing hyperventilation so as to improve the outcomes of patients with severe traumatic brain injuries. End-tidal CO, (PetCO(2)) reflects arterial CO2 (PaCO2), noninvasively and continuously. The aim of this study is to examine the concordance between PaCO2 and PetCO(2) among adults presenting to the emergency department with severe traumatic brain injury and to elucidate the patient groups who had discordance. Methods: From July 1, 2006 to December 31, 2007, 77 patients who presented in the emergency department of the hospital after severe brain injury were enrolled. Glasgow Coma Scale, blood pressure, heart rate, respiration rate, body temperature, arterial blood gas variables, and serum lactate levels were measured under the mechanical ventilation support. Finally, Injury Severity Score and Abbreviated Injury Scale of head and chest were recorded. The concordance between PetCO(2) and PaCO2 analyzed using Bland-Altinan plot. We defined that normal gap of PaCO2 and PetCO(2) [p(a-et)CO2] is -5 mm Hg to 5 mm Hg, and compared the normal and high P(a-et)CO2 groups to find the factors affecting the P(a-et)CO2. Results: Sixty-six patients after exception of 11 patients with nontraumatic brain injury were analyzed. Ten patients (15.2%) were below 30 mm Hg of PaCO2. Pearson's correlation coefficient between PaCO2 and PetCO(2) was 0.666 (p < 0.001) and the concordance between PaCO2 and PetCO(2) was 77.3%. The patients with high P(a-et)CO2 showed significantly higher Injury Severity Score, lower systolic blood pressure, lower arterial pH, lower base deficit, and higher serum lactate levels than patients with normal P(a-et)CO2. Patients with severe chest trauma, hypotension, and metabolic acidosis increased the risk of the discordance between PaCO2 and PetCO(2). Twenty-eight patients who had no hypotension, no metabolic acidosis, and no severe chest trauma showed concordance rate of 100.0% between PaCO2 and PetCO(2). Conclusions: Severe chest trauma and hemodynamic and tissue perfusion state should be considered when attempting to monitor the hyperventilation in severe brain injury patients using PetCO(2)	[Baek, Kwang-Je] Konkuk Univ, Sch Med, Dept Emergency Med, Seoul, South Korea; [Lee, Sung-Woo; Hong, Yun-Sik; Han, Chul; Kin, Su-Jin; Moon, Sung-Woo; Shin, Jung-Ho] Korea Univ, Sch Med, Dept Emergency Med, Ansan 425707, South Korea		Lee, SW (corresponding author), Korea Univ, Ansan Hosp, Emergency Dept, 516 Gojan Dong, Ansan 425707, South Korea.	kuedlee@korea.ac.kr		shin, jungho/0000-0002-5388-2655			Benallal H, 2000, EUR J APPL PHYSIOL, V83, P402, DOI 10.1007/s004210000260; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BULLOCK MR, 2000, J NEUROTRAUM, V17, P513; Corbo J, 2005, ANN EMERG MED, V46, P323, DOI 10.1016/j.annemergmed.2004.12.005; Davis DP, 2007, RESUSCITATION, V73, P354, DOI 10.1016/j.resuscitation.2006.09.015; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Fall Pamela J, 2005, J Intensive Care Med, V20, P255, DOI 10.1177/0885066605278644; Kim Sunghan, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P9; KIRSCH TD, 2006, EMERGENCY MED COMPRE, P1557; Levine RL, 2000, INTENS CARE MED, V26, P1595, DOI 10.1007/s001340000699; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nuckton TJ, 2002, NEW ENGL J MED, V346, P1281, DOI 10.1056/NEJMoa012835; NUNN JF, 1960, J APPL PHYSIOL, V15, P383, DOI 10.1152/jappl.1960.15.3.383; Seguin P, 2001, CAN J ANAESTH, V48, P396, DOI 10.1007/BF03014971; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Ward KR, 1998, ACAD EMERG MED, V5, P628, DOI 10.1111/j.1553-2712.1998.tb02473.x; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032	20	28	32	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2009	67	3					526	530		10.1097/TA.0b013e3181866432			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	493IL	WOS:000269729900019	19741395				2022-02-06	
J	Neumann, CR; Brasil, AV; Albers, F				Neumann, Cristina R.; Brasil, Albert V.; Albers, Felix			Risk Factors for Mortality in Traumatic Cervical Spinal Cord Injury: Brazilian Data	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic cervical spinal cord injury; Mortality; Brain trauma	MULTICENTER; SURVIVAL; PATTERNS; SCORE; CARE	Background: Predictive factors for mortality are different among Countries; knowledge of risk factors is important for planning strategies to reduce mortality in trauma. The objective of this study was to identify predictors of death in traumatic cervical spinal cord injury (TSCI) in Brazil. Methods: From 2001 to 2005, 84 patients with clinically detectable TSCI were identified in this retrospective study. For each patient, neurologic and associated injuries, physiologic variables, complications, treatment, and hospital mortality were recorded. Bivariate and multivariate logistic regression analyses were done to identify predictors of mortality. Results: Twenty-two (26.2%) patients died in hospital. Car crash (39%) and falls (37.85) were the most frequent causes of trauma. The causes of death were as follows: neurologic, 8 (36.4%); respiratory, 4 (18.2%); septic complications, 2 (9.1%); venous thrombosis and embolism, 2 (9.1%); and undetermined, 4 (18.2%). Bivariate analysis identified absent neurologic function (risk ratios [RR] 4.5; 95% confidence intervals [CI], 1.6-12.7), high injury severity score (p = 0.001) and low revised trauma score) = 0.001); Glasgow Coma Scale (GCS.) score <9 (RR 47.4; 95% Cl, 5.4-413.2); shock at admission (RR = 2.5; 95% CI, 0.8-7.9); vasopressor use (RR = 25.8; 95% CI, 6.1-109.6); mechanical ventilation (RR = 31.9; 95% CI, 6.6-154.0); acute renal insufficiency (RR = 10.0; 95% CI, 0.98-102.1) as associated with mortality. The mainly independents predictors for mortality were GCS score <9 and vasopressor use. Lowest mortality rate (5.2%) was observed for patients with TSCI alone. Conclusions: GCS score <9, mechanical ventilation, and vasopressor use were predictors of mortality with TCSI, and if these risk factors were absent, we observed low mortality rate.	[Neumann, Cristina R.] Univ Fed Rio Grande do Sul, Sch Med, Dept Social Med, Intensivist Hosp Pronto Socorro Municipal Porto A, Porto Alegre, RS, Brazil; [Brasil, Albert V.] Complexo Hosp Santa Casa, Hosp Pronto Socorro Municipal Porto Alegre, Porto Alegre, RS, Brazil; [Albers, Felix] Hosp Cristo Redentor, Hosp Pronto Socorro Municipal Porto Alegre, Porto Alegre, RS, Brazil		Neumann, CR (corresponding author), 344 Fatima St, BR-90620250 Porto Alegre, RS, Brazil.	cristinaneumann@via-rs.net	neumann, cristina/K-4692-2012				*AM ASS NEUR SURG, 2007, GUID MAN AC CERV SPI; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Claxton AR, 1998, CAN J ANAESTH, V45, P144, DOI 10.1007/BF03013253; Coelho DG, 2000, ARQ NEURO-PSIQUIAT, V58, P1030, DOI 10.1590/S0004-282X2000000600009; DAVERAT P, 1989, J NEUROL NEUROSUR PS, V52, P403, DOI 10.1136/jnnp.52.3.403; DEVIVO MJ, 1992, ARCH PHYS MED REHAB, V73, P156; Fisher CG, 2006, SPINE, V31, pS2, DOI 10.1097/01.brs.0000217948.02567.3a; Frankel H L, 1969, Paraplegia, V7, P179; FREITAS PEP, 1990, J BRAS NEUROCIR, V2, P1; Gawryszewski Vilma Pinheiro, 2006, Sao Paulo Med. J., V124, P208, DOI 10.1590/S1516-31802006000400007; Geisler FH, 2001, SPINE, V26, pS58, DOI 10.1097/00007632-200112151-00013; Geisler FH, 2001, SPINE, V26, pS87, DOI 10.1097/00007632-200112151-00015; Geisler FH, 2001, SPINE, V26, pS68, DOI 10.1097/00007632-200112151-00014; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; JAULENT MC, 1999, LOGISTIC REGRESSION; Kannus P, 2007, J GERONTOL A-BIOL, V62, P180, DOI 10.1093/gerona/62.2.180; LEAL FSC, 1997, ARQ BRAS NEUROCIR, V16, P111; Marino RJ, 2003, J SPINAL CORD MED S1, V26, pS50; Martin MJ, 2005, AM J SURG, V190, P836, DOI 10.1016/j.amjsurg.2005.05.051; Martins F, 1998, SPINAL CORD, V36, P574, DOI 10.1038/sj.sc.3100657; *NAT SCISC, 2006, ANN REP MOD SPIN COR; O'Connor PJ, 2005, ARCH PHYS MED REHAB, V86, P37, DOI 10.1016/j.apmr.2004.03.018; *PAN AM HLTH ORG, BAS HLTH IND DAT BRA; Pickett W, 2003, J TRAUMA, V55, P1070, DOI 10.1097/01.TA.0000034228.18541.D1; Robertson A, 2002, J TRAUMA, V53, P5, DOI 10.1097/00005373-200207000-00002; TEASDALE G, 1974, LANCET, V2, P81	28	28	32	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2009	67	1					67	70		10.1097/TA.0b013e3181aa63f3			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	470CZ	WOS:000267953100011	19590310				2022-02-06	
J	Rishiraj, N; Lloyd-Smith, R; Lorenz, T; Niven, B; Michel, M				Rishiraj, N.; Lloyd-Smith, R.; Lorenz, T.; Niven, B.; Michel, M.			University men's ice hockey: rates and risk of injuries over 6-years	JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS			English	Article						Hockey; Athletic injuries; Epidemiology; Sports	PLAYERS; MULTIVARIATE; CHECKING; FINLAND; CANADA	Aim. The aim of this study was to determine the injury rates of a Men's Varsity Ice Hockey team over six-years. Data on ice hockey injury rates and profile continue to increase in the hope of assisting with injury prevention. Methods. The University of British Columbia Men's Varsity team has been followed prospectively over a six-year period. All student-athletes completed a preseason medical examinations and physiological assessments. The team physician evaluated each injury and the team therapist completed the injury report forms and the attendance records for each player. Results. A total of 46 215 player exposures were recorded. The combined injury rate was 3.70 injuries/1 000 player game and practice exposures. A statistically significantly higher risk of injury was observed during games and the greatest risk of injury was observed during the second period. Forwards sustained greater percentage of injuries compared to defensemen and goalies. Sprains and strains accounted for 40% of all injuries, followed by concussions (13%). Non-contact injuries were most common, while the anatomy sustaining the most injuries was the head/neck/face region. A high percent-age of the recorded injuries required less than seven days to return to full activity. Conclusion. The risk of injury for university ice hockey players is greater during games and is dependant on playing position. Players are prone to sprains and strains, which may not involve any contact. Concussion and knee joint injury rates continue to cause concern.	[Rishiraj, N.] ACTIN Hlth & Rehabil Inc, Vancouver, BC V6M 2V7, Canada; [Rishiraj, N.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Rishiraj, N.] Univ Otago, Otago, New Zealand; [Lloyd-Smith, R.; Michel, M.] Univ British Columbia Athlet, Vancouver, BC, Canada; [Lloyd-Smith, R.] Allan McGavin Sports Med Ctr, Vancouver, BC, Canada; [Lorenz, T.] SportsMed British Columbia, Vancouver, BC, Canada; [Lorenz, T.] Univ British Columbia Athlet Therapy Serv, Vancouver, BC, Canada; [Niven, B.] Univ Otago, Dept Math & Stat, Ctr Applicat Stat & Math, Dunedin, New Zealand		Rishiraj, N (corresponding author), ACTIN Hlth & Rehabil Inc, 5767 Oak St, Vancouver, BC V6M 2V7, Canada.	nrishiraj@actinhealth.com					Agel J, 2007, J ATHL TRAINING, V42, P241; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; BIASCA N, 1995, UNFALLCHIRURG, V98, P283; BJORKENHEIM JM, 1993, ACTA ORTHOP SCAND, V64, P459; DALY PJ, 1990, SPORTS MED, V10, P122, DOI 10.2165/00007256-199010020-00005; Ferrara MS, 1999, CLIN J SPORT MED, V9, P30; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Groger A, 2001, SPORTVERLETZ SPORTSC, V15, P82, DOI 10.1055/s-2001-19047; Hayes Don, 1975, Phys Sportsmed, V3, P61, DOI 10.1080/00913847.1975.11948128; Hipp E, 1993, Fortschr Med, V111, P173; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Jorgensen U, 1986, Br J Sports Med, V20, P7; LORENTZON R, 1988, AM J SPORT MED, V16, P392, DOI 10.1177/036354658801600415; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; MEEUWISSE WH, 1988, CLIN J SPORT MED, V8, P164; Molsa J, 2000, AM J SPORT MED, V28, P322; Molsa J, 2003, AM J SPORT MED, V31, P751; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; *NCAA, 2003, INJ SURV SYST MENS I; PATTERSSON M, 1993, BRIT J SPORT MED, V27, P251, DOI 10.1136/bjsm.27.4.251; PELLETIER RL, 1993, AM J SPORT MED, V21, P78, DOI 10.1177/036354659302100114; Pforringer W, 1987, J SPORT SCI, V5, P327, DOI 10.1080/02640418708729786; RIELLY MF, 1982, ATHLETIC TRAINING, V17, P88; Schick DM, 2003, AM J SPORT MED, V31, P47, DOI 10.1177/03635465030310011901; SIM FH, 1987, AM J SPORT MED, V15, P30, DOI 10.1177/036354658701500105; Smith AM, 1997, AM J SPORT MED, V25, P500, DOI 10.1177/036354659702500413; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Tator CH, 2000, CAN MED ASSOC J, V162, P787; Watson RC, 1996, CLIN J SPORT MED, V6, P108, DOI 10.1097/00042752-199604000-00008	29	28	28	1	15	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0022-4707	1827-1928		J SPORT MED PHYS FIT	J. Sports Med. Phys. Fit.	JUN	2009	49	2					159	166					8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	510SK	WOS:000271111800005	19528893				2022-02-06	
J	Wang, HE; Weaver, MD; Abo, BN; Kaliappan, R; Fairbanks, RJ				Wang, H. E.; Weaver, M. D.; Abo, B. N.; Kaliappan, R.; Fairbanks, R. J.			Ambulance stretcher adverse events	QUALITY & SAFETY IN HEALTH CARE			English	Article							DESIGNING ERGONOMIC INTERVENTIONS; PATIENT SAFETY; EMS WORKERS	Introduction: Ambulance personnel use wheeled stretchers for moving patients in the out-of-hospital setting. The nature of adverse events and associated injuries occurring during ambulance stretcher operation was characterised. Methods: Data from the United States Food and Drug Administration's Manufacturer and User Facility Device Experience Database (MAUDE) were used. All adverse events involving ambulance stretchers during the years 1996-2005 were identified. The nature of the event, the method of stretcher handling, the individuals injured and the nature of the resulting injuries were identified. Results: There were 671 reported adverse events. The most common adverse events were stretcher collapse (54%; 95% CI 50 to 57%), broken, missing or malfunctioning part (28%; 95% CI 25 to 32%) and dropped stretcher (7%; 95% CI 5 to 9%). Adverse events most commonly occurred during unloading of the stretcher from the ambulance (16%; 13 to 19%). Injuries occurred in 121 events (18%; 95% CI 15 to 21%), most often involving sprains/strains (29%), fractures (16%) and lacerations/avulsions (13%). There were three traumatic brain injuries and three deaths. Patients sustained injuries in 52 events (43%), and ambulance personnel sustained injuries in 64 events (53%). More than one individual sustained injuries in 12 events. Conclusion: Adverse events may occur during ambulance stretcher operation and can result in significant injury to patients and ambulance personnel.	[Wang, H. E.; Weaver, M. D.; Abo, B. N.; Kaliappan, R.] Univ Pittsburgh, Dept Emergency Med, Pittsburgh, PA 15213 USA; [Fairbanks, R. J.] Univ Rochester, Dept Emergency Med, Rochester, NY USA		Wang, HE (corresponding author), Univ Pittsburgh, Dept Emergency Med, 230 McKee Pl,Suite 400, Pittsburgh, PA 15213 USA.	wanghe@upmc.edu			Agency for Healthcare Research and Quality, Rockville, Maryland, United States of AmericaUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08-HS013628]; Emergency Medicine Patient Safety Foundation (Auburn, CA) through the Society for Academic Emergency Medicine (Lansing, MI); AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS013628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K08EB009090] Funding Source: NIH RePORTER	HEW is supported by Clinical Scientist Development Award K08-HS013628 from the Agency for Healthcare Research and Quality, Rockville, Maryland, United States of America. RJF is supported by a research training grant from the Emergency Medicine Patient Safety Foundation (Auburn, CA) through the Society for Academic Emergency Medicine (Lansing, MI). This research was independent from the funders.	Burt CW, 2006, ANN EMERG MED, V47, P317, DOI 10.1016/j.annemergmed.2005.12.001; Cone DC, 1998, ANN EMERG MED, V31, P241, DOI 10.1016/S0196-0644(98)70314-2; CULLEN DJ, 1995, JOINT COMM J QUAL IM, V21, P541, DOI 10.1016/S1070-3241(16)30180-8; *DEP PUBL HLTH OFF, 2006, EL WHEEL COT SAF PRA; Gershon R R, 1995, Prehosp Disaster Med, V10, P14; Gosbee J, 2002, QUAL SAF HEALTH CARE, V11, P352, DOI 10.1136/qhc.11.4.352; ISRAELSKI EW, 2006, HDB HUMAN FACTORS ER, P615; Karsh BT, 2007, ANN EMERG MED, V50, P433, DOI 10.1016/j.annemergmed.2007.06.481; Lavender SA, 2007, APPL ERGON, V38, P227, DOI 10.1016/j.apergo.2006.02.005; Lavender SA, 2007, APPL ERGON, V38, P71, DOI 10.1016/j.apergo.2005.12.005; *MHRA MED DEV AG, 2003, DEV B SAF US AMB STR; Samore MH, 2004, JAMA-J AM MED ASSOC, V291, P325, DOI 10.1001/jama.291.3.325; *US DEP TRANSP, 1995, EMT BAS NAT STAND CU; *USFDA, 2008, MAN US FAC DEV EXP D; WANG HE, 2007, ABSTR PREH EM CAR, V11, P96	15	28	28	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1475-3898			QUAL SAF HEALTH CARE	Qual. Saf. Health Care	JUN	2009	18	3					213	216		10.1136/qshc.2007.024562			4	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	449QI	WOS:000266344700012	19468005				2022-02-06	
J	Nance, ML; Polk-Williams, A; Collins, MW; Wiebe, DJ				Nance, Michael L.; Polk-Williams, Alison; Collins, Michael W.; Wiebe, Douglas J.			Neurocognitive Evaluation of Mild Traumatic Brain Injury in the Hospitalized Pediatric Population	ANNALS OF SURGERY			English	Article							CONCUSSION; IMPACT; SPORTS; EPIDEMIOLOGY; SENSITIVITY; SYMPTOMS	Objective: To test the feasibility of inpatient neurocognitive testing and measure the degree of disability in children hospitalized with mild traumatic brain injury (MTBI). Summary Background Data: MTBI is common in the pediatric Population. A standardized approach to identify neurocognitive impairment and determine optimal time to return to exertional activities (eg, school, sports) is lacking. Methods: For a 2-year period, children (age: 11-17 years) hospitalized at a level 1 urban Pediatric Trauma Center with MTBI were prospectively enrolled. Neurocognitive performance was assessed utilizing previously validated computer-based tests (Immediate Postconcussion Assessment and Cognitive Testing) as inpatient and in Follow-up clinic after discharge. The feasibility of inpatient testing and the degree neurocognitive impairment and symptomatology were assessed. This study was approved by the IRB and registered with clinicaltrials.gov (NCT00715949). Results: For the 2 years of study, 116 Subjects were prospectively enrolled and tested. The population had a mean age of 14 years and 69.8% were male. On initial in-hospital testing, the overall population demonstrated considerable neurocognitive deficits (mean values for all 4 subtests below 25th percentile, norm 50%) with at least one subtest score below 25% in 95.7% and an abnormal symptom score in 83.4% of patients. In comparing initial testing to follow-Lip testing (N = 63), significant improvements were noted for all subtests (verbal memory: 28.0% vs. 37.5%, respectively, norm 50%, P = 0.02; visual memory: 24.9% vs. 38.1%, respectively, norm 50%, P < 0.01; visual motor: 21.8% vs. 31.1%, respectively, norm 50%, P = 0.01% reaction time: 21.8% vs. 30.3%, respectively, norm 50%, P = 0.05), with a decline in the symptom score (26.9 vs. 9.2, respectively, norm 0-8, P < 0.01) as well. Patients not seen in follow-up (N = 53) did not differ demographically from those seen in clinic. Conclusions: Inpatient neurocognitive testing was feasible in pediatric MTBI patients. Neurocognitive abnormalities were nearly universally present on initial evaluation with significant improvements demonstrated at the time of outpatient follow-up. Return to activity recommendations are thus best deferred for most hospitalized MTBI children until formal assessment can be performed after discharge.	[Nance, Michael L.; Polk-Williams, Alison] Childrens Hosp Philadelphia, Dept Surg, Philadelphia, PA 19104 USA; [Collins, Michael W.] Univ Pittsburgh, Med Ctr, Sports Concuss Program, Pittsburgh, PA USA; [Wiebe, Douglas J.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA		Nance, ML (corresponding author), Childrens Hosp Philadelphia, Dept Surg, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	nance@email.chop.edu	Wiebe, Douglas J/Q-1168-2017				Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bergman DA, 1999, PEDIATRICS, V104, P1407; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Field M, 2003, J PEDIAT, V13, P222; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; IVERSON GL, 2005, J CLIN EXP NEUROPSYC, V27, P1; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Sosin DM, 1996, BRAIN INJURY, V10, P47; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	22	28	28	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	MAY	2009	249	5					859	863		10.1097/SLA.0b013e3181a41ae5			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	441HR	WOS:000265760400029	19387313				2022-02-06	
J	Mora, AG; Ritenour, AE; Wade, CE; Holcomb, JB; Blackbourne, LH; Gaylord, KM				Mora, Alejandra G.; Ritenour, Amber E.; Wade, Charles E.; Holcomb, John B.; Blackbourne, Lorne H.; Gaylord, Kathryn M.			Posttraumatic Stress Disorder in Combat Casualties With Burns Sustaining Primary Blast and Concussive Injuries	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Posttraumatic stress disorder; Primary blast injury; Mild traumatic brain injury; Burn injury; Explosion	TRAUMATIC BRAIN-INJURY; OPERATION-ENDURING-FREEDOM; TYMPANIC-MEMBRANE PERFORATION; MENTAL-HEALTH PROBLEMS; IRAQI-FREEDOM; SERVICE MEMBERS; WAR; SYMPTOMS; VETERANS; CARE	Background. There is a heightened focus on postexplosion functional outcomes in combat casualties. Previously, we reported a high prevalence of posttraumatic stress disorder (PTSD) (32%) and mild traumatic brain injury (mTBI) (41%) in patients with explosion-related burns. We hypothesized that the prevalence of PTSD in patients with burn was associated with primary blast injuries (PBIs) and mTBI. Methods. We reviewed the records of 333 patients admitted consecutively to the United States Army Institute of Surgical Research burn center for explosion-related injuries between March 2003 and March 2006. By using the Posttraumatic Checklist, Military Version (PCL-M), patients were evaluated for PTSD symptoms (PCL-M score >= 44). Loss of consciousness defined mTBI. Patient data were analyzed in groups based on PTSD (yes or no), mechanism of injury (improvised explosive device [IED] vs. other explosive), PBI (yes or no), and mTBI (yes or no). Results. Of 333 patients, 119 had PTSD assessments. Overall, PTSD was 22% (26 of 119). The prevalence of PTSD differed between mechanism of injury groups (p = 0.03). In the IED group (n = 105), 25% had PTSD symptoms and 18% had mTBI; patients injured by other explosive devices (n = 14) had no PTSD symptoms and one had mTBI (p = 0.04; p = 0.69, respectively). Also in the IED group, in patients with PBI, PTSD was 45% (9 of 20) compared with 20% (17 of 85) without PBI (odds ratio=3.27; 95% confidence interval, 1.17-9.16). More patients with PBI and mTBI (4 of 6; 67%) had PTSD symptoms compared with other patients (22 of 99; 22%) (odds ratio, 7.00; 95% confidence interval, 1.20-40.78). No other associations were found between PBI and mTBI. Conclusion: IED-wounded burn patients with PBI and mTBI have a greater prevalence of PTSD. Patients who did not have IED-related injuries did not have PTSD and only one had mTBI.	[Mora, Alejandra G.; Ritenour, Amber E.; Wade, Charles E.; Holcomb, John B.; Blackbourne, Lorne H.; Gaylord, Kathryn M.] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA		Gaylord, KM (corresponding author), USA, Inst Surg Res, 3400 Rawley E Chambers Rd, Ft Sam Houston, TX 78234 USA.	Kathryn.Gaylord@amedd.army.mil		holcomb, john/0000-0001-8312-9157			Aboutanos MB, 1997, J TRAUMA, V43, P719, DOI 10.1097/00005373-199710000-00031; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Born CT, 2005, SCAND J SURG, V94, P279, DOI 10.1177/145749690509400406; Bowen Anne Phelan, 2003, J Emerg Nurs, V29, P287, DOI 10.1067/men.2003.90; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cordts PR, 2008, J TRAUMA, V64, pS14, DOI 10.1097/TA.0b013e31816093bd; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dyster-Aas J, 2008, J TRAUMA, V64, P1349, DOI 10.1097/TA.0b013e318047e005; Feinstein Anthony, 2004, Evid Based Ment Health, V7, P88; Frueh BC, 2007, AM J PUBLIC HEALTH, V97, P2143, DOI 10.2105/AJPH.2007.115436; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Hayda R, 2004, CLIN ORTHOP RELAT R, P97, DOI 10.1097/01.blo.0000128295.28666.ee; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; JENSEN JH, 1993, ACTA OTO-LARYNGOL, V113, P62, DOI 10.3109/00016489309135768; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Lu MK, 2007, BURNS, V33, P649, DOI 10.1016/j.burns.2006.09.004; McGhee LL, 2008, J TRAUMA, V64, pS195, DOI 10.1097/TA.0b013e318160ba1d; McKibben JBA, 2008, J BURN CARE RES, V29, P22, DOI 10.1097/BCR.0b013e31815f59c4; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peleg K, 2003, AM J EMERG MED, V21, P258, DOI 10.1016/S0735-6757(03)00043-3; Pols H, 2007, AM J PUBLIC HEALTH, V97, P2132, DOI 10.2105/AJPH.2006.090910; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Ritenour AE, 2008, J TRAUMA, V64, pS174, DOI 10.1097/TA.0b013e318160773e; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Stein M, 2005, SCAND J SURG, V94, P286, DOI 10.1177/145749690509400407; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Trunkey DD, 2008, ARCH SURG-CHICAGO, V143, P112, DOI 10.1001/archsurg.2007.38; Wade CE, 2008, EXPLOSION BLAST RELA, P41; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Xydakis MS, 2006, NEUROSURGERY, V59, P467, DOI 10.1227/00006123-200608000-00078; Yu BH, 1999, J BURN CARE REHABIL, V20, P426, DOI 10.1097/00004630-199909000-00017; 2008, ONE 5 IRAQ AFGHANIST; 2008, BLAST INJURY FAQS	44	28	28	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2009	66	4		S			S178	S184		10.1097/TA.0b013e31819ce2d6			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	431OW	WOS:000265073100028	19359963				2022-02-06	
J	Stalnacke, BM				Stalnacke, Britt-Marie			RELATIONSHIP BETWEEN SYMPTOMS AND PSYCHOLOGICAL FACTORS FIVE YEARS AFTER WHIPLASH INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						whiplash injuries; depression; stress disorders; post-traumatic	POSTTRAUMATIC-STRESS-DISORDER; NECK PAIN INTENSITY; SOFT-TISSUE INJURY; PSYCHOSOCIAL FACTORS; PROGNOSTIC-FACTORS; RECOVERY; DISABILITY; DEPRESSION; ACCIDENTS; FINLAND	Objective: The aims of this study were: to describe the frequency of whiplash-related symptoms and psychological factors in persons 5 years after a whiplash injury; to study the relationship between symptoms and psychological factors; to examine gender differences; and to investigate the cause of sick leave. Methods: Questionnaires addressing neck pain, pain intensity, whiplash-related symptoms, post-traumatic stress, depression, social support and life satisfaction were used. Results: Neck pain was reported by, 59% of subjects, whiplash-related symptoms (Rivermead Post-Concussion Symptoms Questionnaire, RPQ) by 76%, depression (Beck's Depression Inventory, BDI) by 22%, and post-traumatic stress (Impact of Event Scale, IES), by 38%, The scores of pain intensity, and RPQ were correlated to BDI, IES and LiSat-11 scores. Men reported a lower level of quality of social support than women. Men reporting many symptoms also reported reduced availability of social interaction, whereas women with many symptoms reported reduced availability of attachment (i.e. lack of intimate partner, close family and friends). A multivariate logistic regression showed an association between sick leave and depression. Conclusion: These findings indicate the importance of assessing possible relationships between symptoms, depression and post-traumatic stress in persons with long-term problems after whiplash injury, and of treating existing symptoms, especially depression. Because social support may play a role in recovery, social relationships should also be examined.	[Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, SE-90185 Umea, Sweden		Stalnacke, BM (corresponding author), Umea Univ, Umea Univ Hosp, Dept Community Med & Rehabil Rehabil Med, Bldg 9A, SE-90185 Umea, Sweden.	brittmarie.stalnacke@rehabmed.umu.se	Kasch, Helge/H-1325-2012	Kasch, Helge/0000-0002-9302-4946	Swedish Association of Survivors of Traffic Accidents; Polio Cancer and Traffic Injury Fund	The study was supported by the Swedish Association of Survivors of Traffic Accidents and the Polio Cancer and Traffic Injury Fund.	Andersson AL, 1997, INJURY, V28, P539, DOI 10.1016/S0020-1383(97)00083-1; Beck A. T., 2005, BECK DEPRESSION INVE; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berglund A, 2006, PAIN, V125, P244, DOI 10.1016/j.pain.2006.05.026; Berry H, 2000, ARCH NEUROL-CHICAGO, V57, P592, DOI 10.1001/archneur.57.4.592; BJORNSTIG U, 1990, SCAND J SOC MED, V18, P263, DOI 10.1177/140349489001800405; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Buitenhuis J, 2003, SPINE, V28, P896, DOI 10.1097/00007632-200305010-00011; Bunketorp L, 2002, EUR SPINE J, V11, P227, DOI 10.1007/s00586-002-0393-y; Bylund PO, 1998, SPINE, V23, P1023, DOI 10.1097/00007632-199805010-00012; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Guez M, 2002, ACTA ORTHOP SCAND, V73, P455, DOI 10.1080/00016470216329; Hagan KS, 2007, ANN ROY COLL SURG, V89, P624, DOI 10.1308/003588407X202029; Haldorsen T, 2003, APPL NEUROPSYCHOL, V10, P170, DOI 10.1207/S15324826AN1003_06; Herrstrom P, 2000, SCAND J PRIM HEALTH, V18, P154; HILDINGSSON C, 1990, ACTA ORTHOP SCAND, V61, P357, DOI 10.3109/17453679008993536; Holm LW, 2006, SPINE, V31, pE98, DOI 10.1097/01.brs.0000199901.52053.87; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jansen GB, 2008, EUR SPINE J, V17; KARLSSON J, 1995, J CLIN EPIDEMIOL, V48, P817, DOI 10.1016/0895-4356(94)00196-W; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; KISCHKA U, 1991, EUR NEUROL, V31, P136, DOI 10.1159/000116663; Kongsted A, 2008, EUR J PAIN, V12, P455, DOI 10.1016/j.ejpain.2007.07.008; Kyhlback M, 2002, INT J REHABIL RES, V25, P181, DOI 10.1097/00004356-200209000-00003; Mayou R, 1997, PSYCHOSOM MED, V59, P578, DOI 10.1097/00006842-199711000-00004; Mayou R, 1996, INJURY, V27, P617, DOI 10.1016/S0020-1383(96)00114-3; Miettinen T, 2004, EUR SPINE J, V13, P415, DOI 10.1007/s00586-004-0677-5; Miettinen T, 2004, DISABIL REHABIL, V26, P1367, DOI 10.1080/09638280400000203; Peolsson M, 2007, J REHABIL MED, V39, P260, DOI 10.2340/16501977-0052; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; RADANOV BP, 1991, LANCET, V338, P712, DOI 10.1016/0140-6736(91)91441-V; Radanov BP, 1999, J NEUROL NEUROSUR PS, V66, P485, DOI 10.1136/jnnp.66.4.485; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; SPITZER WO, 1995, SPINE, V20, pS1; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Sterner Y, 2003, J SPINAL DISORD TECH, V16, P195, DOI 10.1097/00024720-200304000-00013; Sullivan Michael J L, 2002, Pain Res Manag, V7, P68; Twamley EW, 2004, PSYCHIAT RES, V126, P265, DOI 10.1016/j.psychres.2004.01.008; Williamson E, 2008, PAIN, V135, P20, DOI 10.1016/j.pain.2007.04.035	39	28	31	0	5	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	APR	2009	41	5					353	359		10.2340/16501977-0349			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	446CH	WOS:000266097400010	19363569	gold			2022-02-06	
J	Wei, EP; Hamm, RJ; Baranova, AI; Povlishock, JT				Wei, Enoch P.; Hamm, Robert J.; Baranova, Anna I.; Povlishock, John T.			The Long-Term Microvascular and Behavioral Consequences of Experimental Traumatic Brain Injury after Hypothermic Intervention	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; behavioral assessment; hypothermia; TBI; vascular reactivity	FLUID-PERCUSSION MODEL; CEREBRAL-BLOOD-FLOW; POSTTRAUMATIC HYPOTHERMIA; POTASSIUM CHANNELS; RELAXING FACTOR; SMOOTH-MUSCLE; NITRIC-OXIDE; ENDOTHELIUM; RATS; CATS	Traumatic brain injury (TBI) has been demonstrated to induce cerebral vascular dysfunction that is reflected in altered responses to various vasodilators. While previous reports have focused primarily on the short-term vascular alterations, few have examined these vascular changes for more than 7 days, or have attempted to correlate these alterations with any persisting behavioral changes or potential therapeutic modulation. Accordingly, we evaluated the long-term microvascular and behavioral consequences of experimental TBI and their therapeutic modulation via hypothermia. In this study, one group was injured with no treatment, another group was injured and 1 h later was treated with 120 min of hypothermia followed by slow rewarming, and a third group was non-injured. Animals equipped with cranial windows for visualization of the pial microvasculature were challenged with various vasodilators, including acetylcholine, hypercapnia, adenosine, pinacidil, and sodium nitroprusside, at either 1 or 3 weeks post-TBI. In addition, all animals were tested for vestibulomotor tasks at 1 week post-TBI, and animals surviving for 3 weeks post-TBI were tested in a Morris water maze (MWM). The results of this investigation demonstrated that TBI resulted in long-term vascular dysfunction in terms of altered vascular reactivity to various vasodilators, which was significantly improved with the use of a delayed 120-min hypothermic treatment. In contrast, data from the MWM task indicated that injured animals revealed persistent deficits in the spatial memory test performance, with hypothermia exerting no protective effects. Collectively, these data illustrate that TBI can evoke long-standing brain vascular and spatial memory dysfunction that manifest different responses to hypothermic intervention. These findings further illustrate the complexity of TBI and highlight the fact that the chosen hypothermic intervention may not necessarily exert a global protective response.	[Wei, Enoch P.; Baranova, Anna I.; Povlishock, John T.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Ctr, Richmond, VA 23298 USA; [Wei, Enoch P.] Virginia Commonwealth Univ, Dept Med, Med Ctr, Richmond, VA 23298 USA; [Hamm, Robert J.] Virginia Commonwealth Univ, Dept Psychol, Med Ctr, Richmond, VA 23298 USA		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Ctr, POB 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD055813, NS057175]; Commonwealth Neurotrauma Trust Fund [NCI 04-095]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS057175] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants HD055813 and NS057175 and the Commonwealth Neurotrauma Trust Fund Grant NCI 04-095.	BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1983, PROSTAGLANDINS, V26, P917, DOI 10.1016/0090-6980(83)90154-5; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; FURCHGOTT RF, 1983, CIRC RES, V53, P557, DOI 10.1161/01.RES.53.5.557; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; KITAZONO T, 1995, STROKE, V26, P1713, DOI 10.1161/01.STR.26.9.1713; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kontos H A, 1980, Adv Exp Med Biol, V131, P243; Kontos H A, 1981, Trans Am Clin Climatol Assoc, V92, P111; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1988, AM J PHYSIOL, V255, pH1259, DOI 10.1152/ajpheart.1988.255.5.H1259; Kontos HA, 1998, AM J PHYSIOL-HEART C, V274, pH974; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Povlishock JT, 2004, HYPOTHERMIA FOR ACUTE BRAIN DAMAGE: PATHOMECHANISM AND PRACTICAL ASPECTS, P19; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Ueda Y, 2004, HYPOTHERMIA FOR ACUTE BRAIN DAMAGE: PATHOMECHANISM AND PRACTICAL ASPECTS, P141; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; WEI EP, 1992, STROKE, V23, P1623, DOI 10.1161/01.STR.23.11.1623; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95	42	28	29	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2009	26	4					527	537		10.1089/neu.2008.0797			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	430OV	WOS:000264999300005	19245307	Green Published			2022-02-06	
J	Gerlach, R; Dittrich, S; Schneider, W; Ackermann, H; Seifert, V; Kieslich, M				Gerlach, Ruediger; Dittrich, Simone; Schneider, Wilfried; Ackermann, Hanns; Seifert, Volker; Kieslich, Matthias			Traumatic Epidural Hematomas in Children and Adolescents Outcome Analysis in 39 Consecutive Unselected Cases	PEDIATRIC EMERGENCY CARE			English	Article						epidural hematoma; head injury; skull fracture; surgery; outcome	EXTRADURAL HEMATOMAS; HEAD-INJURY; INTRACRANIAL INJURY; MANAGEMENT; EXPERIENCE; EMERGENCY	Objective: Despite early diagnosis of traumatic epidural hematomas (EDHs) in children, mortality remained quite high in recent series. The aims of this analysis were to review the cause and outcome of pediatric EDH nowadays and to discuss outcome-related variables in a large consecutive series of surgically treated EDH in children. Methods: This is a retrospective case series of 39 patients (27 males, 69%)with surgically treated EDH between June 1997 and February 2007. Patients' medical records, computed tomographic scans, and, if performed, magnetic resonance unagings were reviewed to define variables associated with outcome. Variables included in the analysis were age, associated severe extracranial injury, abnormal pupillary response, hematoma thickness, severity of head injury (Glasgow Coma Scale score <= 8), parenchymal brain injury, and diffuse axonal injury. Long-term follow-up (mean [SD], 51.3 [27] months) was available in 38 patients, and outcomes were classified as excellent (modified Rankin Scale score [mRS], 0; Glasgow Outcome Scale score, 5) and good (mRS scores, I and 2; Glasgow Outcome Scale score, 4). Results: The mean (SD) age of the patients was 83.1 (59.9) months (range, 1-191 months). The mortality was zero, and the outcomes were excellent in 34 and good in 4 patients (one was lost to follow-up). Most of the injuries with EDH occurred in familial settings (23 cases), with falls being the most common mechanism of injury in 20 patients. Trauma was caused by traffic accidents in 14 cases (pedestrians hit by a motor vehicle, 7 cases; bicycle accidents, 5 cases; and motorbike and car accidents, 1 case each). One EDH occurred during delivery. The mean size of the EDH was 18.5 (12) mm (range, 5-40 mm). Three patients were referred with unilateral or bilateral dilated pupil(s). Except in 4 patients, all EDHs were associated with skull fracture(s) (90%). Computed tomography or magnetic resonance imaging revealed brain contusion in 13 patients, and 1 had diffuse axonal injury. None of the tested variables were found to have a prognostic relevance as tested by multivariate analysis (backward exclusion, Wald method). Conclusions: Regardless of the EDH size, the clinical status of the patients, the abnormal pupillary findings, or the cause of injury, the outcome and prognosis of the patients with EDH are excellent.	[Gerlach, Ruediger; Seifert, Volker] Goethe Univ Frankfurt, Dept Neurosurg, D-60528 Frankfurt, Germany; [Dittrich, Simone; Schneider, Wilfried; Kieslich, Matthias] Goethe Univ Frankfurt, Dept Pediat, D-60528 Frankfurt, Germany; [Ackermann, Hanns] Goethe Univ Frankfurt, Inst Biostat, D-60528 Frankfurt, Germany		Gerlach, R (corresponding author), Goethe Univ Frankfurt, Dept Neurosurg, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	r.gerlach@em.uni-frankfurt.de					Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Bejjani GK, 1996, PEDIATR NEUROSURG, V25, P302, DOI 10.1159/000121144; Ben Abraham R, 2000, PEDIATR NEUROSURG, V33, P70, DOI 10.1159/000028990; Beni-Adani L, 1999, J TRAUMA, V46, P306, DOI 10.1097/00005373-199902000-00018; BONADIO WA, 1989, AM J DIS CHILD, V143, P194, DOI 10.1001/archpedi.1989.02150140084025; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Browne GJ, 2002, PEDIATR EMERG CARE, V18, P86, DOI 10.1097/00006565-200204000-00006; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; CHEN TY, 1993, NEUROSURGERY, V32, P176, DOI 10.1227/00006123-199302000-00004; CHOUX M, 1975, CHILD BRAIN, V1, P337; Ciurea AV, 2007, CHILD NERV SYST, V23, P335, DOI 10.1007/s00381-006-0230-4; DAVID PA, 1990, POP STUD-J DEMOG, V44, P421, DOI 10.1080/0032472031000144836; DE SM, 2007, J TRAUMA, V63, P370; DHELLEMMES P, 1985, J NEUROSURG, V62, P861, DOI 10.3171/jns.1985.62.6.0861; DOSSANTOS ALM, 1994, PEDIATR NEUROSURG, V21, P50; Erdogan B, 2003, PEDIATR NEUROSURG, V39, P208, DOI 10.1159/000072473; ERSAHIN Y, 1993, CHILD NERV SYST, V9, P96, DOI 10.1007/BF00305316; ERSAHIN Y, 1993, PEDIATR NEUROSURG, V19, P31, DOI 10.1159/000120697; HELFER RE, 1977, PEDIATRICS, V60, P533; Lee ACW, 1997, J PAEDIATR CHILD H, V33, P446; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUERSSEN TG, 1995, PEDIATR NEUROSURG, V23, P34, DOI 10.1159/000120933; Maggi G, 1998, J Neurosurg Sci, V42, P95; Marion DW, 2006, NEUROSURGERY, V58, P655; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; PASAOGLU A, 1990, ACTA NEUROCHIR, V106, P136, DOI 10.1007/BF01809456; PILLAY R, 1995, S AFR MED J, V85, P672; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Rocchi G, 2005, J CHILD NEUROL, V20, P569, DOI 10.1177/08830738050200070501; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; Stieg PE, 1998, NEUROL CLIN, V16, P373, DOI 10.1016/S0733-8619(05)70069-4; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Zuccarello M, 1983, Zentralbl Neurochir, V44, P11	36	28	33	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2009	25	3					164	169		10.1097/PEC.0b013e31819a8966			6	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	419VX	WOS:000264248900007	19262419				2022-02-06	
J	Hassett, LM; Moseley, AM; Tate, RL; Harmer, AR; Fairbairn, TJ; Leung, J				Hassett, Leanne M.; Moseley, Anne M.; Tate, Robyn L.; Harmer, Alison R.; Fairbairn, Timothy J.; Leung, Joan			EFFICACY OF A FITNESS CENTRE-BASED EXERCISE PROGRAMME COMPARED WITH A HOME-BASED EXERCISE PROGRAMME IN TRAUMATIC BRAIN INJURY: A RANDOMIZED CONTROLLED TRIAL	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain injuries; exercise; physical therapy (specialty); rehabilitation; physical fitness	PHYSICAL-ACTIVITY; AEROBIC CAPACITY; REHABILITATION; DEPRESSION; DISABILITIES; INDIVIDUALS; RELIABILITY; PREVENTION; RECOVERY; PEOPLE	Objective: To compare the effects of a supervised fitness centre-based exercise programme with an unsupervised home-based exercise programme on cardiorespiratory fitness and psychosocial functioning in people with traumatic brain injury. Design: Multi-centre, assessor-blinded, parallel group, randomized controlled trial. Participants: Sixty-two participants with severe traumatic brain injuries, who could walk at a speed exceeding 1 m/sec, discharged from 3 brain injury units. Interventions: The fitness centre group completed a combined fitness and strength training exercise programme supervised by a personal trainer in a local fitness centre 3 times per week for 12 weeks. The home group completed a similar exercise programme unsupervised at home. Main outcome measure: Cardiorespiratory fitness measured using the modified 20-m shuttle test. Results: Both groups improved in fitness: the maximal velocity achieved on the modified 20-m shuttle test increased with intervention and was maintained at follow-up. However, the difference between groups was not significant ( mean between-group difference (95% confidence interval) 0 m/sec (-0.6 to 0.6) at the end of intervention). There were also no between-group differences in psychosocial functioning at the end of intervention or at follow-up. Conclusion: Both interventions were equally effective at improving cardiorespiratory fitness in adults with traumatic brain injuries.	[Hassett, Leanne M.; Harmer, Alison R.] Univ Sydney, Discipline Physiotherapy, Sydney, NSW 2006, Australia; [Hassett, Leanne M.] Univ Sydney, Liverpool Hlth Serv, Brain Injury Rehabil, Sydney, NSW 2006, Australia; [Moseley, Anne M.] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [Tate, Robyn L.] Univ Sydney, No Clin Sch Med, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Fairbairn, Timothy J.] Westmead Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Leung, Joan] Royal Rehabil Ctr Sydney, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Hassett, LM (corresponding author), Liverpool Hlth Serv, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	leanne.hassett@sswahs.nsw.gov.au	Harmer, Alison/I-2593-2013; Leung, Joan/AAC-8623-2019	Harmer, Alison/0000-0003-4877-5801; Leung, Joan/0000-0003-0888-558X; Hassett, Leanne/0000-0002-3546-1822			Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; *AM COLL SPORTS ME, 2005, HLTH REL PHYS FITN A; American College of Sports Medicine Acsm's, 2000, GUID EX TEST PRESCR; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BULL SJ, 1999, ADHERENCE ISSUES SPO; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hassett LM, 2007, BRAIN INJURY, V21, P1069, DOI 10.1080/02699050701630375; LANDIS JR, 1977, BIOMETRICS, V33, P174; LASKIN JJ, 2001, THESIS U ALBERTA ALB; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; LOVIBOND SF, 1996, MANUAL DEPRESSION AN; MCARDLE WD, 1978, MED SCI SPORT EXER, V10, P16; MCNAIR DM, 1992, MANUAL POMS PROFILE; MORAN AJ, 1976, MED J AUSTRALIA, V1, P396, DOI 10.5694/j.1326-5377.1976.tb140699.x; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Palmer-McLean K, 2003, ACSMS EXERCISE MANAG, P238; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Ready AE, 2005, J SPORT MED PHYS FIT, V45, P199; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Rimmer JH, 1999, PHYS THER, V79, P495, DOI 10.1093/ptj/79.5.495; Rusconi S, 2003, DISABIL REHABIL, V25, P1281, DOI 10.1080/09638280310001608582; SALTIN B, 1968, CIRCULATION        S, V7, P1; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Vickers Andrew J, 2005, BMC Med Res Methodol, V5, P35, DOI 10.1186/1471-2288-5-35; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	28	29	1	23	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	MAR	2009	41	4					247	255		10.2340/16501977-0316			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	416PE	WOS:000264017200007	19247544	gold, Green Submitted			2022-02-06	
J	Mello, MJ; Myers, R; Christian, JB; Palmisciano, L; Linakis, JG				Mello, Michael J.; Myers, Richard; Christian, Jennifer B.; Palmisciano, Lynne; Linakis, James G.			Injuries in Youth Football: National Emergency Department Visits during 2001-2005 for Young and Adolescent Players	ACADEMIC EMERGENCY MEDICINE			English	Article						American football; pediatrics; injury	HIGH-SCHOOL FOOTBALL; TRAUMATIC BRAIN-INJURY; UNITED-STATES; RISK-FACTORS; SPORTS; EPIDEMIOLOGY; ATHLETE	Limited research exists describing youth football injuries, and many of these are confined to specific regions or communities. The authors describe U.S. pediatric football injury patterns receiving emergency department (ED) evaluation and compare injury patterns between the younger and older youth football participants. A retrospective analysis of ED data on football injuries was performed using the National Electronic Injury Surveillance System-All Injury Program. Injury risk estimates were calculated over a 5-year period (2001-2005) using participation data from the National Sporting Goods Association. Injury types are described for young (7-11 years) and adolescent (12-17 years) male football participants. There were an estimated total of 1,060,823 visits to U.S. EDs for males with football-related injuries. The most common diagnoses in the younger group (7-11 years) were fracture/dislocation (29%), sprain/strain (27%), and contusion (27%). In the older group (ages 12-17 years), diagnoses included sprain/strain (31%), fracture/dislocation (29%), and contusion (23%). Older participants had a significantly higher injury risk of injury over the 5-year study period: 11.0 (95% confidence interval [CI] = 9.2 to 12.8) versus 6.1 (95% CI = 4.8 to 7.3) per 1,000 participants/year. Older participants had a higher injury risk across all categories, with the greatest disparity being with traumatic brain injury (TBI), 0.8 (95% CI = 0.6 to 1.0) versus 0.3 (95% CI = 0.2 to 0.4) per 1,000 participants/year. National youth football injury patterns are similar to those previously reported in community and cohort studies. Older participants have a significantly higher injury risk, especially with TBI.	[Mello, Michael J.; Myers, Richard; Palmisciano, Lynne; Linakis, James G.] Injury Prevent Ctr Rhode Isl Hosp, Providence, RI USA; [Mello, Michael J.; Palmisciano, Lynne; Linakis, James G.] Brown Univ, Alpert Med Sch, Dept Emergency Med, Providence, RI 02912 USA; [Mello, Michael J.; Christian, Jennifer B.] Brown Univ, Alpert Med Sch, Dept Community Hlth, Providence, RI 02912 USA; [Palmisciano, Lynne; Linakis, James G.] Brown Univ, Alpert Med Sch, Dept Pediat, Providence, RI 02912 USA		Mello, MJ (corresponding author), Injury Prevent Ctr Rhode Isl Hosp, Providence, RI USA.	mjmello@lifespan.org					Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; [Anonymous], 2004, NAT EL INJ SURV SYST; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Dick R, 2007, J ATHL TRAINING, V42, P221; Dompier TP, 2007, J ATHL TRAINING, V42, P395; GOLDBERG B, 1988, PEDIATRICS, V81, P255; Hergenroeder AC, 1998, PEDIATRICS, V101, P1057, DOI 10.1542/peds.101.6.1057; LINDER MM, 1995, CLIN J SPORT MED, V5, P167, DOI 10.1097/00042752-199507000-00006; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; Marshall Stephen W, 2007, N C Med J, V68, P430; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Powell JW, 1999, J ATHL TRAINING, V34, P277; PRAGER BI, 1989, AM J SPORT MED, V17, P681, DOI 10.1177/036354658901700516; Radelet MA, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.3.e28; Ramirez M, 2006, AM J SPORT MED, V34, P1147, DOI 10.1177/0363546505284385; ROSER LA, 1970, CLIN ORTHOP RELAT R, P219; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; *SPORTS BUS RES NE, 2007, FOOTB TACKL MARK RES; Stuart MJ, 2002, MAYO CLIN PROC, V77, P317, DOI 10.4065/77.4.317; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; United States Department of Health and Human Services Centers for Disease Control and Prevention National Center for Injury Prevention and Control United States Consumer Product Safety Commission, 2007, NAT EL INJ SURV SYST; *US DEP HHS, 2006, NAT EL INJ SURV SYST; *US DEP HHS, 2005, NAT EL INJ SURV SYST; *US DEP HHS, 2003, NAT EL INJ SURV SYST; Xiang HY, 2007, BRAIN INJURY, V21, P293, DOI 10.1080/02699050701311034	28	28	28	1	11	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	MAR	2009	16	3					243	248		10.1111/j.1553-2712.2009.00357.x			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	414HZ	WOS:000263855800008	19210487	Bronze			2022-02-06	
J	Ruff, RM; Jamora, CW				Ruff, Ronald M.; Jamora, Christina Weyer			Myths and Mild Traumatic Brain Injury	PSYCHOLOGICAL INJURY & LAW			Welsh	Article						Forensic; Traumatic brain injury; Neuropsychology; Assessment; Myths	EMOTIONAL RISK-FACTORS; HEAD-INJURY; MISCONCEPTIONS; CONCUSSION; COLLEGIATE; SYMPTOMS; RECOVERY; SENSITIVITY	Despite the fact that patients with mild traumatic brain injuries (TBI) are commonly encountered in clinical practice, there are numerous myths surrounding their diagnosis, assessment, and outcome. The purpose of this paper is to review some of the more common myths related to mild TBI including: (a) there is no Miserable Minority; (b) meta-analytic studies have proven that patients with mild TBI do not experience persistent deficits; (c) personality tests can reliably capture psychological problems in patients with a mild TBI; (d) findings from the sports concussion literature can be directly applied to clinical patients; and (e) in the absence of loss of consciousness, the diagnosis of a mild TBI is uncertain.	[Ruff, Ronald M.; Jamora, Christina Weyer] Univ Calif San Francisco, San Francisco Clin Neurosci, 909 Hyde St,Suite 620, San Francisco, CA 94109 USA; [Jamora, Christina Weyer] Univ Calif San Francisco, San Francisco Gen Hosp, San Francisco, CA 94110 USA		Ruff, RM (corresponding author), Univ Calif San Francisco, San Francisco Clin Neurosci, 909 Hyde St,Suite 620, San Francisco, CA 94109 USA.	ronruff@mindspring.com					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; *AM AC NEUR, 1997, PRACT PAR MAN CONC S; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bailey C., 2009, J HEAD TRAU IN PRESS; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blair RJR, 2004, BRAIN COGNITION, V55, P198, DOI 10.1016/s0278-2626(03)00276-8; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cattelani R, 1996, BRAIN INJURY, V10, P187, DOI 10.1080/026990596124502; Centers for Disease Control and Prevention, 2006, TRAUMATIC BRAIN INJU; Cicerone KD, 1997, CLIN NEUROPSYCHOL, V11, P266, DOI 10.1080/13854049708400455; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Foley J, 2006, INT J NEUROSCI, V116, P1377, DOI 10.1080/00207450500514334; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gass C., 2000, ASSESSMENT EMOTIONAL, P457; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Glassmire DM, 2003, ASSESSMENT, V10, P299, DOI 10.1177/1073191103256129; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Graham J. R, 2006, MMPI 2 ASSESSING PER; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Greiffenstein M., 2008, CLIN NEUROPSYCHOL, V22, P1; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kraus J, 1996, NEUROTRAUMA, P13; Larrabee G., 2005, ORENSIC NEUROPSYCHOL; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Millon T., 1994, MILLON CLIN INVENTOR; Paniak C, 1998, J CLIN EXP NEUROPSYC, V20, P852, DOI 10.1076/jcen.20.6.852.1108; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, NEUROREHABILITATION, V7, P39, DOI 10.3233/NRE-1996-7105; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruff RM., 2009, ARCH CLIN N IN PRESS; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sweet JJ, 2000, CLIN NEUROPSYCHOL, V14, P479, DOI 10.1076/clin.14.4.479.7201; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE	60	28	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2009	2	1					34	42		10.1007/s12207-009-9029-4			9	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB3WP	WOS:000415444700005					2022-02-06	
J	Tukhovskaya, EA; Yukin, AY; Khokhlova, ON; Murashev, AN; Vitek, MP				Tukhovskaya, Elena A.; Yukin, Alexey Yu.; Khokhlova, Oksana N.; Murashev, Arkady N.; Vitek, Michael P.			COG1410, a Novel Apolipoprotein-E Mimetic, Improves Functional and Morphological Recovery in a Rat Model of Focal Brain Ischemia	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						apolipoprotein E; MCAO; neuroprotection	SYSTEM INFLAMMATORY RESPONSE; CEREBRAL-ARTERY OCCLUSION; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; TRANSGENIC MICE; APOE; PEPTIDES; ALLELE; STROKE; ONSET	Apolipoprotein E (apoE) is the primary apolipoprotein synthesized in the brain in response to injury with known neuroprotective effects exerted through antioxidant, anti inflammatory, antiexcitotoxic, and neurotrophic mechanisms. We have previously demonstrated that COG1410, an apoE mimetic peptide, exerts neuroprotective and anti inflammatory effects in a murine model of traumatic brain injury (TBI). As in TBI, ischemia-reperfusion injury is a component of acute stroke, which displays a pharmacogenetic association with the APOE4 gene. Using an intraluminal middle cerebral occlusion (MCAO) model in rats, we found that a single intravenous injection of COG1410 at 120 min post-MCAO significantly improved vestibulomotor function, decreased poststroke locomotor asymmetry, and decreased infarct volume of the ipsilateral hemisphere. These results support further exploration of a novel apoE-mimetic peptide, COG1410, as a therapeutic treatment for stroke. (C) 2008 Wiley-Liss, Inc.	[Tukhovskaya, Elena A.; Yukin, Alexey Yu.; Khokhlova, Oksana N.; Murashev, Arkady N.] Russian Acad Sci, Inst Bioorgan Chem, Branch Shemyakin & Ovchinnikov, Moscow, Russia; [Vitek, Michael P.] Duke Univ, Med Ctr, Dept Med, Div Neurol, Durham, NC 27710 USA; [Vitek, Michael P.] Cognosci Inc, Res Triangle Pk, NC USA		Tukhovskaya, EA (corresponding author), Prospect Nauki 6, Pushchino 142290, Moscow Region, Russia.	lenoktuk@rambler.ru	; Khokhlova, Oksana/D-2319-2015	Vitek, Michael/0000-0001-8140-8048; Khokhlova, Oksana/0000-0003-3613-7693	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R44AG020473, R43AG020473] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG 020473, R43 AG020473, R44 AG020473, R44 AG020473-05] Funding Source: Medline		Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Aono M, 2002, NEUROBIOL DIS, V11, P214, DOI 10.1006/nbdi.2002.0541; Arendt T, 1997, J NEUROSCI, V17, P516; ASPLUND K, 1985, STROKE, V16, P885; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Colton CA, 2002, NEUROBIOL AGING, V23, P777, DOI 10.1016/S0197-4580(02)00016-7; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Ferro MM, 2007, BRAZ J MED BIOL RES, V40, P89, DOI 10.1590/S0100-879X2006005000053; FUJIKAWA DG, 1995, EPILEPSIA, V36, P186, DOI 10.1111/j.1528-1157.1995.tb00979.x; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lebedev SV, 2003, B EXP BIOL MED+, V135, P424, DOI 10.1023/A:1024946821482; LINTON M, 1991, J CLIN INVEST, V81, P270; Lomnitski L, 1999, BBA-MOL BASIS DIS, V1453, P359, DOI 10.1016/S0925-4439(99)00010-1; Lopez-Martin E, 1998, EXP BRAIN RES, V120, P153, DOI 10.1007/s002210050389; Lyden PD, 2001, STROKE, V32, P1310, DOI 10.1161/01.STR.32.6.1310; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; McAdoo JD, 2005, NEUROSCI LETT, V381, P305, DOI 10.1016/j.neulet.2005.02.036; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; Spilker J, 1997, J Neurosci Nurs, V29, P384; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; World Health Organization (WHO), 1999, WORLD HLTH REP; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006	42	28	30	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB 15	2009	87	3					677	682		10.1002/jnr.21874			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	404YX	WOS:000263190100010	18803296	Green Accepted			2022-02-06	
J	Emanuelson, I; Uvebrant, P				Emanuelson, I.; Uvebrant, P.			Occurrence of epilepsy during the first 10 years after traumatic brain injury acquired in childhood up to the age of 18 years in the south western Swedish population-based series	BRAIN INJURY			English	Article						Long-term onset epilepsy; traumatic brain injury; children	EARLY POSTTRAUMATIC SEIZURES; HEAD-INJURY; CHILDREN; REHABILITATION; ADOLESCENTS	Background: The risk of seizures is increased after a traumatic brain injury (TBI), but the impact and duration of this increased risk is not well characterized in children. Objective: To identify post-traumatic epilepsy (PTE) and post-concussion symptoms 10 years after a TBI during childhood. Research design: The study is a population-based retrospective follow-up study. Procedure: Ten years after brain injury all 165 survivors, who as children (18 years) in 1987-1991 as residents in the south western Swedish health care region had had a TBI, were invited to participate in a follow-up. A questionnaire regarding medical conditions and medication was filled out by the patients themselves or their parents as was a 21-item questionnaire (PCSQ) regarding post-concussion symptoms. Of the surviving 165 individuals, 109 participated (67%). Results: Eight of 109 developed immediate seizures. During the follow-up period 12/109 had developed active epilepsy. Of these 12, five had had immediate seizures. The incidence of developing PTE within 10 years after a TBI was thus in this series 11%. The relative risk to develop late onset post-traumatic epilepsy (epsilon 1 week after injury) for those who had had immediate seizures was 9.018 (p = 0.0003, 95% CI = 3.69-22.05). Conclusions: TBI is a relatively rare cause of epilepsy in childhood, although immediate seizures are associated with an increased risk of developing post-traumatic epilepsy.	[Emanuelson, I.; Uvebrant, P.] Gothenburg Univ, Inst Clin Sci, Dept Pediat, S-41124 Gothenburg, Sweden		Emanuelson, I (corresponding author), Reg Barn Och Ungdomshabiliteringen, PB 210 62, S-41804 Gothenburg, Sweden.	ingrid.emanuelson@vgregion.se			The Association for Cancer and Traffic Victims; The Swedish Road Administration; The Vastra Gotaland Region	This study was supported by grants from The Association for Cancer and Traffic Victims, The Swedish Road Administration and The Vastra Gotaland Region.	Andersson EE, 2006, J REHABIL MED, V38, P26, DOI 10.1080/16501970500310564; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Dalmady-Israel Christina, 1993, Brain Injury, V7, P263, DOI 10.3109/02699059309029679; Emanuelson I, 1998, Pediatr Rehabil, V2, P65; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; JENETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Tomlin P, 2002, DEV MED CHILD NEUROL, V44, P828	17	28	28	0	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	7-8					612	616	PII 912689904	10.1080/02699050902973913			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	462QL	WOS:000267370600004	19557563				2022-02-06	
J	Huizenga, HM; van Bers, BMCW; Plat, J; van den Wildenberg, WPM; van der Molen, MW				Huizenga, Hilde M.; van Bers, Bianca M. C. W.; Plat, Jacqueline; van den Wildenberg, Wery P. M.; van der Molen, Maurits W.			Task Complexity Enhances Response Inhibition Deficits in Childhood and Adolescent Attention-Deficit/Hyperactivity Disorder: A Meta-Regression Analysis	BIOLOGICAL PSYCHIATRY			English	Article						Attention-deficit/hyperactivity disorder; meta-regression; response inhibition; spatial compatibility of stimulus-response; mappings; stop-signal paradigm	EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; STOP-SIGNAL PARADIGM; HYPERACTIVITY DISORDER; WORKING-MEMORY; BEHAVIORAL-INHIBITION; EXECUTIVE FUNCTIONS; NEUROPSYCHOLOGICAL PROFILES; SELECTIVE-INHIBITION; READING-DISABILITY	Background: The ability to inhibit motor responses, as assessed by the stop-signal reaction time (SSRT), is impaired in children and adolescents with attention-deficit/hyperactivity disorder (ADHD). However, the between-study variation in effect sizes is large. The aim of this study was to investigate whether this variability can be explained by between-study variation in Go task complexity. Method: Forty-one studies comparing children or adolescents diagnosed with ADHD to normal control subjects were incorporated in a random-effects meta-regression analysis. The independent variables were a global index of Go task complexity (i.e., mean reaction time in control subjects [RTc]) and a more specific index (i.e., spatial compatibility of the stimulus-response mapping). The dependent variable was the SSRT difference between ADHD and control subjects. Results: The SSRT difference increased significantly with increasing RTc. Moreover, the SSRT difference was significantly increased in studies that employed a noncompatible, that is, arbitrary, mapping compared with studies that incorporated a spatially compatible stimulus-response mapping. Conclusions: These results indicate that inhibitory dysfunction in children and adolescents with ADHD varies with task complexity: inhibitory dysfunction in ADHD is most pronounced for spatially noncompatible responses. Explanations in terms of inhibition and working memory deficits and a tentative neurobiological explanation are briefly discussed.	[Huizenga, Hilde M.; van den Wildenberg, Wery P. M.] Univ Amsterdam, Dept Psychol, Amsterdam Ctr Study Adapt Control Brain & Behav, NL-1018 WB Amsterdam, Netherlands		Huizenga, HM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam Ctr Study Adapt Control Brain & Behav, Roetersstr 15, NL-1018 WB Amsterdam, Netherlands.	h.m.huizenga@uva.nl	van der Molen, Maurits W/B-7543-2014		VIDINetherlands Organization for Scientific Research (NWO); VENINetherlands Organization for Scientific Research (NWO); Netherlands Organization for Scientific ResearchNetherlands Organization for Scientific Research (NWO)	This research is supported by a VIDI grant (HMH) and a VENI grant (WPMudW) from the Netherlands Organization for Scientific Research.	Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bedard AC, 2003, J ABNORM CHILD PSYCH, V31, P315, DOI 10.1023/A:1023285614844; Bitsakou P, 2008, J NEURAL TRANSM, V115, P261, DOI 10.1007/s00702-007-0828-z; Bond CF, 2003, PSYCHOL METHODS, V8, P406, DOI 10.1037/1082-989X.8.4.406; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chambers CD, 2007, J NEUROPHYSIOL, V98, P3638, DOI 10.1152/jn.00685.2007; Chhabildas N, 2001, J ABNORM CHILD PSYCH, V29, P529, DOI 10.1023/A:1012281226028; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crone EA, 2003, J CHILD PSYCHOL PSYC, V44, P214, DOI 10.1111/1469-7610.00115; DAUGHERTY TK, 1993, J GENET PSYCHOL, V154, P177, DOI 10.1080/00221325.1993.9914731; Dimoska A, 2003, BIOL PSYCHIAT, V54, P1345, DOI 10.1016/S0006-3223(03)00703-0; Fuggetta GP, 2006, CHILD NEUROPSYCHOL, V12, P1, DOI 10.1080/09297040500203418; Geurts HM, 2004, J CHILD PSYCHOL PSYC, V45, P836, DOI 10.1111/j.1469-7610.2004.00276.x; Hommel B, 1997, ADV PSYCHOL, V118, P281; Jennings JR, 1997, DEV PSYCHOL, V33, P308, DOI 10.1037/0012-1649.33.2.308; Johnstone SJ, 2007, INT J PSYCHOPHYSIOL, V66, P37, DOI 10.1016/j.ijpsycho.2007.05.011; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Konrad KN, 2000, BRAIN INJURY, V14, P859; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; KRAMER AF, 1994, PSYCHOL AGING, V9, P491, DOI 10.1037/0882-7974.9.4.491; Kuntsi J, 2001, J CHILD PSYCHOL PSYC, V42, P199, DOI 10.1017/S0021963001006709; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; Liotti M, 2007, PSYCHOPHYSIOLOGY, V44, P936, DOI 10.1111/j.1469-8986.2007.00568.x; Logan G.D., 1994, ABILITY INHIBIT THOU; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan GD, 2000, PSYCHON B REV, V7, P107, DOI 10.3758/BF03210728; Manassis K, 2000, J AM ACAD CHILD PSY, V39, P1152, DOI 10.1097/00004583-200009000-00015; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; McInerney RJ, 2003, CHILD NEUROPSYCHOL, V9, P91, DOI 10.1076/chin.9.2.91.14506; Morein-Zamir S, 2006, Q J EXP PSYCHOL, V59, P2148, DOI 10.1080/17470210500416375; Nigg J, 2007, DEV PSYCHOPATHOL, V19, P767, DOI 10.1017/S0954579407000387; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1424, DOI 10.1016/j.biopsych.2004.11.011; Nigg JT, 2002, J AM ACAD CHILD PSY, V41, P59, DOI 10.1097/00004583-200201000-00012; Nigg JT, 1999, J ABNORM CHILD PSYCH, V27, P393, DOI 10.1023/A:1021980002473; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.3.CO;2-G; Oosterlaan J, 1998, J ABNORM CHILD PSYCH, V26, P161, DOI 10.1023/A:1022650216978; Oosterlaan J, 1998, J CHILD PSYCHOL PSYC, V39, P411, DOI 10.1111/1469-7610.00336; Oosterlaan J, 1996, J ABNORM CHILD PSYCH, V24, P19, DOI 10.1007/BF01448371; Overtoom CCE, 2002, BIOL PSYCHIAT, V51, P668, DOI 10.1016/S0006-3223(01)01290-2; Pliszka SR, 1997, J DEV BEHAV PEDIATR, V18, P254; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Pliszka SR, 2006, AM J PSYCHIAT, V163, P1052, DOI 10.1176/appi.ajp.163.6.1052; Purvis KL, 2000, J AM ACAD CHILD PSY, V39, P485, DOI 10.1097/00004583-200004000-00018; Ridderinkhof KR, 1999, ACTA PSYCHOL, V101, P315; Ridderinkhof KR, 2005, J ABNORM PSYCHOL, V114, P197, DOI 10.1037/0021-843X.114.2.197; Rubia K, 1998, BEHAV BRAIN RES, V94, P25, DOI 10.1016/S0166-4328(97)00166-6; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Rubia K, 2001, BRIT J PSYCHIAT, V179, P138, DOI 10.1192/bjp.179.2.138; Rubia K, 2007, CHILD NEUROPSYCHOL, V13, P276, DOI 10.1080/09297040600770761; Rucklidge JJ, 2002, J CHILD PSYCHOL PSYC, V43, P988, DOI 10.1111/1469-7610.00227; Schachar R, 2000, J ABNORM CHILD PSYCH, V28, P227, DOI 10.1023/A:1005140103162; SCHACHAR R, 1995, J ABNORM CHILD PSYCH, V23, P411, DOI 10.1007/BF01447206; Schachar RJ, 2004, J ABNORM CHILD PSYCH, V32, P285, DOI 10.1023/B:JACP.0000026142.11217.f2; Schachar R, 2007, J ABNORM CHILD PSYCH, V35, P229, DOI 10.1007/s10802-006-9075-2; Scheres A, 2001, J CHILD PSYCHOL PSYC, V42, P347, DOI 10.1111/1469-7610.00728; SCHWARTZ SP, 1977, J EXPT PSYCHOL HUMAN, V3, P402; Sergeant JA, 2005, BIOL PSYCHIAT, V57, P1248, DOI 10.1016/j.biopsych.2004.09.010; Slusarek M, 2001, J AM ACAD CHILD PSY, V40, P355, DOI 10.1097/00004583-200103000-00016; Solanto MV, 2001, J ABNORM CHILD PSYCH, V29, P215, DOI 10.1023/A:1010329714819; Stevens J, 2002, DEV NEUROPSYCHOL, V21, P117, DOI 10.1207/S15326942DN2102_1; van den Wildenberg WPM, 2004, J EXP CHILD PSYCHOL, V87, P201, DOI 10.1016/j.jecp.2003.11.003; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Verbruggen F, 2005, ACTA PSYCHOL, V120, P307, DOI 10.1016/j.actpsy.2005.05.003; Verbruggen F, 2004, ACTA PSYCHOL, V116, P21, DOI 10.1016/j.actpsy.2003.12.011; Walcott CM, 2004, J CLIN CHILD ADOLESC, V33, P772, DOI 10.1207/s15374424jccp3304_12; Willcutt EG, 2005, DEV NEUROPSYCHOL, V27, P35, DOI 10.1207/s15326942dn2701_3; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; [No title captured]	74	28	29	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0006-3223			BIOL PSYCHIAT	Biol. Psychiatry	JAN 1	2009	65	1					39	45		10.1016/j.biopsych.2008.06.021			7	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	384DM	WOS:000261724500008	18723163				2022-02-06	
J	Sancisi, E; Battistini, A; Di Stefano, C; Simoncini, L; Simoncini, L; Montagna, P; Piperno, R				Sancisi, Elisa; Battistini, Alberto; Di Stefano, Cristina; Simoncini, Laura; Simoncini, Loredana; Montagna, Pasquale; Piperno, Roberto			Late recovery from post-traumatic vegetative state	BRAIN INJURY			English	Article						Late recovery; vegetative state; minimally conscious state; outcome; follow-up; traumatic brain injury	MINIMALLY CONSCIOUS STATE; REHABILITATION; IMPROVEMENT	Aim: Late recovery of consciousness after 12 months in vegetative state is very rare and is almost invariably associated with severe disability. The aim of this study was to report that late recovery with moderate disability is possible, even after several months in vegetative state. Case report: This study describes the case of a 22-year-old male student who recovered consciousness from vegetative state 19 months after a traumatic brain injury which had occurred in December 2000. A further slow recovery of motor and cognitive functions up to a moderate disability was observed over 7 years after the brain injury. The patient now lives in the community, speaks, walks and undertakes daily living as well as outdoor leisure activities independently, has resumed his previous university studies and has a part-time non-competitive job. Conclusions: This case demonstrates that attaining a condition of independent living is possible even after more than 1 year of post-traumatic vegetative state, with an improvement of motor and cognitive functions that can continue for years. Cranioplasty and long-term rehabilitation programmes may be among the variables potentially influencing this unexpected recovery.	[Sancisi, Elisa; Montagna, Pasquale] Univ Bologna, Dept Neurol Sci, I-40123 Bologna, Italy; [Battistini, Alberto; Di Stefano, Cristina; Simoncini, Laura; Simoncini, Loredana; Piperno, Roberto] Maggiore Hosp, Rehabil Unit, Bologna, Italy		Sancisi, E (corresponding author), Univ Bologna, Dept Neurol Sci, Via Ugo Foscolo 7, I-40123 Bologna, Italy.	elisa.sancisi@unibo.it	Piperno, Roberto/AAC-3000-2021; Simoncini, Laura/AAB-9410-2022	Piperno, Roberto/0000-0002-2251-9191; Simoncini, Laura/0000-0002-8853-1791			Agner C, 2002, ACTA NEUROCHIR, V144, P1033, DOI 10.1007/s00701-002-0996-4; ARTS WFM, 1985, J NEUROL NEUROSUR PS, V48, P1300, DOI 10.1136/jnnp.48.12.1300; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; Faran S, 2006, J NEUROL NEUROSUR PS, V77, P998, DOI 10.1136/jnnp.2005.076554; Fins JJ, 2007, NEUROLOGY, V68, P304, DOI 10.1212/01.wnl.0000252376.43779.96; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Gruner ML, 2000, BRAIN INJURY, V14, P585; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; Sara M, 2007, BRAIN INJURY, V21, P101, DOI 10.1080/02699050601151761; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; SUZUKI N, 1993, ACTA NEUROCHIR, V122, P49, DOI 10.1007/BF01446986; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Zeman A, 1997, LANCET, V350, P795, DOI 10.1016/S0140-6736(97)06447-7	22	28	28	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	2					163	166	PII 908448418	10.1080/02699050802660446			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	403LD	WOS:000263083200010	19191095				2022-02-06	
J	Sharma, D; Jelacic, J; Chennuri, R; Chaiwat, O; Chandler, W; Vavilala, MS				Sharma, Deepak; Jelacic, Jill; Chennuri, Rohini; Chaiwat, Onuma; Chandler, Wayne; Vavilala, Monica S.			Incidence and Risk Factors for Perioperative Hyperglycemia in Children with Traumatic Brain Injury	ANESTHESIA AND ANALGESIA			English	Article							INTENSIVE INSULIN THERAPY; BLOOD-GLUCOSE; ADMISSION; ACIDOSIS	BACKGROUND: Hyperglycemia after traumatic brain injury (TBI) is associated with poor outcome. In this study, we examined the incidence and risk factors for perioperative hyperglycemia in children with TBI. METHODS: A retrospective cohort study of children <= 13 yr who underwent urgent or emergent craniotomy for TBI at Harborview Medical Center (level I Adult and Pediatric Trauma Center) between 1994 and 2004 was performed. Preoperative (emergency department to general anesthesia start), intraoperative (during general anesthesia), and immediate postoperative (first 24 h after surgery) glucose Values for each patient were retrieved. The incidence of hyperglycemia (glucose >= 200 mg/dL) and hyperglycemia (glucose <60 mg/dL) was determined Persistent. hyperglycemia was defined as hyperglycemia during any 2/3 (preoperative, intraoperative immediate postoperative) study periods, whereas transient hyperglycemia was hyperglycemia during any one study period. Multivariate logistic regression analysis was used to determine the independent predictors of perioperative hyperglycemia. Data are resented as adjusted odds ratio (AOR) (95% CI) and P < 0.05 reflects significance. RESULTS: At least one serum glucose value was recorded during each study period: preoperative (86 [82%]), intraoperative (94 [89%), and postoperative (101 [97%]). Sixty-four percent of children had less than one glucose recorded per anesthetic hour. Forty-seven (45%) children had hyperglycemia during at least one study period. Transient hyperglycemia occurred in 29 (28%) and persistent hyperglcemia Occurred in 18 (17%) children. Independent predictors of perioperative hyperglycemia were a e <4 yr (AOR 95% CI]; 3.5 [1.2-10.6]), Glasgow Coma Scale <= 8 (AOR 95%) CI; 7.2 [2.4-2.5]) and the presence of multi le lesions subdural hematoma (AOR 95%, CI; 34.7 [2.3-525.5]). Six children were treated with insulin, and two children had hypoglycemia, unrelated to insulin treatment. CONCLUSIONS: Perioperative hyperglycemia was common and intraoperative hypo glycemia was not rare, but More frequent intraoperative glucose sampling may be needed to better determine the incidence of hypo and hyperglycemia during the perioperative period. Age <4 yr, severe TBI a and the presence of multiple lesions, including subdural hematoma, were risk factors for perioperative hyperglycemia.	[Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Chandler, Wayne] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Dept Pediat & Neurol Surg, Seattle, WA 98104 USA; [Chaiwat, Onuma; Vavilala, Monica S.] Univ Washington, Harborview Anesthesia Res Ctr, Seattle, WA 98104 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23HDO44632-05]; HARC; Departmental Resources; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD044632] Funding Source: NIH RePORTER	Supported by NIH K23HDO44632-05 (to M.S.V.), HARC (to O.C.), Departmental Resources (to D.S., J.J., R.C.).	Allen HF, 2008, PEDIATR CRIT CARE ME, V9, P153, DOI 10.1097/PCC.0b013e3181668b33; American Association for the Surgery of Trauma, 2003, J Trauma, V54, pS235; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Gandhi GY, 2007, ANN INTERN MED, V146, P233, DOI 10.7326/0003-4819-146-4-200702200-00002; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; LONGSTRETH WT, 1984, ANN NEUROL, V15, P59, DOI 10.1002/ana.410150111; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; PENTELENYI T, 1979, INJURY, V10, P201, DOI 10.1016/0020-1383(79)90009-3; REHNCRONA S, 1980, ACTA PHYSIOL SCAND, V110, P435, DOI 10.1111/j.1748-1716.1980.tb06692.x; ROLIH CA, 1995, MED CLIN N AM, V79, P211, DOI 10.1016/S0025-7125(16)30093-1; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SOOD SC, 1980, ACTA NEUROCHIR, V53, P47, DOI 10.1007/BF02074520; Treggiari MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6807; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Wintergerst KA, 2006, PEDIATRICS, V118, P173, DOI 10.1542/peds.2005-1819; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	31	28	31	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	JAN	2009	108	1					81	89		10.1213/ane.0b013e31818a6f32			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	387PB	WOS:000261963000015	19095835	Green Accepted			2022-02-06	
J	Suchyta, MR; Beck, CJ; Key, CW; Jephson, A; Hopkins, RO				Suchyta, Mary R.; Beck, Callie J.; Key, Colin W.; Jephson, Al; Hopkins, Ramona O.			Substance dependence and psychiatric disorders are related to outcomes in a mixed ICU population	INTENSIVE CARE MEDICINE			English	Article						ICU; Critical care; Alcohol dependence; Drug dependence; Substance dependence; Psychiatric disorders	INTENSIVE-CARE-UNIT; TRAUMATIC BRAIN INJURY; ALCOHOL-USE DISORDERS; SEPTIC SHOCK; ADMISSIONS; ABUSE; PREVALENCE; SEVERITY; SEPSIS	Objective: Substance dependence disorders are common in hospitalized patients and are associated with poor recovery. We compared mortality and discharge disposition in critically ill patients with and without substance dependence and patients with and without psychiatric disorders. We also compared the prevalence of substance dependence and psychiatric disorders to population data. Methods: All medical records of shock trauma intensive care unit (ICU) patients (mixed medical and surgical) at LDS Hospital were reviewed for pre-critical illness alcohol dependence, drug dependence, and psychiatric disorders. Results: There were 742 critically ill patients of whom 54% were male, acute respiratory distress syndrome developed in 5.5% and hospital mortality was 21%. The mean acute physiology and chronic health evaluation II scores were 16.5 +/- 7.9, sequential organ failure assessment scores were 6.7 +/- 4.2, duration of mechanical ventilation was 5 +/- 6.2 days, ICU length of stay (LOS) was 7.3 +/- 10.1 days, hospital LOS was 12.3 +/- 12.9 days. Multivariable regression analyses found psychiatric disorders predicted higher hospital mortality (Odds ratio = 1.50), but was not statistically significant (p = 0.08); substance dependence predicted shorter hospital LOS (R-2 = 0.08, p = 0.01) after controlling for covariates. There was a higher prevalence of substance dependence compared to Utah (p < 0.001) and US population data (p < 0.001). The prevalence of psychiatric disorders was significantly lower in our patients compared to US population data (19 vs. 26%, p < 0.001). Our data suggest that substance dependence increases hospital LOS and that patients with drug or alcohol dependence are at higher risk for ICU admission compared to the general population.	[Suchyta, Mary R.; Jephson, Al; Hopkins, Ramona O.] Intermt Med Ctr, Dept Pulm & Crit Care Med, Murray, UT 84107 USA; [Suchyta, Mary R.; Jephson, Al; Hopkins, Ramona O.] LDS Hosp, Pulm & Crit Care Div, Dept Med, Salt Lake City, UT USA; [Beck, Callie J.; Key, Colin W.; Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA		Hopkins, RO (corresponding author), Intermt Med Ctr, Dept Pulm & Crit Care Med, 5121 S Cotttonwood St, Murray, UT 84107 USA.	mary.suchyta@imail.org; mona_hopkins@byu.edu					*AM PSYCH ASS, 1994, DIAGN STAT MENT DIS; BALDWIN WA, 1993, CHEST, V103, P21, DOI 10.1378/chest.103.1.21; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Chen CH, 2004, GEN HOSP PSYCHIAT, V26, P219, DOI 10.1016/j.genhosppsych.2004.01.001; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Marik P, 1996, ALCOHOL ALCOHOLISM, V31, P393; Moss M, 2003, CRIT CARE MED, V31, P869, DOI 10.1097/01.CCM.0000055389.64497.11; Mostafa SM, 2002, EUR J ANAESTH, V19, P193, DOI 10.1017/S0265021502000340; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; Roche AM, 2006, DRUG ALCOHOL DEPEN, V83, P1, DOI 10.1016/j.drugalcdep.2005.10.011; Smothers BA, 2004, ARCH INTERN MED, V164, P749, DOI 10.1001/archinte.164.7.749; SUCHYTA MR, 2006, P AM THORAC SOC, V3, pA737; Uusaro A, 2005, ACTA ANAESTH SCAND, V49, P1236, DOI 10.1111/j.1399-6576.2005.00839.x; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; WRIGHT D, 2005, NCDUH SERIES, V26; Wright D., 2005, DHHS PUBLICATION, VSMA 05- 3989; Yeatman Richard, 2005, Australas Psychiatry, V13, P124, DOI 10.1111/j.1440-1665.2005.02174.x	19	28	29	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	DEC	2008	34	12					2264	2267		10.1007/s00134-008-1263-9			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374SA	WOS:000261062800020	18802686				2022-02-06	
J	Fan, JY; Kirkness, C; Vicini, P; Burr, R; Mitchell, P				Fan, Jun-Yu; Kirkness, Catherine; Vicini, Paolo; Burr, Robert; Mitchell, Pamela			INTRACRANIAL PRESSURE WAVEFORM MORPHOLOGY AND INTRACRANIAL ADAPTIVE CAPACITY	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; FLUID PULSE PRESSURE; VOLUME INDEX; INTENSIVE-CARE; HYPERTENSION; DYNAMICS; PATIENT	Background Intracranial hypertension due to primary and secondary injuries is a prime concern when providing care to patients with severe traumatic brain injury. Increases in intracranial pressure vary depending on compensatory processes within the craniospinal space, also referred to as intracranial adaptive capacity. In patients with traumatic brain injury and decreased intracranial adaptive capacity, intracranial pressure increases disproportionately in response to a variety of stimuli. However, no well-validated measures are available in clinical practice to predict the development of such an increase. Objectives To examine whether P2 elevation, quantified by determining the P2: P1 ratio (>= 0.8) of the intracranial pressure pulse waveform, is a unique predictor of disproportionate increases in intracranial pressure on a beat-by-beat basis in the 30 minutes preceding the elevation in patients with severe traumatic brain injury, within 48 hours after deployment of an intracranial pressure monitor. Methods A total of 38 patients with severe traumatic brain injury were sampled from a randomized controlled trial of cerebral perfusion pressure management in patients with traumatic brain injury or subarachnoid hemorrhage. Results The P2 elevation was not only present before the disproportionate increase in pressure, but also appeared in the comparison data set (within-subject without such a pressure increase). Conclusions P2 elevation is not a reliable clinical indicator to predict an impending disproportionate increase in intracranial pressure. (American Journal of Critical Care. 2008;17:545-554)	[Fan, Jun-Yu] Chang Gung Inst Technol, Dept Nursing, Tao Yuan 333, Taiwan; [Fan, Jun-Yu] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Vicini, Paolo] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Mitchell, Pamela] Univ Washington, Sch Nursing, Seattle, WA 98195 USA		Fan, JY (corresponding author), Chang Gung Inst Technol, Dept Nursing, 261 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.	jyfan@gw.cgit.edu.tw			National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01 NR04901]; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR004901] Funding Source: NIH RePORTER	The study from which the data were obtained was funded by grant R01 NR04901 from the National Institute of Nursing Research to Pamela H. Mitchell and Catherine Kirkness, principal investigators.	AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; AVEZAAT CJJ, 1986, ACTA NEUROCHIR, V79, P13, DOI 10.1007/BF01403461; AVEZAAT CJJ, 1986, NEUROSURG REV, V9, P113, DOI 10.1007/BF01743061; BRAY RS, 1986, INTRACRANIAL PRESSUR, V6, P260; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOPP M, 1980, J NEUROSURG, V53, P516, DOI 10.3171/jns.1980.53.4.0516; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; CZOSNYKA M, 1988, ACTA NEUROCHIR, V93, P140, DOI 10.1007/BF01402897; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; CZOSNYKA M, 1990, ACTA NEUROCHIR, V105, P112, DOI 10.1007/BF01669992; Gega A, 1980, INTRACRANIAL PRESSUR, P188; Germon K, 1988, J Neurosci Nurs, V20, P344; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; GRAY WJ, 1987, J NEUROSURG, V67, P377, DOI 10.3171/jns.1987.67.3.0377; Hickey J, 2003, CLIN PRACTICE NEUROL; HIRAI O, 1984, SURG NEUROL, V21, P67, DOI 10.1016/0090-3019(84)90404-X; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Kirkness CJ, 2006, AM J CRIT CARE, V15, P600; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; KLASSEN P A, 1991, Neurological Research, V13, P194; Lang E W, 1995, New Horiz, V3, P400; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LEECH P, 1974, J NEUROL NEUROSUR PS, V37, P1093, DOI 10.1136/jnnp.37.10.1093; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; March K, 1990, J Neurosci Nurs, V22, P375; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MILLER J D, 1987, Neurological Research, V9, P198; Miller J D, 1975, Clin Neurosurg, V22, P76; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1992, J NEUROTRAUM, V9, pS317; MILLER JD, 1973, ARCH NEUROL-CHICAGO, V28, P265, DOI 10.1001/archneur.1973.00490220073011; Miller JD, 1972, INTRACRANIAL PRESSUR, P270; Mitchell P H, 1986, J Neurosci Nurs, V18, P170; MITCHELL PH, 1981, NURS RES, V30, P212; Mitchell PH, 2002, ACT NEUR S, V81, P163; MITCHELL PH, 1978, NURS RES, V27, P4; MITCHELL PH, 1986, NURS CLIN N AM, V21, P563; MITCHELL PH, 1998, INTRACRANIAL PRESSUR, P420; Muwaswes M, 1985, J Neurosurg Nurs, V17, P238; NORNES H, 1977, ACTA NEUROCHIR, V38, P177, DOI 10.1007/BF01401089; Piper I, 1997, HEAD INJURY; PORTNOY HD, 1994, PEDIATR NEUROSURG, V20, P92, DOI 10.1159/000120771; PORTNOY HD, 1981, NEUROSURGERY, V9, P14, DOI 10.1227/00006123-198107000-00004; Rauch M E, 1990, J Neurosci Nurs, V22, P173; Resnick DK, 1997, J TRAUMA, V42, P1108, DOI 10.1097/00005373-199706000-00021; Rising C J, 1993, J Neurosci Nurs, V25, P302; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TSEMENTZIS SA, 1982, ACTA NEUROCHIR, V65, P153, DOI 10.1007/BF01405841; WILLIS ML, 1991, THESIS U WASHINGTON; Yau Y, 2002, ACTA NEUROCHIR SUPPL, V81, P167; [No title captured]	56	28	32	0	8	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264			AM J CRIT CARE	Am. J. Crit. Care	NOV 1	2008	17	6					545	554					10	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Nursing	367OK	WOS:000260561100010	18978239				2022-02-06	
J	Kuppermann, N				Kuppermann, Nathan			Pediatric head trauma: the evidence regarding indications for emergent neuroimaging	PEDIATRIC RADIOLOGY			English	Article; Proceedings Paper	4th ALARA Conference on Imaging Safety and Quality for Children in the Emergency Setting	FEB 23-24, 2008	Orlando, FL			Traumatic brain injury; Blunt head trauma; Pediatric trauma; Radiation exposure	COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; YOUNG-CHILDREN; DECISION RULE; CANCER RISKS; PREDICT; CONSCIOUSNESS; MANAGEMENT; INFANTS; HISTORY	Traumatic brain injury (TBI) is a leading cause of childhood death and disability worldwide. In the United States, childhood head trauma results in approximately 3,000 deaths, 50,000 hospitalizations, and 650,000 emergency department (ED) visits annually. Children presenting to the ED with seemingly minor head trauma account for approximately one-half of children with documented TBIs. Despite the frequency and importance of childhood minor head trauma, there exists no highly accurate., reliable and validated clinical scoring system or prediction rule for assessing risk of TBI among those with minor head trauma. At the same time, use of CT scanning in these children in recent years has increased substantially. The major benefit of CT scanning is early identification (and treatment) of TBIs that might otherwise be missed and result in increased risk of morbidity and mortality. Unnecessary CT imaging, however, exposes the child needlessly to the risk of radiation-induced malignancies. What constitutes appropriate criteria for obtaining CT scans in children after minor blunt head trauma remains controversial. Current evidence to guide clinicians in this regard is limited; however, large studies performed in multi-center research networks have recently been conducted. These studies should provide the foundation of	[Kuppermann, Nathan] UC Davis Med Ctr, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Davis Sch Med, Dept Emergency Med & Pediat, Davis, CA 95616 USA		Kuppermann, N (corresponding author), UC Davis Med Ctr, Dept Emergency Med, 2315 Stockton Blvd,PSSB Suite 2100, Sacramento, CA 95817 USA.	nkuppermann@ucdavis.edu					Aitken ME, 1998, ARCH PEDIAT ADOL MED, V152, P1176; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; *CDCP NAT CTR HLTH, 2000, NAT HOSP AMB MED 13; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Dayan PS, 2007, ACAD EMERG MED, V14, P978, DOI 10.1197/j.aem.2007.06.033; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Gerein RB, 2006, ACAD EMERG MED, V13, P653, DOI 10.1197/j.aem.2005.12.025; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Hall EJ, 2002, PEDIATR RADIOL, V32, P700, DOI 10.1007/S00247-002-0774-8; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; National Center for Injury Prevention and Control, 2002, TRAUM BRAIN INJ US A; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983	29	28	28	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	NOV	2008	38			4			S670	S674		10.1007/s00247-008-0996-5			5	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	403FK	WOS:000263068300010	18810402				2022-02-06	
J	Constantinidou, F; Thomas, RD; Robinson, L				Constantinidou, Fofi; Thomas, Robin D.; Robinson, Lacy			Benefits of categorization training in patients with traumatic brain injury during post-acute rehabilitation: Additional evidence from a randomized controlled trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; categorization; cognitive rehabilitation; effectiveness; efficacy	COGNITIVE REHABILITATION; POSTACUTE REHABILITATION; PARKINSONS-DISEASE; CATEGORY; SYSTEMS; SIMILARITY; DEFICITS	Background: Preliminary research with the Categorization Program (CP) indicated that this therapeutic modality is beneficial in improving cognitive abilities in survivors of moderate-to-severe traumatic brain injury (TBI). This study provides additional evidence for the use of the CP in postacute TBI cognitive rehabilitation. Methods: Twenty-one participants in the experimental group received the CP training, and 14 participants in the control group received the conventional treatment used at their rehabilitation center. Following neuropsychological testing, participants began their therapy program. Results: There was no significant difference in the baseline performance of the 2 TBI groups on any of the measures. CP-dependent measures correlated significantly with several neuropsychological tests. Both groups improved in their neuropsychological test performance and on functional outcomes tests. However, subjects in the experimental group improved on more tests than participants in the control group. Posttest performance of subjects in the TBI control group was significantly lower on the CP Test I and CP Test 2 as compared with the experimental group. Furthermore, the performance of participants in the CP group unproved across the 3 probe tasks demonstrating generalizability to new tasks; the performance of participants in the control group did not improve. Conclusions: The CP is an effective therapy method to reduce categorization impairment and improve cognitive performance of survivors of TBI who ire enrolled in postacute rehabilitation. This study contributes to the growing body of evidence supporting cognitive rehabilitation efforts after TBI.	[Constantinidou, Fofi] Univ Cyprus, Dept Psychol, CY-16789 Nicosia, Cyprus; [Constantinidou, Fofi] Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA; [Thomas, Robin D.] Miami Univ, Dept Psychol, Oxford, OH 45056 USA; [Robinson, Lacy] Genesis Healthcare Syst, Zanesville, OH USA		Constantinidou, F (corresponding author), Univ Cyprus, Dept Psychol, 75 Kallipolcos,POB 20537, CY-16789 Nicosia, Cyprus.	fofic@ucy.ac.cy		Constantinidou, Fofi/0000-0002-7928-8363	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R15HD044554A01A1] Funding Source: Medline		Adamovich B. B., 1992, SCALES COGNITIVE ABI; ADAMOVICH BB, 1985, COGNITIVE REHABILITA; Aiken L. S., 2013, APPL MULTIPLE REGRES, DOI 10.4324/9780203774441; Allison PD, 2002, SAGE U PAPERS SERIES; American Psychiatric Association, 1994, DSM 4 DIAGN STAT MAN, V4th; Ashby F Gregory, 2004, Behav Cogn Neurosci Rev, V3, P101, DOI 10.1177/1534582304270782; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Ashby FG, 1999, PSYCHON B REV, V6, P363, DOI 10.3758/BF03210826; Ashby FG, 2003, NEUROPSYCHOLOGY, V17, P115, DOI 10.1037/0894-4105.17.1.115; Ashby FG, 2002, MEM COGNITION, V30, P666, DOI 10.3758/BF03196423; Beck A., 1996, BECK DEPRESSION INVE; Benton A., 1978, MULTILINGUAL APHASIA; Bracy O. L., 1986, COGN REHABIL, V4, P11; Cahn DA, 1998, ARCH CLIN NEUROPSYCH, V13, P575, DOI 10.1016/S0887-6177(98)00024-9; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; CONSTANTINIDOU F, 2001, CATEGORIZATION PROGR; Constantinidou F., 2004, TRAUMATIC BRAIN INJU, P337; Cree GS, 2003, J EXP PSYCHOL GEN, V132, P163, DOI 10.1037/0096-3445.132.2.163; De Filippis N. A., 1998, BOOKLET CATEGORY TES; DeCaro MS, 2008, COGNITION, V107, P284, DOI 10.1016/j.cognition.2007.07.001; Delis D.C., 2000, CALIFORNIA VERBAL LE; Duvvuri R., 1995, ED WORD FREQUENCY GU; Erickson MA, 1998, J EXP PSYCHOL GEN, V127, P107, DOI 10.1037/0096-3445.127.2.107; FARAH MJ, 1991, J EXP PSYCHOL GEN, V120, P339, DOI 10.1037/0096-3445.120.4.339; GENTILINI M, 1989, MILD HEAD INJURY, P163; Goodglass H., 2000, BOSTON DIAGNOSTIC AP; Grant D.A., 1981, WISCONSIN CARD SORTI; Hagen C., 1972, REHABILITATION HEAD; Humphreys GW, 1999, PSYCHOL RES-PSYCH FO, V62, P118, DOI 10.1007/s004260050046; Humphreys GW, 2001, BEHAV BRAIN SCI, V24, P453, DOI 10.1017/S0140525X01004150; *INT C HARM, 1998, ICH TRIP GUID STAT P; Joseph JE, 2001, COGN AFFECT BEHAV NE, V1, P119, DOI 10.3758/CABN.1.2.119; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Levin H. S., 1979, GALVESTON ORIENTATIO; LEVIN HS, 1992, SCAND J REHABIL MED, P14; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Little RJA., 1987, STAT ANAL MISSING DA; Luria AR, 1963, RESTORATION FUNCTION; Maddox WT, 2003, J EXP PSYCHOL LEARN, V29, P650, DOI 10.1037/0278-7393.29.4.650; Maddox WT, 2004, BEHAV PROCESS, V66, P309, DOI 10.1016/j.beproc.2004.03.011; Maddox WT, 2001, J INT NEUROPSYCH SOC, V7, P710, DOI 10.1017/S1355617701766076; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Myers, 1995, REY COMPLEX FIGURE T; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Smith, 1973, SYMBOL DIGIT MODALIT; Task Force on Promotion and Dissemination of Psychological Procedures, 1995, CLIN PSYCHOL, V48, P13; WECHLER D, 1999, WECHSLER MEMORY SCAL; Wechsler D., 2011, WECHSLER ABBREVIATED; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; WOODCOCK RW, 2001, W JOHNSON TESTS COGN; ISHIHARA TEST COLOR	60	28	30	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2008	23	5					312	328		10.1097/01.HTR.0000336844.99079.2c			17	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	357GN	WOS:000259834400006	18815508				2022-02-06	
J	Batten, SV; Pollack, SJ				Batten, Sonja V.; Pollack, Stacey J.			Integrative outpatient treatment for returning service members	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						veterans; postdeployment; posttraumatic stress disorder; integrative treatment; depression; traumatic brain injury; psychotherapy	POSTTRAUMATIC-STRESS-DISORDER; MEDICAL-CARE; VETERANS; THERAPY	Veterans returning from Operations Enduring and Iraqi Freedom (OEF/OIF) frequently present with multiple psychological and physical symptoms. The authors propose an innovative approach in which primary care providers, polytrauma specialists, vocational rehabilitation specialists, and mental health clinicians work together to provide care that is not simply concurrent, but truly integrated. All members of this interdisciplinary team must provide a consistent message that supports treatment engagement and progress. The authors illustrate this approach with a case report of a soldier deployed to both OEF and OIF, requiring subsequent treatment for joint pain, headaches, mild traumatic brain injury, posttraumatic stress disorder, depression, and substance abuse. Despite the emphasis on early intervention, treatment engagement and retention remain challenges in this population. (c) 2008 Wiley Periodicals, Inc.	[Batten, Sonja V.] Univ Maryland, Sch Med, VA Maryland Hlth Care Syst 116MH, Trauma Recovery Programs, Baltimore, MD 21201 USA; [Pollack, Stacey J.] VA Med Ctr, Washington, DC USA		Batten, SV (corresponding author), Univ Maryland, Sch Med, VA Maryland Hlth Care Syst 116MH, Trauma Recovery Programs, 10 N Greene St, Baltimore, MD 21201 USA.	sonja.batten@va.gov					BATTEN SV, ACCEPTANCE IN PRESS; Blake D.D., 1990, CLIN ADM PTSD SCALE; Calhoun PS, 2002, AM J PSYCHIAT, V159, P2081, DOI 10.1176/appi.ajp.159.12.2081; Cummings NA, 2001, INTEGRATED BEHAV HEA; Druss BG, 2001, ARCH GEN PSYCHIAT, V58, P861, DOI 10.1001/archpsyc.58.9.861; Erbes CR, 2008, J CLIN PSYCHOL, V64, P972, DOI 10.1002/jclp.20521; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kulka RA, 1990, TRAUMA VIETNAM WAR G; MARLATT AG, 2002, HARM REDUCTION PRAGM; Martell C.R., 2001, DEPRESSION CONTEXT S; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Pearlman Laurie Anne, 1995, TRAUMA THERAPIST COU; Resick P. A., 1993, COGNITIVE PROCESSING; VHA Office of Public Health and Environmental Hazards, 2008, AN VA HLTH CAR UT US; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Weisner C, 2001, JAMA-J AM MED ASSOC, V286, P1715, DOI 10.1001/jama.286.14.1715	18	28	28	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9762	1097-4679		J CLIN PSYCHOL	J. Clin. Psychol.	AUG	2008	64	8					928	939		10.1002/jclp.20513			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	330ES	WOS:000257922900002	18561182				2022-02-06	
J	Sammons, MT; Batten, SV				Sammons, Morgan T.; Batten, Sonja V.			Psychological services for returning veterans and their families: Evolving	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						combat; veterans; posttraumatic stress disorder; couples; families; psychotherapy	WAR	The provision of effective and timely behavioral health care for veterans returning from the conflicts in, Iraq and Afghanistan has become the focus of national attention. In this special issue, attempts to provide psychological care for service members and their families are examined in light of three key constructs. First, it is contended that at no other time in history has more attention been paid to the psychological consequences of engaging in combat. Second, for the first time in recorded warfare, psychological morbidity is likely to far outstrip physical injury associated with combat. Finally, although posttraunnatic stress disorder and traumatic brain injury are serious concerns, most service members return without significant physical or psychological injury and will be able to return to functioning without notable problems. Accurate diagnosis, a focus on resilience, and the expectation of readjustment are essential precepts that should guide clinical efforts and resource allocation. (c) 2008 Wiley Periodicals, Inc.	[Sammons, Morgan T.] Calif Sch Profess Psychol, San Francisco, CA 94133 USA; [Batten, Sonja V.] Univ Maryland, Sch Med, VA Maryland Hlth Care Syst, Baltimore, MD 21201 USA		Sammons, MT (corresponding author), Calif Sch Profess Psychol, 1 Beach St,Suite 200, San Francisco, CA 94133 USA.	msammons@alliant.edu					Batten SV, 2008, J CLIN PSYCHOL, V64, P928, DOI 10.1002/jclp.20513; Bliese P.D., 2007, PSYCHOL SERV, V4, P141, DOI DOI 10.1037/1541-1559.4.3.141; Chemtob CM, 2000, EFFECTIVE TREATMENTS; CHRISTIAN JR, HARMS WAY P IN PRESS; Collins RC, 2008, J CLIN PSYCHOL, V64, P993, DOI 10.1002/jclp.20515; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Eastridge BJ, 2006, J TRAUMA, V61, P1366, DOI 10.1097/01.ta.0000245894.78941.90; Erbes CR, 2008, J CLIN PSYCHOL, V64, P972, DOI 10.1002/jclp.20521; French LM, 2008, J CLIN PSYCHOL, V64, P1004, DOI 10.1002/jclp.20514; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Lincoln A, 2008, J CLIN PSYCHOL, V64, P984, DOI 10.1002/jclp.20520; Mental Health Advisory Team V, 2008, OP IR FREED 06 08; Monson CM, 2008, J CLIN PSYCHOL, V64, P958, DOI 10.1002/jclp.20511; Reger GM, 2008, J CLIN PSYCHOL, V64, P940, DOI 10.1002/jclp.20512; Silver SM, 2008, J CLIN PSYCHOL, V64, P947, DOI 10.1002/jclp.20510; Tanielian T., 2008, INVISIBLE WOUNDS WAR; VHA Office of Public Health and Environmental Hazards, 2008, AN VA HLTH CAR UT US; Wessely S, 2005, BRIT J PSYCHIAT, V186, P459, DOI 10.1192/bjp.186.6.459	18	28	28	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9762	1097-4679		J CLIN PSYCHOL	J. Clin. Psychol.	AUG	2008	64	8					921	927		10.1002/jclp.20519			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	330ES	WOS:000257922900001	18615709				2022-02-06	
J	Chan, F; Lanctot, KL; Feinstein, A; Herrmann, N; Strauss, J; Sicard, T; Kennedy, JL; McCullagh, S; Rapoport, MJ				Chan, Florance; Lanctot, Krista L.; Feinstein, Anthony; Herrmann, Nathan; Strauss, John; Sicard, Tricia; Kennedy, James L.; McCullagh, Scott; Rapoport, Mark J.			The serotonin transporter polymorphisms and major depression following traumatic brain injury	BRAIN INJURY			English	Article						depression; traumatic brain injury; genetic polymorphism	STRESSFUL LIFE EVENTS; CLOSED-HEAD INJURY; AFFECTIVE-DISORDERS; GENE POLYMORPHISMS; FUNCTIONAL POLYMORPHISM; PARKINSONS-DISEASE; ALLELIC VARIATION; RATING-SCALE; 5-HTTLPR POLYMORPHISM; PSYCHIATRIC-ILLNESS	Objective: The purpose of this study was to examine the role of the serotonin transporter gene polymorphisms on the risk of major depression following traumatic brain injury (TBI). Methods: Seventy-five patients who had sustained a TBI and who met the Diagnostic and Statistical Manual of Mental Disorders (4th ed) (DSM-IV) criteria for mood disorder due to TBI were compared to 99 controls with TBI but no mood disorder. The severity of depression was rated using the Hamilton Depression Rating Scale (HAMD) for the depressed patients. All patients were genotyped for the serotonin transporter gene-linked polymorphic region (5-HTTLPR) with the assay for the rs25531 allelic variant. Results: The distribution of genotype frequencies was not different between the depressed and control groups (chi(2) = 1.43, df = 2, p = 0.488) and for the depressed patients there was no association between HAMD scores and the polymorphisms (t-test = 1.71, df= 68, p = 0.092). Conclusion: There was no evidence of association between the serotonin transporter gene polymorphisms and depression post-TBI. Future research is indicated into the possible role of other candidate genes as risk factors for depression in this population.	[Chan, Florance; Lanctot, Krista L.; Feinstein, Anthony; Herrmann, Nathan; Strauss, John; Sicard, Tricia; Kennedy, James L.; McCullagh, Scott; Rapoport, Mark J.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada		Rapoport, MJ (corresponding author), Sunnybrook Hlth Sci Ctr Psychiat, 2075 Bayview Ave,Suite FG37, Toronto, ON M4N 3M5, Canada.	Mark.Rapoport@Sunnybrook.ca	Rapoport, Mark/AAD-8581-2020; Kennedy, James Lowery/AAZ-6947-2020; Lanctot, Krista L./AAY-4820-2020	Kennedy, James Lowery/0000-0002-8733-3806; Lanctot, Krista L./0000-0001-7024-6637			American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Anguelova M, 2003, MOL PSYCHIATR, V8, P574, DOI 10.1038/sj.mp.4001328; Assal F, 2004, ARCH NEUROL-CHICAGO, V61, P1249, DOI 10.1001/archneur.61.8.1249; Bellivier F, 1998, NEUROSCI LETT, V255, P143, DOI 10.1016/S0304-3940(98)00677-6; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Burn DJ, 2006, PARKINSONISM RELAT D, V12, P139, DOI 10.1016/j.parkreldis.2005.11.005; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Collier DA, 1996, MOL PSYCHIATR, V1, P453; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Deb S, 1999, AM J PSYCHIAT, V156, P374; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Eley TC, 2004, MOL PSYCHIATR, V9, P908, DOI 10.1038/sj.mp.4001546; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; First M.B., 1996, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Furlong RA, 1998, AM J MED GENET, V81, P58, DOI 10.1002/(SICI)1096-8628(19980207)81:1<58::AID-AJMG11>3.0.CO;2-V; Gillespie NA, 2005, PSYCHOL MED, V35, P101, DOI 10.1017/S0033291704002727; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heils A, 1996, J NEUROCHEM, V66, P2621; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Jacobs N, 2006, ARCH GEN PSYCHIAT, V63, P989, DOI 10.1001/archpsyc.63.9.989; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kendler KS, 2006, ARCH GEN PSYCHIAT, V63, P1113, DOI 10.1001/archpsyc.63.10.1113; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kunugi H, 1997, MOL PSYCHIATR, V2, P457, DOI 10.1038/sj.mp.4000334; Lasky-Su JA, 2005, AM J MED GENET B, V133B, P110, DOI 10.1016/j.ajmg.b.30104; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Liu WQ, 1999, PHARMACOGENETICS, V9, P491; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; MARION DW, 1996, MED REHABILITATION T, P35; Menza MA, 1999, J GERIATR PSYCH NEUR, V12, P49, DOI 10.1177/089198879901200202; Micheli D, 2006, J ALZHEIMERS DIS, V10, P371; Mossner R, 2001, MOL PSYCHIATR, V6, P350, DOI 10.1038/sj.mp.4000849; Nakamura M, 2000, MOL PSYCHIATR, V5, P32, DOI 10.1038/sj.mp.4000698; NAYAK AK, 1980, J NEUROL SCI, V47, P211, DOI 10.1016/0022-510X(80)90005-2; Ohara K, 1998, BIOL PSYCHIAT, V44, P550, DOI 10.1016/S0006-3223(98)00112-7; PAZOS A, 1987, NEUROSCIENCE, V21, P123, DOI 10.1016/0306-4522(87)90327-7; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ramasubbu R, 2006, J NEUROPSYCH CLIN N, V18, P96, DOI 10.1176/appi.neuropsych.18.1.96; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Raymer KA, 2005, MED HYPOTHESES, V65, P158, DOI 10.1016/j.mehy.2004.11.042; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Surtees PG, 2006, BIOL PSYCHIAT, V59, P224, DOI 10.1016/j.biopsych.2005.07.014; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Vannemreddy P, 2006, ACTA NEUROCHIR SUPPL, V96, P151; Wilhelm K, 2006, BRIT J PSYCHIAT, V188, P210, DOI 10.1192/bjp.bp.105.009522; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Willis-Owen SAG, 2005, BIOL PSYCHIAT, V58, P451, DOI 10.1016/j.biopsych.2005.04.050; Zalsman G, 2006, AM J PSYCHIAT, V163, P1588, DOI 10.1176/appi.ajp.163.9.1588	60	28	31	0	11	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2008	22	6					471	479		10.1080/02699050802084886			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	316TW	WOS:000256973600004	18465388				2022-02-06	
J	Naim, MY; Hoehn, KS; Hasz, RD; White, LS; Helfaer, MA; Nelson, RM				Naim, Maryam Y.; Hoehn, K. Sarah; Hasz, Richard D.; White, Lori S.; Helfaer, Mark A.; Nelson, Robert M.			The Children's Hospital of Philadelphia's experience with donation after cardiac death	CRITICAL CARE MEDICINE			English	Article						pediatric donation after cardiac death; pediatric non-heart-beating donation; organ transplantation; end-of-life care	ORGAN DONATION; LIFE CARE; DONORS; AUTORESUSCITATION	Objective: To describe our experience with pediatric donation after cardiac death. Design: Retrospective chart review of all cases of donation after cardiac death from 1995 to 2005. Setting: The Children's Hospital of Philadelphia pediatric intensive care unit. Patients: Twelve patients who were pediatric organ donors after cardiac death. Interventions: None. Measurements and Main Results: Charts for 12 patents were located, and donation after cardiac death was confirmed. There were two females and ten males. Patent age ranged from 1 to 17 yrs (mean 8 yrs). Four patients had severe traumatic brain injury, and eight patents had hypoxic ischemic encephalopathy. The organs procured were 24 kidneys, eight livers, four lungs, and one pancreas. The organs transplanted were 23 kidneys, four livers, and one pancreas. Ten of 12 cases of withdrawal of life-sustaining support occurred in the operating room area; the other two occurred in the holding area and the postanesthesia care unit Children received a wide range of medications at the time of extubation. No neummuscular blockers were used. The time of extubation to time of death ranged from 4 mins to 30 mins, with a mean of 14.5 mins. Death was declared based on cardiac asystole confirmed by auscultation and transthoracic impedance, with organ procurement initiated 5 mins later. Regarding who initiated conversation about donation after cardiac death, nine cases were family initiated, one case was physician initiated, and in two there was a collaborative approach with the physician and representative from the organ procurement organization. Of the organs transplanted, all organs other than one kidney and one split liver graft were functioning at 1 yr post-transplant Conclusions: Pediatric donation after cardiac death can be performed successfully; its impact on end-of-life care and bereavement needs further investigation.	[Hoehn, K. Sarah] Univ Chicago, Chicago, IL 60637 USA; [Nelson, Robert M.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [White, Lori S.] Gift Life Donor Program, Philadelphia, PA USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Helfaer, Mark A.] Endowed Chair, Div Crit Care Med, Philadelphia, PA USA		Hoehn, KS (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	sarah1220@comcast.net					Burns JP, 2000, CRIT CARE MED, V28, P3060, DOI 10.1097/00003246-200008000-00064; Cecka JM, 2002, NEW ENGL J MED, V347, P281, DOI 10.1056/NEJMe020069; Daar AS, 2004, TRANSPL P, V36, P1885, DOI 10.1016/j.transproceed.2004.08.130; DeVita MA, 2001, CRIT CARE MED, V29, P1826; Devita Michael A., 1993, Kennedy Institute of Ethics Journal, V3, P113; Devita Michael A., 1993, Kennedy Institute of Ethics Journal, V3, P131; DeVita Michael A, 1995, Kennedy Inst Ethics J, V5, P43; DURALL AL, 2007, J PEDIATR, V119, pE201; Edwards J, 2006, CRIT CARE NURSE, V26, P101; Ferguson M, 2003, J PEDIATR GASTR NUTR, V37, P219, DOI 10.1097/00005176-200309000-00001; Howard RJ, 2005, TRANSPLANTATION, V80, P564, DOI 10.1097/01.tp.0000168156.79847.46; *I HLTH CAR IMPR, 2007, IMPR REP ORG DON BRE; *I MED, 1997, EX SUMM NON HEART BE; *I MED, 2000, NONHEARTBEATING ORG; Koogler T, 1998, PEDIATRICS, V101, P1049, DOI 10.1542/peds.101.6.1049; Lewis Jonathan, 2003, Prog Transplant, V13, P265; Luce JM, 2001, CRIT CARE MED, V29, pN40, DOI 10.1097/00003246-200102001-00008; Olson L, 2005, TRANSPL P, V37, P1188, DOI 10.1016/j.transproceed.2004.12.021; Saiki C, 2001, CAN J PHYSIOL PHARM, V79, P1036, DOI 10.1139/cjpp-79-12-1036; SANOCKA UM, 1992, J APPL PHYSIOL, V73, P749, DOI 10.1152/jappl.1992.73.2.749; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Truog RD, 2003, ANESTHESIOLOGY, V98, P599, DOI 10.1097/00000542-200303000-00003; Weber M, 2002, NEW ENGL J MED, V347, P248, DOI 10.1056/NEJMoa020274	23	28	31	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUN	2008	36	6					1729	1733		10.1097/CCM.0b013e318174dd3d			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310EZ	WOS:000256513000005	18520638				2022-02-06	
J	Corrigan, JA; Bogner, JA				Corrigan, John A.; Bogner, Jennifer A.			Neighborhood characteristics and outcomes after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; environment; rehabilitation; rehabilitation outcome	CRAIG HANDICAP ASSESSMENT; NEW-SOUTH-WALES; ENVIRONMENTAL-FACTORS; LIFE SATISFACTION; SYSTEMATIC BIAS; HEALTH; URBAN; REHABILITATION; VALIDITY; HEAD	Objective: To determine the extent to which characteristics of a person's neighborhood contribute to outcomes after traumatic brain injury (TBI). Design: Prospective cohort. Setting: A specialized brain injury unit providing acute rehabilitation care. Participants: A consecutive sample of participants (N=200) in the Traumatic Brain Injury Model Systems (TBIMS) longitudinal study: 100 participants were 2 years Postinjury, and 100 participants were 5 years postinjury. Interventions: Not applicable. Main Outcome Measures: U.S. Census Bureau block group descriptors of economic and social characteristics and initial and follow-up data from the TBIMS national dataset including the Glasgow Outcome Scale-Extended (GOS-E) and Satisfaction With Life Scale (SWLS). Results: Economic and social characteristics of a person's neighborhood accounted for additional variance in outcomes C beyond what Could be accounted for by individual characteristics, including demographic, premorbid, and injury-related measures; concurrent Measures of functioning; and the persons's perception of environmental influences. Individual characteristics predicted a substantial proportion of the variance in the GOS-E (69%): neighborhood characteristics contributed an additional 1.5%. Individual characteristics predicted 33.3% of the variance in SWLS, with neighborhood characteristics accounting for an additional 6.9%. Conclusions: For both outcomes. a small but important proportion of the variance accounted for by neighborhood indices was Unique to these environmental influences and was not accounted for by individual indices. including concurrent measures of functioning and the individual's perception of environmental influences. Further investigations of how neighborhood factors affect Outcomes after TBI are warranted.	[Corrigan, John A.; Bogner, Jennifer A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Corrigan, JA (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.1@osu.edu			National Institute on Disability and Rehabilitation Research [H133A020503]	Supported by the National Institute on Disability and Rehabilitation Research to the Ohio Regional Traumatic Brain Injury Model Sysiem (grant no. H133A020503).	[Anonymous], 2006, FED REG, V71; Barnett R, 2005, SOC SCI MED, V60, P1515, DOI 10.1016/j.socscimed.2004.08.002; Baum F, 2002, HEALTH PROMOT INT, V17, P351, DOI 10.1093/heapro/17.4.351; Bedell GM, 2004, BRAIN INJURY, V18, P65, DOI 10.1080/0269905031000110517; Breeze E, 2005, INT J EPIDEMIOL, V34, P276, DOI 10.1093/ije/dyh328; Collins CA, 1999, SOCIOL FORUM, V14, P495, DOI 10.1023/A:1021403820451; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Cote Isabelle, 2004, Can J Clin Pharmacol, V11, pe232; Culham LE, 2002, BRIT J OPHTHALMOL, V86, P743, DOI 10.1136/bjo.86.7.743; Cummins S, 2002, URBAN STUD, V39, P2115, DOI 10.1080/0042098022000011399; Cummins S, 2002, BRIT MED J, V325, P436, DOI 10.1136/bmj.325.7361.436; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gill SC, 2007, PSYCHIAT RES, V152, P63, DOI 10.1016/j.psychres.2006.11.005; Gontkovsky ST, 2006, BRAIN INJURY, V20, P701, DOI 10.1080/02699050600744103; Grogan-Kaylor A, 2005, ARCH PEDIAT ADOL MED, V159, P938, DOI 10.1001/archpedi.159.10.938; Hall K., 1998, TOP SPINAL CORD INJ, V4, P16, DOI DOI 10.1310/V5RU-FRFE-50E6-E2NA; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; *I MED, 1997, EN AM ASS ROL REH SC; Jago R, 2006, AM J HEALTH PROMOT, V20, P422, DOI 10.4278/0890-1171-20.6.422; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; Kawachi I., 2003, NEIGHBOURHOODS HLTH; King JT, 2005, J NEUROSURG, V102, P489, DOI 10.3171/jns.2005.102.3.0489; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Mason Michael, 2004, Subst Use Misuse, V39, P1751, DOI 10.1081/LSUM-200033222; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; Moss Margaret P, 2006, Int J Health Geogr, V5, P37, DOI 10.1186/1476-072X-5-37; Oliver M., 1990, POLITICS DISABLEMENT; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Pearce N, 2003, AM J PUBLIC HEALTH, V93, P122, DOI 10.2105/AJPH.93.1.122; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Romley JA, 2007, J STUD ALCOHOL DRUGS, V68, P48, DOI 10.15288/jsad.2007.68.48; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Schootman M, 1999, BRAIN INJURY, V13, P995; Schootman M, 1998, BIOM HLTH R, V21, P73; SEGAL ME, 1995, AM J PHYS MED REHAB, V74, P276, DOI 10.1097/00002060-199507000-00004; Sellstrom E, 2006, SCAND J PUBLIC HEALT, V34, P544, DOI 10.1080/14034940600551251; SIMPSON D, 1981, MED J AUSTRALIA, V2, P660, DOI 10.5694/j.1326-5377.1981.tb113043.x; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; United States Census Bureau, **NON-TRADITIONAL**; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; Ware J.E., 1995, SCORE SF 12 PHYS MEN; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Whiteneck GG, 1992, CRAIG HANDICAP ASSES; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; WOODWARD A, 1984, MED J AUSTRALIA, V141, P13, DOI 10.5694/j.1326-5377.1984.tb132660.x; World Health Organization, 2007, INT CLASS FUNCT DIS; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Young AF, 2004, SOC SCI MED, V59, P2627, DOI 10.1016/j.socscimed.2004.05.001	60	28	28	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2008	89	5					912	921		10.1016/j.apmr.2007.12.027			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	341ST	WOS:000258735900018	18452741				2022-02-06	
J	Sell, SL; Avila, MA; Yu, GX; Vergara, L; Prough, DS; Grady, JJ; DeWitt, DS				Sell, Stacy L.; Avila, Marcela A.; Yu, Guangxiang; Vergara, Leoncio; Prough, Donald S.; Grady, James J.; DeWitt, Douglas S.			Hypertonic resuscitation improves neuronal and behavioral outcomes after traumatic brain injury plus hemorrhage	ANESTHESIOLOGY			English	Article							CEREBRAL-BLOOD-FLOW; CORTICAL IMPACT INJURY; ARGININE METHYL-ESTER; NITRIC-OXIDE; HEAD-INJURY; RATS; HYPOTENSION; SURVIVAL; SHOCK; AMINOGUANIDINE	Background: Resuscitation with hypertonic saline or hypertonic saline Plus L-arginine acutely improves cerebral blood How after traumatic brain injury (TBI) followed by hemorrhagic hypotension. The authors investigated whether hypertonic saline or hypertonic L-arginine would improve long-term neuronal survival and behavioral outcomes 15 days after TBI and hemorrhagic hypotension. Methods: Mean arterial pressure, arterial blood gases, pH, plasma glucose, hematocrit, and hemoglobin were measured in male Sprague-Dawley rats before and after moderate (2.0 atm) fluid percussion TBI. Rats were assigned to one of six groups: (1) sham TBI, (2) hemorrhage only, (3) TBI only, (4) TBI plus hemorrhage and resuscitation with 0.9% saline, (5) TBI plus hemorrhage and resuscitation with hypertonic saline (7.50/6), or (6) TBI plus hemorrhage and resuscitation with L-arginine (100 mg/kg) in hypertonic saline. On postinjury days 1-5, vestibulomotor function was assessed using beam balance and beam walking tasks. On postinjury days 11-15, spatial memory function was assessed using the Morris water maze. After behavioral testing, neuronal counting was performed bilaterally on specific hippocampal. regions. Results: Groups receiving hypertonic saline (P < 0.05, day 15 vs. day 11) or hypertonic L-arginine (P < 0.05, days 13-15 vs. day 11) showed improved performance over time on the Morris water maze, as well as significantly improved neuronal survival in the contralateral hippocampus (P < 0.05, hypertonic saline or hypertonic L-arginine vs. normal saline) compared with untreated TBI or normal saline-treated TBI plus hemorrhage groups. Conclusions: Hypertonic saline and hypertonic L-arginine were both effective at promoting long-term neuronal survival and behavioral recovery. The slightly earlier improvement in Morris water maze performance in the hypertonic L-arginine group warrants further studies to determine whether higher doses Of L-arginine provide additional improvement. This study supports the therapeutic benefits of hypertonic resuscitation after TBI plus hemorrhagic hypotension.	[Sell, Stacy L.; Prough, Donald S.; DeWitt, Douglas S.] Univ Texas Galveston, Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77555 USA; [Vergara, Leoncio] Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Opt Imaging Lab, Galveston, TX 77555 USA; [Grady, James J.] Univ Texas Galveston, Med Branch, Dept Prevent Med & Community Hlth, Off Biostat, Galveston, TX 77555 USA		DeWitt, DS (corresponding author), Univ Texas Galveston, Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, 610 Texas Ave, Galveston, TX 77555 USA.	ddewitt@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS019355-15] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER		Angele MK, 1999, J TRAUMA, V46, P34, DOI 10.1097/00005373-199901000-00006; Atan MS, 2004, J NEUROSURG, V101, P138, DOI 10.3171/jns.2004.101.1.0138; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BICKEL PJ, 1992, STAT SINICA, V2, P1; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Daughters K, 1996, RESUSCITATION, V31, P141, DOI 10.1016/0300-9572(95)00922-1; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hartl R, 1997, ACT NEUR S, V70, P126; Hua TC, 1999, SHOCK, V11, P51, DOI 10.1097/00024382-199901000-00008; Huk I, 1997, CIRCULATION, V96, P667; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Mellander S, 1997, ACTA PHYSIOL SCAND, V160, P57, DOI 10.1046/j.1365-201X.1997.00117.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Prough DS, 2006, SHOCK, V26, P290, DOI 10.1097/01.shk.0000225405.66693.49; Todorovic Z, 2001, PHARMACOL RES, V43, P321, DOI 10.1006/phrs.2001.0805; VANGELDEREN EM, 1991, BRIT J PHARMACOL, V103, P1899; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wade CE, 2003, J TRAUMA, V54, pS144, DOI 10.1097/01.TA.0000047223.62617.AB; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	33	28	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	MAY	2008	108	5					873	881		10.1097/ALN.0b013e31816c8a15			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	292YV	WOS:000255302900014	18431123	Bronze			2022-02-06	
J	Bernard, F; Al-Tamimi, YZ; Chafield, D; Lynch, AG; Matta, BF; Menon, DK				Bernard, Francis; Al-Tamimi, Yahia Z.; Chafield, Doris; Lynch, Andrew G.; Matta, Basil F.; Menon, David K.			Serum albumin level as a predictor of outcome in traumatic brain injury: Potential for treatment	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						traumatic brain injury; albumin; oedema; neurological outcome; therapy	FOCAL CEREBRAL-ISCHEMIA; MARKED NEUROPROTECTIVE EFFICACY; COLLOID ONCOTIC THERAPY; PLASMA-PROTEINS; RATS; EDEMA; MORTALITY; ANTIOXIDANT; INFARCTION; OCCLUSION	Background: Serum albumin level is correlated with outcome in various clinical situations. Albumin has multiple physiologic properties that could be beneficial in brain injury. The Lund therapy for elevated intracranial pressure uses albumin as part of its protocol and demonstrates favorable outcome. We sought to find out if albumin is associated with outcome after traumatic brain injury to justify conducting a randomized trial. Methods: A retrospective study of traumatic brain injury patients was conducted. Characteristics known to influence outcome were included in a multiple logistic regression model to analyze predictors of poor outcome at 6 months. Results: Data were available for 138 patients. The majority of patients (65%) had a severe injury (Glasgow Coma Scale score <9). Seventy percent of patients had a favorable outcome. Albumin levels decrease considerably from normal values in the first few days after injury irrespective of outcome. Albumin remained <25 g/L for a longer period of time in patient with an unfavorable outcome (6 days vs. 3 days, p = 0.012). Multiple logistic regression analysis identified albumin levels, age, Glasgow Coma Scale score at admission, and Injury Severity Score as predictors of poor outcome. Conclusion: Serum albumin level seems to be an independent predictor of poor outcome. The model also identified classic predictors of poor outcome that tends to strengthen its adequacy. Because albumin level is the only modifiable factor influencing outcome, it seems justified to carry out a randomized trial of the use of albumin in the treatment of brain injury.	[Bernard, Francis] Hop Sacre Coeur, Intens Care Dept, Dept Crit Care Med, Montreal, PQ H4J 1C5, Canada; [Al-Tamimi, Yahia Z.; Chafield, Doris; Matta, Basil F.; Menon, David K.] Addenbrookes Hosp, Univ Dept Anaesthesia, Cambridge, England; [Lynch, Andrew G.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Appl Med Stat, Cambridge, England		Bernard, F (corresponding author), Hop Sacre Coeur, Intens Care Dept, Dept Crit Care Med, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada.	bernard.francis@mail.com		Lynch, Andy/0000-0002-7876-7338	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0001237, G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G0001237, G9439390] Funding Source: Medline		Belayev L, 1998, STROKE, V29, P2587, DOI 10.1161/01.STR.29.12.2587; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Belayev L, 1999, BRAIN RES, V845, P107, DOI 10.1016/S0006-8993(99)01952-6; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; CLASEN RA, 1982, J NEUROPATH EXP NEUR, V41, P113, DOI 10.1097/00005072-198203000-00003; Dubois MJ, 2006, CRIT CARE MED, V34, P2536, DOI 10.1097/01.CCM.0000239119.57544.0C; Dubois Marc-Jacques, 2002, Curr Opin Crit Care, V8, P299, DOI 10.1097/00075198-200208000-00005; Dziedzic T, 2004, STROKE, V35, pE156, DOI 10.1161/01.STR.0000126609.18735.be; EMERSON TE, 1989, CRIT CARE MED, V17, P690, DOI 10.1097/00003246-198907000-00020; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Goslinga H, 1992, Ned Tijdschr Geneeskd, V136, P2422; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; HAKAMATA Y, 1995, STROKE, V26, P2149, DOI 10.1161/01.STR.26.11.2149; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Huh PW, 1998, BRAIN RES, V804, P105, DOI 10.1016/S0006-8993(98)00674-X; JORGENSEN KA, 1980, THROMB RES, V17, P13, DOI 10.1016/0049-3848(80)90289-3; KEANEY JF, 1993, J CLIN INVEST, V91, P1582, DOI 10.1172/JCI116364; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LIU HM, 1988, FORENSIC SCI INT, V38, P285, DOI 10.1016/0379-0738(88)90174-0; Martin GS, 2005, CRIT CARE MED, V33, P1681, DOI 10.1097/01.CCM.0000171539.47006.02; MATSUI T, 1993, NEUROSURGERY, V33, P293, DOI 10.1227/00006123-199308000-00017; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; MIYASAKA Y, 1983, SHINKEI GEKA, V11, P947; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Naredi S, 2003, CRIT CARE MED, V31, P2713, DOI 10.1097/01.CCm.0000095462.89651.9C; Nicholson JP, 2000, BRIT J ANAESTH, V85, P599, DOI 10.1093/bja/85.4.599; Sung J, 2004, AM SURGEON, V70, P1099; Tabernero A, 1999, GLIA, V25, P1; TOMITA H, 1994, ACTA NEUROCHIR, P547; Vincent JL, 2005, CRIT CARE, V9, pR745, DOI 10.1186/cc3895; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; Ward RT, 2004, J CRIT CARE, V19, P54, DOI 10.1016/j.jcrc.2004.02.011; WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4; Zoellner H, 1996, J CELL SCI, V109, P2571	37	28	30	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2008	64	4					872	875		10.1097/TA.0b013e31803428cc			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	287UN	WOS:000254942100005	18404050				2022-02-06	
J	Tran, MD; Wanner, IB; Neary, JT				Tran, Minh D.; Wanner, Ina B.; Neary, Joseph T.			Purinergic receptor signaling regulates N-cadherin expression in primary astrocyte cultures	JOURNAL OF NEUROCHEMISTRY			English	Article						Akt; mitogen-activated protein kinase; N-cadherin; purinergic receptors; traumatic brain injury	STRETCH-INDUCED INJURY; RAT CORTICAL ASTROCYTES; CELL-CELL-ADHESION; TRANSFORMED MOUSE FIBROBLASTS; ACTIVATED PROTEIN-KINASE; HAMSTER OVARY CELLS; EXTRACELLULAR ATP; SCHWANN-CELL; IN-VITRO; ADENOSINE-TRIPHOSPHATE	Extracellular ATP exerts both short-term and long-term effects in the CNS by stimulating cell-surface purinergic receptors. Here we have examined the effect of purinergic receptor activation on N-cadherin expression, a calcium-dependent cell adhesion molecule involved in many processes, including glia-glia and axon-glia interactions. When primary cultures of rat cortical astrocytes were treated with ATP, N-cadherin protein expression increased in a time- and concentration-dependent manner. In addition, ATP treatment caused an increase in N-cadherin immunoreactivity in both the cytoplasm and on the cell surface membrane. Interestingly, experiments with cycloheximide revealed that relocalization of N-cadherin to the cell surface membrane were independent of protein synthesis. The ATP-induced increase in N-cadherin protein expression was blocked by reactive blue 2 and 8-(p-sulfophenyl)-theophylline, suggesting involvement of both P2 and P1 purinergic receptors, respectively. In addition, N-cadherin expression was partially blocked when signaling from purinergic receptors to extracellular signal regulated protein kinase or Akt was inhibited by 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene or wortmannin, respectively. By using an in vitro model of traumatic CNS injury, we found that N-cadherin expression was increased when astrocytes were subjected to rapid and reversible mechanical strain. The findings presented here demonstrate a role for extracellular ATP, purinergic receptors and protein kinase signaling in regulating N-cadherin expression and suggest a role for this mechanism in cell-cell interactions.	[Tran, Minh D.; Neary, Joseph T.] Univ Miami, Miller Sch Med, Neurosci Program, Dept Pathol,Miami VA Med Ctr,Res Serv, Miami, FL USA; [Wanner, Ina B.] Univ Calif Los Angeles, David Geffen Sch Med, Mental Retardat Res Ctr, Los Angeles, CA 90095 USA; [Wanner, Ina B.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA		Neary, JT (corresponding author), VA Med Ctr, Res Serv 151, 1201 NW 16th St, Miami, FL 33125 USA.	jneary@med.miami.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS045470, R01NS046651] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS045470, NS46651] Funding Source: Medline		ABBRACCHIO MP, 1994, NEUROSCIENCE, V59, P67, DOI 10.1016/0306-4522(94)90099-X; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; BLASCHUK OW, 1989, DEV BIOL, V136, P564, DOI 10.1016/0012-1606(89)90283-2; Brambilla R, 2002, J NEUROCHEM, V83, P1285, DOI 10.1046/j.1471-4159.2002.01239.x; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chorna NE, 2004, J NEUROCHEM, V91, P119, DOI 10.1111/j.1471-4159.2004.02699.x; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; ERB L, 1990, J BIOL CHEM, V265, P7424; Fairless R, 2005, MOL CELL NEUROSCI, V28, P253, DOI 10.1016/j.mcn.2004.09.009; Farookhi R, 1997, ANN NY ACAD SCI, V816, P165, DOI 10.1111/j.1749-6632.1997.tb52140.x; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Franke H, 1999, GLIA, V28, P190, DOI 10.1002/(SICI)1098-1136(199912)28:3<190::AID-GLIA3>3.3.CO;2-S; Franke H, 2006, PHARMACOL THERAPEUT, V109, P297, DOI 10.1016/j.pharmthera.2005.06.002; Franke H, 2001, BRIT J PHARMACOL, V134, P1180, DOI 10.1038/sj.bjp.0704353; Fumagalli M, 2003, GLIA, V43, P218, DOI 10.1002/glia.10248; Gendron Fernand-Pierre, 2003, Biomedical Research (Aligarh), V14, P47; Glass R, 2002, CELL MOL LIFE SCI, V59, P870, DOI 10.1007/s00018-002-8474-y; GONZALEZ FA, 1989, J CELL PHYSIOL, V139, P109, DOI 10.1002/jcp.1041390116; Hatoko M, 2004, SCAND J PLAST RECONS, V38, P198, DOI 10.1080/02844310410026735; Hatoko M, 2004, J RECONSTR MICROSURG, V20, P267; Jacques-Silva MC, 2004, BRIT J PHARMACOL, V141, P1106, DOI 10.1038/sj.bjp.0705685; Kanemaru K, 2007, J NEUROSCI, V27, P8957, DOI 10.1523/JNEUROSCI.2276-07.2007; King BF, 2005, BRIT J PHARMACOL, V145, P313, DOI 10.1038/sj.bjp.0706187; King BF, 1996, NEUROSCIENCE, V74, P1187, DOI 10.1016/0306-4522(96)00209-6; Kiryushko D, 2004, ANN NY ACAD SCI, V1014, P140, DOI 10.1196/annals.1294.015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI KM, 1991, J NEUROCHEM, V57, P1510, DOI 10.1111/j.1471-4159.1991.tb06345.x; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lamb RG, 1997, J NEUROCHEM, V68, P1904; Lenz G, 2000, BRIT J PHARMACOL, V129, P927, DOI 10.1038/sj.bjp.0703138; Lenz G, 2001, J NEUROCHEM, V77, P1001, DOI 10.1046/j.1471-4159.2001.00299.x; Liu JSH, 2000, J NEUROSCI, V20, P5292, DOI 10.1523/JNEUROSCI.20-14-05292.2000; MacCalman CD, 1997, ENDOCRINOLOGY, V138, P41, DOI 10.1210/en.138.1.41; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Meaney D, 1995, P 1995 INT RES C BIO, P233; Monks DA, 2001, P NATL ACAD SCI USA, V98, P1312, DOI 10.1073/pnas.031562798; Monks DA, 2001, BRAIN RES, V895, P73, DOI 10.1016/S0006-8993(01)02031-5; Neary JT, 1999, PROG BRAIN RES, V120, P323; Neary JT, 2005, J NEUROTRAUM, V22, P491, DOI 10.1089/neu.2005.22.491; NEARY JT, 1994, NEUROREPORT, V5, P1617, DOI 10.1097/00001756-199408150-00019; NEARY JT, 1994, J NEUROCHEM, V63, P490; Neary JT, 1999, J NEUROSCI, V19, P4211, DOI 10.1523/jneurosci.19-11-04211.1999; Neary JT, 1998, NEUROSCI LETT, V242, P159, DOI 10.1016/S0304-3940(98)00067-6; NEARY JT, 1994, ACTA NEUROPATHOL, V87, P8; Neary JT, 1996, TRENDS NEUROSCI, V19, P13, DOI 10.1016/0166-2236(96)81861-3; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; NEUGEBAUER KM, 1988, J CELL BIOL, V107, P1177, DOI 10.1083/jcb.107.3.1177; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Panda DK, 2001, J BIOL CHEM, V276, P41229, DOI 10.1074/jbc.M104231200; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Pannu R, 2005, J BIOL CHEM, V280, P13742, DOI 10.1074/jbc.M411959200; Perryman KJ, 1996, ENDOCRINOLOGY, V137, P3877, DOI 10.1210/en.137.9.3877; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Pon YL, 2005, J BIOL CHEM, V280, P15438, DOI 10.1074/jbc.M410766200; Potter E, 1999, ENDOCR REV, V20, P207, DOI 10.1210/er.20.2.207; RATHBONE MP, 1992, NEUROSCI RES, V13, P1, DOI 10.1016/0168-0102(92)90030-G; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Schnadelbach O, 2000, MOL CELL NEUROSCI, V15, P288, DOI 10.1006/mcne.1999.0819; Schulte G, 2000, MOL PHARMACOL, V58, P477, DOI 10.1124/mol.58.3.477; Schulte G, 2002, MOL PHARMACOL, V62, P1137, DOI 10.1124/mol.62.5.1137; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Seye CI, 2004, J BIOL CHEM, V279, P35679, DOI 10.1074/jbc.M401799200; Shan WS, 2002, J NEUROSCI RES, V69, P292, DOI 10.1002/jnr.10305; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Thornton MR, 2005, J ANAT, V206, P69, DOI 10.1111/j.0021-8782.2005.00369.x; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Tran MD, 2006, P NATL ACAD SCI USA, V103, P9321, DOI 10.1073/pnas.0603146103; Wang M, 2005, J NEUROCHEM, V95, P630, DOI 10.1111/j.1471-4159.2005.03408.x; Wanner IB, 2002, J NEUROSCI, V22, P4066, DOI 10.1523/JNEUROSCI.22-10-04066.2002; Wanner IB, 2006, GLIA, V54, P439, DOI 10.1002/glia.20390; Wanner IB, 2006, GLIA, V54, P424, DOI 10.1002/glia.20389; WIERASZKO A, 1989, BRAIN RES, V485, P244, DOI 10.1016/0006-8993(89)90567-2; Wilby MJ, 1999, MOL CELL NEUROSCI, V14, P66, DOI 10.1006/mcne.1999.0766; WU PH, 1978, NEUROCHEM RES, V3, P563, DOI 10.1007/BF00963759; Zimmermann H, 1999, PROG BRAIN RES, V120, P371; Zimmermann H, 2006, PFLUG ARCH EUR J PHY, V452, P573, DOI 10.1007/s00424-006-0067-4	89	28	28	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	APR	2008	105	1					272	286		10.1111/j.1471-4159.2008.05214.x			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	279VR	WOS:000254383800023	18182057	Bronze			2022-02-06	
J	Cloute, K; Mitchell, A; Yates, P				Cloute, Karen; Mitchell, Annie; Yates, Phil			Traumatic brain injury and the construction of identity: A discursive approach	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							HEAD-INJURY; QUALITATIVE RESEARCH; SELF; ADJUSTMENT; PSYCHOLOGY; DISTURBANCES; DISABILITY; NARRATIVES; COMMUNITY; PEOPLE	Using discourse analysis, this paper explores the co-construction of identity for individuals who have sustained a severe traumatic brain injury (TBI). An analysis of discourse, obtained through interviewing six adults with a TBI, each with one or two significant others, suggested four main interpretative repertoires which informed participants' co-construction of identity: Medical model referencing, dependence as intrinsic to TBI, TBI as deficit and progression and productivity as key life-defining features. Medical model referencing is discussed in relation to the common, passive positioning of individuals with TBI, which often occurred in relation to memory loss. The construction of abandonment was also common, due to participants' dependence on the provision of specialist, expert services in the community. Clinical implications are discussed in terms of facilitating individuals in the co-constructing and re-authorship of more empowering and inclusive narratives and providing community services that promote meaningful social identities, separate from medical discourse.	[Cloute, Karen] Somerset Partnership NHS & Social Care Trust, Yeovil, England; [Mitchell, Annie] Univ Plymouth, Plymouth PL4 8AA, Devon, England; [Yates, Phil] Univ Exeter, Mardon Neurorehabil Ctr, Exeter EX4 4QJ, Devon, England		Cloute, K (corresponding author), Balidon Ctr, Summerlands Site,Preston Rd, Yeovil BA20 2BX, England.	Karen.Cloute@sompar.nhs.uk					BEVAN S, 1999, CRITICAL TEXTWORK IN; BLAXTER L, 2001, SMALL VOICES BIG NOI; Breakwell, 1986, COPING THREATENED ID; Burr V, 1995, INTRO SOCIAL CONSTRU; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Chamberlain K, 1997, PSYCHOL HEALTH, V12, P691, DOI 10.1080/08870449708407415; Corker M., 2003, DISABILITY CULTURE I; Dawodu S.T., 2003, TRAUMATIC BRAIN INJU; Department of Health, 2005, NAT SERV FRAM LONG T; Dowell J, 2002, BRIT J GEN PRACT, V52, P24; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; Epston, 1990, NARRATIVE MEANS THER; FENTON M, 1989, PASSIVITY EMPOWERMEN; FIFE BL, 1994, SOC SCI MED, V38, P309, DOI 10.1016/0277-9536(94)90400-6; GERGEN KJ, 1985, AM PSYCHOL, V40, P266, DOI 10.1037/0003-066X.40.3.266; Judd T, 1999, NEUROPSYCHOTHERAPY C; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KREFTING L, 1990, SOC SCI MED, V30, P859, DOI 10.1016/0277-9536(90)90213-C; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; McCluskey AE, 2000, BRAIN INJURY, V14, P943, DOI 10.1080/02699050050191896; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nochi M, 1997, DISABIL SOC, V12, P533, DOI 10.1080/09687599727119; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Nochi M, 1998, SOC SCI MED, V46, P869, DOI 10.1016/S0277-9536(97)00211-6; Oliver M., 1990, POLITICS DISABLEMENT; Olney MF, 2001, DISABIL SOC, V16, P563, DOI 10.1080/09687590120059540; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; POTTER J, 1995, RETHINKING METHODS P; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Psathas G., 1995, CONVERSATION ANAL ST; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Scior K, 2003, DISABIL SOC, V18, P779, DOI 10.1080/0968759032000119514; *SOC SERV INS, 1996, HIDD DIS REP SSI TRA; Sohlberg M., 2001, COGNITIVE REHABILITA; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; STEEL R, 2004, INVOLVING PUBLIC NHS; STILES WB, 1993, CLIN PSYCHOL REV, V13, P593, DOI 10.1016/0272-7358(93)90048-Q; Tajfel H., 1979, INTEGRATIVE THEORY I; TATE R, 2002, HDB MEMORY DISORDERS; Thaxton L, 2002, J HEAD TRAUMA REHAB, V17, P335, DOI 10.1097/00001199-200208000-00007; Turner J. C, 1987, REDISCOVERING SOCIAL; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; VANBESELAERE N, 1991, BASIC APPL SOC PSYCH, V12, P291; Wetherell, 1987, DISCOURSE SOCIAL PSY; WIDDICOMBE S, 1995, LANGUAGE YOUTH SUBCU; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Williams WH, 1999, NEUROPSYCHOL REHABIL, V9, P421, DOI 10.1080/096020199389482; WILLIAMS WH, 2003, NEUROPSYCHOLOGICAL R; Willig C., 2003, QUALITATIVE PSYCHOL; Yardley L, 1998, J Health Psychol, V3, P313, DOI 10.1177/135910539800300303; YATES PJ, 2003, BIOPSYCHOSOCIAL APPR; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]	53	28	28	0	19	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2008	18	5-6					651	670		10.1080/09602010701306989			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	360PQ	WOS:000260070200012	17852757				2022-02-06	
J	Osiurak, F; Aubin, G; Allain, P; Jarry, C; Etcharry-Bouyx, F; Richard, I; Le Gall, D				Osiurak, Francois; Aubin, Ghislaine; Allain, Philippe; Jarry, Christophe; Etcharry-Bouyx, Frederique; Richard, Isabelle; Le Gall, Didier			Different constraints on grip selection in brain-damaged patients: Object use versus object transport	NEUROPSYCHOLOGIA			English	Article						tool use; apraxia; action; motor control; grasping; pantomime	IDEOMOTOR APRAXIA; POSTURE; HAND	The present study discusses the presence of different constraints on action selection during object use versus object transport. Sixteen left brain-damaged (LBD) patients, 10 right brain-damaged (RBD) and 35 healthy controls were examined on a grip preference test consisting of a grasping-to-transport and a grasping-to-use condition. Assessment included a general praxis testing (pantomime production, object utilization gesture recognition and object use). We also reported the case of a close-head injury patient (DR) with an atypical behavioural pattern. Our results supported the different constraint hypothesis. While several LBD and RBD patients performed inappropriate grips in the grasping-to-transport condition, only two patients (L2 and DR) used inappropriate grips in the grasping-to-use condition. No correlation was found between the two conditions of the grip preference test and measures of the general praxis testing. The discussion focuses on the nature of constraints on grip selection during object use and object transport. (C) 2008 Elsevier Ltd. All rights reserved.	[Osiurak, Francois; Aubin, Ghislaine; Allain, Philippe; Jarry, Christophe; Etcharry-Bouyx, Frederique; Le Gall, Didier] Univ Angers, UPRES EA 2646, Psychol Lab, Angers, France; [Osiurak, Francois; Aubin, Ghislaine; Allain, Philippe; Jarry, Christophe; Etcharry-Bouyx, Frederique; Le Gall, Didier] Univ Hosp Angers, Dept Neurol, Neuropsychol Unit, Angers, France; [Aubin, Ghislaine; Richard, Isabelle] Reg Ctr Funct Rehabil Angers, Angers, France		Le Gall, D (corresponding author), CHU Angers, Dept Neurol, Unite Neuropsychol, 4 Rue Larrey, F-49033 Angers 1, France.	DiLeGall@chu-angers.fr	Osiurak, Francois/F-1400-2011	Osiurak, Francois/0000-0003-3449-6377; ALLAIN, Philiooe/0000-0003-0668-0986			BERGEGO C, 1992, REV NEUROPSYCHOL, V2, P193; Buxbaum LJ, 2005, NEUROPSYCHOLOGIA, V43, P917, DOI 10.1016/j.neuropsychologia.2004.09.006; Buxbaum LJ, 2001, NEUROCASE, V7, P445, DOI 10.1076/neur.7.6.445.16223; Goldenberg G, 1998, NEUROPSYCHOLOGIA, V36, P581, DOI 10.1016/S0028-3932(97)00165-6; Goldenberg G, 1999, NEUROPSYCHOLOGIA, V37, P559, DOI 10.1016/S0028-3932(98)00111-0; Hermsdorfer J, 1999, EXP BRAIN RES, V128, P41, DOI 10.1007/s002210050815; JOHNSONFREY SH, 2003, PROGR BRAIN RES, P127; ROSENBAUM D, 1990, ATTENTION PERFORM, V13, P321; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; Rosenbaum DA, 2001, PSYCHOL REV, V108, P709, DOI 10.1037//0033-295X.108.4.709; ROTHI LJG, 1991, COGN NEUROPSYCHOL, V8, P443, DOI 10.1080/02643299108253382; Steenbergen B, 2004, COGNITIVE BRAIN RES, V19, P145, DOI 10.1016/j.cogbrainres.2003.11.008; Sunderland A, 2000, NEUROPSYCHOLOGIA, V38, P923, DOI 10.1016/S0028-3932(00)00021-X	13	28	28	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia		2008	46	9					2431	2434		10.1016/j.neuropsychologia.2008.03.018			4	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	326EP	WOS:000257641400017	18462765	Green Submitted			2022-02-06	
J	Rosenthal, G; Hemphill, JC; Sorani, M; Martin, C; Morabito, D; Meeker, M; Wang, V; Manley, GT				Rosenthal, Guy; Hemphill, J. Claude, III; Sorani, Marco; Martin, Christine; Morabito, Diane; Meeker, Michele; Wang, Vincent; Manley, Geoffrey T.			The role of lung function in brain tissue oxygenation following traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						brain tissue oxygenation; PF ratio; pulmonary function; traumatic brain injury	SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; CEREBRAL OXYGENATION; HYPEROXIA; TENSION; METABOLISM	Object. Previous studies have demonstrated that periods of low brain tissue oxygen tension (PbtO(2)) are associated with poor outcome after head trauma but have primarily focused on cerebral and hemodynamic factors as causes of low PbtO(2). The purpose of this study was to investigate the influence of lung function on PbtO(2) with an oxygen challenge (increase in fraction of inspired oxygen [FiO(2)] concentration to 1.0). Methods. This prospective observational cohort study was performed in the neurointensive care unit of the Level I trauma center at San Francisco General Hospital. Thirty-seven patients with severe traumatic brain injury (TBI) undergoing brain tissue oxygen monitoring as part of regular care underwent an oxygen challenge, consisting of an increase in FiO(2) concentration from baseline to 1.0 for 20 minutes. Partial pressure of arterial oxygen (PaO2), PbtO(2), and the ratio of PaO2 to FiO(2) (the PF ratio) were determined before and after oxygen challenge. Results. Patients with higher PF ratios achieved greater PbtO(2) during oxygen challenge than those with a low PF ratio because they achieved a higher PaO2 after an oxygen challenge. Lung function, specifically the PF ratio, is a major determinant of the maximal PbtO(2) attained during an oxygen challenge. Conclusions. Given that patients with TBI are at risk for pulmonary complications such as pneumonia, severe atelectasis, and adult respiratory distress syndrome, lung function must be considered when interpreting brain tissue oxygenation.	[Rosenthal, Guy; Martin, Christine; Morabito, Diane; Meeker, Michele; Wang, Vincent; Manley, Geoffrey T.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Neurosurg, San Francisco, CA 94117 USA; [Hemphill, J. Claude, III] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94117 USA; [Sorani, Marco] Univ Calif San Francisco, Program Biol & Med Informat, San Francisco, CA 94117 USA		Manley, GT (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Neurosurg, Bldg 1,Room 101,1001 Potrero Ave, San Francisco, CA 94117 USA.	manley@neurosurg.ucsf.edu	Demchuk, Andrew M/E-1103-2012; Hemphill, Claude/AAY-5630-2021	Demchuk, Andrew M/0000-0002-4930-7789; Hemphill, Claude/0000-0003-4019-7525	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49-CCR903697] Funding Source: Medline		*BRAIN TRAUM FDN, 1996, J NEUROTRAUM, V17, P451; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Longhi L, 2002, ACT NEUR S, V81, P315; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Menzel M, 1998, J NEUROTRAUM, V15, P265, DOI 10.1089/neu.1998.15.265; Miller PR, 2006, J TRAUMA, V60, P98, DOI 10.1097/01.ta.0000196379.74305.e4; Porzecanski I, 2006, CHEST, V130, P597, DOI 10.1378/chest.130.2.597; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P243; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007	19	28	29	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2008	108	1					59	65		10.3171/JNS/2008/108/01/0059			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	248AI	WOS:000252123300008	18173311				2022-02-06	
J	Wagstaff, GF; Wheatcroft, J; Cole, JC; Brunas-Wagstaff, J; Blackmore, V; Pilkington, A				Wagstaff, Graham F.; Wheatcroft, Jacqueline; Cole, Jon C.; Brunas-Wagstaff, Joana; Blackmore, Victoria; Pilkington, Andrew			Some cognitive and neuropsychological aspects of social inhibition and facilitation	EUROPEAN JOURNAL OF COGNITIVE PSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; VERBAL FLUENCY; MERE PRESENCE; EYEWITNESS CONFIDENCE; EXECUTIVE FUNCTIONS; DOMINANT RESPONSES; TASK-PERFORMANCE; WORKING-MEMORY; WORD RETRIEVAL; FRONTAL LOBES	Tasks that, in the working memory and neuropsychological literature, have been related to executive and frontal processing, and nonexecutive and more posterior brain processing, bear distinct similarities with the kinds of tasks that, in the social psychological literature, have been associated with social inhibition and facilitation, respectively. Accordingly, a cognitive-neuropsychological model of social inhibition and facilitation is proposed whereby the presence of others engages the executive and frontal systems, and facilitates the function of systems active in more automatic, nonexecutive processing. In two experiments, the tasks most associated with executive and frontal processing (phonemic switches and answers to complex questions) showed evidence of social inhibition, whereas those more associated with nonexecutive and more posterior temporal processing (phonemic clusters and confidence-accuracy correlations), showed some evidence of social facilitation. Implications are discussed.	[Wagstaff, Graham F.; Cole, Jon C.; Brunas-Wagstaff, Joana; Blackmore, Victoria] Univ Liverpool, Sch Psychol, Liverpool L69 7ZA, Merseyside, England; [Wheatcroft, Jacqueline; Pilkington, Andrew] Manchester Metropolitan Univ, Manchester M15 6BH, Lancs, England		Wagstaff, GF (corresponding author), Univ Liverpool, Sch Psychol, Eleanor Rathbone Bldg,Bedford St S, Liverpool L69 7ZA, Merseyside, England.	gwf@Liverpool.ac.uk		Pilkington, Andrew/0000-0001-7819-3728			Altemeier L, 2006, DEV NEUROPSYCHOL, V29, P161, DOI 10.1207/s15326942dn2901_8; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Baddeley A, 1998, Q J EXP PSYCHOL-A, V51, P819, DOI 10.1080/027249898391413; Baddeley Alan, 1996, Quarterly Journal of Experimental Psychology Section A Human Experimental Psychology, V49, P5, DOI 10.1080/027249896392784; Barber T.X., 1969, HYPNOSIS SCI APPROAC; Baron R. S., 1986, ADV EXP SOC PSYCHOL, P1, DOI [DOI 10.1016/S0065-2601(08)60211-7, 10.1016/S0065-2601(08)60211-7]; BERGER SM, 1981, J PERS SOC PSYCHOL, V40, P479; Blascovich J, 1999, J PERS SOC PSYCHOL, V77, P68, DOI 10.1037/0022-3514.77.1.68; BLISS CB, 1892, STUDIES YALE PSYCHOL, V1, P1; Bond CF, 1996, BASIC APPL SOC PSYCH, V18, P31, DOI 10.1207/s15324834basp1801_4; BOND CF, 1982, J PERS SOC PSYCHOL, V42, P1042, DOI 10.1037/0022-3514.42.6.1042; BOND CF, 1983, PSYCHOL BULL, V94, P265, DOI 10.1037/0033-2909.94.2.265; Chamberlain SR, 2006, PSYCHOPHARMACOLOGY, V188, P397, DOI 10.1007/s00213-006-0391-6; Chua EF, 2004, J COGNITIVE NEUROSCI, V16, P1131, DOI 10.1162/0898929041920568; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; COTTRELL NB, 1968, J PERS SOC PSYCHOL, V9, P245, DOI 10.1037/h0025902; CRISSON JE, 1995, BASIC APPL SOC PSYCH, V17, P357, DOI 10.1207/s15324834basp1703_5; Deffenbacher K. A., 1983, EVALUATING WITNESS E, P235; Deffenbacher KA, 2004, LAW HUMAN BEHAV, V28, P687, DOI 10.1007/s10979-004-0565-x; EDMONSTON WE, 1977, AM J CLIN HYPN, V30, P69; Elfgren CI, 1998, NEUROPSYCHOLOGIA, V36, P505, DOI 10.1016/S0028-3932(97)00146-2; FREDRIKSON M, 1992, BIOL PSYCHOL, V33, P51, DOI 10.1016/0301-0511(92)90005-F; Frith C, 1996, COGNITIVE BRAIN RES, V5, P175, DOI 10.1016/S0926-6410(96)00054-7; GRUZELIER J, 1993, PSYCHOL MED, V23, P93, DOI 10.1017/S0033291700038885; Hardy L, 2007, BRIT J PSYCHOL, V98, P15, DOI 10.1348/000712606X103428; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hirshorn EA, 2006, NEUROPSYCHOLOGIA, V44, P2547, DOI 10.1016/j.neuropsychologia.2006.03.035; Hogg MA, 2002, SOCIAL PSYCHOL; Jahanshahi M, 1998, COGN NEUROPSYCHOL, V15, P483, DOI 10.1080/026432998381005; Jamieson GA, 2005, BRAIN RES BULL, V67, P298, DOI 10.1016/j.brainresbull.2005.06.033; Kallio S, 2001, INT J CLIN EXP HYP, V49, P95, DOI 10.1080/00207140108410061; Kebbell M., 1999, OFFENDER PROFILING 1, P23; Kebbell MR, 1996, BRIT J PSYCHOL, V87, P653, DOI 10.1111/j.2044-8295.1996.tb02614.x; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Lewis BP, 1997, PERS SOC PSYCHOL B, V23, P937, DOI 10.1177/0146167297239003; MANSTEAD ASR, 1980, BRIT J SOC CLIN PSYC, V19, P119, DOI 10.1111/j.2044-8260.1980.tb00937.x; MARKUS H, 1978, J EXP SOC PSYCHOL, V14, P389, DOI 10.1016/0022-1031(78)90034-3; MARTIN A, 1994, NEUROPSYCHOLOGIA, V32, P1487, DOI 10.1016/0028-3932(94)90120-1; MASTERS RSW, 1993, PERS INDIV DIFFER, V14, P655, DOI 10.1016/0191-8869(93)90113-H; McCaffrey RJ, 1996, CLIN NEUROPSYCHOL, V10, P435, DOI 10.1080/13854049608406704; Monsell Stephen, 1996, UNSOLVED MYSTERIES M, P93; Nolan J, 1998, APPL COGNITIVE PSYCH, V12, P43, DOI 10.1002/(SICI)1099-0720(199802)12:1<43::AID-ACP487>3.0.CO;2-1; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Olley AL, 2005, BIPOLAR DISORD, V7, P43, DOI 10.1111/j.1399-5618.2005.00254.x; Platania J, 2001, J SOC PSYCHOL, V141, P190, DOI 10.1080/00224540109600546; Rainville P, 1999, J COGNITIVE NEUROSCI, V11, P110, DOI 10.1162/089892999563175; Reverberi C, 2006, NEUROPSYCHOLOGIA, V44, P469, DOI 10.1016/j.neuropsychologia.2005.05.011; Risse GL, 2006, EPILEPSIA, V47, P87, DOI 10.1111/j.1528-1167.2006.00699.x; Robinson MD, 1998, LAW HUMAN BEHAV, V22, P409, DOI 10.1023/A:1025770926338; SANDERS GS, 1981, J EXP SOC PSYCHOL, V17, P227, DOI 10.1016/0022-1031(81)90024-X; SANNA LJ, 1990, J EXP SOC PSYCHOL, V26, P82, DOI 10.1016/0022-1031(90)90063-R; SCHMITT BH, 1986, J EXP SOC PSYCHOL, V22, P242, DOI 10.1016/0022-1031(86)90027-2; SHALLICE T, 1993, ATTENTION SELECTION, P00171; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Sheehan P.W., 1976, METHODOLOGIES HYPNOS; SMITH VL, 1989, J APPL PSYCHOL, V74, P356, DOI 10.1037/0021-9010.74.2.356; STANG DJ, 1976, J SOC PSYCHOL, V98, P175, DOI 10.1080/00224545.1976.9923388; Sylvester CYC, 2003, NEUROPSYCHOLOGIA, V41, P357, DOI 10.1016/S0028-3932(02)00167-7; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Vandierendonck A, 1998, Q J EXP PSYCHOL-A, V51, P197, DOI 10.1080/713755748; VANGEMMERT WA, 1997, HUMAN PERCEPTION PER, V23, P1299; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Wagstaff G., 1981, HYPNOSIS COMPLIANCE; Wagstaff G. F., 2007, INT J PSYCHOL PSYCHO, V7, P27; Wallace B., 1996, HYPNOSIS IMAGINATION, P253; Warkentin S, 1997, DEMENT GERIATR COGN, V8, P105, DOI 10.1159/000106614; Wheatcroft JM, 2004, LEGAL CRIMINOL PSYCH, V9, P83, DOI 10.1348/135532504322776870; Wrisberg, 2000, MOTOR LEARNING PERFO; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; ZAJONC RB, 1966, J EXP SOC PSYCHOL, V2, P160, DOI 10.1016/0022-1031(66)90077-1; [No title captured]	75	28	28	0	35	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0954-1446	1464-0635		EUR J COGN PSYCHOL	Eur. J. Cogn. Psychol.		2008	20	4					828	846		10.1080/09541440701469749			19	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	318CD	WOS:000257068300009					2022-02-06	
J	Kuo, JR; Lo, CJ; Chio, CC; Chang, CP; Lin, MT				Kuo, Jinn-Rung; Lo, Chong-Jeh; Chio, Chung-Ching; Chang, Ching-Ping; Lin, Mao-Tsun			Resuscitation from experimental traumatic brain injury by agmatine therapy	RESUSCITATION			English	Article						traumatic brain injury; agmatine; intracranial hypertension; glutamate; nitric oxide; cerebral infarction	LATERAL FLUID-PERCUSSION; NITRIC-OXIDE PRODUCTION; EXCITATORY AMINO-ACIDS; SPINAL-CORD-INJURY; CEREBRAL-ISCHEMIA; RAT; RECEPTOR; SYNTHASE; BLOCKADE; PROTECTS	Both nitric oxide and glutamate contribute to ischaemic brain injury. Agmatine inhibits all isoforms of nitric oxide synthase and blocks N-methyl-D-aspartate receptors. In this study, we gave agmatine intraperitoneally and assessed its effect on fluid percussion brain injury in rats. Anaesthetised rats, immediately after the onset of fluid percussion traumatic brain injury (TBI), were divided into two major groups and given the vehicle solution (1 mL/kg) or agmatine (50mg/kg) intraperitoneally. Mean arterial pressure, intracranial pressure, cerebral perfusion pressure, and levels of glutamate, nitric oxide, lactate/pyruvate ratio, and glycerol in hippocampus were monitored continuously within 120 min after TBI. The weight loss was determined by the difference between the first and third day of body weight after TBI. The maximal grip angle in an inclined plane was measured to determine motor performance whereas the percent of maximal possible effect was used to measure blockade of proprioception. The triphenyltetrazolium chloride staining procedures were used for cerebral infarction assay. Compared to those of the sham-operated controls, the animals with TBI had higher values of extracellular levels of glutamate, nitric oxide, lactate-to-pyruvate ratio, and glycerol in hippocampus and intracranial pressure, but tower values of cerebral perfusion pressure. Agmatine administered immediately after TBI significantly attenuated the TBI-induced increased hippocampal levels of glutamate, nitric oxide, lactate-to-pyruvate ratio, and glycerol, intracranial hypertension, and cerebral hypoperfusion. In addition, the TBI-induced cerebral infarction, motor and proprioception deficits, and body weight toss evaluated 3 days after TBI were significantly attenuated by agmatine therapy. The present data indicate that agmatine may attenuate TBI by reducing the excessive accumulation of both glutamate and nitric oxide in the brain. (C) 2007 Etsevier Ireland Ltd. AR rights reserved.	[Lin, Mao-Tsun] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Kuo, Jinn-Rung; Lo, Chong-Jeh] Natl Cheng Kung Univ, Sch Med, Inst Clin Med, Tainan 70101, Taiwan; [Chio, Chung-Ching] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Chang, Ching-Ping] So Taiwan Univ Technol, Dept Biotechnol, Tainan, Taiwan		Lin, MT (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	891201@mait.chimei.org.tw		Chang, Ching-Ping/0000-0003-0890-9414			Abe K, 2000, BRAIN RES, V872, P141, DOI 10.1016/S0006-8993(00)02517-8; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; Cai ZW, 1999, NEUROREPORT, V10, P3927, DOI 10.1097/00001756-199912160-00037; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; CHIO CC, 2007, IN PRESS SHOCK; Demady DR, 2001, MOL PHARMACOL, V59, P24, DOI 10.1124/mol.59.1.24; Fairbanks CA, 2000, P NATL ACAD SCI USA, V97, P10584, DOI 10.1073/pnas.97.19.10584; Galea E, 1996, BIOCHEM J, V316, P247, DOI 10.1042/bj3160247; Gerner P, 2003, ANESTHESIOLOGY, V98, P1484, DOI 10.1097/00000542-200306000-00028; GILAD GM, 1995, LIFE SCI, V58, pPL41, DOI 10.1016/0024-3205(95)02274-0; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; Hillered L, 1999, SCAND J CLIN LAB INV, V59, P9, DOI 10.1080/00365519950185904; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Huang Z., 1996, STROKE, V27, P273; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Kim JH, 2004, EXP NEUROL, V189, P122, DOI 10.1016/j.expneurol.2004.05.029; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Mukhin A, 1996, J NEUROSCI, V16, P6012; Olmos G, 1999, BRIT J PHARMACOL, V127, P1317, DOI 10.1038/sj.bjp.0702679; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Regunathan S, 2000, J NEUROCHEM, V74, P2201, DOI 10.1046/j.1471-4159.2000.0742201.x; REGUNATHAN S, 2000, SOC NEUR ABSTR, V26, P2171; Reis DJ, 2000, TRENDS PHARMACOL SCI, V21, P187, DOI 10.1016/S0165-6147(00)01460-7; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Sudoh Y, 2003, PAIN, V103, P49, DOI 10.1016/S0304-3959(02)00375-5; SUN FY, 1995, BRAIN RES, V693, P163, DOI 10.1016/0006-8993(95)00731-5; THALHAMMER JG, 1995, ANESTHESIOLOGY, V82, P1013, DOI 10.1097/00000542-199504000-00026; Togashi H, 1998, NEUROSCI LETT, V240, P53, DOI 10.1016/S0304-3940(97)00918-X; Tsuji M, 2000, PEDIATR RES, V47, P79, DOI 10.1203/00006450-200001000-00015; Wang Y, 1997, J NEUROSCI, V17, P4341; Yang XC, 1999, J PHARMACOL EXP THER, V288, P544; Yu CG, 2000, NEUROREPORT, V11, P3203, DOI 10.1097/00001756-200009280-00031; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547	39	28	31	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	DEC	2007	75	3					506	514		10.1016/j.resuscitation.2007.05.011			9	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	242QZ	WOS:000251741900015	17629391				2022-02-06	
J	Shein, NA; Tsenter, J; Alexandrovich, AG; Horowitz, M; Shohami, E				Shein, Na'ama A.; Tsenter, Jeanna; Alexandrovich, Alexander G.; Horowitz, Michal; Shohami, Esther			Akt phosphorylation is required for heat acclimation-induced neuroprotection	JOURNAL OF NEUROCHEMISTRY			English	Article						protein kinase B; apoptosis; erythropoietin; traumatic brain injury	TRICYCLIC NUCLEOSIDE PHOSPHATE; FOCAL CEREBRAL-ISCHEMIA; NEURONAL SURVIVAL; CROSS-TOLERANCE; INJURY; ERYTHROPOIETIN; MICE; PATHWAY; INHIBITION; ACTIVATION	Long-term heat exposure, known as heat acclimation (HA; 30 days at 34 +/- 1 degrees C) is neuroprotective against traumatic brain injury. Acclimated mice were previously found to display improved functional recovery as well as an increase in the levels of the specific erythropoietin receptor. As the activation of this receptor is known to facilitate functional recovery on one hand and the phosphorylation and activation of Akt, an intracellular kinase which regulates anti-apoptotic pathways on the other, in this study we investigated whether HA affects Akt phosphorylation prior to and following injury and whether this step is required for development of HA-induced neuroprotection. Akt phosphorylation was blocked using Triciribine (TCN), a compound shown to block the phosphorylation process without affecting upstream effectors of this kinase, and several post-injury functional end-point measures were subsequently evaluated. Acclimation led to a post-injury increase in the levels of phosphorylated Akt, resulting in higher levels when compared with normothermic controls at 4 h post-injury (63.6 +/- 5.2% and 42.7 +/- 3.7%, respectively, p <= 0.05). This increase was diminished following TCN administration. Post-injury TCN treatment abolished the HA-induced functional benefits, including effects on motor and cognitive functions as well as the attenuation of edema formation. We therefore suggest that Akt phosphorylation is essential for HA-induced neuroprotection after traumatic brain injury.	Hebrew Univ Jerusalem, Fac Med Dent, Environm Physiol Lab, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Pharmacol, Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Physiol, Jerusalem, Israel; Hadassah Med Ctr, Rehabil Ctr, Jerusalem, Israel		Horowitz, M (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel.	horowitz@cc.huji.ac.il					Arieli Y, 2003, BRAIN RES, V962, P15, DOI 10.1016/S0006-8993(02)03681-8; ASSAYAG M, 2007, ANN M ISR GROUP HEAR; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Cao L, 2007, ACTA PHARMACOL SIN, V28, P173, DOI 10.1111/j.1745-7254.2007.00504.x; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Delgado-Esteban M, 2007, J NEUROCHEM, V102, P194, DOI 10.1111/j.1471-4159.2007.04450.x; Ennaceur A, 2005, BEHAV BRAIN RES, V159, P247, DOI 10.1016/j.bbr.2004.11.006; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; FEUN LG, 1993, AM J CLIN ONCOL-CANC, V16, P506, DOI 10.1097/00000421-199312000-00010; FEUN LG, 1984, CANCER RES, V44, P3608; Grasso G, 2006, J NEUROSURG-SPINE, V4, P310, DOI 10.3171/spi.2006.4.4.310; Horowitz M, 2004, J APPL PHYSIOL, V97, P1496, DOI 10.1152/japplphysiol.00306.2004; Horowitz M, 2002, COMP BIOCHEM PHYS A, V131, P475, DOI 10.1016/S1095-6433(01)00500-1; Isele NB, 2007, NEUROCHEM INT, V50, P243, DOI 10.1016/j.neuint.2006.08.007; Kilic E, 2006, FASEB J, V20, P1185, DOI 10.1096/fj.05-4829fje; Liu RQ, 2006, J NEUROCHEM, V96, P1101, DOI 10.1111/j.1471-4159.2005.03597.x; Malhotra S, 2006, J NEUROSCI RES, V83, P19, DOI 10.1002/jnr.20705; Maloyan A, 2005, PHYSIOL GENOMICS, V23, P79, DOI 10.1152/physiolgenomics.00279.2004; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Treinin M, 2003, PHYSIOL GENOMICS, V14, P17, DOI 10.1152/physiolgenomics.00179.2002; WOTRING LL, 1990, CANCER RES, V50, P4891; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343; YANNAI EB, 1997, J CEREB BLOOD FLOW M, V17, P273; Yin W, 2007, STROKE, V38, P1017, DOI 10.1161/01.STR.0000258102.18836.ca	29	28	30	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	NOV	2007	103	4					1523	1529		10.1111/j.1471-4159.2007.04862.x			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	223WH	WOS:000250403500023	17725578	Bronze			2022-02-06	
J	Lewis, SB; Velat, GJ; Miralia, L; Papa, L; Aikman, JM; Wolper, RA; Firment, CS; Liu, MC; Pineda, JA; Wang, KKW; Hayes, RL				Lewis, Stephen B.; Velat, Gregory J.; Miralia, Lynn; Papa, Linda; Aikman, Jada M.; Wolper, Regina A.; Firment, Chris S.; Liu, Ming Chen; Pineda, Jose A.; Wang, Kevin K. W.; Hayes, Ronald L.			Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: a novel biomarker of proteolytic injury	JOURNAL OF NEUROSURGERY			English	Article						alpha II spectrin; biomarker; cell death; subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CEREBROSPINAL-FLUID; PERIMESENCEPHALIC HEMORRHAGE; COMPUTED-TOMOGRAPHY; CALPAIN; RAT; ACCUMULATION; ACTIVATION; DEFICITS	Object. Aneurysmal subarachnoid hemorrhage (ASAH) is a serious event with grave consequences. Delayed ischemic neurological deficits caused by cerebral arterial vasospasm contribute significantly to death and disability. Biomarkers may reflect brain injury and provide an early warning of impending neurological decline and stroke from ASAH-induced vasospasm. Alpha-II spectrin is a cytoskeletal protein whose breakdown products are candidate surrogate markers of injury magnitude, treatment efficacy, and outcome. In addition, alpha II spectrin breakdown products (SBDPs) can provide information on the proteolytic mechanisms of injury. Methods. Twenty patients who received a diagnosis of Fisher Grade 3 ASAH were enrolled in this study to examine the clinical utility of SBDPs in the detection of cerebral vasospasm in patients with ASAH. All patients underwent placement of a ventriculostomy for continual cerebrospinal fluid drainage within 72 hours of ASAH onset. Cerebrospinal fluid samples were collected every 6 hours and analyzed using Western Blotting for SBDPs. Onset of vasospasm was defined as an acute onset of a focal neurological deficit or a change in Glasgow Coma Scale score of two or more points. All suspected cases of vasospasm were confirmed on imaging studies. Results. Both calpain- and caspase-mediated SBDP levels are significantly increased in patients suffering ASAH. The concentration of SBDPs was found to increase significantly over baseline level up to 12 hours before the onset of cerebral arterial vasospasm. Conclusions. Differential expression of SBDPs suggests oncotic necrotic proteolysis may be predominant in acute brain injury after ASAH and cerebral arterial vasospasm.	Univ Florida, Dept Neurol Surg, Gainesville, FL 32610 USA; Univ Florida, Dept Emergency Med, Gainesville, FL USA; Univ Florida, Dept Neurosci, Ctr Traumat Brain Injury Studies, Gainesville, FL 32610 USA; Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; Univ Florida, Dept Radiol, Gainesville, FL 32610 USA; Florida State Univ, Coll Med, Tallahassee, FL 32306 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA		Lewis, SB (corresponding author), Univ Florida, Dept Neurol Surg, 100 S Newell Dr,L2-100,POB 100265, Gainesville, FL 32610 USA.	lewis@neurosurgery.ufl.edu	Pineda, Jose/W-2806-2019	Wang, Kevin/0000-0002-9343-6473	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01-RR00082] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000082] Funding Source: NIH RePORTER		Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Bavbek M, 1998, STROKE, V29, P1930, DOI 10.1161/01.STR.29.9.1930; Brilstra EH, 1997, J NEUROL NEUROSUR PS, V63, P382, DOI 10.1136/jnnp.63.3.382; BROUWERS PJAM, 1993, STROKE, V24, P809, DOI 10.1161/01.STR.24.6.809; DAVELLA D, 2004, ACAD EMERG MED, V11, P515; Frijns CJM, 2006, J NEUROL NEUROSUR PS, V77, P77, DOI 10.1136/jnnp.2005.064956; Germano A, 2002, J NEUROTRAUM, V19, P887, DOI 10.1089/08977150260190474; Hop JW, 1998, STROKE, V29, P798, DOI 10.1161/01.STR.29.4.798; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Petzold A, 2006, J NEUROTRAUM, V23, P1179, DOI 10.1089/neu.2006.23.1179; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Polin RS, 1998, J NEUROSURG, V89, P559, DOI 10.3171/jns.1998.89.4.0559; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; VANGIJN J, 1985, NEUROLOGY, V35, P493, DOI 10.1212/WNL.35.4.493; Zhao XR, 2000, J CEREBR BLOOD F MET, V20, P550, DOI 10.1097/00004647-200003000-00014	23	28	28	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2007	107	4					792	796		10.3171/JNS-07/10/0792			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	214NY	WOS:000249746500013	17937225				2022-02-06	
J	Azzopardi, D; Edwards, AD				Azzopardi, D.; Edwards, A. D.			Hypothermia	SEMINARS IN FETAL & NEONATAL MEDICINE			English	Article						asphyxia; disabilities; hypothermia; hypoxia-ischaemia; meta analyses; neuroprotection	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; MILD SYSTEMIC HYPOTHERMIA; TRAUMATIC BRAIN-INJURY; WHOLE-BODY HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; MODERATE HYPOTHERMIA; PERINATAL ASPHYXIA; NEWBORN-INFANTS; POSTISCHEMIC HYPOTHERMIA	Experimental studies show that, following hypoxic ischaemic injury, mild induced hypothermia-a reduction of body temperature by about 3 IC-preserves cerebral energy metabolism, reduces cerebral tissue injury and improves neurological function. Randomized trials in full-term and near-full-term newborns suggest that treatment with mild hypothermia is safe and improves survival without disabilities up to 18 months of age. Although the optimal time of initiation, the depth and duration, and the method of cooling are uncertain, in the absence of specific treatments many clinicians will wish to consider treating asphyxiated infants with hypothermia. Guidance now needs to be provided to promote uniform practice, to avoid inappropriate treatment and to foster continuing collaboration in future studies of neuroprotection following asphyxia. If the promising results of the current trials are confirmed by the findings from other on-going studies, with longer follow-up, the impact of such a treatment on the babies, their families and health resources in the shorter and longer terms will be considerable. (C) 2007 Elsevier Ltd. All rights reserved.	Univ London Imperial Coll Sci Technol & Med, Div Clin Sci, Dept Med, London W12 0NN, England		Azzopardi, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Clin Sci, Dept Med, Hammersmith Campus,DuCane Rd, London W12 0NN, England.	d.azzopardi@imperial.ac.uk		Edwards, Anthony David/0000-0003-4801-7066	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0200270, G0100126] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0100126, G0200270] Funding Source: UKRI		Akisu M, 2003, PROSTAG LEUKOTR ESS, V69, P45, DOI 10.1016/S0952-3278(03)00055-3; Ambalavanan N, 2006, PEDIATRICS, V118, P2084, DOI 10.1542/peds.2006-1591; Amess PN, 1999, DEV MED CHILD NEUROL, V41, P436, DOI 10.1017/S0012162299000973; Amess PN, 1997, PEDIATR RES, V41, P803, DOI 10.1203/00006450-199706000-00002; AZZOPARDI D, 1989, PEDIATR RES, V25, P445, DOI 10.1203/00006450-198905000-00004; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; BARKS J, NEONATAL HYPOTHEMIA; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Blumberg RM, 1997, EXP BRAIN RES, V113, P130, DOI 10.1007/BF02454148; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Colbourne F, 2000, J CEREBR BLOOD F MET, V20, P1702, DOI 10.1097/00004647-200012000-00009; Edwards AD, 2006, ARCH DIS CHILD-FETAL, V91, pF127, DOI 10.1136/adc.2005.071787; Edwards AD, 1995, BIOCHEM BIOPH RES CO, V217, P1193, DOI 10.1006/bbrc.1995.2895; Edwards AD, 2000, PEDIATR RES, V47, P431, DOI 10.1203/00006450-200004000-00003; Eicher DJ, 2005, PEDIATR NEUROL, V32, P18, DOI 10.1016/j.pediatrneurol.2004.06.015; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; Evans K, 2001, J Obstet Gynaecol, V21, P114, DOI 10.1080/01443610020025967; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 2005, LANCET, V365, P1619, DOI 10.1016/S0140-6736(05)66505-1; Gunn AJ, 2005, J PERINAT MED, V33, P340, DOI 10.1515/JPM.2005.061; Gunn AJ, 1999, PEDIATR RES, V46, P274, DOI 10.1203/00006450-199909000-00005; Gunn AJ, 1998, PEDIATRICS, V102, P1098, DOI 10.1542/peds.102.5.1098; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Gunn TR, 1999, PEDIATRICS, V103, P1079, DOI 10.1542/peds.103.5.1079; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Higgins RD, 2006, J PEDIATR-US, V148, P170, DOI 10.1016/j.jpeds.2005.12.009; Higgins RD, 2005, OBSTET GYNECOL, V106, P1385, DOI 10.1097/01.AOG.0000190206.70375.b4; Holzer M, 2002, NEW ENGL J MED, V346, P549; HORAN M, 2006, EARLY HUM DEV   0710; Inder TE, 2004, J PEDIATR-US, V145, P835, DOI 10.1016/j.jpeds.2004.07.034; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lin ZL, 2006, J PERINATOL, V26, P180, DOI 10.1038/sj.jp.7211412; LOREK A, 1994, PEDIATR RES, V36, P699, DOI 10.1203/00006450-199412000-00003; MacLellan CL, 2004, J CEREBR BLOOD F MET, V24, P432, DOI 10.1097/00004647-200404000-00008; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Nakashima K, 1996, STROKE, V27, P913, DOI 10.1161/01.STR.27.5.913; Nolan JP, 2003, RESUSCITATION, V57, P231, DOI 10.1016/S0300-9572(03)00184-9; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Qing M, 2003, CRIT CARE MED, V31, P2769, DOI 10.1097/01.CCM.0000098858.64868.9C; Robertson NJ, 1999, PEDIATR RES, V46, P287, DOI 10.1203/00006450-199909000-00007; ROTH SC, 1992, DEV MED CHILD NEUROL, V34, P285; Rutherford MA, 2005, PEDIATRICS, V116, P1001, DOI 10.1542/peds.2005-0328; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SHANKARAN S, 2008, PEDIATR RES, V57, pA1548; SIESJO BK, 1995, J NEUROSURG ANESTH, V7, P47, DOI 10.1097/00008506-199501000-00009; SIESJO BK, 1995, J NEUROTRAUM, V12, P943, DOI 10.1089/neu.1995.12.943; SIESJO BK, 1984, ACTA PSYCHIAT SCAND, V69, P57; Siesjo BK, 1999, ACTA NEUROCHIR SUPPL, V73, P7; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Speer M, 2006, CLIN PERINATOL, V33, P169, DOI 10.1016/j.clp.2005.11.012; Taylor DL, 2002, PEDIATR RES, V51, P13, DOI 10.1203/00006450-200201000-00005; Taylor DL, 1999, BRAIN PATHOL, V9, P93; Thoresen M, 2005, CURR OPIN NEUROL, V18, P111, DOI 10.1097/01.wco.0000162850.44897.c6; Thoresen M, 2001, PEDIATR RES, V50, P405, DOI 10.1203/00006450-200109000-00017; Thoresen M, 2001, PEDIATR RES, V49, P594, DOI 10.1203/00006450-200104000-00024; Thoresen M, 2000, PEDIATRICS, V106, P92, DOI 10.1542/peds.106.1.92; Tomimatsu T, 2003, PEDIATR RES, V53, P57, DOI 10.1203/01.PDR.0000042444.90269.2A; Tooley JR, 2003, ANN NEUROL, V53, P65, DOI 10.1002/ana.10402; Van Leeuwen GMJ, 2000, PEDIATR RES, V48, P351, DOI 10.1203/00006450-200009000-00015; Wyatt JS, 2005, EARLY HUM DEV, V81, P5, DOI 10.1016/j.earlhumdev.2004.10.014; WYATT JS, IN PRESS PEDIATRICS; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Zhang ZJ, 2001, MOL BRAIN RES, V95, P75, DOI 10.1016/S0169-328X(01)00247-9; Zhou WH, 2002, ACTA PHARMACOL SIN, V23, P64; Zhu CL, 2004, BRAIN RES, V996, P67, DOI 10.1016/j.brainres.2003.10.013	69	28	29	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1744-165X	1878-0946		SEMIN FETAL NEONAT M	Semin. Fetal Neonatal Med.	AUG	2007	12	4					303	310		10.1016/j.siny.2007.01.022			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	189ZT	WOS:000248028200009	17392043				2022-02-06	
J	Valadka, AB; Robertson, CS				Valadka, Alex B.; Robertson, Claudia S.			Surgery of cerebral trauma and associated critical care	NEUROSURGERY			English	Article						computed tomography; guidelines; neurocritical care; neurotrauma; Prehospital; traumatic; brain injury	SEVERE HEAD-INJURY; INTENSIVE INSULIN THERAPY; RECOMBINANT FACTOR VIIA; ACUTE SUBDURAL-HEMATOMA; BRAIN VOLUME REGULATION; DECOMPRESSIVE CRANIECTOMY; PERFUSION-PRESSURE; PROLONGED HYPERVENTILATION; INTRACRANIAL HYPERTENSION; MANAGEMENT	The last 30 years have been both exciting and frustrating for those in the field of traumatic brain injury (TBI). Much has been learned, but no new treatment has been shown to improve patient outcomes despite the execution of many clinical trials. The overall incidence of TBI has decreased, probably because of intensive efforts toward prevention and education. Rigorous assessment of available research has produced several evidence-based guidelines for the management of neurotrauma patients. The creation of organized emergency medical services systems in many regions has improved prehospital care. Computed tomographic scans have become the gold standard for obtaining immediate images of patients with TBI, and ongoing advances in visualizing cerebral metabolism continue to be remarkable. The major current question regarding surgical treatment for TBI involves the role of clecompressive craniectomy, an operation that first fell out of favor and has since (in the last three decades) enjoyed a resurgence of interest. Growing interest in the intensive care management of TBI patients helped to establish the new field of neurocritical care. Prophylactic hyperventilation is no longer recommended, and earlier recommendations for aggressive elevation of blood pressure have been softened to endorsement of a cerebral perfusion pressure of 60 mmHg. Recombinant factor Vlla is increasingly used for minimizing complications related to coagulopathy. Intracranial pressure monitoring is now recommended for the majority of TBI patients. At present, available technologies allow measurement of other aspects, of cerebral metabolism including cerebral blood flow, brain oxygen tension, biochemistry, and electrical activity. Therapeutic interventions that are growing in popularity or are presently under investigation include administration of hypertonic saline, hyperoxygenation, decompressive craniectomy, and hypothermia. Rehabilitation has become accepted as an important part of the TBI recovery process, and additional work is needed to identify optimal interventions in this area. Socioeconomic factors will play a growing role in our treatment of TBI patients. Although much progress has been made in the last 30 years, the challenge now is to find ways to translate that progress into improved care and outcomes for TB I patients.	Univ Texas, Sch Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Valadka, AB (corresponding author), Univ Texas, Sch Med, Dept Neurosurg, 6410 Fannin St,Suite 1020, Houston, TX 77030 USA.	alex.valadka@uthtmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS-38660] Funding Source: Medline		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Alves OL, 2003, ACTA NEUROCHIR, V145, P583, DOI 10.1007/s00701-003-0055-9; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Brody DL, 2005, NEUROCRIT CARE, V2, P263, DOI 10.1385/NCC:2:3:263; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock MR, 2006, NEUROSURGERY, V58, pS2; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Dutton RP, 2003, J CLIN ANESTH, V15, P184, DOI 10.1016/S0952-8180(03)00034-5; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Esposito TJ, 2006, J AM COLL SURGEONS, V202, P655, DOI 10.1016/j.jamcollsurg.2005.12.008; Fakhry SM, 2006, J TRAUMA, V60, P997, DOI 10.1097/01.ta.0000217285.94057.5e; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Gopinath SP, 1996, ANESTH ANALG, V83, P1014, DOI 10.1097/00000539-199611000-00020; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Institute of Medicine, 2006, HOSP BAS EM CAR BREA; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lu J, 2005, ACT NEUR S, V95, P281; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Marion DW, 2006, NEUROSURGERY, V58, P655; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; RICHARDSON JD, 1992, J TRAUMA, V32, P229, DOI 10.1097/00005373-199202000-00020; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; TEASDALE G, 1974, LANCET, V2, P81; Turner-Stokes L, 2004, CLIN MED, V4, P10, DOI 10.7861/clinmedicine.4-1-10; VALADKA AB, 2000, TXB NEUROLOGICAL SUR; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Varelas PN, 2006, J NEUROSURG, V104, P713, DOI 10.3171/jns.2006.104.5.713; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wehner DE, 2005, J EMERG NURS, V31, P383, DOI 10.1016/j.jen.2005.06.001; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; 2001, J TRAUMA S2, V51, pS3	68	28	35	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2007	61	1		S			203	220		10.1227/01.NEU.0000255497.26440.01			18	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	187XW	WOS:000247883600016	18813168				2022-02-06	
J	Cheng, JP; Aslam, HA; Hoffman, AN; Zafonte, RD; Kline, AE				Cheng, Jeffrey P.; Aslam, Haris A.; Hoffman, Ann N.; Zafonte, Ross D.; Kline, Anthony E.			The neurobehavioral benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic window	NEUROSCIENCE LETTERS			English	Article						beam-walk; beam-balance; controlled cortical impact; functional recovery; learning and memory; Morris water maze; neurobehavior; serotonin receptor agonists; traumatic brain injury	5-HT1A RECEPTOR AGONIST; CONTROLLED CORTICAL IMPACT; EXCITATORY AMINO-ACIDS; GLUTAMATE RELEASE; COGNITIVE DEFICITS; NMDA RECEPTORS; IN-VITRO; INJURY; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; RAT	The 5-HT1A receptor agonist 8-OH-DPAT (0.5 mg/kg) enhances behavioral recovery when administered 15 min after experimental traumatic brain injury (TBI). To determine if benefits are still attainable at clinically relevant times, treatment was delayed 1 and 2 It post-TBI and motor/cognitive performance was compared to early (i.e., 15 min) administration. No differences were observed among the vehicle and 8-OH-DPAT groups treated at 1 and 2 h, but all three were significantly impaired versus early 8-OH-DPAT. The data suggest that an early and narrow critical period exists for the behavioral recovery afforded by a single 8-OH-DPAT treatment paradigm. The critical window corresponds to the well documented TBI-induced glutamate increase, suggesting that 8-OH-DPAT may be conferring neuroprotection by attenuating this acute deleterious surge. (c) 2007 Elsevier Ireland Ltd. All rights reserved.	Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA		Kline, AE (corresponding author), Univ Pittsburgh, Ctr Neurosci, 3471 5th Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu		Cheng, Jeffrey/0000-0001-8285-3207	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD046700, R03HD043851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060005] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD046700, HD046700, R03 HD043851, HD043851, R01 HD069620] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS060005] Funding Source: Medline		Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; ANDRADE R, 1992, DRUG DEVELOP RES, V26, P275, DOI 10.1002/ddr.430260307; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Calcagno E, 2006, J NEUROCHEM, V96, P853, DOI 10.1111/j.1471-4159.2005.03600.x; CHOI DW, 1987, J NEUROSCI, V7, P369; De Vry Jean, 1997, Drugs of the Future, V22, P341; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Matsuyama S, 1996, BRAIN RES, V728, P175, DOI 10.1016/0006-8993(96)00395-2; Mauler F, 2001, BRAIN RES, V888, P150, DOI 10.1016/S0006-8993(00)03074-2; Melena J, 2000, EUR J PHARMACOL, V406, P319, DOI 10.1016/S0014-2999(00)00688-9; Mignon LJ, 2005, NEUROREPORT, V16, P699, DOI 10.1097/00001756-200505120-00009; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PREHN JHM, 1991, EUR J PHARMACOL, V203, P213, DOI 10.1016/0014-2999(91)90717-5; RAITERI M, 1991, J PHARMACOL EXP THER, V257, P1184; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; Semkova I, 1998, EUR J PHARMACOL, V359, P251, DOI 10.1016/S0014-2999(98)00634-7; Stover JF, 1999, J NEUROTRAUM, V16, P135, DOI 10.1089/neu.1999.16.135	25	28	28	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	APR 12	2007	416	2					165	168		10.1016/j.neulet.2007.02.006			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	161TN	WOS:000246039100012	17321680	Green Accepted			2022-02-06	
J	Folkerts, MM; Parks, EA; Dedman, JR; Kaetzel, MA; Lyeth, BG; Berman, RF				Folkerts, Michael M.; Parks, Elizabeth A.; Dedman, John R.; Kaetzel, Marcia A.; Lyeth, Bruce G.; Berman, Robert F.			Phosphorylation of calcium calmodulin-dependent protein kinase II following lateral fluid percussion brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						calcium; CaMKII; cortex; hippocampus; protein phosphorylation; traumatic brain injury	LONG-TERM POTENTIATION; MAXIMAL CALCINEURIN ACTIVITY; SIGNIFICANT INCREASE; ENTORHINAL CORTEX; CA2+ HOMEOSTASIS; NEURONAL INJURY; SPINAL-CORD; CELL-DEATH; HIPPOCAMPUS; MODEL	Traumatic brain injury (TBI) can dramatically increase levels of intracellular calcium ([Ca2+](i)). One consequence of increased [Ca2+](i) would be altered activity and function of calcium-regulated proteins, including calcium-calmodulin-dependent protein kinase II (CaMKII), which is autophosphorylated on Thr(286) (pCaMKII(286)) in the presence of calcium and calmodulin. Therefore, we hypothesized that TBI would result in increased levels of pCaMKII(286), and that such increases would occur early after injury in brain regions known to be damaged following lateral fluid percussion TBI (i.e., hippocampus and cortex). In order to test this hypothesis, immunostaining of CaMKII was examined in rat hippocampus and cortex after lateral fluid percussion (LFP) injury using an antibody directed against pCaMKII(286). LFP injury produced a marked increase in pCaMKII(286) immunostaining in the hippocampus and overlying cortex 30 min after TBI. The pattern of increased immunostaining was uneven, and unexpectedly absent in some hippocampal CA3 pyramidal neurons. This suggests that phosphatase activity may also increase following TBI, resulting in dephosphorylation of pCaMKII(286) in subpopulations of CA3 pyramidal neurons. Western blotting confirmed a rapid increase in levels of pCaMKII(286) at 10 and 30 min after brain injury, and that it was transient and no longer significantly elevated when examined at 3, 8, and 24 h. These results demonstrate that TBI alters the autophosphorylation state of CaMKII, an important neuronal regulator of critical cell functions, including enzyme activities, cell structure, gene expression, and neuronal plasticity, and provide a molecular mechanism that is likely to contribute to cell injury and impaired plasticity after TBI.	Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; Pepperdine Univ, Dept Psychol, Malibu, CA 90265 USA; Univ Cincinnati, Coll Med, Genome Res Inst, Cincinnati, OH 45221 USA		Berman, RF (corresponding author), Univ Calif Davis, Dept Neurol Surg, 1 Shields Ave, Davis, CA 95616 USA.	rfberman@ucdavis.edu		Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039090, R01NS029995] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS29995, NS39090] Funding Source: Medline		Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BOLLAG DM, 1991, PROTEIN METHODS; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; CHURN SB, 1990, STROKE, V21, P1715, DOI 10.1161/01.STR.21.12.1715; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; DASILVA FHL, 1990, PHYSIOL REV, V70, P453, DOI 10.1152/physrev.1990.70.2.453; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; ERONDU NE, 1985, J NEUROSCI, V5, P3270; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; GOLDOWITZ D, 1975, EXP NEUROL, V47, P433, DOI 10.1016/0014-4886(75)90075-8; HABERLY LB, 1978, J COMP NEUROL, V181, P781, DOI 10.1002/cne.901810407; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Kampfl A, 1996, J NEUROCHEM, V67, P1575; KENNEDY MB, 1990, COLD SPRING HARB SYM, V55, P101; KOSEL KC, 1982, BRAIN RES, V244, P201, DOI 10.1016/0006-8993(82)90079-8; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Kurz JE, 2001, J NEUROCHEM, V78, P304, DOI 10.1046/j.1471-4159.2001.00426.x; Lie AA, 1998, J NEUROPATH EXP NEUR, V57, P1078, DOI 10.1097/00005072-199811000-00011; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLARD P, 1988, PLANT CELL ENVIRON, V11, P1, DOI 10.1111/j.1365-3040.1988.tb01769.x; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Racay P, 1996, GEN PHYSIOL BIOPHYS, V15, P193; RAPPAPORT ZH, 1987, STROKE, V18, P760, DOI 10.1161/01.STR.18.4.760; Riedel G, 1999, CELL MOL LIFE SCI, V55, P549, DOI 10.1007/s000180050313; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; Schulman H, 1993, CURR OPIN CELL BIOL, V5, P247, DOI 10.1016/0955-0674(93)90111-3; SCHUSTER J, 1993, ADV COMPOS LETT, V2, P18; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; Strack S, 1997, J NEUROCHEM, V68, P2119; SWANSON LW, 1980, BRAIN RES, V197, P207, DOI 10.1016/0006-8993(80)90446-1; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; WITTER MP, 1986, J COMP NEUROL, V252, P1, DOI 10.1002/cne.902520102; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; WU K, 1990, P NATL ACAD SCI USA, V87, P5298, DOI 10.1073/pnas.87.14.5298; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; Zalewska T, 1996, NEUROCHEM INT, V28, P175, DOI 10.1016/0197-0186(95)00072-0; Zalewska T, 1996, ACTA NEUROBIOL EXP, V56, P41; Zalewska T, 1996, NEUROREPORT, V7, P637, DOI 10.1097/00001756-199601310-00062; ZHOU XR, 1994, NEUROSCI LETT, V171, P45, DOI 10.1016/0304-3940(94)90600-9	65	28	29	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2007	24	4					638	650		10.1089/neu.2006.0188			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	159NE	WOS:000245872000006	17439347				2022-02-06	
J	Saltapidas, H; Ponsford, J				Saltapidas, Helen; Ponsford, Jennie			The influence of cultural background on motivation for and participation in rehabilitation and outcome following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						culture; outcome; rehabilitation; traumatic brain injury	BLUNT HEAD-INJURY; IMPACT; ETHNICITY; HANDICAP; FAMILIES; RACE	Aims: To compare motivation for and participation in rehabilitation, outcome, and distress over role changes in persons with traumatic brain injury (TBI) from the dominant English-speaking culture in Australia versus those from minority culturally and linguistically diverse (CALD) backgrounds. Main Measures: Motivation for Traumatic Brain Injury Rehabilitation Questionnaire; Craig Handicap Assessment Reporting Technique. Participants: Two groups of persons with TBI, 38 of English-speaking backgrounds and 32 of CALD backgrounds. Results: Groups had similar education and preinjury employment status, both showed positive attitudes toward rehabilitation and participated equally in rehabilitation. However, CALD participants showed poorer outcomes in several domains, including postinjury employment status, cognitive independence, mobility and social integration, and showed greater distress about changes in ability to perform certain life roles. Conclusions: Differences in outcome and levels of distress over role changes may occur in those from CALD backgrounds following TBI, independent of socioeconomic background and access to rehabilitation. There is a need to further investigate possible reasons for this, including beliefs, coping style, and emotional response to injury.	Epworth Med Fdn, Epworth Rehabil Ctr, Dept Psychol, Richmond, Vic 3121, Australia; Monash Univ, Dept Psychol, Clayton, Vic 3168, Australia		Saltapidas, H (corresponding author), Epworth Med Fdn, Epworth Rehabil Ctr, Dept Psychol, 89 Bridge Rd, Richmond, Vic 3121, Australia.	jennie.ponsford@med.monash.edu.au					Armengol CG, 1999, J HEAD TRAUMA REHAB, V14, P233, DOI 10.1097/00001199-199906000-00004; Banja JD, 1996, DISABIL REHABIL, V18, P279, DOI 10.3109/09638289609165881; BATES MS, 1994, SOC SCI MED, V39, P629, DOI 10.1016/0277-9536(94)90020-5; Blackmer J, 1999, BRAIN INJURY, V13, P627; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CAVALLO MM, 1995, J HEAD TRAUMA REHAB, V10, P66, DOI 10.1097/00001199-199504000-00008; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Daniel A., 1983, POWER PRIVILEGE PRES; Finley LY, 1998, PSYCHIATR REHABIL J, V21, P230, DOI 10.1037/h0095308; FITZGERALD MH, 1992, J REHABIL        APR, P38; Gallaher CK, 2001, REHABIL PSYCHOL, V46, P312, DOI 10.1037/0090-5550.46.3.312; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hoofien D, 2001, BRAIN INJURY, V15, P189; Laroche M, 1996, J CROSS CULT PSYCHOL, V27, P114, DOI 10.1177/0022022196271008; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; MILLARD AV, 1992, MED ANTHROPOL Q, V6, P3, DOI 10.1525/maq.1992.6.1.02a00010; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Nguyen-Long K, 1999, J SOUTHEAST ASIAN ST, V30, P1, DOI 10.1017/S0022463400007992; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Paniagua, 1998, ASSESSING TREATING C; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Possl J, 1996, BRAIN INJURY, V10, P125, DOI 10.1080/026990596124610; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sastry J, 1998, SOC PSYCHOL QUART, V61, P101, DOI 10.2307/2787064; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Stanhope V, 2002, PSYCHIATR REHABIL J, V25, P273, DOI 10.1037/h0095015; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Sue D. W., 1990, COUNSELING CULTURALL; SUINN RM, 1992, EDUC PSYCHOL MEAS, V52, P1041, DOI 10.1177/0013164492052004028; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Uomoto JM, 2000, CRIT ISS NE, P169; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Yody BB, 2000, J HEAD TRAUMA REHAB, V15, P1041, DOI 10.1097/00001199-200008000-00006; [No title captured], DOI DOI 10.1080/09602019108520164	43	28	28	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2007	22	2					132	139		10.1097/01.HTR.0000265101.75177.8d			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	152NU	WOS:000245369500008	17414315				2022-02-06	
J	Hardy, P; Johnston, KM; De Beaumont, L; Montgomery, DL; Lecomte, JM; Soucy, JP; Bourbonnais, D; Lassonde, M				Hardy, Paule; Johnston, Karen M.; De Beaumont, Louis; Montgomery, David L.; Lecomte, Jacqueline M.; Soucy, Jean-Paul; Bourbonnais, Daniel; Lassonde, Maryse			Pilot case study of the therapeutic potential of hyperbaric oxygen therapy on chronic brain injury	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						hyperbaric oxygen; brain injuries; neuropsychology; ERPs; P300; SPECT; MRI; case report	STROKE; P300; STRENGTH; ISCHEMIA; MILD; EEG	Background: Recently, the effect of hyperbaric oxygen (HBO2) therapy was explored in the treatment of chronic TBI. It has been speculated that idling neurons in the penumbra zone remain viable several years after injury and might be reactivated by enhanced oxygenation. We studied the therapeutic potential of HBO2 therapy in a 54-year-old man who had sustained traumatic brain injuries one year before testing that resulted in permanent neurological symptoms. Methods: Two treatment series separated by a one-year inter-session interval were administered. Treatment series consisted of 20 and 60 daily one-hour exposures to 100% oxygen at 2 ATA. Electrophysiological (event-related potentials), metabolic and behavioral (sensorimotor and neuropsychological) measurements were obtained to evaluate the effects of hyperbaric oxygen therapy on neurocognitive functioning. Results: Following the initial treatment, the patient showed improvements in sensorimotor functions, as well as enhanced P300 amplitude in the damaged hemisphere. Although most of these gains were no longer observed one year after treatment, these were reinstated with an additional series of 60 exposures. Neuropsychological improvements were also observed after the completion of the second series of treatments. Conclusion: The present single-case study provides preliminary evidence of neuropsychological and electrophysiological improvements after series of 20 and 60 treatments, although the first dosage appeared to be insufficient to produce permanent benefits. Longitudinal studies using different treatment parameters should be conducted if we are to systematically investigate long-term improvements resulting from HBO2 therapy. (c) 2006 Elsevier B.V. All rights reserved.	Univ Montreal, Canada Res Chair Dev Neuropsychol, Dept Psychol, Ctr Rech Neuropsychol & Cognit, Montreal, PQ H3C 3J7, Canada; McGill Univ, Ctr Hlth, Trauma Unit, Montreal, PQ, Canada; McGill Univ, Seagram Sports Med, Montreal, PQ, Canada; McGill Univ, Seagram Sports Sci Ctr, Cleghorn Hyperbar Oxygen Lab, Montreal, PQ, Canada; Univ Montreal, CHU Montreal, Fac Med Radiol Oncol & Med Nucl, Montreal, PQ, Canada; Univ Montreal, Ecole Readaptat, Montreal, PQ, Canada		Lassonde, M (corresponding author), Univ Montreal, Canada Res Chair Dev Neuropsychol, Dept Psychol, Ctr Rech Neuropsychol & Cognit, POB 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	maryse.lassonde@umontreal.ca					*AM EL SOC AM EL S, 1992, J CLIN NEUROPHYSIOL, V8, P200; ANDERSON DC, 1991, STROKE, V22, P1137, DOI 10.1161/01.STR.22.9.1137; Badr AE, 2001, AM J PHYSIOL-REG I, V280, pR766, DOI 10.1152/ajpregu.2001.280.3.R766; Barrett KF, 1998, NEUROLOGY, V50, pA178; BERG K, 1989, Physiotherapy Canada, V41, P304; CARTER LP, 1983, NEUROSURGERY, V12, P620; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Clifton G L, 1995, New Horiz, V3, P474; Collet JP, 2001, LANCET, V357, P582, DOI 10.1016/S0140-6736(00)04054-X; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Duncan P, 1998, STROKE, V29, P2055, DOI 10.1161/01.STR.29.10.2055; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; ENGARDT M, 1995, ARCH PHYS MED REHAB, V76, P419, DOI 10.1016/S0003-9993(95)80570-2; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Greenberg LM., 1996, TEST VARIABLES ATTEN; HAKIM AM, 1987, CAN J NEUROL SCI, V14, P557; HAMPSON NB, 1999, HYBERBARIC OXYGEN TH; Hardy P, 2002, DEV MED CHILD NEUROL, V44, P436; HOLBACH KH, 1978, J NEUROL, V219, P227, DOI 10.1007/BF00312976; Jain K K, 1996, TXB HYPERBARIC MED; Kondo A, 1996, NEUROPATH APPL NEURO, V22, P350, DOI 10.1111/j.1365-2990.1996.tb01114.x; Lanier WL, 1999, CAN J ANAESTH, V46, pR46, DOI 10.1007/BF03013181; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Leach RM, 1998, BRIT MED J, V317, P1140; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MARCOUX FW, 1982, STROKE, V13, P339, DOI 10.1161/01.STR.13.3.339; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; NEUBAUER RA, 1985, LANCET, V1, P810; NEUBAUER RA, 1980, STROKE, V11, P297, DOI 10.1161/01.STR.11.3.297; Neubauer RA, 1998, NEUROL RES, V20, pS33; NEUBAUER RA, 1990, LANCET, V335, P542, DOI 10.1016/0140-6736(90)90777-3; Nighoghossian N, 1997, J NEUROL SCI, V150, P27, DOI 10.1016/S0022-510X(97)05398-7; Polich J, 1997, EVOKED POTENTIAL, V104, P244, DOI 10.1016/S0168-5597(97)96139-6; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; ROTHI LJG, 1988, APHASIOLOGY, V2, P381, DOI 10.1080/02687038808248942; Santamaria J P, 1995, Adv Pediatr, V42, P335; Sarno JE, 1972, STROKE, V3, P10, DOI 10.1161/01.STR.3.1.10; SARNO MT, 1972, J SPEECH HEAR RES, V15, P42, DOI 10.1044/jshr.1501.42; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Sharp SA, 1997, ARCH PHYS MED REHAB, V78, P1231, DOI 10.1016/S0003-9993(97)90337-3; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Teixeira-Salmela LF, 1999, ARCH PHYS MED REHAB, V80, P1211, DOI 10.1016/S0003-9993(99)90018-7; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; WEINSTEIN PR, 1987, NEUROSURGERY, V20, P518, DOI 10.1227/00006123-198704000-00002; Weiss A, 2000, AM J PHYS MED REHAB, V79, P369, DOI 10.1097/00002060-200007000-00009; Whyte J, 2004, ARCH PHYS MED REHAB, V85, P1732, DOI 10.1016/j.apmr.2004.07.349; ZIVIN J, 1991, POUR SCI, V167, P20	48	28	42	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	FEB 15	2007	253	1-2					94	105		10.1016/j.jns.2006.12.005			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	141ZY	WOS:000244619200017	17234213				2022-02-06	
J	Clark, RSB; Nathaniel, PD; Zhang, XP; Dixon, CE; Alber, SM; Watkins, SC; Melick, JA; Kochanek, PM; Graham, SH				Clark, Robert S. B.; Nathaniel, Paula D.; Zhang, Xiaopeng; Dixon, C. Edward; Alber, Sean M.; Watkins, Simon C.; Melick, John A.; Kochanek, Patrick M.; Graham, Steven H.			boc-Aspartyl(OMe)-fluoromethylketone attenuates mitochondrial release of cytochrome c and delays brain tissue loss after traumatic brain injury in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						apoptosis; caspase; cysteine protease; head injury; nerve growth factor; programmed cell death	CONTROLLED CORTICAL IMPACT; NEURONAL APOPTOSIS; CELL-DEATH; COGNITIVE DEFICITS; CASPASE ACTIVATION; DNA FRAGMENTATION; SPATIAL PROFILE; IN-VITRO; INHIBITION; RECEPTOR	The pathobiology of traumatic brain injury (TBI) includes activation of multiple caspases followed by cell death with a spectrum of apoptotic phenotypes. There are initiator (e. g. caspase-2, -8, and -9) and effector (e. g. caspase-3 and -7) caspases. Recently, caspase-2 and -8 have been shown to regulate cell death via provoking cytochrome c release from the mitochondria upstream of caspase-9. Here, we show that an intracerebral injection of the pan-caspase inhibitor boc-Aspartyl(OMe)fluoromethylketone (BAF; 1 mu mol) 1 min after TBI in rats reduces caspase-3-like activity, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) and tissue damage, and cytochrome c release in ipsilateral cortex at 24 h versus vehicle. To investigate whether either caspase-2 and/or caspase-8 activation may contribute to cytochrome release, the effect of BAF treatment on caspase-2 and caspase-8 proteolysis was also examined. boc-aspartyl(OMe) fluoromethylketone treatment inhibited proteolysis of caspase-2 but not caspase-8 24 h after TBI in rats versus vehicle. However, BAF with or without nerve growth factor (12.5 ng/h x 14 days intracerebrally via osmotic pump) did not result in differences in motor function, Morris water maze performance, hippocampal neuron survival, nor contusion volume at 14 days. These data suggest that BAF treatment reduces acute cell death after TBI by inhibiting mitochondrial release of cytochrome c, possibly via a mechanism involving initiator caspases; however, BAF appears to delay cell death, rather than result in permanent protection.	Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA USA; Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; VA Pittsburgh Hlth Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA		Clark, RSB (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Watkins, Simon/ABG-2590-2021; Kochanek, Patrick M/D-2371-2015	Watkins, Simon/0000-0003-4092-1552; Kochanek, Patrick M/0000-0002-2627-913X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS30318, R01 NS38620] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038620, P50NS030318] Funding Source: NIH RePORTER		Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bizat N, 2005, NEUROPHARMACOLOGY, V49, P695, DOI 10.1016/j.neuropharm.2005.04.030; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 2000, J NEUROSCI, V20, P2825; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Enoksson M, 2004, J BIOL CHEM, V279, P49575, DOI 10.1074/jbc.C400374200; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Henshall DC, 2001, NEUROBIOL DIS, V8, P568, DOI 10.1006/nbdi.2001.0415; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lemaire C, 1998, FEBS LETT, V425, P266, DOI 10.1016/S0014-5793(98)00252-X; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P914, DOI 10.1097/00004647-200108000-00003; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Morita-Fujimura Y, 1999, NEUROSCI LETT, V267, P201, DOI 10.1016/S0304-3940(99)00327-4; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Omori N, 2002, BRAIN RES, V954, P317, DOI 10.1016/S0006-8993(02)03366-8; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Qiu JH, 2002, J NEUROSCI, V22, P3504; Robertson JD, 2004, EMBO REP, V5, P643, DOI 10.1038/sj.embor.7400153; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Snyder SH, 1998, NEURON, V21, P283, DOI 10.1016/S0896-6273(00)80538-3; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Werth JL, 2000, EXP NEUROL, V161, P203, DOI 10.1006/exnr.1999.7241; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	46	28	28	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2007	27	2					316	326		10.1038/sj.jcbfm.9600338			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	128UY	WOS:000243685700008	16736044	Bronze			2022-02-06	
J	Girard, P				Girard, Philip			Military and VA telemedicine systems for patients with traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						brain injury; care coordination; concussion assessment; distance learning; home healthcare; rehabilitation; tele-consultation; telehealth; telemedicine; telerehabilitation	TELEREHABILITATION; RECOVERY	Telemedicine plays a critical role within the Department of Veterans Affairs (VA) Veterans Health Administration by allowing the surveillance and care of patients who are isolated by geography, poverty, and disability. In military settings, telemedicine is being widely used to identify injury and illness and aid in the treatment, rehabilitation, and recovery of combat-wounded soldiers in theater. Rapid advances in both domains are transforming the way clinicians provide care, education, and support to patients with traumatic brain injury (TBI) and their families. This article discusses the military and VA telemedicine capabilities that are supporting the care of service members and veterans with TBI. These capabilities include new technologies that enhance the identification of TBI, management of symptoms in theater, and application of proven technologies (interactive video, Internet, and World Wide Web) to improve overall care coordination throughout military and VA systems. The impact of distance learning, tele-consultation, telerehabilitation, and home telehealth programs is also described within this context.	[Girard, Philip] Manchester Dept Vet Affairs Med Ctr, Off Telemed, Def & Vet Brain Injury Ctr, Manchester, NH 03103 USA; [Girard, Philip] Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA		Girard, P (corresponding author), Manchester Dept Vet Affairs Med Ctr, Off Telemed, Def & Vet Brain Injury Ctr, 718 Smyth Rd, Manchester, NH 03103 USA.	philip.girard@va.gov					ACKERMAN RK, 2005, SIGNAL AFCEA     MAR, P58; ACKERMAN RK, 2005, TELEMEDICINE REACHES, P55; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BERGQUIST T, 2006, 2 FED INT C TBI NAT; COLLINS M, 2006, 2 FED INT C TBI U PI; CORNISPOP M, 2006, CAPABILITIES, V14, P8; Darkins A, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.03.0029; Forducey PG, 2003, NEUROREHABILITATION, V18, P103; KENYON HS, 2005, SIGNAL           MAR, P73; LILIE C, 2005, MOVING IMAGES NOT PA, P63; Martin EM, 2006, REHABIL NURS, V31, P54, DOI 10.1002/j.2048-7940.2006.tb00125.x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; SAMSON K, 2006, NEUROLOGY TODAY 0103, P21; WHITE J, 1993, REHABILITATION PRINC; 2002, US MED           JUL; 2006, DAILY ILLINI    0915	18	28	29	0	11	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.		2007	44	7					1017	1026		10.1682/JRRD.2006.12.0174			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	253NL	WOS:000252524800014	18075958	Bronze			2022-02-06	
J	Kluger, Y; Riou, B; Rossaint, R; Rizoli, SB; Boffard, KD; Choong, PIT; Warren, B; Tillinger, M				Kluger, Yoram; Riou, Bruno; Rossaint, Rolf; Rizoli, Sandro B.; Boffard, Kenneth David; Choong, Philip Iau Tsau; Warren, Brian; Tillinger, Michael			Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: Post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial	CRITICAL CARE			English	Article							ACTIVATED FACTOR-VII; RECOMBINANT-FACTOR-VIIA; COAGULATION-FACTOR-VII; INTRACRANIAL HEMORRHAGE; HEAD-INJURY; COAGULOPATHY; MANAGEMENT; THERAPY; NOVOSEVEN; EFFICACY	Background Trauma is a leading cause of mortality and morbidity, with traumatic brain injury (TBI) and uncontrolled hemorrhage responsible for the majority of these deaths. Recombinant activated factor VIIa (rFVIIa) is being investigated as an adjunctive hemostatic treatment for bleeding refractory to conventional replacement therapy in trauma patients. TBI is a common component of polytrauma injuries. However, the combination of TBI with polytrauma injuries is associated with specific risk factors and treatment modalities somewhat different from those of polytrauma without TBI. Although rFVIIa treatment may offer added potential benefit for patients with combined TBI and polytrauma, its safety in this population has not yet been assessed. We conducted a post hoc sub analysis of patients with TBI and severe blunt polytrauma enrolled into a prospective, international, double-blind, randomized, placebo-controlled study. Methods A post hoc analysis of study data was performed for 143 patients with severe blunt trauma enrolled in a prospective, randomized, placebo-controlled study, evaluating the safety and efficacy of intravenous rFVIIa (200 + 100 + 100 mu g/kg) or placebo, to identify patients with a computed tomography (CT) diagnosis of TBI. The incidences of ventilator-free days, intensive care unit-free days, and thromboembolic, serious, and adverse events within the 30-day study period were assessed in this cohort. Results Thirty polytrauma patients (placebo, n = 13; rFVIIa, n = 17) were identified as having TBI on CT. No significant differences in rates of mortality (placebo, n = 6, 46%, 90% confidence interval (CI): 22% to 71%; rFVIIa, n = 5, 29%, 90% CI: 12% to 56%; P = 0.19), in median numbers of intensive care unit-free days (placebo = 0, rFVIIa = 3; P = 0.26) or ventilator-free days (placebo = 0, rFVIIa = 10; P = 0.19), or in rates of thromboembolic adverse events (placebo, 15%, 90% CI: 3% to 51%; rFVIIa, 0%, 90% CI: 0% to 53%; P = 0.18) or serious adverse events (placebo, 92%, 90% CI: 68% to 98%; rFVIIa, 82%, 90% CI: 60% to 92%; P = 0.61) were observed between treatment groups. Conclusion The use of a total dose of 400 (200 + 100 + 100) mu g/kg rFVIIa in this group of hemodynamically unstable polytrauma patients with TBI was not associated with an increased risk of mortality or with thromboembolic or adverse events.	Rambam Med Ctr, Dept Surg, IL-31096 Haifa, Israel; Univ Paris 06, Assistance Publ Hop Paris, Hop La Pitie Salpetriere, Dept Emergency Med, Paris, France; Univ Paris 06, Assistance Publ Hop Paris, Hop La Pitie Salpetriere, Dept Surg, Paris, France; Univ Paris 06, Assistance Publ Hop Paris, Hop La Pitie Salpetriere, Dept Anesthesiol & Crit Care, Paris, France; Univ Clin, Inst Anesthesiol, Aachen, Germany; Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; Johannesburg Hosp, Dept Surg, Johannesburg, South Africa; Natl Univ Singapore, Singapore 117548, Singapore; Univ Stellenbosch, Dept Surg, ZA-7505 Tygerberg, South Africa; Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark		Kluger, Y (corresponding author), Rambam Med Ctr, Dept Surg, POB 9602, IL-31096 Haifa, Israel.	y_kluger@rambam.health.gov.il	Iau, Philip/B-4641-2011	Choong, Peter/0000-0001-7333-7665; Boffard, Kenneth/0000-0002-7159-5414			Abshire T, 2004, J THROMB HAEMOST, V2, P899, DOI 10.1111/j.1538-7836.2004.00759.x; Ahonen J, 2005, BRIT J ANAESTH, V94, P592, DOI 10.1093/bja/aei094; Amer Soc Anesthesiologists Task Fo, 2006, ANESTHESIOLOGY, V105, P198; Arkin S, 1998, HAEMOSTASIS, V28, P93; Boffard KD, 2005, J TRAUMA, V59, P8, DOI 10.1097/01.TA.0000171453.37949.B7; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Dereeper E, 1998, RESUSCITATION, V36, P15, DOI 10.1016/S0300-9572(97)00080-4; Deveras RAE, 2002, ANN INTERN MED, V137, P884, DOI 10.7326/0003-4819-137-11-200212030-00009; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Gerlach R, 2002, J NEUROSURG, V96, P946, DOI 10.3171/jns.2002.96.5.0946; Grounds M, 2003, BLOOD REV, V17, pS11, DOI 10.1016/S0268-960X(03)90002-6; Harrison TD, 2005, J TRAUMA, V59, P150, DOI 10.1097/01.TA.0000171470.39742.8E; Hawryluk GWJ, 2006, J NEUROSURG, V105, P859, DOI 10.3171/jns.2006.105.6.859; Hedner U, 2006, J BIOTECHNOL, V124, P747, DOI 10.1016/j.jbiotec.2006.03.042; Heisel M, 2004, PEDIATR BLOOD CANCER, V43, P703, DOI 10.1002/pbc.20144; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Hoyt DB, 2004, SEMIN HEMATOL, V41, P40, DOI 10.1053/j.seminhematol.2003.11.009; HOYT DB, 1994, J TRAUMA, V37, P426, DOI 10.1097/00005373-199409000-00016; Karadimov D, 2003, J NEUROSURG ANESTH, V15, P330, DOI 10.1097/00008506-200310000-00008; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Koh MBC, 2003, BLOOD REV, V17, P179, DOI 10.1016/S0268-960X(02)00062-0; Levi M, 2005, CRIT CARE MED, V33, P883, DOI 10.1097/01.CCM.0000159087.85970.38; Levi M, 2004, SEMIN HEMATOL, V41, P65, DOI 10.1053/j.seminhematol.2003.11.013; Levi M, 2004, J THROMB HAEMOST, V2, P1695, DOI 10.1111/j.1538-7836.2004.00912.x; Levy JH, 2006, TRANSFUSION, V46, P919, DOI 10.1111/j.1537-2995.2006.00824.x; Lin J, 2003, J NEUROSURG, V98, P737, DOI 10.3171/jns.2003.98.4.0737; Lynn M, 2002, INTENS CARE MED, V28, pS241, DOI 10.1007/s00134-002-1471-7; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Martinowitz U, 2005, J THROMB HAEMOST, V3, P640, DOI 10.1111/j.1538-7836.2005.01203.x; Martinowitz U, 2001, J TRAUMA, V51, P431, DOI 10.1097/00005373-200109000-00002; Martinowitz Uri, 2004, Mil Med, V169, P16; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Midathada MV, 2004, AM J CLIN PATHOL, V121, P124, DOI 10.1309/D0G0C96V05CJ5B4J; Morenski JD, 2003, J NEUROSURG, V98, P611, DOI 10.3171/jns.2003.98.3.0611; O'Connell KA, 2006, JAMA-J AM MED ASSOC, V295, P293, DOI 10.1001/jama.295.3.293; Park P, 2003, NEUROSURGERY, V53, P34, DOI 10.1227/01.NEU.0000068830.54968.A8; Pathak A, 2005, Neurol India, V53, P178; Pickard JD, 2000, BLOOD COAGUL FIBRIN, V11, pS117, DOI 10.1097/00001721-200004001-00022; Rizoli SB, 2006, J TRAUMA, V61, P1419, DOI 10.1097/01.ta.0000243045.56579.74; Roberts HR, 2005, CAN J ANAESTH, V52, P8, DOI 10.1007/BF03018573; Roberts HR, 2004, SEMIN HEMATOL, V41, P101, DOI 10.1053/j.seminhematol.2003.11.019; Romano JG, 2002, NEUROSURGERY, V50, P1026, DOI 10.1097/00006123-200205000-00016; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Segal S, 2004, ACTA OBSTET GYN SCAN, V83, P771, DOI 10.1111/j.0001-6349.2004.00501.x; Siegel LJ, 2004, ANESTHESIOLOGY, V100, P441, DOI 10.1097/00000542-200402000-00037; Soreide E, 2005, INJURY, V36, P1001, DOI 10.1016/j.injury.2005.01.002; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Thomas GOR, 2007, J TRAUMA, V62, P564, DOI 10.1097/TA.0b013e318031afc2; Veshchev Igor, 2002, Med Sci Monit, V8, pCS98; Vincent JL, 2006, CRIT CARE, V10, DOI 10.1186/cc5026; Vincent JL, 2005, CRIT CARE MED, V33, P1392, DOI 10.1097/01.CCM.0000166890.93559.2D; Warren O, 2007, ANN THORAC SURG, V83, P707, DOI 10.1016/j.athoracsur.2006.10.033; Welsby IJ, 2005, ANAESTHESIA, V60, P1203, DOI 10.1111/j.1365-2044.2005.04376.x; Wong WY, 2000, HAEMOPHILIA, V6, P50; Zaaroor M, 2004, SEMIN HEMATOL, V41, P175, DOI 10.1053/j.seminhematol.2003.11.033	56	28	28	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2007	11	4							R85	10.1186/cc6092			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	224TJ	WOS:000250469000014	17686152	Green Published, gold			2022-02-06	
J	Vassallo, JL; Proctor-Weber, Z; Lebowitz, BK; Curtiss, G; Vanderploeg, RD				Vassallo, Jessica L.; Proctor-Weber, Zoe; Lebowitz, Brian K.; Curtiss, Glenn; Vanderploeg, Rodney D.			Psychiatric risk factors for traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; head injury; risk factors for TBI; psychiatric risk factors	DIAGNOSTIC INTERVIEW SCHEDULE; HEAD-INJURY; ALCOHOL-INTOXICATION; DRUG-USE; MILD; DISABILITY; ILLNESS	Objective: To examine the risk of sustaining a traumatic brain injury (TBI) associated with prior psychiatric conditions beyond that of fixed demographic variables. Design: Retrospective cohort study of non-referred community-dwelling male US veterans. Methods: Two-hundred and seventy-one individuals who sustained a TBI with altered consciousness were compared with 630 controls without a history of head injury, selected from a larger sample of 3766. Results: Hierarchical logistic regression analyses were used to model odds ratios and 95% confidence intervals for the unique association between pre- existing psychiatric disorders and the likelihood of incurring a TBI while adjusting for demographic characteristics and other known predictor variables. Mood (odds ratio 2.48, 95% confidence interval 1.23-5.01), anxiety (OR 1.64, 95% CI 1.01-2.68) and conduct disorders (OR 1.66, 95% CI 1.16 - 2.38) increased the risk of head injury. Conclusions: The pre-existence of psychiatric illness, particularly depression, anxiety and conduct disorder, increased the future risk of incurring a TBI. The implementation of early identification and treatment of psychiatric conditions may potentially lower risk and reduce yearly incidence rates of TBI.	James A Haley Vet Adm Med Ctr, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; Univ S Florida, Dept Psychiat & Behav Med, Tampa, FL USA; Def & Vet Brain Injury Ctr, Tampa, FL USA; Univ S Florida, Dept Psychol, Tampa, FL 33620 USA		Vanderploeg, RD (corresponding author), James A Haley Vet Adm Med Ctr, Dept Mental Hlth & Behav Sci, 13000 N Bruce B Downs Blvd,116B, Tampa, FL 33612 USA.	rodney.vanderploeg@va.gov	Curtiss, Glenn/ABB-5566-2020	Lebowitz, Barry/0000-0002-6467-646X; Lebowitz, Brian/0000-0001-8845-8136			*AM PSYCH ASS, 1980, DIAGN STAT MAN MENT, P1; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P93; [Anonymous], 1988, JAMA, V259, P2701; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; *CDC, 1989, PSYCHOL NEUROPSYCHOL, V4; DESTEFANO F, 1988, JAMA-J AM MED ASSOC, V259, P2708; Dunn L, 2003, J NEUROL NEUROSUR PS, V74, P1060, DOI 10.1136/jnnp.74.8.1060; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; GALE JL, 1983, NEUROSURGERY, V12, P487, DOI 10.1227/00006123-198305000-00001; Gilson SF, 1996, AM J PUBLIC HEALTH, V86, P1613, DOI 10.2105/AJPH.86.11.1613; Hannay HJ, 2004, NEUROPSYCHOLOGICAL A, P718; HONKANEN R, 1991, INJURY, V22, P225, DOI 10.1016/0020-1383(91)90047-I; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; MONTAGUE E K, 1957, U S Armed Forces Med J, V8, P883; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; REYNOLDS HT, 1977, ANAL NOMINAL DATA, P1; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; SHAFFER D, 1993, J AM ACAD CHILD PSY, V32, P643, DOI 10.1097/00004583-199305000-00023; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sosin DM, 1996, BRAIN INJURY, V10, P47; *TBI, INC DISTR; Teasdale TW, 1997, BRIT MED J, V315, P569; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; *VET HLTH IN, TRAUM BRAIN INJ CONT; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Weight DG, 1998, PSYCHIAT CLIN N AM, V21, P609, DOI 10.1016/S0193-953X(05)70026-5	33	28	28	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	6					567	573		10.1080/02699050701426832			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	192LU	WOS:000248204100003	17577707				2022-02-06	
J	Yasokawa, YT; Shinoda, J; Okumura, A; Nakayama, N; Miwa, K; Iwama, T				Yasokawa, Yu-To; Shinoda, Jun; Okumura, Ayumi; Nakayama, Noriyuki; Miwa, Kazuhiro; Iwama, Toru			Correlation between diffusion-tensor magnetic resonance imaging and motor-evoked potential in chronic severe diffuse axonal injury	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; diffusion-tensor imaging; motor dysfunction; motor evoked potential; tractography	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INJURY; HEAD-INJURY; CORPUS-CALLOSUM; MR; TRACTOGRAPHY; EXPERIENCE; RECOVERY; LESIONS; DAMAGE	We conducted a study to evaluate the degree of corticospinal tract (CST) dysfunction associated with diffuse axonal injury (DAI) through analyses of both diffusion-tensor magnetic resonance imaging (DTMRI) and motor-evoked potential (MEP). Using DTMRI and MEP with transcranial magnetic stimulation, we evaluated 138 instances of CST in 52 patients with severe chronic DAI and compared them with the findings in 17 normal volunteers. We determined values of fractional anisotropy (FA) on FA maps obtained with DTMRI of six regions of interest (ROIs) in the CST, consisting of the semioval center, coronal radiation, posterior limb of internal capsule, midbrain, pons and medulla oblongata. The lowest value of %FA for each of the six ROIs in each CST was defined as the minimum %FA, and the lowest magnetic stimulation strength that produced MEP was defined as the minimum threshold for MEP. The mean minimum %FA for CSTs in which MEP could not be obtained even with maximum magnetic stimulation (the MEP-group) was significantly lower than that of CSTs in which MEP could be obtained (the MEP+ group). ROIs with the lowest %FA value were the midbrain in the MEP+ group and the medulla oblongata in the MEP-group. In the MEP+ group, a serial decrease in the minimum %FA value significantly correlated with a serial increase in minimum threshold for MEP. These results show that in patients with chronic DAI, physiological motor dysfunction as revealed by MEP correlates significantly with morphological damage to the CST as detected by DTMRI. This strongly suggests that DTMRI can be a valuable tool for evaluating aberrant motor function and for estimating its severity in DAI.	Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Gifu 5050034, Japan; Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan		Yasokawa, YT (corresponding author), Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, 630 Shimokobi,Kobi Cho, Minokamo, Gifu 5050034, Japan.	yasokawa0512@yahoo.co.jp		Iwama, Toru/0000-0002-9426-284X			ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Conforto AB, 2004, CLIN NEUROPHYSIOL, V115, P812, DOI 10.1016/j.clinph.2003.11.010; DILAZZARO V, 2005, J PHYSL, V15, P315; Ellis CM, 1999, NEUROLOGY, V53, P1051, DOI 10.1212/WNL.53.5.1051; Hendler T, 2003, J NEUROSURG, V99, P1018, DOI 10.3171/jns.2003.99.6.1018; Huisman TAGM, 2003, EUR RADIOL, V13, P2283, DOI 10.1007/s00330-003-1843-6; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Kamada K, 2005, J NEUROSURG, V102, P664, DOI 10.3171/jns.2005.102.4.0664; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Khedr EM, 2004, CLIN NEUROPHYSIOL, V115, P1259, DOI 10.1016/j.clinph.2003.08.025; Konishi J, 2005, NEUROLOGY, V64, P108, DOI 10.1212/01.WNL.0000148477.65273.0C; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Mori S, 2000, ANN NEUROL, V47, P412, DOI 10.1002/1531-8249(200003)47:3<412::AID-ANA28>3.3.CO;2-8; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Neuloh G, 2004, ADV TECH STAND NEUR, V29, P171; Okumura Ayumi, 2005, No To Shinkei, V57, P115; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Sekimoto K, 2006, J NEUROSURG ANESTH, V18, P106, DOI 10.1097/00008506-200604000-00003; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Werring DJ, 1998, J NEUROL NEUROSUR PS, V65, P863, DOI 10.1136/jnnp.65.6.863; Zeman AZJ, 1997, J NEUROL NEUROSUR PS, V62, P549, DOI 10.1136/jnnp.62.6.549	34	28	34	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2007	24	1					163	173		10.1089/neu.2006.0073			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	131GX	WOS:000243858100016	17263680				2022-02-06	
J	Michelucci, R				Michelucci, Roberto			Optimizing therapy of seizures in neurosurgery	NEUROLOGY			English	Article							QUALITY STANDARDS SUBCOMMITTEE; BRAIN-TUMORS; PRACTICE PARAMETER; TREATING SEIZURES; AMERICAN-ACADEMY; KINDLING MODEL; HEAD-INJURY; PHENYTOIN; ANTICONVULSANT; PROPHYLAXIS	The use of antiepileptic drugs (AEDs) in the neurosurgical setting has a number of implications, including their possible role in the prevention of seizures after acute cerebral insults or brain tumors and the potential for toxicity and interactions when these agents are administered in association with radiotherapy or chemotherapy. This review discusses these controversial issues and draws the following conclusions. 1) AEDs should be prescribed on a short-term basis to prevent seizures occurring within the first week after a cerebral insult (trauma, neurosurgical procedure) but are ineffective to avoid true post-traumatic epilepsy or first seizures in patients with primary or secondary cerebral neoplasms. 2) The use of phenytoin and, to a lesser extent, phenobarbital and carbamazepine during cranial irradiation is associated with an increased risk for severe, potentially fatal, mucocutaneous reactions. In this context, new AEDs with a very low potential for allergic cutaneous reactions should be preferred. 3) Enzyme-inducing AEDs, such as phenytoin, phenobarbital, and carbamazepine, may increase the clearance and reduce the clinical efficacy of corticosteroids and anticancer agents that are also metabolized by the cytochrome P450 system. The newly developed AEDs that are devoid of hepatic metabolism, such as levetiracetam and gabapentin, are now recommended because of good results in preliminary studies and because they do not show interactions with anticancer agents.	Bellaria Hosp, Neurol Unit, Dept Neurosci, I-40139 Bologna, Italy		Michelucci, R (corresponding author), Bellaria Hosp, Neurol Unit, Dept Neurosci, Via Altura 3, I-40139 Bologna, Italy.	roberto.michelucci@ausl.bo.it	Michelucci, Roberto/AAB-9074-2020	Michelucci, Roberto/0000-0002-9655-7940			Ahmed I, 2004, INT J DERMATOL, V43, P67, DOI 10.1111/j.1365-4632.2004.01934.x; Amano K, 1998, EPILEPSY RES, V31, P123, DOI 10.1016/S0920-1211(98)00021-7; Bourg V, 2001, ANN ONCOL, V12, P217, DOI 10.1023/A:1008331708395; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chang SM, 1998, J CLIN ONCOL, V16, P2188, DOI 10.1200/JCO.1998.16.6.2188; Fetell MR, 1997, J CLIN ONCOL, V15, P3121, DOI 10.1200/JCO.1997.15.9.3121; Gilbar PJ, 2001, ANN PHARMACOTHER, V35, P1367; Glantz MJ, 1996, NEUROLOGY, V46, P985, DOI 10.1212/WNL.46.4.985; Glantz MJ, 2000, NEUROLOGY, V54, P1886, DOI 10.1212/WNL.54.10.1886; GROSSMAN SA, 1989, AM J MED, V87, P505; JENNETT B, 1975, EPILEPSY NONMISSILE; Khan RB, 2004, J CHILD NEUROL, V19, P97, DOI 10.1177/08830738040190020301; LACKNER TE, 1991, PHARMACOTHERAPY, V11, P344; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; Micali G, 1999, PHARMACOTHERAPY, V19, P223, DOI 10.1592/phco.19.3.223.30917; NEEF C, 1988, CLIN PHARMACOL THER, V43, P372, DOI 10.1038/clpt.1988.45; Oberndorfer S, 2005, J NEURO-ONCOL, V72, P255, DOI 10.1007/s11060-004-2338-2; Packer RJ, 2003, J CLIN ONCOL, V21, P3255, DOI 10.1200/JCO.2003.01.202; Penovich PE, 2004, EPILEPSIA, V45, P311; Perry JR, 1996, CAN J NEUROL SCI, V23, P128, DOI 10.1017/S0317167100038853; PITKANEN A, 2002, ANTIEPILETIC DRUGS, P169; RABINOWICZ AL, 1995, EPILEPSIA, V36, P513, DOI 10.1111/j.1528-1157.1995.tb00494.x; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; Relling MV, 2000, LANCET, V356, P285, DOI 10.1016/S0140-6736(00)02503-4; RZANY B, 1999, LANCET, V354, P1033; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SERVIT Z, 1981, EPILEPSIA, V22, P315, DOI 10.1111/j.1528-1157.1981.tb04115.x; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; Striano S, 2002, EPILEPSY RES, V49, P81, DOI 10.1016/S0920-1211(02)00005-0; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; van Breemen Melanie S M, 2005, Curr Neurol Neurosci Rep, V5, P207; Vecht CJ, 2003, SEMIN ONCOL, V30, P49, DOI 10.1053/j.seminoncol.2003.11.030; Vecht CJ, 2003, LANCET NEUROL, V2, P404, DOI 10.1016/S1474-4422(03)00435-6; VITTORIO CC, 1995, ARCH INTERN MED, V155, P2285, DOI 10.1001/archinte.155.21.2285; Wagner GL, 2003, SEIZURE-EUR J EPILEP, V12, P585, DOI 10.1016/S1059-1311(03)00096-7; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236	40	28	29	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	DEC 26	2006	67	12		4			S14	S18		10.1212/WNL.67.12_suppl_4.S14			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	122AK	WOS:000243197900004	17190915				2022-02-06	
J	Phillips, DJ; Nguyen, P; Adamides, AA; Bye, N; Rosenfeld, JV; Kossmann, T; Vallance, S; Murray, L; Morganti-Kossmann, MC				Phillips, David J.; Nguyen, Phuong; Adamides, Alexios A.; Bye, Nicole; Rosenfeld, Jeffrey V.; Kossmann, Thomas; Vallance, Shirley; Murray, Lynnette; Morganti-Kossmann, Maria C.			Activin A release into cerebrospinal fluid in a subset of patients with severe traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						activin A; inflammation; neuroprotection; traumatic brain injury	INTERSTITIAL GLYCEROL; BARRIER FUNCTION; HEAD-INJURY; SERUM; INTERLEUKIN-6; FOLLISTATIN; EXPRESSION; MODEL; CSF; PATHOPHYSIOLOGY	Activin A is a member of the transforming growth factor-beta superfamily and has been demonstrated to be elevated during inflammation and to have neuroprotective properties following neural insults. In this study, we examined whether traumatic brain injury (TBI) induced a response in activin A or in the concentrations of its binding protein, follistatin. Thirty-nine patients with severe TBI had daily, matched cerebrospinal fluid (CSF) and serum samples collected post-TBI and these were assayed for activin A and follistatin using specific immunoassays. Concentrations of both molecules were assessed relative to a variety of clinical parameters, such as the Glasgow Coma Score, computer tomography classification of TBI, measurement of injury markers, cell metabolism and membrane breakdown products. In about half of the patients, there was a notable increase in CSF activin A concentrations in the first few days post-TBI. There were only minor perturbations in either serum activin or in either CSF or serum follistatin concentrations. The CSF activin A response was not related to any of the common TBI indices, but was strongly correlated with two common markers of brain damage, neuronal specific enolase and S100-beta. Further, activin A levels were also associated with indices of metabolism, such as lactate and pyruvate, excitotoxicity (glutamate) and membrane lipid breakdown products such as glycerol. In one of the two patients who developed a CSF infection, activin A concentrations in CSF became markedly elevated. Thus, some TBI patients have an early release of activin A into the CSF that may result from activation of inflammatory and/or neuroprotective pathways.	Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic 3168, Australia; Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; Alfred Hosp, Dept Trauma Surg, Melbourne, Vic, Australia; Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia		Phillips, DJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, 27-31 Wright St, Clayton, Vic 3168, Australia.	david.phillips@med.monash.edu.au	Phillips, David/A-5007-2009; Rosenfeld, Jeffrey V/B-7249-2011	Morganti-Kossmann, Cristina/0000-0002-0807-2063			Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Florio P, 2004, CLIN CHEM, V50, P2386, DOI 10.1373/clinchem.2004.035774; Foster JA, 2004, J COMP NEUROL, V476, P91, DOI 10.1002/cne.20197; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Green AJE, 1997, J IMMUNOL METHODS, V205, P35, DOI 10.1016/S0022-1759(97)00050-1; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hughes PE, 1999, NEUROSCIENCE, V92, P197, DOI 10.1016/S0306-4522(98)00724-6; Jones KL, 2000, ENDOCRINOLOGY, V141, P1905, DOI 10.1210/en.141.5.1905; Jones KL, 2004, J ENDOCRINOL, V182, P69, DOI 10.1677/joe.0.1820069; Knight PG, 1996, J ENDOCRINOL, V148, P267, DOI 10.1677/joe.0.1480267; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kothari RU, 1998, STROKE, V29, P313; Lai M, 1997, NEUROREPORT, V8, P2691, DOI 10.1097/00001756-199708180-00011; Lai M, 1996, NEUROSCIENCE, V70, P1013, DOI 10.1016/0306-4522(95)00413-0; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Maier B, 2005, J NEUROTRAUM, V22, P822, DOI 10.1089/neu.2005.22.822; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Michel U, 2003, J NEUROCHEM, V86, P238, DOI 10.1046/j.1471-4159.2003.01834.x; Michel U, 2003, EUR J ENDOCRINOL, V148, P559, DOI 10.1530/eje.0.1480559; Michel W, 2000, EUR J ENDOCRINOL, V143, P809, DOI 10.1530/eje.0.1430809; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; O'Connor AE, 1999, HUM REPROD, V14, P827, DOI 10.1093/humrep/14.3.827; PARAMORE CG, 1994, ACTA NEUROCHIR, V127, P79, DOI 10.1007/BF01808552; Phillips DJ, 2003, CYTOKINE HDB, V4, P1153; Pleines UE, 1998, J NEUROTRAUM, V15, P399, DOI 10.1089/neu.1998.15.399; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; SCHUBERT D, 1990, NATURE, V344, P868, DOI 10.1038/344868a0; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Sulyok S, 2004, MOL CELL ENDOCRINOL, V225, P127, DOI 10.1016/j.mce.2004.07.011; Tong S, 2004, BJOG-INT J OBSTET GY, V111, P326, DOI 10.1111/j.1471-0528.2004.00098.x; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Tretter YP, 1996, NEUROREPORT, V7, P1819, DOI 10.1097/00001756-199607290-00026; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039	45	28	29	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2006	23	9					1283	1294		10.1089/neu.2006.23.1283			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	085LP	WOS:000240605900001	16958581				2022-02-06	
J	Yildizdas, D; Altunbasak, S; Celik, U; Herguner, O				Yildizdas, D.; Altunbasak, S.; Celik, U.; Herguner, O.			Hypertonic saline treatment in children with cerebral edema	INDIAN PEDIATRICS			English	Article						cerebral edema; hypertonic saline; mannitol	ELEVATED INTRACRANIAL-PRESSURE; MAGNETIC-RESONANCE SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; CHRONIC HYPONATREMIA; HEMORRHAGIC-SHOCK; SODIUM-TRANSPORT; HYPERTENSION; MANNITOL; RESUSCITATION; HYPERNATREMIA		Cukurova Univ, Fac Med, Pediat Intens Care Unit, TR-01330 Adana, Turkey; Cukurova Univ, Fac Med, Dept Pediat Neurol, Adana, Turkey; Cukurova Univ, Fac Med, Dept Pediat Infect Dis, Adana, Turkey		Yildizdas, D (corresponding author), Cukurova Univ, Fac Med, Pediat Intens Care Unit, TR-01330 Adana, Turkey.	rdy90@hotmail.com	Altunbasak, Sakir/K-6271-2018	Altunbasak, Sakir/0000-0002-0779-3272; yildizdas, dincer/0000-0003-0739-5108			BETZ AL, 1983, J NEUROCHEM, V41, P1158, DOI 10.1111/j.1471-4159.1983.tb09066.x; BETZ AL, 1983, J NEUROCHEM, V41, P1150, DOI 10.1111/j.1471-4159.1983.tb09065.x; Bhardwaj Anish, 2004, Curr Opin Crit Care, V10, P126, DOI 10.1097/00075198-200404000-00009; DUCEY JP, 1989, J TRAUMA, V29, P1518; FENSTERMACHER JD, 1966, AM J PHYSIOL, V211, P311; HAUSSINGER D, 1994, GASTROENTEROLOGY, V107, P1475; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; LIEN YHH, 1991, J CLIN INVEST, V88, P303, DOI 10.1172/JCI115292; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; OLSON JE, 1990, J NEUROSCI RES, V27, P241, DOI 10.1002/jnr.490270215; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Pollay M, 1996, NEUROSURGERY, P335; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; Qureshi AI, 1999, NEUROSURGERY, V44, P1055, DOI 10.1097/00006123-199905000-00064; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; Soupart A, 1996, J NEUROPATH EXP NEUR, V55, P106, DOI 10.1097/00005072-199601000-00011; STACK C, 2004, ESSENTIALS PEDIAT IN, P155; Suarez JI, 1998, CRIT CARE MED, V26, P1118, DOI 10.1097/00003246-199806000-00038; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; VIDEEN JS, 1995, J CLIN INVEST, V95, P788, DOI 10.1172/JCI117728; Weed LH, 1919, AM J PHYSIOL, V48, P531, DOI 10.1152/ajplegacy.1919.48.4.531; WEINSTABL C, 1992, ANESTHESIOLOGY, V75, P201; WISE B L, 1961, Surg Forum, V12, P398; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	29	28	33	0	4	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0019-6061	0974-7559		INDIAN PEDIATR	Indian Pediatrics	SEP	2006	43	9					771	779					9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	087QZ	WOS:000240758500002	17033115				2022-02-06	
J	Davis, DP; Fisher, R; Buono, C; Brainard, C; Smith, S; Ochs, G; Poste, JC; Dunford, JV				Davis, Daniel P.; Fisher, Roger; Buono, Colleen; Brainard, Criss; Smith, Susan; Ochs, Ginger; Poste, Jennifer C.; Dunford, James V.			Predictors of intubation success and therapeutic value of paramedic airway management in a large, urban EMS system	PREHOSPITAL EMERGENCY CARE			English	Article; Proceedings Paper	Field Triage 2005 - A Meeting of Experts	MAY 17-18, 2005	Atlanta, GA	Natl Ctr Injury Preven & Control, Ctrs Disease Control & Preven, Div Injury Response		endotracheal intubation; emergency medical services; end-tidal carbon dioxide	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; MEDICAL-SERVICES SYSTEM; PULSE OXIMETER ACCURACY; TIDAL CARBON-DIOXIDE; SEVERE HEAD-INJURY; BAG-VALVE-MASK; ENDOTRACHEAL INTUBATION; CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION	Background. Endotracheal intubation (ETI) is commonly used by paramedics for definitive airway management. The predictors of success and therapeutic value with regard to oxygenation are not well studied. Objectives. 1) To explore the relationship between intubation success and perfusion status, Glasgow Coma Scale (GCS) score, and end-tidal carbon dioxide (EtCO2); 2) to describe the incidence of unrecognized esophageal intubations with use of continuous capnometry; and 3) to document the incremental benefit of invasive versus noninvasive airway management techniques in correcting hypoxemia. Methods. This was a prospective, observational study conducted in a large urban emergency medical services system. Paramedics completed a telephone debriefing interview with quality assurance personnel following delivery of all patients in whom invasive airway management had been attempted. Continuous capnometry was used for confirmation of tube position in all patients. Descriptive statistics were used to document airway management performance, including first-attempt ETI success, overall ETI success, and Combitube insertion (CTI) success. In addition, the incidence of unrecognized esophageal intubation was recorded. The relationship between intubation success and perfusion status, GCS score, and initial EtCO2 value was explored using logistic regression. Finally, recorded SpO(2) values and the incidence of hypoxemia (SpO(2) < 90%) at baseline, following noninvasive airway maneuvers, and after invasive airway management were compared for perfusing patients. Results. A total of 703 patients were enrolled over 12 months. First-attempt ETI success was 61%, and overall ETI success was 81%; invasive airway management ( ETI or CTI) was unsuccessful in 11% of patients. A single unrecognized esophageal intubation was observed (0.1%). A clear relationship between airway management success and perfusion status, GCS score, and initial EtCO2 value was observed. Only EtCO2 demonstrated an independent association with ETI success after adjusting for the other variables. Significant improvements in mean SpO(2) and the incidence of hypoxemia over baseline were observed with both noninvasive and invasive airway management techniques in 168 perfusing patients. Conclusions. A relationship between intubation success and perfusion status, GCS score, and initial EtCO2 value was observed. Capnometry was effective in eliminating unrecognized esophageal intubations. Both noninvasive and invasive airway management strategies were effective in increasing SpO(2) values and decreasing the incidence of hypoxemia, with additional benefit observed with invasive airway maneuvers in some patients.	Univ Calif San Diego, Dept Emergency Med, San Diego, CA 92103 USA; San Diego Med Serv Enterprise, San Diego, CA USA		Davis, DP (corresponding author), UCSD Emergency Med, 200 W Arbor Dr,8676, San Diego, CA 92103 USA.	davismd@cox.net					APRAHAMIAN C, 1985, ANN EMERG MED, V14, P583, DOI 10.1016/S0196-0644(85)80785-X; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; ATHERTON GL, 1993, ANN EMERG MED, V22, P1263, DOI 10.1016/S0196-0644(05)80104-0; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; BARKER SJ, 1993, ANESTHESIOLOGY, V79, P248, DOI 10.1097/00000542-199308000-00009; Barton CW, 2005, ACAD EMERG MED, V12, P1, DOI 10.1197/j.aem.2004.08.043; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; CHAWLA R, 1992, ANESTH ANALG, V74, P196, DOI 10.1213/00000539-199202000-00004; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DAVIS DP, 2004, J TRAUMA; DAVIS DP, 2005, J TRAUMA; Doerges V, 1999, RESUSCITATION, V41, P63, DOI 10.1016/S0300-9572(99)00036-2; Dorges V, 2003, CRIT CARE MED, V31, P800, DOI 10.1097/01.CCM.0000054869.21603.9A; Dorges V, 2000, RESUSCITATION, V44, P37, DOI 10.1016/S0300-9572(99)00161-6; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Falcone R E, 1996, Air Med J, V15, P163, DOI 10.1016/S1067-991X(96)90024-3; Garza AG, 2003, J EMERG MED, V25, P251, DOI 10.1016/S0736-4679(03)00198-7; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Harrison TH, 2004, PEDIATR EMERG CARE, V20, P101, DOI 10.1097/01.pec.0000113879.10140.7f; Hatley T, 1998, J Emerg Med, V16, P731, DOI 10.1016/S0736-4679(98)00087-0; HEDGES JR, 1988, ANN EMERG MED, V17, P469, DOI 10.1016/S0196-0644(88)80238-5; JAY GD, 1994, ANN EMERG MED, P24; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; LANGBAUM M, 1994, J PEDIATR-US, V125, P591, DOI 10.1016/S0022-3476(94)70016-8; LAWSON D, 1987, ANESTHESIOLOGY, V67, P599, DOI 10.1097/00000542-198710000-00032; Levine RL, 1997, NEW ENGL J MED, V337, P301, DOI 10.1056/NEJM199707313370503; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MATEER JR, 1993, ANN EMERG MED, V22, P675, DOI 10.1016/S0196-0644(05)81846-3; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Ochs M, 2002, ANN EMERG MED, V40, P159, DOI 10.1067/mem.2002.126397; Ochs M, 2000, Prehosp Emerg Care, V4, P333, DOI 10.1080/10903120090941065; Pace SA, 2000, ANN EMERG MED, V35, P568, DOI 10.1016/S0196-0644(00)70029-1; Pepe PE, 2003, J TRAUMA, V54, P1048, DOI 10.1097/01.TA.0000064280.05372.7C; Sagarin MJ, 2002, PEDIATR EMERG CARE, V18, P417, DOI 10.1097/00006565-200212000-00004; Sehra R, 2003, PACE, V26, P515, DOI 10.1046/j.1460-9592.2003.00085.x; SEVERINGHAUS JW, 1990, J CLIN MONITOR, V6, P85, DOI 10.1007/BF02828282; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Sing RF, 1998, AM J EMERG MED, V16, P598, DOI 10.1016/S0735-6757(98)90227-3; Sivilotti MLA, 2003, ACAD EMERG MED, V10, P612, DOI 10.1197/aemj.10.6.612; SMITH JP, 1985, JAMA-J AM MED ASSOC, V253, P544, DOI 10.1001/jama.253.4.544; SYVERUD SA, 1988, ANN EMERG MED, V17, P236, DOI 10.1016/S0196-0644(88)80114-8; VADEBONCOEUR TF, 2004, J EMERG MED; Vilke Gary M., 1994, Journal of Emergency Medicine, V12, P217, DOI 10.1016/0736-4679(94)90702-1; Vilke GM, 2002, J EMERG MED, V22, P71, DOI 10.1016/S0736-4679(01)00439-5; Wang H E, 2001, Prehosp Emerg Care, V5, P10, DOI 10.1080/10903120190940254; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wayne M A, 1999, Prehosp Emerg Care, V3, P107, DOI 10.1080/10903129908958916; Wenzel V, 2001, RESUSCITATION, V49, P123, DOI 10.1016/S0300-9572(00)00349-X; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; 2005, RESUSCITATION, V46, P1	54	28	28	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1090-3127			PREHOSP EMERG CARE	Prehosp. Emerg. Care	JUL-SEP	2006	10	3					356	362		10.1080/10903120600725751			7	Emergency Medicine; Public, Environmental & Occupational Health	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Public, Environmental & Occupational Health	110RQ	WOS:000242396800019	16801280				2022-02-06	
J	Flaherty, EG				Flaherty, Emalee G.			Analysis of caretaker histories in abuse: Comparing initial histories with subsequent confessions	CHILD ABUSE & NEGLECT			English	Article						physical child abuse; abusive head trauma; perpetrator confessions	TRAUMATIC BRAIN-INJURY; CHILD MALTREATMENT; RISK-FACTORS; UNITED-STATES; HEAD-INJURY; PARENTS; PERPETRATOR; ALCOHOL; INFANTS	Objective: We hypothesize that perpetrators of abuse include elements of truth in their initial history and that an analysis of perpetrator confessions can teach professionals how to identify these initial truths. Methods: The information from a consecutive sample of perpetrators' confessions concerning 41 children hospitalized because of injuries caused by child abuse was reviewed. The details about the injuries contained in the confessions were compared with the details provided when these children initially presented for medical care. Information about the perpetrator's gender and relationship to the child, the victim's age and gender, type of injury, family risk factors, the trigger of the abusive event, the circumstances surrounding the event, and the type of trauma were collected. Results: A total of 45 perpetrators abused 41 children; 76% of perpetrators were male; 56% were the child's father; 34% were the child's mother. The perpetrators initially provided no explanation about how 68% of the children received an injury. In 91% of their initial histories, the perpetrators provided some element of truth about the circumstances or triggering event for the abuse. In 67% of confessions, crying was the circumstance that triggered the abuse. Mothers were more likely to describe the situation that triggered the abuse (85% of mothers versus 58% of fathers, p = ns), while fathers were more likely to describe accurately the circumstances surrounding the abuse (79% of fathers versus 62% of mothers, p = ns). Conclusions: Perpetrators of abuse provide initial truths in their presenting history. Child abuse professionals must take a careful history from all caretakers and "listen" for the "elements of truth." These truths are the child's behavior or circumstance that increased stress and triggered the abuse. Employing this method in a careful analysis of confessions can make a significant contribution to the capacity to identify child abuse. In addition, more information about the role of triggers may help to focus child abuse prevention strategies. (c) 2006 Elsevier Ltd. All rights reserved.	Northwestern Univ, Feinberg Sch Med, Childrens Mem Hosp, Chicago, IL 60614 USA		Flaherty, EG (corresponding author), Northwestern Univ, Feinberg Sch Med, Childrens Mem Hosp, 2300 Childrens Pl,Box 16, Chicago, IL 60614 USA.						BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Brewster AL, 1998, CHILD ABUSE NEGLECT, V22, P91, DOI 10.1016/S0145-2134(97)00132-4; Brown J, 1998, CHILD ABUSE NEGLECT, V22, P1065, DOI 10.1016/S0145-2134(98)00087-8; Cadzow SP, 1999, CHILD ABUSE NEGLECT, V23, P845, DOI 10.1016/S0145-2134(99)00063-0; DAVIS HW, 1995, COMT PEDIAT, V12, P94; FELDMAN KW, 2001, PEDIATRICS; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KELLEHER K, 1994, AM J PUBLIC HEALTH, V84, P1586, DOI 10.2105/AJPH.84.10.1586; Knapp J F, 1998, Pediatr Rev, V19, P316, DOI 10.1542/pir.19-9-316; Kotch JB, 1999, CHILD ABUSE NEGLECT, V23, P305, DOI 10.1016/S0145-2134(99)00003-4; Krugman R D, 1983, Pediatrician, V12, P68; Overpeck MD, 1998, NEW ENGL J MED, V339, P1211, DOI 10.1056/NEJM199810223391706; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Rivara FP, 1997, JAMA-J AM MED ASSOC, V278, P569, DOI 10.1001/jama.278.7.569; SCHMITT BD, 1987, CHILD ABUSE NEGLECT, V11, P421, DOI 10.1016/0145-2134(87)90015-9; Sidebotham P, 2001, CHILD ABUSE NEGLECT, V25, P1177, DOI 10.1016/S0145-2134(01)00261-7; *SPSS INC, SPSS WIND COMP VERS; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; STARLING SP, 1995, PEDIATRICS, V95, P259; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; U.S. Department of Health and Services, 2002, CHILD MALTR 2000; *US DEP HHS, 1996, CHILD NEGL CAS LEV D	23	28	28	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134			CHILD ABUSE NEGLECT	Child Abuse Negl.	JUL	2006	30	7					789	798		10.1016/j.chiabu.2005.12.008			10	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	070SO	WOS:000239544400005	16844217				2022-02-06	
J	Shiga, T; Ikoma, K; Katoh, C; Isoyama, H; Matsuyama, T; Kuge, Y; Kageyama, H; Kohno, T; Terae, S; Tamaki, N				Shiga, T; Ikoma, K; Katoh, C; Isoyama, H; Matsuyama, T; Kuge, Y; Kageyama, H; Kohno, T; Terae, S; Tamaki, N			Loss of neuronal integrity: a cause of hypometabolism in patients with traumatic brain injury without MRI abnormality in the chronic stage	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						brain imaging; PET; MRI; flumazenil; traumatic brain injury	POSITRON-EMISSION-TOMOGRAPHY; I-123 IOMAZENIL SPECT; CEREBRAL-ISCHEMIA; CORTICAL DAMAGE; FLUMAZENIL-PET; HEAD-INJURY; BLOOD-FLOW; INFARCTION; EPILEPSY; STROKE	Purpose: Traumatic brain injury (TBI) causes brain dysfunction in many patients. However, some patients have severe brain dysfunction but display no abnormalities on magnetic resonance imaging (MRI). There have been some reports of hypometabolism even in such patients. The purpose of this study was to investigate the relationship between metabolic abnormality and loss of neuronal integrity in TBI patients with some symptoms but without MRI abnormalities. Methods: The study population comprised ten patients with TBI and ten normal volunteers. All of the patients were examined at least 1 year after the injury. O-15-labelled gas PET and [C-11]flumazenil (FMZ) positron emission tomography (PET) were carried out. The cerebral metabolic rate of oxygen (CMRO2) and binding potential (BP) images of FMZ were calculated. Axial T2WI, T2*WI and FLAIR images were obtained. Coronal images were added in some cases. Results: All of the patients had normal MRI findings, and all showed areas with abnormally low CMRO2. Low uptake on BP images was observed in six patients (60%). No lesions that showed low uptake on BP images were without low CMRO2. On the other hand, there were 14 lesions with low CMRO2 but without BP abnormalities. Conclusion: These results indicate that there are metabolic abnormalities in TBI patients with some symptoms after brain injury but without abnormalities on MRI. Some of the hypometabolic lesions showed low BP, indicating a loss of neuronal integrity. Thus, FMZ PET may have potential to distinguish hypometabolism caused by neuronal loss from that caused by other factors.	Hokkaido Univ, Sch Med, Dept Nucl Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; Hokkaido Univ, Dept Rehabil, Sapporo, Hokkaido, Japan; Hokkaido Univ, Dept Tracer Kinet, Sapporo, Hokkaido, Japan; Hokkaido Univ, Dept Radiol, Sapporo, Hokkaido, Japan		Shiga, T (corresponding author), Hokkaido Univ, Sch Med, Dept Nucl Med, Kita Ku, North 15th,West 7th, Sapporo, Hokkaido 0608638, Japan.	tshiga@med.hokudai.ac.jp	Yasuda, Kazunori/D-4156-2012; Kuge, Yuji/E-1290-2012; Ikoma, Katsunori/D-8158-2012; Terae, Satoshi/D-7587-2012; Shiga, Tohru/D-9072-2012				ADAMS JH, 1991, NEUROIMAG CLIN N AM, P397; ADRIAAN AL, 1996, NEUROIMAGE, V4, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; HAGLUND MM, 1992, J NEUROSURG, V77, P209, DOI 10.3171/jns.1992.77.2.0209; Heiss WD, 2000, STROKE, V31, P366, DOI 10.1161/01.STR.31.2.366; Heiss WD, 1998, STROKE, V29, P454, DOI 10.1161/01.STR.29.2.454; Heiss WD, 2001, CEREBROVASC DIS, V11, P73, DOI 10.1159/000047616; Heiss WD, 2001, BRAIN, V124, P20, DOI 10.1093/brain/124.1.20; Juhasz C, 1999, EPILEPSIA, V40, P566, DOI 10.1111/j.1528-1157.1999.tb05558.x; Kaji T, 2004, EUR J NUCL MED MOL I, V31, P64, DOI 10.1007/s00259-003-1319-6; Kuroda S, 2004, J NUCL MED, V45, P943; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; MAZIERE M, 1983, CR ACAD SCI III-VIE, V296, P871; Moriwaki Hiroshi, 1996, Kaku Igaku, V33, P587; Muller V, 2002, NUCL MED COMMUN, V23, P1191, DOI 10.1097/01.mnm.0000046211.83338.0c; Nakagawara J, 1997, STROKE, V28, P124, DOI 10.1161/01.STR.28.1.124; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Ohyama M, 1999, ANN NUCL MED, V13, P309, DOI 10.1007/BF03164869; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Rudolf J, 2000, LANCET, V355, P115, DOI 10.1016/S0140-6736(99)04280-4; Ryvlin P, 1999, NEUROLOGY, V53, P1882, DOI 10.1212/WNL.53.8.1882; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Shiga T, 2001, CLIN NUCL MED, V26, P334, DOI 10.1097/00003072-200104000-00011; Shiozaki T, 2001, J NEUROTRAUM, V18, P665, DOI 10.1089/089771501750357618; Son BC, 2000, ACT NEUR S, V76, P13; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tsuchida T, 1999, ANN NUCL MED, V13, P265, DOI 10.1007/BF03164903; Wechsler D, 1981, WECHSLER ADULT INTEL; Wolf HK, 1996, ACTA NEUROPATHOL, V91, P376, DOI 10.1007/s004010050439	31	28	28	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	1619-7070			EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	JUL	2006	33	7					817	822		10.1007/s00259-005-0033-y			6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	058MK	WOS:000238668900009	16565846				2022-02-06	
J	Zhang, XP; Chen, YM; Ikonomovic, MD; Nathaniel, PD; Kochanek, PM; Marion, DW; DeKosky, ST; Jenkins, LW; Clark, RSB				Zhang, Xiaopeng; Chen, Yaming; Ikonomovic, Milos D.; Nathaniel, Paula D.; Kochanek, Patrick M.; Marion, Donald W.; DeKosky, Steven T.; Jenkins, Larry W.; Clark, Robert S. B.			Increased phosphorylation of protein kinase B and related substrates after traumatic brain injury in humans and rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Akt; apoptosis; Bad; cyclic AMP responsive element binding protein; FKHR; head injury	CONTROLLED CORTICAL IMPACT; ELEMENT-BINDING PROTEIN; GROWTH FACTOR-1-INDUCED PHOSPHORYLATION; TRANSCRIPTION FACTOR FKHRL1; AKT PHOSPHORYLATION; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; CELL-DEATH; MOLECULAR-CLONING; IN-VIVO	Activation of protein kinase B (PKB, also known as Akt) by phosphorylation at serine-473 and threonine-308 promotes cell survival in multiple in vitro and in vivo models where neuronal death is seen, including traumatic brain injury (TBI); however, whether PKB is activated in humans after TBI was heretofore unknown. Activated PKB inhibits apoptogenic factors and is involved in the regulation of several transcription factors. Accordingly, we examined phosphorylation of the PKB signaling pathway in humans as well as rats after TBI using phosphospecific antibodies. Increased phosphorylation of PKB and PKB substrates was detected in injured brain from both humans and rats. In humans, increased phosphorylation of the PKB signaling pathway-related proteins Bad and forkhead transcription factor (FKHR) was detected in patients with TBI versus controls. In rats, increased phosphorylation of FKHR, inhibitor of kB alpha, and cyclic adenosine monophosphate responsive element binding protein (CREB) was detected after TBI versus controls. The deoxyribonucleic acid-binding activity of CREB was also enhanced after TBI in rats. Increased phosphorylation of PKB and PKB substrates was identified in neurons and other cell types by immunohistochemistry in both humans and rats. These data show increased phosphorylation of PKB, PKB substrates, and related proteins after both experimental and clinical TBI, suggesting either activation of the PKB signaling pathway or reduced phosphatase activity in both species.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA		Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Marion, Donald/AAR-5749-2021	Kochanek, Patrick M/0000-0002-2627-913X; DeKosky, Steven/0000-0003-3743-2758	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038620, P50NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005133] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG05133] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS38620, P50 NS30318] Funding Source: Medline		Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Armstead WM, 2003, BRAIN RES, V971, P153, DOI 10.1016/S0006-8993(03)02287-X; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; Cardona E, 1998, NEUROCIRUGIA, V9, P21; Chan PH, 2004, NEUROCHEM RES, V29, P1943, DOI 10.1007/s11064-004-6869-x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Coffer PJ, 1998, BIOCHEM J, V335, P1; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Henshall DC, 2002, J NEUROSCI, V22, P8458; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Jin G, 2003, NEUROL RES, V25, P249, DOI 10.1179/016164103101201454; Jin KL, 2000, NEUROSCIENCE, V99, P577, DOI 10.1016/S0306-4522(00)00207-4; Kasahara J, 2001, J BIOL CHEM, V276, P24044, DOI 10.1074/jbc.M100247200; Lenhard T, 2002, MOL CELL NEUROSCI, V20, P181, DOI 10.1006/mcne.2002.1134; Linseman DA, 2002, J NEUROSCI, V22, P9287; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Omori N, 2002, BRAIN RES, V954, P317, DOI 10.1016/S0006-8993(02)03366-8; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Pei JJ, 2003, ACTA NEUROPATHOL, V105, P381, DOI 10.1007/s00401-002-0657-y; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rickle A, 2004, NEUROREPORT, V15, P955, DOI 10.1097/00001756-200404290-00005; RINK A, 1995, AM J PATHOL, V147, P1575; Shibata M, 2002, BRAIN RES, V942, P1, DOI 10.1016/S0006-8993(02)02474-5; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Smith FM, 2000, ACTA NEUROPATHOL, V100, P537, DOI 10.1007/s004010000222; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; STAAL SP, 1988, J EXP MED, V167, P1259, DOI 10.1084/jem.167.3.1259; STAAL SP, 1977, P NATL ACAD SCI USA, V74, P3065, DOI 10.1073/pnas.74.7.3065; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yano S, 2001, J CEREBR BLOOD F MET, V21, P351, DOI 10.1097/00004647-200104000-00004; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zheng WH, 2002, MOL PHARMACOL, V62, P225, DOI 10.1124/mol.62.2.225; Zheng WH, 2000, J BIOL CHEM, V275, P39152, DOI 10.1074/jbc.M002417200; Zhou HL, 2000, J CELL BIOL, V151, P483, DOI 10.1083/jcb.151.3.483	58	28	28	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	2006	26	7					915	926		10.1038/sj.jcbfm.9600238			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	057IO	WOS:000238589700007	16234845				2022-02-06	
J	Drake, AI; McDonald, EC; Magnus, NE; Gray, N; Gottshall, K				Drake, Angela I.; McDonald, Eric C.; Magnus, Nathalie E.; Gray, Nicola; Gottshall, Kim			Utility of Glasgow Coma Scale-Extended in symptom prediction following mild traumatic brain injury	BRAIN INJURY			English	Article						Glasgow Coma Scale-Extended; GSC-E; PTA; mild TBI; SAC; concussion	MODERATE HEAD-INJURY; UNITED-STATES; DISCHARGE INSTRUCTIONS; CONCUSSION; SENSITIVITY; AMNESIA	Study objective: To examine the efficacy of the Glasgow Coma Scale-Extended (GCS-E) for the prediction of symptoms commonly associated with mild traumatic brain injury (TBI). Method: Three hundred and sixty-one participants with a mild TBI were evaluated using the GCS-E and the Standardized Assessment of Concussion. A sub-group of 185 participants took part in a more extensive evaluation, which also included measures of depression and vestibular symptoms. All participants had a Glasgow Coma Scale score of 15, but experienced varying lengths of post-traumatic amnesia (PTA) as measured by the GCS-E. Results: Use of the GCS-E for assessment of PTA duration revealed that longer lengths of amnesia following mild TBI were associated with greater incidence of dizziness, depression and cognitive impairments during the first weeks after injury. Conclusion: Results suggest that the GCS-E is a useful tool for the prediction of symptoms associated with mild TBI.	USN, Med Ctr, Spatial Orientat Ctr, Dept Neurosci, San Diego, CA 92152 USA; USN, Med Ctr, Spatial Orientat Ctr, Dept Emergency Med, San Diego, CA 92152 USA; USN, Med Ctr, Spatial Orientat Ctr, Dept Otolaryngol, San Diego, CA 92152 USA		Gray, N (corresponding author), 2464 DEN St, St Augustine, FL 32092 USA.	nparimucha@hotmail.com					Ahmed S, 2000, BRAIN INJURY, V14, P765; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bazarian J, 2000, BRAIN INJURY, V14, P285; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BECK AT, 1993, BDI DEPRESSION INVEN; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Fischer J, 2001, Crit Care Nurs Q, V23, P52; FRONSTIN P, 2000, EMPLOYMENT BENEFIT R, V224, P1; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hipskind J E, 1997, Prehosp Disaster Med, V12, P278; Hodgkinson D W, 1994, Eur J Emerg Med, V1, P9, DOI 10.1097/00063110-199403000-00003; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jennett B, 1989, MILD HEAD INJURY, P23; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Martin K M, 1994, J Neurosci Nurs, V26, P210; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Moss NE., 1994, CLIN REHABIL, V8, P149; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Paterson B, 2001, Rehabil Nurs, V26, P48; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Sanguinetti M, 1987, J Neurosci Nurs, V19, P271; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sternbach GL, 2000, J EMERG MED, V19, P67, DOI 10.1016/S0736-4679(00)00182-7; Taylor DM, 2000, J ACCID EMERG MED, V17, P86; *TBI STAT DEM GRAN, 2000, J HEAD TRAUMA REHAB, V15, P750; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177	42	28	28	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2006	20	5					469	475		10.1080/02699050600676370			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	045GO	WOS:000237730800003	16716993				2022-02-06	
J	Lee, JW; Choi, CG; Chun, MH				Lee, Jung Woo; Choi, Choong Gon; Chun, Min Ho			Usefulness of diffusion tensor imaging for evaluation of motor function in patients with traumatic brain injury - Three case studies	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						diffuse axonal injury; diffusion tensor imaging; fractional anisotropy; motoricity index; traumatic brain injury	CLOSED-HEAD INJURY; AXONAL INJURY; WATER-DIFFUSION; WHITE-MATTER; ABNORMALITIES; MRI	Objectives: To determine whether diffusion tensor imaging (DTI) can detect diffuse axonal injury, and to evaluate the association of DTI findings with motor function in patients with traumatic brain injury Design: Three case studies. Setting: An inpatient rehabilitation unit in Korea. Participants: Three patients with traumatic brain injury in whom conventional neuroiniaging showed normal-appearing white matter. Main Outcome Measures: Patients were studied with DTI. Fractional anisotropy (FA) was measured from 3 different anatomic locations on both sides of the corticospinal tract. Motor function was evaluated using the motoricity index. Results: Fractional anisotropy tended to be reduced in normal-appearing corticospinal tracts that were remote from the involved segment. Diffusion tensor imaging showed reduction of FA in areas consistent with motor dysfunction. Conclusion: Fractional anisotropy of the corticospinal tract may be used in the detection of diffuse axonal injury. The association between decreased motoricity index and decreased FA suggests that DTI may be useful in evaluating patients with traumatic brain injury.	Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Seoul 138736, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul 138736, South Korea		Chun, MH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, 388-1 Poongnap Dong, Seoul 138736, South Korea.	mhchun@amc.seoul.kr					Adams JH, 1992, GREENFIELDS NEUROPAT, P106; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BRODAL A, 1981, NEUROLOGICAL ANATOMY, P185; CHENEVERT TL, 1990, RADIOLOGY, V177, P401, DOI 10.1148/radiology.177.2.2217776; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Eriksson SH, 2001, BRAIN, V124, P617, DOI 10.1093/brain/124.3.617; Field AS, 2003, AM J NEURORADIOL, V24, P1461; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1991, JMRI-J MAGN RESON IM, V1, P7, DOI 10.1002/jmri.1880010103; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; MILLER G, 1998, CEREBRAL PALSIES CAU, P112; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; Taber KH, 2002, J NEUROPSYCH CLIN N, V14, P1, DOI 10.1176/appi.neuropsych.14.1.1; Werring DJ, 1998, J NEUROL NEUROSUR PS, V65, P863, DOI 10.1136/jnnp.65.6.863; Wieshmann UC, 1999, LANCET, V353, P1242, DOI 10.1016/S0140-6736(99)00248-2; Wieshmann UC, 1999, MAGN RESON IMAGING, V17, P1269, DOI 10.1016/S0730-725X(99)00082-X	27	28	28	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2006	21	3					272	278		10.1097/00001199-200605000-00007			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	044YL	WOS:000237709600007	16717504				2022-02-06	
J	Giles, GM; Manchester, D				Giles, GM; Manchester, D			Two approaches to behavior disorder after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	Galveston Brain Injury Conference (GBIC)	APR, 2005	Galveston, TX	Moody Fdn		behavior disorder; extinction; motivational interviewing; non-aversive treatment; rehabilitation; therapeutic relationship	NONCONTINGENT REINFORCEMENT; THERAPEUTIC ALLIANCE; AGGRESSIVE-BEHAVIOR; WORKING ALLIANCE; SOCIAL EXCLUSION; OVERT AGGRESSION; REHABILITATION; MANAGEMENT; REDUCTION; ATTENTION	A 3-stage model of intervention is used to contrast the philosophy and treatment practices of 2 behavioral approaches to behavior disorder following traumatic brain injury. The first referred to here as the Operant Neurobehavioral Approach developed from neuropsychology and learning theory. The second referred to as the Relational Neurobehavioral Approach builds on the nonaversive behavioral techniques of the Operant Neurobehavioral Approach. It also incorporates principles of motivational interviewing, places more overt emphasis on the therapeutic relationship, and targets staff attributions for aggression in staff training. The strengths and weaknesses of both approaches are discussed. It is suggested that the Relational Neurobehavioral Approach is more likely to engage and/or reengage clients with traumatic brain injury who are resistant to behavior change. Research implications are discussed including the need to measure the fidelity of all intervention variables.	Samuel Merritt Coll, OTRL, FAOTA, Oakland, CA 94609 USA; Crestwood Treatment Ctr, Fremont, CA USA; Anson Med Ctr, Manchester, Lancs, England		Giles, GM (corresponding author), Samuel Merritt Coll, OTRL, FAOTA, 450 30th Str, Oakland, CA 94609 USA.	ggiles@samuelmerritt.edu					ALDERMAN N, 1994, NEUROPSYCHOL REHABIL, V4, P31, DOI 10.1080/09602019408401454; Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Alderman N, 1999, BRAIN INJURY, V13, P669; ALDERMAN N, 1991, NEUROPSYCHOL REHABIL, V1, P65, DOI DOI 10.1080/09602019108401380; Barrowclough C, 2003, CLIN PSYCHOL REV, V23, P849, DOI 10.1016/S0272-7358(03)00075-8; Baumeister RF, 2005, J PERS SOC PSYCHOL, V88, P589, DOI 10.1037/0022-3514.88.4.589; BLACKERBY EF, 1988, J HEAD TRAUMA REHAB, V3, P33; BREHM SS, 1981, THEORY FREEDOM CONTR; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BURKE WH, 1986, INT J REHABIL RES, V9, P335, DOI 10.1097/00004356-198612000-00003; BURKE WH, 1988, INT J REHABIL RES, V11, P235, DOI 10.1097/00004356-198809000-00003; BURNS DD, 1996, THERAPEUTIC EMPATHY; Castonguay LG, 1996, J CONSULT CLIN PSYCH, V64, P497, DOI 10.1037/0022-006X.64.3.497; EAMES P, 1992, J NEUROL NEUROSUR PS, V55, P1046, DOI 10.1136/jnnp.55.11.1046; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Eames P, 1985, Int Rehabil Med, V7, P130; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; FESTINGER L, 1959, J ABNORM SOC PSYCH, V58, P203, DOI 10.1037/h0041593; Fluharty G, 2001, BRAIN INJURY, V15, P995, DOI 10.1080/02699050010025795; Follette WC, 1996, BEHAV THER, V27, P623, DOI 10.1016/S0005-7894(96)80047-5; FOWLES GP, 1995, CLIN NEUROPSYCHOL, V9, P251, DOI 10.1080/13854049508400490; Giles G. M., 1999, REHABILITATION SEVER, P81; GILES GM, 1989, J CLIN EXP NEUROPSYC, V11, P311, DOI 10.1080/01688638908400891; Giles GM, 2005, BRAIN INJURY, V19, P753, DOI 10.1080/02699050500110108; Giles GM, 2005, COGNITION OCCUPATION, P139; GILES GM, 1993, BRAIN INJURY REHAB N; HAGOPIAN LP, 1994, J APPL BEHAV ANAL, V27, P317, DOI 10.1901/jaba.1994.27-317; Heflin L. J., 2001, FOCUS AUTISM OTHER D, V16, P93, DOI DOI 10.1177/108835760101600205; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; HORVATH AO, 1989, J COUNS PSYCHOL, V36, P223, DOI 10.1037/0022-0167.36.2.223; JOHNSON T, 1986, J PERS SOC PSYCHOL, V3, P1; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Koestner R, 2002, J PERS SOC PSYCHOL, V83, P231, DOI 10.1037//0022-3514.83.1.231; KULIK JA, 1979, J EXP SOC PSYCHOL, V15, P183, DOI 10.1016/0022-1031(79)90029-5; LUBORSKY L, 1985, ARCH GEN PSYCHIAT, V42, P602; MACE FC, 1991, J APPL BEHAV ANAL, V24, P553, DOI 10.1901/jaba.1991.24-553; Man DWK, 2001, BRAIN INJURY, V15, P961, DOI 10.1080/02699050110065664; Manchester D, 1997, BRAIN INJURY, V11, P271; Manchester D, 2001, BRAIN DAM B, P157; MANCHESTER D, 2002, THESIS SURREY U; MANCHESTER D, IN PRESS NEUROPSYCHO; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; Miller W.R., 2002, MOTIVATIONAL INTERVI; Miller WR, 2001, BEHAV COGN PSYCHOTH, V29, P457, DOI 10.1017/S1352465801004064; MILLER WR, 1993, J CONSULT CLIN PSYCH, V61, P455, DOI 10.1037/0022-006X.61.3.455; NOVACO RW, 1989, CLIN APPROACHES VIOL, P39; ORLINSKY DE, 1994, HDB PSYCHOTHERAPY BE, V4, P270; PETERS M D, 1992, Brain Injury, V6, P299, DOI 10.3109/02699059209034944; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; ROOLNICK S, 1999, HLTH BEHAV CHANG PRA; ROSENHAN DL, 1973, SCIENCE, V179, P250, DOI 10.1126/science.179.4070.250; Rothwell NA, 1999, BRAIN INJURY, V13, P521; SHELDON KM, 2001, LIFE GOALS WELL BEIN, P18; Skinner BF, 1938, BEHAV ORGANISMS; Smith RG, 1997, J APPL BEHAV ANAL, V30, P343, DOI 10.1901/jaba.1997.30-343; Swan L, 2004, BRAIN INJURY, V18, P143, DOI 10.1080/02699050310001596923; TERRACE HS, 1963, J EXP ANAL BEHAV, V6, P1, DOI 10.1901/jeab.1963.6-1; Triandis H., 1977, INTERPERSONAL BEHAV; Turner J. M., 1990, BEHAV RESIDENTIAL TR, V5, P15, DOI [10.1002/bin.2360050103, DOI 10.1002/BIN.2360050103]; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037/0022-3514.81.6.1058; VOLLMER TR, 1993, J APPL BEHAV ANAL, V26, P9, DOI 10.1901/jaba.1993.26-9; Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662; WESOLOWSKI MD, 1992, BEHAV RESIDENTIAL TR, V7, P205; Whittington R, 1996, BRIT J CLIN PSYCHOL, V35, P11, DOI 10.1111/j.2044-8260.1996.tb01158.x; Willis TJ, 2003, J HEAD TRAUMA REHAB, V18, P75, DOI 10.1097/00001199-200301000-00008; Wilson S, 1998, Int J Nurs Pract, V4, P51, DOI 10.1111/j.1440-172X.1998.00068.x; WOOD RL, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P153; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; Woody SR, 2002, BEHAV THER, V33, P5, DOI 10.1016/S0005-7894(02)80003-X; Yuen HK, 1996, BRAIN INJURY, V10, P229, DOI 10.1080/026990596124548; Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553; Zimbardo PG, 1991, PSYCHOL ATTITUDE CHA	73	28	29	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2006	21	2					168	178		10.1097/00001199-200603000-00009			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	031PK	WOS:000236716300008	16569990				2022-02-06	
J	Belli, A; Sen, J; Petzold, A; Russo, S; Kitchen, N; Smith, M; Tavazzi, B; Vagnozzi, R; Signoretti, S; Amorini, AM; Bellia, F; Lazzarino, G				Belli, A; Sen, J; Petzold, A; Russo, S; Kitchen, N; Smith, M; Tavazzi, B; Vagnozzi, R; Signoretti, S; Amorini, AM; Bellia, F; Lazzarino, G			Extracellular N-acetylaspartate depletion in traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						microdialysis; mitochondria; N-acetylaspartate; traumatic brain injury	MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; L-ASPARTIC ACID; TEMPORAL-LOBE EPILEPSY; CENTRAL-NERVOUS-SYSTEM; SEVERE HEAD-INJURY; ACETYL-L-ASPARTATE; MITOCHONDRIAL DYSFUNCTION; RAT-BRAIN; AXONAL INJURY	N-Acetylaspartate (NAA) is almost exclusively localized in neurons in the adult brain and is present in high concentration in the CNS. It can be measured by proton magnetic resonance spectroscopy and is seen as a marker of neuronal damage and death. NMR spectroscopy and animal models have shown NAA depletion to occur in various types of chronic and acute brain injury. We investigated 19 patients with traumatic brain injury (TBI). Microdialysis was utilized to recover NAA, lactate, pyruvate, glycerol and glutamate, at 12-h intervals. These markers were correlated with survival and a 6-month Glasgow Outcome Score. Eleven patients died and eight survived. A linear mixed model analysis showed a significant effect of outcome and of the interaction between time of injury and outcome on NAA levels (p = 0.009 and p = 0.004, respectively). Overall, extracellular NAA was 34% lower in non-survivors. A significant non-recoverable fall was observed in this group from day 4 onwards, with a concomitant rise in lactate-pyruvate ratio and glycerol. These results suggest that mitochondrial dysfunction is a significant contributor to poor outcome following TBI and propose extracellular NAA as a potential marker for monitoring interventions aimed at preserving mitochondrial function.	UCL Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, London WC1N 3BG, England; Inst Neurol, Dept Neuroimmunol, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, Dept Neuroanaesthesia & Neurocrit Care, London WC1N 3BG, England; Univ Cattolica Sacro Cuore, Inst Biochem & Clin Biochem, I-00168 Rome, Italy; Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; San Camillo Hosp, Div Neurosurg, Rome, Italy; Univ Catania, Dipartimento Sci Chim, Biochem Lab, I-95125 Catania, Italy		Belli, A (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Dept Neurosurg, Queen Sq,Box 31, London WC1N 3BG, England.	a.belli@ion.ucl.ac.uk	TAVAZZI, BARBARA/AAB-9830-2019; Petzold, Axel/C-1090-2009; Smith, Martin/B-2616-2009; Signoretti, stefano/AAL-5631-2020; Belli, Antonio/I-3799-2015; Bellia, Francesco/H-2812-2013; lazzarino, giuseppe/K-2277-2015	TAVAZZI, BARBARA/0000-0001-8743-0895; Petzold, Axel/0000-0002-0344-9749; Signoretti, stefano/0000-0002-8086-1622; Belli, Antonio/0000-0002-3211-9933; AMORINI, Angela Maria/0000-0003-3525-9955; Bellia, Francesco/0000-0002-9273-5949; lazzarino, giuseppe/0000-0002-5917-7279			Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Al-Samsam RH, 2000, J NEUROTRAUM, V17, P31, DOI 10.1089/neu.2000.17.31; Alessandri B, 2000, NEUROL RES, V22, P705; Barkovich AJ, 1999, AM J NEURORADIOL, V20, P1399; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Baslow MH, 2002, NEUROCHEM INT, V40, P295, DOI 10.1016/S0197-0186(01)00095-X; Bhakoo KK, 2001, J NEUROCHEM, V79, P211, DOI 10.1046/j.1471-4159.2001.00561.x; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; BRENNER RE, 1993, MAGNET RESON MED, V29, P737, DOI 10.1002/mrm.1910290605; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Brooks WM, 1999, J RHEUMATOL, V26, P81; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; CENDES F, 1994, ANN NEUROL, V35, P211, DOI 10.1002/ana.410350213; Cendes F, 1997, NEUROLOGY, V49, P1525, DOI 10.1212/WNL.49.6.1525; Chakraborty G, 2001, J NEUROCHEM, V78, P736, DOI 10.1046/j.1471-4159.2001.00456.x; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; Clark JB, 1998, DEV NEUROSCI-BASEL, V20, P271, DOI 10.1159/000017321; Davie CA, 1997, J NEUROL NEUROSUR PS, V63, P736, DOI 10.1136/jnnp.63.6.736; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2001, J NEUROTRAUM, V18, P241, DOI 10.1089/08977150151070856; GIDEON P, 1992, STROKE, V23, P1566, DOI 10.1161/01.STR.23.11.1566; Giroud M, 1996, NEUROL RES, V18, P241; GOLDSTEIN FB, 1969, J BIOL CHEM, V244, P4257; Gotoh M, 1997, J NEUROCHEM, V69, P655; Harms L, 1997, J NEUROL NEUROSUR PS, V62, P27, DOI 10.1136/jnnp.62.1.27; HEALES SJR, 1995, NEUROCHEM RES, V20, P31; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; HOLSHOUSER BA, 1997, RADIOLOGY, V202, P187; Hutchinson PJA, 2000, ZBL NEUROCHIR, V61, P88, DOI 10.1055/s-2000-8265; Kalra S, 1998, NEUROREPORT, V9, P1757, DOI 10.1097/00001756-199806010-00016; KNIZLEY H, 1967, J BIOL CHEM, V242, P4619; Koura SS, 1998, ACT NEUR S, V71, P244; Lu ZH, 2004, MOL BRAIN RES, V122, P71, DOI 10.1016/j.molbrainres.2003.12.002; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Obrenovitch TP, 1999, ANN NY ACAD SCI, V890, P273, DOI 10.1111/j.1749-6632.1999.tb08004.x; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; OBRENOVITCH TP, 1993, J NEUROSCI METH, V47, P139, DOI 10.1016/0165-0270(93)90030-U; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; PASCHEN W, 1986, METAB BRAIN DIS, V1, P37, DOI 10.1007/BF00998475; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; PEDEN CJ, 1993, DEV MED CHILD NEUROL, V35, P502; RANGO M, 1995, MAGNET RESON MED, V33, P595, DOI 10.1002/mrm.1910330503; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Sager TN, 1997, J NEUROCHEM, V68, P675; SARAGEA M, 1965, MED PHARMACOL EXP, V13, P74; SHIINO A, 1993, SURG NEUROL, V39, P143, DOI 10.1016/0090-3019(93)90093-G; SHONK TK, 1995, RADIOLOGY, V195, P65, DOI 10.1148/radiology.195.1.7892497; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Tavazzi B, 2000, ANAL BIOCHEM, V277, P104, DOI 10.1006/abio.1999.4386; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; TAYLOR DL, 1994, J NEUROCHEM, V62, P2349; TAYLOR DL, 1995, J NEUROCHEM, V65, P275; TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M; Uno Masaaki, 1996, Neurologia Medico-Chirurgica, V36, P560, DOI 10.2176/nmc.36.560; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto T, 1999, ACT NEUR S, V75, P17	71	28	29	0	6	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3042			J NEUROCHEM	J. Neurochem.	FEB	2006	96	3					861	869		10.1111/j.1471-4159.2005.03602.x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	003GV	WOS:000234670700023	16371008				2022-02-06	
J	Cousar, JL; Lai, YC; Marco, CD; Bayir, H; Adelson, PD; Janesko-Feldman, KL; Kochanek, PM; Clark, RSB				Cousar, J'mir L.; Lai, Yichen; Marco, Christina D.; Bayir, Hulya; Adelson, P. David; Janesko-Feldman, Keri L.; Kochanek, Patrick M.; Clark, Robert S. B.			Heme oxygenase 1 in cerebrospinal fluid from infants and children after severe traumatic brain injury	DEVELOPMENTAL NEUROSCIENCE			English	Article						child abuse; head injury; heat shock protein; Hsp32; oxidative stress; stress response	HEAT-SHOCK-PROTEIN; OXIDATIVE STRESS; SPINAL-CORD; RAT-BRAIN; INDUCTION; EXPRESSION; BILIRUBIN; HO-1; GLIA; ANTIOXIDANT	Heme oxygenase 1 (HO-1) is an enzyme important in the catabolism of heme that is induced under conditions of oxidative stress. HO-1 degradation of heme yields biliverdin, bilirubin, carbon monoxide and iron. HO-1 is thought to serve a protective antioxidant function, and upregulation of HO-1 has been demonstrated in experimental models of neurodegeneration, subarachnoid hemorrhage, cerebral ischemia and traumatic brain injury (TBI). We measured HO-1 concentration in cerebral spinal fluid samples from 48 infants and children following TBI and 7 control patients by ELISA. Increased HO-1 was seen in TBI versus control patients mean 2.75 +/- 0.63, peak 4.17 +/- 0.96 ng/ml versus control (< 0.078 ng/ml, not detectable) (p < 0.001). Increased HO-1 concentration was associated with increased injury severity and unfavorable neurological outcome (both p < 0.05). Increased HO-1 concentration was independently associated with younger age; however, statistical analysis could not rule out the possibility that the effect of age was related to inflicted TBI from child abuse. HO-1 increases after TBI and appears to be more prominent in infants compared with older children after injury. Copyright (c) 2006 S. Karger AG, Basel.	Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Neurol Surg, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA		Clark, RSB (corresponding author), Pediat Crit Care Med, 3705 5th Ave, Pittsburgh, PA 15213 USA.	clarkrs@ccm.upmc.edu	Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Lai, Yi-Chen/0000-0002-9450-5506	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD40686, R01 HD045968] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS38620, P50 NS30318] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038620, P50NS030318] Funding Source: NIH RePORTER		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; AMIT Y, 1993, EXP NEUROL, V121, P248, DOI 10.1006/exnr.1993.1092; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Berger RP, 2004, CHILD ABUSE NEGLECT, V28, P739, DOI 10.1016/j.chiabu.2004.01.007; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bergeron M, 1998, DEV BRAIN RES, V105, P181, DOI 10.1016/S0165-3806(97)00169-7; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Hagberg H, 1997, ACTA PAEDIATR, V86, P85; Kaur H, 2003, FEBS LETT, V543, P113, DOI 10.1016/S0014-5793(03)00420-4; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kondo M, 2002, EARLY HUM DEV, V66, P81, DOI 10.1016/S0378-3782(01)00234-1; Kvam E, 2000, FREE RADICAL BIO MED, V28, P1191, DOI 10.1016/S0891-5849(00)00205-7; Lai YC, 2004, J NEUROTRAUM, V21, P229, DOI 10.1089/089771504322972022; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Matz P, 1996, BRAIN RES, V713, P211, DOI 10.1016/0006-8993(95)01511-6; Mautes AEM, 2000, EXP NEUROL, V166, P254, DOI 10.1006/exnr.2000.7520; Mautes AEM, 1998, BRAIN RES, V795, P17, DOI 10.1016/S0006-8993(98)00230-3; Morse D, 2005, AM J RESP CRIT CARE, V172, P660, DOI 10.1164/rccm.200404-465SO; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Schipper HM, 1998, EXP NEUROL, V150, P60, DOI 10.1006/exnr.1997.6752; Schipper HM, 2000, NEUROLOGY, V54, P1297, DOI 10.1212/WNL.54.6.1297; Seidberg NA, 2003, J NEUROCHEM, V84, P514, DOI 10.1046/j.1471-4159.2003.01547.x; SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889; Snyder SH, 1998, BRAIN RES REV, V26, P167, DOI 10.1016/S0165-0173(97)00032-5; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; SUN Y, 1990, J BIOL CHEM, V265, P8212; Takeda A, 1996, NEUROSCI LETT, V205, P169, DOI 10.1016/0304-3940(96)12405-8; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x	38	28	28	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2006	28	4-5					342	347		10.1159/000094160			6	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	080ZS	WOS:000240287600011	16943657				2022-02-06	
J	Guskiewicz, KM; Bruce, SL; Cantu, RC; Ferrara, MS; Kelly, JP; McCrea, M; Putukian, M; McLeod, TCV				Guskiewicz, KM; Bruce, SL; Cantu, RC; Ferrara, MS; Kelly, JP; McCrea, M; Putukian, M; McLeod, TCV			Research based recommendations on management of sport related concussion: summary of the National Athletic Trainers' Association position statement	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							NEUROPSYCHOLOGICAL TEST-PERFORMANCE; COMPUTERIZED COGNITIVE ASSESSMENT; COLLEGIATE FOOTBALL PLAYERS; POSTURAL STABILITY; SAFE RETURN; HEAD-INJURY; MILD; RECOVERY; PATHOPHYSIOLOGY; CONSCIOUSNESS		Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; Calif State Univ Penn, California, PA USA; Brigham & Womens Hosp, Neurol Sports Injury Ctr, Boston, MA 02115 USA; Emerson Hosp, Concord, MA USA; Univ Georgia, Athens, GA 30602 USA; Univ Colorado, Sch Med, Denver, CO USA; Waukesha Mem Hosp, Waukesha, WI USA; Princeton Univ, Princeton, NJ 08544 USA; Arizona Sch Hlth Sci, Dept Sport Hlth Care, Mesa, AZ USA		Guskiewicz, KM (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA.	gus@email.unc.edu	Valovich McLeod, Tamara/AAU-9435-2020; Bruce, Scott L./AAQ-1907-2020	Valovich McLeod, Tamara/0000-0001-9082-8722; Bruce, Scott L./0000-0002-3251-073X; Guskiewicz, Kevin/0000-0002-8682-2130			Adams J, 2001, J PEDIATR SURG, V36, P119, DOI 10.1053/jpsu.2001.20026; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, J ATHL TRAINING, V36, P236; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Daniel JC, 1999, NEUROPSY NEUROPSY BE, V12, P167; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Guskiewicz KM, 2004, AM J MED SPORTS, V6, P13; Halstead PD, 2001, J ATHL TRAINING, V36, P322; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly JP, 1997, NEUROLOGY, V48, P581; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2002, BRIT J SPORT MED, V36, P316, DOI 10.1136/bjsm.36.5.316; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Pottinger LS, 1999, ARCH CLIN NEUROPSYCH, V14, P39, DOI 10.1093/arclin/14.1.39a; Riemann BL, 2000, J ATHL TRAINING, V35, P19	41	28	28	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2006	40	1					6	10		10.1136/bjsm.2005.021683			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	995YG	WOS:000234140600005	16371484	Green Published, Bronze, Green Submitted			2022-02-06	
J	Dallmeijer, AJ; Dekker, J; Roorda, LD; Knol, DL; van Baalen, B; de Groot, V; Schepers, VPM; Lankhorst, GJ				Dallmeijer, AJ; Dekker, J; Roorda, LD; Knol, DL; van Baalen, B; de Groot, V; Schepers, VPM; Lankhorst, GJ		FuPro Study Grp	Differential item functioning of the functional independence measure in higher performing neurological patients	JOURNAL OF REHABILITATION MEDICINE			English	Article						disability evaluation; neurological disorders; Rasch analysis; rehabilitation	APPLYING PSYCHOMETRIC CRITERIA; RASCH ANALYSIS; MEDICAL REHABILITATION; IMPAIRMENT; CATEGORIES; SCALES; MODEL	Objective: When comparing outcomes of the Functional Independence Measure (FIM(TM)) between patient groups, item characteristics of the FIM(TM) should be consistent across groups. The purpose of this study was to compare item difficulty of the FIM(TM) in 3 patient groups with neurological disorders. Subjects: Patients with stroke (n = 295), multiple sclerosis ( n = 150), and traumatic brain injury ( n = 88). Methods: FIM(TM) scores were administered in each group. The FIM(TM) consists of a motor domain ( 13 items) and a cognitive domain ( 5 items). Rasch rating scale analysis was performed to investigate differences in item difficulty ( differential item functioning) between groups. Results: Answering categories of the FIM(TM) items were reduced to 3 ( from the original 7) because of disordered thresholds and low answering frequencies. Two items of the motor domain ("bladder" and "bowel") did not fit the Rasch model. For 7 out of the 11 fitting motor items, item difficulties were different between groups (i.e. showed differential item functioning). All cognitive items fitted the Rasch model, and 4 out of 5 cognitive items showed differential item functioning. Conclusion: Differential item functioning is present in several items of both the motor and cognitive domain of the FIM(TM). Adjustments for differential item functioning may be required when FIM(TM) data will be compared between groups or will be used in a pooled data analysis.	VU Univ Med Ctr Amsterdam, Dept Rehabil Med, NL-1007 MB Amsterdam, Netherlands; VU Univ Med Ctr Amsterdam, Inst Res Extramural Med, EMGO Inst, NL-1007 MB Amsterdam, Netherlands; VU Univ Med Ctr Amsterdam, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands; Erasmus Med Ctr, Dept Rehabil Med, Rotterdam, Netherlands; Univ Med Ctr, Dept Rehabil Med, Utrecht, Netherlands		Dallmeijer, AJ (corresponding author), VU Univ Med Ctr Amsterdam, Dept Rehabil Med, POB 7057, NL-1007 MB Amsterdam, Netherlands.	a.dallmeijer@vumc.nl	De Groot, Vincent/S-3482-2019; de Groot, Vincent/J-8977-2013; IJzerman, Maarten J/Q-8963-2016	de Groot, Vincent/0000-0002-6073-6250; IJzerman, Maarten J/0000-0001-5788-5805; Dekker, Joost/0000-0003-2027-0027; Beckerman, Heleen/0000-0002-8421-3630			ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Brock KA, 2002, ARCH PHYS MED REHAB, V83, P92, DOI 10.1053/apmr.2002.27348; CHANG WC, 1995, ARCH PHYS MED REHAB, V76, P934, DOI 10.1016/S0003-9993(95)80070-0; Dickson HG, 1996, SCAND J REHABIL MED, V28, P159; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; HAMILTON BB, 2003, UNIFORM NATL DATA SY, P137; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Keith R A, 1987, Adv Clin Rehabil, V1, P6; KIM JO, 1996, INTRO FACTOR ANAL WH; Kucukdeveci AA, 2001, CLIN REHABIL, V15, P311, DOI 10.1191/026921501676877265; Linacre J. M., 1998, USERS GUIDE BIGSTEPS; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Norman, 1995, HLTH MEASUREMENT SCA; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Sharrack B, 1999, BRAIN, V122, P141, DOI 10.1093/brain/122.1.141; SILVERSTEIN B, 1992, ARCH PHYS MED REHAB, V73, P507; SILVERSTEIN B, 1991, ARCH PHYS MED REHAB, V72, P631; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; TEASDALE G, 1974, LANCET, V2, P81; Tennant A, 2004, MED CARE, V42, P37, DOI 10.1097/01.mlr.0000103529.63132.77; Tesio L, 2003, J REHABIL MED, V35, P105, DOI 10.1080/16501970310010448; Tsuji T, 1995, AM J PHYS MED REHAB, V74, P432, DOI 10.1097/00002060-199511000-00007; Wade D, 1992, MEASUREMENT NEUROLOG; Wright B, 1994, MEASUREMENT T, V8, P370; Wright BD, 1997, SCAND J REHABIL MED, V29, P267	26	28	28	0	2	TAYLOR & FRANCIS AS	OSLO	PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY	1650-1977			J REHABIL MED	J. Rehabil. Med.	NOV	2005	37	6					346	352		10.1080/16501970510038284			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	984VW	WOS:000233334700003	16287665	gold, Green Submitted			2022-02-06	
J	Hay, E; Moran, C				Hay, E; Moran, C			Discourse formulation in children with closed head injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						narrative and expository discourse; closed head injury; children	TRAUMATIC BRAIN-INJURY; VERBAL WORKING-MEMORY; LANGUAGE-LEARNING DISABILITIES; SCHOOL-AGE-CHILDREN; SENTENCE COMPREHENSION; INDIVIDUAL-DIFFERENCES; EXPOSITORY DISCOURSE; IMPAIRMENT; CAPACITY; PERFORMANCE	In this study, narrative and expository discourse-retelling abilities were compared in 9 children with closed head injury (CHI) age 9;5-15;3 (years;months) and 9 typically developing age-matched peers. Narrative and expository retellings were analyzed according to language variables (i.e., number of words, number of T-units, and sentential complexity) and information variables (i.e., number of propositions, number of episodic structure elements, and number of global structure elements). A measure of participants' ability to generate a story moral or aim was also taken. The children with CHI differed significantly from their age-matched peers across language and information domains and in their ability to formulate a moral or aim in both the expository and narrative retellings. In addition, differences across genre were found with performance on narrative tasks superior to performance on expository tasks. The exception was that it was easier for participants to generate an aim for the expository passage than a story moral for the narrative passage. The results are discussed relative to a working memory theory of impairment following CHI. Future directions for research are proposed.	Univ Canterbury, Dept Commun Disorders, Christchurch 1, New Zealand		Moran, C (corresponding author), Univ Canterbury, Dept Commun Disorders, Private Bag 4800, Christchurch 1, New Zealand.	catherine.moran@canterbury.ac.nz					Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Carpenter P. A., 1994, HDB PSYCHOLINGUISTIC, P1075; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; Cohen J., 2013, STAT POWER ANAL BEHA; Cowan N, 1996, TOP LANG DISORD, V17, P1, DOI 10.1097/00011363-199611000-00003; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dollaghan C, 1998, J SPEECH LANG HEAR R, V41, P1136, DOI 10.1044/jslhr.4105.1136; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; Gillam RB, 1997, TOP LANG DISORD, V18, P72, DOI 10.1097/00011363-199711000-00008; Gillam RB, 1999, TOP LANG DISORD, V20, P33, DOI 10.1097/00011363-199911000-00005; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hunt K. W., 1965, GRAMMATICAL STRUCTUR; JORDAN F M, 1990, Brain Injury, V4, P27; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; JORDAN F M, 1992, Brain Injury, V6, P39, DOI 10.3109/02699059209008120; JORDAN FM, 1995, APHASIOLOGY, V9, P23, DOI 10.1080/02687039508248686; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; Jordan FM, 1996, APHASIOLOGY, V10, P755, DOI 10.1080/02687039608248448; Just MA, 1996, PSYCHOL REV, V103, P773, DOI 10.1037/0033-295X.103.4.773; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; Larson V., 1995, LANGUAGE DISORDERS O; Montgomery JW, 2002, AM J SPEECH-LANG PAT, V11, P77, DOI 10.1044/1058-0360(2002/009); Montgomery JW, 1996, TOP LANG DISORD, V17, P19, DOI 10.1097/00011363-199611000-00004; Moran C, 2005, BRAIN INJURY, V19, P743, DOI 10.1080/02699050500110199; NELSON N, 1993, CHILDHOOD LANGUAGE; NIPPOLD M, 2003, EXPOSITORY DISCOURS; Nippold MA, 2000, TOP LANG DISORD, V20, P15, DOI 10.1097/00011363-200020020-00004; PAUL R, 1995, LANGUAGE DISORDERS; Scott CM, 2000, J SPEECH LANG HEAR R, V43, P324, DOI 10.1044/jslhr.4302.324; SEMEL W, 1997, CLIN EVALUATION LANG; STEVENS T, 2003, REV PLAYSTATION GAME; Stewart S, 1985, COMMUNICATION SKILLS, P341; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Ulatowska H. K., 1994, DISCOURSE ANAL APPL, P29; WARDLONERGAN JM, 1909, J LEARNING DISABILIT, V32, P213; Weismer SE, 1999, J SPEECH LANG HEAR R, V42, P1249, DOI 10.1044/jslhr.4205.1249; Weismer SE, 1996, TOP LANG DISORD, V17, P33, DOI 10.1097/00011363-199611000-00005; Westerveld M., 2001, NZ J SPEECH LANGUAGE, V56, P5; Windsor J, 2000, J SPEECH LANG HEAR R, V43, P1322, DOI 10.1044/jslhr.4306.1322; YEKOVICH FR, 1990, INFERENCES TEXT COMP, P259	47	28	29	1	8	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2005	14	4					324	336		10.1044/1058-0360(2005/031)			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	998JA	WOS:000234313400007	16396615				2022-02-06	
J	Miller, KJ; Schwab, KA; Warden, DL				Miller, KJ; Schwab, KA; Warden, DL			Predictive value of an early Glasgow Outcome Scale score: 15-month score changes	JOURNAL OF NEUROSURGERY			English	Article						head injury; traumatic brain injury; Glasgow Outcome Scale; severity outcome prediction	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; DISABILITY; RECOVERY; REHABILITATION; PROGNOSIS; SEVERITY; MODERATE	Object. Does an early Glasgow Outcome Scale (GOS) assessment provide a reliable indicator of later outcome in a patient with traumatic brain injury (TBI)? The authors examined the utility of the GOS during early treatment as a predictor of outcome score 15 months postinjury by analyzing outcome score change in a group of patients with closed head injuries. Methods. Glasgow Outcome Scale scores assessed within 3 months of injury (baseline) were compared with scores obtained at 15 months postinjury in 121 patients, primarily young military personnel. Score changes between baseline and 8 months postinjury were also studied in a subgroup of 72 patients. The impact of initial injury severity (determined by the duration of unconsciousness) on score change was also explored. The GOS scores at three time points within the 15-month period-baseline (within 3 months of injury), 8, and 15 months postinjury-were examined to ascertain when the maximal GOS score had been reached. Conclusions. Baseline GOS score was a reliable predictor of outcome in patients with an initial score of 5 (no disability) or 4 (mild disability), but not in patients with an initial score of 3 (severe disability). Patients who remained unconscious for more than 24 hours did not have significantly lower outcome scores than those who experienced loss of consciousness for less than 24 hours at 15 months postinjury. Interestingly, the duration of unconsciousness did not affect the likelihood of an improved score during the study period in patients with a GOS score of 3 or 4 at baseline. An updated evaluation conducted after the early phases of treatment is needed to provide a realistic prognosis of severe TBI.	Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA; Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA		Schwab, KA (corresponding author), Walter Reed Army Med Brain Injury Ctr, POB 59181, Washington, DC 20012 USA.	Karen.Schwab@na.amedd.army.mil					Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; GROSWASSER, 1997, HDB NEUROLOGICA RATI, P187; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1976, LANCET, V1, P1031; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kaye AH, 2000, LANCET, V356, P1540, DOI 10.1016/S0140-6736(00)03121-4; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Nissen JJ, 1999, J NEUROL NEUROSUR PS, V67, P796, DOI 10.1136/jnnp.67.6.796; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Salazar, 2000, JAMA, V284, P1783; SBORDONE RJ, 1987, REHABILITATION COGNI; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	27	28	30	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2005	103	2					239	245		10.3171/jns.2005.103.2.0239			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	957KI	WOS:000231368300008	16175852				2022-02-06	
J	Day, SM; Strauss, DJ; Shavelle, RM; Reynolds, RJ				Day, SM; Strauss, DJ; Shavelle, RM; Reynolds, RJ			Causes of death in remote symptomatic epilepsy	NEUROLOGY			English	Article							CAUSE-SPECIFIC MORTALITY; RISK-FACTORS; SEIZURES; CHILDREN; SURVIVAL; SUICIDE; PEOPLE	Objective: To determine the causes of death of individuals with developmental disabilities that occur more frequently among those with remote symptomatic epilepsy (i.e., epilepsy occurring in persons with developmental delay or identified brain lesions) than for those without. Methods: The authors compared causes of mortality in persons with (n = 10,030) and without (n = 96,163) history of epilepsy in a California population of persons with mild developmental disabilities, 1988 to 2002. Subjects had traumatic brain injury, cerebral palsy, Down syndrome, autism, or a developmental disability with other or unknown etiology. There were 721,759 person-years of data, with 2,397 deaths. Underlying causes of death were determined from the State of California's official mortality records. Cause-specific death rates and standardized mortality ratios (SMRs) were computed for those with and without epilepsy relative to subjects in the California general population. Comparisons were then made between SMRs of those with and without epilepsy, and CIs on the ratios of SMRs were determined. Results: Death rates for persons with epilepsy were elevated for several causes. The greatest excess was due to seizures (International Classification of Diseases-9 [ICD-9] 345; SMR 53.1, 95% CI 28.0 to 101.0) and convulsions (ICD-9 780.3; SMR 25.2, 95% CI 11.7 to 54.2). Other causes occurring more frequently in those with epilepsy included brain cancer (SMR 5.2, 95% CI 2.2 to 12.1), respiratory diseases (SMR 1.7, 95% CI 1.2 to 2.5), circulatory diseases (SMR 1.3, 95% CI 1.0 to 1.7), and accidents (SMR 2.7, 95% CI 1.9 to 3.7), especially accidental drowning (SMR 12.8, 95% CI 7.0 to 23.2). Conclusions: Remote symptomatic epilepsy is associated with an increased risk of death. Seizures, aspiration pneumonia, and accidental drowning are among the leading contributors.	Life Expectancy Project, San Francisco, CA 94122 USA; Univ Calif San Francisco, Dept Pediat & Neurol, San Francisco, CA 94143 USA		Day, SM (corresponding author), Life Expectancy Project, 1439 17th Ave, San Francisco, CA 94122 USA.	Day@LifeExpectancy.com	Day, Steven/P-1002-2019	Day, Marc/0000-0002-1711-3963; Day, Steven/0000-0001-8305-5813			Antoniuk SA, 2001, ARQ NEURO-PSIQUIAT, V59, P40, DOI 10.1590/S0004-282X2001000100009; BARRACLOUGH BM, 1987, ACTA PSYCHIAT SCAND, V76, P339, DOI 10.1111/j.1600-0447.1987.tb05616.x; Besag FMC, 2001, BRIT MED J, V322, P975, DOI 10.1136/bmj.322.7292.975; Breningstall GN, 2001, PEDIATR NEUROL, V25, P9, DOI 10.1016/S0887-8994(01)00252-1; *CA6 DEP DEV SERV, 1986, CLIENT DEV EV REP; Day SM, 2005, DEV MED CHILD NEUROL, V47, P171, DOI 10.1017/S0012162205000319; Day Steven, 2003, J Insur Med, V35, P155; DIEKEMA DS, 1993, PEDIATRICS, V91, P612; Goldacre MJ, 2004, EUR J PUBLIC HEALTH, V14, P338, DOI 10.1093/eurpub/14.4.338; Gottesman RF, 2003, INT REV PSYCHIATR, V15, P302, DOI 10.1080/09540260310001606683; Jones JE, 2003, EPILEPSY BEHAV, V4, pS31, DOI 10.1016/j.yebeh.2003.08.019; Kahn HA, 1989, STAT METHODS EPIDEMI; KEMP AM, 1993, ARCH DIS CHILD, V68, P684, DOI 10.1136/adc.68.5.684; Langan Y, 2000, SEIZURE-EUR J EPILEP, V9, P179, DOI 10.1053/seiz.2000.0388; Lhatoo S. D., 2002, Hong Kong Medical Journal, V8, P354; Morgan CL, 2002, EPILEPSIA, V43, P1251, DOI 10.1046/j.1528-1157.2002.38701.x; Nashef L, 1997, EPILEPSIA, V38, P1059, DOI 10.1111/j.1528-1157.1997.tb01193.x; Nashef L, 1996, LANCET, V348, P1324, DOI 10.1016/S0140-6736(05)65402-5; Nilsson L, 1997, EPILEPSIA, V38, P1062, DOI 10.1111/j.1528-1157.1997.tb01194.x; Rafnsson V, 2001, NEUROEPIDEMIOLOGY, V20, P232, DOI 10.1159/000054795; ROHATGI V. K., 1976, INTRO PROBABILITY TH; Shackleton DP, 2002, EPILEPSIA, V43, P445, DOI 10.1046/j.1528-1157.2002.10301.x; Shavelle RM, 2001, J AUTISM DEV DISORD, V31, P569, DOI 10.1023/A:1013247011483; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sheth SG, 2004, NEUROLOGY, V63, P1002, DOI 10.1212/01.WNL.0000138590.00074.9A; smoke T, 2004, IARC MON EV CARC RIS, V83, P1; *STAT CA DEP FIN, 2004, DEP FIN RAC ETHN POP; *STAT CA DEP FIN, 1998, RAC ETHN POP AG SEX; *STAT CA DEP HLTH, 1988, ANN MORT TAP 1988 20; *STAT CAL, 2004, DEP FIN RAC ETHN POP; Strauss D, 1999, DEV MED CHILD NEUROL, V41, P580, DOI 10.1017/S001216229900122X; Strauss DJ, 1998, PEDIATR NEUROL, V18, P143, DOI 10.1016/S0887-8994(97)00172-0; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Strauss DJ, 2003, NEUROLOGY, V60, P395, DOI 10.1212/WNL.60.3.395; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x	35	28	29	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL 26	2005	65	2					216	222		10.1212/01.wnl.0000169018.44950.68			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	949AD	WOS:000230756300008	16043789	Green Submitted			2022-02-06	
J	Fischer, C; Luaute, J				Fischer, C; Luaute, J			Evoked potentials for the prediction of vegetative state in the acute stage of coma	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	Joint Conference of the International-Neuropsychological-Society/German-Society-for-Neuropsychology	JUL 16-19, 2003	Berlin, GERMANY	Int Neuropsychol Soc, German Soc Neuropsychol			EVENT-RELATED POTENTIALS; PROGNOSTIC VALUE; MISMATCH NEGATIVITY; LATENCY; CONSCIOUSNESS	For comatose patients in intensive care units, it is important to anticipate their functional outcome as soon and as reliably as possible. Among clinical variables the Glasgow Coma Score (GCS) and the patient's pupil reactivity are the strongest predictive variables. Evoked potentials help to assess objectively brain function. Over the past 20 years, numerous studies have assessed their prognostic utility in terms of awakening from coma. Fewer studies, however, have focused upon the utility of evoked potentials in predicting progression to the vegetative state. In this area evoked potentials appear to have a highly predictive value. In anoxic coma the abolition of somatosensory evoked potentials (SEPs) is related to a poor outcome, defined as death or survival in a vegetative state, with a 100% specificity. Following traumatic brain injury, the predictive value for unfavourable outcome is 98.5% when there are no focal injuries likely to abolish SEP cortical components. In contrast, the presence of event-related evoked potentials, and particularly mismatched negativity (MMN), is a strong predictor of awakening and precludes comatose patients from moving to a permanent vegetative state (PVS).	Hop Neurol Lyon, F-69677 Bron, France; Hop H Gabrielle, Lyon, France		Fischer, C (corresponding author), Hop Neurol Lyon, 59 Blvd Pinel, F-69677 Bron, France.	catherine.fischer@chu-lyon.fr	Luaute, jacques/H-4618-2017	Luaute, jacques/0000-0002-6387-9572			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; FISCHER C, 1994, NEUROSURGERY, V35, P45, DOI 10.1227/00006123-199407000-00007; GOODWIN SR, 1991, CRIT CARE MED, V19, P518, DOI 10.1097/00003246-199104000-00011; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; JENNETT B, 1975, LANCET, V1, P480; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; KANEKO S, 2000, KINO ZAIRYO, V3, P5; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; Madl C, 2000, CRIT CARE MED, V28, P721, DOI 10.1097/00003246-200003000-00020; Mauguiere F, 1999, EEG CL N SU, V50, P31; Naatanen R, 2002, NEUROSCI LETT, V318, P49, DOI 10.1016/S0304-3940(01)02438-7; Naatanen R, 1995, Int J Neurosci, V80, P317, DOI 10.3109/00207459508986107; Nakabayashi M, 2001, INTENS CARE MED, V27, P1210, DOI 10.1007/s001340100984; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Yvert B, 2001, CEREB CORTEX, V11, P411, DOI 10.1093/cercor/11.5.411; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8; Zingler VC, 2003, EUR NEUROL, V49, P79, DOI 10.1159/000068503	26	28	35	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-SEP	2005	15	3-4					372	380		10.1080/09602010443000434			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychology	965PE	WOS:000231961900022	16350978				2022-02-06	
J	Etherton, J; Bianchini, K; Greve, K; Heinly, M				Etherton, J; Bianchini, K; Greve, K; Heinly, M			Sensitivity and specificity of reliable digit span in malingered pain-related disability	ASSESSMENT			English	Article						malingering; chronic pain; cognition; assessment; attention; back injury	ADULT INTELLIGENCE SCALE; MMPI-2 VALIDITY SCALES; FAKE BAD SCALE; NEUROCOGNITIVE DYSFUNCTION; INJURY; VALIDATION; ATTENTION	The reliable digit span (RDS) performance of chronic pain patients with unambiguous spinal injuries and no evidence of exaggeration or response bias (n = 53) was compared to that of chronic pain patients meeting criteria for definite malingered neurocognitive dysfunction (n = 35), and a group of nonmalingering moderate-severe traumatic brain injury (TBI) patients (n = 69). The results demonstrated that scores of 7 or lower were associated with high specificity (> .90) and sensitivity (up to .60) even when moderate to severe TBI are included. Multiple studies have demonstrated that RDS scores of 7 or lower rarely occur in TBI and pain patients who are not intentionally performing poorly on cognitive testing. This study supports the use of the RDS in detecting response bias in neuropsychological patients complaining of pain as well as in the assessment of pain-related cognitive impairment in patients whose primary complaint is pain.	Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; Loyola Univ, New Orleans, LA 70118 USA		Greve, K (corresponding author), Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Bianchini K. J., 2004, J FORENSIC NEUROPSYC, V4, P65; Bianchini KJ, 2003, CLIN NEUROPSYCHOL, V17, P574, DOI 10.1076/clin.17.4.574.27946; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P461, DOI 10.1076/clin.15.4.461.1890; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1993, PORTLAND DIGIT RECOG; ECCLESTON C, 1994, BRIT J CLIN PSYCHOL, V33, P535, DOI 10.1111/j.2044-8260.1994.tb01150.x; ECCLESTON C, 1995, BEHAV RES THER, V33, P391, DOI 10.1016/0005-7967(94)00057-Q; Etherton JL, 2005, ASSESSMENT, V12, P101, DOI 10.1177/1073191104270789; ETHERTON JL, IN PRESS ARCHIVES CL; GERVAIS RO, 2001, J FORENSIC NEUROPSYC, V2, DOI DOI 10.1300/J151V02N02_01; GRACELY RH, 1978, PAIN, V5, P5, DOI 10.1016/0304-3959(78)90020-9; Gracely RH, 1989, TXB PAIN, P257; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREVE K, 24 ANN M NAT AC NEUR; Greve KW, 2003, ARCH PHYS MED REHAB, V84, P1233, DOI 10.1016/S0003-9993(03)00145-X; HEINLY M, 2004, 24 ANN M NAT AC NEUR; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Langeluddecke PM, 2003, CLIN NEUROPSYCHOL, V17, P273, DOI 10.1076/clin.17.2.273.16499; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; LARRABEE GJ, 2003, J INT NEUROPSYCH SOC, V9, P282; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Meyers J E, 2000, Appl Neuropsychol, V7, P133, DOI 10.1207/S15324826AN0703_3; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Nicholson K, 2001, NEUROREHABILITATION, V16, P225; OWENS RG, 1995, AM J FORENSIC PSYCH, V13, P61; PECKERMAN A, 1991, PSYCHOPHYSIOLOGY, V28, P485, DOI 10.1111/j.1469-8986.1991.tb01985.x; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; STERN RA, 2003, NEUROPSYCHOLIGICAL A; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Thorndike R. L., 1986, STANFORD BINET INTEL; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tsushima WT, 2001, ASSESSMENT, V8, P205, DOI 10.1177/107319110100800208; Wechsler D., 1997, WECHSLER MEMORY SCAL	40	28	28	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	JUN	2005	12	2					130	136		10.1177/1073191105274859			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	928VG	WOS:000229299200002	15914715				2022-02-06	
J	Ayr, LK; Yeates, KO; Enrile, BG				Ayr, LK; Yeates, KO; Enrile, BG			Arithmetic skills and their cognitive correlates in children with acquired and congenital brain disorder	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						arithmetic; children; brain disorder	SHORT-TERM; WISC-III; MATHEMATICS; DISABILITIES; PERFORMANCE; LONDON; TOWER; ABILITY; INJURY; MEMORY	Arithmetic skills and their cognitive correlates were studied in 24 children with myelomeningocele and shunted hydrocephalus (MM), 27 children with severe traumatic brain injuries (TBI), and 26 children with orthopedic injuries (OI). Their average age was 11.56 years (SD = 2.36). They completed the WRAT-3 Arithmetic subtest and a subtraction task consisting of 20 problems of varying difficulty, as well as measures of working memory, declarative memory. processing speed, planning skills. and visuospatial abilities. The MM group performed more poorly on the WRAT-3 Arithmetic subtest and the Subtraction task than the other two groups, which did not differ from each other on either measure. The groups did not differ in the number of math fact errors or visual-spatial errors on the subtraction task, but the MM group made more procedural errors than the OI group. The five cognitive abilities explained substantial variance in performance on both arithmetic tests;, processing speed, working memory, declarative memory. and planning accounted for unique variance. Exploratory analyses showed that the cognitive correlates of arithmetic skills varied across Groups and ages. Congenital and acquired brain disorders are associated with distinct patterns of arithmetic skills. which are related to specific cognitive abilities.	Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Columbus Childrens Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; Childrens Hosp, Sect Behav & Dev Pediat, Columbus, OH USA		Yeates, KO (corresponding author), Childrens Hosp, Dept Psychol, 700 Childrens Dr, Columbus, OH 43205 USA.	yeatesk@chi.osu.edu	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03-HD36680] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD036680] Funding Source: NIH RePORTER		ASHCRAFT MH, 1992, BRAIN COGNITION, V19, P208, DOI 10.1016/0278-2626(92)90046-O; Baddeley A.D., 1994, NEUROPSYCHOLOGY, V8, P485, DOI [10.1037/0894-4105.8.4.485, DOI 10.1037/0894-4105.8.4.485]; BADIAN NA, 1983, PROGR LEARNING DISAB, P00235; Barnes MA, 2002, J INT NEUROPSYCH SOC, V8, P72, DOI 10.1017/S1355617702811079; BROOKSHIRE BL, 1995, J PEDIATR PSYCHOL, V20, P785, DOI 10.1093/jpepsy/20.6.785; Bull R, 1999, DEV NEUROPSYCHOL, V15, P421, DOI 10.1080/87565649909540759; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Bull R, 1997, J EXP CHILD PSYCHOL, V65, P1, DOI 10.1006/jecp.1996.2358; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Cirino PT, 2002, DEV NEUROPSYCHOL, V21, P201, DOI 10.1207/S15326942DN2102_6; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Dennis M, 2002, DEV NEUROPSYCHOL, V21, P141, DOI 10.1207/S15326942DN2102_2; Donders J, 1997, PSYCHOL ASSESSMENT, V9, P15; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; EWINGCOBBS L, 1998, TRAUMATIC BRAIN INJU, P11; GARNETT K, 1987, PEDIATR ANN, V16, P159, DOI 10.3928/0090-4481-19870201-09; Geary D. C., 1994, CHILDRENS MATH DEV R; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; GEARY DC, 1991, DEV PSYCHOL, V27, P787, DOI 10.1037/0012-1649.27.5.787; GEARY DC, 1991, DEV PSYCHOL, V27, P398, DOI 10.1037/0012-1649.27.3.398; Geary DC, 2004, J LEARN DISABIL-US, V37, P4, DOI 10.1177/00222194040370010201; GEARY DC, 1990, J EXP CHILD PSYCHOL, V49, P363, DOI 10.1016/0022-0965(90)90065-G; GEARY DC, 1992, J EXP CHILD PSYCHOL, V54, P372, DOI 10.1016/0022-0965(92)90026-3; Ginsburg HP, 1997, J LEARN DISABIL, V30, P20, DOI 10.1177/002221949703000102; Graham S., 1996, ATTENTION MEMORY EXE, P349; Hartje W., 1987, MATH DISABILITIES CO, P121; HECAEN H., 1961, REV NEUROL [PARIS], V105, P85; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; Jordan NC, 1997, J LEARN DISABIL-US, V30, P624, DOI 10.1177/002221949703000606; Kaemingk KL, 2004, CHILD NEUROPSYCHOL, V10, P14, DOI 10.1076/chin.10.1.14.26240; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; KOSC L, 1974, J LEARN DISABIL, V7, P164, DOI 10.1177/002221947400700309; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; MCCLOSKEY M, 1991, BRAIN COGNITION, V17, P154, DOI 10.1016/0278-2626(91)90074-I; MCCLOSKEY M, 1985, BRAIN COGNITION, V4, P171, DOI 10.1016/0278-2626(85)90069-7; McLean JF, 1999, J EXP CHILD PSYCHOL, V74, P240, DOI 10.1006/jecp.1999.2516; Passolunghi MC, 2001, J EXP CHILD PSYCHOL, V80, P44, DOI 10.1006/jecp.2000.2626; Pennington B., 1996, ATTENTION MEMORY EXE, P327; PENNINGTON BF, 1997, DEV PREFRONTAL CORTE, P2665; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P29, DOI 10.1016/S0887-6177(96)00015-7; Riccio CA, 1997, J PSYCHOEDUC ASSESS, V15, P27, DOI 10.1177/073428299701500103; Rourke BP, 1997, J LEARN DISABIL, V30, P34, DOI 10.1177/002221949703000103; ROURKE BP, 1978, J ABNORM CHILD PSYCH, V6, P121, DOI 10.1007/BF00915788; ROVET J, 1994, J CLIN EXP NEUROPSYC, V16, P820, DOI 10.1080/01688639408402696; Sikora DA, 2002, DEV NEUROPSYCHOL, V21, P243, DOI 10.1207/S15326942DN2103_2; SNOW JH, 1992, J LEARN DISABIL, V25, P265, DOI 10.1177/002221949202500408; Spiers P. A, 1987, MATH DISABILITIES CO, P1; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEMPLE CM, 1989, COGN NEUROPSYCHOL, V6, P93, DOI 10.1080/02643298908253287; Temple CM, 1998, DEV NEUROPSYCHOL, V14, P47, DOI 10.1080/87565649809540700; TEMPLE CM, 1991, COGNITIVE NEUROPSYCH, V8, P155, DOI 10.1080/02643299108253370; TEMPLE CM, 1997, DEV COGNITIVE NEUROP; VanLehn K., 1982, J MATH BEHAV, V3, P3; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; West S. G., 1991, MULTIPLE REGRESSION; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; WOODCOCK RW, 1989, WOODCOCKJOHNSON PSYC; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92	60	28	28	0	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAY	2005	11	3					249	262		10.1017/S1355617705050307			14	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	924UL	WOS:000229005900004	15892901				2022-02-06	
J	McKerracher, G; Powell, T; Oyebode, J				McKerracher, G; Powell, T; Oyebode, J			A single case experimental design comparing two memory notebook formats for a man with memory problems caused by traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							HEAD-INJURY; REHABILITATION; AID; REMEDIATION; DEFICITS; AMNESIA; PATIENT; PEOPLE; IMPAIRMENT; FRAMEWORK	There is extensive literature demonstrating that restoration of memory is not a realistic goal for rehabilitation and that efforts are more effective if focused on developing compensatory strategies. This paper compares two formats of memory notebook using an ABAB single-case experimental design with a 46-year-old man with a history of head injury. Results revealed significantly better performance on a series of prospective memory tasks for the "modified" notebook. The study highlights the importance of tailoring the diary to the patient's needs and giving careful consideration to the way in which the diary is introduced.	Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; Birmingham Childrens Hosp NHS Trust, Birmingham, W Midlands, England		Powell, T (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	t.powell@bham.ac.uk		Powell, Theresa/0000-0002-3351-9453; Oyebode, Jan/0000-0002-0263-8740			ALDERMAN N, 1995, NEUROPSYCHOL REHABIL, V5, P193, DOI 10.1080/09602019508401467; BACKMAN L, 1992, PSYCHOL BULL, V112, P259, DOI 10.1037/0033-2909.112.2.259; BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Beck AT, 1987, BECK DEPRESSION INVE; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; BOAKE C, 1987, J CLIN EXP NEUROPSYC, V9, P53; BURKE JM, 1994, BRAIN INJURY, V8, P71, DOI 10.3109/02699059409150960; CERMAK LS, 1975, NEW DIRECTIONS MEMOR; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Donaghy S, 1998, BRAIN INJURY, V12, P1061, DOI 10.1080/026990598121963; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Fluharty George, 1993, Brain Injury, V7, P85, DOI 10.3109/02699059309008160; GILES GM, 1993, BRAIN INJURY REHABIL; GLISKY EL, 1995, NEUROPSYCHOL REHABIL, V5, P299, DOI 10.1080/09602019508401474; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; GOBBLE EM, 1987, COMMUNITY REENTRY HE; GOLDSTEIN G, 1985, BEHAV MODIF, V9, P357, DOI 10.1177/01454455850093005; KAPUR N, 1995, HDB MEMORY DISORDERS, P533; Kime SK, 1996, BRAIN INJURY, V10, P17; Malec J. F., 1992, NEURO REHABILITATION, V2, P1, DOI [10.3233/NRE-1992-2303, DOI 10.3233/NRE-1992-2303]; MORLEY S, 1989, BEHAV MENTAL HLTH RE; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; PARENTE R, 1991, COGNITIVE REHABILITA; Prigatano G. P., 1991, AWARENESS DEFICIT BR; RANSEEN JD, 1987, J CLIN EXP NEUROPSYC, V9, P56; RICHARDSON JTE, 1995, NEUROPSYCHOLOGIA, V33, P1345, DOI 10.1016/0028-3932(95)00068-E; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Squires EJ, 1996, NEUROPSYCHOL REHABIL, V6, P55, DOI 10.1080/713755494; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; WILSON B, 1981, BEHAV PSYCHOTHER, V9, P338, DOI 10.1017/S0141347300008089; WILSON B, 1995, HDB MEMORY DISORDERS; Wilson B. A, 1984, CLIN MANAGEMENT MEMO, P89; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; WILSON BA, 1995, COMPENSATING PSYCHOL, P171; WILSON BA, 1991, NEUROPSYCHOL REHABIL, V1, P117, DOI DOI 10.1080/09602019108401386; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Yasuda K, 2002, NEUROPSYCHOL REHABIL, V12, P155, DOI 10.1080/09602010143000239; ZENICUS A, 1991, BRAIN INJURY, V5, P321; ZENICUS A, 1990, BRAIN INJURY, V4, P33	48	28	28	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAY	2005	15	2					115	128		10.1080/09602010443000056			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	927IE	WOS:000229186800003	16353505				2022-02-06	
J	Moinard, C; Neveux, N; Royo, N; Genthon, C; Marchand-Verrecchia, C; Plotkine, M; Cynober, L				Moinard, C; Neveux, N; Royo, N; Genthon, C; Marchand-Verrecchia, C; Plotkine, M; Cynober, L			Characterization of the alteration of nutritional state in brain injury induced by fluid percussion in rats	INTENSIVE CARE MEDICINE			English	Article						trauma; hypercatabolism; amino acids; muscles; intestine and renal failure	MUSCLE GLUTAMINE-METABOLISM; SKELETAL-MUSCLE; URINARY-EXCRETION; PROTEIN-TURNOVER; CATABOLIC STATE; AMINO-ACIDS; 3-METHYLHISTIDINE; SEPSIS; RILUZOLE; RELEASE	Objective: Patients suffering from traumatic brain injury (TBI) undergo rapid weight loss with negative nitrogen balance and enhanced whole-body protein breakdown, with protein wasting causing morbidity and increased mortality. Many experimental models of TBI have been used to evaluate strategies to improve the outcome of these patients, but nutritional status has not been considered in experiments published to date, although this may have great importance and influence the results obtained with TBI models. This study characterized the hypercatabolism level and nutritional status of TBI rats. Design: Twenty-four male Wistar rats were randomized into three groups. Rats from the TBI group were anesthetized and fluid percussion was applied. The pair-fed (PF) group was healthy but was pair-fed to the TBI group. The ad libitum (AL) group was healthy and fed ad libitum. The study was performed over 10 days post-TBI. Measurements and results: TBI in rats was characterized by remarkable long-lasting anorexia, renal failure (creatinine clearance: AL 1.8+/-0.2 and PF 1.5+/-0.1 vs. TBI 0.9+/-0.1 l/24 hour), anorexia (appetite depressed throughout the study), increased myofibrillar proteolysis (3-methylhistidine/creatinine ratio (day 2: AL 36+/-1 and PF 38+/-2 vs. TBI 54+/-5 mumol/mmol), and intestinal atrophy (ileum: AL 29.3+/-2.5 and PF 28.7+/-1.1 vs. TBI 22.5+/-1.4 mg/cm). In addition, anorexia led to muscular atrophy and decreased nitrogen balance. The metabolic alterations described above can increase morbidity and mortality. Conclusions: TBI by fluid percussion in rats is a model reproducing the metabolic and nutritional alterations observed in clinical practice and is suitable for further studies exploring the efficacy of optimized nutritional support.	Fac Pharm, Lab Biol Nutr, F-75270 Paris 06, France; Assist Publ Hop Paris, Hotel Dieu, Lab Biochim A, Paris, France; Fac Pharm, Lab Pharmacol Circulat Cerebrale EA 2510, Paris 5, France		Moinard, C (corresponding author), Fac Pharm, Lab Biol Nutr, EA 2498,4 Ave Observat, F-75270 Paris 06, France.	christophe.moinard@univ-paris5.fr	MARCHAND-LEROUX, Catherine/L-7453-2017; Cynober, Luc/ABB-2368-2020	MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; 			ALEXANDER JW, 1995, NUTRITION, V11, P229; AUSTGEN TR, 1992, J TRAUMA, V32, P600, DOI 10.1097/00005373-199205000-00011; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Blanc MC, 2000, CLIN CHEM LAB MED, V38, P465, DOI 10.1515/CCLM.2000.067; Breuille D, 1999, INFECT IMMUN, V67, P1079, DOI 10.1128/IAI.67.3.1079-1085.1999; CANO N, 1990, NUTR CLIN METAB, V4, P151; Chambon-Savanovitch C, 1999, EUR J CLIN INVEST, V29, P504, DOI 10.1046/j.1365-2362.1999.00469.x; Cooney RN, 1997, SHOCK, V7, P1, DOI 10.1097/00024382-199701000-00001; CYNOBER L, 1989, JPEN-PARENTER ENTER, V13, P196, DOI 10.1177/0148607189013002196; DRUML W, 1994, AM J CLIN NUTR, V60, P418, DOI 10.1093/ajcn/60.3.418; Felgines C, 1999, JPEN-PARENTER ENTER, V23, P32, DOI 10.1177/014860719902300132; FISCHER CP, 1995, SHOCK, V3, P315; FLEURY P, 1951, Ann Biol Clin (Paris), V9, P453; HASSELGREN PO, 1990, BIOCHEM J, V267, P37, DOI 10.1042/bj2670037; Herndon DN, 2001, NEW ENGL J MED, V345, P1223, DOI 10.1056/NEJMoa010342; HOLT PR, 1986, AM J PHYSIOL, V251, pG124, DOI 10.1152/ajpgi.1986.251.1.G124; Jeevanandam M., 1995, Amino acid metabolism and therapy in health and nutritional disease., P245; KAIYALA KJ, 1995, AM J CLIN NUTR, V62, P1123; LeBoucher J, 1997, CLIN CHEM, V43, P1421; LEBOUCHER J, 1997, AM J PHYSIOL, V273, P557; Levillain O, 1997, METABOLISM, V46, P611, DOI 10.1016/S0026-0495(97)90002-0; LONG CL, 1981, METABOLISM, V30, P765, DOI 10.1016/0026-0495(81)90022-6; MALTIN CA, 1989, AM J PHYSIOL, V257, pE823, DOI 10.1152/ajpendo.1989.257.6.E823; Mansoor O, 1996, P NATL ACAD SCI USA, V93, P2714, DOI 10.1073/pnas.93.7.2714; Martindale RG, 2001, JPEN-PARENTER ENTER, V25, pS27, DOI 10.1177/014860710102500207; Mendez C, 1996, SHOCK, V6, P7, DOI 10.1097/00024382-199607000-00003; Minet-Quinard R, 2000, JPEN-PARENTER ENTER, V24, P30, DOI 10.1177/014860710002400130; PARRYBILLINGS M, 1989, INT J BIOCHEM, V21, P419, DOI 10.1016/0020-711X(89)90366-2; PARRYBILLINGS M, 1990, LANCET, V336, P523, DOI 10.1016/0140-6736(90)92083-T; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Schlegel L, 1999, CRIT CARE MED, V27, P1511, DOI 10.1097/00003246-199908000-00019; SJOLIN J, 1989, METABOLISM, V38, P23, DOI 10.1016/0026-0495(89)90175-3; SOUBA WW, 1990, JPEN-PARENTER ENTER, V14, pS90, DOI 10.1177/014860719001400411; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; VARY TC, 1992, AM J PHYSIOL, V262, pC445, DOI 10.1152/ajpcell.1992.262.2.C445; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; Wischmeyer PE, 2001, SHOCK, V16, P398, DOI 10.1097/00024382-200116050-00014; YOUNG VR, 1978, FED PROC, V37, P2291	38	28	28	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	FEB	2005	31	2					281	288		10.1007/s00134-004-2489-9			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	896ZN	WOS:000226973400017	15703899				2022-02-06	
J	Chintamani; Khanna, J; Singh, JP; Kulshreshtha, P; Kalra, P; Priyambada, B; Mohil, RS; Bhatnagar, D				Chintamani; Khanna, Jotinder; Singh, J.; Kulshreshtha, Pranjal; Kalra, Pawan; Priyambada, Binita; Mohil, R.; Bhatnagar, Dinesh			Early tracheostomy in closed head injuries: experience at a tertiary center in a developing country - a prospective study	BMC EMERGENCY MEDICINE			English	Article								Background: An important factor contributing to the high mortality in patients with severe head trauma is cerebral hypoxia. The mechanical ventilation helps both by reduction in the intracranial pressure and hypoxia. Ventilatory support is also required in these patients because of patient's inability to protect the airway, persistence of excessive secretions, and inadequacy of spontaneous ventilation. Prolonged endotracheal intubation is however associated with trauma to the larynx, trachea, and patient discomfort in addition to requirement of sedatives. Tracheostomy has been found to play an integral role in the airway management of such patients, but its timing remains subject to considerable practice variation. In a developing country like India where the intensive care facilities are scarce and rarely available, these critical patients have to be managed in high dependency cubicles in the ward, often with inadequately trained nursing staff and equipment to monitor them. An early tracheostomy in the selected group of patients based on Glasgow Coma Score(GCS) may prove to be life saving. Against this background a prospective study was contemplated to assess the role of early tracheostomy in patients with isolated closed head injury. Methods: The series consisted of a cohort of 50 patients admitted to the surgical emergency with isolated closed head injury, that were not considered for surgery by the neuro-surgeon or shifted to ICU, but had GCS score of less than 8 and SAPS II score of more than 50. First 50 case records from January 2001 that fulfilled the criteria constituted the control group. The patients were managed as per ATLS protocol and intubated if required at any time before decision to perform tracheostomy was taken. These patients were serially assessed for GCS (worst score of the day as calculated by senior surgical resident) and SAPS scores till day 15 to chart any changes in their status of head injuries and predictive mortality. Those patients who continued to have a GCS score of < 8 and SAPS score of > 50 for more than 24 hours (to rule out concussion or recovery) underwent tracheostomy. All these patients were finally assessed for mortality rate and hospital stay, the statistical analysis was carried out using SPSS 10 version. The final outcome (in terms of mortality) was analyzed utilizing chi-square test and p value < 0.05 was considered significant. Results: At admission both tracheostomy and non-tracheostomy groups were matched with respect to GCS score and SAPS score. The average day of tracheostomy was 2.18 +/- 1.0038 days. The GCS scores on days I, 2, 3, 4, 5, 10 between tracheostomy and non-tracheostomized group were comparable. However the difference in the GCS scores was statistically significant on day 15 being higher in the tracheostomy group. Thus early tracheostomy was observed to improve the mortality rate significantly in patients with isolated closed head injury Conclusion: It may be concluded that early tracheostomy is beneficial in patients with isolated closed head injury which is severe enough to affect systemic physiological parameters, in terms of decreased mortality and intubation associated complications in centers where ICU care is not readily available. Also, in a selected group of patients, early tracheostomy may do away with the need for prolonged mechanical ventilation.	[Chintamani; Khanna, Jotinder; Singh, J.; Kulshreshtha, Pranjal; Kalra, Pawan; Priyambada, Binita; Mohil, R.; Bhatnagar, Dinesh] Safdarjang Hosp, Vardhman Mahavir Med Col, Dept Surg, New Delhi 110023, India		Chintamani (corresponding author), Safdarjang Hosp, Vardhman Mahavir Med Col, Dept Surg, New Delhi 110023, India.	chintamani7@rediffmail.com; jotinderkhanna@rediffmail.com; chintamani@doctor.com; mrinal5@rediffmsil.com; manu@scientist.com; mrinal5@rediffmail.com; mohilrs@yahoo.com; dineshbhatnagar@yahoo.com	Singh, Jai/AAE-3097-2019	Singh, Jai/0000-0003-4815-0393			Arabi Y, 2004, CRIT CARE, V8, pR347, DOI 10.1186/cc2924; Armstrong PA, 1998, SURGERY, V124, P763, DOI 10.1067/msy.1998.91224; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; COLICE GL, 1989, CHEST, V96, P877, DOI 10.1378/chest.96.4.877; DAMELIO LF, 1994, AM SURGEON, V60, P180; Gurkin MA, 2002, AM SURGEON, V68, P324; JOHNSON SB, 1992, J TRAUMA, V33, P95, DOI 10.1097/00005373-199207000-00018; Kluger Y, 1996, Eur J Emerg Med, V3, P95, DOI 10.1097/00063110-199606000-00007; LANZA DC, 1990, LARYNGOSCOPE, V100, P958; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LESNIK I, 1992, AM SURGEON, V58, P346; Lindholm CE., 1969, ACTA ANAESTH SCAND, V33, P1, DOI [10.1111/j.1399-6576.1969.tb00750.x, DOI 10.1111/J.1399-6576.1969.TB00750.X]; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; RODRIGUEZ JL, 1990, SURGERY, V108, P655; Ross BJ, 1996, AM SURGEON, V62, P19; SANTOS PM, 1994, OTOLARYNG HEAD NECK, V111, P453, DOI 10.1177/019459989411100411; STAUFFER JL, 1981, AM J MED, V70, P65, DOI 10.1016/0002-9343(81)90413-7; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Teoh WHL, 2001, ANN ACAD MED SINGAP, V30, P234; Vincent JL, 2001, J CHEMOTHERAPY, V13, P211, DOI 10.1179/joc.2001.13.Supplement-2.211; WHITED RE, 1984, LARYNGOSCOPE, V94, P367	22	28	29	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.		2005	5								8	10.1186/1471-227X-5-8			8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V54ZH	WOS:000210462400008	16236181	gold, Green Published			2022-02-06	
J	Stapert, S; de Kruijk, J; Houx, P; Menheere, P; Twijnstra, A; Jolles, J				Stapert, S; de Kruijk, J; Houx, P; Menheere, P; Twijnstra, A; Jolles, J			S-100B concentration is not related to neurocognitive performance in the first month after mild traumatic brain injury	EUROPEAN NEUROLOGY			English	Article						mild traumatic brain injury; S-100B; neurocognitive performance	NEURON-SPECIFIC ENOLASE; MINOR HEAD-INJURY; COGNITIVE DYSFUNCTION; DAMAGE; SERUM; MANAGEMENT; SYMPTOMS; AGE	The serum concentration of S-100B is reported to reflect the severity of brain damage. The purpose of this study was to determine whether elevated serum S-100B concentrations were related to neuropsychological test performance of patients in the subacute phase of recovery from mild traumatic brain injury (TBI). S-100B concentrations were measured in blood samples taken within 6 h after TBI. Serum S-100B was estimated using an immunoluminometric assay. Cognitive speed and memory were assessed with neuropsychological tests at a median of 13 days ( range 7 - 21 days) after injury. The two groups, formed on a median split of initial serum S-100B concentrations (> or <0.22 mu g/l) did not differ in age or education. The neuropsychological performance of the TBI patients was also compared with that of a healthy control group. Cognitive speed and memory performance of mild TBI patients were inferior compared to those of healthy subjects. There were no significant differences within the TBI group when serum S-100B concentration was taken into consideration. The findings suggest that serum S-100B levels after mild TBI are not predictive of neuropsychological performance in the subacute stage of recovery. Copyright (C) 2005 S. Karger AG, Basel.	Maastricht Univ, Dept Psychol, Inst Brain & Behav, NL-6200 MD Maastricht, Netherlands; Univ Hosp, Dept Neurol, Maastricht, Netherlands		Stapert, S (corresponding author), Maastricht Univ, Dept Psychol, Inst Brain & Behav, POB 616, NL-6200 MD Maastricht, Netherlands.	S.Stapert@psychology.unimaas.nl					Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; Bosma H, 2000, LANCET, V356, P912, DOI 10.1016/S0140-6736(00)02685-4; BRAND N, 1985, J GEN PSYCHOL, V112, P201, DOI 10.1080/00221309.1985.9711004; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; HOUX PJ, 1991, ALZHEIMERS DISEASE : BASIC MECHANISMS, DIAGNOSIS AND THERAPEUTIC STRATEGIES, P353; Ingebrigtsen T, 1997, ACTA NEUROL SCAND, V95, P51, DOI 10.1111/j.1600-0404.1997.tb00068.x; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Klein M, 1997, J CLIN EXP NEUROPSYC, V19, P77, DOI 10.1080/01688639708403838; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Rasmussen LS, 1999, ACTA ANAESTH SCAND, V43, P495, DOI 10.1034/j.1399-6576.1999.430502.x; van Exel E, 2001, J NEUROL NEUROSUR PS, V71, P29, DOI 10.1136/jnnp.71.1.29; Waterloo K, 1997, ACTA NEUROCHIR, V139, P26, DOI 10.1007/BF01850864	27	28	29	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022	1421-9913		EUR NEUROL	Eur. Neurol.		2005	53	1					22	26		10.1159/000083678			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	912JL	WOS:000228073900004	15677870	Green Published			2022-02-06	
J	Steele, DL; Rajaratnam, SMW; Redman, JR; Ponsford, JL				Steele, DL; Rajaratnam, SMW; Redman, JR; Ponsford, JL			Effect of traumatic brain injury on the timing of sleep	CHRONOBIOLOGY INTERNATIONAL			English	Article						traumatic brain injury; dim light melatonin onset time; morningness-eveningness; circadian rhythm sleep disorders; sleep disruption	BIOLOGICAL RHYTHM RESEARCH; HUMAN CIRCADIAN-RHYTHMS; LIGHT MELATONIN ONSET; MORNINGNESS-EVENINGNESS; PHASE SYNDROME; INDIVIDUAL-DIFFERENCES; ASSOCIATION; TEMPERATURE; EXPOSURE; DAYTIME	While there have been single case reports of the development of circadian rhythm sleep disorders, most commonly delayed sleep phase syndrome following traumatic brain injury (TBI), to our knowledge there have been no group investigations of changes to sleep timing in this population. The aim of the present study was to investigate sleep timing following TBI using the dim light melatonin onset (DLMO) as a marker of circadian phase and the Morningness-Eveningness Questionnaire (MEQ) as a measure of sleep-wake behavior. A sleep-wake diary was also completed. It was hypothesized that the timing of DLMO would be delayed and that there would be a greater tendency toward eveningness on the MEQ in a post-acute TBI group (n = 10) compared to a gender and age matched control group. Participants were recruited at routine outpatient review appointments (TBI) and from the general population (control) as part of a larger study. They attended the sleep laboratory where questionnaires were completed, some retrospectively, and saliva melatonin samples were collected half-hourly according to a standard protocol. The results show that the TBI and control groups reported similar habitual sleep times and this was reflected on the MEQ. There was, however, significant variability in the TBI group's change from the pre-injury to the current MEQ score. The timing of melatonin onset was not different between the groups. While subtle changes (advances or delays) in this small sample may have cancelled each other out, the present study does not provide conclusive objective evidence of shift in circadian timing of sleep following TBI. Furthermore, although participants did report sleep timing changes, it is concluded that the MEQ may not be suitable for use with this cognitively impaired clinical group.	Monash Univ, Sch Psychol Psychiat & Psychol Med, Melbourne, Vic 3800, Australia; Epworth Med Fdn, Monash Epworth Res Dept, Melbourne, Vic, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol Psychiat & Psychol Med, Bldg 17,Clayton Campus, Melbourne, Vic 3800, Australia.	jennie.ponsford@med.monash.edu.au	Sanguansri, Luz/B-6630-2011; Rajaratnam, Shantha/D-8144-2012	Sanguansri, Luz/0000-0003-1908-7604; Rajaratnam, Shantha/0000-0001-7527-8558			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ASCHOFF J, 1965, SCIENCE, V148, P1427, DOI 10.1126/science.148.3676.1427; Baehr EK, 2000, J SLEEP RES, V9, P117, DOI 10.1046/j.1365-2869.2000.00196.x; Baker S, 2000, PRINCIPLES PRACTICE, V3, P606; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Boivin DB, 2003, NEUROLOGY, V60, P1841, DOI 10.1212/01.WNL.0000061482.24750.7C; Cajochen C, 1996, NEUROSCI LETT, V207, P209, DOI 10.1016/0304-3940(96)12517-9; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; CZEISLER CA, 1981, SLEEP, V4, P1; Czeisler CA, 2000, PRINCIPLES PRACTICE, P353; Dagan Y, 2002, SLEEP MED REV, V6, P45, DOI 10.1053/smrv.2001.0190; DEACON S, 1994, NEUROSCI LETT, V167, P191, DOI 10.1016/0304-3940(94)91059-6; Dijk DJ, 1997, J BIOL RHYTHM, V12, P627, DOI 10.1177/074873049701200618; DOLLINS AB, 1994, P NATL ACAD SCI USA, V91, P1824, DOI 10.1073/pnas.91.5.1824; Duffy JF, 1996, J PHYSIOL-LONDON, V495, P289, DOI 10.1113/jphysiol.1996.sp021593; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Gordijn MCM, 1999, J SLEEP RES, V8, P163, DOI 10.1046/j.1365-2869.1999.00156.x; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Katzenberg D, 1998, SLEEP, V21, P569, DOI 10.1093/sleep/21.6.569; Kayumov L, 2000, Semin Clin Neuropsychiatry, V5, P44; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lewy AJ, 1999, BIOL SIGNAL RECEPT, V8, P79; Martin G, 2002, IEEE DES TEST COMPUT, V19, P4, DOI 10.1109/MDT.2002.1047738; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Middleton B, 1996, J SLEEP RES, V5, P69, DOI 10.1046/j.1365-2869.1996.d01-67.x; Monk TH, 2003, SLEEP, V26, P208, DOI 10.1093/sleep/26.2.208; Moore RY, 2002, CELL TISSUE RES, V309, P89, DOI 10.1007/s00441-002-0575-2; Nagtegaal JE, 1997, FUNCT NEUROL, V12, P345; Nebel LE, 1996, PSYCHOPHYSIOLOGY, V33, P273, DOI 10.1111/j.1469-8986.1996.tb00424.x; NEUBAUER AC, 1992, PERS INDIV DIFFER, V13, P125, DOI 10.1016/0191-8869(92)90035-N; Ostberg O., 1976, INT J CHRONOBIOL, V4, P97; PATTEN SB, 1992, J AM ACAD CHILD PSY, V31, P100, DOI 10.1097/00004583-199201000-00015; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P1; Quinto C, 2000, NEUROLOGY, V54, P250, DOI 10.1212/WNL.54.1.250; REGESTEIN QR, 1995, AM J PSYCHIAT, V152, P602; SIEGEL S, NONPARAMETIC STAT, P102; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; TEASDALE G, 1974, LANCET, V2, P81; Touitou Y, 2004, CHRONOBIOL INT, V21, P161, DOI 10.1081/CBI-120030045; Tryon WW, 2004, SLEEP, V27, P158, DOI 10.1093/sleep/27.1.158; TUREK FW, 1995, NEUROSCI BIOBEHAV R, V19, P53, DOI 10.1016/0149-7634(94)00030-5; TZISCHINSKY O, 1993, J BIOL RHYTHM, V8, P199, DOI 10.1177/074873049300800303; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; WIGHT KP, 2001, P NATL ACAD SCI USA, V98, P14027; Yang CM, 2001, SLEEP, V24, P272, DOI 10.1093/sleep/24.3.272; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	28	29	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0742-0528	1525-6073		CHRONOBIOL INT	Chronobiol. Int.		2005	22	1					89	105		10.1081/CBI-200042428			17	Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Life Sciences & Biomedicine - Other Topics; Physiology	922DE	WOS:000228815300008	15865324				2022-02-06	
J	Wolfson, DR; McNally, DS; Clifford, MJ; Vloeberghs, M				Wolfson, DR; McNally, DS; Clifford, MJ; Vloeberghs, M			Rigid-body modelling of shaken baby syndrome	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF ENGINEERING IN MEDICINE			English	Article						shaken baby syndrome; rigid-body modelling; head injury; MADYMO; whiplash; neck model	PERMANENT BRAIN-DAMAGE; MENTAL-RETARDATION; IMPACT SYNDROME; HEAD-INJURY; SHAKING; INFANTS; CRITERIA; CHILDREN; MASS	Recent reassessment of the literature on the shaken baby syndrome (SBS) has revealed a lack of scientific evidence and understanding of all aspects of the syndrome. In particular, studies have been unable to clarify the mechanisms of injury, indicating that impact, rather than shaking alone, is necessary to cause the type of brain damage observed. Rigid-body modelling (RBM) was used to investigate the effect of neck stiffness on head motion and head-torso impacts as a possible mechanism of injury. Realistic shaking data obtained from an anthropometric test dummy (ATD) was used to simulate shaking. In each study injury levels for concussion were exceeded, though impact-type characteristics were required to do so in the neck stiffness study. Levels for the type of injury associated with the syndrome were not exceeded. It is unlikely that further gross biornechanical investigation of the syndrome will be able to significantly contribute to the understanding of SBS. Current injury criteria are based on high-energy, single-impact studies. Since this is not the type of loading in SBS it is suggested that their application here is inappropriate and that future studies should focus on injury mechanisms in low-energy cyclic loading.	Univ Nottingham, Inst Biomech, Sch M3, Nottingham NG7 2RD, England		Wolfson, DR (corresponding author), Univ Nottingham, Inst Biomech, Sch M3, Univ Pk, Nottingham NG7 2RD, England.	eaxdrw@nottingham.ac.uk	Clifford, Mike/AAC-7945-2019; clifford, mike/D-3736-2013; McNally, Donal S/B-2181-2012	Clifford, Mike/0000-0001-6379-2672; McNally, Donal S/0000-0002-2436-0831			Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Conway EE, 1998, PEDIATR ANN, V27, P677, DOI 10.3928/0090-4481-19981001-11; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; Donohoe M, 2003, AM J FOREN MED PATH, V24, P239, DOI 10.1097/01.paf.0000083635.85457.97; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Geddes JF, 2004, BMJ-BRIT MED J, V328, P719, DOI 10.1136/bmj.328.7442.719; GEDEIT RG, 2001, J AGGRESSION MALTREA, V5, P155; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Harding B, 2004, BMJ-BRIT MED J, V328, P720, DOI 10.1136/bmj.328.7442.720; HENNES H, 2001, J AGGRESS MALTREAT T, V5, P19, DOI DOI 10.1300/J146V05N01_03; JENSEN RK, 1986, J BIOMECH, V19, P359, DOI 10.1016/0021-9290(86)90012-6; King WJ, 2003, CAN MED ASSOC J, V168, P155; Klinich K.D., 1996, TECHNIQUES DEV CHILD; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Ommaya A.K., 1985, BIOMECHANICS TRAUMA, P245; SCHNEIDER K, 1992, J BIOMECH, V25, P145, DOI 10.1016/0021-9290(92)90271-2; SUN H, 1994, J BIOMECH, V27, P265, DOI 10.1016/0021-9290(94)90003-5; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; THIBAULT LE, 1985, 10 INT C EXP SAF VEH	24	28	28	0	17	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0954-4119	2041-3033		P I MECH ENG H	Proc. Inst. Mech. Eng. Part H-J. Eng. Med.	JAN	2005	219	H1					63	70		10.1243/095441105X9237			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	910LH	WOS:000227932400007	15777058				2022-02-06	
J	Green, LB; Hornyak, JE; Hurvitz, EA				Green, LB; Hornyak, JE; Hurvitz, EA			Amantadine in pediatric patients with traumatic brain injury - A retrospective, case-controlled study	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						rehabilitation; traumatic brain injury; amantadine; pediatric	FRONTAL-LOBE DYSFUNCTION; CEREBRAL-CORTEX; NMDA RECEPTOR; HYDROCHLORIDE; ANTAGONIST; THERAPY; STATE	Objective: To determine if amantadine use in pediatric patients with traumatic brain injury is well tolerated and to attempt to assess its effectiveness. Design: This was a retrospective, case-controlled study. Results: Of the 54 patients, aged 3-18 yrs, who were administered amantadine, five (9%) had side effects that might have been related to the drug. These included hallucinations, delusions, increased aggression, and nausea/vomiting. The side effects were reversed when the medication was stopped or the dosage decreased. Patients in the amantadine group had a greater increase in Ranchos Los Amigos level during their admission than those in the control group (median, 3 vs. 2; P < 0.01). This difference may be, at least in part, explained by the fact that the amantadine group started at a lower Ranchos Los Amigos level (median, 3 vs. 4; P < 0.01). There were subjective improvements noted in 29 of the 46 patients (63%) in the amantadine group whose full charts were available for review. Conclusion: Amantadine is a well tolerated medication when it is used in pediatric patients with traumatic brain injury. Subjective improvements were noted in the majority of the patients administered amantadine, and the amantadine group showed a greater improvement in Ranchos Los Amigos level during admission, suggesting that it may be effective.	Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48103 USA		Green, LB (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower, Ann Arbor, MI 48103 USA.						ALLEN RM, 1983, CLIN NEUROPHARMACOL, V6, pS64; AOKI FY, 1988, CLIN PHARMACOKINET, V14, P35, DOI 10.2165/00003088-198814010-00003; BROWN RM, 1979, BRAIN RES, V168, P133, DOI 10.1016/0006-8993(79)90132-X; CHANDLER M, 1988, BRAIN INJURY, V4, P309; EDBY K, 1995, CHILD NERV SYST, V11, P607, DOI 10.1007/BF00301001; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; HERRMANN EC, 1960, P SOC EXP BIOL MED, V103, P625, DOI 10.3181/00379727-103-25617; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; KRACH LE, 1999, PEDIAT REHABILITATIO, P245; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; NICKELS JL, 1998, BRAIN INJURY, V8, P708; Patrick PD, 2003, BRAIN INJURY, V17, P497, DOI 10.1080/0269905031000070279; PEARLSON GD, 1981, BRAIN RES, V218, P233, DOI 10.1016/0006-8993(81)91303-2; Rao VLR, 2001, BRAIN RES, V911, P96; Schneider WN, 1999, BRAIN INJURY, V13, P863; SCHWAB RS, 1969, J AMER MED ASSOC, V208, P1168, DOI 10.1001/jama.208.7.1168; VANREEKUM R, 1995, BRAIN INJURY, V9, P49, DOI 10.3109/02699059509004571; VECHT CJ, 1975, ARCH NEUROL-CHICAGO, V32, P792, DOI 10.1001/archneur.1975.00490540036004; WELLER M, 1992, MED HYPOTHESES, V38, P329, DOI 10.1016/0306-9877(92)90027-A; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zafonte RD, 2001, J HEAD TRAUMA REHAB, V16, P112, DOI 10.1097/00001199-200102000-00014	23	28	29	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	2004	83	12					893	897		10.1097/01.PHM.0000143400.15346.C8			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	874HB	WOS:000225340400003	15624567				2022-02-06	
J	Ebel, BE; Mack, C; Diehr, P; Rivara, FP				Ebel, BE; Mack, C; Diehr, P; Rivara, FP			Lost working days, productivity, and restraint use among occupants of motor vehicles that crashed in the United States	INJURY PREVENTION			English	Article							TRAUMATIC BRAIN-INJURY; SEAT-BELTS; RETURN; CONSEQUENCES; DISABILITY; SEVERITY; OUTCOMES; HANDICAP	Background: In 2001, 6.3 million passengers were involved in motor vehicle crashes. This study aimed to determine the number of work days lost as a result of motor vehicle crashes and factors that influenced people's return to work. Methods: This was a retrospective, population based cohort study of occupants in motor vehicles involved in crashes from the 1993-2001 Crashworthiness Data System produced by the National Highway Traffic Safety Administration. The sample population of people aged 18-65 years included two groups: occupants who survived and were working before the crash and occupants who were injured fatally and were estimated to have been working before the crash. Multivariate linear regression was used to analyze the impact of restraint use and injury type on return to work. Results: Overall, 30.1% of occupants of vehicles that crashed missed one or more days of work. A crash resulted in a mean 28.0 (95% confidence interval 15.8 to 40.1) days lost from work, including losses associated with fatalities. The 2.1 million working occupants of vehicles that crashed in 2001 lost a total of 60 million days of work, resulting in annual productivity losses of over $7.5 billion ( 2964 to 12 075). Unrestrained vehicle occupants accounted for $5.6 billion in lost productivity. Conclusions: Motor vehicle crashes result in large and potentially preventable productive losses that are mostly attributable to fatal injuries.	Univ Washington, Dept Pediat, Seattle, WA 98104 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98104 USA; Univ Washington, Harborview Injury Prevent & Res Ctr, Div Gen Res, Seattle, WA 98104 USA		Ebel, BE (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Div Gen Res, 325 9th Ave,Box 359960, Seattle, WA 98104 USA.	bebel@u.washington.edu	Ebel, Beth/F-4544-2014	Ebel, Beth/0000-0001-9310-8325			Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; *BUR LAB STAT, 2003, HISPANIC LATINO ETHN; CAMPBELL BJ, 1987, J TRAUMA, V27, P733, DOI 10.1097/00005373-198707000-00007; *CDCP, 2003, WISQARS WEB BAS INJ; COOPER PJ, 1994, ACCIDENT ANAL PREV, V26, P263, DOI 10.1016/0001-4575(94)90096-5; Cummings P, 2003, ACCIDENT ANAL PREV, V35, P143, DOI 10.1016/S0001-4575(01)00087-2; Currens JAB, 2000, INJURY, V31, P99, DOI 10.1016/S0020-1383(99)00246-6; Engels JM, 2003, J CLIN EPIDEMIOL, V56, P968, DOI 10.1016/S0895-4356(03)00170-7; Gold M., 1996, COST EFFECTIVENESS H; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; MACKENZIE EJ, 1993, J TRAUMA, V34, P528, DOI 10.1097/00005373-199304000-00009; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; MARINE WM, 1994, J TRAUMA, V36, P96, DOI 10.1097/00005373-199401000-00015; Mason S, 2002, J TRAUMA, V53, P98, DOI 10.1097/00005373-200207000-00019; MCGEE DL, 1989, STAT MED, V8, P379, DOI 10.1002/sim.4780080319; MILLER TR, 1993, ACCIDENT ANAL PREV, V25, P593, DOI 10.1016/0001-4575(93)90011-K; Mock C, 2000, J TRAUMA, V49, P1002, DOI 10.1097/00005373-200012000-00005; *NAT CTR STAT AN, 2003, CRASHW DAT SYST; NEWMAN RJ, 1986, J TRAUMA, V26, P561, DOI 10.1097/00005373-198606000-00014; ORSAY EM, 1990, ANN EMERG MED, V19, P258; Rivara FP, 2000, JAMA-J AM MED ASSOC, V283, P2826, DOI 10.1001/jama.283.21.2826; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; van der Sluis CK, 1998, INJURY, V29, P281, DOI 10.1016/S0020-1383(97)00199-X; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470	26	28	29	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047			INJURY PREV	Inj. Prev.	OCT	2004	10	5					314	319		10.1136/ip.2004.005850			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	869MT	WOS:000224989300012	15470014	Green Published, Bronze			2022-02-06	
J	Clausen, T; Scharf, A; Menzel, M; Soukup, J; Holz, C; Rieger, A; Hanisch, F; Brath, E; Nemeth, N; Miko, I; Vajkoczy, P; Radke, J; Henze, D				Clausen, T; Scharf, A; Menzel, M; Soukup, J; Holz, C; Rieger, A; Hanisch, F; Brath, E; Nemeth, N; Miko, I; Vajkoczy, P; Radke, J; Henze, D			Influence of moderate and profound hyperventilation on cerebral blood flow, oxygenation and metabolism	BRAIN RESEARCH			English	Article						hyperventilation; cerebral metabolism; cerebral blood flow; microdialysis; multimodal monitoring	TRAUMATIC BRAIN-INJURY; CARBON-DIOXIDE; HEAD-INJURY; HEMORRHAGIC-SHOCK; NITROUS-OXIDE; TISSUE PO2; INTRACRANIAL-PRESSURE; GLOBAL-ISCHEMIA; AUTO-REGULATION; CO2 REACTIVITY	Objective: The aim of the present study was to examine the impact of moderate and profound hyperventilation on regional cerebral blood flow (rCBF), oxygenation and metabolism. Materials and methods: Twelve anesthetized pigs were subjected to moderate (mHV) and profound (pHV) hyperventilation (target arterial pO(2): 30 and 20 mmHg, respectively) for 30 min each, after baseline normoventilation (BL) for 1 h. Local cerebral extracellular fluid (ECF) concentrations of glucose, lactate, pyruvate and glutamate as well as brain tissue oxygenation (p(ti)O(2)) were monitored using microdialysis and a Licox oxygen sensor, respectively. In nine pigs, regional cerebral blood flow (rCBF) was also continuously measured via a thermal diffusion system. Results: Both moderate and profound hyperventilation resulted in a significant decrease in rCBF (BL: 37.9 +/- 4.3 ml/100 g/min; mHV: 29.4 +/- 3.6 ml/100 g/min; pHV: 23.6 +/- 4.7 ml/100 g/min; p < 0.05) and p(ti)O(2) (BL: 22.7 +/- 4.1 mmHg; mHV: 18.9 +/- 4.9 mmHg; pHV: 13.0 +/- 2.2 mmHg; p < 0.05). A p(ti)O(2) decrease below the critical threshold of 10 mmHg was induced in three animals by moderate hyperventilation and in five animals by profound hyperventilation. Furthermore, significant increases in lactate (BL: 1.06 +/- 0.18 mmol/l; mHV: 1.36 +/- 0.20 mmol/l; pHV: 1.67 +/- 0.17 mmol/l; p < 0.005), pyruvate (BL: 46.4 +/- 7.8 mumol/l; mHV: 58.0 +/- 10.3 mumol/l; pHV: 66.1 +/- 12.7 mumol/l; p < 0.05), and lactate/glucose ratio were observed during hyperventilation. (Data are presented as mean +/- S.E.M.) Conclusions: Both moderate and profound hyperventilation may result in insufficient regional oxygen supply and anaerobic metabolism, even in the uninjured brain. Therefore, the use of hyperventilation cannot be considered as a safe procedure and should either be avoided or used with extreme caution. (C) 2004 Elsevier B.V. All rights reserved.	Univ Halle Wittenberg, Dept Anesthesia & Intens Care Med, D-06120 Halle An Der Saale, Germany; Univ Halle Wittenberg, Dept Neurosurg, Halle An Der Saale, Saale, Germany; Univ Halle Wittenberg, Dept Neurol, Halle An Der Saale, Saale, Germany; Univ Debrecen, Dept Operat Tech & Surg Res, H-4012 Debrecen, Hungary; Hlth Sci Ctr, H-4012 Debrecen, Hungary; Heidelberg Univ, Univ Hosp Mannheim, Dept Neurosurg, D-6800 Mannheim, Germany		Clausen, T (corresponding author), Univ Halle Wittenberg, Dept Anesthesia & Intens Care Med, Ernst Grube Str 40, D-06120 Halle An Der Saale, Germany.	tobias.clausen@medizin.uni-halle.de	Nemeth, Norbert/AAX-8704-2020	Nemeth, Norbert/0000-0002-1162-3778			AKESON J, 1993, ACTA ANAESTH SCAND, V37, P85; ALBERTI E, 1975, BRIT J ANAESTH, V47, P941, DOI 10.1093/bja/47.9.941; Allen CH, 1998, CRIT CARE CLIN, V14, P485, DOI 10.1016/S0749-0704(05)70012-9; ARCHER DP, 1990, ANESTHESIOLOGY, V72, P1031, DOI 10.1097/00000542-199006000-00013; ARCHER DP, 1990, ANESTHESIOLOGY, V73, P798; ARTRU AA, 1989, ANESTHESIOLOGY, V70, P288, DOI 10.1097/00000542-198902000-00018; BAKER AJ, 1991, J NEUROCHEM, V57, P1370, DOI 10.1111/j.1471-4159.1991.tb08303.x; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; CRUZ J, 1995, J NEUROSURG, V82, P379, DOI 10.3171/jns.1995.82.3.0379; DIETRICH HH, 1994, AM J PHYSIOL, V266, pH1681; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; DRUMMOND JC, 1987, ANESTH ANALG, V66, P1083; DRUMMOND WH, 1981, J PEDIATR-US, V98, P603, DOI 10.1016/S0022-3476(81)80775-5; Edge JA, 1996, BRIT J HOSP MED, V55, P508; FOX J, 1992, ANESTHESIOLOGY, V77, P453, DOI 10.1097/00000542-199209000-00008; Goodman JC, 1996, ACT NEUR S, V67, P37; GROTE J, 1981, PFLUG ARCH EUR J PHY, V391, P195, DOI 10.1007/BF00596170; HARADA J, 1991, J NEUROSURG, V75, P103, DOI 10.3171/jns.1991.75.1.0103; HEFFNER JE, 1983, ARCH INTERN MED, V143, P765, DOI 10.1001/archinte.143.4.765; Hemphill JC, 2001, NEUROSURGERY, V48, P377, DOI 10.1097/00006123-200102000-00028; Huttunen J, 1999, EXP BRAIN RES, V125, P248, DOI 10.1007/s002210050680; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; JOHNSON JD, 1986, TOXICOL APPL PHARM, V84, P464, DOI 10.1016/0041-008X(86)90251-6; JOHNSON JD, 1987, TOXICOL APPL PHARM, V88, P217, DOI 10.1016/0041-008X(87)90007-X; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; LUNDBERG N, 1959, Acta Psychiatr Scand Suppl, V34, P1; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; Marion DW, 2000, J TRAUMA, V48, P1032; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Oertel M, 2002, ACT NEUR S, V81, P71; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; ROSENBERG AA, 1988, STROKE, V19, P1365, DOI 10.1161/01.STR.19.11.1365; SATO M, 1984, STROKE, V15, P91, DOI 10.1161/01.STR.15.1.91; Schmid-Elsaesser R, 1999, J NEUROL SCI, V162, P14, DOI 10.1016/S0022-510X(98)00300-1; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; TOMINAGA S, 1976, STROKE, V7, P507, DOI 10.1161/01.STR.7.5.507; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Valtysson J, 1998, ACTA NEUROCHIR, V140, P387, DOI 10.1007/s007010050113; VANICKY I, 1992, NEUROSCI LETT, V135, P167, DOI 10.1016/0304-3940(92)90428-A; YOUNG WL, 1991, BRIT J ANAESTH, V67, P440, DOI 10.1093/bja/67.4.440; ZAUNER A, 1995, NEUROSURGERY, V37, P1168, DOI 10.1227/00006123-199512000-00017	49	28	32	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 3	2004	1019	1-2					113	123		10.1016/j.brainres.2004.05.099			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	851UI	WOS:000223710800014	15306245				2022-02-06	
J	Johnson, EA; Svetlov, SI; Pike, BR; Tolentino, PJ; Shaw, G; Wang, KKW; Hayes, RL; Pineda, JA				Johnson, EA; Svetlov, SI; Pike, BR; Tolentino, PJ; Shaw, G; Wang, KKW; Hayes, RL; Pineda, JA			Cell-specific upregulation of survivin after experimental traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; neuron; PCNA; survivin; traumatic brain injury	MULTIPLE SEQUENCE ALIGNMENT; CONTROLLED CORTICAL IMPACT; ANTI-APOPTOSIS GENE; REACTIVE ASTROCYTES; PROTEIN SURVIVIN; AXONAL INJURY; STEM-CELLS; ADULT-RAT; CYCLIN D1; EXPRESSION	In this study, we examined the expression and cellular localization of survivin and proliferating cell nuclear antigen (PCNA) after controlled cortical impact traumatic brain injury (TBI) in rats. There was a remarkable and sustained induction of survivin mRNA and protein in the ipsilateral cortex and hippocampus of rats after TBI, peaking at five days post injury. In contrast, both survivin mRNA and protein were virtually undetectable in craniotomy control animals. Concomitantly, expression of PCNA was also significantly enhanced in the ipsilateral cortex and hippocampus of these rats with similar temporal and spatial patterns. Immunohistochemistry revealed that survivin and PCNA were co-expressed in the same cells and had a focal distribution within the injured brain. Further analysis revealed a frequent co-localization of survivin and GFAP, an astrocytic marker, in both the ipsilateral cortex and hippocampus, while a much smaller subset of cells showed co-localization of survivin and NeuN, a mature neuronal marker. Neuronal localization of survivin was observed predominantly in the ipsilateral cortex and contralateral hippocampus after TBI. PCNA protein expression was detected in both astrocytes and neurons of the ipsilateral cortex and hippocampus after TBI. Collectively these data demonstrate that the anti-apoptotic protein survivin, previously characterized in cancer cells, is abundantly expressed in brain tissues of adult rats subjected to TBI. We found survivin expression in both astrocytes and a sub-set of neurons. In addition, the expression of survivin was co-incident with PCNA, a cell cycle protein. This suggests that survivin may be involved in regulation of neural cell proliferative responses after traumatic brain injury.	Univ Florida, EF & WL McKnight Brain Inst, Dept Pediat, Gainesville, FL 32610 USA; Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; Univ Florida, Dept Neurosurg, Gainesville, FL 32610 USA; Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA		Pineda, JA (corresponding author), Univ Florida, EF & WL McKnight Brain Inst, Dept Pediat, 100 S Newell Dr,Bldg 59,L1-118, Gainesville, FL 32610 USA.	pinedja@peds.ufl.edu	Pineda, Jose/W-2806-2019; , Gerry/X-2377-2019	Wang, Kevin/0000-0002-9343-6473			Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 1999, LAB INVEST, V79, P1327; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Conway EM, 2000, BLOOD, V95, P1435, DOI 10.1182/blood.V95.4.1435.004k01_1435_1442; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; GIULIAN D, 1991, NEUR CONT B, V6, P73; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Jiang XY, 2001, J CELL BIOCHEM, V83, P342, DOI 10.1002/jcb.1228; Kaya SS, 1999, J NEUROTRAUM, V16, P1187, DOI 10.1089/neu.1999.16.1187; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li FZ, 1999, CANCER RES, V59, P3143; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; MIYAKE T, 1992, BRAIN RES, V590, P300, DOI 10.1016/0006-8993(92)91109-R; Muchmore SW, 2000, MOL CELL, V6, P173, DOI 10.1016/S1097-2765(00)00018-6; Norton WT, 1999, NEUROCHEM RES, V24, P213, DOI 10.1023/A:1022505903312; Otaki M, 2000, BBA-GENE STRUCT EXPR, V1493, P188, DOI 10.1016/S0167-4781(00)00142-1; Peterson DA, 2002, CURR OPIN PHARMACOL, V2, P34, DOI 10.1016/S1471-4892(01)00118-7; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sasaki T, 2002, ACTA NEUROPATHOL, V104, P105, DOI 10.1007/s00401-002-0532-x; Shankar SL, 2001, J NEUROCHEM, V79, P426, DOI 10.1046/j.1471-4159.2001.00596.x; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Smith C, 2001, EUR J NEUROSCI, V13, P443, DOI 10.1046/j.1460-9568.2001.01400.x; Stone JR, 2002, J NEUROTRAUM, V19, P601, DOI 10.1089/089771502753754073; Sykova E, 1999, GLIA, V25, P56, DOI 10.1002/(SICI)1098-1136(19990101)25:1<56::AID-GLIA6>3.0.CO;2-4; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tamm I, 1998, CANCER RES, V58, P5315; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolentino PJ, 2002, J NEUROCHEM, V80, P579, DOI 10.1046/j.0022-3042.2001.00726.x; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Wei LH, 2001, INT J GYNECOL CANCER, V11, P81, DOI 10.1046/j.1525-1438.2001.011001081.x; Wu Q, 2000, NEUROBIOL AGING, V21, P797, DOI 10.1016/S0197-4580(00)00219-0; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001	53	28	30	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	2004	21	9					1183	1195		10.1089/neu.2004.21.1183			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	855HC	WOS:000223962900007	15453988				2022-02-06	
J	Yablon, SA; Rock, WA; Nick, TG; Sherer, M; McGrath, CM; Goodson, KH				Yablon, SA; Rock, WA; Nick, TG; Sherer, M; McGrath, CM; Goodson, KH			Deep vein thrombosis - Prevalence and risk factors in rehabilitation admissions with brain injury	NEUROLOGY			English	Article							POSTOPERATIVE VENOUS THROMBOEMBOLISM; D-DIMER; TRAUMA PATIENTS; PULMONARY-EMBOLISM; PROFILE; TUMORS; HYPERCOAGULABILITY; LIMITATIONS; PROPHYLAXIS; PREVENTION	Objective: To determine the prevalence and risk factors of deep vein thrombosis (DVT) among neurorehabilitation admissions with acquired brain injury (BI). Methods: In this prospective, sequential case series, 709 consecutive initial neurorehabilitation patients with BI < 120 days-including, traumatic brain injury (TBI; n = 360), intracranial hemorrhage (ICH; n = 213), primary brain tumor (n = 66), and hypoxia/other BI (n = 70)-were screened for evidence of DVT with lower extremity venous duplex ultrasonography (VDU). The admission screening protocol combined VDU and a commercial D-dimer (Dimertest(R) [DDLx]) latex agglutination assay. DVT was considered present based upon VDU results only. Results: DVT prevalence was 11.1%, and was higher with brain tumor (21.2%) and ICH (16%) then with TBI (6.7%) (chi(2) test; p = 0.001). DVT risk factors identified by multivariable logistic regression analysis in the overall sample included older age (p = 0.002), type of BI (p = 0.04), DDLx (p = 0.0001), and greater postinjury duration (p = 0.0001), with a trend observed regarding lower Functional Independence Measure (FIM) locomotion (FIM-Loco) subscale score (p = 0.07) However, risk factors also varied with type of BI. Among patients with TBI, only DDLx (p = 0.001) and greater postinjury duration (p 0.001) were associated with DVT. Conclusions: Admission venous duplex ultrasonography revealed occult proximal lower extremity deep vein thrombosis in 11% of neurorehabilitation patients with acquired brain injury. Deep vein thrombosis risk is multifactorial in this heterogenous patient population, with relative factor risk influenced by type of acquired brain injury. Semiquantitative D-dimer latex agglutination assay correlated significantly with presence of deep vein thrombosis.	Univ Mississippi, Med Ctr, Brain Injury Program, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Methodist Rehabil Ctr, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Neurosurg, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Hlth Sci, Jackson, MS 39216 USA; GV Sonny Montgomery Vet Adm Med Ctr, Jackson, MS USA		Yablon, SA (corresponding author), 1350 E Woodrow Wilson, Jackson, MS 39216 USA.	doctory@earthlink.com					BERNSTEIN MJ, 1986, JAMA-J AM MED ASSOC, V256, P744; BOUNAMEAUX H, 1994, THROMB HAEMOSTASIS, V71, P1; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; Britt SL, 2003, AM SURGEON, V69, P459; CHERUKU R, 1991, CANCER, V68, P2621, DOI 10.1002/1097-0142(19911215)68:12<2621::AID-CNCR2820681218>3.0.CO;2-7; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; FLANAGAN SR, 2002, ARCH PHYS MED REHAB, V83, P1649; FUJII Y, 1994, NEUROSURGERY, V35, P26, DOI 10.1227/00006123-199407000-00004; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; Hammond FM, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199802000-00007; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harvey RL, 1996, STROKE, V27, P1516, DOI 10.1161/01.STR.27.9.1516; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; JONGBLOETS LMM, 1994, LANCET, V343, P1142, DOI 10.1016/S0140-6736(94)90240-2; Kelly J, 2003, CHEST, V124, P1116, DOI 10.1016/S0012-3692(15)37675-3; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Kroneman H, 1990, Blood Coagul Fibrinolysis, V1, P91, DOI 10.1097/00001721-199003000-00012; Lai JM, 1997, BRAIN INJURY, V11, P331, DOI 10.1080/026990597123485; Meissner MH, 2003, J TRAUMA, V54, P224, DOI 10.1097/01.TA.0000046253.33495.70; Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P285, DOI 10.1053/apmr.2003.50116; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; Owings JT, 2001, J TRAUMA, V51, P425, DOI 10.1097/00005373-200109000-00001; Peltonen S, 1997, J NEUROSURG, V87, P207, DOI 10.3171/jns.1997.87.2.0207; Philbrick JT, 2003, CLIN CHEM, V49, P570, DOI 10.1373/49.4.570; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; RUFF RL, 1983, ANN NEUROL, V13, P334, DOI 10.1002/ana.410130320; SAWAYA R, 1992, J NEURO-ONCOL, V14, P113; SAWAYA R, 1992, J NEURO-ONCOL, V14, P119; SAWAYA R, 1992, J NEURO-ONCOL, V14, P127; SCHMIDT U, 1992, J TRAUMA, V33, P312, DOI 10.1097/00005373-199208000-00023; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; Stern JB, 2002, CHEST, V122, P115, DOI 10.1378/chest.122.1.115; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3; Yablon SA, 2000, AM J PHYS MED REHABI, V79, P204; YABLON SA, 1999, ARCH PHYS MED REHAB, V80, P1132	39	28	29	4	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	AUG 10	2004	63	3					485	491		10.1212/01.WNL.0000133009.24727.9F			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	845GK	WOS:000223229100014	15304579				2022-02-06	
J	Kovac, AD; Kwidzinski, E; Heimrich, B; Bittigau, P; Deller, T; Nitsch, R; Bechmann, I				Kovac, AD; Kwidzinski, E; Heimrich, B; Bittigau, P; Deller, T; Nitsch, R; Bechmann, I			Entorhinal cortex lesion in the mouse induces transsynaptic death of perforant path target neurons	BRAIN PATHOLOGY			English	Article							METHYL-D-ASPARTATE; TRAUMATIC BRAIN-INJURY; APOPTOTIC CELL-DEATH; DEVELOPING RAT-BRAIN; RECEPTOR ANTAGONIST MK-801; CYTOCHROME-C RELEASE; FASCIA-DENTATA; ADULT-RAT; ASTROGLIAL REACTIONS; GLOBAL-ISCHEMIA	Entorhinal cortex lesion (ECL) is a well described model of anterograde axonal degeneration, subsequent sprouting and reactive synaptogenesis in the hippocampus. Here, we show that such lesions induce transsynaptic degeneration of the target cells of the lesions pathway in the dentate gyrus. Peaking between 24 and 36 hours post-lesion, dying neurons were labeled with DeOlmos silver-staining and antisera against activated caspase 3 (CCP32), a downstream inductor of programmed cell death. Within caspase 3-positive neurons, fragmented nuclei were co-localized using Hoechst 33342 staining. Chromatin condensation and nuclear fragmentation were also evident in semithin sections and at the ultrastructural level, where virtually all caspase 3-positive neurons showed these hallmarks of apoptosis. There is a well-described upregulation of the apoptosis-inducing CD95/L system within the CNS after trauma, yet a comparison of caspase 3-staining patterns between CD95 (lpr)- and CD95L (gld)-deficient with non-deficient mice (C57/bl6) provided no evidence for CD95L-mediated neuronal cell death in this setting. However, inhibition of NMDA receptors with MK-801 completely suppressed caspase 3 activation, pointing to glutamate neurotoxicity as the upstream inducer of the observed cell death. Thus, these data show that axonal injury in the CNS does not only damage the axotomized neurons themselves, but can also lethally affect their target cells, apparently by activating glutamate-mediated intracellular pathways of programmed cell death.	Univ Med Berlin, Charite, Inst Anat, Dept Cell & Neurobiol, D-10098 Berlin, Germany; Univ Med Berlin, Charite, Dept Pediat Neurol, D-10098 Berlin, Germany; Goethe Univ Frankfurt, D-6000 Frankfurt, Germany		Bechmann, I (corresponding author), Univ Med Berlin, Charite, Inst Anat, Dept Cell & Neurobiol, D-10098 Berlin, Germany.	ingo.bechmann@charite.de	Nitsch, Robert/AAI-9129-2021				Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Bechmann I, 2000, GLIA, V32, P25, DOI 10.1002/1098-1136(200010)32:1<25::AID-GLIA30>3.0.CO;2-Y; Bechmann I, 1997, GLIA, V20, P145, DOI 10.1002/(SICI)1098-1136(199706)20:2<145::AID-GLIA6>3.0.CO;2-8; Bechmann I, 2002, BIOCHEM PHARMACOL, V64, P363, DOI 10.1016/S0006-2952(02)01166-8; Bechmann I, 2001, RESTOR NEUROL NEUROS, V19, P189; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; BUCHAN A, 1990, J NEUROSCI, V10, P311; Buki A, 2000, J NEUROSCI, V20, P2825; CAMERON HA, 1995, J NEUROSCI, V15, P4687; CHAPMAN AG, 1991, EPILEPSIA, V32, P578, DOI 10.1111/j.1528-1157.1991.tb04695.x; Cid C, 2003, J NEUROL SCI, V206, P91, DOI 10.1016/S0022-510X(02)00339-8; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; COHEN PL, 1992, IMMUNOL TODAY, V13, P427, DOI 10.1016/0167-5699(92)90066-G; Colbourne F, 1999, J NEUROSCI, V19, P4200; Conti AC, 1998, J NEUROSCI, V18, P5663; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Del Turco D, 2003, HIPPOCAMPUS, V13, P685, DOI 10.1002/hipo.10118; Deller T, 2001, RESTOR NEUROL NEUROS, V19, P159; DEOLMOS JS, 1971, BRAIN RES, V33, P523, DOI 10.1016/0006-8993(71)90130-2; DIETRICH WD, 1992, ACTA NEUROPATHOL, V84, P630, DOI 10.1007/BF00227740; Dodd PR, 2002, BIOGERONTOLOGY, V3, P51, DOI 10.1023/A:1015255312948; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Felderhoff-Mueser U, 2000, BRAIN PATHOL, V10, P17; FIX AS, 1993, EXP NEUROL, V123, P204, DOI 10.1006/exnr.1993.1153; FROIDEVAUX S, 1991, AUTOIMMUNITY, V10, P233, DOI 10.3109/08916939109001894; Frotscher M, 1997, TRENDS NEUROSCI, V20, P218, DOI 10.1016/S0166-2236(96)01018-1; GALL C, 1979, BRAIN RES, V175, P37, DOI 10.1016/0006-8993(79)90512-2; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Gould E, 1997, NEUROSCIENCE, V80, P427, DOI 10.1016/S0306-4522(97)00127-9; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Ishimaru MJ, 1999, J COMP NEUROL, V408, P461; Jensen MB, 1997, EXP NEUROL, V143, P103, DOI 10.1006/exnr.1996.6337; JENSEN MB, 1994, EXP BRAIN RES, V98, P245; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kerr JFR, 2002, TOXICOLOGY, V181, P471, DOI 10.1016/S0300-483X(02)00457-2; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; LEWIS SJ, 1989, HYPERTENSION, V13, P759, DOI 10.1161/01.HYP.13.6.759; Lok J, 2002, J NEUROTRAUM, V19, P815, DOI 10.1089/08977150260190410; Luetjens CM, 2000, J NEUROSCI, V20, P5715; LYNCH G, 1972, BRAIN RES, V42, P311, DOI 10.1016/0006-8993(72)90533-1; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; MONTECINORODRIGUEZ EM, 1991, IMMUNOLOGY, V74, P127; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NITSCH R, 1992, P NATL ACAD SCI USA, V89, P5197, DOI 10.1073/pnas.89.11.5197; NITSCH R, 1993, HIPPOCAMPUS, V3, P481, DOI 10.1002/hipo.450030409; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Olney JW, 2002, BRAIN PATHOL, V12, P488, DOI 10.1111/j.1750-3639.2002.tb00467.x; OLNEY JW, 1994, NEUROBIOL AGING, V15, P259, DOI 10.1016/0197-4580(94)90127-9; PODURI A, 1995, NEUROSCI LETT, V197, P1, DOI 10.1016/0304-3940(95)11879-2; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Puig B, 2002, NEUROSCI LETT, V321, P182, DOI 10.1016/S0304-3940(01)02518-6; Qiu JH, 2002, J NEUROSCI, V22, P3504; Racke MM, 2002, J NEUROCHEM, V80, P1039, DOI 10.1046/j.0022-3042.2002.00787.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ribotta MG, 2002, PROG BRAIN RES, V137, P191; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; Sloviter RS, 1996, J COMP NEUROL, V366, P516, DOI 10.1002/(SICI)1096-9861(19960311)366:3<516::AID-CNE10>3.0.CO;2-N; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Stuart LM, 2002, J IMMUNOL, V168, P1627, DOI 10.4049/jimmunol.168.4.1627; Tang DM, 2000, J BIOL CHEM, V275, P9303, DOI 10.1074/jbc.275.13.9303; Tenneti L, 1998, J NEUROCHEM, V71, P946; Ullrich O, 2001, FASEB J, V15, P1460, DOI 10.1096/fj.00-0540fje; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Viswanath V, 2000, P NATL ACAD SCI USA, V97, P2270, DOI 10.1073/pnas.030365297; Waldmeier PC, 2003, PROG NEURO-PSYCHOPH, V27, P303, DOI 10.1016/S0278-5846(03)00025-3; Wang XD, 2001, GENE DEV, V15, P2922; Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Zhang CY, 2002, NEUROSCI LETT, V328, P265, DOI 10.1016/S0304-3940(02)00543-8	81	28	29	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	JUL	2004	14	3					249	257					9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	846ZW	WOS:000223359400003	15446579				2022-02-06	
J	Hohlrieder, M; Hinterhoelzl, J; Ulmer, H; Hackl, W; Schmutzhard, E; Gassner, R				Hohlrieder, M; Hinterhoelzl, J; Ulmer, H; Hackl, W; Schmutzhard, E; Gassner, R			Maxillofacial fractures masking traumatic intracranial hemorrhages	INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article						craniofacial trauma; maxillofacial; fractures; intracranial hemorrhage; skull base fractures; risk factors; injury mechanisms	CLOSED-HEAD INJURIES; FACIAL FRACTURES; COMA SCORE; HEMATOMA; SEVERITY; ADULTS; IMPACT; RISKS	Maxillofacial trauma may mask intracranial injuries prompting intensive care treatment. The purpose of this study was to identify whether craniofacial fracture patterns predispose patients with maxillofacial fractures to different types of intracranial hemorrhages. Within 7 years, 6649 patients with craniomaxillofacial injuries were admitted for treatment. The charts of the patients were analyzed according to age, sex, cause and mechanism of injury, type and location of facial injury, and intracranial trauma; 2195 sustained maxillofacial fractures. Statistical analyses were followed by logistic regression analyses for the four main types of intracranial hemorrhage to determine the impact of the different maxillofacial fractures. Intracranial hemorrhages in 212 patients (9.7%) occurred as epidural (2.5%), subdural (4.3%), subarachnoid (5.3%), and intracerebral hemorrhages (6.3%). Le Fort, orbit, nose, zygoma, and maxillary fractures increased the risk for accompanying intracranial hemorrhage by two- to fourfold (P < 0.05). Basal skull fractures caused a multiplication of the risk up to 17-fold, while fractures of the cranial vault were associated with a risk up to 14-fold. Nearly 10% of patients with craniomaxillofacial fractures sustain intracranial hemorrhages requiring frequently immediate neurosurgical intervention. Those patients, suffering from central midface fractures and skull base fractures, are prone to highly significant elevated risks of intracranial hemorrhage.	Univ Innsbruck, Dept Oral & Maxillofacial Surg, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Anesthesiol & Crit Care Med, A-6020 Innsbruck, Austria; Univ Innsbruck, Intens Care Unit, Dept Neurol, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Biostat, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Traumatol, A-6020 Innsbruck, Austria		Hohlrieder, M (corresponding author), Univ Innsbruck, Dept Oral & Maxillofacial Surg, Maximilianstr 10, A-6020 Innsbruck, Austria.	robert.gassner@uibk.ac.at	Ulmer, Hanno/S-6615-2019	Ulmer, Hanno/0000-0001-5911-1002; Schmutzhard, Erich/0000-0003-3295-7491			Alvarez M, 1998, CRIT CARE MED, V26, P142, DOI 10.1097/00003246-199801000-00030; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; DERDYN C, 1990, PLAST RECONSTR SURG, V86, P238, DOI 10.1097/00006534-199008000-00005; Egol A, 1999, CRIT CARE MED, V27, P633; Gopalakrishna G, 1998, ANN EMERG MED, V32, P425, DOI 10.1016/S0196-0644(98)70170-2; Hachl O, 2002, INT J ORAL MAX SURG, V31, P90, DOI 10.1054/ijom.2001.0166; Hackl W, 2001, J TRAUMA, V50, P41, DOI 10.1097/00005373-200101000-00007; Hanley DF, 1999, CRIT CARE MED, V27, P477, DOI 10.1097/00003246-199903000-00019; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; HAUG RH, 1994, J ORAL MAXIL SURG, V52, P729, DOI 10.1016/0278-2391(94)90488-X; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Heard C, 2002, CRIT CARE MED, V30, P1403, DOI 10.1097/00003246-200206000-00059; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; LUCE EA, 1979, PLAST RECONSTR SURG, V63, P26, DOI 10.1097/00006534-197901000-00005; Maladiere E, 2001, INT J ORAL MAX SURG, V30, P291, DOI 10.1054/ijom.2001.0059; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Plaisier BR, 2000, J ORAL MAXIL SURG, V58, P708, DOI 10.1053/joms.2000.7250; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; Teasdale GM, 2000, INTENS CARE MED, V26, P153, DOI 10.1007/s001340050037; Woisetschlager C, 2000, INTENS CARE MED, V26, P1561, DOI 10.1007/s001340000663; Yang WG, 2003, PLAST RECONSTR SURG, V111, P789, DOI 10.1097/01.PRS.0000041541.72469.53	26	28	28	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0901-5027	1399-0020		INT J ORAL MAX SURG	Int. J. Oral Maxillofac. Surg.	JUN	2004	33	4					389	395		10.1016/j.ijom.2003.10.011			7	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	828BJ	WOS:000221947300012	15145043				2022-02-06	
J	Abe, T; Takagi, N; Nakano, M; Furuya, M; Takeo, S				Abe, T; Takagi, N; Nakano, M; Furuya, M; Takeo, S			Altered Bad localization and interaction between Bad and Bcl-xL in the hippocampus after transient global ischemia	BRAIN RESEARCH			English	Article						Bad; Bcl-xL; mitochondria; transient global ischemia	SPINAL-CORD-INJURY; CASPASE-3 APOPTOTIC CASCADE; TRAUMATIC BRAIN-INJURY; CYTOCHROME-C RELEASE; CEREBRAL-ISCHEMIA; PROTEIN-KINASE; CELL-DEATH; FOCAL ISCHEMIA; PERMEABILITY TRANSITION; ISOLATED-MITOCHONDRIA	Accumulating evidence indicates that the mitochondrial cell-death pathway, which involves the release of cytochrome c from mitochondria, participates in neuronal cell death after transient cerebral ischemia. However, the upstream events, that induce cytochrome c release after transient global ischemia are not fully understood. Bad is a pro-apoptotic member of the bcl-2 gene family that promotes apoptosis by binding to and inhibiting functions of anti-apoptotic proteins Bcl-2 and Bcl-xL. We investigated the effects of transient (15 min) global ischemia on the intracellular localization of Bad and the interaction of Bad with calcineurin, Akt or Bcl-xL in the vulnerable CA1 and resistant CA3/dentate gyrus of the hippocampus. Immunoblotting analysis revealed that the amount of Bad in mitochondria significantly increased after ischemia. Co-immunoprecipitation studies showed decreased interactions of Bad with Akt and calcineurin in the cytosol and increased binding with Bcl-xL in the mitochondrial fraction of hippocampal CA1, but not in the CA3/dentate gyros region. Further, we examined the effect of recombinant Bad on the cytochrome c release front isolated mitochondria. Treatment with both recombinant Bad and calcium, but not with recombinant Bad alone, induced cytochrome c release. These results suggest that changes in localization and complex formation by Bad are, at least in part, involved in the vulnerability of cells after transient global ischemia. (C) 2004 Elsevier B.V. All rights reserved.	Tokyo Univ Pharm & Life Sci, Dept Pharmacol, Fac Pharmaceut Sci, Hachioji, Tokyo 1910392, Japan		Takagi, N (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Pharmacol, Fac Pharmaceut Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1910392, Japan.	takagino@ps.toyaku.ac.jp					Adachi S, 1997, J BIOL CHEM, V272, P21878, DOI 10.1074/jbc.272.35.21878; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Chen J, 1996, J NEUROCHEM, V67, P64; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DEL PL, 1997, SCIENCE, V278, P687; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; Fink K, 1998, J CEREBR BLOOD F MET, V18, P1071, DOI 10.1097/00004647-199810000-00003; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hsu SY, 1997, MOL ENDOCRINOL, V11, P1858, DOI 10.1210/me.11.12.1858; Janelidze S, 2001, NEUROBIOL DIS, V8, P147, DOI 10.1006/nbdi.2000.0325; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kennedy SG, 1999, MOL CELL BIOL, V19, P5800; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KRAJEWSKI S, 1995, J NEUROSCI, V15, P6364; LI Y, 1995, AM J PATHOL, V146, P1045; LI Y, 1995, J CEREB BLOOD FLOW M, V15, P89; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MARTINS E, 1988, J CEREBR BLOOD F MET, V8, P531, DOI 10.1038/jcbfm.1988.93; Namura S, 2000, J CEREBR BLOOD F MET, V20, P1301, DOI 10.1097/00004647-200009000-00004; Namura S, 1998, J NEUROSCI, V18, P3659; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Ouyang YB, 1999, J CEREBR BLOOD F MET, V19, P1126, DOI 10.1097/00004647-199910000-00009; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Polster BM, 2003, J NEUROSCI, V23, P2735; Saito A, 2003, J NEUROSCI, V23, P1710; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Springer JE, 2000, J NEUROSCI, V20, P7246; SUGIO K, 1988, STROKE, V19, P922, DOI 10.1161/str.19.7.922a; Takagi N, 2003, J NEUROCHEM, V84, P67, DOI 10.1046/j.1471-4159.2003.01500.x; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Uchino H, 2002, NEUROBIOL DIS, V10, P219, DOI 10.1006/nbdi.2002.0514; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yano S, 2001, J CEREBR BLOOD F MET, V21, P351, DOI 10.1097/00004647-200104000-00004; Yoshimoto T, 2001, BRAIN RES, V899, P148, DOI 10.1016/S0006-8993(01)02220-X; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang C, 1999, J NEUROCHEM, V73, P1650, DOI 10.1046/j.1471-4159.1999.0731650.x; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	50	28	30	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 29	2004	1009	1-2					159	168		10.1016/j.brainres.2004.03.003			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	821TQ	WOS:000221486000017	15120593				2022-02-06	
J	Floyd, CL; Rzigalinski, BA; Sitterding, HA; Willoughby, KA; Ellis, EF				Floyd, CL; Rzigalinski, BA; Sitterding, HA; Willoughby, KA; Ellis, EF			Antagonism of group I metabotropic glutamate receptors and PLC attenuates increases in inositol trisphosphate and reduces reactive gliosis in strain-injured astrocytes	JOURNAL OF NEUROTRAUMA			English	Article						intracellular free calcium; GFAP; IP3; reactive astrocytes; TBI	TRAUMATIC BRAIN-INJURY; STRETCH-INDUCED INJURY; INTRACELLULAR FREE CALCIUM; CULTURED ASTROCYTES; NEURONAL DEATH; UP-REGULATION; CELL-DEATH; NMDA; PROTEIN; MODEL	We have previously found that in vitro traumatic injury uncouples IP3-mediated intracellular free calcium ([Ca2+](i)) signaling in astrocytes (Rzigalinski et al., 1998; Floyd et al., 2001). Since Group I metabotropic glutamate receptors (mGluRs) are coupled to IP3-mediated Ca2+ signaling, we investigated their role in the in vitro strain injury of cultured astrocytes. Astrocytes grown on Silastic membranes were labeled with H-3-myo-inositol and strain (stretch)-injured. Cells injured in the presence of LiCl to prevent inositol phosphate metabolism were acid extracted and inositol phosphates (IPx) isolated using anion exchange columns. Reactive gliosis was assessed as increased glial fibrillary acidic protein immunoreactivity (GFAP-IR). Pre- but not post-injury administration of (RS)-1-aminoindan-15-decarboxylic acid (AIDA) or (S)-4-carboxy-3-hydroxyphenylglycine (S4CH3HPG), both group I mGluR antagonists, attenuated injury-induced increases in IPx. Injury increased GFAP-IR in astrocytes at 24 and 48 h post injury, which was reduced or blocked by AIDA or inhibition of phospholipase C (PLC) with U73122. These findings suggest that strain injury activates Group I mGluRs, causing aberrant IPx production and uncoupling of the PLC signaling pathway. Changes in this signaling pathway may be related to induction of reactive gliosis. Additionally, our results suggest a complex physical coupling between G protein receptor, PLC, and IP3 receptor, in support of the conformational coupling model.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA		Ellis, EF (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	eellis@mail2.vcu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-27214, NS-40490, NS-07288] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040490, R01NS027214] Funding Source: NIH RePORTER		Ahmed SM, 2002, J NEUROTRAUM, V19, P1619, DOI 10.1089/089771502762300274; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Aronica E, 2000, EUR J NEUROSCI, V12, P2333, DOI 10.1046/j.1460-9568.2000.00131.x; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; CHEN T, 2002, J NEUROTRAUM, V19, P1365; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Floyd CL, 2001, GLIA, V33, P12, DOI 10.1002/1098-1136(20010101)33:1<12::AID-GLIA1002>3.0.CO;2-V; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; HAYASHI Y, 1994, J NEUROSCI, V14, P3370; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hoffman SW, 2000, J NEUROTRAUM, V17, P415, DOI 10.1089/neu.2000.17.415; Inglis WL, 1997, BRAIN RES, V755, P17, DOI 10.1016/S0006-8993(97)00101-7; Janssens N, 2001, J NEUROCHEM, V77, P1457, DOI 10.1046/j.1471-4159.2001.00369.x; Lamb RG, 1997, J NEUROCHEM, V68, P1904; Lievens JC, 2000, GLIA, V29, P222, DOI 10.1002/(SICI)1098-1136(20000201)29:3<222::AID-GLIA4>3.0.CO;2-0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; MacGregor DG, 1997, EXP NEUROL, V148, P110, DOI 10.1006/exnr.1997.6625; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Moroni F, 1997, J PHARMACOL EXP THER, V281, P721; Mukhin AG, 1998, J NEUROSCI RES, V51, P748, DOI 10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B; Nebigil CG, 1997, BIOCHEMISTRY-US, V36, P15949, DOI 10.1021/bi971721m; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; OCALLAGHAN JP, 1994, PSYCHOPHARMACOL BULL, V30, P549; Ostrow LW, 2000, J CARDIOVASC PHARM, V36, pS274; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; Pellegrini-Giampietro DE, 1999, NEUROPHARMACOLOGY, V38, P1607, DOI 10.1016/S0028-3908(99)00097-0; PETITO CK, 1992, PROG BRAIN RES, V94, P381; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; Rostworowski M, 1997, J NEUROSCI, V17, P3664; RUDGE JS, 1990, J NEUROSCI, V10, P3594; Rzigalinski BA, 1997, J NEUROCHEM, V68, P289; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; SCHREIBER D, 1995, P 1995 INT RES C BIO; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; STANIMIROVIC DB, 1995, GLIA, V15, P119, DOI 10.1002/glia.440150204; Strasser U, 1998, EUR J NEUROSCI, V10, P2848, DOI 10.1046/j.1460-9568.1998.00291.x; Stringer JL, 1996, BRAIN RES, V717, P147, DOI 10.1016/0006-8993(96)00059-5; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; Welsh DJ, 1998, AM J RESP CRIT CARE, V158, P1757, DOI 10.1164/ajrccm.158.6.9706054; Westenbroek RE, 1998, J NEUROSCI, V18, P2321; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	69	28	29	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2004	21	2					205	216		10.1089/089771504322778668			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	774WB	WOS:000189008200008	15000761				2022-02-06	
J	Chen, CC; Heinemann, AW; Bode, RK; Granger, CV; Mallinson, T				Chen, CC; Heinemann, AW; Bode, RK; Granger, CV; Mallinson, T			Impact of pediatric rehabilitation services on children's functional outcomes	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						rehabilitation therapy; treatment effectiveness; WeeFIM (R)	TRAUMATIC BRAIN INJURY; INDEPENDENCE MEASURE; DEVELOPMENTAL-DISABILITIES; PERFORMANCE; STABILITY; RELIABILITY; INTENSITY; AGREEMENT; VALIDITY; WEEFIM	OBJECTIVES. Relatively little is known about the treatment effectiveness and functional outcomes of pediatric rehabilitation therapies. This study was conducted to gain knowledge of the type and quantity of inpatient rehabilitation services provided to children who received acute inpatient rehabilitation and compare functional gains by age and diagnosis. METHOD. A retrospective cohort design was used. Records of rehabilitation therapies and functional assessments of 814 pediatric patients who received inpatient rehabilitation during 1996, 1997, and 1998 were collected. The admission and discharge item ratings of the WeeFIM(R) instrument were first transformed into interval-level measures of self-care, mobility, and cognition. Parametric analyses were, used to compare functional gains across impairment groups and to examine the relationship between amount of treatment and functional gains. RESULTS. Occupational therapy and physical therapy were the primary rehabilitation services received by patients across impairment groups (98% and 99%, respectively). A large proportion of children with traumatic brain injuries also received speech therapy (97%) and psychology services (60%). Across domains (self-care, mobility, cognition), the largest gains were made by children who were older than 7 years and had traumatic injuries. Functional gains were significantly related to the amount of discipline-specific treatment received, after controlling for age, impairment, and functional status at admission. CONCLUSION. Rehabilitation therapy provision in pediatric inpatient rehabilitation varies greatly depending on children's age and the nature of the impairment. Systematic reporting of type and quantity of rehabilitation therapies along with functional assessments before and after hospitalization would allow researchers to track functional changes and study the determinants of functional improvement.	NYU, Steinhardt Sch Educ, Dept Occupat Therapy, New York, NY 10012 USA; Inst Rehabil, Ctr Rehabil Outcomes Res, Chicago, IL USA; SUNY Buffalo, Dept Rehabil Med, Buffalo, NY USA; Uniform Data Syst Med Rehabil UDSMR, Amherst, NY USA		Chen, CC (corresponding author), NYU, Steinhardt Sch Educ, Dept Occupat Therapy, 35 W 4 St,11th Floor, New York, NY 10012 USA.	christine.chen@nyu.edu	Heinemann, Allen W/K-6283-2012; Mallinson, Trudy/S-7381-2019; Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W/0000-0003-2782-7326; Mallinson, Trudy/0000-0002-4888-5579; Heinemann, Allen W./0000-0003-2782-7326			Bonder B, 2001, OCCUP THER J RES, V21, P3, DOI 10.1177/153944920102100101; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; Bundy AC, 2001, OCCUP THER J RES, V21, P276, DOI 10.1177/153944920102100405; Case-Smith J, 1998, AM J OCCUP THER, V52, P788, DOI 10.5014/ajot.52.10.788; Case-Smith J, 2002, AM J OCCUP THER, V56, P17, DOI 10.5014/ajot.56.1.17; Chen CC, 2002, ARCH PHYS MED REHAB, V83, P1514, DOI 10.1053/apmr.2002.35107; Coster W, 1998, AM J OCCUP THER, V52, P337, DOI 10.5014/ajot.52.5.337; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; COSTER WJ, 1992, INFANT YOUNG CHILD, V4, P11; Daniels LE, 1998, AM J OCCUP THER, V52, P857, DOI 10.5014/ajot.52.10.857; Deutsch A, 1996, CRITICAL REV PHYS ME, V8, P267; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; Dorval G, 1996, OCCUP THER INT, V3, P241, DOI DOI 10.1002/(ISSN)1557-0703; DUDGEON BJ, 1996, OCCUPATIONAL THERAPY, P777; Fiedler RC, 1998, AM J PHYS MED REHAB, V77, P444, DOI 10.1097/00002060-199809000-00019; Fisher W., 1992, RASCH MEAS T, V6, P238; FUHRER MJ, 1997, ASSESSING MED REHABI; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; HALEY SM, 1992, ADM MANUAL PEDIAT EV; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; HEINEMANN AW, 1999, EFFECTIVENESS OCCUPA; Hwang JL, 2002, OTJR-OCCUP PART HEAL, V22, P48, DOI 10.1177/153944920202200202; Johnson M.L., 1997, ASSESSING MED REHABI, P1; Kleinbaum DG., 1988, APPL REGRESSION ANAL; Law M, 1999, ARCH PHYS MED REHAB, V80, P629, DOI 10.1016/S0003-9993(99)90164-8; Linacre J. M., 2001, WINSTEPS COMPUTER PR; Linacre J.M., 2000, USERS GUIDE WINSTEPS; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lollar DJ, 2000, ARCH PHYS MED REHAB, V81, pS46, DOI 10.1053/apmr.2000.20624; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Ottenbacher KJ, 1999, AM J OCCUP THER, V53, P181, DOI 10.5014/ajot.53.2.181; Ottenbacher KJ, 1996, DEV MED CHILD NEUROL, V38, P907; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Ottenbacher KJ, 1999, DEV MED CHILD NEUROL, V41, P186, DOI 10.1017/S0012162299000377; Ottenbacher KJ, 2000, AM J PHYS MED REHAB, V79, P114, DOI 10.1097/00002060-200003000-00002; Ottenbacher KJ, 2000, ARCH PHYS MED REHAB, V81, P1317, DOI 10.1053/apmr.2000.9387; Pedhazur E. J., 1982, MULTIPLE REGRESSION; Scheffe H, 1959, ANAL VARIANCE; *SPSS, 2002, SPSS WIND; Swaine BR, 2000, AM J PHYS MED REHAB, V79, P412, DOI 10.1097/00002060-200009000-00002; *UDSMR, 1993, GUID UN DAT SET MED; *UDSMR, 1997, GUID UN DAT SET MED; Vargas S, 1999, AM J OCCUP THER, V53, P189, DOI 10.5014/ajot.53.2.189; Wright B. D., 1996, RASCH MEASUREMENT T, V9; Yung A, 1999, Pediatr Rehabil, V3, P21	47	28	29	0	4	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	JAN-FEB	2004	58	1					44	53		10.5014/ajot.58.1.44			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	764NG	WOS:000188212500006	14763635				2022-02-06	
J	Gillette, Y; DePompei, R				Gillette, Y; DePompei, R			The potential of electronic organizers as a tool in the cognitive rehabilitation of young people	NEUROREHABILITATION			English	Article						assistive technology; personal data assistants; cell phones; developmental disabilities; mental retardation; traumatic brain injury		Youths who have traumatic brain injury (TBI) or mental retardation and other developmental disabilities often experience cognitive challenges in using memory and organization for learning, managing daily routines, or conducting social interactions. This article presents the results of a survey of 53 youth-parent-teacher triads probing their views regarding the youth's relationship with technology. Since the sample is small, results should be viewed with caution, yet keeping in mind the study presents some of the only data available on the use of generic technologies with youths who have disabilities. Primary findings indicate: 1) youths use a variety of technologies and are more likely to be exposed to computers than cell phones or personal data assistants respectively; 2) youths with finger, reading, and copying skills use more technologies; 3) youths value many varied features of technology, but rated most highly good technical support, simple learning requirements, capacity to store information, and long battery life. The data also indicated that the most common memory and organization strategy the youths used was "someone does it for me".	Univ Akron, Sch Speech Language Pathol & Audiol, Akron, OH 44325 USA		DePompei, R (corresponding author), Univ Akron, Sch Speech Language Pathol & Audiol, Polsky 188K, Akron, OH 44325 USA.	rdepom1@uakron.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A0101607A] Funding Source: Medline		BATSHAW M, 1997, CHILDREN DISABILITIE, P693; Bauer A., 2002, TEACHING EXCEPTIONAL, V35, P18; BEUKELMAN DR, 1998, AUGMENTATIVE ALTERNA, P150; BLOSSER JL, 2003, PEDIAT TRAUMATIC BRA, P5; CAPUTE A, 1996, DEV DISABILITIES INF, P212; CARR EJ, 1994, COMMUNICATIOON BASED, P11; CHESTER CC, 1998, TRAUMATIC BRAIN INJU, P107; Cohen J., 2013, STAT POWER ANAL BEHA; DEPOMPEI R, 1999, REHABILITATION ADULT, P393; Gillette Y, 2001, J HEAD TRAUMA REHAB, V16, P484, DOI 10.1097/00001199-200110000-00007; GORDON D, 2000, DIGITAL CLASSROOM TE, P143; GRIFFETH M, REHABILITATION ADULT, P393; HUGHES C, 2003, TRANSITION HDB STRAT; KOPPENHAVER D A, 1992, Seminars in Speech and Language, V13, P143, DOI 10.1055/s-2008-1064193; LUECK A, 2001, REVIEW, V33, P21; LYNCH K, 2002, USING AT CHECKLIST F; MacArthur CA, 2000, TOP LANG DISORD, V20, P85, DOI 10.1097/00011363-200020040-00008; MALE M, 2003, TECHNOLOGY INCLUSION, P75; MIKULINCER M, PLENUM SERIES SOCIAL, V11; Mirenda P., 1997, AUGMENTATIVE ALTERNA, V13, P207, DOI [10.1080/07434619712331278048, DOI 10.1080/07434619712331278048]; Parette P., 2000, Journal of Special Education Technology, V15, P45; PUGLIESE M, 2000, STAGES BOOK; SAINBACK S, 1996, INCLUSION GUIDE ED, P3; Savage R. C., 1994, ED DIMENSIONS ACQUIR, P3; SEMRUDCLIEKMAN, 2001, GUILLIFORD SCH PRACT, P31; SMITH SJ, 1999, J LAW EDUC, V2, P247; Sturm J, 2000, TOP LANG DISORD, V20, P73, DOI 10.1097/00011363-200020020-00007; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, Vxiv; Zabala J., 2000, J SPECIAL ED TECHNOL, V15, P25; [No title captured]	30	28	28	1	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2004	19	3					233	243					11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	883HU	WOS:000226003000006	15502256				2022-02-06	
J	Levy, DT; Mallonee, S; Miller, TR; Smith, GS; Spicer, RS; Romano, EO; Fisher, DA				Levy, DT; Mallonee, S; Miller, TR; Smith, GS; Spicer, RS; Romano, EO; Fisher, DA			Alcohol involvement in burn, submersion, spinal cord, and brain injuries	MEDICAL SCIENCE MONITOR			English	Article						alcohol; injury; intentional; unintentional; nonfatal	TRAUMA PATIENTS; EMERGENCY-ROOM; RISK FACTOR; ABUSE	Background : Alcohol is involved in many injuries, but estimates of this involvement vary considerably. Most information pertains to deaths although most injuries are nonfatal. Material/Method : The portion of fatal and nonfatal injuries involving alcohol was determined from a comprehensive Oklahoma surveillance system that tracks persons killed or hospitalized due to burns, submersions, spinal cord injuries (SCIs), and traumatic brain injuries (TBIs). Logistic regression was used to determine factors that explain the percentage of alcohol involvement in fatal versus nonfatal cases. Results : The victim was alcohol involved in 17% of fire burns, 4% of scald burns, 24% of submersions, 34% of SCIs, and 41% of TBIs where involvement was known. Large differences existed in total alcohol involvement between age and gender groups and between fatal and nonfatal cases of fire burns (31% vs. 1.1%) and submersions (33% vs. 6%). Large differences also existed in victim alcohol involvement between fatal and nonfatal cases of intentional SCIs (0% vs. 48%) and TBIs (38% vs. 70%). Those who imbibed during the day were not at excess risk of scald injury, but they were twice as likely to suffer a serious fire burn, 3 times as likely to suffer a spinal cord injury, 3.5 times as likely to suffer a submersion injury, and 2 to 4 times as likely to suffer a TBI. These excess risks persisted for all age groups between 15 and 64, with the excess risk especially high for underage drinkers aged 15 to 20. In contrast, people aged 65 and older did not appear to be at excess risk on days that they imbibed. Conclusion : A large percentage of fatal and nonfatal injuries as classified by diagnosis group involve alcohol. People who had been drinking were substantially more likely to suffer serious nonfatal and fatal injuries other than scald burns.	Univ Baltimore, Baltimore, MD 21201 USA; Pacific Inst Res & Evaluat, Beltsville, MD USA; Oklahoma Dept Hlth, Oklahoma City, OK USA; Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA		Levy, DT (corresponding author), 14403 Sylvan Glade Dr, N Potomac, MD 20878 USA.	levy@pire.org		Miller, Ted/0000-0002-0958-2639; Smith, Gordon/0000-0002-2911-3071	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA012208, R01AA009812] Funding Source: NIH RePORTER; NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01 AA12208-01, R01 AA09812-02] Funding Source: Medline		Blake R B, 1997, Am J Orthop (Belle Mead NJ), V26, P704; CHERPITEL CJ, 1995, ANN EMERG MED, V26, P158, DOI 10.1016/S0196-0644(95)70146-X; Cherpitel CJ, 1996, ALCOHOL CLIN EXP RES, V20, P338, DOI 10.1111/j.1530-0277.1996.tb01649.x; CHERPITEL CJ, 1993, ADDICTION, V88, P923, DOI 10.1111/j.1360-0443.1993.tb02110.x; HOWLAND J, 1988, ACCIDENT ANAL PREV, V20, P19, DOI 10.1016/0001-4575(88)90011-5; HOWLAND J, 1987, PUBLIC HEALTH REP, V102, P475; HOWLAND J, 1988, CONTEMP DRUG PROBL, P95; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Levy DT, 2002, ADDICTION, V97, P909, DOI 10.1046/j.1360-0443.2002.00133.x; Li GH, 1996, ALCOHOL CLIN EXP RES, V20, P1553, DOI 10.1111/j.1530-0277.1996.tb01698.x; Li GH, 1997, J TRAUMA, V42, P562, DOI 10.1097/00005373-199703000-00032; MILLER TR, 1994, ACCIDENT ANAL PREV, V26, P583, DOI 10.1016/0001-4575(94)90020-5; *NIAAA, 1997, EFF ALC BEH SAF, P247; PAYNE SR, 1989, J TRAUMA, V29, P424, DOI 10.1097/00005373-198904000-00002; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; Roizen J, 1988, DRINKING CASUALTIES, P21; SMITH GS, 1988, ANNU REV PUBL HEALTH, V9, P99; Smith GS, 1999, ANN EMERG MED, V33, P659, DOI 10.1016/S0196-0644(99)70195-2; SMITH GS, 1995, ADOLESC MED, V6, P153; SODERSTROM CA, 1988, ARCH SURG-CHICAGO, V123, P733; Streicker J., 1999, EPIDEMIOLOGY ALCOHOL; WALLER JA, 1994, ACCIDENT ANAL PREV, V26, P635, DOI 10.1016/0001-4575(94)90025-6	22	28	29	0	5	INT SCIENTIFIC LITERATURE, INC	ALBERTSON	1125 WILLIS AVE, ALBERTSON, NY 11507 USA	1234-1010			MED SCI MONITOR	Med. Sci. Monitor	JAN	2004	10	1					CR17	CR24					8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	865XC	WOS:000224736500008	14704631				2022-02-06	
J	Tokutomi, T; Miyagi, T; Morimoto, K; Karukaya, T; Shigemori, M				Tokutomi, T; Miyagi, T; Morimoto, K; Karukaya, T; Shigemori, M			Effect of hypothermia on serum electrolyte, inflammation, coagulation, and nutritional parameters in patients with severe traumatic brain injury	NEUROCRITICAL CARE			English	Article						traumatic brain injury; hypothermia; biochemical parameters; inflammation; coagulopathy; hypokalemia	SEVERE HEAD-INJURY; MILD HYPOTHERMIA; INTRACRANIAL-PRESSURE; POTASSIUM CONCENTRATION; MODERATE HYPOTHERMIA; TEMPERATURE; COAGULOPATHY; RATS; HYPERTENSION; DYSFUNCTION	Introduction: We evaluated the effect of induced hypothermia on biochemical parameters in patients with severe traumatic brain injury. Methods: We obtained hemoglobin, hematocrit, white blood count, lymphocyte count, platelet count, and serum concentrations of sodium, potassium, glucose, albumin, and C-reactive protein, and prothrombin time, hepaplastin test, activated partial thromboplastin time, antithrombin-III, alpha 2PI, and nitrogen excretion on the day of admission, and on days 1, 3,5, 7, 14, and 21 after the injury in 31 patients with severe head injury who were treated with hypothermia of 33 degrees ranging from 48 to 72 hours. We selected 33 normothermic patients as a control group; these patients were selected from patients who had been treated before hypothermia was used as a treatment modality, by the same criteria for hypothermia therapy. We compared the biochemical markers and rectal temperature and intracranial pressure in the hypothermia group with those in the normothermia group. Outcome was assessed using the Glasgow Outcome Scale at 6 months after injury. Results: The demographic characteristics, severity, and outcome were similar in the hypothermia and normothermia group. Intracranial pressure was significantly decreased by hypothermia. Serum potassium concentration decreased significantly during hypothermia. White blood cell counts and C-reactive protein levels were higher after rewarming in the hypothermia group, and these were also higher in the patients with infectious complications, although the incidence of infectious complications did not differ between the hypothermia and normothermia groups. There were no statistically significant prolongations of activated partial thromboplastin time and no decline in prothrombin time with hypothermia. Platelet count, antithrombin-III, and alpha 2PI did not differ significantly between the two groups. Conclusion: Hypothermia of 33 degrees for 48-72 hours does not appear to increase the risk for coagulopathy and infections, although hypothermic patients exhibited significant increments in inflammatory markers such as C-reactive protein and white blood counts after rewarming.	Kurume Univ, Sch Med, Dept Neurosurg, Kurume, Fukuoka 8300011, Japan		Tokutomi, T (corresponding author), Kurume Univ, Sch Med, Dept Neurosurg, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	toku@mail.med.kurume-u.ac.jp					Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; BOELHOUWER RU, 1987, CRIT CARE MED, V15, P310, DOI 10.1097/00003246-198704000-00006; BOLDT J, 1993, ANN THORAC SURG, V55, P652, DOI 10.1016/0003-4975(93)90269-N; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; GADISSEUX P, 1989, TXB HEAD INJURY; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; GUBLER KD, 1994, J TRAUMA, V36, P847, DOI 10.1097/00005373-199406000-00015; JOHNSTON TD, 1994, J TRAUMA, V37, P413, DOI 10.1097/00005373-199409000-00014; Kawai N, 2001, BRAIN RES, V895, P50, DOI 10.1016/S0006-8993(01)02026-1; Krause KR, 2000, AM SURGEON, V66, P348; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marion DW, 1996, CRIT CARE MED, V24, pS81; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Miller PR, 1999, J TRAUMA, V47, P1004, DOI 10.1097/00005373-199912000-00003; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Reny JL, 2002, CRIT CARE MED, V30, P529, DOI 10.1097/00003246-200203000-00006; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; SPRUNG J, 1992, ACTA ANAESTH SCAND, V36, P825, DOI 10.1111/j.1399-6576.1992.tb03572.x; SPRUNG J, 1991, CRIT CARE MED, V19, P1545, DOI 10.1097/00003246-199112000-00018; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Tveita T, 1998, J APPL PHYSIOL, V85, P2135, DOI 10.1152/jappl.1998.85.6.2135; VALERI CR, 1987, ANN SURG, V205, P175, DOI 10.1097/00000658-198702000-00012; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561	34	28	31	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2004	1	2					171	182		10.1385/NCC:1:2:171			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	945FN	WOS:000230488500005	16174912				2022-02-06	
J	Zaltzman, R; Alexandrovich, A; Beni, SM; Trembovler, V; Shohami, E; Gozes, I				Zaltzman, R; Alexandrovich, A; Beni, SM; Trembovler, V; Shohami, E; Gozes, I			Brain injury-dependent expression of activity-dependent neuroprotective protein	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						head trauma; gene expression; real-time polymerase chain reaction (PCR); activity-dependent; neuroprotective protein (ADNP)	VASOACTIVE-INTESTINAL-PEPTIDE; CLOSED-HEAD INJURY; RAT-BRAIN; NEUROGENESIS; MICE; NAP; DEFICITS; SYSTEM; MODEL; ADNP	Activity-dependent neuroprotective protein (ADNP), a crucial brain development factor, contains a unique sequence, termed NAPVSIPQ, which protects mice against closed head injury (CHI). The aim of this study was to determine whether CHI affects ADNP mRNA expression in the injured brain hemisphere. Male C57JBL/6J mice were subjected to CHI. Brains were removed 5 h, 24 h, 7 d, and 29 d post-CHI. A comparison was made between ADNP mRNA in the injured versus the noninjured hemisphere using real-time polymerase chain reaction. A nonsignificant change (p > 0.05) was found 5 h, 24 h, and 7 d post-CHI. However, a significant increase (p < 0.05) in ADNP mRNA expression was detected in the injured cerebral hemisphere 29 d post-CHI. The data presented may be associated with ADNP's crucial involvement in brain development and response to injury.	Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Pharmacol, Jerusalem, Israel		Gozes, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel.	igozes@post.tau.ac.il					Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Benimetskaya L, 1997, NAT MED, V3, P414, DOI 10.1038/nm0497-414; Brenneman DE, 2000, BIOCHEM SOC T, V28, P452, DOI 10.1042/0300-5127:0280452; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Delgado M, 2003, FASEB J, V17, P1922, DOI 10.1096/fj.02-1029fje; Delgado M, 2002, J MOL MED, V80, P16, DOI 10.1007/s00109-001-0291-5; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Gozes I, 2003, J MOL NEUROSCI, V20, P315, DOI 10.1385/JMN:20:3:315; Gozes I, 2002, J MOL NEUROSCI, V19, P167, DOI 10.1007/s12031-002-0028-0; Gozes I, 2001, TRENDS NEUROSCI, V24, P700, DOI 10.1016/S0166-2236(00)01931-7; Hailer NP, 2001, NEUROSCI LETT, V298, P33, DOI 10.1016/S0304-3940(00)01711-0; Hallbergson AF, 2003, J CLIN INVEST, V112, P1128, DOI 10.1172/JCI200320098; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Poggi SH, 2003, AM J OBSTET GYNECOL, V189, P790, DOI 10.1067/S0002-9378(03)00834-2; Poggi SH, 2002, AM J OBSTET GYNECOL, V187, P973, DOI 10.1067/mob.2002.127141; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; RALPH P, 1977, J IMMUNOL, V119, P950; Romano J, 2002, J MOL NEUROSCI, V18, P37, DOI 10.1385/JMN:18:1-2:37; Roy NS, 2000, NAT MED, V6, P271; SMITHSWINTOSKY VL, 2000, SOC NEUR 30 ANN M NE; Tan SM, 2000, J IMMUNOL, V165, P2574, DOI 10.4049/jimmunol.165.5.2574; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zaltzman R, 2003, NEUROREPORT, V14, P481, DOI 10.1097/01.wnr.0000058036.29600.ff; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200	32	28	29	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.		2004	24	2					181	187		10.1385/JMN:24:2:181			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	864IX	WOS:000224628300004	15456931				2022-02-06	
J	Bridges, EJ; Rouah, F; Johnston, KM				Bridges, EJ; Rouah, F; Johnston, KM			Snowblading injuries in Eastern Canada	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							ALPINE SKIING INJURIES; SNOWBOARDING INJURIES; HEAD-INJURIES; SPINAL-INJURIES; CHILDREN; ADOLESCENTS; RISK; SKIERS; 4-YEAR	Objectives: To evaluate injury patterns of snowbladers and compare them with those of skiers and snowboarders. To determine possible effects of helmet use in these sports on injury to the head and neck. Methods: This prospective case series observational study was conducted by collecting the injury reports from the ski patrol during the 1999-2000 season at Mont Tremblant ski resort, Quebec. All participants in downhill winter sports who presented themselves to the ski patrol with traumatic injury related to their sport were included. A concussion was defined as any loss of consciousness, amnesia, confusion, disorientation, vertigo, or headache that resulted from injury. The ski patroller reported helmet use on the accident report at the time of injury. Results: Snowbladers present with a unique pattern of injury compared with skiers and snowboarders. The incidence of leg, knee, and ankle/foot injuries were 20.5%, 25.6%, and 10.3% respectively. Concussions represented 11% of all injuries. There was no increase in other injury, including neck injury, related to helmet use. Conclusions: Unique injury patterns in snowbladers warrant reconsideration of equipment design. Concussion is a common injury on the ski slope. Although the effects of helmet use on concussion rate are inconclusive based on this study, helmet use did not increase the rate of neck injury, even when adjusted for age.	McGill Sports Med Ctr, Montreal, PQ H2W 1S4, Canada; McGill Univ, Dept Math & Stat, Montreal, PQ H3A 2T5, Canada		Bridges, EJ (corresponding author), McGill Sports Med Ctr, 475 Pine Ave W, Montreal, PQ H2W 1S4, Canada.						ABULABAN RB, 1991, CAN MED ASSOC J, V145, P1097; BLADIN C, 1993, AM J SPORT MED, V21, P701, DOI 10.1177/036354659302100511; BLITZER CM, 1984, AM J SPORT MED, V12, P142, DOI 10.1177/036354658401200210; BOUTER LM, 1989, AM J SPORT MED, V17, P226, DOI 10.1177/036354658901700213; Cadman R, 1996, AM SOC TEST MATER, V1266, P58, DOI 10.1520/STP37914S; CALLE SC, 1995, J PEDIATR SURG, V30, P791, DOI 10.1016/0022-3468(95)90749-1; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Chissell HR, 1996, SPORTS MED, V22, P141, DOI 10.2165/00007256-199622030-00001; Chow TK, 1996, J TRAUMA, V41, P321, DOI 10.1097/00005373-199608000-00021; Davidson TM, 1996, WESTERN J MED, V164, P231; Davidson TM, 1996, WESTERN J MED, V164, P310; Deibert MC, 1998, J BONE JOINT SURG AM, V80A, P25, DOI 10.2106/00004623-199801000-00006; EKELAND A, 1993, AM SOC TEST MATER, V1182, P43, DOI 10.1520/STP25558S; GANONG RB, 1992, PHYSICIAN SPORTSMED, V20, P114, DOI 10.1080/00913847.1992.11947543; Hagel BE, 1999, CLIN J SPORT MED, V9, P9, DOI 10.1097/00042752-199901000-00003; HAUSER W, 1989, ASTM STP, V1022, P18; Hentschel S, 2001, CAN J NEUROL SCI, V28, P42; Holowenko D, 2000, CLIN J SPORT MED, V10, P67, DOI 10.1097/00042752-200001000-00012; Hosmer D, 1989, APPL LOGISTIC REGRES; JOHNSON RJ, 1997, SKI TRAUMA SAFETY, V11, P37; JOHNSON RJ, 1989, STP AM SOC TESTING M, V1022, P25; Machold W, 2000, J TRAUMA, V48, P1109, DOI 10.1097/00005373-200006000-00018; Macnab A J, 1996, Inj Prev, V2, P286, DOI 10.1136/ip.2.4.286; Meeuwisse WH, 1997, SPORTS MED, V24, P184, DOI 10.2165/00007256-199724030-00008; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; O'Neill DF, 1999, AM J SPORT MED, V27, P94; PINO EC, 1989, AM J SPORT MED, V17, P778, DOI 10.1177/036354658901700610; PRALL JA, 1995, INJURY, V26, P539, DOI 10.1016/0020-1383(95)00085-N; REQUA RK, 1977, MED SCI SPORT EXER, V9, P185; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; SAS Institute Inc, 1990, SAS STAT US GUID VER, V2; SAS Institute Inc., 1990, SAS STAT US GUID VER, V1; SHEALY JE, 1993, AM SOC TEST MATER, V1182, P241, DOI 10.1520/STP25575S; Shorter NA, 1999, AM J EMERG MED, V17, P261, DOI 10.1016/S0735-6757(99)90121-3; Shorter NA, 1996, J TRAUMA, V40, P997, DOI 10.1097/00005373-199606000-00024; Sutherland AG, 1996, INJURY, V27, P423, DOI 10.1016/0020-1383(96)00026-5; Tarazi F, 1999, AM J SPORT MED, V27, P177, DOI 10.1177/03635465990270021101; TATOR CH, 1987, CLIN SPORT MED, V6, P101; US Consumer Product Safety Commission, 1999, SKIING HELM EV POT R; WEISS BD, 1994, CLIN SPORT MED, V13, P99; Yamakawa H, 2001, J TRAUMA, V50, P1101, DOI 10.1097/00005373-200106000-00020	41	28	28	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	DEC 1	2003	37	6					511	515		10.1136/bjsm.37.6.511			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	751YN	WOS:000187118300012	14665590	Green Published, Bronze			2022-02-06	
J	Bianchini, KJ; Greve, KW; Love, JM				Bianchini, KJ; Greve, KW; Love, JM			Definite malingered neurocognitive dysfunction in moderate/severe traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							HEAD-INJURY; PERFORMANCE; MMPI-2; LITIGANTS; DEFICITS; SCALE	There has been disagreement in the literature about whether persons with documented neuropathology can be diagnosed as malingering. To address this question, we present three moderate severe traumatic brain injury patients who were evaluated in the context of litigation who met the Slick, Sherman, and Iverson (1999) criteria for a diagnosis of "Definite Malingered Neurocognitive Dysfunction." Each performed significantly below-chance on at least one forced-choice symptom validity test, thereby demonstrating a deliberate attempt to appear impaired. These cases represent the first definitive evidence of an intentional effort to appear impaired in the context of documented moderate/severe traumatic brain injury.	Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; Jefferson Neurobehav Grp, Metairie, LA USA		Greve, KW (corresponding author), Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Bianchini KJ, 2003, J OCCUP ENVIRON MED, V45, P1087, DOI 10.1097/01.jom.0000085886.18136.7d; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bigler E, 1997, DIAGNOSTIC CLIN NEUR; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BINDER LM, 2002, J FORENSIC NEUROPSYC, V2, P27; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; Greene RL, 2000, MMPI 2 INTERPRETIVE; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREVE K, 2002, 36 ANN M ASS ADV BEH; Greve KW, 2003, ARCH PHYS MED REHAB, V84, P1233, DOI 10.1016/S0003-9993(03)00145-X; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2003, HANDBOOK OF FORENSIC NEUROPSYCHOLOGY, P137; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; LARRABEE GJ, 1992, FORENSIC REPORTS, V5, P257; Larrabee GJ, 2000, CLIN GUIDE NEUROPSYC, P301; MAPOU RL, 1988, J CLIN EXP NEUROPSYC, V10, P271, DOI 10.1080/01688638808408241; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; PALMER BW, 1995, CLIN NEUROPSYCHOL, V9, P68, DOI 10.1080/13854049508402060; Reitan RM, 1998, CRIT ISS NE, P163; Reynolds CR, 1998, CRIT ISS NE, P261; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TOMBAUGH TN, 2003, J FORENSIC NEUROPSYC, V2, P69, DOI DOI 10.1300/J151V02N03_04	35	28	28	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	2003	17	4					574	580		10.1076/clin.17.4.574.27946			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	776XV	WOS:000189145400013	15168921				2022-02-06	
J	Sauerland, S; Hensler, T; Bouillon, B; Rixen, D; Raum, MR; Andermahr, J; Neugebauer, EAM				Sauerland, S; Hensler, T; Bouillon, B; Rixen, D; Raum, MR; Andermahr, J; Neugebauer, EAM			Plasma levels of procalcitonin and neopterin in multiple trauma patients with or without brain injury	JOURNAL OF NEUROTRAUMA			English	Article						mediators; multiple injuries; neopterin; procalcitonin; traumatic brain injury	CEREBROSPINAL-FLUID; INTENSIVE-CARE; SEPTIC SHOCK; BLUNT TRAUMA; INTERLEUKIN-10; SEVERITY; SERUM; IMMUNODEPRESSION; CYTOKINES; CHILDREN	Clinical and experimental evidence suggests that traumatic brain injury (TBI) leads to a systemic immune response. To examine whether TBI causes a release of procalcitonin (PCT) or neopterin (NT) into the circulation, we compared plasmatic mediator levels among multiple injured patients with or without TBI. In total, 98 trauma patients (24 with TBI only, 39 with extracranial injuries excluding TBI, and 35 with combined injuries) and 35 healthy volunteers were studied. Blood was sampled at 15 predefined time points within 132 h after injury and analysed for NT and PCT. Multivariate statistical comparisons were adjusted for different severity of head, thorax, abdomen and extremity injuries, as quantified by the Abbreviated Injury Scale (AIS). PCT was normal 3 h after trauma, but 24 h after extracranial injuries a massive release (median 3 ng/mL) was observed. Significant positive associations between injury severity and posttraumatic PCT levels were found for abdominal and extremity, but not for cranial or thoracic injuries. Only modest changes of marginal statistical significance were detected for NT. The maximum increase per AIS point was 9% (95% confidence intervals [CI]: 3-16%). The effect of TBI on NT release was significant only at 108 h posttrauma with a 5% (95% CI: 1-10%) increase per AIS point. TBI induces a release of PCT and NT into the plasma, but this effect seems to be smaller for intra- than for extracranial injuries, probably due to more extensive surgery for abdominal and extremity injuries.	Univ Cologne, Dept Surg 2, Biochem & Expt Div, D-51109 Cologne, Germany		Neugebauer, EAM (corresponding author), Univ Cologne, Dept Surg 2, Biochem & Expt Div, Ostmerheimer Str 200, D-51109 Cologne, Germany.			Sauerland, Stefan/0000-0003-1048-796X			ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell MJ, 1997, ACT NEUR S, V70, P96; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Benoist JF, 1998, ANN BIOL CLIN-PARIS, V56, P571; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; DANDONA P, 1994, J CLIN ENDOCR METAB, V79, P1605, DOI 10.1210/jc.79.6.1605; FAIST E, 1992, SURGERY, V112, P562; HAGBERG L, 1996, PTERIDINES, V6, P147; Hensler T, 2000, INFLAMM RES, V49, P524, DOI 10.1007/s000110050626; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Kretzschmar M, 2001, ACTA ANAESTH SCAND, V45, P1162, DOI 10.1034/j.1399-6576.2001.450918.x; Lenzlinger PM, 2001, J NEUROTRAUM, V18, P479, DOI 10.1089/089771501300227288; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Monneret G, 1999, INFECTION, V27, P34, DOI 10.1007/BF02565168; NASTKOLB D, 1992, UNFALLCHIRURG, V95, P59; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; Oberhoffer M, 1999, J LAB CLIN MED, V134, P49, DOI 10.1016/S0022-2143(99)90053-7; Pape HC, 2001, J TRAUMA, V50, P989, DOI 10.1097/00005373-200106000-00004; ROGY MA, 1994, J AM COLL SURGEONS, V178, P132; ROUMEN RMH, 1995, CRIT CARE MED, V23, P474, DOI 10.1097/00003246-199503000-00010; Russwurm S, 1999, CLIN CHEM LAB MED, V37, P789, DOI 10.1515/CCLM.1999.119; Schroder J, 1999, LANGENBECK ARCH SURG, V384, P33, DOI 10.1007/s004230050170; Seekamp A, 2002, EUR J TRAUMA, V3, P183; Stiletto RJ, 2001, CRIT CARE MED, V29, P1690, DOI 10.1097/00003246-200109000-00006; STROHMAIER W, 1987, CRIT CARE MED, V15, P757, DOI 10.1097/00003246-198708000-00009; WAYDHAS C, 1993, UNFALLCHIRURG, V96, P62; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Woiciechowsky C, 1999, J MOL MED-JMM, V77, P769, DOI 10.1007/s001099900051	31	28	34	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2003	20	10					953	960		10.1089/089771503770195803			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	734RX	WOS:000186072300004	14588112				2022-02-06	
J	Field, AS; Hasan, K; Jellison, BJ; Arfanakis, K; Alexander, AL				Field, AS; Hasan, K; Jellison, BJ; Arfanakis, K; Alexander, AL			Diffusion tensor imaging in an infant with traumatic brain swelling	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							HEAD-INJURY; CEREBRAL-ISCHEMIA; WATER DIFFUSION; ACUTE STROKE; RAT-BRAIN; ANISOTROPY; CHILDREN; IMAGES; MRI	We present the case of a 14-month-old male infant who underwent diffusion tensor imaging within 24 hours of traumatic brain injury. Although conventional MR findings that included those of diffusion-weighted imaging were unremarkable, full-tensor diffusion imaging revealed striking abnormalities in regions of brain that subsequently developed overt swelling. This case engenders important hypotheses regarding mechanisms of traumatic brain swelling and anisotropic diffusion of water in pathologic tissues.	Univ Wisconsin, Sch Med, Dept Radiol, Madison, WI 53792 USA; Univ Wisconsin, Sch Med, Dept Med Phys, Madison, WI 53792 USA; Univ Wisconsin, Sch Med, Dept Psychiat, Madison, WI 53792 USA		Field, AS (corresponding author), Univ Wisconsin, Sch Med, Dept Radiol, E3-311 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.		Hasan, Khader M./ABB-5767-2020; Arfanakis, Konstantinos/AAN-3148-2021; Alexander, Andrew/ABA-2806-2020	Arfanakis, Konstantinos/0000-0001-9705-597X; 			Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barlow KM, 1999, ACTA PAEDIATR, V88, P734; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 1996, MAGNET RESON MED, V36, P39, DOI 10.1002/mrm.1910360108; Carano RAD, 2000, J MAGN RESON IMAGING, V12, P842, DOI 10.1002/1522-2586(200012)12:6<842::AID-JMRI7>3.0.CO;2-5; Chabrol B, 1999, CHILD ABUSE NEGLECT, V23, P217, DOI 10.1016/S0145-2134(98)00128-8; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Green HAL, 2002, STROKE, V33, P1517, DOI 10.1161/01.STR.0000016973.80180.7B; Jones DK, 2000, NEUROSURGERY, V47, P306, DOI 10.1097/00006123-200008000-00008; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Mukherjee P, 2001, RADIOLOGY, V219, P756, DOI 10.1148/radiology.219.3.r01jn48756; Petitti N, 1998, ACAD RADIOL, V5, P215, DOI 10.1016/S1076-6332(98)80287-0; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Sorensen AG, 1999, RADIOLOGY, V212, P785, DOI 10.1148/radiology.212.3.r99se24785; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; vanderToorn A, 1996, MAGN RESON MED, V36, P52, DOI 10.1002/mrm.1910360110; Woodcock RJ, 2001, SEMIN ULTRASOUND CT, V22, P162, DOI 10.1016/S0887-2171(01)90043-5; Yang Q, 1999, STROKE, V30, P2382, DOI 10.1161/01.STR.30.11.2382	21	28	28	0	2	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	AUG	2003	24	7					1461	1464					4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	713MB	WOS:000184860800038	12917147				2022-02-06	
J	Kennedy, JE; Clement, PF; Curtiss, G				Kennedy, JE; Clement, PF; Curtiss, G			WAIS-III processing speed index scores after TBI: The influence of working memory, psychomotor speed and perceptual processing	CLINICAL NEUROPSYCHOLOGIST			English	Article							TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; INTELLIGENCE; INDICATORS; CHILDREN	This study investigates the extent to which working memory, motor speed and perceptual processing speed influence Wechsler Adult Intelligence Scale-III (WAIS-III) Processing Speed Index (PSI) scores. Sixty-eight adult outpatients with Traumatic Brain Injury (TBI) of varying severity and complete data on all outcome measures were identified. Two cases with outlying values on one outcome measure were omitted from the final sample. Working memory was measured by the Working Memory Index score from the WAIS-III. Motor speed was measured as score on the Halstead-Reitan Finger Oscillation Test (finger tapping) and perceptual processing as score on the Trail Making Test-Part B. In hierarchical multiple regression analyses, working memory accounted for 10% of the variance in PSI scores, whereas motor speed only accounted for 3%. An independent measure of perceptual processing, Trail Making Test-B, accounted for 26% of the variance in WAIS-III PSI scores. The total variance accounted for by the three factors was 56%. Findings confirm that the WAIS-III PSI scores of individuals who have received a TBI reflect perceptual processing speed, with an additional component attributable to working memory. Motor speed made only a small contribution to WAIS-III PSI scores in the present sample.	Wilford Hall USAF Med Ctr, Def & Vet Brain Injury Ctr, San Antonio, TX 78227 USA; Brooke Army Med Ctr, ATTN MCHE CP, Ft Sam Houston, TX 78234 USA; James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL 33612 USA; Univ S Florida, Dept Psychiat & Behav Med, Tampa, FL USA		Kennedy, JE (corresponding author), Wilford Hall USAF Med Ctr, Def & Vet Brain Injury Ctr, POB 27376, San Antonio, TX 78227 USA.	jan.kennedy@lackland.af.mil	Curtiss, Glenn/ABB-5566-2020				Donders J, 1997, ASSESSMENT, V4, P107, DOI 10.1177/107319119700400114; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; HANNAY H J, 1982, Journal of Clinical Neuropsychology, V4, P117; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton RK, 1991, COMPREHENSIVE NORMS; Luciano M, 2001, BEHAV GENET, V31, P581, DOI 10.1023/A:1013397428612; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; *PSYCH CORP, 1997, WECHSL AD INT SCAL; Reitan RM, 1985, HALSTEADREITAN NEURO; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; STERNBERG S, 1969, AM SCI, V57, P421; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; STOKX LC, 1986, J CLIN EXP NEUROPSYC, V8, P421, DOI 10.1080/01688638608401332; TROMP E, 1991, J CLIN EXP NEUROPSYC, V13, P821, DOI 10.1080/01688639108405100; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924	19	28	29	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG	2003	17	3					303	307		10.1076/clin.17.3.303.18091			5	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	748DP	WOS:000186847100002	14704894				2022-02-06	
J	Coelho, CA; Youse, KM; Le, KN; Feinn, R				Coelho, CA; Youse, KM; Le, KN; Feinn, R			Narrative and conversational discourse of adults with closed head injuries and non-brain-injured adults: A discriminant analysis	APHASIOLOGY			English	Article; Proceedings Paper	32nd Annual Clinical Aphasiology Conference	JUN, 2002	RIDGEDALE, MO					Background: Although there is general agreement regarding the clinical utility of discourse analyses for detecting the often subtle communicative impairments following closed head injuries (CHI), there is little consensus regarding discourse elicitation or analysis procedures. Consequently it has been difficult to compare findings across studies. Aims: In an effort to facilitate a movement towards the adoption of a more consistent methodology for the assessment of discourse abilities, the current study examined several commonly used measures of discourse performance and the accuracy with which these measures were able to distinguish individuals with CHI from non-brain-injured (NBI) controls. Previous studies have suggested that conversation is less demanding than narrative discourse because such narratives require greater manipulation of extended units of language while conversational discourse can be maintained with minimal responses (Chapman, 1997; Galski, Tompkins, & Johnston, 1998). On the basis of these reports it was hypothesised that the measures of narrative story performance would more accurately discriminate the participant groups than conversational measures. Methods & Procedures: Discourse samples were elicited from 32 adults with CHI and 43 NBI adults. Discourse samples included two story narratives, generation and retelling, and 15 minutes of conversation. A variety of discourse analyses were performed including story narrative measures of grammatical complexity, cohesive adequacy, and story grammar. Measures of conversation included appropriateness and topic initiation. Discriminant function analyses (DFA) were then employed to determine the accuracy of the selected measures in classifying the participants into their respective groups. Outcomes & Results: Results of the DFA with only the story narrative measures indicated that 70% of the cases, 64.5% of the CHI group, and 74.4% of the NBI group were accurately classified. This finding was not significant, suggesting that the story narrative measures did not reliably discriminate the CHI from the NBI participants. The DFA with the conversational measures correctly classified over 77% of the cases, 78.1% of the CHI participants, and 72.1% of the NBI group. This finding was significant, which suggests that the measures of conversational discourse were better able to discriminate the participant groups. A third DFA was performed, with all of the story narrative and conversational discourse measures included, which revealed that the conversational measures, comments and adequate plus responses, and the story narrative measure, T-units within episode structure in the generation task, made the greatest contributions to discriminating between the groups. Overall, group membership was correctly classified by the DFA in 81% of the cases, 84.4% of the CHI group, and 77.5% of the NBI participants. This finding was significant, suggesting that these three discourse measures discriminated the two participant groups with the highest degree of reliability. Conclusions: These findings did not support the hypothesis that the narrative discourse measures would more accurately predict group membership of the CHI and NBI participants than the conversational measures. A variety of factors may account for these findings including the interactive nature of conversation as well as social factors which appear to make this genre more difficult for individuals with CHI and a more sensitive index of their cognitive-communicative impairments.	Univ Connecticut, Dept Commun Sci, Unit 1085, Storrs, CT 06268 USA; Hosp Special Care, New Britain, CT USA; Univ Connecticut, Ctr Hlth, Farmington, CT USA		Coelho, CA (corresponding author), Univ Connecticut, Dept Commun Sci, Unit 1085, Storrs, CT 06268 USA.	coelho@uconn.edu					BLANK M, 1980, APPL PSYCHOLINGUIST, V1, P127, DOI 10.1017/S0142716400000801; BRINTON B, 1989, CONVERSATIONAL MANAG; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Doyle P. J., 1995, AM J SPEECH-LANG PAT, V4, P130, DOI [10.1044/1058-0360.0404.130, DOI 10.1044/1058-0360.0404.130]; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; HAGAN C, 1980, REHABILITATION HEAD; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HOLLINGSHEAD A, 1972, UNPUB 4 FACTOR INDEX; Kertesz A., 1982, W APHASIA BATTERY; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LILES BZ, 1995, J SPEECH HEAR RES, V38, P415, DOI 10.1044/jshr.3802.415; LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; Mackenzie C, 2000, INT J LANG COMM DIS, V35, P269, DOI 10.1080/136828200247188; MANDLER JM, 1977, COGNITIVE PSYCHOL, V9, P111, DOI 10.1016/0010-0285(77)90006-8; Maths S, 1976, GERIATRIC PSYCHIAT; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Prince S, 2002, J MED SPEECH-LANG PA, V10, P19; Simmons-Mackie N, 2002, APHASIOLOGY, V16, P837, DOI 10.1080/02687030244000185; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Togher L, 2001, J COMMUN DISORD, V34, P131, DOI 10.1016/S0021-9924(00)00045-9; TOGHER L, 1999, BRAIN DAM B, P113; Wilkinson R, 1999, APHASIOLOGY, V13, P327, DOI 10.1080/026870399402127; WINTER P, 1976, BEAR FLY; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745	31	28	28	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	MAY	2003	17	5					499	510		10.1080/02687030344000111			12	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	669DB	WOS:000182335700008					2022-02-06	
J	Wade, SL; Taylor, HG; Drotar, D; Stancin, T; Yeates, KO; Minich, NM				Wade, SL; Taylor, HG; Drotar, D; Stancin, T; Yeates, KO; Minich, NM			Parent-adolescent interactions after traumatic brain injury - Their relationship to family adaptation and adolescent adjustment	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; child adjustment; conflict; criticism; family adaptation; parent-adolescent interaction; pediatric	EXPRESSED EMOTION; CHILDREN; RELIABILITY; PREDICTORS; VALIDITY; SEVERITY; BURDEN	To examine changes in parent-adolescent interactions after traumatic brain injury (17131) and their relationship to parent and adolescent adjustment. Design: Concurrent cohort, cross-sectional study. Analysis of variance was used to examine group differences and regression analysis to assess associations between interactional measures and concurrent adjustment. Setting: Four hospitals in north-central Ohio. Participants: Adolescents with severe TBI (25), moderate TBI (22), and orthopedic injuries (35) and their parents. Main outcome measures: Observer ratings of parent-adolescent interactions, Conflict Behavior Questionnaire (CBQ), Family Burden of Injury Interview (FBII), Brief Symptom Inventory (BSI), Family Assessment Device (FAD), Child Behavior Checklist, Vineland Adaptive Behavior Scale, and Children's Depression Inventory. Results: No group differences were found on ratings of parent-adolescent interaction or the parent or child CBQ. However, observed criticism/coldness and self-rated conflict had stronger associations with the FBII, BSI, and FAD in the severe TBI group than in the orthopedic injury group, suggesting that conflict is more disruptive after TBI. Ratings of criticism/coldness and parent and adolescent CBQ scores were also associated with parent and adolescent adjustment. Conclusions: Results support the utility of observational measures in assessing dyadic interactions after TBI.	Cincinnati Childrens Hosp, Med Ctr, Div Pediat Phys Med & Rehabil, Dept Pediat, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Metrohlth Med Ctr, Cleveland, OH USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Columbus Childrens Hosp, Columbus, OH USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Pediat Phys Med & Rehabil, Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.		Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 36335] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCJ 380611] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036335] Funding Source: NIH RePORTER		Achenbach TM, 1991, MANUAL CHILD BEHAV C; AIKEN IS, 1991, MULTIPLE REGRESSION; Borduin C. M., 1985, CHILD FAMILY BEHAV T, V7, P51, DOI DOI 10.1300/J019V07N02_04; Borduln CM, 1987, J APPL DEV PSYCHOL, V8, P273; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; Ciccetti D., 1984, VINELAND ADAPTIVE BE; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Derogatis LR., 1982, BRIEF SYMPTOM INVENT; DISHION TJ, 1985, AM J DRUG ALCOHOL AB, V11, P11, DOI 10.3109/00952998509016846; DOSSETOR DR, 1994, J INTELL DISABIL RES, V38, P487; FLANNERY DJ, 1993, J SOC PERS RELAT, V10, P495, DOI 10.1177/0265407593104002; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Henggeler S.W., 1987, J APPLIED DEV PSYCHO, V8, P97, DOI [10.1016/0193-3973(87)90023-2, DOI 10.1016/0193-3973(87)90023-2]; Hodes M, 1999, J CHILD PSYCHOL PSYC, V40, P1083, DOI 10.1017/S002196309900462X; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; KOVACS M, 1981, ACTA PAEDOPSYCHIATR, V46, P305; Marks M, 1993, NeuroRehabilitation, V3, P1, DOI 10.3233/NRE-1993-3303; Max JE, 1998, J AM ACAD CHILD PSY, V37, P83, DOI 10.1097/00004583-199801000-00021; MAYER T, 1980, J PEDIATR SURG, V15, P719, DOI 10.1016/S0022-3468(80)80271-5; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Patterson G.R., 1982, PATTERSON; PATTERSON GR, 1983, COPING DEV CHILDREN, P235; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; ROBIN AL, 1989, NEGOTIATING PARENT A; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; Singer G. H. S., 1996, CHILDREN ACQUIRED BR, P23; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Wamboldt MZ, 2000, J AM ACAD CHILD PSY, V39, P1212, DOI 10.1097/00004583-200010000-00006; WEBSTERSTRATTON C, 1990, J CLIN CHILD PSYCHOL, V19, P302, DOI 10.1207/s15374424jccp1904_2; WILLIAMS J, 1991, HEAD INJURY FAMILY M; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; ZARSKI J, 1988, J HEAD TRAUMA REHAB, V3, P31	36	28	28	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2003	18	2					164	176		10.1097/00001199-200303000-00007			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	663DU	WOS:000181991600007	12802225				2022-02-06	
J	Seidberg, NA; Clark, RSB; Zhang, XP; Lai, YC; Chen, MZ; Graham, SH; Kochanek, PM; Watkins, SC; Marion, DW				Seidberg, NA; Clark, RSB; Zhang, XP; Lai, YC; Chen, MZ; Graham, SH; Kochanek, PM; Watkins, SC; Marion, DW			Alterations in inducible 72-kDa heat shock protein and the chaperone cofactor BAG-1 in human brain after head injury	JOURNAL OF NEUROCHEMISTRY			English	Article						apoptosis; Bcl-2; head injury; Hsc70; Hsp70; trauma	OXIDE SYNTHASE EXPRESSION; CULTURED NEURONS; STRESS-RESPONSE; RAT-BRAIN; INDUCTION; HSP70; HEAT-SHOCK-PROTEIN-70; CELLS; FLUID; GENE	The stress response in injured brain is well characterized after experimental ischemic and traumatic brain injury (TBI); however, the induction and regulation of the stress response in humans after TBI remains largely undefined. Accordingly, we examined injured brain tissue from adult patients (n=8) that underwent emergent surgical decompression after TBI, for alterations in the inducible 72-kDa heat shock protein (Hsp70), the constitutive 73-kDa heat shock protein (Hsc70), and isoforms of the chaperone cofactor BAG-1. Control samples (n=6) were obtained postmortem from patients dying of causes unrelated to CNS trauma. Western blot analysis showed that Hsp70, but not Hsc70, was increased in patients after TBI versus controls. Both Hsp70 and Hsc70 coimmunoprecipitated with the cofactor BAG-1. The 33 and 46, but not the 50-kDa BAG-1 isoforms were increased in patients after TBI versus controls. The ratio of the 46/33-kDa isoforms was increased in TBI versus controls, suggesting negative modulation of Hsp70/Hsc70 protein refolding activity in injured brain. These data implicate induction of the stress response and its modulation by the chaperone cofactor and Bcl-2 family member BAG-1, after TBI in humans.	Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Pediat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Anesthesiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Neurol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Neurol Surg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; VA Pittsburgh Hlth Syst, Ctr Geriatr Res Educ & Clin, Pittsburgh, PA USA		Clark, RSB (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015; Marion, Donald/AAR-5749-2021; Watkins, Simon/ABG-2590-2021	Kochanek, Patrick M/0000-0002-2627-913X; Watkins, Simon/0000-0003-4092-1552; Lai, Yi-Chen/0000-0002-9450-5506	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS001946, R01NS038620, P50NS030318] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [KO8 NS01946, P50 NS30318, R01 NS38620] Funding Source: Medline		Bechtold DA, 2000, J NEUROCHEM, V74, P641, DOI 10.1046/j.1471-4159.2000.740641.x; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; Bullock R, 1994, INTRACRANIAL PRESSUR, P264; BURDON RH, 1993, MOL ASPECTS MED, V14, P83, DOI 10.1016/0098-2997(93)90020-E; Champagne MJ, 1999, HYPERTENSION, V33, P906, DOI 10.1161/01.HYP.33.3.906; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; CHEN Q, 1993, J CEREBR BLOOD F MET, V13, P389, DOI 10.1038/jcbfm.1993.52; Clark D, 1999, IEEE INTERNET COMPUT, V3, P13; deVera ME, 1996, HEPATOLOGY, V24, P1238; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Dutcher SA, 1998, J NEUROTRAUM, V15, P421, DOI 10.1089/neu.1998.15.421; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feinstein DL, 1996, J BIOL CHEM, V271, P17724, DOI 10.1074/jbc.271.30.17724; Froesch BA, 1998, J BIOL CHEM, V273, P11660, DOI 10.1074/jbc.273.19.11660; Gotohda Takako, 2000, Journal of Medical Investigation, V47, P76; HOSSMANN KA, 1993, PROG BRAIN RES, V96, P161; JAATTELA M, 1992, EMBO J, V11, P3507, DOI 10.1002/j.1460-2075.1992.tb05433.x; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; KATO M, 1992, ACTA NEUROPATHOL, V83, P420, DOI 10.1007/BF00713535; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; LI Y, 1992, ACTA NEUROPATHOL, V84, P94, DOI 10.1007/BF00427221; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LING J, 1998, GENE DEV, V12, P3236; LOWENSTEIN DH, 1994, MOL BRAIN RES, V22, P299, DOI 10.1016/0169-328X(94)90058-2; LOWENSTEIN DH, 1991, NEURON, V7, P1053, DOI 10.1016/0896-6273(91)90349-5; Luders J, 2000, J BIOL CHEM, V275, P14817, DOI 10.1074/jbc.275.20.14817; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; MAILHOS C, 1993, NEUROSCIENCE, V55, P621, DOI 10.1016/0306-4522(93)90428-I; Massa SM, 1996, CEREBROVAS BRAIN MET, V8, P95; Matz PG, 1996, J NEUROSURG, V85, P138, DOI 10.3171/jns.1996.85.1.0138; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MORRISONBOGORAD M, 1995, J NEUROCHEM, V64, P235; Papadopoulos MC, 1996, NEUROREPORT, V7, P429, DOI 10.1097/00001756-199601310-00013; Planas AM, 1997, PROG NEUROBIOL, V51, P607, DOI 10.1016/S0301-0082(97)00004-X; PUARUD S, 1994, CELL MOL NEUROBIOL, V14, P341; RAGHUPATHI R, 1995, J CEREBR BLOOD F MET, V15, P467, DOI 10.1038/jcbfm.1995.58; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; RORDORF G, 1991, NEURON, V7, P1043, DOI 10.1016/0896-6273(91)90348-4; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Schett G, 1999, FASEB J, V13, P833, DOI 10.1096/fasebj.13.8.833; Schneikert J, 1999, J CELL BIOL, V146, P929, DOI 10.1083/jcb.146.5.929; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; SIMON RP, 1991, J NEUROSCI, V11, P881; Someren JS, 1999, BIOCHEM BIOPH RES CO, V260, P619, DOI 10.1006/bbrc.1999.0800; Stuart JK, 1998, J BIOL CHEM, V273, P22506, DOI 10.1074/jbc.273.35.22506; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; Tytell M, 1998, MOL CHEM NEUROPATHOL, V35, P97, DOI 10.1007/BF02815118; VASS K, 1989, NEUROSCI LETT, V100, P259, DOI 10.1016/0304-3940(89)90695-2; Yenari MA, 1998, ANN NEUROL, V44, P584, DOI 10.1002/ana.410440403	52	28	29	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	FEB	2003	84	3					514	521		10.1046/j.1471-4159.2003.01547.x			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	635UF	WOS:000180417200011	12558971	Bronze			2022-02-06	
J	Diamond, BJ; Shreve, GM; Bonilla, JM; Johnston, MV; Morodan, J; Branneck, R				Diamond, BJ; Shreve, GM; Bonilla, JM; Johnston, MV; Morodan, J; Branneck, R			Telerehabilitation, cognition and user-accessibility	NEUROREHABILITATION			English	Article						telerehabilitation; traumatic brain injury; cognitive impairment; NBCSE	TRAUMATIC BRAIN-INJURY; REHABILITATION	Survivors of traumatic brain injury (TBI) often experience cognitive and physical impairments. The aims of this study were to: 1) build an internet-based, "Virtual Rehabilitation Center" (VRC) that provides rehabilitation, education and support services to individuals with TBI; and 2) to determine the relationships between the nature and severity of the participants' cognitive impairments and their ability to use the VRC. Eight individuals with brain injuries (Age: M = 43, SD = 15.4; Years of Education: M = 13.8, SD = 3.15) participated. The Neurobehavioral Cognitive Status Exam (NBCSE) was used to assess intellectual functioning. The VRC modules consisted of reaction time, functional modules, and communication capabilities. All participants learned how to use the VRC. However, those requiring more "trials to acquisition" showed greater cognitive impairment than those requiring fewer trials in: Construction (p = 0.02), Reasoning-Similarities (p = 0.01) and in calculation and language repetition. (i.e., a non-significant trend). Importantly, all participants learned how to use the system although learning rates varied. Moreover, one case-study demonstrated that learning on the VRC generalized to the community. Overall, impairments on the NBCSE in visual-constructional integration and executive-type functions, as well as language processing appeared to be related to how effectively participants teamed how to use the VRC.	William Paterson Univ, Dept Psychol, Wayne, NJ USA; Kent State Univ, Inst Appl Linguist, Kent, OH 44242 USA; Res & Educ Corp, Kessler Med Rehabil, W Orange, NJ USA; Univ Med & Dent New Jersey, NJ Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA		Diamond, BJ (corresponding author), POB 43592, Montclair, NJ 07043 USA.	diamondb@wpunj.edu	Shreve, Gregory/AAF-4497-2020	Shreve, Gregory/0000-0002-6907-1590			Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; FITZGIBBONS M, 2000, CORRECTIONS TODAY, V62, P104; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; Guerrero JL, 1999, DISABIL REHABIL, V21, P187; GUERRIER T, 2001, INT J COGNITIVE TECH, V6, P3; GUNJAN S, 2000, POPULAR SCI, V257, P58; Judd D. P., 1999, COUNSELLING PSYCHOL, V14, P4; LEWIN ICF, 1992, COST DISORDERS BRAIN; Logan RA, 2000, ARTHRIT CARE RES, V13, P320, DOI 10.1002/1529-0131(200010)13:5<320::AID-ANR12>3.0.CO;2-H; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Nitzkin J L, 1997, Telemed J, V3, P141, DOI 10.1089/tmj.1.1997.3.141; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Popescu VG, 2000, IEEE T INF TECHNOL B, V4, P45, DOI 10.1109/4233.826858; Schopp LH, 2000, J TELEMED TELECARE, V6, P146, DOI 10.1258/1357633001934474; Schultheis MT, 2001, PRESENCE-TELEOP VIRT, V10, P431, DOI 10.1162/1054746011470271; SCHWAMM LH, 1987, ANN INTERN MED, V107, P486, DOI 10.7326/0003-4819-107-4-486; Swett H A, 1995, Conn Med, V59, P593; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Warden DL, 2000, J HEAD TRAUMA REHAB, V15, P1092, DOI 10.1097/00001199-200010000-00003; Webster G, 1999, BRAIN INJURY, V13, P593; 1997, ECONOMIST, V342, P27	22	28	29	2	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2003	18	2					171	177					7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	743ZU	WOS:000186604100009	12867679				2022-02-06	
J	Parker, MW; Chen, Y; Hallenbeck, JM; Ford, BD				Parker, MW; Chen, Y; Hallenbeck, JM; Ford, BD			Neuregulin expression after focal stroke in the rat	NEUROSCIENCE LETTERS			English	Article						stroke; glial growth factor; heregulin; acetylcholine receptor inducing activity; focal cerebral ischemia	NERVOUS-SYSTEM; BRAIN; CELLS; RECEPTOR; ISOFORMS; ISCHEMIA; INJURY; DEATH; ARIA	Upregulation of neuregulin has been demonstrated in traumatic brain injury, but a role for neuregulin in ischemic brain injury has not been investigated. Therefore, we used a rat permanent middle cerebral artery occlusion model to examine the distribution of neuregulin after the onset of ischemic stroke. We found an increase in immunohistochemical staining for neuregulin in the penumbral regions of the cortex. The increase in neuregulin appeared to be neuronal. There was no neuregulin co-localization with astrocytes or macrophages. These results demonstrate that neuregulin is induced in neurons following ischemic stroke and may be involved in neuroprotection and repair. (C) 2002 Published by Elsevier Science Ireland Ltd.	Morehouse Sch Med, Inst Neurosci, Dept Anat & Neurobiol, Atlanta, GA 30310 USA; Johns Hopkins Sch Med, Baltimore, MD USA; NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA		Ford, BD (corresponding author), Morehouse Sch Med, Inst Neurosci, Dept Anat & Neurobiol, 720 Westview Dr,Sw,MRC 223, Atlanta, GA 30310 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS34194] Funding Source: Medline		Abe K, 2000, J CEREBR BLOOD F MET, V20, P1393, DOI 10.1097/00004647-200010000-00001; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; CHEN MS, 1994, J COMP NEUROL, V349, P389, DOI 10.1002/cne.903490306; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Davies CA, 1998, EXP NEUROL, V154, P199, DOI 10.1006/exnr.1998.6891; Erlich S, 2001, NEUROSCIENCE, V107, P353, DOI 10.1016/S0306-4522(01)00350-5; Erlich S, 2000, MOL CELL NEUROSCI, V16, P597, DOI 10.1006/mcne.2000.0894; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Furuya K, 2001, J CEREBR BLOOD F MET, V21, P226, DOI 10.1097/00004647-200103000-00006; Gerecke KM, 2001, J COMP NEUROL, V433, P86, DOI 10.1002/cne.1127; Goldshmit Y, 2001, J BIOL CHEM, V276, P46379, DOI 10.1074/jbc.M105637200; Goldstein LB, 2001, STROKE, V32, P280, DOI 10.1161/01.STR.32.1.280; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Mattson MP, 1997, NEUROSCI BIOBEHAV R, V21, P193, DOI 10.1016/S0149-7634(96)00010-3; MCAULEY MA, 1995, CEREBROVAS BRAIN MET, V7, P153; ter Laak MP, 2000, J NEUROSCI RES, V60, P237, DOI 10.1002/(SICI)1097-4547(20000415)60:2<237::AID-JNR13>3.0.CO;2-5; Tokita Y, 2001, J NEUROSCI, V21, P1257; Wang JY, 2001, J BIOL CHEM, V276, P2841, DOI 10.1074/jbc.M005700200	18	28	30	0	3	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	DEC 16	2002	334	3					169	172	PII S0304-3940(02)01126-6	10.1016/S0304-3940(02)01126-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	624MK	WOS:000179763300007	12453622				2022-02-06	
J	Kupina, NC; Detloff, MR; Dutta, S; Hall, ED				Kupina, NC; Detloff, MR; Dutta, S; Hall, ED			Neuroimmunophilin ligand V-10,367 is neuroprotective after 24-hour delayed administration in a mouse model of diffuse traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						traumatic brain injury; V-10,367; cytoskeleton; calpain; neurofilament; spectrin	AMYLOID PRECURSOR PROTEIN; IMMUNOSUPPRESSANT FK506; AXONAL INJURY; HEAD-INJURY; CYCLOSPORINE-A; IN-VIVO; IMMUNOPHILIN LIGANDS; DOPAMINERGIC-NEURONS; NEUROTROPHIC ACTIONS; PARKINSONS-DISEASE	The authors present two studies that investigate the biochemical and histologic effects of the nonimmunosuppressive neuroimmunophilin (NIMM) ligand V-10,367 in a mouse model of traumatic brain injury (TBI). In study 1, the authors examined the effect of V-10,367 (50 mg/kg x 2 per day, by mouth) on neurofilament M (NFM) protein levels and on alpha-spectrin breakdown products (SBDPs) when dosed for 2 days, starting 24 hours after TBI and killed on day 3. In study 2, V-10,367 was given for 10 days, starting 24 hours after TBI and the mice killed 6 weeks after TBI, to measure the extent of neurodegeneration (amino CuAg stain). The results in study 1 revealed that V-10,367-treatment significantly increased NFM protein levels in both sham and TBI mice. In addition, V-10,367 attenuated SBDP 150 levels in the cortex, striatum, and hippocampus. The results of study 2 indicated that TBI mice treated with V-10,367 demonstrated significantly less neurodegeneration compared to injured, vehicle-treated mice. In summary, these results suggest that NIMMs may be neuroprotective indirectly through inhibition of calpain-mediated cytoskeletal damage and perhaps via maintenance of neuronal plasticity. In the context of this mouse model of TBI, the therapeutic window for V-10,367's positive effects is at least 24 hours after injury, which, in the case of TBI models, is largely unprecedented for a neuroprotective compound.	Pfizer Global Res & Dev, CNS Pharmacol, Ann Arbor, MI USA		Hall, ED (corresponding author), Univ Kentucky, Chandler Med Ctr, Spinal Cord & Brain Injury Res Ctr, 232 Hlth Sci Res Bldg, Lexington, KY 40536 USA.		Hall, Edward D/F-8930-2013				Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; ARMISTEAD DM, 1995, ACTA CRYSTALLOGR D, V51, P522, DOI 10.1107/S0907444994014502; Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Buki A, 2000, J NEUROSCI, V20, P2825; Butcher SP, 1997, J NEUROSCI, V17, P6939; Campbell G, 1999, NEUROREPORT, V10, P3955, DOI 10.1097/00001756-199912160-00042; Costantini LC, 2000, NEUROSCIENCE, V100, P515, DOI 10.1016/S0306-4522(00)00312-2; Costantini LC, 1998, NEUROBIOL DIS, V5, P97, DOI 10.1006/nbdi.1998.0185; Costantini LC, 2001, EUR J NEUROSCI, V13, P1085, DOI 10.1046/j.0953-816x.2001.01473.x; DAWSON TM, 1993, P NATL ACAD SCI USA, V90, P9808, DOI 10.1073/pnas.90.21.9808; DAWSON TM, 1994, NEUROSCIENCE, V62, P569, DOI 10.1016/0306-4522(94)90389-1; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; DICKERSON RN, 1990, J AM COLL NUTR, V9, P86; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gogarten W, 1998, J NEUROSURG ANESTH, V10, P101, DOI 10.1097/00008506-199804000-00006; Gold BG, 1997, EXP NEUROL, V147, P269, DOI 10.1006/exnr.1997.6630; Gold BG, 1999, J PHARMACOL EXP THER, V289, P1202; GOLD BG, 1995, J NEUROSCI, V15, P7509; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAFE MR, 1980, J NEUROPATH EXP NEUR, V39, P555, DOI 10.1097/00005072-198009000-00005; Guo X, 2001, EUR J NEUROSCI, V13, P1683, DOI 10.1046/j.0953-816x.2001.01542.x; Hall E.D., 1995, CENTRAL NERVOUS SYST, P213; HALL ED, 1995, NEUROSURGERY 96 MANU, P505; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Harper S, 1999, NEUROSCIENCE, V88, P257, DOI 10.1016/S0306-4522(98)00221-8; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; KITAMURA Y, 1994, J NEUROIMMUNOL, V50, P221; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; KUPINA N, 2002, UNPUB EXP NEUROL; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Langham J., 2000, COCHRANE DATABASE SY, V2; LYONS WE, 1994, P NATL ACAD SCI USA, V91, P3191, DOI 10.1073/pnas.91.8.3191; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; McIntosh TK, 1996, LAB INVEST, V74, P315; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; SNYDER SH, 1995, NAT MED, V1, P32, DOI 10.1038/nm0195-32; Steiner JP, 1997, P NATL ACAD SCI USA, V94, P2019, DOI 10.1073/pnas.94.5.2019; Steiner JP, 1997, NAT MED, V3, P421, DOI 10.1038/nm0497-421; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Toung TJ, 1999, STROKE, V30, P1279, DOI 10.1161/01.STR.30.6.1279; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; YAMAMOTO T, 1986, BRAIN RES, V374, P419, DOI 10.1016/0006-8993(86)90442-7; Young B, 1991, Neurosurg Clin N Am, V2, P301; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; [No title captured]	57	28	28	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2002	22	10					1212	1221		10.1097/01.wbc.0000037994.34930.bc			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	600PF	WOS:000178399200009	12368660				2022-02-06	
J	Berger, S; Schwarz, M; Huth, R				Berger, S; Schwarz, M; Huth, R			Hypertonic saline solution and decompressive craniectomy for treatment of intracranial hypertension in pediatric severe traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; PRESSURE; RESUSCITATION; CHILDREN; COMPLICATIONS; DEXTRAN; EDEMA		Johannes Gutenberg Univ Mainz, Dept Pediat Surg, D-55101 Mainz, Germany; Johannes Gutenberg Univ Mainz, Dept Neurosurg, D-55101 Mainz, Germany; Johannes Gutenberg Univ Mainz, Dept Pediat, Pediat ICU, D-55101 Mainz, Germany		Berger, S (corresponding author), Johannes Gutenberg Univ Mainz, Dept Pediat Surg, Langenbeckstr 1, D-55101 Mainz, Germany.	berger@kinderchir.klinik.uni-mainz.de					BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; CHAN KH, 1990, CHILD NERV SYST, V6, P27, DOI 10.1007/BF00262262; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Gemma M, 1996, J NEUROSURG ANESTH, V8, P137, DOI 10.1097/00008506-199604000-00007; Hartl R, 1997, ZBL CHIR, V122, P181; Hieu PD, 1996, CHILD NERV SYST, V12, P270; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; KOFKE WA, 1993, J NEUROSURG ANESTH, V5, P1; Kreimeier U, 1997, ANAESTHESIST, V46, P309, DOI 10.1007/s001010050406; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; POLIN R, 1999, NEUROSURGERY, V41, P84; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Schatzmann C, 1998, ACT NEUR S, V71, P31; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; YOUNES RN, 1985, SURGERY, V98, P900; ZORNOW MH, 1990, ACT NEUR S, V51, P324; Zornow MH, 1996, J NEUROSURG ANESTH, V8, P175, DOI 10.1097/00008506-199604000-00021	29	28	29	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2002	53	3					558	563		10.1097/00005373-200209000-00027			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	599GA	WOS:000178324700036	12352497				2022-02-06	
J	Woertgen, C; Rothoerl, RD; Brawanski, A				Woertgen, C; Rothoerl, RD; Brawanski, A			Early S-100B serum level correlates to quality of life in patients after severe head injury	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; GLASGOW-OUTCOME-SCALE; PROTEIN MEASUREMENTS; FOLLOW-UP; OF-LIFE; INDIVIDUALS; DAMAGE; CONSEQUENCES; PREDICTORS	Purpose: S-100B protein is a new possible indicator of brain damage after severe head injury. In outcome assessment there is an increasing focus on measures of health outcome incorporating the person's own perspective. Therefore, the aim of the study was to investigate the correlation of early S-100B serum level to the quality of life. Method: Fifty-one patients with severe head injury were included in a prospective study. Blood samples were taken on admission (mean 2.5 hours). The outcome was assessed at follow-up using the Glasgow Outcome Scale and a questionnaire according to Blau to assess the quality of life. Results: High serum concentrations of S-100B on admission correlate to unfavourable outcome according to the GOS (4.9 mug/l vs 1.6 mug/l, mean, p<0.0008). In addition, the S-100B serum concentrations on admission correlate to quality of life in the survivor group. Patients with S-100B serum levels &LE; 0.5 &mu;g/l scored 71.4 points (mean) on the QoL index compared to patients with elevated S-100B concentrations, who scored 55.4 points (mean, p<0.05). Conclusion: S-100B seems to be able to assess the extent of primary brain damage after trauma.	Univ Regensburg, Dept Neurosurg, D-93042 Regensburg, Germany		Woertgen, C (corresponding author), Univ Regensburg, Dept Neurosurg, Franz Josef Str Allee 11, D-93042 Regensburg, Germany.						BLAU TH, 1977, PROFESSIONAL PSY NOV, P464; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; Bullock MR, 1999, NEUROSURGERY, V45, P483; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; JENNETT B, 1975, LANCET, V1, P480; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; MISSLER U, 1995, EUR J CLIN CHEM CLIN, V33, P743; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olver JH, 1995, CURR OPIN NEUROL, V8, P443, DOI 10.1097/00019052-199512000-00008; Raabe A, 1999, NEUROSURGERY, V45, P477, DOI 10.1097/00006123-199909000-00012; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Rothoerl RD, 2000, ACTA NEUROCHIR, V142, P199, DOI 10.1007/s007010050024; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; TEASDALE G, 1974, LANCET, V2, P81; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; Woischneck D, 1998, ACT NEUR S, V71, P138	24	28	33	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2002	16	9					807	816		10.1080/02699050210128933			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	585PD	WOS:000177532800006	12217206				2022-02-06	
J	White, H; Baker, A				White, H; Baker, A			Continuous jugular venous oximetry in the neurointensive care unit - a brief review	CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE			English	Article							SEVERE HEAD-INJURY; BULB OXYHEMOGLOBIN SATURATION; OXYGEN-SATURATION; CEREBRAL OXYGENATION; COMATOSE PATIENTS; CARDIAC-SURGERY; INTENSIVE-CARE; BRAIN INJURY; MANAGEMENT; ACCURACY	Purpose: To describe the technique of continuous jugular venous oxygen saturation (SjVO2) monitoring and review its applications in the neurointensive care unit (NICU), with special reference to the management of raised intracranial pressure (ICP) following severe acute brain injury. Source: This narrative review is based on a selection of current literature on SjVO2 monitoring in conjunction with local experience using this technique. Principal findings: Despite limitations, the use of SjVO2 monitoring has the potential to impact on patient care in the NICU. The placement of the catheter is relatively simple. Studies have confirmed that abnormalities in cerebral venous oxygen saturation are associated with adverse outcome following traumatic brain injury. There is evidence that SjVO2 may be a useful adjunct to ICP monitoring of patients with intracranial hypertension. Furthermore, managing cerebral extraction of oxygen in conjunction with cerebral perfusion pressure may result in an improved outcome. Further research in this area is needed. Other indications for SjVO2 monitoring include subarachnoid hemorrhage, cardiopulmonary/bypass and following ischemic stroke. Conclusion: In the past, the management of severe acute brain injury was targeted at ICP and perfusion pressure with little consideration for the metabolic requirements of the injured brain. SjVO2 monitoring is another tool the intensivist can use to obtain information about the global oxygen requirements of the injured brain on a continuous basis. Whether this will impact on care in the long term remains to be seen.	St Michaels Hosp, Dept Anaesthesia, Trauma & Neurosurg Intens Care Unit, Toronto, ON M5B 1W8, Canada		Baker, A (corresponding author), St Michaels Hosp, Dept Anaesthesia, Trauma & Neurosurg Intens Care Unit, 30 Bond St, Toronto, ON M5B 1W8, Canada.						Anastasiou E, 1999, J CARDIOTHOR VASC AN, V13, P276, DOI 10.1016/S1053-0770(99)90263-X; Artru F, 1998, NEUROL RES, V20, pS48; BANKIER AA, 1995, AM J ROENTGENOL, V16, P437; Bardt TF, 1998, ACTA NEUROCHIR, V140, P357, DOI 10.1007/s007010050109; Basso A, 2001, WORLD J SURG, V25, P1174; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Buunk G, 1999, RESUSCITATION, V41, P257, DOI 10.1016/S0300-9572(99)00060-X; Cheng CSA, 1996, J ACCOUNTING RES, V34, P173, DOI 10.2307/2491338; Citerio G, 1998, ACT NEUR S, V71, P316; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; CROUGHWELL ND, 1994, ANN THORAC SURG, V58, P1702, DOI 10.1016/0003-4975(94)91666-7; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; De Deyne C, 1996, Eur J Emerg Med, V3, P69, DOI 10.1097/00063110-199606000-00002; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Fandino J, 2000, J CLIN NEUROSCI, V7, P226, DOI 10.1054/jocn.1999.0202; Feldman Z, 1997, CRIT CARE CLIN, V13, P51, DOI 10.1016/S0749-0704(05)70296-7; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; HATIBOGLU MT, 1992, J ANAT, V180, P191; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Komiyama M, 1999, NEUROSURGERY, V45, P1469, DOI 10.1097/00006123-199912000-00040; Lam JMK, 1996, BRIT J NEUROSURG, V10, P357; Lewis SB, 1996, CRIT CARE MED, V24, P1334, DOI 10.1097/00003246-199608000-00011; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Macmillan CSA, 2000, INTENS CARE MED, V26, P1028, DOI 10.1007/s001340051315; Manno EM, 1997, CRIT CARE CLIN, V13, P79, DOI 10.1016/S0749-0704(05)70297-9; Matta BF, 1997, ANESTHESIOLOGY, V86, P806, DOI 10.1097/00000542-199704000-00010; Metz C, 1998, ACT NEUR S, V71, P324; Mutch WAC, 2000, ANN THORAC SURG, V69, P491, DOI 10.1016/S0003-4975(99)01077-2; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Procaccio F, 2000, J Neurosurg Sci, V44, P1; Schaffranietz L, 1998, NEUROL RES, V20, pS66; Schell RM, 2000, ANESTH ANALG, V90, P559, DOI 10.1097/00000539-200003000-00012; SCHNEIDER GH, 1995, ACTA NEUROCHIR, V134, P71, DOI 10.1007/BF01428507; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Souter MJ, 1998, BRIT J ANAESTH, V81, P239, DOI 10.1093/bja/81.2.239; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; Trubiano P, 1996, ANESTH ANALG, V82, P964, DOI 10.1097/00000539-199605000-00013; Unterberg AW, 1997, J TRAUMA, V42, pS32, DOI 10.1097/00005373-199705001-00006; van den Brink WA, 1998, ACT NEUR S, V71, P190; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878	44	28	34	0	1	CANADIAN ANESTHESIOLOGISTS SOC	TORONTO	1 EGLINTON AVE EAST, SUITE 208, TORONTO, ONTARIO M4P 3A1, CANADA	0832-610X			CAN J ANAESTH	Can. J. Anaesth.-J. Can. Anesth.	JUN-JUL	2002	49	6		S			623	629		10.1007/BF03017393			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	573NB	WOS:000176835400020	12067878	Bronze			2022-02-06	
J	Levin, AV				Levin, AV			Ophthalmology of shaken baby syndrome	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							PERMANENT BRAIN-DAMAGE; OPTIC-NERVE SHEATH; RETINAL HEMORRHAGES; INFANT SYNDROME; HEAD-INJURIES; CARDIOPULMONARY-RESUSCITATION; CHILD-ABUSE; SHAKING; TRAUMA; RETINOSCHISIS	Retinal hemorrhages are an important indicator of Shaken Baby syndrome, However, a thorough description which includes the number, type, and distribution pattern of hemorrhages can be useful in determining their specificity. In particular, numerous preretinal, iatraretinal, and subretinal hemorrhages extending out to the edges of the retina and/or splitting of the retina (traumatic retinoschisis) seem to be particularly indicative of shaking with a very narrow differential diagnosis. Shaking appears to be a key element in creating hemorrhagic retinopathy.	Hosp Sick Children, Dept Ophthalmol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Dept Genet, Toronto, ON, Canada; Univ Toronto, Dept Ophthalmol, Toronto, ON M5S 1A1, Canada		Levin, AV (corresponding author), Hosp Sick Children, Dept Ophthalmol, 555 Univ Ave,M158, Toronto, ON M5G 1X8, Canada.	alex.levin@sickkids.ca					AOKI N, 1984, J NEUROSURG, V61, P273, DOI 10.3171/jns.1984.61.2.0273; Aron J J, 1970, Ann Ocul (Paris), V203, P533; BENNETT HS, 1980, CLIN PEDIATR, V19, P633, DOI 10.1177/000992288001900912; Betz P, 1996, FORENSIC SCI INT, V78, P71, DOI 10.1016/0379-0738(95)01866-2; Botash Ann S., 1998, Current Opinion in Pediatrics, V10, P217, DOI 10.1097/00008480-199804000-00018; Brown SM, 1999, ARCH OPHTHALMOL-CHIC, V117, P838; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1946, AM J ROENTGENOL, V56, P163; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Carter J E, 1983, Child Abuse Negl, V7, P279, DOI 10.1016/0145-2134(83)90005-4; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; CLARK RSB, 1995, CLIN PEDIATR, V34, P281, DOI 10.1177/000992289503400512; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; ELNER SG, 1990, ARCH OPHTHALMOL-CHIC, V108, P1094, DOI 10.1001/archopht.1990.01070100050033; Emerson MV, 2001, OPHTHALMOLOGY, V108, P36, DOI 10.1016/S0161-6420(00)00474-7; FAHMY JA, 1973, ACTA OPHTHALMOL, V51, P289; FISCHER H, 1994, CLIN PEDIATR, V33, P696, DOI 10.1177/000992289403301113; GIANGIACOMO J, 1985, Journal of Pediatric Ophthalmology and Strabismus, V22, P234; GILBERTBARNESS E, 1991, AM J FOREN MED PATH, V12, P27, DOI 10.1097/00000433-199103000-00004; GILLILAND MGF, 1994, FORENSIC SCI INT, V68, P117, DOI 10.1016/0379-0738(94)90309-3; GOETTING MG, 1990, PEDIATRICS, V85, P585; Green MA, 1996, BRIT J OPHTHALMOL, V80, P282, DOI 10.1136/bjo.80.4.282; GREENWALD MJ, 1986, OPHTHALMOLOGY, V93, P618; Hattenbach LO, 1999, J AAPOS, V3, P188, DOI 10.1016/S1091-8531(99)70066-2; HOLLENHORST RW, 1958, ARCH OPHTHALMOL-CHIC, V60, P187; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; JOHNSON DL, 1993, NEUROSURGERY, V33, P231; Kivlin JD, 2001, CURR OPIN OPHTHALMOL, V12, P158, DOI 10.1097/00055735-200106000-00002; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; KRAMER K, 1993, CLIN PEDIATR, V32, P366, DOI 10.1177/000992289303200610; Krugman SD, 2000, PEDIATR EMERG CARE, V16, P432, DOI 10.1097/00006565-200012000-00016; LAMBERT SR, 1986, ARCH OPHTHALMOL-CHIC, V104, P1509; LEVIN A, 1986, PEDIATR EMERG CARE, V2, P269; LEVIN A, 2001, APSAC ADVISOR, V13, P17; LEVIN A V, 1989, Pediatric Emergency Care, V5, P181, DOI 10.1097/00006565-198909000-00011; Levin A V, 1991, Pediatr Emerg Care, V7, P129, DOI 10.1097/00006565-199104000-00028; LEVIN AV, 2000, RECENT ADV PAEDIAT, V18, P151; MADSEN PH, 1972, OPHTHALMOLOGICA, V165, P453, DOI 10.1159/000308538; MASSICOTTE SJ, 1991, OPHTHALMOLOGY, V98, P1124; MULLER PJ, 1974, J NEUROSURG, V41, P160, DOI 10.3171/jns.1974.41.2.0160; MUNGER CE, 1993, AM J FOREN MED PATH, V14, P193, DOI 10.1097/00000433-199309000-00004; Nakagawa TA, 2001, ARCH PEDIAT ADOL MED, V155, P1149, DOI 10.1001/archpedi.155.10.1149; Odom A, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e3; Papasian NC, 2000, PEDIATR NEUROSURG, V33, P188, DOI 10.1159/000055951; Paviglianiti JC, 1999, J AAPOS, V3, P383, DOI 10.1016/S1091-8531(99)70052-2; Piatt JH, 1999, NEUROSURG FOCUS, V7, P1; Plunkett J, 1999, AM J FOREN MED PATH, V20, P17, DOI 10.1097/00000433-199903000-00005; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; REIBER GD, 1993, AM J FOREN MED PATH, V14, P201, DOI 10.1097/00000433-199309000-00005; SCHOENFELD A, 1985, ARCH OPHTHALMOL-CHIC, V103, P932; SEZEN F, 1971, BRIT J OPHTHALMOL, V55, P248, DOI 10.1136/bjo.55.4.248; SILVERMAN FN, 1972, RADIOLOGY, V104, P337, DOI 10.1148/104.2.337; Smith R A, 1976, Surg Neurol, V5, P246; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; WILKINSON WS, 1989, ARCH OPHTHALMOL-CHIC, V107, P1472, DOI 10.1001/archopht.1989.01070020546037; Young TA, 1997, PEDIATR EMERG CARE, V13, P61, DOI 10.1097/00006565-199702000-00018; Zaman F, 1999, ARCH OPHTHALMOL-CHIC, V117, P694	61	28	28	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2002	13	2					201	+	PII S1042-3680(02)00004-9	10.1016/S1042-3680(02)00004-9			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	573HM	WOS:000176823500006	12391704				2022-02-06	
J	Edwards, L; Nashmi, R; Jones, O; Backx, P; Ackerley, C; Becker, L; Fehlings, MG				Edwards, L; Nashmi, R; Jones, O; Backx, P; Ackerley, C; Becker, L; Fehlings, MG			Upregulation of Kv 1.4 protein and gene expression after chronic spinal cord injury	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						neurotrauma; voltage-gated potassium channels; glia; axons; rat	ION CHANNEL EXPRESSION; WHITE MATTER GLIA; OLIGODENDROCYTE PROGENITOR CELLS; HETEROMULTIMERIC K+ CHANNELS; GATED POTASSIUM CHANNELS; MYELIN BASIC-PROTEIN; DM20 TRANSGENIC MICE; IN-VIVO; PRECURSOR CELLS; MULTIPLE-SCLEROSIS	After spinal cord injury (SCI), white matter tracts are characterized by demyelination and increased sensitivity to the K+ channel blocker 4-aminopyridine (4-AP). These effects appear to contribute to neurological impairment after SCI, although the molecular changes in K+ channel subunit expression remain poorly understood. We examined changes in gene expression of the 4-AP-sensitive voltage-gated K+ channel Kv 1.4 after chronic SCI in the rat. Quantitative immunoblotting showed that Kv 1.4 protein was significantly increased at 6 weeks, but not at 1 week, after SCI in spinal cord white matter. Kv 1.4 was localized to astrocytes, oligodendrocytes, and oligodendrocyte progenitor cells but not to axons in both the normal and the injured spinal cord white matter. Because glial cells proliferate after SCI, we used immunogold electron microscopy to quantify Kv 1.4 protein in individual glial cells and found a sixfold increase of Kv 1.4 in cells of the oligodendrocyte lineage after chronic injury. Finally, quantitative in situ hybridization showed that Kv 1.4 mRNA was significantly upregulated in spinal cord white matter, but not gray matter, after SCI. In summary, we show that Kv 1.4 is expressed in glial cells and not in axons in the rat spinal cord white matter and that its expression is markedly increased in cells of the oligodendrocyte lineage after chronic SCI. Given that K+ channels play a role in glial cell proliferation, cells exhibiting changes in Kv 1.4 expression may represent proliferating oligodendroglia in the chronically injured spinal cord. (C) 2002. 9 2002 Wiley-Liss, Inc.	Univ Toronto, Div Neurosurg, Toronto Western Res Inst, Hlth Network, Toronto, ON M5T 2S8, Canada; Univ Toronto, Div Cellular & Mol Biol, Toronto Western Res Inst, Hlth Network, Toronto, ON M5T 2S8, Canada; Univ Toronto, Dept Physiol, Toronto Gen Res Inst, Hlth Network, Toronto, ON M5G 2C4, Canada; Hosp Sick Children, Div Pathol, Toronto, ON M5G 1X8, Canada		Fehlings, MG (corresponding author), MCL 12-407,399 Bathurst St, Toronto, ON M5T 2S8, Canada.			Nashmi, Raad/0000-0001-6596-2620; Fehlings, Michael/0000-0002-5722-6364			Amat JA, 1998, GLIA, V22, P64, DOI 10.1002/(SICI)1098-1136(199801)22:1<64::AID-GLIA6>3.0.CO;2-8; ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; Attali B, 1997, J NEUROSCI, V17, P8234; BALENTINE JD, 1978, LAB INVEST, V39, P254; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; BARRES BA, 1990, NEURON, V5, P527, DOI 10.1016/0896-6273(90)90091-S; BARRES BA, 1988, GLIA, V1, P10, DOI 10.1002/glia.440010104; BLACK JA, 1990, TRENDS NEUROSCI, V13, P48, DOI 10.1016/0166-2236(90)90068-L; BLIGHT AR, 1983, NEUROSCIENCE, V10, P1471, DOI 10.1016/0306-4522(83)90128-8; BLIGHT AR, 1989, BRAIN RES BULL, V22, P47, DOI 10.1016/0361-9230(89)90126-3; BLIGHT AR, 1987, J NEUROL SCI, V82, P145, DOI 10.1016/0022-510X(87)90014-1; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; CHITTAJALLU R, 2000, SOC NEUR ABSTR, V26, P1890; CHVATAL A, 1995, EUR J NEUROSCI, V7, P129, DOI 10.1111/j.1460-9568.1995.tb01027.x; FEHLINGS MG, 1995, BRAIN RES, V677, P291, DOI 10.1016/0006-8993(95)00141-C; Fehlings MG, 1996, BRAIN RES, V736, P135, DOI 10.1016/S0006-8993(96)00667-1; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; GRIFFITHS IR, 1983, J NEUROL SCI, V58, P335, DOI 10.1016/0022-510X(83)90093-X; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; HANSEBOUT RR, 1993, J NEUROTRAUM, V10, P1, DOI 10.1089/neu.1993.10.1; HAYES KC, 1994, J NEUROTRAUM, V11, P433, DOI 10.1089/neu.1994.11.433; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jou I, 1998, GLIA, V24, P408, DOI 10.1002/(SICI)1098-1136(199812)24:4<408::AID-GLIA6>3.0.CO;2-D; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.0.CO;2-A; Knutson P, 1997, J NEUROSCI, V17, P2669, DOI 10.1523/jneurosci.17-08-02669.1997; Kotecha SA, 1999, J NEUROSCI, V19, P10680, DOI 10.1523/JNEUROSCI.19-24-10680.1999; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; LUDWIN SK, 1985, LAB INVEST, V52, P20; LUDWIN SK, 1988, J NEUROSCI, V8, P1239; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; Mastronardi FG, 1996, J CLIN INVEST, V97, P349, DOI 10.1172/JCI118422; Mastronardi FG, 1996, J NEUROSCI RES, V44, P301, DOI 10.1002/(SICI)1097-4547(19960515)44:4<301::AID-JNR1>3.0.CO;2-G; MatusLeibovitch N, 1996, MOL BRAIN RES, V40, P261, DOI 10.1016/0169-328X(96)00054-X; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; MIDHA R, 1987, BRAIN RES, V410, P299, DOI 10.1016/0006-8993(87)90328-3; Nashmi R, 2000, EUR J NEUROSCI, V12, P491, DOI 10.1046/j.1460-9568.2000.00926.x; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Qiao J, 1997, J NEUROTRAUM, V14, P135, DOI 10.1089/neu.1997.14.135; Rasband M, 1998, J NEUROSCI, V18, P36; Redwine JM, 1998, J NEUROBIOL, V37, P413, DOI 10.1002/(SICI)1097-4695(19981115)37:3<413::AID-NEU7>3.0.CO;2-8; Reynolds R, 1997, J NEUROSCI RES, V47, P455, DOI 10.1002/(SICI)1097-4547(19970301)47:5<455::AID-JNR1>3.0.CO;2-G; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Roy ML, 1996, GLIA, V18, P177, DOI 10.1002/(SICI)1098-1136(199611)18:3<177::AID-GLIA2>3.0.CO;2-X; Schlichter LC, 1996, GLIA, V17, P225, DOI 10.1002/(SICI)1098-1136(199607)17:3<225::AID-GLIA5>3.0.CO;2-#; Schmidt K, 1999, BRAIN RES, V843, P145, DOI 10.1016/S0006-8993(99)01938-1; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Shi JY, 1998, J NEUROSCI, V18, P4627; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Smart SL, 1997, GLIA, V20, P127, DOI 10.1002/(SICI)1098-1136(199706)20:2<127::AID-GLIA4>3.0.CO;2-6; SONTHEIMER H, 1992, J NEUROPHYSIOL, V68, P985, DOI 10.1152/jn.1992.68.4.985; SONTHEIMER H, 1989, NEURON, V2, P1135, DOI 10.1016/0896-6273(89)90180-3; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; WAXMAN SG, 1989, J NEUROL SCI, V91, P1, DOI 10.1016/0022-510X(89)90072-5; Wickenden AD, 1997, J PHYSIOL-LONDON, V504, P271, DOI 10.1111/j.1469-7793.1997.271be.x; Wrathall JR, 1998, J NEUROSCI, V18, P8780; Yuan XQ, 1998, DEVELOPMENT, V125, P2901	69	28	28	0	4	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0021-9967			J COMP NEUROL	J. Comp. Neurol.	FEB 4	2002	443	2					154	167		10.1002/cne.10115			14	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	508PM	WOS:000173097700004	11793353				2022-02-06	
J	Csokay, A; Egyud, L; Nagy, L; Pataki, G				Csokay, A; Egyud, L; Nagy, L; Pataki, G			Vascular tunnel creation to improve the efficacy of decompressive craniotomy in post-traumatic cerebral edema and ischemic stroke	SURGICAL NEUROLOGY			English	Article						brain swelling; trauma; infarction; decompressive craniectomy; vascular tunnel	HEAD-INJURY; CRANIECTOMY; BRAIN; BIOMECHANICS; SUPPORT; RAT	BACKGROUND Decompressive craniectomy with durotomy has been well described but remains a controversial treatment for traumatic or ischemic brain swelling. Although the technique can reduce intracranial pressure it frequently results in infarction of the brain tissue which extends through the durotomy because of compression and subsequent complications associated with decompressive craniectomy. METHODS All patients treated with surgical decompression were comatose with Grade 3 or 4 Glasgow Coma Scores. Since 1998 we have changed our technique for decompressive craniectomy by creating vascular channels around the major vessels crossing the durotomy margin. Outcomes in 21 patients treated with this technique are compared to 20 patients treated with a conventional decompression and durotomy between 1997 through 1999. RESULTS Clinical outcome was substantially better in the group treated with a vascular tunnel. CONCLUSIONS Our results suggest that placing vascular tunnels at the margins of a durotomy when performing a decompression may reduce vascular congestion and the subsequent ischemia in brain tissue which herniates through the durotomy, leading to better clinical outcomes. (C) 2002 by EIsevier Science Inc.	Natl Inst Traumatol, Dept Neurosurg, Budapest, Hungary; MAV Hosp, Dept Neurosurg, Budapest, Hungary		Csokay, A (corresponding author), Peton U 9-B, H-1039 Budapest, Hungary.						Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; CSOKAY A, 2001, HUNGARIAN MED J, V142, P75; DIERSSEN G, 1983, ACTA NEUROCHIR, V69, P53, DOI 10.1007/BF02055853; Doerfler A, 1996, J NEUROSURG, V85, P853, DOI 10.3171/jns.1996.85.5.0853; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; GAAB MR, 1990, ACT NEUR S, V51, P326; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; HATASHITA S, 1988, STROKE, V19, P91, DOI 10.1161/01.STR.19.1.91; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; ISHII S, 1983, INTRACRANIAL PRESSUR, V5, P549; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; RINALDI A, 1990, ACT NEUR S, V51, P394; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Shigemori M, 1979, Acta Neurochir Suppl (Wien), V28, P195; Shimada K, 1999, SPINAL CORD, V37, P410, DOI 10.1038/sj.sc.3100858; WHITFIELD P, 1995, STROKE, V26, P1125; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YAMAURA A, 1979, Neurologia Medico-Chirurgica, V19, P717, DOI 10.2176/nmc.19.717; [No title captured]	29	28	31	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	FEB	2002	57	2					126	129	PII S0090-3019(01)00686-3	10.1016/S0090-3019(01)00686-3			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	534HK	WOS:000174578900016	11904208				2022-02-06	
J	Soustiel, JF; Shik, V; Feinsod, M				Soustiel, JF; Shik, V; Feinsod, M			Basilar vasospasm following spontaneous and traumatic subarachnoid haemorrhage: Clinical implications	ACTA NEUROCHIRURGICA			English	Article						basilar artery; vasospasm; subarachnoid haemorrhage; transcranial Doppler	TRANSCRANIAL DOPPLER ULTRASOUND; CEREBRAL ARTERIAL SPASM; FLOW VELOCITIES; HEAD-INJURY; VERTEBROBASILAR VASOSPASM; BLOOD-FLOW; HEMORRHAGE; ULTRASONOGRAPHY; HYPEREMIA	Background. Cerebral vasospasm has been commonly described following subarachnoid haemorrhage (SAH) though its impact on neurological outcome, especially in head trauma, has not been yet elucidated. The purpose of this study was to monitor and correlate neurological condition and flow velocities (FVs) in the arteries of the brain after SAH and more particularly to investigate the influence of basilar artery (BA) vasospasm on neurological outcome. Methods. Daily transcranial Doppler (TCD) evaluations were conducted in 116 consecutive patients with subarachnoid haemorrhage. SAH was of traumatic origin (tSAH) in 59 patients an spontaneous (sSAH) in 57 patients. Vasospasm in the MCA and ACA was defined by a mean FV exceeding 120 cm/s and three times the mean FV of the ipsilateral ICA. Basilar artery (BA) vasospasm was defined as moderate whenever the FV was higher than 60 cm/s and severe above 85 cm/s. Findings. Sixty-two patients (53.4%) had elevated FVs in the BA, among these 34 (29.3%) had FVs above 85 cm/s. Basilar vasospasm was significantly more common in tSAH (59.7%) than in sSAH (40.3%, P = 0.041). In patients with moderate and severe BA vasospasm, FVs in the BA increased on the third day after admission and remained elevated for a week before returning to normal value by them end of the second week. This elevation in BA FVs in patients with BA vasospasm. was followed by a significant and progressive worsening in the neurological condition at the end of the first week. Permanent neurological deficit was associated with elevated BA FVs consistent with moderate BA vasospasm whereas patients who remained in persistent vegetative state, had FVs consistent with severe BA vasospasm (P = 0.00019). Interpretation. The present results further support that BA vasospasm may act as an independent factor of ischaemic brain damage following SAH, especially in head trauma.	Technion Israel Inst Technol, Rambam Med Ctr, Dept Neurosurg, Brain Injury Appl Res Ctr, IL-31096 Haifa, Israel		Soustiel, JF (corresponding author), Technion Israel Inst Technol, Rambam Med Ctr, Dept Neurosurg, Brain Injury Appl Res Ctr, POB 9602, IL-31096 Haifa, Israel.						AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fujioka KA., 1992, TRANSCRANIAL DOPPLER, P9; JENNETT B, 1975, LANCET, V1, P480; LAUMER R, 1993, NEUROSURGERY, V33, P1, DOI 10.1227/00006123-199307000-00001; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; SLOAN MA, 1994, STROKE, V25, P2187, DOI 10.1161/01.STR.25.11.2187; Soustiel JF, 1998, NEUROSURGERY, V43, P282, DOI 10.1097/00006123-199808000-00061; Soustiel JF, 2001, STROKE, V32, P629, DOI 10.1161/01.STR.32.3.629; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; TEASDALE G, 1974, LANCET, V2, P81; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	19	28	29	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		2002	144	2					137	144		10.1007/s007010200016			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	525VQ	WOS:000174095100006	11862513				2022-02-06	
J	Ward, H; Shum, D; Wallace, G; Boon, J				Ward, H; Shum, D; Wallace, G; Boon, J			Pediatric traumatic brain injury and procedural memory	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED HEAD-INJURY; EXPLICIT MEMORY; IMPLICIT; AMNESIA; SKILL; DISSOCIATION	This study investigated the effects of pediatric Traumatic brain injury (TBI) on procedural memory. Fifteen children with moderate to severe TBI and 15 matched controls were compared on two procedural-memory tasks: motor-perceptual (rotary pursuit) and cognitive (mirror reading). Explicit-memory tasks were also completed: recall or recognition of rotary-pursuit items and mirror-reading words. On both procedural tasks, the TBI group learned at a similar rate and retained equally well as the controls. On the explicit-memory tasks, however, the TBI group recalled and recognized fewer test items than the controls. These results are consistent with those reported in the adult TBI literature and suggest that procedural memory, a type of implicit memory, is preserved in children with TBI. Implications of these findings for the management and rehabilitation of children with TBI were discussed.	Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4111, Australia; Griffith Univ, Neuropsychol Unit, Brisbane, Qld 4111, Australia; Mater Misericordiae Childrens Hosp, Brisbane, Qld, Australia		Ward, H (corresponding author), Griffith Univ, Sch Appl Psychol, Nathan, Qld 4111, Australia.		Shum, David/A-3914-2008; Wallace, Geoff/H-1252-2013	Shum, David/0000-0002-4810-9262; Wallace, Geoff/0000-0001-9306-3542			Baddeley A.D., 1997, HUMAN MEMORY THEORY; BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Bruce D. A., 1995, TRAUMATIC HEAD INJUR, P40; *CEDR CORP, 1996, SUP PRO EXP LAB SOFT; CLUTTERBUCK PM, 1990, ART TEACHING SPELLIN; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CORKIN S, 1968, NEUROPSYCHOLOGIA, V6, P255, DOI 10.1016/0028-3932(68)90024-9; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Eysenck M. W., 1979, LEVELS PROCESSING HU; Francis W.N., 1982, FREQUENCY ANAL ENGLI; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; GREEN DM, 1966, SIGNAL DETECTION THE; HANNAY HJ, 1998, J CLIN EXPT NEUROPSY, V11, P444; Howell D. C., 1999, FUNDAMENTAL STAT BEH, V4th; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JENNETT WB, 1969, BRIT J PSYCHIAT, V4, P40; *KIN, 1998, 3D STUD MAX; MILNER B, 1985, HUM NEUROBIOL, V4, P137; MOSCOVITCH M, 1992, NEUROPSYCHOLOGY MEMO, P5; Moscovitch M., 1989, VARIETIES MEMORY CON, P133; Naito Mika, 1993, P231; NISSEN MJ, 1992, NEUROPSYCHOLOGY MEMO, P203; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; SAINTCYR JA, 1992, NEUROPSYCHOLOGY MEMO, P188; Schacter D. L., 2000, OXFORD HDB MEMORY, P627; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P149, DOI 10.1076/jcen.21.2.149.929; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; SNOW JH, 1994, PEDIAT TRAUMATIC BRA; SQUIRE LR, 1984, NEUROPSYCHOLOGIA, V22, P145, DOI 10.1016/0028-3932(84)90057-5; Vakil E, 1996, BRAIN COGNITION, V31, P75, DOI 10.1006/brcg.1996.0026; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; Yamadori A, 1996, COGNITIVE BRAIN RES, V5, P49, DOI 10.1016/S0926-6410(96)00040-7; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	35	28	28	0	6	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2002	24	4					458	470		10.1076/jcen.24.4.458.1032			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	568ZJ	WOS:000176574600005	12187459				2022-02-06	
J	Rapoport, MJ; Feinstein, A				Rapoport, MJ; Feinstein, A			Age and functioning after mild traumatic brain injury: the acute picture	BRAIN INJURY			English	Article; Proceedings Paper	Annual Meeting of the Canadian-Association-of-Geriatric-Psychiatry	OCT   04, 2000	VICTORIA, CANADA	Canadian Assoc Geriat Psychiat			CLOSED-HEAD INJURY; GENERAL HEALTH QUESTIONNAIRE; FOLLOW-UP; NEUROBEHAVIORAL CONSEQUENCES; SUBSTANCE-ABUSE; OLDER ADULTS; SEQUELAE; STROKE; DEPRESSION; SURVIVAL	Hypothesis: There will be acute harbingers of poor outcome following mild traumatic brain injury (TBI) in the elderly. Participants: Twenty-six subjects age 60 and over were compared to 30 subjects aged 18-59, seen within 1 month, on average, following a mild TBI. Main outcome measures: Functioning was assessed using the Glasgow Outcome Scale (GOS), a global measure of outcome, as well as self-report measures of psychosocial functioning, physical symptoms and psychological distress. Results: Contrary to the hypothesis, the older group did better than their younger counterparts on the GOS (p=0.002), and reported less psychosocial impairment (p<0.0001), less psychological distress (p=0.002), and less physical symptoms (p=0.005). However, once employment was controlled for, these results only approached statistical significance. Discussion: The assumption that elderly subjects have a worse outcome following TBI needs to be reconsidered, at least within the acute recovery period. The importance of psychosocial factors as modifiers of outcome according to age are emphasized. Whether this finding holds true over a longer follow-up period is the subject of ongoing research.	Univ Toronto, Sunnybrook & Womens Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada		Rapoport, MJ (corresponding author), Univ Toronto, Sunnybrook & Womens Hlth Sci Ctr, Dept Psychiat, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.		Rapoport, Mark/AAD-8581-2020				AharonPeretz J, 1997, BRAIN INJURY, V11, P871; Barker LH, 1999, J INT NEUROPSYCH SOC, V5, P593, DOI 10.1017/S1355617799577023; Barnfield TV, 1998, BRAIN INJURY, V12, P951, DOI 10.1080/026990598122007; Bennun IS, 1999, MED SCI LAW, V39, P167, DOI 10.1177/002580249903900212; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BURVILL PW, 1995, BRIT J PSYCHIAT, V166, P320, DOI 10.1192/bjp.166.3.320; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; DEPAULO JR, 1980, PSYCHOL MED, V10, P125, DOI 10.1017/S0033291700039659; DEPAULO JR, 1978, ANN NEUROL, V4, P225, DOI 10.1002/ana.410040306; Drubach D A, 1993, Md Med J, V42, P989; Feinstein A, 2000, CAN J PUBLIC HEALTH, V91, P325, DOI 10.1007/BF03404799; FIELDS RB, 1994, TXB GERIATRIC NEUROP, P479; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; Goldstein FC, 1999, J NEUROPSYCH CLIN N, V11, P38, DOI 10.1176/jnp.11.1.38; Herrmann N, 1998, STROKE, V29, P618, DOI 10.1161/01.STR.29.3.618; ISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460; JENNETT B, 1975, LANCET, V1, P480; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Koren D, 1999, AM J PSYCHIAT, V156, P367; MAZZUCCHI A, 1992, J NEUROL, V239, P256; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, P28; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; RABINS PV, 1981, PSYCHOL MED, V11, P425, DOI 10.1017/S0033291700052259; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; ROBINSON RG, 1983, STROKE, V14, P736, DOI 10.1161/01.STR.14.5.736; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Tate PS, 1999, BRAIN INJURY, V13, P767; TURNER RJ, 1990, J NERV MENT DIS, V178, P343, DOI 10.1097/00005053-199006000-00001; Vingilis E, 1996, ACCIDENT ANAL PREV, V28, P637, DOI 10.1016/0001-4575(96)00036-X; Vollmer DG, 1991, J NEUROSURG S, V75, P37; [No title captured]	40	28	28	0	5	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2001	15	10					857	864		10.1080/02699050110065303			8	Neurosciences; Rehabilitation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	483HF	WOS:000171627000002	11595082				2022-02-06	
J	Kahveci, FS; Kahveci, N; Alkan, T; Goren, B; Korfali, E; Ozluk, K				Kahveci, FS; Kahveci, N; Alkan, T; Goren, B; Korfali, E; Ozluk, K			Propofol versus isoflurane anesthesia under hypothermic conditions: Effects on intracranial pressure and local cerebral blood flow after diffuse traumatic brain injury in the rat	SURGICAL NEUROLOGY			English	Article						propofol; isoflurane; hypothermia; head injury; rat; LCBF	GLUCOSE-UTILIZATION; MILD HYPOTHERMIA; HEAD-INJURY; HIPPOCAMPAL GLUTAMATE; MODERATE HYPOTHERMIA; ELECTRICAL-ACTIVITY; ISCHEMIA; METABOLISM; HALOTHANE; ANTIOXIDANT	BACKGROUND The aim of this study was to compare the cerebral protective effects of two known protective anesthetics, isoflurane and propofol, when these were used in combination with moderate hypothermia (33-34 degreesC) after diffuse traumatic brain injury (TBI) in the rat. We assessed cerebral protection by measuring local cerebral blood flow (LCBF), mean arterial blood pressure (MABP), cerebral perfusion pressure (CPP) and intracranial pressure (ICP). METHODS Sixteen female Wistar rats weighing 275 to 350 g were anesthetized and subjected to an accelerated-impact weight-drop model of diffuse TBI. Hypothermia (33-34 degreesC) was induced 45 minutes after TBI (baseline), and was maintained for 180 minutes. The isoflurane group (n = 8) received 70% N2O in O-2, and isoflurane at 0.9 +/- 0.04%. The propofol group (n = 8) received 70% N2O in O-2 and a propofol infusion (12 mg/kg/hr). LCBF was measured by laser Doppler flowmeter. MABP, ICP, and brain and rectal temperatures were measured every 15 minutes from baseline through 180 minutes. Blood gas and hematocrit testing was also done at baseline and every 60 minutes thereafter to assess the animals' physiological state. RESULTS In the isoflurane group, MABP and CPP decreased significantly from baseline to 180 minutes (p <0.05 and p <0.01, respectively), and MABP was significantly lower than the pressure in the propofol group from 45 minutes through 180 minutes (p <0.05, p <0.01). ICP and LCBF remained unchanged in this group. In the propofol group, from baseline to 180 minutes, CPP increased to maximum 120 +/- 8 mmHg at 75 minutes from 98 +/- 5 mmHg (p <0.05) and ICP fell from 18 +/- 2 mmHg to 7 +/- 1 mmHg (p <0.01); and the latter was significantly lower than ICP in the isoflurane group (P <0.05, p <0.01, p <0.001). LCBF in this group was significantly higher than LCBF in the isoflurane group in the last 30 minutes of the experiment (p <0.05). The propofol group showed no change in MABP over the course of the experiment. CONCLUSION In the clinical setting, propofol anesthesia may be better for use in combination with hypothermia in cases of traumatic brain injury, as it reduces ICP and increases CPP under these conditions. (C) 2001 by Elsevier Science Inc.	Uludag Univ, Sch Med, Dept Neurosurg, TR-16059 Gorukle, Bursa, Turkey; Uludag Univ, Sch Med, Dept Anesthesiol, Gorukle, Bursa, Turkey; Uludag Univ, Sch Med, Intens Care Unit, Gorukle, Bursa, Turkey; Uludag Univ, Sch Med, Dept Physiol, Gorukle, Bursa, Turkey		Korfali, E (corresponding author), Uludag Univ, Sch Med, Dept Neurosurg, TR-16059 Gorukle, Bursa, Turkey.		Alkan, Tulin/AAH-1792-2021; Kahveci, Ferda/AAG-9356-2021; Kahveci, Nevzat/AAG-7070-2021; Goren, Bulent/AAH-1718-2021	Kahveci, Nevzat/0000-0003-0841-8201; Kahveci, Ferda Sohret/0000-0003-4820-2288			AARTS L, 1995, FEBS LETT, V357, P83, DOI 10.1016/0014-5793(94)01337-Z; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; ARCHER DP, 1987, ANESTHESIOLOGY, V67, P642, DOI 10.1097/00000542-198711000-00005; BERNARD JM, 1990, ANESTHESIOLOGY, V72, P659, DOI 10.1097/00000542-199004000-00014; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CHEN Q, 1993, J CEREBR BLOOD F MET, V13, P389, DOI 10.1038/jcbfm.1993.52; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CRAWFORD MW, 1992, ANESTH ANALG, V75, P1000; DAM M, 1990, ANESTHESIOLOGY, V73, P499, DOI 10.1097/00000542-199009000-00021; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; FARLING PA, 1989, ANAESTHESIA, V44, P222, DOI 10.1111/j.1365-2044.1989.tb11228.x; GELB AW, 1989, ANESTHESIOLOGY, V70, P678, DOI 10.1097/00000542-198904000-00023; HAGERDAL M, 1975, J NEUROCHEM, V24, P311, DOI 10.1111/j.1471-4159.1975.tb11881.x; Hans P, 1997, J NEUROSURG ANESTH, V9, P234, DOI 10.1097/00008506-199707000-00006; HARA M, 1994, ANESTHESIOLOGY, V81, P988, DOI 10.1097/00000542-199410000-00026; Herregods L, 1988, Anaesthesia, V43 Suppl, P107, DOI 10.1111/j.1365-2044.1988.tb09089.x; HINDMAN BJ, 1991, ANESTHESIOLOGY, V75, P662, DOI 10.1097/00000542-199110000-00017; Hollrigel GS, 1996, J NEUROPHYSIOL, V76, P2412, DOI 10.1152/jn.1996.76.4.2412; Hudspith MJ, 1997, BRIT J ANAESTH, V78, P731, DOI 10.1093/bja/78.6.731; ILLIEVICH UM, 1994, ANESTHESIOLOGY, V80, P177, DOI 10.1097/00000542-199401000-00025; ILLIEVICH UM, 1994, ANESTH ANALG, V78, P905; ILLIEVICH UM, 1993, ANESTH ANALG, V77, P155; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P571, DOI 10.1097/00000542-198910000-00016; Kawaguchi M, 2000, ANESTHESIOLOGY, V92, P1335, DOI 10.1097/00000542-200005000-00023; KIM HK, 1888, J NEUROSURG ANESTHES, V6, P260; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Krafft P, 2000, STROKE, V31, P1393, DOI 10.1161/01.STR.31.6.1393; LAPTOOK AR, 1995, PEDIATR RES, V38, P919, DOI 10.1203/00006450-199512000-00015; Lenz C, 1998, ANESTHESIOLOGY, V89, P1480, DOI 10.1097/00000542-199812000-00026; LESLIE K, 1995, ANESTH ANALG, V80, P1007, DOI 10.1097/00000539-199505000-00027; LUMB WV, 1973, VET ANESTHESIA, P285; MAEKAWA T, 1986, ANESTHESIOLOGY, V65, P144, DOI 10.1097/00000542-198608000-00003; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; MCCULLOCH J, 1982, J NEUROCHEM, V39, P255, DOI 10.1111/j.1471-4159.1982.tb04729.x; MERGAERT C, 1991, EUR J ANAESTH, V8, P324; MOSS E, 1990, BRIT J ANAESTH, V65, P823, DOI 10.1093/bja/65.6.823; MURPHY PG, 1992, BRIT J ANAESTH, V68, P613, DOI 10.1093/bja/68.6.613; NEWBERG LA, 1983, ANESTHESIOLOGY, V59, P23, DOI 10.1097/00000542-198307000-00005; Niwa K, 1998, BRAIN RES, V789, P68, DOI 10.1016/S0006-8993(98)00013-4; ORSER BA, 1995, BRIT J PHARMACOL, V116, P1761, DOI 10.1111/j.1476-5381.1995.tb16660.x; PATEL PM, 1995, ANESTHESIOLOGY, V82, P996, DOI 10.1097/00000542-199504000-00024; PINAUD M, 1990, ANESTHESIOLOGY, V73, P404, DOI 10.1097/00000542-199009000-00007; RAMANI R, 1992, J NEUROSURG ANESTH, V4, P110, DOI 10.1097/00008506-199204000-00006; RAMANI R, 2000, ANESTHESIOLOGY, V73, pA703; Sakabe T, 1994, ANESTHESIA NEUROSURG, P149; Sarraf-Yazdi S, 1998, ANESTH ANALG, V87, P72, DOI 10.1097/00000539-199807000-00016; SCHELLER MS, 1987, ANESTHESIOLOGY, V67, P507, DOI 10.1097/00000542-198710000-00011; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P51, DOI 10.1097/00008506-199701000-00012; Shuaib A, 1996, NEUROSCI LETT, V204, P1, DOI 10.1016/0304-3940(96)12336-3; SMITH AL, 1976, ANESTHESIOLOGY, V45, P64, DOI 10.1097/00000542-197607000-00012; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; TODD MM, 1984, ANESTHESIOLOGY, V60, P276, DOI 10.1097/00000542-198404000-00002; VANHEMELRIJCK J, 1990, ANESTH ANALG, V71, P49; VITEZ TS, 1974, ANESTHESIOLOGY, V41, P80, DOI 10.1097/00000542-197407000-00020; Weir D L, 1989, J Neurosurg Anesthesiol, V1, P284, DOI 10.1097/00008506-198909000-00014; WHITE PF, 1974, ANESTHESIOLOGY, V40, P52, DOI 10.1097/00000542-197401000-00012; Winfree CJ, 1996, NEUROSURGERY, V38, P1216, DOI 10.1097/00006123-199606000-00034; YANG J, 1991, ANN NY ACAD SCI, V625, P287, DOI 10.1111/j.1749-6632.1991.tb33851.x; Young Y, 1997, EUR J ANAESTH, V14, P320, DOI 10.1046/j.1365-2346.1997.00130.x; ZAPP M, 1992, NEUROCHEM RES, V17, P301, DOI 10.1007/BF00974569	63	28	31	0	9	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0090-3019			SURG NEUROL	Surg. Neurol.	SEP	2001	56	3					206	214		10.1016/S0090-3019(01)00555-9			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	480NX	WOS:000171468800026	11597656				2022-02-06	
J	Hausmann, R; Betz, P				Hausmann, R; Betz, P			Course of glial immunoreactivity for vimentin, tenascin and alpha 1-antichymotrypsin after traumatic injury to human brain	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						human brain injury; glial reaction; immunohistochemistry; wound age	EPITHELIAL MESENCHYMAL INTERACTIONS; FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; REACTIVE ASTROCYTES; ENHANCED EXPRESSION; ALZHEIMERS-DISEASE; AMYLOID DEPOSITS; BETA-PROTEIN; MACROPHAGES; CELLS	In a total of 104 individuals who had sustained traumatic brain injury (TBI), the course of glial immunoreactivity was investigated at the injured cortical area during the first 30 weeks after the trauma, in order to provide data for a forensic wound age estimation. Glial cells were stained with antibodies against the intermediate filament protein vimentin, the extracellular matrix protein tenascin and the serine protease inhibitor (alpha1-antichymotrypsin (alpha1-ACT). Injury-induced glial staining reactions could be observed, at the earliest, after a post-infliction interval of 3.1 h for alpha1-ACT, 22 It for vimentin and 7 days for tenascin.	Univ Erlangen Nurnberg, Dept Legal Med, D-91054 Erlangen, Germany		Hausmann, R (corresponding author), Univ Erlangen Nurnberg, Dept Legal Med, Univ Str 22, D-91054 Erlangen, Germany.						ABRAHAM CR, 1993, BRAIN RES, V621, P222, DOI 10.1016/0006-8993(93)90110-9; ABRAHAM CR, 1990, NEUROBIOL AGING, V11, P123, DOI 10.1016/0197-4580(90)90045-2; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; AGUAYO AJ, 1981, J EXP BIOL, V95, P231; AUFDERHEIDE E, 1988, J CELL BIOL, V107, P2341, DOI 10.1083/jcb.107.6.2341; AUFDERHEIDE E, 1987, J CELL BIOL, V105, P599, DOI 10.1083/jcb.105.1.599; BAUMANN H, 1987, J IMMUNOL, V139, P4122; BERKENBOSCH F, 1992, ANN NY ACAD SCI, V650, P186; BRODKEY JA, 1995, J NEUROSURG, V82, P106, DOI 10.3171/jns.1995.82.1.0106; CALVO JL, 1991, BRAIN RES, V566, P333, DOI 10.1016/0006-8993(91)91720-L; CHIQUET M, 1984, J CELL BIOL, V98, P1937, DOI 10.1083/jcb.98.6.1937; CHIQUETEHRISMANN R, 1986, CELL, V47, P131, DOI 10.1016/0092-8674(86)90374-0; DAVID S, 1990, NEURON, V5, P463, DOI 10.1016/0896-6273(90)90085-T; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; GRAEBER MB, 1988, J NEUROCYTOL, V17, P573, DOI 10.1007/BF01189811; Hausmann R, 2000, INT J LEGAL MED, V113, P70, DOI 10.1007/PL00007711; Hausmann R, 1999, INT J LEGAL MED, V112, P227, DOI 10.1007/s004140050241; HOZUMI I, 1990, BRAIN RES, V524, P64, DOI 10.1016/0006-8993(90)90492-T; INAGUMA Y, 1988, DEV BIOL, V128, P245, DOI 10.1016/0012-1606(88)90288-6; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; LAYWELL ED, 1992, P NATL ACAD SCI USA, V89, P2634, DOI 10.1073/pnas.89.7.2634; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; MACKIE EJ, 1987, J CELL BIOL, V105, P2569, DOI 10.1083/jcb.105.6.2569; MAIER A, 1987, AM J ANAT, V180, P226, DOI 10.1002/aja.1001800303; OBLINGER MM, 1993, INT J DEV NEUROSCI, V11, P149, DOI 10.1016/0736-5748(93)90075-O; PASTERNACK JM, 1989, AM J PATHOL, V135, P827; PERRY VH, 1993, TRENDS NEUROSCI, V16, P268, DOI 10.1016/0166-2236(93)90180-T; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SCHIFFER D, 1993, INT J DEV NEUROSCI, V11, P269, DOI 10.1016/0736-5748(93)90085-R; SHOJI M, 1991, AM J PATHOL, V138, P247; THESLEFF I, 1987, DEVELOPMENT, V101, P289; THOMAS WE, 1992, BRAIN RES REV, V17, P61; YAMAMOTO C, 1990, Okajimas Folia Anatomica Japonica, V67, P21	34	28	28	0	2	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0937-9827			INT J LEGAL MED	Int. J. Legal Med.	JUL	2001	114	6					338	342		10.1007/s004140000199			5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	457DY	WOS:000170122900006	11508799				2022-02-06	
J	Tooth, L; McKenna, K; Strong, J; Ottenbacher, K; Connell, J; Cleary, M				Tooth, L; McKenna, K; Strong, J; Ottenbacher, K; Connell, J; Cleary, M			Rehabilitation outcomes for brain injured patients in Australia: functional status, length of stay and discharge destination	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; DISABILITY RATING-SCALE; MEDICAL REHABILITATION; INDEPENDENCE; RECOVERY; RELIABILITY; PREDICTION; COMMUNITY; SYSTEM; TRAUMA	This study describes the rehabilitation length of stay (LOS), discharge destination and discharge functional status of 149 patients admitted with traumatic brain injury (TBI) to an Australian hospital over a 5-year period. Hospital charts of patients admitted between 1993-1998 were reviewed. Average LOS over the 5-year time period was 61.8 days and only decreased nominally over this time. Longer LOS was predicted by lower admission motor FIM scores and presence of comorbidities. Mean admission and discharge motor FIM scores were 58 and 79, which represented a gain of 21 points. Higher discharge motor FIM scores were predicted by higher admission motor FIM scores and younger age. FIM gain was predicted by cognitive status and age. Most patients, 88%, were discharged back to the community, with 30% changing their living setting or situation. Changing living status was predicted by living alone and having poorer functional status on admission.	Univ Queensland, Dept Social & Prevent Med, Brisbane, Qld 4072, Australia; Univ Queensland, Dept Occupat Therapy, Brisbane, Qld 4072, Australia; Princess Alexandra Hosp, Brisbane, Qld 4102, Australia		Tooth, L (corresponding author), Univ Queensland, Dept Social & Prevent Med, Brisbane, Qld 4072, Australia.		Strong, Jenny/F-1211-2010; Tooth, Leigh/F-2769-2010	Strong, Jenny/0000-0002-9367-8755; Ottenbacher, Kenneth/0000-0001-5990-3982; Tooth, Leigh/0000-0002-1569-934X			BARRY P, 1989, ARCH PHYS MED REHAB, V70, P902; CAREY RG, 1988, ARCH PHYS MED REHAB, V69, P337; Davis CH, 1997, AM J PHYS MED REHAB, V76, P213, DOI 10.1097/00002060-199705000-00011; EAGER K, 1997, AUSTR NATL SUBACUTE; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Fiedler RC, 1998, AM J PHYS MED REHAB, V77, P444, DOI 10.1097/00002060-199809000-00019; Fleming J, 1999, BRAIN INJURY, V13, P417; Fleming JM, 1997, J HEAD TRAUMA REHAB, V12, P27, DOI 10.1097/00001199-199706000-00004; FORTUNE N, 1999, 15 AIHW DIS; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Jong CN, 1999, BRAIN INJURY, V13, P1017; KAPLAN CP, 1994, ARCH PHYS MED REHAB, V75, P643, DOI 10.1016/0003-9993(94)90186-4; LYLE DM, 1986, J NEUROSURG, V65, P15, DOI 10.3171/jns.1986.65.1.0015; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McPherson KM, 1997, INT J REHABIL RES, V20, P1, DOI 10.1097/00004356-199703000-00001; Nyein K, 1999, CLIN REHABIL, V13, P56, DOI 10.1191/026921599701532135; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; STINEMAN MG, 1994, MED CARE, V32, P366, DOI 10.1097/00005650-199404000-00005; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Torenbeek M, 1998, BRAIN INJURY, V12, P307, DOI 10.1080/026990598122610; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Zafonte R, 1999, BRAIN INJURY, V13, P31, DOI 10.1080/026990599121854; Zafonte RD, 1997, BRAIN INJURY, V11, P403; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P456, DOI 10.1097/00002060-199611000-00011	34	28	28	0	1	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2001	15	7					613	631		10.1080/02699050010013923			19	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	444PD	WOS:000169407900006	11429090				2022-02-06	
J	Kennedy, MRT				Kennedy, MRT			Retrospective confidence judgements made by adults with traumatic brain injury: relative and absolute accuracy	BRAIN INJURY			English	Article							SELF-AWARENESS; LEARNING JOLS; MEMORY; METAMEMORY; SCALE; UNAWARENESS; DIFFICULTY; DEFICITS	Eighteen adult survivors of moderate or severe traumatic brain injury (TBI) and 18 controls studied and were tested on two lists of noun-pairs, and made item-by-item retrospective confidence judgements (RCJs) of their answers using a Likert scale. For both groups, correlations between RCJ ratings and recall were extremely high, indicating that survivors of TBI were as accurate as non-injured controls when comparing their confidence in one answer to another. However, as groups, survivors of TBI were over-confident and control participants were under-confident, but only when uncertain as to the accuracy of their answer. Recall errors of 'interference' were analysed post-hoc. Survivors of TBI displayed higher confidence in interference errors than in non-interference errors, while control participants did not. These results are discussed within the context of self-monitoring by clinical and non-clinical populations. The importance of both relative and absolute measures of metamemory accuracy is highlighted.	Univ Minnesota, Dept Commun Disorders, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Cognit Sci, Minneapolis, MN 55455 USA		Kennedy, MRT (corresponding author), Univ Minnesota, Dept Commun Disorders, 115 Shevlin Hall,164 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	kenne047@tc.umn.edu					ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; AMMONS RB, 1979, PSYCHOL REP, V45, P943, DOI 10.2466/pr0.1979.45.3.943; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; BROOKS DN, 1975, CORTEX, V2, P329; COSTERMANS J, 1992, J EXP PSYCHOL LEARN, V18, P142, DOI 10.1037/0278-7393.18.1.142; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; DUNLOSKY J, 1992, MEM COGNITION, V20, P374, DOI 10.3758/BF03210921; DUNLOSKY J, 1994, J MEM LANG, V33, P545, DOI 10.1006/jmla.1994.1026; Dunlosky J, 1998, EDUC PSYCHO, P249; FISCHHOFF B, 1997, J EXPT PSYCHOL HUMAN, V3, P522; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming JM, 1996, BRAIN INJURY, V10, P1; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; Gonzalez R, 1996, PSYCHOL BULL, V119, P159, DOI 10.1037/0033-2909.119.1.159; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KENNEDY MR, 1995, AM J SPEECH-LANG PAT, V4, P159; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; KENNEDY MRT, 1997, DISS ABSTR INT, V57, P4338; Kertesz A., 1982, W APHASIA BATTERY; KORIAT A, 1980, J EXP PSYCHOL-HUM L, V6, P107, DOI 10.1037/0278-7393.6.2.107; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LICHTENSTEIN D, 1982, JUDGMENT UNCERTAINTY, P306; LICHTENSTEIN S, 1977, DECISION MAKING CHAN; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; NAWROCKI MD, 2000, THESIS U MINNESOTA M; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; NELSON TO, 1991, PSYCHOL SCI, V2, P267, DOI 10.1111/j.1467-9280.1991.tb00147.x; NELSON TO, 1994, PSYCHOL SCI, V5, P207, DOI 10.1111/j.1467-9280.1994.tb00502.x; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Nelson TO, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P161; Newman AC, 2000, BRAIN INJURY, V14, P333; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; REITAN RM, 1985, HALSTADREITAN NEUROP; ROTH DL, 1990, J CLIN EXP NEUROPSYC, V12, P834; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; SCHACTER DL, 1991, AWARENESS DEFICIT BR, P127; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; SCHRAW G, 1994, MEM COGNITION, V22, P63, DOI 10.3758/BF03202762; SHIMAMURA AP, 1986, J EXP PSYCHOL LEARN, V12, P452, DOI 10.1037/0278-7393.12.3.452; THIEDE KW, 1994, J EDUC PSYCHOL, V86, P290, DOI 10.1037/0022-0663.86.2.290; Trosset M W, 1996, J Int Neuropsychol Soc, V2, P315; WEAVER CA, 1995, MEM COGNITION, V23, P12, DOI 10.3758/BF03210553; Wechsler D, 1987, MEMORY SCALE REVISED; ZAKAY D, 1992, PSYCHOL REC, V42, P519, DOI 10.1007/BF03399619; [No title captured]	61	28	28	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2001	15	6					469	487		10.1080/02699050010007380			19	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	439VE	WOS:000169137600001	11394967				2022-02-06	
J	Ginsberg, MD; Zhao, WH; Belayev, L; Alonso, OF; Liu, Y; Loor, JY; Busto, R				Ginsberg, MD; Zhao, WH; Belayev, L; Alonso, OF; Liu, Y; Loor, JY; Busto, R			Diminution of metabolism/blood flow uncoupling following traumatic brain injury in rats in response to high-dose human albumin treatment	JOURNAL OF NEUROSURGERY			English	Article						glucose utilization; cerebral blood flow; deoxyglucose; hyperglycolysis; fluid-percussion injury; image analysis; rat	CEREBRAL BLOOD-FLOW; REDUCES HISTOPATHOLOGICAL DAMAGE; CLOSED-HEAD-INJURY; SERUM-ALBUMIN; GLUCOSE-UTILIZATION; ARTERY OCCLUSION; POSTTRAUMATIC HYPOTHERMIA; INTRALUMINAL SUTURE; DISPARITY ANALYSIS; PLASMA-ALBUMIN	Object. The authors have recently demonstrated that high-dose human albumin is markedly neuroprotective in experimental traumatic brain injury (TBI) and cerebral ischemia. The pathophysiology of TBI involves acute uncoupling of cerebral glucose utilization and blood flow. The intent of this study was to establish whether the use of human albumin therapy in a model of acute TBI would influence this phenomenon. Methods. Anesthetized, physiologically regulated rats received moderate (1.5-2 atm) fluid-percussion injury to the parietal lobe. Fifteen minutes after trauma or sham injury, rats in one group received human albumin (2.5 g/kg) administered intravenously and those in another group received 0.9% saline vehicle. At 60 minutes and 24 hours posttrauma, autoradiographic studies of local cerebral blood flow (LCBF) and local cerebral glucose utilization (LCMRglu) were conducted, and the LCMRglu/LCBF ratio was determined. Sham-injured rats had normal levels of LCBF and LCMRglu, and no differences between vehicle- and albumin-treated rats were evident. Sixty minutes after TBI, LCBF was moderately reduced bilaterally in vehicle-treated rats, whereas in albumin-treated animals, the LCBF contralateral to the side of injury was generally normal. Despite acutely depressed LCBF, LCMRglu in vehicle-treated rats at 60 minutes was paradoxically normal bilaterally, and foci of elevated LCMRglu were noted in the ipsilateral hippocampus and thalamus. By contrast, in albumin-treated rats studied 60 minutes post TBI, reduced LCMRglu values were measured in the ipsilateral caudoputamen and parietal cortex, whereas LCMRglu in other ipsilateral and contralateral sites did not differ from that measured in sham-injured animals. The metabolism/blood flow ratio was normal in sham-injured rats, but became markedly elevated in vehicle-treated rats 60 minutes post-TBI ton average, by threefold ipsilaterally and 2.1-fold contralaterally). By contrast, the mean metabolism/blood flow ratio in albumin-treated animals was elevated by only 1.6-fold ipsilaterally and was normal contralaterally. Twenty-four hours after TBI, LCBF contralateral to the side of injury had generally returned to normal levels in the albumin-treated group. Conclusions. These results demonstrate that human albumin therapy benefits the posttraumatic brain by diminishing the pronounced metabolism > blood flow dissociation that would otherwise occur within the Ist hour after injury. Viewed together with our previous evidence of histological neuroprotection, these findings indicate that human albumin therapy may represent a desirable treatment modality for acute TBI.	Univ Miami, Sch Med, Cerebral Vasc Dis Res Ctr, Dept Neurol D45, Miami, FL 33101 USA; Univ Miami, Sch Med, Neurotrauma Res Ctr, Dept Neurol, Miami, FL 33101 USA		Ginsberg, MD (corresponding author), Univ Miami, Sch Med, Cerebral Vasc Dis Res Ctr, Dept Neurol D45, POB 016960, Miami, FL 33101 USA.	mdginsberg@stroke.med.miami.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS005820, P01NS005820, P50NS030291] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 30291, NS 05820] Funding Source: Medline		Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; BACK T, 1995, J CEREBR BLOOD F MET, V15, P566, DOI 10.1038/jcbfm.1995.70; Back T, 1998, NEUROL RES, V20, P643; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Belayev L, 1997, J CEREBR BLOOD F MET, V17, P1266, DOI 10.1097/00004647-199712000-00002; Belayev L, 1998, STROKE, V29, P2587, DOI 10.1161/01.STR.29.12.2587; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Belayev L, 1999, BRAIN RES, V845, P107, DOI 10.1016/S0006-8993(99)01952-6; Belayev L, 1997, J NEUROSURG, V87, P595, DOI 10.3171/jns.1997.87.4.0595; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Chorny I, 1999, J NEUROSURG ANESTH, V11, P273, DOI 10.1097/00008506-199910000-00008; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; DeWitt DS, 1996, CRIT CARE MED, V24, P109, DOI 10.1097/00003246-199601000-00019; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; EMERSON TE, 1989, CRIT CARE MED, V17, P690, DOI 10.1097/00003246-198907000-00020; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; HALLIWELL B, 1990, ARCH BIOCHEM BIOPHYS, V280, P1, DOI 10.1016/0003-9861(90)90510-6; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HE P, 1993, AM J PHYSIOL, V265, pH74, DOI 10.1152/ajpheart.1993.265.1.H74; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Homayoun P, 1997, J NEUROCHEM, V69, P199; HU ML, 1993, J LAB CLIN MED, V121, P257; Huh PW, 1998, BRAIN RES, V804, P105, DOI 10.1016/S0006-8993(98)00674-X; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KEANEY JF, 1993, J CLIN INVEST, V91, P1582, DOI 10.1172/JCI116364; KOCHWESER J, 1976, NEW ENGL J MED, V294, P311, DOI 10.1056/NEJM197602052940605; KOCHWESER J, 1976, NEW ENGL J MED, V294, P526, DOI 10.1056/NEJM197603042941005; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LINDSBERG PJ, 1991, ANN NEUROL, V30, P117, DOI 10.1002/ana.410300202; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Mead C O, 1970, Proc Inst Med Chic, V28, P173; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; NADAL A, 1995, P NATL ACAD SCI USA, V92, P1426, DOI 10.1073/pnas.92.5.1426; Nadal A, 1997, GLIA, V19, P343, DOI 10.1002/(SICI)1098-1136(199704)19:4<343::AID-GLIA7>3.0.CO;2-Y; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Peters T., 1996, ALL ALBUMIN BIOCH GE; REINHART WH, 1995, EUR J CLIN INVEST, V25, P523, DOI 10.1111/j.1365-2362.1995.tb01739.x; Remmers M, 1999, BRAIN RES, V827, P237, DOI 10.1016/S0006-8993(99)01304-9; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; SAVAKI HE, 1980, J NEUROCHEM, V35, P495, DOI 10.1111/j.1471-4159.1980.tb06293.x; SCHNITZER JE, 1992, J BIOL CHEM, V267, P24544; SCHNITZER JE, 1992, AM J PHYSIOL, V262, pH246, DOI 10.1152/ajpheart.1992.262.1.H246; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; SMITH C, 1992, FOOD CHEM TOXICOL, V30, P483, DOI 10.1016/0278-6915(92)90099-7; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Stephenson D, 1999, GLIA, V27, P110, DOI 10.1002/(SICI)1098-1136(199908)27:2<110::AID-GLIA2>3.0.CO;2-C; Tabernero A, 1999, GLIA, V25, P1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsacopoulos M, 1996, J NEUROSCI, V16, P877; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; ZHAO WZ, 1995, J CEREBR BLOOD F MET, V15, P552, DOI 10.1038/jcbfm.1995.69; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510; Zhao WZ, 1997, J CEREBR BLOOD F MET, V17, P1281, DOI 10.1097/00004647-199712000-00003; ZHAO WZ, 1993, IEEE T MED IMAGING, V12, P782, DOI 10.1109/42.251130; Zhao YW, 1996, BIOCHEMISTRY-US, V35, P7174, DOI 10.1021/bi952242v; Zilles K., 1985, CORTEX RAT STEREOTAX; Zoellner H, 1996, J CELL SCI, V109, P2571	71	28	30	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2001	94	3					499	509		10.3171/jns.2001.94.3.0499			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	405KB	WOS:000167157600019	11235957				2022-02-06	
J	McCracken, E; Dewar, D; Hunter, AJ				McCracken, E; Dewar, D; Hunter, AJ			White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat	BRAIN RESEARCH			English	Article						ischemia; oxidative stress; axon	TRAUMATIC BRAIN INJURY; METHYL-D-ASPARTATE; SUCCINATE-DEHYDROGENASE; FREE-RADICALS; CALPAIN ACTIVATION; OXIDATIVE STRESS; GLOBAL-ISCHEMIA; TOXIN; NEURODEGENERATION; NEUROTOXICITY	Oxidative stress has been implicated as a pathogenic mediator of neuronal perikarya cell death. Axons and oligodendrocytes. components of white matter, could also be vulnerable to oxidative damage. An experimental model of oxidative stress was induced by systemic injection of 3-nitropropionic acid (3-NPA). Animals received an i.p. injection of 10, 15, 20 or 30 mg/kg 3-NPA or vehicle and were killed 24 h later. 3-NPA produced a concentration-dependent increase in axonal pathology within the striatum reflected by the amount of beta -APP and SNAP-25 accumulation. Axonal damage was anatomically coincident with the neuronal lesion. There was no neuronal or axonal damage in the subcortical white matter or cerebral cortex in any of the animals treated with 3-NPA. Manganese superoxide dismutase (Mn-SOD) immunoreactivity was present in the vehicle and all 3-NPA treated groups. The amount of Mn-SOD cellular staining was concentration-dependently increased within the striatum supporting a role for oxidative stress in the mechanism of 3-NPA neurotoxicity. Oligodendrocyte-like cells within the subcortical white matter were immunopositive for calpain-mediated spectrin breakdown products and increased in a concentration-dependent manner. Therefore in this experimental modal, mitochondrial inhibition may lead to the initiation of oxidative stress and calpain activation, which could mediate cytoskeletal breakdown in axons and oligodendrocytes suggesting an interaction between at least two pathogenic mechanisms. (C) 2001 Elsevier Science B.V. All rights reserved.	Univ Glasgow, Wellcome Surg Inst, Glasgow G61 1QH, Lanark, Scotland; SmithKline Beecham Pharmaceut, Harlow CM19 5AD, Essex, England		McCracken, E (corresponding author), Univ Glasgow, Wellcome Surg Inst, Garscube Estate,Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland.	emc27m@udcf.gla.ac.uk	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763			Alexi T, 1998, NEUROREPORT, V9, pR57, DOI 10.1097/00001756-199808030-00001; ALSTON TA, 1977, P NATL ACAD SCI USA, V74, P3767, DOI 10.1073/pnas.74.9.3767; Bartus RT, 1998, BRAIN RES, V790, P1, DOI 10.1016/S0006-8993(97)01414-5; BARTUS RT, 1995, J CEREBR BLOOD F MET, V15, P969, DOI 10.1038/jcbfm.1995.123; BEAL MF, 1995, J NEUROCHEM, V65, P919; BEAL MF, 1993, J NEUROSCI, V13, P4181; Binienda Z, 1998, NEUROSCI LETT, V251, P173, DOI 10.1016/S0304-3940(98)00539-4; BORLONGAN CV, 1995, BRAIN RES BULL, V36, P549, DOI 10.1016/0361-9230(94)00242-S; Brouillet E, 1998, J NEUROCHEM, V70, P794; BROUILLET E, 1993, J NEUROCHEM, V60, P356, DOI 10.1111/j.1471-4159.1993.tb05859.x; CHAN PH, 1994, BRAIN PATHOL, V4, P59; CINO M, 1989, ARCH BIOCHEM BIOPHYS, V269, P623, DOI 10.1016/0003-9861(89)90148-3; COLES CJ, 1979, J BIOL CHEM, V254, P5161; Deshpande SB, 1997, EXP NEUROL, V145, P38, DOI 10.1006/exnr.1997.6457; DUGAN LL, 1995, J NEUROSCI, V15, P6377; DYKENS JA, 1994, J NEUROCHEM, V63, P584; FITZPATRICK MO, 1997, J CEREB BLOOD FLO S1, V17, pS415; FLAMM ES, 1978, BRAIN RES, V624, P445; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; FU YT, 1995, TOXICON, V33, P327, DOI 10.1016/0041-0101(94)00173-6; Geddes JW, 1996, MOL CHEM NEUROPATHOL, V28, P65, DOI 10.1007/BF02815206; GEDDES JW, 1994, NEUROBIOL AGING S, V25; Greene JG, 1998, NEUROSCIENCE, V84, P503, DOI 10.1016/S0306-4522(97)00389-8; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P119, DOI 10.1097/00004647-200001000-00016; Love S, 1999, BRAIN PATHOL, V9, P119; LUDOLPH AC, 1991, CAN J NEUROL SCI, V18, P492, DOI 10.1017/S0317167100032212; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; Miller PJ, 1997, EXP NEUROL, V146, P212, DOI 10.1006/exnr.1997.6522; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Nishino H, 1996, J CHEM NEUROANAT, V10, P209, DOI 10.1016/0891-0618(96)00134-2; Pang Z, 1997, J NEUROSCI, V17, P3064; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; RAICHLE ME, 1983, ANN NEUROL, V13, P2, DOI 10.1002/ana.410130103; RIEPE MW, 1995, NEUROSCIENCE, V64, P91, DOI 10.1016/0306-4522(94)00332-Y; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SCHRAUFSTATTER IU, 1985, J CLIN INVEST, V76, P1131, DOI 10.1172/JCI112068; Schulz JB, 1996, NEUROCHEM INT, V29, P167, DOI 10.1016/0197-0186(95)00122-0; SHIGENAGA MK, 1994, METHOD ENZYMOL, V234, P16; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; SUSSMAN MS, 1990, METHOD ENZYMOL, V186, P711; Takamatsu H, 1998, EUR J PHARMACOL, V352, P165, DOI 10.1016/S0014-2999(98)00353-7; Tsai MJ, 1997, NEUROSCIENCE, V79, P819, DOI 10.1016/S0306-4522(97)00015-8; WATSON BD, 1984, J NEUROCHEM, V42, P268, DOI 10.1111/j.1471-4159.1984.tb09728.x; WULLNER U, 1994, J NEUROCHEM, V63, P1772	51	28	29	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 23	2001	892	2					329	335		10.1016/S0006-8993(00)03266-2			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	403BJ	WOS:000167022400012	11172780				2022-02-06	
J	de Kruijk, JR; Twijnstra, A; Meerhoff, S; Leffers, P				de Kruijk, JR; Twijnstra, A; Meerhoff, S; Leffers, P			Management of mild traumatic brain injury: lack of consensus in Europe	BRAIN INJURY			English	Article							MINOR HEAD-INJURIES; CLASSIFICATION; ADMISSION	Mild traumatic brain injury (MTBI) accounts for most traumatic brain injuries and is an important cause of morbidity. Recent studies in various European countries have shown that no consensus exists about management of patients with MTBI. This study describes the management of MTBI patients in various European hospitals. A short questionnaire covering the areas of interest was sent to several EFNS members in European countries. The results of the inquiry show that there is, at present, no consensus about criteria for, or management of MTBI in European hospitals.	Univ Hosp Maastricht, Dept Neurol, NL-6229 HX Maastricht, Netherlands; Maastricht Univ, Fac Med, Maastricht, Netherlands; Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands		de Kruijk, JR (corresponding author), Univ Hosp Maastricht, Dept Neurol, P Debeylaan 25, NL-6229 HX Maastricht, Netherlands.		Leffers, Pieter/B-8642-2009				ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; de Kruijk J R, 1996, Ned Tijdschr Geneeskd, V140, P1763; de Louw A, 1994, Ned Tijdschr Geneeskd, V138, P2197; DEKRUIJK J, 1994, NEDERLANDS TIJDSCHRI, V5, P119; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Ingebrigtsen T, 1997, ACTA NEUROL SCAND, V95, P51, DOI 10.1111/j.1600-0404.1997.tb00068.x; Ingebrigtsen T, 1997, J CLIN NEUROSCI, V4, P29, DOI 10.1016/S0967-5868(97)90007-2; KRUGER J, 1991, NERVENARZT, V62, P226; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; MILLER JD, 1992, BRIT J SURG, V79, P60, DOI 10.1002/bjs.1800790122; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SAUNDERS CE, 1986, ANN EMERG MED, V15, P160, DOI 10.1016/S0196-0644(86)80012-9; SERVADEI F, 1995, J TRAUMA, V39, P696, DOI 10.1097/00005373-199510000-00015; VANTHOOFT F, 1973, COMMOTIO CEREBRI AND; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; VONWILD K, 1998, EUROPEAN J NEUROL S3, V5, pS235; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WARREN D, 1989, Pediatric Emergency Care, V5, P83, DOI 10.1097/00006565-198906000-00003; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YOUNG WB, 1994, SEMIN NEUROL, V14, P46, DOI 10.1055/s-2008-1041058	23	28	29	0	0	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2001	15	2					117	123		10.1080/026990501458353			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	398BG	WOS:000166733800004	11260762				2022-02-06	
J	Tyerman, A; Booth, J				Tyerman, A; Booth, J			Family interventions after traumatic brain injury: A service example	NEUROREHABILITATION			English	Article						TBI; family assessment; family education; family interventions	HEAD-INJURY; FOLLOW-UP; RELATIVES; BEHAVIOR; MEMBERS; NEEDS	Traumatic brain injury (TBI) often exerts a major impact upon the family with high levels of stress and distress, particularly amongst primary carers, disruption to family life style and functioning, changes in family roles, and marital and sexual difficulties. In response to the documented impact upon the family a range of family services have been advocated including family education, counselling and support. This paper outlines family services developed within a community head injury service in the UK. The family assessment programme comprises a relatives' screening questionnaire and structured interview schedules and ratings scales, some drawn from the family assessment literature, others developed within the service. Four components of family intervention are described: an annual series of educational workshops; follow-up workshops; individual family support; and specialist marital counselling. Our experience of providing these family services over the last 7 years is discussed along with the need for further evaluation of family assessment and interventions after TBI.	Bedgrove Hlth Ctr, Community Head Injury Serv, Aylesbury HP21 7ET, Bucks, England		Tyerman, A (corresponding author), Bedgrove Hlth Ctr, Community Head Injury Serv, Jansel Sq, Aylesbury HP21 7ET, Bucks, England.						ACORN S, 1995, J ADV NURS, V21, P872, DOI 10.1046/j.1365-2648.1995.21050872.x; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P464; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Florian V, 1989, INT DISABILITY STUDI, V13, P150; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Gosling J, 1999, BRAIN INJURY, V13, P785; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; JACOBS HE, 1989, NEUROPSYCHOLOGICAL T; Junque C, 1997, BRAIN INJURY, V11, P251, DOI 10.1080/026990597123557; Kabacoff R.I., 1990, J FAM PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Perlesz A, 1998, INT J REHABIL RES, V21, P339, DOI 10.1097/00004356-199812000-00001; PESSAR LF, 1993, BRAIN INJURY, V7, P231, DOI 10.3109/02699059309029675; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; RUST J, 1988, GOLOMBOK RUST INVENT; SACHS PR, 1991, TREATING FAMILIES BR; SCHAEFER MT, 1981, J MARITAL FAM THER, V7, P47, DOI 10.1111/j.1752-0606.1981.tb01351.x; SOLOMON C R, 1991, Brain Injury, V5, P253, DOI 10.3109/02699059109008096; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tyerman A, 1987, THESIS U LONDON; TYERMAN A, 1994, 4 C INT ASS STUD TRA; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; WHITEHOUSE AM, 1991, COGNITIVE REHABI NOV, P26; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; YOUNG K, 1994, THESIS BRIT PSYCHOL; ZARSKI J, 1988, J HEAD TRAUMA REHAB, V3, P31	36	28	31	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2001	16	1					59	66					8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	439YA	WOS:000169144100008	11455104				2022-02-06	
J	Verbois, SL; Sullivan, PG; Scheff, SW; Pauly, JR				Verbois, SL; Sullivan, PG; Scheff, SW; Pauly, JR			Traumatic brain injury reduces hippocampal alpha 7 nicotinic cholinergic receptor binding	JOURNAL OF NEUROTRAUMA			English	Article						autoradiography; bungarotoxin; isradipine; MK-801; nicotine; QNB	FLUID-PERCUSSION INJURY; CLOSED-HEAD-INJURY; CONTROLLED CORTICAL IMPACT; RAT-BRAIN; COGNITIVE DEFICITS; ACETYLCHOLINE; MEMORY; CALCIUM; ACETYLTRANSFERASE; DYSFUNCTION	Changes in the expression of central nervous system (CNS) neurotransmitter receptors may contribute to behavioral and physiological deficits that occur following traumatic brain injury (TBI), Studies investigating the neurochemical basis for the protracted cognitive dysfunction that follows TBI have focused in part on cholinergic mechanisms. The present study compared the effects of mild and moderate cortical contusion injury (CCI) on the density of cholinergic receptor subtypes, NMDA-type glutamate receptors, and calcium channel expression. Quantitative autoradiography was used to determine the effects of CCI on receptor expression, 48 h following injury. The most robust and consistent change in receptor binding was in the density of alpha7 nicotinic receptors as determined by alpha-[I-125]-bungarotoxin (BTX) binding. Bilateral deficits in BTX binding were present following both mild and moderate levels of injury. In contrast, changes in the density of alpha3/alpha4 nAChr's, muscarinic AChr's, NMDA-type glutamate receptors, and L-type calcium channel expression were more regionally restricted and lower in magnitude, as compared to changes in BTX binding. The high calcium permeability of the alpha7 nAChr may be related to the extensive decrease in BTX binding that occurs following TBI.	Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA		Pauly, JR (corresponding author), Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA.	jpauly@pop.uky.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS3122] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003122] Funding Source: NIH RePORTER		Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Changeux JP, 1998, BRAIN RES REV, V26, P198, DOI 10.1016/S0165-0173(97)00040-4; Chen Y, 1998, J NEUROTRAUM, V15, P231, DOI 10.1089/neu.1998.15.231; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; CORTES R, 1984, J NEURAL TRANSM, V60, P169, DOI 10.1007/BF01249092; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Delbono O, 1997, J PHARMACOL EXP THER, V280, P428; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1996, J NEUROTRAUM, V14, P615; DUNNETT SB, 1993, PROG BRAIN RES, V98, P413; ENTERS EK, 1992, BRAIN RES, V576, P271; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Jenkins LW, 1999, BRAIN RES, V817, P132, DOI 10.1016/S0006-8993(98)01237-2; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Leonard JR, 1997, EXP NEUROL, V143, P177, DOI 10.1006/exnr.1996.6366; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MATTSON MP, 1989, BRAIN RES, V497, P402, DOI 10.1016/0006-8993(89)90289-8; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PAULY JR, 1993, NEUROENDOCRINOLOGY, V57, P262, DOI 10.1159/000126368; PERRY DC, 1995, J PHARMACOL EXP THER, V275, P1030; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; PIKE BR, 1997, PHARM BIOCH BEHAV, V57, P1; PORTER RHP, 1994, NEUROSCI LETT, V169, P105, DOI 10.1016/0304-3940(94)90367-0; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; SAHAR A, 1966, J NEUROL NEUROSUR PS, V29, P77, DOI 10.1136/jnnp.29.1.77; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; SANDS SB, 1993, BIOPHYS J, V65, P2614, DOI 10.1016/S0006-3495(93)81296-7; Sarter M, 1997, BRAIN RES REV, V23, P28, DOI 10.1016/S0165-0173(96)00009-4; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SEGUELA P, 1993, J NEUROSCI, V13, P596; Shoaib M, 1997, PSYCHOPHARMACOLOGY, V134, P121, DOI 10.1007/s002130050433; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Sparks JA, 1999, PSYCHOPHARMACOLOGY, V141, P145, DOI 10.1007/s002130050818; Taverni JP, 1998, BRAIN INJURY, V12, P77; WEAVERS AW, 1999, J ALZHEIMERS DIS, V1, P207; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P917, DOI 10.1111/j.1530-0277.1990.tb01838.x	56	28	28	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2000	17	11					1001	1011		10.1089/neu.2000.17.1001			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	374KY	WOS:000165345400001	11101204				2022-02-06	
J	Robertson, CL; Clark, RSB; Dixon, CE; Alexander, HL; Graham, SH; Wisniewski, SR; Marion, DW; Safar, PJ; Kochanek, PM				Robertson, CL; Clark, RSB; Dixon, CE; Alexander, HL; Graham, SH; Wisniewski, SR; Marion, DW; Safar, PJ; Kochanek, PM			No long-term benefit from hypothermia after severe traumatic brain injury with secondary insult in rats	CRITICAL CARE MEDICINE			English	Article						traumatic brain injury; hypothermia; hypoxemia	CONTROLLED CORTICAL IMPACT; SEVERE HEAD-INJURY; ISCHEMIC NEURONAL INJURY; CEREBRAL BLOOD-FLOW; MODERATE HYPOTHERMIA; POSTTRAUMATIC HYPOTHERMIA; MILD HYPOTHERMIA; HIPPOCAMPAL; RELEASE; HYPOXIA	Objectives: To evaluate the effect of application of transient, moderate hypothermia on outcome after experimental traumatic brain injury (TBI) with a secondary hypoxemic insult. Design: Prospective, randomized study. Setting: University-based animal research facility. Subjects: Male Sprague-Dawley rats. Interventions: All rats were subjected to severe TBI followed by 30 mins of moderate hypoxemia, associated with mild hypotension. Rats were randomized to three groups: a) normothermia (37 degrees C +/- 0.5 degrees C); b) immediate hypothermia (32 degrees C +/- 0.5 degrees C initiated after trauma, before hypoxemia); and c) delayed hypothermia (32 degrees C +/- 0.5 degrees C after hypoxemia), The brain temperature was controlled for 4 hrs after TBI and hypoxemia, Measurements and Main Results: Animals were evaluated after TBI for motor and cognitive performance using beam balance (days 1-5 after TBI), beam walking (days 1-5 after TBI), and Morris Water Maze (days 14-18 after TBI) assessments, On day 21 after TBI, rats were perfused with paraformaldehyde and brains were histologically evaluated for lesion volume and hippocampal neuron counts. All three groups showed marked deficits in beam balance, beam walking, and Morris Water Maze performance. However, these deficits did not differ between groups. There was no difference in lesion volume between groups. All animals had significant hippocampal neuronal loss on the side ipsilateral to injury, but this loss was similar between groups. Conclusions:ln this rat model of severe TBI with secondary insult, moderate hypothermia for 4 hrs posttrauma failed to improve motor function, cognitive function, lesion volume or hippocampal neuronal survival. Combination therapies may be necessary in this difficult setting.	Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Pediat, Safar Ctr Rsuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol Surg, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Publ Hlth, Safar Ctr resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA USA; Pittsburgh Vet Adm Hlth Syst, Ctr Geriatr Res Educ & Clin, Pittsburgh, PA USA		Robertson, CL (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15261 USA.		Marion, Donald/AAR-5749-2021; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860			Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; BUSTO R, 1989, NEUROSCI LETT, V101, P299, DOI 10.1016/0304-3940(89)90549-1; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; KATSURADA K, 1973, SURGERY, V73, P191; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MORIKAWA E, 1991, J CEREB BLOOD FLO S2, V11, pS116; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SINHA RP, 1973, JAMA-J AM MED ASSOC, V224, P1258, DOI 10.1001/jama.224.9.1258; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510	38	28	29	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2000	28	9					3218	3223		10.1097/00003246-200009000-00017			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356RW	WOS:000089457500015	11008985				2022-02-06	
J	O'Connell, MJ				O'Connell, MJ			Prediction of return to work following traumatic brain injury: Intellectual, memory, and demographic variables	REHABILITATION PSYCHOLOGY			English	Article							HEAD-INJURY; REHABILITATION	Objective: To identify predictors of return to work for individuals with traumatic brain injury (TBI). Study Design: Data gathered from a retrospective chart review that included predictor variables (demographic, intellectual, and memory) and an outcome variable (employment status I year postprogram) were entered into a logistical regression analysis. Setting: A Commission for Accreditation of Rehabilitation Facilities-accredited outpatient brain injury program. Participants: Forty-three adults with TBI who completed the brain injury program. Main Outcome Measurer Employment status at I-year follow-up. Results: Individuals with higher scores on measures of Performance IQ and Verbal Memory were more likely to return to work. Conclusions: When the effects of many demographic variables are controlled for intelligence and memory variables can provide valuable information to patients, families, and service providers (e.g., rehabilitation centers) with regard to returning to work after TBI.	Sinai Rehabil Ctr, Baltimore, MD 21215 USA		O'Connell, MJ (corresponding author), Sinai Rehabil Ctr, 2401 W Belvedere Ave, Baltimore, MD 21215 USA.						BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED	9	28	28	0	2	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2000	45	2					212	217		10.1037/0090-5550.45.2.212			6	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	315PT	WOS:000087122700008					2022-02-06	
J	Togher, L				Togher, L			Giving information: The importance of context on communicative opportunity for people with traumatic brain injury	APHASIOLOGY			English	Article							HEAD-INJURY; DISCOURSE; ADULTS; CONVERSATION; POPULATION; LANGUAGE; PARTNERS	This study is one of a series investigating everyday communication skills of people with traumatic brain injury (TBI) using communication partners other than speech pathologists or research assistants. The first of these studies examined telephone conversations where subjects were asked to request specific information during telephone interactions with a range of communication partners. Results indicated that people with TBI were disadvantaged in some of their interactions on the telephone with community agencies and family members during information-seeking interactions, when compared with matched controls. TBI subjects were given less information than matched controls and were also asked for less information. For example, therapists never asked TBI subjects questions to which they didn't already know the answer. This was in contrast to the control interactions, where subjects were asked for novel information. In the current study seven subjects with TBI were compared with seven matched control subjects across two conditions: a community education information-giving session with two schoolboys, and an information-requesting interaction with the researcher. Exchange structure analysis showed that when placed in an information-giving role, TBI subjects gave similar amounts of information as control subjects. TBI subjects used joke telling as an information-giving device, serving a number of communicative functions, which are discussed. There was no significant difference in the amount of information requested or given by TBI and control subjects in the researcher condition; however there were significant qualitative differences in the nature of the requesting. It has been previously emphasized that people with TBI should be evaluated with a number of interlocutors as part of a thorough communication needs assessment (Hartley 1995). Merely varying the interlocutor is not sufficient, however, as the goal of the interaction and the primary speaking roles of participants are also important, and will determine the language choices available to both speakers. Exchange structure analysis is a useful way to delineate these language choices, as it is interpreted in light of the genre of the interaction and the tenor and communicative purpose of the participants.	Univ Sydney, Sch Commun Sci & Disorders, Lidcome, NSW 2141, Australia		Togher, L (corresponding author), Univ Sydney, Sch Commun Sci & Disorders, POB 170, Lidcome, NSW 2141, Australia.		Togher, Leanne/AAC-7083-2019	Togher, Leanne/0000-0002-4518-6748			Adamovich B. B., 1992, SCALES COGNITIVE ABI; Bateson G, 1973, STEPS ECOLOGY MIND; BERRY M, 1981, STUDIES DISCOURSE AN, P120; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Braun C M, 1989, Brain Inj, V3, P345, DOI 10.3109/02699058909004559; CASHION JL, 1987, J LANGUAGE SOCIAL PS, V5, P303; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; EDELSKY C, 1981, LANG SOC, V10, P383, DOI 10.1017/S004740450000885X; EGGINS S, 1990, THESIS U SYDNEY SYDN; Eggins S., 1997, ANAL CASUAL CONVERSA; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; EHRLICH J, 1985, COGNITIVE REHABILITA, P32; Fairclough N., 1992, DISCOURSE SOCIAL CHA; FISHMAN PM, 1978, LANGUAGE GENDER SOC, P89; Giles G M, 1988, Brain Inj, V2, P75, DOI 10.3109/02699058809150933; GILES H, 1976, HUMOUR LAUGHTER THEO, P75; Glosser G., 1990, BRAIN LANG, V40, P67; Halliday M., 2004, INTRO FUNCTIONAL GRA; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Holmes J, 1995, WOMEN MEN POLITENESS; Jefferson G, 1987, TALK SOCIAL ORG, P152; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; MALIA K, 1995, BRAIN INJURY, V9, P697, DOI 10.3109/02699059509008226; Maltz D. N., 1982, LANGUAGE SOCIAL IDEN, P195; Martin J. R., 1992, ENGLISH TEXT SYSTEM; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McTear M., 1991, MISCOMMUNICATION PRO, P195; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Mulkay M., 1988, HUMOUR; Norrick Neal., 1993, CONVERSATIONAL JOKIN; PARSONS CL, 1989, AUSTR J HUMAN COMMUN, V17, P37; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; Poynton C., 1985, LANGUAGE GENDER MAKI; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; SCHLOSS PJ, 1985, APPL RES MENT RETARD, V6, P269, DOI 10.1016/0270-3092(85)90001-3; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1999, APHASIOLOGY, V13, P709, DOI 10.1080/026870399401821; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; VENTOLA E, 1987, STRUCTURAL SOCIAL IN; WEST C, 1984, DISCOURSE PROCESS, V7, P107, DOI 10.1080/01638538409544586	48	28	31	0	7	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	APR	2000	14	4					365	390		10.1080/026870300401414			26	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	315AV	WOS:000087091200003					2022-02-06	
J	Butler, PV				Butler, PV			Reverse Othello syndrome subsequent to traumatic brain injury	PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES			English	Article							DELUSIONAL MISIDENTIFICATION; EROTOMANIA; SELF; DISORDER	Delusional syndromes that occur following head injury are frequently ascribed directly to the consequences of organic insult and seen as empty of psychological significance. The presence of an organic factor, however, does not necessarily indicate that delusional ideation is a direct product of that factor. In this article a detailed report is given of Reverse Othello syndrome (a delusional belief in the fidelity of a romantic partner) appearing in a 49-year-old male following extremely severe traumatic brain injury. This case report highlights the interaction and interpenetration of a complex array of biological, psychological, and social factors in the crystallization of a delusion system. It is argued, following Jaspers, that the emergence of erotically themed delusions following trauma may represent an active attempt to regain intrapsychic coherence and to confer meaning on otherwise catastrophic loss or emptiness.	Royal Rehabil Ctr, Psychol Serv, Ryde, NSW 2112, Australia		Butler, PV (corresponding author), Royal Rehabil Ctr, Psychol Serv, Ryde, NSW 2112, Australia.	butlerp@doh.health.nsw.gov.au					Bowins B, 1998, CAN J PSYCHIAT, V43, P154, DOI 10.1177/070674379804300204; Burgess P. W., 1996, METHOD MADNESS CASE, P51, DOI [DOI 10.1006/CC0G.1995.1002, 10.1006/ccog.1995.1002]; COLERIDGE ST, 1997, ST COLERIDGE SELECTE, P155; Crichton P, 1996, J FORENSIC PSYCHIATR, V7, P161, DOI 10.1080/09585189608409924; Enoch M. D., 1991, UNCOMMON PSYCHIAT SY; EVANS DL, 1982, B MENNINGER CLIN, V46, P507; FLEMINGER S, 1994, PSYCHOPATHOLOGY, V27, P161, DOI 10.1159/000284865; FLEMINGER S, 1993, BIOL PSYCHIAT, V33, P22, DOI 10.1016/0006-3223(93)90274-H; FREUD S, 1979, PELICAN FREUD LIB, V10, P209; GELDER M, 1990, OXFORD TXB PSYCHIAT; GILLETT T, 1990, ACTA PSYCHIAT SCAND, V82, P65, DOI 10.1111/j.1600-0447.1990.tb01357.x; Halligan P. W., 1996, METHOD MADNESS CASE; Hoenig J., 1963, GEN PSYCHOPATHOLOGY; John S, 1996, J INTELL DISABIL RES, V40, P279, DOI 10.1046/j.1365-2788.1996.765765.x; LABAW WL, 1997, INJURED BRAINS MED M, P298; LEONG GB, 1994, J FORENSIC SCI, V39, P1445; Lo Y, 1997, ACTA PSYCHIAT SCAND, V95, P161, DOI 10.1111/j.1600-0447.1997.tb00390.x; LYON HM, 1994, BRIT J PSYCHIAT, V164, P637, DOI 10.1192/bjp.164.5.637; MALLOY PF, 1994, J NEUROPSYCH CLIN N, V6, P455; Marshall J.C., 1996, METHOD MADNESS CASE, P3; Miller L., 1994, J COGNITIVE REHABILI, V12, P12; MORSE JM, 1995, J ADV NURS, V21, P886, DOI 10.1046/j.1365-2648.1995.21050886.x; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199112000-00004, DOI 10.1097/00001199-199112000-00004]; PRIGATANO GP, 1995, J HEAD TRAUMA REHAB, V10, P87; ROBERTS G, 1991, BRIT J PSYCHIAT, V159, P19, DOI 10.1192/S0007125000296438; Sacks Oliver., 1986, MAN WHO MISTOOK HIS; SEGAL JH, 1989, AM J PSYCHIAT, V146, P1261; SIGNER SF, 1987, BRIT J PSYCHIAT, V151, P402, DOI 10.1192/bjp.151.3.402; Sutker, 1984, COMPREHENSIVE HDB PS, P383; TODD J, 1959, J NERV MENT DIS, V122, P367; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; WEINSTEIN E, 1996, METHOD MADNESS, P13; Werblowsky R. J. Zwi, 1997, OXFORD DICT JEWISH R; Young A.W., 1996, METHOD MADNESS CASE, P147	35	28	28	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0033-2747	1943-281X		PSYCHIATRY	Psychiatry-Interpers. Biol. Process.	SPR	2000	63	1					85	92		10.1080/00332747.2000.11024897			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	318BW	WOS:000087264900011	10855763				2022-02-06	
J	Gauggel, S; Peleska, B; Bode, RK				Gauggel, S; Peleska, B; Bode, RK			Relationship between cognitive impairments and rated activity restrictions in stroke patients	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						competency rating; disability; neuropsychological tests; stroke	TRAUMATIC BRAIN INJURY; BARTHEL ADL INDEX; FUNCTIONAL INDEPENDENCE; BEHAVIORAL LIMITATIONS; DISABILITY; LIFE; AWARENESS; RELATIVES; QUALITY; PEOPLE	Objective: To investigate the relationship between cognitive impairments and rated activity restrictions. Design: Comparison of neuropsychological tests and activity questionnaires. Activity ratings were made by staff and stroke patients. Setting: Two neurological rehabilitation hospitals. Participants: Eighty-seven stroke patients. Results: Moderately high correlations were found between cognitive test scores and activity ratings made by staff members. In contrast, correlations between ratings made by patients and cognitive rests were much lower. There was also little agreement between the staffs' ratings and the patients' own ratings. Multiple regression analyses indicate that cognitive impairments account for 28.9% of the variance in the activin rating made by the staff members. The coefficient of determination was slightly higher when age, time since onset of illness, and depression scores were included as predictors. Conclusions: These findings provide partial support fur a hierarchical structure of the "International Classification of Impairment, Activities and Participation" model of the World Health Organization.	Univ Marburg, Dept Psychol, D-35032 Marburg, Germany; Northwestern Univ, Sch Med, Rehabil Inst Chicago, Rehabil Serv Evaluat Unit, Chicago, IL 60611 USA		Gauggel, S (corresponding author), Univ Marburg, Dept Psychol, Gutenbergstr 18, D-35032 Marburg, Germany.			Gauggel, Siegfried/0000-0002-2742-4917			Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; Beck R, 1996, AGRO FOOD IND HI TEC, V7, P3; BENDALL MJ, 1989, AGE AGEING, V18, P327, DOI 10.1093/ageing/18.5.327; BOHANNON RW, 1990, ARCH PHYS MED REHAB, V71, P330; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; DEHAAN R, 1993, STROKE, V24, P1178, DOI 10.1161/01.STR.24.8.1178; Dittmar S., 1997, FUNCTIONAL ASSESSMEN; FUGLMEYER AR, 1980, SCAND J REHABIL MED, P140; GAUGGEL S, 1999, UNPUB MARBURGER KOMP; GRESHAM GE, 1995, POST STROKE REHABILI, V16; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; HOLBROOK M, 1983, AGE AGEING, V12, P166, DOI 10.1093/ageing/12.2.166; Horn W, 1983, LEISTUNGSPRUFSYSTEM; KAPLAN CP, 1994, ARCH PHYS MED REHAB, V75, P643, DOI 10.1016/0003-9993(94)90186-4; Lai SM, 1998, STROKE, V29, P1838, DOI 10.1161/01.STR.29.9.1838; LAWRENCE L, 1979, AGE AGEING, V8, P167, DOI 10.1093/ageing/8.3.167; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Pohjasvaara T, 1997, STROKE, V28, P729, DOI 10.1161/01.STR.28.4.729; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RANHOFF AH, 1993, AGE AGEING, V22, P171, DOI 10.1093/ageing/22.3.171; ROBINSON RG, 1985, ARCH PHYS MED REHAB, V66, P496; Roth EJ, 1998, ARCH PHYS MED REHAB, V79, P329, DOI 10.1016/S0003-9993(98)90015-6; SEGAL ME, 1994, STROKE, V25, P2391, DOI 10.1161/01.STR.25.12.2391; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; SQUIRE LR, 1988, J CLIN EXP NEUROPSYC, V10, P727, DOI 10.1080/01688638808402810; Wade D, 1992, MEASUREMENT NEUROLOG; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009; World Health Organization, 1997, ICIDH 2 INT CLASS IM; WRIGHT BD, 1997, BIGSTEPS RASCH COMPU; WYLLER TB, 1995, AGE AGEING, V24, P398, DOI 10.1093/ageing/24.5.398; Wyller TB, 1996, DISABIL REHABIL, V18, P454, DOI 10.3109/09638289609165909; [No title captured]	37	28	28	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2000	15	1					710	723		10.1097/00001199-200002000-00009			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	287MX	WOS:000085510800010	10745186				2022-02-06	
J	Marlowe, WB				Marlowe, WB			An intervention for children with disorders of executive functions	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							FRONTAL-LOBE DAMAGE; CLOSED-HEAD-INJURY; LEARNING-DISABILITIES; CHILDHOOD; ATTENTION; CONSEQUENCES; PERFORMANCE; ADOLESCENTS; DISCOURSE; DEFICITS	This article describes a cognitive-behavioral approach to teaching metacognitive executive thinking strategies to children with disorders of executive function. The intervention is based on the notion that some children with disorders of executive function have disorders of higher level language, which predispose them to the executive impairments. It is proposed that teaching and reinforcing metacognitive thinking strategies may help advance verbal mediation of complex tasks and self-regulation of behavior. Despite the growing literature on developmental executive disorders, little has been written about interventions that may enable the children to acquire some of the requisite adaptive skills. The ideas expressed herein should be considered an invitation for the initiation of empirical studies of intervention and outcome effects.			Marlowe, WB (corresponding author), Cabrini Towers,901 Boren Ave,Suite 610, Seattle, WA 98104 USA.						ACKERLY SS, 1947, RES PUBL ASSOC RES N, V27, P479; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; APPELLOF ES, 1985, J CLIN EXP NEUROPSYC, V7, P604; BARKLEY RA, 1992, J ABNORM CHILD PSYCH, V20, P163, DOI 10.1007/BF00916547; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BECKER MG, 1987, DEV NEUROPSYCHOL, V3, P275, DOI 10.1080/87565648709540381; BELL N, 1986, VISUALIZING VERBALIZ; BERNSTEIN JH, 1996, LEARNING LEARN SKILL; BROUWERS P, 1990, AM J PEDIAT HEMATOL, V12, P174; BRUNER JS, 1973, CHILD DEV, V44, P1; Carton A. S., 1987, COLLECTED WORKS LS V; Chance P., 1986, THINKING CLASSROOM S; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CHELUNE GJ, 1987, DEV NEUROPSYCHOL, V3, P81, DOI 10.1080/87565648709540365; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; Connor PD, 2000, DEV NEUROPSYCHOL, V18, P331, DOI 10.1207/S1532694204Connor; Denckla MB., 1989, INT PEDIAT, V4, P155; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; ENGLEMANN S, 1969, CONCEPTUAL LEARNING; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; Fletcher JM, 1996, DEV NEUROPSYCHOL, V12, P53, DOI 10.1080/87565649609540640; GRATTAN LM, 1991, DEV NEUROPSYCHOL, V7, P283, DOI 10.1080/87565649109540496; GRATTAN LM, 1992, BRAIN COGNITION, V20, P185, DOI 10.1016/0278-2626(92)90068-W; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Holmes-Bernstein J., 1990, NEUROPSYCHOLOGY, P311, DOI DOI 10.1385/0-89603-133-0:311; KIRK U, 1985, J CLIN EXP NEUROPSYC, V7, P604; LANDRY HS, 1994, ADV CHILD NEUROPSYCH, V1, P85; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Luria A.R., 1961, ROLE SPEECH REGULATI; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; Montessori M., 1967, THE ABSORBENT MIND; Montessori M., 1912, MONTESSORI METHOD; NEEDLEMAN HL, 1982, PSYCHOL MED, V12, P461, DOI 10.1017/S0033291700055550; Nelson K., 1996, LANGUAGE COGNITIVE D; Passler MA, 1985, DEV NEUROPSYCHOL, V1, P349, DOI 10.1080/87565648509540320; Pentland L, 1998, NEUROPSYCHOL REHABIL, V8, P301, DOI 10.1080/713755572; PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383; STORES G, 1978, DEV MED CHILD NEUROL, V20, P502; STREISSGUTH AP, 1994, ALCOHOL CLIN EXP RES, V18, P202, DOI 10.1111/j.1530-0277.1994.tb00904.x; STUSS DT, 1999, FUNCTIONS FRONTAL LO; Taylor HG, 1996, DEV NEUROPSYCHOL, V12, P35, DOI 10.1080/87565649609540639; TAYLOR HG, 1995, J PEDIATR PSYCHOL, V20, P703, DOI 10.1093/jpepsy/20.6.703; TAYLOR HG, 1987, J PEDIATR PSYCHOL, V12, P395, DOI 10.1093/jpepsy/12.3.395; TAYLOR HG, 1993, J CLIN CHILD PSYCHOL, V22, P196, DOI 10.1207/s15374424jccp2202_6; TRANEL D, 1994, HDB NEUROPSYCHOLOGY, V9; Vygotsky L. S., 1962, THOUGHT LANGUAGE; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WELSH MC, 1990, CHILD DEV, V61, P1697, DOI 10.1111/j.1467-8624.1990.tb03560.x; WILLIAMS D, 1992, BRAIN COGNITION, V20, P196, DOI 10.1016/0278-2626(92)90069-X; Wilson D., 1986, RELEVANCE COMMUNICAT; [No title captured]	58	28	28	0	22	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2000	18	3					445	454		10.1207/S1532694209Marlowe			10	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	432UW	WOS:000168714900009	11385834				2022-02-06	
J	Mathew, BP; Dewitt, DS; Bryan, RM; Bukoski, RD; Prough, DS				Mathew, BP; Dewitt, DS; Bryan, RM; Bukoski, RD; Prough, DS			Traumatic brain injury reduces myogenic responses in pressurized rodent middle cerebral arteries	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; cerebral arteries; myogenic response; traumatic brain injury	FLUID PERCUSSION INJURY; BLOOD-FLOW; AUTO-REGULATION; HEAD-INJURY; ENDOGENOUS OPIOIDS; RAT; AUTOREGULATION; CATS; ENDOTHELIUM; ABNORMALITIES	Traumatic brain injury (TBI) reduces cerebral vascular pressure autoregulation in experimental animals and in patients. In order to understand better the mechanisms of impaired autoregulation, we measured myogenic responses to changes in intraluminal pressure in vitro in pressurized, rodent middle cerebral arteries (MCAs) harvested after TBI. In an approved study, male Sprague-Dawrey rats (275-400 g) were anesthetized, intubated, ventilated with 2.0% isoflurane in O-2/air, and prepared for fluid percussion TBI. The isoflurane concentration was reduced to 1.5%, and rats (n = 6 per group) were randomly assigned to receive sham TBI followed by decapitation 5 or 30 min later or moderate TBI (2.0 atm) followed by decapitation 5 or 30 min later. After decapitation, MCA segments were removed, mounted on an arteriograph, and pressurized. MCA diameters were measured as transmural pressure was sequentially reduced. MCA diameters remained constant or increased in the sham groups as intraluminal pressure was reduced from 100 to 40 mm Hg. In both TBI groups, diameter decreased with each reduction in pressure. In summary, MCAs removed from uninjured, isoflurane-anesthetized rats had normal vasodilatory responses to decreased intraluminal pressure. In contrast, after TBI, myogenic vasodilatory responses were significantly reduced within 5 min of TBI and the impaired myogenic responses persisted for at least 30 min after TBI.	Univ Texas, Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77555 USA; Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; Univ Texas, Med Branch, Dept Internal Med, Sect Hypertens & Vasc Res, Galveston, TX 77550 USA		Dewitt, DS (corresponding author), Univ Texas, Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, 610 Texas Ave, Galveston, TX 77555 USA.		Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27618, NS19355] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER		ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P220; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BRANSTON NM, 1995, CEREBROVAS BRAIN MET, V7, P339; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; Bukoski RD, 1997, AM J PHYSIOL-HEART C, V272, pH1406; BURNSTOCK G, 1994, BRIT J PLAST SURG, V47, P527, DOI 10.1016/0007-1226(94)90136-8; BUSIJA DW, 1993, REGULATION CEREBRAL, P46; DAVIS MJ, 1993, AM J PHYSIOL, V264, pH2168, DOI 10.1152/ajpheart.1993.264.6.H2168; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS E F, 1989, Journal of Neurotrauma, V6, P31, DOI 10.1089/neu.1989.6.31; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; Fabian RH, 1998, J NEUROTRAUM, V15, P433, DOI 10.1089/neu.1998.15.433; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fog M, 1937, ARCH NEURO PSYCHIATR, V37, P351, DOI 10.1001/archneurpsyc.1937.02260140137007; Golding EM, 1998, J NEUROTRAUM, V15, P635, DOI 10.1089/neu.1998.15.635; Golding EM, 1998, BRAIN RES, V785, P293, DOI 10.1016/S0006-8993(97)01419-4; HARPER SL, 1984, AM J PHYSIOL, V246, pH17, DOI 10.1152/ajpheart.1984.246.1.H17; HONG KW, 1994, AM J PHYSIOL, V266, pH11, DOI 10.1152/ajpheart.1994.266.1.H11; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1978, AM J PHYSIOL, V234, P371; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MCCARRON JG, 1989, BLOOD VESSELS, V26, P315; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MEININGER GA, 1992, AM J PHYSIOL, V263, pH647, DOI 10.1152/ajpheart.1992.263.3.H647; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Nelson MT, 1997, J PHYSIOL-LONDON, V502, P259, DOI 10.1111/j.1469-7793.1997.259bk.x; OSOL G, 1989, J HYPERTENS, V7, pS67; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Roy C S, 1890, J Physiol, V11, P85; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95	44	28	28	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	1999	16	12					1177	1186		10.1089/neu.1999.16.1177			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	266WC	WOS:000084322400005	10619196				2022-02-06	
J	Guerit, JM				Guerit, JM			EEG and evoked potentials in the intensive care unit	NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY			English	Article						brain anoxia; brain death; coma; electroencephalogram; evoked potentials; head trauma; intensive care medicine; neuromonitoring	AUDITORY BRAIN-STEM; LOCKED-IN-SYNDROME; SEVERE HEAD-INJURY; EVENT-RELATED POTENTIALS; POST-TRAUMATIC COMA; EARLY PREDICTION; MIDDLE-LATENCY; SUBARACHNOID HEMORRHAGE; PROGNOSTIC VALUE; CONDUCTION TIME	We review the principal aspects of EEG and evoked potential (EP) neuromonitoring in the intensive care unit. The electrophysiological methods allow functional assessment of comatose patients and can be used (a) as a help to diagnose the origin of coma, (b) as a means to predict outcome, and (c) for monitoring purposes. The combination of the EEG and long-, middle-, and short-latency EPs allows widespread assessment of the cerebral cortex, the brain-stem, and the spinal cord. The EEG and the EP interpretation first requires taking into account non-neurological factors that may interfere with the recorded activities (sensory pathologies, toxic or metabolic problems, body temperature). The sensitivity and the specificity of any neurophysiological technique depend on the etiology of coma. Anoxic comas are associated with a predominantly cortical involvement, while the cortical and brain-stem functions are to be taken into account to interpret the EEG and the EPs in head trauma. The EEG and the EPs can be used to differentiate the comas due to structural lesions from those of metabolic origin, to confirm brain death and help to diagnose psychogenic unresponsiveness or a de-efferented state. While the prognostic value of the EEG is markedly hampered by the widespread use of sedative drugs, it has been possible to design efficient systems based on early- and middle-latency multimodality evoked potentials in anoxic and traumatic comas and, more generally, in all comas associated with an increase of the intracranial pressure. Continuous neuromonitoring techniques are currently under development. They have already been proven useful for the early detection and for the prevention of subclinical seizures, transtentorial herniation, vasospasm, and other causes of brain or spinal-cord ischemia. (C) 1999 Editions scientifiques et medicales Elsevier SAS.	Catholic Univ Louvain, Clin Neurophysiol Unit, B-1200 Brussels, Belgium		Guerit, JM (corresponding author), Catholic Univ Louvain, Clin Neurophysiol Unit, B-1200 Brussels, Belgium.						ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; *AM EL SOC, 1994, J CLIN NEUROPHYSIOL, V11, P10; [Anonymous], 1987, PEDIATRICS, V80, P298; AUSTIN EJ, 1988, NEUROLOGY, V38, P773, DOI 10.1212/WNL.38.5.773; Bassetti C, 1996, J NEUROL NEUROSUR PS, V61, P610, DOI 10.1136/jnnp.61.6.610; BASSETTI C, 1994, J NEUROL NEUROSUR PS, V57, P1403, DOI 10.1136/jnnp.57.11.1403; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; BINNIE CD, 1970, BMJ-BRIT MED J, V4, P265, DOI 10.1136/bmj.4.5730.265; BLANCAFORT JB, 1995, CHILD NERV SYST, V11, P400, DOI 10.1007/BF00717405; Brierly J, 1984, GREENFIELDS NEUROPAT, P125; BRUNKO E, 1987, ELECTROEN CLIN NEURO, V66, P15, DOI 10.1016/0013-4694(87)90133-7; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Chatrian GE, 1996, ELECTROEN CLIN NEURO, V99, P103, DOI 10.1016/0013-4694(96)96059-9; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; CHOKROVERTY S, 1975, NEUROLOGY, V25, P655, DOI 10.1212/WNL.25.7.655; Clinique Bdlsdn, 1989, NEUROPHYSIOL CLIN, V19, P339; COSELLI JS, 1988, ANN THORAC SURG, V45, P638, DOI 10.1016/S0003-4975(10)64766-2; FACCO E, 1985, ELECTROEN CLIN NEURO, V62, P332, DOI 10.1016/0168-5597(85)90041-3; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; FACCO E, 1989, ELECTROEN CLIN NEURO, V73, P552, DOI 10.1016/0013-4694(89)90265-4; FERBERT A, 1988, ELECTROEN CLIN NEURO, V69, P136, DOI 10.1016/0013-4694(88)90209-X; FIRSCHING R, 1994, NEUROL RES, V16, P18; FISCHER C, 1994, NEUROSURGERY, V35, P45, DOI 10.1227/00006123-199407000-00007; GARCIALARREA L, 1988, NEUROLOGY, V38, P1487, DOI 10.1212/WNL.38.9.1487; GOLDIE WD, 1981, NEUROLOGY, V31, P248, DOI 10.1212/WNL.31.3.248; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; Guerit J. M., 1993, Neurophysiologie Clinique, V23, P209, DOI 10.1016/S0987-7053(05)80231-X; Guerit J M, 1992, Eur J Med, V1, P233; GUERIT JM, 1990, ELECTROEN CLIN NEURO, V77, P163, DOI 10.1016/0168-5597(90)90034-B; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; Guerit JM, 1998, ELECTROEN CLIN NEURO, V106, P1, DOI 10.1016/S0013-4694(97)00077-1; GUERIT JM, 1994, ACTA NEUROL BELG, V94, P174; GUERIT JM, 1998, POTENTIELS EVOQUES; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; *INT FED SOC EL CL, 1983, REC PRACT CLIN NEUR, P66; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; KARNAZE DS, 1985, NEUROLOGY, V35, P1122, DOI 10.1212/WNL.35.8.1122; KULLMANN F, 1995, J HEPATOL, V22, P101, DOI 10.1016/0168-8278(95)80267-3; Landi A, 1994, J Neurosurg Sci, V38, P123; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; Machado C, 1993, J Neurosurg Sci, V37, P125; Madl C, 1996, ARCH NEUROL-CHICAGO, V53, P512, DOI 10.1001/archneur.1996.00550060054017; MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5; MARKAND ON, 1984, ELECTROEN CLIN NEURO, V59, P432, DOI 10.1016/0168-5597(84)90002-9; MAUGUIERE F, 1983, BRAIN, V106, P271, DOI 10.1093/brain/106.2.271; Michel C, 1998, NEUROPHYSIOL CLIN, V28, P343, DOI 10.1016/S0987-7053(98)80005-1; Misra UK, 1996, J NEUROL, V243, P96; Mutschler V, 1996, NEUROPHYSIOL CLIN, V26, P158, DOI 10.1016/0987-7053(96)89626-2; NAGAO S, 1979, J NEUROSURG, V51, P846, DOI 10.3171/jns.1979.51.6.0846; NEWLON PG, 1982, J NEUROSURG, V57, P168, DOI 10.3171/jns.1982.57.2.0168; NIEDERMEYER E, 1996, ELECTROENCEPHALOGRAP; Nuwer M R, 1994, Neurosurg Clin N Am, V5, P647; Onofrj M, 1997, J NEUROL NEUROSUR PS, V63, P759, DOI 10.1136/jnnp.63.6.759; Onofrj M, 1996, COGNITIVE BRAIN RES, V4, P95; OTTAVIANI F, 1986, ELECTROEN CLIN NEURO, V65, P196, DOI 10.1016/0168-5597(86)90054-7; PFURTSCHELLER G, 1987, J CLIN NEUROPHYSIOL, V4, P389, DOI 10.1097/00004691-198710000-00004; PohlmannEden B, 1997, INTENS CARE MED, V23, P301, DOI 10.1007/s001340050332; RAEGRANT AD, 1991, ELECTROEN CLIN NEURO, V79, P349, DOI 10.1016/0013-4694(91)90199-E; ROSENBERG C, 1984, ARCH NEUROL-CHICAGO, V41, P835, DOI 10.1001/archneur.1984.04050190041012; ROTHSTEIN TL, 1991, ELECTROEN CLIN NEURO, V79, P101, DOI 10.1016/0013-4694(91)90046-7; RUMPL E, 1979, ELECTROEN CLIN NEURO, V46, P487, DOI 10.1016/0013-4694(79)90002-6; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P583, DOI 10.1016/0013-4694(83)90026-3; SANDRONI C, 1995, EUR J EMERG MED, V2, P3; SOHMER H, 1986, ELECTROEN CLIN NEURO, V64, P334, DOI 10.1016/0013-4694(86)90157-4; SORENSEN K, 1978, J NEUROL NEUROSUR PS, V41, P840, DOI 10.1136/jnnp.41.9.840; STOCKARD JJ, 1978, ANN NEUROL, V3, P368, DOI 10.1002/ana.410030416; STONE JL, 1988, J CLIN NEUROPHYSIOL, V5, P135, DOI 10.1097/00004691-198804000-00002; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; TOWLE VL, 1989, ELECTROEN CLIN NEURO, V73, P419, DOI 10.1016/0013-4694(89)90091-6; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; VIGNAENDRA V, 1974, NEUROLOGY, V24, P582, DOI 10.1212/WNL.24.6.582; Wagner W, 1996, BRAIN, V119, P1507, DOI 10.1093/brain/119.5.1507; WALSER H, 1985, ARCH NEUROL-CHICAGO, V42, P32, DOI 10.1001/archneur.1985.04060010038013; WESTMORELAND BF, 1975, ARCH NEUROL-CHICAGO, V32, P713, DOI 10.1001/archneur.1975.00490530035001; YORK DH, 1981, J NEUROSURG, V55, P909, DOI 10.3171/jns.1981.55.6.0909; YOUNG GB, 1994, ELECTROEN CLIN NEURO, V91, P93, DOI 10.1016/0013-4694(94)90030-2; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8	81	28	30	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0987-7053	1769-7131		NEUROPHYSIOL CLIN	Neurophysiol. Clin.-Clin. Neurophysiol.	SEP	1999	29	4					301	317		10.1016/S0987-7053(99)90044-8			17	Clinical Neurology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	248QD	WOS:000083286100002	10546249				2022-02-06	
J	Lew, HL; Slimp, J; Price, R; Massagli, TL; Robinson, LR				Lew, HL; Slimp, J; Price, R; Massagli, TL; Robinson, LR			Comparison of speech-evoked v tone-evoked P300 response - Implications for predicting outcomes in patients with traumatic brain injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article; Proceedings Paper	Annual Meeting of the Association-of-Academic-Physiatrists	FEB 19-20, 1998	SAN ANTONIO, TEXAS	Assoc Acad Physiatrists		brain injury; auditory event-related potentials; P300; evoked potentials; coma; awakening	EVENT-RELATED POTENTIALS; INITIAL-VALUE; COMA; RECOVERY; LATENCY; LAW	The P300 response is a cognitive event-related potential recorded over the scalp. The tone-evoked P300 response has been used to predict outcomes of patients with brain injury. However, it may lead to false predictions because some normal people have a very small tone-evoked P300 response. It is hypothesized that speech may generate a more robust P300 response than tones. A voice-generator prototype was designed for this study. The rare speech signal was the word "mommy" in a female voice. The common signal was a 1000-Hz tone. Twenty-two normal adults (11 males, 11 females; age range, 18-60 yr) were tested for both speech-evoked and tone-evoked P300 responses. Speech-evoked P300 responses had significantly larger amplitudes (mean, 12.1 mu V) than the tone-evoked responses (mean, 5.9 mu V P < 0.0001). Six subjects with brain injury were also tested using the same protocol: two subjects with severe brain injury showed no response to either stimulus. Both died within 1 wk after the testing. Although two subjects with moderate brain injury could not complete the testing because of agitated behavior, two other subjects with mild traumatic brain injury showed a larger speech-evoked than tone-evoked P300 response. The speech-evoked P300 response may be promising in predicting outcomes of patients with brain injury.	Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA		Lew, HL (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Box 356490,1959 NE Pacific St, Seattle, WA 98195 USA.		Robinson, Lawrence/D-8455-2013	Robinson, Lawrence/0000-0002-9590-8745			AHMED I, 1988, CLIN ELECTROENCEPHAL, V19, P78, DOI 10.1177/155005948801900209; DANZE F, 1989, Neurosurgical Review, V12, P477, DOI 10.1007/BF01790694; Fowler B, 1997, BIOL PSYCHOL, V46, P113, DOI 10.1016/S0301-0511(97)05253-8; JENNETT B, 1975, LANCET, V7905, P480; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KUGLER CFA, 1993, GERONTOLOGY, V39, P280; Lew H, 1997, J Am Acad Audiol, V8, P104; NISHIMURA N, 1995, PSYCHIAT CLIN NEUROS, V49, P79, DOI 10.1111/j.1440-1819.1995.tb01863.x; OMAHONY D, 1990, LANCET, V336, P1265, DOI 10.1016/0140-6736(90)92887-N; PAPANICOLAOU AC, 1986, NEUROSURGERY, V18, P173, DOI 10.1227/00006123-198602000-00009; PFURTSCHELLER G, 1985, ELECTROEN CLIN NEURO, V62, P88, DOI 10.1016/0168-5597(85)90020-6; POLICH J, 1989, ELECTROEN CLIN NEURO, V74, P312, DOI 10.1016/0168-5597(89)90061-0; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; TAKESHITA S, 1994, INT J PSYCHOPHYSIOL, V16, P99, DOI 10.1016/0167-8760(94)90046-9; WAYMAN JW, 1992, J ACOUST SOC AM, V91, P3527, DOI 10.1121/1.402841; YINGLING CD, 1990, LANCET, V336, P873, DOI 10.1016/0140-6736(90)92372-O; ZENTNER J, 1992, NEUROSURGERY, V31, P429, DOI 10.1227/00006123-199209000-00007	18	28	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL-AUG	1999	78	4					367	371		10.1097/00002060-199907000-00014			5	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	216AP	WOS:000081418600012	10418844				2022-02-06	
J	Dutcher, SA; Underwood, BD; Walker, PD; Diaz, FG; Michael, DB				Dutcher, SA; Underwood, BD; Walker, PD; Diaz, FG; Michael, DB			Patterns of immediate early gene mRNA expression following rodent and human traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						zif/268; human brain injury; gene expression; cerebral cortex	PROGRAMMED CELL-DEATH; C-FOS; AMINO-ACIDS; PROTEIN; GROWTH; MOUSE; EXCITOTOXICITY; TRANSCRIPTION; HIPPOCAMPUS; INDUCTION	Cell stimulation which leads to degeneration triggers a prolonged wave of immediate early gene (IEG) transcription that correlates with neuronal demise. In order to determine the relevance of the prolonged IEG response to human traumatic brain injury, we analyzed IEG mRNA levels in brain tissue isolated following a controlled penetrating injury and an injection of the excitotoxin Quinolinic acid (QA), as well as from tissue recovered during routine neurosurgery for trauma. Total RNA was extracted from tissue and subjected to Northern analysis of IEG mRNAs (c-fos and zif/268). Both models produced rapid and prolonged waves of IEG transcription that appeared to correlate with the severity of injury. Increases in zif/268 mRNA were observed within 1 h with levels reaching their peak at 6 h following excitotoxic injury and 3 h following a controlled penetration. In general, human traumatic brain injury resulted in variable increases in IEG mRNA levels following traumatic injury with the largest IEC mRNA increases observed in tissue collected 0-10 h after injury. This post-injury time corresponds to the peak of the prolonged IEG response observed in rodents following excitotoxic injury. Comparisons were made in IEG response between rodent frontal cortex and human cortex, because the majority of the human tissue originated from the cerebral cortex. These results further support the hypothesis that prolonged IEG transcription serves as a marker of traumatic brain injury and may play a role in neurodegeneration and/or glial activation. Moreover, observations of similar IEC patterns of expression reinforces the importance of rodent models of brain injury providing useful information directly applicable to human brain injury.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA		Dutcher, SA (corresponding author), Univ Detroit, Ctr Hlth, Detroit Med Ctr, Dept Neurosurg, Suite 6E,4201 St Antoine, Detroit, MI 48201 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS030550] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30550] Funding Source: Medline		ALLEN IV, 1983, ACTA NEUROPATHOL, V59, P277, DOI 10.1007/BF00691493; BENEVISTE H, 1984, J NEUROCHEM, V43, P1369; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; Cooper PR, 1993, HEAD INJURY, P355; CURRAN T, 1983, MOL CELL BIOL, V3, P914, DOI 10.1128/MCB.3.5.914; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; DRAGUNOW M, 1994, MOL BRAIN RES, V25, P19, DOI 10.1016/0169-328X(94)90274-7; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Dutcher SA, 1998, J NEUROTRAUM, V15, P421, DOI 10.1089/neu.1998.15.421; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Goodman J. C., 1995, Journal of Neurotrauma, V12, P371; HERSCHMAN HR, 1989, TRENDS BIOCHEM SCI, V14, P455, DOI 10.1016/0968-0004(89)90105-9; HU RM, 1994, J CLIN INVEST, V93, P1820, DOI 10.1172/JCI117167; HUGHES P, 1995, PHARMACOL REV, V47, P133; KASOF GM, 1995, J NEUROSCI, V15, P4238; KONOPKA D, 1995, NEUROSCI LETT, V185, P167, DOI 10.1016/0304-3940(95)11252-R; LEWIS SA, 1984, P NATL ACAD SCI-BIOL, V81, P2743, DOI 10.1073/pnas.81.9.2743; OLNEY JW, 1990, ANNU REV PHARMACOL, V30, P47; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PAXINOS G, 1986, RAT BRAIN STEREOTAXI, P12; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; Sall JM, 1996, EXP NEUROL, V139, P257, DOI 10.1006/exnr.1996.0099; Shan Y, 1997, EXP NEUROL, V144, P406, DOI 10.1006/exnr.1997.6427; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; WALKER PD, 1993, J NEUROSCI RES, V36, P588, DOI 10.1002/jnr.490360511; WALKER PD, 1993, NEUROREPORT, V4, P699, DOI 10.1097/00001756-199306000-00024	31	28	28	0	1	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	APR	1999	21	3					234	242		10.1080/01616412.1999.11740924			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	191LH	WOS:000080023600001	10319329				2022-02-06	
J	Brambrink, AM; Ichord, RN; Martin, LJ; Koehler, RC; Traystman, RJ				Brambrink, AM; Ichord, RN; Martin, LJ; Koehler, RC; Traystman, RJ			Poor outcome after hypoxia-ischemia in newborns is associated with physiological abnormalities during early recovery - Possible relevance to secondary brain injury after head trauma in infants	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	IIIrd International Congress of Pathophysiology	JUN 28-JUL 03, 1998	LAHTI, FINLAND			brain injury, infants; head trauma; hypoxia, brain injury; ischemia, brain injury; newborns, brain injury	CEREBRAL BLOOD-FLOW; GLASGOW COMA SCALE; RAT-BRAIN; MILD HYPOTHERMIA; IMMATURE RAT; STATUS EPILEPTICUS; INTRACEREBRAL MICRODIALYSIS; INTRACRANIAL HYPERTENSION; INDUCED NEURODEGENERATION; SUBARACHNOID HEMORRHAGE	"Secondary hypoxia/ischemia" (i.e. regional impairment of oxygen and substrate delivery) results in secondary deterioration after traumatic brain injury in adults as well as in children and infants. However, detailed analysis regarding critical physiological abnormalities resulting from hppoxia/ischemia in the immature brain, e.g. acid-base-status, serum glucose levels and brain temperature, and their influence on outcome, are only available from non-traumatic experimental models. In recent studies on hypoxic/asphyxic cardiac arrest in neonatal piglets, we were able to predict short-term outcome using specific physiologic abnormalities immediately after the insult. Severe acidosis, low serum glucose levels and fever after resuscitation were associated with an adverse neurologic recovery one day after the insult. The occurrence of clinically apparent seizure activity during later recovery increased mortality (epileptic state), and survivors had greater neocortical and striatal brain damage. Brain damage after transient hypoxia/ischemia and "secondary brain injury" after head trauma may have some mechanistic overlap, and these findings on physiological predictors of outcome may also apply to pathologic conditions in the post-traumatic immature brain. Evaluation of data from other models of brain injury will be important to develop candidate treatment strategies for head-injured infants and children and may help to initiate specific studies about the possible role of these physiological predictors of brain damage in the traumatically injured immature brain.	Johannes Gutenberg Univ Mainz, Dept Anaesthesiol, D-55131 Mainz, Germany; Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Anaesthesiol & Crit Care Med, Baltimore, MD 21205 USA		Brambrink, AM (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anaesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	brambrin@mail.uni-mainz.de			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS020020] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 20020] Funding Source: Medline		*ACS COT, 1993, RES OPT CAR INJ PAT; Almeida A, 1996, PEDIATR RES, V40, P410, DOI 10.1203/00006450-199609000-00008; Alojado ES, 1996, ANESTH ANALG, V83, P1002; AUER RN, 1988, ANN NEUROL, V24, P699, DOI 10.1002/ana.410240602; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; Berg AT, 1997, J CLIN NEUROPHYSIOL, V14, P102, DOI 10.1097/00004691-199703000-00003; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; Brambrink A. M., 1996, Society for Neuroscience Abstracts, V22, P1938; BRUDER N, 1994, CRIT CARE MED, V22, P1114, DOI 10.1097/00003246-199407000-00011; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CATALTEPE O, 1995, PEDIATR RES, V38, P251, DOI 10.1203/00006450-199508000-00019; Cherian L, 1997, CRIT CARE MED, V25, P1378, DOI 10.1097/00003246-199708000-00027; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLANCY RR, 1997, FETAL NEONATAL BRAIN, P442; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; COLLINS RC, 1982, SCIENCE, V218, P177, DOI 10.1126/science.7123229; Conti AC, 1998, J NEUROSCI, V18, P5663; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FLOYD RA, 1997, PRIMER CEREBROVASCUL, P165; Fujisawa H, 1996, J NEUROTRAUM, V13, P245, DOI 10.1089/neu.1996.13.245; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; Goel V, 1996, IEEE T BIO-MED ENG, V43, P1083, DOI 10.1109/10.541250; GORDON E, 1971, ACTA ANAESTH SCAND, V15, P209, DOI 10.1111/j.1399-6576.1971.tb05462.x; HALL ED, 1997, PRIMER CEREBROVASCUL, P200; HATTORI H, 1990, ANN NEUROL, V28, P122, DOI 10.1002/ana.410280203; HAUN SE, 1995, GOLDEN HOUR HDB PEDI, P293; HAUSDORFER J, 1974, MED WELT, V25, P865; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HILLERED L, 1984, J CEREBR BLOOD F MET, V4, P430, DOI 10.1038/jcbfm.1984.62; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; Ikonomidou C, 1996, METAB BRAIN DIS, V11, P125, DOI 10.1007/BF02069500; JOHNSTON MV, 1986, PEDIATR NEUROSCI, V12, P87; KATSURA KI, 1997, PRIMER CEREBROVASCUL, P159; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kelly D F, 1995, New Horiz, V3, P453; Kempski O, 1997, J TRAUMA, V42, pS38, DOI 10.1097/00005373-199705001-00007; Kim H, 1996, STROKE, V27, P114, DOI 10.1161/01.STR.27.1.114; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; KUNIEVSKY B, 1994, DEV NEUROSCI-BASEL, V16, P313, DOI 10.1159/000112125; Laptook AR, 1997, PEDIATR RES, V42, P17, DOI 10.1203/00006450-199707000-00004; LAPTOOK AR, 1992, STROKE, V23, P1504, DOI 10.1161/01.STR.23.10.1504; LAPTOOK AR, 1994, BRAIN RES, V638, P78, DOI 10.1016/0006-8993(94)90635-1; LEBLANC MH, 1994, STROKE, V25, P1443, DOI 10.1161/01.STR.25.7.1443; LUDBROOK GL, 1997, HEAD INJURY PATHOPHY, P363; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARMAROU A, 1992, J NEUROTRAUM, V9, pS551; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Martin LJ, 1997, J COMP NEUROL, V377, P262, DOI 10.1002/(SICI)1096-9861(19970113)377:2<262::AID-CNE8>3.0.CO;2-1; Martin LJ, 1997, ANN NEUROL, V42, P335, DOI 10.1002/ana.410420310; MARTIN LJ, 1985, BRAIN RES, V325, P287, DOI 10.1016/0006-8993(85)90324-5; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; MCCALL AL, 1995, BRAIN RES, V670, P29, DOI 10.1016/0006-8993(94)01248-G; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MYERS RE, 1972, AM J OBSTET GYNECOL, V112, P246, DOI 10.1016/0002-9378(72)90124-X; Myers RE, 1977, INTRAUTERINE ASPHYXI, P37; NAWASHIRO H, 1994, ACTA NEUROCHIR, P440; NEVANDER G, 1985, ANN NEUROL, V18, P281, DOI 10.1002/ana.410180303; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; PASCHEN W, 1987, J NEUROCHEM, V48, P154, DOI 10.1111/j.1471-4159.1987.tb13140.x; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; REHNCRONA S, 1989, J CEREBR BLOOD F MET, V9, P65, DOI 10.1038/jcbfm.1989.9; REILLY P, 1997, HEAD INJURY, P385; SCHUBERT A, 1992, J NEUROSURG ANESTH, V4, P216, DOI 10.1097/00008506-199207000-00013; SHELDON RA, 1992, PEDIATR RES, V32, P489, DOI 10.1203/00006450-199210000-00022; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; SIESJO BK, 1985, J CEREBR BLOOD F MET, V5, P253, DOI 10.1038/jcbfm.1985.32; SIESJO BK, 1997, PRIMER CEREBROVASCUL, P223; Sirimanne ES, 1996, PEDIATR RES, V39, P591, DOI 10.1203/00006450-199604000-00005; SMITH RF, 1990, J TRAUMA, V30, P1066, DOI 10.1097/00005373-199009000-00002; TASKER RC, 1995, GOLDEN HOUR HDB PEDI, P217; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; THOMPSON CT, 1992, J TRAUMA, V32, P336, DOI 10.1097/00005373-199203000-00011; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; TREIMAN DM, 1997, J CLIN NEUROPHYSIOL, V14, P159; Trescher WH, 1997, BRAIN DEV-JPN, V19, P326, DOI 10.1016/S0387-7604(97)00027-2; UCHINO H, 1994, STROKE, V25, P1825, DOI 10.1161/01.STR.25.9.1825; Vannucci RC, 1997, PEDIATR RES, V42, P24, DOI 10.1203/00006450-199707000-00005; Vannucci RC, 1996, J CEREBR BLOOD F MET, V16, P1026, DOI 10.1097/00004647-199609000-00028; VANNUCCI RC, 1992, BIOL NEONATE, V62, P215; Vannucci SJ, 1996, J CEREBR BLOOD F MET, V16, P77, DOI 10.1097/00004647-199601000-00009; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Vink R, 1997, J CEREBR BLOOD F MET, V17, P50, DOI 10.1097/00004647-199701000-00007; VOORHIES TM, 1986, NEUROLOGY, V36, P1115, DOI 10.1212/WNL.36.8.1115; WAGNER KR, 1990, J CEREBR BLOOD F MET, V10, P417, DOI 10.1038/jcbfm.1990.72; *WAN DGAI, 1998, ANASTH INTENSIVMED, V7, P399; WASTERLAIN CG, 1990, NEONATAL SEIZURES, P69; WELCH FA, 1982, J CEREB BLOOD FLOW M, V2, P221; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; Yager JY, 1996, STROKE, V27, P919, DOI 10.1161/01.STR.27.5.919; Yanpeng L, 1996, J PERINAT MED, V24, P581, DOI 10.1515/jpme.1996.24.6.581; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG RSK, 1985, ANN NEUROL, V18, P291, DOI 10.1002/ana.410180304	111	28	28	0	1	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	FEB	1999	51	2					151	162		10.1016/S0940-2993(99)80089-X			12	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	177NZ	WOS:000079218000007	10192584				2022-02-06	
J	Benz, B; Ritz, A; Kiesow, S				Benz, B; Ritz, A; Kiesow, S			Influence of age-related factors on long-term outcome after traumatic brain injury (TBI) in children: A review of recent literature and some preliminary findings	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						pediatric TBI; age at injury; follow-up; post-traumatic development; long-term outcome	CLOSED HEAD-INJURY; FOLLOW-UP; SEQUELAE; ADOLESCENTS; OLDER	Cerebral plasticity of the immature brain is often inferred to Iced to less serious consequences of early traumatic brain injury (TBI) in the pediatric age group. This notion is seriously challenged by recent research findings. Data from prospective studies point to some children's difficulties in ongoing skill-acquisition and the possibility of late-emerging deficits. Accordingly, preliminary group data of an own ongoing study support the notion of an increased risk for pervasive neuropsychological impairment in subjects with severe TBI and early age at trauma. The pattern of neuropsychological deficits may depend on the developmental level at the time of injury, although effects of hemispheric site of lesion were also found to persist in individual cases. Theoretical considerations and empirical findings stress the importance of a longitudinal developmental perspective for the evaluation of long-term outcome after pediatric TBI.	NRZ Kinder & Jugendliche Friedehorst, D-28717 Bremen, Germany		Benz, B (corresponding author), NRZ Kinder & Jugendliche Friedehorst, Rotdornallee 64, D-28717 Bremen, Germany.	barbara.benz@t-online.de					Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BARTH JT, 1989, MILD HEAD INJURY, P255; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; BENZ B, 1996, FALLBUCH KLIN NEUROP, P241; Benz B, 1993, SPEKTRUM NEUROREHABI, P228; BENZ B, 1993, AKTUELLE NEUROPADIAT, P125; BENZ B, 1997, NEUROLOGISCHE GUTACH, P179; BENZ B, 1996, KINDH ENTWICKL, V5, P221; BOLL TJ, 1983, J CLIN CHILD PSYCHOL, V12, P74, DOI 10.1080/15374418309533114; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CASEY R, 1986, PEDIATRICS, V78, P497; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; DENCKLA M, 1995, TRAUMATIC HEAD INJUR, P3; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; JOHNSON DA, 1989, CHILDRENS HEAD INJUR, P96; Kleinpeter U, 1993, AKTUELLE NEUROPADIAT, P151; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KLUN B, 1993, SPEKTRUM NEUROREHABI, P208; Koelfen W, 1997, MONATSSCHR KINDERH, V145, P489, DOI 10.1007/s001120050147; KRAUS JF, 1987, PEDIATRICS, V79, P501; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; LEHMKUHL G, 1986, THESIS HEIDELBERG; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; MIDDLETON J, 1989, CHILDRENS HEAD INJUR, P96; PIORRECK S, 1993, SPEKTRUM NEUROREHABI, P256; RANTAKALLIO P, 1985, J EPIDEMIOL COMMUN H, V39, P353, DOI 10.1136/jech.39.4.353; RITZ A, 1993, AKTUELLE NEUROPADIAT, P181; RITZ A, 1997, HDB POSTTRAUMATISCHE, P108; RITZ A, 1993, PADIATR PRAX, V45, P237; Ritz A., 1993, SPEKTRUM NEUROREHABI, P208; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; SHAFFER D, 1995, TRAUMATIC HEAD INJUR, P55; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEUBER HL, 1967, DEV MED CHILD NEUROL, V4, P3; [No title captured]; [No title captured]	46	28	29	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		1999	14	2-3					135	141					7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	183XN	WOS:000079579700008					2022-02-06	
J	Farmer, JE; Haut, JS; Williams, J; Kapila, C; Johnstone, B; Kirk, KS				Farmer, JE; Haut, JS; Williams, J; Kapila, C; Johnstone, B; Kirk, KS			Comprehensive assessment of memory functioning following traumatic brain injury in children	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	103rd Annual Meeting of the American-Psychological-Association	AUG 11-15, 1995	NEW YORK, NEW YORK	Amer Psychol Assoc			CLOSED-HEAD-INJURY; ADOLESCENTS; SEQUELAE; COHORT	This study examined specific memory functions in 52 children with mild-moderate or severe traumatic brain injury (TBI) and 29 noninjured controls using the Wide Range Assessment of Memory and Learning (WRAML). Children's recall varied as a function of injury severity and task demands. The participants with severe brain injuries performed worse than controls on global measures of visual memory, learning, and general memory functioning, as well as on specific subtests measuring recall of contextual verbal information. Children with mild-moderate brain injuries performed similarly to controls except for poorer performance on 2 subtests measuring sound-symbol learning and recall of geometric designs. Results suggest that the WRAML provides clinically useful information and that specific aspects of memory processing need to be evaluated following childhood TBI.	Univ Missouri, Sch Med, Dept Phys Med & Rehabil, Columbia, MO 65211 USA; W Virginia Univ, Hlth Sci Ctr, Dept Behav Med & Psychiat, Morgantown, WV 26506 USA; Univ Arkansas Med Sci, Dept Pediat Psychol, Little Rock, AR 72205 USA		Farmer, JE (corresponding author), Rusk Rehabil Ctr, 501, Columbia, MO 65212 USA.			Johnstone, Brick/0000-0001-8845-9649			ADAMS W, 1991, 11 ANN M NAT AC NEUR; AYLWARD GP, 1995, J PSYCHOEDUC ASSESS, V13, P132, DOI 10.1177/073428299501300203; BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; Begali V., 1992, HEAD INJURY CHILDREN; CALLAHAN TSA, 1993, 101ST ANN M AM PSYCH; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Chapman S.B, 1995, TRAUMATIC HEAD INJUR, P95; Daniel W. W., 1990, APPL NONPARAMETRIC S, V2nd; Delis D, 1994, MANUAL CALIFORNIA VE; DENCKLA MB, 1994, ATYPICAL COGNITIVE D, P283; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; EWINGCOBBS L, 1996, 24 ANN M INT NEUR SO; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Fletcher JM, 1995, HDB PEDIAT PSYCHOL, P362; GIOIA G, 1991, 19 ANN M INT NEUR SO; HANNAY HJ, 1989, J CLIN EXP NEUROPSYC, V11, P444, DOI 10.1080/01688638908400905; HAUT JS, 1992, 12 ANN M NAT AC NEUR; JORDAN F M, 1992, Brain Injury, V6, P39, DOI 10.3109/02699059209008120; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; Savage R. C., 1994, ED DIMENSIONS ACQUIR; Sheslow D., 1990, MANUAL WIDE RANGE AS; TEASDALE G, 1974, LANCET, V2, P81; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1989, WECHSLER PRESCHOOL P; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WILLIAMS J, 1995, DEV NEUROPSYCHOL, V11, P201, DOI 10.1080/87565649509540613; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296	40	28	29	0	1	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		1999	15	2					269	289		10.1080/87565649909540749			21	Psychology, Developmental; Psychology; Psychology, Experimental	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	182YJ	WOS:000079525500006					2022-02-06	
J	Grady, MS; Cody, RF; Maris, DO; McCall, TD; Seckin, H; Sharar, SR; Winn, HR				Grady, MS; Cody, RF; Maris, DO; McCall, TD; Seckin, H; Sharar, SR; Winn, HR			P-selectin blockade following fluid-percussion injury: Behavioral and immunochemical sequelae	JOURNAL OF NEUROTRAUMA			English	Article						cell adhesion molecule; fluid-percussion injury; Morris water maze; neuroprotection; neutrophil migration; P-selectin; rats	TRAUMATIC BRAIN INJURY; ENDOTHELIAL ADHESION MOLECULES; CONTROLLED CORTICAL IMPACT; CLOSED HEAD-INJURY; NEUTROPHIL ACCUMULATION; REPERFUSION INJURY; CHOLINE-ACETYLTRANSFERASE; ISCHEMIA-REPERFUSION; RAT; DAMAGE	Traumatic brain injury (TBI) can cause polymorphonuclear leukocyte (PMN) migration into brain parenchyma, mediating various cytodestructive mechanisms. We examined the effect of blocking leukocyte/endothelial cell adhesion molecules (CAMs) on the anatomic and behavioral sequelae in lateral fluid-percussion injury in rats. Monoclonal antibodies (MAb) directed against a functional (PB1.3) or nonfunctional (PNB1.6) epitope on endothelial P-selectin were used as treatments. Subjects were tested in the Morris water maze (MWM) at 7 and 14 days postinjury then immunohistochemistry was performed using antibodies that recognize ChAT, GFAP and OX-42. A second set of animals underwent myeloperoxidase (MPO) assay in the brain parenchyma and a third set was used to examine neutrophil migration using the MAb RP-3. Time in quadrant, but not escape latency or proximity improved with PB1.3 (p < 0.05). Similarly, PB1.3 reduced MPO levels after injury (p < 0.05), in the ipsilateral cortex. No significant difference occurred in neutrophil counts in cortex, corpus callosum, hippocampus, and thalamus between injured only rats and injured rats treated with PB1.3. Quantitative analysis of cholinergic cells in the medial septum showed a protective effect by PB1.3. Densitometry readings of GFAP and OX-42 immunolabeling revealed no discernible differences between the treated and untreated injured rats. Qualitatively, there was no difference in microglia or astrocyte response to treatment. Treatment with P-selectin blockade in brain-injured rats may reduce PMN migration into brain, help preserve cholinergic immunolabeling of medial septal nucleus neurons, and may alleviate mnemonic deficits.	Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA; Univ Washington, Sch Med, Dept Anesthesia, Seattle, WA 98104 USA		Grady, MS (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, 325 9th Ave,Box 359766, Seattle, WA 98104 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030305, R01NS033107] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 33107, P50 NS30305] Funding Source: Medline		AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; ARSENIONUNES ML, 1973, ACTA NEUROPATHOL, V26, P329, DOI 10.1007/BF00688080; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; BRAUGHLER JM, 1987, J NEUROSURG, V67, P102, DOI 10.3171/jns.1987.67.1.0102; CAO W, 1988, NEUROSCI LETT, V88, P233, DOI 10.1016/0304-3940(88)90132-2; CARLOS TM, 1994, BLOOD, V84, P2068; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; CHIANG J, 1968, AM J PATHOL, V52, P455; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cody R. F., 1995, Society for Neuroscience Abstracts, V21, P1731; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DAVENPECK KL, 1994, AM J PHYSIOL, V267, pH622, DOI 10.1152/ajpheart.1994.267.2.H622; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Gibbs SAL, 1996, SURGERY, V119, P652, DOI 10.1016/S0039-6060(96)80189-9; GNAHN H, 1983, DEV BRAIN RES, V9, P45, DOI 10.1016/0165-3806(83)90107-4; GRAMMAS P, 1993, FREE RADICAL BIO MED, V14, P553, DOI 10.1016/0891-5849(93)90113-9; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HARLAN JM, 1992, ADHESION ITS ROLE IN, P117; HERNANDEZ LA, 1987, AM J PHYSIOL, V253, pH699, DOI 10.1152/ajpheart.1987.253.3.H699; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; Kochanek P M, 1993, Crit Care Med, V21, pS333, DOI 10.1097/00003246-199309001-00016; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Leonard JR, 1997, EXP NEUROL, V143, P177, DOI 10.1006/exnr.1996.6366; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MARTY S, 1991, NEUROSCIENCE, V45, P529, DOI 10.1016/0306-4522(91)90268-S; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLIGAN MS, 1992, J CLIN INVEST, V90, P1600, DOI 10.1172/JCI116029; OKADA Y, 1994, STROKE, V25, P202, DOI 10.1161/01.STR.25.1.202; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; ROSOMOFF HL, 1965, ARCH NEUROL-CHICAGO, V13, P337, DOI 10.1001/archneur.1965.00470040003001; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SEEKAMP A, 1994, AM J PATHOL, V144, P592; SHARAR SR, 1993, J IMMUNOL, V151, P4982; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; SIESJO BK, 1988, CRIT CARE MED, V16, P954, DOI 10.1097/00003246-198810000-00006; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Soares HD, 1995, J NEUROSCI, V15, P8223; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; Weiser MR, 1996, SHOCK, V5, P402, DOI 10.1097/00024382-199606000-00003; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; WHALEN MJ, 1997, J CEREB BLOOD FLOW M, V17, pS77; WINN RK, 1994, AM J PHYSIOL-HEART C, V267, pH2391, DOI 10.1152/ajpheart.1994.267.6.H2391; WINN RK, 1993, J CLIN INVEST, V92, P2042, DOI 10.1172/JCI116799; ZIMMERMAN J, 1986, CRITICAL CARE STATE, P281	59	28	34	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	1999	16	1					13	25		10.1089/neu.1999.16.13			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	162BL	WOS:000078325300002	9989463				2022-02-06	
J	Trombly, CA; Radomski, MV; Davis, ES				Trombly, CA; Radomski, MV; Davis, ES			Achievement of self-identified goals by adults with traumatic brain injury: Phase I	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; motivation; planning process, occupational therapy	REHABILITATION; REINTEGRATION; PROGRAM	Objective. This study sought to determine whether persons with traumatic brain injury who received outpatient occupational therapy services achieved self-identified goals related to tasks of daily life. Method. Sixteen participants completed the study Occupational therapists used their usual treatment procedures to restore independence in home and community occupational functioning. The Canadian Occupational Performance Measure identified the five most important problems that interfered with independence in the roles the participant valued as well as the participant's perception of performance ability and satisfaction with performance. Coal Attainment Scaling documented achievement of the five self-identified goals. The independent Living Skills Evaluation (ILSE) and the Reintegration to Normal Living Scale (RNL) measured changes in overall instrumental activities of daily living and community reintegration. Results. The participants significantly achieved (p <.001) their goals from admission to discharge, rated themselves as performing significantly better (p <.001), and were significantly more satisfied (P =.001) with performance after treatment than before. Additionally they improved significantly on the ILSE (p <. 001) and the RNL (p <.001) from admission to discharge. There were no significant changes in perfoemance from discharge to follow-up on any of the scales. Conclusion. Although causality cannot be inferred, it can be concluded that participants attending outpatient occupational therapy significantly improved, and improvements were sustained after discharge, but no further improvement occurred spontaneously.	Boston Univ, Sargent Coll Hlth & Rehabil Sci, Dept Occupat Therapy, Boston, MA 02215 USA; Sister Kenny Inst, Outpatient Brain Injury Program, Minneapolis, MN USA		Trombly, CA (corresponding author), Boston Univ, Sargent Coll Hlth & Rehabil Sci, Dept Occupat Therapy, 635 Commonwealth Ave, Boston, MA 02215 USA.						ASHER IA, 1989, ANNOTATED INDEX OCCU; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Cohen J., 2013, STAT POWER ANAL BEHA; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; DUNCAN PW, 1990, REHABILITATION ADULT, P264; ELOVIC E, 1996, MED REHABILITATION T, P1; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Heinemann AW, 1990, J NEUROL REHABIL, V4, P27; HELLMAN S, 1991, NEW ENGL J MED, V324, P1585, DOI 10.1056/NEJM199105303242208; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JOHNSON TP, 1980, OCCUPATIONAL THERAPY, V1, P5; JOHNSTON MV, 1994, ARCH PHYSICAL MED RE, V75, P2; JOHNSTON MV, 1996, MED REHABILITATION T, P197; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; Law M., 1994, CANADIAN OCCUPATIONA, V2; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; MAHONEY F I, 1965, Md State Med J, V14, P61; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; MALKMUS D, 1980, REHABILITATION HEAD; Nelson DL, 1996, AM J OCCUP THER, V50, P223, DOI 10.5014/ajot.50.3.223; OTTENBACHER KJ, 1990, AM J OCCUP THER, V44, P519, DOI 10.5014/ajot.44.6.519; PANIKOFF LB, 1983, AM J OCCUP THER, V37, P735, DOI 10.5014/ajot.37.11.735; Rosenthal R, 1991, ESSENTIALS BEHAV RES, V2nd; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Scott A.D., 1995, OCCUPATIONAL THERAPY, P705; SMIGIELSKI JS, 1992, MAYO CLIN PROC, V67, P767, DOI 10.1016/S0025-6196(12)60802-7; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951; WOODDAUPHINEE S, 1987, J CHRON DIS, V40, P491, DOI 10.1016/0021-9681(87)90005-1; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583; ZWEBER B, 1990, Occupational Therapy in Health Care, V7, P45, DOI 10.1080/J003v07n01_05	32	28	28	0	3	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	NOV-DEC	1998	52	10					810	818		10.5014/ajot.52.10.810			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	141JJ	WOS:000077139800006					2022-02-06	
J	Hogg, S; Sanger, DJ; Moser, PC				Hogg, S; Sanger, DJ; Moser, PC			Mild traumatic lesion of the right parietal cortex in the rat: Characterisation of a conditioned freezing deficit and its reversal by dizocilpine	BEHAVIOURAL BRAIN RESEARCH			English	Article						cerebral trauma; context; conditioned emotional response; dizocilpine; MK-801	CLOSED-HEAD-INJURY; PERCUSSION BRAIN INJURY; CONTEXTUAL FEAR; BILATERAL LESIONS; HIPPOCAMPUS; INFORMATION; IMPAIRMENT; ATTENTION; AMYGDALA; MEMORY	We have previously demonstrated that traumatic injury of the lateral aspect of the right parietal cortex results in reduced acquisition of the passive avoidance task but enhanced learning in an active avoidance procedure. In order to try to explain the apparent dichotomy between these findings a series of experiments examined the effect of fluid percussion-induced traumatic brain injury (FP-TBI) on the conditioned freezing response to a context previously paired with an aversive stimulus. Rats subjected to FP-TBI displayed less conditioned freezing than the sham-operated controls. This effect was particularly marked when the delay between context exposure and footshock was short (less than or equal to 30 s) and was no longer significant when this delay was 3 min, indicating that the injured animals did not have an impaired freezing response per se. This phenomenon was enduring such that it could still be observed 2 months following the surgery. There was no significant freezing deficit after FP-TBI of the motor cortex, demonstrating that the site of injury is important and that the freezing deficit is not a general response to CNS trauma. The NMDA receptor antagonist dizocilpine (MK-801: 1 mg/kg i.v.) significantly reduced the trauma-induced freezing deficit when administered as a single bolus 15 min prior to the surgery, or as three repeated treatments (3 x 0.33 mg/kg) 15 min, and 6 and 24 h following lesion. The trauma-induced deficit in conditioned freezing can explain the differences in active and passive avoidance behaviours and appears to be specific to lesion of the lateral parietal cortex. In addition, the behavioural deficit can be attenuated using the neuroprotective agent dizocilpine, suggesting that it may prove useful as a sensitive and specific measure of cortical damage following traumatic injury. (C) 1998 Elsevier Science B.V. All rights reserved.	Synthelabo Rech, F-92500 Rueil Malmaison, France; Synthelabo Rech, F-92220 Bagneux, France		Moser, PC (corresponding author), Synthelabo Rech, 10 Rue Carrieres, F-92500 Rueil Malmaison, France.			Moser, Paul/0000-0002-6887-3508			BEVINS RA, 1995, ANIM LEARN BEHAV, V23, P400, DOI 10.3758/BF03198940; BLANCHARD RJ, 1976, B PSYCHONOMIC SOC, V8, P129, DOI 10.3758/BF03335103; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; CROWNE DP, 1987, BEHAV NEUROSCI, V101, P134, DOI 10.1037/0735-7044.101.1.134; CROWNE DP, 1992, BEHAV NEUROSCI, V106, P808, DOI 10.1037/0735-7044.106.5.808; CROWNE DP, 1986, BEHAV BRAIN RES, V22, P227, DOI 10.1016/0166-4328(86)90067-7; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; DRISCOLL P, 1983, GENETICS BRAIN, P95; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853; Frysztak RJ, 1991, CEREB CORTEX, V1, P418, DOI 10.1093/cercor/1.5.418; GOOD M, 1991, BEHAV NEUROSCI, V105, P499, DOI 10.1037/0735-7044.105.4.499; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HIRAKAWA M, 1994, STROKE, V25, P2471, DOI 10.1161/01.STR.25.12.2471; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; HOGG S, 1997, BEHAV BRAIN RES; Holm Soren, 1993, Acta Neurobiologiae Experimentalis (Warsaw), V53, P569; KEMP JA, 1987, TRENDS NEUROSCI, V10, P294, DOI 10.1016/0166-2236(87)90176-7; KIERNAN MJ, 1993, Q J EXP PSYCHOL-B, V46, P271, DOI 10.1080/14640749308401089; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KING VR, 1992, BEHAV BRAIN RES, V50, P53; Kraemer PJ, 1996, BRAIN RES BULL, V39, P17, DOI 10.1016/0361-9230(95)02028-4; LANDEIRAFERNANDEZ J, 1995, ANIM LEARN BEHAV, V23, P335, DOI 10.3758/BF03198930; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; LORENZINI CA, 1991, PHYSIOL BEHAV, V49, P765, DOI 10.1016/0031-9384(91)90316-G; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MAIER SE, 1993, BEHAV BRAIN RES, V56, P31, DOI 10.1016/0166-4328(93)90020-Q; MCINTOSH T, 1988, NEUROL NEUR, V46, P653; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Miller E, 1970, Cortex, V6, P121; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; PETERSEN SE, 1989, EXP BRAIN RES, V76, P267; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1995, J NEUROSCI, V15, P5308; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; POLSTER MR, 1994, CORTEX, V30, P487, DOI 10.1016/S0010-9452(13)80344-9; POSNER MI, 1984, J NEUROSCI, V4, P1863; RAPCSAK SZ, 1994, CORTEX, V30, P565, DOI 10.1016/S0010-9452(13)80236-5; ROBERTSON LC, 1988, J NEUROSCI, V8, P3757; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; STOEHR JD, 1995, PSYCHOBIOLOGY, V23, P173; Tortella FC, 1996, NEUROPHARMACOLOGY, V35, P441, DOI 10.1016/0028-3908(95)00190-5; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; TROMP E, 1991, J CLIN EXP NEUROPSYC, V13, P821, DOI 10.1080/01688639108405100; UEKI A, 1994, J NEUROL SCI, V125, P14, DOI 10.1016/0022-510X(94)90236-4; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; WILSON A, 1995, BEHAV NEUROSCI, V109, P828, DOI 10.1037/0735-7044.109.5.828; Yamaguchi T, 1996, NEUROPHARMACOLOGY, V35, P329, DOI 10.1016/0028-3908(95)00171-9	56	28	32	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUN	1998	93	1-2					157	165		10.1016/S0166-4328(97)00145-9			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	ZX806	WOS:000074557300017	9659997				2022-02-06	
J	Johnson, R				Johnson, R			How do people get back to work after severe head injury? A 10 year follow-up study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; EMPLOYMENT; RETURN; REHABILITATION; PROGRAM	Sixty four patients, who were previously followed up about 3 years, 6 months post-injury, were investigated again 10 years or more after very severe head injury (post-traumatic amnesia more than 7 days). Of the total, 42% had re-established themselves in employment, a further 20% showed an irregular pattern of work, and the remainder had made little or no attempt to work at all. There were few changes in work status once 18 months to 2 years had elapsed since the injury, and the pattern of employment, once established, tended to remain stable. Settlement of compensation claims did not lead to improvement in work status, and in several cases the converse was true. The first follow-up study showed that support and "in vivo" training at work was essential in helping people back to work, and this could be effective even when there had been a severe brain injury with permanent disability. The longer term follow-up of these patients gave further support to the view that a gradual and supported return to work is essential after severe brain injury if a return to stable employment is to be achieved. A number of guidelines are identified which can help people return to work.	Addenbrookes Hosp, Dept Clin Neuropsychol, Lewin Rehabil Unit, Cambridge CB2 2QQ, England								Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CAIRNS H, 1942, P ROY SOC MED, V35, P299; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; GODFREY HPD, 1993, NEW ZEAL MED J, V106, P301; Greenwood R. J., 1993, CLIN REHABIL, V7, P248; HUMPHREY M, 1980, INJURY, V12, P107, DOI 10.1016/0020-1383(80)90133-3; Johnson R, 1987, Int Disabil Stud, V9, P49; JOHNSON R, 1987, INJURY, V18, P7, DOI 10.1016/0020-1383(87)90374-3; JOHNSON R, 1989, INJURY, V20, P5, DOI 10.1016/0020-1383(89)90034-X; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; JOHNSON RP, 1987, CLIN REHABIL, V1, P319; Kreutzer J S, 1991, Int Disabil Stud, V13, P162; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; McMillan T. M., 1993, CLIN REHABIL, V7, P346; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER H, 1965, LANCET, V1, P225; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; ODDY M, 1984, CLOSED HEAD INJURY P, P108; Office of Population Censuses and Surveys (OPCS), 1980, CLASS OCC; PARENTE R, 1991, J HEAD TRAUMA REHAB, V6, P35; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; ROBERTS AH, 1976, P ROY SOC MED, V69, P137, DOI 10.1177/003591577606900228; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; WELLER MPI, 1985, RECENT ADV CLIN PSYC, V5, P245; WEST M, 1991, ARCH PHYS MED REHAB, V72, P127	33	28	28	0	5	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN	1998	8	1					61	79		10.1080/713755552			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	YW987	WOS:000071994900005					2022-02-06	
J	Phillips, LL; Lyeth, BG; Hamm, RJ; Reeves, TM; Povlishock, JT				Phillips, LL; Lyeth, BG; Hamm, RJ; Reeves, TM; Povlishock, JT			Glutamate antagonism during secondary deafferentation enhances cognition and axo-dendritic integrity after traumatic brain injury	HIPPOCAMPUS			English	Article						neuroexcitation; deafferentation; spatial memory; receptor antagonists	COMBINED FLUID PERCUSSION; LONG-TERM POTENTIATION; ENTORHINAL CORTICAL LESION; RAT DENTATE GYRUS; NEUROTROPHIC FACTOR; MESSENGER-RNA; SYNAPTOPHYSIN IMMUNOREACTIVITY; HIPPOCAMPAL-NEURONS; CORTEX LESIONS; C-FOS	The combination of central fluid percussion traumatic brain injury (TBI) followed 24 h later by a bilateral entorhinal cortical deafferentation (BEG) produces profound cognitive morbidity. We recently showed that MK-801 given prior to TBI in this insult improved spatial memory for up to 15 days. In the present study we examine whether MK-801 treatment of the BEG component in the combined insult model affects cognitive recovery. Two strategies for drug treatment were tested. Fifteen minutes prior to the BEC lesion in the combined insult, rats were given i.p. doses of either 3 mg/kg (acute group) or 1 mg/kg (chronic group) MK-801. The acute group received no further injections, whereas the chronic group received 1 mg/kg MK-801 i.p, twice a day for 2 days post-BEG lesion. Two additional groups of animals received BEC lesion alone and either acute or chronic MK-801 treatment identical with the combined insult cases. Each group was then assessed for spatial memory deficits with the Morris water maze at days 11-15 and 60-64 postinjury. Both acute and chronic MK-801 treatment in the combined insult group significantly reduced spatial memory deficits at 15 days postinjury relative to untreated injured cases (P < .01). This reduction appeared more robust at 15 days and persisted for up to 64 days in the chronically treated group (P <.05). By contrast, neither acute nor chronic MK-801 treatment affected memory performance with the BEC insult alone. Immunocytochemical localization of parvalbumin showed that chronic administration of MK-801 in the combined insult cases attenuated the injury-induced dendritic atrophy of inhibitory neurons in the dentate gyrus and area CA1. Synaptophysin immunobinding revealed that chronic MK-801 treatment of the BEC component of the combined insult normalized the distribution of presynaptic terminals within the dentate gyrus. These results suggest that cognitive deficits produced by head trauma involving both neuroexcitation and deafferentation can be attenuated with chronic application of glutamatergic antagonists during the period of deafferentation injury and that this attenuation is correlated with axo-dendritic integrity. Hippocampus 1998;8:390-407. (C) 1998 Wiley-Liss, Inc.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Psychol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Anat, Richmond, VA 23298 USA		Phillips, LL (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, POB 980693,MCV Stn, Richmond, VA 23298 USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995, P50NS012587, P01NS012587, R01NS020193] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 20193, NS 29995, NS 12587] Funding Source: Medline		Alexi T, 1997, NEUROSCIENCE, V78, P73, DOI 10.1016/S0306-4522(97)83046-1; BURGOS I, 1995, BRAIN RES, V692, P154, DOI 10.1016/0006-8993(95)00696-N; CALBAKA LM, 1992, NEUROBIOL AGING, V13, P283; CASTREN E, 1993, EXP NEUROL, V122, P244, DOI 10.1006/exnr.1993.1124; CLUSMANN H, 1994, NEUROSCIENCE, V61, P805, DOI 10.1016/0306-4522(94)90403-0; CONNER JM, 1994, J COMP NEUROL, V345, P409, DOI 10.1002/cne.903450307; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FUKUDA T, 1990, J COMP NEUROL, V302, P100, DOI 10.1002/cne.903020108; GIOVANNINI MG, 1994, J NEUROSCI, V14, P1358, DOI 10.1523/JNEUROSCI.14-03-01358.1994; GLOBUS MYT, 1991, NEUROSCI LETT, V127, P39, DOI 10.1016/0304-3940(91)90889-2; Gordon D. E., 1996, Society for Neuroscience Abstracts, V22, P2153; GUTHRIE KM, 1995, J COMP NEUROL, V352, P147, DOI 10.1002/cne.903520111; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAMM RJ, 1994, J NEUROSURG, V81, P267, DOI 10.3171/jns.1994.81.2.0267; HAUSINGER A, 1995, NEUROREPORT, V6, P637, DOI 10.1097/00001756-199503000-00013; HAYES RL, 1992, J NEUROTRAUMA S1, V9, P173; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; HUGHES P, 1993, NEUROREPORT, V4, P183, DOI 10.1097/00001756-199302000-00017; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Keppel G., 1991, DESIGN ANAL RES HDB; KESEBERG U, 1995, BEHAV BRAIN RES, V67, P255, DOI 10.1016/0166-4328(94)00156-A; Lee MY, 1997, J NEUROSCI, V17, P1137; LOESCHE J, 1977, BRAIN RES BULL, V2, P31, DOI 10.1016/0361-9230(77)90022-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; MATTSON MP, 1988, NEURON, V1, P865, DOI 10.1016/0896-6273(88)90134-1; MATTSON MP, 1989, BRAIN RES, V478, P337, DOI 10.1016/0006-8993(89)91514-X; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MIYAZAWA T, 1993, ACTA NEUROPATHOL, V85, P526; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; NITSCH R, 1992, P NATL ACAD SCI USA, V89, P5197, DOI 10.1073/pnas.89.11.5197; NITSCH R, 1993, HIPPOCAMPUS, V3, P247; NORUSIS MJ, SPSS WINDOWS ADV STA; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; PerezNavarro E, 1996, NEUROSCIENCE, V75, P345, DOI 10.1016/0306-4522(96)00336-3; Phillips LL, 1997, J NEUROSCI RES, V49, P197; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; PHILLIPS LL, 1994, NEUROSCIENCE, V58, P503, DOI 10.1016/0306-4522(94)90076-0; PHILLIPS LL, 1995, J NEUROTRAUM, V12, P964; Povlishock John T., 1995, P504; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; Rossner S, 1996, J NEUROSCI RES, V45, P40; Schultz LM, 1997, NEUROSCIENTIST, V3, P226, DOI 10.1177/107385849700300410; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; Shi L. Z., 1995, Yaoxue Xuebao, V30, P789; STROEMER RP, 1992, NEUROSCI LETT, V147, P21, DOI 10.1016/0304-3940(92)90765-Y; Takei N, 1997, J NEUROCHEM, V68, P370; TOMASULO RA, 1991, BRAIN RES, V561, P27, DOI 10.1016/0006-8993(91)90745-H; Wilson DA, 1996, BRAIN RES, V719, P62, DOI 10.1016/0006-8993(96)00083-2; WILSON RC, 1981, J NEUROPHYSIOL, V46, P324, DOI 10.1152/jn.1981.46.2.324; Xing J, 1996, J NEUROPHYSIOL, V75, P184, DOI 10.1152/jn.1996.75.1.184; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037; [No title captured]	56	28	30	0	2	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	1050-9631			HIPPOCAMPUS	Hippocampus		1998	8	4					390	401		10.1002/(SICI)1098-1063(1998)8:4<390::AID-HIPO7>3.3.CO;2-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	116PC	WOS:000075732900007	9744424				2022-02-06	
J	Tate, R; Simpson, G; Flanagan, S; Coffey, M				Tate, R; Simpson, G; Flanagan, S; Coffey, M			Completed suicide after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disability; neuropsychological impairment; suicide; traumatic brain injury	CLOSED-HEAD-INJURY; FOLLOW-UP; ADJUSTMENT	Suicide ideation and behaviors after traumatic brain injury (TBI) pose a dire, albeit infrequent, clinical emergency. The literature on suicide after TBI is sparse, but that on suicide in the general population may have limited applicability. Persons with TBI frequently experience impairments and disabilities that introduce additional complexities to the management of suicidality in this population. The current study examines in detail the premorbid psychosocial variables, injury details, and posttraumatic sequelae of eight completed suicides after TBI. The eight suicides were among 50 deaths occurring in 896 admissions to a regional brain injury rehabilitation service over a period of 18 years. The most notable feature of the group was the presence of psychiatric and emotional symptomatology in most cases, superimposed on a range of neuropsychological impairments. This combination imposed major limitations on the subjects' psychosocial reintegration, and we propose that it was in this context that they were vulnerable to suicide. The article concludes with recommendations for clinical management of people who exhibit suicide ideation or make suicide attempts after TBI.	LIVERPOOL HOSP,BRAIN INJURY REHABIL UNIT,LIVERPOOL,MERSEYSIDE,ENGLAND; BANKSTOWN LIDCOMBE MENTAL HLTH SERV,SYDNEY,NSW,AUSTRALIA		Tate, R (corresponding author), UNIV SYDNEY,DEPT PSYCHOL A16,SYDNEY,NSW 2006,AUSTRALIA.		Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060			ACHTE KA, 1971, ACTA PSYCHIAT SCAN S, V225, P1; *AUSTR BUR STAT, 1993, CAUS DEATH; BARRACLOUGH B, 1974, BRIT J PSYCHIAT, V125, P355, DOI 10.1192/bjp.125.4.355; BECK AT, 1979, COGNITIVE THERAPY DE; BONGAR B, 1991, SUICIDAL PATIENT CLI; BROE GA, 1992, BRAIN IMPAIRMENT; EAMES P, 1990, REHABILITATION ADULT; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; KLONOFF PS, 1995, J HEAD TRAUMA REHAB, V10, P16, DOI 10.1097/00001199-199512000-00005; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ROY A, 1982, BRIT J PSYCHIAT, V141, P171, DOI 10.1192/bjp.141.2.171; SCHNEIDMAN ES, 1989, SUICIDE UNDERSTANDIN; SCHOTTE DE, 1987, J CONSULT CLIN PSYCH, V55, P49, DOI 10.1037/0022-006X.55.1.49; STENAGER EN, 1992, J NEUROL NEUROSUR PS, V55, P542, DOI 10.1136/jnnp.55.7.542; STENAGER EN, 1992, ARCH NEUROL-CHICAGO, V49, P1296, DOI 10.1001/archneur.1992.00530360098025; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; [No title captured]; [No title captured]	23	28	28	0	3	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1997	12	6					16	28		10.1097/00001199-199712000-00003			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YK459	WOS:A1997YK45900003					2022-02-06	
J	LeesHaley, PR; Williams, CW; Zasler, ND; Marguilies, S; English, LT; Stevens, KB				LeesHaley, PR; Williams, CW; Zasler, ND; Marguilies, S; English, LT; Stevens, KB			Response bias in plaintiffs' histories	BRAIN INJURY			English	Article								This study investigated response bias in self-reported history of factors relevant to the assessment of traumatic brain injury, toxic brain injury and related emotional distress. Response bias refers to systematic error in self-report data. A total of 446 subjects (comprising 131 litigating and 315 non-litigating adults from five locations in the United States) completed a symptom questionnaire. Data were obtained from university faculty and students, from patients in clinics specializing in physiatry, neurology, and family medicine, and from plaintiffs undergoing forensic neuropsychological evaluations. Comparisons were made for litigant and non litigant ratings of their past and current cognitive and emotional functioning, including life in general, ability to concentrate, memory, depression, anxiety, alcohol, drugs, ability to work or attend school, irritability, headaches, confusion, self-esteem, and fatigue. Although there is no basis for hypothesizing plaintiffs to be healthier than the general population, plaintiffs rated their pre-injury functioning superior to non-plaintiffs. These findings suggest that response biases need to be taken into account by forensic examiners when relying on litigants' self-reports of pre-injury status.	LEES HALEY PSYCHOL CORP,WOODLAND HILLS,CA; NATL NEUROREHABIL CONSORTIUM INC,RICHMOND,VA; HLTH EDUC SERV,HUNTSVILLE,AL; UNIV KENTUCKY,COLL EDUC,DEPT SPECIAL EDUC & REHABIL COUNSELING,LEXINGTON,KY								Bartlett FC, 1932, REMEMBERING; BRUNER JS, 1957, PSYCHOL REV, V64, P123, DOI 10.1037/h0043805; EICH E, 1985, PAIN, V23, P375, DOI 10.1016/0304-3959(85)90007-7; FEINSTEIN AR, 1982, NEW ENGL J MED, V307, P1611, DOI 10.1056/NEJM198212233072604; FEINSTEIN AR, 1979, J CHRON DIS, V18, P35; Fiske S. T., 1991, SOCIAL COGNITION, V2nd; GEHLBACH SH, 1983, INTERPRETING MED LIT; GOETHALS GR, 1973, J EXP PSYCHOL, V9, P491, DOI 10.1016/0022-1031(73)90030-9; KULIK JA, 1986, J PERS SOC PSYCHOL, V50, P587, DOI 10.1037/0022-3514.50.3.587; LEESHALEY PR, PSYCHOL REP, V79, P811; Markus H., 1985, HDB SOCIAL PSYCHOL, V1, P137; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; ROSS M, 1989, PSYCHOL REV, V96, P341, DOI 10.1037/0033-295X.96.2.341; Rothman KJ, 1986, MODERN EPIDEMIOLOGY; SWANN WB, 1981, J EXP SOC PSYCHOL, V17, P351, DOI 10.1016/0022-1031(81)90043-3; SWANN WB, 1981, J PERS SOC PSYCHOL, V41, P1119, DOI 10.1037/0022-3514.41.6.1119; SWANN WB, 1984, PSYCHOL PERSPECTIVES, P33; TAYLOR SE, 1981, SOCIAL COGNITION ONT, P89; Turk DC, 1988, REASONING INFERENCE	19	28	28	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV	1997	11	11					791	799					9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YA149	WOS:A1997YA14900003	9354256				2022-02-06	
J	AbouHamden, A; Blumbergs, PC; Scott, G; Manavis, J; Wainwright, H; Jones, N; McLean, J				AbouHamden, A; Blumbergs, PC; Scott, G; Manavis, J; Wainwright, H; Jones, N; McLean, J			Axonal injury in falls	JOURNAL OF NEUROTRAUMA			English	Article						falls; human head injury; axonal injury; amyloid precursor protein; axonal injury score; hypoxia-ischemia	AMYLOID PRECURSOR PROTEIN; ACUTE SUBDURAL-HEMATOMA; CLOSED-HEAD-INJURY; HUMAN BRAIN; TRAUMATIC COMA; LEUKO-ARAIOSIS; BETA-APP; LESIONS; DAMAGE; IMMUNOREACTIVITY	Amyloid precursor protein (APP) immunocytochemistry was used as a marker for axonal injury (AI) in a series of 16 cases of head trauma associated with fatal falls. Nine cases were falls from not more than the person's own height (falls from less than or equal to own height) and seven cases were falls from a distance greater than the person's own height (falls from > own height). AI was recorded on a series of line diagrams of standard brain sections divided into 116 sectors. AI around focal lesions (infarcts, hemorrhages, contusions) was distinguished from nonfocal axonal injury that was distant from any focal area of damage. The percentage of sectors showing focal AI provided the Focal Axonal Injury Score (FAIS) and the percentage showing nonfocal AI the Non-Focal Axonal Injury Score (NFAIS). The FAIS is a measure of secondary AI and the NFAIS of diffuse axonal injury (DAI). The percentage of sectors involved with AI (focal and nonfocal) provided the cumulative Axonal Injury Score (AIS). A semiquantitative grading system was also used to assess the severity of axonal injury in each sector and the sum of the grades from all sectors was expressed as a percentage to provide the Axonal Injury Severity Score (AISS). Widespread AI was present in all cases irrespective of the height of the fall. AI was present in the midbrain (94%), pens (94%), corpus callosum (100%), central grey matter (100%), and cerebral hemispheric white matter (94%). AIS ranged from 10 to 94 in falls from less than or equal to own height (mean 73) and from 38 to 92 in falls from > own height (mean 82). AISS ranged from 6 to 95 in falls from less than or equal to own height (mean 65) and 28 to 95 in falls from > own height (mean 72). There was no statistically significant difference in AIS or AISS between the two groups. The extent and severity of AI cannot be predicted from biomechanical data, such as the height of the fall, as the total AI in a given case is a variable mixture of Nonfocal AI (DAI) and Focal AI arising dy secondary mechanisms, and APP immunostaining is unable to distinguish primary from secondary AI. However, the combination of the Hypoxic-Ischemic Score (HIS) defined as the percentage of sectors showing any hypoxic-ischemic damage ranging from neuronal ''red cell change'' to infarction in conjunction with the FAIS and NFAIS provided a measure of the relative contribution of primary and secondary AI in a given brain.	UNIV ADELAIDE,DEPT NEUROSURG,ADELAIDE,SA,AUSTRALIA; UNIV ADELAIDE,ROAD ACCIDENT RES UNIT,NH & MRC,ADELAIDE,SA,AUSTRALIA		AbouHamden, A (corresponding author), INST MED & VET SCI,NEUROPATHOL LAB,POB 14,RUNDLE MALL,ADELAIDE,SA 5000,AUSTRALIA.						ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1986, J NEUROL NEUROSUR PS, V49, P1039, DOI 10.1136/jnnp.49.9.1039; ADAMS JH, 1985, CENTRAL NERVOUS SYST, P65; ADAMS JH, 1992, GREENFIELDS NEUROPAT, P122; ADAMS JH, 1986, ACTA PATHOL LAB MED, V100, P485; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; COCHRAN E, 1991, AM J PATHOL, V139, P485; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; GULTEKIN BH, 1994, ARCH PATHOL LAB MED, V188, P168; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; HEDREEN JC, 1994, J NEUROPATH EXP NEUR, V53, P663, DOI 10.1097/00005072-199411000-00013; HONKANEN R, 1991, INJURY, V22, P225, DOI 10.1016/0020-1383(91)90047-I; IMAJO T, 1992, AM J FOREN MED PATH, V13, P169; JONES NR, 1986, AUST NZ J SURG, V56, P907, DOI 10.1111/j.1445-2197.1986.tb01853.x; KAWAMURA J, 1991, STROKE, V22, P609, DOI 10.1161/01.STR.22.5.609; KOBARI M, 1990, ARCH NEUROL-CHICAGO, V47, P161, DOI 10.1001/archneur.1990.00530020061017; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVI L, 1990, ISRAEL J MED SCI, V26, P555; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MIKLOSSY J, 1991, J NEUROPATH EXP NEUR, V50, P1, DOI 10.1097/00005072-199101000-00001; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; North JB, 1991, P INT RES COUNC BIOK, P77; OHGAMI T, 1992, NEUROSCI LETT, V136, P75, DOI 10.1016/0304-3940(92)90651-M; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; RICHARDS T, 1974, SURGERY, V75, P253; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; SHIGEMATSU K, 1992, AM J PATHOL, V140, P787; SIESJO BK, 1985, CENTRAL NERVOUS SYST, P513; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; SUENAGA T, 1994, ACTA NEUROPATHOL, V87, P450; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; YAMAKI T, 1992, ACTA NEUROCHIR, V119, P153, DOI 10.1007/BF01541800; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121	54	28	28	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	1997	14	10					699	713		10.1089/neu.1997.14.699			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YE057	WOS:A1997YE05700002	9383089				2022-02-06	
J	Prough, DS; Lang, J				Prough, DS; Lang, J			Therapy of patients with head injuries: Key parameters for management	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	14th Bodensee Symposium on Microcirculation: Small Volume Resuscitation in Head Injury	JUN 14-16, 1996	BODENSEE, GERMANY				CEREBRAL BLOOD-FLOW; HYPERTONIC FLUID RESUSCITATION; 7.5-PERCENT SODIUM-CHLORIDE; RANDOMIZED CLINICAL-TRIAL; SYSTEMIC OXYGEN DELIVERY; CRITICALLY ILL PATIENTS; TRAUMATIC BRAIN INJURY; HEMORRHAGIC-SHOCK; INTRACRANIAL-PRESSURE; AGGRESSIVE TREATMENT	Background: Secondary brain injury, presumed secondary to ischemia, increases the mortality and morbidity of traumatic brain injury. Although many mechanisms appear to be involved, many potential ischemic insults result from changes in readily observable physiologic variables. Methods: A focused search of scientific articles published in English to determine what data are available to suggest parameters within which key physiologic variables should be maintained. Results: Few data demonstrate that maintenance of variables within specific ranges alters outcome; however, considerable evidence establishes associations with poor outcome and hypotension, intracranial hypertension, and cerebral venous saturation. Key parameters vary somewhat based upon the phase of treatment after injury. Other variables, such as systemic oxygen delivery and brain saturation measured by near-infrared spectroscopy, are less well linked to outcome. Conclusions: Further research is necessary to establish that manipulation of physiologic variables to maintain them within preset ranges improves outcome.			Prough, DS (corresponding author), UNIV TEXAS, MED BRANCH, DEPT ANESTHESIOL, GALVESTON, TX 77555 USA.		Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X			BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BISHOP MH, 1995, J TRAUMA, V38, P780, DOI 10.1097/00005373-199505000-00018; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOYD O, 1993, JAMA-J AM MED ASSOC, V270, P2699, DOI 10.1001/jama.270.22.2699; BRAZY JE, 1985, PEDIATRICS, V75, P217; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Chesnut R M, 1995, New Horiz, V3, P366; Chesnut R M, 1995, New Horiz, V3, P581; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; DARBY JM, 1988, NEUROSURGERY, V23, P84, DOI 10.1227/00006123-198807000-00014; Delpy D T, 1989, Adv Exp Med Biol, V248, P41; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; GATTINONI L, 1996, YB INTENSIVE CARE EM, P308; Ghajar J, 1995, New Horiz, V3, P395; GOETTING MG, 1990, CRIT CARE MED, V18, P1220, DOI 10.1097/00003246-199011000-00006; GROSS D, 1990, SURG GYNECOL OBSTET, V170, P106; GUNNAR W, 1989, BRAZ J MED BIOL RES, V22, P287; GUNNAR W, 1988, SURGERY, V103, P398; HARTL R, 1995, SHOCK, V3, P274; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Heyland DK, 1996, CRIT CARE MED, V24, P517, DOI 10.1097/00003246-199603000-00025; JING ZA, 1992, J TRAUMA, V33, P83, DOI 10.1097/00005373-199207000-00016; JOBSISVANDERVLI.FF, 1987, ADV OXYGEN MONITORIN, P209; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lang E W, 1995, New Horiz, V3, P400; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; LONGSTRETH WT, 1986, NEUROLOGY, V36, P1186, DOI 10.1212/WNL.36.9.1186; Marion D W, 1995, New Horiz, V3, P439; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; METRANGOLO L, 1995, CRIT CARE MED, V23, P1971, DOI 10.1097/00003246-199512000-00005; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Myerson A, 1927, ARCH NEURO PSYCHIATR, V17, P807, DOI 10.1001/archneurpsyc.1927.02200360087006; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1987, CEREBRAL VASCULAR DI, V6, P251; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Pollard V, 1996, ANESTH ANALG, V82, P278, DOI 10.1097/00000539-199602000-00011; Pollard V, 1996, ANESTH ANALG, V82, P269, DOI 10.1097/00000539-199602000-00010; PROCTOR HJ, 1984, SURGERY, V96, P273; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; PROUGH DS, 1986, J NEUROSURG, V64, P627, DOI 10.3171/jns.1986.64.4.0627; Robertson C S, 1995, New Horiz, V3, P410; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCALEA TM, 1990, J TRAUMA, V30, P129, DOI 10.1097/00005373-199002000-00001; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; SCHMOKER JD, 1992, J TRAUMA, V33, P476, DOI 10.1097/00005373-199209000-00024; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; SMITH DS, 1990, ANESTHESIOLOGY, V73, P12, DOI 10.1097/00000542-199007000-00003; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902; TIGHE D, 1995, CRIT CARE MED, V23, P1997, DOI 10.1097/00003246-199512000-00008; TUCHSCHMIDT J, 1992, CHEST, V102, P216, DOI 10.1378/chest.102.1.216; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VRIES JK, 1973, J NEUROSURG, V39, P416, DOI 10.3171/jns.1973.39.3.0416; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; WHITLEY JM, 1991, SURGERY, V110, P514; YU MH, 1995, CRIT CARE MED, V23, P1025, DOI 10.1097/00003246-199506000-00006; Zornow M H, 1995, New Horiz, V3, P488	78	28	28	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	1997	42	5		S			S10	S18		10.1097/00005373-199705001-00003			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	XE879	WOS:A1997XE87900004	9191690				2022-02-06	
J	Cazzadori, A; DiPerri, G; Vento, S; Bonora, S; Fendt, D; Rossi, M; Lanzafame, M; Mirandola, F; Concia, E				Cazzadori, A; DiPerri, G; Vento, S; Bonora, S; Fendt, D; Rossi, M; Lanzafame, M; Mirandola, F; Concia, E			Aetiology of pneumonia following isolated closed head injury	RESPIRATORY MEDICINE			English	Article							MECHANICALLY VENTILATED PATIENTS; PROTECTED SPECIMEN BRUSH; RESPIRATORY-TRACT INFECTIONS; MULTIPLE TRAUMA PATIENTS; CRITICALLY ILL PATIENTS; NOSOCOMIAL PNEUMONIA; BRONCHOALVEOLAR LAVAGE; STAPHYLOCOCCUS-AUREUS; BACTERIAL PNEUMONIA; RISK-FACTORS		UNIV VERONA, BRONCHOSCOPY UNIT, I-37100 VERONA, ITALY; UNIV VERONA, INST IMMUNOL & INFECT DIS, I-37100 VERONA, ITALY; UNIV VERONA, INST NEUROSURG, I-37100 VERONA, ITALY				bonora, stefano/AAC-2993-2019; Cazzadori, Angelo/AAH-1058-2019; Lanzafame, Massimiliano/AAU-5736-2021; Vento, Sandro/I-1662-2017	bonora, stefano/0000-0002-7537-3341; Vento, Sandro/0000-0003-0084-4062			AERDTS SJA, 1991, CHEST, V100, P783, DOI 10.1378/chest.100.3.783; BRAUN SR, 1987, CRIT CARE MED, V15, P930; CHASTRE J, 1988, AM J MED, V85, P499; Chesnut Randall M., 1993, P203; CRAVEN DE, 1986, AM REV RESPIR DIS, V133, P792; ESPERSEN F, 1981, SCAND J INFECT DIS, V13, P161, DOI 10.3109/inf.1981.13.issue-3.01; ESPERSEN F, 1981, J INFECT DIS, V144, P19, DOI 10.1093/infdis/144.1.19; FAGON JY, 1988, AM REV RESPIR DIS, V138, P110, DOI 10.1164/ajrccm/138.1.110; FARR BM, 1994, RESP INFECTIONS, P249; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; JIMENEZ P, 1989, CRIT CARE MED, V17, P882, DOI 10.1097/00003246-198909000-00007; JOHANSON WG, 1972, ANN INTERN MED, V77, P701, DOI 10.7326/0003-4819-77-5-701; JOHANSON WG, 1988, AM REV RESPIR DIS, V137, P259, DOI 10.1164/ajrccm/137.2.259; LAFORCE FM, 1981, AM J MED, V70, P664, DOI 10.1016/0002-9343(81)90593-3; LANGER M, 1989, AM REV RESPIR DIS, V140, P302, DOI 10.1164/ajrccm/140.2.302; LANGER M, 1987, INTENS CARE MED, V13, P342; MACRAE W, 1981, BRIT MED J, V283, P1220, DOI 10.1136/bmj.283.6301.1220; MANDELLI M, 1986, LANCET, V2, P1094; MEDURI GU, 1992, CHEST, V102, pS557, DOI 10.1378/chest.102.5_Supplement_1.557S; PINGLETON SK, 1992, CHEST, V102, pS553, DOI 10.1378/chest.102.5_Supplement_1.553S; RELLO J, 1992, CHEST, V102, P525, DOI 10.1378/chest.102.2.525; RELLO J, 1991, CHEST, V100, P439, DOI 10.1378/chest.100.2.439; RELLO J, 1992, EUR RESPIR J, V5, P1249; RELLO J, 1990, AM REV RESPIR DIS, V142, P1320, DOI 10.1164/ajrccm/142.6_Pt_1.1320; STOUTENBEEK CP, 1987, J TRAUMA, V27, P357, DOI 10.1097/00005373-198704000-00003; SWINSCOW T, 1983, STATISTICS SQUARE ON, P28; TORRES A, 1990, AM REV RESPIR DIS, V142, P523, DOI 10.1164/ajrccm/142.3.523; TORRES A, 1989, AM REV RESPIR DIS, V140, P306, DOI 10.1164/ajrccm/140.2.306; TORRES A, 1993, AM REV RESPIR DIS, V147, P952, DOI 10.1164/ajrccm/147.4.952; WIMBERLEY N, 1979, AM REV RESPIR DIS, V119, P337	30	28	29	0	2	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0954-6111	1532-3064		RESP MED	Respir. Med.	APR	1997	91	4					193	199		10.1016/S0954-6111(97)90038-X			7	Cardiac & Cardiovascular Systems; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System	WV181	WOS:A1997WV18100002	9156141	Bronze			2022-02-06	
J	Bowen, JM; Clark, E; Bigler, ED; Gardner, M; Nilsson, D; Gooch, J; Pompa, J				Bowen, JM; Clark, E; Bigler, ED; Gardner, M; Nilsson, D; Gooch, J; Pompa, J			Childhood traumatic brain injury: Neuropsychological status at the time of hospital discharge	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							HEAD-INJURY; RECOVERY	The present study examined the status at the time of hospital discharge of 22 children who had sustained moderate to severe closed head injuries. Despite an average length of stay of 46 days, on average the children performed significantly below normal on cognitive, memory, and motor tests. The children who did the worst were those who sustained their injuries riding in a vehicle, as opposed to being hit by a vehicle while walking or riding a bicycle, No reliable associations were found between neuroimaging data and cognitive measures; however, children whose scans showed more diffuse severe injury (e.g. white matter hemorrhages) performed more poorly than those who did not, Of further importance were detailed morphometric analyses of tissue quantity and ventricular volume that showed significantly increased ventricle to brain ratios (VBR) over a 3 to 4 week period following injury.	BRIGHAM YOUNG UNIV,DEPT PSYCHOL,PROVO,UT 84602; BRIGHAM YOUNG UNIV,NEUROL LEARNING & BEHAV CLIN,PROVO,UT 84602; BRIGHAM YOUNG UNIV,PRIMARY CHILDRENS MED CTR,PROVO,UT 84602		Bowen, JM (corresponding author), UNIV UTAH,DEPT EDUC PSYCHOL,327 MILTON BENNION HALL,SALT LAKE CITY,UT 84112, USA.						ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; BIGLER ED, 1992, BRAIN INJURY, V6, P1; BLATTER DD, 1995, AM J NEURORADIOL, V15, P1; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333	9	28	29	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	JAN	1997	39	1					17	25					9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	WA301	WOS:A1997WA30100005	9003725				2022-02-06	
J	Brzuzy, S; Speziale, BA				Brzuzy, S; Speziale, BA			Persons with traumatic brain injuries and their families: Living arrangements and well-being post injury	SOCIAL WORK IN HEALTH CARE			English	Article							SEVERE HEAD-INJURY; RELATIVES VIEW; RECOVERY	This article discusses an empirical study of 66 single, adult survivors of moderate to severe traumatic brain injury (TBI) who were either living alone or living with their parents. The researchers determined perceived levels of stress, life satisfaction, family satisfaction, and community integration within the two groups. Survivors, who were typically ten years or more pose injury, and selected family members, responded to structured telephone interviews and standardized questionnaires. The findings of the study and their implications point to a need for practice interventions that will reestablish life cycle trajectories and meet developmental needs, as well as reintegrate affected individuals and their families into larger social systems.	OHIO STATE UNIV,COLL SOCIAL WORK,COLUMBUS,OH 43210; ARIZONA STATE UNIV,SCH SOCIAL WORK,TEMPE,AZ 85287								BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Imber-Black E., 1988, FAMILIES LARGER SYST; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; *NAT HEAD INJ FDN, 1988, FACT SHEET; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; *OH REH SERV COMM, 1992, OH HEAD INJ NEEDS AS; OLSON DH, 1985, FAMILY INVENTORIES, P43; PATTERSON JM, 1989, FAMILY SYSTEMS MED, P95; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Rolland JS, 1994, FAMILIES ILLNESS DIS; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009	27	28	28	0	1	HAWORTH PRESS INC	BINGHAMTON	10 ALICE ST, BINGHAMTON, NY 13904-1580	0098-1389			SOC WORK HEALTH CARE	Soc. Work Health Care		1997	26	1					77	88		10.1300/J010v26n01_05			12	Social Work	Social Science Citation Index (SSCI)	Social Work	YJ943	WOS:A1997YJ94300005	9406340				2022-02-06	
J	Vaz, R; Sarmento, A; Borges, N; Cruz, C; Azevedo, I				Vaz, R; Sarmento, A; Borges, N; Cruz, C; Azevedo, I			Ultrastructural study of brain microvessels in patients with traumatic cerebral contusions	ACTA NEUROCHIRURGICA			English	Article						blood-brain barrier; brain oedema; head trauma; ultrastructure	BLUNT HEAD TRAUMA; WHITE-MATTER EDEMA; ACUTE RESPONSES; INJURY; MODEL; RATS; TOPOGRAPHY; MEMBRANE	Brain tissue from ii patients with traumatic cerebral contusions submitted to surgery was studied. Control biopsy specimens were obtained from 5 patients undergoing ventriculo-peritoneal shunts for ''communicating'' hydrocephalus. After collection, the small fragments were fixed by immersion in glutaraldehyde-osmium and embedded in Epon. Semi-thin sections stained with toluidine blue were observed with the light microscope. Thin sections stained with lead citrate and uranyl acetate were observed using a Jeol electron microscope. In tissues from patients with head trauma a clear space most probably corresponding to fluid accumulation was systematically observed around microvessels. Ultrastructurally endothelial cells from these specimens exhibited signs of marked intracellular oedema, tight junctions being intact. Pinocytotic activity was increased, mainly at the abluminal surface. Swelling of astrocytic perivascular processes and the appearance of macrophagic cells with voluminous lysosomes were also observed. The authors conclude that the oedema of endothelial cells probably represent a central fact in the pathophysiology of traumatic brain oedema and speculate on the putative involvement of stretch-activated receptors in this condition.	HOSP SAO JOAO, FAC MED, DEPT NEUROL & NEUROSURG, OPORTO, PORTUGAL; HOSP SAO JOAO, FAC MED, DEPT THERAPEUT & PHARMACOL, OPORTO, PORTUGAL				Sarmento, Antonio/M-5235-2013; Cruz, Celia/K-3977-2013; Borges, Nuno/K-7051-2013	Sarmento, Antonio/0000-0001-5269-7231; Cruz, Celia/0000-0001-8922-5713; Vaz, Rui/0000-0001-7527-8187; Borges, Nuno/0000-0001-6357-0615			BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; BULLOCK R, 1985, J NEUROSURG, V63, P64, DOI 10.3171/jns.1985.63.1.0064; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EBISU T, 1993, JMRI-J MAGN RESON IM, V3, P863, DOI 10.1002/jmri.1880030612; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; HAGIWARA N, 1992, J PHYSL, V456, P283; Hariri R J, 1994, Neurosurg Clin N Am, V5, P687; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; KIMELBERG HK, 1992, J NEUROTRAUM, V9, pS71; LANG DA, 1994, J NEUROSURG, V80, P675, DOI 10.3171/jns.1994.80.4.0675; LIU HM, 1988, FORENSIC SCI INT, V38, P285, DOI 10.1016/0379-0738(88)90174-0; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; LONG DM, 1982, CLIN NEUR, V29, P174; MARMAROU A, 1994, ACTA NEUROCHIR, P421; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; NARUSE K, 1993, AM J PHYSIOL, V264, pC1037, DOI 10.1152/ajpcell.1993.264.4.C1037; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; POPP R, 1992, J PHYSIOL-LONDON, V454, P435, DOI 10.1113/jphysiol.1992.sp019272; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; SEVICK RJ, 1992, RADIOLOGY, V185, P687, DOI 10.1148/radiology.185.3.1438745; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TORNHEIM PA, 1984, J NEUROSURG, V60, P473, DOI 10.3171/jns.1984.60.3.0473; TORNHEIM PA, 1983, J NEUROSURG, V59, P431, DOI 10.3171/jns.1983.59.3.0431; TORNHEIM PA, 1981, J NEUROSURG, V55, P407, DOI 10.3171/jns.1981.55.3.0407; TORNHEIM PA, 1985, BRAIN RES, V337, P81, DOI 10.1016/0006-8993(85)91611-7; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P	34	28	28	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1997	139	3					215	220		10.1007/BF01844754			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	WQ307	WOS:A1997WQ30700019	9143587				2022-02-06	
J	Deshpande, SA; Millis, SR; Reeder, KP; Fuerst, D; Ricker, JH				Deshpande, SA; Millis, SR; Reeder, KP; Fuerst, D; Ricker, JH			Verbal learning subtypes ire traumatic brain injury: A replication	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							HEAD-INJURY; 1-YEAR; COMA	Traumatic brain injury (TBI) has been associated with memory impairments, but the severity and qualitative aspects of such impairment do not appear homogeneous across patients. This study sought to replicate an earlier investigation that found distinct verbal learning subtypes in TBI using the California Verbal Learning Test (CVLT). CVLT data from 88 acute rehabilitation inpatients with mild, moderate, and severe traumatic brain injuries were analyzed with multiple cluster analytic techniques. Cluster analyses yielded five learning subtypes, three of which appeared similar to the subtypes previously identified as Active, Disorganized, and Passive subtypes, and two that appeared similar to the Deficient subgroup. Traumatic brain injury appears to be characterized by heterogeneous, but fairly reliable, verbal learning subtypes that can be detected early postinjury.	REHABIL INST MICHIGAN,DETROIT,MI 48201; WAYNE STATE UNIV,SCH MED,DETROIT,MI 48202; UNIV WINDSOR,WINDSOR,ON N9B 3P4,CANADA					Ricker, Joseph/0000-0003-3415-991X			BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BLASHFIELD RK, 1980, J CONSULT CLIN PSYCH, V48, P456; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; DELIS D, 1987, CALIFORNIA VERBAL LE; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FRIDLUND AJ, 1987, IBM USERS GUIDE CVLT; FUERST DR, 1993, J ABNORM CHILD PSYCH, V21, P597, DOI 10.1007/BF00916445; Hamster K., 1983, MULTILINGUAL APHASIA; Haut M., 1992, NEUROPSYCHOLOGY, V6, P51; Heaton R.K., 1981, WISCONSIN CARD SORTI; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Reitan R, 1985, HALSTEAD REITAN NEUR; SARLE WS, 1985, SAS USERS GUIDE STAT, V5, P255; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sorensen T.A., 1948, KONGELIGE DANSKE VIE, V5, P1; TEASDALE G, 1974, LANCET, V2, P81; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wechsler D, 1987, MEMORY SCALE REVISED; [No title captured]	23	28	28	1	3	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	DEC	1996	18	6					836	842		10.1080/01688639608408306			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WJ027	WOS:A1996WJ02700006	9157108				2022-02-06	
J	Greene, KA; Jacobowitz, R; Marciano, FF; Johnson, BA; Spetzler, RF; Harrington, TR				Greene, KA; Jacobowitz, R; Marciano, FF; Johnson, BA; Spetzler, RF; Harrington, TR			Impact of traumatic subarachnoid hemorrhage on outcome in nonpenetrating head injury .2. Relationship to clinical course and outcome variables during acute hospitalization	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	Annual Meeting of the American-College-of-Surgeons Committee-on-Trauma-for-the-Resident	APR, 1994	WASHINGTON, DC	Amer Coll Surgeons, Comm Trauma Resident			CEREBRAL BLOOD-FLOW; ANGIOGRAPHIC FINDINGS; SEVERITY SCORE; ARTERIAL SPASM; BRAIN INJURY; METABOLISM; COMA; CIRCULATION; ULTRASOUND; PRESSURE	Patients with a nonpenetrating head injury and traumatic subarachnoid hemorrhage (tSAH) on admission head computed tomography scan (n = 240) were compared with patients without tSAH matched in terms of admission postresuscitation Glasgow Coma Scale (GCS) values. age, ses, and the presence of orae or more types of intracranial mass lesions, Admission Injury Severity Score was higher only in tSAH patients with admission GCS scores between 13 and 15; GCS values at 6, 24, and 48 hours were lower for tSAH patients. Patients with tSAH underwent fewer craniotomies, but more than twice as many tSAH patients had high intracranial pressure at the time of ventriculostomy placement and 6 hours after admission, tSAH patients underwent more chest procedures and their incidence of hypoxia and hypotension was greater, tSAH patients spent more days in intensive care unit, more total days hospitalized, and had worse Glasgow Outcome Scale scores at acute hospital discharge. Fewer tSAH patients were discharged home, and almost 1.5 times as many tSAH patients died during hospitalization. Given a similar overall degree of injury at admission, patients with tSAH associated with a nonpenetrating head injury had a worse outcome than similar patients without tSAH.	ST JOSEPHS HOSP,BARROW NEUROL INST,DIV NEUROL SURG,PHOENIX,AZ; ST JOSEPHS HOSP,BARROW NEUROL INST,DIV NEURORADIOL,PHOENIX,AZ; ARIZONA STATE UNIV,DEPT MATH,TEMPE,AZ 85287								ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BAIGELMAN W, 1981, NEUROSURGERY, V9, P729, DOI 10.1227/00006123-198112000-00021; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BECKMAN DL, 1985, CENTRAL NERVOUS SYST, P417; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COLUMELLA F, 1963, ACTA RADIOL DIAGN, V1, P239, DOI 10.1177/028418516300100217; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Enevoldsen E, 1986, Acta Neurochir Suppl (Wien), V36, P133; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FALSETTI HL, 1966, DIS CHEST, V49, P420, DOI 10.1378/chest.49.4.420; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; GREITZ T, 1961, ANGIOGRAPHY, P95; GROLIMUND P, 1988, LANCET, V1, P1173; HUBER P, 1963, Fortschr Geb Rontgenstr Nuklearmed, V98, P292; JENNETT B, 1975, LANCET, V1, P480; LEEDS NE, 1966, ACTA RADIOL DIAGN, V5, P320, DOI 10.1177/02841851660050P135; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; LIN JPT, 1966, ACTA RADIOL DIAGN, V5, P341, DOI 10.1177/02841851660050P138; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LUERSSEN TG, 1989, INTRACRANIAL PRESSUR, P598; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MILLER JD, 1980, CEREBRAL ARTERIAL SP, P476; MUIZELAAR JP, 1989, TXB HEAD INJURY, P221; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; RUTLEDGE R, 1993, AM J SURG, V166, P244, DOI 10.1016/S0002-9610(05)80966-3; SEILER RW, 1986, J NEUROSURG, V64, P594, DOI 10.3171/jns.1986.64.4.0594; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; TEASDALE G, 1974, LANCET, V2, P81; VILATO RJ, 1962, NEURO-CHIR, V8, P217; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; Wilkins R H, 1990, Neurosurg Clin N Am, V1, P329; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626; WILKINS RH, 1980, CEREBRAL ARTERIAL SP, P472	48	28	29	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	1996	41	6					964	971		10.1097/00005373-199612000-00004			8	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	VY407	WOS:A1996VY40700004	8970547				2022-02-06	
J	Bowman, ML				Bowman, ML			Ecological validity of neuropsychological and other predictors following head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							TRAUMATIC BRAIN INJURY; PSYCHOSOCIAL CONSEQUENCES; WORK STATUS; RECOVERY; EMPLOYMENT; IMPAIRMENT; SYMPTOMS; TESTS	This study evaluated the predictive value of neuropsychological variables as compared to three other types of variables (demographic, medical, and emotional) in predicting three outcomes (occupational function:OccF; activity impairment:AI; and pension impairment percent) in 483 head-injured ambulatory workers. OccF was equally well-predicted by neuropsychological or demographic variable-families. Al was best predicted by neuropsychological or emotional variable-families, and pension impairment percent was predicted equally well by all but emotional variable-families. Cross-validation showed good stability of the level of prediction. Discriminant analysis correctly classified 72% of subjects as Un/Employed. Neuropsychological test performance is related to important behavior in outpatient brain-injury survivors.			Bowman, ML (corresponding author), SIMON FRASER UNIV, DEPT PSYCHOL, BURNABY, BC V5A 1S6, CANADA.						American Medical Association, 1990, GUID EV PERM IMP; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; *BMDP, 1990, BMDP STAT SOFTW SG I; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; CHUNG F, 1990, ANESTH ANALG, V71, P217; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DIAMOND R, 1988, INT J CLIN NEUROPSYC, V10, P35; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FISHER J, 1959, J CONSULT PSYCHOL, V23, P400, DOI 10.1037/h0044080; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; GODFREY HPD, 1993, NEW ZEAL MED J, V106, P301; GRONWALL D, 1974, LANCET, V2, P605; Hathaway S.R., 1989, MINNESOTA MULTIPHASI; Hathaway S.R., 1951, MINNESOTA MULTIPHASI; HEATON RK, 1978, J NERV MENT DIS, V166, P408, DOI 10.1097/00005053-197806000-00004; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; Jennett B., 1986, MED N AM, V36, P5210; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; LANDSMAN IS, 1990, J BEHAV MED, V13, P561, DOI 10.1007/BF00844735; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEVIN HS, 1989, HDB NEUROPSYCHOLOGY, V3, P183; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; MALEC J, 1990, J HEAD TRAUMA REHAB, V5, P60; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; MCSWEENY AJ, 1985, J CLIN EXP NEUROPSYC, V7, P281, DOI 10.1080/01688638508401260; MILLER JD, 1985, J NEUROL NEUROSUR PS, V48, P596; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PUTNAM SH, 1992, CLIN NEUROPSYCHOL, V6, P383; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Russell W Ritchie, 1934, Edinb Med J, V41, P129; SAURELCUBIZOLLES MJ, 1992, BRIT J IND MED, V49, P276; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Symonds C.P., 1940, INJURIES SKULL BRAIN, P69; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; [No title captured]	59	28	28	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	1996	10	4					382	396		10.1080/13854049608406699			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	VZ755	WOS:A1996VZ75500003					2022-02-06	
J	Tayag, EC; Nair, SN; Wahhab, S; Katsetos, CD; Lighthall, JW; Lehmann, JC				Tayag, EC; Nair, SN; Wahhab, S; Katsetos, CD; Lighthall, JW; Lehmann, JC			Cerebral uric acid increases following experimental traumatic brain injury in rat	BRAIN RESEARCH			English	Article						uric acid; thalamus; cortex; rat; traumatic brain injury; microdialysis	CORTICAL IMPACT INJURY; NERVOUS-SYSTEM TRAUMA; LIPID-PEROXIDATION; XANTHINE-OXIDASE; FOCAL ISCHEMIA; INTENSIVE-CARE; MICRODIALYSIS; HYPOXANTHINE; RADICALS; STROKE	Following traumatic brain injury (TBI), cortical and thalamic areas were analyzed histologically and by high-performance liquid chromatography with electrochemical detection for uric acid at various survival times. Following TBI, cortical uric acid was elevated by ten-fold at 24 and 48 h, but not at 1 h post-TBI. Histological evidence of neurodegeneration was found not only in cortex but also in the anteroventral thalamus. These data suggest that as in stroke, uric acid measurements may be a convenient and sensitive method for measuring peroxidative status in TBI.	MED COLL PENN & HAHNEMANN UNIV, DEPT NEUROSURG, PHILADELPHIA, PA 19102 USA; MED COLL PENN & HAHNEMANN UNIV, DEPT PATHOL, PHILADELPHIA, PA 19102 USA; GM CORP, RES LABS, DEPT BIOMED SCI, WARREN, MI 48090 USA								BETZ AL, 1985, J NEUROCHEM, V44, P574, DOI 10.1111/j.1471-4159.1985.tb05451.x; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ENGERSON TD, 1987, J CLIN INVEST, V79, P1564, DOI 10.1172/JCI112990; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALLIWELL B, 1989, ACTA NEUROL SCAND, V80, P23, DOI 10.1111/j.1600-0404.1989.tb01779.x; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; KANEMITSU H, 1989, BRAIN RES, V499, P367, DOI 10.1016/0006-8993(89)90786-5; KANEMITSU H, 1988, J NEUROCHEM, V51, P1882, DOI 10.1111/j.1471-4159.1988.tb01172.x; KINUTA Y, 1989, J NEUROSURG, V71, P417, DOI 10.3171/jns.1989.71.3.0417; KINUTA Y, 1989, J NEUROSURG, V71, P421, DOI 10.3171/jns.1989.71.3.0421; LANDOLT H, 1994, ACTA NEUROCHIR, P475; LEHMANN JC, 1993, DRUG NEWS PERSPECT, V6, P692; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; NIHEI H, 1989, NEUROSURGERY, V25, P613, DOI 10.1227/00006123-198910000-00016; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; UEMURA Y, 1991, STROKE, V22, P1548, DOI 10.1161/01.STR.22.12.1548; YOSHIURA M, 1986, J LIQ CHROMATOGR, V9, P177, DOI 10.1080/01483918608076630	25	28	32	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 16	1996	733	2					287	291		10.1016/0006-8993(96)00669-5			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VK400	WOS:A1996VK40000016	8891312				2022-02-06	
J	Maffulli, N; Bundoc, RC; Chan, KM; Cheng, JCY				Maffulli, N; Bundoc, RC; Chan, KM; Cheng, JCY			Paediatric sports injuries in Hong Kong: A seven year survey	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						sports injuries; children; epidemiology	ISOMETRIC STRENGTH; CHILDREN	Objective-To ascertain the epidemiological characteristics of sports injuries in children in Hong Kong. Methods-Retrospective review of all cases seen in the Sports Injury Clinic of the Prince of Wales Hospital, Shatin, Hong Kong, in the period May 1984 to December 1990. The variables studied were age at presentation, gender, side of the body injured, anatomical location of the injury, type and severity of injury, sport played, level (school, recreational, amateur and professional) and frequency of sports participation, length in years of sports practice, and initial management of the injury. Results-Of the 2293 patients seen, 238 were youngsters (54% boys) 16 years old or younger. Ball games accounted for the greatest number of injuries, with 37 children taking part in basketball, 28 in soccer, 12 in volleyball, and 31 children taking part in a variety of other ball games. Of the remaining children, the single largest group was practising track and field, with sprinting and middle distance running accounting for 42 injuries, and 28 children were injured while cycling. Most of the injuries (85%) were classified as non-serious, but 15% of children presented with a total of 21 fractures, two joint dislocations, five concussions, and seven torn knee ligaments. Conclusions-Children sports participation in Hong Kong, although not at high level and not as widespread as in the West, accounts for significant morbidity. These injuries should be carefully monitored to ascertain whether they result in any detrimental long term effects.	CHINESE UNIV HONG KONG, DEPT ORTHOPAED & TRAUMATOL, PRINCE WALES HOSP, SHATIN, NEW TERR, HONG KONG		Maffulli, N (corresponding author), UNIV ABERDEEN, SCH MED, DEPT ORTHOPAED SURG, POLWARTH BLDG, ABERDEEN AB9 2ZD, SCOTLAND.		Cheng, Jack/J-3878-2018; Maffulli, Nicola/A-1839-2014	Cheng, Jack/0000-0001-8153-364X; Maffulli, Nicola/0000-0002-5327-3702			ANDERSEN LB, 1987, EUR J APPL PHYSIOL, V56, P83, DOI 10.1007/BF00696381; BAXTERJONES A, 1993, ARCH DIS CHILD, V68, P130, DOI 10.1136/adc.68.1.130; BEATY J H, 1987, Annals of Sports Medicine, V3, P97; Booth F W, 1975, Exerc Sport Sci Rev, V3, P83; CHAN KM, 1993, BRIT J SPORT MED, V27, P263, DOI 10.1136/bjsm.27.4.263; Gallagher S.S., 1984, AM J PUBLIC HEALTH, V8, P318; KVIST M, 1989, INT J SPORTS MED, V10, P81, DOI 10.1055/s-2007-1024879; LYSENS R, 1984, SPORTS MED, V1, P6, DOI 10.2165/00007256-198401010-00002; LYSENS RJ, 1989, AM J SPORT MED, V17, P612, DOI 10.1177/036354658901700504; MAFFULLI N, 1990, SPORTS MED, V9, P229, DOI 10.2165/00007256-199009040-00004; MAFFULLI N, 1994, BRIT J SPORT MED, V28, P123, DOI 10.1136/bjsm.28.2.123; MAFFULLI N, 1988, ARCH DIS CHILD, V63, P1405, DOI 10.1136/adc.63.11.1405; Maffulli N, 1990, Br J Sports Med, V24, P237; PRAGER BI, 1989, AM J SPORT MED, V17, P681, DOI 10.1177/036354658901700516; Sahlin Y, 1990, Br J Sports Med, V24, P40; SCHMIDTOLSEN S, 1991, AM J SPORT MED, V19, P273, DOI 10.1177/036354659101900311; SOWINSKI J, 1986, NEW STUDIES ATHLETIC, V4, P91; TURSZ A, 1986, AM J SPORT MED, V14, P294, DOI 10.1177/036354658601400409; Yde J, 1990, Br J Sports Med, V24, P51; ZARICZNYJ B, 1980, AM J SPORT MED, V8, P318, DOI 10.1177/036354658000800504	20	28	29	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	1996	30	3					218	221		10.1136/bjsm.30.3.218			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	VJ620	WOS:A1996VJ62000011	8889114	Bronze, Green Published			2022-02-06	
J	Gass, CS				Gass, CS			MMPI-2 variables in attention and memory test performance	PSYCHOLOGICAL ASSESSMENT			English	Article								Attention span (Digit Span), verbal list learning, and memory test performance( Wechsler Memory Scale-Revised; WMS-R) were examined in relation to Minnesota Multiphasic Personality Inventory-2 (MMPI-2) measures of depression, anxiety, and psychotic thinking in male patients with closed-head injury (n = 48) and with psychiatric disorder (n = 80). In both samples, MMPI-2 scores were significantly related to Attention Span but independent of List Learning performance. MMPI-2 scores correlated with factor scores derived from the Logical Memory and Visual Reproduction subtests of the WMS-R. The results of a hierarchical regression analysis, which examined the relative effects of neurologic and emotional status, support the view that MMP1-2 scores are relevant to the interpretation of performance on neuropsychological tests of attention and memory.			Gass, CS (corresponding author), VET AFFAIRS MED CTR,PSYCHOL SERV 116B,1201 NW 16TH ST,MIAMI,FL 33125, USA.		Gass, Carlton/AAO-5906-2020				BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; CALSYN DA, 1982, PERCEPT MOTOR SKILL, V55, P1099, DOI 10.2466/pms.1982.55.3f.1099; GASS CS, 1994, J CLIN PSYCHOL, V50, P586, DOI 10.1002/1097-4679(199407)50:4<586::AID-JCLP2270500414>3.0.CO;2-Z; GASS CS, 1991, J CLIN PSYCHOL, V47, P153; HEATON RK, 1978, PSYCHOL BULL, V85, P141, DOI 10.1037/0033-2909.85.1.141; Heaton RK, 1981, HDB CLIN NEUROPSYCHO, V1, P481; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; RABINS PV, 1993, DEMENTIA, P359; Russell E. W., 1970, ASSESSMENT BRAIN DAM; STREINER DL, 1994, CAN J PSYCHIAT, V39, P191, DOI 10.1177/070674379403900401; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wolfson, 1993, HALSTEAD REITAN NEUR	13	28	28	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	1996	8	2					135	138		10.1037/1040-3590.8.2.135			4	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UT983	WOS:A1996UT98300003					2022-02-06	
J	Olby, NJ; Blakemore, WF				Olby, NJ; Blakemore, WF			A new method of quantifying the extent of tissue loss following spinal cord injury in the rat	EXPERIMENTAL NEUROLOGY			English	Article							COMPRESSION; CONTUSION; NALOXONE; TRAUMA; LESION; CAT; METHYLPREDNISOLONE; REGENERATION; INFARCTION; BRAIN	Many agents are being tested for their ability to limit the development of secondary tissue damage following trauma to the spinal cord by comparing the extent of trauma-induced tissue destruction between groups of animals receiving different treatments. However, the changes that occur following spinal concussion result in initial swelling of the cord and then progressive shrinkage. It is therefore impossible to determine the preinjury cross-sectional area of cord once it has been damaged, making accurate calculation of the extent of tissue destruction difficult. To overcome this problem, a method for predicting the preinjury cross-sectional area of damaged spinal cord was developed in the rat by establishing correction factors that related the cross-sectional area of a reference transverse section to the area of sections at other points along the cord. This method was used to calculate the volume of tissue destruction in groups of rats 48 h, 4 days, and 4 weeks after photochemically induced cord injury. The results were compared with the volume of tissue destruction obtained when calculated from measured rather than predicted cord area. One month following photochemically induced injury, the spinal cord had shrunk significantly. This resulted in significant underestimation of the lesion volume when calculated from the measured area of injured cord. This demonstrates that the preinjury area of the cord must be established in order to calculate the full extent of tissue destruction and that it can be estimated accurately using the method described in this study. (C) 1996 Academic Press, Inc.			Olby, NJ (corresponding author), UNIV CAMBRIDGE, DEPT CLIN VET MED, MADINGLEY RD, CAMBRIDGE CB3 0ES, ENGLAND.			Olby, Natasha/0000-0003-1349-3484	Wellcome TrustWellcome TrustEuropean Commission Funding Source: Medline		BALENTINE JD, 1978, LAB INVEST, V39, P236; BEHRMANN DL, 1993, EXP NEUROL, V119, P258, DOI 10.1006/exnr.1993.1028; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; BRAUGHLER JM, 1987, J NEUROSURG, V67, P102, DOI 10.3171/jns.1987.67.1.0102; BUNGE MB, 1994, EXP NEUROL, V127, P76, DOI 10.1006/exnr.1994.1082; CAMERON T, 1990, EXP NEUROL, V109, P214, DOI 10.1016/0014-4886(90)90076-5; COATES JR, 1995, VET SURG, V24, P128, DOI 10.1111/j.1532-950X.1995.tb01307.x; CONSTANTINI S, 1994, J NEUROSURG, V80, P97, DOI 10.3171/jns.1994.80.1.0097; DIETRICH WD, 1984, STROKE, V15, P191; Dohrmann G J, 1976, Surg Neurol, V6, P263; FADEN AI, 1983, NEUROLOGY, V33, P673, DOI 10.1212/WNL.33.6.673; FADEN AI, 1981, ANN NEUROL, V10, P326, DOI 10.1002/ana.410100403; FISH CJ, 1983, NEUROPATH APPL NEURO, V9, P109, DOI 10.1111/j.1365-2990.1983.tb00329.x; GUTH L, 1994, P NATL ACAD SCI USA, V91, P12308, DOI 10.1073/pnas.91.25.12308; HOOVLER DW, 1991, ACTA NEUROPATHOL, V81, P303, DOI 10.1007/BF00305872; MEANS ED, 1981, J NEUROSURG, V55, P200, DOI 10.3171/jns.1981.55.2.0200; NOBLE LJ, 1985, EXP NEUROL, V88, P135, DOI 10.1016/0014-4886(85)90119-0; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; PAINO CL, 1994, J NEUROCYTOL, V23, P433, DOI 10.1007/BF01207115; PENCALET P, 1993, J NEUROSURG, V78, P603, DOI 10.3171/jns.1993.78.4.0603; PRADO R, 1987, J NEUROSURG, V67, P745, DOI 10.3171/jns.1987.67.5.0745; REIER PJ, 1992, EXP NEUROL, V115, P177, DOI 10.1016/0014-4886(92)90245-L; RICHARDSON PM, 1984, J NEUROCYTOL, V13, P165, DOI 10.1007/BF01148324; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; WAGNER FC, 1981, J NEUROSURG, V54, P802, DOI 10.3171/jns.1981.54.6.0802; WATSON BD, 1986, BRAIN RES, V367, P296, DOI 10.1016/0006-8993(86)91606-9; WATSON BD, 1985, ANN NEUROL, V17, P497, DOI 10.1002/ana.410170513; WRATHALL JR, 1982, ACTA NEUROPATHOL, V57, P59, DOI 10.1007/BF00688878; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; YOUNG W, 1981, J NEUROSURG, V55, P209, DOI 10.3171/jns.1981.55.2.0209	31	28	30	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	1996	138	1					82	92		10.1006/exnr.1996.0049			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UA434	WOS:A1996UA43400009	8593899				2022-02-06	
J	NILSSON, F; BJORKMAN, S; ROSEN, I; MESSETER, K; NORDSTROM, CH				NILSSON, F; BJORKMAN, S; ROSEN, I; MESSETER, K; NORDSTROM, CH			CEREBRAL VASOCONSTRICTION BY INDOMETHACIN IN INTRACRANIAL HYPERTENSION - AN EXPERIMENTAL INVESTIGATION IN PIGS	ANESTHESIOLOGY			English	Article							SEVERE HEAD-INJURY; TRAUMATIC BRAIN-LESIONS; BLOOD-FLOW; PROSTAGLANDIN SYNTHESIS; PERFUSION-PRESSURE; AUTO-REGULATION; CARBON-DIOXIDE; DIHYDROERGOTAMINE; HYPERVENTILATION; INHIBITION	Background: Uncontrolled increase in intracranial pressure is the most significant cause of mortality in patients with severe traumatic brain lesions, and the efficacy of common nonsurgical treatments has been questioned. Pharmacologically induced cerebral vasoconstriction aiming at a decrease of cerebral blood volume and brain edema has recently been suggested as an alternative. Limited clinical experience with indomethacin as a cerebral vasoconstrictor has been reported but dose- or concentration-effect relationships were not investigated. In particular, there is a lack of data showing whether a therapeutic window exists in which risk of cerebral ischemia is minimized. Methods: In a porcine model of intracranial hypertension induced with two epidural balloons to a level of 26-28 mmHg, 18 animals were randomized into three groups receiving 0.1, 0.3, and 3.0 mg . kg(-1). h(-1) indomethacin, respectively, as an infusion during 80 min. Intracranial pressure, mean arterial blood pressure, and electrocortical activity were recorded continuously and measurements of cerebral blood now, arteriovenous difference in oxygen content and cerebral venous pH were performed at 5, 20, 40, 60, and 75 min during and 10 min after the indomethacin infusion. Baseline measurements, performed before the indomethacin infusion, were used as an internal control. The infusions were pharmacokinetically designed to mimic the reported clinical conditions. Results: An 11% mean decrease in intracranial pressure during the infusion, but no effects on cerebral blood flow, arteriovenous difference in oxygen content, venous pH, and electrocortical activity were observed in the group of animals receiving 0.1 mg . kg(-1). h(-1). When the rate of infusion was 0.3 and 3.0 mg . kg(-1). h(-1), the decrease in intracranial pressure was 20 and 25%, respectively, but this was accompanied by a decrease in cerebral blood flow and venous pH, an increase in arteriovenous difference in oxygen content, and a slowing of the electrocortical activity. All changes were statistically significant. Conclusions: Indomethacin, which is known to constrict precapillary resistance vessels, caused a decrease in intracranial pressure during experimental intracranial hypertension. This was accompanied by signs of cerebral ischemia when Indomethacin was used in a dose that has previously been suggested for the treatment of increased intracranial pressure in patients.									AKESON J, 1992, ACTA ANAESTH SCAND, V36, P419, DOI 10.1111/j.1399-6576.1992.tb03491.x; ALBRECHT RF, 1987, STROKE, V18, P649, DOI 10.1161/01.STR.18.3.649; ALVAN G, 1975, CLIN PHARMACOL THER, V18, P364; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P922, DOI 10.1111/j.1399-6576.1995.tb04199.x; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P354; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; INGVAR M, 1981, ACTA PHYSIOL SCAND, V111, P205, DOI 10.1111/j.1748-1716.1981.tb06726.x; JENSEN K, 1991, ACTA NEUROCHIR, V108, P116, DOI 10.1007/BF01418518; JONKMAN EJ, 1986, HDB EL CLIN NEUROPHY, P205; KAGSTROM E, 1983, ACTA PHYSIOL SCAND, V118, P193, DOI 10.1111/j.1748-1716.1983.tb07262.x; KAUFMAN AM, 1992, J NEUROSURG, V77, P854; KRAAIER V, 1992, ELECTROEN CLIN NEURO, V82, P208, DOI 10.1016/0013-4694(92)90169-I; LUNDBERG N, 1959, ACTA PSYCHIAT SCAND, V34, P139; MCCARTHY BG, 1989, HEADACHE, V29, P420, DOI 10.1111/j.1526-4610.1989.hed2907420.x; MELLANDER S, 1970, CLIN SCI, V39, P183, DOI 10.1042/cs0390183; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MULLER H, 1988, PHARMACOLOGY, V37, P248, DOI 10.1159/000138473; NAGATA K, 1986, TOPOGRAPHIC MAPPING, P357; NILSSON B, 1981, ACTA PHYSIOL SCAND, V111, P455, DOI 10.1111/j.1748-1716.1981.tb06763.x; NILSSON F, 1995, ACTA ANAESTH SCAND, V39, P827, DOI 10.1111/j.1399-6576.1995.tb04179.x; NILSSON F, 1995, ACTA ANAESTH SCAND, V39, P916, DOI 10.1111/j.1399-6576.1995.tb04198.x; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; PICKARD JD, 1977, CIRC RES, V40, P198, DOI 10.1161/01.RES.40.2.198; PICKARD JD, 1973, NATURE-NEW BIOL, V245, P187, DOI 10.1038/newbio245187a0; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAKABE T, 1979, ACTA PHYSIOL SCAND, V107, P283, DOI 10.1111/j.1748-1716.1979.tb06476.x; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SEVERINGHAUS JW, 1967, CIRC RES, V20, P272, DOI 10.1161/01.RES.20.2.272; SUNDBARG G, 1987, J NEUROSURG, V67, P841, DOI 10.3171/jns.1987.67.6.0841; THOMAS RM, 1989, B LOND MATH SOC, V21, P463, DOI 10.1112/blms/21.5.463; VANHUFFELEN AC, 1984, PROG BRAIN RES, V62, P3; WAHLINBOLL E, 1981, EUR J CLIN PHARMACOL, V20, P375, DOI 10.1007/BF00615408; WENNMALM A, 1981, CLIN PHYSIOL, V1, P227, DOI 10.1111/j.1475-097X.1981.tb00891.x	44	28	28	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQUARE, PHILADELPHIA, PA 19106	0003-3022			ANESTHESIOLOGY	Anesthesiology	DEC	1995	83	6					1283	1292		10.1097/00000542-199512000-00019			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	TJ329	WOS:A1995TJ32900019	8533921				2022-02-06	
J	MALIA, K; POWELL, G; TORODE, S				MALIA, K; POWELL, G; TORODE, S			PERSONALITY AND PSYCHOSOCIAL FUNCTION AFTER BRAIN INJURY	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; STRESS RESISTANCE; FOLLOW-UP; REHABILITATION; RECOVERY; HEALTH; TRAUMA	A total of 74 brain-injured patients and 46 non-neurologically matched controls consecutively admitted to a specialist medical rehabilitation unit, were administered the 'Headley Court psychosocial rating scale' and four questionnaires examining personality traits of 'locus of control', use of humour', 'optimism' and 'easy-going disposition'. Both pre- and post-injury personality ratings were obtained. The relatives of all participants were sent the same scales. Personality changes are reported in each of the four areas; however, time post-injury appears to be a significant factor in the type of change reported; in this cross-sectional study, at 6 and 12 months post-injury, changes are noted in all variables except locus of control, whereas at 18 months post-injury only 'easy-going disposition' showed significant change, at 24 months post-injury changes were noted in all variables except optimism, and at 30 months post-injury no changes were noted. In the present study, examining a period of 2.5 years post-injury, the personality changes remain static once they have occurred. Despite widespread reports in the literature on the importance of pre- and post-trauma personality to good psychosocial functioning, the present study found that it was only an 'easy-going disposition' post-trauma that was consistently related to good psychosocial functioning. Reasons for this are discussed.	UNIV SURREY,SURREY,ENGLAND		MALIA, K (corresponding author), RAF,DSMRU,HEADLEY COURT,EPSOM KT18 6JN,SURREY,ENGLAND.						BENYISHAY Y, 1990, C NEW YORK U HEAD TR; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1984, PSYCHOL SOCIAL FAMIL, P4; BROOKS N, 1991, Brain Injury, V5, P103, DOI 10.3109/02699059109008082; BROOKS N, 1986, J NEUROL NEUROSUR PS, V47, P764; Cohadon F, 1981, Prog Neurol Surg, V10, P344, DOI 10.1159/000384774; HINCKLE LE, 1974, STRESSFUL LIFE EVENT, P9; HOLAHAN CJ, 1987, J PERS SOC PSYCHOL, V52, P946, DOI 10.1037/0022-3514.52.5.946; HOLAHAN CJ, 1985, J PERS SOC PSYCHOL, V49, P739, DOI 10.1037/0022-3514.49.3.739; HOLAHAN CJ, 1986, J PERS SOC PSYCHOL, V51, P389, DOI 10.1037/0022-3514.51.2.389; JACKSON H F, 1992, Brain Injury, V6, P109, DOI 10.3109/02699059209029650; JENNETT B, 1975, LANCET, V1, P480; KINSELLA G, 1988, PSYCHOL MED, V18, P157; Lazarus RS., 1984, STRESS APPRAISAL COP, P141; Lezak, 1989, ASSESSMENT BEHAV CON, V7, P113; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; Livingston M G, 1985, Int Rehabil Med, V7, P145; MALIA KB, 1993, CLIN REHABILITATION, V7, P35; Martin R. A., 1983, J PERS SOC PSYCHOL, V47, P145; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MILLER L, 1991, COGNITIVE REHABI MAR; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1986, CLIN NEUROPSYCHOLOGY, P136; RANSEEN J, 1990, COGNITIVE REHABI MAR; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosenthal M., 1983, REHABILITATION HEAD, P197; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; STEPHENS CK, 1991, DISS ABSTR INT B, V51; STERN JM, 1985, ISRAEL J PSYCHIAT, V22, P83; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; [No title captured], DOI DOI 10.1037/H0092976; [No title captured]; 1987, UNPUB FUNCTIONAL ASS	41	28	28	0	4	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1995	9	7					697	712		10.3109/02699059509008226			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RZ814	WOS:A1995RZ81400003	8680397				2022-02-06	
J	CHOU, PI; SADUN, AA; LEE, H				CHOU, PI; SADUN, AA; LEE, H			VASCULATURE AND MORPHOMETRY OF THE OPTIC CANAL AND INTRACANALICULAR OPTIC-NERVE	JOURNAL OF NEURO-OPHTHALMOLOGY			English	Article						OPTIC CANAL; OPHTHALMIC ARTERY; OPTIC NERVE TRAUMA	DECOMPRESSION	Objectives: To study the bony structure of the optic canal and the vasculature of the intracanalicular optic nerve in human cadavers. Materials and Methods: Gross and microscopic examinations were performed in 25 optic canals from 13 cadavers to study the pattern of vascular supply of the intracanalicular optic nerve. Neoprene latex was injected through the most proximal part of the ophthalmic artery in seven optic canals. The intracanalicular branches from the ophthalmic artery were carefully identified and quantified. Quantitative measurements of the canal length, canal thickness, canal transverse area, optic nerve transverse area, and subdural space were done for the other 18 canals by means of semiautomated morphometric analysis system. Each canal was divided into anterior, middle, and posterior parts for better visualization and measurement. Results: The ophthalmic artery gives off three branches that supply the intracanalicular optic nerve: medial collateral branch, lateral collateral branch, and ventral branch. Each branch pierces the dura and then supplies the nerve through the pia mater. The middle medial wall was the thinnest bony part of the canal (0.31 +/- 0.06 mm). The optic canal, optic nerve, and subdural space transverse area varied at different transection levels. The narrowest space was in the middle part of the optic canal. The mean subdural cross-sectional space was only 1.84 mm(2). This, multiplied by the average canal length (11.79 mm), can be considered the potential space for hemorrhage, optic nerve edema, or hematoma. Conclusions: The vasculature within the bony canal is extremely delicate. Due to the limitation of this space, even a tiny amount of blood or swelling of the nerve (21.69 mm(3)) may cause optic nerve compression, It appears that these vessels could easily be disrupted in closed head injury by a shearing or concussive force, leading to ischemic infarction of the optic nerve. Since the narrowest portion of the canal is in the middle portion, it is the middle part of the optic canal that is most critical in doing an optic canal decompression.	UNIV SO CALIF, SCH MED, DOHENY EYE INST, DEPT OPHTHALMOL, LOS ANGELES, CA 90033 USA; UNIV SO CALIF, SCH MED, DOHENY EYE INST, DEPT NEUROSURG, LOS ANGELES, CA 90033 USA		CHOU, PI (corresponding author), TRISERV GEN HOSP, NATL DEF MED CTR,DEPT OPHTHALMOL,42,SEC 3, TING CHOU RD, TAIPEI, TAIWAN.						ANDERSON RL, 1982, OPHTHALMOLOGY, V89, P445; CHOU PI, IN PRESS NEUROOPHTHA; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; FRANCOIS J, 1956, Br J Ophthalmol, V40, P45, DOI 10.1136/bjo.40.1.45; FRANCOIS J, 1954, BRIT J OPHTHALMOL, V38, P472, DOI 10.1136/bjo.38.8.472; FRANCOIS J, 1955, Br J Ophthalmol, V39, P220, DOI 10.1136/bjo.39.4.220; Fukado Y, 1975, Mod Probl Ophthalmol, V14, P474; HABAL MB, 1977, J SURG RES, V22, P527, DOI 10.1016/0022-4804(77)90036-1; Hayreh S S, 1962, Br J Ophthalmol, V46, P165, DOI 10.1136/bjo.46.3.165; Hayreh S S, 1962, Br J Ophthalmol, V46, P212, DOI 10.1136/bjo.46.4.212; Hayreh S S, 1962, Br J Ophthalmol, V46, P65, DOI 10.1136/bjo.46.2.65; HAYREH SS, 1963, ANAL I BARRAQUER, V4, P7; HAYREH SS, 1972, OPTIC NERVE, P59; KENNERDELL JS, 1976, ARCH OPHTHALMOL-CHIC, V94, P1040; LANG J, 1981, CRANIAL NERVES, P77; MANFREDI SJ, 1981, PLAST RECONSTR SURG, V68, P479, DOI 10.1097/00006534-198110000-00001; MANISCALCO JE, 1978, J NEUROSURG, V48, P402, DOI 10.3171/jns.1978.48.3.0402; MATSUZAKI H, 1986, NEURO-OPHTHALMOLOGY, V6, P23, DOI 10.3109/01658108608997321; NIHO S, 1961, AM J OPHTHALMOL, V51, P659, DOI 10.1016/0002-9394(61)91611-7; NIHO S, 1970, CAN J OPHTHALMOLOGY, V5, P22; Pringle JH, 1922, BRIT MED J, V2, P1156; RENN WH, 1975, J NEUROSURG, V43, P288, DOI 10.3171/jns.1975.43.3.0288; Rodger F C, 1943, Br J Ophthalmol, V27, P23, DOI 10.1136/bjo.27.1.23; SAVINO PJ, 1987, OPHTHAL PLAST RECONS, P311; WALSH FRANK B., 1966, INVEST OPHTHALMOL, V5, P433	25	28	44	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1070-8022	1536-5166		J NEURO-OPHTHALMOL	J. Neuro-Ophthal.	SEP	1995	15	3					186	190					5	Clinical Neurology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology	RZ792	WOS:A1995RZ79200012	8574366				2022-02-06	
J	BROOKS, CA; LINDSTROM, J; MCCRAY, J; WHITENECK, GG				BROOKS, CA; LINDSTROM, J; MCCRAY, J; WHITENECK, GG			COST OF MEDICAL-CARE FOR A POPULATION-BASED SAMPLE OF PERSONS SURVIVING TRAUMATIC BRAIN INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							SEVERITY SCORE	To determine the cost of health care services received by persons hospitalized with traumatic brain injuries, a population-based sample of individuals treated at the trauma centers in El Paso County, Colorado, was followed retrospectively for 4 years after injury. Of the random sample of 251 survivors who sustained brain trauma in 1989 and 1990 (stratified by severity), 127 were successfully located and agreed to participate in the research. All medical services provided were identified through both medical record review and extensive patient interviews. Actual charges were obtained directly from the 482 vendors serving these clients. Mean charges for initial hospitalization (including acute care and rehabilitation) ranged from $17,015 for mild injuries to $133,467 for severe injuries. Four-year follow-up charges for rehospitalizations, physician visits, outpatient services, medications, equipment and supplies, attendant care, and miscellaneous services ranged from a mean of $2,323 for mild injuries to $54,701 for severe injuries. At an incidence rate of 69 per 100,000, it is projected that the total costs for new cases of hospitalized traumatic brain injury in any given year in the United States will exceed $8 billion over the course of the first 4 years following injury.	COLORADO DEPT PUBL HLTH & ENVIRONM, DENVER, CO USA		BROOKS, CA (corresponding author), CRAIG HOSP, ENGLEWOOD, CO 80110 USA.						BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BENNETT BR, 1989, J TRAUMA, V29, P556, DOI 10.1097/00005373-198905000-00003; Haase J, 1992, Acta Neurochir Suppl (Wien), V55, P75; HOLMES W, 1991, THESIS U COLORADO DE; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; *NAT HEAD INJ F, FACTS TRAUM BRAIN IN; RUSSELL WR, 1988, CURR CONCEPTS REHABI, V4, P19; Sakata R, 1991, Brain Inj, V5, P411, DOI 10.3109/02699059109008114; SCALING JC, 1980, ABBREVIATED INJURY S; *US BUR CENS, 1990, CENS POP GEN POP CHA	13	28	28	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1995	10	4					1	13		10.1097/00001199-199508000-00002			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RN010	WOS:A1995RN01000002					2022-02-06	
J	MARSH, NV; SMITH, MD				MARSH, NV; SMITH, MD			POST-CONCUSSION SYNDROME AND THE COPING HYPOTHESIS	BRAIN INJURY			English	Article							MINOR HEAD-INJURY; MILD CONCUSSION; RECOVERY; SYMPTOMS; SEQUELAE; MEMORY	Neuropsychological functioning and level of subjective symptomatology was assessed in 15 adults at 2 weeks, 1 month, and 3 months post-concussion. Performance by the concussion subjects was compared to the results obtained by a matched group of normal controls. At 2 weeks post-injury the concussion subjects had deficits in intellectual, attentional, memory, and language abilities. Visuospatial constructional abilities were relatively preserved. Concussed subjects also reported high levels of disturbance in affective, cognitive, and social functioning. By 3 months post-injury the concussed subjects were still displaying deficits in attentional and language functioning. The level of subjective symptoms reported by the concussed subjects was not significantly different fi om that reported by controls. Results provide some support for the 'coping hypothesis' explanation of post-concussion syndrome.			MARSH, NV (corresponding author), UNIV WAIKATO,DEPT PSYCHOL,PRIVATE BAG 3105,HAMILTON,NEW ZEALAND.		Marsh, Nigel/ABA-3609-2021; Marsh, Nigel V./F-5433-2019	Marsh, Nigel/0000-0002-4060-6432; Marsh, Nigel V./0000-0002-4060-6432			BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Beck AT, 1987, BECK DEPRESSION INVE; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1989, ASSESSMENT BEHAV CON, P37; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROOKER BH, 1986, J CLIN PSYCHOL, V42, P982, DOI 10.1002/1097-4679(198611)42:6<982::AID-JCLP2270420624>3.0.CO;2-G; BROOKS DN, 1984, J CLIN NEUROPSYCHOL, V6, P71, DOI 10.1080/01688638408401198; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; JOHNSTON R, 1983, REVISION SOCIOECONOM; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; Nelson H. E, 1982, NATIONAL ADULT READI; OSHAUGHNESSY EJ, 1984, J FAMILY PRACTICE, V18, P394; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SMITH MD, 1993, THESIS U WAIKATO HAM; SPIELBERGER CD, 1983, MANUAL STATE TRAIT A; Spreen O, 1991, COMPENDIUM NEUROPSYC; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	32	28	28	0	5	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	AUG-SEP	1995	9	6					553	562		10.3109/02699059509008214			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RU016	WOS:A1995RU01600002	7581351				2022-02-06	
J	MUIR, JK; TYNAN, M; CALDWELL, R; ELLIS, EF				MUIR, JK; TYNAN, M; CALDWELL, R; ELLIS, EF			SUPEROXIDE-DISMUTASE IMPROVES POSTTRAUMATIC CORTICAL BLOOD-FLOW IN RATS	JOURNAL OF NEUROTRAUMA			English	Article						BRAIN INJURY; SUPEROXIDE; OXYGEN RADICAL; CEREBRAL BLOOD FLOW; LASER-DOPPLER FLOWMETRY; RAT	EXPERIMENTAL BRAIN INJURY; LASER-DOPPLER ASSESSMENT; FLUID-PERCUSSION MODEL; SEVERE HEAD-INJURY; CEREBRAL-ISCHEMIA; OXYGEN RADICALS; EDEMA; CATS; MICROCIRCULATION; PERMEABILITY	Oxygen free radicals, such as the superoxide anion, are known to mediate damage to the; cerebral microcirculation following traumatic brain injury. The purpose of this study was to determine if superoxide dismutase (SOD), a scavenger of superoxide anion, could alter posttraumatic cortical blood flow, Following barbiturate anesthesia, rats were surgically prepared for moderate fluid percussion brain injury, Cortical blood flow contralateral to the site of injury was measured using laser-Doppler flowmetry, Laser-Doppler flowmetry assesses flow by measuring Cell volume and velocity, which are multiplied electronically to give flow, Starting 10 min before injury, animals received either superoxide dismutase (24,000 U/kg bolus, followed by continuous infusion of 1600 U/kg/min) or an equal volume of saline, Blood pressure, heart rate, and cortical blood flow were measured up to 1 h posttrauma, Rats receiving superoxide dismutase had significantly higher cortical blood flow posttrauma (F = 6.91, p < 0.02), One hour posttrauma, the blood flow in SOD-treated rats was 89 +/- 8% of preinjury baseline, whereas this value was only 66 +/- 6% of control in saline-treated rats, SOD caused not only greater blood velocity but also less reduction in cortical blood volume after injury, There were no significant differences between the groups with respect to blood pressure or heart rate, This study further supports the role of oxygen radical-mediated cerebrovascular dysfunction following traumatic brain injury and is the first to show the beneficial effect of SOD on cortical blood flow following fluid percussion brain injury.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298						PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [07027, 27214] Funding Source: Medline		BERNE RM, 1972, CARDIOVASCULAR PHYSL, P1; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CHAN PH, 1984, NEUROLOGY, V34, P315, DOI 10.1212/WNL.34.3.315; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; ELLIS EF, 1995, FASEB J, V9, pA591; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247, DOI 10.1152/ajpheart.1989.256.4.H1247; HABERL RL, 1989, AM J PHYSIOL, V256, pH1255, DOI 10.1152/ajpheart.1989.256.4.H1255; HE YY, 1993, AM J PHYSIOL, V265, pH252, DOI 10.1152/ajpheart.1993.265.1.H252; IKEDA Y, 1990, NEUROSURGERY, V27, P1; KIRSCH JR, 1993, PEDIATR RES, V34, P530, DOI 10.1203/00006450-199310000-00030; KONTOS CD, 1992, AM J PHYSIOL, V263, pH1234, DOI 10.1152/ajpheart.1992.263.4.H1234; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; KUKREJA RC, 1986, CIRC RES, V59, P612, DOI 10.1161/01.RES.59.6.612; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MUIR JK, 1995, J NEUROTRAUM, V12, P87, DOI 10.1089/neu.1995.12.87; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; MUIR JK, 1992, J NEUROTRAUM, V9, P394; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; PFISTER HW, 1992, J INFECT DIS, V166, P1442, DOI 10.1093/infdis/166.6.1442; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; SCHLEIEN CL, 1994, STROKE, V25, P1830, DOI 10.1161/01.STR.25.9.1830; TRUELOVE D, 1994, FREE RADICAL BIO MED, V17, P445, DOI 10.1016/0891-5849(94)90171-6; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YANG GY, 1994, STROKE, V25, P165, DOI 10.1161/01.STR.25.1.165; YOSHIDA K, 1992, J NEUROTRAUM, V9, P85, DOI 10.1089/neu.1992.9.85; YOSHIDA K, 1992, STROKE, V23, P865, DOI 10.1161/01.STR.23.6.865; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; ZHANG XM, 1991, STROKE, V22, P489, DOI 10.1161/01.STR.22.4.489; ZHANG XM, 1990, AM J PHYSIOL, V259, pH497, DOI 10.1152/ajpheart.1990.259.2.H497	44	28	28	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	1995	12	2					179	188		10.1089/neu.1995.12.179			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QZ508	WOS:A1995QZ50800004	7629864				2022-02-06	
J	BIGLER, ED; BURR, R; GALE, S; NORMAN, M; KURTH, S; BLATTER, D; ABILDSKOV, T				BIGLER, ED; BURR, R; GALE, S; NORMAN, M; KURTH, S; BLATTER, D; ABILDSKOV, T			DAY OF INJURY CT SCAN AS AN INDEX TO PRE-INJURY BRAIN MORPHOLOGY	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; DEGENERATIVE CHANGES; CORTICAL ATROPHY; COMA	This study compared the ventricle-to-brain ratio (VBR) of the day-of-injury (DOI) computerized tomogram (CT) in traumatic brain-injured (TBI) patients with post-injury (2 months or greater) magnetic resonance (MR) VBRs in the same patients and in medical control subjects. The DOI VBR did not differ significantly from the medical controls, but both (DOI and medical control VBR) differed significantly from post-injury VBR. Additionally, a case study is presented wherein MR imaging studies were obtained prior to TBI so that a direct comparison of preinjury to DOI to post-injury changes could be made. In this case the pre-injury and DOI VBRs were within approximately 9% of each other. In contrast, the post-injury VBR demonstrated over a 100% increase in comparison to either the pre-injury or DOI scan. This case and another case are illustrated using three-dimensional image analysis to represent ventricular change over time. These cases, along with the similarity of the DOI VBR with the medical controls, suggests that the DOI VBR can be utilized as an estimate or index of pre-injury ventricle/brain morphology. This will permit the use of DOI CT data for within-subject designs in TBI research that examines the course of degenerative changes over time.	LDS HOSP, PROVO, UT USA		BIGLER, ED (corresponding author), BRIGHAM YOUNG UNIV, DEPT PSYCHOL, 148B SWKT, PROVO, UT 84602 USA.						Bigler E. D., 1990, TRAUMATIC BRAIN INJU; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 1992, ARCH CLIN NEUROPSYCH, V7, P449, DOI 10.1016/0887-6177(92)90158-J; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; BLATTER D, 1992, JUN AM SOC NEUR M ST; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; Levin HS., 1982, NEUROBEHAVIORAL CONS; MACNAMARA SE, 1992, ARCH CLIN NEUROPSYCH, V7, P275, DOI 10.1016/0887-6177(92)90169-N; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; MASSMAN PJ, 1986, INT J NEUROSCI, V30, P87, DOI 10.3109/00207458608985659; Ruff RM, 1989, NEUROPSYCHOLOGICAL F, P161; SALAZAR AM, 1992, CHALLENGES NEUROLOGY, P55; TEASDALE G, 1974, LANCET, V2, P81; VILKKI J, 1992, J CLIN EXP NEUROPSYC, V14, P518, DOI 10.1080/01688639208402841	17	28	28	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	1994	8	3					231	238		10.3109/02699059409150975			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ND714	WOS:A1994ND71400004	8004081				2022-02-06	
J	WRIGLEY, JM; YOELS, WC; WEBB, CR; FINE, PR				WRIGLEY, JM; YOELS, WC; WEBB, CR; FINE, PR			SOCIAL AND PHYSICAL FACTORS IN THE REFERRAL OF PEOPLE WITH TRAUMATIC BRAIN INJURIES TO REHABILITATION	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SPINAL-CORD INJURY; CARE		UNIV ALABAMA,DEPT SOCIOL,BIRMINGHAM,AL 35394		WRIGLEY, JM (corresponding author), UNIV ALABAMA,INJURY CONTROL RES CTR,933 S 19TH ST,CHSB 19TH,RM 403,UAB STN,BIRMINGHAM,AL 35394, USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR403641] Funding Source: Medline		BAMFORD E, 1984, BRIT MED J, V292, P546; Blumer H., 1969, SYMB INTERACT; CAPLAN A, 1987, HASTINGS CTR REP S, P1; CURLEY SP, 1989, MED DECIS MAKING, V9, P116, DOI 10.1177/0272989X8900900206; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P449; FINDLEY TW, 1987, MED CARE, V25, P753, DOI 10.1097/00005650-198708000-00008; HAAS JF, 1988, ARCH PHYS MED REHAB, V69, P329; HEINEMANN AW, 1989, ARCH NEUROL-CHICAGO, V46, P1098, DOI 10.1001/archneur.1989.00520460084017; Kassirer JP, 1991, LEARNING CLIN REASON; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; KOSKA M, 1988, HOSPITALS, V4, P63; MCSHERRY JA, 1989, AM FAM PHYSICIAN, V40, P186; MELVIN JL, 1988, ARCH PHYS MED REHAB, V69, P163; SCHWARTZ RJ, 1989, J TRAUMA, V29, P1611, DOI 10.1097/00005373-198912000-00002; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V27, P230; Wehman P, 1989, Brain Inj, V3, P397, DOI 10.3109/02699058909004563; YARKONY GM, 1990, AM J PHYS MED REHAB, V69, P23, DOI 10.1097/00002060-199002000-00006; Zola Irving Kenneth, 1983, SOCIOMEDICAL INQUIRI; 1985, INJURY AM	19	28	28	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	1994	75	2					149	155					7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	MW994	WOS:A1994MW99400004	8311670				2022-02-06	
J	GODFREY, HPD; BISHARA, SN; PARTRIDGE, FM; KNIGHT, RG				GODFREY, HPD; BISHARA, SN; PARTRIDGE, FM; KNIGHT, RG			NEUROPSYCHOLOGICAL IMPAIRMENT AND RETURN TO WORK FOLLOWING SEVERE CLOSED-HEAD INJURY - IMPLICATIONS FOR CLINICAL MANAGEMENT	NEW ZEALAND MEDICAL JOURNAL			English	Article								Aims. To study the rate and timing of return to work following severe closed head injury, and to compare the neuropsychological functioning of patients who successfully return to work with that of patients who fail to return to work. Methods. The vocational status, level of cognitive functioning and personality functioning of a consecutive series of 66 patients who survived severe closed head injury was assessed between six months and three years postinjury. The level of cognitive and personality functioning of patients who returned to work, were compared with that of patients who failed to return to work. Results. Twenty five percent of patients failed to return to work, and a further 17% returned to work under special conditions of employment. Failure to return to work was related to the degree of neuropsychological impairment (cognitive deficit and adverse personality change), injury severity (duration of posttraumatic amnesia), and age. Multiple regression analysis found the total number of neuropsychological symptoms to be the strongest predictor of the patients' return to work. Conclusions. These findings suggest that neuropsychological symptoms are the main mechanism through which severe brain injury affects the ability to return to work. It is recommended that vocational rehabilitation of severe closed head injury patients be based on a comprehensive neuropsychological assessment.	UNIV OTAGO,DEPT SURG NEUROSURG,DUNEDIN,NEW ZEALAND		GODFREY, HPD (corresponding author), UNIV OTAGO,DEPT PSYCHOL,CTR CLIN PSYCHOL RES & TRAINING,POB 56,DUNEDIN,NEW ZEALAND.						BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Brooks D N, 1979, Int Rehabil Med, V1, P160; GODFREY HPD, 1993, IN PRESS J CLIN EXP; GODFREY HPD, 1989, UNPUB MANUAL INPATIE; Gronwall D, 1974, PSYCHOL EFFECTS CONC; HUMPHREY M, 1980, BRAIN INJURIES, V12, P107; Johnson R, 1987, Int Disabil Stud, V9, P49; KNIGHT RG, 1984, J CONSULT CLIN PSYCH, V52, P769; Nelson H. E, 1982, NATIONAL ADULT READI; ODONNELL WE, 1984, J CLIN PSYCHOL, V40, P549, DOI 10.1002/1097-4679(198403)40:2<549::AID-JCLP2270400228>3.0.CO;2-1; PARTRIDGE FM, 1991, THESIS U OTAGO; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; RAVEN JC, 1977, MANUAL RAVENS PROGR; REY A, 1963, EXAMEN CLIN PSYCHOL; RUSSELL WR, 1961, TRAUMATIC AMNESIAS; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164	16	28	29	0	3	NEW ZEALAND MED ASSN	WELLINGTON	PO BOX 156, WELLINGTON, NEW ZEALAND	0028-8446			NEW ZEAL MED J	N. Z. Med. J.	JUL 28	1993	106	960					301	303					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LR336	WOS:A1993LR33600002	8341452				2022-02-06	
J	ALFANO, DP; NEILSON, PM; FINK, MP				ALFANO, DP; NEILSON, PM; FINK, MP			LONG-TERM PSYCHOSOCIAL ADJUSTMENT FOLLOWING HEAD OR SPINAL-CORD INJURY	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						CLOSED HEAD INJURY; SPINAL CORD INJURY; PREINJURY; POSTINJURY; PSYCHOSOCIAL FUNCTIONING	NEUROPSYCHOLOGICAL RECOVERY; SOCIAL-ADJUSTMENT; BRAIN INJURY; REHABILITATION; DEPRESSION; MODERATE; SEQUELAE; DEFICIT; FAMILY; STAFF	The long-term psychosocial sequelae of traumatic injury to the brain or spinal cord were comparatively examined in patients who had sustained either moderate-to-severe closed head injury (CHI) or spinal cord injury (SCI). Both groups experienced significant pre- to postinjury reductions in socioeconomic and employment status. In addition to cognitive dysfunction, the patients with CHI reported significantly greater depressive symptomotology, and a pattern of psychological adjustment characterized by greater chronic tension, social alienation, and moodiness. No differences were found between patients' reports of psychosocial functioning as assessed across a broad range of relevant dimensions that included the vocational, domestic, and social environments. In the group with CHI, memory dysfunction was consistently correlated with a broad range of psychological variables, including degree of depressive symptomotology and anxiety. Memory dysfunction was also the most significant correlate of long-term psychosocial adjustment for the patients with CHI; degree of depressive symptomotology, age at injury, and level of injury to the spinal cord were the most significant correlates for the patients with SCI. The relatives of the patients with CHI reported significantly greater patient dysfunction in the areas of vocational and social-role performance outside the home than did the patients themselves. The results are discussed in terms of the specific and the general long-term sequelae resulting from traumatic injury to the brain or spinal cord and associated implications for rehabilitation.	WASCANA REHABIL CTR, REGINA, SK, CANADA		ALFANO, DP (corresponding author), UNIV REGINA, DEPT PSYCHOL, REGINA S4S 0A2, SASKATCHEWAN, CANADA.						Adams RD, 1989, PRINCIPLES NEUROLOGY; Alfano D. P., 1987, CLIN NEUROPSYCHOL, V1, P105; Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; ALFANO DP, 1991, J CLIN EXP NEUROPSYC, V13, P23; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; [Anonymous], 1978, INT CLASSIFICATION D; BLISHEN BR, 1976, CAN REV SOC ANTHROP, V13, P71, DOI 10.1111/j.1755-618X.1976.tb00759.x; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Chelune G. J, 1986, NEUROPSYCHOLOGY HDB, P489; Chelune GJ, 1986, ADV CLIN NEUROPSYCHO, V3, P95, DOI [10.1007/978-1-4613-2211-5_4, DOI 10.1007/978-1-4613-2211-5_4]; CUSHMAN LA, 1990, ARCH PHYS MED REHAB, V71, P191; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DECKER SD, 1985, AM J OCCUP THER, V39, P740, DOI 10.5014/ajot.39.11.740; Derogatis L. R., 1983, PSYCHOSOCIAL ADJUSTM; Devins G., 1988, PSYCHOL HEALTH, V2, P139, DOI DOI 10.1080/08870448808400349; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; Fidell L.S., 1983, USING MULTIVARIATE S; FINLAYSON MAJ, 1988, CAN PSYCHOL, V29, P250; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; FRANK RG, 1987, CLIN PSYCHOL REV, V7, P611, DOI 10.1016/0272-7358(87)90009-2; GRANT I, 1987, NEUROBEHAVIORAL RECO, P232; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KATKIN ES, 1978, 8TH MENT MEAS YB, V683; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Miller WG, 1986, NEUROPSYCHOLOGY HDB, P347; MILLON T, 1979, PROF PSYCHOL, V10, P529, DOI 10.1037/0735-7028.10.4.529; MILLON T, 1982, BEHAVIORAL HLTH INVE; Najenson T, 1980, Int Rehabil Med, V2, P17; NEILSON PM, 1991, CAN PSYCHOL, V32, P215; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PANIAK CE, 1991, J CLIN EXP NEUROPSYC, V13, P92; PANIAK CE, 1990, THESIS U WINDSON WIN; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Roueche JR, 1983, COGNITIVE REHABILITA, V1, P4; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; STAMBROOK M, 1991, J CLIN EXP NEUROPSYC, V13, P521, DOI 10.1080/01688639108401068; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; STUSS DT, 1988, J CLIN EXP NEUROPSYC, V10, P42; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; TEASDALE G, 1974, LANCET, V2, P81; TRIESCHMANN RB, 1980, SPINAL CORD INJURIES; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	56	28	28	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	APR	1993	6	2					117	125					9	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	KV540	WOS:A1993KV54000007					2022-02-06	
J	GARSKE, GG; THOMAS, KR				GARSKE, GG; THOMAS, KR			SELF-REPORTED SELF-ESTEEM AND DEPRESSION - INDEXES OF PSYCHOSOCIAL ADJUSTMENT FOLLOWING SEVERE TRAUMATIC BRAIN INJURY	REHABILITATION COUNSELING BULLETIN			English	Article								The authors investigated self-reported psychosocial adjustment of young adults who received inpatient treatment for severe closed head injuries and were later discharged into the community.	UNIV WISCONSIN,DEPT REHABIL PSYCHOL & SPECIAL EDUC,MADISON,WI 53706; UNIV WISCONSIN,DEPT THERAPEUT SCI,MADISON,WI 53706		GARSKE, GG (corresponding author), UNIV ILLINOIS,DIV REHABIL EDUC SERV,URBANA,IL 61801, USA.						ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Beck A.T., 1967, DEPRESSION CAUSES TR; BECK AT, 1979, COGNITIVE THERAPY DE; Beck AT, 1987, BECK DEPRESSION INVE; BRACY OL, 1986, COGNITIVE REHABILITA, V4, P10; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; BURTON LA, 1988, J NEUROLOGICAL REHAB, V2, P151; COLE JR, 1984, INNOVATIONS HEAD INJ; CRANDALL R, 1973, MEASURES SOCIAL PSYC, P00045; FORER SK, 1984, FUNCTIONAL ASSESSMEN, P171; GOLDSTEIN H, 1942, EFFECTS BRAIN INJURI; HEINEMANN AW, 1982, REHABILITATION COUNS, V24, P197; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KRAVETZ S, 1985, REHABIL PSYCHOL, V30, P195, DOI 10.1037//0090-5550.30.4.195; KRAVETZ S, 1973, THESIS U WISCONSIN; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Maslow Abraham., 1954, MOTIVATION PERSONALI; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; PASINO J, 1979, REHABILITATION HEAD; PRENDERGAST MA, 1975, MEAS EVAL GUID, V8, P92, DOI 10.1080/00256307.1975.12022675; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; REAGLES KW, 1976, J REHABIL, V42, P34; REYNOLDS WM, 1988, J PERS ASSESS, V52, P441; Robinson John P., 1973, MEASURES SOCIAL PSYC; ROGERS CR, 1951, CLIENT CENTERED THER; ROMANO MD, 1984, REHABILITATION PSYCH; Rosenberg M., 1965, SOC ADOLESCENT SELF; THOMAS KR, 1986, APPL REHABILITATION, P34; TRIESCHMAN R, 1978, PSYCHOL SOCIAL VOCAT; Williams J., 1990, J HEAD TRAUMA REHAB, V5, P9, DOI [https://doi.org/10.1097/00001199-199003000-00004, DOI 10.1097/00001199-199003000-00004]; WYLIE RC, 1974, SELF CONCEPT, V1; [No title captured]	34	28	28	0	2	AMER COUNSELING ASSOC	ALEXANDRIA	5999 STEVENSON AVE, ALEXANDRIA, VA 22304-3300	0034-3552			REHABIL COUNS BULL	Rehabil. Couns. Bull.	SEP	1992	36	1					44	52					9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	JJ715	WOS:A1992JJ71500004					2022-02-06	
J	DONDERS, J				DONDERS, J			PREMORBID BEHAVIORAL AND PSYCHOSOCIAL ADJUSTMENT OF CHILDREN WITH TRAUMATIC BRAIN INJURY	JOURNAL OF ABNORMAL CHILD PSYCHOLOGY			English	Article							HEAD-INJURIES; SEQUELAE	The premorbid adjustment of 85 six- to sixteen-year-old children with traumatic brain injury was assessed by means of standardized rating forms that were completed by the children's parents and teachers. Parents and teachers were in moderate agreement when rating children's premorbid functioning. Less than 11 % of the children appeared to have premorbid disturbances. Premorbid adjustment did not appear to be clearly related to injury severity or to type of injury. It is concluded that premorbid behavioral and psychosocial factors are not strongly related to the incidence of traumatic brain injury in a sample of children with predominantly relatively severe injuries.			DONDERS, J (corresponding author), MARY FREE BED HOSP & REHABIL CTR,DEPT PSYCHOL,235 WEALTHY SE,GRAND RAPIDS,MI 49503, USA.						ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; Annegers J. F., 1983, PEDIATRIC HEAD TRAUM, P1; BIJUR PE, 1986, AM J DIS CHILD, V140, P487, DOI 10.1001/archpedi.1986.02140190097036; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Edelbrock C., 1986, MANUAL TEACHERS REPO; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; JAFFE KM, 1986, J HEAD TRAUMA REHAB, V1, P30; KLONOFF H, 1971, AM J PUBLIC HEALTH N, V61, P2405, DOI 10.2105/AJPH.61.12.2405; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; MCGUIRE TL, 1986, J HEAD TRAUMA REHAB, V1, P1; RIVERA FP, 1986, J HEAD TRAUMA REHABI, V1, P7; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; TEASDALE G, 1974, LANCET, V2, P81; [No title captured]; [No title captured]	19	28	28	0	4	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0091-0627			J ABNORM CHILD PSYCH	J. Abnorm. Child Psychol.	JUN	1992	20	3					233	246		10.1007/BF00916690			14	Psychology, Clinical; Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	JA534	WOS:A1992JA53400001	1619132				2022-02-06	
J	DEHAAN, EHF; YOUNG, AW; NEWCOMBE, F				DEHAAN, EHF; YOUNG, AW; NEWCOMBE, F			NEUROPSYCHOLOGICAL IMPAIRMENT OF FACE RECOGNITION UNITS	QUARTERLY JOURNAL OF EXPERIMENTAL PSYCHOLOGY SECTION A-HUMAN EXPERIMENTAL PSYCHOLOGY			English	Article							PROSOPAGNOSIC PATIENT; COVERT RECOGNITION; FACIAL RECOGNITION; UNFAMILIAR FACES; FAMILIAR FACES; EXTERNAL FEATURES; MATCHING FAMILIAR; AWARENESS; IDENTIFICATION; PERCEPTION	Despite the absence of "conscious", overt identification, some patients with face recognition impairments continue covertly to process information regarding face familiarity. The fact that by no means all patients show these covert effects has led to the suggestion that indirect recognition tasks may help in identifying different types of face recognition impairment. The present report describes a number of experiments with the patient NR, who, after a closed head injury, has been severely impaired at recognizing familiar faces. Investigations mostly failed to show overt or covert face recognition, but NR performed at an above-chance level in selecting the familiar face on a task requiring a forced-choice between a familiar and an unfamiliar face. This discrepancy between a degree of rudimentary overt recognition and absence of covert effects on most indirect tests was addressed using a cross-domain identity priming paradigm. This examined separately the possibility of preserved recognition for faces that NR consistently chose correctly in a forced-choice familiarity decision and those on which he performed at chance level. Priming effects were apparent only for the faces that were consistently chosen as "familiar" in forced-choice. We suggest that NR's stored representations of familiar faces are degraded, so that face recognition is possible only via a limited set of relatively preserved representations able to support a rudimentary form of overt recognition and to facilitate performance in matching and priming tasks.	RADCLIFFE INFIRM,OXFORD OX2 6HE,ENGLAND; UNIV DURHAM,DURHAM DH1 3HP,ENGLAND		DEHAAN, EHF (corresponding author), UNIV UTRECHT,DEPT PSYCHONOM,POB 80 140,3508 TC UTRECHT,NETHERLANDS.		Young, Andy/G-2189-2011	Young, Andy/0000-0002-1202-6297; de Haan, Edward/0000-0003-0312-3674			Bauer R.M., 1986, ASPECTS FACE PROCESS, P253, DOI 10.1007/978-94-009-4420-6_27.; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; BENTON A L, 1978, Archives of Neurology, V35, P364; BENTON AL, 1973, NEUROSENSORY CTR PUB, V287; BENTON AL, 1977, VISUAL RETENTION TES, V1; BLANCGARIN J, 1984, ANN PSYCHOL, V84, P573; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BRUCE V, 1985, BRIT J PSYCHOL, V76, P373, DOI 10.1111/j.2044-8295.1985.tb01960.x; BRUCE V, 1986, Q J EXP PSYCHOL-A, V38, P125, DOI 10.1080/14640748608401588; Bruce V., 1988, RECOGNISING FACES; BRUYER R, 1983, BRAIN COGNITION, V2, P257, DOI 10.1016/0278-2626(83)90014-3; CHAPMAN JC, 1924, CHAPMAN COOK SPEED R; Cheesman J., 1985, READING RES ADV THEO, V5, P311; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; De Haan E. H., 1991, EUROPEAN J COGNITIVE, V3, P51, DOI DOI 10.1080/09541449108406219; DEHAAN EHF, 1987, COGN NEUROPSYCHOL, V4, P385, DOI 10.1080/02643298708252045; DEHAAN EHF, 1987, CORTEX, V23, P309, DOI 10.1016/S0010-9452(87)80041-2; DEHAAN EHF, 1986, ASPECTS FACE PROCESS, P279; ELLIS AW, 1987, Q J EXP PSYCHOL-A, V39, P193, DOI 10.1080/14640748708401784; Ellis H. D., 1986, ASPECTS FACE PROCESS, P243, DOI DOI 10.1007/978-94-009-4420-6_26; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; Ellis HD, 1986, NEUROPSYCHOLOGY FACE, P1; ENDO M, 1984, Tohoku Psychologica Folia, V43, P23; ETCOFF NL, 1991, J COGNITIVE NEUROSCI, V3, P25, DOI 10.1162/jocn.1991.3.1.25; Hay D., 1982, NORMALITY PATHOLOGY, P173; Hecaen H., 1981, PERCEIVING REMEMBERI, P39; HUMPHREYS GW, 1981, BRIT J PSYCHOL, V72, P323, DOI 10.1111/j.2044-8295.1981.tb02191.x; HUMPHREYS GW, 1991, NEUROPSYCHOLOGY CONS; JACOBY LL, 1982, CAN J PSYCHOL, V36, P300, DOI 10.1037/h0080638; KUNSTWILSON WR, 1980, SCIENCE, V207, P557, DOI 10.1126/science.7352271; LANDIS T, 1986, CORTEX, V22, P243, DOI 10.1016/S0010-9452(86)80048-X; LANSDELL H, 1968, PHYSIOL BEHAV, V3, P271, DOI 10.1016/0031-9384(68)90097-8; MCNEIL JE, 1991, Q J EXP PSYCHOL-A, V43, P267, DOI 10.1080/14640749108400970; MEADOWS JC, 1974, J NEUROL NEUROSUR PS, V37, P489, DOI 10.1136/jnnp.37.5.489; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; NEWCOMBE F, 1971, J NEUROL NEUROSUR PS, V34, P329, DOI 10.1136/jnnp.34.3.329; NEWCOMBE F, 1989, NEUROPSYCHOLOGIA, V27, P179, DOI 10.1016/0028-3932(89)90170-X; REINGOLD EM, 1988, PERCEPT PSYCHOPHYS, V44, P563, DOI 10.3758/BF03207490; REINGOLD EM, 1990, MIND LANGUAGE, V5, P93; RENAULT B, 1989, NEUROPSYCHOLOGIA, V27, P905, DOI 10.1016/0028-3932(89)90066-3; RIZZO M, 1987, ANN NEUROL, V22, P41, DOI 10.1002/ana.410220111; Schacter D.L., 1988, THOUGHT LANGUAGE, P242; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SERGENT J, 1989, BRAIN, V112, P975, DOI 10.1093/brain/112.4.975; SERGENT J, 1990, BRAIN, V113, P989, DOI 10.1093/brain/113.4.989; SHALLICE T, 1988, COGNITIVE NEUROPSYCH, V5, P133, DOI 10.1080/02643298808252929; SHALLICE T, 1986, COGN NEUROPSYCHOL, V3, P429, DOI 10.1080/02643298608252030; THURSTONE LL, 1937, PSYCHOL TEST STUDY M; TRANEL D, 1985, SCIENCE, V228, P1453, DOI 10.1126/science.4012303; TRANEL O, 1987, J CLIN EXP NEUROPSYC, V9, P15; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; Weiskrantz L., 1986, OXFORD PSYCHOL SERIE, V12; YOUNG A W, 1991, European Journal of Cognitive Psychology, V3, P5, DOI 10.1080/09541449108406218; YOUNG AW, 1986, PSYCHOL RES-PSYCH FO, V48, P63, DOI 10.1007/BF00309318; YOUNG AW, 1990, BRAIN COGNITION, V14, P1, DOI 10.1016/0278-2626(90)90056-T; YOUNG AW, 1986, J EXP PSYCHOL HUMAN, V12, P466, DOI 10.1037/0096-1523.12.4.466; YOUNG AW, 1988, Q J EXP PSYCHOL-A, V40, P561, DOI 10.1080/02724988843000087; YOUNG AW, 1988, COGNITIVE NEUROPSYCH, V5, P317, DOI 10.1080/02643298808252938; YOUNG AW, 1985, PERCEPTION, V14, P737, DOI 10.1068/p140737; YOUNG AW, 1989, BRAIN COGNITION, V9, P16, DOI 10.1016/0278-2626(89)90042-0; YOUNG AW, 1988, THOUGHT LANGUAGE, P78; YOUNG AW, UNPUB NATURE SEMANTI; YOUNG AW, 1991, NEUROPSYCHOLOGY CONS; YOUNG AW, 1990, MIND LANG, V5, P29	65	28	28	0	1	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE, EAST SUSSEX, ENGLAND BN3 2FA	0272-4987			Q J EXP PSYCHOL-A	Q. J. Exp. Psychol. Sect A-Hum. Exp. Psychol.	JAN	1992	44	1					141	175		10.1080/14640749208401287			35	Psychology; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	GY955	WOS:A1992GY95500007	1546182				2022-02-06	
J	MCGUIRT, WF; STOOL, SE				MCGUIRT, WF; STOOL, SE			TEMPORAL BONE-FRACTURES IN CHILDREN - A REVIEW WITH EMPHASIS ON LONG-TERM SEQUELAE	CLINICAL PEDIATRICS			English	Article							HEAD-INJURY; FACIAL PARALYSIS	A 10-year retrospective study of pediatric basilar skull fractures identified 102 patients with temporal bone fractures, of which 92 had otolaryngologic and audiologic evaluations. The otologic data provide documentation of the nature, common physical findings, complications, and management of these fractures. The prognosis of hearing impairment in children caused by temporal bone fractures is elucidated, as 76 of the 92 patients were available for long-term follow-up. Close interaction between involved services evaluating and treating pediatric trauma cases is mandatory for optimal patient outcome. A literature review of the presentation, complications, and management of pediatric temporal bone fractures is presented.	CHILDRENS HOSP,PEDIAT & OTOLARYNGOL,PITTSBURGH,PA 15213		MCGUIRT, WF (corresponding author), UNIV PITTSBURGH,DEPT OTOLARYNGOL,PITTSBURGH,PA 15213, USA.						AQUILAR EA, 1987, HEAD NECK SURG, V9, P162; BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; BRAWLEY BW, 1967, J NEUROSURG, V26, P56; CALDICOTT WJ, 1973, J NEUROSURG, V38, P1, DOI 10.3171/jns.1973.38.1.0001; CANNON CR, 1983, ARCH OTOLARYNGOL, V109, P285; EAVEY RD, 1989, ARCH OTOLARYNGOL, V115, P600; FISCH U, 1974, LARYNGOSCOPE, V84, P2141, DOI 10.1288/00005537-197412000-00005; FISCH U, 1984, AM J OTOL, V5, P494; GOODWIN WJ, 1983, OTOLARYNG CLIN N AM, V16, P651; GRIFFIN JE, 1979, LARYNGOSCOPE, V89, P1432, DOI 10.1002/lary.5540890908; GRIFFITH MV, 1979, J LARYNGOL OTOL, V93, P252; GROVE WE, 1939, LARYNGOSCOPE, V45, P678; HARKER LA, 1974, OTOLARYNG CLIN N AM, V7, P425; HASSO AN, 1988, OTOLARYNG CLIN N AM, V21, P295; Hendrick E B, 1964, Clin Neurosurg, V11, P46; Hicks G W, 1980, Laryngoscope, V90, P1, DOI 10.1288/00005537-198011001-00001; HOUGH JVD, 1969, ANN OTO RHINOL LARYN, V78, P210, DOI 10.1177/000348946907800202; Klastersky J, 1976, Surg Neurol, V6, P111; LEECH PJ, 1973, LANCET, V1, P1013; LINDSAY JR, 1976, ANN OTO RHINOL LARYN, V86, P699; LIUSHINDO M, 1989, INT J PEDIATR OTORHI, V17, P109, DOI 10.1016/0165-5876(89)90086-4; MACGEE EE, 1970, J NEUROSURG, V33, P312, DOI 10.3171/jns.1970.33.3.0312; MAKASHIMA K, 1975, ARCH OTOLARYNGOL, V101, P426; MAY M, 1979, LARYNGOSCOPE, V89, P906; MAY M, 1982, DISORDERS FACIAL NER, P413; MEALEY J, 1982, PEDIAT NEUROSURGERY, P292; Muller D, 1965, HNO, V13, P161; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; SCHUBIGER O, 1986, NEURORADIOLOGY, V28, P93, DOI 10.1007/BF00327878; SCHUKNECHT JF, 1969, ANN OTO RHINOL LARYN, V78, P253; Tos M, 1971, J Laryngol Otol, V85, P1147, DOI 10.1017/S0022215100074569; TOS M, 1973, ACTA OTO-LARYNGOL, V75, P353, DOI 10.3109/00016487309139745; VARTIAINEN E, 1985, ACTA OTO-LARYNGOL, V99, P529, DOI 10.3109/00016488509182257; WIET RJ, 1985, AM J OTOL, V6, P207	34	28	28	0	1	WESTMINSTER PUBL INC	GLEN HEAD	708 GLEN COVE AVE, GLEN HEAD, NY 11545	0009-9228			CLIN PEDIATR	Clin. Pediatr.	JAN	1992	31	1					12	18		10.1177/000992289203100103			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	HE454	WOS:A1992HE45400003	1737413				2022-02-06	
J	OSHIRO, Y; SAKURAI, Y; TANAKA, T; KIKUCHI, T; HIROSE, T; TOTTORI, K				OSHIRO, Y; SAKURAI, Y; TANAKA, T; KIKUCHI, T; HIROSE, T; TOTTORI, K			NOVEL CEREBROPROTECTIVE AGENTS WITH CENTRAL-NERVOUS-SYSTEM STIMULATING ACTIVITY .2. SYNTHESIS AND PHARMACOLOGY OF THE 1-(ACYLAMINO)-7-HYDROXYINDAN DERIVATIVES	JOURNAL OF MEDICINAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; CEREBRAL-ISCHEMIA; ASSAY	In a continuous search for a novel cerebroprotective drug with a central nervous system (CNS) stimulating activity, a series of 1-(acylamino)-7-hydroxyindan derivatives has been synthesized and tested for its dual activities. The cerebroprotective activities of the compounds in this series were evaluated in terms of their effect on the survival of mice in hypoxic conditions (210 mmHg), and their CNS stimulating activities were examined by evaluating their promotional effects on the recovery from coma induced by cerebral concussion in mice. Several compounds prolonged the survival of mice in the hypoxic conditions at a dose of 30 mg/kg po. Four compounds in this series showed the CNS-stimulating effect at the same dose. Among them, 7-hydroxy-1-[[4-(3-methoxyphenyl)-1-piperazinyl]acetyl]amino]-2,2,4,6-tetramethylindan (18, OPC-14117), which was active in the two tests with no side effect up to 500 mg/kg po daily for 2 weeks of administration to rats, was selected for preclinical investigations.			OSHIRO, Y (corresponding author), OTSUKA PHARMACEUT CO LTD,INST NEW DRUG RES 3,364-10 KAGASUNO,TOKUSHIMA 77101,JAPAN.						AYER ED, 1990, J MED CHEM, V33, P1145; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; GIANNOTTA SL, 1984, NEUROSURGERY, V15, P497, DOI 10.1227/00006123-198410000-00004; GOLDSTEIN A, 1966, ARCH INT PHARMACOD T, V161, P128; Hashi K, 1988, No To Shinkei, V40, P373; JINNO J, 1990, 12TH ANN M MAGN RES; JOHNSON H, 1986, SIGPLAN NOTICES, V21, P109; MANAKA S, 1977, IGAKU NO AYUMI, V102, P867; MIYAMOTO M, 1981, LIFE SCI, V28, P861, DOI 10.1016/0024-3205(81)90047-3; NAKANISHI M, 1973, LIFE SCI, V13, P467, DOI 10.1016/0024-3205(73)90038-6; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OSHIRO Y, 1991, J MED CHEM, V34, P2004, DOI 10.1021/jm00111a013; SAFAR P, 1977, BRAIN HEART INFARCT, V2, P251; SMITH AL, 1974, STROKE, V5, P1; STOCKS J, 1974, CLIN SCI MOL MED, V47, P215, DOI 10.1042/cs0470215; SUNO M, 1984, JPN J PHARMACOL, V35, P196, DOI 10.1254/jjp.35.196; TURNBULL MJ, 1976, BRIT J PHARMACOL, V58, P27, DOI 10.1111/j.1476-5381.1976.tb07689.x; YAMAMOTO M, 1983, STROKE, V14, P977, DOI 10.1161/01.STR.14.6.977; YASUDA H, 1978, ARCH INT PHARMACOD T, V233, P136; YASUDA H, 1978, J NEUROCHEM, V37, P934; Yatsu FM, 1972, STROKE, V3, P726, DOI 10.1161/01.STR.3.6.726	21	28	28	0	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036	0022-2623			J MED CHEM	J. Med. Chem.	JUL	1991	34	7					2014	2023		10.1021/jm00111a014			10	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FW170	WOS:A1991FW17000014	1676757				2022-02-06	
J	JORDAN, FM; MURDOCH, BE; BUTTSWORTH, DL				JORDAN, FM; MURDOCH, BE; BUTTSWORTH, DL			CLOSED-HEAD-INJURED CHILDRENS PERFORMANCE ON NARRATIVE TASKS	JOURNAL OF SPEECH AND HEARING RESEARCH			English	Article						CLOSED HEAD INJURY; NARRATIVE; CHILDRENS LANGUAGE	DISCOURSE; COHESION; ADULTS				JORDAN, FM (corresponding author), UNIV QUEENSLAND,DEPT SPEECH & HEARING,ST LUCIA,QLD 4067,AUSTRALIA.		Murdoch, Bruce E/C-1397-2012				Applebee A., 1978, CHILDS CONCEPT STORY; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BLOOM L, 1975, REV CHILD DEV RES, V4; CRAFT AW, 1972, BMJ-BRIT MED J, V4, P200, DOI 10.1136/bmj.4.5834.200; Enderby P.M, 1983, BRIT J DISORDERS COM, V17, P165; EWINGCOBBS L, 1985, HEAD INJURY REHABILI; EWINGCOBBS L, 1987, J CLIN EXPT NEUROPSY, V5, P575; Fillmore C.J., 1968, UNIVERSALS LINGUISTI, P1; GAIDOLFI E, 1980, ITAL J NEUROL SCI, V1, P65; Halliday M. K., 1976, COHESION ENGLISH; HAMMILL D, 1982, TEST LANGUAGE DEV IN; Hammill D. D., 1987, TEST ADOLESCENT LANG; HOLM S, 1979, SCAND J STAT, V6, P65; Johnston J. R., 1982, LANG SPEECH HEAR SER, V13, P144, DOI [10.1044/0161-1461.1303.144, DOI 10.1044/0161-1461.1303.144]; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; Kaplan E, 1983, BOSTON NAMING TEST; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; LEVIN H, 1983, PEDIATRIC HEAD TRAUM; LEVIN HS, 1979, CHILD BRAIN, V5, P281; Levin HS., 1982, NEUROBEHAVIORAL CONS; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; MANDLER JM, 1977, COGNITIVE PSYCHOL, V9, P111, DOI 10.1016/0010-0285(77)90006-8; MCLEOD S, 1989, APR AUSTR ASS SPEECH; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Merritt D. D., 1989, J SPEECH HEAR DISORD, V54, P429; Newcomer P, 1982, TEST LANGUAGE DEV; OLLEY L, 1989, AUSTR J HUMAN COMMUN, V17, P43, DOI DOI 10.3109/asl2.1989.17.issue-1.04; OWENS RE, 1988, LANGUAGE DEV INTRO; PAGE JL, 1985, TOPICS LANGUAGE  MAR, P16; ROTH FP, 1986, J SPEECH HEAR DISORD, V51, P8, DOI 10.1044/jshd.5101.08; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; Spreen O., 1969, NEUROSENSORY CTR COM; Stein NL., 1979, NEW DIRECTIONS DISCO; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE G, 1984, CLOSED HEAD INJURY P	37	28	28	0	0	AMER SPEECH-LANG-HEARING ASSN	ROCKVILLE	10801 ROCKVILLE PIKE RD, ROCKVILLE, MD 20852-3279	0022-4685			J SPEECH HEAR RES	J. Speech Hear. Res.	JUN	1991	34	3					572	582		10.1044/jshr.3403.572			11	Language & Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	FQ361	WOS:A1991FQ36100015	2072682				2022-02-06	
J	GOLDSTEIN, FC; LEVIN, HS; BOAKE, C				GOLDSTEIN, FC; LEVIN, HS; BOAKE, C			CONCEPTUAL ENCODING FOLLOWING SEVERE CLOSED HEAD-INJURY	CORTEX			English	Article									UNIV TEXAS, MED BRANCH, DIV NEUROSURG, D-73, GALVESTON, TX 77550 USA; INST REHAB & RES, HOUSTON, TX USA; EMORY UNIV, DEPT NEUROL, ATLANTA, GA 30322 USA						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; BENTON AL, 1978, MANUAL MULTILINGUAL; BOND M, 1984, CLOSED HEAD INJURY P; Bousfield WA, 1953, J GEN PSYCHOL, V49, P229, DOI 10.1080/00221309.1953.9710088; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Butters N., 1980, ALCOHOLIC KORSAKOFFS; CERMAK LS, 1974, BRAIN LANG, V1, P141, DOI 10.1016/0093-934X(74)90030-3; CERMAK LS, 1976, BRAIN LANG, V3, P375, DOI 10.1016/0093-934X(76)90033-X; FREEDMAN M, 1986, BRAIN COGNITION, V5, P108, DOI 10.1016/0278-2626(86)90063-1; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hunt Earl., 1973, PSYCHOL LEARNING MOT, V7; INCISADELLAROCCHETTA A, 1986, CORTEX, V22, P189, DOI 10.1016/S0010-9452(86)80045-4; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; MOFFAT N, 1984, CLIN MANAGEMENT MEMO; MOSCOVITCH M, 1982, HUMAN MEMORY AMNESIA; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; OCONNOR M, 1986, NEUROPSYCHOLOGICAL R; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; RICHARDSON JTE, 1984, CORTEX, V20, P413, DOI 10.1016/S0010-9452(84)80009-X; RUBIN DC, 1981, NEUROPSYCHOLOGIA, V19, P137, DOI 10.1016/0028-3932(81)90053-1; SALMON DP, 1986, NEUROPSYCHOLOGICAL R; SCHACTER DL, 1986, CLIN NEUROPSYCHOLOGY; SQUIRE LR, 1982, J EXP PSYCHOL LEARN, V8, P560, DOI 10.1037/0278-7393.8.6.560; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; TEASDALE G, 1974, LANCET, V2, P81; TULVING E, 1984, BEHAV BRAIN SCI, V7, P257, DOI 10.1017/S0140525X00044617; Tulving E., 1983, ELEMENTS EPISODIC ME; TULVING E, 1987, NEUROBEHAVIORAL RECO; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wechsler, 1997, WECHSLER ADULT INTEL; WEINGARTNER H, 1981, J ABNORM PSYCHOL, V90, P187, DOI 10.1037/0021-843X.90.3.187; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; WICKENS DD, 1970, PSYCHOL REV, V77, P1, DOI 10.1037/h0028569; ZATORRE RJ, 1983, BRAIN COGNITION, V2, P331, DOI 10.1016/0278-2626(83)90017-9; [No title captured]	41	28	28	0	3	ELSEVIER MASSON, CORPORATION OFFICE	PARIS	65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE	0010-9452	1973-8102		CORTEX	Cortex	DEC	1989	25	4					541	554		10.1016/S0010-9452(89)80016-4			14	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychology	CH970	WOS:A1989CH97000001	2612174	Bronze			2022-02-06	
J	KARNAZE, DS; WEINER, JM; MARSHALL, LF				KARNAZE, DS; WEINER, JM; MARSHALL, LF			AUDITORY EVOKED-POTENTIALS IN COMA AFTER CLOSED HEAD-INJURY - A CLINICAL-NEUROPHYSIOLOGIC COMA SCALE FOR PREDICTING OUTCOME	NEUROLOGY			English	Article									UNIV SO CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90033; UNIV CALIF SAN DIEGO,DIV NEUROSURG,LA JOLLA,CA 92093		KARNAZE, DS (corresponding author), UNIV SO CALIF,SCH MED,DEPT NEUROL,2025 ZONAL AVE,ROOM 5641,LOS ANGELES,CA 90033, USA.						ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; BATES D, 1977, ANN NEUROL, V2, P211, DOI 10.1002/ana.410020306; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GOLDIE WD, 1981, NEUROLOGY, V31, P248, DOI 10.1212/WNL.31.3.248; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KARNAZE DS, 1982, NEUROLOGY, V32, P299, DOI 10.1212/WNL.32.3.299; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; NARAYAN R, 1982, J NEUROSURG, V56, P26; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; PLUM F, 1980, DIAGNOSIS STUPOR COM, P326; SALCMAN M, 1981, NEUROSURGERY, V8, P301; SATYAMURTI S, 1983, ELECTROEN CLIN NEURO, V56, P304, DOI 10.1016/0013-4694(83)90255-9; TAKASHI T, 1980, J NEUROL NEUROSURG P, V43, P1005; TEASDALE G, 1974, LANCET, V2, P81; YORK DH, 1981, J NEUROSURG, V55, P909, DOI 10.3171/jns.1981.55.6.0909	21	28	29	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0028-3878			NEUROLOGY	Neurology		1985	35	8					1122	1126		10.1212/WNL.35.8.1122			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ANH03	WOS:A1985ANH0300006	4022346				2022-02-06	
J	BENNETTLEVY, JM				BENNETTLEVY, JM			LONG-TERM EFFECTS OF SEVERE CLOSED HEAD-INJURY ON MEMORY - EVIDENCE FROM A CONSECUTIVE SERIES OF YOUNG-ADULTS	ACTA NEUROLOGICA SCANDINAVICA			English	Article									RADCLIFFE INFIRM, NEUROPSYCHOL UNIT, OXFORD OX2 6HE, ENGLAND					Bennett-Levy, James/0000-0003-0998-116X			ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; BENNETTLEVY J, 1980, BRIT J SOC CLIN PSYC, V19, P177, DOI 10.1111/j.2044-8260.1980.tb00946.x; BENNETTLEVY J, 1984, BRIT J CLIN PSYCHOL, V23, P109, DOI 10.1111/j.2044-8260.1984.tb00634.x; BENNETTLEVY J, 1980, CORTEX, V16, P543, DOI 10.1016/S0010-9452(80)80002-5; BLAKEMORE CB, 1967, J NEUROL NEUROSUR PS, V30, P364, DOI 10.1136/jnnp.30.4.364; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Conkey RC, 1938, ARCH PSYCHOL, P5; DYE OA, 1981, J CLIN PSYCHOL, V37, P472, DOI 10.1002/1097-4679(198107)37:3<472::AID-JCLP2270370304>3.0.CO;2-Q; FODOR IE, 1972, J NEUROL NEUROSUR PS, V35, P818, DOI 10.1136/jnnp.35.6.818; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; JENNETT B, 1975, LANCET, V1, P480; LAWLER KA, 1981, THESIS OXFORD U; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; LEVIN HS, 1977, CORTEX, V13, P119, DOI 10.1016/S0010-9452(77)80003-8; LEVIN HS, 1976, DIS NERV SYST, V37, P68; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; Miller E, 1970, Cortex, V6, P121; MOONEY CM, 1956, CAN J PSYCHOLOGY, V10, P191, DOI 10.1037/h0083671; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Newcombe F., 1969, MISSILE WOUNDS BRAIN; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Russell W Ritchie, 1934, Edinb Med J, V41, P129; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SMITH E, 1974, J NEUROL NEUROSUR PS, V37, P719, DOI 10.1136/jnnp.37.6.719; STEVENS M, 1979, BRIT PSYCHOL SOC C N; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; YNTEMA DB, 1963, HUM FACTORS, V5, P7, DOI 10.1177/001872086300500102	37	28	29	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.		1984	70	4					285	298					14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	TP933	WOS:A1984TP93300004	6507038				2022-02-06	
J	Shahim, P; Politis, A; van der Merwe, A; Moore, B; Ekanayake, V; Lippa, SM; Chou, YY; Pham, DL; Butman, JA; Diaz-Arrastia, R; Zetterberg, H; Blennow, K; Gill, JM; Brody, DL; Chan, L				Shahim, Pashtun; Politis, Adam; van der Merwe, Andre; Moore, Brian; Ekanayake, Vindhya; Lippa, Sara M.; Chou, Yi-Yu; Pham, Dzung L.; Butman, John A.; Diaz-Arrastia, Ramon; Zetterberg, Henrik; Blennow, Kaj; Gill, Jessica M.; Brody, David L.; Chan, Leighton			Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; NEUROCHEMICAL AFTERMATH; NEUROFILAMENT LIGHT; BLOOD BIOMARKERS; PROTEIN	Objective To determine whether neurofilament light (NfL), glial fibrillary acidic protein (GFAP), tau, and ubiquitin C-terminal hydrolase-L1 (UCH-L1) measured in serum relate to traumatic brain injury (TBI) diagnosis, injury severity, brain volume, and diffusion tensor imaging (DTI) measures of traumatic axonal injury (TAI) in patients with TBI. Methods Patients with TBI (n = 162) and controls (n = 68) were prospectively enrolled between 2011 and 2019. Patients with TBI also underwent serum, functional outcome, and imaging assessments at 30 (n = 30), 90 (n = 48), and 180 (n = 59) days, and 1 (n = 84), 2 (n = 57), 3 (n = 46), 4 (n = 38), and 5 (n = 29) years after injury. Results At enrollment, patients with TBI had increased serum NfL compared to controls (p < 0.0001). Serum NfL decreased over the course of 5 years but remained significantly elevated compared to controls. Serum NfL at 30 days distinguished patients with mild, moderate, and severe TBI from controls with an area under the receiver-operating characteristic curve (AUROC) of 0.84, 0.92, and 0.92, respectively. At enrollment, serum GFAP was elevated in patients with TBI compared to controls (p < 0.001). GFAP showed a biphasic release in serum, with levels decreasing during the first 6 months of injury but increasing over the subsequent study visits. The highest AUROC for GFAP was measured at 30 days, distinguishing patients with moderate and severe TBI from controls (both 0.89). Serum tau and UCH-L1 showed weak associations with TBI severity and neuroimaging measures. Longitudinally, serum NfL was the only biomarker that was associated with the likely rate of MRI brain atrophy and DTI measures of progression of TAI. Conclusions Serum NfL shows greater diagnostic and prognostic utility than GFAP, tau, and UCH-L1 for subacute and chronic TBI. Classification of evidence This study provides Class III evidence that serum NfL distinguishes patients with mild TBI from healthy controls.	[Shahim, Pashtun; Politis, Adam; Lippa, Sara M.; Chou, Yi-Yu; Pham, Dzung L.; Butman, John A.; Gill, Jessica M.; Brody, David L.; Chan, Leighton] NIH, Bldg 10, Bethesda, MD 20892 USA; [Shahim, Pashtun; Politis, Adam; van der Merwe, Andre; Moore, Brian; Ekanayake, Vindhya; Chou, Yi-Yu; Pham, Dzung L.; Butman, John A.; Gill, Jessica M.; Brody, David L.; Chan, Leighton] Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Shahim, Pashtun; Politis, Adam; van der Merwe, Andre; Moore, Brian; Ekanayake, Vindhya; Brody, David L.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Shahim, Pashtun; Politis, Adam; Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Shahim, Pashtun; Politis, Adam; Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Politis, Adam; Lippa, Sara M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Politis, Adam; Lippa, Sara M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Politis, Adam; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Politis, Adam; Zetterberg, Henrik] UK Dementia Res Inst UCL, London, England; [Politis, Adam; Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Politis, Adam; Brody, David L.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Shahim, P (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.; Shahim, P (corresponding author), Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA.; Shahim, P (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.; Shahim, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden.; Shahim, P (corresponding author), Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden.	pashtun-poh.shahim@nih.gov	Butman, John/J-2780-2013	Butman, John/0000-0002-1547-9195	Intramural Research Program at the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; DoD (Center for Neuroscience and Regenerative Medicine)United States Department of Defense	Funding provided by the Intramural Research Program at the NIH and the DoD (Center for Neuroscience and Regenerative Medicine).	Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bazin PL, 2011, NEUROIMAGE, V58, P458, DOI 10.1016/j.neuroimage.2011.06.020; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Department of Veterans Affairs, VA DOD CLIN PRACT GU; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Gill J, 2018, NEUROLOGY, V91, pE1385, DOI 10.1212/WNL.0000000000006321; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Gravesteijn BY, 2020, J NEUROTRAUM, V37, P1002, DOI 10.1089/neu.2019.6764; Hossain I, 2019, J NEUROTRAUM, V36, P1551, DOI 10.1089/neu.2018.5952; Hsu ET, 2018, ACTA NEUROPATHOL, V136, P955, DOI 10.1007/s00401-018-1902-3; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hunter LE, 2019, J NEUROTRAUM, V36, P1222, DOI 10.1089/neu.2018.5838; Iverson GL, 2019, J NEUROTRAUM, V36, P2400, DOI 10.1089/neu.2018.6341; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Mouzon B, 2019, J NEUROTRAUM, V36, P576, DOI 10.1089/neu.2018.5720; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Pierpaoli C., 2010, ISMRM 18 ANN M, P1597; Roy S, 2017, NEUROIMAGE, V146, P132, DOI 10.1016/j.neuroimage.2016.11.017; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; WILKINSON KD, 1992, BIOCHEM SOC T, V20, P631, DOI 10.1042/bst0200631; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	37	27	27	4	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	AUG 11	2020	95	6					E623	E636		10.1212/WNL.0000000000009985			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OH2AX	WOS:000582373300017	32641529	Green Submitted, Green Published			2022-02-06	
J	Plog, BA; Lou, NH; Pierre, CA; Cove, A; Kenney, HM; Hitomi, E; Kang, HY; Iliff, JJ; Zeppenfeld, DM; Nedergaard, M; Vates, GE				Plog, Benjamin A.; Lou, Nanhong; Pierre, Clifford A.; Cove, Alex; Kenney, H. Mark; Hitomi, Emi; Kang, Hongyi; Iliff, Jeffrey J.; Zeppenfeld, Douglas M.; Nedergaard, Maiken; Vates, G. Edward			When the air hits your brain: decreased arterial pulsatility after craniectomy leading to impaired glymphatic flow	JOURNAL OF NEUROSURGERY			English	Article						craniectomy; cranioplasty; syndrome of the trephined; glymphatic; CSF; arterial pulsatility	CEREBRAL HEMODYNAMIC-CHANGES; DECOMPRESSIVE CRANIECTOMY; INTERSTITIAL FLUID; MOUSE MODEL; HEAD-INJURY; BLOOD-FLOW; CRANIOPLASTY; HYDROCEPHALUS; PHYSIOLOGY; PATHWAY	OBJECTIVE Cranial neurosurgical procedures can cause changes in brain function. There are many potential explanations, but the effect of simply opening the skull has not been addressed, except for research into syndrome of the trephined. The glymphatic circulation, by which CSF and interstitial fluid circulate through periarterial spaces, brain parenchyma, and perivenous spaces, depends on arterial pulsations to provide the driving force for bulk flow; opening the cranial cavity could dampen this force. The authors hypothesized that a craniectomy, without any other pathological insult, is sufficient to alter brain function due to reduced arterial pulsatility and decreased glymphatic flow. Furthermore, they postulated that glymphatic impairment would produce activation of astrocytes and microglia; with the reestablishment of a closed cranial compartment, the glymphatic impairment, astrocytic/microglial activation, and neurobehavioral decline caused by opening the cranial compartment might be reversed. METHODS Using two-photon in vivo microscopy, the pulsatility index of cortical vessels was quantified through a thinned murine skull and then again after craniectomy. Glymphatic influx was determined with ex vivo fluorescence microscopy of mice 0, 14, 28, and 56 days following craniectomy or cranioplasty; brain sections were immunohistochemically labeled for GFAP and CD68. Motor and cognitive performance was quantified with rotarod and novel object recognition tests at baseline and 14, 21, and 28 days following craniectomy or cranioplasty. RESULTS Penetrating arterial pulsatility decreased significantly and bilaterally following unilateral craniectomy, producing immediate and chronic impairment of glymphatic CSF influx in the ipsilateral and contralateral brain parenchyma. Craniectomy-related glymphatic dysfunction was associated with an astrocytic and microglial inflammatory response, as well as with the development of motor and cognitive deficits. Recovery of glymphatic flow preceded reduced gliosis and return of normal neurological function, and cranioplasty accelerated this recovery. CONCLUSIONS Craniectomy causes glymphatic dysfunction, gliosis, and changes in neurological function in this murine model of syndrome of the trephined.	[Plog, Benjamin A.; Lou, Nanhong; Pierre, Clifford A.; Cove, Alex; Kenney, H. Mark; Hitomi, Emi; Kang, Hongyi; Nedergaard, Maiken; Vates, G. Edward] Univ Rochester, Med Ctr, Dept Neurosurg, Ctr Translat Neuromed, Rochester, NY 14642 USA; [Plog, Benjamin A.] Univ Rochester, Med Ctr, Dept Pathol, Rochester, NY 14642 USA; [Iliff, Jeffrey J.; Zeppenfeld, Douglas M.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Iliff, Jeffrey J.; Zeppenfeld, Douglas M.] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR 97201 USA		Nedergaard, M (corresponding author), Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14642 USA.	nedergaard@urmc.rochester.edu		Kenney, H. Mark/0000-0002-0598-3232	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS078394, RF1AG057575, AG048769]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation	This work was supported by the National Institutes of Health grant nos. NS078394, RF1AG057575, and AG048769 (M.N.) and by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (M.N.).	Abbott NJ, 2004, NEUROCHEM INT, V45, P545, DOI 10.1016/j.neuint.2003.11.006; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Cai RY, 2019, NAT NEUROSCI, V22, P317, DOI 10.1038/s41593-018-0301-3; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CSERR HF, 1981, AM J PHYSIOL, V240, pF319, DOI 10.1152/ajprenal.1981.240.4.F319; CSERR HF, 1971, PHYSIOL REV, V51, P273, DOI 10.1152/physrev.1971.51.2.273; Daboussi A, 2009, J NEUROSURG ANESTH, V21, P339, DOI 10.1097/ANA.0b013e3181b1dbba; Damkier HH, 2013, PHYSIOL REV, V93, P1847, DOI 10.1152/physrev.00004.2013; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; Dujovny M, 1997, NEUROL RES, V19, P311, DOI 10.1080/01616412.1997.11740818; Eide PK, 2015, ACTA RADIOL OPEN, V4, DOI 10.1177/2058460115609635; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Herisson F, 2018, NAT NEUROSCI, V21, P1209, DOI 10.1038/s41593-018-0213-2; HOLNESS CL, 1993, BLOOD, V81, P1607; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Hong JY, 2011, SPINE J, V11, P1121, DOI 10.1016/j.spinee.2011.11.001; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Joseph V, 2009, J NEUROSURG, V111, P650, DOI 10.3171/2009.3.JNS0984; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lazaridis C, 2012, J CLIN NEUROSCI, V19, P1052, DOI 10.1016/j.jocn.2011.08.039; Lee HD, 2015, J NEUROSCI, V35, P11034, DOI 10.1523/JNEUROSCI.1625-15.2015; Louveau A, 2017, J CLIN INVEST, V127, P3210, DOI 10.1172/JCI90603; Lundgaard I, 2017, J CEREBR BLOOD F MET, V37, P2112, DOI 10.1177/0271678X16661202; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Ratner V, 2015, PROC SPIE, V9413, DOI 10.1117/12.2076289; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Shih AY, 2012, JOVE-J VIS EXP, V61, P1; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; SZENTISTVANYI I, 1984, AM J PHYSIOL, V246, pF835, DOI 10.1152/ajprenal.1984.246.6.F835; Thrane VR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02582; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Vertosick FT., 1996, AIR HITS YOUR BRAIN; Wang MH, 2012, J NEUROSCI, V32, P17948, DOI 10.1523/JNEUROSCI.1860-12.2012; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	47	27	28	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2020	133	1					210	223		10.3171/2019.2.JNS182675			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OK0VT	WOS:000584371500037	31100725	Green Accepted			2022-02-06	
J	Vaibhav, K; Braun, M; Alverson, K; Khodadadi, H; Kutiyanawalla, A; Ward, A; Banerjee, C; Sparks, T; Malik, A; Rashid, MH; Khan, MB; Waters, MF; Hesss, DC; Arbab, AS; Vender, JR; Hoda, N; Baban, B; Dhandapani, KM				Vaibhav, Kumar; Braun, Molly; Alverson, Katelyn; Khodadadi, Hesam; Kutiyanawalla, Ammar; Ward, Ayobami; Banerjee, Christopher; Sparks, Tyler; Malik, Aneeq; Rashid, Mohammad H.; Khan, Mohammad Badruzzaman; Waters, Michael F.; Hesss, David C.; Arbab, Ali S.; Vender, John R.; Hoda, Nasrul; Baban, Babak; Dhandapani, Krishnan M.			Neutrophil extracellular traps exacerbate neurological deficits after traumatic brain injury	SCIENCE ADVANCES			English	Article							BLOOD-FLOW; EDEMA; ACCUMULATION; RECRUITMENT; ACTIVATION; THROMBOSIS; DNA	Traumatic brain injury (TBI) is a major cause of mortality and morbidity. Preventative measures reduce injury incidence and/or severity, yet one-third of hospitalized patients with TBI die from secondary pathological processes that develop during supervised care. Neutrophils, which orchestrate innate immune responses, worsen TBI outcomes via undefined mechanisms. We hypothesized that formation of neutrophil extracellular traps ( NETs), a purported mechanism of microbial trapping, exacerbates acute neurological injury after TBI. NET formation coincided with cerebral hypoperfusion and tissue hypoxia after experimental TBI, while elevated circulating NETs correlated with reduced serum deoxyribonuclease-1 (DNase- I) activity in patients with TBI. Functionally, Tolllike receptor 4 (TLR4) and the downstream kinase peptidylarginine deiminase 4 (PAD4) mediated NET formation and cerebrovascular dysfunction after TBI. Last, recombinant human DNase-I degraded NETs and improved neurological function. Thus, therapeutically targeting NETs may provide a mechanistically innovative approach to improve TBI outcomes without the associated risks of global neutrophil depletion.	[Vaibhav, Kumar; Braun, Molly; Alverson, Katelyn; Kutiyanawalla, Ammar; Ward, Ayobami; Banerjee, Christopher; Sparks, Tyler; Vender, John R.; Dhandapani, Krishnan M.] Augusta Univ, Med Coll Georgia, Dept Neurosurg, Augusta, GA 30912 USA; [Khodadadi, Hesam; Malik, Aneeq; Baban, Babak] Augusta Univ, Dent Coll Georgia, Dept Oral Biol, Augusta, GA USA; [Rashid, Mohammad H.; Arbab, Ali S.] Augusta Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA; [Rashid, Mohammad H.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA; [Khan, Mohammad Badruzzaman; Hesss, David C.; Hoda, Nasrul; Baban, Babak] Augusta Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA; [Waters, Michael F.; Hoda, Nasrul] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ USA; [Hoda, Nasrul] St Josephs Hosp, Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ USA; [Baban, Babak] Augusta Univ, Med Coll Georgia, Dept Surg, Augusta, GA USA		Dhandapani, KM (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurosurg, Augusta, GA 30912 USA.	kdhandapani@augusta.edu	Arbab, Ali/AAS-1933-2020; Vaibhav, Kumar/H-4120-2019; Rashid, Mohammad Harun/E-3985-2019	Rashid, Mohammad Harun/0000-0003-1056-4910; Vaibhav, Kumar/0000-0002-4206-3830; Dhandapani, Krishnan/0000-0001-7044-1117	National Institutes of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS065172, NS097825, NS110378]; National Institutes of Child Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD094606]; American Heart AssociationAmerican Heart Association [GRNT33700286]	Financial support for this project was provided by grants from the National Institutes of Neurological Diseases and Stroke (NS065172 and NS097825 to K.M.D. and NS110378 to K.M.D., B.B., and A.S.A.), the National Institutes of Child Health and Development (HD094606 to K.V.), and the American Heart Association (GRNT33700286 to K.M.D.).	Braun M, 2017, J IMMUNOL, V198, P3615, DOI 10.4049/jimmunol.1601948; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Frenette AJ, 2007, PHARMACOTHERAPY, V27, P464, DOI 10.1592/phco.27.3.464; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; Hoda MN, 2012, STROKE, V43, P2794, DOI 10.1161/STROKEAHA.112.660373; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC; Jimenez-Alcazar M, 2015, J THROMB HAEMOST, V13, P732, DOI 10.1111/jth.12796; Jimenez-Alcazar M, 2017, SCIENCE, V358, P1202, DOI 10.1126/science.aam8897; Kawamata T, 2006, ACTA NEUROCHIR SUPPL, V96, P3; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Kielian T, 2001, J IMMUNOL, V166, P4634, DOI 10.4049/jimmunol.166.7.4634; King MD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09223; Kulik T, 2008, NEUROPHARMACOLOGY, V55, P281, DOI 10.1016/j.neuropharm.2008.04.017; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; LUNDQVIST EHA, 1992, CLIN CHIM ACTA, V205, P43, DOI 10.1016/0009-8981(92)90352-Q; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; Martinod K, 2015, BLOOD, V125, P1948, DOI 10.1182/blood-2014-07-587709; Martinod K, 2013, P NATL ACAD SCI USA, V110, P8674, DOI 10.1073/pnas.1301059110; Mastronardi FG, 2006, J NEUROSCI, V26, P11387, DOI 10.1523/JNEUROSCI.3349-06.2006; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Niesen WD, 2004, STROKE, V35, P1873, DOI 10.1161/01.STR.0000132195.17366.2b; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Soares HD, 1995, J NEUROSCI, V15, P8223; Stark K, 2016, BLOOD, V128, P2435, DOI 10.1182/blood-2016-04-710632; Tadie JM, 2013, AM J PHYSIOL-LUNG C, V304, pL342, DOI 10.1152/ajplung.00151.2012; UHL MW, 1994, J NEUROTRAUM, V11, P303, DOI 10.1089/neu.1994.11.303; Valles J, 2017, THROMB HAEMOSTASIS, V117, P1919, DOI 10.1160/TH17-02-0130; von Kockritz-Blickwede M, 2009, BLOOD, V114, P5245, DOI 10.1182/blood-2009-08-240713; Walko TD, 2014, SHOCK, V41, P499, DOI 10.1097/SHK.0000000000000160; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	40	27	28	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	MAY	2020	6	22							eaax8847	10.1126/sciadv.aax8847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LT7HR	WOS:000537238200002	32523980	Green Published, gold			2022-02-06	
J	Zewdie, E; Ciechanski, P; Kuo, HC; Giuffre, A; Kahl, C; King, R; Cole, L; Godfrey, H; Seeger, T; Swansburg, R; Damji, O; Rajapakse, T; Hodge, J; Nelson, S; Selby, B; Gan, L; Jadavji, Z; Larson, JR; MacMaster, F; Yang, JF; Barlow, K; Gorassini, M; Brunton, K; Kirton, A				Zewdie, E.; Ciechanski, P.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Seeger, T.; Swansburg, R.; Damji, O.; Rajapakse, T.; Hodge, J.; Nelson, S.; Selby, B.; Gan, L.; Jadavji, Z.; Larson, J. R.; MacMaster, F.; Yang, J. F.; Barlow, K.; Gorassini, M.; Brunton, K.; Kirton, A.			Safety and tolerability of transcranial magnetic and direct current stimulation in children: Prospective single center evidence from 3.5 million stimulations	BRAIN STIMULATION			English	Article						TMS; tDCS; Children; HD-tDCS; Safety; Tolerability	HUMAN MOTOR CORTEX; NONINVASIVE BRAIN-STIMULATION; PERINATAL STROKE; CORTICAL EXCITABILITY; MAJOR DEPRESSION; ENHANCE WALKING; PLASTICITY; PRINCIPLES; IMPACT; RTMS	Background: Non-invasive brain stimulation is being increasingly used to interrogate neurophysiology and modulate brain function. Despite the high scientific and therapeutic potential of non-invasive brain stimulation, experience in the developing brain has been limited. Objective: To determine the safety and tolerability of non-invasive neurostimulation in children across diverse modalities of stimulation and pediatric populations. Methods: A non-invasive brain stimulation program was established in 2008 at our pediatric, academic institution. Multi-disciplinary neurophysiological studies included single- and paired-pulse Transcranial Magnetic Stimulation (TMS) methods. Motor mapping employed robotic TMS. Interventional trials included repetitive TMS (rTMS) and transcranial direct current stimulation (tDCS). Standardized safety and tolerability measures were completed prospectively by all participants. Results: Over 10 years, 384 children underwent brain stimulation (median 13 years, range 0.8-18.0). Populations included typical development (n = 118), perinatal stroke/cerebral palsy (n = 101), mild traumatic brain injury (n = 121) neuropsychiatric disorders (n = 37), and other (n = 7). No serious adverse events occurred. Drop-outs were rare (<1%). No seizures were reported despite >100 participants having brain injuries and/or epilepsy. Tolerability between single and paired-pulse TMS (542340 stimulations) and rTMS (3.0 million stimulations) was comparable and favourable. TMS-related headache was more common in perinatal stroke (40%) than healthy participants (13%) but was mild and self-limiting. Tolerability improved over time with side-effect frequency decreasing by >50%. Robotic TMS motor mapping was well-tolerated though neck pain was more common than with manual TMS (33% vs 3%). Across 612 tDCS sessions including 92 children, tolerability was favourable with mild itching/tingling reported in 37%. Conclusions: Standard non-invasive brain stimulation paradigms are safe and well-tolerated in children and should be considered minimal risk. Advancement of applications in the developing brain are warranted. A new and improved pediatric NIBS safety and tolerability form is included. (C) 2020 The Authors. Published by Elsevier Inc.	[Zewdie, E.; Ciechanski, P.; Kuo, H. C.; Giuffre, A.; Cole, L.; Seeger, T.; Damji, O.; Hodge, J.; Jadavji, Z.; Larson, J. R.; Kirton, A.] Univ Calgary, Calgary Pediat Stroke Program, Calgary, AB, Canada; [Zewdie, E.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Swansburg, R.; Rajapakse, T.; MacMaster, F.; Barlow, K.; Kirton, A.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Zewdie, E.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Swansburg, R.; Rajapakse, T.; MacMaster, F.; Barlow, K.; Kirton, A.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Zewdie, E.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Swansburg, R.; Rajapakse, T.; MacMaster, F.; Barlow, K.; Brunton, K.; Kirton, A.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Zewdie, E.; Ciechanski, P.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Swansburg, R.; Damji, O.; Rajapakse, T.; MacMaster, F.; Barlow, K.; Kirton, A.] Univ Calgary, Dept Neurosci, Calgary, AB, Canada; [Zewdie, E.; Ciechanski, P.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Seeger, T.; Swansburg, R.; Damji, O.; Rajapakse, T.; Hodge, J.; Nelson, S.; Selby, B.; Gan, L.; Jadavji, Z.; Larson, J. R.; MacMaster, F.; Barlow, K.; Kirton, A.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Yang, J. F.] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada; [Gorassini, M.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada		Zewdie, E (corresponding author), Alberta Childrens Prov Gen Hosp, Oki Dr, Calgary, AB T3B 6A8, Canada.	ephrem.zewdie@ucalgary.ca	Barlow, Karen/C-1323-2014; Rajapakse, Thilinie/ABF-6181-2021	Barlow, Karen/0000-0003-2612-8507; Rajapakse, Thilinie/0000-0002-0425-7132; Giuffre, Adrianna/0000-0001-9632-0612; Swansburg, Rose/0000-0003-0679-6380	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Children's Hospital Foundation; Hotchkiss Brain Institute of University of Calgary	We would like to thank all the participants of the studies and their families. We also would like to thank the several funding agencies that funded the 27 studies included in this paper. We would like to thank Alberto NettelAguirre for his contribution to build the brain stimulation laboratories. We also would like to thank the Canadian Institutes of Health Research, Alberta Children's Hospital Foundation and Hotchkiss Brain Institute of University of Calgary that funded the Pediatric NIBS laboratory.	Allen CH, 2017, PEDIATR NEUROL, V68, P3, DOI 10.1016/j.pediatrneurol.2016.12.009; Andre-Obadia N, 2006, CLIN NEUROPHYSIOL, V117, P1536, DOI 10.1016/j.clinph.2006.03.025; Bae EH, 2007, EPILEPSY BEHAV, V10, P521, DOI 10.1016/j.yebeh.2007.03.004; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Chae Jeong-Ho, 2004, Cogn Behav Neurol, V17, P109, DOI 10.1097/01.wnn.0000116253.78804.3a; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Chhatbar PY, 2016, BRAIN STIMUL, V9, P16, DOI 10.1016/j.brs.2015.09.002; Ciechanski P, 2016, PEDIAT BRAIN STIMULA, P475; Ciechanski P, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00268; Ciechanski P, 2017, CEREB CORTEX, V27, P2758, DOI 10.1093/cercor/bhw114; Cole L, EFFECTS HIGH DEFINIT; Croarkin PE, 2010, J ECT, V26, P323, DOI 10.1097/YCT.0b013e3181dd17eb; Damji O, 2015, DEV MED CHILD NEUROL, V57, P548, DOI 10.1111/dmcn.12704; Durmaz O, 2017, PSYCHIAT CLIN PSYCH, V27, P14, DOI 10.1080/24750573.2017.1293239; Eng D, CLIN NEUROPHYS; Garvey MA, 2004, EUR J PAEDIATR NEURO, V8, P7, DOI 10.1016/j.ejpn.2003.11.002; Garvey MA, 2003, CLIN NEUROPHYSIOL, V114, P1662, DOI 10.1016/S1388-2457(03)00130-5; George MS, 1996, J NEUROPSYCH CLIN N, V8, P172; Grab JG, 2018, J NEUROSCI METH, V309, P41, DOI 10.1016/j.jneumeth.2018.08.007; Hameed MQ, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0719-0; Hong YJH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00029; Hosomi K, 2016, J STROKE CEREBROVASC, V25, P1655, DOI 10.1016/j.jstrokecerebrovasdis.2016.02.024; Hurd C, 2017, PHYS THER, V97, P818, DOI 10.1093/ptj/pzx045; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jamil A, 2017, J PHYSIOL-LONDON, V595, P1273, DOI 10.1113/JP272738; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kessler SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076112; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; Kirton A, 2015, EUR J PAEDIAT NEU S1, V19, pS10, DOI [10.1016/S1090-3798(15)30030-1, DOI 10.1016/S1090-3798(15)30030-1, 10.1016/S1090-3798(15)30030-1;NCT01189058;OP29-2815]; Kirton A, 2017, NEUROLOGY, V88, P259, DOI 10.1212/WNL.0000000000003518; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Krishnan C, 2015, BRAIN STIMUL, V8, P76, DOI 10.1016/j.brs.2014.10.012; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lisanby SH, 2009, NEUROPSYCHOPHARMACOL, V34, P522, DOI 10.1038/npp.2008.118; Machii K, 2006, CLIN NEUROPHYSIOL, V117, P455, DOI 10.1016/j.clinph.2005.10.014; Moliadze V, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/837141; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Quintana H, 2005, J ECT, V21, P88, DOI 10.1097/01.yct.0000162556.02720.58; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schrader LM, 2004, CLIN NEUROPHYSIOL, V115, P2728, DOI 10.1016/j.clinph.2004.06.018; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Tarapore PE, 2016, CLIN NEUROPHYSIOL, V127, P1916, DOI 10.1016/j.clinph.2015.11.043; Tokimura H, 1996, ELECTROMYOGR MOTOR C, V101, P263, DOI 10.1016/0924-980X(96)95664-7; Valero-Cabre A, 2017, NEUROSCI BIOBEHAV R, V83, P381, DOI 10.1016/j.neubiorev.2017.10.006; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wu SW, 2012, DEV MED CHILD NEUROL, V54, P636, DOI 10.1111/j.1469-8749.2012.04300.x; Yang JF, 2013, SEMIN PEDIATR NEUROL, V20, P106, DOI 10.1016/j.spen.2013.06.011; Zewdie E., 2016, PEDIAT BRAIN STIMULA, P475; Zewdie E, 2017, NEUROREHAB NEURAL RE, V31, P261, DOI 10.1177/1545968316680485; Ziemann U, 1998, J PHYSIOL-LONDON, V511, P181, DOI 10.1111/j.1469-7793.1998.181bi.x	56	27	28	3	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	MAY-JUN	2020	13	3					565	575		10.1016/j.brs.2019.12.025			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LO3IP	WOS:000533522600011	32289678	hybrid			2022-02-06	
J	McDonald, SJ; Sharkey, JM; Sun, M; Kaukas, LM; Shultz, SR; Turner, RJ; Leonard, AV; Brady, RD; Corrigan, F				McDonald, Stuart J.; Sharkey, Jessica M.; Sun, Mujun; Kaukas, Lola M.; Shultz, Sandy R.; Turner, Renee J.; Leonard, Anna, V; Brady, Rhys D.; Corrigan, Frances			Beyond the Brain: Peripheral Interactions after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						autonomic dysfunction; infection; inflammation; polytrauma; traumatic brain injury	ENHANCED PULMONARY INFLAMMATION; BONE-MINERAL DENSITY; ACUTE KIDNEY INJURY; HETEROTOPIC OSSIFICATION; RISK-FACTORS; SPINAL-CORD; SODIUM SELENATE; HYPERPHOSPHORYLATED TAU; LUNG INJURY; MOUSE MODEL	Traumatic brain injury (TBI) is a leading cause of death and disability, and there are currently no pharmacological treatments known to improve patient outcomes. Unquestionably, contributing toward a lack of effective treatments is the highly complex and heterogenous nature of TBI. In this review, we highlight the recent surge of research that has demonstrated various central interactions with the periphery as a potential major contributor toward this heterogeneity and, in particular, the breadth of research from Australia. We describe the growing evidence of how extracranial factors, such as polytrauma and infection, can significantly alter TBI neuropathology. In addition, we highlight how dysregulation of the autonomic nervous system and the systemic inflammatory response induced by TBI can have profound pathophysiological effects on peripheral organs, such as the heart, lung, gastrointestinal tract, liver, kidney, spleen, and bone. Collectively, this review firmly establishes TBI as a systemic condition. Further, the central and peripheral interactions that can occur after TBI must be further explored and accounted for in the ongoing search for effective treatments.	[McDonald, Stuart J.; Sun, Mujun; Shultz, Sandy R.; Brady, Rhys D.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Sharkey, Jessica M.; Turner, Renee J.; Leonard, Anna, V] Univ Adelaide, Fac Hlth & Med Sci, Adelaide Med Sch, Discipline Anat & Pathol, Adelaide, SA, Australia; [Kaukas, Lola M.; Corrigan, Frances] Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia; [Shultz, Sandy R.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia		McDonald, SJ (corresponding author), Monash Univ, Dept Neurosci, Alfred Ctr, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	stuart.mcdonald@monash.edu		Corrigan, Frances/0000-0001-6150-8893; McDonald, Stuart/0000-0001-5190-3179; Sun, Mujun/0000-0002-9923-9913	Neurosurgical Research Foundation; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [APP1145483]	This work was supported by funding from the Neurosurgical Research Foundation and the National Health and Medical Research Council (APP1145483).	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Abdel-Haq R, 2019, J EXP MED, V216, P41, DOI 10.1084/jem.20180794; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Ahmed M, 2015, BRIT J NEUROSURG, V29, P544, DOI 10.3109/02688697.2015.1016892; Ajmo CT, 2009, EXP NEUROL, V218, P47, DOI 10.1016/j.expneurol.2009.03.044; Alfieri KA, 2012, BONE JOINT RES, V1, P174, DOI 10.1302/2046-3758.18.2000102; Alharfi IM, 2014, J NEUROTRAUM, V31, P452, DOI [10.1089/neu.2013.2904, 10.1089/NEU.2013.2904]; Almangour W, 2016, ANN PHYS REHABIL MED, V59, P263, DOI 10.1016/j.rehab.2016.03.009; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Andres-Hernando A, 2012, NEPHROL DIAL TRANSPL, V27, P4339, DOI 10.1093/ndt/gfs256; Avlonitis VS, 2005, AM J TRANSPLANT, V5, P684, DOI 10.1111/j.1600-6143.2005.00755.x; AYALA A, 1991, AM J PHYSIOL, V260, pR167, DOI 10.1152/ajpregu.1991.260.1.R167; BALDA MS, 1992, YALE J BIOL MED, V65, P725; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Beaupre GS, 2006, AM J PHYS MED REHAB, V85, P464, DOI 10.1097/01.phm.0000214275.69286.7a; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Brady RD, 2016, J MUSCULOSKEL NEURON, V16, P369; Brady RD, 2020, BONE, V133, DOI 10.1016/j.bone.2020.115263; Brady RD, 2018, BONE, V109, P35, DOI 10.1016/j.bone.2017.05.015; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Brown S, 2011, BRAIN INJURY, V25, P453, DOI 10.3109/02699052.2011.556581; Calsavara AJC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22754-3; Campos MM, 2000, NEUROPEPTIDES, V34, P314, DOI 10.1054/npep.2000.0823; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Cheng LK, 2010, WIRES SYST BIOL MED, V2, P65, DOI 10.1002/wsbm.19; Chmielewski C., 2003, NEPHROL NURS J, V30, P191; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Civiletti F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42147-4; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Corrigan F, 2017, BRAIN BEHAV IMMUN, V64, P124, DOI 10.1016/j.bbi.2017.04.006; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Davydow DS, 2013, AM J GERIAT PSYCHIAT, V21, P887, DOI 10.1016/j.jagp.2013.01.017; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dijkstra-Kersten SMA, 2020, J CRIT CARE, V55, P171, DOI 10.1016/j.jcrc.2019.11.006; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Dong TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0663-y; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; Feighery L, 2008, J TRAUMA, V64, P131, DOI 10.1097/TA.0b013e3181568d9f; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Ferguson ND, 2012, INTENS CARE MED, V38, P1573, DOI 10.1007/s00134-012-2682-1; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fisher AJ, 1999, LANCET, V353, P1412, DOI 10.1016/S0140-6736(99)00494-8; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Freeman WD, 2015, NEUROCRIT CARE, V22, P173, DOI 10.1007/s12028-015-0119-8; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Genet F, 2015, J PATHOL, V236, P229, DOI 10.1002/path.4519; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Gonzalvo R, 2007, CRIT CARE, V11, DOI 10.1186/cc5930; Gregory T, 2012, BJA EDUC, V12, P67, DOI 10.1093/bjaceaccp/mkr058; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hardy R, 2009, J ENDOCRINOL, V201, P309, DOI 10.1677/JOE-08-0568; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Ho CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190683; Hofman M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/204842; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Jin W, 2008, CYTOKINE, V44, P135, DOI 10.1016/j.cyto.2008.07.005; Junger WG, 2013, SHOCK, V40, P366, DOI 10.1097/SHK.0000000000000038; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Kondo H, 2013, AM J PHYSIOL-ENDOC M, V304, pE507, DOI 10.1152/ajpendo.00191.2012; Kong XD, 2014, NEUROSCI BULL, V30, P903, DOI 10.1007/s12264-014-1481-9; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Koutsoukou Antonia, 2016, World J Crit Care Med, V5, P65, DOI 10.5492/wjccm.v5.i1.65; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Kristensen E, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/294965; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Li H, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13260; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Liao DH, 2009, WORLD J GASTROENTERO, V15, P169, DOI 10.3748/wjg.15.169; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lippert-Gruner M, 2007, BRAIN INJURY, V21, P451, DOI 10.1080/02699050701343961; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; Ma QQ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1434-3; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Matsumoto T, 1997, J LEUKOCYTE BIOL, V62, P581, DOI 10.1002/jlb.62.5.581; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Morioka K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48126-z; Morley J, 2005, INJURY, V36, P363, DOI 10.1016/j.injury.2004.08.028; Mrakovcic-Sutic I, 2010, SCAND J IMMUNOL, V72, P57, DOI 10.1111/j.1365-3083.2010.02407.x; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; MUELLER M, 1991, J BONE MINER RES, V6, P401; Nagao M, 2011, P NATL ACAD SCI USA, V108, P17767, DOI 10.1073/pnas.1109402108; Navarro Solano J., 2009, INT J IMMUNOPATHOL S, V22, P13; Nicholson SE, 2019, SHOCK, V52, P240, DOI 10.1097/SHK.0000000000001211; Nicolls MR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010259; Nizamutdinov D, 2017, SCI REP-UK, V7, DOI 10.1038/srep40112; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; O'Leary R, 2011, BJA EDUC, V11, P87, DOI 10.1093/bjaceaccp/mkr006; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Oppl B, 2014, J BONE MINER RES, V29, P1096, DOI 10.1002/jbmr.2122; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Park Chang-Yong, 2016, Korean J Neurotrauma, V12, P89, DOI 10.13004/kjnt.2016.12.2.89; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; Pelosi P., 2002, RESP FAILURE BRAIN I; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Prescott HC, 2019, AM J RESP CRIT CARE, V200, P972, DOI 10.1164/rccm.201812-2383CP; Probst C, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/136020; Purkayastha S, 2019, BRAIN INJURY, V33, P1129, DOI 10.1080/02699052.2019.1631488; Rael LT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-57; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Reed Mary L, 2013, Front Endocrinol (Lausanne), V4, P64, DOI 10.3389/fendo.2013.00064; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; Rizoli SB, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1620-6; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Russo M.V., 2018, J IMMUNOL, V200, P108; Sahbaie P, 2018, J PAIN, V19, P1392, DOI 10.1016/j.jpain.2018.06.004; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; SCHRAUFNAGEL DE, 1993, AM REV RESPIR DIS, V148, P477, DOI 10.1164/ajrccm/148.2.477; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Shahidi B, 2018, J NEUROTRAUM, V35, P398, DOI 10.1089/neu.2017.5172; Sharma R, 2019, BRAIN BEHAV IMMUN, V79, P63, DOI 10.1016/j.bbi.2019.04.034; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00315; Singleton Q, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010063; Skrabal CA, 2005, J SURG RES, V123, P118, DOI 10.1016/j.jss.2004.07.245; Skrifvars MB, 2019, ACTA ANAESTH SCAND, V63, P200, DOI 10.1111/aas.13244; Skrifvars MB, 2017, J TRAUMA ACUTE CARE, V83, P449, DOI 10.1097/TA.0000000000001594; Smith E, 2016, IRISH J MED SCI, V185, P473, DOI 10.1007/s11845-016-1399-5; Smith EM, 2009, ARCH PHYS MED REHAB, V90, P1127, DOI 10.1016/j.apmr.2008.09.578; Smith WS, 1997, CHEST, V111, P1326, DOI 10.1378/chest.111.5.1326; Smithason S, 2013, ACTA NEUROCHIR SUPPL, V115, P253, DOI 10.1007/978-3-7091-1192-5_45; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Sonneville R, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-15; Sun B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128214; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Suto Y, 2019, J NEUROTRAUM, V36, P609, DOI 10.1089/neu.2018.5812; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; THEODORE J, 1975, LANCET, V2, P749; Thompson BT, 2017, NEW ENGL J MED, V377, P562, DOI [10.1056/NEJMra1608077, 10.1056/NEJMc1711824]; Torossian F, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96034; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Turner Ryan C, 2017, Neuroimmunol Neuroinflamm, V4, P6, DOI 10.20517/2347-8659.2016.40; Valencic L., 2015, SANAMED, V10, P185, DOI [10.5937/sanamed1503185V, DOI 10.5937/SANAMED1503185V]; Venturi L, 2009, J NEUROTRAUM, V26, P1547, DOI [10.1089/neu.2008.0723, 10.1089/neu.2008-0723]; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang L, 2011, CHIN J TRAUMATOL, V14, P7, DOI 10.3760/cma.j.issn.1008-1275.2011.01.002; Wang Y, 2017, J NEUROL SCI, V381, P82, DOI 10.1016/j.jns.2017.08.279; Wang YB, 2011, WORLD J GASTROENTERO, V17, P657, DOI 10.3748/wjg.v17.i5.657; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P489, DOI 10.1097/TA.0b013e31827d5f1b; Weckbach S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/890816; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013; Wicker E, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5967816; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wu S, 2006, EXP NEUROL, V200, P245, DOI 10.1016/j.expneurol.2006.01.027; Yang L, 2016, SCAND J IMMUNOL, V83, P26, DOI 10.1111/sji.12393; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhou ZW, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.827; Zhuang YF, 2013, ASIAN PAC J TROP MED, V6, P383, DOI 10.1016/S1995-7645(13)60043-7; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	185	27	28	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2020	37	5					770	781		10.1089/neu.2019.6885			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LD0OA	WOS:000525731200007	32041478				2022-02-06	
J	Erlangsen, A; Stenager, E; Conwell, Y; Andersen, PK; Hawton, K; Benros, ME; Nordentoft, M; Stenager, E				Erlangsen, Annette; Stenager, Egon; Conwell, Yeates; Andersen, Per Kragh; Hawton, Keith; Benros, Michael Eriksen; Nordentoft, Merete; Stenager, Elsebeth			Association Between Neurological Disorders and Death by Suicide in Denmark	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAUMATIC BRAIN-INJURY; DEPRESSIVE SYMPTOMS; PUBLIC-HEALTH; RISK; NATIONWIDE; DEMENTIA; SCLEROSIS; EPILEPSY; PEOPLE; STROKE	This population epidemiology study uses Danish registry data to examine associations between neurological disorders and higher suicide rates from 1980 through 2016. Question Is there an association between neurological disorders and a higher risk of death by suicide? Findings In this retrospective cohort study that included 7300395 persons in Denmark from 1980 through 2016, there was a significantly higher rate of suicide among those with a diagnosed neurological disorder than all other persons (44.0 per 100000 person-years vs 20.1 per 100000 person-years, adjusted incidence rate ratio, 1.8). Meaning In Denmark, having a diagnosis of a neurological disorder was associated with a small but statistically significant increased risk of death by suicide. Importance Neurological disorders have been linked to suicide, but the risk across a broad spectrum of neurological disorders remains to be assessed. Objectives To examine whether people with neurological disorders die by suicide more often than other people and to assess for temporal associations. Design, Setting, and Participants Nationwide, retrospective cohort study on all persons 15 years or older living in Denmark, from 1980 through 2016 (N = 7300395). Exposures Medical contact for head injury, stroke, epilepsy, polyneuropathy, diseases of myoneural junction, Parkinson disease, multiple sclerosis, central nervous system infections, meningitis, encephalitis, amyotrophic lateral sclerosis, Huntington disease, dementia, intellectual disability, and other brain diseases from 1977 through 2016 (n = 1248252). Main Outcomes and Measures Death by suicide during 1980-2016. Adjusted incidence rate ratio (IRRs) were estimated using Poisson regressions, adjusted for sociodemographics, comorbidity, psychiatric diagnoses, and self-harm. Results Of the more than 7.3 million individuals observed over 161935233 person-years (49.1% males), 35483 died by suicide (median duration of follow-up, 23.6 years; interquartile range, 10.0-37.0 years; mean age, 51.9 years; SD, 17.9 years). Of those, 77.4% were males, and 14.7% (n = 5141) were diagnosed with a neurological disorder, equivalent to a suicide rate of 44.0 per 100000 person-years compared with 20.1 per 100000 person-years among individuals not diagnosed with a neurological disorder. People diagnosed with a neurological disorder had an adjusted IRR of 1.8 (95% CI, 1.7-1.8) compared with those not diagnosed. The excess adjusted IRRs were 4.9 (95% CI, 3.5-6.9) for amyotrophic lateral sclerosis, 4.9 (95% CI, 3.1-7.7) for Huntington disease, 2.2 (95% CI, 1.9-2.6) for multiple sclerosis, 1.7 (95% CI, 1.6-1.7) for head injury, 1.3 (95% CI, 1.2-1.3) for stroke, and 1.7 (95% CI, 1.6-1.8) for epilepsy. The association varied according to time since diagnosis with an adjusted IRR for 1 to 3 months of 3.1 (95% CI, 2.7-3.6) and for 10 or more years, 1.5 (95% CI, 1.4 to 1.6, P < .001). Compared with those who were not diagnosed with a neurological disorder, those with dementia had a lower overall adjusted IRR of 0.8 (95% CI, 0.7-0.9), which was elevated during the first month after diagnosis to 3.0 (95% CI, 1.9-4.6; P < .001). The absolute risk of suicide for people with Huntington disease was 1.6% (95% CI, 1.0%-2.5%). Conclusions and Relevance In Denmark from 1980 through 2016, there was a significantly higher rate of suicide among those with a diagnosed neurological disorder than persons not diagnosed with a neurological disorder. However, the absolute risk difference was small.	[Erlangsen, Annette; Nordentoft, Merete] Mental Hlth Ctr Copenhagen, Danish Res Inst Suicide Prevent, Gentofte Hosp Vej 15,4, DK-2900 Hellerup, Denmark; [Erlangsen, Annette] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Erlangsen, Annette] Univ Hosp Reg Southern Denmark, Dept Psychiat, Focused Res Unit, Aabenraa, Denmark; [Erlangsen, Annette] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; Hosp Southern Jutland, MS Clin Southern Jutland Sonderborg Esbjerg Koldi, Sonderborg, Denmark; Hosp Southern Jutland, Dept Neurol, Sonderborg, Denmark; [Stenager, Egon; Stenager, Elsebeth] Univ Southern Denmark, Dept Reg Hlth Res, Odense, Denmark; Hosp Southern Jutland, Ctr Sonderjylland, Focused Res Unit, Aabenraa, Denmark; [Conwell, Yeates] Univ Rochester, Med Ctr, Ctr Study & Prevent Suicide, Rochester, NY 14642 USA; [Andersen, Per Kragh] Univ Copenhagen, Sect Biostat, Copenhagen, Denmark; [Hawton, Keith] Univ Oxford, Ctr Suicide Res, Oxford, England; [Hawton, Keith] Oxford Hlth NHS Fdn Trust, Warnerford Hosp, Oxford, England; [Benros, Michael Eriksen; Nordentoft, Merete] Mental Hlth Ctr Copenhagen, Copenhagen Res Ctr Mental Hlth, Copenhagen, Denmark; [Nordentoft, Merete] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark		Erlangsen, A (corresponding author), Mental Hlth Ctr Copenhagen, Danish Res Inst Suicide Prevent, Gentofte Hosp Vej 15,4, DK-2900 Hellerup, Denmark.	annette.erlangsen@regionh.dk	Stenager, Egon/AAU-4463-2020; Benros, Michael Eriksen/N-5868-2016; Erlangsen, Annette/ABE-1547-2021	Benros, Michael Eriksen/0000-0003-4939-9465; Erlangsen, Annette/0000-0003-3475-0558	Psychiatric Research Foundation; Region of Southern Denmark, Denmark	Supported by a grant from the Psychiatric Research Foundation, Region of Southern Denmark, Denmark.	Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Bronnum-Hansen H, 2005, J NEUROL NEUROSUR PS, V76, P1457, DOI 10.1136/jnnp.2004.056747; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8; Clayton D, 2013, STAT MODELS EPIDEMIO; Cukrowicz KC, 2011, PSYCHOL AGING, V26, P331, DOI 10.1037/a0021836; Elman I, 2013, PROG NEUROBIOL, V109, P1, DOI 10.1016/j.pneurobio.2013.06.003; Erlangsen A, 2008, AM J GERIAT PSYCHIAT, V16, P220, DOI 10.1097/JGP.0b013e3181602a12; Erlangsen A, 2015, SOC PSYCH PSYCH EPID, V50, P1427, DOI 10.1007/s00127-015-1051-0; Erlangsen A, 2015, SCAND J PUBLIC HEALT, V43, P333, DOI 10.1177/1403494815575193; Fang F, 2008, BRAIN, V131, P2729, DOI 10.1093/brain/awn161; Feigin VL, 2019, LANCET NEUROL, V18, P459, DOI 10.1016/S1474-4422(18)30499-X; Fernstrom J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176358; Forsstrom E, 2010, J NEUROPSYCH CLIN N, V22, P182, DOI 10.1176/appi.neuropsych.22.2.182; Fredrikson S, 2003, NEUROEPIDEMIOLOGY, V22, P146, DOI 10.1159/000068746; Haw C, 2009, INT PSYCHOGERIATR, V21, P440, DOI 10.1017/S1041610209009065; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Henson KE, 2019, JAMA PSYCHIAT, V76, P51, DOI 10.1001/jamapsychiatry.2018.3181; Hubers AAM, 2015, J NEUROENDOCRINOL, V27, P234, DOI 10.1111/jne.12255; Lee T, 2016, PARKINSONISM RELAT D, V32, P102, DOI 10.1016/j.parkreldis.2016.09.006; Lund-Sorensen H, 2016, JAMA PSYCHIAT, V73, P912, DOI 10.1001/jamapsychiatry.2016.1594; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Mellion M, 2011, MUSCLE NERVE, V43, P309, DOI 10.1002/mus.21946; Merkies ISJ, 2016, EUR NEUROL, V75, P199, DOI 10.1159/000445347; Nakanishi M, 2014, ALZHEIMERS DEMENT, V10, P468, DOI 10.1016/j.jalz.2013.06.005; Nilsson FM, 2002, J NEUROL NEUROSUR PS, V73, P40, DOI 10.1136/jnnp.73.1.40; Nordentoft M, 2019, SCIENCE, V365, P725, DOI 10.1126/science.aaz1568; Patja K, 2001, ACTA PSYCHIAT SCAND, V103, P307, DOI 10.1034/j.1600-0447.2001.00019.x; Polsky D, 2005, ARCH INTERN MED, V165, P1260, DOI 10.1001/archinte.165.11.1260; Singhal A, 2014, J ROY SOC MED, V107, P194, DOI 10.1177/0141076814522033; Stenager EN, 1996, PSYCHOTHER PSYCHOSOM, V65, P86, DOI 10.1159/000289052; Stenager EN, 1997, DIS PAIN SUICIDAL BE; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Teasdale TW, 2001, J EPIDEMIOL COMMUN H, V55, P863, DOI 10.1136/jech.55.12.863; Tian N, 2016, EPILEPSY BEHAV, V61, P210, DOI 10.1016/j.yebeh.2016.05.028; Tollefsen IM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009120; van Heeringen K, 2014, LANCET PSYCHIAT, V1, P63, DOI 10.1016/S2215-0366(14)70220-2; Veldink JH, 2002, NEW ENGL J MED, V346, P1638, DOI 10.1056/NEJMsa012739; Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561	40	27	27	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 4	2020	323	5					444	454		10.1001/jama.2019.21834			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KL0PK	WOS:000513134700014	32016308	Green Published, Bronze			2022-02-06	
J	Honan, CA; McDonald, S; Tate, R; Ownsworth, T; Togher, L; Fleming, J; Anderson, V; Morgan, A; Catroppa, C; Douglas, J; Francis, H; Wearne, T; Sigmundsdottir, L; Ponsford, J				Honan, Cynthia A.; McDonald, Skye; Tate, Robyn; Ownsworth, Tamara; Togher, Leanne; Fleming, Jennifer; Anderson, Vicki; Morgan, Angela; Catroppa, Cathy; Douglas, Jacinta; Francis, Heather; Wearne, Travis; Sigmundsdottir, Linda; Ponsford, Jennie			Outcome instruments in moderate-to-severe adult traumatic brain injury: recommendations for use in psychosocial research	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; psychosocial; outcome assessment; remediation; research; recommendations	INTERNATIONAL CLASSIFICATION; NEUROPSYCHOLOGICAL OUTCOMES; SHORT-TERM; SCALE; DISABILITY; QUALITY; HEALTH; RELIABILITY; PERCEPTION; AWARENESS	Background: Traumatic brain injury (TBI) can reduce psychosocial functioning, causing relationship, family, and employment difficulties. The present study by Moving Ahead: Centre for Research Excellence (CRE) in Brain Recovery aimed to identify a set of adult outcome instruments for moderate-to-severe TBI psychosocial research. Procedure: A review of 115 instruments (identified through nomination, literature search, and international expert opinion) was conducted over a 15-month period. Eleven psychosocial areas were examined: Global Outcome, Communication, Social Cognition, Behavioural and Executive Function, Other Neuropsychological Functioning, Psychological Status, TBI-related Symptoms, Activities and Participation, Support and Relationships, Sense of Self, and Health-related Quality of Life. Individual instruments were considered against selection guidelines, and specific measures that best met the guidelines were identified as core (common across all studies), supplemental (dependent on study type) or emerging. Results: The final recommendations, organised in accordance with the World Health Organisation's International Classification of Functioning taxonomy, comprised 56 instruments for use in early recovery, outcome, and intervention studies. Conclusion: These recommendations provide a coherent framework along with identified outcome instruments to guide psychosocial research in moderate-to-severe TBI. Adherence to the recommendations will enable data-pooling and comparison across studies and research settings facilitating consistent measurement across the lifespan.	[Honan, Cynthia A.] Univ Tasmania, Sch Med, Dept Psychol, Newnham, Australia; [Honan, Cynthia A.; McDonald, Skye; Tate, Robyn; Ownsworth, Tamara; Togher, Leanne; Fleming, Jennifer; Anderson, Vicki; Morgan, Angela; Catroppa, Cathy; Douglas, Jacinta; Francis, Heather; Wearne, Travis; Sigmundsdottir, Linda; Ponsford, Jennie] Moving Ahead Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia; [McDonald, Skye; Wearne, Travis] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Tate, Robyn; Sigmundsdottir, Linda] Univ Sydney, Sydney Med Sch, Northern Clin Sch, Sydney, NSW, Australia; [Tate, Robyn; Sigmundsdottir, Linda] John Walsh Ctr Rehabil Studies, Sydney, NSW, Australia; [Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Brisbane, Qld, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Fleming, Jennifer] Univ Queensland, Fac Hlth & Behav Sci, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Anderson, Vicki; Catroppa, Cathy] Univ Melbourne, Murdoch Childrens Res Inst, Psychol Sci & Paediat, Melbourne, Vic, Australia; [Morgan, Angela] Univ Melbourne, Murdoch Childrens Res Inst, Ctr Neurosci Speech, Melbourne, Vic, Australia; [Douglas, Jacinta] La Trobe Univ, Dept Community & Clin Allied Hlth, Sch Allied Hlth, Melbourne, Vic, Australia; [Francis, Heather] Macquarie Univ, Fac Human Sci, Dept Psychol, Sydney, NSW, Australia; [Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia		McDonald, S (corresponding author), Moving Ahead Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia.; McDonald, S (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	Catroppa, Cathy/AAX-9458-2021; Togher, Leanne/AAC-7083-2019; Douglas, Jacinta M/C-2380-2009; Fleming, Jennifer/AAH-5108-2020; Ownsworth, Tamara/ABB-6961-2021; Morgan, Angela/J-5235-2017; McDonald, Skye/G-4118-2014; Honan, Cynthia/O-6332-2017	Catroppa, Cathy/0000-0002-9750-0436; Ownsworth, Tamara/0000-0003-1835-7094; Douglas, Jacinta/0000-0003-0940-6624; Anderson, Vicki/0000-0001-5233-3147; Morgan, Angela/0000-0003-1147-7405; Francis, Heather/0000-0002-7223-7782; Fleming, Jennifer/0000-0002-5603-2410; McDonald, Skye/0000-0003-0723-6094; Wearne, Travis/0000-0002-7565-9163; Togher, Leanne/0000-0002-4518-6748; Honan, Cynthia/0000-0001-5735-4270	National Health and Medical Research Council (NHMRC) Centre for Research Excellence grant for the period 2012-2017	The Moving Ahead CRE is funded by the National Health and Medical Research Council (NHMRC) Centre for Research Excellence grant for the period 2012-2017.	Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; ANDERSON V, 2001, DEV NEUROPSYCHOLOGY; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; [Anonymous], 2013, US ICF PRACT MAN US; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benton A., 1976, MULTILINGUAL APHASIA; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bickenbach J, 2012, ICF CORE SETS MANUAL; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Burgess P.W., 1996, DYSEXECUTIVE QUESTIO; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Carter R, 2015, REHABILITATION RES P; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coetzer R., 2001, PSYCHIATR BULL, V25, P421, DOI [https://doi.org/10.1192/pb.25.11.421, DOI 10.1192/PB.25.11.421]; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Drummond AER, 1994, BR J OCCUP THER, V57, P414, DOI DOI 10.1177/030802269405701102; Enderby P. M., 2008, FDA 2 FRENCHAY DYSAR; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fitts W. H., 1997, TENNESSE SELF CONCEP; Fleming JM, 1996, BRAIN INJURY, V10, P1; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; GAVIN DR, 1989, BRIT J ADDICT, V84, P301; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hays SJ, 2004, APHASIOLOGY, V18, P693, DOI 10.1080/02687030444000183; Honan CA, 2016, CLIN NEUROPSYCHOL, V30, P243, DOI 10.1080/13854046.2015.1136691; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kaplan E, 1983, BOSTON NAMING TEST; Kelly G, 2006, BRAIN INJURY, V20, P307, DOI 10.1080/02699050500488074; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kertesz A., 2007, WAB R W APHASIA BATT; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Law M., 2014, CANADIAN OCCUPATIONA, V5th; Laxe S, 2012, CLIN NEUROL NEUROSUR, V114, P645, DOI 10.1016/j.clineuro.2011.12.038; Lezak, 2008, MANUAL MAYO PORTLAND; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lubben J., 2004, SOCIAL NETWORKS SOCI, P20; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2012, BRAIN IMPAIR, V13, P256, DOI 10.1017/BrImp.2012.21; McMillan TM, 2013, J NEUROTRAUM, V30, P970, DOI 10.1089/neu.2012.2703; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Oddy M, 2008, J CLIN EXP NEUROPSYC, V30, P568, DOI 10.1080/13803390701555598; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rey A., 1964, EXAMEN CLIN PSYCHOL; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Roebuck-Spencer T., 2012, FORENSIC NEUROPSYCHO, P260; Rosenberg M., 1965, SOC ADOLESCENT SELF; Roth RM, 2005, BRIEF A BEHAV RATING; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schmidt M., 1996, REY AUDITORY VERBAL; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Shipley WC, 2009, SHIPLEY 2 MANUAL; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Tate R., 2011, MANUAL SYDNEY PSYCHO; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; Tate RL, 2010, COMPENDIUM TESTS SCA; Tate RL, 2013, NEUROREHABILITATION, V32, P729, DOI 10.3233/NRE-130898; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tellez N, 2005, MULT SCLER J, V11, P198, DOI 10.1191/1352458505ms1148oa; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; World Health Organisation, 2004, WHODAS 2 TRAIN MAN G; World Health Organization, 2007, INT CLASS FUNCT DIS; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	89	27	27	2	19	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL 3	2019	29	6					896	916		10.1080/09602011.2017.1339616			21	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	HU3MB	WOS:000465176100004	28671050				2022-02-06	
J	Sarkar, C; Jones, JW; Hegdekar, N; Thayer, JA; Kumar, A; Faden, AI; Kane, MA; Lipinski, MM				Sarkar, Chinmoy; Jones, Jace W.; Hegdekar, Nivedita; Thayer, Julia A.; Kumar, Alok; Faden, Alan I.; Kane, Maureen A.; Lipinski, Marta M.			PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma	AUTOPHAGY			English	Article						Amyloid beta; autophagy; cytosolic phospholipase A2 (cPLA2); lysosomal membrane permeabilization (LMP); membrane lipidomic analysis; traumatic brain injury (TBI)	CYTOSOLIC PHOSPHOLIPASE A(2); CELL-DEATH; ARACHIDONIC-ACID; MOUSE MODEL; PERMEABILIZATION; INJURY; NEUROPROTECTION; METABOLOMICS; CARDIOLIPIN; HOMEOSTASIS	Lysosomal membrane permeabilization (LMP) is observed under many pathological conditions, leading to cellular dysfunction and death. However, the mechanisms by which lysosomal membranes become leaky in vivo are not clear. Our data demonstrate that LMP occurs in neurons following controlled cortical impact induced (CCI) traumatic brain injury (TBI) in mice, leading to impaired macroautophagy (autophagy) and neuronal cell death. Comparison of LC-MS/MS lysosomal membrane lipid profiles from TBI and sham animals suggested a role for PLA2G4A/cPLA2 (phospholipase A2, group IVA [cytosolic, calcium-dependent]) in TBI-induced LMP. Activation of PLA2G4A caused LMP and inhibition of autophagy flux in cell lines and primary neurons. In vivo pharmacological inhibition of PLA2G4A attenuated TBI-induced LMP, as well as subsequent impairment of autophagy and neuronal loss, and was associated with improved neurological outcomes. Inhibition of PLA2G4A in vitro limited amyloid-beta-induced LMP and inhibition of autophagy. Together, our data indicate that PLA2G4A -mediated lysosomal membrane damage is involved in neuronal cell death following CCI-induced TBI and potentially in other neurodegenerative disorders.	[Sarkar, Chinmoy; Hegdekar, Nivedita; Thayer, Julia A.; Kumar, Alok; Faden, Alan I.; Lipinski, Marta M.] Univ Maryland, Sch Med, Dept Anesthesiol, Shock Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA; [Jones, Jace W.; Kane, Maureen A.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Kumar, Alok] Sanjay Gandhi Postgrad Inst Med Sci SGPGIMS, Dept Mol Med & Biotechnol, Lucknow, UP, India; [Faden, Alan I.; Lipinski, Marta M.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA		Lipinski, MM (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol Anat & Neurobiol, Baltimore, MD 21201 USA.	mlipinski@som.umaryland.edu	Sarkar, Chinmoy/AAI-2461-2019	Kumar, Alok/0000-0003-3717-7435; Jones, Jace/0000-0003-0460-0380	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS 091218, R01NS 094527]; Maryland Stem Cell Research Fund [MSCRFE-2747]	This work was supported by R01NS 091218 and R01NS 094527 from National Institutes of Health to MML and MSCRFE-2747 from Maryland Stem Cell Research Fund to CS.	Aits S, 2015, METHOD CELL BIOL, V126, P261, DOI 10.1016/bs.mcb.2014.10.032; Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Chu CT, 2014, AUTOPHAGY, V10, P376, DOI 10.4161/auto.27191; Corrotte M, 2015, METHOD CELL BIOL, V126, P139, DOI 10.1016/bs.mcb.2014.11.009; Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9; Damen CWN, 2014, J LIPID RES, V55, P1772, DOI 10.1194/jlr.D047795; Dean JM, 2018, PROTEIN CELL, V9, P196, DOI 10.1007/s13238-017-0423-5; DEDUVE C, 1969, PROC R SOC SER B-BIO, V173, P71, DOI 10.1098/rspb.1969.0039; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Farooqui AA, 2004, PROSTAG LEUKOTR ESS, V71, P161, DOI 10.1016/j.plefa.2004.03.004; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Gomez-Sintes R, 2016, AGEING RES REV, V32, P150, DOI 10.1016/j.arr.2016.02.009; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kalyvas A, 2004, NEURON, V41, P323, DOI 10.1016/S0896-6273(04)00003-0; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kilpatrick BS, 2015, METHOD CELL BIOL, V126, P1, DOI 10.1016/bs.mcb.2014.10.018; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Lee JCM, 2011, J NEUROCHEM, V116, P813, DOI 10.1111/j.1471-4159.2010.07033.x; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Leslie CC, 2015, J LIPID RES, V56, P1386, DOI 10.1194/jlr.R057588; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Liu NK, 2014, ANN NEUROL, V75, P644, DOI 10.1002/ana.24134; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McNeil PL, 2002, J CELL SCI, V115, P873; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Monteiro-Cardoso VF, 2015, J ALZHEIMERS DIS, V43, P1375, DOI 10.3233/JAD-141002; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ofengeim D, 2012, J BIOL CHEM, V287, P8714, DOI 10.1074/jbc.M111.290957; Paglia G, 2017, NAT PROTOC, V12, P797, DOI 10.1038/nprot.2017.013; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Phillis JW, 2004, BRAIN RES REV, V44, P13, DOI 10.1016/j.brainresrev.2003.10.002; Rodriguez-Muela N, 2015, CELL DEATH DIFFER, V22, P476, DOI 10.1038/cdd.2014.203; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Slomiany Bronislaw L, 2010, Int J Biomed Sci, V6, P37; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Syrbu SI, 1999, J IMMUNOL, V162, P2334; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]; Ullio C, 2012, J LIPID RES, V53, P1134, DOI 10.1194/jlr.M022384; Walker MW, 2015, METHOD CELL BIOL, V126, P21, DOI 10.1016/bs.mcb.2014.10.019; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Zhang ZJ, 2007, HUM MOL GENET, V16, P837, DOI 10.1093/hmg/ddm029; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Zhu DH, 2006, J NEUROSCI, V26, P11111, DOI 10.1523/JNEUROSCI.3505-06.2006; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	72	27	27	5	14	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy	MAR 3	2020	16	3					466	485		10.1080/15548627.2019.1628538		JUN 2019	20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	LE0LH	WOS:000475190600001	31238788	Green Published, hybrid			2022-02-06	
J	Hemphill, M; Ko, J; Yang, Z; Beard, K; Sewell, E; Shallcross, J; Schweizer, M; Sandsmark, DK; Diaz-Arrastia, R; Kim, J; Meaney, D; Issador, D				Hemphill, Matthew; Ko, Jina; Yang, Zijian; Beard, Kryshawna; Sewell, Emily; Shallcross, Jamie; Schweizer, Melissa; Sandsmark, Danielle K.; Diaz-Arrastia, Ramon; Kim, Junhyong; Meaney, David; Issador, David			Multi-Dimensional Mapping of Brain-Derived Extracellular Vesicle MicroRNA Biomarker for Traumatic Brain Injury Diagnostics	JOURNAL OF NEUROTRAUMA			English	Article						extracellular vesicles; miRNA; statistical learning; traumatic brain injury	CONTROLLED CORTICAL IMPACT; NEUROTROPHIC FACTOR; SIGNALING PATHWAY; PLASMA-LEVELS; AMYLOID-BETA; MOUSE; MILD; ACTIVATION; INHIBITION; PROTEIN	The diagnosis and prognosis of traumatic brain injury (TBI) is complicated by variability in the type and severity of injuries and the multiple endophenotypes that describe each patient's response and recovery to the injury. It has been challenging to capture the multiple dimensions that describe an injury and its recovery to provide clinically useful information. To address this challenge, we have performed an open-ended search for panels of microRNA (miRNA) biomarkers, packaged inside of brain-derived extracellular vesicles (EVs), that can be combined algorithmically to accurately classify various states of injury. We mapped GluR2+ EV miRNA across a variety of injury types, injury intensities, history of injuries, and time elapsed after injury, and sham controls in a pre-clinical murine model (n = 116), as well as in clinical samples (n = 36). We combined next-generation sequencing with a technology recently developed by our lab, Track Etched Magnetic Nanopore (TENPO) sorting, to enrich for GluR2+ EVs and profile their miRNA. By mapping and comparing brain-derived EV miRNA between various injuries, we have identified signaling pathways in the packaged miRNA that connect these biomarkers to underlying mechanisms of TBI. Many of these pathways are shared between the pre-clinical model and the clinical samples, and present distinct signatures across different injury models and times elapsed after injury. Using this map of EV miRNA, we applied machine learning to define a panel of biomarkers to successfully classify specific states of injury, paving the way for a prognostic blood test for TBI. We generated a panel of eight miRNAs (miR-150-5p, miR-669c-5p, miR-488-3p, miR-22-5p, miR-9-5p, miR-6236, miR-219a.2-3p, miR-351-3p) for injured mice versus sham mice and four miRNAs (miR-203b-5p, miR-203a-3p, miR-206, miR-185-5p) for TBI patients versus healthy controls.	[Hemphill, Matthew; Ko, Jina; Yang, Zijian; Beard, Kryshawna; Sewell, Emily; Schweizer, Melissa; Meaney, David; Issador, David] Univ Penn, Dept Bioengn, 210 33rd St, Philadelphia, PA 19104 USA; [Shallcross, Jamie; Kim, Junhyong] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Sandsmark, Danielle K.; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Kim, Junhyong] Univ Penn, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA; [Issador, David] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Meaney, David] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Issador, D (corresponding author), Univ Penn, Dept Bioengn, 210 33rd St, Philadelphia, PA 19104 USA.	issadore@seas.upenn.edu	Yang, Zijian/AAO-9763-2021		New Jersey Commission on Brain Injury Research [CSCR14IRG005]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 088276]; Allen Foundation [U01 NS086090]; Commonwealth of Pennsylvania [4100077073]; Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21CA182336-01A1]; American Cancer Society-CEOs Against Cancer-CA Division Research Scholar Grant [RSG-15-227-01-CSM]; National Science Foundation's CAREER Award [1554200]; Hartwell Individual Research Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS104239] Funding Source: NIH RePORTER	We thank Tawny Meredith-Duliba and Erika Silverman from the Diaz-Arrastia lab at Penn for collecting and processing clinical samples that were used for this study. Funding was provided by the New Jersey Commission on Brain Injury Research (CSCR14IRG005) to DI and DM, National Institutes of Health NS 088276 to DM, Allen Foundation to DM and DI, U01 NS086090 to RDA, Health Research Formula Fund 4100077073 from Commonwealth of Pennsylvania to JK, the Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program, the National Institute of Health: 1R21CA182336-01A1 to DI and JK, and DI was supported by an American Cancer Society-CEOs Against Cancer-CA Division Research Scholar Grant, (RSG-15-227-01-CSM), the National Science Foundation's CAREER Award (#1554200), and The Hartwell Individual Research Award.	Almonte AG, 2013, J NEUROCHEM, V124, P109, DOI 10.1111/jnc.12075; Arenth PM, 2011, PM&R, V3, pS123, DOI 10.1016/j.pmrj.2011.03.012; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Butler CR, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0134-17.2017; Butler CR, 2016, EXP NEUROL, V280, P30, DOI 10.1016/j.expneurol.2016.03.022; Carlson SW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00532; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Chen T, 2017, NEUROCHEM RES, V42, P3073, DOI 10.1007/s11064-017-2340-7; Chen YH, 2017, CELL TRANSPLANT, V26, P1156, DOI 10.1177/0963689717714105; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Don ASA, 2012, DRUG DISCOV TODAY, V17, P861, DOI 10.1016/j.drudis.2012.04.010; Ferriero D. M., 2014, J BIOL METHODS, V1, DOI DOI 10.14440/JBM.2014.33; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Gahlot G, 2017, INDIAN J MEDNODENT A, V5, P24, DOI DOI 10.5958/2347-6206.2017.00005.X; Gao YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0939-5; Gao YY, 2016, J SURG RES, V206, P67, DOI 10.1016/j.jss.2016.07.014; Garling RJ, 2018, NEURAL REGEN RES, V13, P434, DOI 10.4103/1673-5374.228725; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kirik, 2016, NEUROSCI BEHAV PHYSL, V46, P284, DOI [DOI 10.1007/S11055-016-0231-Z, 10.1007/s11055-016-0231-z]; Ko J, 2018, LAB CHIP, V18, P3617, DOI 10.1039/c8lc00672e; Ko J, 2018, LAB CHIP, V18, P395, DOI 10.1039/c7lc00955k; Ko J, 2017, ACS NANO, V11, P11182, DOI 10.1021/acsnano.7b05503; Ko JN, 2017, LAB CHIP, V17, P3086, DOI 10.1039/c7lc00703e; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Mulherkar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11113-3; Muluneh M, 2014, ADV HEALTHC MATER, V3, P1078, DOI 10.1002/adhm.201300502; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Rozas NS, 2015, J NEUROTRAUM, V32, P149, DOI 10.1089/neu.2014.3469; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Sun LQ, 2018, BEHAV BRAIN RES, V337, P271, DOI 10.1016/j.bbr.2017.08.042; Titus DJ, 2015, CURR PHARM DESIGN, V21, P332; Vascak M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00157; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Vos P., 2014, TRAUMATIC BRAIN INJU; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wang ZF, 2017, BIOCHEM BIOPH RES CO, V482, P948, DOI 10.1016/j.bbrc.2016.11.138; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhu Q., 2016, BIORXIV	73	27	28	2	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2020	37	22					2424	2434		10.1089/neu.2018.6220		MAY 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	OP2MH	WOS:000468297500001	30950328	Bronze, Green Published			2022-02-06	
J	Nguyen, VT; Zafonte, RD; Chen, JT; Kponee-Shovein, KZ; Paganoni, S; Pascual-Leone, A; Speizer, FE; Baggish, AL; Taylor, HA; Nadler, LM; Courtney, TK; Connor, A; Weisskopf, MG				Nguyen, Vy T.; Zafonte, Ross D.; Chen, Jarvis T.; Kponee-Shovein, Kale Z.; Paganoni, Sabrina; Pascual-Leone, Alvaro; Speizer, Frank E.; Baggish, Aaron L.; Taylor, Herman A., Jr.; Nadler, Lee M.; Courtney, Theodore K.; Connor, Ann; Weisskopf, Marc G.			Mortality Among Professional American-Style Football Players and Professional American Baseball Players	JAMA NETWORK OPEN			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; BODY-MASS INDEX; HEAD-INJURY; ALZHEIMERS-DISEASE; SMOKELESS TOBACCO; SOCCER PLAYERS; LEAGUE PLAYERS; RISK; ASSOCIATION	IMPORTANCE Studies of American-style football players have suggested lower overall mortality rates compared with general populations, but with possibly increased neurodegenerative mortality. However, comparisons with general populations can introduce bias. This study compared mortality between US National Football League (NFL) and US Major League Baseball (MLB) players, a more appropriate comparison group of professional athletes. OBJECTIVE To compare all-cause and cause-specific mortality between NFL and MLB players. DESIGN, SETTING, AND PARTICIPANTS In this retrospective cohort study, the setting was US mortality from January 1, 1979, through December 31, 2013. The dates of analysis were January 2016 to April 2019. Participants were 3419 NFL and 2708 MLB players with at least 5 playing seasons. EXPOSURES Participation in the NFL compared with the MLB. MAIN OUTCOMES AND MEASURES Vital status and causes of death from the National Death Index from 1979 through 2013 were obtained. Cox proportional hazards regression models using age as the timescale were used to calculate hazard ratios (HRs) and 95% CIs to examine all-cause and cause-specific mortality among NFL players compared with MLB players, adjusted for race and decade of birth. RESULTS By the end of follow-up, there were 517 deaths (mean [SD] age, 59.6 [13.2] years) in the NFL cohort and 431 deaths (mean [SD] age, 66.7 [12.3] years) in the MLB cohort. Cardiovascular and neurodegenerative conditions, respectively, were noted as underlying or contributing causes in 498 and 39 deaths in the NFL and 225 and 16 deaths in the MLB. Compared with MLB players, NFL players had significantly elevated rates of all-cause (HR, 1.26; 95% CI, 1.10-1.44), cardiovascular disease (HR, 2.40; 95% CI, 2.03-2.84), and neurodegenerative disease (HR, 2.99; 95% CI, 1.64-5.45) mortality. Comparing hypothetical populations of 1000 NFL and 1000 MLB players followed up to age 75 years, there would be an excess 21 all-cause deaths among NFL players, as well as 77 and 11 more deaths with underlying or contributing causes that included cardiovascular and neurodegenerative conditions, respectively. CONCLUSIONS AND RELEVANCE This study found that NFL players had elevated all-cause, cardiovascular, and neurodegenerative mortality rates compared with MLB players, although the absolute number of excess neurodegenerative deaths was still small. Factors that vary across these sports (eg, body habitus and head trauma) as opposed to those common across sports (eg, physical activity) could underlie the differences.	[Nguyen, Vy T.; Kponee-Shovein, Kale Z.; Speizer, Frank E.; Courtney, Theodore K.; Weisskopf, Marc G.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 665 Huntington Ave,Bldg 1-1402, Boston, MA 02115 USA; [Zafonte, Ross D.; Paganoni, Sabrina] Brigham & Womens Hosp, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Massachusetts Gen Hosp, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross D.; Paganoni, Sabrina; Courtney, Theodore K.] Harvard Med Sch, Boston, MA 02115 USA; [Chen, Jarvis T.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Kponee-Shovein, Kale Z.; Taylor, Herman A., Jr.; Weisskopf, Marc G.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Pascual-Leone, Alvaro; Connor, Ann] Harvard Med Sch, Dept Neurol, Berenson Allen Ctr Noninvas Brain Stimulat, Div Cognit Neurol,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Speizer, Frank E.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Baggish, Aaron L.] Massachusetts Gen Hosp, Cardiovasc Performance Program, Boston, MA 02114 USA; [Taylor, Herman A., Jr.] Morehouse Univ, Cardiovasc Res Inst, Sch Med, Atlanta, GA USA; [Nadler, Lee M.] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA		Weisskopf, MG (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, 665 Huntington Ave,Bldg 1-1402, Boston, MA 02115 USA.	mweissko@hsph.harvard.edu	Courtney, Theodore K./P-4829-2019; Pascual-Leone, Alvaro/AAC-5101-2019	Courtney, Theodore K./0000-0001-8139-1565; Pascual-Leone, Alvaro/0000-0001-8975-0382	Spaulding Research Institute; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 ES000002]; National Institute for Occupational Safety and HealthUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [T42 OH008416]; Football Players Health Study at Harvard University	This work was supported by the Spaulding Research Institute and by grant P30 ES000002 from the National Institutes of Health. Ms Nguyen was supported by grant T42 OH008416 from the National Institute for Occupational Safety and Health. Drs Zafonte, Pascual-Leone, Speizer, Baggish, Taylor, Nadler, and Weisskopf, Mr Courtney, and Ms Connor received support from the Football Players Health Study at Harvard University.	Abel EL, 2007, PERCEPT MOTOR SKILL, V104, P1251, DOI 10.2466/PMS.104.4.1251-1254; Abel Ernest L, 2006, Res Sports Med, V14, P239, DOI 10.1080/15438620600985795; Abel Ernest L, 2006, Res Sports Med, V14, P83, DOI 10.1080/15438620500528406; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Blum A, 2005, TOB CONTROL, V14, P1, DOI 10.1136/tc.2004.010728; Chague F, 2015, ARCH CARDIOVASC DIS, V108, P75, DOI 10.1016/j.acvd.2014.10.003; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P205, DOI 10.1080/17482960902721634; Churchill TW, 2018, AM J MED, V131, P1491, DOI 10.1016/j.amjmed.2018.07.042; Cologne J, 2012, EPIDEMIOLOGY, V23, P565, DOI 10.1097/EDE.0b013e318253e418; CONNOLLY GN, 1988, NEW ENGL J MED, V318, P1281, DOI 10.1056/NEJM198805123181918; Conrad Amy K, 2015, J Calif Dent Assoc, V43, P14; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Engber D., NFL PLAYERS DIE YOUN; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Flynn D., WHY EVERYTHING YOU H; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Grashow RG, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119829212; Helzberg JH, 2010, AM J CARDIOL, V106, P664, DOI 10.1016/j.amjcard.2010.04.022; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Imai K, 2016, POLIT ANAL, V24, P263, DOI 10.1093/pan/mpw001; Kim JH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008620; KLEIN J. P., 2003, SURVIVAL ANAL TECHNI; Lehman EJ, 2016, AM J SPORT MED, V44, P2486, DOI 10.1177/0363546516645093; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lemez S, 2018, SCAND J MED SCI SPOR, V28, P1722, DOI 10.1111/sms.13066; Lemez S, 2015, SPORTS MED-OPEN, V1, DOI 10.1186/s40798-015-0024-x; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Lincoln AE, 2018, MED SCI SPORT EXER, V50, P486, DOI 10.1249/MSS.0000000000001466; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2018, AM J CARDIOL, V122, P1879, DOI 10.1016/j.amjcard.2018.08.030; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; O'Reilly EJ, 2013, AMYOTROPH LAT SCL FR, V14, P205, DOI 10.3109/21678421.2012.735240; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Pupillo E, 2018, AMYOTROPH LAT SCL FR, V19, P118, DOI 10.1080/21678421.2017.1386687; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; STEENLAND K, 1992, AM J EPIDEMIOL, V136, P855, DOI 10.1093/aje/136.7.855; Taioli E, 2007, EUR J PUBLIC HEALTH, V17, P600, DOI 10.1093/eurpub/ckm035; Venkataramani AS, 2018, JAMA-J AM MED ASSOC, V319, P800, DOI 10.1001/jama.2018.0140; Visser AE, 2018, J NEUROL NEUROSUR PS, V89, P797, DOI 10.1136/jnnp-2017-317724; WALSH MM, 1994, ADDICT BEHAV, V19, P411, DOI 10.1016/0306-4603(94)90064-7; Watanabe Y, 2017, EUR J EPIDEMIOL, V32, P867, DOI 10.1007/s10654-017-0327-y	47	27	27	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2574-3805			JAMA NETW OPEN	JAMA Netw. Open	MAY	2019	2	5							e194223	10.1001/jamanetworkopen.2019.4223			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IK7XE	WOS:000476806200070	31125098	gold, Green Published			2022-02-06	
J	Shandra, O; Winemiller, AR; Heithoff, BP; Munoz-Ballester, C; George, KK; Benko, MJ; Zuidhoek, IA; Besser, MN; Curley, DE; Edwards, GF; Mey, A; Harrington, AN; Kitchen, JP; Robel, S				Shandra, Oleksii; Winemiller, Alexander R.; Heithoff, Benjamin P.; Munoz-Ballester, Carmen; George, Kijana K.; Benko, Michael J.; Zuidhoek, Ivan A.; Besser, Michelle N.; Curley, Dallece E.; Edwards, G. Franklin, III; Mey, Anroux; Harrington, Alexys N.; Kitchen, Jeremy P.; Robel, Stefanie			Repetitive Diffuse Mild Traumatic Brain Injury Causes an Atypical Astrocyte Response and Spontaneous Recurrent Seizures	JOURNAL OF NEUROSCIENCE			English	Article						astrogliosis; concussion; diffuse TBI; gap junctions; neuroinflammation; posttraumatic epilepsy	POSTTRAUMATIC EPILEPSY; REACTIVE ASTROCYTES; SCAR FORMATION; ANIMAL-MODELS; HEAD-INJURY; IN-VITRO; POPULATION; GLIA; DEFICITS; RISK	Focal traumatic brain injury (TBI) induces astrogliosis, a process essential to protecting uninjured brain areas from secondary damage. However, astrogliosis can cause loss of astrocyte homeostatic functions and possibly contributes to comorbidities such as posttraumatic epilepsy (PTE). Scar-forming astrocytes seal focal injuries off from healthy brain tissue. It is these glial scars that are associated with epilepsy originating in the cerebral cortex and hippocampus. However, the vast majority of human TBIs also present with diffuse brain injury caused by acceleration-deceleration forces leading to tissue shearing. The resulting diffuse tissue damage may be intrinsically different from focal lesions that would trigger glial scar formation. Here, we used mice of both sexes in a model of repetitive mild/concussive closed-head TBI, which only induced diffuse injury, to test the hypothesis that astrocytes respond uniquely to diffuse TBI and that diffuse TBI is sufficient to cause PTE. Astrocytes did not form scars and classic astrogliosis characterized by upregulation of glial fibrillary acidic protein was limited. Surprisingly, an unrelated population of atypical reactive astrocytes was characterized by the lack of glial fibrillary acidic protein expression, rapid and sustained downregulation of homeostatic proteins and impaired astrocyte coupling. After a latency period, a subset of mice developed spontaneous recurrent seizures reminiscent of PTE in human TBI patients. Seizing m ice had larger areas of atypical astrocytes compared with nonseizing mice, suggesting that these atypical astrocytes might contribute to epileptogenesis after diffuse TBI.	[Shandra, Oleksii; Winemiller, Alexander R.; Heithoff, Benjamin P.; Munoz-Ballester, Carmen; George, Kijana K.; Benko, Michael J.; Zuidhoek, Ivan A.; Besser, Michelle N.; Curley, Dallece E.; Edwards, G. Franklin, III; Mey, Anroux; Harrington, Alexys N.; Kitchen, Jeremy P.; Robel, Stefanie] Virginia Tech Caril, Fralin Biomed Res Inst, Roanoke, VA 24016 USA; [Heithoff, Benjamin P.; Robel, Stefanie] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24060 USA; [Curley, Dallece E.; Edwards, G. Franklin, III; Mey, Anroux; Robel, Stefanie] Virginia Tech, Sch Neurosci, Blacksburg, VA 24060 USA; [George, Kijana K.; Zuidhoek, Ivan A.; Edwards, G. Franklin, III; Kitchen, Jeremy P.] Virginia Tech, Grad Program Translat Biol Med & Hlth, Roanoke, VA 24016 USA; [Benko, Michael J.] VTCSOM Caril Clin, Dept Neurosurg, Blacksburg, VA 24014 USA		Robel, S (corresponding author), Virginia Tech Caril, Fralin Biomed Res Inst, Roanoke, VA 24016 USA.; Robel, S (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24060 USA.; Robel, S (corresponding author), Virginia Tech, Sch Neurosci, Blacksburg, VA 24060 USA.	srobel@vt.edu	Shandra, Oleksii/AAD-2622-2020; Robel, Stefanie/AAA-7166-2019	Shandra, Oleksii/0000-0003-4447-3312; Munoz-Ballester, Carmen/0000-0002-2298-7753; Robel, Stefanie/0000-0001-6716-3670; Curley, Dallece/0000-0002-1562-7979; Edwards, George/0000-0002-5071-5288; George, Kijana/0000-0002-2459-9500	National Institute of Neurological Disorders and Stroke at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS105807, R21NS107941]; Institute for Critical Technology and Applied Science (ICTAS) at Virginia Tech; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS105807, R21NS107941] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (Grants R01NS105807 and R21NS107941) and the Institute for Critical Technology and Applied Science (ICTAS) at Virginia Tech. Wethank Kelly McKay and John-Paul O'Shea for assistance with brain tissue processing and Western blot analysis and Katherine E. Horwath for assistance with area quantification.	Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Bedner P, 2015, BRAIN, V138, P1208, DOI 10.1093/brain/awv067; Bouchat J, 2018, GLIA, V66, P606, DOI 10.1002/glia.23268; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Condamine S, 2018, JOVE-J VIS EXP, DOI 10.3791/58116; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Foresti ML, 2011, BRAIN RES REV, V66, P115, DOI 10.1016/j.brainresrev.2010.09.002; Freeman MR, 2010, SCIENCE, V330, P774, DOI 10.1126/science.1190928; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Gee JM, 2014, NEURON, V83, P1058, DOI 10.1016/j.neuron.2014.07.024; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; Gotz M, 2015, GLIA, V63, P1452, DOI 10.1002/glia.22850; Griemsmann S, 2015, CEREB CORTEX, V25, P3420, DOI 10.1093/cercor/bhu157; Grosche A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069143; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Jany PL, 2013, ASN NEURO, V5, P81, DOI 10.1042/AN20130003; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; KONIETZKO U, 1994, HIPPOCAMPUS, V4, P297, DOI 10.1002/hipo.450040313; Kumar R, 2003, AM J NEURORADIOL, V24, P218; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Mader EC, 2012, CLIN MED INSIGHT-CAS, V5, P99, DOI 10.4137/CCRep.S9861; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Christina R., 2009, P393, DOI 10.1007/978-1-60327-185-1_34; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Neshige S, 2015, J NEUROL SCI, V359, P318, DOI 10.1016/j.jns.2015.09.358; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; NIQUET J, 1994, J NEUROCYTOL, V23, P641, DOI 10.1007/BF01191558; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; POLLEN D A, 1970, Science (Washington D C), V167, P1252, DOI 10.1126/science.167.3922.1252; Reyes RC, 2012, ASN NEURO, V4, P33, DOI 10.1042/AN20110059; Robel S, 2017, NEUROSCIENTIST, V23, P152, DOI 10.1177/1073858416645498; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Robert SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8103; Samoilova M, 2008, EXP NEUROL, V210, P762, DOI 10.1016/j.expneurol.2008.01.005; Seifert G, 2010, BRAIN RES REV, V63, P212, DOI 10.1016/j.brainresrev.2009.10.004; Shandra O, 2019, METHODS MOL BIOL, V1938, P233, DOI 10.1007/978-1-4939-9068-9_16; Shandra O, 2017, ADV PROTEIN CHEM STR, V108, P59, DOI 10.1016/bs.apcsb.2017.01.005; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Steinhauser C, 2012, GLIA, V60, P1192, DOI 10.1002/glia.22313; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; VIJAYAN VK, 1990, MOL CHEM NEUROPATHOL, V13, P107, DOI 10.1007/BF03159912; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Wennberg R, 2018, CAN J NEUROL SCI, V45, P275, DOI 10.1017/cjn.2017.300; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Ye ZC, 1998, PROG BRAIN RES, V118, P241; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.35; Zhao MR, 2007, EPILEPSIA, V48, P2059, DOI 10.1111/j.1528-1167.2007.01229.x; Zhao YQ, 2012, SEIZURE-EUR J EPILEP, V21, P322, DOI 10.1016/j.seizure.2012.02.007	81	27	27	0	6	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	MAR 6	2019	39	10					1944	1963		10.1523/JNEUROSCI.1067-18.2018			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN7WJ	WOS:000460403400015	30665946	Bronze, Green Published			2022-02-06	
J	Gallagher, MJ; Hogg, FRA; Zoumprouli, A; Papadopoulos, MC; Saadoun, S				Gallagher, Mathew J.; Hogg, Florence R. A.; Zoumprouli, Argyro; Papadopoulos, Marios C.; Saadoun, Samira			Spinal Cord Blood Flow in Patients with Acute Spinal Cord Injuries	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; blood pressure; laser speckle contrast imaging; spinal cord injury; spinal cord ischemia	INTRASPINAL PRESSURE; PERFUSION-PRESSURE; BRAIN-DAMAGE; MECHANISMS; PROFILE	The effect of traumatic spinal cord injury (TSCI) on spinal cord blood flow (SCBF) in humans is unknown. Whether intervention to achieve the recommended mean arterial pressure (MAP) guideline of 85-90mm Hg improves SCBF is also unclear. Here, we use laser speckle contrast imaging intraoperatively to visualize blood flow at the injury site in 22 patients with acute, severe spinal cord injuries (American Spinal Injuries Association Impairment Scale, grades A-C). In 17 of 22 patients, injury-site metabolism was also monitored with a microdialysis catheter placed intradurally on the surface of the injured cord. We observed three different SCBF patterns, characterized by distinct injury-site metabolic signatures, which we term necrosis-penumbra, hyperperfusion, and patchy-perfusion. The necrosis-penumbra pattern, only observed in thoracic injuries, had a core of low blood flow (necrosis) with regions of intermediate blood flow on either side (penumbra). The hyperperfusion pattern, only observed in cervical injuries, had very high blood flow throughout the injury site. The patchy-perfusion pattern, found in cervical and thoracic injuries, had irregular regions of low, intermediate, and high blood flow. Though intervention to increase MAP by 20mm Hg increased overall blood flow at the injury site, in 5 of 22 patients, blood flow increased in some regions, but, surprisingly, decreased in other regions. We term this phenomenon blood pressure-induced local steal. In 7 of 19 patients with MAP 85-90mm Hg, parts of the injury site were only perfused in systole, but not in diastole, which we term diastolic ischemia. We conclude that acute, severe TSCI produces three pathological blood flow patterns at the injury site. Intervention to increase blood pressure may elicit potentially detrimental SCBF responses in some patients.	[Gallagher, Mathew J.; Hogg, Florence R. A.; Papadopoulos, Marios C.; Saadoun, Samira] St Georges Univ London, Acad Neurosurg Unit, Cranmer Terrace, London SW17 0RE, England; [Zoumprouli, Argyro] St George Hosp, Neurointens Care Unit, London, England		Saadoun, S (corresponding author), St Georges Univ London, Acad Neurosurg Unit, Cranmer Terrace, London SW17 0RE, England.	ssaadoun@sgul.ac.uk		Zoumprouli, Argyro/0000-0003-0890-690X; Saadoun, Samira/0000-0002-5480-5678; Papadopoulos, Marios/0000-0001-9174-4176	Wings for Life Spinal Cord Research Foundation; Fletcher Fund; Neurosciences Research Foundation; London Deanery	This work was supported by the Wings for Life Spinal Cord Research Foundation, the Fletcher Fund, the Neurosciences Research Foundation, and the London Deanery.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Benton RL, 2009, CURR NEUROVASC RES, V6, P124, DOI 10.2174/156720209788185678; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Cao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12643; Chen SL, 2017, J NEUROTRAUM, V34, P2941, DOI 10.1089/neu.2017.4982; Chen SL, 2016, J NEUROCHEM, V139, P700, DOI 10.1111/jnc.13854; Davis MA, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086001; Dubory A, 2015, JOVE-J VIS EXP, DOI 10.3791/52536; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; Fassbender JM, 2011, EXP NEUROL, V227, P302, DOI 10.1016/j.expneurol.2010.12.002; FRIED LC, 1974, ANAT REC, V178, P41, DOI 10.1002/ar.1091780105; Gallagher MJ, 2018, CRIT CARE MED, V46, P1150, DOI 10.1097/CCM.0000000000003134; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hecht N, 2016, J CEREBR BLOOD F MET, V36, P1022, DOI 10.1177/0271678X15612487; Hecht N, 2013, J CEREBR BLOOD F MET, V33, P1000, DOI 10.1038/jcbfm.2013.42; Hecht N, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09148; HEISS WD, 1994, CURR OPIN NEUROL, V7, P11, DOI 10.1097/00019052-199402000-00004; Ideguchi M, 2017, J NEUROSURG, V126, P274, DOI 10.3171/2016.1.JNS152067; Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Klijn E, 2013, J NEUROSURG, V118, P280, DOI 10.3171/2012.10.JNS1219; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Lenehan B, 2010, SPINE, V35, pS174, DOI 10.1097/BRS.0b013e3181f32c82; Ma ZW, 2016, EXP NEUROL, V279, P261, DOI 10.1016/j.expneurol.2016.02.008; Muradov JM, 2013, J NEUROTRAUM, V30, P840, DOI 10.1089/neu.2012.2670; NEDERGAARD M, 1988, ACTA NEUROL SCAND, V77, P81, DOI 10.1111/j.1600-0404.1988.tb05878.x; Phang I, 2016, ANN NEUROL, V80, P522, DOI 10.1002/ana.24750; Phang I, 2016, J NEUROSURG-SPINE, V25, P398, DOI 10.3171/2016.1.SPINE151317; Saadoun S, 2017, J NEUROL NEUROSUR PS, V88, P452, DOI 10.1136/jnnp-2016-314600; Saadoun S, 2016, BRIT J NEUROSURG, V30, P582, DOI 10.3109/02688697.2016.1173191; Safar ME, 2004, HYPERTENSION, V44, P121, DOI 10.1161/01.HYP.0000135448.73199.75; Soubeyrand M, 2014, EUR SPINE J, V23, P658, DOI 10.1007/s00586-013-3086-9; Strauch JT, 2007, ANN THORAC SURG, V83, P2130, DOI 10.1016/j.athoracsur.2007.01.060; Streijger F, 2017, J NEUROTRAUM, V34, P3336, DOI 10.1089/neu.2017.5034; Streijger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078765; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; Varsos GV, 2015, J NEUROSURG-SPINE, V23, P763, DOI 10.3171/2015.3.SPINE14870; Werndle MC, 2016, ACTA NEUROCHIR SUPPL, V122, P323, DOI 10.1007/978-3-319-22533-3_64; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; Werndle MC, 2012, J NEUROTRAUM, V29, P880, DOI 10.1089/neu.2011.2038	41	27	27	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2019	36	6					919	929		10.1089/neu.2018.5961			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6BH	WOS:000463232300008	30351245				2022-02-06	
J	Zeiler, FA; Ercole, A; Cabeleira, M; Carbonara, M; Stocchetti, N; Menon, DK; Smielewski, P; Czosnyka, M; Anke, A; Beer, R; Bellander, BM; Buki, A; Chevallard, G; Chieregato, A; Citerio, G; Czeiter, E; Depreitere, B; Eapen, G; Frisvold, S; Helbok, R; Jankowski, S; Kondziella, D; Koskinen, LO; Meyfroidt, G; Moeller, K; Nelson, D; Piippo-Karjalainen, A; Radoi, A; Ragauskas, A; Raj, R; Rhodes, J; Rocka, S; Rossaint, R; Sahuquillo, J; Sakowitz, O; Stevanovic, A; Sundstrom, N; Takala, R; Tamosuitis, T; Tenovuo, O; Vajkoczy, P; Vargiolu, A; Vilcinis, R; Wolf, S; Younsi, A				Zeiler, Frederick A.; Ercole, Ari; Cabeleira, Manuel; Carbonara, Marco; Stocchetti, Nino; Menon, David K.; Smielewski, Peter; Czosnyka, Marek; Anke, Audny; Beer, Ronny; Bellander, Bo-Michael; Buki, Andras; Chevallard, Giorgio; Chieregato, Arturo; Citerio, Giuseppe; Czeiter, Endre; Depreitere, Bart; Eapen, George; Frisvold, Shirin; Helbok, Raimund; Jankowski, Stefan; Kondziella, Daniel; Koskinen, Lars-Owe; Meyfroidt, Geert; Moeller, Kirsten; Nelson, David; Piippo-Karjalainen, Anna; Radoi, Andreea; Ragauskas, Arminas; Raj, Rahul; Rhodes, Jonathan; Rocka, Saulius; Rossaint, Rolf; Sahuquillo, Juan; Sakowitz, Oliver; Stevanovic, Ana; Sundstrom, Nina; Takala, Riikka; Tamosuitis, Tomas; Tenovuo, Olli; Vajkoczy, Peter; Vargiolu, Alessia; Vilcinis, Rimantas; Wolf, Stefan; Younsi, Alexander		CENTER-TBI High Resolution HR ICU	Comparison of Performance of Different Optimal Cerebral Perfusion Pressure Parameters for Outcome Prediction in Adult Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; CPP optimum; ICP indices; outcome analysis	REACTIVITY	It has been postulated previously that individualized cerebral perfusion pressure (CPP) targets can be derived from cerebrovascular reactivity indices. Differences between real CPP and target CPP (named generically optimal CPP) has been linked to global outcome in adult traumatic brain injury (TBI). Different vascular reactivity indices can be utilized in the determination. The goal of this study is to evaluate CPPopt parameters, derived from three intracranial pressure (ICP)-derived cerebrovascular reactivity indices, and determine which one is superior for 6- to 12-month outcome prediction. Using the prospectively collected data from the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study, the following indices of cerebrovascular reactivity were derived: pressure reactivity index (PRx; correlation between ICP and mean arterial pressure [MAP]), pulse amplitude index (PAx; correlation between pulse amplitude of ICP [AMP] and MAP), and RAC (correlation between AMP and CPP). CPPopt was derived using each index. Univariate logistic regression models were created to assess the association between CPPopt with global dichotomized outcome at 6 to 12 months, as assessed by Glasgow Outcome Score-Extended. Models were compared via area under the receiver operating curve (AUC) and Delong's Test. A total of 204 patients had available data. CPPopt derived from PRx, PAx, and RAC performed variably in their association with outcomes. PRx- and RAC-based CPPopt performed similarly, with RAC parameters trending towards highest AUC values. PAx-based CPPopt parameters failed to reach significant associations with dichotomized outcomes at 6 to 12 months. CPPopt parameters derived from PRx and RAC appear similar in their overall ability for 6- to 12-month outcome prediction in moderate/severe adult TBI.	[Zeiler, Frederick A.; Ercole, Ari; Menon, David K.] Univ Cambridge, Div Anesthesia, Addenbrookes Hosp, Cambridge, England; [Cabeleira, Manuel; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Brain Phys Lab, Addenbrookes Hosp, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Dept Surg, Rady Fac Hlth Sci, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.] Univ Manitoba, Clinician Investigator Program, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Carbonara, Marco] Granda Osped Maggiore Policlin, Neuro ICU Fdn IRCCS, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiol & Transplantat, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Anke, Audny] Univ Hosp Northern Norway, Dept Phys Med & Rehab, Tromso, Norway; [Beer, Ronny; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care Med, Stockholm, Sweden; [Buki, Andras; Czeiter, Endre] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, Hungarian Brain Res Program, MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, Hungarian Brain Res Program, Janos Szentagothai Res Ctr, Pecs, Hungary; [Chevallard, Giorgio; Chieregato, Arturo] Osped Niguarda Ca Granda, NeuroIntens Care, Milan, Italy; [Citerio, Giuseppe; Vargiolu, Alessia] ASST Monza, NeuroIntens Care Unit, Dept Anesthesia & Intens Care, Monza, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [Eapen, George; Jankowski, Stefan] Sheffield Teaching Hosp NHS Fdn Trust, Neurointens Care, Sheffield, S Yorkshire, England; [Frisvold, Shirin] Univ Hosp Northern Norway, Dept Anesthesiol & Intens Care, Tromso, Norway; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Neurol, Copenhagen, Denmark; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Kondziella, Daniel; Moeller, Kirsten] Reg Hovedstaden Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Koskinen, Lars-Owe] Umea Univ Hosp, Dept Clin Neurosci, Umea, Sweden; [Meyfroidt, Geert] Univ Hosp Leuven, Intens Care Med, Leuven, Belgium; [Nelson, David] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care mMed, Stockholm, Sweden; [Piippo-Karjalainen, Anna; Raj, Rahul] Helsinki Univ Cent Hosp, Helsinki, Finland; [Radoi, Andreea; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Ragauskas, Arminas; Rocka, Saulius] Kaunas Univ Technol, Dept Neurosurg, Vilnius, Lithuania; [Ragauskas, Arminas; Rocka, Saulius] Vilnius Univ, Vilnius, Lithuania; [Rhodes, Jonathan] Crit Careand Pain Med NHS Lothian, Dept Anaesthesia, Edinburgh, Midlothian, Scotland; [Rhodes, Jonathan] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Rossaint, Rolf; Stevanovic, Ana] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Sakowitz, Oliver] Klinikum Ludwigsburg, Klin Neurochirurg, Ludwigsburg, Germany; [Sakowitz, Oliver; Younsi, Alexander] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany; [Sundstrom, Nina] Umea Univ Hosp, Dept Radiat Sci, Biomed Engn, Umea, Sweden; [Takala, Riikka] Turku Univ Cent Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka; Tenovuo, Olli] Univ Turku, Turku, Finland; [Tamosuitis, Tomas] Kaunas Univ Hlth Sci, Neurointens Care Unit, Kaunas, Lithuania; [Tenovuo, Olli] Turku Univ Cent Hosp, Rehabil & Brain Trauma, Turku, Finland; [Vajkoczy, Peter] Charite Univ Med Berlin, Neurol Neurochirurg & Psychiat, Berlin, Germany; [Vilcinis, Rimantas] Kaunas Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania; [Wolf, Stefan] Charite Univ Med Berlin, Interdisciplinary Neuro Intens Care Unit, Berlin, Germany		Zeiler, FA (corresponding author), Univ Manitoba, Dept Surg, Rady Fac Hlth Sci, Winnipeg, MB R3A 1R9, Canada.	umzeiler@myumanitoba.ca	Carbonara, Marco/N-3793-2015; Koskinen, Lars-Owe/AAQ-8957-2020; Younsi, Alexander/AAW-7869-2020; Radoi, Andreea/N-5613-2019; Depreitere, Bart/AAA-9846-2020; Raj, Rahul/K-7693-2012; Helbok, Raimund/AAA-8361-2021; Citerio, Giuseppe/B-1839-2015; Sahuquillo, Juan/B-3577-2008; Ercole, Ari/B-6288-2009; Moller, Kirsten/A-4751-2009	Carbonara, Marco/0000-0002-1431-8322; Younsi, Alexander/0000-0002-8218-9243; Radoi, Andreea/0000-0002-0677-3544; Depreitere, Bart/0000-0002-7458-0648; Raj, Rahul/0000-0003-4243-9591; Citerio, Giuseppe/0000-0002-5374-3161; Sahuquillo, Juan/0000-0003-0713-5875; Ercole, Ari/0000-0001-8350-8093; Nelson, David/0000-0003-2530-8207; Zeiler, Frederick/0000-0003-1737-0510; Sakowitz, Oliver/0000-0003-3248-6335; Moller, Kirsten/0000-0003-3058-1072	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra Life-Sciences Corporation (USA); NIHRNational Institute for Health Research (NIHR); Cambridge Biomedical Research Centre at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust; NIHR Clinical Research network; Cambridge Commonwealth Trust Scholarship	This study was supported by The European Union seventh Framework Program (grant 602150) for Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI). Additional funding was obtained from Hannelore Kohl Stiftung (Germany), OneMind (USA), and Integra Life-Sciences Corporation (USA).; DKM also was supported by funding from the NIHR through a Senior Investigator award and the Cambridge Biomedical Research Centre at the Cambridge University Hospitals National Health Service (NHS) Foundation Trust. The study also received additional support from the NIHR Clinical Research network.; FAZ has received salary support for dedicated research time, during which this project was completed. Such salary support came from the Cambridge Commonwealth Trust Scholarship, the University of Manitoba Clinician Investigator Program, and the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2018, ACTA NEUROCHIR SUPPL, V126, P209, DOI 10.1007/978-3-319-65798-1_43; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Howells T, 2018, CRIT CARE MED, V46, pe235, DOI 10.1097/CCM.0000000000002930; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Thiara S, 2018, CAN J NEUROL SCI, V45, P313, DOI 10.1017/cjn.2017.292; Zeiler F.A., 2018, J NEUROTRAUM; Zeiler FA, 2018, J NEUROTRAUM, V35, P2812, DOI 10.1089/neu.2017.5604; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	15	27	27	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1505	1517		10.1089/neu.2018.6182		DEC 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000453519400001	30384809	Green Submitted, Green Accepted			2022-02-06	
J	Acosta-Cabronero, J; Milovic, C; Mattern, H; Tejos, C; Speck, O; Callaghan, MF				Acosta-Cabronero, Julio; Milovic, Carlos; Mattern, Hendrik; Tejos, Cristian; Speck, Oliver; Callaghan, Martina F.			A robust multi-scale approach to quantitative susceptibility mapping	NEUROIMAGE			English	Article						Magnetic susceptibility; Quantitative MRI; Iron mapping; Venography; Variational regularisation; Laplacian pyramid	MULTIPLE-SCLEROSIS LESIONS; ENABLED DIPOLE INVERSION; OXYGEN EXTRACTION FRACTION; BRAIN IRON; MAGNETIC-SUSCEPTIBILITY; FIELD INHOMOGENEITY; SPATIAL VARIATION; MOTOR CORTEX; AMYLOID-BETA; QSM	Quantitative Susceptibility Mapping (QSM), best known as a surrogate for tissue iron content, is becoming a highly relevant MRI contrast for monitoring cellular and vascular status in aging, addiction, traumatic brain injury and, in general, a wide range of neurological disorders. In this study we present a new Bayesian QSM algorithm, named Multi-Scale Dipole Inversion (MSDI), which builds on the nonlinear Morphology-Enabled Dipole Inversion (nMEDI) framework, incorporating three additional features: (i) improved implementation of Laplace's equation to reduce the influence of background fields through variable harmonic filtering and subsequent deconvolution, (ii) improved error control through dynamic phase-reliability compensation across spatial scales, and (iii) scalewise use of the morphological prior. More generally, this new pre-conditioned QSM formalism aims to reduce the impact of dipole-incompatible fields and measurement errors such as flow effects, poor signal-to-noise ratio or other data inconsistencies that can lead to streaking and shadowing artefacts. In terms of performance, MSDI is the first algorithm to rank in the top-10 for all metrics evaluated in the 2016 QSM Reconstruction Challenge. It also demonstrated lower variance than nMEDI and more stable behaviour in scan-rescan reproducibility experiments for different MRI acquisitions at 3 and 7 Tesla. In the present work, we also explored new forms of susceptibility MRI contrast making explicit use of the differential information across spatial scales. Specifically, we show MSDI-derived examples of: (i) enhanced anatomical detail with susceptibility inversions from short-range dipole fields (hereby referred to as High-Pass Susceptibility Mapping or HPSM), (ii) high specificity to venousblood susceptibilities for highly regularised HPSM (making a case for MSDI-based Venography or VenoMSDI), (iii) improved tissue specificity (and possibly statistical conditioning) for Macroscopic-Vessel Suppressed Susceptibility Mapping (MVSSM), and (iv) high spatial specificity and definition for HPSM-based SusceptibilityWeighted Imaging (HPSM-SWI) and related intensity projections.	[Acosta-Cabronero, Julio; Callaghan, Martina F.] UCL, UCL Inst Neurol, Wellcome Ctr Human Neuroimaging, 12 Queen Sq, London WC1N 3BG, England; [Acosta-Cabronero, Julio; Speck, Oliver] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Milovic, Carlos; Tejos, Cristian] Pontificia Univ Catolica Chile, Dept Elect Engn, Santiago, Chile; [Milovic, Carlos; Tejos, Cristian] Pontificia Univ Catolica Chile, Biomed Imaging Ctr, Santiago, Chile; [Mattern, Hendrik; Speck, Oliver] Otto von Guericke Univ, Inst Expt Phys, Dept Biomed Magnet Resonance, Magdeburg, Germany; [Speck, Oliver] Leibniz Inst Neurobiol, Magdeburg, Germany		Acosta-Cabronero, J (corresponding author), UCL, UCL Inst Neurol, Wellcome Ctr Human Neuroimaging, 12 Queen Sq, London WC1N 3BG, England.	jac@cantab.net	Speck, Oliver/F-1406-2013; Tejos, Cristian/F-8270-2013; Callaghan, Martina F/H-5297-2019; Acosta-Cabronero, Julio/C-8225-2014	Speck, Oliver/0000-0002-6019-5597; Callaghan, Martina F/0000-0003-0374-1659; Milovic, Carlos/0000-0002-1196-6703; Acosta-Cabronero, Julio/0000-0003-1174-5983	Wellcome [203147/Z/16/Z]; EU Joint Programme - Neurodegenerative Disease Research, JPND; FONDECYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [1161448]; CONICYTComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [ACT1416]; Becas de Doctorado Nacional CONICYT [Folio 21150369]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01-DA021146]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Spinal Research Charity through the ERA-NET Neuron [MR/R000050/1]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R000050/1] Funding Source: UKRI	The Wellcome Centre for Human Neuroimaging is supported by core funding from the Wellcome (203147/Z/16/Z). We thank the EUFIND consortium (funded by the EU Joint Programme - Neurodegenerative Disease Research, JPND) for contributing to this study with a 7 Tesla MRI dataset. We would also like thank FONDECYT (1161448), CONICYT (Programa PIA Anillo ACT1416), and Becas de Doctorado Nacional CONICYT (Folio 21150369) for their funding support to CT and CM. HM was supported by NIH (1R01-DA021146). MFC is supported by the MRC and Spinal Research Charity through the ERA-NET Neuron joint call (MR/R000050/1).	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Acosta-Cabronero J, 2018, RADIOLOGY, V289, P195, DOI 10.1148/radiol.2018180112; Acosta-Cabronero J, 2017, BRAIN, V140, P118, DOI 10.1093/brain/aww278; Acosta-Cabronero J, 2016, J NEUROSCI, V36, P364, DOI 10.1523/JNEUROSCI.1907-15.2016; Acosta-Cabronero J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081093; Ayton S, 2017, BRAIN, V140, P2112, DOI 10.1093/brain/awx137; Balla DZ, 2014, NEUROIMAGE, V100, P112, DOI 10.1016/j.neuroimage.2014.06.011; Betts MJ, 2016, NEUROIMAGE, V138, P43, DOI 10.1016/j.neuroimage.2016.05.024; Bian W., 2016, AJNR AM J NEURORADIO; Bianciardi M, 2014, HUM BRAIN MAPP, V35, P2191, DOI 10.1002/hbm.22320; Buch S, 2017, J CEREBR BLOOD F MET, V37, P825, DOI 10.1177/0271678X16641129; BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851; Callaghan MF, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00097; Chatnuntawech I, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3570; Chen WW, 2014, RADIOLOGY, V271, P183, DOI 10.1148/radiol.13130353; Chen ZK, 2015, J NEUROSCI METH, V241, P85, DOI 10.1016/j.jneumeth.2014.12.014; Costagli M, 2016, NEUROIMAGE-CLIN, V12, P965, DOI 10.1016/j.nicl.2016.04.011; Cronin MJ, 2017, NEUROIMAGE, V149, P98, DOI 10.1016/j.neuroimage.2017.01.053; Cronin MJ, 2016, MAGN RESON MATER PHY, V29, P543, DOI 10.1007/s10334-016-0560-5; Darki F, 2016, NEUROIMAGE, V136, P208, DOI 10.1016/j.neuroimage.2016.04.065; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Deh K, 2015, J MAGN RESON IMAGING, V42, P1592, DOI 10.1002/jmri.24943; Deistung A, 2008, MAGN RESON MED, V60, P1155, DOI 10.1002/mrm.21754; Deistung A, 2013, NEUROIMAGE, V65, P299, DOI 10.1016/j.neuroimage.2012.09.055; Dominguez DJF, 2016, J NEUROL NEUROSUR PS, V87, P545, DOI 10.1136/jnnp-2014-310183; Ersche KD, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.271; Fan AP, 2016, NEUROIMAGE, V125, P920, DOI 10.1016/j.neuroimage.2015.11.007; Fan AP, 2015, J CEREBR BLOOD F MET, V35, P131, DOI 10.1038/jcbfm.2014.187; Fan AP, 2014, MAGN RESON MED, V72, P149, DOI 10.1002/mrm.24918; Feng X., 2017, Z MED PHYS; Gho SM, 2014, MAGN RESON MED, V72, P337, DOI 10.1002/mrm.24920; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Guan XJ, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3489; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; He NY, 2015, HUM BRAIN MAPP, V36, P4407, DOI 10.1002/hbm.22928; Hinoda T, 2015, INVEST RADIOL, V50, P522, DOI 10.1097/RLI.0000000000000159; Kee Y, 2017, IEEE T BIO-MED ENG, V64, P2531, DOI 10.1109/TBME.2017.2749298; Langkammer C, 2018, MAGN RESON MED, V79, P1661, DOI 10.1002/mrm.26830; Langkammer C, 2015, NEUROIMAGE, V111, P622, DOI 10.1016/j.neuroimage.2015.02.041; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Lauzon ML, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3492; Li W, 2014, HUM BRAIN MAPP, V35, P2698, DOI 10.1002/hbm.22360; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Li X, 2016, J MAGN RESON IMAGING, V43, P463, DOI 10.1002/jmri.24976; Lin PY, 2015, AM J NEURORADIOL, V36, P467, DOI 10.3174/ajnr.A4137; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Liu J, 2016, J NEUROTRAUM, V33, P10, DOI 10.1089/neu.2014.3856; Liu T, 2013, MAGN RESON MED, V69, P467, DOI 10.1002/mrm.24272; Liu T, 2012, IEEE T MED IMAGING, V31, P816, DOI 10.1109/TMI.2011.2182523; Liu T, 2011, MAGN RESON MED, V66, P777, DOI 10.1002/mrm.22816; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Liu Z, 2018, MAGN RESON MED, V79, P2795, DOI 10.1002/mrm.26946; Liu Z, 2017, MAGN RESON MED, V78, P303, DOI 10.1002/mrm.26331; Lobel U, 2014, ANN CLIN TRANSL NEUR, V1, P1041, DOI 10.1002/acn3.116; Lusebrink F, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.62; Lusebrink F, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.32; Maclaren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048088; Marques JP, 2005, CONCEPT MAGN RESON B, V25B, P65, DOI 10.1002/cmr.b.20034; Mattern H, 2018, MAGN RESON MED, V80, P248, DOI 10.1002/mrm.27033; Milovic C, 2018, MAGN RESON MED, V80, P814, DOI 10.1002/mrm.27073; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Moon Y, 2016, J ALZHEIMERS DIS, V51, P737, DOI 10.3233/JAD-151037; MORRIS CM, 1992, ACTA ANAT, V144, P235; Ozbay PS, 2015, NMR BIOMED, V28, P1688, DOI 10.1002/nbm.3433; Ozbay PS, 2016, NEUROIMAGE, V137, P52, DOI 10.1016/j.neuroimage.2016.05.013; Persson N, 2015, NEUROIMAGE, V122, P385, DOI 10.1016/j.neuroimage.2015.07.050; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.3.CO;2-J; Ravishankar S, 2011, IEEE T MED IMAGING, V30, P1028, DOI 10.1109/TMI.2010.2090538; Salomir R, 2003, CONCEPT MAGN RESON B, V19B, P26, DOI 10.1002/cmr.b.10083; Santin MD, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3491; Schofield MA, 2003, OPT LETT, V28, P1194, DOI 10.1364/OL.28.001194; Schweitzer AD, 2015, AM J ROENTGENOL, V204, P1086, DOI 10.2214/AJR.14.13459; Schweser F, 2017, NMR BIOMED, V30; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sood S, 2017, MAGN RESON MED, V77, P1946, DOI 10.1002/mrm.26281; Straub S, 2017, MAGN RESON MED, V78, P204, DOI 10.1002/mrm.26369; Stucht D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133921; Sun H, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3619; Sun HF, 2015, NEUROIMAGE, V105, P486, DOI 10.1016/j.neuroimage.2014.11.010; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van Bergen JMG, 2016, SCI REP-UK, V6, DOI 10.1038/srep35514; van Bergen JMG, 2016, AM J NEURORADIOL, V37, P789, DOI 10.3174/ajnr.A4617; Wang S., 2016, BIOMED RES INT, V2016; Wang S, 2013, IEEE T BIO-MED ENG, V60, P3441, DOI 10.1109/TBME.2013.2266795; Wang Y, 2017, J MAGN RESON IMAGING, V46, P951, DOI 10.1002/jmri.25693; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wharton S, 2015, MAGN RESON MED, V73, P1258, DOI 10.1002/mrm.25189; Wisnieff C, 2015, MAGN RESON MED, V74, P564, DOI 10.1002/mrm.25420; Zhang JW, 2018, MAGN RESON MED, V79, P172, DOI 10.1002/mrm.26657; Zhang Y, 2016, AM J NEURORADIOL, V37, P1629, DOI 10.3174/ajnr.A4825; Zheng WL, 2013, NEUROIMAGE, V78, P68, DOI 10.1016/j.neuroimage.2013.04.022; Zhou D, 2014, NMR BIOMED, V27, P312, DOI 10.1002/nbm.3064	97	27	27	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	DEC	2018	183						7	24		10.1016/j.neuroimage.2018.07.065			18	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GX4ZU	WOS:000447750200002	30075277	hybrid, Green Published			2022-02-06	
J	Jha, RM; Elmer, J; Zusman, BE; Desai, S; Puccio, AM; Okonkwo, DO; Park, SY; Shutter, LA; Wallisch, JS; Conley, YP; Kochanek, PM				Jha, Ruchira M.; Elmer, Jonathan; Zusman, Benjamin E.; Desai, Shashvat; Puccio, Ava M.; Okonkwo, David O.; Park, Seo Young; Shutter, Lori A.; Wallisch, Jessica S.; Conley, Yvette P.; Kochanek, Patrick M.			Intracranial Pressure Trajectories: A Novel Approach to Informing Severe Traumatic Brain Injury Phenotypes*	CRITICAL CARE MEDICINE			English	Article						intracranial pressure trajectory; traumatic brain injury; group based trajectory modeling; ABCC8; sulfonylurea receptor 1	SINGLE NUCLEOTIDE POLYMORPHISMS; CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; ISCHEMIC-STROKE; CARDIAC-ARREST; SEVERE TBI; HYPERTENSION; EDEMA; TRIAL	Objectives: Intracranial pressure in traumatic brain injury is dynamic and influenced by factors like injury patterns, treatments, and genetics. Existing studies use time invariant summary intracranial pressure measures thus potentially losing critical information about temporal trends. We identified longitudinal intracranial pressure trajectories in severe traumatic brain injury and evaluated whether they predicted outcome. We further interrogated the model to explore whether ABCC8 polymorphisms (a known cerebraledema regulator) differed across trajectory groups. Design: Prospective observational cohort. Setting: Single-center academic medical center. Patients: Four-hundred four severe traumatic brain injury patients. Interventions: None. Measurements and Main Results: We used group-based trajectory modeling to identify hourly intracranial pressure trajectories in days 0-5 post traumatic brain injury incorporating risk factor adjustment (age, sex, Glasgow Coma Scale 6score, craniectomy, primary hemorrhage pattern). We compared 6-month outcomes (Glasgow Outcome Scale, Disability Rating Scale, mortality) and ABCC8 tag-single-nucleotide polymorphisms associated with cerebral edema (rs2237982, rs7105832) across groups. Regression models determined whether trajectory groups predicted outcome. A six trajectory group model best fit the data, identifying cohorts differing in initial intracranial pressure, evolution, and number/proportion of spikes greater than 20mm Hg. There were pattern differences in age, hemorrhage type, and craniectomy rates. ABCC8 polymorphisms differed across groups. GOS (p = 0.006), Disability Rating Scale (p = 0.001), mortality (p < 0.0001), and rs2237982 (p = 0.035) differed across groups. Unfavorable outcomes were surprisingly predicted by both low intracranial pressure trajectories and sustained intracranial hypertension. Intracranial pressure variability differed across groups (p < 0.001) and may reflect preserved/impaired intracranial elastance/compliance. Conclusions: We employed a novel approach investigating longitudinal/dynamic intracranial pressure patterns in traumatic brain injury. In a risk adjusted model, six groups were identified and predicted outcomes. If validated, trajectory modeling may be a first step toward developing a new, granular approach for intracranial pressure phenotyping in conjunction with other phenotyping tools like biomarkers and neuroimaging. This may be particularly relevant in light of changing traumatic brain injury demographics toward the elderly.	[Jha, Ruchira M.; Elmer, Jonathan; Shutter, Lori A.; Wallisch, Jessica S.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Jha, Ruchira M.; Elmer, Jonathan; Desai, Shashvat; Shutter, Lori A.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Jha, Ruchira M.; Zusman, Benjamin E.; Puccio, Ava M.; Okonkwo, David O.; Shutter, Lori A.] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; [Jha, Ruchira M.; Wallisch, Jessica S.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Jha, Ruchira M.; Conley, Yvette P.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA; [Elmer, Jonathan] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; [Park, Seo Young] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Park, Seo Young] Univ Pittsburgh, Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15260 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Med, Dept Human Genet, Pittsburgh, PA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesia, Pittsburgh, PA USA		Jha, RM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Jha, RM (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA.; Jha, RM (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA.; Jha, RM (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Jha, RM (corresponding author), Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA.	jharm3@upmc.edu	Desai, Shashvat/AAM-2615-2021; Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628; Wallisch, Jessica/0000-0002-7908-9479; Conley, Yvette/0000-0002-1784-6067	National Institutes of Health (NIH) National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Center for Advancing Translational Science; UPP Foundation award; University of Pittsburgh School of Medicine Dean's Faculty Advancement Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000146, KL2TR001856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101036, K23NS097629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013342, R00NR013176] Funding Source: NIH RePORTER	We are grateful to the following institutions for their grant support: the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke, National Institute of Nursing Research, National Center for Advancing Translational Science, UPP Foundation award, and University of Pittsburgh School of Medicine Dean's Faculty Advancement Award.	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Elmer J, 2016, NEUROCRIT CARE, V25, P415, DOI 10.1007/s12028-016-0263-9; Feldmann H, 1979, Acta Neurochir Suppl (Wien), V28, P74; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jha RM, 2017, LANCET NEUROL, V16, P578, DOI 10.1016/S1474-4422(17)30225-9; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Nagin D.S., 2005, GROUP BASED MODELING; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Sajobi TT, 2017, STROKE, V48, P105, DOI 10.1161/STROKEAHA.116.014456; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stein DM, 2013, NEUROCRIT CARE, V18, P332, DOI 10.1007/s12028-013-9832-3; Stippler M, 2012, J NEUROSURG-PEDIATR, V10, P383, DOI 10.3171/2012.8.PEDS12165; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wallisch J, 2016, CRIT CARE MED, V44; Weaver SM, 2014, BRAIN IMAGING BEHAV, V8, P420, DOI 10.1007/s11682-012-9197-9	39	27	28	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	NOV	2018	46	11					1792	1802		10.1097/CCM.0000000000003361			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW5XM	WOS:000447016100025	30119071	Green Accepted			2022-02-06	
J	Jha, RM; Koleck, TA; Puccio, AM; Okonkwo, DO; Park, SY; Zusman, BE; Clark, RSB; Shutter, LA; Wallisch, JS; Empey, PE; Kochanek, PM; Conley, YP				Jha, Ruchira Menka; Koleck, Theresa A.; Puccio, Ava M.; Okonkwo, David O.; Park, Seo-Young; Zusman, Benjamin E.; Clark, Robert S. B.; Shutter, Lori A.; Wallisch, Jessica S.; Empey, Philip E.; Kochanek, Patrick M.; Conley, Yvette P.			Regionally clustered ABCC8 polymorphisms in a prospective cohort predict cerebral oedema and outcome in severe traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							SULFONYLUREA RECEPTOR 1; SINGLE NUCLEOTIDE POLYMORPHISMS; EFFICACY; SYSTEM; VISUALIZATION; ASSOCIATION; GLYBURIDE; VARIANTS; GENOTYPE	Objective ABCC8 encodes sulfonylurea receptor 1, a key regulatory protein of cerebral oedema in many neurological disorders including traumatic brain injury (TBI). Sulfonylurea-receptor-1 inhibition has been promising in ameliorating cerebral oedema in clinical trials. We evaluated whether ABCC8 tag single-nucleotide polymorphisms predicted oedema and outcome in TBI. Methods DNA was extracted from 485 prospectively enrolled patients with severe TBI. 410 were analysed after quality control. ABCC8 tag single-nucleotide polymorphisms (SNPs) were identified (Hapmap, r(2)>0.8, minor-allele frequency >0.20) and sequenced (iPlex-Gold, MassArray). Outcomes included radiographic oedema, intracranial pressure (ICP) and 3-month Glasgow Outcome Scale (GOS) score. Proxy SNPs, spatial modelling, amino acid topology and functional predictions were determined using established software programs. Results Wild-type rs7105832 and rs2237982 alleles and genotypes were associated with lower average ICP (beta=-2.91, p=0.001; beta=-2.28, p=0.003) and decreased radiographic oedema (OR 0.42, p=0.012; OR 0.52, p=0.017). Wild-type rs2237982 also increased favourable 3-month GOS (OR 2.45, p=0.006); this was partially mediated by oedema (p=0.03). Different polymorphisms predicted 3-month outcome: variant rs11024286 increased (OR 1.84, p=0.006) and wild-type rs4148622 decreased (OR 0.40, p=0.01) the odds of favourable outcome. Significant tag and concordant proxy SNPs regionally span introns/exons 2-15 of the 39-exon gene. Conclusions This study identifies four ABCC8 tag SNPs associated with cerebral oedema and/or outcome in TBI, tagging a region including 33 polymorphisms. In polymorphisms predictive of oedema, variant alleles/genotypes confer increased risk. Different variant polymorphisms were associated with favourable outcome, potentially suggesting distinct mechanisms. Significant polymorphisms spatially clustered flanking exons encoding the sulfonylurea receptor site and transmembrane domain 0/loop 0 (juxtaposing the channel pore/binding site). This, if validated, may help build a foundation for developing future strategies that may guide individualised care, treatment response, prognosis and patient selection for clinical trials.	[Jha, Ruchira Menka; Clark, Robert S. B.; Shutter, Lori A.; Wallisch, Jessica S.; Kochanek, Patrick M.] Univ Pittsburgh, Dept Crit Care Med, Sch Med, Pittsburgh, PA 15260 USA; [Jha, Ruchira Menka; Shutter, Lori A.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Jha, Ruchira Menka; Puccio, Ava M.; Okonkwo, David O.; Zusman, Benjamin E.; Shutter, Lori A.] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; [Jha, Ruchira Menka; Clark, Robert S. B.; Wallisch, Jessica S.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Jha, Ruchira Menka; Empey, Philip E.; Kochanek, Patrick M.; Conley, Yvette P.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Koleck, Theresa A.] Columbia Univ, Sch Nursing, New York, NY USA; [Park, Seo-Young] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Park, Seo-Young] Univ Pittsburgh, Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15260 USA; [Clark, Robert S. B.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesia, Pittsburgh, PA USA; [Empey, Philip E.] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Dept Human Genet, Sch Med, Pittsburgh, PA USA		Jha, RM (corresponding author), Univ Pittsburgh, Dept Crit Care Med, Neurol, Neurosurg, Pittsburgh, PA 15260 USA.	jharm3@upmc.edu	Shutter, Lori A/G-2957-2013; Empey, Philip/L-9604-2019	Empey, Philip/0000-0001-7474-2339; Wallisch, Jessica/0000-0002-7908-9479; Jha, Ruchira/0000-0002-3047-7649; Shutter, Lori/0000-0002-1390-0628; Conley, Yvette/0000-0002-1784-6067	U.S. Department of Health and Human Services; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T-32HL007820, NCATS KL2-TR000146, NCATS KL2-TR001856, NINDS K23NS101036, NINR F31NR014590, T32NR007969, NINR R00 NR013176, NICHD T32-HD040686, 1R01NS087978-01, NINR R01NR013342]; UPP Foundation Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000146, KL2TR001856] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087978, K23NS101036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R00NR013176, F31NR014590, T32NR007969, R01NR013342] Funding Source: NIH RePORTER	This study was funded by U.S. Department of Health and Human Services. RMJ discloses funding by the following NIH grants: T-32HL007820, NCATS KL2-TR000146, NCATS KL2-TR001856 and NINDS K23NS101036. TAK discloses NIH funding NINR F31NR014590 and T32NR007969. AMP discloses funding by the NIH grant NINR R00 NR013176. JSW discloses funding by the NIH grant NICHD T32-HD040686. PEE reports no disclosures. PMK discloses funding by the NIH grant 1R01NS087978-01. YPC discloses funding by the NIH grant NINR R01NR013342. RMJ have received a UPP Foundation Award.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Feng Y, 2008, DIABETES CARE, V31, P1939, DOI 10.2337/dc07-2248; Flanagan SE, 2009, HUM MUTAT, V30, P170, DOI 10.1002/humu.20838; Jablonski KA, 2010, DIABETES, V59, P2672, DOI 10.2337/db10-0543; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Kimberly WT, 2014, NEUROCRIT CARE, V20, P193, DOI 10.1007/s12028-013-9917-z; Knuppel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068941; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Mall T, 2016, BIOINFORMATICS, V32, P2499, DOI 10.1093/bioinformatics/btw068; Marmarou A., 2007, NEUROSURG FOCUS, V22, P1; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nestorowicz A, 1998, HUM MOL GENET, V7, P1119, DOI 10.1093/hmg/7.7.1119; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Osier ND, 2017, J NEUROTRAUM, V34, P86, DOI 10.1089/neu.2015.4343; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Shah S, 2016, SEMIN NEUROL, V36, P502, DOI 10.1055/s-0036-1592109; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Weaver SM, 2014, BRAIN IMAGING BEHAV, V8, P420, DOI 10.1007/s11682-012-9197-9; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Woo SK, J BIOL CHEM; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yue JK, 2017, NEUROGENETICS, V18, P29, DOI 10.1007/s10048-016-0500-6; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	39	27	27	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2018	89	11					1152	1162		10.1136/jnnp-2017-317741			11	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	HA6VV	WOS:000450420200006	29674479	Green Accepted			2022-02-06	
J	Covassin, T; Savage, JL; Bretzin, AC; Fox, ME				Covassin, Tracey; Savage, Jennifer L.; Bretzin, Abigail C.; Fox, Meghan E.			Sex differences in sport-related concussion long-term outcomes	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Sex differences; Neurocognitive; Electrophysiology; Symptoms	TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE PERFORMANCE; SOCCER PLAYERS; BASE-LINE; REPORTING BEHAVIORS; SYMPTOMS; RECOVERY; GENDER; MANAGEMENT; BALANCE	Approximately 1.6 to 3.8 million recreational and sports-related concussions (SRC) occur each year in the Unites States. Research suggest that female athletes are at a greater risk for a SRC compared to male athletes competing in comparable sports (i.e., soccer, basketball). Moreover, female athletes have reported more total symptoms and greater neurocognitive impairments following a SRC. Female athletes have been found to report greater symptom provocation as measured by the Vestibular/Ocular Motor Screening (VOMS), and increased brain activation compared to males. There is a scarcity of research on long-term effects of SRC in male and female athletes. Therefore, the aim of this review article is to summarize the existing literature on sex differences in acute and sub-acute SRC outcomes.	[Covassin, Tracey; Savage, Jennifer L.; Bretzin, Abigail C.] Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA; [Fox, Meghan E.] Grand Valley State Univ, Allendale, MI 49401 USA		Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA.	covassin@msu.edu	Savage, Jennifer/C-4680-2018	Bretzin, Abigail/0000-0003-3730-2849			Baker J. G, 2015, CLIN PEDIAT; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Beatty WW, 2003, J CLIN EXP NEUROPSYC, V25, P1065, DOI 10.1076/jcen.25.8.1065.16732; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Halpern D, 2000, SEX DIFFERENCES COGN; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; HIDDEMA F, 1963, Psychiatr Neurol Neurochir, V66, P517; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Kerr Z. Y, 2016, JAMA PEDIAT; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kimura D, 2002, PSYCHOL REP, V91, P1137, DOI 10.2466/PR0.91.7.1137-1142; Kontos A. P, 2015, BRAIN IMAGING BEHAV, P1, DOI DOI 10.1007/S11682-015-9412-6; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Laibow R. E., 2001, Journal of Neurotherapy, V5, P45, DOI 10.1300/J184v05n04_04; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; LEWIS RS, 1987, BRAIN COGNITION, V6, P142, DOI 10.1016/0278-2626(87)90115-1; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lipton RB, 2001, HEADACHE, V41, P638, DOI 10.1046/j.1526-4610.2001.041007638.x; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; NCAA, 2016, NCAA PART RAT 2014 2; NFHS, 2016, PART HIGH SCH SPORTS; Ono K. E, 2015, AM J SPORTS MED; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Register-Mihalik J. K, 2010, ASSESSMENT HIGH SCH; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Schneider K. J, 2010, BR J SPORTS MED; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Sufrinko A. M, 2016, CLIN J SPORT MED; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; Westfall DR, 2015, J PEDIATR REHAB MED, V8, P297, DOI 10.3233/PRM-150348; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2012, J NEUROSURG-PEDIATR, V10, P504, DOI 10.3171/2012.8.PEDS12139	63	27	27	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		9	13		10.1016/j.ijpsycho.2017.09.010			5	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000003	28927725				2022-02-06	
J	Li, ZZ; Zeng, G; Zheng, XW; Wang, WB; Ling, Y; Tang, HM; Zhang, JF				Li, Zhengzhao; Zeng, Guang; Zheng, Xiaowen; Wang, Wenbo; Ling, Yun; Tang, Huamin; Zhang, Jianfeng			Neuroprotective effect of formononetin against TBI in rats via suppressing inflammatory reaction in cortical neurons	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Formononetin; Traumatic brain injury; Interleukin-10; Inflammation	TRAUMATIC BRAIN-INJURY; INTERLEUKIN-10; APOPTOSIS; CALYCOSIN; PATHWAY; STRESS; CELLS	Traumatic brain injury (TBI) refers to external force-induced brain damage, characterized with necrosis and cell loss in cerebral cortex. Interestingly, a plant-extract named formononetin (FN) is found to possess promising pharmacological activities, including cellular neuroprotection. Thus, we propose that FN may exert biological protection against TBI and discuss the underlying mechanism. In the current study, a rat TBI model was established via Feeney's classical method, followed by different concentrations of FN treatment. Nissl-special and DAPI-labeled stains were utilized to assess the proliferation of cortical neurons nearing lesioned tissue. The contents of interleukin-6 (IL6), tumor necrosis factor (TNF-alpha), and interleukin-10 (IL10) in serum and the cortical neurons were determined by ELISA. Further, intracephalic IL10 expression levels were detected through immunoassay and RT-PCR. Interestingly, the results exhibited within the FN-treated TBI rat model indicated elevated cortical proliferation. The levels of IL10 in serum and the cortical neurons were increased following FN treatments, while TNF-alpha and IL6 levels in the blood were decreased. In addition, both mRNA and protein expression levels of IL10 in the FN-treated TBI rat model were up-regulated in a dose-dependent manner. Collectively, our present findings indicate that FN provides effective neuroprotection against TBI, likely by activating IL10 expression in cortical neurons nearing lesioned tissue to inhibit neuroinflammatory reaction.	[Li, Zhengzhao; Zeng, Guang; Zheng, Xiaowen; Ling, Yun; Tang, Huamin; Zhang, Jianfeng] Guangxi Med Univ, Affiliated Hosp 2, Dept Emergency, 166 Daxuedonglu Rd, Nanning 530007, Peoples R China; [Wang, Wenbo] Guilin Med Univ, Affiliated Hosp, Dept Neurosurg, Guilin 541001, Peoples R China		Zhang, JF (corresponding author), Guangxi Med Univ, Affiliated Hosp 2, Dept Emergency, 166 Daxuedonglu Rd, Nanning 530007, Peoples R China.	jf_zhang68@126.com		Zhang, Jianfeng/0000-0003-4213-9310	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81460211, 81560378]; Guangxi Emergency and Medical Rescue Talent Highland [GXJZ201506]	Our present study was supported by the National Natural Science Foundation of China (81460211, 81560378) and the Guangxi Emergency and Medical Rescue Talent Highland (GXJZ201506).	Berti FCB, 2017, CYTOKINE GROWTH F R, V34, P1, DOI 10.1016/j.cytogfr.2017.03.002; Brogan RJ, 2017, BRAIN INJURY, V31, P581, DOI 10.1080/02699052.2017.1287956; Chen J, 2015, FOOD FUNCT, V6, P3091, DOI [10.1039/c5fo00374a, 10.1039/C5FO00374A]; Durand E., 2017, ANN PHYS REHABIL MED; Eme R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7050046; Fouda AY, 2017, EUR J PHARMACOL, V799, P128, DOI 10.1016/j.ejphar.2017.02.016; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Ge B, 2018, INT IMMUNOPHARMACOL, V54, P139, DOI 10.1016/j.intimp.2017.11.010; Greene N. H., 2017, J BURN CARE RES, V60, P95; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; Latina V, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00068; Li R, 2016, GENE, V595, P168, DOI 10.1016/j.gene.2016.09.036; Li R, 2013, BRAIN RES, V1517, P28, DOI 10.1016/j.brainres.2013.04.013; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Qiu GZ, 2017, EXP BIOL MED, V242, P223, DOI 10.1177/1535370216657445; Sarkaki A, 2015, CAN J PHYSIOL PHARM, V93, P687, DOI 10.1139/cjpp-2014-0546; Stabile A, 2016, BIOL CHEM, V397, P157, DOI 10.1515/hsz-2015-0208; Suryanarayanan A, 2016, NEUROPHARMACOLOGY, V107, P181, DOI 10.1016/j.neuropharm.2016.03.027; Tian J, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0625-y; Wang Y, 2018, CELL PHYSIOL BIOCHEM, V45, P537, DOI 10.1159/000487031; Wu K, 2017, CELL PHYSIOL BIOCHEM, V43, P1562, DOI 10.1159/000482003; Wu XO, 2017, ENVIRON SCI POLLUT R, V24, P24201, DOI 10.1007/s11356-017-0072-5; Wu YY, 2017, FOOD FUNCT, V8, P1061, DOI 10.1039/c6fo01535b; Zhu Y, 2017, INT IMMUNOPHARMACOL, V50, P353, DOI 10.1016/j.intimp.2017.07.017	25	27	31	3	12	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	OCT	2018	106						349	354		10.1016/j.biopha.2018.06.041			6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GR4QO	WOS:000442600300044	29966980				2022-02-06	
J	Xia, YG; Pu, HJ; Leak, RK; Shi, YJ; Mu, HF; Hu, XM; Lu, ZY; Foley, LM; Hitchens, TK; Dixon, CE; Bennett, MVL; Chen, J				Xia, Yuguo; Pu, Hongjian; Leak, Rehana K.; Shi, Yejie; Mu, Hongfeng; Hu, Xiaoming; Lu, Zhengyu; Foley, Lesley M.; Hitchens, T. Kevin; Dixon, C. Edward; Bennett, Michael V. L.; Chen, Jun			Tissue plasminogen activator promotes white matter integrity and functional recovery in a murine model of traumatic brain injury	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						white matter; head injury; trauma; contusion; alteplase	CHONDROITIN SULFATE PROTEOGLYCAN; CENTRAL-NERVOUS-SYSTEM; PREVENTS IMPAIRMENT; CEREBRAL AUTOREGULATION; THERAPEUTIC STRATEGIES; ENDOGENOUS TPA; AXONAL INJURY; STROKE; INTRANASAL; MICE	Recombinant tissue plasminogen activator (tPA) is a Food and Drug Administration-approved thrombolytic treatment for ischemic stroke. tPA is also naturally expressed in glial and neuronal cells of the brain, where it promotes axon outgrowth and synaptic plasticity. However, there are conflicting reports of harmful versus neuroprotective effects of tPA in acute brain injury models. Furthermore, its impact on white matter integrity in preclinical traumatic brain injury (TBI) has not been thoroughly explored, although white matter disruption is a better predictor of long-term clinical outcomes than focal lesion volumes. Here we show that the absence of endogenous tPA in knockout mice impedes long-term recovery of white matter and neurological function after TBI. tPA-knockout mice exhibited greater asymmetries in forepaw use, poorer sensorimotor balance and coordination, and inferior spatial learning and memory up to 35 d after TBI. White matter damage was also more prominent in tPA knockouts, as shown by diffusion tensor imaging, histological criteria, and electrophysiological assessments of axon conduction properties. Replenishment of tPA through intranasal application of the recombinant protein in tPA-knockout mice enhanced neurological function, the structural and functional integrity of white matter, and postinjury compensatory sprouting in corticofugal projections. tPA also promoted neurite outgrowth in vitro, partly through the epidermal growth factor receptor. Both endogenous and exogenous tPA protected against white matter injury after TBI without increasing intracerebral hemorrhage volumes. These results unveil a previously unappreciated role for tPA in the protection and/or repair of white matter and long-term functional recovery after TBI.	[Xia, Yuguo; Pu, Hongjian; Shi, Yejie; Mu, Hongfeng; Hu, Xiaoming; Lu, Zhengyu; Chen, Jun] Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, Pittsburgh, PA 15213 USA; [Xia, Yuguo; Pu, Hongjian; Shi, Yejie; Mu, Hongfeng; Hu, Xiaoming; Lu, Zhengyu; Chen, Jun] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA; [Leak, Rehana K.] Duquesne Univ, Sch Pharm, Grad Sch Pharmaceut Sci, Pittsburgh, PA 15282 USA; [Hu, Xiaoming; Dixon, C. Edward; Chen, Jun] Vet Affairs Pittsburgh Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15261 USA; [Foley, Lesley M.; Hitchens, T. Kevin] Univ Pittsburgh, Anim Imaging Ctr, Pittsburgh, PA 15203 USA; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; [Bennett, Michael V. L.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA		Chen, J (corresponding author), Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, Pittsburgh, PA 15213 USA.; Chen, J (corresponding author), Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA.; Chen, J (corresponding author), Vet Affairs Pittsburgh Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15261 USA.; Bennett, MVL (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA.	michael.bennett@einstein.yu.edu; chenj2@upmc.edu	Pu, Hongjian/AAW-3322-2020; Leak, Rehana K/I-2607-2019; Shi, Yejie/C-2355-2018	Leak, Rehana K/0000-0003-2817-7417; Shi, Yejie/0000-0001-7502-9201	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS095029, NS108695]; US Department of Veterans Affairs (VA) Merit ReviewUS Department of Veterans Affairs [BX003377]; VA Senior Research Career Scientist Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS108695, R01NS095029] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003377] Funding Source: NIH RePORTER	We thank Carol Culver for editorial assistance and Patricia Strickler for administrative support. This project was supported by NIH Grants NS095029 and NS108695 (to M.V.L.B. and J.C.), and US Department of Veterans Affairs (VA) Merit Review BX003377 (to J.C.). J.C. is the Richard King Mellon Professor of Neurology and a recipient of a VA Senior Research Career Scientist Award. M.V.L.B. is the Sylvia and Robert S. Olnick Professor of Neuroscience.	Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Armstead WM, 2018, J NEUROSCI RES, V96, P128, DOI 10.1002/jnr.24112; Armstead WM, 2016, STROKE, V47, P2096, DOI 10.1161/STROKEAHA.116.012678; Armstead WM, 2013, J NEUROTRAUM, V30, P1898, DOI 10.1089/neu.2013.2962; Armstead WM, 2012, J NEUROTRAUM, V29, P1794, DOI 10.1089/neu.2012.2328; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; BABHAIR SA, 1990, RES COMMUN CHEM PATH, V67, P241; Bertrand T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.296; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Chevilley A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00415; Christrup LL, 2008, CLIN THER, V30, P469, DOI 10.1016/j.clinthera.2008.03.001; Correa F, 2011, J EXP MED, V208, P1229, DOI 10.1084/jem.20101880; Crumrine R Christian, 2011, Exp Transl Stroke Med, V3, P10, DOI 10.1186/2040-7378-3-10; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Echeverry R, 2010, J CLIN INVEST, V120, P2194, DOI 10.1172/JCI41722; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gravanis I, 2008, EXPERT OPIN THER TAR, V12, P159, DOI [10.1517/14728222.12.2.159, 10.1517/14728222.12.2.159 ]; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Haile WB, 2012, J CEREBR BLOOD F MET, V32, P57, DOI 10.1038/jcbfm.2011.106; Hanson LR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S3-S5; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Hynds DL, 1999, EXP NEUROL, V160, P244, DOI 10.1006/exnr.1999.7212; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; Kim YH, 1999, SCIENCE, V284, P647, DOI 10.1126/science.284.5414.647; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kozlovskaya L, 2014, J CONTROL RELEASE, V189, P133, DOI 10.1016/j.jconrel.2014.06.053; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; Lee TW, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00396; Lemarchand E, 2016, CELL DEATH DIFFER, V23, P123, DOI 10.1038/cdd.2015.76; Leonetti C, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0160-5; Li LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165637; Liot G, 2006, J NEUROCHEM, V98, P1458, DOI 10.1111/j.1471-4159.2006.03982.x; Liu ZW, 2012, NEUROBIOL DIS, V45, P804, DOI 10.1016/j.nbd.2011.11.004; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mao LL, 2017, BRAIN, V140, P1914, DOI 10.1093/brain/awx111; Meng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106238; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Minor K, 2009, J NEUROCHEM, V109, P706, DOI 10.1111/j.1471-4159.2009.05977.x; National Research Council, 2011, GUIDE CARE USE LAB A; Nusbaum F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00173; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Pu HJ, 2013, J CEREBR BLOOD F MET, V33, P1474, DOI 10.1038/jcbfm.2013.108; Seeds NW, 2003, J NEUROSCI, V23, P7368; Shen LH, 2011, STROKE, V42, P459, DOI 10.1161/STROKEAHA.110.593863; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Stein SC, 2009, J NEUROTRAUM, V26, P1585, DOI [10.1089/neu.2008.0720, 10.1089/neu.2008-0720]; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Tomkins AJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16026; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tsirka SE, 2002, BIOCHEM SOC T, V30, P222, DOI 10.1042/bst0300222; VERSTRAETE M, 1985, J PHARMACOL EXP THER, V235, P506; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Yepes M, 2004, EXP BIOL MED, V229, P1097, DOI 10.1177/153537020422901103; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Zou T, 2006, J NEUROPATH EXP NEUR, V65, P78, DOI 10.1097/01.jnen.0000195942.25163.f5	59	27	27	0	9	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	SEP 25	2018	115	39					E9230	E9238		10.1073/pnas.1810693115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU7XK	WOS:000445545200024	30201709	Bronze, Green Published			2022-02-06	
J	Foks, KA; van den Brand, CL; Lingsma, HF; van der Naalt, J; Jacobs, B; de Jong, E; den Boogert, HF; Sir, O; Patka, P; Polinder, S; Gaakeer, MI; Schutte, CE; Jie, KE; Visee, HF; Hunink, MGM; Reijners, E; Braaksma, M; Schoonman, GG; Steyerberg, EW; Jellema, K; Dippel, DWJ				Foks, Kelly A.; van den Brand, Crispijn L.; Lingsma, Hester F.; van der Naalt, Joukje; Jacobs, Bram; de Jong, Eline; den Boogert, Hugo F.; Sir, Ozcan; Patka, Peter; Polinder, Suzanne; Gaakeer, Menno I.; Schutte, Charlotte E.; Jie, Kim E.; Visee, Huib F.; Hunink, Myriam G. M.; Reijners, Eef; Braaksma, Meriam; Schoonman, Guus G.; Steyerberg, Ewout W.; Jellema, Korne; Dippel, Diederik W. J.			External validation of computed tomography decision rules for minor head injury: prospective, multicentre cohort study in the Netherlands	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; INTRACRANIAL INJURY; METAANALYSIS; EPIDEMIOLOGY; MANAGEMENT; MORTALITY; ADULTS	OBJECTIVE To externally validate four commonly used rules in computed tomography (CT) for minor head injury. DESIGN Prospective, multicentre cohort study. SETTING Three university and six non-university hospitals in the Netherlands. PARTICIPANTS Consecutive adult patients aged 16 years and over who presented with minor head injury at the emergency department with a Glasgow coma scale score of 13-15 between March 2015 and December 2016. MAIN OUTCOME MEASURES The primary outcome was any intracranial traumatic finding on CT; the secondary outcome was a potential neurosurgical lesion on CT, which was defined as an intracranial traumatic finding on CT that could lead to a neurosurgical intervention or death. The sensitivity, specificity, and clinical usefulness (defined as net proportional benefit, a weighted sum of true positive classifications) of the four CT decision rules. The rules included the CT in head injury patients (CHIP) rule, New Orleans criteria (NOC), Canadian CT head rule CCHR), and National Institute for Health and Care Excellence (NICE) guideline for head injury. RESULTS For the primary analysis, only six centres that included patients with and without CT were selected. Of 4557 eligible patients who presented with minor head injury, 3742 (82%) received a CT scan; 384 (8%) had a intracranial traumatic finding on CT, and 74 (2%) had a potential neurosurgical lesion. The sensitivity for any intracranial traumatic finding on CT ranged from 73% (NICE) to 99% (NOC); specificity ranged from 4% (NOC) to 61% (NICE). Sensitivity for a potential neurosurgical lesion ranged between 85% (NICE) and 100% (NOC); specificity from 4% (NOC) to 59% (NICE). Clinical usefulness depended on thresholds for performing CT scanning: the NOC rule was preferable at a low threshold, the NICE rule was preferable at a higher threshold, whereas the CHIP rule was preferable for an intermediate threshold. CONCLUSIONS Application of the CHIP, NOC, CCHR, or NICE decision rules can lead to a wide variation in CT scanning among patients with minor head injury, resulting in many unnecessary CT scans and some missed intracranial traumatic findings. Until an existing decision rule has been updated, any of the four rules can be used for patients presenting minor head injuries at the emergency department. Use of the CHIP rule is recommended because it leads to a substantial reduction in CT scans while missing few potential neurosurgical lesions.	[Foks, Kelly A.; Lingsma, Hester F.; Polinder, Suzanne; Steyerberg, Ewout W.] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Foks, Kelly A.; Dippel, Diederik W. J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands; [van den Brand, Crispijn L.; de Jong, Eline] Haaglanden Med Ctr, Dept Emergency Med, The Hague, Netherlands; [van den Brand, Crispijn L.; Patka, Peter] Erasmus MC Univ Med Ctr Rotterdam, Dept Emergency Med, Rotterdam, Netherlands; [van der Naalt, Joukje; Jacobs, Bram] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [den Boogert, Hugo F.] Radboud Univ Nijmegen, Dept Neurosurg, Med Ctr, Nijmegen, Netherlands; [Sir, Ozcan] Radboud Univ Nijmegen, Dept Emergency Med, Med Ctr, Nijmegen, Netherlands; [Gaakeer, Menno I.; Schutte, Charlotte E.] Admiraal De Ruyter Hosp, Dept Emergency Med, Goes, Netherlands; [Jie, Kim E.] Jeroen Bosch Hosp, Dept Emergency Med, sHertogenbosch, Netherlands; [Visee, Huib F.] Jeroen Bosch Hosp, Dept Neurol, sHertogenbosch, Netherlands; [Hunink, Myriam G. M.] Erasmus MC Univ Med Ctr Rotterdam, Dept Radiol, Rotterdam, Netherlands; [Hunink, Myriam G. M.] Erasmus MC Univ Med Ctr Rotterdam, Dept Epidemiol, Rotterdam, Netherlands; [Hunink, Myriam G. M.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA; [Reijners, Eef] Elisabeth Tweesteden Hosp, Dept Emergency Med, Tilburg, Netherlands; [Braaksma, Meriam; Schoonman, Guus G.] Elisabeth Tweesteden Hosp, Dept Neurol, Tilburg, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands; [Jellema, Korne] Haaglanden Med Ctr, Dept Neurol, The Hague, Netherlands		Foks, KA (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.; Foks, KA (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Neurol, Rotterdam, Netherlands.	k.foks@erasmusmc.nl	Boogert, Hugo F den/B-2782-2016; Dippel, Diederik/AAJ-2192-2020	Dippel, Diederik/0000-0002-9234-3515; van der Naalt, Joukje/0000-0001-9873-2418	St Jacobus Foundation	This study did not receive any specific funding. CLvdB received a personal grant from the St Jacobus Foundation, which is a non-profit organisation that supports research; the funder played no role in the design, analysis, or presentation of the study.	af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Batchelor JS, 2012, BRIT J NEUROSURG, V26, P525, DOI 10.3109/02688697.2011.650736; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Dunning J, 2004, J NEUROTRAUM, V21, P877, DOI 10.1089/0897715041526122; Easter JS, 2015, JAMA-J AM MED ASSOC, V314, P2672, DOI 10.1001/jama.2015.16316; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hunink MGM, 2014, DECISION MAKING HLTH, DOI [10.1017/CBO9781139506779, DOI 10.1017/CB09781139506779]; Leard Statistics, 2018, COCHR Q TEST US SPSS; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; National Clinical Guideline C. National Clinical Guidance Centre, 2014, CG 176 HEAD INJ TRIA; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Smits M, 2007, J NEUROL NEUROSUR PS, V78, P1359, DOI 10.1136/jnnp.2007.117143; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Steyerberg E. W., 2009, CLIN PREDICTION MODE, DOI [10.1007/978-0-387-77244-8, 10. 1007/978-0-387-77244-8., DOI 10.1007/978-0-387-77244-8]; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sullivan TR, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0414-5; Van den Brand CL, 2018, EUR J EMERG MED, V25, P355, DOI 10.1097/MEJ.0000000000000457; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; Vickers AJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i6	31	27	28	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2018	362								k3527	10.1136/bmj.k3527			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR8SY	WOS:000443000000002	30143521	Green Published, hybrid			2022-02-06	
J	Logsdon, AF; Meabon, JS; Cline, MM; Bullock, KM; Raskind, MA; Peskind, ER; Banks, WA; Cook, DG				Logsdon, Aric F.; Meabon, James S.; Cline, Marcella M.; Bullock, Kristin M.; Raskind, Murray A.; Peskind, Elaine R.; Banks, William A.; Cook, David G.			Blast exposure elicits blood-brain barrier disruption and repair mediated by tight junction integrity and nitric oxide dependent processes	SCIENTIFIC REPORTS			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; CEREBRAL-ARTERY OCCLUSION; OPERATION IRAQI FREEDOM; ESTER L-NAME; L-ARGININE; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; REPERFUSION INJURY; NEUROVASCULAR UNIT; HEAD-INJURY	Mild blast-induced traumatic brain injury (TBI) is associated with blood-brain barrier (BBB) disruption. However, the mechanisms whereby blast disrupts BBB integrity are not well understood. To address this issue BBB permeability to peripherally injected C-14-sucrose and Tc-99m-albumin was quantified in ten brain regions at time points ranging from 0.25 to 72 hours. In mice, repetitive (2X) blast provoked BBB permeability to C-14-sucrose that persisted in specific brain regions from 0.25 to 72 hours. However, Tc-99m-albumin revealed biphasic BBB disruption (open-closed-open) over the same interval, which was most pronounced in frontal cortex and hippocampus. This indicates that blast initiates interacting BBB disruption and reparative processes in specific brain regions. Further investigation of delayed (72 hour) BBB disruption revealed that claudin-5 (CLD5) expression was disrupted specifically in the hippocampus, but not in dorsal striatum, a brain region that showed no blast-induced BBB permeability to sucrose or albumin. In addition, we found that delayed BBB permeability and disrupted CLD5 expression were blocked by the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME). These data argue that latent nitric oxide-dependent signaling pathways initiate processes that result in delayed BBB disruption, which are manifested in a brain-region specific manner.	[Logsdon, Aric F.; Cline, Marcella M.; Bullock, Kristin M.; Banks, William A.; Cook, David G.] Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA 98108 USA; [Logsdon, Aric F.; Banks, William A.; Cook, David G.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Meabon, James S.; Raskind, Murray A.; Peskind, Elaine R.] Vet Affairs Puget Sound Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Vet Affairs Northwest Network, Seattle, WA 98108 USA; [Meabon, James S.; Raskind, Murray A.; Peskind, Elaine R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Cline, Marcella M.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA		Cook, DG (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA 98108 USA.; Cook, DG (corresponding author), Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA.	dgcook@u.washington.edu	Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619; Cline, Marcella/0000-0002-9590-3725	VA Puget Sound Health Care System Seed Grant; Department of Veterans Affairs Office of Research and Development Medical Research Service RDIS [0005]; Veterans Affairs Rehabilitation Research and Development Service Merit Review Grant [B77421]; University of Washington Friends of Alzheimer's Research; University of Washington Royalty Research FundUniversity of Washington; Northwest Network Mental Illness Research Education and Clinical Center;  [R01AG046619];  [T32AG052354]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG046619, T32AG052354] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002311, I01RX001612] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: These studies were supported by R01AG046619 (WAB), and T32AG052354 (A.F.L.), VA Puget Sound Health Care System Seed Grant (J.S.M.), Department of Veterans Affairs Office of Research and Development Medical Research Service RDIS# 0005 (D.G.C.), Veterans Affairs Rehabilitation Research and Development Service Merit Review Grant #B77421 (E.R.P.), University of Washington Friends of Alzheimer's Research (D.G.C., E.R.P.), University of Washington Royalty Research Fund (D.G.C.), Northwest Network Mental Illness Research Education and Clinical Center (J.S.M., E.R.P., M.A.R.).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Banks WA, 2008, ENDOCRINOLOGY, V149, P1514, DOI 10.1210/en.2007-1091; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Chip S, 2013, J CEREBR BLOOD F MET, V33, P508, DOI 10.1038/jcbfm.2012.190; Clark PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120075; Cooper I, 2011, METHODS MOL BIOL, V762, P347, DOI 10.1007/978-1-61779-185-7_25; Del Razo MJ, 2016, SIAM J SCI COMPUT, V38, pB347, DOI 10.1137/15M1010750; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gu Y, 2012, J NEUROCHEM, V120, P147, DOI 10.1111/j.1471-4159.2011.07542.x; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Khaldi A, 2002, ANN NY ACAD SCI, V962, P53, DOI 10.1111/j.1749-6632.2002.tb04055.x; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kuraikose M., 2018, SCI REPORTS, V8; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; LEVIN VA, 1970, AM J PHYSIOL, V219, P1528, DOI 10.1152/ajplegacy.1970.219.5.1528; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lowenstein CJ, 1996, J CLIN INVEST, V97, P1837, DOI 10.1172/JCI118613; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Macdonald A, 2011, J TRAUMA STRESS, V24, P268, DOI 10.1002/jts.20642; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; MAYHAN WG, 1985, AM J PHYSIOL, V248, pH712, DOI 10.1152/ajpheart.1985.248.5.H712; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; MULSCH A, 1990, N-S ARCH PHARMACOL, V341, P143; Nakaizumi A, 2012, CELL MOL NEUROBIOL, V32, P95, DOI 10.1007/s10571-011-9739-5; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pfeiffer S, 1996, BRIT J PHARMACOL, V118, P1433, DOI 10.1111/j.1476-5381.1996.tb15557.x; Pillai DR, 2009, J CEREBR BLOOD F MET, V29, P1846, DOI 10.1038/jcbfm.2009.106; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; REES DD, 1989, BRIT J PHARMACOL, V96, P418, DOI 10.1111/j.1476-5381.1989.tb11833.x; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Schindler AG, 2017, NEUROBIOL DIS, V106, P23, DOI 10.1016/j.nbd.2017.06.004; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schubert W, 2002, J BIOL CHEM, V277, P40091, DOI 10.1074/jbc.M205948200; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Stamatovic SM, 2009, J BIOL CHEM, V284, P19053, DOI 10.1074/jbc.M109.000521; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Theas S, 2001, NEUROENDOCRINOLOGY, V74, P82, DOI 10.1159/000054673; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Willis CL, 2013, NEUROSCIENCE, V250, P773, DOI 10.1016/j.neuroscience.2013.06.061; Winger RC, 2014, J IMMUNOL, V193, P2427, DOI 10.4049/jimmunol.1400700; Xaio HP, 2001, BRAIN RES, V896, P36, DOI 10.1016/S0006-8993(00)03247-9; Yamaguchi H, 2008, MOL CELL BIOCHEM, V312, P103, DOI 10.1007/s11010-008-9725-5; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; ZIYLAN YZ, 1984, AM J PHYSIOL, V247, pR634, DOI 10.1152/ajpregu.1984.247.4.R634; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	83	27	28	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 27	2018	8								11344	10.1038/s41598-018-29341-6			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GO4HC	WOS:000439965200037	30054495	Green Published, gold			2022-02-06	
J	Jha, RM; Molyneaux, BJ; Jackson, TC; Wallisch, JS; Park, SY; Poloyac, S; Vagni, VA; Janesko-Feldman, KL; Hoshitsuki, K; Minnigh, MB; Kochanek, PM				Jha, Ruchira M.; Molyneaux, Bradley J.; Jackson, Travis C.; Wallisch, Jessica S.; Park, Seo-Young; Poloyac, Samuel; Vagni, Vincent A.; Janesko-Feldman, Keri L.; Hoshitsuki, Keito; Minnigh, M. Beth; Kochanek, Patrick M.			Glibenclamide Produces Region-Dependent Effects on Cerebral Edema in a Combined Injury Model of Traumatic Brain Injury and Hemorrhagic Shock in Mice	JOURNAL OF NEUROTRAUMA			English	Article						cerebral edema; glibenclamide/glyburide; HS; Sur1; TBI	CONTROLLED CORTICAL IMPACT; NONSELECTIVE CATION CHANNEL; SULFONYLUREA RECEPTOR 1; SEVERE HEAD-INJURY; REACTIVE ASTROCYTES; RESUSCITATION; CONTUSION; ISCHEMIA; DAMAGE; ATP	Cerebral edema is critical to morbidity/mortality in traumatic brain injury (TBI) and is worsened by hypotension. Glibenclamide may reduce cerebral edema by inhibiting sulfonylurea receptor-1 (Sur1); its effect on diffuse cerebral edema exacerbated by hypotension/resuscitation is unknown. We aimed to determine if glibenclamide improves pericontusional and/or diffuse edema in controlled cortical impact (CCI) (5m/sec, 1mm depth) plus hemorrhagic shock (HS) (35min), and compare its effects in CCI alone. C57BL/6 mice were divided into five groups (n=10/group): naive, CCI+vehicle, CCI+glibenclamide, CCI+HS+vehicle, and CCI+HS+glibenclamide. Intravenous glibenclamide (10min post-injury) was followed by a subcutaneous infusion for 24h. Brain edema in injured and contralateral hemispheres was subsequently quantified (wet-dry weight). This protocol brain water (BW)=80.4% vehicle vs. 78.3% naive, p<0.01) but was not reduced by glibenclamide (I%BW=80.4%). Ipsilateral edema also developed in CCI alone (I%BW=80.2% vehicle vs. 78.3% naive, p<0.01); again unaffected by glibenclamide (I%BW=80.5%). Contralateral (C) %BW in CCI+HS was increased in vehicle (78.6%) versus naive (78.3%, p=0.02) but unchanged in CCI (78.3%). At 24h, glibenclamide treatment in CCI+HS eliminated contralateral cerebral edema (C%BW=78.3%) with no difference versus naive. By 72h, contralateral cerebral edema had resolved (C%BW=78.5 +/- 0.09% vehicle vs. 78.3 +/- 0.05% naive). Glibenclamide decreased 24h contralateral cerebral edema in CCI+HS. This beneficial effect merits additional exploration in the important setting of TBI with polytrauma, shock, and resuscitation. Contralateral edema did not develop in CCI alone. Surprisingly, 24h of glibenclamide treatment failed to decrease ipsilateral edema in either model. Interspecies dosing differences versus prior studies may play an important role in these findings. Mechanisms underlying brain edema may differ regionally, with pericontusional/osmolar swelling refractory to glibenclamide but diffuse edema (via Sur1) from combined injury and/or resuscitation responsive to this therapy. TBI phenotype may mandate precision medicine approaches to treat brain edema.	[Jha, Ruchira M.; Molyneaux, Bradley J.; Jackson, Travis C.; Wallisch, Jessica S.; Vagni, Vincent A.; Janesko-Feldman, Keri L.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Jha, Ruchira M.; Molyneaux, Bradley J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Jha, Ruchira M.; Molyneaux, Bradley J.] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; [Park, Seo-Young] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Poloyac, Samuel; Hoshitsuki, Keito; Minnigh, M. Beth] Univ Pittsburgh, Sch Med, Dept Pharm & Therapeut, Pittsburgh, PA USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesia, Pittsburgh, PA USA; [Jha, Ruchira M.; Jackson, Travis C.; Wallisch, Jessica S.; Vagni, Vincent A.; Janesko-Feldman, Keri L.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Jha, Ruchira M.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Park, Seo-Young] Univ Pittsburgh, Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15260 USA		Jha, RM (corresponding author), Univ Pittsburgh, Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	jharm3@upmc.edu	Hoshitsuki, Keito/F-9429-2019	Hoshitsuki, Keito/0000-0002-6723-0711; Wallisch, Jessica/0000-0002-7908-9479	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T-32HL007820, KL2 TR000146, KL2-TR001856, K23NS101036, T32 HD040686, R01 NS087978]; United States Department of DefenseUnited States Department of Defense [W81XWH-10-1-0623, W81XWH-14-2-0018]; UPP Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001856] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087978, K23NS101036] Funding Source: NIH RePORTER	We are grateful for National Institutes of Health (NIH) grants: T-32HL007820 (R.M.J.), KL2 TR000146 (R.M.J.), KL2-TR001856 (R.M.J.), K23NS101036 (R.M.J.), T32 HD040686 (J.S.W.), and R01 NS087978 (P.M.K.) for providing generous support. We are also grateful for United States Department of Defense grants W81XWH-10-1-0623 (P.M.K.) and W81XWH-14-2-0018 (P.M.K.) for providing generous support. We are also grateful to the UPP Foundation Grant for its generous support (RMJ).	Brockman EC, 2013, J CEREBR BLOOD F MET, V33, P1457, DOI 10.1038/jcbfm.2013.104; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Chen JQ, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.898190; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Feldmann H, 1979, Acta Neurochir Suppl (Wien), V28, P74; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Huang KB, 2015, CRIT CARE MED, V43, pE341, DOI 10.1097/CCM.0000000000001093; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jha R., 2016, CRIT CARE MED, V45, pe255; Jha R, 2015, J NEUROTRAUM, V32, pA119; Katayama Y, 1998, ACT NEUR S, V71, P289; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; KLATZO I, 1994, ACTA NEUROCHIR, P3; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Krieg SM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00455; Krieg SM, 2017, J NEUROTRAUM, V34, P1329, DOI 10.1089/neu.2016.4514; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Langfitt T W, 1966, W V Med J, V62, P49; LANGFITT THOMAS W., 1964, TRANS AMER NEUROL ASS, V89, P214; LANGFITT TW, 1966, J NEUROSURG, V24, P47, DOI 10.3171/jns.1966.24.1.0047; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Makar TK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0432-3; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; McBride DW, 2014, J NEUROTRAUM, V31, P1948, DOI 10.1089/neu.2014.3439; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Munoz A, 2003, STROKE, V34, P164, DOI 10.1161/01.STR.0000048215.36747.D1; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nagata K, 2016, J TRAUMA ACUTE CARE, V81, P1088, DOI 10.1097/TA.0000000000001215; Naraharisetti SB, 2007, J CHROMATOGR B, V860, P34, DOI 10.1016/j.jchromb.2007.10.010; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Ortega FJ, 2013, J CEREBR BLOOD F MET, V33, P356, DOI 10.1038/jcbfm.2012.166; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Portella G, 2000, ACT NEUR S, V76, P273; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; SCHUTTA HS, 1968, BRAIN, V91, P281, DOI 10.1093/brain/91.2.281; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Shigemori Y, 2006, ACTA NEUROCHIR SUPPL, V96, P130; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2014, NEUROCRIT CARE, V20, P319, DOI 10.1007/s12028-013-9923-1; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2012, EXP NEUROL, V233, P829, DOI 10.1016/j.expneurol.2011.11.048; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Teng ZP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06932-3; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Tress EE, 2014, NEUROSCI LETT, V578, P17, DOI 10.1016/j.neulet.2014.06.020; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Walcott BP, 2012, NEUROTHERAPEUTICS, V9, P65, DOI 10.1007/s13311-011-0087-4; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; Zafardoost P, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.25113; Zhang MA, 2016, ENERGY STORAGE MATER, V4, P1, DOI 10.1016/j.ensm.2016.02.001; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	84	27	28	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	17					2125	2135		10.1089/neu.2016.4696		JUN 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GQ7LU	WOS:000434471100001	29648981	Green Published			2022-02-06	
J	Xu, KB; Wu, FF; Xu, K; Li, ZM; Wei, XJ; Lu, Q; Jiang, T; Wu, FZ; Xu, XL; Xiao, J; Chen, DQ; Zhang, HY				Xu, Kebin; Wu, Fangfang; Xu, Ke; Li, Zhengmao; Wei, Xiaojie; Lu, Qi; Jiang, Ting; Wu, Fenzan; Xu, Xinlong; Xiao, Jian; Chen, Daqing; Zhang, Hongyu			NaHS restores mitochondrial function and inhibits autophagy by activating the PI3K/Akt/mTOR signalling pathway to improve functional recovery after traumatic brain injury	CHEMICO-BIOLOGICAL INTERACTIONS			English	Article						Hydrogen sulfide; Traumatic brain injury; Blood brain barrier; Autophagy	HYDROGEN-SULFIDE PROTECTS; BARRIER INTEGRITY; CELL-DEATH; AXON REGENERATION; DYSFUNCTION; CARDIOPROTECTION; NEUROPROTECTION; DEGENERATION; CHALLENGES; APOPTOSIS	Traumatic brain injury (TBI) is one of the most serious public health problems in the world. TBI causes neurological deficits by triggering secondary injuries. Hydrogen sulfide (H2S), a gaseous mediator, has been reported to exert neuroprotective effects in central nervous system diseases, such as TBI. However, the molecular mechanisms involved in this effect are still unclear. The present study was designed to explore the ability of NaHS, a H2S donor, to provide neuroprotection in a mouse model of TBI and to discover the associated molecular mechanisms of these protective effects. Here, we found that administration of NaHS not only maintained the integrity of the blood brain barrier (BBB), protected neurons from apoptosis, and promoted remyelination and axonal reparation but also protected mitochondrial function. In addition, we found that autophagy was inhibited after treatment with NaHS following TBI, an effect that was induced by activation of the PI3K/AKT/mTOR signalling pathway. Our study indicated that H2S treatment is beneficial for TBI, pointing to H2S as a potential therapeutic target for treating TBI.	[Xu, Kebin; Li, Zhengmao; Lu, Qi; Jiang, Ting; Xiao, Jian; Zhang, Hongyu] Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou 325035, Zhejiang, Peoples R China; [Wu, Fangfang; Chen, Daqing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou 325027, Zhejiang, Peoples R China; [Wu, Fangfang; Chen, Daqing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China; [Xu, Ke] Wenzhou Univ, Inst Life Sci, Wenzhou 325035, Zhejiang, Peoples R China; [Wei, Xiaojie; Xu, Xinlong] Wenzhou Med Univ, Cixi Peoples Hosp, Dept Neurosurg, Ningbo 315300, Zhejiang, Peoples R China; [Wu, Fenzan] Wenzhou Med Univ, Cixi Peoples Hosp, Sci & Educ Div, Ningbo 315300, Zhejiang, Peoples R China; [Zhang, Hongyu] Wenzhou Med Univ, Dongyang Peoples Hosp, Expt Res Ctr, Jinhua 322100, Zhejiang, Peoples R China		Zhang, HY (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou 325035, Zhejiang, Peoples R China.; Chen, DQ (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China.; Chen, DQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou 325027, Zhejiang, Peoples R China.	cdq@wzhealth.com; hyzhang@wmu.edu.cn		Wu, Fangfang/0000-0002-1888-4516	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81472165, 81772450, 81572237, 81501953]; National Science Fund for Outstanding Young ScholarsNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars [81722028]; Zhejiang Provincial Natural Science Funding [LQ16H090007]; Traditional Chinese Medicine Health Science and Technology Program of Zhejiang Province [2018ZA117]	This work was supported by research grants from the National Natural Science Foundation of China (81472165, 81772450, 81572237, 81501953), The National Science Fund for Outstanding Young Scholars (81722028), Zhejiang Provincial Natural Science Funding (LQ16H090007) and Traditional Chinese Medicine Health Science and Technology Program of Zhejiang Province (2018ZA117).	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Calvert JW, 2010, CIRCULATION, V122, P11, DOI 10.1161/CIRCULATIONAHA.109.920991; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Chen JT, 2016, INT J CARDIOL, V220, P681, DOI 10.1016/j.ijcard.2016.06.200; Chen Y, 2012, LIFE SCI, V91, P271, DOI 10.1016/j.lfs.2012.07.026; Chen ZQ, 2016, BIOCHEM BIOPH RES CO, V478, P1304, DOI 10.1016/j.bbrc.2016.08.116; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Hadadha M, 2015, J STROKE CEREBROVASC, V24, P2676, DOI 10.1016/j.jstrokecerebrovasdis.2015.07.020; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Jung J, 2014, NEURAL REGEN RES, V9, P2119, DOI 10.4103/1673-5374.147940; Koch JC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.191; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li L, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0135-1; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lin CJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.123; Lo Faro ML, 2014, NITRIC OXIDE-BIOL CH, V41, P38, DOI 10.1016/j.niox.2014.05.014; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Luo YG, 2013, NEUROCHEM INT, V63, P826, DOI 10.1016/j.neuint.2013.06.004; Nakazato R, 2017, J NEUROSCI, V37, P10052, DOI 10.1523/JNEUROSCI.3639-16.2017; Nie J, 2016, PEERJ, V4, DOI 10.7717/peerj.2739; Park BS, 2015, J NEUROCHEM, V132, P230, DOI 10.1111/jnc.12932; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shan HY, 2017, MOL MED REP, V16, P5938, DOI 10.3892/mmr.2017.7363; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Wang YL, 2014, J NEUROCHEM, V129, P827, DOI 10.1111/jnc.12695; Xiao J, 2015, CELL PHYSIOL BIOCHEM, V37, P2444, DOI 10.1159/000438597; Xiao L, 2018, J HYPERTENS, V36, P651, DOI 10.1097/HJH.0000000000001605; Xiao T, 2016, MOL MED REP, V13, P1765, DOI 10.3892/mmr.2015.4689; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Yokobori S, 2014, CNS NEUROL DISORD-DR, V13, P606, DOI 10.2174/187152731304140702112805; Zhao FL, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8360738	40	27	30	0	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0009-2797	1872-7786		CHEM-BIOL INTERACT	Chem.-Biol. Interact.	APR 25	2018	286						96	105		10.1016/j.cbi.2018.02.028			10	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	GC2DK	WOS:000429592200012	29567101				2022-02-06	
J	Ondruschka, B; Schuch, S; Pohlers, D; Franke, H; Dressler, J				Ondruschka, Benjamin; Schuch, Sandra; Pohlers, Dirk; Franke, Heike; Dressler, Jan			Acute phase response after fatal traumatic brain injury	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Acute phase response; Cytokines; Fatal traumatic brain injury; Inflammation; Postmortem biochemistry	C-REACTIVE PROTEIN; CEREBROSPINAL-FLUID FERRITIN; SERUM; INTERLEUKIN-6; NECROSIS; APOPTOSIS; DIAGNOSIS; SEVERITY; RECEPTOR; CYTOKINES	An inflammatory response occurring after fatal traumatic brain injury (TBI) initiates time-dependent cascades of acute phase response. This may offer the potential to monitor postmortem biomarker levels of several pro-inflammatory cytokines to gain information about the cause of death and the trauma survival time. Cerebrospinal fluid (CSF) and serum samples were collected from forensic autopsies of 95 adult cadavers after postmortem intervals up to 6 days. The cases were divided according to their cause of death into fatal TBI (n = 46) with different survival times and age- and gender-matching non-TBI fatalities as controls (n = 49). Quantitative marker levels of interleukin-6 (IL-6), ferritin, soluble tumor necrosis factor receptor type 1, C-reactive protein, and lactate dehydrogenase were analyzed using immunoassays. Standardized statistical tests were performed to differentiate causes of death and survival time of TBI cases. The CSF IL-6, ferritin, and LDH levels after TBI were significantly higher than those in the controls (p < 0.001). Only serum IL-6 values showed comparable differences (p < 0.05). Both CSF and serum ferritin levels were discriminative between early and delayed death after TBI (p < 0.05). There were partly distinctive correlations between marker levels in both fluids with rising values after longer survival. There were up to moderate correlation between the marker levels and the postmortem interval due to postmortem hemolysis. However, neither CSF nor serum level ranges were affected by the age or gender of the subjects. This study is the first to measure all five proteins systematically in postmortem trauma cases. Ferritin and IL-6 proved themselves to be interesting postmortem biomarkers to provide specific information on the injury pattern and the survival time of traumatic fatalities. Such forensic investigations could serve as inexpensive and fast laboratory tests.	[Ondruschka, Benjamin; Schuch, Sandra; Dressler, Jan] Univ Leipzig, Inst Legal Med, Fac Med, Johannisallee 28, D-04103 Leipzig, Germany; [Pohlers, Dirk] Klinikum Chemnitz, Ctr Diagnost GmbH, Chemnitz, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Fac Med, Leipzig, Germany		Ondruschka, B (corresponding author), Univ Leipzig, Inst Legal Med, Fac Med, Johannisallee 28, D-04103 Leipzig, Germany.	benjamin.ondruschka@medizin.uni-leipzig.de			German Ministry of Defense	This work was partly supported by the German Ministry of Defense.	Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Astrup BS, 2007, FORENSIC SCI INT, V172, P49, DOI 10.1016/j.forsciint.2006.10.021; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Ferreira LCB, 2014, BRAIN INJURY, V28, P1311, DOI 10.3109/02699052.2014.916818; Carbonell T, 2007, CURR MED CHEM, V14, P857, DOI 10.2174/092986707780363014; Diniz BS, 2010, J ALZHEIMERS DIS, V22, P1305, DOI 10.3233/JAD-2010-100921; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Hans VHJ, 1999, NEUROREPORT, V10, P409; Hausmann R, 2004, INT J LEGAL MED, V118, P32, DOI 10.1007/s00414-003-0413-4; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hope S, 2013, SCHIZOPHR RES, V145, P36, DOI 10.1016/j.schres.2012.12.023; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; KEIR G, 1993, CLIN CHIM ACTA, V216, P153, DOI 10.1016/0009-8981(93)90148-W; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Li Dong-Ri, 2009, Leg Med (Tokyo), V11 Suppl 1, pS273, DOI 10.1016/j.legalmed.2009.02.042; Liao YG, 2013, PROCEEDINGS OF THE 2013 INTERNATIONAL WORKSHOP ON COMPUTER SCIENCE IN SPORTS, P10; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Maeda Hitoshi, 2009, Leg Med (Tokyo), V11 Suppl 1, pS46, DOI 10.1016/j.legalmed.2009.01.048; Maier B, 2006, SHOCK, V26, P122, DOI 10.1097/01.shk.0000223127.41641.f4; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Mimasaka S, 2001, TOHOKU J EXP MED, V193, P319, DOI 10.1620/tjem.193.319; Mulder SD, 2010, J ALZHEIMERS DIS, V22, P1073, DOI 10.3233/JAD-2010-100888; Muller K, 2006, CLIN CHEM LAB MED, V44, P1111, DOI 10.1515/CCLM.2006.211; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; OSUNA E, 1992, FORENSIC SCI INT, V52, P193, DOI 10.1016/0379-0738(92)90107-8; Palmiere C, 2012, INT J LEGAL MED, V126, P187, DOI 10.1007/s00414-011-0625-y; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Park YH, 2016, BMB REP, V49, P159, DOI 10.5483/BMBRep.2016.49.3.205; Petzold A, 2011, J STROKE CEREBROVASC, V20, P489, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.021; Roth P, 2000, Crit Care Nurs Q, V23, P14; SANCHEZRODRIGUEZ VF, 1995, AM J FOREN MED PATH, V16, P210, DOI 10.1097/00000433-199509000-00004; Schrag B, 2012, INT J LEGAL MED, V126, P505, DOI 10.1007/s00414-011-0596-z; Simon D, 2015, BRAIN INJURY, V29, P612, DOI 10.3109/02699052.2014.995228; Taniguchi T, 1999, AM J EMERG MED, V17, P548, DOI 10.1016/S0735-6757(99)90194-8; TEASDALE G, 1974, LANCET, V2, P81; Tsokos M, 2001, FORENSIC SCI INT, V119, P47, DOI 10.1016/S0379-0738(00)00391-1; Tsokos M, 2007, FORENSIC SCI INT, V165, P155, DOI 10.1016/j.forsciint.2006.05.015; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; YAMAUCHITAKIHARA K, 1995, CIRCULATION, V91, P1520, DOI 10.1161/01.CIR.91.5.1520; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	50	27	29	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	MAR	2018	132	2					531	539		10.1007/s00414-017-1768-2			9	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	FV5WK	WOS:000424652900021	29306988				2022-02-06	
J	Chan, C; Iverson, GL; Purtzki, J; Wong, K; Kwan, V; Gagnon, I; Silverberg, ND				Chan, Catherine; Iverson, Grant L.; Purtzki, Jacqueline; Wong, Kathy; Kwan, Vivian; Gagnon, Isabelle; Silverberg, Noah D.			Safety of Active Rehabilitation for Persistent Symptoms After Pediatric Sport-Related Concussion: A Randomized Controlled Trial	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Adolescent health; Athletic injuries; Craniocerebral trauma; Physical therapy modalities; Post-concussion syndrome; Rehabilitation	POSTCONCUSSIVE SYMPTOMS; PSYCHOMETRIC PROPERTIES; RECOVERY; CHILDREN; SCALES; ADOLESCENTS; RELIABILITY; VALIDITY; IMPACT; SLOW	Objectives: To examine the safety and tolerability of an active rehabilitation program for adolescents who are slow to recover from a sport-related concussion, and secondarily to estimate the treatment effect for this intervention. Design: Single-site, parallel, open-label, randomized controlled trial comparing treatment as usual (TAU) to TAU plus active rehabilitation. Setting: Outpatient concussion clinic. Participants: Adolescents (N=19) aged 12 to 18 years with postconcussion symptoms lasting >= 1 month after a sports-related concussion. Interventions: TAU consisted of symptom management and return-to-play advice, return-to-school facilitation, and physiatry consultation. The active rehabilitation program involved in-clinic subsymptom threshold aerobic training, coordination exercises, and visualization and imagery techniques with a physiotherapist (mean, 3.4 sessions) as well as a home exercise program, over 6 weeks. Main Outcome Measures: A blinded assessor systematically monitored for predetermined adverse events in weekly telephone calls over the 6-week intervention period. The treating physiotherapist also recorded in-clinic symptom exacerbations during aerobic training. The Post Concussion Symptom Scale was the primary efficacy outcome. Results: Nineteen participants were randomized, and none dropped out of the study. Of the 12 adverse events detected (6 in each group), 10 were symptom exacerbations from 1 weekly telephone assessment to the next, and 2 were emergency department visits. Four adverse events were referred to an external safety committee and deemed unrelated to the study procedures. In-clinic symptom exacerbations occurred in 30% (9/30) of aerobic training sessions, but resolved within 24 hours in all instances. In linear mixed modeling, active rehabilitation was associated with a greater reduction on the Post-Concussion Symptom Scale than TAU only. Conclusions: The results support the safety, tolerability, and potential efficacy of active rehabilitation for adolescents with persistent postconcussion symptoms. (C) 2017 by the American Congress of Rehabilitation Medicine	[Chan, Catherine; Purtzki, Jacqueline; Wong, Kathy] GF Strong Rehab Ctr, Vancouver, BC, Canada; [Chan, Catherine; Wong, Kathy] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] A Red Sox Fdn, Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Iverson, Grant L.] MassGeneral Hosp Children, Sport Concuss Program, Boston, MA USA; [Purtzki, Jacqueline; Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Wong, Kathy] Univ British Columbia, Dept Occupat Sci & Occupat Therapy, Vancouver, BC, Canada; [Kwan, Vivian] Univ Calgary, Calgary, AB, Canada; [Gagnon, Isabelle] McGill Univ, Montreal, PQ, Canada; [Gagnon, Isabelle] Montreal Childrens Hosp, Montreal, PQ, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada		Silverberg, ND (corresponding author), Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Iverson, Grant/0000-0001-7348-9570; Gagnon, Isabelle/0000-0003-2043-1644	Vancouver Coastal Health Research Institute	Supported by a Team Grant Award from the Vancouver Coastal Health Research Institute. Clinical Trial Registration No.: NCT02031068.	Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Imhoff S, 2016, J SPORTS MED, V2016, P5127374, DOI DOI 10.1155/2016/5127374; Irwin DE, 2010, QUAL LIFE RES, V19, P595, DOI 10.1007/s11136-010-9619-3; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Stallard N, 2012, STAT MED, V31, P1031, DOI 10.1002/sim.4357; Steer, 2005, BECK YOUTH INVENTORI; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Varni JW, 2008, QUAL LIFE RES, V17, P105, DOI 10.1007/s11136-007-9282-5; Varni JW, 2014, QUAL LIFE RES, V23, P1233, DOI 10.1007/s11136-013-0544-0; Varni JW, 2010, J PAIN, V11, P1109, DOI 10.1016/j.jpain.2010.02.005; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152; Wiebe DJ, 2016, JAMA PEDIATR, V170, P1108, DOI 10.1001/jamapediatrics.2016.1979	41	27	28	1	30	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2					242	249		10.1016/j.apmr.2017.09.108			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YX	WOS:000424069800004	28989074				2022-02-06	
J	Pervez, M; Kitagawa, RS; Chang, TR				Pervez, Mubashir; Kitagawa, Ryan S.; Chang, Tiffany R.			Definition of Traumatic Brain Injury, Neurosurgery, Trauma Orthopedics, Neuroimaging, Psychology, and Psychiatry in Mild Traumatic Brain Injury	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury (TBI); Neurotrauma; Concussion; Trauma orthopedics; Traumatic brain injury imaging; Postconcussion syndrome	CHRONIC SUBDURAL-HEMATOMA; HEAD-INJURY; INTRACRANIAL HYPERTENSION; DECOMPRESSIVE CRANIECTOMY; HYPERTONIC SALINE; CONTROLLED-TRIAL; SKULL FRACTURE; CONCUSSION; MANAGEMENT; RESUSCITATION	Traumatic brain injury (TBI) disrupts the normal function of the brain. This condition can adversely affect a person's quality of life with cognitive, behavioral, emotional, and physical symptoms that limit interpersonal, social, and occupational functioning. Although many systems exist, the simplest classification includes mild, moderate, and severe TBI depending on the nature of injury and the impact on the patient's clinical status. Patients with TBI require prompt evaluation and multidisciplinary management. Aside from the type and severity of the TBI, recovery is influenced by individual patient characteristics, social and environmental factors, and access to medical and rehabilitation services.	[Pervez, Mubashir] Univ Connecticut, Sch Med, Dept Neurol, Jefferson Bldg,Suite 607,80 Seymour St,POB 5037, Hartford, CT 06112 USA; [Kitagawa, Ryan S.; Chang, Tiffany R.] Mem Hermann Texas Med Ctr, Mischer Neurosci Inst, Vivian L Smith Dept Neurosurg, 6431 Fannin St MSB 7-154, Houston, TX 77030 USA		Pervez, M (corresponding author), Univ Connecticut, Sch Med, Dept Neurol, Jefferson Bldg,Suite 607,80 Seymour St,POB 5037, Hartford, CT 06112 USA.	mubashir.pervez@hhchealth.org					Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRAAKMAN R, 1972, J NEUROL NEUROSUR PS, V35, P395, DOI 10.1136/jnnp.35.3.395; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, VIn: Vol 12, P386; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; DURWARD QJ, 1983, J NEUROSURG, V59, P938, DOI 10.3171/jns.1983.59.6.0938; Esposito DP, 2009, NEUROSURG QUART, V19, P249, DOI 10.1097/WNQ.0b013e3181bd1d53; Fattahi TT, 2003, J CRANIOFAC SURG, V14, P240, DOI 10.1097/00001665-200303000-00020; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Fox JL, 2010, CAN J EMERG MED, V12, P355; Frieden TR., TRAUMATIC BRAIN INJU, DOI [10.3171/2009.10.JNS091500, DOI 10.3171/2009.10.JNS091500]; Gennarelli TA, HEAD LESION; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Golfinos JG, 2000, HEAD INJURY, P155; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; John R, 2014, ANAEST INTENS CARE M, V15, P161, DOI 10.1016/j.mpaic.2014.01.010; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; LoPachin RM, 1997, TOXICOL APPL PHARM, V143, P233, DOI 10.1006/taap.1997.8106; Marr A., 2004, CENTRAL NERVOUS SYST; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Martland HS, 1943, THER INT DIS, V3, P291; McCrory P, 2017, BR J SPORTS MED; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MILLER JD, 1968, LANCET, V2, P991; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; Rust T, 2006, J CLIN NEUROSCI, V13, P823, DOI 10.1016/j.jocn.2004.12.013; Shutter LA, 2016, NEW ENGL J MED, V375, P1183, DOI 10.1056/NEJMe1609722; Sim YW, 2012, J KOREAN NEUROSURG S, V52, P234, DOI 10.3340/jkns.2012.52.3.234; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Takeuchi Satoru, 2013, Acta Neurochir Suppl, V118, P135, DOI 10.1007/978-3-7091-1434-6_24; Teale EA, 2014, BMJ-BRIT MED J, V348, pg1682; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; Tubbs RS, 2010, J NEUROSURG, V112, P186, DOI 10.3171/2008.8.JNS08241; Wasserman JR, KOENIGSBERG RA DIFFU, DOI [10.1007/3-540-27660-2_104, DOI 10.1007/3-540-27660-2_104]; White H, 2006, ANESTH ANALG, V102, P1836, DOI 10.1213/01.ane.0000217208.51017.56; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6; Zhao X, 2008, J NEUROTRAUM, V25, P104, DOI 10.1089/neu.2007.0351	66	27	27	5	45	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2018	28	1					1	+		10.1016/j.nic.2017.09.010			14	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FR3UA	WOS:000418990900003	29157846				2022-02-06	
J	Yuan, Q; Yu, J; Wu, X; Sun, YR; Li, ZQ; Du, ZY; Wu, XH; Hu, J				Yuan, Qiang; Yu, Jian; Wu, Xing; Sun, Yi-rui; Li, Zhi-qi; Du, Zhuo-ying; Wu, Xue-hai; Hu, Jin			Prognostic value of coagulation tests for in-hospital mortality in patients with traumatic brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Coagulopathy; Coagulation tests; Mortality; Prediction model	HEAD-INJURY; COAGULOPATHY; MODELS; PROGRESSION; IMPACT	Background: Coagulopathy is commonly observed after traumatic brain injury (TBI). However, it is not known whether using the standard independent predictors in conjunction with coagulation tests would improve their prognostic value. We determined the incidence of TBI-associated coagulopathy in patients with isolated TBI (iTBI), evaluated the prognostic value of coagulation tests for in-hospital mortality, and tested their predictive power for in-hospital mortality in patients with iTBI. Methods: We conducted a retrospective, observational database study on 2319 consecutive patients with iTBI who attended the Huashan Hospital Department of the Neurosurgery Neurotrauma Center at Fudan University in China between December 2004 and June 2015. Two models based on the admission characteristics were developed: model A included predictors such as age, Glasgow Coma Scale (GCS) score, pupil reactivity, type of injury, and hemoglobin and glucose levels, while model B included the predictors from model A as well as coagulation test results. A total of 1643 patients enrolled between December 2004 and December 2011 were used to derive the prognostic models, and 676 patients enrolled between January 2012 and June 2015 were used to validate the models. Results: Overall, 18.6% (n = 432) of the patients developed coagulopathy after iTBI. The prevalence of acute traumatic coagulopathy is associated with the severity of brain injury. The percentage of platelet count <100x109/L, international normalized ratio (INR) > 1.25, the prothrombin time (PT)>14 s, activated partial thromboplastin time (APTT) > 36 s, D-dimer >5 mg/L and fibrinogen (FIB) < 1.5 g/L was also closely related to the severity of brain injury, significance being found among three groups. Age, pupillary reactivity, GCS score, epidural hematoma (EDH), and glucose levels were independent prognostic factors for in-hospital mortality in model A, whereas age, pupillary reactivity, GCS score, EDH, glucose levels, INR >1.25, and APTT >36 s exhibited strong prognostic effects in model B. Discrimination and calibration were good for the development group in both prediction models. However, the external validation test showed that calibration was better in mode ! B than in mode ! A for patients from the validation population (Hosmer-Lemeshow test, p = 0.152 vs. p = 0.046, respectively). Conclusions: Coagulation tests can improve the predictive power of the standard mode ! for in-hospital mortality after TBI.	[Yuan, Qiang; Yu, Jian; Wu, Xing; Sun, Yi-rui; Li, Zhi-qi; Du, Zhuo-ying; Wu, Xue-hai; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.	yq123abc20146@163.com; hujindn@126.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81471241, 81271375, 81171133]	This work was supported by the National Natural Science Foundation of China (NSFC Grants 81471241, 81271375 and 81171133).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Dewall Jeremy, 2010, JEMS, V35, P54, DOI 10.1016/S0197-2510(10)70095-4; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Lustenberger T, 2010, INJURY, V41, P924, DOI 10.1016/j.injury.2010.04.019; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Steyerberg EW, 2008, BRIT MED J, V336, P789, DOI 10.1136/bmj.39542.610000.3A; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; West KL, 2011, J NEUROSURG, V114, P9, DOI 10.3171/2010.7.JNS091857; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zehtahchi S, 2008, J TRAUMA, V65, P1571, DOI 10.1097/TA.0b013e31818c9c33	29	27	29	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JAN 5	2018	26								3	10.1186/s13049-017-0471-0			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FS2PO	WOS:000419620800002	29304855	gold, Green Published			2022-02-06	
J	Chen, WQ; Yang, JH; Li, BB; Peng, GY; Li, TF; Li, LJ; Wang, SS				Chen, Weiqiang; Yang, Jinhua; Li, Bingbing; Peng, Guoyi; Li, Tianfei; Li, Lianjie; Wang, Shousen			Neutrophil to Lymphocyte Ratio as a Novel Predictor of Outcome in Patients With Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Glasgow Coma Scale; Glasgow Outcome Scale; neutrophil to lymphocyte ratio; prognosis; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; SURVEILLANCE; MORTALITY; COUNT	Objective: The neutrophil to lymphocyte ratio (NLR) has been reported to be a predictor of outcome in critical illness. Objective of this study was to investigate the changes of the NLR in patients with severe traumatic brain injury (TBI) and analyze the relationship between the NLR and TBI outcome. Setting: China. Participants: A total of 855 patients with severe TBI from January 2007 to April 2012. Design: Retrospective. Main Measurement: Data on the NLR and other indicators were collected. After follow-up until death or 1 year, the relationship between the NLR and TBI outcome was analyzed retrospectively. Results: The final analysis included 688 patients. There were 508 (73.8%) who had an unfavorable outcome by 1 year after head trauma. The value of the NLR on admission was significantly higher in the unfavorable outcome group than in the favorable outcome group (P < .001). Multivariate logistic analysis showed that higher NLR was associated with an unfavorable outcome (odds ratio, 1.100; P < .001). Receiver operating characteristic curve analysis showed that the NLR had a sensitivity of 60.2% and a specificity of 71.1% for predicting unfavorable outcome at 1 year on the basis of the best threshold. Conclusion: The NLR might be useful as a novel predictor for 1-year outcome and mortality in severe TBI.	[Chen, Weiqiang; Li, Bingbing; Li, Tianfei; Li, Lianjie; Wang, Shousen] Xiamen Univ, Coll Med, Dept Neurosurg, Fuzhou Gen Hosp, Fuzhou 350025, Fujian, Peoples R China; [Yang, Jinhua; Peng, Guoyi] Shantou Univ, Coll Med, Dept Neurosurg, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China		Wang, SS (corresponding author), Xiamen Univ, Coll Med, Dept Neurosurg, Fuzhou Gen Hosp, Fuzhou 350025, Fujian, Peoples R China.	wshsen@xmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170852, 31300761, 81001322, 81001340, 81172795, 81374040, 81471622]; Guangdong Natural Science FoundationNational Natural Science Foundation of Guangdong Province [S2012040007470]; Medical Scientific Research Foundation of Guangdong Province, China [A2015211]; Foundation for Distinguished Young Teachers in Higher Education of Guangdong [Yq2013077, Yq2013079]; Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases [2015026]; Science and Technology Plan of Shantou [2014-62-2]	This study was supported by grants from the National Natural Science Foundation of China (31170852, 31300761, 81001322, 81001340, 81172795, 81374040, and 81471622), Guangdong Natural Science Foundation (S2012040007470), the Medical Scientific Research Foundation of Guangdong Province, China (A2015211), the Foundation for Distinguished Young Teachers in Higher Education of Guangdong (Yq2013077 and Yq2013079), the Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases (2015026), and the Science and Technology Plan of Shantou (2014-62-2).	Akil E, 2014, J STROKE CEREBROVASC, V23, P2328, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.028; Alexiou GA, 2013, J NEURO-ONCOL, V115, P521, DOI 10.1007/s11060-013-1240-1; Benarroch EE, 2013, NEUROLOGY, V81, P1079, DOI 10.1212/WNL.0b013e3182a4a577; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Celikbilek A, 2014, J CLIN LAB ANAL, V28, P27, DOI 10.1002/jcla.21639; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; JENNETT B, 1975, LANCET, V1, P480; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lang EW, 2016, ACTA NEUROCHIR SUPPL, V122, P221, DOI 10.1007/978-3-319-22533-3_44; Lattanzi S, 2016, STROKE, V47, P1654, DOI 10.1161/STROKEAHA.116.013627; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morotti A, 2016, STROKE, V47, P1473, DOI 10.1161/STROKEAHA.116.013176; Osler T, 2016, INJURY, V47, P1879, DOI 10.1016/j.injury.2016.04.016; Ozdemir HH, 2017, INT J NEUROSCI, V127, P417, DOI 10.1080/00207454.2016.1187606; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sinha S, 2016, J CLIN NEUROSCI, V30, P31, DOI 10.1016/j.jocn.2015.10.051; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Weller RO, 1996, BRAIN PATHOL, V6, P275, DOI 10.1111/j.1750-3639.1996.tb00855.x; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zadora P, 2015, NEUROL NEUROCHIR POL, V49, P41, DOI 10.1016/j.pjnns.2014.12.006	25	27	27	2	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2018	33	1					E53	E59		10.1097/HTR.0000000000000320			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GB0QS	WOS:000428752300007	28520670				2022-02-06	
J	Salas, CE; Casassus, M; Rowlands, L; Pimm, S; Flanagan, DAJ				Salas, Christian E.; Casassus, Martin; Rowlands, Leanne; Pimm, Steve; Flanagan, Desmond A. J.			"Relating through sameness": a qualitative study of friendship and social isolation in chronic traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; friendship; social isolation; neuropsychological rehabilitation; identity	FOLLOW-UP; COMMUNITY INTEGRATION; LIFE SATISFACTION; PEOPLE; ADULTS; COMMUNICATION; INDIVIDUALS; ABILITIES; OUTCOMES; ISSUES	Social isolation has been described as a common problem among traumatic brain injury (TBI) survivors during the chronic phase. Due to physical, cognitive and behavioural changes, survivors become less socially active and experience a marked decrease in the number of friends. The goal of this investigation is to explore TBI survivors' subjective account of the challenges encountered in sustaining friendships, as well as gaining insight into their particular understanding of such difficulties. Using a thematic analysis approach, 11 survivors of TBI were interviewed in relation to their experience of social isolation and friendship during the chronic stage. Four main themes emerged from the interviews: (1) The impact of long-term cognitive and behavioural problems on relationships; (2) Loss of old friends; (3) Difficulties making new friends, and (4) Relating to other survivors in order to fight social isolation (sameness). Clinical implications of these findings, as well as their relevance in the design of long-term rehabilitation programmes, are discussed. Particular emphasis is placed on the need to acknowledge the value of relating to other survivors, as a way of resisting cultural discourses about disability, and as a source of self-cohesion in the process of identity re-construction.	[Salas, Christian E.] Univ Diego Portales, Fac Psicol, Lab Neurociencia Cognit & Social, Veragara 275, Santiago, Chile; [Salas, Christian E.; Casassus, Martin; Flanagan, Desmond A. J.] Head Forward Ctr, Manchester, Lancs, England; [Casassus, Martin] Univ Manchester, Div Neurosci & Expt Psychol, Manchester, Lancs, England; [Salas, Christian E.; Rowlands, Leanne] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Pimm, Steve] Rehabil Without Walls, Milton Keynes, Bucks, England		Salas, CE (corresponding author), Univ Diego Portales, Fac Psicol, Lab Neurociencia Cognit & Social, Veragara 275, Santiago, Chile.	salasriquelme@gmail.com		Casassus, Martin/0000-0002-7908-327X	CONICYT (Chile)Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); Neuropsychoanalysis Foundation (New York, USA)	The first author of this article was supported by a Post-Doc grant from CONICYT (Chile) as well as a young researcher grant from the Neuropsychoanalysis Foundation (New York, USA).	Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Andrews S., 2005, TRAUMATIC BRAIN INJU, P539; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Carlsson E, 2007, QUAL HEALTH RES, V17, P1361, DOI 10.1177/1049732307306926; COETZER BR, 2004, ILLNESS CRISIS LOSS, V12, P171, DOI DOI 10.1177/1054137303262216; Coetzer R, 2014, REV CHIL NEUROPSICOL, V9, P8, DOI 10.5839/rcnp.2014.0901E.03; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Freeman A, 2015, NEUROPSYCHOL REHABIL, V25, P189, DOI 10.1080/09602011.2014.917686; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Greenwood R. J., 1993, CLIN REHABIL, V7, P248; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hayes N., 1997, DOING QUALITATIVE AN, P93; Hoofien D, 2001, BRAIN INJURY, V15, P189; Judd T, 1999, NEUROPSYCHOTHERAPY C; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Jumisko E, 2009, J CLIN NURS, V18, P2273, DOI 10.1111/j.1365-2702.2008.02738.x; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Karlovits T, 1999, BRAIN INJURY, V13, P845; Kinsella G, 1989, Int Disabil Stud, V11, P9; Klonoff P. S., 2010, PSYCHOTHERAPY BRAIN; Klonoff P. S., 2005, BARROW Q, V21, P14; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Martelli MF, 2012, NEUROREHABILITATION, V31, P3, DOI 10.3233/NRE-2012-0770; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; MILLER L, 1993, PSYCHOTHERAPY BRAIN; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Mukherjee D, 2003, WOMEN THER, V26, P3, DOI 10.1300/J015v26n01_01; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Paterson J., 2002, REHABIL NURS, V27, P13, DOI DOI 10.1002/J.2048-7940.2002.TB01973.X; Patton M.Q., 1990, QUALITATIVE EVALUATI; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Roscigno CI, 2008, J NEUROSCI NURS, V40, P212, DOI 10.1097/01376517-200808000-00005; Rowlands A., 2000, BRAIN IMPAIR, V1, P151, DOI [10.1375/brim.1.2.151, DOI 10.1375/BRIM.1.2.151]; Salmon N, 2013, J INTELL DISABIL RES, V57, P347, DOI 10.1111/j.1365-2788.2012.01541.x; Sander AM, 2011, J HEAD TRAUMA REHAB, V26, P1, DOI 10.1097/HTR.0b013e3182068588; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Tate R, 2014, BRAIN IMPAIR, V15, P157, DOI 10.1017/BrImp.2014.28; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; Yeates G, 2013, NEURO DISABILITY PSY, V1, P108	63	27	27	4	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2018	28	7					1161	1178		10.1080/09602011.2016.1247730			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GM7WO	WOS:000438408000007	27802787				2022-02-06	
J	Yuan, WH; Foss, KDB; Thomas, S; DiCesare, CA; Dudley, JA; Kitchen, K; Gadd, B; Leach, JL; Smith, D; Altaye, M; Gubanich, P; Galloway, RT; McCrory, P; Bailes, JE; Mannix, R; Meehan, WP; Myer, GD				Yuan, Weihong; Foss, Kim D. Barber; Thomas, Staci; DiCesare, Christopher A.; Dudley, Jonathan A.; Kitchen, Katie; Gadd, Brooke; Leach, James L.; Smith, David; Altaye, Mekibib; Gubanich, Paul; Galloway, Ryan T.; McCrory, Paul; Bailes, Julian E.; Mannix, Rebekah; Meehan, William P., III; Myer, Gregory D.			White matter alterations over the course of two consecutive high-school football seasons and the effect of a jugular compression collar: A preliminary longitudinal diffusion tensor imaging study	HUMAN BRAIN MAPPING			English	Article						white matter alteration; subconcussive head impact; neck collar	TRAUMATIC BRAIN-INJURY; HEAD IMPACT EXPOSURE; SPORTS-RELATED CONCUSSION; CORPUS-CALLOSUM; YOUTH FOOTBALL; AXONAL INJURY; ADOLESCENCE; MICROSTRUCTURE; MODEL; CHILDHOOD	The cumulative effects of repetitive subclinical head impacts during sports may result in chronic white matter (WM) changes and possibly, neurodegenerative sequelae. In this pilot study, we investigated the longitudinal WM changes over the course of two consecutive high-school football seasons and explored the long-term effects of a jugular vein compression collar on these WM alterations. Diffusion tensor imaging data were prospectively collected both pre- and postseason in the two consecutive seasons. Participants were assigned into either collar or noncollar groups. Tract-based spatial statistics (TBSS) approach and region of interest-based approach were used to quantify changes in WM diffusion properties. Despite comparable exposure to repetitive head impacts, significant reductions in mean, axial, and/or radial diffusivity were identified in Season 1 in multiple WM regions in the noncollar group but not in the collar group. After an 8- to 9-month long off-season, these changes observed in the noncollar group partially and significantly reversed but also remained significantly different from the baseline. In Season 2, trend level WM alterations in the noncollar group were found but located in spatially different regions than Season 1. Last, the WM integrity in the collar group remained unchanged throughout the four time points. In conclusion, we quantitatively assessed the WM structural changes and partial reversal over the course of two consecutive high-school football seasons. In addition, the mitigated WM alterations in athletes in the collar group might indicate potential effect of the collar in ameliorating the changes against repetitive head impacts. Hum Brain Mapp 39:491-508, 2018. (c) 2017 Wiley Periodicals, Inc.	[Yuan, Weihong; Dudley, Jonathan A.] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Yuan, Weihong; Dudley, Jonathan A.; Leach, James L.] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Yuan, Weihong; Leach, James L.] Univ Cincinnati, Coll Med, Dept Radiol, Cincinnati, OH USA; [Foss, Kim D. Barber; Thomas, Staci; DiCesare, Christopher A.; Kitchen, Katie; Gadd, Brooke; Smith, David; Gubanich, Paul; Galloway, Ryan T.; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, SPORT Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Altaye, Mekibib] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Bailes, Julian E.] NorthShore Univ Hlth Syst, Dept Neurosurg, Evanston, IL USA; [Mannix, Rebekah; Meehan, William P., III; Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Myer, Gregory D.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA; [Myer, Gregory D.] Univ Penn, Dept Orthopaed, Philadelphia, PA 19104 USA		Myer, GD (corresponding author), Cincinnati Childrens Hosp, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	greg.myer@cchmc.org	DiCesare, Christopher/ABH-9573-2020; McCrory, Paul/Q-8688-2019; DiCesare, Christopher/AAA-3327-2021; Mannix, Rebekah/AAD-8702-2020; Myer, Gregory/H-6572-2016	DiCesare, Christopher/0000-0002-6576-4904; Myer, Gregory/0000-0002-9983-8422; McCrory, Paul/0000-0003-4850-0568; Dudley, Jonathan/0000-0002-5189-9568	Heidt Family Foundation; Robert S. Heidt, Sr. - Wellington Foundation; Q30 Sports Sciences, LLC.	Contract grant sponsors: The Heidt Family Foundation, Robert S. Heidt, Sr. - Wellington Foundation and Q30 Sports Sciences, LLC.	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Alosco ML, 2016, ALZHEIMERS DEMENT, V7, P33; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Di X, 2012, BRAIN CONNECT, V2, P225, DOI 10.1089/brain.2011.0050; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Freund W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-170; GILLAND O, 1969, AMER J ROENTGENOL RA, V106, P369, DOI 10.2214/ajr.106.2.369; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Lao Y, 2015, P SPIE INT SOC OPT E, V9287; Leach JL, 2013, AM SOC NEUR 51 ANN M; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rumyantsev, 1968, DYNAMIC STABILITY BO; Schmithorst VJ, 2002, RADIOLOGY, V222, P212, DOI 10.1148/radiol.2221010626; Schneider DK, 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2015-095645<original-structure ref=info:doi/10.1136/bjsports-2015-095645></original-structure>, DOI 10.1136/BJSP0RTS-2015-095645]; Smith DW, 2012, NEUROSURGERY, V70, P740, DOI 10.1227/NEU.0b013e318235b991; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Szeszko PR, 2003, NEUROREPORT, V14, P2469, DOI 10.1097/00001756-200312190-00035; Turner RC, 2012, J NEUROSURG, V117, P1110, DOI 10.3171/2012.8.JNS12358; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yuan W, 2017, J NEUROTRAUMA; Yuan W, 2008, J NEUROSURG-PEDIATR, V1, P263, DOI 10.3171/PED/2008/1/4/263; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	58	27	28	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JAN	2018	39	1					491	508		10.1002/hbm.23859			18	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FP0IF	WOS:000417282000033	29080230	Green Published			2022-02-06	
J	Gao, C; Qian, Y; Huang, JH; Wang, D; Su, WQ; Wang, P; Guo, LY; Quan, W; An, S; Zhang, JN; Jiang, RC				Gao, Chuang; Qian, Yu; Huang, Jinhao; Wang, Dong; Su, Wanqiang; Wang, Peng; Guo, Linyue; Quan, Wei; An, Shuo; Zhang, Jianning; Jiang, Rongcai			A Three-Day Consecutive Fingolimod Administration Improves Neurological Functions and Modulates Multiple Immune Responses of CCI Mice	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury (TBI); Fingolimod; Immuno-inflammatory response; Regulatory T cell (Treg); Macrophage/microglia subtype; Cytokine array	TRAUMATIC BRAIN-INJURY; MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; CENTRAL-NERVOUS-SYSTEM; REGULATORY T-CELLS; MACROPHAGE SUBSETS; WHITE-MATTER; FTY720; RECRUITMENT; NEUROTOXICITY; DEGENERATION	Excessive inflammation after traumatic brain injury (TBI) is a major cause of secondary TBI. Though several inflammatory biomarkers have been postulated as the risk factors of TBI, there has not been any comprehensive description of them. Fingolimod, a new kind of immunomodulatory agent which can diminish various kinds of inflammatory responses, has shown additional therapeutic effects in the treatment of intracranial cerebral hematoma (ICH), ischemia, spinal cord injury (SCI), and many other CNS disorders. However, its therapeutic application has not been confirmed in TBI. Thus, we hypothesized that a 3-day consecutive fingolimod administration could broadly modulate the inflammatory reactions and improve the outcomes of TBI. The TBI models of C57/BL6 mice were established with the controlled cortical impact injury (CCI) system. A 3-day consecutive fingolimod therapy (given at 1, 24, and 48 h post injury) was performed at a dose of 1 mg/kg. The flow cytometry, immunoflourence, cytokine array, and ELISA were all applied to evaluate the immune cells and inflammatory markers in the injured brains. Immunohistochemical staining with anti-APP antibody was performed to assess the axonal damage. The neurological functions of these TBI models were assessed by mNSS/Rota-rod and Morris water maze (MWM). The brain water content and integrity of the blood-brain barrier (BBB) were also observed. On the 3rd day after TBI, the accumulation of inflammatory cytokines and chemokines reached the peak and administration of fingolimod reduced as many as 20 kinds of cytokines and chemokines. Fingolimod decreased infiltrated T lymphocytes and NK cells but increased the percentage of regulatory T (Treg) cells, and the concentration of IL-10 on the 3rd day after TBI. Fingolimod also notably attenuated the general activated microglia but augmented the M2/M1 ratio accompanied by decreased axonal damage. The neurological functions were improved after the fingolimod treatment accompanied with alleviation of the brain edema and BBB damage. This study suggests that the 3-day consecutive fingolimod administration extensively modulates multiple immuno-inflammatory responses and improves the neurological deficits after TBI, and therefore, it may be a new approach to the treatment of secondary TBI.	[Gao, Chuang; Qian, Yu; Huang, Jinhao; Wang, Dong; Su, Wanqiang; Wang, Peng; Guo, Linyue; Quan, Wei; An, Shuo; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Gao, Chuang; Qian, Yu; Huang, Jinhao; Wang, Dong; Su, Wanqiang; Wang, Peng; Guo, Linyue; Quan, Wei; An, Shuo; Zhang, Jianning; Jiang, Rongcai] Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China		Jiang, RC (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.; Jiang, RC (corresponding author), Tianjin Neurol Inst, Key Lab Injuries Variat & Regenerat Nervous Syst, Tianjin, Peoples R China.	jiang116216@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271359, 81330059, 81671380]; Ontario-China Research and Innovation Fund (OCRIF) [2011DFG33430]; Tianjin Research Program of Application Foundation and Advanced Technology [14ZCZDSY00179]	We are grateful to Guoqiang Chang, Guili Yang, Weiyun Cui, Lei Zhou, and Li Liu from the Tianjin Neurological Institute for their assistance with the experiments and data analyses. This work was supported by the National Natural Science Foundation of China (grant81271359, 81330059, and 81671380), the Ontario-China Research and Innovation Fund (OCRIF, 2011DFG33430), and the Tianjin Research Program of Application Foundation and Advanced Technology (grant 14ZCZDSY00179).	[Anonymous], 2012, J NEUROINFLAMM, V7, P9; Bai XF, 2004, J EXP MED, V200, P447, DOI 10.1084/jem.20040131; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bergold PJ, 2016, EXP NEUROL, V275, P367, DOI 10.1016/j.expneurol.2015.05.024; Brunkhorst R, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/frice1.2014.00283, 10.3389/fncel.2014.00283]; Budde K, 2003, AM J TRANSPLANT, V38, P683; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Fu Y, 2014, JAMA NEUROL, V71, P1092, DOI 10.1001/jamaneurol.2014.1065; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lee KD, 2009, J NEUROTRAUM, V26, P2335, DOI 10.1089/neu.2008.0840; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Li MY, 2015, CHINESE MED J-PEKING, V128, P2019, DOI 10.4103/0366-6999.161351; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Mencl S, 2014, J NEUROIMMUNOL, V274, P125, DOI 10.1016/j.jneuroim.2014.07.010; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Noda H, 2013, J NEUROIMMUNOL, V256, P13, DOI 10.1016/j.jneuroim.2012.12.005; Rolland WB, 2013, EXP NEUROL, V241, P45, DOI 10.1016/j.expneurol.2012.12.009; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Slowik A, 2015, BRIT J PHARMACOL, V172, P80, DOI 10.1111/bph.12938; Soares HD, 1995, J NEUROSCI, V15, P8223; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Taams LS, 2005, HUM IMMUNOL, V66, P222, DOI 10.1016/j.humimm.2004.12.006; Tang ZW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-26; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhang Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-79; Zhang Z, 2008, NEUROPATH APPL NEURO, V34, P330, DOI 10.1111/j.1365-2990.2007.00893.x; Zhang ZY, 2007, J CELL MOL MED, V11, P307, DOI 10.1111/j.1582-4934.2007.00019.x	51	27	28	0	19	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2017	54	10					8348	8360		10.1007/s12035-016-0318-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM8MF	WOS:000415341900064					2022-02-06	
J	Kerr, ZY; Cortes, N; Caswell, AM; Ambegaonkar, JP; Hallsmith, KR; Milbert, AF; Caswell, SV				Kerr, Zachary Y.; Cortes, Nelson; Caswell, Amanda M.; Ambegaonkar, Jatin P.; Hallsmith, Kaitlin Romm; Milbert, A. Frederick; Caswell, Shane V.			Concussion Rates in US Middle School Athletes, 2015-2016 School Year	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							SPORTS-RELATED CONCUSSION; STATES HIGH-SCHOOL; FOOTBALL PLAYERS; EPIDEMIOLOGY; INJURY; YOUTH; SYMPTOMS; TRENDS	Introduction: Concussion incidence estimates in middle school sports settings are limited. This study examines concussion incidence in nine U.S. middle schools during the 2015-2016 school year. Methods: Concussion data originated from nine public middle schools in Prince William County, Virginia, during the 2015-2016 school year. Certified athletic trainers collected concussion and athlete exposure (AE) data in school-sanctioned games and practices in boys' baseball, basketball, football, soccer, track, and wrestling; and girls' basketball, cheerleading, soccer, softball, track, and volleyball. Athletic trainers also acquired data on non-school sanctioned sport concussions. In 2017, concussion rates were calculated per 1,000 AEs. Injury rate ratios with 95% CIs compared rates between games and practices and by sex. Results: Overall, 73 concussions were reported, of which 21.9% were from non-school sanctioned sport settings. The 57 remaining game and practice concussions were reported during 76,384 AEs, for a concussion rate of 0.75/1,000 AEs. Football had the highest concussion rate (2.61/1,000 AEs). Concussion rates were higher in games versus practices (injury rate ratio = 1.83, 95% CI = 1.06, 3.15), and in girls versus boys in sex-comparable sports, i.e., baseball/softball, basketball, soccer, and track (injury rate ratio = 3.73, 95% CI = 1.24, 11.23). Conclusions: Current findings parallel those found in high school and college sports settings in that higher concussion rates were reported in girls and competitions. However, concussion rates exceeded those recently reported in high school and youth league settings, highlighting the need for continued research in the middle school sports setting. Given that one in five concussions were from non-school sanctioned sport settings, prevention efforts in middle school sports settings should consider sport and non-sport at-risk exposure. (C) 2017 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA; [Cortes, Nelson; Caswell, Amanda M.; Ambegaonkar, Jatin P.; Hallsmith, Kaitlin Romm; Caswell, Shane V.] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Manassas, VA 20110 USA; [Milbert, A. Frederick] Prince William Cty Virginia, Prince William Cty Publ Sch, Manassas, VA USA		Caswell, SV (corresponding author), George Mason Univ, 10900 Univ Blvd,MS 4E5, Manassas, VA 20110 USA.	scaswell@gmu.edu		Ambegaonkar, Jatin/0000-0002-3790-915X; Cortes, Nelson/0000-0001-8762-3144	Potomac Health Foundation	We greatly appreciate the collaboration of the Prince William County Public Schools and support of the middle school principals, nurses, athletic coordinators, coaches, and athletic trainers. The Middle School ACHIEVES (Advancing Healthcare Initiatives for Underserved Students) Project aims to increase access to health care for underserved communities and is made possible with grant funding from the Potomac Health Foundation, of which S. Caswell is the Principal Investigator and N. Cortes, J. Ambegaonkar, and A. Caswell are co-investigators.	Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buzas D, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Comstock RD, CONVENIENCE SAMPLE S; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Jacobson NA, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113517860; Kerr Zachary Y, 2016, Inj Epidemiol, V3, P3; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3; KERR ZY, 2015, ORTHOP J SPORTS MED, V3, DOI DOI 10.1177/23259; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; National Academy of Medicine, SPORTS RELATED CONCU; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Turbeville SD, 2003, AM J SPORT MED, V31, P276, DOI 10.1177/03635465030310022001; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	25	27	26	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	DEC	2017	53	6					914	918		10.1016/j.amepre.2017.05.017			5	Public, Environmental & Occupational Health; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine	FM9VP	WOS:000415620200021	28739314				2022-02-06	
J	Li, J; Chen, SX; Zhao, ZK; Luo, YH; Hou, YH; Li, H; He, LM; Zhou, LB; Wu, WT				Li, Jing; Chen, Shuangxi; Zhao, Zhikai; Luo, Yunhao; Hou, Yuhui; Li, Heng; He, Liumin; Zhou, Libing; Wu, Wutian			Effect of VEGF on Inflammatory Regulation, Neural Survival, and Functional Improvement in Rats following a Complete Spinal Cord Transection	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						spinal cord transection; locomotor function; vascular endothelial growth factor; MAPK signaling; neural circuitry	ENDOTHELIAL GROWTH-FACTOR; PROMOTE NEURONAL SURVIVAL; TRAUMATIC BRAIN-INJURY; STEM-CELLS; AXONAL REGENERATION; SIGNALING PATHWAY; LOCOMOTOR RECOVERY; OXIDATIVE STRESS; RATING-SCALE; LESION SITE	After complete transection of the thoracic spinal segment, neonatal rats exhibit spontaneous locomotor recovery of hindlimbs, but this recovery is not found in adult rats after similar injury. The potential mechanism related to the difference in recovery of neonatal and adult rats remains unknown. In this study, 342 animals were analyzed. The vascular endothelial growth factor (VEGF) level in spinal segments below injury sites was significantly higher in postnatal day 1 rats (P1) compared with 28-day-old adult rats (P28) following a complete T9 transection. VEGF administration in P28 rats with T9 transection significantly improved the functional recovery; by contrast, treatment with VEGF receptor inhibitors in P1 rats with T9 transection slowed down the spontaneous functional recovery. Results showed more neurons reduced in the lumbar spinal cord and worse local neural network reorganization below injury sites in P28 rats than those in P1 rats. Transynaptic tracing with pseudorabies virus and double immunofluorescence analysis indicated that VEGF treatment in P28 rats alleviated the reduced number of neurons and improved their network reorganization. VEGF inhibition in neonates resulted in high neuronal death rate and deteriorated network reorganization. In in vivo studies, T9 transection induced less increase in the number of microglia in the spinal cord in P1 animals than P28 animals. VEGF treatment reduced the increase in microglial cells in P28 animals. VEGF administration in cultured spinal motoneurons prevented lipopolysaccharide (LPS)-induced neuronal death and facilitated neurite growth. Western blots of the samples of lumbar spinal cord after spinal transection and cultured spinal motoneurons showed a lower level of Erk1/2 phosphorylation after the injury or LPS induction compared with that in the control. The phosphorylation level increased after VEGF treatment. In conclusion, VEGF is a critical mediator involved in functional recovery after spinal transection and can be considered a potential target for clinical therapy.	[Li, Jing; Chen, Shuangxi; Zhao, Zhikai; Luo, Yunhao; Hou, Yuhui; Zhou, Libing; Wu, Wutian] Jinan Univ, Minist Educ CNS Regenerat Collaborat Joint Lab, Guangdong Hongkong Macau Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China; [Li, Jing] Hubei Univ Med, Inst Basic Med Sci, Dept Anat, Shiyan, Peoples R China; [Li, Heng; Wu, Wutian] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [He, Liumin] Jinan Univ, Coll Life Sci & Technol, Dept Biomed Engn, Key Lab Biomat,Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China; [Wu, Wutian] Restem Biotechnol Co Ltd, Suzhou, Peoples R China		Wu, WT (corresponding author), Jinan Univ, Minist Educ CNS Regenerat Collaborat Joint Lab, Guangdong Hongkong Macau Inst CNS Regenerat, Guangzhou, Guangdong, Peoples R China.; Wu, WT (corresponding author), Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China.; Wu, WT (corresponding author), Restem Biotechnol Co Ltd, Suzhou, Peoples R China.	wtwu@hku.hk		Zhou, Libing/0000-0002-8975-5228	National Basic Research Program of China (973 Program)National Basic Research Program of China [2014CB542205]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81641047]	This work was supported by National Basic Research Program of China (973 Program, 2014CB542205) and the National Natural Science Foundation of China (81641047).	Alam M, 2017, EXP NEUROL, V291, P141, DOI 10.1016/j.expneurol.2017.02.006; Andrews EM, 2012, EXP NEUROL, V235, P174, DOI 10.1016/j.expneurol.2011.09.008; Araujo MR, 2017, EXP NEUROL, V294, P45, DOI 10.1016/j.expneurol.2017.04.009; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Beazley-Long N, 2013, AM J PATHOL, V183, P918, DOI 10.1016/j.ajpath.2013.05.031; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; BERNSTEIN DR, 1981, NEUROSCI LETT, V26, P55, DOI 10.1016/0304-3940(81)90425-0; Bhuiyan MIH, 2015, NEUROSCIENCE, V290, P90, DOI 10.1016/j.neuroscience.2015.01.025; Bisicchia E, 2017, MOL NEUROBIOL, V54, P4896, DOI 10.1007/s12035-016-0031-z; Chen S, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00021; Chen T, 2017, NEURAL REGEN RES, V12, P433, DOI 10.4103/1673-5374.202947; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dulin JN, 2015, J NEUROSCI, V35, P13860, DOI 10.1523/JNEUROSCI.2599-15.2015; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Guo JS, 2007, SPINAL CORD, V45, P15, DOI 10.1038/sj.sc.3101943; Gwak SJ, 2017, BIOMATERIALS, V121, P155, DOI 10.1016/j.biomaterials.2017.01.003; Han Q, 2015, EXP NEUROL, V267, P194, DOI 10.1016/j.expneurol.2015.03.008; Hase T, 2002, J NEUROTRAUM, V19, P267, DOI 10.1089/08977150252807009; Hase T, 2002, EUR J NEUROSCI, V15, P969, DOI 10.1046/j.1460-9568.2002.01932.x; He WW, 2016, NATURE, V532, P402, DOI 10.1038/nature16499; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; Hu JL, 2017, NEURAL REGEN RES, V12, P525, DOI 10.4103/1673-5374.205080; Hwang WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02439; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kalaria RN, 1998, MOL BRAIN RES, V62, P101, DOI 10.1016/S0169-328X(98)00190-9; Kawabori M, 2015, METAB BRAIN DIS, V30, P381, DOI 10.1007/s11011-014-9531-6; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Khaibullina AA, 2004, DEV BRAIN RES, V148, P59, DOI 10.1016/j.devbrainres.2003.09.022; Kitayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025234; Lai BQ, 2016, BIOMATERIALS, V109, P40, DOI 10.1016/j.biomaterials.2016.08.005; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Leach MK, 2011, JOVE-J VIS EXP, DOI 10.3791/2389; Lee H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6514; LI LX, 1994, J NEUROBIOL, V25, P759, DOI 10.1002/neu.480250702; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Merrill MJ, 2005, J NEUROSURG, V103, P853, DOI 10.3171/jns.2005.103.5.0853; Mukhamedshina YO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151745; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nicola FD, 2017, BRAIN RES, V1663, P95, DOI 10.1016/j.brainres.2017.03.015; Oh JS, 2012, NEUROREPORT, V23, P174, DOI 10.1097/WNR.0b013e32834f4f3a; Park SS, 2012, CYTOTHERAPY, V14, P584, DOI 10.3109/14653249.2012.658913; Patel BN, 2002, J NEUROSCI, V22, P6578; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Qi C, 2014, J NEUROSCI, V34, P4494, DOI 10.1523/JNEUROSCI.3647-13.2014; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Rossi SL, 2009, CURR OPIN BIOTECH, V20, P552, DOI 10.1016/j.copbio.2009.09.008; Rossignol S, 2006, PHILOS T R SOC B, V361, P1647, DOI 10.1098/rstb.2006.1889; Rossignol S, 2011, ANNU REV NEUROSCI, V34, P413, DOI 10.1146/annurev-neuro-061010-113746; Saban MR, 2008, AM J PHYSIOL-RENAL, V295, pF60, DOI 10.1152/ajprenal.00618.2007; Sanchez A, 2010, NEUROPEPTIDES, V44, P323, DOI 10.1016/j.npep.2010.04.002; Scheff SW, 2002, J NEUROTRAUM, V19, P1251, DOI 10.1089/08977150260338038; Seiler S, 2017, BRAIN RES, V1668, P56, DOI 10.1016/j.brainres.2017.05.015; Shen ZL, 2017, NEUROCHEM RES, V42, P2336, DOI 10.1007/s11064-017-2251-7; Shore PM, 2004, NEUROSURGERY, V54, P605, DOI 10.1227/01.NEU.0000108642.88724.DB; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Sivasankaran R, 2004, NAT NEUROSCI, V7, P261, DOI 10.1038/nn1193; Skirgaudas M, 1996, NEUROSURGERY, V39, P537, DOI 10.1097/00006123-199609000-00021; Skold M, 2000, EUR J NEUROSCI, V12, P3675, DOI 10.1046/j.1460-9568.2000.00263.x; Stenudd M, 2015, JAMA NEUROL, V72, P235, DOI 10.1001/jamaneurol.2014.2927; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Tillakaratne NJK, 2010, NEUROSCIENCE, V166, P23, DOI 10.1016/j.neuroscience.2009.12.010; Wakabayashi Y, 2001, SPINE, V26, P1215, DOI 10.1097/00007632-200106010-00009; Wang HY, 2015, BIOCHEM BIOPH RES CO, V464, P453, DOI 10.1016/j.bbrc.2015.06.146; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Willerslev-Olsen M, 2015, BRAIN, V138, P589, DOI 10.1093/brain/awu399; Xia X, 2014, MOL BIOL REP, V41, P6827, DOI 10.1007/s11033-014-3568-9; Xu JP, 2017, BRAIN RES, V1670, P32, DOI 10.1016/j.brainres.2017.06.012; Xu S, 2015, NEUROSCI LETT, V589, P31, DOI 10.1016/j.neulet.2015.01.015; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051853, 10.1371/journal.pone.0038381]; Yuan QJ, 2006, NEUROREPORT, V17, P711, DOI 10.1097/01.wnr.0000214390.35480.1a; Yuan QJ, 2013, NEUROSCI BULL, V29, P509, DOI 10.1007/s12264-013-1356-5; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zeng X, 2015, BIOMATERIALS, V53, P184, DOI 10.1016/j.biomaterials.2015.02.073; Zhang J, 2014, J NEUROSCI, V34, P5184, DOI 10.1523/JNEUROSCI.4129-13.2014; Zhou ZP, 2016, NEUROSCIENCE, V329, P193, DOI 10.1016/j.neuroscience.2016.05.019	81	27	27	2	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	NOV 29	2017	11								381	10.3389/fncel.2017.00381			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FO0NQ	WOS:000416442000001	29238292	Green Published, gold			2022-02-06	
J	Chen, T; Wu, Y; Wang, YZ; Zhu, JG; Chu, HY; Kong, L; Yin, LW; Ma, HY				Chen, Tao; Wu, Yu; Wang, Yuzi; Zhu, Jigao; Chu, Haiying; Kong, Li; Yin, Liangwei; Ma, Haiying			Brain-Derived Neurotrophic Factor Increases Synaptic Protein Levels via the MAPK/Erk Signaling Pathway and Nrf2/Trx Axis Following the Transplantation of Neural Stem Cells in a Rat Model of Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						Brain-derived neurotrophic factor; Traumatic brain injury; Transplantation; Differentiation; TrkB; MAPK/Erk; Thioredoxin; PSD-95; Synaptogenesis	OXIDATIVE STRESS; FUNCTIONAL RECOVERY; DENDRITIC SPINES; BDNF; EXPRESSION; MODULATION; ACTIVATION; RECEPTORS; PHOSPHORYLATION; THIOREDOXIN-1	Brain-derived neurotrophic factor (BDNF) plays an important role in promoting the growth, differentiation, survival and synaptic stability of neurons. Presently, the transplantation of neural stem cells (NSCs) is known to induce neural repair to some extent after injury or disease. In this study, to investigate whether NSCs genetically modified to encode the BDNF gene (BDNF/NSCs) would further enhance synaptogenesis, BDNF/NSCs or naive NSCs were directly engrafted into lesions in a rat model of traumatic brain injury (TBI). Immunohistochemistry, western blotting and RT-PCR were performed to detect synaptic proteins, BDNF-TrkB and its downstream signaling pathways, at 1, 2, 3 or 4 weeks after transplantation. Our results showed that BDNF significantly increased the expression levels of the TrkB receptor gene and the phosphorylation of the TrkB protein in the lesions. The expression levels of Ras, phosphorylated Erk1/2 and postsynaptic density protein-95 were elevated in the BDNF/NSCs-transplanted groups compared with those in the NSCs-transplanted groups throughout the experimental period. Moreover, the nuclear factor (erythroid-derived 2)-like 2/Thioredoxin (Nrf2/Trx) axis, which is a specific therapeutic target for the treatment of injury or cell death, was upregulated by BDNF overexpression. Therefore, we determined that the increased synaptic proteins level implicated in synaptogenesis might be associated with the activation of the MAPK/Erk1/2 signaling pathway and the upregulation of the antioxidant agent Trx modified by BDNF-TrkB following the BDNF/NSCs transplantation after TBI.	[Chen, Tao] Dalian Med Univ, Dept Neurosurg, Affiliated Hosp 1, Dalian 116011, Peoples R China; [Wu, Yu; Wang, Yuzi; Zhu, Jigao; Chu, Haiying; Kong, Li; Ma, Haiying] Dalian Med Univ, Dept Histol & Embryol, Dalian 116044, Peoples R China; [Yin, Liangwei] Dalian Cent Hosp, Dept Oncol, Dalian 116033, Liaoning, Peoples R China		Ma, HY (corresponding author), Dalian Med Univ, Dept Histol & Embryol, Dalian 116044, Peoples R China.; Yin, LW (corresponding author), Dalian Cent Hosp, Dept Oncol, Dalian 116033, Liaoning, Peoples R China.	lwyin2008@163.com; hyma20060602@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31300812, 31371218]	We thank Professor Shui Guan and Xuehu Ma from the Stem Cell and Tissue Engineering Laboratory of the Dalian University of Technology for their support in culturing the NSCs. This work was supported by Grant Nos. 31300812 and 31371218 from the National Natural Science Foundation of China.	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Ammar MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14778; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Aroeira RI, 2016, NEUROCHEM INT, V99, P94, DOI 10.1016/j.neuint.2016.06.007; Bathina S, 2015, ARCH MED SCI, V11, P1164, DOI 10.5114/aoms.2015.56342; Bonnamain V, 2012, FRONT CELL NEUROSCI, V6; Bramham CR, 2014, NEUROPHARMACOLOGY, V76, P601, DOI 10.1016/j.neuropharm.2013.08.012; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZM, 2008, AM J MED GENET B, V147B, P363, DOI 10.1002/ajmg.b.30607; Cornejo BJ, 2007, ANN NEUROL, V61, P411, DOI 10.1002/ana.21071; Crowther AJ, 2014, NEUROSCI BULL, V30, P542, DOI 10.1007/s12264-014-1453-5; Deinhardt K, 2014, NEUROPHARMACOLOGY, V76, P603, DOI 10.1016/j.neuropharm.2013.04.054; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Elkabetz Y, 2008, COLD SH Q B, V73, P377, DOI 10.1101/sqb.2008.73.052; Fiorin FD, 2016, J NEUROTRAUM, V33, P1317, DOI 10.1089/neu.2015.4068; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Habas A, 2013, P NATL ACAD SCI USA, V110, P18291, DOI 10.1073/pnas.1208764110; Hu XD, 2011, J NEUROSCI, V31, P15597, DOI 10.1523/JNEUROSCI.2445-11.2011; Ichiki H, 2005, BIOCHEM BIOPH RES CO, V334, P1141, DOI 10.1016/j.bbrc.2005.07.007; Itoh T, 2006, NEUROCHEM RES, V31, P1381, DOI 10.1007/s11064-006-9186-8; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Li L, 2015, NEUROSCIENCE, V284, P815, DOI 10.1016/j.neuroscience.2014.10.066; Li R, 2013, BRAIN RES, V1523, P1, DOI 10.1016/j.brainres.2013.05.046; Lin H, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00034; Liu Y, 2016, EXP NEUROL, V275, P126, DOI 10.1016/j.expneurol.2015.10.002; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Luine V, 2013, NEUROSCIENCE, V239, P34, DOI 10.1016/j.neuroscience.2012.10.019; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Ma HY, 2011, MOL MED REP, V4, P849, DOI 10.3892/mmr.2011.510; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Moosavi F, 2016, DRUG DES DEV THER, V10, P23, DOI 10.2147/DDDT.S96936; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Nakajima S, 2015, NEUROCHEM INT, V91, P55, DOI 10.1016/j.neuint.2015.10.009; Niso-Santano M, 2010, FREE RADICAL BIO MED, V48, P1370, DOI 10.1016/j.freeradbiomed.2010.02.024; Park HH, 2016, NEUROTOXICOLOGY, V55, P131, DOI 10.1016/j.neuro.2016.05.022; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Paspala SAB, 2011, NEUROL INDIA, V59, P69, DOI 10.4103/0028-3886.84338; Ratajczak J, 2011, J PHYSIOL PHARMACOL, V62, P3; Sakaguchi M, 2012, DEV NEUROBIOL, V72, P1059, DOI 10.1002/dneu.22023; Santos AR, 2010, PROG NEUROBIOL, V92, P505, DOI 10.1016/j.pneurobio.2010.08.004; Song JS, 2016, TOXICOL APPL PHARM, V307, P138, DOI 10.1016/j.taap.2016.08.003; Stabenfeldt SE, 2011, CURR STEM CELL RES T, V6, P208; Tan J, 2006, AM J PATHOL, V169, P528, DOI 10.2353/ajpath.2006.060122; Tian L, 2014, NEUROPHARMACOLOGY, V77, P453, DOI 10.1016/j.neuropharm.2013.10.027; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Yoshii Akira, 2014, Front Synaptic Neurosci, V6, P6, DOI 10.3389/fnsyn.2014.00006; Zagrebelsky M, 2014, NEUROPHARMACOLOGY, V76, P628, DOI 10.1016/j.neuropharm.2013.05.029; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou XJ, 2010, J NEUROSCI RES, V88, P1420, DOI 10.1002/jnr.22321; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	54	27	28	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	NOV	2017	42	11					3073	3083		10.1007/s11064-017-2340-7			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FK4IR	WOS:000413457000007	28780733				2022-02-06	
J	Dremmen, MHG; Wagner, MW; Bosemani, T; Tekes, A; Agostino, D; Day, E; Soares, BP; Huisman, TAGM				Dremmen, M. H. G.; Wagner, M. W.; Bosemani, T.; Tekes, A.; Agostino, D.; Day, E.; Soares, B. P.; Huisman, T. A. G. M.			Does the Addition of a "Black Bone" Sequence to a Fast Multisequence Trauma MR Protocol Allow MRI to Replace CT after Traumatic Brain Injury in Children?	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							MINOR HEAD TRAUMA; PEDIATRIC SKULL; 3-DIMENSIONAL RECONSTRUCTION; COMPUTED-TOMOGRAPHY; UNIQUE FEATURES; COMPLICATIONS; EXPERIENCE; MECHANISMS; FRACTURES; DIAGNOSIS	BACKGROUND AND PURPOSE: Head CT is the current neuroimaging tool of choice in acute evaluation of pediatric head trauma. The potential cancer risks of CT-related ionizing radiation should limit its use in children. We evaluated the role of MR imaging, including a "black bone" sequence, compared with CT in detecting skull fractures and intracranial hemorrhages in children with acute head trauma. MATERIALS AND METHODS: We performed a retrospective evaluation of 2D head CT and brain MR imaging studies including the black bone sequence of children with head trauma. Two experienced pediatric neuroradiologists in consensus created the standard of reference. Another pediatric neuroradiologist blinded to the diagnosis evaluated brain MR images and head CT images in 2 separate sessions. The presence of skull fractures and intracranial posttraumatic hemorrhages was evaluated. We calculated the sensitivity and specificity of CT and MR imaging with the black bone sequence in the diagnosis of skull fractures and intracranial hemorrhages. RESULTS: Twenty-eight children (24 boys; mean age, 4.89 years; range, 0-15.5 years) with head trauma were included. MR imaging with the black bone sequence revealed lower sensitivity (66.7% versus 100%) and specificity (87.5% versus 100%) in identifying skull fractures. Four of 6 incorrectly interpreted black bone MR imaging studies showed cranial sutures being misinterpreted as skull fractures and vice versa. CONCLUSIONS: Our preliminary results show that brain MR imaging complemented by a black bone sequence is a promising nonionizing alternative to head CT for the assessment of skull fractures in children. However, accuracy in the detection of linear fractures in young children and fractures of aerated bone remains limited.	[Dremmen, M. H. G.; Wagner, M. W.; Bosemani, T.; Tekes, A.; Agostino, D.; Day, E.; Soares, B. P.; Huisman, T. A. G. M.] Johns Hopkins Univ Hosp, Dept Radiol & Radiol Sci, Div Pediat Radiol & Pediat Neuroradiol, Sect Pediat Neuroradiol, Baltimore, MD 21287 USA; [Dremmen, M. H. G.] Erasmus Univ, Med Ctr Rotterdam, Div Pediat Radiol, Dept Radiol, Rotterdam, Netherlands; [Wagner, M. W.] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland		Dremmen, MHG (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Radiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.dremmen@erasmusmc.nl		Huisman, Thierry A.G.M./0000-0003-2302-6724; Wagner, Matthias W./0000-0001-6501-839X			Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Bosemani T, 2014, J MAGN RESON IMAGING, V40, P530, DOI 10.1002/jmri.24410; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Eley KA, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20130236; Eley KA, 2012, BRIT J RADIOL, V85, P1457, DOI 10.1259/bjr/16830245; Eley KA, 2012, BRIT J RADIOL, V85, P272, DOI 10.1259/bjr/95110289; Eley KA, 2014, EUR RADIOL, V24, P2417, DOI 10.1007/s00330-014-3286-7; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Orman G, 2015, J NEUROSURG-PEDIATR, V16, P426, DOI 10.3171/2015.3.PEDS1553; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Schmutz B, 2014, J ORAL MAXIL SURG, V72, P611, DOI 10.1016/j.joms.2013.08.030; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Tang PH, 2009, PEDIATR RADIOL, V39, P438, DOI 10.1007/s00247-008-1083-7; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123	21	27	27	1	3	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	NOV	2017	38	11					2187	2192		10.3174/ajnr.A5405			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FN4SI	WOS:000415996600034	28970241	Green Published, hybrid			2022-02-06	
J	Teh, DBL; Prasad, A; Jiang, WX; Ariffin, MZ; Khanna, S; Belorkar, A; Wong, L; Liu, XG; All, AH				Teh, Daniel Boon Loong; Prasad, Ankshita; Jiang, Wenxuan; Ariffin, Mohd. Zacky; Khanna, Sanjay; Belorkar, Abha; Wong, Limsoon; Liu, Xiaogang; All, Angelo H.			Transcriptome Analysis Reveals Neuroprotective aspects of Human Reactive Astrocytes induced by Interleukin 1 beta	SCIENTIFIC REPORTS			English	Article							SPINAL-CORD-INJURY; NEURITE OUTGROWTH; SULFATE PROTEOGLYCAN; AXONAL REGENERATION; FUNCTIONAL RECOVERY; SCAR FORMATION; GROWTH; EXPRESSION; MATRIX; CELLS	Reactive astrogliosis is a critical process in neuropathological conditions and neurotrauma. Although it has been suggested that it confers neuroprotective effects, the exact genomic mechanism has not been explored. The prevailing dogma of the role of astrogliosis in inhibition of axonal regeneration has been challenged by recent findings in rodent model's spinal cord injury, demonstrating its neuroprotection and axonal regeneration properties. We examined whether their neuroprotective and axonal regeneration potentials can be identify in human spinal cord reactive astrocytes in vitro. Here, reactive astrogliosis was induced with IL1 beta. Within 24 hours of IL1 beta induction, astrocytes acquired reactive characteristics. Transcriptome analysis of over 40000 transcripts of genes and analysis with PFSnet subnetwork revealed upregulation of chemokines and axonal permissive factors including FGF2, BDNF, and NGF. In addition, most genes regulating axonal inhibitory molecules, including ROBO1 and ROBO2 were downregulated. There was no increase in the gene expression of "Chondroitin Sulfate Proteoglycans" (CSPGs') clusters. This suggests that reactive astrocytes may not be the main CSPG contributory factor in glial scar. PFSnet analysis also indicated an upregulation of "Axonal Guidance Signaling" pathway. Our result suggests that human spinal cord reactive astrocytes is potentially neuroprotective at an early onset of reactive astrogliosis.	[Teh, Daniel Boon Loong; All, Angelo H.] Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, 28 Med Dr,5-COR, Singapore 117456, Singapore; [Prasad, Ankshita] Natl Univ Singapore, Dept Biomed Engn, E4,4 Engn Dr 3, Singapore 117583, Singapore; [Jiang, Wenxuan] Natl Univ Singapore, Dept Orthopaed Surg, 1E Kent Ridge Rd, Singapore 119228, Singapore; [Ariffin, Mohd. Zacky; Khanna, Sanjay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Belorkar, Abha; Wong, Limsoon] Natl Univ Singapore, Dept Comp Sci, 13 Comp Dr, Singapore 117417, Singapore; [Liu, Xiaogang] Natl Univ Singapore, Dept Chem, 3 Sci Dr 3, Singapore 117543, Singapore; [All, Angelo H.] Dept Biomed Engn, 701C Rutland Ave 720, Baltimore, MD 21205 USA; [All, Angelo H.] Johns Hopkins Sch Med, 701C Rutland Ave 720, Baltimore, MD 21205 USA; [All, Angelo H.] Johns Hopkins Sch Med, Dept Neurol, 701C Rutland Ave 720, Baltimore, MD 21205 USA		All, AH (corresponding author), Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, 28 Med Dr,5-COR, Singapore 117456, Singapore.; Liu, XG (corresponding author), Natl Univ Singapore, Dept Chem, 3 Sci Dr 3, Singapore 117543, Singapore.; All, AH (corresponding author), Dept Biomed Engn, 701C Rutland Ave 720, Baltimore, MD 21205 USA.; All, AH (corresponding author), Johns Hopkins Sch Med, 701C Rutland Ave 720, Baltimore, MD 21205 USA.; All, AH (corresponding author), Johns Hopkins Sch Med, Dept Neurol, 701C Rutland Ave 720, Baltimore, MD 21205 USA.	xiaogangliu@nus.edu.sg; hmn@jhu.edu	LIU, XIAOGANG/A-8038-2011; Wong, Limsoon/W-3611-2019; Ariffin, Mohammed Zacky/ABF-9613-2020; Wong, Limsoon/E-5033-2010; Loong, Daniel Teh Boon/AAF-6660-2019	LIU, XIAOGANG/0000-0003-2517-5790; Wong, Limsoon/0000-0003-1241-5441; Ariffin, Mohammed Zacky/0000-0002-6228-3830; Wong, Limsoon/0000-0003-1241-5441; Loong, Daniel Teh Boon/0000-0002-4560-8568; Khanna, Sanjay/0000-0002-7304-6259	Singapore's Ministry of Education Tier 1Ministry of Education, Singapore [R-175-000-137-112]; Singapore Institute for Neurotechnology Seed Fund [R-175-000-121-733]; State of Maryland, USA [2013-MSCRFII-0109-00]	We would like to thank Ms. Low Kay En and Ms Tan Soon Huat from Electron Microscopy Unit, Yong Loo Lin School of Medicine, and Ms. Tan Shu Ying from the Confocal Microscopy Unity of National University of Singapore, for their technical assistance. This work is supported by the R-175-000-137-112 (Singapore's Ministry of Education Tier 1), R-175-000-121-733 (Singapore Institute for Neurotechnology Seed Fund), (2013-MSCRFII-0109-00, PI: A. ALL) State of Maryland, USA.	Ahmed G, 2011, J NEUROSCI, V31, P14018, DOI 10.1523/JNEUROSCI.0943-11.2011; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Austin JW, 2012, J NEUROCHEM, V122, P344, DOI 10.1111/j.1471-4159.2012.07789.x; Baydyuk M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00254; Beaudet MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16763; Bin Goh WW, 2016, J PROTEOME RES, V15, P3167, DOI 10.1021/acs.jproteome.6b00402; Chandrasekaran A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00215; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Dawes JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002193; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Edwards TJ, 2014, CELL REP, V8, P272, DOI 10.1016/j.celrep.2014.06.008; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Gao DH, 2010, CELL MOL BIOL LETT, V15, P582, DOI 10.2478/s11658-010-0029-x; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hansson E, 2015, NEUROCHEM RES, V40, P372, DOI 10.1007/s11064-014-1363-6; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Herx LM, 2001, J NEUROPATH EXP NEUR, V60, P961, DOI 10.1093/jnen/60.10.961; Hill JJ, 2012, P NATL ACAD SCI USA, V109, P9155, DOI 10.1073/pnas.1205697109; Ito M, 2009, J NEUROTRAUM, V26, P41, DOI 10.1089/neu.2008.0646; Jankovski A, 1996, J COMP NEUROL, V371, P376; John GR, 2002, NAT MED, V8, P1115, DOI 10.1038/nm781; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Lafortune L, 1996, J NEUROPATH EXP NEUR, V55, P515, DOI 10.1097/00005072-199605000-00003; Lim K, 2014, BIOINFORMATICS, V30, P189, DOI 10.1093/bioinformatics/btt625; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Liu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075804; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2007, EXP NEUROL, V203, P8, DOI 10.1016/j.expneurol.2006.07.030; M'Dahoma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102027; Malin D, 2009, J CELL SCI, V122, P995, DOI 10.1242/jcs.040378; Min SK, 2015, SCI REP-UK, V5, DOI 10.1038/srep14418; Minor K, 2008, NEUROBIOL DIS, V32, P88, DOI 10.1016/j.nbd.2008.06.009; Mirshafiey Abbas, 2014, Sultan Qaboos Univ Med J, V14, pe13; Molina-Holgado F, 2000, J NEUROIMMUNOL, V111, P1, DOI 10.1016/S0165-5728(00)00344-1; Nakanishi K, 2006, J BIOL CHEM, V281, P24970, DOI 10.1074/jbc.M601498200; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Paniagua-Torija B, 2015, NEUROSCIENCE, V284, P283, DOI 10.1016/j.neuroscience.2014.10.013; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Rao VTS, 2016, J NEUROPATH EXP NEUR, V75, P156, DOI 10.1093/jnen/nlv016; Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021; Santos-Galindo Maria, 2011, Biol Sex Differ, V2, P7, DOI 10.1186/2042-6410-2-7; Sato A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-65; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; Selvaraj P, 2015, MOL CELL NEUROSCI, V68, P222, DOI 10.1016/j.mcn.2015.08.005; Skuljec J, 2011, J NEUROPATH EXP NEUR, V70, P758, DOI 10.1097/NEN.0b013e3182294fad; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Spisak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046215; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; Tarassishin L, 2014, GLIA, V62, P999, DOI 10.1002/glia.22657; Teller P, 2009, SURG CLIN N AM, V89, P599, DOI 10.1016/j.suc.2009.03.006; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Tselnicker IF, 2014, BIOCHEM SOC T, V42, P1263, DOI 10.1042/BST20140166; Tsiperson V, 2015, ASN NEURO, V7, DOI 10.1177/1759091414566878; von Boyen GBT, 2004, GUT, V53, P222, DOI 10.1136/gut.2003.012625; Walsh FS, 1997, ANNU REV CELL DEV BI, V13, P425, DOI 10.1146/annurev.cellbio.13.1.425; Wang SM, 2016, MOL NEUROBIOL, V53, P5912, DOI 10.1007/s12035-015-9486-6; Wang W., 2016, DRUG DISCOVERY TODAY; Wang YJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110024, 10.1371/journal.pone.0096339, 10.1371/journal.pone.0085234, 10.1371/journal.pone.0108223]; White RE, 2008, EXP NEUROL, V214, P10, DOI 10.1016/j.expneurol.2008.06.012; Wu D, 2005, J NEUROCYTOL, V34, P459, DOI 10.1007/s11068-006-8998-4; Yang ZS, 2006, J NEUROSCI, V26, P3829, DOI 10.1523/JNEUROSCI.4247-05.2006; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang J, 2003, J RECONSTR MICROSURG, V19, P467	73	27	28	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	OCT 25	2017	7								13988	10.1038/s41598-017-13174-w			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK7PS	WOS:000413700200027	29070875	Green Published, gold			2022-02-06	
J	Huang, B; Jiang, XC; Zhang, TY; Hu, YL; Tabata, Y; Chen, Z; Pluchino, S; Gao, JQ				Huang, Bing; Jiang, Xin-Chi; Zhang, Tian-Yuan; Hu, Yu-Lan; Tabata, Yasuhiko; Chen, Zhong; Pluchino, Stefano; Gao, Jian-Qing			Peptide modified mesenchymal stem cells as targeting delivery system transfected with miR-133b for the treatment of cerebral ischemia	INTERNATIONAL JOURNAL OF PHARMACEUTICS			English	Article						Mesenchymal stem cells; Targeting delivery system; Cerebral ischemia; Membrane coating; Peptide-based cell targeting; MiR-133b transfection Stem; cell-based targeting therapy	MARROW STROMAL CELLS; LEUKOTRIENE RECEPTOR-1 ANTAGONIST; HUMAN MYOCARDIAL-INFARCTION; CLOSED-HEAD INJURY; NONVIRAL TRANSFECTION; BEHAVIORAL DEFICITS; FUNCTIONAL RECOVERY; ARTERY OCCLUSION; PROGENITOR CELLS; RAT MODEL	Mesenchymal stem cells (MSCs) have been regarded as potential targeting vehicles and demonstrated to exert therapeutic benefits for brain diseases. Direct homing to diseased tissue is crucial for stem cell-based therapy. In this study, a peptide-based targeting approach was established to enhance cell homing to cerebral ischemic lesion. Palmitic acid-peptide painted onto the cell membrane was able to direct MSCs to ischemic tissues without any observed cell cytotoxicity and influence on differentiation, thus reducing accumulation of cells in peripheral organs and increasing engraftment of cells in the targeted tissues. With enhanced cell homing, MSCs were used to deliver miR-133b to increase the expression level of miR-133b in an ischemic lesion and further improve therapeutic effects. This study is the first to develop MSCs co-modified with targeting peptide and microRNAs as potential targeting therapeutic agents. This targeting delivery system is expected to be applicable to other cell types and other diseases aside from stroke.	[Huang, Bing; Jiang, Xin-Chi; Zhang, Tian-Yuan; Hu, Yu-Lan; Gao, Jian-Qing] Zhejiang Univ, Inst Pharmaceut, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto, Japan; [Chen, Zhong] Zhejiang Univ, Dept Pharmacol, Coll Pharmaceut Sci, Key Lab Med Neurobiol,Minist Hlth China, Hangzhou, Zhejiang, Peoples R China; [Pluchino, Stefano] Univ Cambridge, Dept Clin Neurosci, Wellcome Trust Med Res Council Stem Cell Inst, Cambridge, Cambs, England; [Gao, Jian-Qing] Zhejiang Univ, Dr Li Dak Sum & Yip Yio Chin Ctr Stem Cell & Rege, Hangzhou, Zhejiang, Peoples R China		Gao, JQ (corresponding author), Zhejiang Univ, Dr Li Dak Sum & Yip Yio Chin Ctr Stem Cell & Rege, Inst Pharmaceut, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China.	gaojianqing@zju.edu.cn	Song, Eun Joo/Z-5130-2019; Pluchino, Stefano/AAE-9037-2019	Pluchino, Stefano/0000-0002-6267-9472	Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [LZ14H300001]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81620108028, 81473143, 81273441]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_PC_12009] Funding Source: researchfish	This work was supported by Zhejiang Provincial Natural Science Foundation of China (LZ14H300001) and National Natural Science Foundation of China (81620108028, 81473143, 81273441).	Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bacigaluppi M, 2008, J NEUROL SCI, V265, P73, DOI 10.1016/j.jns.2007.06.012; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Bao XJ, 2011, BRAIN RES, V1367, P103, DOI 10.1016/j.brainres.2010.10.063; Boado RJ, 1998, J NEUROCHEM, V71, P1761; BORLONGAN CV, 1995, BRAIN RES, V676, P231, DOI 10.1016/0006-8993(95)00150-O; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Bostjancic E, 2009, DIS MARKERS, V27, P255, DOI 10.3233/DMA-2009-0671; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Celia C, 2011, MED RES REV, V31, P716, DOI 10.1002/med.20201; Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004; Chen AS, 2000, J IMMUNOL, V164, P705, DOI 10.4049/jimmunol.164.2.705; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Dharmasaroja P, 2009, J CLIN NEUROSCI, V16, P12, DOI 10.1016/j.jocn.2008.05.006; Doeppner TR, 2012, STEM CELLS, V30, P1297, DOI 10.1002/stem.1098; Dreyer JL, 2010, GENOME MED, V2, DOI 10.1186/gm213; Garcia-Garcia E, 2005, INT J PHARMACEUT, V298, P274, DOI 10.1016/j.ijpharm.2005.03.031; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Hayase M., 2015, J CEREB BLOOD FLOW M, V149, P1334; He CX, 2012, BIOTECHNOL APPL BIOC, V59, P163, DOI 10.1002/bab.1001; He CX, 2011, PHARM RES-DORDR, V28, P1577, DOI 10.1007/s11095-011-0390-0; Hong HY, 2008, J CONTROL RELEASE, V131, P167, DOI 10.1016/j.jconrel.2008.07.020; Hu YL, 2012, MOL PHARMACEUT, V9, P2698, DOI 10.1021/mp300254s; Hu YL, 2010, J CONTROL RELEASE, V147, P154, DOI 10.1016/j.jconrel.2010.05.015; Huang B, 2012, J CONTROL RELEASE, V162, P464, DOI 10.1016/j.jconrel.2012.07.034; Ikeda N, 2005, STROKE, V36, P2725, DOI 10.1161/01.STR.0000190006.88896.d3; Jo J, 2007, J CONTROL RELEASE, V118, P389, DOI 10.1016/j.jconrel.2007.01.005; Jo J, 2010, J BIOMAT SCI-POLYM E, V21, P185, DOI 10.1163/156856209X415495; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kang S. K., 2011, STEM CELLS INT, V2012, P147; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kean TJ, 2012, J DRUG TARGET, V20, P23, DOI 10.3109/1061186X.2011.622398; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Ko IK, 2009, BIOMATERIALS, V30, P3702, DOI 10.1016/j.biomaterials.2009.03.038; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Li JW, 2011, BIOMATERIALS, V32, P4943, DOI 10.1016/j.biomaterials.2011.03.031; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Sanchez-Simon FM, 2010, MOL PHARMACOL, V78, P935, DOI 10.1124/mol.110.066837; Matsuse D, 2011, TISSUE ENG PT A, V17, P1993, DOI [10.1089/ten.tea.2010.0585, 10.1089/ten.TEA.2010.0585]; Nakamura K, 2004, GENE THER, V11, P1155, DOI 10.1038/sj.gt.3302276; Pardridge W. M., 2003, BLOOD BRAIN BARRIER; Pardridge WM, 2007, PHARM RES, V24, P1733, DOI 10.1007/s11095-007-9324-2; Pardridge WM, 1999, ADV DRUG DELIVER REV, V36, P299, DOI 10.1016/S0169-409X(98)00087-8; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Qin Y, 2012, J DRUG TARGET, V20, P235, DOI 10.3109/1061186X.2011.639022; Rosenblum S, 2012, STROKE, V43, P1624, DOI 10.1161/STROKEAHA.111.637884; Schallert T, 1997, ADV NEUROL, V73, P229; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; van Gijn J., 1998, LANCET S3, V352; Xin H., 2013, STROKE A, V135; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yano S, 2005, BRAIN RES, V1065, P60, DOI 10.1016/j.brainres.2005.10.031; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Yu GL, 2005, BRAIN RES, V1053, P116, DOI 10.1016/j.brainres.2005.06.046; Yu GL, 2005, PHARMACOLOGY, V73, P31, DOI 10.1159/000081072; Yu XL, 2012, J NEUROL SCI, V316, P141, DOI 10.1016/j.jns.2012.01.001; Yu YM, 2011, EUR J NEUROSCI, V33, P1587, DOI 10.1111/j.1460-9568.2011.07643.x; Zhang TY, 2014, NANOMED-NANOTECHNOL, V10, P257, DOI 10.1016/j.nano.2013.06.003; Zhang ZH, 2008, NEUROSCI LETT, V444, P227, DOI 10.1016/j.neulet.2008.08.049	66	27	31	3	38	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-5173	1873-3476		INT J PHARMACEUT	Int. J. Pharm.	OCT 5	2017	531	1					90	100		10.1016/j.ijpharm.2017.08.073			11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FG8AP	WOS:000410648200009	28827201	Green Accepted			2022-02-06	
J	Cherry, JD; Stein, TD; Tripodis, Y; Alvarez, VE; Huber, BR; Au, R; Kiernan, PT; Daneshvar, DH; Mez, J; Solomon, TM; Alosco, ML; McKee, AC				Cherry, Jonathan D.; Stein, Thor D.; Tripodis, Yorghos; Alvarez, Victor E.; Huber, Bertrand R.; Au, Rhoda; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Solomon, Todd M.; Alosco, Michael L.; McKee, Ann C.			CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease	PLOS ONE			English	Article							NATIONAL INSTITUTE; NEUROPATHOLOGIC ASSESSMENT; ASSOCIATION GUIDELINES; BRAIN-INJURY; TAU; CRITERIA; RELIABILITY; MICROGLIA; DIAGNOSIS; CONSENSUS	CCL11, a protein previously associated with age-associated cognitive decline, is observed to be increased in the brain and cerebrospinal fluid (CSF) in chronic traumatic encephalopathy (CTE) compared to Alzheimer's disease (AD). Using a cohort of 23 deceased American football players with neuropathologically verified CTE, 50 subjects with neuropathologically diagnosed AD, and 18 non-athlete controls, CCL11 was measured with ELISA in the dorsolateral frontal cortex (DLFC) and CSF. CCL11 levels were significantly increased in the DLFC in subjects with CTE (fold change = 1.234, p < 0.050) compared to non-athlete controls and AD subjects with out a history of head trauma. This increase was also seen to correlate with years of exposure to American football (beta = 0.426, p = 0.048) independent of age (beta = -0.046, p = 0.824). Preliminary analyses of a subset of subjects with available post-mortem CSF showed a trend for increased CCL11 among individuals with CTE (p = 0.069) mirroring the increase in the DLFC. Furthermore, an association between CSF CCL11 levels and the number of years exposed to football (beta = 0.685, p = 0.040) was observed independent of age (beta = -0.103, p = 0.716). Finally, a receiver operating characteristic (ROC) curve analysis demonstrated CSF CCL11 accurately distinguished CTE subjects from non-athlete controls and AD subjects (AUC = 0.839, 95% CI 0.62 - 1.058, p = 0.028). Overall, the current findings provide preliminary evidence that CCL11 may be a novel target for future CTE biomarker studies.	[Cherry, Jonathan D.; Stein, Thor D.; Alvarez, Victor E.; Huber, Bertrand R.; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Solomon, Todd M.; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Sch Med, Boston Univ Alzheimers Dis, Boston, MA 02118 USA; [Cherry, Jonathan D.; Stein, Thor D.; Alvarez, Victor E.; Huber, Bertrand R.; Kiernan, Patrick T.; Daneshvar, Daniel H.; Mez, Jesse; Solomon, Todd M.; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA; [Cherry, Jonathan D.; Stein, Thor D.; Alvarez, Victor E.; Huber, Bertrand R.; Au, Rhoda; Mez, Jesse; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand R.; McKee, Ann C.] VA Boston Healthcare Syst, Boston, MA 02130 USA; [Stein, Thor D.; Alvarez, Victor E.; McKee, Ann C.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Au, Rhoda] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA		Cherry, JD (corresponding author), Boston Univ, Sch Med, Boston Univ Alzheimers Dis, Boston, MA 02118 USA.; Cherry, JD (corresponding author), Boston Univ, Sch Med, CTE Ctr, Boston, MA 02118 USA.; Cherry, JD (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.; Cherry, JD (corresponding author), VA Boston Healthcare Syst, Boston, MA 02130 USA.	Jdcherry@bu.edu		Tripodis, Yorghos/0000-0003-2190-7608; Stein, Thor/0000-0001-6954-4477; Daneshvar, Daniel/0000-0003-3691-9513	Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and DevelopmentUS Department of Veterans Affairs [I01-CX001038]; Alzheimer's AssociationAlzheimer's Association [NIRG-305779]; Veterans Affairs Biorepository [CSP 501]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1RF1AG054156-01]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; Department of Defense Peer Reviewed Alzheimer's Research Program [DoD-PRARP 13267017]; National Heart, Lung, and Blood Institute, Framingham Heart Study, (NHLBI/NIH) [N01-HC-25195, R01AG08122]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1F32NS096803-01]; Concussion Legacy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846, RF1AG054156, RF1AG057902, K23AG046377] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Clinical Sciences Research and Development Merit Award (I01-CX001038 to TDS); Alzheimer's Association (NIRG-305779 to TDS); Veterans Affairs Biorepository (CSP 501 to ACM); National Institute of Aging (1RF1AG054156-01); National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5 to ACM); Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP #13267017 to ACM); National Heart, Lung, and Blood Institute, Framingham Heart Study, (NHLBI/NIH #N01-HC-25195 and R01AG08122 to RA); NINDS (1F32NS096803-01 to MLA); Concussion Legacy Foundation to ACM. This work was also supported by unrestricted gifts from the Andlinger Foundation and WWE to ACM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachstetter AD, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0209-z; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Belkhelfa M, 2014, J INTERFERON CYTOKIN; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Castellano JM, 2015, JAMA NEUROL, V72, P1191, DOI 10.1001/jamaneurol.2015.1616; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Flynn G, 2003, J NEUROIMMUNOL, V136, P84, DOI 10.1016/S0165-5728(03)00009-2; Furukawa T, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000138; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Huber A. K., 2016, CLIN IMMUNOL; Huber AK, 2014, NEUROLOGY, V83, P1500, DOI 10.1212/WNL.0000000000000908; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Leung R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064971; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Love S., 2008, GREENFIELDS NEUROPAT; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mishra A, 1999, J CLIN INVEST, V103, P1719, DOI 10.1172/JCI6560; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Okamura N, 2016, AGEING RES REV, V30, P107, DOI 10.1016/j.arr.2015.12.010; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Parajuli B, 2015, GLIA, V63, P2274, DOI 10.1002/glia.22892; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Shahim P, 2017, JAMA NEUROL; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Spergel JM, 1999, J CLIN INVEST, V103, P1103, DOI 10.1172/JCI5669; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Wild E., 2011, PLOS CURR, V3, DOI [10.1371/currents.RRN1231, DOI 10.1371/CURRENTS.RRN1231]; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Yang LP, 2007, MOL VIS, V13, P1083; Zhu C, 2016, MOL NEUROBIOL	63	27	27	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2017	12	9							e0185541	10.1371/journal.pone.0185541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FI1DL	WOS:000411671000062	28950005	gold, Green Published, Green Submitted			2022-02-06	
J	Tao, WS; Dvoriantchikova, G; Tse, BC; Pappas, S; Chou, TH; Tapia, M; Porciatti, V; Ivanov, D; Tse, DT; Pelaez, D				Tao, Wensi; Dvoriantchikova, Galina; Tse, Brian C.; Pappas, Steven; Chou, Tsung-Han; Tapia, Manuel; Porciatti, Vittorio; Ivanov, Dmitry; Tse, David T.; Pelaez, Daniel			A Novel Mouse Model of Traumatic Optic Neuropathy Using External Ultrasound Energy to Achieve Focal, Indirect Optic Nerve Injury	SCIENTIFIC REPORTS			English	Article							RETINAL INJURY; CONTRIBUTES; CASCADE; MICE	Traumatic optic neuropathy (TON) is a devastating cause of permanent visual loss following blunt injury to the head. Animal models for TON exist, but most fail to recapitulate the clinical scenario of closed head indirect trauma to the nerve and subsequent neurodegeneration. Thus, we developed a clinically-relevant animal model for TON using a novel ultrasonic pulse injury modality (sonication-induced TON; SI-TON). To trigger TON, a microtip probe sonifier was placed on the supraorbital ridge directly above the entrance of the optic nerve into the bony canal. An ultrasonic pulse was then delivered to the optic nerve. After injury, the number of RGCs in the retina as well as visual function measured by PERG steadily decreased over a two-week period. In the optic nerve, pro-inflammatory markers were upregulated within 6 hours following injury. Immunohistochemistry showed activation of microglia and infiltration of CD45-positive leukocytes in the optic nerve and initiation of a gliotic response. The SI-TON model is capable of delivering a non-contact concussive injury to the optic nerve and induce TON in mice. Thus, our data indicate that the SI-TON model reliably recapitulates the pathophysiology and progressive neurodegeneration seen in the human manifestation.	[Tao, Wensi; Dvoriantchikova, Galina; Tse, Brian C.; Pappas, Steven; Chou, Tsung-Han; Tapia, Manuel; Porciatti, Vittorio; Ivanov, Dmitry; Tse, David T.; Pelaez, Daniel] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dr Nasser Al Rashid Orbital Vis Res Ctr,Dept Opht, Miami, FL 33136 USA; [Ivanov, Dmitry] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Porciatti, Vittorio; Pelaez, Daniel] Univ Miami, Coll Engn, Dept Biomed Engn, Coral Gables, FL 33146 USA		Pelaez, D (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dr Nasser Al Rashid Orbital Vis Res Ctr,Dept Opht, Miami, FL 33136 USA.; Pelaez, D (corresponding author), Univ Miami, Coll Engn, Dept Biomed Engn, Coral Gables, FL 33146 USA.	dpelaez@miami.edu	Tse, Brian/AAH-4158-2019	Pelaez, Daniel/0000-0002-4483-5160; Porciatti, Vittorio/0000-0002-1592-3532; Ivanov, Dmitry/0000-0002-5573-4402	Dr. Nasser Al-Rashid Orbital Research Fund; NIH NEI R01 Grant [EY019077]; NIH NEI Grant [R01 EY027311]; NIH NIA Grant [R56 AG053369]; NIH Center Core GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30EY014801]; Research to Prevent Blindness Unrestricted Grant, Inc, New York, New York; Dr. Nasser Ibrahim Al-Rashid Orbital Vision Research Fund; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY014801, R01EY019077, R01EY027311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R56AG053369] Funding Source: NIH RePORTER	This work was performed in the Dr. Nasser Al-Rashid Orbital Vision Research Center at the Bascom Palmer Eye Institute, and generously supported by the Dr. Nasser Al-Rashid Orbital Research Fund. We appreciate the valuable comments from several lab members, including Ravi Doddapaneni, and Zenith Acosta Torres. The authors thank Dr. Hong Yu for her expert assistance. We are grateful to Gabriel Gaidosh from the University of Miami Analytical Imaging Core Facility for his assistance with confocal microscopy. This work was supported in part by the NIH NEI R01 Grant EY019077 (V.P.), NIH NEI Grant R01 EY027311 (D.I.), NIH NIA Grant R56 AG053369 (D.I.), NIH Center Core Grant P30EY014801; Research to Prevent Blindness Unrestricted Grant, Inc, New York, New York; and the Dr. Nasser Ibrahim Al-Rashid Orbital Vision Research Fund. The sponsor or funding organizations had no role in the design or conduct of this research.	Camp AS, 2011, INVEST OPHTH VIS SCI, V52, P5226, DOI 10.1167/iovs.10-6307; Carta A, 2003, J NEUROL NEUROSUR PS, V74, P246, DOI 10.1136/jnnp.74.2.246; Chaon BC, 2015, CURR OPIN OPHTHALMOL, V26, P445, DOI 10.1097/ICU.0000000000000198; Chierzi S, 1999, J NEUROSCI, V19, P8367; Chou TH, 2014, INVEST OPHTH VIS SCI, V55, P2469, DOI 10.1167/iovs.14-13943; Dvoriantchikova G, 2014, EUR J NEUROSCI, V40, P2502, DOI 10.1111/ejn.12603; Dvoriantchikova G, 2014, EXP EYE RES, V123, P1, DOI 10.1016/j.exer.2014.04.009; Dvoriantchikova G, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-81; Dvoriantchikova G, 2011, INVEST OPHTH VIS SCI, V52, P7187, DOI 10.1167/iovs.11-7793; Dvoriantchikova G, 2010, MOL VIS, V16, P1907; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldberg RA, 1996, OPHTHALMIC PLAST REC, V12, P163, DOI 10.1097/00002341-199609000-00002; Guy WM, 2014, JAMA OPHTHALMOL, V132, P567, DOI 10.1001/jamaophthalmol.2014.82; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Kumaran AM, 2015, CRANIOMAX TRAUM REC, V8, P31, DOI 10.1055/s-0034-1393734; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Medeiros FA, 2003, AM J OPHTHALMOL, V135, P406, DOI 10.1016/S0002-9394(02)02049-4; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Singman EL, 2016, MILITARY MED RES, V3, DOI 10.1186/s40779-016-0069-2; Solomon AS, 1996, J NEUROSCI METH, V70, P21, DOI 10.1016/S0165-0270(96)00098-2; Steinsapir K D, 1999, Curr Opin Ophthalmol, V10, P340, DOI 10.1097/00055735-199910000-00011; Steinsapir KD, 2011, AM J OPHTHALMOL, V151, P928, DOI 10.1016/j.ajo.2011.02.007; Xue F, 2016, BIOMED REP, V4, P188, DOI 10.3892/br.2016.567; Yu-Wai-Man P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005024.pub3; Yu-Wai-Man P, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858	28	27	29	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 18	2017	7								11779	10.1038/s41598-017-12225-6			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH1RC	WOS:000410916100037	28924145	Green Published, gold			2022-02-06	
J	Farnsworth, JL; Dargo, L; Ragan, BG; Kang, M				Farnsworth, James L., II; Dargo, Lucas; Ragan, Brian G.; Kang, Minsoo			Reliability of Computerized Neurocognitive Tests for Concussion Assessment: A Meta-Analysis	JOURNAL OF ATHLETIC TRAINING			English	Article						test-retest design; cognitive function; head injuries; traumatic brain injuries	TEST-RETEST RELIABILITY; BASE-LINE; NEUROPSYCHOLOGICAL ASSESSMENT; ASSESSMENT TOOLS; IMPACT; SPORT; VALIDITY; MANAGEMENT; STATEMENT; BATTERY	Objective: Although widely used, computerized neurocognitive tests (CNTs) have been criticized because of low reliability and poor sensitivity. A systematic review was published summarizing the reliability of Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) scores; however, this was limited to a single CNT. Expansion of the previous review to include additional CNTs and a meta-analysis is needed. Therefore, our purpose was to analyze reliability data for CNTs using meta-analysis and examine moderating factors that may influence reliability. Data Sources: A systematic literature search (key terms: reliability, computerized neurocognitive test, concussion) of electronic databases (MEDLINE, PubMed, Google Scholar, and SPORTDiscus) was conducted to identify relevant studies. Study Selection: Studies were included if they met all of the following criteria: used a test-retest design, involved at least 1 CNT, provided sufficient statistical data to allow for effect-size calculation, and were published in English. Data Extraction: Two independent reviewers investigated each article to assess inclusion criteria. Eighteen studies involving 2674 participants were retained. Intraclass correlation coefficients were extracted to calculate effect sizes and determine overall reliability. The Fisher Z transformation adjusted for sampling error associated with averaging correlations. Moderator analyses were conducted to evaluate the effects of the length of the test-retest interval, intraclass correlation coefficient model selection, participant demographics, and study design on reliability. Heterogeneity was evaluated using the Cochran Q statistic. Data Synthesis: The proportion of acceptable outcomes was greatest for the Axon Sports CogState Test (75%) and lowest for the ImPACT (25%). Moderator analyses indicated that the type of intraclass correlation coefficient model used significantly influenced effect-size estimates, accounting for 17% of the variation in reliability. Conclusions: The Axon Sports CogState Test, which has a higher proportion of acceptable outcomes and shorter test duration relative to other CNTs, may be a reliable option; however, future studies are needed to compare the diagnostic accuracy of these instruments.	[Farnsworth, James L., II] Buena Vista Univ, Sch Educ & Exercise Sci, 610 West 4th St, Storm Lake, IA 50588 USA; [Dargo, Lucas] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Kang, Minsoo] Middle Tennessee State Univ, Murfreesboro, TN 37130 USA		Farnsworth, JL (corresponding author), Buena Vista Univ, Sch Educ & Exercise Sci, 610 West 4th St, Storm Lake, IA 50588 USA.	farnsworth@bvu.edu					Ackerman PL, 2009, J EXP PSYCHOL-APPL, V15, P163, DOI 10.1037/a0015719; Ahn S, 2015, INTRO INTERMEDIATE A, P233; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; [Anonymous], 2016, R LANGUAGE ENV STAT; Baumgartner TA, 2015, RELIABILITY OBJECTIV, P90; Becker B.J., 2000, HDB APPL MULTIVARIAT, P499, DOI [https://doi.org/10.1016/B978-012691360-6/50018-5, DOI 10.1016/B978-012691360-6/50018-5]; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Brunner HI, 2013, ARTHRIT CARE RES, V65, P372, DOI 10.1002/acr.21835; Carrasco JL, 2003, BIOMETRICS, V59, P849, DOI 10.1111/j.0006-341X.2003.00099.x; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Cousino E, 2006, J ATHL TRAINING, V41, pS; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Covassin T, 2009, J ATHL TRAINING, V44, P400, DOI 10.4085/1062-6050-44.4.400; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Hedges L.V., 1985, STAT METHODS META AN; Irwin CC, 2014, AM ALL HLTH PHYS ED; Kim Y, 2013, PUBLIC HEALTH NUTR, V16, P440, DOI 10.1017/S1368980012002996; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Ragan BG, 2009, ATHLETIC TRAIN SPORT, V1, P180; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; SILVER NC, 1987, J APPL PSYCHOL, V72, P146, DOI 10.1037/0021-9010.72.1.146; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03	44	27	27	1	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2017	52	9					826	833		10.4085/1062-6050-52.6.03			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FN2LO	WOS:000415824000004	28771032	Bronze, Green Published			2022-02-06	
J	Foks, KA; Cnossen, MC; Dippel, DWJ; Maas, AIR; Menon, D; van der Naalt, J; Steyerberg, EW; Lingsma, HF; Polinder, S				Foks, Kelly A.; Cnossen, Maryse C.; Dippel, Diederik W. J.; Maas, Andrew I. R.; Menon, David; van der Naalt, Joukje; Steyerberg, Ewout W.; Lingsma, Hester F.; Polinder, Suzanne		CTR-TBI Investigators Participants	Management of Mild Traumatic Brain Injury at the Emergency Department and Hospital Admission in Europe: A Survey of 71 Neurotrauma Centers Participating in the CENTER-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						admission; emergency department; guideline; survey; traumatic brain injury	MINOR HEAD-INJURY; SCANDINAVIAN GUIDELINES; COMPUTED-TOMOGRAPHY; INITIAL MANAGEMENT; EPIDEMIOLOGY; BIOMARKERS; CONSENSUS; ADULTS; RULE	Previous studies have indicated that there is no consensus about management of mild traumatic brain injury (mTBI) at the emergency department (ED) and during hospital admission. We aim to study variability between management policies for TBI patients at the ED and at the hospital ward across Europe. Centers participating in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study received questionnaires about different phases of TBI care. These questionnaires included 71 questions about TBI management at the ED and at the hospital ward. We found differences in how centers defined mTBI. For example, 40 centers (59%) defined mTBI as a Glasgow Coma Scale (GCS) score between 13 and 15 and 26 (38%) defined it as a GCS score between 14 and 15. At the ED various guidelines for the use of head computed tomography (CT) in mTBI patients were used; 32 centers (49%) used national guidelines, 10 centers (15%) local guidelines, and 14 centers (21%) used no guidelines at all. Also, differences in indication for admission between centers were found. After ED discharge, 7 centers (10%) scheduled a routine follow-up appointment, whereas 38 (54%) did so only after ward admission. In conclusion, large between-center variation exists in policies for diagnostics, admission, and discharge decisions in patients with mTBI at the ED and in the hospital. Guidelines are not always operational in centers, and reported policies systematically diverge from what is recommended in those guidelines. The results of this study may be useful in the understanding of mTBI care in Europe and show the need for further studies on the effectiveness of different policies on outcome.	[Foks, Kelly A.; Cnossen, Maryse C.; Steyerberg, Ewout W.; Lingsma, Hester F.; Polinder, Suzanne] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Foks, Kelly A.; Dippel, Diederik W. J.] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Menon, David] Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Cambridge, England; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands		Foks, KA (corresponding author), Erasmus MC, Dept Publ Hlth Na 2424, PO 2040, NL-3000 CA Rotterdam, Netherlands.	k.foks@erasmusmc.nl	Badenes, Rafael/K-6628-2019; Dippel, Diederik/AAJ-2192-2020; Maas, Andrew IR/C-5584-2013	Badenes, Rafael/0000-0001-7017-0150; Dippel, Diederik/0000-0002-9234-3515; Maas, Andrew IR/0000-0003-1612-1264; van der Naalt, Joukje/0000-0001-9873-2418	European Commission 7th Framework program [602150]	The authors would like to thank all the CENTER-TBI participants for completing the PP questionnaires. Data used in this article were obtained in the context of the CENTER-TBI study with support of the European Commission 7th Framework program (602150).	Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; de Kruijk JR, 2001, BRAIN INJURY, V15, P117, DOI 10.1080/026990501458353; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; National Institute for Health and Clinical Excellence, 2014, HEAD INJ TRIAG ASS I; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pulhorn H, 2016, BRIT J NEUROSURG, V30, P536, DOI 10.1080/02688697.2016.1211249; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	22	27	27	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2529	2535		10.1089/neu.2016.4919			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200005	28398105	Green Submitted, Green Accepted			2022-02-06	
J	Riha, HM; Erdman, MJ; Vandigo, JE; Kimmons, LA; Goyal, N; Davidson, KE; Pandhi, A; Jones, GM				Riha, Heidi M.; Erdman, Michael J.; Vandigo, Joseph E.; Kimmons, Lauren A.; Goyal, Nitin; Davidson, K. Erin; Pandhi, Abhi; Jones, G. Morgan			Impact of Moderate Hyperchloremia on Clinical Outcomes in Intracerebral Hemorrhage Patients Treated With Continuous Infusion Hypertonic Saline: A Pilot Study	CRITICAL CARE MEDICINE			English	Article						hemorrhage; length of stay; mortality; neurology; stroke	TRAUMATIC BRAIN-INJURY; IN-HOSPITAL MORTALITY; CRITICALLY-ILL ADULTS; CEREBRAL EDEMA; KIDNEY INJURY; ASSOCIATION; STROKE; MANAGEMENT; HYPERGLYCEMIA; GUIDELINE	Objectives: Hyperchloremia has been associated with increased morbidity and mortality in critically ill patients. While previous research has demonstrated an association between hypertonic saline and hyperchloremia, limited data exist in neurocritical care patients. The objective of this study is to determine the impact of moderate hyperchloremia (chloride >= 115 mmol/L) on clinical outcomes in intracerebral hemorrhage patients treated with continuous IV infusion 3% hypertonic saline. Design: Multicenter, retrospective, propensity-matched cohort study. Setting: Neurocritical care units at two academic medical centers with dedicated neurocritical care teams and comprehensive stroke center designation. Patients: Intracerebral hemorrhage patients discharged between September 2011 and September 2015 were evaluated and matched 1:1 based on propensity scoring. Interventions: Continuous IV infusion 3% hypertonic saline. Measurements and Main Results: A total of 219 patients were included in the unmatched cohort (143 moderate hyperchloremia and 76 nonhyperchloremia) and 100 patients in the propensity-matched cohort. In-hospital mortality was significantly higher in those who developed moderate hyperchloremia in a propensity-matched cohort (34% vs 14%; p = 0.02). Moderate hyperchloremia independently predicted in-hospital mortality in multivariable logistic regression analysis (odds ratio, 4.4 [95% CI, 1.4-13.5]; p = 0.01). Conclusions: We observed higher rates of in-hospital mortality in patients who developed moderate hyperchloremia during treatment with continuous IV infusion 3% hypertonic saline, with moderate hyperchloremia independently predicting in-hospital mortality. These results suggest that chloride values should be monitored closely during hypertonic saline treatment as moderate elevations may impact outcomes in intracerebral hemorrhage patients.	[Riha, Heidi M.; Kimmons, Lauren A.; Davidson, K. Erin; Jones, G. Morgan] Methodist Univ Hosp, Dept Pharm, Memphis, TN USA; [Erdman, Michael J.] Univ Florida Hlth, Dept Pharm, Jacksonville, FL USA; [Vandigo, Joseph E.] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Kimmons, Lauren A.; Jones, G. Morgan] Univ Tennessee, Hlth Sci Ctr, Dept Clin Pharm, 1265 Union Ave, Memphis, TN 38104 USA; [Goyal, Nitin; Pandhi, Abhi; Jones, G. Morgan] Univ Tennessee, Hlth Sci Ctr, Dept Neurol, 1265 Union Ave, Memphis, TN 38104 USA; [Jones, G. Morgan] Univ Tennessee, Hlth Sci Ctr, Dept Neurosurg, 1265 Union Ave, Memphis, TN 38104 USA		Jones, GM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Clin Pharm, 1265 Union Ave, Memphis, TN 38104 USA.; Jones, GM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Neurol, 1265 Union Ave, Memphis, TN 38104 USA.; Jones, GM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Neurosurg, 1265 Union Ave, Memphis, TN 38104 USA.; Jones, GM (corresponding author), Methodist Univ Hosp, Memphis, TN 38104 USA.	Morgan.Jones@mlh.org	Erdman, Michael/H-5771-2019; Pandhi, Abhi/J-9871-2019; Goyal, Nitin/M-6360-2017	Erdman, Michael/0000-0003-2990-0259; Pandhi, Abhi/0000-0001-5878-6112; Goyal, Nitin/0000-0002-4699-0922			Allen Sara J, 2014, J Extra Corpor Technol, V46, P28; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; Boniatti MM, 2011, J CRIT CARE, V26, P175, DOI 10.1016/j.jcrc.2010.04.013; Erdman MJ, 2017, NEUROHOSPITALIST, V7, P9, DOI 10.1177/1941874416665744; Feasal A, 2015, EGYPT J CRIT CARE ME, V3, P1, DOI 10.1016/j.ejccm.2015.05.001; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Forsyth LL, 2008, PHARMACOTHERAPY, V28, P469, DOI 10.1592/phco.28.4.469; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Jones GM, 2017, AM J CRIT CARE, V26, P37, DOI 10.4037/ajcc2017439; Lee JY, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0311-7; Leuven E., 2003, PSMATCH2 STATA MODUL; Lord AS, 2014, STROKE, V45, P3535, DOI 10.1161/STROKEAHA.114.006435; Maguigan KL, 2017, J CLIN NEUROSCI, V39, P147, DOI 10.1016/j.jocn.2017.01.025; Mangat HS, 2015, ANN NY ACAD SCI, V1345, P83, DOI 10.1111/nyas.12704; Marttinen M, 2016, ACTA ANAESTH SCAND, V60, P790, DOI 10.1111/aas.12694; McCluskey SA, 2013, ANESTH ANALG, V117, P412, DOI 10.1213/ANE.0b013e318293d81e; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Neyra JA, 2015, CRIT CARE MED, V43, P1938, DOI 10.1097/CCM.0000000000001161; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Raghunathan K, 2014, CRIT CARE MED, V42, P1585, DOI 10.1097/CCM.0000000000000305; Roquilly A, 2011, CRIT CARE, V15, DOI 10.1186/cc10522; Shaw AD, 2014, INTENS CARE MED, V40, P1897, DOI 10.1007/s00134-014-3505-3; Silva Junior João Manoel, 2009, Rev. Bras. Anestesiol., V59, P304, DOI 10.1590/S0034-70942009000300005; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tani M, 2012, SCI WORLD J, DOI 10.1100/2012/474185; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zhao YX, 2017, NEUROL RES, V39, P152, DOI 10.1080/01616412.2016.1270575; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	32	27	27	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2017	45	9					E947	E953		10.1097/CCM.0000000000002522			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD9LJ	WOS:000407843600006	28538442				2022-02-06	
J	Wallace, J; Covassin, T; Nogle, S; Gould, D; Kovan, J				Wallace, Jessica; Covassin, Tracey; Nogle, Sally; Gould, Daniel; Kovan, Jeffrey			Concussion Knowledge and Reporting Behavior Differences Between High School Athletes at Urban and Suburban High Schools	JOURNAL OF SCHOOL HEALTH			English	Article						concussion knowledge; reporting behaviors; adolescent health; urban health; suburban health	TRAUMATIC BRAIN-INJURY; RECURRENT CONCUSSION; FOOTBALL PLAYERS; TEST-SCORES; AMERICAN; SPORT; YOUTH; ASSOCIATION; STATEMENT; RISK	BACKGROUNDWe determined differences in knowledge of concussion and reporting behaviors of high school athletes attending urban and suburban high schools, and whether a relationship exists between underreporting and access to an athletic trainer in urban schools. METHODSHigh school athletes (N = 715) from 14 high schools completed a validated knowledge of concussion survey consisting of 83 questions. The independent variable was school type (urban/suburban). We examined the proportion of athletes who correctly identified signs and symptoms of concussion, knowledge of concussion and reasons why high school athletes would not disclose a potential concussive injury across school classification. Data were analyzed using descriptive, non-parametric, and inferential statistics. RESULTSAthletes attending urban schools have less concussion knowledge than athletes attending suburban schools (p < .01). Athletes attending urban schools without an athletic trainer have less knowledge than urban athletes at schools with an athletic trainer (p < .01) There was no significant relationship between reporting percentage and school type (p = .73); however, significant relationships exist between AT access at urban schools and 10 reasons for not reporting. CONCLUSIONConcussion education efforts cannot be homogeneous in all communities. Education interventions must reflect the needs of each community.	[Wallace, Jessica] Youngstown State Univ, Kinesiol & Sport Sci Dept, Beeghly Ctr 307L, 1 Univ Plaza, Youngstown, OH 44555 USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, 105 IM Circle, E Lansing, MI 48824 USA; [Nogle, Sally] Michigan State Univ, Dept Athlet, 105 IM Circle, E Lansing, MI 48824 USA; [Gould, Daniel] Michigan State Univ, Dept Kinesiol, 308 W Circle Dr, E Lansing, MI 48824 USA; [Kovan, Jeffrey] Michigan State Univ, Dept Radiol, Sports Med, 4660 South Hagadom Rd,Suite 420, E Lansing, MI 48824 USA		Wallace, J (corresponding author), Youngstown State Univ, Kinesiol & Sport Sci Dept, Beeghly Ctr 307L, 1 Univ Plaza, Youngstown, OH 44555 USA.	Jwallace02@ysu.edu; covassin@msu.edu; nogle@ath.msu.edu; drgould@msu.edu; Jeff.kovan@ht.msu.edu			Pentecost Foundation; Blue Cross Blue Shield of Michigan Foundation	Funding for the project was provided by the Pentecost Foundation and the Blue Cross Blue Shield of Michigan Foundation.	Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Borden BP, 2007, AM J SPORTS MED, V35, P1075; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HANNAWAY J, 1993, EDUC ADMIN QUART, V29, P164, DOI 10.1177/0013161X93029002004; Herbers JE, 2012, EDUC RESEARCHER, V41, P366, DOI 10.3102/0013189X12445320; Ickovics JR, 2014, J SCHOOL HEALTH, V84, P40, DOI 10.1111/josh.12117; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2013, J ATHL TRAINING, V48, P483, DOI 10.4085/1062-6050-48.4.04; Povlishock JT, 2013, J NEUROTRAUM, V30, P1, DOI 10.1089/neu.2013.9942; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik JK, 2009, ATHL TRAIN SPORTS HL, V1, P227; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Sandy J, 2010, EDUC ECON, V18, P297, DOI 10.1080/09645290903465713; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; US Department of Education Institute of Education Sciences, CHILDR LIV POV; WATSON BC, 1989, J NEGRO EDUC, V58, P309, DOI 10.2307/2295664; WAYSON WW, 1972, URBAN EDUC, V7, P109, DOI 10.1177/004208597200700202; Willie CV, 2001, URBAN EDUC, V36, P461, DOI 10.1177/0042085901364002	35	27	27	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-4391	1746-1561		J SCHOOL HEALTH	J. Sch. Health	SEP	2017	87	9					665	674		10.1111/josh.12543			10	Education & Educational Research; Education, Scientific Disciplines; Health Care Sciences & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services; Public, Environmental & Occupational Health	FC8IW	WOS:000407086000004	28766322				2022-02-06	
J	Karibe, H; Hayashi, T; Narisawa, A; Kameyama, M; Nakagawa, A; Tominaga, T				Karibe, Hiroshi; Hayashi, Toshiaki; Narisawa, Ayumi; Kameyama, Motonobu; Nakagawa, Atsuhiro; Tominaga, Teiji			Clinical Characteristics and Outcome in Elderly Patients with Traumatic Brain Injury: For Establishment of Management Strategy	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						traumatic brain injury (TBI); elderly; delayed deterioration; antiplatelet; anticoagulant	INTERHEMISPHERIC SUBDURAL-HEMATOMA; SEVERE HEAD-INJURIES; INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN; GERIATRIC TRAUMA; ANTIPLATELET THERAPY; CEREBRAL-CIRCULATION; MORTALITY; AGE; ANTICOAGULATION	In recent years, instances of neurotrauma in the elderly have been increasing. This article addresses the clinical characteristics, management strategy, and outcome in elderly patients with traumatic brain injury (TBI). Falls to the ground either from standing or from heights are the most common causes of TBI in the elderly, since both motor and physiological functions are degraded in the elderly. Subdural, contusional and intracerebral hematomas are more common in the elderly than the young as the acute traumatic intracranial lesion. High frequency of those lesions has been proposed to be associated with increased volume of the subdural space resulting from the atrophy of the brain in the elderly. The delayed aggravation of intracranial hematomas has been also explained by such anatomical and physiological changes present in the elderly. Delayed hyperemia/hyperperfusion may also be a characteristic of the elderly TBI, although its mechanisms are not fully understood. In addition, widely used pre-injury anticoagulant and antiplatelet therapies may be associated with delayed aggravation, making the management difficult for elderly TBI. It is an urgent issue to establish preventions and treatments for elderly TBI, since its outcome has been remained poor for more than 40 years.	[Karibe, Hiroshi; Hayashi, Toshiaki; Narisawa, Ayumi; Kameyama, Motonobu] Sendai City Hosp, Dept Neurosurg, Sendai, Miyagi, Japan; [Nakagawa, Atsuhiro; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi, Japan		Karibe, H (corresponding author), Sendai City Hosp, Dept Neurosurg, Taihaku Ku, 1-1-1 Asuto Nagamachi, Sendai, Miyagi 9828502, Japan.	karibe@nsg.med.tohoku.ac.jp					Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Albeck MJ, 1998, J NEUROSURG, V89, P275, DOI 10.3171/jns.1998.89.2.0275; [Anonymous], 2013, SEV TRAUM HEAD INJ E, P150; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Bonville DJ, 2011, SURGERY, V150, P861, DOI 10.1016/j.surg.2011.07.070; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Cabinet Office, ANN REP AG SOC 2015; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Chieregato A, 2009, NEUROSURGERY, V64, P705, DOI 10.1227/01.NEU.0000341872.17024.44; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; COHEN TI, 1996, NEUROTRAUMA, P689; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Deiner Stacie, 2004, Curr Opin Anaesthesiol, V17, P165, DOI 10.1097/00001503-200404000-00013; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Di Minno MND, 2009, INTERN EMERG MED, V4, P279, DOI 10.1007/s11739-009-0265-0; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Feeney JM, 2016, J TRAUMA ACUTE CARE, V81, P843, DOI 10.1097/TA.0000000000001245; Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Grossman MD, 2002, J TRAUMA, V52, P242, DOI 10.1097/00005373-200202000-00007; Hedman AM, 2012, HUM BRAIN MAPP, V33, P1987, DOI 10.1002/hbm.21334; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Inamasu J, 2010, NEUROL MED-CHIR, V50, P1051, DOI 10.2176/nmc.50.1051; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jane J, 1996, NEUROTRAUMA, P793; Kameyama M., 2013, NEUROTRAUMATOLOGY, V36, P10; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; Karibe H, 2009, PROGR COMPUTED IMAGI, V31, P255; Karni A, 2001, AM SURGEON, V67, P1098; Katayama Y, 2000, NEUROTRAUMATOLOGY, V23, P6; Kawamata T, 2002, NEUROTRAUMATOLOGY, V25, P205; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; MEYER JS, 1993, CEREBROVAS BRAIN MET, V5, P122; Milos V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-40; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Moussa ID, 2009, CATHETER CARDIO INTE, V74, P1047, DOI 10.1002/ccd.22167; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Ono Junichi, 1993, Neurological Surgery, V21, P717; Patel MR, 2013, J AM COLL CARDIOL, V61, P651, DOI 10.1016/j.jacc.2012.09.057; Peisker T, 2010, J NEUROL SCI, V299, P112, DOI 10.1016/j.jns.2010.08.064; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Pudelek Barbara, 2002, AACN Clin Issues, V13, P61; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; Takeuchi S, 2010, J CLIN NEUROSCI, V17, P1527, DOI 10.1016/j.jocn.2010.03.055; Tokutomi T, 2005, NEUROTRAUMATOLOGY, V28, P1; TOMINAGA, 2008, NEUROTRAUMATOLOGY, V31, P49; Urculo E, 1996, ACTA NEUROCHIR, V138, P776, DOI 10.1007/BF01411487; Vicenzi MN, 2006, BRIT J ANAESTH, V96, P686, DOI 10.1093/bja/ael083; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Yilmaz S, 2006, EUR J EMERG MED, V13, P295, DOI 10.1097/00063110-200610000-00010; Yokohori S, 2013, NEUROTRAUMATOLOGY, V36, P76; Yokosuka K, 2015, J NEUROSURG, V123, P1065, DOI 10.3171/2014.10.JNS14915	65	27	28	1	8	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	AUG	2017	57	8					418	425		10.2176/nmc.st.2017-0058			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	FG2OC	WOS:000409948800006	28679968	gold, Green Published, Green Submitted			2022-02-06	
J	Chen, HZ; Desai, A; Kim, HY				Chen, Huazhen; Desai, Abhishek; Kim, Hee-Yong			Repetitive Closed-Head Impact Model of Engineered Rotational Acceleration Induces Long-Term Cognitive Impairments with Persistent Astrogliosis and Microgliosis in Mice	JOURNAL OF NEUROTRAUMA			English	Article						CHIMERA; learning and memory; neuroinflammation; rmTBI	TRAUMATIC BRAIN-INJURY; MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; WHITE-MATTER INJURY; PHOSPHORYLATED TAU; DISEASE; ENCEPHALOPATHY; EXPRESSION; PROTEIN; MEMORY; NEUROPATHOLOGY	Repeated mild traumatic brain injury (rmTBI) has been identified by epidemiology as a high-risk factor for dementia at a later stage in life. Animal models to replicate complex features of human rmTBI and/or to evaluate long-term effects on brain function have not been established. In this study, we used a novel closed-head impact model of engineered rotational acceleration (CHIMERA) to investigate the long-term neuropathological and cognitive functional consequences of rmTBI. Adult C57BL/6 male mice were subjected to CHIMERA for 3 consecutive days 24h apart. Functional outcomes were assessed by the beam walk and Morris water maze tests. Neuropathology was evaluated by immunostaining of glial fibrillary acidic protein (GFAP), amyloid precursor protein (APP), and ionizing calcium-binding adaptor molecule-1 (Iba-1), and by quantitative reverse transcription polymerase chain reaction (qRT-PCR) or Western blotting of GFAP, Iba-1, and tumor necrosis factor (TNF)-. Repeated CHIMERA (rCHIMERA) resulted in motor deficits at 3 days, and in learning and memory impairments that were sustained up to 6 months post injury. GFAP and TNF- gene expression was increased within a week, whereas astrogliosis and microgliosis were induced starting from day 1 up to 6.5 months after rCHIMERA with upregulated GFAP and Iba-1 protein levels. rCHIMERA also induced APP deposition from day 1 to day 7, but this diminished by 1 month. In conclusion, rCHIMERA produces long-lasting cognitive impairments with astrogliosis and microgliosis in mice, suggesting that rCHIMERA can be a useful animal model to study the long-term complications, as well as the cellular and molecular mechanisms, of human rmTBI.	[Chen, Huazhen; Desai, Abhishek; Kim, Hee-Yong] NIAAA, Lab Mol Signaling, NIH, Rockville, MD 20852 USA; [Chen, Huazhen] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Kim, HY (corresponding author), NIAAA, NIH, 5625 Fishers Lane, Rockville, MD 20852 USA.	hykim@nih.gov			Intramural Program of the NIAAA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [ZIAAA000501] Funding Source: NIH RePORTER	This study was supported by the Intramural Program of the NIAAA, the NIH, and the Department of Defense in the Center for Neuroscience and Regenerative Medicine. The authors thank the NIAAA animal facility staff for their support.	AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Binder S, 2003, REPORT C MILD TRAUMA; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Goodrich GL, 2014, J REHABIL RES DEV, V51, P547, DOI 10.1682/JRRD.2013.02.0049; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hennessy E, 2015, J NEUROSCI, V35, P8411, DOI 10.1523/JNEUROSCI.2745-14.2015; Hibbits N, 2012, ASN NEURO, V4, DOI 10.1042/AN20120062; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Lu KP, 2016, JAMA NEUROL, V73, P1356, DOI 10.1001/jamaneurol.2016.2027; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stalder M, 2001, NEUROBIOL AGING, V22, P427, DOI 10.1016/S0197-4580(01)00209-3; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Zetterberg H, 2010, EXP GERONTOL, V45, P23, DOI 10.1016/j.exger.2009.08.002	62	27	27	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2291	2302		10.1089/neu.2016.4870			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000012	28288551	Green Published			2022-02-06	
J	Clark, RSB; Empey, PE; Bay, H; Rosario, BL; Poloyac, SM; Kochanek, PM; Nolin, TD; Au, AK; Horvat, CM; Wisniewski, SR; Bell, MJ				Clark, Robert S. B.; Empey, Philip E.; Bay, Hulya; Rosario, Bedda L.; Poloyac, Samuel M.; Kochanek, Patrick M.; Nolin, Thomas D.; Au, Alicia K.; Horvat, Christopher M.; Wisniewski, Stephen R.; Bell, Michael J.			Phase I randomized clinical trial of Nacetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children	PLOS ONE			English	Article							N-ACETYLCYSTEINE; DOUBLE-BLIND; PHARMACOKINETICS; EFFICACY; GLUTATHIONE; SYSTEMS	Background There are no therapies shown to improve outcome after severe traumatic brain injury (TBI) in humans, a leading cause of morbidity and mortality. We sought to verify brain exposure of the systemically administered antioxidant N-acetylcysteine (NAC) and the synergistic adjuvant probenecid, and identify adverse effects of this drug combination after severe TBI in children. Methods IRB-approved, randomized, double- blind, placebo controlled Phase I study in children 2 to 18 years-of-age admitted to a Pediatric Intensive Care Unit after severe TBI (Glasgow Coma Scale [GCS] score <= 8) requiring an externalized ventricular drain for measurement of intracranial pressure (ICP). Patients were recruited from November 2011-August 2013. Fourteen patients (n = 7/group) were randomly assigned after obtaining informed consent to receive probenecid (25 mg/kg load, then 10 mg/kg/dose q6hx11 doses) and NAC (140 mg/kg load, then 70 mg/kg/dose q4hx17 doses), or placebos via naso/orogastric tube. Serum and CSF samples were drawn pre-bolus and 1-96 h after randomization and drug concentrations were measured via UPLC-MS/MS. Glasgow Outcome Scale (GOS) score was assessed at 3 months. Results There were no adverse events attributable to drug treatment. One patient in the placebo group was withdrawn due to adverse effects. In the treatment group, NAC concentrations ranged from 16,977.3 +/- 2,212.3 to 16,786.1 +/- 3,285.3 in serum and from 269.3 +/- 113.0 to 467.9 +/- 262.7 ng/mL in CSF, at 24 to 72 h post-bolus, respectively; and probenecid concentrations ranged from 75.4.3 +/- 10.0 to 52.9 +/- 25.8 in serum and 5.4 +/- 1.0 to 4.6 +/- 2.1 mu g/mL in CSF, at 24 to 72 h post-bolus, respectively (mean +/- SEM). Temperature, mean arterial pressure, ICP, use of ICP-directed therapies, surveillance serum brain injury biomarkers, and GOS at 3 months were not different between groups. Conclusions Treatment resulted in detectable concentrations of NAC and probenecid in CSF and was not associated with undesirable effects after TBI in children.	[Clark, Robert S. B.; Bay, Hulya; Kochanek, Patrick M.; Au, Alicia K.; Horvat, Christopher M.; Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Clark, Robert S. B.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Clark, Robert S. B.; Bay, Hulya; Kochanek, Patrick M.; Au, Alicia K.; Horvat, Christopher M.; Bell, Michael J.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Clark, Robert S. B.; Bay, Hulya; Kochanek, Patrick M.; Au, Alicia K.; Horvat, Christopher M.; Bell, Michael J.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Clark, Robert S. B.; Empey, Philip E.; Kochanek, Patrick M.] Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA; [Empey, Philip E.; Poloyac, Samuel M.; Nolin, Thomas D.] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Ctr Clin Pharmaceut Sci, Pittsburgh, PA USA; [Bay, Hulya] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Rosario, Bedda L.; Wisniewski, Stephen R.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Bell, Michael J.] Childrens Natl Hlth Syst, Dept Pediat, Washington, DC USA		Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA.; Clark, RSB (corresponding author), UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA.; Clark, RSB (corresponding author), Univ Pittsburgh, Clin & Translat Sci Inst, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Empey, Philip/L-9604-2019; Nolin, Thomas/AAB-7311-2020	Empey, Philip/0000-0001-7474-2339; Nolin, Thomas/0000-0003-4339-1382	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS069247]; NCATSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000146, U01NS081041]; Children's Hospital of Pittsburgh of UPMC Scientific Program and Brain Care Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER	This work was supported by NIH grants R01NS069247 (RSBC, PEE, MJB, PMK), NCATS KL2TR000146 (PEE), and U01NS081041 (MJB, SRW, PMK); and the Children's Hospital of Pittsburgh of UPMC Scientific Program and Brain Care Institute. The funding sources had no role in study design, data collection, data analysis, data interpretation, or writing of there port.	Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berk M, 2014, J CLIN PSYCHIAT, V75, P628, DOI 10.4088/JCP.13m08454; BORGSTROM L, 1986, EUR J CLIN PHARMACOL, V31, P217, DOI 10.1007/BF00606662; BURNELL JM, 1951, J CLIN INVEST, V30, P697, DOI 10.1172/JCI102482; Du LN, 2016, J NEUROTRAUM, V33, P1913, DOI 10.1089/neu.2015.4342; Exo J, 2011, PEDIATR CRIT CARE ME, V12, P560, DOI 10.1097/PCC.0b013e3181e8b3ee; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Giustarini D, 2012, BIOCHEM PHARMACOL, V84, P1522, DOI 10.1016/j.bcp.2012.09.010; Hagos FT, 2016, XENOBIOTICA, P1; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Katz M, 2015, PARKINSONISM RELAT D, V21, P500, DOI 10.1016/j.parkreldis.2015.02.020; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Levin SW, 2014, LANCET NEUROL, V13, P777, DOI 10.1016/S1474-4422(14)70142-5; Maeda K, 2014, EUR J PHARM SCI, V59, P94, DOI 10.1016/j.ejps.2014.04.004; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Nikoo M, 2015, CLIN NEUROPHARMACOL, V38, P11, DOI 10.1097/WNF.0000000000000063; NOZAKI K, 1992, J CEREBR BLOOD F MET, V12, P400, DOI 10.1038/jcbfm.1992.57; OLSSON B, 1988, EUR J CLIN PHARMACOL, V34, P77, DOI 10.1007/BF01061422; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; SELEN A, 1982, J PHARM SCI, V71, P1238, DOI 10.1002/jps.2600711114; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Wiest DB, 2014, J PEDIATR-US, V165, P672, DOI 10.1016/j.jpeds.2014.06.044; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	28	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2017	12	7							e0180280	10.1371/journal.pone.0180280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5DZ	WOS:000405464100047	28686657	gold, Green Published, Green Submitted			2022-02-06	
J	Kawwass, JF; Sanders, KM; Loucks, TL; Rohan, LC; Berga, SL				Kawwass, Jennifer F.; Sanders, Kristen M.; Loucks, Tammy L.; Rohan, Lisa Cencia; Berga, Sarah L.			Increased cerebrospinal fluid levels of GABA, testosterone and estradiol in women with polycystic ovary syndrome	HUMAN REPRODUCTION			English	Article						polycystic ovary syndrome; GABA; estradiol; testosterone; CSF	HORMONE PULSE-GENERATOR; FUNCTIONAL HYPOTHALAMIC AMENORRHEA; FOLLICLE-STIMULATING-HORMONE; ALPHA-SUBUNIT SECRETION; TRAUMATIC BRAIN-INJURY; LUTEINIZING-HORMONE; GONADOTROPIN-SECRETION; HYPERANDROGENIC ANOVULATION; GENE-EXPRESSION; NEURONS	Do cerebrospinal fluid (CSF) concentrations of gamma-aminobutyric acid (GABA), testosterone (T) and estradiol (E2) differ in women with polycystic ovary syndrome (PCOS) as compared to eumenorrheic, ovulatory women (EW)? Women with PCOS displayed higher CSF levels of GABA and E2, and possibly T, than EW. The chronic anovulation characteristic of PCOS has been attributed to increased central GnRH drive and resulting gonadotropin aberrations. Androgens are thought to regulate GABA, which in turn regulates the neural cascade that modulates GnRH drive. This cross-sectional observational study included 15 EW and 12 non-obese women with PCOS who consented to a lumbar puncture in addition to 24 h of serum blood collection at 15-min intervals. In total, 27 women were studied at a the General Clinical Research Center (GCRC) at the University of Pittsburgh. Serum analytes included T, E2 and androstenedione. CSF analytes included GABA, glutamate, glucose, T and E2. Women with PCOS had higher CSF GABA as compared to EW (9.04 versus 7.04 mu mol/L, P < 0.05). CSF glucose and glutamate concentrations were similar between the two groups. CSF T was 52% higher (P = 0.1) and CSF E2 was 30% higher (P < 0.01) in women with PCOS compared to EW. Circulating T was 122% higher (P < 0.01) and circulating E2 was 75% higher (P < 0.01) in women with PCOS than in EW. The study is limited by its small sample size and the technical limitations of measuring CSF analytes that are pulsatile and have short half-lives. Women with PCOS displayed significantly higher circulating levels of T and E2, significantly higher CSF levels of E2, and higher levels of CSF testosterone, although the latter was not statistically significant. A better understanding of the central milieu informs our understanding of the mechanisms mediating increased the GnRH drive in PCOS and lends a new perspective for understanding the presentation, pathogenesis and potential health consequences of PCOS, including gender identity issues.	[Kawwass, Jennifer F.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Endocrinol & Infertil, Atlanta, GA USA; [Sanders, Kristen M.] Temple Univ, Lewis Katz Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA; [Loucks, Tammy L.] Emory Univ, Dept Gynecol & Obstet, Div Res, Atlanta, GA 30322 USA; [Rohan, Lisa Cencia] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Rohan, Lisa Cencia] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Berga, Sarah L.] Wake Forest Sch Med, Sect Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Med Ctr Blvd, Winston Salem, NC 27157 USA		Berga, SL (corresponding author), Wake Forest Sch Med, Sect Reprod Endocrinol & Infertil, Dept Obstet & Gynecol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	sberga@wakehealth.edu	Loucks, Tammy/N-8223-2019	Loucks, Tammy/0000-0001-7651-7602; Sanders, Kristen/0000-0002-9326-427X; Kawwass, Jennifer/0000-0001-7345-735X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-MH50748, RR-00056]; NICHD/NIH as part of the Specialized Cooperative Centers Program in Reproduction Research [U54 HD08610]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD008610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH045074] Funding Source: NIH RePORTER	This work was supported in part by grants to SLB from NIH R01-MH50748, from NICHD/NIH as part of the Specialized Cooperative Centers Program in Reproduction Research through cooperative agreement U54 HD08610 (Project I-PI SLB, Program Director Tony Plant), and by grant NIH RR-00056 to the General Clinical Research Center of the University of Pittsburgh.	ARCHER DF, 1988, FERTIL STERIL, V50, P555; Berga SL, 2009, J CLIN ENDOCR METAB, V94, P2250, DOI 10.1210/jc.2009-0959; BERGA SL, 1993, J CLIN ENDOCR METAB, V77, P895, DOI 10.1210/jc.77.4.895; Berga SL, 1997, FERTIL STERIL, V67, P1024, DOI 10.1016/S0015-0282(97)81434-3; Berga SL, 2000, AM J OBSTET GYNECOL, V182, P776, DOI 10.1016/S0002-9378(00)70326-7; Cesta CE, 2016, PSYCHONEUROENDOCRINO, V73, P196, DOI 10.1016/j.psyneuen.2016.08.005; Chan YM, 2013, ADV EXP MED BIOL, V784, P89, DOI 10.1007/978-1-4614-6199-9_5; Chapman IM, 1997, CLIN ENDOCRINOL, V46, P175, DOI 10.1046/j.1365-2265.1997.1200936.x; Chiapponi C, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00061; Daniels TL, 1997, J CLIN ENDOCR METAB, V82, P4179, DOI 10.1210/jc.82.12.4179; De Bond JAP, 2014, REPRODUCTION, V147, pR53, DOI 10.1530/REP-13-0509; DeFazio RA, 2002, MOL ENDOCRINOL, V16, P2872, DOI 10.1210/me.2002-0163; Deligiannidis KM, 2016, PSYCHONEUROENDOCRINO, V70, P98, DOI 10.1016/j.psyneuen.2016.05.010; Eagleson CA, 2000, J CLIN ENDOCR METAB, V85, P4047, DOI 10.1210/jc.85.11.4047; Franks S, 2012, FERTIL STERIL, V97, P2, DOI 10.1016/j.fertnstert.2011.11.029; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Huang W, 2008, ENDOCRINOLOGY, V149, P2423, DOI 10.1210/en.2007-0830; Kalro BN, 2001, OBSTET GYN CLIN N AM, V28, P35, DOI 10.1016/S0889-8545(05)70184-4; KAZER RR, 1987, J CLIN ENDOCR METAB, V65, P233, DOI 10.1210/jcem-65-2-233; Kerr ME, 2003, CRIT CARE MED, V31, P2371, DOI 10.1097/01.CCM.0000080484.72004.C4; Kowalczyk R, 2012, ACTA OBSTET GYN SCAN, V91, P710, DOI 10.1111/j.1600-0412.2012.01408.x; LEONHARDT S, 1995, NEUROENDOCRINOLOGY, V61, P655, DOI 10.1159/000126892; Loscher W, 1999, PROG NEUROBIOL, V58, P31, DOI 10.1016/S0301-0082(98)00075-6; Manlove HA, 2008, ANN HUM BIOL, V35, P584, DOI 10.1080/03014460802337067; Marsh CA, 2013, FERTIL STERIL, V100, P200, DOI 10.1016/j.fertnstert.2013.02.054; Martin C, 2014, J NEUROSCI, V34, P6047, DOI 10.1523/JNEUROSCI.3003-13.2014; MATSUMOTO AM, 1984, J CLIN ENDOCR METAB, V58, P609, DOI 10.1210/jcem-58-4-609; McCartney CR, 2016, NEW ENGL J MED, V375, P54, DOI 10.1056/NEJMcp1514916; McCartney CR, 2002, SEMIN REPROD MED, V20, P317, DOI 10.1055/s-2002-36706; Michopoulos V, 2013, NEUROSCIENCE, V250, P300, DOI 10.1016/j.neuroscience.2013.07.002; Moore AM, 2016, J STEROID BIOCHEM, V160, P106, DOI 10.1016/j.jsbmb.2015.10.002; Morales AJ, 1996, J CLIN ENDOCR METAB, V81, P2854, DOI 10.1210/jc.81.8.2854; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Pastor CL, 1998, J CLIN ENDOCR METAB, V83, P582, DOI 10.1210/jc.83.2.582; Perrot-Sinal TS, 2001, ENDOCRINOLOGY, V142, P2238, DOI 10.1210/en.142.6.2238; Pielecka J, 2006, ENDOCRINOLOGY, V147, P1474, DOI 10.1210/en.2005-1029; Pielecka-Fortuna J, 2008, ENDOCRINOLOGY, V149, P1979, DOI 10.1210/en.2007-1365; Pielecka-Fortuna J, 2010, ENDOCRINOLOGY, V151, P291, DOI 10.1210/en.2009-0692; PLANT TM, 1986, ENDOCRINOLOGY, V119, P539, DOI 10.1210/endo-119-2-539; Ratnasabapathy R, 2013, CURR DRUG TARGETS, V14, P365; Rees DA, 2016, J CLIN ENDOCR METAB, V101, P313, DOI 10.1210/jc.2015-2318; Rickenlund A, 2003, FERTIL STERIL, V79, P947, DOI 10.1016/S0015-0282(02)04850-1; Smith JT, 2013, ADV EXP MED BIOL, V784, P275, DOI 10.1007/978-1-4614-6199-9_13; SPRATT DI, 1986, J CLIN ENDOCR METAB, V62, P102, DOI 10.1210/jcem-62-1-102; Sullivan SD, 2005, BIOL REPROD, V72, P33, DOI 10.1095/biolreprod.104.033126; Sullivan SD, 2004, P NATL ACAD SCI USA, V101, P7129, DOI 10.1073/pnas.0308058101; Taylor AE, 1997, J CLIN ENDOCR METAB, V82, P2248, DOI 10.1210/jc.82.7.2248; Terasawa E, 1998, GEN COMP ENDOCR, V112, P283, DOI 10.1006/gcen.1998.7155; Van der Meer M, 1998, J CLIN ENDOCR METAB, V83, P423, DOI 10.1210/jc.83.2.423; VELDHUIS JD, 1986, AM J PHYSIOL, V250, pE486, DOI 10.1152/ajpendo.1986.250.4.E486; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; WALDSTREICHER J, 1988, J CLIN ENDOCR METAB, V66, P165, DOI 10.1210/jcem-66-1-165; Yan XN, 2014, J ENDOCRINOL, V222, P73, DOI 10.1530/JOE-14-0021; YEN SSC, 1970, J CLIN ENDOCR METAB, V30, P435, DOI 10.1210/jcem-30-4-435; Zawadzki JK, 1992, POLYCYSTIC OVARY SYN; Zhang C, 2007, J NEUROSCI, V27, P10153, DOI 10.1523/JNEUROSCI.1657-07.2007	56	27	27	2	13	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0268-1161	1460-2350		HUM REPROD	Hum. Reprod.	JUL	2017	32	7					1450	1456		10.1093/humrep/dex086			7	Obstetrics & Gynecology; Reproductive Biology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Reproductive Biology	EZ7GC	WOS:000404889000012	28453773	Green Published, Bronze			2022-02-06	
J	Kelly, M; McDonald, S; Frith, MHJ				Kelly, Michelle; McDonald, Skye; Frith, Matthew H. J.			A Survey of Clinicians Working in Brain Injury Rehabilitation: Are Social Cognition Impairments on the Radar?	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; assessment practices; clinician; social cognition; social function; staff; survey; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; BLUNT HEAD-INJURY; EMOTION RECOGNITION; PERCEPTION DEFICITS; INDIVIDUALS; AWARENESS; VALIDITY; PROSODY; ABILITY; TASIT	Objectives: To examine the social cognition assessment practices of clinicians working with children and adults with traumatic brain injury. Main Measures: Online survey addressing frequency of social cognition impairments, how these are assessed and obstacles to same, and treatment practices. Participants: A total of 443 clinicians worldwide working in inpatient and outpatient settings. Results: While 84% of clinicians reported that more than half of their clients with severe traumatic brain injury had social cognition impairments, 78% of these reported that they infrequently or never assessed these domains using a formal assessment tool. Lack of reliable tests was most frequently (33% of respondents) cited as the greatest barrier to undertaking social cognition assessment. Conclusions and Implications: Improvements are needed in the development and norming of instruments capable of detecting social cognition impairments in the traumatic brain injury population. Additional training and education is needed in the use of social cognition assessment tools.	[Kelly, Michelle] Univ Newcastle, Sch Psychol, Univ Dr, Callaghan, NSW 2308, Australia; [Kelly, Michelle; Frith, Matthew H. J.] Hunter New England Hlth, Paediat Brain Injury Rehabil Team, Newcastle, NSW, Australia; [McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Kelly, Michelle; McDonald, Skye] Moving Ahead Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia; [Frith, Matthew H. J.] Hunter New England Hlth, Children Young People & Families, Newcastle, NSW, Australia		Kelly, M (corresponding author), Univ Newcastle, Sch Psychol, Univ Dr, Callaghan, NSW 2308, Australia.	Michelle.Kelly@newcastle.edu.au	Kelly, Michelle/J-9739-2019	Kelly, Michelle/0000-0003-0375-816X	Lifetime Care and Support Authority	This research was funded by Lifetime Care and Support Authority.	Agresti Alan., 2013, CATEGORICAL DATA ANA, V3rd ed; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 2006, TRAUM BRAIN INJ DIAG; [Anonymous], 2011, AW SOC INF TEST REV; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Bliksted V, 2014, SCHIZOPHR RES, V153, P9, DOI 10.1016/j.schres.2014.01.010; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Bramham J, 2009, J NEUROPSYCHOL, V3, P125, DOI 10.1348/174866408X293994; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Hofmans J, 2009, QUAL QUANT, V43, P703, DOI 10.1007/s11135-007-9154-7; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; Howell D.C., 2007, STAT METHODS PSYCHOL; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Jenkins VA, 2001, QUAL HEALTH CARE, V10, P70, DOI 10.1136/qhc.10.2.70; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Kurtz MM, 2012, SCHIZOPHRENIA BULL, V38, P1092, DOI 10.1093/schbul/sbr036; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; McDonald S., 2009, NEUROPSYCHOL REHABIL, V7, P1; McDonald S, 2014, SOCIAL COMMUNICATION; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Mehrabian A., 2000, MANUAL BALANCED EMOT; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Motor Accidents Authority, 2013, NEUR ASS CHILDR AD T; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Royal College of Physicians and British Society of Rehabilitation Medicine, 2003, REH FOLL ACQ BRAIN I; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P466, DOI 10.1016/j.ijpsycho.2013.06.013; Ryan NP, 2015, HUM BRAIN MAPP, V36, P1677, DOI 10.1002/hbm.22729; Ryan NP, 2015, NEUROPSYCHOLOGIA, V66, P32, DOI 10.1016/j.neuropsychologia.2014.10.040; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Simpson JR, 2014, J AM ACAD PSYCHIATRY, V42, P159; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; Umeasiegbu VI, 2013, AUST J REHABIL COUNS, V19, P155, DOI 10.1017/jrc.2013.18; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Westerhof-Evers HJ, 2014, J CLIN EXP NEUROPSYC, V36, P1031, DOI 10.1080/13803395.2014.966661; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518	68	27	27	2	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					E55	E65		10.1097/HTR.0000000000000269			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200007	28489703	Green Submitted			2022-02-06	
J	Pierce, MC; Kaczor, K; Acker, D; Webb, T; Brenzel, A; Lorenz, DJ; Young, A; Thompson, R				Pierce, Mary Clyde; Kaczor, Kim; Acker, Deborah; Webb, Tina; Brenzel, Allen; Lorenz, Douglas J.; Young, Audrey; Thompson, Richard			History, injury, and psychosocial risk factor commonalities among cases of fatal and near-fatal physical child abuse	CHILD ABUSE & NEGLECT			English	Article						Child maltreatment; Recidivism; Homicide; Sentinel injury; Missed abuse	HEAD TRAUMA; SUBSTANCE-ABUSE; UNITED-STATES; MALTREATMENT; PARENTS; COMMUNITY; VIOLENCE; INFANTS; ATTRIBUTIONS; FAMILIES	Failure to recognize child maltreatment results in chronic exposure to high-risk environments where re-injury or death may occur. We analyzed a series (n = 20) of fatal (n = 10) and near fatal (n = 10) physical child abuse cases from the Commonwealth of Kentucky to identify commonalities and determine whether indicators of maltreatment were present prior to the child's fatal or near-fatal event. We conducted retrospective state record reviews involving children < 4 years of age classified as physical child abuse by the Cabinet for Health and Family Services during a 12 month period. Cases were distributed across 17 counties. IRS approvals were obtained. Three reviewers concurrently abstracted case data from medical, social, and legal documents, and descriptive statistics were analyzed. Median age of subjects was 7.5 months (range 1-32 months); 55% were male. Psychosocial risk factors (PRFs) were present in 100% of cases. Traumatic brain injury (95%) and bruising (90%) were the most common injuries. Of the 14 children with available prior medical records, 9 (64%) had sentinel injuries in the form of prior unexplained bruising; all nine suffered subsequent traumatic brain injury resulting in four deaths. A male was caring for the child at the time of the final event in 70% of cases. Our study identified key commonalities across cases of fatal and near-fatal abuse, highlighting the prevalence of psychosocial risk factors and the significance of prior unexplained bruising as a herald of escalating abuse. Further study is warranted to ascertain the predictive value of our findings in the larger population.	[Pierce, Mary Clyde; Kaczor, Kim] Univ Louisville, Dept Pediat, 571 S Floyd St, Louisville, KY 40202 USA; [Acker, Deborah; Brenzel, Allen] Commonwealth Kentucky, Cabinet Hlth & Family Serv, Dept Community Based Serv, 275 East Main St, Frankfort, KY 40621 USA; [Webb, Tina] Commonwealth Kentucky, Cabinet Hlth & Family Serv, Div Protect & Permanency, 275 East Main St, Frankfort, KY 40621 USA; [Brenzel, Allen] Univ Kentucky, Coll Med, Dept Psychiat, 245 Fountain Court, Lexington, KY 40509 USA; [Lorenz, Douglas J.] Univ Louisville, Sch Publ Hlth & Informat Sci, Dept Bioinforrnat & Biostat, 485 E Gray St, Louisville, KY 40202 USA; [Young, Audrey] Northwestern Univ, Feinberg Sch Med, 225 E Chicago Ave, Chicago, IL 60611 USA; [Thompson, Richard] Juvenile Protect Assoc, Richard H Calico Ctr Innovat Children & Family Se, 1707 N Halsted St, Chicago, IL 60614 USA; [Pierce, Mary Clyde; Kaczor, Kim] Ann & Robert H Lurie Childrens Hosp Chicago, Div Emergency Med, 225 E Chicago Ave,Box 62, Chicago, IL 60611 USA; [Pierce, Mary Clyde] Northwestern Univ, Dept Pediat, Feinberg Sch Med, 225 E Chicago Ave, Chicago, IL 60611 USA; [Webb, Tina] Commonwealth Kentucky, Div Maternal & Child Hlth, Dept Publ Hlth, 275 East Main St, Frankfort, KY 40621 USA; [Brenzel, Allen] Commonwealth Kentucky, Dept Behav Hlth, 275 East Main St, Frankfort, KY 40621 USA		Pierce, MC (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Div Emergency Med, 225 E Chicago Ave,Box 62, Chicago, IL 60611 USA.	MPierce@luriechildrens.org	Pierce, Mary Clyde/AAQ-3509-2021; Kaczor, Kim/ABA-7462-2021	Kaczor, Kim/0000-0001-8519-1464			Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Berlin LJ, 2013, JAMA PEDIATR, V167, P549, DOI 10.1001/jamapediatrics.2013.1212; Bugental DB, 2004, DEV PSYCHOL, V40, P234, DOI 10.1037/0012-1649.40.2.234; Chaffin M, 1996, CHILD ABUSE NEGLECT, V20, P191, DOI 10.1016/S0145-2134(95)00144-1; Children's Bureau, 2016, CHILD AB NEGL FAT 20; Dakil SR, 2011, ARCH PEDIAT ADOL MED, V165, P1006, DOI 10.1001/archpediatrics.2011.129; De Leeuw M, 2013, AM J FOREN MED PATH, V34, P130, DOI 10.1097/PAF.0b013e31828629ca; DiLauro MD, 2004, CHILD WELFARE, V83, P69; Division of Protection and Permanency Department for Community Based Services Cabinet for Health and Family Services, 2014, CHILD AB NEGL ANN RE; EDLESON JL, 1999, VIOLENCE WOMEN, V0005; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Farc MM, 2008, CHILD ABUSE NEGLECT, V32, P177, DOI 10.1016/j.chiabu.2007.06.001; FRYER GE, 1994, CHILD ABUSE NEGLECT, V18, P1063, DOI 10.1016/0145-2134(94)90132-5; Herrenkohl TI, 2008, TRAUMA VIOLENCE ABUS, V9, P84, DOI 10.1177/1524838008314797; Huebner RA, 2010, PROTECT CHILD, V25, P76; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; KELLEHER K, 1994, AM J PUBLIC HEALTH, V84, P1586, DOI 10.2105/AJPH.84.10.1586; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Kolko D. J., 2002, ASSESSING TREATING P, P1; Kotch JB, 1999, CHILD ABUSE NEGLECT, V23, P305, DOI 10.1016/S0145-2134(99)00003-4; Lamers-Winkelman F, 2012, CHILD ABUSE NEGLECT, V36, P166, DOI 10.1016/j.chiabu.2011.07.006; Lau AS, 2006, CHILD ABUSE NEGLECT, V30, P639, DOI 10.1016/j.chiabu.2005.11.009; Lucas DR, 2002, CHILD ABUSE NEGLECT, V26, P167, DOI 10.1016/S0145-2134(01)00315-5; Maguire S, 2005, ARCH DIS CHILD, V90, P182, DOI 10.1136/adc.2003.044065; Pears KC, 2001, CHILD ABUSE NEGLECT, V25, P1439, DOI 10.1016/S0145-2134(01)00286-1; Phillips SD, 2004, AM J ORTHOPSYCHIAT, V74, P174, DOI 10.1037/0002-9432.74.2.174; Phillips SD, 2010, CHILD YOUTH SERV REV, V32, P544, DOI 10.1016/j.childyouth.2009.11.008; Pierce M. C., 2017, DATA BRIEF UNPUB; Pierce MC, 2010, PEDIATRICS, V125, P67, DOI 10.1542/peds.2008-3632; Saade DN, 2002, ACAD EMERG MED, V9, P524; Seng A, 2008, CLIN CHILD FAM PSYCH, V11, P163, DOI 10.1007/s10567-008-0035-y; Serinelli S., 2016, J FORENSIC SCI; Sheets LK, 2013, PEDIATRICS, V131, P701, DOI 10.1542/peds.2012-2780; Sieswerda-Hoogendoorn T, 2013, ACTA PAEDIATR, V102, pE497, DOI 10.1111/apa.12377; Stiffman MN, 2002, PEDIATRICS, V109, P615, DOI 10.1542/peds.109.4.615; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; Thompson R, 2009, CHILD MALTREATMENT, V14, P89, DOI 10.1177/1077559508325317; U. S. Department of Health and Human Services Administration for Children and Families Administration on Children Youth and Families Children's Bureau, 2016, ADM CHILDR FAM ADM C; Walsh C, 2003, CHILD ABUSE NEGLECT, V27, P1409, DOI 10.1016/j.chiabu.2003.07.002; Zolotor AJ, 2008, AM J PREV MED, V35, P364, DOI 10.1016/j.amepre.2008.06.031	40	27	27	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	JUL	2017	69						263	277		10.1016/j.chiabu.2017.04.033			15	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	EY6GO	WOS:000404080700026	28500923				2022-02-06	
J	Raj, R; Kaprio, J; Korja, M; Mikkonen, ED; Jousilahti, P; Siironen, J				Raj, Rahul; Kaprio, Jaakko; Korja, Miikka; Mikkonen, Era D.; Jousilahti, Pekka; Siironen, Jari			Risk of hospitalization with neurodegenerative disease after moderate-to-severe traumatic brain injury in the working- age population: A retrospective cohort study using the Finnish national health registries	PLOS MEDICINE			English	Article							HEAD-INJURY; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; PARKINSON DISEASE; DEMENTIA RISK; EPIDEMIOLOGY	Background Previous epidemiological studies suggest that working-aged persons with a history of moderate-to-severe traumatic brain injury (TBI) may have an increased risk for developing neurodegenerative disease (NDD) while persons with a history of mild TBI do not. In this comprehensive nationwide study in Finland, we assessed the risk of NDD and history of moderate-to-severe TBI in the working-age population. Methods and findings We performed a population-based follow-up study using the Finnish Care Register for Health Care to identify all persons between the ages of 18 and 65 years hospitalized during 1987-2014 due to TBI who did not have a baseline NDD diagnosis. We compared the risk of hospitalization with NDD between persons hospitalized due to moderate-to-severe TBI (intracranial lesions) and persons hospitalized due to mild TBI (no intracranial lesions). Follow-up NDD diagnoses were recorded from 1 year following the TBI to the end of 2014. NDD diagnoses included dementia, Parkinson disease, and amyotrophic lateral sclerosis. We used a Cox proportional hazards model, adjusting for age, sex, education, and socioeconomic group, to assess the association between TBI and NDD. In total, 19,936 and 20,703 persons with a history of moderate-to-severe TBI and mild TBI, respectively, were included. The overall time at risk was 453,079 person-years (median 10 years per person). In total, 3.5% (N = 696) persons in the moderate-to-severe TBI group developed NDD compared to 1.6% (N = 326) in the mild TBI group. After adjusting for covariates, moderate-to-severe TBI was associated with an increased risk for NDD, with a hazard ratio (HR) of 1.8 (95% CI 1.6-2.1) compared to mild TBI. Of the NDD subtypes, only moderate-to-severe TBI was associated with an increased risk for dementia (HR 1.9, 95% CI 1.6-2.2). Yet, this large-scale epidemiological study does not prove that there is a causal relationship between moderate-to-severe TBI and NDD. Further, the Care Register for Health Care includes only hospitalized persons; thus, patients diagnosed with NDD in the outpatient setting may have been missed. Additional limitations include the potential for miscoding and unmeasured confounds. Conclusions In working-aged persons, a history of moderate-to-severe TBI is associated with an increased risk for future dementia but not for Parkinson disease or amyotrophic lateral sclerosis.	[Raj, Rahul; Korja, Miikka; Siironen, Jari] Univ Helsinki, Dept Neurosurg, Helsinki, Finland; [Raj, Rahul; Korja, Miikka; Mikkonen, Era D.; Siironen, Jari] Helsinki Univ Hosp, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Kaprio, Jaakko] Inst Mol Med Finland FIMM, Helsinki, Finland; [Mikkonen, Era D.] Univ Helsinki, Dept Anesthesiol Intens Care Emergency Care & Pai, Helsinki, Finland; [Jousilahti, Pekka] Natl Inst Hlth & Welf, Helsinki, Finland		Raj, R (corresponding author), Univ Helsinki, Dept Neurosurg, Helsinki, Finland.; Raj, R (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	rahul.raj@hus.fi	Kaprio, Jaakko/A-1820-2008; Raj, Rahul/K-7693-2012; Korja, Miikka/E-4292-2016	Kaprio, Jaakko/0000-0002-3716-2455; Raj, Rahul/0000-0003-4243-9591; Korja, Miikka/0000-0002-4463-6954; Mikkonen, Era Daniel/0000-0003-1379-0235	Suomen AkatemiaAcademy of Finland [263278]; Svenska Kulturfonden [17/2921]; Medicinska Understodsforeningen Liv Halsa; Finska Lakaresallskapet; Maud Kuistilan Saatio; Eemil Aaltosen Saatio; Ella & Georg Ehrnroothin Saatio; Suomalais-Norjalainen Laaketieteen Saatio; Suomen Laaketieteen Saatio; Maire Taposen Saatio	JK is supported by the Suomen Akatemia (Grant #263278). RR has received personal research grants from Svenska Kulturfonden (Grant #17/2921), Medicinska Understodsforeningen Liv & Halsa, Finska Lakaresallskapet, Maud Kuistilan Saatio, Eemil Aaltosen Saatio, Ella & Georg Ehrnroothin Saatio, Suomalais-Norjalainen Laaketieteen Saatio, Suomen Laaketieteen Saatio, and Maire Taposen Saatio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Benchimol EI, 2016, Z EVIDENZ FORTBILD Q, V115, P33, DOI [10.1016/j.zefq.2016.07.010, 10.1371/journal.pmed.1001885]; Centers for Disease Control and Prevention and others, 2003, REP C MILD TRAUM BRA REP C MILD TRAUM BRA; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Helakorpi S, ALCOHOL ALCOHOL, V45, P286; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Kenborg L, 2015, NEUROLOGY, V84, P1098, DOI 10.1212/WNL.0000000000001362; Keskimaki I, 1991, INT J HLTH SCI, V2, P15; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Li YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169650; Lu FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004144; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Puljula J, 2016, ANN SURG, V263, P1235, DOI 10.1097/SLA.0000000000001392; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rossor MN, 2010, LANCET NEUROL, V9, P793, DOI 10.1016/S1474-4422(10)70159-9; Rugbjerg Kathrine, 2008, BMJ, V337, pa2494, DOI 10.1136/bmj.a2494; Savva GM, 2010, STROKE, V41, pE41, DOI 10.1161/STROKEAHA.109.559880; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vuoksimaa Eero, 2016, Alzheimers Dement (Amst), V4, P118; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015	41	27	27	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1676			PLOS MED	PLos Med.	JUL	2017	14	7							e1002316	10.1371/journal.pmed.1002316			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC1QA	WOS:000406611200003	28678790	Green Published, Green Submitted, gold			2022-02-06	
J	Silverberg, ND; Iverson, GL; Panenka, W				Silverberg, Noah D.; Iverson, Grant L.; Panenka, William			Cogniphobia in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						avoidance behavior; craniocerebral trauma; headache; neuropsychological tests; post-concussion symptoms	SYMPTOM VALIDITY TEST; RECURRENT HEADACHE; AVOIDANCE-BEHAVIOR; FEAR-AVOIDANCE; NIH TOOLBOX; PAIN; KINESIOPHOBIA; PERFORMANCE; RECOVERY; REST	Cogniphobia refers to avoidance of mental exertion out of a fear of developing or exacerbating a headache. Headaches are very common after mild traumatic brain injury (mTBI) and often become chronic. Cogniphobia is hypothesized to contribute to poor cognitive test performance and persistent disability in some patients with mTBI. Eighty patients with mTBI and posttraumatic headaches were recruited from specialty outpatient clinics. They completed a battery of questionnaires (including a cogniphobia scale) and neuropsychological tests (the National Institutes of Health Toolbox Cognition Battery and the Medical Symptom Validity Test) at 2-3 months post injury, in a cross-sectional design. Participants with more severe headaches reported higher levels of cogniphobia. Cogniphobia was associated with lower performance on memory testing (but not other cognitive tests), independent of headache severity. Participants who avoided mental exertion also tended to avoid physical activity and traumatic stress triggers. The findings provide preliminary support for the role of cogniphobia in persistent cognitive difficulties after mTBI, and suggest that cogniphobia may reflect a broader avoidant coping style.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Dept Psychiat, Vancouver, BC, Canada; [Panenka, William] Univ British Columbia, British Columbia Neuropsychiat Program, Dept Psychiat, Vancouver, BC, Canada; [Silverberg, Noah D.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Silverberg, Noah D.] GF Strong Rehab Ctr, Rehabil Res Program, Vancouver, BC, Canada; [Iverson, Grant L.] Spaudling Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp, Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] A Red Sox Fdn, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp, Boston, MA 02114 USA		Silverberg, ND (corresponding author), Univ British Columbia, Div Phys Med & Rehabil, Rehabil Res Program, GF Strong Rehab Ctr, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Panenka, William/0000-0001-7143-6512; Iverson, Grant/0000-0001-7348-9570	Specific Priorities Research Grant from WorkSafeBC [RS2014-SP03]; Clinician-Scientist Career Development Award from the Vancouver Coastal Health Research Institute	The authors thank research assistants Mary Ellen Johnson and Sabrina Khan as well as the clinical staff at our recruitment sites, including Kelsey Davies, Jennifer Loffree, and Grace Boutilier (GF Strong Rehab Centre); Deanna Yells, Heather MacNeil, and Rod Macdonald (Fraser Health Concussion Clinic); Denise Silva and Lesley Norris (Back in Motion); and Karilyn Lao, Wayne Tang, and Cyrus Huang (LifeMark). This study was funded by a Specific Priorities Research Grant from WorkSafeBC (#RS2014-SP03). N.D.S. receives salary support from a Clinician-Scientist Career Development Award from the Vancouver Coastal Health Research Institute.	Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Brooks BL, 2016, J NEUROTRAUM, V33, P2091, DOI 10.1089/neu.2015.4301; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Covassin T, 2013, BRAIN INJURY, V27, P1589, DOI 10.3109/02699052.2013.823656; Craton N, 2014, CURR SPORT MED REP, V13, P201, DOI 10.1249/JSR.0000000000000072; Gil-Gouveia R, 2015, J NEUROL, V262, P654, DOI 10.1007/s00415-014-7603-5; Green P, 2004, GREENS MED SYMPTOM V; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; HURSEY KG, 1992, HEADACHE, V32, P283, DOI 10.1111/j.1526-4610.1992.hed3206283.x; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Lingsma H. F., J NEUROTRAUMA; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lundberg M, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/494196; Marsden KR, 2015, CURR RES CONCUSSION, V2, P17; Martelli MF, 1999, ARCH CLIN NEUROPSYCH, V14, P804, DOI 10.1016/S0887-6177(99)80356-4; Martin PR, 2014, BEHAV RES THER, V61, P1, DOI 10.1016/j.brat.2014.07.002; Martins IP, 2006, J PAIN, V7, P445, DOI 10.1016/j.jpain.2006.01.449; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Nijs J, 2013, CLIN RHEUMATOL, V32, P1121, DOI 10.1007/s10067-013-2277-4; Norton PJ, 2004, PAIN, V111, P218, DOI 10.1016/j.pain.2004.06.018; Ozen LJ, 2011, J INT NEUROPSYCH SOC, V17, P219, DOI 10.1017/S135561771000144X; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Peres Mario F P, 2007, J Headache Pain, V8, P56, DOI 10.1007/s10194-007-0361-3; Potter S, 2012, NEUROPSYCHOL REHABIL, V22, P1, DOI 10.1080/09602011.2011.630883; Schmidt AJM, 2003, BEHAV RES THER, V41, P1243, DOI 10.1016/S0005-7967(03)00155-4; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Todd D., 1998, COGNIPHOBIA SCALE C, pdomain; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P145, DOI 10.1093/arclin/acp020	45	27	27	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2017	34	13					2141	2146		10.1089/neu.2016.4719			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EZ2HM	WOS:000404530400452	28114873				2022-02-06	
J	Krishnamoorthy, V; Rowhani-Rahbar, A; Gibbons, EF; Rivara, FP; Temkin, NR; Pontius, C; Luk, K; Graves, M; Lozier, D; Chaikittisilpa, N; Kiatchai, T; Vavilala, MS				Krishnamoorthy, Vijay; Rowhani-Rahbar, Ali; Gibbons, Edward F.; Rivara, Frederick P.; Temkin, Nancy R.; Pontius, Crystal; Luk, Kevin; Graves, Morgan; Lozier, Danielle; Chaikittisilpa, Nophanan; Kiatchai, Taniga; Vavilala, Monica S.			Early Systolic Dysfunction Following Traumatic Brain Injury: A Cohort Study	CRITICAL CARE MEDICINE			English	Article						echocardiography; stress cardiomyopathy; trauma; traumatic brain injury	VENTRICULAR DIASTOLIC FUNCTION; OF-ECHOCARDIOGRAPHYS GUIDELINES; AMERICAN-SOCIETY; EXTRACRANIAL COMPLICATIONS; CHAMBER QUANTIFICATION; EUROPEAN-ASSOCIATION; STANDARDS COMMITTEE; CARDIAC DYSFUNCTION; RECOMMENDATIONS; SEVOFLURANE	Objective: Prior studies have suggested that traumatic brain injury may affect cardiac function. Our study aims were to determine the frequency, longitudinal course, and admission risk factors for systolic dysfunction in patients with moderate-severe traumatic brain injury. Design: Prospective cohort study. Setting: Level 1 trauma center. Measurements: Transthoracic echocardiogram within 1 day and over the first week after moderate-severe traumatic brain injury; transthoracic echocardiogram within 1 day after mild traumatic brain injury (comparison group). Measurements and Main Results: Systolic function was assessed by transthoracic echocardiogram, and systolic dysfunction was defined as fractional shortening less than 25%. Multivariable Poisson regression models examined admission risk factors for systolic dysfunction. Systolic function in 32 patients with isolated moderate-severe traumatic brain injury and 32 patients with isolated mild traumatic brain injury (comparison group) was assessed with trans thoracic echocardiogram. Seven (22%) moderate-severe traumatic brain injury and 0 (0%) mild traumatic brain injury patients had systolic dysfunction within the first day after injury (p < 0.01). All patients with early systolic dysfunction recovered in 1 week. Younger age (relative risk, 0.87; 95% CI, 0.79-0.94; for 1 yr increase in age) and lower admission Glasgow Coma Scale score (relative risk, 0.34; 95% CI, 0.20-0.58; for one unit increase in Glasgow Coma Scale) were independently associated with the development of systolic dysfunction among moderate-severe traumatic brain injury patients. Conclusions: Early systolic dysfunction can occur in previously healthy patients with moderate-severe traumatic brain injury, and it is reversible over the first week of hospitalization. Younger age and lower admission Glasgow Coma Scale score are independently associated with the development of systolic dysfunction after moderate-severe traumatic brain injury.	[Krishnamoorthy, Vijay; Luk, Kevin; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Rowhani-Rahbar, Ali; Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay; Rowhani-Rahbar, Ali; Gibbons, Edward F.; Rivara, Frederick P.; Temkin, Nancy R.; Graves, Morgan; Lozier, Danielle; Chaikittisilpa, Nophanan; Kiatchai, Taniga; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Gibbons, Edward F.; Pontius, Crystal] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Neurosurg, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Graves, Morgan] Georgetown Univ, Sch Med, Washington, DC USA		Krishnamoorthy, V (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.; Krishnamoorthy, V (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Krishnamoorthy, V (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.	vkrish@u.washington.edu		Rowhani-Rahbar, Ali/0000-0002-2705-4485	National Institutes of Health National Research Service AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM086270]; Washington State Society of Anesthesiologists Seafair Research Grant; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Washington State Society of Anesthesiologists; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Foundation for Anesthesia Education and Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM086270] Funding Source: NIH RePORTER	Supported, in part, by grants from National Institutes of Health National Research Service Award (T32 GM086270) and Washington State Society of Anesthesiologists Seafair Research Grant.; Dr. Krishnamoorthy's institution received funding from the National Institutes of Health (NIH) and Washington State Society of Anesthesiologists, and he received support for article research from the NIH. Dr. Temkin's institution received funding from multiple grant and applications to different U.S. federal sources, and she received funding from consulting for Data and Safety Monitoring Boards and Statistical Consulting (unrelated to article topic). Mr. Graves received support for article research from the NIH and Foundation for Anesthesia Education and Research. Dr. Vavilala received support for article research from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Ay H, 2006, NEUROLOGY, V66, P1325, DOI 10.1212/01.wnl.0000206077.13705.6d; Banki N, 2006, J NEUROSURG, V105, P15, DOI 10.3171/jns.2006.105.1.15; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bolliger D, 2010, BRIT J ANAESTH, V104, P547, DOI 10.1093/bja/aeq066; Borbely XI, 2015, NEUROCRIT CARE, V23, P66, DOI 10.1007/s12028-014-0101-x; Bratton SL, 2007, J NEUROTRAUMA, V24, pS7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; EBSTEIN RP, 1985, ISRAEL J MED SCI, V21, P302; Filipovic M, 2005, BRIT J ANAESTH, V94, P186, DOI 10.1093/bja/aei028; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Grunsfeld Alexander, 2005, Curr Neurol Neurosci Rep, V5, P488, DOI 10.1007/s11910-005-0039-7; Hirsch LJ, 2004, LANCET, V364, P2157, DOI 10.1016/S0140-6736(04)17605-8; Hravnak M, 2009, STROKE, V40, P3478, DOI 10.1161/STROKEAHA.109.556753; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; KENDALL MJ, 1982, BRIT J CLIN PHARMACO, V14, P821, DOI 10.1111/j.1365-2125.1982.tb02043.x; Krishnamoorthy V, 2013, CASE REP ANESTHESIOL, V2013; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Krishnamoorthy V, 2015, PEDIATR CRIT CARE ME, V16, pE107, DOI 10.1097/PCC.0000000000000397; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Marr A., 2004, CENTRAL NERVOUS SYST; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Meng LZ, 2015, ANESTHESIOLOGY, V123, P1198, DOI 10.1097/ALN.0000000000000872; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; Shah AM, 2012, CIRCULATION, V125, pE244, DOI 10.1161/CIRCULATIONAHA.111.086348; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Strzelczyk A, 2011, EPILEPSIA, V52, P2112, DOI 10.1111/j.1528-1167.2011.03266.x; TEASDALE G, 1974, LANCET, V2, P81; Wang TD, 1997, INT J CARDIOL, V58, P308, DOI 10.1016/S0167-5273(96)02879-3; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38	41	27	27	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUN	2017	45	6					1028	1036		10.1097/CCM.0000000000002404			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV3WO	WOS:000401690000014	28398926	Green Accepted			2022-02-06	
J	Lu, WN; Albalawi, F; Beckel, JM; Lim, JC; Laties, AM; Mitchell, CH				Lu, Wennan; Albalawi, Farraj; Beckel, Jonathan M.; Lim, Jason C.; Laties, Alan M.; Mitchell, Claire H.			The P2X7 receptor links mechanical strain to cytokine IL-6 up-regulation and release in neurons and astrocytes	JOURNAL OF NEUROCHEMISTRY			English	Article						astrocytes; cytokines; IOP; mechanical strain; P2X7; retina	OPTIC-NERVE HEAD; RETINAL GANGLION-CELLS; TRAUMATIC BRAIN-INJURY; MEDIATED ATP RELEASE; INTRAOCULAR-PRESSURE; EXTRACELLULAR ATP; P2X(7) RECEPTOR; INTERLEUKIN-6 RELEASE; SUSTAINED ELEVATION; ANTERIOR-CHAMBER	Mechanical strain in neural tissues can lead to the up-regulation and release of multiple cytokines including interleukin 6 (IL-6). In the retina, the mechanosensitive release of ATP can autostimulate P2X7 receptors on both retinal ganglion cell neurons and optic nerve head astrocytes. Here, we asked whether the purinergic signaling contributed to the IL-6 response to increased intraocular pressure (IOP) invivo, and stretch or swelling invitro. Rat and mouse eyes were exposed to non-ischemic elevations in IOP to 50-60mmHg for 4h. A PCR array was used to screen cytokine changes, with quantitative (q)PCR used to confirm mRNA elevations and immunoblots used for protein levels. P2X7 antagonist Brilliant Blue G (BBG) and agonist (4-benzoyl-benzoyl)-ATP (BzATP) were injected intravitreally. ELISA was used to quantify IL-6 release from optic nerve head astrocytes or retinal ganglion cells. Receptor identity was confirmed pharmacologically and in P2X7(-/-) mice, acute elevation of IOP altered retinal expression of multiple cytokine genes. Elevation of IL-6 was greatest, with expression of IL1rn, IL24, Tnf, Csf1, and Lif also increased more than twofold, while expression of Tnfsf11, Gdf9, and Tnfsf4 were reduced. qPCR confirmed the rise in IL-6 and extracellular ATP marker ENTPD1, but not pro-apoptotic genes. Intravitreal injection of P2X7 receptor antagonist BBG prevented the pressure-dependent rise in IL-6 mRNA and protein in the rat retina, while injection of P2X7 receptor agonist BzATP was sufficient to elevate IL-6 expression. IOP elevation increased IL-6 in wild-type but not P2X7R knockout mice. Application of mechanical strain to isolated optic nerve head astrocytes increased IL-6 levels. This response was mimicked by agonist BzATP, but blocked by antagonists BBG and A839977. Stretch or BzATP led to IL-6 release from both astrocytes and isolated retinal ganglion cells. The mechanosensitive up-regulation and release of cytokine IL-6 from the retina involves the P2X7 receptor, with both astrocytes and neurons contributing to the response.	[Lu, Wennan; Albalawi, Farraj; Beckel, Jonathan M.; Lim, Jason C.; Mitchell, Claire H.] Univ Penn, Dept Anat & Cell Biol, 240 S 40th St, Philadelphia, PA 19104 USA; [Albalawi, Farraj] Univ Penn, Dept Orthodont, Philadelphia, PA 19104 USA; [Beckel, Jonathan M.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Laties, Alan M.; Mitchell, Claire H.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Mitchell, Claire H.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA		Mitchell, CH (corresponding author), Univ Penn, Dept Anat & Cell Biol, 240 S 40th St, Philadelphia, PA 19104 USA.	chm@upenn.edu	Beckel, Jonathan M./A-6758-2008	Beckel, Jonathan M./0000-0003-1390-2292	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY015537, EY013434, EY001583, DK106115]; Jody Sack Fund; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY015537, R01EY013434, P30EY001583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [K01DK106115] Funding Source: NIH RePORTER	The authors thank Jonathan Huwe for help with qPCR experiments. The authors declare that they have no competing interests. This work is supported by grants from the NIH EY015537 and EY013434 and core grant EY001583 (CHM). NIH DK106115 (JMB), Jody Sack Fund (WL). These funding bodies had no direct role in the design of the study and collection, analysis, and interpretation of data or and in writing the manuscript. The authors have no conflict of interest to declare.	Abbott CJ, 2014, INVEST OPHTH VIS SCI, V55, P674, DOI 10.1167/iovs.13-12811; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Bustamante M, 2014, AM J PHYSIOL-ENDOC M, V306, pE869, DOI 10.1152/ajpendo.00450.2013; Cabrera CL, 1999, ACTA OPHTHALMOL SCAN, V77, P33, DOI 10.1034/j.1600-0420.1999.770108.x; CADMAN ED, 1994, NEUROSCI LETT, V178, P251, DOI 10.1016/0304-3940(94)90771-4; Cepurna W. O., 2008, INVEST OPHTH VIS SCI, V49, P3695; Chen KH, 1999, INVEST OPHTH VIS SCI, V40, P2627; Chidlow G, 2012, NEUROBIOL DIS, V48, P568, DOI 10.1016/j.nbd.2012.07.026; Chrysostomou V, 2013, INVEST OPHTH VIS SCI, V54, P4691, DOI 10.1167/iovs.13-12415; Codeluppi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092649; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Crowston JG, 2015, EXP EYE RES, V141, P3, DOI 10.1016/j.exer.2015.03.006; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Downs JC, 2015, EXP EYE RES, V133, P19, DOI 10.1016/j.exer.2015.02.011; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Franceschini A, 2015, FASEB J, V29, P2450, DOI 10.1096/fj.14-268714; Franke H, 2007, PURINERG SIGNAL, V3, P435, DOI 10.1007/s11302-007-9082-y; Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414; Guha S, 2013, FASEB J, V27, P4500, DOI 10.1096/fj.13-236166; Guo Y, 2011, INVEST OPHTH VIS SCI, V52, P1460, DOI 10.1167/iovs.10-5930; Hanley PJ, 2004, P NATL ACAD SCI USA, V101, P9479, DOI 10.1073/pnas.0400733101; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Honore P, 2009, BEHAV BRAIN RES, V204, P77, DOI 10.1016/j.bbr.2009.05.018; Hu HL, 2010, EXP EYE RES, V91, P425, DOI 10.1016/j.exer.2010.06.017; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Inoue K, 2007, J INVEST DERMATOL, V127, P362, DOI 10.1038/sj.jid.5700526; Jo AO, 2015, J NEUROSCI, V35, P13525, DOI 10.1523/JNEUROSCI.1987-15.2015; Johnson EC, 2011, INVEST OPHTH VIS SCI, V52, P504, DOI 10.1167/iovs.10-5317; Kawano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127919; Kezic JM, 2013, INVEST OPHTH VIS SCI, V54, P3028, DOI 10.1167/iovs.13-11865; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Li A, 2011, EXP EYE RES, V93, P528, DOI 10.1016/j.exer.2011.06.020; Lim J. C., 2011, INVEST OPHTH VIS SCI, V52, P5458; Lim JC, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00270; Lu W., 2011, INVEST OPHTH VIS SCI, V52, P5345; Lu W, 2007, J PHARMACOL EXP THER, V323, P157, DOI 10.1124/jpet.107.124545; Lu W, 2013, INVEST OPHTH VIS SCI, V54; Lu WN, 2015, INVEST OPHTH VIS SCI, V56, P3075, DOI 10.1167/iovs.14-15891; Mandal A, 2009, AM J PHYSIOL-CELL PH, V297, pC111, DOI 10.1152/ajpcell.00539.2008; Morrison JC, 2010, INVEST OPHTH VIS SCI, V51; Morrison JC, 2014, INVEST OPHTH VIS SCI, V55; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Reigada D, 2008, NEUROSCIENCE, V157, P396, DOI 10.1016/j.neuroscience.2008.08.036; Sanderson J, 2014, EXP EYE RES, V127, P270, DOI 10.1016/j.exer.2014.08.009; Sappington RM, 2006, INVEST OPHTH VIS SCI, V47, P2932, DOI 10.1167/iovs.05-1407; Satrawaha S, 2011, ARCH ORAL BIOL, V56, P1230, DOI 10.1016/j.archoralbio.2011.05.003; Shahidullah M, 2012, AM J PHYSIOL-CELL PH, V302, pC1751, DOI 10.1152/ajpcell.00010.2012; Shieh CH, 2014, GLIA, V62, P592, DOI 10.1002/glia.22628; Shigemoto-Mogami Y, 2001, J NEUROCHEM, V78, P1339, DOI 10.1046/j.1471-4159.2001.00514.x; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Totan Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03956; Wildman SS, 2003, BRIT J PHARMACOL, V140, P1177, DOI 10.1038/sj.bjp.0705544; Wilson GN, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0399-0; WINSTON FK, 1989, J APPL PHYSIOL, V67, P397, DOI 10.1152/jappl.1989.67.1.397; Xia JS, 2012, J PHYSIOL-LONDON, V590, P2285, DOI 10.1113/jphysiol.2012.227983; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Zenkel M, 2010, AM J PATHOL, V176, P2868, DOI 10.2353/ajpath.2010.090914; Zhang M, 2010, NEUROCHEM INT, V56, P35, DOI 10.1016/j.neuint.2009.08.011; Zhang X, 2007, EXP EYE RES, V85, P637, DOI 10.1016/j.exer.2007.07.016; Zhang XL, 2006, J NEUROCHEM, V98, P566, DOI 10.1111/j.1471-4159.2006.03900.x; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220	68	27	27	2	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAY	2017	141	3					436	448		10.1111/jnc.13998			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	ES6JV	WOS:000399654500011	28244110	Green Accepted, Bronze			2022-02-06	
J	Velosky, AG; Tucker, LB; Fu, AH; Liu, J; McCabe, JT				Velosky, Alexander G.; Tucker, Laura B.; Fu, Amanda H.; Liu, Jiong; McCabe, Joseph T.			Cognitive performance of male and female C57BL/6J mice after repetitive concussive brain injuries	BEHAVIOURAL BRAIN RESEARCH			English	Article						Sex differences; Traumatic brain injury; Learning and memory; Cognition; Behavior	CHRONIC TRAUMATIC ENCEPHALOPATHY; MOUSE MODEL; SEX-DIFFERENCES; HEAD-INJURY; NEUROBEHAVIORAL CHANGES; STEROID-HORMONES; CORPUS-CALLOSUM; WHITE-MATTER; HIGH-SCHOOL; GENDER	In contact sports, repetitive concussive brain injury (rCBI) is the prevalent form of head injury seen in athletes. The need for effective treatment is urgent as rCBI has been associated with a host of cognitive, behavioral and neurological complaints. There has been a growing trend in the use of female animals in pre-clinical research, but few studies have investigated possible sex differences following rCBI. The goal of the current study was to determine any differences between male and female C57BL/6J mice on assessments of learning and memory after repetitive concussive injury. Following rCBI by impact to the scalp, male mice exhibited longer righting reflexes during acute recovery. In both sexes, there were no evident histopathological changes observed in the underlying cerebral cortex or hippocampus. Reactive astrogliosis was elevated in the corpus callosum and optic tract, and astrogliosis was slightly less in the optic tract of female mice. rCBI mice exhibited impairment during the learning phase of the Morris water maze (MWM), but female mice, in comparison to male mice, were observed to have superior spatial memory during standard MWM probe trials. Female mice were overall more active, evidenced by greater distances traveled in the y-maze and greater swim speeds in the MWM. The results of this study demonstrate sex differences in cognitive performance following rCBI and support previous research suggesting the neuroprotective role of sex in brain injury. Published by Elsevier B.V.	[Velosky, Alexander G.; Tucker, Laura B.; Fu, Amanda H.; Liu, Jiong; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, FE Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Tucker, Laura B.; Fu, Amanda H.; McCabe, Joseph T.] Ctr Neurosci & Regenerat Med, Preclin Studies Core, Bethesda, MD USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, FE Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Joseph.McCabe@usuhs.edu	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Tucker, Laura/0000-0002-5984-6399	The Center for Neuroscience and Regenerative Medicine [60855-300600-7.01]	This work was supported by The Center for Neuroscience and Regenerative Medicine, 60855-300600-7.01.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Alstott J, 2009, BEHAV BRAIN RES, V196, P214, DOI 10.1016/j.bbr.2008.09.001; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Briggs DI, 2016, AM J PATHOL, V186, P2869, DOI 10.1016/j.ajpath.2016.07.013; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Chakrabarti M, 2016, REV NEUROSCIENCE, V27, P271, DOI 10.1515/revneuro-2015-0032; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Demarest TG, 2015, J BIOENERG BIOMEMBR, V47, P173, DOI 10.1007/s10863-014-9583-7; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Jones NC, 2005, EUR J NEUROSCI, V21, P1547, DOI 10.1111/j.1460-9568.2005.03995.x; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McCullough LD, 2014, BIOL SEX DIFFER, V5, DOI 10.1186/s13293-014-0015-5; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Morgan MA, 2002, BEHAV BRAIN RES, V132, P85, DOI 10.1016/S0166-4328(01)00398-9; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ngun TC, 2011, FRONT NEUROENDOCRIN, V32, P227, DOI 10.1016/j.yfrne.2010.10.001; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; O'Leary TP, 2013, BEHAV GENET, V43, P34, DOI 10.1007/s10519-012-9572-8; Ogawa S, 2003, ENDOCRINOLOGY, V144, P230, DOI 10.1210/en.2002-220519; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Ratnu VS, 2017, J NEUROSCI RES, V95, P301, DOI 10.1002/jnr.23886; Reyes-Haro D, 2013, BIOL RES, V46, P27, DOI 10.4067/S0716-97602013000100004; Safinia Cyrus, 2016, J Vasc Interv Neurol, V9, P34; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Soltani Z, 2016, J PHYSIOL BIOCHEM, V72, P33, DOI 10.1007/s13105-015-0453-5; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/NMETH.2935, 10.1038/nmeth.2935]; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Van Swearingen AED, 2013, PSYCHOPHARMACOLOGY, V225, P707, DOI 10.1007/s00213-012-2860-4; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Zhou J, 2013, P NATL ACAD SCI USA, V110, pE2714, DOI 10.1073/pnas.1310233110	56	27	27	0	29	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAY 1	2017	324						115	124		10.1016/j.bbr.2017.02.017			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EP9JY	WOS:000397691100015	28214540	hybrid, Green Published			2022-02-06	
J	Chio, CC; Lin, HJ; Tian, YF; Chen, YC; Lin, MT; Lin, CH; Chang, CP; Hsu, CC				Chio, Chung-Ching; Lin, Hung-Jung; Tian, Yu-Feng; Chen, Yu-Chieh; Lin, Mao-Tsun; Lin, Cheng-Hsien; Chang, Ching-Ping; Hsu, Chien-Chin			Exercise attenuates neurological deficits by stimulating a critical HSP70/NF-kappa B/IL-6/synapsin I axis in traumatic brain injury rats	JOURNAL OF NEUROINFLAMMATION			English	Article						Brain injury; Neuroprotection; Neuroinflammation; Exercise; IL-6; HSP70; Synapsin I	SPINAL-CORD-INJURY; FACTOR-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; HEAT-SHOCK-PROTEIN; CEREBRAL-ISCHEMIA; INFLAMMATORY CYTOKINES; MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTOR; NEUROTROPHIC FACTOR; STEM-CELLS	Background: Despite previous evidence for a potent inflammatory response after a traumatic brain injury (TBI), it is unknown whether exercise preconditioning (EP) improves outcomes after a TBI by modulating inflammatory responses. Methods: We performed quantitative real-time PCR (qPCR) to quantify the genes encoding 84 cytokines and chemokines in the peripheral blood and used ELISA to determine both the cerebral and blood levels of interleukin-6 (IL-6). We also performed the chromatin immunoprecipitation (ChIP) assay to evaluate the extent of nuclear factor kappa-B (NF-kappa B) binding to the DNA elements in the IL-6 promoter regions. Also, we adopted the Western blotting assay to measure the cerebral levels of heat shock protein (HSP) 70, synapsin I, and beta-actin. Finally, we performed both histoimmunological and behavioral assessment to measure brain injury and neurological deficits, respectively. Results: We first demonstrated that TBI upregulated nine pro-inflammatory and/or neurodegenerative messenger RNAs (mRNAs) in the peripheral blood such as CXCL10, IL-18, IL-16, Cd-70, Mif, Ppbp, Ltd, Tnfrsf 11b, and Faslg. In addition to causing neurological injuries, TBI also upregulated the following 14 anti-inflammatory and/or neuroregenerative mRNAs in the peripheral blood such as Ccl19, Ccl3, Cxcl19, IL-10, IL-22, IL-6, Bmp6, Ccl22, IL-7, Bmp7, Ccl2, Ccl17, IL-1rn, and Gpi. Second, we observed that EP inhibited both neurological injuries and six proinflammatory and/or neurodegenerative genes (Cxcl10, IL-18, IL-16, Cd70, Mif, and Faslg) but potentiated four antiinflammatory and/or neuroregenerative genes (Bmp6, IL-10, IL-22, and IL-6). Prior depletion of cerebral HSP70 with gene silence significantly reversed the beneficial effects of EP in reducing neurological injuries and altered gene profiles after a TBI. A positive Pearson correlation exists between IL-6 and HSP70 in the peripheral blood or in the cerebral levels. In addition, gene silence of cerebral HSP70 significantly reduced the overexpression of NF-kappa B, IL-6, and synapsin I in the ipsilateral brain regions after an EP in rats. Conclusions: TBI causes neurological deficits associated with stimulating several pro-inflammatory gene profiles but inhibiting several anti-inflammatory gene profiles of cytokines and chemokines. Exercise protects against neurological injuries via stimulating an anti-inflammatory HSP70/NF-kappa B/IL-6/synapsin I axis in the injured brains.	[Chio, Chung-Ching] Chi Mei Med Ctr, Dept Surg, Tainan 710, Taiwan; [Chio, Chung-Ching; Hsu, Chien-Chin] Chi Mei Med Ctr, Dept Emergency Med, Tainan 710, Taiwan; [Lin, Hung-Jung; Chen, Yu-Chieh; Chang, Ching-Ping; Hsu, Chien-Chin] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan 710, Taiwan; [Tian, Yu-Feng] Chi Mei Med Ctr, Dept Surg, Div Gen Surg, Tainan 710, Taiwan; [Tian, Yu-Feng] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan 717, Taiwan; [Lin, Mao-Tsun; Chang, Ching-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan; [Lin, Cheng-Hsien] Meridigen Biotech Co Ltd, Taipei 11493, Taiwan; [Chang, Ching-Ping] Taipei Med Univ, PhD Program Neural Regenerat Med, Taipei 110, Taiwan		Hsu, CC (corresponding author), Chi Mei Med Ctr, Dept Emergency Med, Tainan 710, Taiwan.; Chang, CP; Hsu, CC (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan 710, Taiwan.; Chang, CP (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan.; Chang, CP (corresponding author), Taipei Med Univ, PhD Program Neural Regenerat Med, Taipei 110, Taiwan.	jessica@stust.edu.tw; nych2525@gmail.com		Chang, Ching-Ping/0000-0003-0890-9414	Ministry of Science and Technology (Taiwan)Ministry of Science and Technology, Taiwan [NSC 102-2628-B-384-001-MY3, MOST 104-2314-B-384-003-MY3, MOST 104-2314-B-218-001-MY3]; Chi Mei Medical Center (Taiwan) [CMFHT 10504]	This work was supported by Ministry of Science and Technology (Taiwan) grants NSC 102-2628-B-384-001-MY3 (to CCC), MOST 104-2314-B-384-003-MY3 (to CCC), MOST 104-2314-B-218-001-MY3 (to CPC) and Chi Mei Medical Center (Taiwan) grants CMFHT 10504 (to CPC).	Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; AREND WP, 1991, J CLIN INVEST, V88, P1445, DOI 10.1172/JCI115453; Bielecki B, 2015, ARCH IMMUNOL THER EX, V63, P367, DOI 10.1007/s00005-015-0339-9; Bis JC, 2008, ATHEROSCLEROSIS, V198, P166, DOI 10.1016/j.atherosclerosis.2007.09.031; Bowen KK, 2011, NEUROREPORT, V22, P126, DOI 10.1097/WNR.0b013e3283430a44; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang CK, 2014, INT J MOL SCI, V15, P19018, DOI 10.3390/ijms151019018; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen YW, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.033829; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Deola S, 2008, J IMMUNOL, V180, P1362, DOI 10.4049/jimmunol.180.3.1362; Ehrlich DE, 2016, GENES BRAIN BEHAV, V15, P125, DOI 10.1111/gbb.12255; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Fairbanks SL, 2010, BEST PRACT RES-CLIN, V24, P521, DOI 10.1016/j.bpa.2010.10.004; Febbraio MA, 2002, FASEB J, V16, P1335, DOI 10.1096/fj.01-0876rev; Fehrenbach E, 2006, SPORTS MED, V36, P373, DOI 10.2165/00007256-200636050-00001; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Fujiki M, 2004, BRAIN RES, V1021, P281, DOI 10.1016/j.brainres.2004.06.054; Ghasemzadeh M, 2013, BLOOD, V121, P4555, DOI 10.1182/blood-2012-09-459636; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; GURNEY ME, 1986, SCIENCE, V234, P566, DOI 10.1126/science.3764429; Hergenroeder GW, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-19; Himi T, 1997, ACTA OTO-LARYNGOL, V117, P123, DOI 10.3109/00016489709118003; Howell JM, 2006, PROTEOMICS, V6, P2050, DOI 10.1002/pmic.200500517; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Kittipatarin C, 2007, CYTOKINE, V39, P75, DOI 10.1016/j.cyto.2007.07.183; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; KUSHIMA Y, 1992, NEUROSCI RES, V13, P267, DOI 10.1016/0168-0102(92)90039-F; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Liebelt B, 2010, NEUROSCIENCE, V166, P1091, DOI 10.1016/j.neuroscience.2009.12.067; Liu YT, 2001, BRAIN RES, V905, P81, DOI 10.1016/S0006-8993(01)02502-1; Manecka DL, 2013, J BIOL CHEM, V288, P14936, DOI 10.1074/jbc.M112.434597; Martire A, 2003, CARDIOVASC RES, V57, P523, DOI 10.1016/S0008-6363(02)00697-1; Mathy NL, 2000, IMMUNOLOGY, V100, P63, DOI 10.1046/j.1365-2567.2000.00997.x; Mazzeo AT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0624-5; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Mortberg E, 2011, ACTA ANAESTH SCAND, V55, P1132, DOI 10.1111/j.1399-6576.2011.02505.x; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Muramatsu R, 2012, NAT MED, V18, P1658, DOI 10.1038/nm.2943; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nakajima H, 2012, J BIOTECHNOL, V157, P326, DOI 10.1016/j.jbiotec.2011.10.003; Neidl R, 2016, J NEUROSCI, V36, P4351, DOI 10.1523/JNEUROSCI.3239-15.2016; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Okamura H, 1998, ADV IMMUNOL, V70, P281, DOI 10.1016/S0065-2776(08)60389-2; Paxinos G., 2013, RAT BRAIN STEREOTAXI; Pedersen BK, 2007, TRENDS PHARMACOL SCI, V28, P152, DOI 10.1016/j.tips.2007.02.002; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Petersen AMW, 2006, J PHYSIOL PHARMACOL, V57, P43; Phillips C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00170; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pittet JF, 2002, J TRAUMA, V52, P611, DOI 10.1097/00005373-200204000-00001; QIAGEN. QIAGEN Redwood City, QIAGENS ING PATHW AN; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shimamura M, 2014, P NATL ACAD SCI USA, V111, P8191, DOI 10.1073/pnas.1400544111; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Wang XK, 2000, MOL PHARMACOL, V57, P1190; Wang Y, 2001, STROKE, V32, P2170, DOI 10.1161/hs0901.095650; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu MH, 2016, MOL NEUROBIOL, V53, P3702, DOI 10.1007/s12035-015-9305-0; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yu XZ, 2012, INT J CANCER, V131, P1491, DOI 10.1002/ijc.27634; Yu Y, 2007, CIRC RES, V101, P304, DOI 10.1161/CIRCRESAHA.107.148940; Zaremba J, 2006, FOLIA NEUROPATHOL, V44, P282; Zhao ZR, 2013, J CEREBR BLOOD F MET, V33, P1897, DOI 10.1038/jcbfm.2013.144; Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x	92	27	31	1	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	APR 24	2017	14								90	10.1186/s12974-017-0867-9			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	EV3EJ	WOS:000401640300002	28438174	Green Published, gold			2022-02-06	
J	Dennis, EL; Rashid, F; Ellis, MU; Babikian, T; Vlasova, RM; Villalon-Reina, JE; Jin, Y; Olsen, A; Mink, R; Babbitt, C; Johnson, J; Giza, CC; Thompson, PM; Asarnow, RF				Dennis, Emily L.; Rashid, Faisal; Ellis, Monica U.; Babikian, Talin; Vlasova, Roza M.; Villalon-Reina, Julio E.; Jin, Yan; Olsen, Alexander; Mink, Richard; Babbitt, Christopher; Johnson, Jeffrey; Giza, Christopher C.; Thompson, Paul M.; Asarnow, Robert F.			Diverging white matter trajectories in children after traumatic brain injury The RAPBI study	NEUROLOGY			English	Article							MODERATE; INFLAMMATION; OUTCOMES; REVEALS; TRACTS; UCLA	Objective: To examine longitudinal trajectories of white matter organization in pediatric moderate/severe traumatic brain injury (msTBI) over a 12-month period. Methods: We studied 21 children (16 M/5 F) with msTBI, assessed 2-5 months postinjury and again 13-19 months postinjury, as well as 20 well-matched healthy control children. We assessed corpus callosum function through interhemispheric transfer time (IHTT), measured using event-related potentials, and related this to diffusion-weighted MRI measures of white matter (WM) microstructure. At the first time point, half of the patients with TBI had significantly slower IHTT (TBI-slow-IHTT, n = 11) and half were in the normal range (TBI-normal-IHTT, n = 10). Results: The TBI-normal-IHTT group did not differ significantly from healthy controls, either inWM organization in the chronic phase or in the longitudinal trajectory of WM organization between the 2 evaluations. In contrast, the WM organization of the TBI-slow-IHTT group was significantly lower than in healthy controls across a large portion of the WM. Longitudinal analyses showed that the TBI-slow-IHTT group experienced a progressive decline between the 2 evaluations in WM organization throughout the brain. Conclusions: We present preliminary evidence suggesting a potential biomarker that identifies a subset of patients with impaired callosal organization in the first months postinjury who subsequently experience widespread continuing and progressive degeneration in the first year postinjury.	[Dennis, Emily L.; Rashid, Faisal; Villalon-Reina, Julio E.; Jin, Yan; Thompson, Paul M.] Univ Southern Calif, Keck Sch Med, Imaging Genet Ctr, Mary & Mark Stevens Inst Neuroimaging & Informat, Los Angeles, CA 90033 USA; [Ellis, Monica U.; Babikian, Talin; Olsen, Alexander; Asarnow, Robert F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Ellis, Monica U.] Fuller Theol Seminary Sch Psychol, Pasadena, CA USA; [Vlasova, Roza M.] Childrens Hosp Los Angeles, Dept Radiol, CIBORG Lab, Los Angeles, CA 90027 USA; [Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway; [Olsen, Alexander] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Mink, Richard] Harbor UCLA Med Ctr, Dept Pediat, Torrance, CA USA; [Mink, Richard] Los Angeles BioMed Res Inst, Dept Pediat, Torrance, CA USA; [Babbitt, Christopher] Miller Childrens Hosp, Long Beach, CA USA; [Johnson, Jeffrey] LAC USC Med Ctr, Dept Pediat, Los Angeles, CA USA; [Giza, Christopher C.] Mattel Childrens Hosp, UCLA Brain Injury Res Ctr, Dept Neurosurg & Div Pediat Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Radiol Engn & Ophthalmol, Los Angeles, CA USA		Dennis, EL (corresponding author), Univ Southern Calif, Keck Sch Med, Imaging Genet Ctr, Mary & Mark Stevens Inst Neuroimaging & Informat, Los Angeles, CA 90033 USA.	emily.dennis@ini.usc.edu	Thompson, Paul M/C-4194-2018; Olsen, Alexander/P-5235-2019; Dennis, Emily/AAD-5223-2021	Thompson, Paul M/0000-0002-4720-8867; Olsen, Alexander/0000-0001-8691-3860; Dennis, Emily/0000-0001-7112-4009	NICHDS [R01 HD061504]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99 NS096116]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD061504, K99 NS096116, U54 EB020403, R01 EB008432, R01 AG040060, R01 NS080655, NS027544, NS05489]; UCLA BIRC [NS027544, NS05489]; UCLA Steve Tisch BrainSPORT Program; Easton Foundation; Staglin IMHRO Center for Cognitive Neuroscience; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015922, U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99NS096116] Funding Source: NIH RePORTER	This study was supported by the NICHDS (R01 HD061504). E.L.D. is supported by a grant from the NINDS (K99 NS096116). E.L.D., F.R., Y.J., J.V., and P.T. are also supported by NIH grants to P.T.: U54 EB020403, R01 EB008432, R01 AG040060, and R01 NS080655. C.C.G. is supported by the UCLA BIRC, NS027544, NS05489, UCLA Steve Tisch BrainSPORT Program, and Easton Foundation. Scanning was supported by the Staglin IMHRO Center for Cognitive Neuroscience. The Recovery After Pediatric Brain Injury Study (RAPBI) was supported by NIH (R01 HD061504, K99 NS096116, U54 EB020403, R01 EB008432, R01 AG040060, R01 NS080655, NS027544, NS05489), the UCLA BIRC, the UCLA Steve Tisch BrainSPORT Program, the Easton Foundation, and the Staglin IMHRO Center for Cognitive Neuroscience.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Daianu M, 2016, BRAIN IMAGING BEHAV, V10, P1038, DOI 10.1007/s11682-015-9458-5; Dennis EL, 2015, P 12 IEEE INT S BIOM; Dennis EL, 2016, J NEUROTRAUM, V33, P840, DOI 10.1089/neu.2015.4012; Dennis EL, 2015, PROC SPIE, V9681, DOI 10.1117/12.2207574; Dennis EL, 2015, I S BIOMED IMAGING, P930, DOI 10.1109/ISBI.2015.7164023; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Ellis MU, 2016, J NEUROTRAUM, V33, P990, DOI 10.1089/neu.2015.4023; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jin Y, 2014, NEUROIMAGE, V100, P75, DOI 10.1016/j.neuroimage.2014.04.048; Jin Y, 2013, I S BIOMED IMAGING, P512, DOI 10.1109/isbi.2013.6556524; Jin Yan, 2012, Multimodal Brain Image Anal (2012), V7509, P147, DOI 10.1007/978-3-642-33530-3_12; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Pasternak O, 2012, J NEUROSCI, V32, P17365, DOI 10.1523/JNEUROSCI.2904-12.2012; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Zhang YJ, 2010, NEUROIMAGE, V52, P1289, DOI 10.1016/j.neuroimage.2010.05.049	33	27	27	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	APR 11	2017	88	15					1392	1399		10.1212/WNL.0000000000003808			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER3CW	WOS:000398674100007	28298549	Green Published			2022-02-06	
J	Song, JW; Li, K; Liang, ZW; Dai, C; Shen, XF; Gong, YZ; Wang, S; Hu, XY; Wang, Z				Song, Ji Wei; Li, Kun; Liang, Zhuo Wen; Dai, Chen; Shen, Xue Feng; Gong, Yu Ze; Wang, Shuang; Hu, Xue Yu; Wang, Zhe			Low-level laser facilitates alternatively activated macrophage/microglia polarization and promotes functional recovery after crush spinal cord inj\ury in rats	SCIENTIFIC REPORTS			English	Article							MEDIATED AXONAL DIEBACK; INFLAMMATORY RESPONSE; MACROPHAGES; REGENERATION; THERAPY; PHENOTYPE; BARRIER; CNS; MICROGLIA/MACROPHAGES; TRANSPLANTATION	Macrophages and resident microglia play an import role in the secondary neuroinflammation response following spinal cord injury. Reprogramming of macrophage/microglia polarization is an import strategy for spinal cord injury restoration. Low-level laser therapy (LLLT) is a noninvasive treatment that has been widely used in neurotrauma and neurodegenerative diseases. However, the influence of low-level laser on polarization of macrophage/microglia following spinal cord injury remains unknown. The present study applied low-level laser therapy on a crush spinal cord injury rat model. Using immunofluorescence, flow cytometry, RT-qPCR, and western blot assays, we found that low-level laser therapy altered the polarization state to a M2 tendency. A greater number of neurons survived in the pare injury site, which was accompanied by higher BBB scores in the LLLT group. Furthermore, low-level laser therapy elevated expression of interleukin 4 (IL-4) and interleukin 13 (IL-13). Results from this study show that low-level laser therapy has the potential for reducing inflammation, regulating macrophage/microglia polarization, and promoting neuronal survival. These beneficial effects demonstrate that low-level laser therapy may be an effective candidate for clinical treatment of spinal cord injury.	[Song, Ji Wei; Li, Kun; Liang, Zhuo Wen; Dai, Chen; Hu, Xue Yu; Wang, Zhe] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China; [Shen, Xue Feng] Fourth Mil Med Univ, Dept Occupat & Environm Hlth, Xian, Shaanxi, Peoples R China; [Shen, Xue Feng] Fourth Mil Med Univ, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Xian, Shaanxi, Peoples R China; [Gong, Yu Ze; Wang, Shuang] Northwest Univ Xian, Inst Photon & Photon Technol, Dept Phys, Xian, Shaanxi, Peoples R China		Hu, XY; Wang, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian, Shaanxi, Peoples R China.	huxueyu@fmmu.edu.cn; wangzhe@fmmu.edu.cn			National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81572151, 81070996, 81101352]; Key Science and Technology Program in Social Development of Shaanxi Province [2016SF-143]	This work was supported by the National Natural Scientific Foundation of China Grant (No. 81572151, No. 81070996, No. 81101352) and Key Science and Technology Program in Social Development of Shaanxi Province (2016SF-143).	Aimbire F, 2006, PHOTOMED LASER SURG, V24, P33, DOI 10.1089/pho.2006.24.33; Ando T, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.098002; Barbosa D, 2013, LASER MED SCI, V28, P651, DOI 10.1007/s10103-012-1125-0; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Boehler RM, 2014, BIOTECHNOL BIOENG, V111, P1210, DOI 10.1002/bit.25175; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109012, 10.1371/journal.pone.0086159, 10.1371/journal.pone.0094614]; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Evans TA, 2014, EXP NEUROL, V254, P109, DOI 10.1016/j.expneurol.2014.01.013; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Gruner JA, 1996, BRAIN RES, V729, P90, DOI 10.1016/S0006-8993(96)00366-6; Guo J, 2015, MOL MED REP, V12, P37, DOI 10.3892/mmr.2015.3390; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Huang YY, 2012, J BIOPHOTONICS, V5, P827, DOI 10.1002/jbio.201200077; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Kwon MJ, 2013, J NEUROSCI, V33, P15095, DOI 10.1523/JNEUROSCI.0278-13.2013; Lee SI, 2010, J NEUROSCI RES, V88, P2409, DOI 10.1002/jnr.22411; Liu NK, 2014, ANN NEUROL, V75, P644, DOI 10.1002/ana.24134; Liu XZ, 1997, J NEUROSCI, V17, P5395; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Plemel JR, 2008, J NEUROTRAUM, V25, P350, DOI 10.1089/neu.2007.0426; Plemel JR, 2014, EXP NEUROL, V258, P91, DOI 10.1016/j.expneurol.2014.01.025; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Ren Y, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/945034; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Sato A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-65; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Stirling DP, 2008, J NEUROSCI RES, V86, P1944, DOI 10.1002/jnr.21659; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Vaughn CN, 2013, ANAT REC, V296, P1229, DOI 10.1002/ar.22730; Wang J. M., 2014, CHINESE J LASER, V41, P253; Wang Zhe, 2009, Chinese Journal of Lasers, V36, P3084, DOI 10.3788/CJL20093611.3084; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Wu XJ, 2009, LASER SURG MED, V41, P36, DOI 10.1002/lsm.20729; Zhang Q, 2016, MOL NEUROBIOL, V53, P662, DOI 10.1007/s12035-014-9035-8; Zhu D, 2016, J ALZHEIMERS DIS, V52, P483, DOI 10.3233/JAD-151090	54	27	35	4	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 4	2017	7								620	10.1038/s41598-017-00553-6			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ5ZU	WOS:000398162400031	28377600	Green Published, gold			2022-02-06	
J	Hanlon, LA; Raghupathi, R; Huh, JW				Hanlon, L. A.; Raghupathi, R.; Huh, J. W.			Differential effects of minocycline on microglial activation and neurodegeneration following closed head injury in the neonate rat	EXPERIMENTAL NEUROLOGY			English	Article						Pediatric TBI; Microglia; Cognition; Axonal injury; Cortex; Thalamus; Subiculum; Corpus callosum	TRAUMATIC BRAIN-INJURY; HYPOXIC-ISCHEMIC INJURY; FOCAL CEREBRAL-ISCHEMIA; WHITE-MATTER INJURY; AXONAL INJURY; CEREBROSPINAL-FLUID; IMMATURE BRAIN; COGNITIVE DEFICITS; UNITED-STATES; JUVENILE RAT	The role of microglia in the pathophysiology of injury to the developing brain has been extensively studied. In children under the age of 4 who have sustained a traumatic brain injury (TBI), markers of microglial/macrophage activation were increased in the cerebrospinal fluid and were associated with worse neurologic outcome. Minocycline is an antibiotic that decreases microglial/macrophage activation following hypoxic-ischemia in neonatal rodents and TBI in adult rodents thereby reducing neurodegeneration and behavioral deficits. In study 1, 11-day-old rats received an impact to the intact skull and were treated for 3 days with minocycline. Immediately following termination of minocycline administration, microglial reactivity was reduced in the cortex and hippo campus (p < 0.001) and was accompanied by an increase in the number of fluoro-Jade B profiles (p < 0.001) suggestive of a reduced clearance of degenerating cells; however, this effect was not sustained at 7 days post-injury. Although microglial reactivity was reduced in the white matter tracts (p < 0.001), minocycline treatment did not reduce axonal injury or degeneration. In the thalamus, minocycline treatment did not affect microglial reactivity, axonal injury and degeneration, and neurodegeneration. Injury-induced spatial learning and memory deficits were also not affected by minocycline. In study 2, to test whether extended dosing of minocycline may be necessary to reduce the ongoing pathologic alterations, a separate group of animals received minocycline for 9 days. Immediately following termination of treatment, microglial reactivity and neurodegeneration in all regions examined were exacerbated in minocycline-treated brain-injured animals compared to brain-injured animals that received vehicle (p < 0.001), an effect that was only sustained in the cortex and hippocampus up to 15 days post-injury (p < 0.001). Whereas injury-induced spatial learning deficits remained unaffected by minocycline treatment, memory deficits appeared to be significantly worse (p < 0.05). Sex had minimal effects on either injury-induced alterations or the efficacy of minocycline treatment. Collectively, these data demonstrate the differential effects of minocycline in the immature brain following impact trauma and suggest that minocycline may not be an effective therapeutic strategy for TBI in the immature brain. (C) 2016 Elsevier Inc. All rights reserved.	[Hanlon, L. A.; Raghupathi, R.] Drexel Univ, Coll Med, Program Neurosci, Philadelphia, PA 19104 USA; [Raghupathi, R.] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Raghupathi, R.] Coatesville Vet Adm Med Ctr, Coatesville, PA USA; [Huh, J. W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, 7 South Tower 7C06,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA		Huh, JW (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, 7 South Tower 7C06,34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	HUH@email.chop.edu	Raghupathi, Ramesh/AAX-5538-2021		National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 061963]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061963] Funding Source: NIH RePORTER	This study was funded, in part, by a grant from National Institute of Child Health and Human Development (NICHD) (HD 061963). The authors would like to thank Ms. Rupal Prasad and Mr. Douglas Fox for their technical assistance in performing animal surgeries/injuries and histologic analyses, respectively.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Andes D, 2002, INT J ANTIMICROB AG, V19, P261, DOI 10.1016/S0924-8579(02)00022-5; Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Buller KM, 2009, J NEUROSCI RES, V87, P599, DOI 10.1002/jnr.21890; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cai Z, 2006, NEUROSCIENCE, V137, P425, DOI 10.1016/j.neuroscience.2005.09.023; Carty ML, 2008, INT J DEV NEUROSCI, V26, P477, DOI 10.1016/j.ijdevneu.2008.02.005; Catroppa C, 2008, J CHILD NEUROL, V23, P486, DOI 10.1177/0883073807309773; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chhor V., 2016, BRAIN BEHAV IMMUN; Cikla U, 2016, J NEUROIMMUNOL, V291, P18, DOI 10.1016/j.jneuroim.2015.12.004; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Denker SP, 2007, J NEUROCHEM, V100, P893, DOI 10.1111/j.1471-4159.2006.04162.x; Duhaime AC, 1999, EXP TOXICOL PATHOL, V51, P172, DOI 10.1016/S0940-2993(99)80091-8; Elewa HF, 2006, PHARMACOTHERAPY, V26, P515, DOI 10.1592/phco.26.4.515; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Fan LW, 2006, EUR J NEUROSCI, V24, P341, DOI 10.1111/j.1460-9568.2006.04918.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Faustino JV, 2011, J NEUROSCI, V31, P12992, DOI 10.1523/JNEUROSCI.2102-11.2011; Ferrazzano P, 2013, CNS NEUROL DISORD-DR, V12, P338, DOI 10.2174/1871527311312030007; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanlon LA, 2016, J NEUROPATH EXP NEUR, V75, P214, DOI 10.1093/jnen/nlv021; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Ivacko JA, 1996, PEDIATR RES, V39, P39, DOI 10.1203/00006450-199601000-00006; Kelso ML, 2011, NEUROSCI LETT, V488, P60, DOI 10.1016/j.neulet.2010.11.003; Kim HS, 2009, BEHAV BRAIN RES, V196, P168, DOI 10.1016/j.bbr.2008.09.040; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lechpammer M, 2008, NEUROPATH APPL NEURO, V34, P379, DOI 10.1111/j.1365-2990.2007.00925.x; Leonardo CC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-34; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; MCRAE A, 1995, DEV BRAIN RES, V84, P245, DOI 10.1016/0165-3806(94)00177-2; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Mara S, 2005, J ANAT, V207, P271, DOI 10.1111/j.1469-7580.2005.00446.x; O'Mara SM, 2009, PROG NEURO-PSYCHOPH, V33, P782, DOI 10.1016/j.pnpbp.2009.03.040; Plane JM, 2010, ARCH NEUROL-CHICAGO, V67, P1442, DOI 10.1001/archneurol.2010.191; Potter EG, 2009, J NEUROSCI RES, V87, P1356, DOI 10.1002/jnr.21963; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Robertson CL, 2015, J BIOENERG BIOMEMBR, V47, P43, DOI 10.1007/s10863-014-9585-5; Ross FM, 2003, J NEUROIMMUNOL, V144, P61, DOI 10.1016/j.jneuroim.2003.08.030; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Tang MK, 2010, J CEREBR BLOOD F MET, V30, P119, DOI 10.1038/jcbfm.2009.194; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Trofimov A N, 2012, Ross Fiziol Zh Im I M Sechenova, V98, P782; Tsuji M, 2004, EXP NEUROL, V189, P58, DOI 10.1016/j.expneurol.2004.01.011; Vexler ZS, 2009, DEV NEUROSCI-BASEL, V31, P378, DOI 10.1159/000232556; Wang AL, 2005, NEUROCHEM INT, V47, P152, DOI 10.1016/j.neuint.2005.04.018; Wasserman JK, 2007, EXP NEUROL, V207, P227, DOI 10.1016/j.expneurol.2007.06.025; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Wixey JA, 2011, NEUROSCIENCE, V182, P184, DOI 10.1016/j.neuroscience.2011.03.033; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhang Z, 2015, J NEUROTRAUM, V32, P1369, DOI 10.1089/neu.2014.3701	78	27	29	1	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	APR	2017	290						1	14		10.1016/j.expneurol.2016.12.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EM5QR	WOS:000395368000001	28038986	Green Accepted			2022-02-06	
J	Hoover, EC; Souza, PE; Gallun, FJ				Hoover, Eric C.; Souza, Pamela E.; Gallun, Frederick J.			Auditory and Cognitive Factors Associated with Speech-in-Noise Complaints following Mild Traumatic Brain Injury	JOURNAL OF THE AMERICAN ACADEMY OF AUDIOLOGY			English	Article						auditory processing disorder; hearing impairment; postconcussive syndrome; traumatic brain injury	HEARING-LOSS; FREQUENCY-SELECTIVITY; SENSITIVITY; RECEPTION; SEQUELAE; MEMORY; INFORMATION; VETERANS; RELEASE; SCALE	Background: Auditory complaints following mild traumatic brain injury (MTBI) are common, but few studies have addressed the role of auditory temporal processing in speech recognition complaints. Purpose: In this study, deficits understanding speech in a background of speech noise following MTBI were evaluated with the goal of comparing the relative contributions of auditory and nonauditory factors. Research Design: A matched-groups design was used in which a group of listeners with a history of MTBI were compared to a group matched in age and pure-tone thresholds, as well as a control group of young listeners with normal hearing (YNH). Study Sample: Of the 33 listeners who participated in the study, 13 were included in the MTBI group (mean age = 46.7 yr), 11 in the Matched group (mean age = 49 yr), and 9 in the YNH group (mean age = 20.8 yr). Data Collection and Analysis: Speech-in-noise deficits were evaluated using subjective measures as well as monaural word (Words-in-Noise test) and sentence (Quick Speech-in-Noise test) tasks, and a binaural spatial release task. Performance on these measures was compared to psychophysical tasks that evaluate monaural and binaural temporal fine-structure tasks and spectral resolution. Cognitive measures of attention, processing speed, and working memory were evaluated as possible causes of differences between MTBI and Matched groups that might contribute to speech-in-noise perception deficits. Results: A high proportion of listeners in the MTBI group reported difficulty understanding speech in noise (84%) compared to the Matched group (9.1%), and listeners who reported difficulty were more likely to have abnormal results on objective measures of speech in noise. No significant group differences were found between the MTBI and Matched listeners on any of the measures reported, but the number of abnormal tests differed across groups. Regression analysis revealed that a combination of auditory and auditory processing factors contributed to monaural speech-in-noise scores, but the benefit of spatial separation was related to a combination of working memory and peripheral auditory factors across all listeners in the study. Conclusions: The results of this study are consistent with previous findings that a subset of listeners with MTBI has objective auditory deficits. Speech-in-noise performance was related to a combination of auditory and nonauditory factors, confirming the important role of audiology in MTBI rehabilitation. Further research is needed to evaluate the prevalence and causal relationship of auditory deficits following MTBI.	[Hoover, Eric C.] Univ S Florida, Dept Commun Sci & Disorders, Tampa, FL 33620 USA; [Souza, Pamela E.] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA; [Souza, Pamela E.] Northwestern Univ, Knowles Hearing Ctr, Evanston, IL USA; [Gallun, Frederick J.] Oregon Hlth & Sci Univ, Natl Ctr Rehabilitat Auditory Res, Portland VA Med Ctr & Otolaryngol, Portland, OR 97201 USA; [Gallun, Frederick J.] Oregon Hlth & Sci Univ, Head & Neck Surg Dept, Portland, OR 97201 USA		Hoover, EC (corresponding author), Univ S Florida, Dept Commun Sci & Disorders, Tampa, FL 33620 USA.	erichoover@usf.edu	Gallun, Frederick J./G-3792-2012	Gallun, Frederick J./0000-0002-4145-2199	NIH grantsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 DC60014, R01 DC12289]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC012289, R01DC006014] Funding Source: NIH RePORTER	This work was supported by NIH grants R01 DC60014 and R01 DC12289 (to author P.E.S.)	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; BERNSTEIN LR, 1982, J ACOUST SOC AM, V71, P147, DOI 10.1121/1.387254; Bolia RS, 2000, J ACOUST SOC AM, V107, P1065, DOI 10.1121/1.428288; COCKRELL J L, 1992, Brain Injury, V6, P261, DOI 10.3109/02699059209029667; Cox RM, 1997, EAR HEARING, V18, P388, DOI 10.1097/00003446-199710000-00004; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Frisina RD, 2001, HEARING RES, V158, P1, DOI 10.1016/S0378-5955(01)00296-9; Gallun FJ, J REHABIL R IN PRESS; Gallun FJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00252; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gygi B, 2012, ACTA ACUST UNITED AC, V98, P142, DOI 10.3813/AAA.918500; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hartmann WM, 2011, J ACOUST SOC AM, V130, P292, DOI 10.1121/1.3596475; Hoffer ME, 2013, PSYCHIAT ANN, V43, P318, DOI 10.3928/00485713-20130703-06; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hoover E, 2014, J ACOUST SOC AM, V135, P2166, DOI DOI 10.1121/1.4877039; Hoover EC, 2015, SIG 6 PERSPECT HEAR, V19, P12; Hopkins K, 2011, J ACOUST SOC AM, V130, P334, DOI 10.1121/1.3585848; Hopkins K, 2010, INT J AUDIOL, V49, P940, DOI 10.3109/14992027.2010.512613; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Killion MC, 2000, HEAR J, V53, P46; Krause MO, 2014, BRAIN INJURY, V28, P1473, DOI 10.3109/02699052.2014.920520; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; McArdle RA, 2006, J AM ACAD AUDIOL, V17, P157, DOI 10.3766/jaaa.17.3.2; McArdle Rachel A, 2005, J Am Acad Audiol, V16, P726, DOI 10.3766/jaaa.16.9.9; Moore BCJ, 2006, J ACOUST SOC AM, V119, P480, DOI 10.1121/1.2139070; Moore BCJ, 2009, INT J AUDIOL, V48, P161, DOI 10.1080/14992020802475235; Musiek Frank E, 2004, J Am Acad Audiol, V15, P117, DOI 10.3766/jaaa.15.2.3; Noble W, 2013, INT J AUDIOL, V52, P409, DOI 10.3109/14992027.2013.781278; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; Oxenham AJ, 2009, J ACOUST SOC AM, V125, P2189, DOI 10.1121/1.3089220; Puckette M., 1996, P 2 INT COMP MUS CON, P37; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roup Christina M, 1998, Am J Audiol, V7, P55, DOI 10.1044/1059-0889(1998/014); Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Shah P, 1996, J EXP PSYCHOL GEN, V125, P4, DOI 10.1037/0096-3445.125.1.4; Souza PE, 2014, CHARACTERIZING SEVER; Strelcyk O, 2009, J ACOUST SOC AM, V125, P3328, DOI 10.1121/1.3097469; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wang XQ, 2007, HEARING RES, V229, P81, DOI 10.1016/j.heares.2007.01.019; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Whitmer WM, 2012, J ACOUST SOC AM, V132, P369, DOI 10.1121/1.4728200; Wilson RH, 2005, J REHABIL RES DEV, V42, P839, DOI 10.1682/JRRD.2005.01.0009; Wilson Richard H, 2003, J Am Acad Audiol, V14, P453; Won JH, 2007, JARO-J ASSOC RES OTO, V8, P384, DOI 10.1007/s10162-007-0085-8; [No title captured], DOI DOI 10.1007/978-1-4419-0993-0_8	56	27	27	3	21	AMER ACAD AUDIOLOGY	RESTON	11730 PLAZA DR, STE 300, RESTON, VA 20190 USA	1050-0545	2157-3107		J AM ACAD AUDIOL	J. Am. Acad. Audiol.	APR	2017	28	4					325	339		10.3766/jaaa.16051			15	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	ER7IA	WOS:000398983800006	28418327	Green Accepted			2022-02-06	
J	Trifan, G; Gattu, R; Haacke, EM; Kou, ZF; Benson, RR				Trifan, Gabriela; Gattu, Ramtilak; Haacke, Ewart Mark; Kou, Zhifeng; Benson, Randall R.			MR imaging findings in mild traumatic brain injury with persistent neurological impairment	MAGNETIC RESONANCE IMAGING			English	Article						Traumatic brain injury; Mild TBI; Litigation; Subcortical; Deep; Microhemorrhage; Post concussive symptoms; White matter; Hyperintensities; Fluid-attenuated inversion recovery; Flair; Susceptibility-weighted imaging; SWI; MRI; Sensitivity; Detection; Agerelated	WHITE-MATTER HYPERINTENSITIES; SUSCEPTIBILITY-WEIGHTED MRI; DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE; CEREBRAL MICROBLEEDS; RISK-FACTORS; LESIONS; PREVALENCE; MIGRAINE; SPECTRUM	Traumatic brain injury (TBI) is a widespread cause of neurologic disability, with >70% of cases being mild in severity. Magnetic resonance imaging provides objective biomarlcers in the diagnosis of brain injury by detecting brain lesions resulting from trauma. This paper reports on the detection rates of presumed trauma related pathology using fluid-attenuated inversion recovery (FLAIR) and susceptibility-weighted imaging (SWI) in TBI patients with chronic, persistent symptoms. Methods: 180 subjects with persistent neurobehavioral symptoms following head trauma referred by personal injury attorneys and 94 asymptomatic, age-matched volunteers were included in the study. 83% of TBI subjects were classified as mild. Results: TBI subjects had a significantly greater number of lesions detected by FLAIR than controls (42% vs. 22%) and more lesions detected by SWI than controls (28% vs. 3%). To reduce the confounding effects of aging, we examined mild TBI subjects <45 years of age, which reduced the rate of lesions detected by FLAIR (26% vs. 2%) and SWI (15% vs. 0%). This younger group, which contained few age-related lesions, also demonstrated that subcortical lesions on FLAIR are more specific for TBI than deeper lesions. Conclusions: While the presence of litigation in mild TBI cases with incomplete recovery has been associated with greater expression of symptomatology and, by extension, poorer outcomes, this study shows that mild TBI patients in litigation with chronic, persistent symptoms may have associated brain injury underlying their symptoms detectable by MRI biomarkers. (C) 2016 Elsevier Inc. All rights reserved.	[Trifan, Gabriela; Benson, Randall R.] Ctr Neurol Studies, 23400 Michigan Ave,Suite 210, Dearborn, MI 48124 USA; [Gattu, Ramtilak; Haacke, Ewart Mark; Kou, Zhifeng] Wayne State Univ, MR Res Ctr, Sch Med, Dept Radiol, 3990 John R St,HUH Harper Suite 4J, Detroit, MI 48201 USA; [Haacke, Ewart Mark; Kou, Zhifeng] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA		Benson, RR (corresponding author), Ctr Neurol Studies, Dearborn, MI 48375 USA.	gabby@neurologicstudies.com; ramtilak.gattu@wayne.edu; nmrimaging@aol.com; zhifeng_kou@wayne.edu; drbenson@neurologicstudies.com		Trifan, Gabriela/0000-0003-3427-2605	NIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R37 AG011230]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG011230] Funding Source: NIH RePORTER	The authors thank Dr. Naftali Raz, who shared data on 50 control participants (acquired under NIH grant R37 AG011230), and Dr. Darren Fuerst for assistance with statistical analysis. Portions of this paper were presented at the WSU 75th Anniversary Symposium, August 2014, and at the International Society for Magnetic Resonance in Medicine, May 2014.	Alaee A, 2014, IRAN J RADIOL, V11, DOI 10.5812/iranjradiol.14275; [Anonymous], 2014, NAT DIAB STAT REP; Aradi M, 2013, HEADACHE, V53, P752, DOI 10.1111/head.12013; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Ashikaga Ryuichiro, 1996, Nippon Acta Radiologica, V56, P1045; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; BROWN FW, 1992, AM J PSYCHIAT, V149, P620; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chowdhury MH, 2011, J STROKE CEREBROVASC, V20, P302, DOI 10.1016/j.jstrokecerebrovasdis.2009.12.010; Chutinet Aurauma, 2014, Curr Treat Options Cardiovasc Med, V16, P292, DOI 10.1007/s11936-013-0292-z; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Datta SGS, 2009, NEUROL INDIA, V57, P594, DOI 10.4103/0028-3886.57810; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; DeCuypere M, 2012, SURG CLIN N AM, V92, P939, DOI 10.1016/j.suc.2012.04.005; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Fazekas F, 1998, J NEURAL TRANSM-SUPP, P31; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Figiel G S, 1991, J Neuropsychiatry Clin Neurosci, V3, P18; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gunde E, 2011, J PSYCHIATR RES, V45, P76, DOI 10.1016/j.jpsychires.2010.04.019; Hamedani AG, 2013, NEUROLOGY, V81, P1308, DOI 10.1212/WNL.0b013e3182a8235b; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Imaizumi T, 2011, J NEUROIMAGING, V21, P359, DOI 10.1111/j.1552-6569.2011.00593.x; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Kanekar S, 2014, RADIOL CLIN N AM, V52, P241, DOI 10.1016/j.rcl.2013.11.010; Kennedy KM, 2009, BRAIN RES, V1297, P41, DOI 10.1016/j.brainres.2009.08.058; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Liu G, 2014, ACTA RADIOL; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Loitfelder M, 2012, PANMINERVA MED, V54, P149; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mantyla R, 1999, STROKE, V30, P2053, DOI 10.1161/01.STR.30.10.2053; McMahon PJ, 2013, J NEUROTRAUM; Mooney G, 1997, NEUROREHABILITATION, V8, P223, DOI 10.3233/NRE-1997-8308; Morais DF, 2008, ARQ NEURO-PSIQUIAT, V66, P53, DOI 10.1590/S0004-282X2008000100013; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Neema M, 2009, AM J NEURORADIOL, V30, P911, DOI 10.3174/ajnr.A1514; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Raz N, 2009, IMAGING AGING BRAIN, P151; Raz N, 2012, BBA-MOL BASIS DIS, V1822, P361, DOI 10.1016/j.bbadis.2011.08.007; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Salat DH, 2013, NEUROSCIENCE; Sassi RB, 2003, J AFFECT DISORDERS, V77, P237, DOI 10.1016/S0165-0327(02)00170-2; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; SCHMIDT R, 1991, ARCH NEUROL-CHICAGO, V48, P417, DOI 10.1001/archneur.1991.00530160087019; Seneviratne U, 2013, CLIN NEUROL NEUROSUR, V115, P1040, DOI 10.1016/j.clineuro.2012.10.033; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shukla D, 2010, J NEUROSCI RURAL PRA, V1, P82, DOI 10.4103/0976-3147.71723; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Spitz G, 2013, J NEUROTRAUM; Stehling C, 2008, ACAD RADIOL, V15, P895, DOI 10.1016/j.acra.2008.01.013; Tsurushima H, 1996, NEUROL SURG TOKYO, V24, P891; Wang X, 2014, NEUROL SCI, V35, P1533, DOI 10.1007/s10072-014-1788-3; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Young VG, 2008, NEUROLOGY, V71, P804, DOI 10.1212/01.wnl.0000319691.50117.54	70	27	27	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	APR	2017	37						243	251		10.1016/j.mri.2016.12.009			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Radiology, Nuclear Medicine & Medical Imaging	EO0IT	WOS:000396382200033	27939436				2022-02-06	
J	Sharma, R; Rosenberg, A; Bennett, ER; Laskowitz, DT; Acheson, SK				Sharma, Richa; Rosenberg, Alexandra; Bennett, Ellen R.; Laskowitz, Daniel T.; Acheson, Shawn K.			A blood-based biomarker panel to risk-stratify mild traumatic brain injury	PLOS ONE			English	Article							NEW-ORLEANS CRITERIA; C-REACTIVE PROTEIN; CREATINE-KINASE-BB; COMPUTED-TOMOGRAPHY SCANS; NECROSIS-FACTOR-ALPHA; MINOR HEAD TRAUMA; CEREBROSPINAL-FLUID; EXTERNAL VALIDATION; DIAGNOSTIC-TEST; ACUTE-PHASE	Mild traumatic brain injury (TBI) accounts for the vast majority of the nearly two million brain injuries suffered in the United States each year. Mild TBI is commonly classified as complicated (radiographic evidence of intracranial injury) or uncomplicated (radiographically negative). Such a distinction is important because it helps to determine the need for further neuroimaging, potential admission, or neurosurgical intervention. Unfortunately, imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) are costly and not without some risk. The purpose of this study was to screen 87 serum biomarkers to identify a select panel of biomarkers that would predict the presence of intracranial injury as determined by initial brain CT. Serum was collected from 110 patients who sustained a mild TBI within 24 hours of blood draw. Two models were created. In the broad inclusive model, 72kDa type IV collagenase (MMP-2), C-reactive protein (CRP), creatine kinase B type (CKBB), fatty acid binding protein heart (hFABP), granulocyte-macrophage colony-stimulating factor (GM-CSF) and malondialdehyde modified low density lipoprotein (MDA-LDL) significantly predicted injury visualized on CT, yielding an overall c-statistic of 0.975 and a negative predictive value (NPV) of 98.6. In the parsimonious model, MMP-2, CRP, and CKBB type significantly predicted injury visualized on CT, yielding an overall c-statistic of 0.964 and a negative predictive value (NPV) of 97.2. These results suggest that a serum based biomarker panel can accurately differentiate patients with complicated mild TBI from those with uncomplicated mild TBI. Such a panel could be useful to guide early triage decisions, including the need for further evaluation or admission, especially in those environments in which resources are limited.	[Sharma, Richa; Rosenberg, Alexandra; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Sch Med, Durham, NC 27710 USA; [Bennett, Ellen R.; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Acheson, Shawn K.] Durham VA Med Ctr, Durham, NC 27705 USA; [Acheson, Shawn K.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27708 USA		Sharma, R (corresponding author), Duke Univ, Med Ctr, Sch Med, Durham, NC 27710 USA.; Acheson, SK (corresponding author), Durham VA Med Ctr, Durham, NC 27705 USA.; Acheson, SK (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.	rsharm23@jhmi.edu; shawn.acheson@duke.edu			Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development [IK2BX001267]; Astute Medical, Inc.	This work was funded in part by Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development Award IK2BX001267 (to SKA). The study was subsidized by a research grant from Astute Medical, Inc., which performed the antibody-based assays used in this study.	Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Arfanakis K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073107; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cardali S, 2006, J Neurosurg Sci, V50, P25; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; COOPER PR, 1983, NEUROSURGERY, V12, P536, DOI 10.1227/00006123-198305000-00010; Coplin WM, 1999, ARCH NEUROL-CHICAGO, V56, P1348, DOI 10.1001/archneur.56.11.1348; Dickerson F, 2012, SCHIZOPHR RES, V134, P83, DOI 10.1016/j.schres.2011.10.003; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Faul M, 2010, TRAUMATIC BRAIN INJU; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hosmer DW, 2000, APPL LOGISTIC REGRES, pxii; Hughes CM, 2014, J AM COLL RADIOLOGY; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; KASTE M, 1981, J NEUROSURG, V55, P511, DOI 10.3171/jns.1981.55.4.0511; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Kelly JP, 1997, NEUROLOGY, V48, P581; Kleinert K, 2010, ZBL CHIR, V135, P277, DOI 10.1055/s-0028-1098766; Koenig W, 2003, AM J EPIDEMIOL, P158; Laskowitz DT, 2009, STROKE, V40, P77, DOI 10.1161/STROKEAHA.108.516377; Laskowitz DT, 2005, ANN NY ACAD SCI, V1053, P30, DOI 10.1196/annals.1344.051; LEVITT MA, 1995, ACAD EMERG MED, V2, P675, DOI 10.1111/j.1553-2712.1995.tb03617.x; Lynch JR, 2004, STROKE, V35, P57, DOI 10.1161/01.STR.0000105927.62344.4C; McGirt MJ, 2002, NEUROSURGERY, V51, P1128, DOI 10.1097/00006123-200211000-00005; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Parma C, 2014, AM SURGEON, V80, P664; Paul AB, 2015, J AM COLL RADIOL, V12, P453, DOI 10.1016/j.jacr.2014.12.016; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PHILLIPS JP, 1980, BRIT MED J, V281, P777, DOI 10.1136/bmj.281.6243.777; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Reynolds TA, 2013, ANN EMERG MED, V61, P528, DOI 10.1016/j.annemergmed.2012.12.006; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Schachar JL, 2011, PEDIATR RADIOL, V41, P971, DOI 10.1007/s00247-011-2032-4; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Sjodin MOD, 2010, J CHROMATOGR B, V878, P2003, DOI 10.1016/j.jchromb.2010.05.036; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Unden Johan, 2013, Lakartidningen, V110, P1868; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wium-Andersen MK, 2014, BIOL PSYCHIAT, V76, P249, DOI 10.1016/j.biopsych.2013.10.009; Wright J, 2011, ENCY CLIN NEUROPSYCH, P1149; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Zyluk A, 2015, NEUROL NEUROCHIR POL, V49, P52, DOI 10.1016/j.pjnns.2014.12.007	74	27	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173798	10.1371/journal.pone.0173798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	WOS:000399174600027	28355230	gold, Green Published, Green Submitted			2022-02-06	
J	Clark, MD; Asken, BM; Marshall, SW; Guskiewicz, KM				Clark, Michael D.; Asken, Breton M.; Marshall, Stephen W.; Guskiewicz, Kevin M.			Descriptive Characteristics of Concussions in National Football League Games, 2010-2011 to 2013-2014	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; American football; National Football League; head impacts	HEAD IMPACT EXPOSURE; SPORT-RELATED CONCUSSION; HIGH-SCHOOL SPORTS; PROFESSIONAL FOOTBALL; YOUTH FOOTBALL; INJURIES; EPIDEMIOLOGY; PLAYERS; COLLEGIATE; PERFORMANCE	Background: Despite a high reported incidence rate of concussion, little is known about the on-field characteristics of injurious head impacts in National Football League (NFL) games. Purpose: To characterize on-field features (location, player position, and time during game) and biomechanical features (anticipation status, closing distance, impact location and type) associated with concussions in NFL games over a 4-season period (2010-2011 to 2013-2014). Study Design: Descriptive epidemiology study. Methods: We analyzed video of a subset of reported, in-game concussions for the 2010-2011 to 2013-2014 seasons. These videos represented a sample of injuries that were diagnosed and reported on the same day and that could be clearly associated with an in-game collision as captured on video. We determined anticipation status, closing distance, impact location on the injured player's helmet, and impact type (helmet-to-helmet, helmet-to-body, or helmet-to-ground). Associations between these variables were analyzed by use of descriptive statistics and tests of association. Results: A total of 871 diagnosed concussions were reported as occurring during NFL preseason, regular season, and postseason games for the 2010-2011, 2011-2012, 2012-2013, and 2013-2014 seasons. A total of 1324 games were played during this period, giving a concussion incidence rate of 0.658 per game (95% CI, 0.61-0.70). From the video-reviewed subset (n = 429; 49.3%), the majority of injurious impacts occurred with good anticipation (57.3%) and <10 yards of closing distance (59.0%). An association was found between anticipation status and play type ( <mml:msubsup>32</mml:msubsup> = 27.398, P < .001), largely because injuries occurring on pass plays were more likely to be poorly anticipated than injuries during run plays (43.0% vs 21.4%; <mml:msubsup>12</mml:msubsup> = 14.78, P < .001). Kick returns had the greatest proportion of well-anticipated impacts (78%) and the greatest proportion of impacts with 10 yards of closing distance (80%). The type of impact was approximately equally divided between helmet-to-helmet, helmet-to-body, and helmet-to-ground types. The impact location was broadly distributed over the helmet of the injured player. Conclusion: In-game concussions in the NFL occurred through a diverse variety of mechanisms, surprisingly tended to be well-anticipated, and, also surprisingly, occurred with <10 yards of closing distance. The impacts causing concussion were broadly distributed over the helmet. More concussions occurred during the second half of game play, but we do not have evidence to explain this finding.	[Clark, Michael D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, CB 8700, Chapel Hill, NC 27599 USA; [Clark, Michael D.; Guskiewicz, Kevin M.] Univ N Carolina, Sch Med, Dept Allied Hlth Sci, Curriculum Human Movement Sci, CB 8700, Chapel Hill, NC 27599 USA; [Asken, Breton M.] Univ Florida, Dept Clin & Hlth Psychol, Neuropsychol Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Injury Prevent Res Ctr, CB 8700, Chapel Hill, NC 27599 USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, CB 8700, Chapel Hill, NC 27599 USA		Guskiewicz, KM (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, CB 8700, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Asken, Breton/0000-0001-8419-142X; Clark, Michael/0000-0002-5019-0290	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008719] Funding Source: NIH RePORTER		Badgeley MA, 2013, J PHYS ACT HEALTH, V10, P160, DOI 10.1123/jpah.10.2.160; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Cantu RC, 2000, NEUROSURGERY, V47, P673, DOI 10.1097/00006123-200009000-00029; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Fainaru S, YOUTH FOOTBALL PARTI; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Gwin JT, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000249; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Mueller F O, 1991, Exerc Sport Sci Rev, V19, P261; Mueller FO, 2001, J ATHL TRAINING, V36, P312; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2	32	27	27	0	19	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2017	45	4					929	936		10.1177/0363546516677793			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	EP6MD	WOS:000397492700023	28056179				2022-02-06	
J	Crescenzi, R; DeBrosse, C; Nanga, RPR; Byrne, MD; Krishnamoorthy, G; D'Aquilla, K; Nath, H; Morales, KH; Iba, M; Hariharan, H; Lee, VMY; Detre, JA; Reddy, R				Crescenzi, Rachelle; DeBrosse, Catherine; Nanga, Ravi P. R.; Byrne, Matthew D.; Krishnamoorthy, Guruprasad; D'Aquilla, Kevin; Nath, Hari; Morales, Knashawn H.; Iba, Michiyo; Hariharan, Hari; Lee, Virginia M. Y.; Detre, John A.; Reddy, Ravinder			Longitudinal Imaging Reveals Subhippocampal Dynamics in Glutamate Levels Associated with Histopathologic Events in a Mouse Model of Tauopathy and Healthy Mice	HIPPOCAMPUS			English	Article						tauopathy; CEST; synapse; glutamate; glia	MILD COGNITIVE IMPAIRMENT; LONG-TERM POTENTIATION; CHRONIC TRAUMATIC ENCEPHALOPATHY; TAU TRANSGENIC MICE; ALZHEIMERS-DISEASE; SYNAPSE LOSS; BINDING-SITES; IN-VIVO; FUNCTIONAL DOMAINS; PREFRONTAL CORTEX	Tauopathies are neurodegenerative disorders characterized by abnormal intracellular aggregates of tau protein, and include Alzheimer's disease, corticobasal degeneration, frontotemporal dementia, and traumatic brain injury. Glutamate metabolism is altered in neurodegenerative disorders manifesting in higher or lower concentrations of glutamate, its transporters or receptors. Previously, glutamate chemical exchange saturation transfer (GluCEST) magnetic resonance imaging (MRI) demonstrated that glutamate levels are reduced in regions of synapse loss in the hippocampus of a mouse model of late-stage tauopathy. We performed a longitudinal GluCEST imaging experiment paired with a cross-sectional study of histologic markers of tauopathy to determine whether (1) early GluCEST changes are associated with synapse loss before volume loss occurs in the hippocampus, and whether (2) subhippocampal dynamics in GluCEST are associated with histopathologic events related to glutamate alterations in tauopathy. Live imaging of the hippocampus in three serial slices was performed without exogenous contrast agents, and subregions were segmented based on a k-means cluster model. Subregions of the hippocampus were analyzed (cornu ammonis CA1, CA3, dentate gyrus DG, and ventricle) in order to associate local MRIobservable changes in glutamate with histological measures of glial cell proliferation (GFAP), synapse density (synaptophysin, VGlut1) and glutamate receptor (NMDA-NR1) levels. Early differences in GluCEST between healthy and tauopathy mice were measured in the CA1 and DG subregions (30% reduction, P <= 0.001). Synapse density was also significantly reduced in every subregion of the hippocampus in tauopathy mice by 6 months. Volume was not significantly reduced in any subregion until 13 months. Further, a gradient in glutamate levels was observed in vivo along hippocampal axes that became polarized as tauopathy progressed. Dynamics in hippocampal glutamate levels throughout lifetime were most closely correlated with combined changes in synaptophysin and GFAP, indicating that GluCEST imaging may be a surrogate marker of glutamate concentration in glial cells and at the synaptic level. (C) 2016 Wiley Periodicals, Inc.	[Crescenzi, Rachelle; DeBrosse, Catherine] Univ Penn, Dept Biochem & Mol Biophys BMB, Philadelphia, PA 19104 USA; [Crescenzi, Rachelle; DeBrosse, Catherine; Nanga, Ravi P. R.; Krishnamoorthy, Guruprasad; D'Aquilla, Kevin; Nath, Hari; Hariharan, Hari; Reddy, Ravinder] Univ Penn, CMROI, Philadelphia, PA 19104 USA; [Byrne, Matthew D.; Iba, Michiyo; Lee, Virginia M. Y.] Univ Penn, CNDR, Philadelphia, PA 19104 USA; [Morales, Knashawn H.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, CfN, Philadelphia, PA 19104 USA		Crescenzi, R (corresponding author), Univ Penn, Dept Biochem & Mol Biophys BMB, CMROI, B1 Stellar Chance Lab,422 Curie Blvd, Philadelphia, PA 19104 USA.	rachelle.cre-scenzi@gmail.com			NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015893S1]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG17586]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087516]; National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1TR000003]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000003, UL1TR001878] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS087516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG017586] Funding Source: NIH RePORTER	Grant sponsor: NIBIB; Grant number: P41EB015893S1; Grant sponsor: NIA; Grant number: P01AG17586; Grant sponsor: NINDS; Grant number: R01NS087516; Grant sponsor: National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health; Grant number: UL1TR000003.	Adler DH, 2014, NEUROIMAGE, V84, P505, DOI 10.1016/j.neuroimage.2013.08.067; Alsop DC, 2008, NEUROIMAGE, V42, P1267, DOI 10.1016/j.neuroimage.2008.06.006; Amadoro G, 2006, P NATL ACAD SCI USA, V103, P2892, DOI 10.1073/pnas.0511065103; Aronica E, 1998, NEUROSCIENCE, V82, P979; Bell KFS, 2007, J NEUROSCI, V27, P10810, DOI 10.1523/JNEUROSCI.3269-07.2007; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BENJAMIN AM, 1975, J NEUROCHEM, V25, P197, DOI 10.1111/j.1471-4159.1975.tb06953.x; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021660; Chen Y, 2011, NEUROLOGY, V77, P1977, DOI 10.1212/WNL.0b013e31823a0ef7; Chohan MO, 2011, NEUROBIOL AGING, V32, P1420, DOI 10.1016/j.neurobiolaging.2009.08.008; Chong SA, 2011, NEUROBIOL DIS, V44, P284, DOI 10.1016/j.nbd.2011.07.006; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; Crescenzi R, 2014, NEUROIMAGE, V101, P185, DOI 10.1016/j.neuroimage.2014.06.067; Dai WY, 2009, RADIOLOGY, V250, P856, DOI 10.1148/radiol.2503080751; David JP, 1997, NEUROSCI LETT, V235, P53, DOI 10.1016/S0304-3940(97)00708-8; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; DEWAR D, 1991, BRAIN RES, V553, P58, DOI 10.1016/0006-8993(91)90230-S; DOLPHIN AC, 1982, NATURE, V297, P496, DOI 10.1038/297496a0; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gong YS, 2010, AM J ALZHEIMERS DIS, V25, P547, DOI 10.1177/1533317510382893; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Haley GE, 2010, AGE, V32, P283, DOI 10.1007/s11357-010-9137-9; Haris M, 2013, NMR BIOMED, V26, P386, DOI 10.1002/nbm.2875; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.0.CO;2-N; Hochgrafe K, 2013, FEBS J, V280, P4371, DOI 10.1111/febs.12250; Hoover BR, 2011, NIH PUBLIC ACCESS, V68, P1067, DOI [10.1016/j.neuron.2010.11.030, DOI 10.1016/J.NEURON.2010.11.030.TAU]; Hoover BR, 2010, NEURON, V68, P1067, DOI 10.1016/j.neuron.2010.11.030; Hu WT, 2010, NEUROLOGY, V75, P881, DOI 10.1212/WNL.0b013e3181f11e35; Hunsberger HC, 2015, J NEUROCHEM, V132, P169, DOI 10.1111/jnc.12967; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Jacob CP, 2007, J ALZHEIMERS DIS, V11, P97; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; JANSEN KLR, 1990, NEUROSCIENCE, V39, P613, DOI 10.1016/0306-4522(90)90246-Z; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Kashani A, 2008, NEUROBIOL AGING, V29, P1619, DOI 10.1016/j.neurobiolaging.2007.04.010; Kirvell SL, 2006, J NEUROCHEM, V98, P939, DOI 10.1111/j.1471-4159.2006.03935.x; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; KOHAMA SG, 1995, NEUROBIOL AGING, V16, P59, DOI 10.1016/0197-4580(95)80008-F; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Landau SM, 2011, NEUROBIOL AGING, V32, P1207, DOI 10.1016/j.neurobiolaging.2009.07.002; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Leung KK, 2015, NEUROIMAGE, V107, P46, DOI 10.1016/j.neuroimage.2014.11.049; Li Y, 2008, EUR J NUCL MED MOL I, V35, P2169, DOI 10.1007/s00259-008-0833-y; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Martens U, 1998, ANAT EMBRYOL, V198, P195, DOI 10.1007/s004290050177; Maurin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087605; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Nicholls DG, 1998, BBA-BIOENERGETICS, V1366, P97, DOI 10.1016/S0005-2728(98)00123-6; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nilsen LH, 2014, NEUROCHEM RES, V39, P305, DOI 10.1007/s11064-013-1222-x; Nilsen LH, 2014, J CEREBR BLOOD F MET, V34, P906, DOI 10.1038/jcbfm.2014.37; Pennanen L, 2006, GENES BRAIN BEHAV, V5, P369, DOI 10.1111/j.1601-183X.2005.00165.x; PENNEY JB, 1990, J NEUROL NEUROSUR PS, V53, P314, DOI 10.1136/jnnp.53.4.314; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Robinson JL, 2014, BRAIN, V137, P2578, DOI 10.1093/brain/awu190; Rocher AB, 2010, EXP NEUROL, V223, P385, DOI 10.1016/j.expneurol.2009.07.029; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sasaki K, 2009, FEBS LETT, V583, P2194, DOI 10.1016/j.febslet.2009.06.015; Schousboe A, 1981, Int Rev Neurobiol, V22, P1, DOI 10.1016/S0074-7742(08)60289-5; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Snyder JS, 2011, NEUROBIOL AGING, V32, P1149, DOI 10.1016/j.neurobiolaging.2009.05.022; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Staresina BP, 2012, NAT NEUROSCI, V15, P1167, DOI 10.1038/nn.3154; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Sydow A, 2011, J MOL NEUROSCI, V45, P432, DOI 10.1007/s12031-011-9604-5; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thibodeau MP, 2009, CANADIAN REV ALZHEIM, V12, P4; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Van der Jeugd A, 2012, ACTA NEUROPATHOL, V123, P787, DOI 10.1007/s00401-012-0987-3; Vemuri P, 2008, NEUROIMAGE, V42, P559, DOI 10.1016/j.neuroimage.2008.05.012; Volgyi K, 2015, CURR ALZHEIMER RES, V12, P655, DOI 10.2174/1567205012666150710095035; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Wells JA, 2015, NEUROIMAGE, V111, P369, DOI 10.1016/j.neuroimage.2015.02.023; WESTERGAARD N, 1995, DEV NEUROSCI-BASEL, V17, P203, DOI 10.1159/000111288; YASUDA RP, 1995, BRAIN RES, V678, P161, DOI 10.1016/0006-8993(95)00178-S; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012; Zheng BW, 2010, NMR BIOMED, V23, P1061, DOI 10.1002/nbm.1533	86	27	28	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus	MAR	2017	27	3					285	302		10.1002/hipo.22693			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EP5FB	WOS:000397403300007	27997993	Green Accepted			2022-02-06	
J	de Jongh, MAC; Kruithof, N; Gosens, T; van de Ree, CLP; de Munter, L; Brouwers, L; Polinder, S; Lansink, KWW				de Jongh, M. A. C.; Kruithof, N.; Gosens, T.; van de Ree, C. L. P.; de Munter, L.; Brouwers, L.; Polinder, S.; Lansink, K. W. W.		BIOS-Grp	Prevalence, recovery patterns and predictors of quality of life and costs after non-fatal injury: the Brabant Injury Outcome Surveillance (BIOS) study	INJURY PREVENTION			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MAJOR TRAUMA; SEVERITY SCORE; HEALTH-STATUS; HEAD-INJURY; UK BURDEN; SCALE; VALIDATION; FRAILTY	Introduction Trauma is a major public health problem worldwide that leads to high medical and societal costs. Overall, improved understanding of the full spectrum of the societal impact and burden of injury is needed. The main purpose of the Brabant Injury Outcome Surveillance (BIOS) study is to provide insight into prevalence, predictors and recovery patterns of short-term and long-term health-related quality of life (HRQoL) and costs after injury. Materials and methods This is a prospective, observational, follow-up cohort study in which HRQoL, psychological, social and functional outcome, and costs after trauma will be assessed during 24 months follow-up within injured patients admitted in 1 of 10 hospitals in the county Noord-Brabant, the Netherlands. Data will be collected by self-reported questionnaires at 1 week (including preinjury assessment), and 1, 3, 6, 12 and 24 months after injury. If patients are not capable of filling out the questionnaires, proxies will be asked to participate. Also, information about mechanism and severity of injury, comorbidity and indirect and direct costs will be collected. Mixed models will be used to examine the course of HRQoL, functional and psychological outcome, costs over time and between different groups, and to identify predictors for poor or good outcome. Relevance This study should make a substantial contribution to the international collaborative effort to assess the societal impact and burden of injuries more accurately. The BIOS results will also be used to develop an outcome prediction model for outcome evaluation including, besides the classic fatal, non-fatal outcome.	[de Jongh, M. A. C.; Kruithof, N.; Gosens, T.; van de Ree, C. L. P.; de Munter, L.; Lansink, K. W. W.] Elisabeth TweeSteden Hosp, Dept Trauma TopCare, Postbus 90151, NL-5000 LC Tilburg, Netherlands; [de Jongh, M. A. C.; Brouwers, L.; Lansink, K. W. W.] Brabant Trauma Registry, Network Emergency Care Brabant, Tilburg, Netherlands; [Gosens, T.] Elisabeth TweeSteden Hosp, Dept Orthopaed, Tilburg, Netherlands; [Polinder, S.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Lansink, K. W. W.] Elisabeth TweeSteden Hosp, Dept Surg, Tilburg, Netherlands		de Jongh, MAC (corresponding author), Elisabeth TweeSteden Hosp, Dept Trauma TopCare, Postbus 90151, NL-5000 LC Tilburg, Netherlands.	m.dejongh@etz.nl		de Munter, Leonie/0000-0001-6573-2032	ZonMwNetherlands Organization for Health Research and Development [80-84200-98-14255]	ZonMw (80-84200-98-14255).	Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; [Anonymous], 1984, J TRAUMA INJURY INFE, P21201; Ardolino A, 2012, INJURY, V43, P1662, DOI 10.1016/j.injury.2012.05.008; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bakker FC, 2015, INTERD T GERONT GERI, V41, P95, DOI 10.1159/000381171; Baranyi A, 2010, PSYCHOSOMATICS, V51, P237, DOI 10.1176/appi.psy.51.3.237; Bergeron E, 2004, J TRAUMA, V56, P760, DOI 10.1097/01.TA.0000119199.52226.C0; Bhalla K, 2009, PLOS MED, V6, P22, DOI 10.1371/journal.pmed.1000001; Bocci MG, 2016, MINERVA ANESTESIOL, V82, P22; Bouwmans C, 2013, HANDLEIDING IMTA MED; Bouwmans C, 2013, HANDLEIDING IMTA PRO; Bouwmans C, 2013, MED CONSUMPTION QUES; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brouwer WBF, 1999, HEALTH POLICY, V48, P13, DOI 10.1016/S0168-8510(99)00028-7; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; Dagum C, 2004, HUMAN CAPITAL; DAUBIGNE RM, 1954, J BONE JOINT SURG AM, V36-A, P451, DOI 10.2106/00004623-195436030-00001; Derrett S, 2009, INJURY PREV, V15, DOI [10.1136/ip.2009.022558, 10.1136/ip.2009.022558a]; Drake AI, 2006, BRAIN INJURY, V20, P469, DOI 10.1080/02699050600676370; Edwards ER, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2005.02.027; Furlong W, 2000, HLTH UTILITIES INDEX; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; Gabbe BJ, 2015, INJURY PREV, V21, P348, DOI 10.1136/injuryprev-2014-041336; Gabbe BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113467; Gabbe BJ, 2013, ANN SURG, V257, P166, DOI 10.1097/SLA.0b013e31825d7422; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; Hanna CL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-14; Hasselberg Marie, 2003, Traffic Inj Prev, V4, P249, DOI 10.1080/15389580309882; Holtslag HR, 2007, INJURY, V38, P280, DOI 10.1016/j.injury.2006.10.026; Holtslag HR, 2008, B WORLD HEALTH ORGAN, V86, P111, DOI 10.2471/BLT.06.033803; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jones JM, 2014, ACTA ANAESTH SCAND, V58, P303, DOI 10.1111/aas.12256; Kendrick D, 2013, INJURY PREV, V19, P370, DOI 10.1136/injuryprev-2012-040658; Kennedy RL, 2001, J TRAUMA, V51, P717, DOI 10.1097/00005373-200110000-00016; Kim SW, 2014, JAMA SURG, V149, P633, DOI 10.1001/jamasurg.2014.241; Koopmanschap Marc A, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P23, DOI 10.1586/14737167.5.1.23; Langley J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-68; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Lyons RA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-317; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; MAJEED SA, 1989, J BONE JOINT SURG BR, V71, P304, DOI 10.1302/0301-620X.71B2.2925751; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Moore L, 2011, J AM COLL SURGEONS, V213, P402, DOI 10.1016/j.jamcollsurg.2011.05.007; Nichol AD, 2011, INJURY, V42, P281, DOI 10.1016/j.injury.2010.11.047; O'Donnell ML, 2013, J CLIN PSYCHIAT, V74, pE137, DOI 10.4088/JCP.12m08011; PERRY S, 1992, AM J PSYCHIAT, V149, P931; Peters LL, 2012, J AM MED DIR ASSOC, V13, P546, DOI 10.1016/j.jamda.2012.04.007; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Polinder S, 2007, B WORLD HEALTH ORGAN, V85, P27, DOI 10.2471/BLT.06.030973; Polinder S, 2012, EPIDEMIOL REV, V34, P17, DOI 10.1093/epirev/mxr022; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Polinder S, 2010, INJURY PREV, V16, P147, DOI 10.1136/ip.2009.022418; Ringburg AN, 2011, J TRAUMA, V70, P916, DOI 10.1097/TA.0b013e3181f6bce8; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Shi QY, 2014, J HAND THER, V27, P55, DOI 10.1016/j.jht.2013.10.001; Steverink N, 2001, GERONTOLOGIST, V41, P236; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Sutherland AG, 2006, J TRAUMA, V61, P1408, DOI 10.1097/01.ta.0000197562.34651.df; Tan S, 2012, TIJDSCHR GEZONDHEIDS, V90, P367, DOI DOI 10.1007/S12508-012-0128-3; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Van Beeck EF, 2007, J TRAUMA, V62, P534, DOI 10.1097/TA.0b013e31802e70c7; van Delft-Schreurs CCHM, 2014, QUAL LIFE RES, V23, P1353, DOI 10.1007/s11136-013-0546-y; van Delft-Schreurs CCHM, 2014, INJURY, V45, P320, DOI 10.1016/j.injury.2013.02.025; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; van Erp S, 2014, INJURY, V45, P629, DOI 10.1016/j.injury.2013.10.019; vanRoijen L, 1996, INT J TECHNOL ASSESS, V12, P405, DOI 10.1017/S0266462300009764; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; von Steinbuechel N., 2014, EUR HLTH PSYCHOL S, V16, P642; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williamson OD, 2011, J TRAUMA, V71, P63, DOI 10.1097/TA.0b013e31820e898d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wohlfarth TD, 2003, PSYCHOL ASSESSMENT, V15, P101, DOI 10.1037/1040-3590.15.1.101; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	90	27	27	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	FEB	2017	23	1					59	U108		10.1136/injuryprev-2016-042032			9	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	EJ6IT	WOS:000393323400011	27154507				2022-02-06	
J	MacPhersona, SE; Healy, C; Allerhanda, M; Spano, B; Tudor-Sfetea, C; White, M; Smirnif, D; Shalliceg, T; Chan, E; Bozzali, M; Cipolotti, L				MacPhersona, Sarah E.; Healy, Colm; Allerhanda, Michael; Spano, Barbara; Tudor-Sfetea, Carina; White, Mark; Smirni, Daniela; Shalliceg, Tim; Chan, Edgar; Bozzali, Marco; Cipolotti, Lisa			Cognitive reserve and cognitive performance of patients with focal frontal lesions	NEUROPSYCHOLOGIA			English	Article						Cognitive reserve; Frontal lesions; Education; Literacy attainment; Cognitive performance; Age	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; SOCIOECONOMIC-STATUS; EDUCATION; DECLINE; DEMENTIA; AGE; MEMORY; IMPACT; PATHOLOGY	The Cognitive reserve (CR) hypothesis was put forward to account for the variability in cognitive performance of patients with similar degrees of brain pathology. Compensatory neural activity within the frontal lobes has often been associated with CR. For the first time we investigated the independent effects of two CR proxies, education and NART IQ, on measures of executive function, fluid intelligence, speed of information processing, verbal short term memory (vSTM), naming, and perception in a sample of 86 patients with focal, unilateral frontal lesions and 142 healthy controls. We fitted multiple linear regression models for each of the cognitive measures and found that only NART IQ predicted executive and naming performance. Neither education nor NART IQ predicted performance on fluid intelligence, processing speed, vSTM or perceptual abilities. Education and NART IQ did not modify the effect of lesion severity on cognitive impairment. We also found that age significantly predicted performance on executive tests and the majority of our other cognitive measures, except vSTM and GNT. Age was the only predictor for fluid intelligence. This latter finding suggests that age plays a role in executive performance over and above the contribution of CR proxies in patients with focal frontal lesions. Overall, our results suggest that the CR proxies do not appear to modify the relationship between cognitive impairment and frontal lesions.	[MacPhersona, Sarah E.; Allerhanda, Michael] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [MacPhersona, Sarah E.; Allerhanda, Michael] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Healy, Colm; Tudor-Sfetea, Carina; Chan, Edgar; Cipolotti, Lisa] Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, London, England; [Spano, Barbara; Bozzali, Marco] Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [White, Mark] Natl Hosp Neurol & Neurosurg, Dept Neuroradiol, London, England; [Smirni, Daniela; Cipolotti, Lisa] Univ Palermo, Dipartimento Sci Psicol Pedagog & Formaz, Palermo, Italy; [Shalliceg, Tim] UCL, Inst Cognit Neurosci, London WC1E 6BT, England; [Shalliceg, Tim] Int Sch Adv Studies SISSA ISAS, Trieste, Italy		Cipolotti, L (corresponding author), Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, London, England.; Cipolotti, L (corresponding author), Univ Palermo, Dipartimento Sci Psicol Pedagog & Formaz, Palermo, Italy.	l.cipolotti@ucl.ac.uk	Bozzali, Marco/AAC-1031-2022; Smirni, Daniela/R-3445-2019; Spano', Barbara/AAG-1671-2021	Smirni, Daniela/0000-0002-4410-2047; Spano', Barbara/0000-0002-5291-0984; cipolotti, lisa/0000-0001-5838-3647; Healy, Colm/0000-0001-7974-1861; MacPherson, Sarah E./0000-0001-8676-6514; Bozzali, Marco/0000-0002-0568-2026	Wellcome TrustWellcome TrustEuropean Commission [089231/A/09/Z]; Department of Health's National Institute for Health Research Biomedical Research Centre's funding schemeNational Institute for Health Research (NIHR); Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/K026992/1] Funding Source: researchfish	This work was supported by the Wellcome Trust Grant (089231/A/09/Z). This work was undertaken at UCLH/UCL, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme.	Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Allerhand M, 2014, PSYCHOL AGING, V29, P306, DOI 10.1037/a0036551; Arenaza-Urquijo EM, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00134; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Benedict RHB, 2010, J INT NEUROPSYCH SOC, V16, P829, DOI 10.1017/S1355617710000688; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Bozzali M, 2015, J ALZHEIMERS DIS, V44, P243, DOI 10.3233/JAD-141824; Brickman AM, 2011, NEUROBIOL AGING, V32, P1588, DOI 10.1016/j.neurobiolaging.2009.10.013; Cipolotti L, 2016, NEUROPSYCHOLOGIA, V93, P1, DOI 10.1016/j.neuropsychologia.2016.09.018; Cipolotti L, 2015, NEUROPSYCHOLOGIA, V75, P233, DOI 10.1016/j.neuropsychologia.2015.06.011; Cipolotti L, 2015, NEUROPSYCHOLOGIA, V68, P21, DOI 10.1016/j.neuropsychologia.2014.12.025; Deary IJ, 2015, INTELLIGENCE, V50, P1, DOI 10.1016/j.intell.2015.02.002; Duvernoy H.M, 1991, HUMAN BRAIN STRUCTUR; Elderkin-Thompson V, 2008, NEUROPSYCHOLOGY, V22, P626, DOI 10.1037/0894-4105.22.5.626; Elkins JS, 2006, NEUROLOGY, V67, P435, DOI 10.1212/01.wnl.0000228246.89109.98; Farfel JM, 2013, NEUROLOGY, V81, P650, DOI 10.1212/WNL.0b013e3182a08f1b; Gonzalez-Fernandez M, 2011, ARCH PHYS MED REHAB, V92, P1809, DOI 10.1016/j.apmr.2011.05.026; GRAFMAN J, 1986, J NEUROSCI, V6, P301; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Ikanga J, 2017, J CLIN EXP NEUROPSYC, V39, P72, DOI 10.1080/13803395.2016.1201462; Jefferson AL, 2011, J AM GERIATR SOC, V59, P1403, DOI 10.1111/j.1532-5415.2011.03499.x; Jones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748; Kaleita TA, 2004, J NEURO-ONCOL, V67, P245, DOI 10.1023/B:NEON.0000021900.29176.58; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; Lindenberger U., 2013, PRINCIPLES FRONTAL L, P609; Liu YY, 2013, J CLIN NEUROSCI, V20, P548, DOI 10.1016/j.jocn.2012.04.020; Lo RY, 2013, ALZ DIS ASSOC DIS, V27, P343, DOI 10.1097/WAD.0b013e3182900b2b; MacPherson SE, 2016, NEUROPSYCHOLOGY, V30, P332, DOI 10.1037/neu0000240; MacPherson SE, 2010, NEUROPSYCHOLOGIA, V48, P3679, DOI 10.1016/j.neuropsychologia.2010.07.033; Manly JJ, 2003, J CLIN EXP NEUROPSYC, V25, P680, DOI 10.1076/jcen.25.5.680.14579; McKenna P., 1983, GRADED NAMING TEST; Meguro K, 2001, PSYCHIAT CLIN NEUROS, V55, P565, DOI 10.1046/j.1440-1819.2001.00907.x; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Mirowsky J, 2005, AGEING INT, V30, P27, DOI 10.1007/BF02681006; Morris JC, 2005, ALZ DIS ASSOC DIS, V19, P163; Murphy P, 2013, NEUROPSYCHOLOGIA, V51, P2075, DOI 10.1016/j.neuropsychologia.2013.06.029; Murray AD, 2011, BRAIN, V134, P3684, DOI 10.1093/brain/awr259; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Nelson H.E., 1982, NATL ADULT READING T; Ngandu T, 2007, NEUROLOGY, V69, P1442, DOI 10.1212/01.wnl.0000277456.29440.16; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Ojala-Oksala J, 2012, STROKE, V43, P2931, DOI 10.1161/STROKEAHA.112.667618; Okonkwo OC, 2014, NEUROLOGY, V83, P1753, DOI 10.1212/WNL.0000000000000964; Opdebeeck C, 2016, AGING NEUROPSYCHOL C, V23, P40, DOI 10.1080/13825585.2015.1041450; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Perneczky R, 2006, J NEUROL NEUROSUR PS, V77, P1060, DOI 10.1136/jnnp.2006.094714; Persson N, 2016, NEUROIMAGE, V126, P15, DOI 10.1016/j.neuroimage.2015.11.028; Raven J, 1998, MANUAL RAVENS PROGR; Raven J.C., 1976, MANUAL ADV PROGR MAT; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raz N, 2007, NEUROPSYCHOLOGY, V21, P149, DOI 10.1037/0894-4105.21.2.149; Reitan RM, 1992, TRAIL MAKING TEST MA; Reuter-Lorenz PA, 2014, NEUROPSYCHOL REV, V24, P355, DOI 10.1007/s11065-014-9270-9; Richards M, 2003, J CLIN EXP NEUROPSYC, V25, P614, DOI 10.1076/jcen.25.5.614.14581; Ritchie SJ, 2013, PSYCHOL AGING, V28, P515, DOI 10.1037/a0030820; Robertson IH, 2014, NEUROBIOL AGING, V35, P1375, DOI 10.1016/j.neurobiolaging.2013.11.028; Robinson G, 2012, BRAIN, V135, P2202, DOI 10.1093/brain/aws142; Robinson GA, 2015, BRAIN, V138, P1084, DOI 10.1093/brain/awv003; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Ryan NS, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt91; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Scarmeas N, 2006, J NEUROL NEUROSUR PS, V77, P308, DOI 10.1136/jnnp.2005.072306; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Serra L., 2014, NEUROBIOL AGING, P1; Siedlecki KL, 2009, J INT NEUROPSYCH SOC, V15, P558, DOI 10.1017/S1355617709090857; Singh-Manoux A, 2011, ANN NEUROL, V70, P296, DOI 10.1002/ana.22391; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2008, CEREB CORTEX, V18, P959, DOI 10.1093/cercor/bhm134; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Suchy Y, 2011, J CLIN EXP NEUROPSYC, V33, P92, DOI 10.1080/13803395.2010.493148; Sumowski JF, 2014, NEUROLOGY, V82, P1776, DOI 10.1212/WNL.0000000000000433; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Trenerry M.R., 1989, SHOOP NEUROPSYCHOLOG; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354; Tucker-Drob EA, 2009, DEV PSYCHOL, V45, P431, DOI 10.1037/a0014012; Valenzuela MJ, 2006, PSYCHOL MED, V36, P1065, DOI 10.1017/S0033291706007744; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Vemuri P, 2011, BRAIN, V134, P1479, DOI 10.1093/brain/awr049; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; Warrington E. K., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wechsler D., 1981, WAIS R MANUAL WECHSL; WIENS AN, 1993, CLIN NEUROPSYCHOL, V7, P70, DOI 10.1080/13854049308401889; Xu W, 2015, MOL NEUROBIOL, V51, P187, DOI 10.1007/s12035-014-8720-y; Zahodne LB, 2011, J INT NEUROPSYCH SOC, V17, P1039, DOI 10.1017/S1355617711001044; Zieren N, 2013, NEUROBIOL AGING, V34, P400, DOI 10.1016/j.neurobiolaging.2012.04.019	89	27	27	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	FEB	2017	96						19	28		10.1016/j.neuropsychologia.2016.12.028			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	EM3LQ	WOS:000395216900003	28041947	Green Published, Green Accepted, hybrid			2022-02-06	
J	Roberts, SP; Trewartha, G; England, M; Goodison, W; Stokes, KA				Roberts, Simon P.; Trewartha, Grant; England, Michael; Goodison, William; Stokes, Keith A.			Concussions and Head Injuries in English Community Rugby Union Match Play	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						rugby union; concussion; injury; epidemiology	PERFORMANCE PROJECT; CONSENSUS STATEMENT; EPIDEMIOLOGY; METAANALYSIS; COHORT; RISK	Background: Previous research has described general injury patterns in community-level rugby union, but specific information on time-loss head injuries has not been reported. Purpose: To establish the incidence and nature of significant time-loss head injuries in English community rugby match play, and to identify the injury risk for specific contact events. Study Design: Descriptive epidemiology study. Methods: Over 6 seasons, injury information was collected from 46 (2009-2010), 67 (2010-2011), 76 (2011-2012), 50 (2012-2013), 67 (2013-2014), and 58 (2014-2015) English community rugby clubs (Rugby Football Union levels 3-9) over a total of 175,940 hours of player match exposure. Club injury management staff reported information for all head injuries sustained during match play whereby the player was absent for 8 days or greater. Clubs were subdivided into semiprofessional (mean player age, 24.6 4.7 years), amateur (24.9 5.1 years), and recreational (25.6 +/- 6.1 years) playing levels. Contact events from a sample of 30 matches filmed over seasons 2009-2010, 2010-2011, and 2011-2012 provided mean values for the frequency of contact events. Results: The overall incidence for time-loss head injuries was 2.43 injuries per 1000 player match hours, with a higher incidence for the amateur (2.78; 95% CI, 2.37-3.20) compared with recreational (2.20; 95% CI, 1.86-2.53) (P = .032) playing level but not different to the semiprofessional (2.31; 95% CI, 1.83-2.79) playing level. Concussion was the most common time-loss head injury, with 1.46 per 1000 player match hours. The tackle event was associated with 64% of all head injuries and 74% of all concussions. There was also a higher risk of injuries per tackle (0.33 per 1000 events; 95% CI, 0.30-0.37) compared with all other contact events. Conclusion: Concussion was the most common head injury diagnosis, although it is likely that this injury was underreported. Continuing education programs for medical staff and players are essential for the improved identification and management of these injuries. With the majority of head injuries occurring during a tackle, an improved technique in this contact event through coach and player education may be effective in reducing these injuries.	[Roberts, Simon P.; Trewartha, Grant; England, Michael; Goodison, William; Stokes, Keith A.] Univ Bath, Bath, Avon, England; [Roberts, Simon P.; Trewartha, Grant; Stokes, Keith A.] Univ Bath, Dept Hlth, 1 West 4-112, Bath BA2 7AY, Avon, England; [England, Michael] Rugby Football Union, Twickenham, England; [Goodison, William] Royal Natl Orthopaed Hosp, Stanmore, Middx, England		Roberts, SP (corresponding author), Univ Bath, Dept Hlth, 1 West 4-112, Bath BA2 7AY, Avon, England.	s.p.roberts@bath.ac.uk	; Stokes, Keith/C-2605-2009	Goodison, William/0000-0002-4109-9049; Stokes, Keith/0000-0002-5049-2838	RFU Injured Players Foundation	The study was funded by a grant from the RFU Injured Players Foundation in which S.P.R., G.T., and K.A.S. are investigators.	Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Best JP, 2005, BRIT J SPORT MED, V39, P812, DOI 10.1136/bjsm.2004.016402; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2007, CLIN J SPORT MED, V17, P177, DOI 10.1097/JSM.0b013e31803220b3; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Holtzhausen LJ, 2006, SAMJ S AFR MED J, V96, P1260; Kemp S, ENGLAND PROFESSIONAL; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Mcintosh AS, 2010, MED SCI SPORT EXER, V42, P977, DOI 10.1249/MSS.0b013e3181c07b5b; McIntosh AS, 2008, RUGBY UNION INJURY S; Quarrie KL, 2001, BRIT J SPORT MED, V35, P157, DOI 10.1136/bjsm.35.3.157; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Roberts SP, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114562781; Roberts SP, 2015, BRIT J SPORT MED, V49, P536, DOI 10.1136/bjsports-2013-092988; Roberts SP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003998; Rugby Football Union, CONC HEADC; Schneiders AG, 2009, PHYS THER SPORT, V10, P85, DOI 10.1016/j.ptsp.2009.05.001; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; World Rugby, CONC GUID	30	27	27	2	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	FEB	2017	45	2					480	487		10.1177/0363546516668296			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	EL7BU	WOS:000394776900029	28146395	Green Accepted			2022-02-06	
J	Tamargo, IA; Bader, M; Li, YZ; Yu, SJ; Wang, Y; Talbot, K; DiMarchi, RD; Pick, CG; Greig, NH				Tamargo, Ian A.; Bader, Miaad; Li, Yazhou; Yu, Seong-Jin; Wang, Yun; Talbot, Konrad; DiMarchi, Richard D.; Pick, Chaim G.; Greig, Nigel H.			Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Neurodegeneration; Incretin mimetic; Incretin; Glucagon-like peptide-1; Glucose-dependent insulinotropic peptide	GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; REVERSES BEHAVIORAL IMPAIRMENTS; SECONDARY NEURONAL DAMAGE; FOCAL CEREBRAL-ISCHEMIA; RECEPTOR AGONIST; PARKINSONS-DISEASE; MOUSE MODEL; GENE-EXPRESSION; HEAD-INJURY	Several single incretin receptor agonists that are approved for the treatment of type 2 diabetes mellitus (T2DM) have been shown to be neuroprotective in cell and animal models of neurodegeneration. Recently, a synthetic dual incretin receptor agonist, nicknamed "twincretin," was shown to improve upon the metabolic benefits of single receptor agonists in mouse and monkey models of T2DM. In the current study, the neuroprotective effects of twincretin are probed in cell and mouse models of mild traumatic brain injury (mTBI), a prevalent cause of neurodegeneration in toddlers, teenagers and the elderly. Twincretin is herein shown to have activity at two different receptors, dose-dependently increase levels of intermediates in the neurotrophic CREB pathway and enhance viability of human neuroblastoma cells exposed to toxic concentrations of glutamate and hydrogen peroxide, insults mimicking the inflammatory conditions in the brain post-mTBI. Additionally, twincretin is shown to improve upon the neurotrophic effects of single incretin receptor agonists in these same cells. Finally, a clinically translatable dose of twincretin, when administered post-mTBI, is shown to fully restore the visual and spatial memory deficits induced by mTBI, as evaluated in a mouse model of weight drop close head injury. These results establish twincretin as a novel neuroprotective agent and suggest that it may improve upon the effects of the single incretin receptor agonists via dual agonism. Published by Elsevier Inc.	[Tamargo, Ian A.; Li, Yazhou; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Bader, Miaad; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, Tel Aviv, Israel; [Yu, Seong-Jin; Wang, Yun] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan; [Talbot, Konrad] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA USA; [DiMarchi, Richard D.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel		Tamargo, IA; Greig, NH (corresponding author), NIA, Drug Design & Dev Sect, Translat Gerontol Branch, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	iatamargo@gmail.com; Greign@mail.nih.gov		Talbot, Konrad/0000-0003-4549-0835	Intramural Research Program of the National Institute on Aging, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG000333]; Ari and Regine Aprijaskis Fund at Tel-Aviv University; Israel Science FoundationIsrael Science Foundation [108/09]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000333] Funding Source: NIH RePORTER	This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, grant number AG000333 (2016), (ii) the Ari and Regine Aprijaskis Fund at Tel-Aviv University, and (iii) a grant from the Israel Science Foundation, grant number 108/09.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Al-Sabah S, 2014, EUR J PHARMACOL, V741, P311, DOI 10.1016/j.ejphar.2014.08.019; Alcalay RN, 2004, NEUROSCI LETT, V361, P128, DOI 10.1016/j.neulet.2003.12.005; Alvarez E, 2005, J NEUROCHEM, V92, P798, DOI 10.1111/j.1471-4159.2004.02914.x; Anderberg RH, 2016, PSYCHONEUROENDOCRINO, V65, P54, DOI 10.1016/j.psyneuen.2015.11.021; Athauda D, 2016, DRUG DISCOV TODAY, V21, P802, DOI 10.1016/j.drudis.2016.01.013; Bales James W, 2010, Open Drug Discov J, V2, P119; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barkhoudarian G., 2011, SPORTS MED, V30, pvii; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Belzung C, 2001, BEHAV BRAIN RES, V125, P141, DOI 10.1016/S0166-4328(01)00291-1; Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483; Briyal S, 2012, BRAIN RES, V1427, P23, DOI 10.1016/j.brainres.2011.10.026; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Cao L, 2016, NEUROREPORT; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen Y, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00022; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; CICCARONE V, 1989, CANCER RES, V49, P219; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; De Toro-Martin J, 2014, ENDOCRINOLOGY, V155, P3769, DOI 10.1210/en.2013-2043; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Deselms H., 2016, J NEUROSCI METH; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Doulames VM, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00369, 10.3389/fnbeh.2015.00275]; Duarte AI, 2013, BBA-MOL BASIS DIS, V1832, P527, DOI 10.1016/j.bbadis.2013.01.008; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Faul M, 2010, TRAUMATIC BRAIN INJU; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gault VA, 2003, DIABETOLOGIA, V46, P222, DOI 10.1007/s00125-002-1028-x; Gault VA, 2002, BIOCHEM BIOPH RES CO, V290, P1420, DOI 10.1006/bbrc.2002.6364; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Han L, 2016, NEUROREPORT, V27, P23, DOI 10.1097/WNR.0000000000000490; Hansen HH, 2015, J ALZHEIMERS DIS, V46, P877, DOI 10.3233/JAD-143090; Harkavyi A, 2010, BRIT J PHARMACOL, V159, P495, DOI 10.1111/j.1476-5381.2009.00486.x; Holscher C, 2014, J ENDOCRINOL, V221, pT31, DOI 10.1530/JOE-13-0221; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Isacson R, 2011, EUR J PHARMACOL, V650, P249, DOI 10.1016/j.ejphar.2010.10.008; Ji CH, 2016, BRAIN RES, V1634, P1, DOI 10.1016/j.brainres.2015.09.035; Kastin AJ, 2002, J MOL NEUROSCI, V18, P7, DOI 10.1385/JMN:18:1-2:07; Kim SJ, 2008, MOL CELL BIOL, V28, P1644, DOI 10.1128/MCB.00325-07; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Li YZ, 2010, J NEUROCHEM, V113, P1621, DOI 10.1111/j.1471-4159.2010.06731.x; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liu W, 2015, NEUROSCIENCE, V303, P42, DOI 10.1016/j.neuroscience.2015.06.054; Liu WZ, 2015, REV NEUROSCIENCE, V26, P371, DOI 10.1515/revneuro-2015-0005; Lotharius J, 1999, J NEUROSCI, V19, P1284; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; McClean PL, 2010, REGUL PEPTIDES, V164, P40, DOI 10.1016/j.regpep.2010.07.102; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Melo A, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/467180; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nyberg J, 2007, J NEUROSCI RES, V85, P2099, DOI 10.1002/jnr.21349; Orman J. A. L., 2011, EPIDEMIOLOGY TXB TRA, P3; Perry T, 2003, TRENDS PHARMACOL SCI, V24, P377, DOI 10.1016/S0165-6147(03)00160-3; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Schiehser DM, 2016, PARKINSONISM RELAT D, V30, P58, DOI 10.1016/j.parkreldis.2016.05.024; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shahaduzzaman M, 2013, MED HYPOTHESES, V81, P675, DOI 10.1016/j.mehy.2013.07.025; Shao WJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE1263, DOI 10.1152/ajpendo.00600.2012; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Sparre-Ulrich AH, 2016, BRIT J PHARMACOL, V173, P27, DOI 10.1111/bph.13323; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wu Ting, 2015, Modular Machine Tool & Automatic Manufacturing Technique, P137, DOI 10.13462/j.cnki.mmtamt.2015.06.037; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	90	27	27	0	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2017	288						176	186		10.1016/j.expneurol.2016.11.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EI4JY	WOS:000392461100017	27845037	Green Accepted			2022-02-06	
J	Yuan, WH; Treble-Barna, A; Sohlberg, MM; Harn, B; Wade, SL				Yuan, Weihong; Treble-Barna, Amery; Sohlberg, McKay M.; Harn, Beth; Wade, Shari L.			Changes in Structural Connectivity Following a Cognitive Intervention in Children With Traumatic Brain Injury: A Pilot Study	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; structural connectivity; graph theoretical analysis; diffusion tensor imaging; behavioral assessment; cognitive intervention; neuroplasticity	DIFFUSION TENSOR; WHITE-MATTER; EXECUTIVE FUNCTIONS; WORKING-MEMORY; AXONAL INJURY; ATTENTION; ADHD; ACTIVATION; IMPAIRMENT; PLASTICITY	Objective. Structural connectivity analysis based on graph theory and diffusion tensor imaging tractography is a novel method that quantifies the topological characteristics in the brain network. This study aimed to examine structural connectivity changes following the Attention Intervention and Management (AIM) program designed to improve attention and executive function (EF) in children with traumatic brain injury (TBI). Methods. Seventeen children with complicated mild to severe TBI (13.66 +/- 2.68 years; >12 months postinjury) completed magnetic resonance imaging (MRI) and neurobehavioral measures at time 1, 10 of whom completed AIM and assessment at time 2. Eleven matched healthy comparison (HC) children (13.37 +/- 2.08 years) completed MRI and neurobehavioral assessment at both time points, but did not complete AIM. Network characteristics were analyzed to quantify the structural connectivity before and after the intervention. Results. Mixed model analyses showed that small-worldness was significantly higher in the TBI group than the HC group at time 1, and both small-worldness and normalized clustering coefficient decreased significantly at time 2 in the TBI group whereas the HC group remained relatively unchanged. Reductions in mean local efficiency were significantly correlated with improvements in verbal inhibition and both parent- and child-reported EF. Increased normalized characteristic path length was significantly correlated with improved sustained attention. Conclusion. The results provide preliminary evidence suggesting that graph theoretical analysis may be a sensitive tool in pediatric TBI for detecting (a) abnormalities of structural connectivity in brain network and (b) structural neuroplasticity associated with neurobehavioral improvement following a short-term intervention for attention and EF.	[Yuan, Weihong; Treble-Barna, Amery; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Yuan, Weihong; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Sohlberg, McKay M.; Harn, Beth] Univ Oregon, Eugene, OR 97403 USA		Yuan, WH (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, 3333 Burnet Ave,MLC 5033, Cincinnati, OH 45229 USA.	weihong.yuan@cchmc.org	Hassan, Randa/AAW-3624-2021		Department of Education's National Institute on Disability and Rehabilitation Research (Center on Intervention for Children and Youth with Traumatic Brain Injury) [H133B090010-10]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90RT5004]; Emergency Medical Services Grant from the Ohio Department of Public Safety Emergency Medical Services; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by the Department of Education's National Institute on Disability and Rehabilitation Research (Center on Intervention for Children and Youth with Traumatic Brain Injury; Grant No. H133B090010-10, PI Wade), the National Institute on Disability, Independent Living, and Rehabilitation Research (Grant No. 90RT5004, PI Wade), and an Emergency Medical Services Grant from the Ohio Department of Public Safety Emergency Medical Services (Title: The Effects of Cognitive Training on Attention and Neural Processing Following Pediatric TBI, PIs Wade/Yuan).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Bryden DW, 2015, J NEUROSCI, V35, P3903, DOI 10.1523/JNEUROSCI.3587-14.2015; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Butler RW, 2008, J CONSULT CLIN PSYCH, V76, P367, DOI 10.1037/0022-006X.76.3.367; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cohen J., 1988, STAT POWER ANAL BEHA; Curtis CE, 2006, HDB FUNCTIONAL NEURO, P269; Delis D., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; Engvig A, 2012, HUM BRAIN MAPP, V33, P2390, DOI 10.1002/hbm.21370; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Gebauer D, 2012, BRAIN STRUCT FUNCT, V217, P747, DOI 10.1007/s00429-011-0371-4; Gioia GA IP, 2000, BEHAV RATING INVENTO; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Karch S, 2009, HUM BRAIN MAPP, V30, P2971, DOI 10.1002/hbm.20722; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lazaridou A, 2013, INT J MOL MED, V32, P995, DOI 10.3892/ijmm.2013.1476; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lovden M, 2010, NEUROPSYCHOLOGIA, V48, P3878, DOI 10.1016/j.neuropsychologia.2010.08.026; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Neufang S, 2008, NEUROIMAGE, V43, P399, DOI 10.1016/j.neuroimage.2008.07.039; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prosperini L, 2013, NEUROREHAB NEURAL RE, V27, P516, DOI 10.1177/1545968313478484; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schlaug G, 2009, ANN NY ACAD SCI, V1169, P385, DOI 10.1111/j.1749-6632.2009.04587.x; Sisti HM, 2012, LEARN MEMORY, V19, P351, DOI 10.1101/lm.026534.112; Sohlberg MM, 2003, BRAIN INJURY, V17, P609, DOI 10.1080/0269905031000070189; Sohlberg MM., 2014, CLIN PRACT PEDIAT PS, V2, P263, DOI [10.1037/cpp0000072, DOI 10.1037/CPP0000072]; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Strangman GE, 2012, NEUROREHABILITATION, V31, P295, DOI 10.3233/NRE-2012-0797; Susanto TAK, 2015, J ALZHEIMERS DIS, V45, P253, DOI 10.3233/JAD-142451; Takeuchi H, 2013, BRAIN STRUCT FUNCT, V218, P1017, DOI 10.1007/s00429-012-0444-z; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Treble-Barna A, 2016, J HEAD TRAUMA REHAB, V31, P407, DOI 10.1097/HTR.0000000000000200; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Wang SH, 2013, CLIN NEUROPHYSIOL, V124, P2181, DOI 10.1016/j.clinph.2013.05.008; Wolraich ML, 2003, J PEDIATR PSYCHOL, V28, P559, DOI 10.1093/jpepsy/jsg046; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664	57	27	27	3	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	FEB	2017	31	2					190	201		10.1177/1545968316675430			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EO8DU	WOS:000396920000008	27798379	Bronze			2022-02-06	
J	Bell, KR; Fann, JR; Brockway, JA; Cole, WR; Bush, NE; Dikmen, S; Hart, T; Lang, AJ; Grant, G; Gahm, G; Reger, MA; St De Lore, J; Machamer, J; Ernstrom, K; Raman, R; Jain, S; Stein, MB; Temkin, N				Bell, Kathleen R.; Fann, Jesse R.; Brockway, Jo Ann; Cole, Wesley R.; Bush, Nigel E.; Dikmen, Sureyya; Hart, Tessa; Lang, Ariel J.; Grant, Gerald; Gahm, Gregory; Reger, Mark A.; St De Lore, Jef; Machamer, Joan; Ernstrom, Karin; Raman, Rema; Jain, Sonia; Stein, Murray B.; Temkin, Nancy		INTRuST Investigators	Telephone Problem Solving for Service Members with Mild Traumatic Brain Injury: A Randomized, Clinical Trial	JOURNAL OF NEUROTRAUMA			English	Article						mild traumatic brain injury; problem-solving treatment (or training or therapy); service members (or military); telehealth	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH-CARE; 1ST YEAR; DEPRESSION; SYMPTOMS; INTERVENTION; THERAPY; VETERANS; PTSD; RELIABILITY	Mild traumatic brain injury (mTBI) is a common injury for service members in recent military conflicts. There is insufficient evidence of how best to treat the consequences of mTBI. In a randomized, clinical trial, we evaluated the efficacy of telephone-delivered problem-solving treatment (PST) on psychological and physical symptoms in 356 post-deployment active duty service members from Joint Base Lewis McChord, Washington, and Fort Bragg, North Carolina. Members with medically confirmed mTBI sustained during deployment to Iraq and Afghanistan within the previous 24 months received PST or education-only (EO) interventions. The PST group received up to 12 biweekly telephone calls from a counselor for subject-selected problems. Both groups received 12 educational brochures describing common mTBI and post-deployment problems, with follow-up for all at 6 months (end of PST), and at 12 months. At 6 months, the PST group significantly improved on a measure of psychological distress (Brief Symptom Inventory; BSI-18) compared to the EO group (p = 0.005), but not on post-concussion symptoms (Rivermead Post-Concussion Symptoms Questionnaire [RPQ]; p = 0.19), the two primary endpoints. However, these effects did not persist at 12-month follow-up (BSI, p = 0.54; RPQ, p = 0.45). The PST group also had significant short-term improvement on secondary endpoints, including sleep (p = 0.01), depression (p = 0.03), post-traumatic stress disorder (p = 0.04), and physical functioning (p = 0.03). Participants preferred PST overEO(p < 0.001). Telephone-delivered PST appears to be a well-accepted treatment that offers promise for reducing psychological distress after combat-related mTBI and could be a useful adjunct treatment post-mTBI. Further studies are required to determine how to sustain its effects. (Trial registration: ClinicalTrials.gov Identifier: NCT01387490 https://clinicaltrials. gov)	[Bell, Kathleen R.; Fann, Jesse R.; Brockway, Jo Ann; Dikmen, Sureyya; Machamer, Joan; Temkin, Nancy] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Cole, Wesley R.] Womack Army Med Ctr, Def & Vet Brain Injury Ctr, Intrepid Spirit, Ft Bragg, NC USA; [Bush, Nigel E.; Gahm, Gregory; Reger, Mark A.] Natl Ctr Telehealth & Technol, Joint Base Lewis McChord, Tacoma, WA USA; [Dikmen, Sureyya; St De Lore, Jef; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Lang, Ariel J.; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Lang, Ariel J.; Stein, Murray B.] VA San Diego Healthcare Syst Ctr Excellence Stres, La Jolla, CA 92093 USA; [Grant, Gerald] Duke Univ, Dept Surg, Durham, NC USA; [Ernstrom, Karin; Raman, Rema; Jain, Sonia; Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Bell, Kathleen R.] Univ Texas Southwestern, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Grant, Gerald] Stanford Univ, Dept Neurosurg, Palo Alto, CA 94304 USA; [Ernstrom, Karin; Raman, Rema] Univ Southern Calif, Alzheimers Therapeut Res Inst, San Diego, CA USA		Bell, KR (corresponding author), Univ Texas Southwestern, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Kathleen.Bell@UTSouthwestern.edu		Bush, Nigel/0000-0002-8137-7998; Bell, Kathleen/0000-0002-0928-2046	U.S. Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-2-0159]; National Institute on Disability and Rehabilitation Research [H133G070143]	This study was supported by the U.S. Army Medical Research and Materiel Command (USAMRMC; contract no.: W81XWH-08-2-0159). Supplementary support was provided by the National Institute on Disability and Rehabilitation Research (grant no.: H133G070143).	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Arean P, 2008, GERONTOLOGIST, V48, P311, DOI 10.1093/geront/48.3.311; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Bell AC, 2009, CLIN PSYCHOL REV, V29, P348, DOI 10.1016/j.cpr.2009.02.003; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2015, CONTEMP CLIN TRIALS, V40, P54, DOI 10.1016/j.cct.2014.11.001; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bush NE, 2013, MIL MED, V178, P1157, DOI 10.7205/MILMED-D-13-00234; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Choi NG, 2014, DEPRESS ANXIETY, V31, P653, DOI 10.1002/da.22242; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hopko DR, 2011, J CONSULT CLIN PSYCH, V79, P834, DOI 10.1037/a0025450; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnson DR, 1997, J TRAUMA STRESS, V10, P391, DOI 10.1023/A:1024885103409; Kasckow J, 2012, INT J GERIATR PSYCH, V27, P1106, DOI 10.1002/gps.2826; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Ladouceur R, 2000, J CONSULT CLIN PSYCH, V68, P957, DOI 10.1037/0022-006X.68.6.957; Marx B. P., 2009, 25 ANN M INT SOC TRA; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilson JAB, 2008, CYBERPSYCHOL BEHAV, V11, P767, DOI 10.1089/cpb.2008.0071	41	27	27	1	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					313	321		10.1089/neu.2016.4444			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800006	27579992	Green Published			2022-02-06	
J	Naci, L; Sinai, L; Owen, AM				Naci, Lorina; Sinai, Leah; Owen, Adrian M.			Detecting and interpreting conscious experiences in behaviorally non-responsive patients	NEUROIMAGE			English	Article							INDEPENDENT COMPONENT ANALYSIS; NATURAL VIEWING CONDITIONS; TRAUMATIC BRAIN-INJURY; SPATIAL NORMALIZATION; SUSTAINED ATTENTION; DISORDERS; AWARENESS; STATE; ACCURACY; CORTEX	Decoding the contents of consciousness from brain activity is one of the most challenging frontiers of cognitive neuroscience. The ability to interpret mental content without recourse to behavior is most relevant for understanding patients who may be demonstrably conscious, but entirely unable to speak or move willfully in any way, precluding any systematic investigation of their conscious experience. The lack of consistent behavioral responsivity engenders unique challenges to decoding any conscious experiences these patients may have solely based on their brain activity. For this reason, paradigms that have been successful in healthy individuals cannot serve to interpret conscious mental states in this patient group. Until recently, patient studies have used structured instructions to elicit willful modulation of brain activity according to command, in order to decode the presence of willful brain-based responses in this patient group. In recent work, we have used naturalistic paradigms, such as watching a movie or listening to an audio-story, to demonstrate that a common neural code supports conscious experiences in different individuals. Moreover, we have demonstrated that this code can be used to interpret the conscious experiences of a patient who had remained non-responsive for several years. This approach is easy to administer, brief, and does not require compliance with task instructions. Rather, it engages attention naturally through meaningful stimuli that are similar to the real-world sensory information in a patient's environment. Therefore, it may be particularly suited to probing consciousness and revealing residual brain function in highly impaired, acute, patients in a comatose state, thus helping to improve diagnostication and prognostication for this vulnerable patient group from the critical early stages of severe brain-injury. (C) 2015 Elsevier Inc. All rights reserved.	[Naci, Lorina; Sinai, Leah; Owen, Adrian M.] Univ Western ON, Dept Psychol, Brain & Mind Inst, London, ON N6A 5B7, Canada		Naci, L (corresponding author), Univ Western ON, Dept Psychol, Brain & Mind Inst, London, ON N6A 5B7, Canada.	lnaci@uwo.ca		Naci, Lorina/0000-0001-9630-3978	Canada Excellence Research Chairs (CERC) program [215063]	We thank Conor Wild and Rhodri Cusack for their help with the stimuli. This research was supported by the Canada Excellence Research Chairs (CERC) (215063) program.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Bardin JC, 2012, ARCH NEUROL-CHICAGO, V69, P176, DOI 10.1001/archneurol.2011.892; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Bartels A, 2008, CEREB CORTEX, V18, P705, DOI 10.1093/cercor/bhm107; Bartels A, 2004, NEUROIMAGE, V22, P419, DOI 10.1016/j.neuroimage.2004.01.007; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2005, NEUROIMAGE, V25, P294, DOI 10.1016/j.neuroimage.2004.10.043; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beisteiner R, 2010, HUM BRAIN MAPP, V31, P1951, DOI 10.1002/hbm.20990; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Chennu S, 2013, NEUROIMAGE-CLIN, V3, P450, DOI 10.1016/j.nicl.2013.10.008; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Chung CSY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008391.pub2; Collette F, 2005, COGNITIVE BRAIN RES, V24, P237, DOI 10.1016/j.cogbrainres.2005.01.023; Crinion J, 2007, NEUROIMAGE, V37, P866, DOI 10.1016/j.neuroimage.2007.04.065; Cruse D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049933; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Datta A., 2007, COMPUT INTELL NEUROS, V2007; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Dmochowski JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5567; Dmochowski JP, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00112; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fernandez-Espejo D, 2013, NAT REV NEUROSCI, V14, P801, DOI 10.1038/nrn3608; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Hasson U, 2008, PROJECTIONS, V2, P1, DOI 10.3167/proj.2008.020102; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Hasson U, 2009, AUTISM RES, V2, P220, DOI 10.1002/aur.89; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; MacDonald AA, 2015, TRENDS COGN SCI, V19, P100, DOI 10.1016/j.tics.2014.12.005; Malinen S, 2007, NEUROIMAGE, V35, P131, DOI 10.1016/j.neuroimage.2006.11.015; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mizuno K, 2012, NEUROPSYCHOLOGIA, V50, P1998, DOI 10.1016/j.neuropsychologia.2012.04.025; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Naci L., 2015, SOC NEUR ANN M CHIC; Naci L, 2014, P NATL ACAD SCI USA, V111, P14277, DOI 10.1073/pnas.1407007111; Naci L, 2013, JAMA NEUROL, V70, P1235, DOI 10.1001/jamaneurol.2013.3686; Naci L, 2013, J NEUROSCI, V33, P9385, DOI 10.1523/JNEUROSCI.5577-12.2013; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2008, FUNCT NEUROL, V23, P189; Pettit LD, 2013, BRAIN, V136, P3290, DOI 10.1093/brain/awt243; Plum F, 1966, DIAGNOSIS STUPOR COM; Ptak R, 2012, NEUROSCIENTIST, V18, P502, DOI 10.1177/1073858411409051; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Young GB, 2009, ANN NY ACAD SCI, V1157, P32, DOI 10.1111/j.1749-6632.2009.04471.x	60	27	28	0	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	JAN 15	2017	145		B		SI		304	313		10.1016/j.neuroimage.2015.11.059			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EG3WU	WOS:000390976200015	26679327				2022-02-06	
J	Wojtowicz, M; Iverson, GL; Silverberg, ND; Mannix, R; Zafonte, R; Maxwell, B; Berkner, PD				Wojtowicz, Magdalena; Iverson, Grant L.; Silverberg, Noah D.; Mannix, Rebekah; Zafonte, Ross; Maxwell, Bruce; Berkner, Paul D.			Consistency of Self-Reported Concussion History in Adolescent Athletes	JOURNAL OF NEUROTRAUMA			English	Article						assessment tools; head trauma; pediatric brain injury	SPORT-RELATED CONCUSSIONS; STATES HIGH-SCHOOL; YOUTH ICE HOCKEY; FOOTBALL PLAYERS; NEUROCOGNITIVE PERFORMANCE; SYMPTOMS; MANAGEMENT; EPIDEMIOLOGY; DIAGNOSIS; CHILDREN	Relying on self-reported concussion injury history is common in both clinical care and research. However, young athletes may not provide consistent medical information. To date, little is known about the reliability of self-reported concussion history in high school students. This study examined whether student athletes reported their lifetime history of concussions consistently over time. Self-reported concussion history was examined in 4792 student athletes (ages 13-18) from Maine who completed a preseason health survey on two occasions (median re-test interval = 23.7 months; standard deviation = 7.3; interquartile range = 12.4-24.5). Consistency of self-reported concussion history was determined by differences in the number of concussions reported during the second survey. Inconsistent concussion history was defined primarily by a decrease in the number of lifetime concussions reported at the second testing, compared with at the first testing. The majority of the sample (80.3%) reported no change in the number of concussions between the two baseline assessments. A minority (15.9%; n = 763) reported more concussions during the second assessment. Only 3.8% (n = 181) of student athletes provided inconsistent concussion histories, defined as fewer concussions at the second assessment. Boys provided inconsistent concussion histories a little more frequently, compared with girls (5.3% and 2.0%, respectively; p < 0.001). Similarly, athletes with self-reported attention-deficit hyperactivity disorder (ADHD) provided inconsistent concussion histories somewhat more frequently, compared with those without ADHD (7.8% and 3.5%, respectively; p < 0.001). Of the athletes with inconsistent concussion histories, greater degree of inconsistency was associated with a greater number of concussions initially reported at baseline (r(s) = 0.54; p < 0.001). Only a small proportion of student athletes provided inconsistent concussion histories. Male gender, ADHD, and greater number of baseline concussions were significantly associated with inconsistency in reporting. Overall, these findings suggest that student athletes are quite consistent when reporting their concussion history when surveyed twice during high school.	[Wojtowicz, Magdalena] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Wojtowicz, Magdalena; Iverson, Grant L.; Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, 101 Merrimac 250, Boston, MA 02124 USA; [Wojtowicz, Magdalena; Iverson, Grant L.; Zafonte, Ross] MassGeneral Hosp Children Sports Concuss Program, Boston, MA USA; [Wojtowicz, Magdalena; Iverson, Grant L.; Silverberg, Noah D.; Zafonte, Ross] Red Sox Fdn, Boston, MA USA; [Wojtowicz, Magdalena; Iverson, Grant L.; Silverberg, Noah D.; Zafonte, Ross] Massachusetts Gen Hosp Home Base Program, Boston, MA USA; [Iverson, Grant L.; Silverberg, Noah D.; Zafonte, Ross] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehabil Ctr, Vancouver, BC, Canada; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Zafonte, Ross] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA		Wojtowicz, M (corresponding author), Harvard Med Sch, Dept Phys Med & Rehabil, 101 Merrimac 250, Boston, MA 02124 USA.	mwojtowicz@mgh.harvard.edu	Mannix, Rebekah/AAD-8702-2020	Iverson, Grant/0000-0001-7348-9570	Goldfarb Center for Public Policy and Civic Engagement/Colby College; Bill and Joan Alfond Foundation; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD40128-11A1]; Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members; Mooney-Reed Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758] Funding Source: NIH RePORTER	Funding source: Goldfarb Center for Public Policy and Civic Engagement/Colby College and the Bill and Joan Alfond Foundation. RM is funded by NICHD T32 HD40128-11A1. RZ was supported in part by the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. The research program at MassGeneral Hospital for Children Sport Concussion Program acknowledges funding support from the Mooney-Reed Charitable Foundation.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Belanger H. G, 2005, NEUROPSYCHOLOGICAL I, P345; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Frommer L. J., J ATHL TRAIN, V46, P76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HAREL Y, 1994, AM J PUBLIC HEALTH, V84, P599, DOI 10.2105/AJPH.84.4.599; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mckay CD, 2014, J ORTHOP SPORT PHYS, V44, P329, DOI 10.2519/jospt.2014.5053; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Sullivan L, 2016, INT J ADOLESC MED HL; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	30	27	27	0	27	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					322	327		10.1089/neu.2016.4412			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800007	27349296	Green Published			2022-02-06	
J	Carter, CJ				Carter, Chris J.			Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease	JOURNAL OF ALZHEIMERS DISEASE REPORTS			English	Article						Alzheimer's disease; bacteria; blood-brain barrier; fungi; gene/environment; immune system; inflammation; microbes; virus		Diverse pathogens are detected in Alzheimer's disease (AD) brains. A bioinformatics survey showed that AD genome-wide association study (GWAS) genes (localized in bone marrow, immune locations and microglia) relate to multiple host/pathogen interactomes (Candida albicans, Cryptococcus neoformans, Bornavirus, Borrelia burgdorferri, cytomegalovirus, Ebola virus, HSV-1, HERV-W, HIV-1, Epstein-Barr, hepatitis C, influenza, Chlamydia pneumoniae, Porphyrymonas gingivalis, Helicobacter pylori, Toxoplasma gondii, Trypanosoma cruzi). These interactomes also relate to the AD hippocampal transcriptome and to plaque or tangle proteins. Upregulated AD hippocampal genes match those upregulated by multiple bacteria, viruses, fungi, or protozoa in immunocompetent cells. AD genes are enriched in GWAS datasets reflecting pathogen diversity, suggesting selection for pathogen resistance, as supported by the old age of AD patients, implying resistance to earlier infections. APOE4 is concentrated in regions of high parasitic burden and protects against childhood tropical infections and hepatitis C. Immune/inflammatory gain of function applies to APOE4, CR1, and TREM2 variants. AD genes are also expressed in the blood-brain barrier (BBB), which is disrupted by AD risk factors (age, alcohol, aluminum, concussion, cerebral hypoperfusion, diabetes, homocysteine, hypercholesterolemia, hypertension, obesity, pesticides, pollution, physical inactivity, sleep disruption, smoking) and by pathogens, directly or via olfactory routes to basal-forebrain BBB control centers. The BBB benefits from statins, NSAIDs, estrogen, melatonin, memantine, and the Mediterranean diet. Polymicrobial involvement is supported by upregulation of bacterial, viral, and fungal sensors/defenders in the AD brain, blood, or cerebrospinal fluid. AD serum amyloid-beta autoantibodies may attenuate its antimicrobial effects favoring microbial survival and cerebral invasion leading to activation of neurodestructive immune/inflammatory processes, which may also be augmented by age-related immunosenescence. AD may thus respond to antibiotic, antifungal, or antiviral therapy.	[Carter, Chris J.] PolygenicPathways, Flat 2,40 Baldslow Rd, Hastings TN34 2EY, E Sussex, England		Carter, CJ (corresponding author), PolygenicPathways, Flat 2,40 Baldslow Rd, Hastings TN34 2EY, E Sussex, England.	chris_car@yahoo.com		Carter, Christopher/0000-0003-1368-4205			Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Abu-Qare AW, 2003, J TOXICOL ENV HEAL B, V6, P41, DOI 10.1080/10937400390155481; ADACHI T, 1990, BRAIN RES, V514, P163, DOI 10.1016/0006-8993(90)90452-H; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Ako-Adjei D, 2015, NUCLEIC ACIDS RES, V43, pD566, DOI 10.1093/nar/gku1126; Ala TA, 2004, J ALZHEIMERS DIS, V6, P503; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Alenquer M, 2015, VIRUSES-BASEL, V7, P5066, DOI 10.3390/v7092862; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Alonso R, 2017, J ALZHEIMERS DIS, V58, P55, DOI [10.3233/JAD-170058, 10.3233/jad-170058]; Alonso R, 2015, J ALZHEIMERS DIS, V47, P873, DOI 10.3233/JAD-150382; Alonso R, 2014, J ALZHEIMERS DIS, V41, P301, DOI 10.3233/JAD-132681; Arnold SE, 2010, ANN NEUROL, V67, P462, DOI 10.1002/ana.21910; Attems J, 2005, J ALZHEIMERS DIS, V7, P149; Aucan C, 2004, J MED GENET, V41, P21, DOI 10.1136/jmg.2003.011981; Badhwar A, 2014, J CEREBR BLOOD F MET, V34, P1033, DOI 10.1038/jcbfm.2014.52; Balbuena P, 2011, NEUROTOXICOLOGY, V32, P58, DOI 10.1016/j.neuro.2010.10.004; Banks WA, 1999, J NEUROVIROL, V5, P538, DOI 10.3109/13550289909021284; Baranyai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145686; Barichello T, 2015, AGING DIS, V6, P342, DOI 10.14336/AD.2015.0521; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Beard RS, 2011, BLOOD, V118, P2007, DOI 10.1182/blood-2011-02-338269; BECKER Y, 1995, VIRUS GENES, V10, P217, DOI 10.1007/BF01701811; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergen AA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2159-z; Beydoun MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-643; BIESOLD D, 1989, NEUROSCI LETT, V98, P39, DOI 10.1016/0304-3940(89)90370-4; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Boelen E, 2007, ACTA NEUROPATHOL, V114, P255, DOI 10.1007/s00401-007-0252-3; Bourgade K, 2016, J ALZHEIMERS DIS, V50, P1227, DOI 10.3233/JAD-150652; Bourgade K, 2015, BIOGERONTOLOGY, V16, P85, DOI 10.1007/s10522-014-9538-8; Branco FJ, 2005, J VIROL, V79, P9019, DOI 10.1128/JVI.79.14.9019-9025.2005; Branger P, 2016, NEUROBIOL AGING, V41, P107, DOI 10.1016/j.neurobiolaging.2016.02.009; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Brinkworth JF, 2014, CURR OPIN IMMUNOL, V31, P66, DOI 10.1016/j.coi.2014.09.008; Brison E, 2014, J VIROL, V88, P1548, DOI 10.1128/JVI.02972-13; Brkic M, 2015, J NEUROSCI, V35, P12766, DOI 10.1523/JNEUROSCI.0006-15.2015; Brunnstrom HR, 2009, EUR J NEUROL, V16, P488, DOI 10.1111/j.1468-1331.2008.02503.x; Bu XL, 2015, EUR J NEUROL, V22, P1519, DOI 10.1111/ene.12477; Bynoe MS, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0017-7; Caggiu E, 2016, J NEUROIMMUNOL, V291, P110, DOI 10.1016/j.jneuroim.2016.01.007; Cagliani Rachele, 2013, Int J Evol Biol, V2013, P204240, DOI 10.1155/2013/204240; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2015, J ALZHEIMERS DIS, V48, P1065, DOI 10.3233/JAD-150415; Camargo LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115369; Candelario-Jalil E, 2008, PHARMACOL RES, V57, P266, DOI 10.1016/j.phrs.2008.03.003; Carbone I, 2014, NEUROBIOL AGING, V35, P122, DOI 10.1016/j.neurobiolaging.2013.06.024; Cardinali DP, 2014, ANTIOXIDANTS, V3, P245, DOI 10.3390/antiox3020245; Carlisle MD, 2009, J INNATE IMMUN, V1, P118, DOI 10.1159/000181015; Carter CJ, 2013, J PATHOG, V2013, DOI 10.1155/2013/965046; Carter CJ, 2011, NEUROCHEM INT, V58, P301, DOI 10.1016/j.neuint.2010.12.003; Carter Chris, 2011, Int J Alzheimers Dis, V2011, P501862, DOI 10.4061/2011/501862; Carter CJ, 2013, PATHOG DIS, V69, P240, DOI 10.1111/2049-632X.12077; Carter CJ, 2011, ISRN NEUROL, V2011; Cattaneo A, 2017, NEUROBIOL AGING, V49, P60, DOI 10.1016/j.neurobiolaging.2016.08.019; Chakraborty S, 2010, J NEUROSCI RES, V88, P1615, DOI 10.1002/jnr.22343; Chang YP, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/175729; Chen N, 2000, VIROLOGY, V276, P44, DOI 10.1006/viro.2000.0562; Chen XS, 2010, J ALZHEIMERS DIS, V20, pS127, DOI 10.3233/JAD-2010-1376; Chetelat G, 2016, BRAIN, V139, P2528, DOI 10.1093/brain/aww159; Chiu WC, 2014, EUR J NEUROL, V21, P1068, DOI 10.1111/ene.12317; Cho SW, 2013, J BIOL CHEM, V288, P6814, DOI 10.1074/jbc.M112.393363; Christen-Zaech S, 2003, CAN J NEUROL SCI, V30, P20, DOI 10.1017/S0317167100002389; Ciaramella A, 2010, J ALZHEIMERS DIS, V19, P559, DOI 10.3233/JAD-2010-1257; Cochran JN, 2015, HUM MOL GENET, V24, P6667, DOI 10.1093/hmg/ddv371; Colasanti T, 2010, AUTOIMMUN REV, V9, P807, DOI 10.1016/j.autrev.2010.07.008; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Czygan M, 1999, J INFECT DIS, V180, P1695, DOI 10.1086/315068; Da Mesquita S, 2016, NEUROSCI BIOBEHAV R, V68, P547, DOI 10.1016/j.neubiorev.2016.06.014; de Chaves EP, 2008, FUTURE LIPIDOL, V3, P505, DOI 10.2217/17460875.3.5.505; de la Torre JC, 2010, NEURODEGENER DIS, V7, P116, DOI 10.1159/000285520; de Senna PN, 2015, BRAIN RES, V1618, P75, DOI 10.1016/j.brainres.2015.05.026; Delahaye NF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-452; Di Marco LY, 2015, NEUROBIOL DIS, V82, P593, DOI 10.1016/j.nbd.2015.08.014; Dumurgier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053587; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Efthymiou AG, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0184-x; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Emamian F, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00078; Emery DC, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00195; Engler-Chiurazzi EB, 2016, BRAIN RES, V1633, P96, DOI 10.1016/j.brainres.2015.12.044; Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29; Feart C, 2015, CURR OPIN CLIN NUTR, V18, P51, DOI 10.1097/MCO.0000000000000131; Feldman HH, 2008, STROKE, V39, P2894, DOI 10.1161/STROKEAHA.107.510826; Ferencz B, 2014, PSYCHOL AGING, V29, P440, DOI 10.1037/a0035465; Ferreira PC, 2008, REV LAT-AM ENFERM, V16, P151, DOI 10.1590/S0104-11692008000100023; Finch CE, 2016, EVOLUTIONARY THINKIN, P277; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fonseca MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149792; Fujihashi K, 2009, TRENDS IMMUNOL, V30, P334, DOI 10.1016/j.it.2009.04.004; Fujioka H, 2013, J HEALTH CARE POOR U, V24, P70, DOI 10.1353/hpu.2014.0009; Fulop T, 2017, CLIN EXP IMMUNOL, V187, P35, DOI 10.1111/cei.12836; Fulop T, 2016, BIOGERONTOLOGY, V17, P147, DOI 10.1007/s10522-015-9615-7; Fumagalli M, 2014, CURR OPIN IMMUNOL, V30, P9, DOI 10.1016/j.coi.2014.05.001; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Fumagalli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-264; Fumagalli M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000849; Gagliano SA, 2016, ANN CLIN TRANSL NEUR, V3, P924, DOI 10.1002/acn3.369; Gale SC, 2014, J ALLERGY CLIN IMMUN, V134, P127, DOI 10.1016/j.jaci.2014.01.032; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Gies U, 2001, NEUROREPORT, V12, P3767, DOI 10.1097/00001756-200112040-00033; Gies U, 1998, BRAIN PATHOL, V8, P39; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Harris SA, 2015, J ALZHEIMERS DIS, V48, P319, DOI 10.3233/JAD-142853; He JY, 2014, J NEUROSCI, V34, P14697, DOI 10.1523/JNEUROSCI.2111-14.2014; Helen G, 2014, FREE RADICAL BIO MED, V75, pS15, DOI 10.1016/j.freeradbiomed.2014.10.591; Hempel P, 2016, THER APHER DIAL, V20, P523, DOI 10.1111/1744-9987.12415; Hendrie HC, 2015, ETHNIC DIS, V25, P345, DOI 10.18865/ed.25.3.345; HENKE H, 1983, BRAIN RES, V267, P281, DOI 10.1016/0006-8993(83)90880-6; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Heron M, 2013, NATL VITAL STAT REPO, V65, P1; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Himi T, 2011, ADV OTO-RHINO-LARYNG, V72, P28, DOI 10.1159/000324590; Hintermann E, 2002, INFECT IMMUN, V70, P5846, DOI 10.1128/IAI.70.10.5846-5856.2002; Hoffmann M, 2009, J ALZHEIMERS DIS, V16, P517, DOI 10.3233/JAD-2009-0985; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Hu RF, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00098; Hussain M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00045; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Inoue Y, 2016, AM J NEURORADIOL, V37, P223, DOI 10.3174/ajnr.A4496; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Janeway CA, 2011, IMMUNE SYSTEM HLTH D; Jiang QH, 2017, MOL NEUROBIOL, V54, P594, DOI 10.1007/s12035-015-9670-8; Jiang X., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/109324; Jiang XZ, 2011, J VIROL, V85, P2325, DOI 10.1128/JVI.01791-10; Johnson DC, 2002, CURR TOP MICROBIOL, V269, P101; Kageyama Mitsuyo, 2008, Asia Pac J Public Health, V20 Suppl, P111; Kalamvoki M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0518-2; Kalinin S, 2006, EUR J NEUROSCI, V24, P3393, DOI 10.1111/j.1460-9568.2006.05223.x; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kamer AR, 2015, NEUROBIOL AGING, V36, P627, DOI 10.1016/j.neurobiolaging.2014.10.038; Kang R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003511; KAPUR N, 1994, J NEUROL NEUROSUR PS, V57, P1334, DOI 10.1136/jnnp.57.11.1334; Karch Celeste M, 1800, Biol Psychiatry, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Katz J, 2000, INFECT IMMUN, V68, P1441, DOI 10.1128/IAI.68.3.1441-1449.2000; Kellner A, 2009, ANN NEUROL, V65, P24, DOI 10.1002/ana.21475; Kiernan J A, 2012, Epilepsy Res Treat, V2012, P176157, DOI 10.1155/2012/176157; Kim YK, 2016, YONSEI MED J, V57, P5, DOI 10.3349/ymj.2016.57.1.5; Kornhuber HH, 1996, EUR ARCH PSY CLIN N, V246, P108, DOI 10.1007/BF02274902; Kountouras J, 2009, J NEUROL, V256, P758, DOI 10.1007/s00415-009-5011-z; Koyuncu E, 2014, MBIO, V5, DOI 10.1128/mBio.02249-14; Kraft P, 2013, EXP NEUROL, V247, P80, DOI 10.1016/j.expneurol.2013.03.026; Kristen H, 2015, NEUROBIOL AGING, V36, P2737, DOI 10.1016/j.neurobiolaging.2015.06.014; KRISTENSSON K, 1969, ACTA NEUROPATHOL, V14, P38, DOI 10.1007/BF00687701; Kumar DKV, 2016, NEURODEGENER DIS MAN, V6, P345, DOI 10.2217/nmt-2016-0035; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Kusuhara H, 2004, ADV DRUG DELIVER REV, V56, P1741, DOI 10.1016/j.addr.2004.07.007; Latruffe N, 2013, CURR PHARM DESIGN, V19, P6053, DOI 10.2174/1381612811319340002; Lecler A, 2017, RADIOLOGY, V282, P923, DOI 10.1148/radiol.2017162578; Lee J, 2002, NEUROMOL MED, V2, P29; Lee JH, 2012, J PEDIAT HEMATOL ONC, V34, P491, DOI 10.1097/MPH.0b013e318266c0ef; Lehmann M, 2003, DEMENT GERIATR COGN, V16, P145, DOI 10.1159/000071002; Leira Y, 2017, NEUROEPIDEMIOLOGY, V48, P21, DOI 10.1159/000458411; Lembo D, 2016, MOL ASPECTS MED, V49, P23, DOI 10.1016/j.mam.2016.04.003; Li SM, 2010, J GEN VIROL, V91, P858, DOI 10.1099/vir.0.015719-0; Li XW, 2015, FASEB J, V29, P1754, DOI 10.1096/fj.14-262683; Lia LJ, 2004, J BIOL CHEM, V279, P37061, DOI 10.1074/jbc.M403672200; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin FC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002143; Little CS, 2004, NEUROBIOL AGING, V25, P419, DOI 10.1016/S0197-4580(03)00127-1; Liu TB, 2012, VIRULENCE, V3, P173, DOI 10.4161/viru.18685; Loeb MB, 2004, J AM GERIATR SOC, V52, P381, DOI 10.1111/j.1532-5415.2004.52109.x; Loef M, 2012, BRIT J NUTR, V107, P7, DOI 10.1017/S000711451100376X; Lurain NS, 2013, J INFECT DIS, V208, P564, DOI 10.1093/infdis/jit210; MacIntyre A, 2003, J NEUROSCI RES, V71, P740, DOI 10.1002/jnr.10519; MacKenzie CR, 2007, CURR DRUG METAB, V8, P237, DOI 10.2174/138920007780362518; Maftei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068996; Maggioli E, 2016, BRAIN BEHAV IMMUN, V51, P212, DOI 10.1016/j.bbi.2015.08.020; Maheshwari P, 2015, J ALZHEIMERS DIS, V43, P957, DOI 10.3233/JAD-140621; Mahmoudvand H, 2016, J PARASITOL, V102, P629, DOI 10.1645/16-28; Maizels RM, 2014, CLIN EXP IMMUNOL, V177, P38, DOI 10.1111/cei.12353; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martinez-Pinilla E, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00030; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mayerhofer R, 2017, BRAIN BEHAV IMMUN, V60, P174, DOI 10.1016/j.bbi.2016.10.011; MCCLURE CL, 1992, AM FAM PHYSICIAN, V45, P2691; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; McManus RM, 2014, NEUROBIOL AGING, V35, P109, DOI 10.1016/j.neurobiolaging.2013.07.025; Mechelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063300; Meckes DG, 2015, J VIROL, V89, P5200, DOI 10.1128/JVI.02470-14; Mehraj V, 2015, INT J TRYPTOPHAN RES, V8, P41, DOI 10.4137/IJTR.S26862; Menon PK, 2012, CNS NEUROL DISORD-DR, V11, P40; Mielke MM, 2010, NEUROLOGY, V75, P1888, DOI 10.1212/WNL.0b013e3181feb2bf; MIKLOSSY J, 1993, NEUROREPORT, V4, P841, DOI 10.1097/00001756-199307000-00002; Miklossy J, 2006, NEUROBIOL AGING, V27, P228, DOI 10.1016/j.neurobiolaging.2005.01.018; Miklossy J, 2016, J ALZHEIMERS DIS, V53, P1459, DOI 10.3233/JAD-160451; Mohle L, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0293-8; Mohagheghi F, 2010, THESCIENTIFICWORLDJO, V10, P1180, DOI 10.1100/tsw.2010.128; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Moreira A, 2016, J ALZHEIMERS DIS, V53, P85, DOI 10.3233/JAD-160142; Mori I, 2015, ACTA VIROL, V59, P338, DOI 10.4149/av_2015_04_338; Mouton CP, 2001, AM FAM PHYSICIAN, V63, P257; Mueller T, 2016, LIVER INT, V36, P1267, DOI 10.1111/liv.13094; NADAL D, 1990, LUNG, V168, P379, DOI 10.1007/BF02718155; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Oakley R, 2014, AGING DIS, V5, P114, DOI 10.14336/AD.2014.0500114; Okin D, 2012, CURR BIOL, V22, pR733, DOI 10.1016/j.cub.2012.07.029; Oria RB, 2005, PEDIATR RES, V57, P310, DOI 10.1203/01.PDR.0000148719.82468.CA; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Palomares JA, 2015, J NEUROIMAGING, V25, P900, DOI 10.1111/jon.12288; Park SC, 2016, BIOCHEM BIOPH RES CO, V478, P924, DOI 10.1016/j.bbrc.2016.08.052; Parran DK, 2005, NEUROTOXICOLOGY, V26, P77, DOI 10.1016/j.neuro.2004.07.003; Parron T, 2011, TOXICOL APPL PHARM, V256, P379, DOI 10.1016/j.taap.2011.05.006; Pase MP, 2017, ALZHEIMERS DEMENT, V13, P955, DOI 10.1016/j.jalz.2017.01.024; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Patnaik R, 2000, ACTA NEUROCHIR SUPPL, V76, P535; PATRICK D, 1992, J INFECT DIS, V165, P865, DOI 10.1093/infdis/165.5.865; Pellicano M, 2010, J ALZHEIMERS DIS, V21, P181, DOI 10.3233/JAD-2010-091714; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Persidsky Y, 2011, BRAIN BEHAV IMMUN, V25, pS61, DOI 10.1016/j.bbi.2011.03.001; Pike CJ, 2009, FRONT NEUROENDOCRIN, V30, P239, DOI 10.1016/j.yfrne.2009.04.015; Pires PW, 2013, AM J PHYSIOL-HEART C, V304, pH1598, DOI 10.1152/ajpheart.00490.2012; Pisa D, 2015, SCI REP-UK, V5, DOI 10.1038/srep15015; Pizza V, 2011, CNS NEUROL DISORD-DR, V10, P621, DOI 10.2174/187152711796235014; Poole S, 2013, J ALZHEIMERS DIS, V36, P665, DOI 10.3233/JAD-121918; Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242; Power C, 2009, CAN J NEUROL SCI, V36, P285, DOI 10.1017/S0317167100007009; Pozzoli U, 2010, TRENDS GENET, V26, P95, DOI 10.1016/j.tig.2009.12.010; Prasad Shikha, 2014, J Pharmacovigil, V2, P125; Pretorius E, 2016, J ALZHEIMERS DIS, V53, P1237, DOI 10.3233/JAD-160318; Pulzova L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00086; Qosa H, 2016, J ALZHEIMERS DIS, V53, P1499, DOI 10.3233/JAD-151179; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rawji KS, 2016, BRAIN, V139, P653, DOI 10.1093/brain/awv395; REICHMAN HR, 1986, J NEUROSURG, V65, P233, DOI 10.3171/jns.1986.65.2.0233; Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099; Reniewicz Patryk, 2016, Postepy Hig Med Dosw (Online), V70, P337; Reynolds E H, 2014, Handb Clin Neurol, V120, P927, DOI 10.1016/B978-0-7020-4087-0.00061-9; Richards RI, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00193; Richardson JR, 2014, JAMA NEUROL, V71, P284, DOI 10.1001/jamaneurol.2013.6030; Roberts RO, 2016, JAMA NEUROL, V73, P93, DOI 10.1001/jamaneurol.2015.2952; Roher AE, 2003, ARTERIOSCL THROM VAS, V23, P2055, DOI 10.1161/01.ATV.0000095973.42032.44; Roher AE, 2000, ANN NY ACAD SCI, V903, P366, DOI 10.1111/j.1749-6632.2000.tb06388.x; Romano JD, 2013, EUKARYOT CELL, V12, P265, DOI 10.1128/EC.00313-12; Rondeau V, 2009, AM J EPIDEMIOL, V169, P489, DOI 10.1093/aje/kwn348; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Roussos P, 2015, ALZHEIMERS DEMENT, V11, P1163, DOI 10.1016/j.jalz.2014.10.013; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; Russell KL, 2014, PROSTAG LEUKOTR ESS, V90, P5, DOI 10.1016/j.plefa.2013.11.003; RYTIK PG, 1991, AIDS RES HUM RETROV, V7, P89, DOI 10.1089/aid.1991.7.89; Saavedra JM, 2016, CELL MOL NEUROBIOL, V36, P259, DOI 10.1007/s10571-015-0327-y; Safouris A, 2015, CURR ALZHEIMER RES, V12, P736, DOI 10.2174/1567205012666150710114430; Sajja RK, 2016, J CEREBR BLOOD F MET, V36, P539, DOI 10.1177/0271678X15616978; Sanchez-Barcelo EJ, 2010, CURR MED CHEM, V17, P2070, DOI 10.2174/092986710791233689; Santiago-Tirado FH, 2017, MBIO, V8, DOI 10.1128/mBio.02183-16; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; SARMENTO A, 1994, ACTA NEUROCHIR, V127, P215, DOI 10.1007/BF01808769; Sato A, 2001, INT J DEV NEUROSCI, V19, P327, DOI 10.1016/S0736-5748(01)00017-X; Schain M, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0733-2; SCHEIBEL AB, 1989, ANN MED, V21, P103, DOI 10.3109/07853898909149194; Schmitz TW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13249; Scholtissek C, 1998, ANTIVIR RES, V37, P83, DOI 10.1016/S0166-3542(97)00061-2; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schwerk C, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00080; Seker FB, 2016, NUTR NEUROSCI, V19, P55, DOI 10.1179/1476830514Y.0000000154; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Seske LM, 2017, MATERN CHILD HLTH J, V21, P727, DOI 10.1007/s10995-016-2159-x; Sheets SA, 2005, INFECT IMMUN, V73, P1543, DOI 10.1128/IAI.73.3.1543-1552.2005; Shin JA, 2016, FREE RADICAL BIO MED, V92, P78, DOI 10.1016/j.freeradbiomed.2016.01.010; Shindler-Itskovitch T, 2016, J ALZHEIMERS DIS, V52, P1431, DOI 10.3233/JAD-160132; Simpson RJ, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18374; SIMS NR, 1980, LANCET, V1, P333; Singhrao SK, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2016.1270602; Slonska A, 2012, POSTEP HIG MED DOSW, V66, P810, DOI 10.5604/17322693.1016360; SMITH SP, 1992, PHARMACOTHERAPY, V12, pS11; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Sohn JH, 2009, FRONT BIOSCI-LANDMRK, V14, P3879, DOI 10.2735/3496; Song Y, 2008, NEUROSCI LETT, V445, P42, DOI 10.1016/j.neulet.2008.08.081; Soontornniyomkij V, 2012, AIDS, V26, P2327, DOI 10.1097/QAD.0b013e32835a117c; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Spindler KR, 2012, TRENDS MICROBIOL, V20, P282, DOI 10.1016/j.tim.2012.03.009; Srinivasan V, 2012, RECENT PATENTS ENDOC, V6, P30, DOI 10.2174/187221412799015317; Stahl T, 2006, EUR J NEUROSCI, V24, P1923, DOI 10.1111/j.1460-9568.2006.05069.x; Steel AJ, 2015, J ALZHEIMERS DIS, V47, P351, DOI 10.3233/JAD-140822; Stern JL, 2017, MOL BIOL CELL, V28, P1079, DOI 10.1091/mbc.E16-10-0728; Storace D, 2010, ARCH NEUROL-CHICAGO, V67, P867, DOI 10.1001/archneurol.2010.137; Sugimoto N, 2014, NUTR CANCER, V66, P419, DOI 10.1080/01635581.2013.877497; Sun DM, 2013, ADV DRUG DELIVER REV, V65, P342, DOI 10.1016/j.addr.2012.07.002; Takechi R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-73; Tan IL, 2012, CNS DRUGS, V26, P123, DOI 10.2165/11597770-000000000-00000; Ting M, 2016, EUR J ORAL SCI, V124, P4, DOI 10.1111/eos.12239; Trumble BC, 2017, FASEB J, V31, P1508, DOI 10.1096/fj.201601084R; Tucsek Z, 2014, J GERONTOL A-BIOL, V69, P1212, DOI 10.1093/gerona/glt177; Tufano A, 2012, SEMIN THROMB HEMOST, V38, P515, DOI 10.1055/s-0032-1315759; Tyler KM, 2005, CELL MICROBIOL, V7, P1579, DOI 10.1111/j.1462-5822.2005.00576.x; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; van de Haar HJ, 2016, NEUROBIOL AGING, V45, P190, DOI 10.1016/j.neurobiolaging.2016.06.006; van der Wal FJ, 2002, CURR TOP MICROBIOL, V269, P37; van Exel E, 2009, ARCH GEN PSYCHIAT, V66, P1263, DOI 10.1001/archgenpsychiatry.2009.146; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Vincents B, 2011, FASEB J, V25, P3741, DOI 10.1096/fj.11-187799; Volzke H, 2006, ATHEROSCLEROSIS, V184, P108, DOI 10.1016/j.atherosclerosis.2004.10.048; Vu K, 2014, MBIO, V5, DOI 10.1128/mBio.01101-14; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wang X, 2014, NEUROSCIENCE, V271, P99, DOI 10.1016/j.neuroscience.2014.04.030; Wang XL, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00066; Wei HD, 2015, J MOL NEUROSCI, V55, P872, DOI 10.1007/s12031-014-0441-1; Welter Danielle, 2014, Nucleic Acids Res, V42, pD1001, DOI 10.1093/nar/gkt1229; White MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101364; Witt Ken A, 2014, Adv Pharmacol, V71, P361, DOI 10.1016/bs.apha.2014.06.018; Wolff G, 2015, BIOCHEM BIOPH RES CO, V463, P811, DOI 10.1016/j.bbrc.2015.04.153; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Wolters FJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002143; Wong CW, 2016, DRUG AGING, V33, P451, DOI 10.1007/s40266-016-0372-3; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271; Wozniak MA, 2003, J MED GENET, V40, P348, DOI 10.1136/jmg.40.5.348; Wu HL, 2012, CELL MICROBIOL, V14, P546, DOI 10.1111/j.1462-5822.2011.01740.x; Wu Yun-Chun, 2015, Alzheimers Dement (Amst), V1, P220, DOI 10.1016/j.dadm.2014.11.015; Wu Z, 2017, BRAIN BEHAV IMMUN, V65, P350, DOI 10.1016/j.bbi.2017.06.002; Xu CY, 2014, J INT MED RES, V42, P85, DOI 10.1177/0300060513504365; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548; Yang CH, 2015, J SURG RES, V194, P591, DOI 10.1016/j.jss.2014.11.030; Yang Dongmei, 2013, J Behav Brain Sci, V3, P100; Yates PA, 2014, NEUROLOGY, V82, P1266, DOI 10.1212/WNL.0000000000000285; Yin Z, 2014, CHEM BIOL, V21, P481, DOI 10.1016/j.chembiol.2014.02.009; Yun PLW, 2001, INFECT IMMUN, V69, P5650, DOI 10.1128/IAI.69.9.5650-5660.2001; Zahid Aliya, 2004, J Coll Physicians Surg Pak, V14, P256; Zhan XH, 2016, NEUROLOGY, V87, P2324, DOI 10.1212/WNL.0000000000003391; Zhang N, 2016, ALLERGY, V71, P295, DOI 10.1111/all.12809; Zhang PY, 2015, CAN J NEUROL SCI, V42, P213, DOI 10.1017/cjn.2015.39; Zhang RZ, 2013, J NEUROIMMUNOL, V256, P38, DOI 10.1016/j.jneuroim.2013.01.002; Zhang WT, 2016, NEUROBIOL DIS, V91, P37, DOI 10.1016/j.nbd.2016.02.020; Zhang ZG, 2015, ARCH IMMUNOL THER EX, V63, P333, DOI 10.1007/s00005-015-0351-0; Zhao ZH, 2017, ONCOTARGET, V8, P30030, DOI 10.18632/oncotarget.16273; Zhao ZH, 2014, EXP MOL PATHOL, V97, P386, DOI 10.1016/j.yexmp.2014.09.006	337	27	27	1	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS		2542-4823		J ALZHEIMERS DIS REP	J. Alzheimers Dis. Rep.		2017	1	1					125	157		10.3233/ADR-170017			33	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VK0AM	WOS:000651067800014	30480234	Green Published, Green Submitted			2022-02-06	
J	Dorsett, CR; McGuire, JL; Niedzielko, TL; DePasquale, EAK; Meller, J; Floyd, CL; McCullumsmith, RE				Dorsett, Christopher R.; McGuire, Jennifer L.; Niedzielko, Tracy L.; DePasquale, Erica A. K.; Meller, Jaroslaw; Floyd, Candace L.; McCullumsmith, Robert E.			Traumatic Brain Injury Induces Alterations in Cortical Glutamate Uptake without a Reduction in Glutamate Transporter-1 Protein Expression	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; GLT-1; glutamate; kinome array; membrane vesicles	CELL-SURFACE EXPRESSION; KINASE-C; DIFFERENTIAL REGULATION; NEURONAL DAMAGE; AMINO-ACIDS; RAT-BRAIN; GLT-1; ACTIVATION; AKT; PHOSPHORYLATION	We hypothesize that the primary mechanism for removal of glutamate from the extracellular space is altered after traumatic brain injury (TBI). To evaluate this hypothesis, we initiated TBI in adult male rats using a 2.0 atm lateral fluid percussion injury (LFPI) model. In the ipsilateral cortex and hippocampus, we found no differences in expression of the primary glutamate transporter in the brain (GLT-1) 24 h after TBI. In contrast, we found a decrease in glutamate uptake in the cortex, but not the hippocampus, 24 h after injury. Because glutamate uptake is potently regulated by protein kinases, we assessed global serine-threonine protein kinase activity using a kinome array platform. Twenty-five kinome array peptide substrates were differentially phoshorylated between LFPI and controls in the cortex, whereas 19 peptide substrates were differentially phosphorylated in the hippocampus (fold change >= +/- 1.15). We identified several kinases as likely to be involved in acute TBI, including protein kinase B (Akt) and protein kinase C (PKC), which are well-characterized modulators of GLT-1. Exploratory studies using an inhibitor of Akt suggest selective activation of kinases in LFPI versus controls. Ingenuity pathway analyses of implicated kinases from our network model found apoptosis and cell death pathways as top functions in acute LFPI. Taken together, our data suggest diminished activity of glutamate transporters in the prefrontal cortex, with no changes in protein expression of the primary glutamate transporter GLT-1, and global alterations in signaling networks that include serine-threonine kinases that are known modulators of glutamate transport activity.	[Dorsett, Christopher R.] Univ N Carolina, Biol & Biomed Sci Doctoral Program, Chapel Hill, NC USA; [McGuire, Jennifer L.; DePasquale, Erica A. K.; McCullumsmith, Robert E.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, MSB 5255A,d31 Albert Sabin Way, Cincinnati, OH 45267 USA; [Niedzielko, Tracy L.; Floyd, Candace L.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Meller, Jaroslaw] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Meller, Jaroslaw] Univ Cincinnati, Coll Med, Dept Elect Engn & Comp Syst, Cincinnati, OH USA; [Meller, Jaroslaw] Univ Cincinnati, Coll Med, Dept Biomed Informat, Cincinnati, OH USA; [Meller, Jaroslaw] Cincinnati Childrens Hosp, Med Ctr, Dept Biomed Informat, Cincinnati, OH USA		McCullumsmith, RE (corresponding author), Univ Cincinnati, Dept Psychiat & Behav Neurosci, MSB 5255A,d31 Albert Sabin Way, Cincinnati, OH 45267 USA.	robert.mccullumsmith@uc.edu	Meller, Jaroslaw/A-1971-2011	Meller, Jaroslaw/0000-0002-1162-8253; McGuire, Jennifer/0000-0003-3058-5241	 [R01NS075162]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH107487, R01MH094445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS075162] Funding Source: NIH RePORTER	This work was partially supported by R01NS075162 (C.L.F.).	Abe K, 2002, BRAIN RES, V952, P211, DOI 10.1016/S0006-8993(02)03194-3; Adolph O, 2007, GLIA, V55, P1699, DOI 10.1002/glia.20583; Allen NJ, 2004, PFLUG ARCH EUR J PHY, V449, P132, DOI 10.1007/s00424-004-1318-x; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CASADO M, 1993, J BIOL CHEM, V268, P27313; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Daniels KK, 1999, NEUROCHEM RES, V24, P1017, DOI 10.1023/A:1021004809991; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Figiel M, 2003, EXP NEUROL, V183, P124, DOI 10.1016/S0014-4886(03)00134-1; Garling RJ, 2014, NEURAL REGEN RES, V9, P1891, DOI 10.4103/1673-5374.145355; Gegelashvili G, 2000, NEUROCHEM INT, V37, P163, DOI 10.1016/S0197-0186(00)00019-X; Gibb SL, 2007, J BIOL CHEM, V282, P32480, DOI 10.1074/jbc.M704314200; Gonzalez MI, 2004, MOL INTERV, V4, P48, DOI 10.1124/mi.4.1.48; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Jarboe JS, 2012, RADIOTHER ONCOL, V103, P380, DOI 10.1016/j.radonc.2012.03.014; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kobori N, 2015, J NEUROTRAUM, V32, P139, DOI 10.1089/neu.2014.3487; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauriat TL, 2007, MOL PSYCHIATR, V12, P1065, DOI 10.1038/sj.mp.4002065; Li L, 2006, J ENG FIBER FABR, V1, P1; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Lucke-Wold BP, 2015, MOL NEUROBIOL, V52, P1119, DOI 10.1007/s12035-014-8902-7; LUDBROOK J, 1994, CLIN EXP PHARMACOL P, V21, P673, DOI 10.1111/j.1440-1681.1994.tb02570.x; LUDBROOK J, 1995, AUST NZ J SURG, V65, P812, DOI 10.1111/j.1445-2197.1995.tb00567.x; McGuire JL, 2014, BRAIN RES, V1568, P42, DOI 10.1016/j.brainres.2014.04.029; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Murphy-Royal C, 2015, NAT NEUROSCI, V18, P219, DOI 10.1038/nn.3901; Muurling T, 2014, OTOL NEUROTOL, V35, P1, DOI 10.1097/MAO.0000000000000254; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Olney J W, 1990, Can Dis Wkly Rep, V16 Suppl 1E, P47; Padmaperuma B, 1996, BRAIN RES, V714, P19, DOI 10.1016/0006-8993(95)01579-5; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Pow DV, 2004, DEV BRAIN RES, V153, P1, DOI 10.1016/j.devbrainres.2004.06.019; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rao VLR, 2001, EUR J NEUROSCI, V13, P119, DOI 10.1046/j.1460-9568.2001.01367.x; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Safaei J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S6; Shan D, 2013, SCHIZOPHR RES, V144, P1, DOI 10.1016/j.schres.2012.12.019; Shigeri Y, 2004, BRAIN RES REV, V45, P250, DOI 10.1016/j.brainresrev.2004.04.004; Sullivan CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123158; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Susarla BTS, 2008, NEUROCHEM INT, V52, P709, DOI 10.1016/j.neuint.2007.08.020; Tan ZJ, 2013, STROKE, V44, P3490, DOI 10.1161/STROKEAHA.113.002411; Toker Alex, 2014, Advances in Biological Regulation, V55, P28, DOI 10.1016/j.jbior.2014.04.001; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Underhill SM, 2015, J NEUROSCI, V35, P5260, DOI 10.1523/JNEUROSCI.4365-14.2015; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Velasco I, 1996, J NEUROSCI RES, V44, P551, DOI 10.1002/(SICI)1097-4547(19960615)44:6<551::AID-JNR5>3.0.CO;2-A; WHITTAKER VP, 1988, J NEUROCHEM, V50, P324, DOI 10.1111/j.1471-4159.1988.tb13270.x; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Zelenaia O, 2000, MOL PHARMACOL, V57, P667, DOI 10.1124/mol.57.4.667; Zelenaia OA, 2000, J NEUROCHEM, V75, P2252, DOI 10.1046/j.1471-4159.2000.0752252.x; Zhang C., 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI DOI 10.1089/CBR.2014.1653; Zhang J, 2012, CHIN J TRAUMATOL, V15, P338, DOI 10.3760/cma.j.issn.1008-1275.2012.06.004; Zhang L, 2016, CELL MOL NEUROBIOL, V36, P131, DOI 10.1007/s10571-015-0227-1; Zhang XP, 2006, J CEREBR BLOOD F MET, V26, P915, DOI 10.1038/sj.jcbfm.9600238; Zhao SF, 2014, NEUROL RES, V36, P483, DOI 10.1179/1743132814Y.0000000353; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	73	27	28	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					220	234		10.1089/neu.2015.4372			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100024	27312729	Green Submitted, Green Published			2022-02-06	
J	Gouttebarge, V; Aoki, H; Lambert, M; Stewart, W; Kerkhoffs, G				Gouttebarge, Vincent; Aoki, Haruhito; Lambert, Michael; Stewart, William; Kerkhoffs, Gino			A history of concussions is associated with symptoms of common mental disorders in former male professional athletes across a range of sports	PHYSICIAN AND SPORTSMEDICINE			English	Article						Concussions; sports; mental disorders; epidemiology; athletes	CHRONIC TRAUMATIC ENCEPHALOPATHY; REPORTED OUTCOME MEASURES; FOOTBALL PLAYERS; SLEEP DISTURBANCE; RUGBY UNION; RISK; DETERMINANTS; DEPRESSION; PREVALENCE; DIAGNOSIS	Objective: Recent reports suggest that exposure to repetitive concussions in sports is associated with an increased risk of symptoms of distress, anxiety and depression, sleep disturbance or substance abuse/dependence (typically referred as symptoms of common mental disorders[CMD]) and of later development of neurodegenerative disease, in particular chronic traumatic encephalopathy (CTE). The primary aim of this study was to explore the relationship between sports career-related concussions and the subsequent occurrence of symptoms of CMD among former male professional athletes retired from football (soccer), ice hockey and rugby (union).Methods: Cross-sectional analyses were performed on baseline electronic questionnaires from three prospective cohort studies among former male professional athletes retired from football (soccer), ice hockey and rugby (union). The number of confirmed concussions was examined through a single question, while symptoms of distress, anxiety and depression, sleep disturbance and adverse alcohol use were assessed using validated questionnaires.Results: From 1,957 former professional athletes contacted, a total of 576 (29%) completed the questionnaire. Of these, 23% had not incurred a concussion during their career, 34% had two or three, 18% four or five, and 11% six or more concussions. The number of sports career-related concussions was a predictor for all outcome measures (=0.072-0.109; P0.040). Specifically, former professional athletes who reported a history of four or five concussions were approximately 1.5 times more likely to report symptoms of CMD, rising to a two- to five-fold increase in those reporting a history of six or more sports career-related concussions.Conclusions: These data demonstrate an association between exposure to sports concussion and subsequent risk of symptoms of CMD in former professional athletes across a range of contact sports. Further work to explore the association between sports concussion and symptoms of CMD is required; in the meanwhile, strategies for effective risk reduction and improved management appear indicated.	[Gouttebarge, Vincent; Kerkhoffs, Gino] Acad Med Ctr, Acad Ctr Evidence Based Sports Med ACES, Amsterdam, Netherlands; [Gouttebarge, Vincent] World Players Union FIFPro, Hoofddorp, Netherlands; [Gouttebarge, Vincent; Lambert, Michael] Univ Cape Town, Div Exercise Sci & Sports Med ESSM, Cape Town, South Africa; [Aoki, Haruhito] St Marianna Univ, Sch Med, Kawazaki, Japan; [Stewart, William] Queen Elizabeth Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland; [Kerkhoffs, Gino] Vrije Univ Amsterdam, Med Ctr, Acad Med Ctr, ACHSS, Amsterdam, Netherlands		Gouttebarge, V (corresponding author), Acad Med Ctr, Acad Ctr Evidence Based Sports Med ACES, Amsterdam, Netherlands.	v.gouttebarge@amc.nl		Stewart, William/0000-0003-2199-2582; Lambert, Michael/0000-0001-8979-1504			Araujo CGS, 2016, SCAND J MED SCI SPOR, V26, P4, DOI 10.1111/sms.12632; Blake C., 2014, BRIT J SPORT MED, V48, P569, DOI 10.1136/bjsports-2014-093494.25; Braam C, 2009, J OCCUP REHABIL, V19, P231, DOI 10.1007/s10926-009-9178-z; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Davis JC, 2015, BRIT J SPORT MED, V49, P1545, DOI 10.1136/bjsports-2014-093707; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; England Professional Rugby Injury Surveillance Project Steering Group, 2016, RUGB PLAYERS ENGL PR; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gouttebarge V, 2016, J SPORT MED PHYS FIT, V56, P648; Gouttebarge V, 2016, EUR J SPORT SCI, V16, P595, DOI 10.1080/17461391.2015.1086819; Green Sb, 1991, MULTIVARIATE BEHAV R; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; JACOBSON E, 1957, J AM PSYCHOANAL ASS, V5, P61, DOI 10.1177/000306515700500102; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Martland H, 1991, JAMA-J AM MED ASSOC, V91, P1103; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meneses-Gaya Carolina de, 2009, Psychol. Neurosci., V2, P83, DOI 10.3922/j.psns.2009.1.12; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Salama-Younes M, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-22; Schuring N, 2017, KNEE SURG SPORT TR A, V25, P3179, DOI 10.1007/s00167-016-4255-2; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith AM., 2016, BMJ OPEN SPORT EXERC, V2, DOI [10.1136/bmjsem-2015-000074, DOI 10.1136/BMJSEM-2015-000074]; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Terluin B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-34; Walden M, 2013, SCAND J MED SCI SPOR, V23, P424, DOI 10.1111/j.1600-0838.2011.01409.x; Woodward M., 2013, EPIDEMIOLOGY STUDY D; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266	34	27	28	2	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2017	45	4					443	449		10.1080/00913847.2017.1376572			7	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	FN4HT	WOS:000415966600013	28870119	hybrid, Green Accepted			2022-02-06	
J	Reynolds, BB; Patrie, J; Henry, EJ; Goodkin, HP; Broshek, DK; Wintermark, M; Druzgal, TJ				Reynolds, Bryson B.; Patrie, James; Henry, Erich J.; Goodkin, Howard P.; Broshek, Donna K.; Wintermark, Max; Druzgal, T. Jason			Comparative Analysis of Head Impact in Contact and Collision Sports	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; epidemiology; head trauma; pediatric brain injury; subconcussion	COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL FOOTBALL; CHRONIC TRAUMATIC ENCEPHALOPATHY; VIDEO INCIDENT ANALYSIS; WHITE-MATTER INTEGRITY; PROFESSIONAL FOOTBALL; BRAIN-INJURY; UNITED-STATES; IN-VIVO; CONCUSSION	As concerns about head impact in American football have grown, similar concerns have started to extend to other sports thought to experience less head impact, such as soccer and lacrosse. However, the amount of head impact experienced in soccer and lacrosse is relatively unknown, particularly compared with the substantial amount of data from football. This pilot study quantifies and compares head impact from four different types of sports teams: college football, high school football, college soccer, and college lacrosse. During the 2013 and 2014 seasons, 61 players wore mastoid patch accelerometers to quantify head impact during official athletic events (i.e., practices and games). In both practices and games, college football players experienced the most or second-most impacts per athletic event, highest average peak resultant linear and rotational acceleration per impact, and highest cumulative linear and rotational acceleration per athletic event. For average peak resultant linear and rotational acceleration per individual impact, college football was followed by high school football, then college lacrosse, and then college soccer, with similar trends in both practices and games. In the four teams under study, college football players experienced a categorically higher burden of head impact. However, for cumulative impact burden, the high school football cohort was not significantly different from the college soccer cohort. The results suggest that head impact in sport substantially varies by both the type of sport (football vs. soccer vs. lacrosse) and level of play (college vs. high school).	[Reynolds, Bryson B.; Henry, Erich J.; Druzgal, T. Jason] Univ Virginia Hlth Syst, Div Neuroradiol, Dept Radiol & Med Imaging, Box 800170, Charlottesville, VA 22908 USA; [Patrie, James] Univ Virginia Hlth Syst, Dept Publ Hlth Sci, Charlottesville, VA USA; [Goodkin, Howard P.] Univ Virginia Hlth Syst, Dept Neurol, Charlottesville, VA USA; [Goodkin, Howard P.] Univ Virginia Hlth Syst, Dept Pediat, Charlottesville, VA USA; [Broshek, Donna K.] Univ Virginia Hlth Syst, Neurocognit Assessment Lab, Charlottesville, VA USA; [Wintermark, Max] Stanford Univ, Dept Neuroradiol, Stanford, CA 94305 USA		Druzgal, TJ (corresponding author), Univ Virginia Hlth Syst, Div Neuroradiol, Dept Radiol & Med Imaging, Box 800170, Charlottesville, VA 22908 USA.	tjd4m@virginia.edu	Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815; Goodkin, Howard/0000-0003-0528-4949; Druzgal, Jason/0000-0001-7240-9487; Reynolds, Bryson/0000-0001-9196-1461	University of Virginia Health System; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2 T32 GM 8328-21]; University of Virginia Department of Radiology and Medical Imaging; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB001628] Funding Source: NIH RePORTER	We thank the athletes, trainers, and coaches of the University of Virginia and football, men's lacrosse, and men's soccer teams and the athletes, trainers, and coaches of St. Anne's Belfield football team for their invaluable assistance in collecting these data. We are also grateful for the financial support that was provided by a University of Virginia Health System Research Award, NIH 2 T32 GM 8328-21, and the University of Virginia Department of Radiology and Medical Imaging. Access to the xPatch impact sensors was obtained through a research agreement with X2 Biosystems.	Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Crisco JJ, 2015, J APPL BIOMECH, V31, P122, DOI [10.1123/jab.2014-0102, 10.1123/JAB.2014-0102]; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cummiskey B., 2016, J SPORT ENG TECH; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Funk J R, 2007, Annu Proc Assoc Adv Automot Med, V51, P343; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Huber P., 1967, P 5 BERK S MATH STAT; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Johnson B.D., 2014, CONCUSSIONS ATHLETIC, P331, DOI [10.1007/978-1-4939-0295-8_19, DOI 10.1007/978-1-4939-0295-8_19]; Kerr Z. Y., 2015, OJSM, V3; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Svaldi D. O., 2016, BRAIN IMAGING BEHAV; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Withnall C, 2005, BRIT J SPORT MED, V39, pI49, DOI 10.1136/bjsm.2005.019182; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	74	27	27	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					38	49		10.1089/neu.2015.4308			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100006	27541183	Green Published			2022-02-06	
J	Sennik, S; Schweizer, TA; Fischer, CE; Munoz, DG				Sennik, Simrin; Schweizer, Tom A.; Fischer, Corinne E.; Munoz, David G.			Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; agitation; aggression; neuropathology; (p)-TDP-43; traumatic brain injury; vascular lesions; vascular risk factors	DEMENTIA; SEVERITY; SYMPTOMS; ONSET	Background: Neuropsychiatric symptoms are common manifestations of Alzheimer's disease (AD). A number of studies have targeted psychosis, i.e., hallucinations and delusions in AD, but few have assessed agitation/aggression in AD. Objective: To investigate the risk factors and pathological substrates associated with presence [A(+)] and absence [A(-)] of agitation/aggression (A) in autopsy-confirmed AD. Methods: Data was collected from the UDS data as of 2015 on the NACC database. Patients were stratified as intermediate (IAD) or high (HAD) pathological load of AD. Clinical diagnoses were not considered; additional pathological diagnoses were treated as variables. Analysis of data did not include a control group or corrections for multiple comparisons. Results: 1,716 patients met the eligibility criteria; 34.6% of the IAD and 49.6% of the HAD patients were A(+), indicating an association with severity of pathology (p = 0.001). Risk factors for A(+) included: age at initial visit, age at death, years of education, smoking (in females), recent cardiac events (in males), and clinical history of traumatic brain injury (TBI) (in males). A history of hypertension was not related to A(+). In terms of comorbidity, clinical diagnosis of Lewy body dementia syndrome was associated with A(+) but the association was not confirmed when pathological diagnosis based on demonstration of Lewy bodies was used as the criterion. The additional presence of phosphorylated TDP-43, but not tau pathologies, was associated with A(+) HAD. Vascular lesions, including lacunes, large arterial infarcts, and severity of atherosclerosis were negatively associated with A(+). Associated symptoms included delusions, hallucinations, and depression, but not irritability, aberrant motor behavior, sleep and night time behavioral changes, or changes in appetite and eating habits. Conclusions: Smoking, TBI, and phosphorylated TDP-43 are associated with A(+) AD in specific groups, respectively. A(+) is directly associated with AD pathology load and inversely with vascular lesions.	[Sennik, Simrin; Schweizer, Tom A.; Fischer, Corinne E.; Munoz, David G.] St Michaels Hosp, Keenan Biomed Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Dept Surg, Div Neurosurg, Fac Med, Toronto, ON, Canada; [Schweizer, Tom A.] St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada; [Fischer, Corinne E.] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON, Canada; [Munoz, David G.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Munoz, David G.] St Michaels Hosp, Dept Lab Med, Room 2-097 CC Wing,30 Bond St, Toronto, ON M5B 1W8, Canada		Munoz, DG (corresponding author), St Michaels Hosp, Dept Lab Med, Room 2-097 CC Wing,30 Bond St, Toronto, ON M5B 1W8, Canada.	MunozD@smh.ca	Munoz, David G./AAQ-8003-2020	Munoz, David G./0000-0003-0957-6244	NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG016976, U01 AG032984]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG019610, P30 AG013846, P50 AG008702, P50 AG025688, P50 AG047266, P30 AG010133, P50 AG005146, P50AG005134, P50 AG016574];  [P50 AG047366];  [P30 AG010129];  [P50AG016573];  [P50 AG016570];  [P50 AG005131];  [P50 AG023501];  [P30 AG035982];  [P30AG028383];  [P30 AG010124];  [P50 AG005138];  [P30 AG008051];  [P30 AG013854];  [P30 AG008017];  [P30 AG010161];  [P50 AG005133];  [P50 AG005142];  [P30 AG012300];  [P50 AG005136];  [P50 AG033514];  [P50AG005681];  [P50 AG047270]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG010129, P30AG008017, P30AG008051, P30AG035982, P50AG005142, P50AG016570, P50AG025688, P50AG047270, P50AG023501, P50AG005138, U01AG016976, P30AG013854, U01AG032984, P50AG005131, P30AG010124, P50AG008702, P30AG019610, P30AG028383, P50AG016574, P30AG010133, P50AG047366, P50AG005134, P50AG005146, P30AG013846, P50AG005136, P50AG005681, P30AG010161, P50AG047266, P50AG005133, P50AG033514, P30AG012300, P50AG016573] Funding Source: NIH RePORTER	The NACC database is funded by NIA/NIH Grant U01 AG016976. NACC data are contributed by the NIA funded ADCs: P30 AG019610 (PI Eric Reiman, MD), P30 AG013846 (PI Neil Kowall, MD), P50 AG008702 (PI Scott Small, MD), P50 AG025688 (PI Allan Levey, MD, PhD), P50 AG047266 (PI Todd Golde, MD, PhD), P30 AG010133 (PI Andrew Saykin, PsyD), P50 AG005146 (PI Marilyn Albert, PhD), P50AG005134(PI Bradley Hyman, MD, PhD), P50 AG016574 (PI Ronald Petersen, MD, PhD), P50 AG005138 (PI Mary Sano, PhD), P30 AG008051 (PI Steven Ferris, PhD), P30 AG013854 (PI M. Marsel Mesulam, MD), P30 AG008017 (PI Jeffrey Kaye, MD), P30 AG010161 (PI David Bennett, MD), P50 AG047366 (PI Victor Henderson, MD, MS), P30 AG010129(PI Charles DeCarli, MD), P50AG016573 (PI Frank LaFerla, PhD), P50 AG016570 (PI Marie-Francoise Chesselet, MD, PhD), P50 AG005131 (PI Douglas Galasko, MD), P50 AG023501 (PI Bruce Miller, MD), P30 AG035982 (PI Russell Swerdlow, MD), P30AG028383 (PI LindaVan Eldik, PhD), P30 AG010124 (PI John Trojanowski, MD, PhD), P50 AG005133 (PI Oscar Lopez, MD), P50 AG005142 (PI Helena Chui, MD), P30 AG012300 (PI Roger Rosenberg, MD), P50 AG005136 (PI Thomas Montine, MD, PhD), P50 AG033514 (PI Sanjay Asthana, MD, FRCP), P50AG005681 (PI John Morris, MD), and P50 AG047270 (PI Stephen Strittmatter, MD, PhD) [1].; Alzheimer's Disease Genetic Consortium (ADGC) (NIA/NIH Grant U01 AG032984).	Aarsland D, 1996, AM J PSYCHIAT, V153, P243; Abner EL, 2016, ALZHEIMERS DEMENT, V12, P882, DOI 10.1016/j.jalz.2015.12.006; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gavett BE, 2016, J ALZHEIMERS DIS, V49, P531, DOI 10.3233/JAD-150252; Holmes C, 1998, HUM MOL GENET, V7, P1507, DOI 10.1093/hmg/7.9.1507; Lopez OL, 2003, J NEUROPSYCH CLIN N, V15, P346, DOI 10.1176/appi.neuropsych.15.3.346; Luchsinger Jose A, 2004, Curr Atheroscler Rep, V6, P261, DOI 10.1007/s11883-004-0056-z; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Ortiz CA, 2007, ANN NEUROL, V61, P435; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Tekin S, 2001, ANN NEUROL, V49, P355, DOI 10.1002/ana.72	13	27	27	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2017	55	4					1519	1528		10.3233/JAD-160780			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EH1JQ	WOS:000391523200023	27911311	Green Accepted			2022-02-06	
J	Wu, Y; Wang, JY; Shi, YJ; Pu, HJ; Leak, RK; Liou, AKF; Badylak, SF; Liu, ZX; Zhang, J; Chen, J; Chen, L				Wu, Yun; Wang, Jiayin; Shi, Yejie; Pu, Hongjian; Leak, Rehana K.; Liou, Anthony K. F.; Badylak, Stephen F.; Liu, Zhixiong; Zhang, Jun; Chen, Jun; Chen, Ling			Implantation of Brain-Derived Extracellular Matrix Enhances Neurological Recovery after Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article						astrogliosis; microglia; neurobehavioral function; neurodegeneration; white matter injury; concussion	MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; WHITE-MATTER; NERVOUS-SYSTEM; BIOLOGIC SCAFFOLDS; CEREBRAL-ISCHEMIA; PROGENITOR CELLS; MOUSE MODEL; STEM-CELLS; STROKE; RATS	Scaffolds composed of extracellular matrix (ECM) are being investigated for their ability to facilitate brain tissue remodeling and repair following injury. The present study tested the hypothesis that the implantation of brain-derived ECM would attenuate experimental traumatic brain injury (TBI) and explored potential underlying mechanisms. TBI was induced in mice by a controlled cortical impact (CCI). ECM was isolated from normal porcine brain tissue by decellularization methods, prepared as a hydrogel, and injected into the ipsilesional corpus callosum and striatum 1 h after CCI. Lesion volume and neurological function were evaluated up to 35 d after TBI. Immunohistochemistry was performed to assess post-TBI white matter integrity, reactive astrogliosis, and microglial activation. We found that ECM treatment reduced lesion volume and improved neuro-behavioral function. ECM-treated mice showed less post-TBI neurodegeneration in the hippocampus and less white matter injury than control, vehicle-treated mice. Furthermore, ECM ameliorated TBI-induced gliosis and microglial pro-inflammatory responses, thereby providing a favorable microenvironment for tissue repair. Our study indicates that brain ECM hydrogel implantation improved the brain microenvironment that facilitates post-TBI tissue recovery. Brain ECM offers excellent biocompatibility and holds potential as a therapeutic agent for TBI, alone or in combination with other treatments.	[Wu, Yun; Liu, Zhixiong] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China; [Wu, Yun; Shi, Yejie; Pu, Hongjian; Liou, Anthony K. F.; Chen, Jun] Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, S507 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15213 USA; [Wu, Yun; Shi, Yejie; Pu, Hongjian; Liou, Anthony K. F.; Chen, Jun] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Wang, Jiayin] Capital Med Univ, Xuanwu Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China; [Leak, Rehana K.] Duquesne Univ, Mylan Sch Pharm, Div Pharmaceut Sci, Pittsburgh, PA 15219 USA; [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Zhang, Jun; Chen, Ling] Gen Hosp PLA, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China		Chen, J (corresponding author), Univ Pittsburgh, Pittsburgh Inst Brain Disorders & Recovery, S507 Biomed Sci Tower,3500 Terrace St, Pittsburgh, PA 15213 USA.; Chen, L (corresponding author), Gen Hosp PLA, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China.	chenj2@upmc.edu; chen_ling301@163.com	Pu, Hongjian/AAW-3322-2020; Shi, Yejie/C-2355-2018; Leak, Rehana K/I-2607-2019	Shi, Yejie/0000-0001-7502-9201; Leak, Rehana K/0000-0003-2817-7417	U. S. National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS045048, NS095671]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30970939, 81272804, 81301066, 81271365]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7132046]; Beijing Nova ProgramBeijing Municipal Science & Technology Commission [XX2013019]; VA Senior Research Career Scientist Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095029, R01NS045048, R01NS095671] Funding Source: NIH RePORTER	author(s) disclosed receipt of the following financial support for the research and/or authorship of this article: This project was supported by the U. S. National Institutes of Health grants NS045048, NS095671, and NS095029 (to J.C.), National Natural Science Foundation of China grants (#30970939 and # 81272804 to L.C., #81301066 to J.W., and #81271365 to J.Z.), Beijing Natural Science Foundation (#7132046 to J.W.), and Beijing Nova Program (# XX2013019 to J.W.). J.C. is also supported by the VA Senior Research Career Scientist Award. The authors are indebted to Pat Strickler for excellent administrative support.	Agrawal V, 2011, TISSUE ENG PT A, V17, P2435, DOI [10.1089/ten.TEA.2011.0036, 10.1089/ten.tea.2011.0036]; An CR, 2014, PROG NEUROBIOL, V115, P6, DOI 10.1016/j.pneurobio.2013.12.002; Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034; Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]; Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044; Desmond DW, 2002, CEREBROVASC DIS, V13, P53, DOI 10.1159/000049151; Dutta S, 2013, CNS NEUROSCI THER, V19, P5, DOI 10.1111/cns.12027; Gan Y, 2012, ANTIOXID REDOX SIGN, V17, P719, DOI 10.1089/ars.2011.4298; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Ho PW, 2005, STROKE, V36, P2742, DOI 10.1161/01.STR.0000189748.52500.a7; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Liu FT, 2014, CNS NEUROSCI THER, V20, P778, DOI 10.1111/cns.12258; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062; Mifsud G, 2014, CNS NEUROSCI THER, V20, P603, DOI 10.1111/cns.12263; Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425; Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Stetler RA, 2008, J NEUROSCI, V28, P13038, DOI 10.1523/JNEUROSCI.4407-08.2008; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang JY, 2013, CNS NEUROL DISORD-DR, V12, P413, DOI 10.2174/1871527311312030014; Wang JY, 2014, NEUROBIOL DIS, V68, P91, DOI 10.1016/j.nbd.2014.04.014; Wood JD, 2005, JAVMA-J AM VET MED A, V226, P1095, DOI 10.2460/javma.2005.226.1095; Yan T, 2014, CNS NEUROSCI THER, V20, P935, DOI 10.1111/cns.12307; Zantop T, 2006, J ORTHOP RES, V24, P1299, DOI 10.1002/jor.20071; Zhao YH, 2013, CNS NEUROSCI THER, V19, P67, DOI 10.1111/cns.12040	39	27	27	5	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	7					1224	1234		10.1177/0963689717714090			11	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	EZ4GO	WOS:000404671800010	28933217	Green Published, gold, Green Accepted			2022-02-06	
J	Gutierrez, PM; Pease, J; Matarazzo, BB; Monteith, LL; Hernandez, T; Osman, A				Gutierrez, Peter M.; Pease, James; Matarazzo, Bridget B.; Monteith, Lindsey L.; Hernandez, Theresa; Osman, Augustine			Evaluating the Psychometric Properties of the Interpersonal Needs Questionnaire and the Acquired Capability for Suicide Scale in Military Veterans	PSYCHOLOGICAL ASSESSMENT			English	Article						Interpersonal Needs Questionnaire; Acquired Capability for Suicide Scale; veterans; psychometrics	TRAUMATIC BRAIN-INJURY; PSYCHOLOGICAL THEORY; CONSTRUCT-VALIDITY; PERCEIVED BURDENSOMENESS; SCREENING-TEST; 2 SAMPLES; RISK; IDEATION; BEHAVIOR; TESTS	Joiner's (2005) interpersonal-psychological theory of suicide (IPTS) has become one of the most frequently studied in the field. Currently there are 2 primary measures designed to assess the 3 main constructs of the theory-the Interpersonal Needs Questionnaire (INQ; Van Orden, Witte, Gordon, Bender, & Joiner, 2008) and the Acquired Capability for Suicide Scale (ACSS; Van Orden et al., 2008). The psychometric properties of these 2 measures were evaluated in a sample of 477 U.S. military veterans. It was determined that the factor structure for both measures is consistent with the underlying theory and that all internal consistency reliability estimates are good. Acceptable convergent validity was found for the INQ, but not for the ACSS. Recommendations for refining the ACSS based on the results of the current analyses are provided. Comparisons of scale performance were made with data from participants with and without a history of 1 or more suicide attempts. Burdensomeness alone and the interaction between thwarted belongingness and burdensomeness were associated with prior suicide attempts. In conclusion, although some refinement may improve performance of the ACSS, both measures are appropriate and psychometrically sound for use in research and clinical applications with veterans of the U.S. military.	[Gutierrez, Peter M.; Pease, James; Matarazzo, Bridget B.; Monteith, Lindsey L.; Hernandez, Theresa] Denver Vet Affairs Med Ctr, Rocky Mt Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Gutierrez, Peter M.; Pease, James; Matarazzo, Bridget B.; Monteith, Lindsey L.] Univ Colorado, Sch Med, Dept Psychiat, Boulder, CO 80309 USA; [Hernandez, Theresa] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Osman, Augustine] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA		Gutierrez, PM (corresponding author), Denver Vet Affairs Med Ctr, Rocky Mt Mental Illness Res Educ & Clin Ctr, MIRECC, 1055 Clermont St, Denver, CO 80220 USA.	peter.gutierrez@va.gov	Monteith, Lindsey L./X-3658-2019; Gutierrez, Peter/K-8905-2019	Monteith, Lindsey L./0000-0002-8104-5280; Gutierrez, Peter/0000-0001-8981-8404; Osman, Augustine/0000-0002-3306-3249			Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Baglin J., 2014, PRACTICAL ASSESS RES, V19, P1, DOI DOI 10.7275/DSEP-4220; Bahraini NH, 2013, J CONTEXTUAL BEHAV S, V2, P31, DOI 10.1016/j.jcbs.2013.03.001; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; Beck AT., 1991, MANUAL BECK SCALE SU; Bender T. W., 2007, IMPULSIVEITY S UNPUB; Bezdjian S, 2015, MIL PSYCHOL, V27, P325, DOI 10.1037/mil0000090; BONNER RL, 1991, J NERV MENT DIS, V179, P29, DOI 10.1097/00005053-199101000-00006; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Brenner L.A., 2008, J MENTAL HEALTH COUN, V30, P211, DOI [10.17744/mehc.30.3.n6418tm72231j606, DOI 10.17744/MEHC.30.3.N6418TM72231J606]; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brown GK, REV SUICIDE ASSESSME; Brown M.W., 1993, SOCIOL METHOD RES, P136; Bryan CJ, 2013, J CLIN PSYCHOL, V69, P64, DOI 10.1002/jclp.21932; Bryan CJ, 2010, PERS INDIV DIFFER, V48, P347, DOI 10.1016/j.paid.2009.10.023; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Ciarrochi J., 2008, CBT PRACTITIONERS GU; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Frearson J., 2008, LINKING LIFE P UNPUB; Freedenthal S, 2011, J CLIN PSYCHOL, V67, P609, DOI 10.1002/jclp.20782; GAVIN DR, 1989, BRIT J ADDICT, V84, P301; Gutierrez PM, 2013, J CLIN PSYCHOL, V69, P923, DOI 10.1002/jclp.21997; Haney E. M, 2012, 05225 VAESP; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; IBM Corp, 2012, IBM SPSS WIND 21 0 S; Jobes D., 2006, MANAGING SUICIDAL RI; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; Joiner TE, 2000, J CONSULT CLIN PSYCH, V68, P909, DOI 10.1037/0022-006X.68.5.909; Joiner TE, 2002, J SOC CLIN PSYCHOL, V21, P531, DOI 10.1521/jscp.21.5.531.22624; Joiner TE, 2009, J ABNORM PSYCHOL, V118, P634, DOI 10.1037/a0016500; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; Lance CE, 2006, ORGAN RES METHODS, V9, P202, DOI 10.1177/1094428105284919; LINEHAN MM, 1983, J CONSULT CLIN PSYCH, V51, P276, DOI 10.1037/0022-006X.51.2.276; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.2307/2334770; Marsh HW, 2013, PSYCHOL ASSESSMENT, V25, P796, DOI 10.1037/a0032573; Marty MA, 2012, J CLIN PSYCHOL, V68, P1008, DOI 10.1002/jclp.21877; McDonald R, 1999, TEST THEORY UNIFIED; Monteith LL, 2013, SUICIDE LIFE-THREAT, V43, P418, DOI 10.1111/sltb.12027; Muthen L. K., 1998, MPLUS 7 3 COMPUTER S; Nademin E, 2008, ARCH SUICIDE RES, V12, P309, DOI 10.1080/13811110802324847; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Osman A, 1993, PSYCHOL ASSESSMENT, V5, P154, DOI DOI 10.1037/1040-3590.5.2.154; Osman A., 2010, MSRI28 U TEX SAN AN; Pfeiffer PN, 2014, J AFFECT DISORDERS, V152, P277, DOI 10.1016/j.jad.2013.09.025; Ribeiro JD, 2013, J PSYCHOTHER INTEGR, V23, P207, DOI 10.1037/a0031416; Ribeiro JD, 2014, PSYCHOL ASSESSMENT, V26, P115, DOI 10.1037/a0034858; Rogers J. R., 2001, SUICIDE RESOURCES NE, P31; Schwartz SH, 2004, J RES PERS, V38, P230, DOI 10.1016/S0092-6566(03)00069-2; Selby EA, 2010, CLIN PSYCHOL REV, V30, P298, DOI 10.1016/j.cpr.2009.12.004; Stefanic N., 2008, LINKING LIFE P UNPUB; STROSAHL K, 1992, COMPR PSYCHIAT, V33, P366, DOI 10.1016/0010-440X(92)90057-W; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Tucker RP, 2015, SUICIDE LIFE-THREAT, V45, P679, DOI 10.1111/sltb.12161; Van Orden KA, 2008, J CONSULT CLIN PSYCH, V76, P72, DOI 10.1037/0022-006X.76.1.72; Van Orden KA, 2012, PSYCHOL ASSESSMENT, V24, P197, DOI 10.1037/a0025358; Yuan KH, 2000, SOCIOL METHODOL, V30, P165, DOI 10.1111/0081-1750.00078; Zinbarg RE, 2005, PSYCHOMETRIKA, V70, P123, DOI 10.1007/s11336-003-0974-7	65	27	27	1	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	DEC	2016	28	12					1684	1694		10.1037/pas0000310			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	EE0ZE	WOS:000389308700015	26998894				2022-02-06	
J	Isaev, NK; Stelmashook, EV; Genrikhs, EE; Korshunova, GA; Sumbatyan, NV; Kapkaeva, MR; Skulachev, VP				Isaev, Nickolay K.; Stelmashook, Elena V.; Genrikhs, Elisaveta E.; Korshunova, Galina A.; Sumbatyan, Natalya V.; Kapkaeva, Marina R.; Skulachev, Vladimir P.			Neuroprotective properties of mitochondria-targeted antioxidants of the SkQ-type	REVIEWS IN THE NEUROSCIENCES			English	Article						Alzheimer's disease; brain stroke; mitochondria-targeted antioxidant; neuroprotection; traumatic brain injury	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; INDUCED NEUROLOGICAL DEFICIT; BETA-INDUCED IMPAIRMENT; AMYLOID-BETA; ALZHEIMERS-DISEASE; PLASTOQUINONE DERIVATIVES; INTERRUPT EXECUTION; CEREBRAL-ISCHEMIA; RAT	In 2008, using a model of compression brain ischemia, we presented the first evidence that mitochondria-targeted antioxidants of the SkQ family, i.e. SkQR1 [10-(6'-plastoquinonyl)decylrhodamine], have a neuroprotective action. It was shown that intraperitoneal injections of SkQR1 (0.5-1 mu mol/kg) 1 day before ischemia significantly decreased the damaged brain area. Later, we studied in more detail the anti-ischemic action of this antioxidant in a model of experimental focal ischemia provoked by unilateral intravascular occlusion of the middle cerebral artery. The neuroprotective action of SkQ family compounds (SkQR1, SkQ1, SkQTR1, SkQT1) was manifested through the decrease in trauma-induced neurological deficit in animals and prevention of amyloid-beta-induced impairment of long-term potentiation in rat hippocampal slices. At present, most neurophysiologists suppose that long-term potentiation underlies cellular mechanisms of memory and learning. They consider inhibition of this process by amyloid-beta(1-42) as an in vitro model of memory disturbance in Alzheimer's disease. Further development of the above studies revealed that mitochondria- targeted antioxidants could retard accumulation of hyperphosphorylated tau-protein, as well as amyloid-beta(1-42), and its precursor APP in the brain, which are involved in developing neurodegenerative processes in Alzheimer's disease.	[Isaev, Nickolay K.; Korshunova, Galina A.; Sumbatyan, Natalya V.; Skulachev, Vladimir P.] Lomonosov Moscow State Univ, Belozersky Res Inst Physicochem Biol, Dept Bioenerget, Leninsky Gory,1,B 40, Moscow 119992, Russia; [Isaev, Nickolay K.; Stelmashook, Elena V.; Genrikhs, Elisaveta E.; Kapkaeva, Marina R.] Res Ctr Neurol, Brain Res Dept, Moscow 125367, Russia		Isaev, NK (corresponding author), Lomonosov Moscow State Univ, Belozersky Res Inst Physicochem Biol, Dept Bioenerget, Leninsky Gory,1,B 40, Moscow 119992, Russia.; Isaev, NK (corresponding author), Res Ctr Neurol, Brain Res Dept, Moscow 125367, Russia.	isaev@genebee.msu.ru	Genrikhs, Elizaveta E/C-3854-2012; Sumbatyan, Natalia/AAI-4474-2021; Sumbatyan, Nataliya V./B-2902-2015; Isaev, Nikolay K/B-4194-2012; Stelmashook, Elena V/B-4442-2012; Kapkaeva, Marina/AAO-1646-2020	Sumbatyan, Natalia/0000-0001-9361-7314; Skulachev, Vladimir/0000-0001-5141-7517; Genrikhs, Elizaveta/0000-0002-3203-0250; Kapkaeva, Marina/0000-0002-2833-2897	Russian Science FoundationRussian Science Foundation (RSF) [16-15-10108, 14-24-00107]	This work was done with financial support from the Russian Science Foundation (Project no. 16-15-10108, section 'SkQs decrease brain damage after traumatic brain injury', and no. 14-24-00107, section 'SkQs decrease brain damage after ischemia' and 'SkQ in models of Alzheimer's disease').	Antonenko YN, 2008, J MEMBRANE BIOL, V222, P141, DOI 10.1007/s00232-008-9108-6; Antonenko YN, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1273, DOI 10.1134/S0006297908120018; Bakeeva LE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1288, DOI 10.1134/S000629790812002X; Burits M, 2000, PHYTOTHER RES, V14, P323, DOI 10.1002/1099-1573(200008)14:5&lt;323::AID-PTR621&gt;3.0.CO;2-Q; Calkins MJ, 2012, PHARMACEUTICALS-BASE, V5, P1103, DOI 10.3390/ph5101103; Chatagner A, 2010, ARCH PEDIATRIE, V17, pS78, DOI 10.1016/S0929-693X(10)70905-2; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Di Domenico F, 2015, EXPERT REV NEUROTHER, V15, P19, DOI 10.1586/14737175.2015.955853; Egea J, 2014, NEUROSCIENCE, V267, P11, DOI 10.1016/j.neuroscience.2014.02.025; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Genrikhs EE, 2015, J DRUG TARGET, V23, P347, DOI 10.3109/1061186X.2014.997736; GREEN DE, 1974, BIOCHIM BIOPHYS ACTA, V346, P27, DOI 10.1016/0304-4173(74)90011-1; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hobbs CE, 2008, PEDIATR INT, V50, P481, DOI 10.1111/j.1442-200X.2008.02705.x; Isaev NK, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1578, DOI 10.1134/S0006297915120056; Isaev NK, 2012, BIOCHEMISTRY-MOSCOW+, V77, P996, DOI 10.1134/S0006297912090052; Ji J, 2015, J CEREBR BLOOD F MET, V35, P319, DOI 10.1038/jcbfm.2014.204; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Kapay NA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1367, DOI 10.1134/S0006297911120108; Kapay NA, 2013, J ALZHEIMERS DIS, V36, P377, DOI 10.3233/JAD-122428; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; Kirpatovsky VI, 2013, BIOCHEMISTRY-MOSCOW+, V78, P542, DOI 10.1134/S0006297913050131; Lloret A, 2011, J ALZHEIMERS DIS, V27, P701, DOI 10.3233/JAD-2011-110890; Loshchenova PS, 2015, BIOCHEMISTRY-MOSCOW+, V80, P596, DOI 10.1134/S0006297915050120; Ma T, 2011, J NEUROSCI, V31, P5589, DOI 10.1523/JNEUROSCI.6566-10.2011; Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564; McManus MJ, 2011, J NEUROSCI, V31, P15703, DOI 10.1523/JNEUROSCI.0552-11.2011; Persson T, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/427318; Plotnikov EY, 2010, BIOCHEMISTRY-MOSCOW+, V75, P145, DOI 10.1134/S0006297910020045; Severina II, 2013, FEBS LETT, V587, P2018, DOI 10.1016/j.febslet.2013.04.043; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Silachev DN, 2015, MOLECULES, V20, P14487, DOI 10.3390/molecules200814487; Silachev DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051553; Skulachev MV, 2011, CURR DRUG TARGETS, V12, P800; Skulachev VP, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1385, DOI 10.1134/S0006297907120139; Skulachev V. P., 2014, MITOCHONDRIA TARGETE, P195, DOI 10.1016/B978-0-12-405933-7.00019-6; Skulachev VP, 2012, J ALZHEIMERS DIS, V28, P283, DOI 10.3233/JAD-2011-111391; Skulachev VP, 2009, BBA-BIOENERGETICS, V1787, P437, DOI 10.1016/j.bbabio.2008.12.008; Stefanova NA, 2014, J ALZHEIMERS DIS, V38, P681, DOI 10.3233/JAD-131034; Stelmashook EV, 2015, BIOCHEMISTRY-MOSCOW+, V80, P592, DOI 10.1134/S0006297915050119; Ulamek-Koziol M, 2016, PHARMACOL REP, V68, P582, DOI 10.1016/j.pharep.2016.01.006; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Watanabe S, 2001, STROKE, V32, P2615, DOI 10.1161/hs1101.097384; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang ST, 2015, J NEUROL SCI, V349, P99, DOI 10.1016/j.jns.2014.12.032; Yani EV, 2012, PRACTICHESKAYA MED, V59, P134	51	27	32	0	13	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	DEC	2016	27	8					849	855		10.1515/revneuro-2016-0036			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED9SU	WOS:000389213900006	27559690				2022-02-06	
J	Makdissi, M; Davis, G				Makdissi, Michael; Davis, Gavin			Using video analysis for concussion surveillance in Australian football	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; Football; Video analysis; Epidemiology	SPORT-RELATED CONCUSSION; HOCKEY LEAGUE NHL; KNOWLEDGE; INJURIES; EPIDEMIOLOGY; MECHANISMS; RISK	Objectives: The objectives of the study were to assess the relationship between various player and game factors and risk of concussion; and to assess the reliability of video analysis for mechanistic assessment of concussion in Australian football. Design: Prospective cohort study. Methods: All impacts and collisions resulting in concussion were identified during the 2011 Australian Football League season. An extensive list of factors for assessment was created based upon previous analysis of concussion in Australian Football League and expert opinions. The authors independently reviewed the video clips and correlation for each factor was examined. Results: A total of 82 concussions were reported in 194 games (rate: 8.7 concussions per 1000 match hours; 95% confidence interval: 6.9-10.5). Player demographics and game variables such as venue, timing of the game (day, night or twilight), quarter, travel status (home or interstate) or score margin did not demonstrate a significant relationship with risk of concussion; although a higher percentage of concussions occurred in the first 5 min of game time of the quarter (36.6%), when compared to the last 5 min (20.7%). Variables with good inter-rater agreement included position on the ground, circumstances of the injury and cause of the impact. The remainder of the variables assessed had fair-poor inter-rater agreement. Common problems included insufficient or poor quality video and interpretation issues related to the definitions used. Conclusions: Clear definitions and good quality video from multiple camera angles are required to improve the utility of video analysis for concussion surveillance in Australian football. (C) 2016 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Makdissi, Michael; Davis, Gavin] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Melbourne, Vic, Australia; [Makdissi, Michael] Federat Univ, Australian Ctr Res Injury Sport & Its Prevent ACR, Ballarat, Vic, Australia; [Makdissi, Michael] La Trobe Univ, Sch Allied Hlth, Bundoora, Vic 3086, Australia; [Davis, Gavin] Austin Hosp, Dept Neurosurg, Heidelberg, Vic, Australia; [Davis, Gavin] Cabrini Hlth, Dept Neurosurg, Malvern, Vic, Australia		Makdissi, M (corresponding author), Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Austin Campus, Melbourne, Vic, Australia.; Makdissi, M (corresponding author), Federat Univ, Australian Ctr Res Injury Sport & Its Prevent ACR, Ballarat, Vic, Australia.; Makdissi, M (corresponding author), La Trobe Univ, Sch Allied Hlth, Bundoora, Vic 3086, Australia.	makdissi@unimelb.edu.au		makdissi, michael/0000-0003-0334-7133			Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Bjorneboe J, 2014, BRIT J SPORT MED, V48, P774, DOI 10.1136/bjsports-2012-091856; Bjorneboe J, 2013, BRIT J SPORT MED, V47, P508, DOI 10.1136/bjsports-2012-091522; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Gardner AJ, 2015, BRAIN INJURY, V17, P1; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Hutchison MG, 2014, BRIT J SPORT MED, V48, P125, DOI 10.1136/bjsports-2012-092059; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785	17	27	27	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	DEC	2016	19	12					958	963		10.1016/j.jsams.2016.02.014			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG3VO	WOS:000390973000002	27006067				2022-02-06	
J	Spiegelberg, A; Preuss, M; Kurtcuoglu, V				Spiegelberg, Andreas; Preuss, Matthias; Kurtcuoglu, Vartan			B-waves revisited	INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT			English	Article						Intracranial pressure; B-waves; Slow waves; Vasogenic waves; Waveform analysis	BLOOD-FLOW-VELOCITY; INTRACRANIAL-PRESSURE OSCILLATIONS; RHYTHMIC OSCILLATIONS; HYDROCEPHALUS; DIAGNOSIS; HEALTHY	Reduced intracranial compliance is a key manifestation common to a number of pathological conditions of the brain. It is encountered in, but not limited to, traumatic brain injury, cerebral edema, and hydrocephalus. There are no clinically accepted methods to measure intracranial compliance available to date. Intracranial pressure (ICP) waveform analysis is seeing a revival driven by advances in our understanding of cerebrospinal fluid and pressure dynamics. Its translation to widespread clinical use is dependent on the possibility to derive relevant metrics such as intracranial compliance reliably and non-invasively. The B-wave is one of the features of the ICP waveform, reflecting vasogenic activity of cerebral autoregulation. Bwaves were originally defined to occupy the 0.5 to 2 cycles per minute frequency range. Recently renamed and redefined as slow waves with an extended range of 0.33 to 3 cycles per minute, specific changes in their pattern of occurrence are considered to be indicative of reduced intracranial compliance. With the still unmet need for a clinically acceptable method for acquiring intracranial compliance, and the revival of ICP waveform analysis, B-waves are moving back into the research focus. Herein we provide a concise review of the literature on B-waves, including a critical assessment of non-invasive methods for obtaining B-wave surrogates. (C) 2016 The Authors. Published by Elsevier B.V.	[Spiegelberg, Andreas; Kurtcuoglu, Vartan] Univ Zurich, Inst Physiol, Interface Grp, Zurich, Switzerland; [Kurtcuoglu, Vartan] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Kurtcuoglu, Vartan] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Preuss, Matthias] Universitatsklinikum Leipzig AoR, Klin & Poliklin Neurochirurg, Leipzig, Germany		Kurtcuoglu, V (corresponding author), Univ Zurich, Inst Physiol, Interface Grp, Zurich, Switzerland.	vartan.kurtcuoglu@uzh.ch	Kurtcuoglu, Vartan/A-8940-2008	Kurtcuoglu, Vartan/0000-0003-2665-0995	Swiss National Science Foundation (NCCR Kidney.CH) through NCCR Kidney.CH	We gratefully acknowledge the financial support of the Swiss National Science Foundation (NCCR Kidney.CH) through NCCR Kidney.CH.	Aaslid R., 1986, INTRACRANIAL PRESSUR, P226; Agren-Wilsson A., 2005, THESIS; AUER LM, 1983, ACTA NEUROCHIR, V68, P93, DOI 10.1007/BF01406205; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; BORGESEN SE, 1982, BRAIN, V105, P65, DOI 10.1093/brain/105.1.65; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; BROCK M, 1977, RADIOLOGE, V17, P460; Brock M., 1978, HEAD INJURIES TUMORS, P188; Cushing H., 1901, DEFINITE REGULATORY; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2004, PHYSIOL MEAS, V25, pR51, DOI 10.1088/0967-3334/25/5/R01; Czosnyka M., 2015, COMMUNICATIONS; Czosnyka Z., 2014, HYDROCEPH, P78; De Rougemont J., 1972, INTRACRANIAL PRESSUR, P232; Diehl R. R., 2013, FUNKTIONELLE DOPPLER; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; DROSTE DW, 1993, SLEEP, V16, P603; DROSTE DW, 1993, J NEUROL NEUROSUR PS, V56, P75, DOI 10.1136/jnnp.56.1.75; Droste DW, 1999, NEUROL RES, V21, P627, DOI 10.1080/01616412.1999.11740987; DROSTE DW, 1994, ACTA NEUROL SCAND, V90, P99; Einhaupl K. M., 1986, INTRACRANIAL PRESSUR, VVI, P290, DOI 10.1007/978-3-642-70971-5_55; Eklund A, 2001, J NEUROSURG, V94, P392, DOI 10.3171/jns.2001.94.3.0392; Gaab M. R., 1981, THESIS; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; Hashimoto M., 1989, INTRACRANIAL PRESSUR, P217; Higashi S., 1989, INTRACRANIAL PRESSUR, P220; Huber P, 1967, Invest Radiol, V2, P17, DOI 10.1097/00004424-196701000-00016; Kasprowicz M, 2010, J NEUROSCI METH, V190, P310, DOI 10.1016/j.jneumeth.2010.05.015; Kiefer M, 2002, UNFALLCHIRURG, V105, P578, DOI 10.1007/s00113-002-0469-5; KRAUSS JK, 1994, NEUROL RES, V16, P398; KRAUSS JK, 1995, ACTA NEUROCHIR, V136, P195, DOI 10.1007/BF01410626; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; Lenfeldt N, 2004, J NEUROSURG, V101, P944, DOI 10.3171/jns.2004.101.6.0944; Lundberg N, 1959, ACTA PSYCHIAT SCAND, V36, P1; Maldonado E. R., 2013, THESIS; MARTIN G, 1978, SURG NEUROL, V9, P347; MAUTNER-HUPPERT D, 1989, Neurological Research, V11, P194; Minns R. A., 1991, HYDROCEPHALUS PATHOG, P270; Momjian S, 2004, BRIT J NEUROSURG, V18, P56, DOI 10.1080/02688690410001660481; Mueller JU, 2000, ZENTRALBL NEUROCH S1, V61, P14; Muller J. - U., 2000, FEEDBACK, P4; Muller J. U., 1998, ZENTRALBL NEUROCHI S; Nasi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025415; NEWELL DW, 1992, J NEUROSURG, V76, P415, DOI 10.3171/jns.1992.76.3.0415; NILSSON C, 1992, AM J PHYSIOL, V262, pR20, DOI 10.1152/ajpregu.1992.262.1.R20; Pfisterer WK, 2007, ACTA NEUROCHIR, V149, P983, DOI 10.1007/s00701-007-1240-z; Pickard J.D., 1980, INTRACRANIAL PRESSUR, P498; PIERREKAHN A, 1976, CHILD BRAIN, V2, P156; Poca M. A., 2013, INT ICP S 2013, P42; Raftopoulos Christian, 1992, Neurological Research, V14, P389; Rosner M., 1986, INTRACRANIAL PRESSUR, P137, DOI [10.1007/978-3-642-70971-5_25, DOI 10.1007/978-3-642-70971-5_25]; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Sorensen S. C., 1980, INTRACRANIAL PRESSUR, P123; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; Stephensen H, 2005, J NEUROL NEUROSUR PS, V76, P965, DOI 10.1136/jnnp.2004.039834; Symon L, 1977, Clin Neurosurg, V24, P285; SYMON L, 1972, LANCET, V2, P1291; Tamaki N, 1983, No To Shinkei, V35, P131; VENES JL, 1979, CHILD BRAIN, V5, P352; Virtanen J., 2011, EUR C BIOM OPT; Weerakkody Ruwan Alwis, 2012, Acta Neurochir Suppl, V114, P181, DOI 10.1007/978-3-7091-0956-4_35; Williams MA, 1998, ACT NEUR S, V71, P328; Woodworth GF, 2009, NEUROSURGERY, V64, P919, DOI 10.1227/01.NEU.0000341902.44760.10; Yamamoto S., 1983, INTRACRANIAL PRESSUR, P333; Zunker P., 1997, NEW TRENDS CEREBRAL, P718	66	27	27	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2214-7519			INTERDISCIP NEUROSUR	Interdiscip. Neurosurg.	DEC	2016	6						13	17		10.1016/j.inat.2016.03.004			5	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	ER8OG	WOS:000399078500004		Green Accepted, gold			2022-02-06	
J	Dadas, A; Washington, J; Marchi, N; Janigro, D				Dadas, Aaron; Washington, Jolewis; Marchi, Nicola; Janigro, Damir			Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers	FLUIDS AND BARRIERS OF THE CNS			English	Article						Physiologically-based pharmacokinetic model; Precision medicine; Traumatic brain injury; Glomerular filtration; Serum markers	PRIMARY CNS LYMPHOMA; BARRIER DISRUPTION; POSSIBLE MARKER; S100B PROTEIN; SERUM-LEVELS; S100-BETA; VOLUME; MILD	Background: Blood biomarkers of neurovascular damage are used clinically to diagnose the presence severity or absence of neurological diseases, but data interpretation is confounded by a limited understanding of their dependence on variables other than the disease condition itself. These include half-life in blood, molecular weight, and marker-specific biophysical properties, as well as the effects of glomerular filtration, age, gender, and ethnicity. To study these factors, and to provide a method for markers' analyses, we developed a kinetic model that allows the integrated interpretation of these properties. Methods: The pharmacokinetic behaviors of S100B (monomer and homodimer), Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase L1 were modeled using relevant chemical and physical properties; modeling results were validated by comparison with data obtained from healthy subjects or individuals affected by neurological diseases. Brain imaging data were used to model passage of biomarkers across the blood-brain barrier. Results: Our results show the following: (1) changes in biomarker serum levels due to age or disease progression are accounted for by differences in kidney filtration; (2) a significant change in the brain-to-blood volumetric ratio, which is characteristic of infant and adult development, contributes to variation in blood concentration of biomarkers; (3) the effects of extracranial contribution at steady-state are predicted in our model to be less important than suspected, while the contribution of blood-brain barrier disruption is confirmed as a significant factor in controlling markers' appearance in blood, where the biomarkers are typically detected; (4) the contribution of skin to the marker S100B blood levels depends on a direct correlation with pigmentation and not ethnicity; the contribution of extracranial sources for other markers requires further investigation. Conclusions: We developed a multi-compartment, pharmacokinetic model that integrates the biophysical properties of a given brain molecule and predicts its time-dependent concentration in blood, for populations of varying physical and anatomical characteristics. This model emphasizes the importance of the blood-brain barrier as a gatekeeper for markers' blood appearance and, ultimately, for rational clinical use of peripherally-detected brain protein.	[Dadas, Aaron; Washington, Jolewis; Janigro, Damir] Flocel Inc, Cleveland, OH 44103 USA; [Dadas, Aaron] Ohio State Univ, Columbus, OH 43210 USA; [Washington, Jolewis] John Carroll Univ, University Hts, OH USA; [Marchi, Nicola] Univ Montpellier, Inst Genom Fonct, Lab Cerebrovasc Mech Brain Disorders, Montpellier, France; [Janigro, Damir] Case Western Reserve Univ, Cleveland, OH 44106 USA		Janigro, D (corresponding author), Flocel Inc, Cleveland, OH 44103 USA.; Janigro, D (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	djanigro@flocel.com	Marchi, Nicola/J-8607-2016; Janigro, Damir/P-1750-2018	Marchi, Nicola/0000-0001-9124-0226; Janigro, Damir/0000-0002-9645-0318	 [R01NS078307];  [UH4TR000491];  [R01NS43284];  [R41MH093302];  [R21NS077236];  [R42MH093302];  [R21HD057256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD057256] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UH2TR000491, UH3TR000491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R41MH093302, R42MH093302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078307, R01NS043284, R21NS077236] Funding Source: NIH RePORTER	The work was supported by R01NS078307 (NM, DJ). UH4TR000491, awarded to DJ. R01NS43284, R41MH093302, R21NS077236, R42MH093302, and R21HD057256, awarded to DJ.	Allen JS, 2002, AM J PHYS ANTHROPOL, V118, P341, DOI 10.1002/ajpa.10092; Angelov L, 2009, J CLIN ONCOL, V27, P3503, DOI 10.1200/JCO.2008.19.3789; Astor BC, 2009, J AM SOC NEPHROL, V20, P2214, DOI 10.1681/ASN.2008090980; Bargerstock E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101477; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Bernareggi A, 1998, CLIN PHARMACOKINET, V35, P247, DOI 10.2165/00003088-199835040-00001; BERNAREGGI A, 1991, J PHARMACOKINET BIOP, V19, P21, DOI 10.1007/BF01062191; Biberthaler P, 2002, EUR J MED RES, V7, P164; Boron WF, 2003, MED PHYSL CELLULAR M, P757; Bouvier D, 2016, CLIN CHEM LAB MED, V54, P833, DOI 10.1515/cclm-2015-0771; Falcone T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011089; Ghanem G, 2001, INT J CANCER, V94, P586, DOI 10.1002/ijc.1504; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Hostetter TH, 2010, CLIN CHEM, V56, P1381, DOI 10.1373/clinchem.2010.147827; Janigro D, 2003, US Patent, Patent No. [20030170747 A1, 20030170747]; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2007, EPILEPSIA, V48, P732, DOI 10.1111/j.1528-1167.2007.00988.x; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Morera-Fumero AL, 2013, J PSYCHIATR RES, V47, P791, DOI 10.1016/j.jpsychires.2013.03.001; NEUWELT EA, 1991, J CLIN ONCOL, V9, P1580, DOI 10.1200/JCO.1991.9.9.1580; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Orasanu E, 2014, NEUROIMAGE-CLIN, V6, P438, DOI 10.1016/j.nicl.2014.10.007; Peters SA, 2008, CLIN PHARMACOKINET, V47, P261, DOI 10.2165/00003088-200847040-00004; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; ROMANGOLDSTEIN S, 1994, AM J NEURORADIOL, V15, P581; Schiavi Paolo, 2012, Acta Biomed, V83, P5; SISSON TRC, 1959, J PEDIATR-US, V55, P163, DOI 10.1016/S0022-3476(59)80084-6; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Vogelbaum MA, 2005, CANCER-AM CANCER SOC, V104, P817, DOI 10.1002/cncr.21220; WEISS L, 1980, AM J PATHOL, V101, P101; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149	40	27	27	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-8118			FLUIDS BARRIERS CNS	Fluids Barriers CNS	NOV 30	2016	13								21	10.1186/s12987-016-0045-y			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EM4WY	WOS:000395314900001	27903281	gold, Green Published			2022-02-06	
J	Zhao, WD; Stutzman, S; Olson, D; Saju, C; Wilson, M; Aiyagari, V				Zhao, Weidan; Stutzman, Sonja; Olson, DaiWai; Saju, Ciji; Wilson, Margaret; Aiyagari, Venkatesh			Inter-device reliability of the NPi-100 pupillometer	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Interrater reliability; Neurological illness; Pupil assessment; Pupillometery; Traumatic brain injury	INFRARED PUPILLOMETRY; AGREEMENT	The purpose of this study was to explore the inter-device reliability of NPi-100 pupillometers (NeuroOptics, Inc.). The pupillary examination is a fundamental element of the neurological exam. Current evidence suggests that the traditional examination of the pupil with a hand held flashlight has limited inter-rater reliability. Automated pupillometers were developed to provide an objective scoring of pupil size and reactivity. However, there are no data examining inter-device reliability of automated pupil assessments. This study included 210 paired pupillometer measurements were obtained by 33 practitioners from 20 patients at risk for cerebral edema. There was no statistically significant difference between the mean maximum pupil size at rest, the minimum pupil size during light stimulation, and the mean pupil reactivity, for both the right and left eye, when assessed by two investigators, each with a different pupillometer. In addition, Cohen's Kappa assessments of pupil size and reactivity revealed an almost perfect agreement between the two pupillometers for the maximum pupil size, the minimum pupil size, and for pupil reactivity for both eyes. There is a high inter-device reliability of automated pupillary assessments by two practitioners examining the same patient using different NPi-100 pupillometers. (C) 2016 Elsevier Ltd. All rights reserved.	[Zhao, Weidan; Aiyagari, Venkatesh] UT Southwestern Med Ctr, Dept Neurol Surg, Dallas, TX 75390 USA; [Stutzman, Sonja; Olson, DaiWai; Saju, Ciji; Wilson, Margaret; Aiyagari, Venkatesh] UT Southwestern Med Ctr, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75093 USA		Aiyagari, V (corresponding author), UT Southwestern Med Ctr, Dept Neurol Surg, Dallas, TX 75390 USA.; Aiyagari, V (corresponding author), UT Southwestern Med Ctr, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75093 USA.	venkatesh.aiyagari@utsouthwestern.edu	Olson, DaiWai/I-5932-2019	Olson, DaiWai/0000-0002-9280-078X; Aiyagari, Venkatesh/0000-0001-8139-3819			Behrends M, 2012, RESUSCITATION, V83, P1223, DOI 10.1016/j.resuscitation.2012.05.013; Campbell WW., 2005, DEJONGS NEUROLOGICAL, V6th ed.; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Clark A, 2006, EMERG MED J, V23, P440, DOI 10.1136/emj.2005.030247; Du R, 2005, NEUROSURGERY, V57, P198, DOI 10.1227/01.NEU.0000163425.79170.CB; GOEBERT HW, 1970, SURG CLIN N AM, V50, P427; Hurts KN, 2006, J NEUROSCI NURS, V38, P447; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; Loewenfeld I. E., 1993, PUPIL ANATOMY PHYSL; Manley GT, 2002, J NEUROSURG ANESTH, V14, P223, DOI 10.1097/00008506-200207000-00009; Meeker R, 2005, J NEUROSCI NURS, V37, P34; Sahar F, 2014, J CRIT CARE, V29, P599; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Viera AJ, 2005, FAM MED, V37, P360; Wilson S F, 1988, J Neurosci Nurs, V20, P189; Worthley LI, 2000, CRIT CARE RESUSC, V2, P34	17	27	30	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2016	33						79	82		10.1016/j.jocn.2016.01.039			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DZ9JW	WOS:000386192200012	27422586				2022-02-06	
J	Kamins, J; Giza, CC				Kamins, Joshua; Giza, Christopher C.			Concussion-Mild Traumatic Brain Injury Recoverable Injury with Potential for Serious Sequelae	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Concussion; Mild TBI; Sequalae of concussion	MINOR HEAD TRAUMA; SPORADIC HEMIPLEGIC MIGRAINE; SPORTS-RELATED CONCUSSION; DELAYED CEREBRAL EDEMA; POSTCONCUSSION SYNDROME; EARLY INTERVENTION; CONTROLLED-TRIAL; UNITED-STATES; EXERCISE; EPIDEMIOLOGY	Concussion is increasingly recognized as a major public health issue. Most patients will return to baseline and experience full recovery, although a subset experiences persistent symptoms. Newer animal models and imaging studies are beginning to demonstrate that metabolic and neurovascular resolution may actually take longer than symptomatic recovery. Repeat traumatic brain injury within the metabolic window of dysfunction may result in worsened symptoms and prolonged recovery. The true risk for second impact syndrome appears to be small, and development of cerebral edema after a mild impact may be related to genetic risks rather than serial impacts.	[Kamins, Joshua] Univ Calif Los Angeles, Dept Neurol, 710 Westwood Plaza,Suite 1-240, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Neurosurg, Room 531 Wasserman,300 Stein Plaza, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp UCLA, Dept Pediat, Room 531 Wasserman,300 Stein Plaza, Los Angeles, CA 90095 USA		Giza, CC (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, Room 531 Wasserman,300 Stein Plaza, Los Angeles, CA 90095 USA.; Giza, CC (corresponding author), Univ Calif Los Angeles, Mattel Childrens Hosp UCLA, Dept Pediat, Room 531 Wasserman,300 Stein Plaza, Los Angeles, CA 90095 USA.	cgiza@mednet.ucla.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NCAA; DODUnited States Department of Defense; NFL-GE; Today's and Tomorrow's Children Fund; UCLA BIRC; UCLA FGP; UCLA Steve Tisch BrainSPORT program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061504] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027544] Funding Source: NIH RePORTER	For full transparency, all funding sources are listed. Grants/Research Support: NIH, NCAA, DOD, NFL-GE, Today's and Tomorrow's Children Fund, UCLA BIRC, UCLA FGP, UCLA Steve Tisch BrainSPORT program; Consultant: NFL-NCP, NHLPA, Neural Analytics; Advisory Panel: LoveYourBrain, MLS, NBA, NCAA, Neural Analytics, USSF; Medicolegal: One or 2 cases annually; Speaker's Bureau: Medical Education Speakers Network; Stock Shareholder: None; Other Financial or Material Support: None; Other: Commissioner California State Athletic Commission (end 2/2015).	Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2981, DOI 10.1073/pnas.1508756112; Bey T, 2009, WEST J EMERG MED, V10, P6; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Bruner J.S., 1960, PROCESS ED; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Clark PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141898; Curtain RP, 2006, PEDIATR NEUROL, V34, P329, DOI 10.1016/j.pediatrneurol.2005.08.033; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; GAGE NL, 1963, HDB RES TEACHING; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Giesser BS, 2015, THER ADV NEUROL DISO, V8, P123, DOI 10.1177/1756285615576663; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greco T, 2013, J NEUROTRAUM, V30, P1983, DOI 10.1089/neu.2013.2990; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Groot C, 2016, AGEING RES REV, V25, P13, DOI 10.1016/j.arr.2015.11.005; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kavalci C, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-31; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lewis MS, 2011, NEUROUROL URODYNAM, V30, P183, DOI 10.1002/nau.20963; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Malmivaara A, 1995, Duodecim, V111, P2101; Malpas TJ, 2010, DEV MED CHILD NEUROL, V52, P103, DOI 10.1111/j.1469-8749.2009.03493.x; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Randolph C, 2013, J INT NEUROPSYCH SOC, V19, P873, DOI 10.1017/S1355617713000805; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Schonfeld D, 2014, ARCH DIS CHILD, V99, P427, DOI 10.1136/archdischild-2013-305004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	76	27	27	0	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	2016	27	4					441	+		10.1016/j.nec.2016.05.005			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY9SQ	WOS:000385475800006	27637394	Green Accepted, Bronze			2022-02-06	
J	Zhou, HL; Zhang, XJ; Zhang, MY; Yan, ZJ; Xu, ZM; Xu, RX				Zhou, Hong-Long; Zhang, Xue-Jun; Zhang, Mao-Ying; Yan, Zhong-Jie; Xu, Zhi-Min; Xu, Ru-Xiang			Transplantation of Human Amniotic Mesenchymal Stem Cells Promotes Functional Recovery in a Rat Model of Traumatic Spinal Cord Injury	NEUROCHEMICAL RESEARCH			English	Article						Human amnion; Mesenchymal stem cells; Spinal cord injury; Transplantation; Functional recovery	MARROW STROMAL CELLS; TISSUE; DIFFERENTIATION; ANGIOGENESIS; MEMBRANE; ISCHEMIA; BLOOD; VEGF	Human amniotic membrane mesenchymal stem cells (hAMSCs) are considered ideal candidate stem cells for cell-based therapy. In this study, we assessed whether hAMSCs transplantation promotes neurological functional recovery in rats after traumatic spinal cord injury (SCI). In addition, the potential mechanisms underlying the possible benefits of this therapy were investigated. Female Sprague-Dawley rats were subjected to SCI using a weight drop device and then hAMSCs, or phosphate-buffered saline (PBS) were immediately injected into the contused dorsal spinal cord at 2 mm rostral and 2 mm caudal to the injury site. Our results indicated that transplanted hAMSCs migrated in the host spinal cord without differentiating into neuronal or glial cells. Compared with the control group, hAMSCs transplantation significantly decreased the numbers of ED1(+) macrophages/microglia and caspase-3(+) cells. In addition, hAMSCs transplantation significantly increased the levels of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) in the injured spinal cord, and promoted both angiogenesis and axonal regeneration. These effects were associated with significantly improved neurobehavioral recovery in the hAMSCs transplantation group. These results show that transplantation of hAMSCs provides neuroprotective effects in rats after SCI, and could be candidate stem cells for the treatment of SCI.	[Zhou, Hong-Long; Zhang, Mao-Ying; Xu, Ru-Xiang] Southern Med Univ, Affiliated Bayi Brain Hosp, Bayi Clin Coll, Beijing, Peoples R China; [Zhou, Hong-Long; Zhang, Mao-Ying; Xu, Zhi-Min; Xu, Ru-Xiang] PLA, Beijing Mil Reg, Gen Hosp, Affiliated Bayi Brain Hosp, 5 Nanmen Cang, Beijing 100700, Peoples R China; [Zhou, Hong-Long; Zhang, Mao-Ying; Xu, Zhi-Min; Xu, Ru-Xiang] Beijing Mil Reg, Inst Neurosurg, Beijing, Peoples R China; [Zhang, Xue-Jun] Beijing Mil Reg, Gen Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China; [Yan, Zhong-Jie] Hebei Med Univ, Hosp 2, Dept Neurosurg, Shijiazhuang, Peoples R China		Xu, RX (corresponding author), Southern Med Univ, Affiliated Bayi Brain Hosp, Bayi Clin Coll, Beijing, Peoples R China.; Xu, RX (corresponding author), PLA, Beijing Mil Reg, Gen Hosp, Affiliated Bayi Brain Hosp, 5 Nanmen Cang, Beijing 100700, Peoples R China.; Xu, RX (corresponding author), Beijing Mil Reg, Inst Neurosurg, Beijing, Peoples R China.	jzxuruxiang@163.com			Military Twelfth Five-Year Key Sci-Tech Research Projects [BWS11J002, BWS12J010]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401032]	This work was supported by funding from the Military Twelfth Five-Year Key Sci-Tech Research Projects (Grants Nos. BWS11J002 and BWS12J010) and the Natural Science Foundation of China (81401032).	Abrams MB, 2009, RESTOR NEUROL NEUROS, V27, P307, DOI 10.3233/RNN-2009-0480; Bottai D, 2010, EXP NEUROL, V223, P452, DOI 10.1016/j.expneurol.2010.01.010; Chang YJ, 2010, CELLS TISSUES ORGANS, V192, P93, DOI 10.1159/000295774; Dasari VR, 2007, NEUROCHEM RES, V32, P2080, DOI 10.1007/s11064-007-9368-z; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Diaz-Prado S, 2011, DIFFERENTIATION, V81, P162, DOI 10.1016/j.diff.2011.01.005; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e; Kang JW, 2012, J VET SCI, V13, P23, DOI 10.4142/jvs.2012.13.1.23; Kawabe J, 2011, J NEUROSURG-SPINE, V15, P414, DOI 10.3171/2011.5.SPINE10421; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kim KS, 2013, NEUROBIOL AGING, V34, P2408, DOI 10.1016/j.neurobiolaging.2013.03.029; Kim SW, 2013, INT J CARDIOL, V168, P1062, DOI 10.1016/j.ijcard.2012.11.003; Kim SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041105; Kim SW, 2012, CARDIOVASC RES, V93, P525, DOI 10.1093/cvr/cvr328; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; Lee KH, 2007, ACTA NEUROBIOL EXP, V67, P13; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Magatti M, 2009, CELL TRANSPLANT, V18, P899, DOI 10.3727/096368909X471314; McMahon SS, 2010, CYTOTHERAPY, V12, P313, DOI 10.3109/14653241003695018; Novikova L, 1996, NEUROSCI LETT, V220, P203, DOI 10.1016/S0304-3940(96)13267-5; Oudega M, 2012, CELL TISSUE RES, V349, P269, DOI 10.1007/s00441-012-1440-6; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sundberg LM, 2011, J NEUROTRAUM, V28, P565, DOI 10.1089/neu.2010.1533; Tao J, 2012, BRAIN RES, V1448, P1, DOI 10.1016/j.brainres.2012.01.069; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397	37	27	29	1	6	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	OCT	2016	41	10					2708	2718		10.1007/s11064-016-1987-9			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EA1TY	WOS:000386376000021	27351200				2022-02-06	
J	Rom, S; Zuluaga-Ramirez, V; Reichenbach, NL; Dykstra, H; Gajghate, S; Pacher, P; Persidsky, Y				Rom, Slava; Zuluaga-Ramirez, Viviana; Reichenbach, Nancy L.; Dykstra, Holly; Gajghate, Sachin; Pacher, Pal; Persidsky, Yuri			PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier	JOURNAL OF NEUROINFLAMMATION			English	Article						Leukocyte-endothelial interaction; VLA-4; LFA-1; Actin cytoskeleton; PARP-1	NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE-1 INHIBITOR; MICROVASCULAR ENDOTHELIAL-CELLS; FOCAL CEREBRAL-ISCHEMIA; CANNABINOID RECEPTOR 2; TRANSENDOTHELIAL MIGRATION; MULTIPLE-SCLEROSIS; NEUROINFLAMMATORY CONDITIONS; VASCULAR-DISEASE; OXIDATIVE STRESS	Background: Blood-brain barrier (BBB) dysfunction/disruption followed by leukocyte infiltration into the brain causes neuroinflammation and contributes to morbidity in multiple sclerosis, encephalitis, traumatic brain injury, and stroke. The identification of pathways that decreases the inflammatory potential of leukocytes would prevent such injury. Poly(ADP-ribose) polymerase 1 (PARP) controls various genes via its interaction with myriad transcription factors. Selective PARP inhibitors have appeared lately as potent anti-inflammatory tools. Their effects are outside the recognized PARP functions in DNA repair and transcriptional regulation. In this study, we explored the idea that selective inhibition of PARP in leukocytes would diminish their engagement of the brain endothelium. Methods: Cerebral vascular changes and leukocyte-endothelium interactions were surveyed by intravital videomicroscopy utilizing a novel in vivo model of localized aseptic meningitis when TNFa was introduced intracerebrally in wild-type (PARP(+/+)) and PARP-deficient (PARP(-/-)) mice. The effects of selective PARP inhibition on primary human monocytes ability to adhere to or migrate across the BBB were also tested in vitro, employing primary human brain microvascular endothelial cells (BMVEC) as an in vitro model of the BBB. Results: PARP suppression in monocytes diminished their adhesion to and migration across BBB in vitro models and prevented barrier injury. In monocytes, PARP inactivation decreased conformational activation of integrins that plays a key role in their tissue infiltration. Such changes were mediated by suppression of activation of small Rho GTPases and cytoskeletal rearrangements in monocytes. In vitro observations were confirmed in vivo showing diminished leukocyte-endothelial interaction after selective PARP suppression in leukocytes accompanied by BBB protection. PARP knockout animals demonstrated a substantial diminution of inflammatory responses in brain microvasculature and a decrease in BBB permeability. Conclusions: These results suggest PARP inhibition in leukocytes as a novel approach to BBB protection in the setting of endothelial dysfunction caused by inflammation-induced leukocyte engagement.	[Rom, Slava; Zuluaga-Ramirez, Viviana; Reichenbach, Nancy L.; Dykstra, Holly; Gajghate, Sachin; Persidsky, Yuri] Temple Univ, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA; [Rom, Slava; Persidsky, Yuri] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA; [Pacher, Pal] NIAAA, Lab Cardiovasc Physiol & Tissue Injury, NIH, Bethesda, MD 20852 USA		Rom, S; Persidsky, Y (corresponding author), Temple Univ, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA.; Rom, S; Persidsky, Y (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA.	srom@temple.edu; yuri.persidsky@tuhs.temple.edu	Pacher, Pal/B-6378-2008; Rom, Slava/AAF-6872-2020	Pacher, Pal/0000-0001-7036-8108; Rom, Slava/0000-0002-1050-1955	 [MH65151];  [AA015913];  [DA013429];  [NS087385];  [ZIAAA000375]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R29AI042404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH065151, R01MH106967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS087385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [U01AA023552, R01AA015913, ZIAAA000375, R37AA015913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [P30DA013429] Funding Source: NIH RePORTER	The work performed in the authors' laboratories is supported by grants from MH65151 (YP), AA015913 (YP), DA013429 (YP), NS087385 (SR), and ZIAAA000375 (PP). The fund agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SF, 2015, MOL IMMUNOL, V63, P394, DOI 10.1016/j.molimm.2014.09.009; Ahmad SF, 2014, CYTOKINE, V68, P76, DOI 10.1016/j.cyto.2014.04.006; Alevriadou BR, 2003, AM J PHYSIOL-CELL PH, V285, pC250, DOI 10.1152/ajpcell.00189.2003; Allport JR, 1997, J EXP MED, V186, P517, DOI 10.1084/jem.186.4.517; Alon R, 2005, J CELL BIOL, V171, P1073, DOI 10.1083/jcb.200503155; Aoyagi-Scharber M, 2014, ACTA CRYSTALLOGR F, V70, P1143, DOI 10.1107/S2053230X14015088; Ba XQ, 2011, AM J PATHOL, V178, P946, DOI 10.1016/j.ajpath.2010.12.004; Bai P, 2015, TRENDS ENDOCRIN MET, V26, P75, DOI 10.1016/j.tem.2014.11.003; Barthel SR, 2008, J LEUKOCYTE BIOL, V83, P1, DOI 10.1189/jlb.0607344; Bernas MJ, 2010, NAT PROTOC, V5, P1265, DOI 10.1038/nprot.2010.76; Bolomini-Vittori M, 2009, NAT IMMUNOL, V10, P185, DOI 10.1038/ni.1691; Canan S, 2011, METHODS MOL BIOL, V780, P463, DOI 10.1007/978-1-61779-270-0_28; Cavone L, 2011, MULT SCLER J, V17, P794, DOI 10.1177/1352458511399113; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Chamorro A, 2006, STROKE, V37, P291, DOI 10.1161/01.STR.0000200561.69611.f8; Chigaev A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00242; Chigaev A, 2009, J BIOL CHEM, V284, P14337, DOI 10.1074/jbc.M901178200; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; del Zoppo GJ, 2009, NEUROSCIENCE, V158, P972, DOI 10.1016/j.neuroscience.2008.08.028; Etienne-Manneville S, 2000, J IMMUNOL, V165, P3375, DOI 10.4049/jimmunol.165.6.3375; Evans R, 2011, BLOOD, V117, P3331, DOI 10.1182/blood-2010-06-289140; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Ferreira AM, 2006, MICROCIRCULATION, V13, P439, DOI 10.1080/10739680600776062; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Goldey GJ, 2014, NAT PROTOC, V9, P2515, DOI 10.1038/nprot.2014.165; Gorina R, 2014, J IMMUNOL, V192, P324, DOI 10.4049/jimmunol.1300858; Haider L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/725370; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Horvath B, 2012, BRIT J PHARMACOL, V165, P2462, DOI 10.1111/j.1476-5381.2011.01381.x; Hottiger MO, 2015, EXPERT OPIN THER TAR, V19, P1149, DOI 10.1517/14728222.2015.1073262; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kameoka M, 2000, BIOCHEM J, V346, P641, DOI 10.1042/0264-6021:3460641; Kauppinen TM, 2005, J NEUROSCI RES, V81, P190, DOI 10.1002/jnr.20525; Kebir H, 1862, BIOCHIM BIOPHYS ACTA, V2015, P472; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Koedel U, 2002, J CEREBR BLOOD F MET, V22, P39, DOI 10.1097/00004647-200201000-00005; Larochelle C, 2011, FEBS LETT, V585, P3770, DOI 10.1016/j.febslet.2011.04.066; Lenzser G, 2007, J CEREBR BLOOD F MET, V27, P1318, DOI 10.1038/sj.jcbfm.9600437; Lescot T, 2010, J NEUROTRAUM, V27, P1069, DOI 10.1089/neu.2009.1188; Lim YC, 2000, MICROCIRCULATION, V7, P201, DOI 10.1038/sj.mn.7300103; Liu LL, 2012, HUM IMMUNOL, V73, P439, DOI 10.1016/j.humimm.2012.02.002; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Martinez-Zamudio RI, 2014, BRAIN BEHAV, V4, P552, DOI 10.1002/brb3.239; Martire S, 2015, MECH AGEING DEV, V146, P53, DOI 10.1016/j.mad.2015.04.001; Mathews MT, 2008, ARTERIOSCL THROM VAS, V28, P711, DOI 10.1161/ATVBAHA.107.156406; Milzani A, 1997, ARCH BIOCHEM BIOPHYS, V339, P267, DOI 10.1006/abbi.1996.9847; Mizuno K, 2013, CELL SIGNAL, V25, P457, DOI 10.1016/j.cellsig.2012.11.001; Moroni F, 2008, CURR OPIN PHARMACOL, V8, P96, DOI 10.1016/j.coph.2007.10.005; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Nakagawa Y, 2015, ONCOTARGET, V6, P3825, DOI 10.18632/oncotarget.2868; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pasqualetti G, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0531-7; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Persidsky Y, 2015, AM J PATHOL, V185, P1548, DOI 10.1016/j.ajpath.2015.03.001; Prat A, 2002, ARCH NEUROL-CHICAGO, V59, P391, DOI 10.1001/archneur.59.3.391; Qiu W, 2014, ACTA CRYSTALLOGR D, V70, P2740, DOI 10.1107/S1399004714017660; Ramirez SH, 2008, J IMMUNOL, V180, P1854, DOI 10.4049/jimmunol.180.3.1854; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; Rom S, 2015, J CEREBR BLOOD F MET, V35, P1957, DOI 10.1038/jcbfm.2015.154; Rom S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00878; Rom S, 2015, J CEREBR BLOOD F MET, V35, P28, DOI 10.1038/jcbfm.2014.167; Rom S, 2013, AM J PATHOL, V183, P1548, DOI 10.1016/j.ajpath.2013.07.033; Rom S, 2012, AM J PATHOL, V181, P1414, DOI 10.1016/j.ajpath.2012.06.018; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; Shimizu Y, 2001, AM J RESP CRIT CARE, V163, P210, DOI 10.1164/ajrccm.163.1.2001089; Stevens SL, 2002, BRAIN RES, V932, P110, DOI 10.1016/S0006-8993(02)02292-8; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Ana MT, 2014, FREE RADICAL BIO MED, V75, pS19, DOI 10.1016/j.freeradbiomed.2014.10.633; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; van Buul JD, 2004, ARTERIOSCL THROM VAS, V24, P824, DOI 10.1161/01.ATV.0000122854.76267.5c; Venter G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097378; Veres B, 2003, BIOCHEM PHARMACOL, V65, P1373, DOI 10.1016/S0006-2952(03)00077-7; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Vuong B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0448-8; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Woska JR, 2001, J LEUKOCYTE BIOL, V70, P329; Zhang CX, 2004, AM J PHYSIOL-HEART C, V287, pH659, DOI 10.1152/ajpheart.00162.2004; Zohrabian VM, 2009, ANTICANCER RES, V29, P119; Zuluaga-Ramirez V, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0021-y	86	27	27	0	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	SEP 27	2016	13								254	10.1186/s12974-016-0729-x			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	DX8EJ	WOS:000384620600001	27677851	Green Published, gold			2022-02-06	
J	McDonald, T; Burghart, MA; Nazir, N				McDonald, Tracy; Burghart, Mark A.; Nazir, Niaman			Underreporting of Concussions and Concussion-Like Symptoms in Female High School Athletes	JOURNAL OF TRAUMA NURSING			English	Article						Adolescents; Concussion education; Female athletes; Mild traumatic brain injury; Sport-related concussion	SPORTS-RELATED CONCUSSION; HEAD-INJURY; MANAGEMENT; KNOWLEDGE; PLAYERS; HISTORY	Underreporting of concussions and concussion-like symptoms in athletes continues to be a serious medical concern and research focus. Despite mounting worry, little evidence exists examining incidence of underreporting and documenting characteristics of head injury in female athletes participating in high school sports. This study examined the self-reporting behaviors of female high school athletes. Seventy-seven athletes participated, representing 14 high school sports. Nearly half of the athletes (31 participants) reported a suspected concussion, with 10 of the 31 athletes refraining from reporting symptoms to training staff after injury. Only 66% reported receiving concussion education. Concussion education appeared to have no relationship with diagnosed concussion rates in athletes, removing athletes from play, or follow-up medical care after injury. In conclusion, female high school athletes underreport signs and symptoms of concussions. Concussion education should occur at higher rates among female athletes to influence reporting behaviors.	[McDonald, Tracy] Univ Kansas Hosp, Trauma Acute Care Surg Burn & Concuss Adm, Kansas City, KS USA; [Burghart, Mark A.] Univ Kansas, Med Ctr, Occupat Therapy Educ, Sch Hlth Profess, Kansas City, KS 66103 USA; [Nazir, Niaman] Univ Kansas, Med Ctr, Sch Med, Prevent Med & Publ Hlth, Kansas City, KS 66103 USA		McDonald, T (corresponding author), Univ Kansas Hosp, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	trogers@kumc.edu					Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guthrie RM, 2015, PHYSICIAN SPORTSMED, V43, P333, DOI 10.1080/00913847.2015.1081552; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; LaBotz M, 2005, CLIN J SPORT MED, V15, P73, DOI 10.1097/01.jsm.0000157649.99867.fc; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Moreno MA, 2012, ARCH PEDIAT ADOL MED, V166, P296, DOI [10.1001/archpediatrics.2012.8, 10.1001/archpediatrics.2012.79]; Moreno MA, 2011, ARCH PEDIAT ADOL MED, V165, P376, DOI 10.1001/archpediatrics.2011.31; Patel Dilip R, 2002, Adolesc Med, V13, P569; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Tomei KL, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12280; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	24	27	27	8	25	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1078-7496	1932-3883		J TRAUMA NURS	J. Trauma Nurs.	SEP-OCT	2016	23	5					241	246		10.1097/JTN.0000000000000227			6	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Nursing	DX1FY	WOS:000384112700003	27618372				2022-02-06	
J	Wang, P; Li, H; Barde, S; Zhang, MD; Sun, J; Wang, T; Zhang, P; Luo, HJ; Wang, YJ; Yang, YT; Wang, CY; Svenningsson, P; Theodorsson, E; Hokfelt, TGM; Xu, ZQD				Wang, Peng; Li, Hui; Barde, Swapnali; Zhang, Ming-Dong; Sun, Jing; Wang, Tong; Zhang, Pan; Luo, Hanjiang; Wang, Yongjun; Yang, Yutao; Wang, Chuanyue; Svenningsson, Per; Theodorsson, Elvar; Hokfelt, Tomas G. M.; Xu, Zhi-Qing David			Depression-like behavior in rat: Involvement of galanin receptor subtype 1 in the ventral periaqueductal gray	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						dorsal raphe; neuropeptide; siRNA; stress; transmitter coexistence	DORSAL RAPHE NUCLEUS; CENTRAL-NERVOUS-SYSTEM; NONSEROTONERGIC PROJECTION NEURONS; GAMMA-AMINOBUTYRIC-ACID; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; SINGLE-CELL TRANSCRIPTOMICS; PREPROGALANIN MESSENGER-RNA; UNPREDICTABLE MILD STRESS; MEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY	The neuropeptide galanin coexists in rat brain with serotonin in the dorsal raphe nucleus and with noradrenaline in the locus coeruleus (LC), and it has been suggested to be involved in depression. We studied rats exposed to chronic mild stress (CMS), a rodent model of depression. As expected, these rats showed several endophenotypes relevant to depression-like behavior compared with controls. All these endophenotypes were normalized after administration of a selective serotonin reuptake inhibitor. The transcripts for galanin and two of its receptors, galanin receptor 1 (GALR1) and GALR2, were analyzed with quantitative real-time PCR using laser capture microdissection in the following brain regions: the hippocampal formation, LC, and ventral periaqueductal gray (vPAG). Only Galr1 mRNA levels were significantly increased, and only in the latter region. After knocking down Galr1 in the vPAG with an siRNA technique, all parameters of the depressive behavioral phenotype were similar to controls. Thus, the depression-like behavior in rats exposed to CMS is likely related to an elevated expression of Galr1 in the vPAG, suggesting that a GALR1 antagonist could have antidepressant effects.	[Wang, Peng; Li, Hui; Sun, Jing; Wang, Tong; Zhang, Pan; Luo, Hanjiang; Yang, Yutao; Xu, Zhi-Qing David] Capital Med Univ, Beijing Inst Brain Disorders, Minist Sci & Technol, Beijing Lab Brain Disorders,Dept Neurobiol,Beijin, Beijing 100069, Peoples R China; [Barde, Swapnali; Zhang, Ming-Dong; Hokfelt, Tomas G. M.] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Zhang, Ming-Dong] Karolinska Inst, Dept Biochem & Biophys, Div Mol Neurobiol, SE-17177 Stockholm, Sweden; [Wang, Yongjun; Wang, Chuanyue] Capital Med Univ, Anding Hosp, Beijing 100088, Peoples R China; [Svenningsson, Per] Karolinska Inst, Dept Neurol & Clin Neurosci, Ctr Mol Med, SE-17176 Stockholm, Sweden; [Svenningsson, Per] Karolinska Univ Hosp, SE-17176 Stockholm, Sweden; [Theodorsson, Elvar] Linkoping Univ, Dept Clin Chem, SE-58183 Linkoping, Sweden; [Theodorsson, Elvar] Linkoping Univ, Dept Clin & Expt Med, SE-58183 Linkoping, Sweden; [Wang, Peng] Logist Univ Peoples Armed Police Force, Dept Anat & Histoembryol, Tianjin 300309, Peoples R China		Xu, ZQD (corresponding author), Capital Med Univ, Beijing Inst Brain Disorders, Minist Sci & Technol, Beijing Lab Brain Disorders,Dept Neurobiol,Beijin, Beijing 100069, Peoples R China.; Hokfelt, TGM (corresponding author), Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden.	tomas.hokfelt@ki.se; zhiqingx@ccmu.edu.cn	Svenningsson, Per JL/K-5210-2014; Wang, Chuan-Yue/C-9369-2015; Theodorsson, Elvar/H-2096-2011; Xu, Zhi-Qing David/H-9757-2013	Wang, Chuan-Yue/0000-0001-6549-3713; Theodorsson, Elvar/0000-0003-0756-7723; Zhang, Mingdong/0000-0002-6348-1994; Xu, Zhi-Qing David/0000-0002-0387-7559	National Natural Sciences Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870815, 31171032]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7091002]; National Basic Research Program of China 973 ProgramNational Basic Research Program of China [2010CB912003]; Beijing Talent Project [PHR20100510]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [4X-2887]; Seed Grant of the International Alliance of Translational Neuroscience [PXM2014_014226_000006]; Beijing Brain Project [Z161100000216142]; KI	We thank Prof. Staffan Cullheim [Karolinska Institutet (KI)] for critical support and Professor Kathryn Commons (Childrens Hospital, Harvard University) for valuable advice. Laser-scanning microscopy was made available by the center for Live Imaging of Cells at the KI, an imaging core facility supported by the Knut and Alice Wallenberg Foundation. This study was supported by the National Natural Sciences Foundation of China (Grants 30870815 and 31171032), Beijing Natural Science Foundation (Key Project 7091002), National Basic Research Program of China 973 Program (Grant 2010CB912003), Beijing Talent Project (Grant PHR20100510), Swedish Research Council (Grant 4X-2887), Seed Grant PXM2014_014226_000006 of the International Alliance of Translational Neuroscience, and Beijing Brain Project (Grant Z161100000216142), as well as by funds from the KI.	Abrams JK, 2004, ANN NY ACAD SCI, V1018, P46, DOI 10.1196/annals.1296.005; AGHAJANIAN GK, 1977, BRAIN RES, V122, P229, DOI 10.1016/0006-8993(77)90291-8; Bang SJ, 2012, J COMP NEUROL, V520, P4157, DOI 10.1002/cne.23146; BARABAN JM, 1981, BRAIN RES, V204, P1, DOI 10.1016/0006-8993(81)90646-6; BARBARESI P, 1988, NEUROSCIENCE, V27, P183, DOI 10.1016/0306-4522(88)90229-1; Barr AM, 2006, NEUROSCI LETT, V405, P111, DOI 10.1016/j.neulet.2006.06.033; Barrera G, 2005, NEUROPEPTIDES, V39, P289, DOI 10.1016/j.npep.2004.12.008; Bartfai T, 2012, TRENDS PHARMACOL SCI, V33, P9, DOI 10.1016/j.tips.2011.09.006; BELIN MF, 1983, BRAIN RES, V275, P329, DOI 10.1016/0006-8993(83)90994-0; BELIN MF, 1979, BRAIN RES, V170, P279, DOI 10.1016/0006-8993(79)90107-0; BING O, 1993, NEUROSCI LETT, V164, P17, DOI 10.1016/0304-3940(93)90846-D; Borroto-Escuela DO, 2010, BIOCHEM BIOPH RES CO, V393, P767, DOI 10.1016/j.bbrc.2010.02.078; Branchek TA, 2000, TRENDS PHARMACOL SCI, V21, P109, DOI 10.1016/S0165-6147(00)01446-2; Brown RE, 2008, EUR J NEUROSCI, V27, P352, DOI 10.1111/j.1460-9568.2008.06024.x; Burazin TCD, 2000, EUR J NEUROSCI, V12, P2901, DOI 10.1046/j.1460-9568.2000.00184.x; Burbach JPH, 2010, EUR J PHARMACOL, V626, P27, DOI 10.1016/j.ejphar.2009.10.015; Calizo LH, 2011, NEUROPHARMACOLOGY, V61, P524, DOI 10.1016/j.neuropharm.2011.04.008; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Celada P, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00025; Chandler DJ, 2013, BRAIN RES, V1522, P38, DOI 10.1016/j.brainres.2013.04.057; Cheung CC, 2001, NEUROSCIENCE, V103, P423, DOI 10.1016/S0306-4522(01)00012-4; Commons KG, 2009, J CHEM NEUROANAT, V38, P273, DOI 10.1016/j.jchemneu.2009.05.005; Commons KG, 2015, J COMP NEUROL, V523, P1488, DOI 10.1002/cne.23748; Commons KG, 2005, EUR J NEUROSCI, V21, P1577, DOI 10.1111/j.1460-9568.2005.03991.x; Coppen A J, 1968, Adv Pharmacol, V6, P283; Crawford LK, 2010, J NEUROPHYSIOL, V103, P2652, DOI 10.1152/jn.01132.2009; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1; DESCARRIES L, 1982, J COMP NEUROL, V207, P239, DOI 10.1002/cne.902070305; Dorocic IP, 2014, NEURON, V83, P663, DOI 10.1016/j.neuron.2014.07.002; Eberwine J, 2011, PHARMACOL THERAPEUT, V129, P241, DOI 10.1016/j.pharmthera.2010.09.010; FORD B, 1995, J COMP NEUROL, V363, P177, DOI 10.1002/cne.903630203; FRITSCHY JM, 1990, J COMP NEUROL, V293, P616, DOI 10.1002/cne.902930407; Fu WY, 2010, J COMP NEUROL, V518, P3464, DOI 10.1002/cne.22407; Fuxe K, 1998, ANN NY ACAD SCI, V863, P274, DOI 10.1111/j.1749-6632.1998.tb10702.x; FUXE K, 1990, SEROTONIN, P169; Fuxe K., 1991, GALANIN NEW MULTIFUN, P221, DOI DOI 10.1007/978-1-349-12664-4_16; Fuxe Kjell, 2012, Front Endocrinol (Lausanne), V3, P127, DOI 10.3389/fendo.2012.00127; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gervasoni D, 2000, J NEUROSCI, V20, P4217; Gras C, 2002, J NEUROSCI, V22, P5442; Griebel G, 2013, NAT REV DRUG DISCOV, V12, P667, DOI 10.1038/nrd4075; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; GUNDLACH AL, 1990, EUR J PHARMACOL, V184, P163, DOI 10.1016/0014-2999(90)90677-X; HABERTORTOLI E, 1994, P NATL ACAD SCI USA, V91, P9780, DOI 10.1073/pnas.91.21.9780; Hajos M, 1998, NEUROSCIENCE, V87, P95, DOI 10.1016/S0306-4522(98)00157-2; HARANDI M, 1987, NEUROSCIENCE, V21, P237, DOI 10.1016/0306-4522(87)90336-8; HEDLUND PB, 1992, EUR J PHARMACOL, V224, P203, DOI 10.1016/0014-2999(92)90806-F; Hioki H, 2010, J COMP NEUROL, V518, P668, DOI 10.1002/cne.22237; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Hokfelt T., 1984, CLASSICAL NEUROTRA 1, V2, P157; Hokfelt T., 1984, HDB CHEM NEUROANATOM, VVol 2, P157; HOLETS VR, 1988, NEUROSCIENCE, V24, P893, DOI 10.1016/0306-4522(88)90076-0; Holmes A, 2005, PSYCHOPHARMACOLOGY, V178, P276, DOI 10.1007/s00213-004-1997-1; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Holmes A., 2006, CNS & Neurological Disorders-Drug Targets, V5, P225, DOI 10.2174/187152706776359600; Holmes A, 2003, NEUROPSYCHOPHARMACOL; HOLMES PV, 1995, PHARMACOL BIOCHEM BE, V50, P655, DOI 10.1016/0091-3057(94)00334-3; Iismaa T P, 1999, Results Probl Cell Differ, V26, P257; Jackson J, 2009, SYNAPSE, V63, P31, DOI 10.1002/syn.20581; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Jankowski MP, 2004, J COMP NEUROL, V468, P518, DOI 10.1002/cne.10976; Johnson PL, 2008, J PSYCHOPHARMACOL, V22, P642, DOI 10.1177/0269881107082900; Johnson PL, 2004, ANN NY ACAD SCI, V1018, P58, DOI 10.1196/annals.1296.006; Jolas T, 1997, BRAIN RES, V755, P229, DOI 10.1016/S0006-8993(97)00103-0; Juhasz G, 2014, P NATL ACAD SCI USA, V111, pE1666, DOI 10.1073/pnas.1403649111; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Karlsson RM, 2006, AMINO ACIDS, V31, P231, DOI 10.1007/s00726-006-0336-8; Kawa L, 2016, EXP NEUROL, V279, P159, DOI 10.1016/j.expneurol.2016.02.019; Kendell SF, 2005, EXPERT OPIN THER TAR, V9, P153, DOI 10.1517/14728222.9.1.153; Khoshbouei H, 2002, PHARMACOL BIOCHEM BE, V71, P407, DOI 10.1016/S0091-3057(01)00683-9; Kim MA, 2004, BRAIN RES, V1026, P56, DOI 10.1016/j.brainres.2004.08.022; Kirby LG, 2003, NEUROSCIENCE, V116, P669, DOI 10.1016/S0306-4522(02)00584-5; Kuteeva E, 2008, NEUROPSYCHOPHARMACOL, V33, P2573, DOI 10.1038/sj.npp.1301660; Kuteeva E, 2010, EXPERIENTIA SUPPL, V102, P163, DOI 10.1007/978-3-0346-0228-0_12; Lang R, 2015, PHARMACOL REV, V67, P118, DOI 10.1124/pr.112.006536; Larm JA, 2003, EUR J NEUROSCI, V17, P481, DOI 10.1046/j.1460-9568.2003.02471.x; Le Maitre E, 2013, P NATL ACAD SCI USA, V110, pE536, DOI 10.1073/pnas.1221378110; Lee HS, 2003, BRAIN RES, V963, P57, DOI 10.1016/S0006-8993(02)03841-6; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li YQ, 2001, BRAIN RES, V900, P110, DOI 10.1016/S0006-8993(01)02272-7; LLOYD KG, 1989, PROG NEURO-PSYCHOPH, V13, P341, DOI 10.1016/0278-5846(89)90123-1; Lu Xiaoying, 2007, CNS & Neurological Disorders-Drug Targets, V6, P183, DOI 10.2174/187152707780619335; Lu XY, 2005, P NATL ACAD SCI USA, V102, P874, DOI 10.1073/pnas.0408891102; Machado-Vieira R, 2009, PHARMACOL THERAPEUT, V123, P143, DOI 10.1016/j.pharmthera.2009.02.010; Maes Michael, 1995, P933; MAGOUL R, 1986, J HISTOCHEM CYTOCHEM, V34, P735, DOI 10.1177/34.6.2422252; Marinelli S, 2004, J NEUROPHYSIOL, V92, P3532, DOI 10.1152/jn.00437.2004; Maubach KA, 1999, CURR OPIN CHEM BIOL, V3, P481, DOI 10.1016/S1367-5931(99)80070-2; MELANDER T, 1986, J COMP NEUROL, V248, P475, DOI 10.1002/cne.902480404; Melander T, 1988, J Chem Neuroanat, V1, P213; Melander T., 1986, GABA NEUROPEPTIDES R, V6, P3640; Mennicken F, 2002, J CHEM NEUROANAT, V24, P257, DOI 10.1016/S0891-0618(02)00068-6; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Millon C, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu064; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; Moller C, 1999, NEUROPSYCHOPHARMACOL, V21, P507, DOI 10.1016/S0893-133X(98)00102-X; MOORE RY, 1981, SEROTONIN NEUROTRANS, P35; Moreau J L, 1992, Eur Neuropsychopharmacol, V2, P43; NANOPOULOS D, 1982, BRAIN RES, V232, P375, DOI 10.1016/0006-8993(82)90281-5; Nemeroff CB, 2005, J CLIN PSYCHIAT, V66, P5; O'Donnell D, 1999, J COMP NEUROL, V409, P469; O'Leary OF, 2007, EUR NEUROPSYCHOPHARM, V17, P215, DOI 10.1016/j.euroneuro.2006.06.012; ODONNELL D, 2003, HAND CHEM N, V20, P195; Ogren SO, 2006, CNS DRUGS, V20, P633; OTTERSEN OP, 1984, J COMP NEUROL, V229, P374, DOI 10.1002/cne.902290308; Paul IA, 2003, ANN NY ACAD SCI, V1003, P250, DOI 10.1196/annals.1300.016; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Perez SE, 2001, J COMP NEUROL, V434, P158, DOI 10.1002/cne.1171; Petschner P, 2016, NEUROPEPTIDES, V57, P65, DOI 10.1016/j.npep.2016.01.010; Peyron C, 1998, NEUROSCIENCE, V82, P443; Peyron C, 1996, J COMP NEUROL, V364, P402; Picciotto MR, 2010, BRAIN RES, V1314, P206, DOI 10.1016/j.brainres.2009.08.033; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Pittenger Christopher, 2007, CNS & Neurological Disorders-Drug Targets, V6, P101, DOI 10.2174/187152707780363267; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; PRIESTLEY JV, 1993, J NEUROSCI METH, V48, P99, DOI 10.1016/S0165-0270(05)80011-1; Puig MV, 2005, CEREB CORTEX, V15, P1, DOI 10.1093/cercor/bhh104; Rovin ML, 2012, NEUROPEPTIDES, V46, P81, DOI 10.1016/j.npep.2012.01.001; Saar I, 2013, J NEUROCHEM, V127, P114, DOI 10.1111/jnc.12274; Saar I, 2013, NEUROCHEM RES, V38, P398, DOI 10.1007/s11064-012-0933-8; Sajdyk TJ, 2004, NEUROPEPTIDES, V38, P225, DOI 10.1016/j.npep.2004.05.006; Schafer MKH, 2002, J BIOL CHEM, V277, P50734, DOI 10.1074/jbc.M206738200; Schatzberg Alan F., 1995, P911; SCHILDKRAUT JJ, 1965, AM J PSYCHIAT, V122, P509, DOI 10.1176/ajp.122.5.509; Sciolino NR, 2012, NEUROSCI BIOBEHAV R, V36, P1965, DOI 10.1016/j.neubiorev.2012.06.005; Sciolino NR, 2012, BEHAV BRAIN RES, V233, P191, DOI 10.1016/j.bbr.2012.05.001; Sergeyev V, 2005, PSYCHOPHARMACOLOGY, V178, P115, DOI 10.1007/s00213-004-2015-3; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Sharkey LM, 2008, NEUROCHEM RES, V33, P285, DOI 10.1007/s11064-007-9524-5; Sharp T, 2007, TRENDS PHARMACOL SCI, V28, P629, DOI 10.1016/j.tips.2007.10.009; Sharp T, 2011, CURR OPIN PHARMACOL, V11, P45, DOI 10.1016/j.coph.2011.02.003; Shi TJS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-80; Shikanai H, 2012, J NEUROSCI, V32, P14415, DOI 10.1523/JNEUROSCI.5929-11.2012; Shutoh F, 2008, NEUROSCI LETT, V432, P132, DOI 10.1016/j.neulet.2007.12.050; SKOFITSCH G, 1985, PEPTIDES, V6, P509, DOI 10.1016/0196-9781(85)90118-4; SKOFITSCH G, 1986, PEPTIDES, V7, P1029, DOI 10.1016/0196-9781(86)90133-6; SMITH GST, 1994, J COMP NEUROL, V350, P23, DOI 10.1002/cne.903500103; Soiza-Reilly M, 2011, J CHEM NEUROANAT, V41, P247, DOI 10.1016/j.jchemneu.2011.04.004; Spaethling JM, 2014, FASEB J, V28, P771, DOI 10.1096/fj.13-240267; STAMP JA, 1995, BRAIN RES, V677, P39, DOI 10.1016/0006-8993(95)00119-B; Steckler T, 2008, HBK BEHAV NEUROSCI, V17, P157, DOI 10.1016/S1569-7339(07)00010-0; STEINBUSCH HWM, 1982, J HISTOCHEM CYTOCHEM, V30, P756, DOI 10.1177/30.8.6749970; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Swanson CJ, 2005, P NATL ACAD SCI USA, V102, P17489, DOI 10.1073/pnas.0508970102; Sweerts BW, 1999, MOL BRAIN RES, V69, P113, DOI 10.1016/S0169-328X(99)00095-9; TATEMOTO K, 1983, FEBS LETT, V164, P124, DOI 10.1016/0014-5793(83)80033-7; Taylor M, 2003, PSYCHOL MED, V33, P387, DOI 10.1017/S0033291702006876; Templin JS, 2012, BRAIN RES, V1457, P1, DOI 10.1016/j.brainres.2012.03.066; Theodorsson E, 2000, SCAND J CLIN LAB INV, V60, P411; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; TRULLAS R, 1990, EUR J PHARMACOL, V185, P1, DOI 10.1016/0014-2999(90)90204-J; Valentino RJ, 2005, NEUROPEPTIDES, V39, P1, DOI 10.1016/j.npep.2004.09.005; Varga V, 2001, NEUROSCIENCE, V106, P783, DOI 10.1016/S0306-4522(01)00294-9; Wang P, 2011, EXPRESSION GALANIN I, pS; WANG QP, 1992, BRAIN RES BULL, V29, P943; Waters SM, 2000, NEUROSCIENCE, V95, P265; Weiss JM, 2005, NEUROPEPTIDES, V39, P281, DOI 10.1016/j.npep.2004.12.028; Weiss JM, 1998, ANN NY ACAD SCI, V863, P364, DOI 10.1111/j.1749-6632.1998.tb10707.x; Weissbourd B, 2014, NEURON, V83, P645, DOI 10.1016/j.neuron.2014.06.024; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wu G, 2011, EXPERT OPIN THER TAR, V15, P1317, DOI 10.1517/14728222.2011.628314; Xu ZQD, 1998, NEUROSCIENCE, V87, P79, DOI 10.1016/S0306-4522(98)00151-1; Xu ZQD, 1998, J COMP NEUROL, V392, P227, DOI 10.1002/(SICI)1096-9861(19980309)392:2<227::AID-CNE6>3.0.CO;2-4; Xu ZQD, 2005, NEUROPEPTIDES, V39, P269, DOI 10.1016/j.npep.2005.02.003; Xu ZQD, 1997, J CHEM NEUROANAT, V13, P169, DOI 10.1016/S0891-0618(97)00043-4; Xu ZQD, 1999, P NATL ACAD SCI USA, V96, P14583, DOI 10.1073/pnas.96.25.14583; Yilmaz A, 2002, PHARMACOL BIOCHEM BE, V71, P341, DOI 10.1016/S0091-3057(01)00693-1; Zarate CA, 2004, AM J PSYCHIAT, V161, P171, DOI 10.1176/appi.ajp.161.1.171	171	27	28	2	10	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	AUG 9	2016	113	32					E4726	E4735		10.1073/pnas.1609198113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT2EJ	WOS:000381293300021	27457954	Green Published, Bronze			2022-02-06	
J	Kramer, AH; Deis, N; Ruddell, S; Couillard, P; Zygun, DA; Doig, CJ; Gallagher, C				Kramer, Andreas H.; Deis, Nathan; Ruddell, Stacy; Couillard, Philippe; Zygun, David A.; Doig, Christopher J.; Gallagher, Clare			Decompressive Craniectomy in Patients with Traumatic Brain Injury: Are the Usual Indications Congruent with Those Evaluated in Clinical Trials?	NEUROCRITICAL CARE			English	Article						Decompressive craniectomy; Transtentorial herniation; Midline shift; Pupillary light reflex; Cerebral edema; Intracranial pressure	REFRACTORY INTRACRANIAL HYPERTENSION; MIDDLE-CEREBRAL-ARTERY; SEVERE HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; RANDOMIZED-TRIAL; PRACTICAL SCALE; HEMICRANIECTOMY; CLASSIFICATION; PREDICTORS; MANAGEMENT	In patients with traumatic brain injury (TBI), multicenter randomized controlled trials have assessed decompressive craniectomy (DC) exclusively as treatment for refractory elevation of intracranial pressure (ICP). DC reliably lowers ICP but does not necessarily improve outcomes. However, some patients undergo DC as treatment for impending or established transtentorial herniation, irrespective of ICP. We performed a population-based cohort study assessing consecutive patients with moderate-severe TBI. Indications for DC were compared with enrollment criteria for the DECRA and RESCUE-ICP trials. Of 644 consecutive patients, 51 (8 %) were treated with DC. All patients undergoing DC had compressed basal cisterns, 82 % had at least temporary preoperative loss of a parts per thousand yen1 pupillary light reflex (PLR), and 80 % had > 5 mm of midline shift. Most DC procedures (67 %) were "primary," having been performed concomitantly with evacuation of a space-occupying lesion. ICP measurements influenced the decision to perform DC in 18 % of patients. Only 10 and 16 % of patients, respectively, would have been eligible for the DECRA and RESCUE-ICP trials. DC improved basal cistern compression in 76 %, and midline shift in 94 % of patients. Among patients with a parts per thousand yen1 absent PLR at admission, DC was associated with lower mortality (46 vs. 68 %, p = 0.03), especially when the admission Marshall CT score was 3-4 (p = 0.0005). No patients treated with DC progressed to brain death. Variables predictive of poor outcome following DC included loss of PLR(s), poor motor score, midline shift a parts per thousand yen11 mm, and development of perioperative cerebral infarcts. DC is most often performed for clinical and radiographic evidence of herniation, rather than for refractory ICP elevation. Results of previously completed randomized trials do not directly apply to a large proportion of patients undergoing DC in practice.	[Kramer, Andreas H.; Deis, Nathan; Ruddell, Stacy; Couillard, Philippe; Doig, Christopher J.; Gallagher, Clare] Univ Calgary, Dept Crit Care Med, Foothills Med Ctr, 3132 Hosp Dr NW, Calgary, AB T2N 2T9, Canada; [Kramer, Andreas H.; Deis, Nathan; Couillard, Philippe; Gallagher, Clare] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Kramer, Andreas H.; Couillard, Philippe; Gallagher, Clare] Hotchkiss Brain Inst, Calgary, AB, Canada; [Zygun, David A.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Doig, Christopher J.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada		Kramer, AH (corresponding author), Univ Calgary, Dept Crit Care Med, Foothills Med Ctr, 3132 Hosp Dr NW, Calgary, AB T2N 2T9, Canada.; Kramer, AH (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.; Kramer, AH (corresponding author), Hotchkiss Brain Inst, Calgary, AB, Canada.	andreas.kramer@albertahealthservices.ca	Doig, Christopher/AAC-7949-2020	Doig, Christopher/0000-0002-8576-9139			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Al-Jishi A, 2011, CAN J NEUROL SCI, V38, P612, DOI 10.1017/S0317167100012154; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dandaleh NS, 2012, J CLIN NEUROSCI, V19, P1236, DOI 10.1016/j.jocn.2011.11.025; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; Fujimoto K, 2015, J NEUROSURG, V23, P1; HORNIG CR, 1994, STROKE, V25, P372, DOI 10.1161/01.STR.25.2.372; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; JENNETT B, 1975, LANCET, V1, P480; Juttler E, 2014, NEW ENGL J MED, V370, P1091, DOI 10.1056/NEJMoa1311367; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Saade Nelson, 2014, Rev. Col. Bras. Cir., V41, P256, DOI 10.1590/0100-69912014004006; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Sturiale CL, 2012, J NEUROTRAUM, V29, P2723, DOI 10.1089/neu.2012.2556; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; TEASDALE G, 1974, LANCET, V2, P81; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; Trauma Foundation, 2007, J NEUROTRAUM, pS; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Yuan Q, 2013, BRIT J NEUROSURG, V27, P483, DOI 10.3109/02688697.2013.763897	35	27	28	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2016	25	1					10	19		10.1007/s12028-015-0232-8			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DR8LZ	WOS:000380150700003	26732269				2022-02-06	
J	Newsome, MR; Li, XQ; Lin, XD; Wilde, EA; Ott, S; Biekman, B; Hunter, JV; Dash, PK; Taylor, BA; Levin, HS				Newsome, Mary R.; Li, Xiaoqi; Lin, Xiaodi; Wilde, Elisabeth A.; Ott, Summer; Biekman, Brian; Hunter, Jill V.; Dash, Pramod K.; Taylor, Brian A.; Levin, Harvey S.			Functional Connectivity Is Altered in Concussed Adolescent Athletes Despite Medical Clearance to Return to Play: A Preliminary Report	FRONTIERS IN NEUROLOGY			English	Article						sports concussion; functional connectivity; adolescent; memory; athletic injuries; traumatic brain injury	SPORTS-RELATED CONCUSSION; DEFAULT NETWORK; SAMPLE-SIZE; BRAIN; INJURY; RELIABILITY; IMPACT	Recovery following sports-related concussion (SRC) is slower and often more complicated in young adolescent athletes than in collegiate players. Further, the clinical decision to return to play is currently based on symptoms and cognitive performance without direct knowledge of brain function. We tested the hypothesis that brain functional connectivity (FC) would be aberrant in recently concussed, asymptomatic athletes who had been cleared to return to play. A seed-based FC analysis measured the FC of the default mode network (DMN) (seeds = anterior cingulate cortex, posterior cingulate cortex (PCC), right lateral parietal cortex, and left lateral parietal cortex) 30 days after SRC in asymptomatic high school athletes cleared to return to play (n = 13) and was compared to the FC of high school athletes with orthopedic injury (OI) ( n = 13). The SRC group demonstrated greater FC than the OI group between the PCC and the ventral lateral prefrontal cortex, as well as between the right lateral parietal cortex and lateral temporal cortex (with regions both outside of and within the DMN). Additionally, the OI group demonstrated greater FC than the SRC group between right lateral parietal cortex and supramarginal gyrus. When relating the FC results to verbal memory performance approximately 1 week and 1 month after injury, significantly different between-group relations were found for the posterior cingulate and right lateral parietal cortex seeds. However, the groups did not differ in verbal memory at 1 month. We suggest that changes in FC are apparent 1-month post-SRC despite resolution of post-concussion symptoms and recovery of cognitive performance in adolescent athletes cleared to return to play.	[Newsome, Mary R.; Li, Xiaoqi; Lin, Xiaodi; Wilde, Elisabeth A.; Biekman, Brian; Taylor, Brian A.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Taylor, Brian A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Ott, Summer] UTHlth McGovern Med Sch, Dept Orthoped Surg, Houston, TX USA; [Hunter, Jill V.] Texas Childrens Hosp, Dept Radiol, Houston, TX 77030 USA; [Dash, Pramod K.] UTHlth McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX USA		Newsome, MR (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA.	mnewsome@bcm.edu		Taylor, Brian/0000-0001-9745-1075	National Institutes of Health: National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R21NS086714-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS086714] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I21RX001608] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health: National Institutes of Neurological Disorders and Stroke, #1R21NS086714-01 (HL, SO, PD). The South Central Mental Illness Research, Education, and Clinical Center (SCMIRECC) at the Michael E. DeBakey VA Medical Center provided facilities that allowed analyses of the fMRI data. We also gratefully acknowledge Coy VanValkenburgh, Marlene Diaz, and Qisheng Liu; David Ress, Ph.D. and the Center for Advanced Magnetic Resonance Imaging at Baylor College of Medicine; Memorial Hermann Ironman Sports Medicine Institute; and the computing resources provided by the CIBR Center for Computational and Integrative Biomedical Research of Baylor College of Medicine. We are grateful to the athletes for taking part in this research. The content is solely the responsibility of the authors and does not necessarily represent the official views of Baylor College of Medicine or University of Texas Health Science Center at Houston. There are no potential conflicts of interest, including financial, between any of the authors and the work presented in this manuscript.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Ashby F. G., 2011, PROCESSING STAT ANAL; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 2013, NEUROIMAGE, V81, P503, DOI 10.1016/j.neuroimage.2013.02.057; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Lindquist MA, 2013, NEUROIMAGE, V81, P499, DOI 10.1016/j.neuroimage.2013.02.056; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P287; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Slobounov S, 2014, BRIT J SPORT MED, V48, P75, DOI 10.1136/bjsports-2013-092362; Snedecor G.W., 1980, STAT METHODS, V7th; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; TEASDALE G, 1974, LANCET, V2, P81; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wiech K, 2014, PAIN, V155, P2047, DOI 10.1016/j.pain.2014.07.009; Wilde EA, 2016, J NEUROTRAUMA; [No title captured]	28	27	27	0	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 25	2016	7								116	10.3389/fneur.2016.00116			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DS1FI	WOS:000380340800001	27504104	Green Published, gold			2022-02-06	
J	Karpman, S; Reid, P; Phillips, L; Qin, ZL; Gross, DP				Karpman, Shelby; Reid, Patrick; Phillips, Leah; Qin, Ziling; Gross, Douglas P.			Combative Sports Injuries: An Edmonton Retrospective	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						case series; injury; incidence; concussion; mixed martial arts; boxing	MIXED MARTIAL ARTS; COMPETITION	Objective: Mixed martial arts (MMA) is an increasingly popular combative sport involving aggressive techniques that present substantial injury risk. We examined the incidence and types of injuries sustained in MMA fights and compared this with injuries sustained in boxing matches. Design: Consecutive Case Series. Setting: We used data from post-fight medical examinations on all bouts in Edmonton, Canada, between 2000 and 2013. Participants: The participants were 1181 MMA competitors and 550 boxers. Main Outcome Measures: The attending physician conducted a mandatory post-fight examination of all fighters and documented the nature of injuries sustained. Results: Boxers were significantly more likely not to experience injury (49.8% vs 59.4%, P < 0.001), whereas MMA fighters were significantly more likely to experience 1 injury (typically contusion/bruising, P < 0.001). Boxers were more likely to experience loss of consciousness (7.1% vs 4.2%, P = 0.01) and serious eye injury (1.1% vs 0.3%, P = 0.02). Conclusions: The overall injury incidence in MMA competitors appears slightly higher than for boxers, but MMA fighters experience more minor contusion/bruising injuries. Boxers are more likely to experience serious injury such as concussion/head trauma involving loss of consciousness or eye injury such as retinal detachment.	[Karpman, Shelby; Gross, Douglas P.] Univ Alberta, Glen Sather Sports Med Clin, Edmonton, AB, Canada; [Reid, Patrick] Univ Alberta, Fac Phys Educ, Edmonton, AB, Canada; [Reid, Patrick] Edmonton Combat Sports Commiss, Edmonton, AB, Canada; [Phillips, Leah] Alberta Hlth Serv, Edmonton, AB, Canada; [Qin, Ziling; Gross, Douglas P.] Univ Alberta, Fac Rehabil Med, Rehabil Res Ctr, Edmonton, AB, Canada; [Gross, Douglas P.] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada		Gross, DP (corresponding author), Univ Alberta, 2-50 Corbett Hall, Edmonton, AB T6G 2G4, Canada.	dgross@ualberta.ca	Gross, Douglas P./AAF-6997-2020	Gross, Douglas P./0000-0002-2427-6277	Glen Sather University of Alberta Sports Medicine Clinic in Edmonton, Alberta, Canada	The Glen Sather University of Alberta Sports Medicine Clinic in Edmonton, Alberta, Canada, provided resources and funding for this research. The Edmonton Combative Sports Commission facilitated data collection.	Bledsoe GH, 2006, J SPORT SCI MED, V5, P136; Buse GJ, 2006, BRIT J SPORT MED, V40, P169, DOI 10.1136/bjsm.2005.021295; Kochhar T, 2005, BRIT J SPORT MED, V39, P444, DOI 10.1136/bjsm.2004.011270; Ngai KM, 2008, BRIT J SPORT MED, V42, P686, DOI 10.1136/bjsm.2007.044891; Pappas E, 2007, J SPORT SCI MED, V6, P58; Rainey Charles E, 2009, N Am J Sports Phys Ther, V4, P190; Scoggin James F 3rd, 2010, Am J Orthop (Belle Mead NJ), V39, P247; Walrod B, 2011, CURR SPORT MED REP, V10, P288, DOI 10.1249/JSR.0b013e31822dc2c2; Woodward Thomas W, 2009, WMJ, V108, P40; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321	10	27	27	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2016	26	4					332	334		10.1097/JSM.0000000000000235			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	DQ8DC	WOS:000379438300012	26327287				2022-02-06	
J	Rowe, RK; Rumney, BM; May, HG; Permana, P; Adelson, PD; Harman, SM; Lifshitz, J; Thomas, TC				Rowe, Rachel K.; Rumney, Benjamin M.; May, Hazel G.; Permana, Paska; Adelson, P. David; Harman, S. Mitchell; Lifshitz, Jonathan; Thomas, Theresa C.			Diffuse traumatic brain injury affects chronic corticosterone function in the rat	ENDOCRINE CONNECTIONS			English	Article						TBI; concussion; corticosterone; stress	PITUITARY DYSFUNCTION; PARAVENTRICULAR NUCLEUS; BEHAVIORAL MORBIDITY; GROWTH-HORMONE; LATE-ONSET; HYPOPITUITARISM; NEURONS; TBI; DEXAMETHASONE; STRESS	As many as 20-55% of patients with a history of traumatic brain injury (TBI) experience chronic endocrine dysfunction, leading to impaired quality of life, impaired rehabilitation efforts and lowered life expectancy. Endocrine dysfunction after TBI is thought to result from acceleration-deceleration forces to the brain within the skull, creating enduring hypothalamic and pituitary neuropathology, and subsequent hypothalamic-pituitary endocrine (HPE) dysfunction. These experiments were designed to test the hypothesis that a single diffuse TBI results in chronic dysfunction of corticosterone (CORT), a glucocorticoid released in response to stress and testosterone. We used a rodent model of diffuse TBI induced by midline fluid percussion injury (mFPI). At 2 months postinjury compared with uninjured control animals, circulating levels of CORT were evaluated at rest, under restraint stress and in response to dexamethasone, a synthetic glucocorticoid commonly used to test HPE axis regulation. Testosterone was evaluated at rest. Further, we assessed changes in injury-induced neuron morphology (Golgi stain), neuropathology (silver stain) and activated astrocytes (GFAP) in the paraventricular nucleus (PVN) of the hypothalamus. Resting plasma CORT levels were decreased at 2 months postinjury and there was a blunted CORT increase in response to restraint induced stress. No changes in testosterone were measured. These changes in CORT were observed concomitantly with altered complexity of neuron processes in the PVN over time, devoid of neuropathology or astrocytosis. Results provide evidence that a single moderate diffuse TBI leads to changes in CORT function, which can contribute to the persistence of symptoms related to endocrine dysfunction. Future experiments aim to evaluate additional HP-related hormones and endocrine circuit pathology following diffuse TBI.	[Rowe, Rachel K.; Permana, Paska; Harman, S. Mitchell; Lifshitz, Jonathan; Thomas, Theresa C.] Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ 85012 USA; [Rowe, Rachel K.; Rumney, Benjamin M.; May, Hazel G.; Adelson, P. David; Lifshitz, Jonathan; Thomas, Theresa C.] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA; [Rowe, Rachel K.; Rumney, Benjamin M.; May, Hazel G.; Adelson, P. David; Lifshitz, Jonathan; Thomas, Theresa C.] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA; [Rumney, Benjamin M.; May, Hazel G.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Adelson, P. David] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA		Thomas, TC (corresponding author), Phoenix Vet Affairs Hlth Care Syst, Phoenix, AZ 85012 USA.; Thomas, TC (corresponding author), Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA.; Thomas, TC (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA.	theresathomas@email.arizona.edu	Thomas, Theresa Currier/K-1979-2019; Adelson, David/W-2083-2019	Thomas, Theresa Currier/0000-0002-9619-7666; Rowe, Rachel/0000-0002-9034-3159	Phoenix VA Health Care System; Arizona Biomedical Research Commission through the Arizona Department of Health Services [ADHS14-00003606]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-065052]; Phoenix Children's Hospital Leadership Circle; Phoenix Children's Hospital Mission Support Funds; Bisgrove Scholar award - Science Foundation Arizona	Research reported in this manuscript was supported, in part, by Phoenix VA Health Care System, Arizona Biomedical Research Commission as made available through the Arizona Department of Health Services under award number ADHS14-00003606, National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number R01 NS-065052, Phoenix Children's Hospital Leadership Circle and Phoenix Children's Hospital Mission Support Funds. Dr Rowe was supported by the Bisgrove Scholar award funded by Science Foundation Arizona.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; BARRY J, 1975, CR SOC BIOL, V169, P978; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Cernak I, 1999, BRAIN INJURY, V13, P1005; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Cole Chad D, 2004, Neurosurg Focus, V16, pE9; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; Dabrowska J, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00156; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Dubourg J, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11182; Dziedzic N, 2014, DEV NEUROSCI-BASEL, V36, P261, DOI 10.1159/000362873; FRANZONI MF, 1984, CELL TISSUE RES, V236, P357, DOI 10.1007/BF00214239; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Gomez F, 1998, AM J PHYSIOL-REG I, V274, pR420, DOI 10.1152/ajpregu.1998.274.2.R420; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Javed Zeeshan, 2015, Indian J Endocrinol Metab, V19, P753, DOI 10.4103/2230-8210.167561; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kleindienst A, 2016, J NEUROTRAUM, V33, P615, DOI 10.1089/neu.2015.3981; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Lifshitz Jonathan, 2009, P369, DOI 10.1007/978-1-60327-185-1_32; Mangiola A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/736104; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Mikics E, 2008, PHYSIOL BEHAV, V94, P341, DOI 10.1016/j.physbeh.2008.01.023; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Munoz A, 1999, J COMP NEUROL, V409, P549; Nemes O, 2015, HORM-INT J ENDOCRINO, V14, P383, DOI 10.14310/horm.2002.1564; Newman CB, 2015, PITUITARY, V18, P297, DOI 10.1007/s11102-014-0571-z; Pillai AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038971; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; RHO JH, 1989, J NEUROSCI, V9, P1375; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Rosario ER, 2013, J HEAD TRAUMA REHAB, V28, P390, DOI 10.1097/HTR.0b013e318250eac6; Schneider Harald J, 2007, Pediatr Endocrinol Rev, V4, P205; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Tanriverdi F, 2015, J CLIN MED, V4, P847, DOI 10.3390/jcm4050847; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; TASKER JG, 1991, J PHYSIOL-LONDON, V434, P271, DOI 10.1113/jphysiol.1991.sp018469; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Thomas TC, 2015, BRAIN NEUROTRAUMA MO; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Tripodi M, 2008, PLOS BIOL, V6, P2172, DOI 10.1371/journal.pbio.0060260; VANDENPOL AN, 1982, J COMP NEUROL, V206, P317, DOI 10.1002/cne.902060402; VANDENPOL AN, 1990, J COMP NEUROL, V296, P654, DOI 10.1002/cne.902960410; VandeVord PJ, 2016, J NEUROTRAUM, V33, P82, DOI 10.1089/neu.2014.3786; Wamsteeker Cusulin JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064943; Webb NE, 2014, NEUROREHABILITATION, V34, P625, DOI 10.3233/NRE-141074; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; Xu FF, 2014, BRAIN INJURY, V28, P1594, DOI 10.3109/02699052.2014.943289; Yin J, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00439; Zaben M, 2013, DISABIL REHABIL, V35, P522, DOI 10.3109/09638288.2012.697252; Zhu H, 2013, BRAIN RES, V1541, P69, DOI 10.1016/j.brainres.2013.10.002; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	74	27	27	0	11	BIOSCIENTIFICA LTD	BRISTOL	STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND	2049-3614			ENDOCR CONNECT	Endocr. Connect.	JUL 1	2016	5	4					152	166		10.1530/EC-16-0031			15	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	DV9MU	WOS:000383265500003	27317610	Green Submitted, Green Published, gold			2022-02-06	
J	Walker, MS; Kaimal, G; Koffman, R; DeGraba, TJ				Walker, Melissa S.; Kaimal, Girija; Koffman, Robert; DeGraba, Thomas J.			Art therapy for PTSD and TBI: A senior active duty military service member's therapeutic journey	ARTS IN PSYCHOTHERAPY			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS; SYMPTOM PROVOCATION; ARMY	Art therapy is increasingly being accepted as a form of complementary and integrative care for military veterans affected by trauma and injuries in the line of duty. Less is known, however, about the applications of art therapy for co-morbid traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD). In addition, most studies to date have focused on art therapy with veterans (former military service members) rather than with active duty service members; furthermore, there are no studies that have examined the unique context of PTSD in senior military personnel. This case study presents the therapeutic process through art therapy in the case of a senior active duty military service member (with chronic PTSD and TBI), in the context of an integrated model of care that included medical and complementary therapies. (C) 2016 The Authors. Published by Elsevier Ltd.	[Walker, Melissa S.; Koffman, Robert; DeGraba, Thomas J.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bldg 51,4860 S Palmer Rd, Bethesda, MD 20889 USA; [Kaimal, Girija] Drexel Univ, Coll Nursing & Hlth Profess, 1601 Cherry St, Philadelphia, PA 19102 USA		Walker, MS (corresponding author), Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bldg 51,4860 S Palmer Rd, Bethesda, MD 20889 USA.	Melissa.s.walker12.civ@mail.mil; Gk27@drexel.edu; Rlkoffman@gmail.com; Thomas.j.degraba.civ@mail.mil		Walker, Melissa/0000-0001-9375-567X	National Endowment for the Arts (NEA) Military Healing Arts Partnership	The authors would like to thank the National Endowment for the Arts (NEA) Military Healing Arts Partnership for funding support. We would also like to thank Drs. Anda and Mihai Popescu for the magnetoencephalography analysis. In addition we would like to acknowledge COL Geoffrey Grammer, Ms. Katherine Myers Coffman, Ms. Adele Gonzaga, and Ms. Barbara Granger for their help with various stages of the manuscript.	Balfour M, 2015, ARTS HEALTH, V7, P87, DOI 10.1080/17533015.2014.999247; Barker V.L., 1991, MUSIC THERAPY PERSPE, V9, P26; Burnam MA, 2008, INVISIBLE WOUNDS WAR, P245; Collie K, 2006, ART THER, V23, P157, DOI 10.1080/07421656.2006.10129335; Creswell J.W., 2000, DESIGNING CONDUCTING; Dodd F., 1975, J ART THERAPY, V14, P83; Gantt L, 2009, ART PSYCHOTHER, V36, P148, DOI 10.1016/j.aip.2008.12.005; GOLUB D, 1985, ART PSYCHOTHER, V12, P285, DOI 10.1016/0197-4556(85)90041-3; Greece M, 2003, ART PSYCHOTHER, V30, P229, DOI 10.1016/S0197-4556(03)00057-1; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Howie P., 2002, ART THERAPY J AM ART, V19, P100; Lamonthe D., 2015, WASHINGTON POST; Lazarus-Leff B., 2013, J AM ART THERAPY ASS, V15, P120; Lehrner A, 2016, POSTTRAUMATIC STRESS DISORDER: FROM NEUROBIOLOGY TO TREATMENT, P265; Malchiodi CA, 2012, HDB ART THERAPY, P320; Peres JFP, 2008, AUST NZ J PSYCHIAT, V42, P478, DOI 10.1080/00048670802050561; Rauch SL, 1997, BIOL PSYCHIAT, V42, P446, DOI 10.1016/S0006-3223(97)00145-5; Shenton AndrewK., 2004, EDUC INFORM, V22, P63, DOI DOI 10.3233/EFI-2004-22201; Shin LM, 1997, ANN NY ACAD SCI, V821, P521, DOI 10.1111/j.1749-6632.1997.tb48320.x; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Van Der Kolk Bessel, 1996, P303; Yin R., 1994, CASE STUDY RES DESIG, V2; Zinzow HM, 2013, MIL PSYCHOL, V25, P514, DOI 10.1037/mil0000015	23	27	27	2	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-4556	1873-5878		ART PSYCHOTHER	Arts Psychother.	JUL	2016	49						10	18		10.1016/j.aip.2016.05.015			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	DP3CH	WOS:000378369500004		hybrid			2022-02-06	
J	Zhou, ZL; Mo, BL; Qiu, SJ; Chao, D; Shi, BC; Shuai, H; Shun, Y; Hui, Z				Zhou Zhilai; Mo Biling; Qiu Sujun; Chao, Dong; Shi Benchao; Shuai, Huang; Shun, Yao; Hui, Zhang			Preconditioning in lowered oxygen enhances the therapeutic potential of human umbilical mesenchymal stem cells in a rat model of spinal cord injury	BRAIN RESEARCH			English	Article						Spinal cord injury; Umbilical cord; Physioxic; Mesenchymal stem cells; Transplantation	TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; TRANSPLANTATION; HYPOXIA; PROLIFERATION; STROKE; BLOOD; HEMORRHAGE; THERAPIES	Human umbilical cord mesenchymal stem cells (UCMSCs) have recently been shown to hold great therapeutic potential for the treatment of spinal cord injury (SCI). However, the number of engrafted cells has been shown to decrease dramatically post-transplantation. Physioxia is known to enhance the paracrine properties and immune modulation of stem cells, a notion that has been applied in many clinical settings. We therefore hypothesized that preconditioning of UCMSCs in physioxic environment would enhance the regenerative properties of these cells in the treatment of rat SCI. UCMSCs were pretreated with either atmospheric normoxia (21% O-2, N-UCMSC) or physioxia (5% O-2. P-UCMSC). The MSCs were characterized using flow cytometry, immunocytochemistry, and real-time polymerase chain reaction. Furthermore, 10(5) N-UCMSC or P-UCMSC were injected into the injured spinal cord immediately after SCI, and locomotor function as well as cellular, molecular and pathological changes were compared between the groups. We found that N-UCMSC and P-UCMSC displayed similar surface protein expression. P-UCMSC grew faster, while physioxia up-regulated the expression of trophic and growth factors, including hepatocyte growth factor (HGF), brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor(VEGF), in UCMSCs. Compared to N-UCMSC, treatment with P-UCMSC was associated with marked changes in the SCI environment, with a significant increase in axonal preservation and a decrease in the number of caspase-3+ cells and ED-1+ macrophages. These changes were accompanied by improved functional recovery. Thus, the present study indicated that preculturing UCMSCs under 5% lowered oxygen physioxic conditions prior to transplantation improves their therapeutic potential for the treatment of SCI in rats. (C) 2016 Elsevier B.V. All rights reserved.	[Zhou Zhilai; Qiu Sujun; Chao, Dong; Shi Benchao; Shuai, Huang; Shun, Yao; Hui, Zhang] Southern Med Univ, Zhujiang Hosp, Dept Orthoped, 253 Gongye Rd, Guangzhou 510282, Guangdong, Peoples R China; [Mo Biling] Guangzhou Med Univ, Liwan Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China		Hui, Z (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Orthoped, 253 Gongye Rd, Guangzhou 510282, Guangdong, Peoples R China.	13312959@qq.com; zzlspine@foxmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400996]; Natural Science Foundation of Guangdong Province, ChinaNational Natural Science Foundation of Guangdong Province [2014A030310100]; Science and Technology Plan Projects of Guangdong Province, China [2011B031800282]	This work was supported by the National Natural Science Foundation of China (No. 81400996), the Natural Science Foundation of Guangdong Province, China (No. 2014A030310100) and the Science and Technology Plan Projects of Guangdong Province, China (No. 2011B031800282).	Ahn SY, 2013, STROKE, V44, P497, DOI 10.1161/STROKEAHA.112.679092; Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231; Barcia RN, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/583984; Bicknese AR, 2002, CELL TRANSPLANT, V11, P261; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Cheng HB, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0253-7; Drela K, 2014, CYTOTHERAPY, V16, P881, DOI 10.1016/j.jcyt.2014.02.009; Ejtehadifar M, 2015, ADV PHARM BULL, V5, P141, DOI 10.15171/apb.2015.021; Gong W, 2012, CELL TRANSPLANT, V21, P207, DOI 10.3727/096368911X586756; Han K.H., 2015, CELL BIOL INT; Hu SL, 2010, CRIT CARE MED, V38, P2181, DOI 10.1097/CCM.0b013e3181f17c0e; Jeong SR, 2012, EXP NEUROL, V233, P312, DOI 10.1016/j.expneurol.2011.10.021; Lan YW, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0081-6; Lavrentieva A, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-18; Lee HJ, 2015, STEM CELLS, V33, P2182, DOI 10.1002/stem.2020; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; Lindenmair Andrea, 2012, Cells, V1, P1061, DOI 10.3390/cells1041061; Liu JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126715; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; MILLER WM, 1987, J CELL PHYSIOL, V132, P524, DOI 10.1002/jcp.1041320315; Nakamura Y, 2007, STEM CELLS, V25, P612, DOI 10.1634/stemcells.2006-0168; Nascimento DS, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt394; Parekkadan B, 2010, ANNU REV BIOMED ENG, V12, P87, DOI 10.1146/annurev-bioeng-070909-105309; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Schira J, 2012, BRAIN, V135, P431, DOI 10.1093/brain/awr222; Sun JM, 2015, EXP NEUROL, V272, P78, DOI 10.1016/j.expneurol.2015.03.011; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; van der Bogt KEA, 2009, TRANSPLANTATION, V87, P642, DOI 10.1097/TP.0b013e31819609d9; Wang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118951; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yang DM, 2012, BRAIN RES, V1444, P1, DOI 10.1016/j.brainres.2012.01.024; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou ZL, 2012, BRAIN RES, V1481, P79, DOI 10.1016/j.brainres.2012.08.051	41	27	33	0	22	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 1	2016	1642						426	435		10.1016/j.brainres.2016.04.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP7EI	WOS:000378661600048	27085204				2022-02-06	
J	Pignat, JM; Mauron, E; Johr, J; de Keranflec'h, CG; Van De Ville, D; Preti, MG; Meskaldji, DE; Homberg, V; Laureys, S; Draganski, B; Frackowiak, R; Diserens, K				Pignat, Jean-Michel; Mauron, Etienne; Johr, Jane; de Keranflec'h, Charlotte Gilart; Van De Ville, Dimitri; Preti, Maria Giulia; Meskaldji, Djalel E.; Hoemberg, Volker; Laureys, Steven; Draganski, Bogdan; Frackowiak, Richard; Diserens, Karin			Outcome Prediction of Consciousness Disorders in the Acute Stage Based on a Complementary Motor Behavioural Tool	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; VEGETATIVE STATE; UNRESPONSIVE WAKEFULNESS; DIAGNOSTIC-ACCURACY; FOLLOW-UP; RECOVERY; REHABILITATION; PROGNOSIS; COMA	Introduction Attaining an accurate diagnosis in the acute phase for severely brain-damaged patients presenting Disorders of Consciousness (DOC) is crucial for prognostic validity; such a diagnosis determines further medical management, in terms of therapeutic choices and end-of-life decisions. However, DOC evaluation based on validated scales, such as the Revised Coma Recovery Scale (CRS-R), can lead to an underestimation of consciousness and to frequent misdiagnoses particularly in cases of cognitive motor dissociation due to other aetiologies. The purpose of this study is to determine the clinical signs that lead to a more accurate consciousness assessment allowing more reliable outcome prediction. Methods From the Unit of Acute Neurorehabilitation (University Hospital, Lausanne, Switzerland) between 2011 and 2014, we enrolled 33 DOC patients with a DOC diagnosis according to the CRS-R that had been established within 28 days of brain damage. The first CRS-R assessment established the initial diagnosis of Unresponsive Wakefulness Syndrome (UWS) in 20 patients and a Minimally Consciousness State (MCS) in the remaining13 patients. We clinically evaluated the patients over time using the CRS-R scale and concurrently from the beginning with complementary clinical items of a new observational Motor Behaviour Tool (MBT). Primary endpoint was outcome at unit discharge distinguishing two main classes of patients (DOC patients having emerged from DOC and those remaining in DOC) and 6 subclasses detailing the outcome of UWS and MCS patients, respectively. Based on CRS-R and MBT scores assessed separately and jointly, statistical testing was performed in the acute phase using a non-parametric Mann-Whitney U test; longitudinal CRS-R data were modelled with a Generalized Linear Model. Results Fifty-five per cent of the UWS patients and 77% of the MCS patients had emerged from DOC. First, statistical prediction of the first CRS-R scores did not permit outcome differentiation between classes; longitudinal regression modelling of the CRS-R data identified distinct outcome evolution, but not earlier than 19 days. Second, the MBT yielded a significant outcome predictability in the acute phase (p<0.02, sensitivity>0.81). Third, a statistical comparison of the CRS-R subscales weighted by MBT became significantly predictive for DOC outcome (p<0.02). Discussion The association of MBT and CRS-R scoring improves significantly the evaluation of consciousness and the predictability of outcome in the acute phase. Subtle motor behaviour assessment provides accurate insight into the amount and the content of consciousness even in the case of cognitive motor dissociation.	[Pignat, Jean-Michel; Johr, Jane; de Keranflec'h, Charlotte Gilart; Diserens, Karin] Univ Lausanne Hosp, Dept Clin Neurosci, Acute Neurorehabil Unit, Lausanne, Switzerland; [Pignat, Jean-Michel; Draganski, Bogdan; Frackowiak, Richard; Diserens, Karin] Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland; [Mauron, Etienne] Univ Lausanne, Fac Med, Lausanne, Switzerland; [Laureys, Steven] Univ Liege, Coma Sci Grp, Liege, Belgium; [Van De Ville, Dimitri; Preti, Maria Giulia; Meskaldji, Djalel E.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Van De Ville, Dimitri; Preti, Maria Giulia; Meskaldji, Djalel E.] Univ Geneva, Fac Med, Geneva, Switzerland; [Hoemberg, Volker] SRH Gesundheitszentrum, Dept Neurol, Bad Wimpfen, Germany		Pignat, JM (corresponding author), Univ Lausanne Hosp, Dept Clin Neurosci, Acute Neurorehabil Unit, Lausanne, Switzerland.; Pignat, JM (corresponding author), Univ Lausanne Hosp, Dept Clin Neurosci, Lausanne, Switzerland.	jean-michel.pignat@chuv.ch	Frackowiak, Richard/H-4383-2011; Johr, Jane/AAL-3611-2021; Draganski, Bogdan/C-3096-2016; Van De Ville, Dimitri/A-5364-2008; Laureys, Steven/AAN-2097-2021; Preti, Maria Giulia/X-9430-2019; Laureys, Steven/A-3349-2011	Frackowiak, Richard/0000-0002-3151-822X; Draganski, Bogdan/0000-0002-5159-5919; Van De Ville, Dimitri/0000-0002-2879-3861; Laureys, Steven/0000-0002-3096-3807; Preti, Maria Giulia/0000-0002-5323-5327; Johr, Jane/0000-0003-4280-9310	German Research FoundationGerman Research Foundation (DFG); National Fund for Scientific Research (NFSR); Foundation Parkinson Switzerland; Foundation Synapsis; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission; Fondation Roger de Spoelberch; Partridge FoundationGeneral Electric; Gianni Biaggi de Blasys Foundation; Schumacher Foundation; company Merz; company AllerganAbbVieAllergan	V. Homberg received funding from the German Research Foundation. S. Laureys received funding from National Fund for Scientific Research (NFSR). B. Draganski received funding from the Foundation Parkinson Switzerland, the Foundation Synapsis, the German Research Foundation and the Swiss National Science Foundation. R. Frackowiak received funding from the Fondation Roger de Spoelberch, the Partridge Foundation and for the LREN research neuroimaging platform. K. Diserens received funding from the Gianni Biaggi de Blasys Foundation and the Schumacher Foundation. K. Diserens received also funding from the companies Merz and Allergan for research on botulinum toxin treatment. This study was financially supported by the peer reviewed Gianni Biaggi de Blasys Foundation, which had no role in study design, in data collection, analysis and interpretation, nor in writing the final report. All the aforementioned institutions and companies had no role in study design, in data collection, analysis and interpretation, nor in writing the final report.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2015, CLIN NEUROPHYSIOL, V126, P959, DOI 10.1016/j.clinph.2014.08.005; Bodart O, 2013, SEMIN NEUROL, V33, P83, DOI 10.1055/s-0033-1348965; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cavanna AE, 2011, BEHAV NEUROL, V24, P107, DOI [10.3233/BEN-2011-0322, 10.1155/2011/645159]; Chatelle C, 2012, BRAIN INJURY, V26, P1510, DOI 10.3109/02699052.2012.698362; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Di Perri C, 2014, WORLD J RADIOL, V6, P589, DOI 10.4329/wjr.v6.i8.589; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; EDGREN E, 1994, LANCET, V343, P1055, DOI 10.1016/S0140-6736(94)90179-1; Fernandez-Espejo D, 2015, JAMA NEUROL, P1, DOI [10.1001/jamaneurol.2015.2614, DOI 10.1001/JAMANEUROL.2015.2614]; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Formisano R, 2011, FUNCT NEUROL, V26, P15; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gill-Thwaites H, 2006, BRAIN INJURY, V20, P1321, DOI 10.1080/02699050601081802; Holler Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080479; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lechinger J, 2013, J NEUROL, V260, P2348, DOI 10.1007/s00415-013-6982-3; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lupi A, 2014, CURR RADIOPHARM, V7, P57, DOI 10.2174/1874471007666140411103819; Owen AM, 2014, NAT REV NEUROL, V10, P370, DOI 10.1038/nrneurol.2014.102; Posner JB, 2007, PLUM POSNERS DIAGNOS; Rossetti AO, 2012, NEUROLOGY, V78, P796, DOI 10.1212/WNL.0b013e318249f6bb; SAZBON L, 1991, Brain Injury, V5, P3, DOI 10.3109/02699059108998505; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2015, NEUROREHAB NEURAL RE, V29, P41, DOI 10.1177/1545968314528067; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Serrao M, 2006, J NEUROSCI, V26, P3505, DOI 10.1523/JNEUROSCI.5160-05.2006; Silva S, 2015, NEUROLOGY, V85, P2036, DOI 10.1212/WNL.0000000000002196; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; 1994, NEW ENGL J MED, V330, P1572, DOI DOI 10.1056/NEJM199406023302206	45	27	30	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2016	11	6							e0156882	10.1371/journal.pone.0156882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ0CH	WOS:000378865200004	27359335	Green Published, gold, Green Submitted			2022-02-06	
J	Tan, JKY; Pham, B; Zong, YJ; Perez, C; Maris, DO; Hemphill, A; Miao, CH; Matula, TJ; Mourad, PD; Wei, H; Sellers, DL; Horner, PJ; Pun, SH				Tan, James-Kevin Y.; Binhan Pham; Zong, Yujin; Perez, Camilo; Maris, Don O.; Hemphill, Ashton; Miao, Carol H.; Matula, Thomas J.; Mourad, Pierre D.; Wei, Hua; Sellers, Drew L.; Horner, Philip J.; Pun, Suzie H.			Microbubbles and ultrasound increase intraventricular polyplex gene transfer to the brain	JOURNAL OF CONTROLLED RELEASE			English	Article; Proceedings Paper	13th Nanomedicine and Drug Delivery Symposium (NanoDDS)	SEP 16-18, 2015	Univ Washington, Seattle, WA	Precision NanoSystems, Inc, Sigma Aldrich, Izon Sci, Perkin Elmer, Univ Washington, Coll Engn, UW Bioengineering, UW Mol Engn & Sci Inst, Bio Pact, iThera Med, Quidel, Wyatt Technol, Miltenyi Biotec	Univ Washington	Gene delivery; Microbubble; Polyplex; Ultrasound; In vivo; Choroid plexus epithelium	CONTRAST AGENT MICROBUBBLES; MEDIATED DRUG-DELIVERY; FOCUSED ULTRASOUND; CHOROID-PLEXUS; FLOW-CYTOMETRY; ADULT BRAIN; IN-VITRO; BARRIER; NEUROGENESIS; CAVITATION	Neurons in the brain can be damaged or lost from neurodegenerative disease, stroke, or traumatic injury. Although neurogenesis occurs in mammalian adult brains, the levels of natural neurogenesis are insufficient to restore function in these cases. Gene therapy has been pursued as a promising strategy to induce differentiation of neural progenitor cells into functional neurons. Non-viral vectors are a preferred method of gene transfer due to potential safety and manufacturing benefits but suffer from lower delivery efficiencies compared to viral vectors. Since the neural stem and progenitor cells reside in the subventricular zone of the brain, intraventricular injection has been used as an administration route for gene transfer to these cells. However, the choroid plexus epithelium remains an obstacle to delivery. Recently, transient disruption of the blood-brain barrier by microbubble-enhanced ultrasound has been used to successfully improve drug delivery to the brain after intravenous injection. In this work, we demonstrate that microbubble-enhanced ultrasound can similarly improve gene transfer to the subventricular zone after intraventricular injection. Microbubbles of different surface charges (neutral, slightly cationic, and cationic) were prepared, characterized by acoustic flow cytometry, and evaluated for their ability to increase the permeability of immortalized choroid plexus epithelium monolayers in vitro. Based on these results, slightly cationic microbubbles were evaluated for microbubble and ultrasound-mediated enhancement of non-viral gene transfer in vivo. When coupled with our previously reported gene delivery vehicles, the slightly cationic microbubbles significantly increased ultrasound-mediated transfection of the murine brain when compared to commercially available Definity (R) microbubbles. Temporary disruption of the choroid plexus by microbubble-enhanced ultrasound is therefore a viable way of enhancing gene delivery to the brain and merits further research. (C) 2016 Elsevier B.V. All rights reserved.	[Tan, James-Kevin Y.; Binhan Pham; Perez, Camilo; Hemphill, Ashton; Sellers, Drew L.; Pun, Suzie H.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Tan, James-Kevin Y.; Binhan Pham; Hemphill, Ashton; Sellers, Drew L.; Pun, Suzie H.] Univ Washington, Mol Engn & Sci Inst, Seattle, WA 98195 USA; [Zong, Yujin; Perez, Camilo; Matula, Thomas J.] Univ Washington, Ctr Ind & Med Ultrasound, Seattle, WA 98195 USA; [Zong, Yujin] Xi An Jiao Tong Univ, Dept Biomed Engn, Xian 710049, Peoples R China; [Maris, Don O.; Mourad, Pierre D.; Horner, Philip J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98109 USA; [Miao, Carol H.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Wei, Hua] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China		Horner, PJ (corresponding author), Houston Methodist Res Inst, Ctr Neuroregenerat Med, 6670 Bertner Ave,MSR10-112, Houston, TX 77030 USA.; Pun, SH (corresponding author), Univ Washington, Dept Bioengn, Mol Engn & Sci Inst, William H Foege Bldg,Box 355061, Seattle, WA 98195 USA.	pjhorner@houstonmethodist.org; spun@uw.edu	Wei, Hua-liang/AAX-4771-2020; Horner, Philip J./AAF-7012-2021	Wei, Hua-liang/0000-0002-4704-7346; Pham, Binhan/0000-0002-1989-4169	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL128139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS064404, R01NS066357] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL128139] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS064404, R01 NS066357] Funding Source: Medline		Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Cavalieri F, 2013, ACS APPL MATER INTER, V5, P10920, DOI 10.1021/am403108y; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; Choi JJ, 2007, ULTRASOUND MED BIOL, V33, P95, DOI 10.1016/j.ultrasmedbio.2006.07.018; Choi JJ, 2011, J CEREBR BLOOD F MET, V31, P725, DOI 10.1038/jcbfm.2010.155; Choi JJ, 2010, ULTRASOUND MED BIOL, V36, P58, DOI 10.1016/j.ultrasmedbio.2009.08.006; Choi JL, 2015, BIOMATERIALS, V54, P87, DOI 10.1016/j.biomaterials.2015.03.008; Dass CR, 2004, BIOTECHNOL APPL BIOC, V40, P113, DOI 10.1042/BA20040005; De Cock I, 2015, J CONTROL RELEASE, V197, P20, DOI 10.1016/j.jconrel.2014.10.031; Delalande A., 2015, ULTRASOUND MED BIOL, P1; Dicker S., 2010, Bubble Science, Engineering & Technology, V2, P55, DOI 10.1179/1758897910Y.0000000001; Dicker S, 2013, ULTRASOUND MED BIOL, V39, P1292, DOI 10.1016/j.ultrasmedbio.2013.02.462; Dodge JC, 2010, MOL THER, V18, P2075, DOI 10.1038/mt.2010.206; Doinikov AA, 2009, ULTRASONICS, V49, P269, DOI 10.1016/j.ultras.2008.09.007; Fan Z, 2013, J CONTROL RELEASE, V170, P401, DOI 10.1016/j.jconrel.2013.05.039; Feshitan JA, 2009, J COLLOID INTERF SCI, V329, P316, DOI 10.1016/j.jcis.2008.09.066; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Greenleaf WJ, 1998, ULTRASOUND MED BIOL, V24, P587, DOI 10.1016/S0301-5629(98)00003-9; Guo XS, 2013, J ACOUST SOC AM, V134, P1622, DOI 10.1121/1.4812887; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Matsuoka N, 2003, STROKE, V34, P1519, DOI 10.1161/01.STR.0000070840.56414.3B; Matula T. J., 2011, 2011 IEEE International Ultrasonics Symposium (IUS), P156, DOI 10.1109/ULTSYM.2011.0039; McDannold N, 2012, CANCER RES, V72, P3652, DOI 10.1158/0008-5472.CAN-12-0128; Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019; Meairs S, 2009, MED BIOL ENG COMPUT, V47, P839, DOI 10.1007/s11517-009-0468-6; Mortazavi MM, 2014, CHILD NERV SYST, V30, P205, DOI 10.1007/s00381-013-2326-y; Panje CM, 2013, INVEST RADIOL, V48, P755, DOI 10.1097/RLI.0b013e3182982cc1; Pardridge WM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-7; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Rychak JJ, 2014, ADV DRUG DELIVER REV, V72, P82, DOI 10.1016/j.addr.2014.01.009; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Samiotaki G., 2015, J CEREB BLOOD FLOW M, P1; Sawada Masato, 2013, Keio Journal of Medicine, V62, P13, DOI 10.2302/kjm.2012-0005-RE; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Shi LZ, 2008, TOXICOL IN VITRO, V22, P190, DOI 10.1016/j.tiv.2007.07.007; Sugiura S, 2005, STROKE, V36, P859, DOI 10.1161/01.STR.0000158905.22871.95; Sun RR, 2014, J CONTROL RELEASE, V182, P111, DOI 10.1016/j.jconrel.2014.03.002; Tan JKY, 2015, BIOMATER SCI-UK, V3, P112, DOI 10.1039/c4bm00240g; Tu J, 2011, IEEE T ULTRASON FERR, V58, P955, DOI 10.1109/TUFFC.2011.1896; Wang DS, 2012, RADIOLOGY, V264, P721, DOI 10.1148/radiol.12112368; Wang S, 2015, GENE THER, V22, P104, DOI 10.1038/gt.2014.91; Wang ST, 2014, ULTRASOUND MED BIOL, V40, P130, DOI 10.1016/j.ultrasmedbio.2013.09.015; Weber-Adrian D., 2015, GENE THER, P1; Wei H, 2013, ANGEW CHEM INT EDIT, V52, P5377, DOI 10.1002/anie.201301896; Wu SY, 2015, J CONTROL RELEASE, V212, P30, DOI 10.1016/j.jconrel.2015.06.007; Xie F, 2008, ULTRASOUND MED BIOL, V34, P2028, DOI 10.1016/j.ultrasmedbio.2008.05.004; Zheng W, 2002, BRAIN RES, V958, P371, DOI 10.1016/S0006-8993(02)03683-1; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhou Y, 2012, J CONTROL RELEASE, V157, P103, DOI 10.1016/j.jconrel.2011.09.068	50	27	27	0	23	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	JUN 10	2016	231						86	93		10.1016/j.jconrel.2016.02.003			8	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Chemistry; Pharmacology & Pharmacy	DM6EY	WOS:000376444600010	26860281	Green Accepted			2022-02-06	
J	Hajra, SG; Liu, CC; Song, XW; Fickling, S; Liu, LE; Pawlowski, G; Jorgensen, JK; Smith, AM; Schnaider-Beeri, M; Van Den Broek, R; Rizzotti, R; Fisher, K; D'Arcy, RCN				Hajra, Shjoy Ghosh; Liu, Careesa C.; Song, Xiaowei; Fickling, Shaun; Liu, Luke E.; Pawlowski, Gabriela; Jorgensen, Janelle K.; Smith, Anysley M.; Schnaider-Beeri, Michal; Van Den Broek, Rudi; Rizzotti, Rowena; Fisher, Kirk; D'Arcy, Ryan C. N.			Developing Brain Vital Signs: Initial Framework for Monitoring Brain Function Changes Over Time	FRONTIERS IN NEUROSCIENCE			English	Article						clinical neuroscience; ERPs; evoked potentials; vital signs; neurology	EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY; RETEST RELIABILITY; VEGETATIVE STATE; CONSCIOUSNESS; COMA; IMPAIRMENT; DISORDERS; SCALE	Clinical assessment of brain function relies heavily on indirect behavior-based tests. Unfortunately, behavior-based assessments are subjective and therefore susceptible to several confounding factors. Event-related brain potentials (ERPs), derived from electroencephalography (EEG), are often used to provide objective, physiological measures of brain function. Historically, ERPs have been characterized extensively within research settings, with limited but growing clinical applications. Over the past 20 years, we have developed clinical ERP applications for the evaluation of functional status following serious injury and/or disease. This work has identified an important gap: the need for a clinically accessible framework to evaluate ERP measures. Crucially, this enables baseline measures before brain dysfunction occurs, and might enable the routine collection of brain function metrics in the future much like blood pressure measures today. Here, we propose such a framework for extracting specific ERPs as potential "brain vital signs." This framework enabled the translation/transformation of complex ERP data into accessible metrics of brain function for wider clinical utilization. To formalize the framework, three essential ERPs were selected as initial indicators: (1) the auditory N100 (Auditory sensation): (2) the auditory oddball P300 (Basic attention): and (3) the auditory speech processing N400 (Cognitive processing). First step validation was conducted on healthy younger and older adults (age range: 22-82 years). Results confirmed specific ERPs at the individual level (86.81-98.96%), verified predictable age-related differences (P300 latency delays in older adults, p < 0.05), and demonstrated successful linear transformation into the proposed brain vital sign (BVS) framework (basic attention latency sub-component of BVS framework reflects delays in older adults, p < 0.05). The findings represent an initial critical step in developing, extracting, and characterizing ERPs as vital signs, critical for subsequent evaluation of dysfunction in conditions like concussion and/or dementia.	[Hajra, Shjoy Ghosh; Liu, Careesa C.; Song, Xiaowei; Fickling, Shaun; D'Arcy, Ryan C. N.] Simon Fraser Univ, Sch Engn Sci, Fac Sci Appl, Burnaby, BC V5A 1S6, Canada; [Hajra, Shjoy Ghosh; Liu, Careesa C.; Song, Xiaowei; Fickling, Shaun; Liu, Luke E.; Pawlowski, Gabriela; D'Arcy, Ryan C. N.] Simon Fraser Univ, NeuroTech Lab, Surrey, BC, Canada; [Hajra, Shjoy Ghosh; Liu, Careesa C.; Song, Xiaowei; Fickling, Shaun; Liu, Luke E.; Pawlowski, Gabriela; D'Arcy, Ryan C. N.] Fraser Heath Author, Surrey, BC, Canada; [Song, Xiaowei; D'Arcy, Ryan C. N.] Fraser Hlth Author, Surrey Mem Hosp, Hth Sci & Innovat, Surrey, BC, Canada; [Pawlowski, Gabriela; D'Arcy, Ryan C. N.] Simon Fraser Univ, Fac Sci, Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada; [Jorgensen, Janelle K.; Smith, Anysley M.] Mayo Clin, Sports Med Ctr, Rochester, MN USA; [Schnaider-Beeri, Michal] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Schnaider-Beeri, Michal] Sheeba Med Ctr, Joseph Sago Neurosci Ctr, Ramat Gan, Israel; [Van Den Broek, Rudi; Rizzotti, Rowena; Fisher, Kirk; D'Arcy, Ryan C. N.] Hlth Tech Connex Inc, Surrey, BC, Canada		D'Arcy, RCN (corresponding author), Simon Fraser Univ, Sch Engn Sci, Fac Sci Appl, Burnaby, BC V5A 1S6, Canada.; D'Arcy, RCN (corresponding author), Simon Fraser Univ, NeuroTech Lab, Surrey, BC, Canada.; D'Arcy, RCN (corresponding author), Fraser Heath Author, Surrey, BC, Canada.; D'Arcy, RCN (corresponding author), Fraser Hlth Author, Surrey Mem Hosp, Hth Sci & Innovat, Surrey, BC, Canada.; D'Arcy, RCN (corresponding author), Simon Fraser Univ, Fac Sci, Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada.; D'Arcy, RCN (corresponding author), Hlth Tech Connex Inc, Surrey, BC, Canada.	rdarcy@sfu.ca		Ghosh Hajra, Sujoy/0000-0002-8347-6578	Mathematics of Information Technology and Complex Systems (MITACS) [IT03210]; National Sciences and Engineering Council Canada (NSERC) [298457-2009]; Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [CCI-109608]	This work was supported in part by Mathematics of Information Technology and Complex Systems (MITACS, Grant #IT03210), National Sciences and Engineering Council Canada (NSERC, Grant #298457-2009), and Canadian Institutes for Health Research (CIHR, Grant #CCI-109608).	Braverman ER, 2003, CLIN ELECTROENCEPHAL, V34, P124, DOI 10.1177/155005940303400306; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V37, P31, DOI 10.1016/S0167-8760(00)00093-3; CONNOLLY JF, 1995, J CLIN EXP NEUROPSYC, V17, P548, DOI 10.1080/01688639508405145; D'Arcy RCN, 2003, CLIN NEUROPHYSIOL, V114, P662, DOI 10.1016/S1388-2457(03)00007-5; D'Arcy RCN, 2011, IEEE T BIO-MED ENG, V58, P750, DOI 10.1109/TBME.2010.2090880; Daltrozzo J, 2009, COGN BEHAV NEUROL, V22, P53, DOI 10.1097/WNN.0b013e318192ccc8; Davis PA, 1939, J NEUROPHYSIOL, V2, P494, DOI 10.1152/jn.1939.2.6.494; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Fleck-Prediger C., 2014, CLIN APPL HALIFAX CO; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gawryluk J. R., 2010, HDB PHYS MED BIOL, V24-1-24-14; Gawryluk JR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-11; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Golland P., 2003, PERMUTATION TESTS CL, DOI [10.1007/978-3-540-45087-0_28, DOI 10.1007/978-3-540-45087-0_28]; Kotchoubey B, 2005, CLIN NEUROPHYSIOL, V116, P2441, DOI 10.1016/j.clinph.2005.03.028; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Marchand Y, 2002, CLIN NEUROPHYSIOL, V113, P1715, DOI 10.1016/S1388-2457(02)00224-9; Morlet D, 2000, AUDIOL NEURO-OTOL, V5, P198, DOI 10.1159/000013881; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Parvar Hossein, 2015, Brain Inform, V2, P1; Pravdich-Neminsky V.V., 1913, ZBL PHYSL, V27, P951; Reith FCM, 2016, J NEUROTRAUM, V33, P89, DOI 10.1089/neu.2014.3843; Ries A.J., 2014, J NEUROSCI NEUROENG, V3, P10, DOI [DOI 10.1166/JNSNE.2014.1092, 10.1166/jnsne.2014.1092, DOI 10.1166/jnsne.2014.1092]; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sculthorpe-Petley L, 2015, J NEUROSCI METH, V245, P64, DOI 10.1016/j.jneumeth.2015.02.008; SUTTON S, 1967, SCIENCE, V155, P1436, DOI 10.1126/science.155.3768.1436; TEASDALE G, 1974, LANCET, V2, P81; Vanhaudenhuyse A, 2008, NEUROCRIT CARE, V8, P262, DOI 10.1007/s12028-007-9016-0; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Williams LM, 2005, INT J NEUROSCI, V115, P1605, DOI 10.1080/00207450590958475; Yeo MVM, 2009, SAFETY SCI, V47, P115, DOI 10.1016/j.ssci.2008.01.007	34	27	28	0	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 12	2016	10								211	10.3389/fnins.2016.00211			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DL7OA	WOS:000375828800001	27242415	Green Published, gold			2022-02-06	
J	Atabaki, SM; Hoyle, JD; Schunk, JE; Monroe, DJ; Alpern, ER; Quayle, KS; Glass, TF; Badawy, MK; Miskin, M; Schalick, WO; Dayan, PS; Holmes, JF; Kuppermann, N				Atabaki, Shireen M.; Hoyle, John D., Jr.; Schunk, Jeff E.; Monroe, David J.; Alpern, Elizabeth R.; Quayle, Kimberly S.; Glass, Todd F.; Badawy, Mohamed K.; Miskin, Michelle; Schalick, Walton O.; Dayan, Peter S.; Holmes, James F.; Kuppermann, Nathan			Comparison of Prediction Rules and Clinician Suspicion for Identifying Children With Clinically Important Brain Injuries After Blunt Head Trauma	ACADEMIC EMERGENCY MEDICINE			English	Article							COMPUTED-TOMOGRAPHY USE; EMERGENCY-DEPARTMENT; RADIATION-EXPOSURE; DECISION RULES; UNITED-STATES; RISK; IMPROVEMENT; PHYSICIAN; JUDGMENT; PATIENT	Objective: Children with minor head trauma frequently present to emergency departments (EDs). Identifying those with traumatic brain injuries (TBIs) can be difficult, and it is unknown whether clinical prediction rules outperform clinician suspicion. Our primary objective was to compare the test characteristics of the Pediatric Emergency Care Applied Research Network (PECARN) TBI prediction rules to clinician suspicion for identifying children with clinically important TBIs (ciTBIs) after minor blunt head trauma. Our secondary objective was to determine the reasons for obtaining computed tomography (CT) scans when clinical suspicion of ciTBI was low. Methods: This was a planned secondary analysis of a previously conducted observational cohort study conducted in PECARN to derive and validate clinical prediction rules for ciTBI among children with minor blunt head trauma in 25 PECARN EDs. Clinicians recorded their suspicion of ciTBI before CT as <1, 1-5, 6-10, 11-50, or >50%. We defined ciTBI as 1) death from TBI, 2) neurosurgery, 3) intubation for more than 24 hours for TBI, or 4) hospital admission of 2 nights or more associated with TBI on CT. To avoid overfitting of the prediction rules, we performed comparisons of the prediction rules and clinician suspicion on the validation group only. On the validation group, we compared the test accuracies of clinician suspicion >1% versus having at least one predictor in the PECARN TBI age-specific prediction rules for identifying children with ciTBIs (one rule for children <2 years [preverbal], the other rule for children >2 years [verbal]). Results: In the parent study, we enrolled 8,627 children to validate the prediction rules, after enrolling 33,785 children to derive the prediction rules. In the validation group, clinician suspicion of ciTBI was recorded in 8,496/8,627 (98.5%) patients, and 87 (1.0%) had ciTBIs. CT scans were obtained in 2,857 (33.6%) patients in the validation group for whom clinician suspicion of ciTBI was recorded, including 2,099/7,688 (27.3%) of those with clinician suspicion of ciTBI of <1% and 758/808 (93.8%) of those with clinician suspicion >1%. The PECARN prediction rules were significantly more sensitive than clinician suspicion >1% of ciTBI for preverbal (100% [95% confidence interval {CI} = 86.3% to 100%] vs. 60.0% [95% CI = 38.7% to 78.9%]) and verbal children (96.8% [95% CI = 88.8% to 99.6%] vs. 64.5% [95% CI = 51.3% to 76.3%]). Prediction rule specificity, however, was lower than clinician suspicion >1% for preverbal children (53.6% [95% CI = 51.5% to 55.7%] vs. 92.4% [95% CI = 91.2% to 93.5%]) and verbal children (58.2% [95% CI = 56.9% to 59.4%] vs. 90.6% [95% CI = 89.8% to 91.3%]). Of the 7,688 patients in the validation group with clinician suspicion recorded as <1%, CTs were nevertheless obtained in 2,099 (27.3%). Three of 16 (18.8%) patients undergoing neurosurgery had clinician suspicion of ciTBI <1%. Conclusions: The PECARN TBI prediction rules had substantially greater sensitivity, but lower specificity, than clinician suspicion of ciTBI for children with minor blunt head trauma. Because CT ordering did not follow clinician suspicion of <1%, these prediction rules can augment clinician judgment and help obviate CT ordering for children at very low risk of ciTBI. (C) 2016 by the Society for Academic Emergency Medicine	[Atabaki, Shireen M.] George Washington Univ, Sch Med, Dept Pediat & Emergency Med, Washington, DC USA; [Hoyle, John D., Jr.] Michigan State Univ, Sch Med, Dept Emergency Med, Grand Rapids, MI USA; [Hoyle, John D., Jr.] Western Michigan Univ, Dept Emergency Med, Homer Stryker Sch Med, Kalamazoo, MI 49008 USA; [Hoyle, John D., Jr.] Western Michigan Univ, Dept Pediat, Homer Stryker Sch Med, Kalamazoo, MI 49008 USA; [Schunk, Jeff E.; Miskin, Michelle] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Monroe, David J.] Howard Cty Gen Hosp, Dept Emergency Med, Columbia, MD USA; [Alpern, Elizabeth R.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Alpern, Elizabeth R.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Quayle, Kimberly S.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Glass, Todd F.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Glass, Todd F.] Nemours Childrens Hosp, Dept Pediat, Orlando, FL USA; [Badawy, Mohamed K.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Badawy, Mohamed K.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Badawy, Mohamed K.] Univ Texas SW Med Ctr Dallas, Dept Emergency Med, Dallas, TX 75390 USA; [Schalick, Walton O.] Univ Wisconsin, Sch Med, Dept Orthoped Rehabil, Madison, WI USA; [Dayan, Peter S.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10027 USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA		Atabaki, SM (corresponding author), George Washington Univ, Sch Med, Dept Pediat & Emergency Med, Washington, DC USA.	satabaki@childrensnational.org		Alpern, Elizabeth/0000-0001-7887-3563	Health Resources and Services Administration/Maternal and Child Health Bureau (HRSA/MCHB), Division of Research, Education, and Training (DRTE); Emergency Medical Services of Children (EMSC) Program [R40MC02461]; Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program [U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, U03MC22685]	This work was supported by a grant from the Health Resources and Services Administration/Maternal and Child Health Bureau (HRSA/MCHB), Division of Research, Education, and Training (DRTE) and the Emergency Medical Services of Children (EMSC) Program (R40MC02461). This project was also supported in part by the Health Resources and Services Administration (HRSA), Maternal and Child Health Bureau (MCHB), Emergency Medical Services for Children (EMSC) Network Development Demonstration Program under cooperative agreements U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, and U03MC22685. The information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.	American Academy of Pediatrics, 5 THINGS PHYS PAT SH; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Bandiera G, 2003, ANN EMERG MED, V42, P395, DOI 10.1016/S0196-0644(03)00422-0; Bergman DA, 1999, PEDIATRICS, V104, P1407; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Fan E, 2010, JAMA-J AM MED ASSOC, V304, P2279, DOI 10.1001/jama.2010.1692; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigal DW, 2002, PEDIATR RADIOL, V32, P314, DOI 10.1007/s00247-002-0687-6; Finnerty NM, 2015, ACAD EMERG MED, V22, P1406, DOI 10.1111/acem.12828; GAUSCHE M, 1995, ANN EMERG MED, V25, P804, DOI 10.1016/S0196-0644(95)70212-1; Goske MJ, 2011, PEDIATR RADIOL, V41, P611, DOI [10.1007/s00247-010-1957-3, 10.1007/s00247-011-2133-0]; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; Hartling L, 2007, ACAD EMERG MED, V14, P968, DOI 10.1197/j.aem.2007.05.010; Klassen TP, 2000, ACAD EMERG MED, V7, P739, DOI 10.1111/j.1553-2712.2000.tb02260.x; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lodwick DL, 2015, PEDIATRICS, V136, pE1212, DOI 10.1542/peds.2015-1671; Maguire JL, 2011, PEDIATRICS, V128, pE666, DOI 10.1542/peds.2011-0043; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; National Cancer Institute, RAD RISKS PED COMP T; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Palchak MJ, 2009, PEDIATR EMERG CARE, V25, P61, DOI 10.1097/PEC.0b013e318196e9c0; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Schriger DL, 2012, ANN EMERG MED, V59, P219, DOI 10.1016/j.annemergmed.2011.08.015; Sheehan B, 2013, J BIOMED INFORM, V46, P905, DOI 10.1016/j.jbi.2013.07.005; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008	35	27	27	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAY	2016	23	5					566	575		10.1111/acem.12923			10	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DL2TT	WOS:000375488800005	26825755				2022-02-06	
J	Purcell, L; Harvey, J; Seabrook, JA				Purcell, Laura; Harvey, Janice; Seabrook, Jamie A.			Patterns of Recovery Following Sport-Related Concussion in Children and Adolescents	CLINICAL PEDIATRICS			English	Article						sport concussion; children; adolescents; youth; recovery	HIGH-SCHOOL; PROLONGED RECOVERY; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; EMERGENCY-DEPARTMENTS; CONSENSUS STATEMENT; HEAD-INJURY; SYMPTOMS; EPIDEMIOLOGY; MANAGEMENT	Time to symptom resolution, return to school, and return to play after a sport-related concussion in children and adolescents (8-17 years of age) was examined using a retrospective cohort design. A total of 198 patients aged 8 to 17 years were included, with a mean age of 13.5 years (SD = 2.2). Patients aged 8 to 12 years were symptom-free in a median of 12.0 (range 1-60) days whereas 13- to 17-year olds were symptom-free in a median of 14.0 (range 1-300) days (P = .04). Patients aged 8 to 12 years returned to learn in a median of 4.0 (range 0-30) days compared with 2.5 (range 0-55.0) days in 13- to 17-year-olds (P = .86). Patients aged 8 to 12 years returned to play in a median of 14.0 (range 4-75) days compared with a median of 19.5 (range 5-75) days in 13- to 17-year-olds (P = .06). These results indicate that children and adolescents generally take 2 to 4 weeks to recover from a sport-related concussion.	[Purcell, Laura; Harvey, Janice] McMaster Univ, Hamilton, ON, Canada; [Seabrook, Jamie A.] Brescia Univ Coll, London, ON, Canada; [Seabrook, Jamie A.] London Hlth Sci Ctr, London, ON, Canada		Purcell, L (corresponding author), McMaster Univ, Hamilton, ON, Canada.	lpurcell1015@rogers.com					Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], 2009, BR J SPORTS MED S1, V43, pi85; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Emery CA, 2006, CLIN J SPORT MED, V16, P20, DOI 10.1097/01.jsm.0000184638.72075.b7; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fridman L, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-30; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris AW, 2012, J SCI MED SPORT, V15, P298, DOI 10.1016/j.jsams.2011.12.005; Institute of Medicine, 2014, SPORTS REL CONC YOUT; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475	38	27	27	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	MAY	2016	55	5					452	458		10.1177/0009922815589915			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DJ5FM	WOS:000374232200008	26063756				2022-02-06	
J	Zatzick, DF; Russo, J; Darnell, D; Chambers, DA; Palinkas, L; Van Eaton, E; Wang, J; Ingraham, LM; Guiney, R; Heagerty, P; Comstock, B; Whiteside, LK; Jurkovich, G				Zatzick, Douglas F.; Russo, Joan; Darnell, Doyanne; Chambers, David A.; Palinkas, Lawrence; Van Eaton, Erik; Wang, Jin; Ingraham, Leah M.; Guiney, Roxanne; Heagerty, Patrick; Comstock, Bryan; Whiteside, Lauren K.; Jurkovich, Gregory			An effectiveness-implementation hybrid trial study protocol targeting posttraumatic stress disorder and comorbidity	IMPLEMENTATION SCIENCE			English	Article						Traumatic injury; Multiple chronic conditions; Posttraumatic stress disorder; Depression; Suicidal ideation; Substance abuse; Effectiveness-implementation hybrid; Pragmatic clinical trial; American College of Surgeons; Policy	RANDOMIZED CONTROLLED-TRIAL; STEPPED COLLABORATIVE CARE; INJURED TRAUMA SURVIVORS; POLYTRAUMA-CLINICAL-TRIAD; TIME TRADE-OFF; BRIEF INTERVENTION; SUBSTANCE USE; PREVENTIVE INTERVENTIONS; FUNCTIONAL OUTCOMES; DEPRESSIVE SYMPTOMS	Background: Each year in the USA, 1.5-2.5 million Americans are so severely injured that they require inpatient hospitalization. Multiple conditions including posttraumatic stress disorder (PTSD), alcohol and drug use problems, depression, and chronic medical conditions are endemic among physical trauma survivors with and without traumatic brain injuries. Methods/design: The trauma survivors outcomes and support (TSOS) effectiveness-implementation hybrid trial is designed to test the delivery of high-quality screening and intervention for PTSD and comorbidities across 24 US level I trauma center sites. The pragmatic trial aims to recruit 960 patients. The TSOS investigation employs a stepped wedge cluster randomized design in which sites are randomized sequentially to initiate the intervention. Patients identified by a 10-domain electronic health record screen as high risk for PTSD are formally assessed with the PTSD Checklist for study entry. Patients randomized to the intervention condition will receive stepped collaborative care, while patients randomized to the control condition will receive enhanced usual care. The intervention training begins with a 1-day on-site workshop in the collaborative care intervention core elements that include care management, medication, cognitive behavioral therapy, and motivational-interviewing elements targeting PTSD and comorbidity. The training is followed by site supervision from the study team. The investigation aims to determine if intervention patients demonstrate significant reductions in PTSD and depressive symptoms, suicidal ideation, alcohol consumption, and improvements in physical function when compared to control patients. The study uses implementation science conceptual frameworks to evaluate the uptake of the intervention model. At the completion of the pragmatic trial, results will be presented at an American College of Surgeons' policy summit. Twenty-four representative US level I trauma centers have been selected for the study, and the protocol is being rolled out nationally. Discussion: The TSOS pragmatic trial simultaneously aims to establish the effectiveness of the collaborative care intervention targeting PTSD and comorbidity while also addressing sustainable implementation through American College of Surgeons' regulatory policy. The TSOS effectiveness-implementation hybrid design highlights the importance of partnerships with professional societies that can provide regulatory mandates targeting enhanced health care system sustainability of pragmatic trial results.	[Zatzick, Douglas F.; Russo, Joan; Darnell, Doyanne; Ingraham, Leah M.; Guiney, Roxanne] Univ Washington, Dept Psychiat & Behav Sci, 325 Ninth Ave,Box 359911, Seattle, WA 98104 USA; [Chambers, David A.] NCI, Div Canc Control & Populat Sci, BG 9609 MSC 9760,9609 Med Ctr Dr, Bethesda, MD 20892 USA; [Palinkas, Lawrence] Univ So Calif, Sch Social Work, Montgomery Ross Fisher Bldg,Room 339, Los Angeles, CA 90089 USA; [Van Eaton, Erik] Univ Washington, Dept Surg, 325 Ninth Ave,Box 359796, Seattle, WA 98104 USA; [Zatzick, Douglas F.; Wang, Jin] Univ Washington, Harborview Injury Prevent Res Ctr, 325 Ninth Ave,Box 359960, Seattle, WA 98104 USA; [Heagerty, Patrick; Comstock, Bryan] Univ Washington, Dept Biostat, 1705 NE Pacific St,Box 357232, Seattle, WA 98195 USA; [Whiteside, Lauren K.] Univ Washington, Div Emergency Med, 25 Ninth Ave,Box 359702, Seattle, WA 98104 USA; [Jurkovich, Gregory] Univ Calif Davis, Dept Surg, 2221 Stockton Blvd,Cypress 3111, Sacramento, CA 95817 USA		Zatzick, DF (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, 325 Ninth Ave,Box 359911, Seattle, WA 98104 USA.; Zatzick, DF (corresponding author), Univ Washington, Harborview Injury Prevent Res Ctr, 325 Ninth Ave,Box 359960, Seattle, WA 98104 USA.	dzatzick@uw.edu		Whiteside, Lauren/0000-0002-0284-5336	National Institutes of Health (NIH) Common Fund, through Office of Strategic Coordination within the Office of the NIH Director [U54 AT007748, 1UH2MH106338-01/4UH3MH106338-02]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1 K24MH086814-01A1]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54AT007748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [UH3MH106338, UH2MH106338, K24MH086814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K23DA039974] Funding Source: NIH RePORTER	This work is supported by the National Institutes of Health (NIH) Common Fund, through cooperative agreements (U54 AT007748, 1UH2MH106338-01/4UH3MH106338-02) from the Office of Strategic Coordination within the Office of the NIH Director, and the National Institute of Mental Health (1 K24MH086814-01A1). The views presented here are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	Adams GA, 1998, PERS PSYCHOL, V51, P643, DOI 10.1111/j.1744-6570.1998.tb00255.x; Adams JG, 2013, JAMA-J AM MED ASSOC, V309, P1173, DOI 10.1001/jama.2013.2476; *AM COLL SURG COMM, 2006, RES OPT CAR INJ PAT; American College of Surgeon Committee on Trauma, 2014, RES OPT CAR INJ PAT; [Anonymous], 1999, RES OPT CAR INJ PAT; Babor T., 1989, ALCOHOL USE DISORDER; Badia X, 1999, QUAL LIFE RES, V8, P303, DOI 10.1023/A:1008952423122; Benner P.E., 1994, TRADITION SKILL INTE; BERGEN G, 2008, DHHS PUBLICATION; Bergman Karen, 2010, J Trauma Nurs, V17, P102, DOI 10.1097/JTN.0b013e3181ecc452; Bindman AB, 2013, JAMA-J AM MED ASSOC, V310, P1125, DOI 10.1001/jama.2013.276525; Bonnie R.J., 1999, REDUCING BURDEN INJU; Bosch M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-281; Boye KS, 2014, EXPERT REV PHARM OUT, V14, P437, DOI 10.1586/14737167.2014.912562; Bradley K, 2014, RESULTS POPULATION B; Bride BE, 2004, RES SOCIAL WORK PRAC, V14, P27, DOI 10.1177/1049731503254106; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Burke RE, 2013, JAMA INTERN MED, V173, P695, DOI 10.1001/jamainternmed.2013.171; Caldwell SD, 2004, J APPL PSYCHOL, V89, P868, DOI 10.1037/0021-9010.89.5.868; Creswell JW., 1998, QUAL INQ; Curran GM, 2012, MED CARE, V50, P217, DOI 10.1097/MLR.0b013e3182408812; Darnell D, 2016, J SUBST ABUSE TREAT, V60, P36, DOI 10.1016/j.jsat.2015.05.010; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; English M, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-124; Faul M, 2010, TRAUMATIC BRAIN INJU; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Fixsen D.L., 2005, IMPLEMENTATION RES S; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frankel HL, 2012, J TRAUMA ACUTE CARE, V73, P20, DOI 10.1097/TA.0b013e31825a78d5; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Glasgow RE, 2012, CTS-CLIN TRANSL SCI, V5, P48, DOI 10.1111/j.1752-8062.2011.00383.x; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Hemming K, 2014, STATA J, V14, P363, DOI 10.1177/1536867X1401400208; Hogan SJ, 2014, J BUS RES, V67, P1609, DOI 10.1016/j.jbusres.2013.09.007; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hom P. W., 1995, EMPLOYEE TURNOVER; Hughes JP, 2015, CONTEMP CLIN TRIALS, V45, P55, DOI 10.1016/j.cct.2015.07.006; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Inst. Med, 2008, LEARN HEALTHC SYST C; Johnson KE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6826; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P148, DOI 10.1097/TA.0000000000000271; Katon W, 1997, GEN HOSP PSYCHIAT, V19, P169, DOI 10.1016/S0163-8343(97)00016-9; Katon W, 2001, ARCH GEN PSYCHIAT, V58, P241, DOI 10.1001/archpsyc.58.3.241; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Katon WJ, 2004, ARCH GEN PSYCHIAT, V61, P1042, DOI 10.1001/archpsyc.61.10.1042; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khoury AL, 2013, J TRAUMA ACUTE CARE, V75, P512, DOI 10.1097/TA.0b013e3182924977; Klar, 2000, DESIGN ANAL CLUSTER; Koepsell TD, 2011, AM J PREV MED, V40, P191, DOI 10.1016/j.amepre.2010.10.022; Krebs EE, 2010, MED CARE, V48, P1007, DOI 10.1097/MLR.0b013e3181eaf835; Krebs EE, 2009, J GEN INTERN MED, V24, P733, DOI 10.1007/s11606-009-0981-1; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, JAMA-J AM MED ASSOC, V304, P163, DOI 10.1001/jama.2010.944; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V309, P2425, DOI 10.1001/jama.2013.6494; Love J, 2014, PSYCHIAT SERV, V65, P918, DOI 10.1176/appi.ps.201300399; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; MACKENZIE EJ, 1989, J TRAUMA, V29, P757, DOI 10.1097/00005373-198906000-00011; March J, 2010, NEUROPSYCHOPHARMACOL, V35, P2491, DOI 10.1038/npp.2010.115; McCaig LF, 1994, ADV DATA VITAL HLTH; Mdege ND, 2011, J CLIN EPIDEMIOL, V64, P936, DOI 10.1016/j.jclinepi.2010.12.003; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Mobley W. H., 1982, EMPLOYEE TURNOVER CA; Murray D. M., 1998, DESIGN ANAL GROUP RA; Murray DM, 2008, JNCI-J NATL CANCER I, V100, P483, DOI 10.1093/jnci/djn066; Murray DM, 2004, AM J PUBLIC HEALTH, V94, P423, DOI 10.2105/AJPH.94.3.423; National Center for Complementary and Alternative Medicine, 2012, RFARM12002 NAT CTR C; National Center for Injury Prevention, 2012, CDC 2012; National Institute of Neurological Disorders and Stroke, 2009, TRAUM BRAIN INJ HOP; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; O'Connor SS, 2014, SUICIDE LIFE-THREAT, V44, P473, DOI 10.1111/sltb.12085; Palinkas Lawrence A, 2004, Prehosp Disaster Med, V19, P113; Palinkas LA, 2011, PSYCHIAT SERV, V62, P255, DOI 10.1176/ps.62.3.pss6203_0255; Palinkas LA, 2011, ADM POLICY MENT HLTH, V38, P44, DOI 10.1007/s10488-010-0314-z; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Peek C.J., 2011, COLLABORATIVE CARE L; Plano Clark, 2018, DESIGNING CONDUCTING; Proctor E, 2010, ADM POLICY MENT HLTH; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Raghavan R., 2012, DISSEMINATION IMPLEM, P89; Ramstad SM, 2004, J TRAUMA STRESS, V17, P529, DOI 10.1007/s10960-004-5802-z; Raudenbush SW, 2000, PSYCHOL METHODS, V5, P199, DOI 10.1037//1082-989X.5.2.199; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rice DP, 1989, COST INJURY US REPOR; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Richesson RL, 2013, J AM MED INFORM ASSN, V20, pE226, DOI 10.1136/amiajnl-2013-001926; Rogers E., 1995, DIFFUSION INNOVATION, V4th edn.; Rollman BL, 2005, ARCH GEN PSYCHIAT, V62, P1332, DOI 10.1001/archpsyc.62.12.1332; Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670; Roy-Byrne P, 2010, JAMA-J AM MED ASSOC, V303, P1921, DOI 10.1001/jama.2010.608; Russo J, 2013, GEN HOSP PSYCHIAT, V35, P485, DOI 10.1016/j.genhosppsych.2013.04.016; Sacks GD, 2011, J TRAUMA, V71, P1011, DOI 10.1097/TA.0b013e3182092c27; Saldana L, 2014, CHILD YOUTH SERV REV, V39, P177, DOI 10.1016/j.childyouth.2013.10.006; Scrimshaw NS, 1992, RAPID ASSESSMENT PRO; Shafi S, 2012, J TRAUMA ACUTE CARE, V73, P1303, DOI 10.1097/TA.0b013e318265d219; Shafi S, 2010, J TRAUMA, V69, P1367, DOI 10.1097/TA.0b013e3181fb785d; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Soderstrom CA, 1997, JAMA-J AM MED ASSOC, V277, P1769, DOI 10.1001/jama.277.22.1769; Tavender EJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0264-7; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; TEASDALE G, 1974, LANCET, V2, P81; Terrell F, 2008, J AM COLL SURGEONS, V207, P630, DOI 10.1016/j.jamcollsurg.2008.05.021; The Johns Hopkins Health Services Research and Development Center, 1989, DET INJ SEV HOSP SIS; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1016/j.jclinepi.2008.12.011, 10.1503/cmaj.090523]; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; United States. President's Commission on Care for America's Returning Wounded Warriors, 2007, SERV SUPP SIMPL REP; Unutzer J, 2002, PSYCHIATR SERV, V53, P671, DOI 10.1176/appi.ps.53.6.671; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; US Department of Health and Human Services, 2010, MULTIPLE CHRONIC CON; Van Eaton EG, 2014, J AM COLL SURGEONS, V219, P505, DOI 10.1016/j.jamcollsurg.2014.02.032; Vashi AA, 2013, JAMA-J AM MED ASSOC, V309, P364, DOI 10.1001/jama.2012.216219; Wallace RB, 2013, CENT DIS CONTROL PRE, V10, P5; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers FW, 1994, SAN ANT TX 9 ANN M I; Weathers FW, 1996, MEASUREMENT STRESS T, P250; Weathers FW, 1991, PTSD CHECKLIST CIVIL; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Woertman W, 2013, J CLIN EPIDEMIOL, V66, P752, DOI 10.1016/j.jclinepi.2013.01.009; World Health Organization, 2012, DIS INJ COUNTR EST; Wright DR, 2009, PHARMACOECONOMICS, V27, P713, DOI 10.2165/11317060-000000000-00000; Zatzick CD, 2003, ORGAN SCI, V14, P483, DOI 10.1287/orsc.14.5.483.16768; Zatzick CD, 2011, SAN TX AC MAN ANN M; Zatzick CD, 2013, HEALTH CARE MANAGE R, V38, P115, DOI 10.1097/HMR.0b013e318249aa60; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498; Zatzick DF, 2006, CLIN PSYCHOL-SCI PR, V13, P53, DOI 10.1111/j.1468-2850.2006.00006.x; Zatzick DF, 2002, ARCH SURG-CHICAGO, V137, P200, DOI 10.1001/archsurg.137.2.200; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941; Zatzick DF, 2001, MED CARE, V39, P327, DOI 10.1097/00005650-200104000-00004; Zatzick DF, 2001, GEN HOSP PSYCHIAT, V23, P114, DOI 10.1016/S0163-8343(01)00140-2; Zatzick D, 2008, ANN SURG, V248, P429, DOI 10.1097/SLA.0b013e318185a6b8; Zatzick D, 2015, J TRAUMA STRESS, V28, P391, DOI 10.1002/jts.22041; Zatzick D, 2014, JAMA PEDIATR, V168, P532, DOI 10.1001/jamapediatrics.2013.4784; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492; Zatzick D, 2013, ANN SURG, V257, P390, DOI 10.1097/SLA.0b013e31826bc313; Zatzick D, 2012, J SUBST ABUSE TREAT, V43, P410, DOI 10.1016/j.jsat.2012.08.009; Zatzick D, 2011, GEN HOSP PSYCHIAT, V33, P123, DOI 10.1016/j.genhosppsych.2011.01.001; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943; Zatzick DF, 2007, PSYCHIATRY, V70, P260, DOI 10.1521/psyc.2007.70.3.260; Zatzick DF, 2013, GEN HOSP PSYCHIAT, V35, P174, DOI 10.1016/j.genhosppsych.2012.11.012; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; Zatzick DF, 2009, PSYCHIATRY, V72, P346, DOI 10.1521/psyc.2009.72.4.346; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390; [No title captured]	152	27	27	2	22	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	APR 30	2016	11								58	10.1186/s13012-016-0424-4			16	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	DK7MO	WOS:000375110000001	27130272	Green Published, gold			2022-02-06	
J	Bogdanov, VB; Middleton, NA; Theriot, JJ; Parker, PD; Abdullah, OM; Ju, YS; Hartings, JA; Brennan, KC				Bogdanov, Volodymyr B.; Middleton, Natalie A.; Theriot, Jeremy J.; Parker, Patrick D.; Abdullah, Osama M.; Ju, Y. Sungtaek; Hartings, Jed A.; Brennan, K. C.			Susceptibility of Primary Sensory Cortex to Spreading Depolarizations	JOURNAL OF NEUROSCIENCE			English	Article						anoxic depolarization; cortical spreading depression; migraine; sensory cortex; traumatic brain injury	MOUSE BARREL CORTEX; CYTOCHROME-OXIDASE; CEREBRAL-CORTEX; VISUAL-CORTEX; MIGRAINE AURA; BRAIN TRAUMA; RAT-BRAIN; DEPRESSION; NEOCORTEX; SLICES	Spreading depolarizations (SDs) are recognized as actors in neurological disorders as diverse as migraine and traumatic brain injury (TBI). Migraine aura involves sensory percepts, suggesting that sensory cortices might be intrinsically susceptible to SDs. We used optical imaging, MRI, and field potential and potassium electrode recordings in mice and electrocorticographic recordings in humans to determine the susceptibility of different brain regions to SDs. Optical imaging experiments in mice under isoflurane anesthesia showed that both cortical spreading depression and terminal anoxic depolarization arose preferentially in the whisker barrel region of parietal sensory cortex. MRI recordings under isoflurane, ketamine/xylazine, ketamine/isoflurane, and urethane anesthesia demonstrated that the depolarizations did not propagate from a subcortical source. Potassium concentrations showed larger increases in sensory cortex, suggesting a mechanism of susceptibility. Sensory stimulation biased the timing but not the location of depolarization onset. In humans with TBI, there was a trend toward increased incidence of SDs in parietal/temporal sensory cortex compared with other regions. In conclusion, SDs are inducible preferentially in primary sensory cortex in mice and most likely in humans. This tropism can explain the predominant sensory phenomenology of migraine aura. It also demonstrates that sensory cortices are vulnerable in brain injury.	[Bogdanov, Volodymyr B.; Middleton, Natalie A.; Theriot, Jeremy J.; Parker, Patrick D.; Brennan, K. C.] Univ Utah, Dept Neurol, 383 Colorow Dr,Room 364, Salt Lake City, UT 84108 USA; [Abdullah, Osama M.] Univ Utah, Dept Bioengn & Small Anim Imaging, Salt Lake City, UT 84108 USA; [Parker, Patrick D.] Univ Utah, Interdept Program Neurosci, Salt Lake City, UT 84108 USA; [Ju, Y. Sungtaek] Univ Calif Los Angeles, Dept Mech & Aerosp Engn, Los Angeles, CA 90095 USA; [Hartings, Jed A.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45220 USA		Brennan, KC (corresponding author), Univ Utah, Dept Neurol, 383 Colorow Dr,Room 364, Salt Lake City, UT 84108 USA.	k.c.brennan@hsc.utah.edu	Bogdanov, Volodymyr/AAN-6209-2020	Brennan, K.C./0000-0003-4193-5841; Hartings, Jed/0000-0001-8583-3471; Bogdanov, Volodymyr/0000-0002-7107-1426; Ju, Y. Sungtaek/0000-0003-1238-8674; Parker, Patrick/0000-0001-5217-107X	International Headache Society; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 085413]; US Army Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Medical Research Program [PR100060, PR130373]; US Army Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Medical Research Program (Psychological Health/Traumatic Brain Injury Research Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS085413] Funding Source: NIH RePORTER	This work was supported by the International Headache Society (Research Fellowship to V.B.B.), the National Institutes of Health (Grant NS 085413), US Army Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Medical Research Program (Grants PR100060 and PR130373 to K.C.B. and Psychological Health/Traumatic Brain Injury Research Program Grant to J.A.H.). We thank David O. Okonkwo, Clemens Pahl, M. Ross Bullock, Bruce Mathern, and Norberto Andaluz (Co-Operative Study on Brain Injury Depolarizations) for contributing clinical data, and we thank the members of the Headache Physiology Laboratory for helpful discussions on experimental design, analysis, and review of the manuscript.	Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Bere Z, 2014, NEUROSCIENCE, V260, P217, DOI 10.1016/j.neuroscience.2013.12.032; Bergman T., 2011, FUNDAMENTALS HEAT MA; Cetas JS, 2009, NEUROSCIENCE, V163, P719, DOI 10.1016/j.neuroscience.2009.06.031; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; Collins CE, 2010, P NATL ACAD SCI USA, V107, P15927, DOI 10.1073/pnas.1010356107; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; de Crespigny A, 1998, J CEREBR BLOOD F MET, V18, P1008, DOI 10.1097/00004647-199809000-00010; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Eikermann-Haerter K, 2011, J NEUROSCI, V31, P5755, DOI 10.1523/JNEUROSCI.5346-10.2011; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Fujita S, 2016, CEREB CORTEX, V26, P1580, DOI 10.1093/cercor/bhu336; HARLEY CA, 1992, J COMP NEUROL, V322, P377, DOI 10.1002/cne.903220307; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; HEINEMANN U, 1977, BRAIN RES, V120, P231, DOI 10.1016/0006-8993(77)90903-9; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Herculano-Houzel S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00035; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; HEVNER RF, 1995, NEUROSCIENCE, V65, P313, DOI 10.1016/0306-4522(94)00514-6; HORTON JC, 1981, NATURE, V292, P762, DOI 10.1038/292762a0; Houades V, 2008, J NEUROSCI, V28, P5207, DOI 10.1523/JNEUROSCI.5100-07.2008; HUBEL DH, 1969, NATURE, V221, P747, DOI 10.1038/221747a0; Kaas JH, 2012, P NATL ACAD SCI USA, V109, P10655, DOI 10.1073/pnas.1201892109; Kelman L, 2004, CEPHALALGIA, V24, P728, DOI 10.1111/j.1468-2982.2004.00748.x; Lashley KS, 1941, ARCH NEURO PSYCHIATR, V46, P331, DOI 10.1001/archneurpsyc.1941.02280200137007; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lopez-Valdes HE, 2014, STROKE, V45, P2093, DOI 10.1161/STROKEAHA.113.004476; LOTHMAN E, 1975, BRAIN RES, V88, P15, DOI 10.1016/0006-8993(75)90943-9; MATSUURA T, 1971, EXP BRAIN RES, V12, P238, DOI 10.1007/BF00237916; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Periasamy N, 1998, BIOPHYS J, V75, P557, DOI 10.1016/S0006-3495(98)77545-9; Petzold GC, 2008, STROKE, V39, P1292, DOI 10.1161/STROKEAHA.107.500710; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Russell MB, 1996, BRAIN, V119, P355, DOI 10.1093/brain/119.2.355; Schott GD, 2007, BRAIN, V130, P1690, DOI 10.1093/brain/awl348; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; SUR M, 1981, SCIENCE, V212, P1059, DOI 10.1126/science.7233199; Tang YT, 2014, J NEUROPHYSIOL, V112, P2572, DOI 10.1152/jn.00205.2014; TOOTELL RBH, 1985, J NEUROSCI, V5, P2786; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Wang FS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002334; Wu JP, 2016, CEREB CORTEX, V26, P23, DOI 10.1093/cercor/bhu166; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	52	27	27	1	8	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	APR 27	2016	36	17					4733	4743		10.1523/JNEUROSCI.3694-15.2016			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK7UF	WOS:000375130500009	27122032	Green Published, Bronze			2022-02-06	
J	Cao, Y; Gao, Y; Xu, SY; Bao, JG; Lin, YY; Luo, XG; Wang, Y; Luo, QZ; Jiang, JY; Neale, JH; Zhong, CL				Cao, Yang; Gao, Yang; Xu, Siyi; Bao, Jingang; Lin, Yingying; Luo, Xingguang; Wang, Yong; Luo, Qizhong; Jiang, Jiyao; Neale, Joseph H.; Zhong, Chunlong			Glutamate carboxypeptidase II gene knockout attenuates oxidative stress and cortical apoptosis after traumatic brain injury	BMC NEUROSCIENCE			English	Article						NAAG; Glutamate carboxypeptidase II; Gene knockout; Traumatic brain injury; Oxidative stress; Apoptosis	NAAG PEPTIDASE INHIBITION; N-ACETYLASPARTYLGLUTAMATE; RECEPTORS; NEUROTOXICITY; ACTIVATION; NEUROTRANSMITTER; EXCITOTOXICITY; ASPARTATE; TOXICITY; RELEASE	Background: Glutamate carboxypeptidase II (GCPII) inactivates the peptide co-transmitter N-acetylaspartylglutamate following synaptic release. Inhibition of GCPII elevates extracellular levels of the peptide, inhibits glutamate release and is neuroprotective in an animal model of traumatic brain injury. GCPII gene knockout mice were used to examine the cellular mechanisms underlying the neuroprotective efficacy of this transmitter system. Results: Following controlled cortical impact injury, GCPII knockout (KO) mice exhibited reduced TUNEL-positive nuclei in the contusion margin of the cerebral cortex relative to wild type mice. Impact injury reduced glutathione levels and superoxide dismutase and glutathione peroxidase activities and increased malondialdehyde. Each of these effects was moderated in KO mice relative to wild type. Similarly, the injury-induced increases in cleaved caspase-3, cytosolic cytochrome c levels and Bcl-2/Bax ratio observed in wild type mice were attenuated in the knockout mice. Conclusions: These data support the hypothesis that the neuroprotective efficacy of GCPII KO in traumatic brain injury is mediated via a reduction in oxidative stress.	[Cao, Yang; Gao, Yang; Xu, Siyi; Bao, Jingang; Lin, Yingying; Wang, Yong; Luo, Qizhong; Jiang, Jiyao; Zhong, Chunlong] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Luo, Xingguang] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA; [Neale, Joseph H.] Georgetown Univ, Dept Biol, Washington, DC 20075 USA		Zhong, CL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, 160 Pujian Rd, Shanghai 200127, Peoples R China.	drchunlongzhong@126.com		, caoyang/0000-0002-3431-8231	Ministry of Science and Technology of ChinaMinistry of Science and Technology, China [2011CB013304]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571184, 81070990, 30670719, 30500525]; Shanghai Science and Technology CommissionShanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM) [15140902100, 10QH1401700, 09140901300]; Shanghai Municipal Education CommissionShanghai Municipal Education Commission (SHMEC) [09SG20]	This research was supported in part by a basic research program of project 973 by the Ministry of Science and Technology of China (2011CB013304), and by Grants from the National Natural Science Foundation of China (Nos. 81571184, 81070990, 30670719, 30500525), the Shanghai Science and Technology Commission (Nos. 15140902100, 10QH1401700, 09140901300) and the Shanghai Municipal Education Commission (No. 09SG20). JHN supported by an endowment and generous gifts from Nancy and Daniel Paduano.	Aronica E, 2003, EUR J NEUROSCI, V17, P2106, DOI 10.1046/j.1460-9568.2003.02657.x; Atlante A, 2001, FEBS LETT, V497, P1, DOI 10.1016/S0014-5793(01)02437-1; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Berent-Spillson A, 2007, J NEUROCHEM, V101, P342, DOI 10.1111/j.1471-4159.2006.04373.x; Budd SL, 1996, J NEUROCHEM, V67, P2282; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763, 10.1371/journal.pone.0050456]; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; D'Onofrio M, 2001, J NEUROCHEM, V78, P435, DOI 10.1046/j.1471-4159.2001.00435.x; Durand D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022235; Gao Y, 2015, J NEUROCHEM, V134, P340, DOI 10.1111/jnc.13123; Gogvadze V, 2006, CHEM-BIOL INTERACT, V163, P4, DOI 10.1016/j.cbi.2006.04.010; He YL, 2012, BRAIN RES, V1433, P127, DOI 10.1016/j.brainres.2011.11.027; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Ndountse LT, 2009, TOXICOL LETT, V184, P50, DOI 10.1016/j.toxlet.2008.10.013; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2011, J NEUROCHEM, V119, P891, DOI 10.1111/j.1471-4159.2011.07380.x; Neale JH, 2011, J NEUROCHEM, V118, P490, DOI 10.1111/j.1471-4159.2011.07338.x; Pereira CF, 2000, NEUROSCI RES, V37, P227, DOI 10.1016/S0168-0102(00)00124-3; Sanabria ERG, 2004, J NEUROPHYSIOL, V91, P182, DOI 10.1152/jn.00465.2003; SIMS NR, 1995, INT J BIOCHEM CELL B, V27, P531, DOI 10.1016/1357-2725(95)00026-L; Slomka M, 2008, FOLIA NEUROPATHOL, V46, P69; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Yamada T, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-67; Yao HH, 2005, J NEUROCHEM, V92, P948, DOI 10.1111/j.1471-4159.2004.02937.x; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhong CL, 2014, INT J NEUROSCI, V124, P867, DOI 10.3109/00207454.2014.890935; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266; Zhou F, 2006, J NEUROSCI RES, V84, P268, DOI 10.1002/jnr.20897; Zuo DY, 2012, J BIOL CHEM, V287, P21773, DOI 10.1074/jbc.M112.363226	33	27	27	4	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	APR 18	2016	17								15	10.1186/s12868-016-0251-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DJ9MN	WOS:000374537700002	27091009	Green Published, gold			2022-02-06	
J	Brooks, BL; Daya, H; Khan, S; Carlson, HL; Mikrogianakis, A; Barlow, KM				Brooks, Brian L.; Daya, Hussain; Khan, Samna; Carlson, Helen L.; Mikrogianakis, Angelo; Barlow, Karen M.			Cognition in the Emergency Department as a Predictor of Recovery after Pediatric Mild Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; Traumatic; Concussion; Mild; Cognition; Outcomes research; Child; Post-concussion syndrome	POSTCONCUSSION SYNDROME; CONCUSSION; SYMPTOMS; ADOLESCENTS; CHILDREN; OUTCOMES; SEVERITY	Cognitive abilities can be acutely disrupted in children and adolescents who sustain a mild traumatic brain injury (mTBI), with the potential that these disruptions may be predictive of recovery. The objective of this study was to determine if cognitive abilities in the emergency department (ED) can differentiate and predict poor symptom recovery following a pediatric mTBI. Participants included 77 male and female youth with a mTBI (mean age = 13.6; SD = 2.6). All participants completed computerized cognitive testing (four subtests from the CNS Vital Signs) when they presented to the ED. Symptom measurement occurred in the ED (for pre-injury), at 7-10 days, 1 month, 2 months, and 3 months post-mTBI using the post-concussion symptom inventory (PCSI). Recovery was determined using reliable change scores for symptom ratings from 28 orthopedic injury controls (mean age = 13.9 years; SD = 2.1). Significantly worse Reaction Time scores (i.e., rapid information processing) in the ED were found in those who remained symptomatic at 1 month. Performances on the Reaction Time and Cognitive Flexibility domain scores were predictive of symptom outcome at 1 month for youth (above and beyond sex and baseline symptom burden). Youth with low scores on Reaction Time and/or Cognitive Flexibility were nearly 15 times (95%CI = 1.8-323.5) more likely to remain symptomatic at 1 month post-mTBI. No significant group differences were found at 7-10 days, 2 months, or 3 months post-injury. Rapid computerized cognitive testing in the ED following a mTBI may help clinicians predict which youth may or may not remain symptomatic at follow-up.	[Brooks, Brian L.; Carlson, Helen L.; Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Neurosci Brain Injury & Vi Riddell Rehabil Progra, Calgary, AB T3B 6A8, Canada; [Brooks, Brian L.; Mikrogianakis, Angelo; Barlow, Karen M.] Univ Calgary, Dept Paediat, Cumming Sch Med, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.; Mikrogianakis, Angelo; Barlow, Karen M.] Univ Calgary, Dept Clin Neurosci, Cumming Sch Med, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Fac Arts, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Brooks, Brian L.; Carlson, Helen L.; Mikrogianakis, Angelo; Barlow, Karen M.] Univ Calgary, Alberta Childrens Hosp, Res Inst Child & Maternal Hlth, Calgary, AB, Canada; [Daya, Hussain] Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada; [Khan, Samna] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada; [Mikrogianakis, Angelo] Alberta Childrens Prov Gen Hosp, Sect Emergency Med, Calgary, AB T3B 6A8, Canada		Brooks, BL (corresponding author), Alberta Childrens Prov Gen Hosp, Neurosci Program, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	brian.brooks@albertahealthservices.ca	Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014; Mikrogianakis, Angelo/AAW-5929-2021; Meijer, Anna/K-5118-2016	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Mikrogianakis, Angelo/0000-0002-8854-0620; Carlson, Helen/0000-0002-5788-0542	Pediatric Brain Injury Research Program; Canadian Institutes of Health Research training programCanadian Institutes of Health Research (CIHR); McCarthy Tetrault Award	Funding for this study was provided by: the Pediatric Brain Injury Research Program (administered by the Alberta Children's Hospital Research Institute) awarded to Drs. Barlow and Brooks; summer studentships from the Canadian Institutes of Health Research training program (administered by the Alberta Children's Hospital Research Institute; the McCarthy Tetrault Award (administered by the Alberta Children's Hospital Research Institute) awarded to Dr. Brooks; in-kind test credits from the computerized test publisher (CNS Vital Signs); and in-kind support from the neurosciences program at Alberta Children's Hospital (Conny Betuzzi). None of the funding sources were involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	*AM ASS AUT MED, 1990, ABBR INJ SCAL AIS 19; [Anonymous], 2010, IBM SPSS STAT WIND V; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Brooks BL, 2012, J CHILD NEUROL, V27, P982, DOI 10.1177/0883073811430863; Brooks BL, 2011, J CHILD NEUROL, V26, P786, DOI 10.1177/0883073810391532; Brooks BL, 2010, APPL NEUROPSYCHOL, V17, P37, DOI 10.1080/09084280903526083; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2011, NONF TRAUM BRAIN INJ; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Haring RS, 2015, BRAIN INJURY, V29, P989, DOI 10.3109/02699052.2015.1033014; Iverson G, 2007, CLIN J SPORT MED, V17, P31; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Khetani A, 2014, BRAIN INJURY, V28, P844; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; R Core Team, 2012, R LANG ENV STAT COMP; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Therneau T. M., 2014, INTRO RECURSIVE PART; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	47	27	27	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2016	22	4					379	387		10.1017/S1355617715001368			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	DI1ZK	WOS:000373295300001	26786357				2022-02-06	
J	Ko, A; Harada, MY; Barmparas, G; Thomsen, GM; Alban, RF; Bloom, MB; Chung, R; Melo, N; Margulies, DR; Ley, EJ				Ko, Ara; Harada, Megan Y.; Barmparas, Galinos; Thomsen, Gretchen M.; Alban, Rodrigo F.; Bloom, Matthew B.; Chung, Rex; Melo, Nicolas; Margulies, Daniel R.; Ley, Eric J.			Early propranolol after traumatic brain injury is associated with lower mortality	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; propranolol; -blockers; mortality	CEREBRAL PERFUSION; BETA-BLOCKADE; BLOCKERS; SURVIVAL	BACKGROUND -Adrenergic receptor blockers (BBs) administered after trauma blunt the cascade of immune and inflammatory changes associated with injury. BBs are associated with improved outcomes after traumatic brain injury (TBI). Propranolol may be an ideal BB because of its nonselective inhibition and ability to cross the blood-brain barrier. We determined if early administration of propranolol after TBI is associated with lower mortality. METHODS All adults (age 18 years) with moderate-to-severe TBI (head Abbreviated Injury Scale [AIS] score, 3-5) requiring intensive care unit (ICU) admission at a Level I trauma center from January 1, 2013, to May 31, 2015, were prospectively entered into a database. Administration of early propranolol was dosed within 24 hours of admission at 1 mg intravenous every 6 hours. Patients who received early propranolol after TBI (EPAT) were compared with those who did not (non-EPAT). Data including demographics, hospital length of stay (LOS), ICU LOS, and mortality were collected. RESULTS Over 29 months, 440 patients with moderate-to-severe TBI met inclusion criteria. Early propranolol was administered to 25% (109 of 440) of the patients. The EPAT cohort was younger (49.6 years vs. 60.4 years, p < 0.001), had lower Glasgow Coma Scale (GCS) score (11.7 vs. 12.4, p = 0.003), had lower head AIS score (3.6 vs. 3.9, p = 0.001), had higher admission heart rate (95.8 beats/min vs. 88.4 beats/min, p = 0.002), and required more days on the ventilator (5.9 days vs. 2.6 days, p < 0.001). Similarities were noted in sex, Injury Severity Score (ISS), admission systolic blood pressure, hospital LOS, ICU LOS, and mortality rate. Multivariate regression showed that EPAT was independently associated with lower mortality (adjusted odds ratio, 0.25; p = 0.012). CONCLUSION After adjusting for predictors of mortality, early administration of propranolol after TBI was associated with improved survival. Future studies are needed to identify additional benefits and optimal dosing regimens. LEVEL OF EVIDENCE Therapeutic study, level IV.	[Ko, Ara; Harada, Megan Y.; Barmparas, Galinos; Thomsen, Gretchen M.; Alban, Rodrigo F.; Bloom, Matthew B.; Chung, Rex; Melo, Nicolas; Margulies, Daniel R.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Suite 8215 N, Los Angeles, CA 90048 USA.	Eric.Ley@cshs.org	Barmparas, Galinos/L-6530-2019; Bloom, Matthew/E-5660-2013	Bloom, Matthew/0000-0001-8102-4394			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Bible LE, 2014, J TRAUMA ACUTE CARE, V77, P54, DOI 10.1097/TA.0000000000000264; Bukur M, 2012, J TRAUMA ACUTE CARE, V72, P1013, DOI 10.1097/TA.0b013e318241bc5b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; COLGAN FJ, 1983, CRIT CARE MED, V11, P368, DOI 10.1097/00003246-198305000-00010; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; CRUICKSHANK JM, 1987, LANCET, V2, P585, DOI 10.1016/s0140-6736(87)92984-9; Faul M, 2010, TRAUMATIC BRAIN INJU; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LIU MY, 1995, J FORMOS MED ASSOC, V94, P386; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Murry JS, 2016, J SURG RES, V200, P221, DOI 10.1016/j.jss.2015.06.045; NEILDWYER G, 1981, BRIT J CLIN PHARMACO, V11, P549, DOI 10.1111/j.1365-2125.1981.tb01169.x; ROSENBERG PA, 1988, J NEUROSCI, V8, P2887, DOI 10.1523/jneurosci.08-08-02887.1988; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; WALTER P, 1982, BRIT MED J, V284, P1661, DOI 10.1136/bmj.284.6330.1661; Zangbar B, 2016, J SURG RES, V200, P586, DOI 10.1016/j.jss.2015.08.020	26	27	27	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2016	80	4					637	642		10.1097/TA.0000000000000959			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DI1ED	WOS:000373237900016	26808028				2022-02-06	
J	Mollayeva, T; Pratt, B; Mollayeva, S; Shapiro, CM; Cassidy, JD; Colantonio, A				Mollayeva, Tatyana; Pratt, Brandy; Mollayeva, Shirin; Shapiro, Colin M.; Cassidy, J. David; Colantonio, Angela			The relationship between insomnia and disability in workers with mild traumatic brain injury/concussion Insomnia and disability in chronic mild traumatic brain injury	SLEEP MEDICINE			English	Article						Insomnia; Mild traumatic brain injury; Concussion; Work disability; Social disability; Family life disability	QUALITY-OF-LIFE; ASSESSING DEPRESSION; SLEEP DYSFUNCTION; SEX-DIFFERENCES; PANIC DISORDER; CHRONIC PAIN; FOLLOW-UP; HEALTH; POPULATION; SYMPTOMS	Aim/Background: The principal aim of this study was to, for the first time, examine the relationship between insomnia and perceived disability among workers with mild traumatic brain injury (mTBI)/concussion. Patients/Methods: A cross-sectional study was conducted at the Workplace Safety and Insurance Board Clinic of the largest rehabilitation teaching hospital in Canada. Data from questionnaires, insurer records and clinical investigations were analysed. The Insomnia Severity Index measured the primary independent variable, and the Sheehan Disability Scale measured disability outcomes, classified as 'mild/moderate' or 'marked/extreme'. Two-sided t-tests and Chi-squared tests were used for bivariate associations. A binomial logistic regression model was fit using previously identified variables. Results: The sample comprised 92 workers (45.1 +/- 9.9 years old, 61% male) with mTBI/concussion at median time 196 days after injury. When compared with workers reporting lower disability, workers with higher disability were found with more severe insomnia, depression, anxiety and pain. In the multivariable analysis, the odds of reporting higher global disability increased with increasing insomnia and pain [adjusted odds ratio (OR) 1.16 (95% CI 1.03-1.31) and 1.117 (95% CI 1.01-1.24), respectively]. Insomnia was the only significant covariate in a fully adjusted work disability model. None of the variables studied were statistically significant in the social and family life disability models. Conclusions: Greater attention should be given to the diagnosis and management of insomnia in persons with mTBI/concussion. (C) 2015 Elsevier B.V. All rights reserved.	[Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Fac Med, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Mollayeva, Tatyana] Univ Toronto, Collaborat Program Neurosci, Toronto, ON, Canada; [Mollayeva, Tatyana; Colantonio, Angela] Toronto Rehab Univ Hlth Network, Toronto, ON, Canada; [Pratt, Brandy; Cassidy, J. David] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada; [Mollayeva, Shirin; Shapiro, Colin M.] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada; [Mollayeva, Shirin; Colantonio, Angela] Univ Toronto, Aquired Brain Injury Res Lab, Toronto, ON, Canada; [Mollayeva, Shirin; Shapiro, Colin M.] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada; [Shapiro, Colin M.] Youthdale Child & Adolescent Sleep Clin, Toronto, ON, Canada; [Cassidy, J. David] Univ Hlth Network, Div Hlth Care & Outcomes Res, Toronto Western Res Inst, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Mollayeva, T (corresponding author), Toronto Rehabil Inst, 550 Univ Ave,Rm 11207, Toronto, ON M5G 2A2, Canada.	tatyana.mollayeva@utoronto.ca	, Mollayeva/A-4522-2018	Colantonio, Angela/0000-0003-2094-4765; Mollayeva, Tatyana/0000-0002-2787-1848	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Work Disability Prevention CIHR Strategic Training Program; CIHR Travel AwardsCanadian Institutes of Health Research (CIHR) [142525]; Canadian Institutes for Health Research Grant - Institute for Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	This study had no external funding source. The first author was supported by 2010/2011 Toronto Rehabilitation Institute Scholarship, the Ontario Graduate Scholarship 2012/2013 and the 2013/2015 Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health Research (CIHR), the 2014/2015 Work Disability Prevention CIHR Strategic Training Program and the CIHR Travel Awards (#142525). Angela Colantonio was supported by the Canadian Institutes for Health Research Grant - Institute for Gender and Health (#CGW-126580).	*AM PSYCH ASS, 2000, AM PSYCH ASS DIAGN S; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Brain Injury Association of America, BRAIN INJ; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; Cancelliere C, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-17; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cochiarella L, 2001, GUIDES EVALUATION PE; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Crain TL, 2014, J OCCUP HEALTH PSYCH, V19, P155, DOI 10.1037/a0036010; Crocker TF, 2015, J CLIN EPIDEMIOL, V68, P584, DOI 10.1016/j.jclinepi.2014.12.007; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Davis CG, 2013, J FORENSIC LEG MED, V20, P74, DOI 10.1016/j.jflm.2012.05.004; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Fuller-Iglesias HR, 2016, RES AGING, V38, P3, DOI 10.1177/0164027514568324; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Gamboa AM, 2006, NEUROREHABILITATION, V21, P327; Gutierrez-Rojas L, 2011, PSYCHIAT RES, V186, P254, DOI 10.1016/j.psychres.2010.06.020; He Yuxin, 2014, Glob Adv Health Med, V3, P35, DOI 10.7453/gahmj.2014.034; Himanen L, 2011, BRAIN INJURY, V25, P443, DOI 10.3109/02699052.2011.556580; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hou LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076087; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Jain A, 2014, ASIAN J PSYCHIATR, V8, P99, DOI 10.1016/j.ajp.2013.12.017; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kucharczyk Erica R, 2012, Sleep Med Rev, V16, P547, DOI 10.1016/j.smrv.2012.01.005; Lentino Cynthia V, 2013, US Army Med Dep J, P98; LEON AC, 1992, SOC PSYCH PSYCH EPID, V27, P78, DOI 10.1007/BF00788510; Li YH, 2013, J AM STAT ASSOC, V108, P1284, DOI 10.1080/01621459.2013.788980; LILLISTON BA, 1985, SOC WORK HEALTH CARE, V10, P1, DOI 10.1300/J010v10n04_01; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; Malfliet A, 2015, PAIN PRACT, V15, P757, DOI 10.1111/papr.12244; Maroon JC, 2014, PROG NEUROL SURG, V28, P1, DOI 10.1159/000358746; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McDougall J, 2014, DISABIL REHABIL, V36, P2143, DOI 10.3109/09638288.2014.892642; Mollayeva T, 2016, SLEEP MED, V19, P153, DOI 10.1016/j.sleep.2015.05.014; Mollayeva T, 2013, SLEEP MED, V14, P1235, DOI 10.1016/j.sleep.2013.07.009; Mollayeya T, 2013, SLEEP MED REV, V17, P411, DOI 10.1016/j.smrv.2013.02.001; Motor Accidents Authority of NSW (MAA NSW), 2008, GUID MILD TRAUM BRAI; O'Neill J, 2014, J CLIN EPIDEMIOL, V67, P56, DOI 10.1016/j.jclinepi.2013.08.005; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Paul P, 2013, STAT MED, V32, P67, DOI 10.1002/sim.5525; Paunio T, 2015, J AFFECT DISORDERS, V172, P381, DOI 10.1016/j.jad.2014.10.002; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Quatrano LA, 2011, ARCH PHYS MED REHAB, V92, pS7, DOI 10.1016/j.apmr.2010.08.032; Rubin HC, 2000, J AFFECT DISORDERS, V57, P217, DOI 10.1016/S0165-0327(99)00030-0; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Scalo J, 2015, QUAL LIFE RES, V24, P1223, DOI 10.1007/s11136-014-0842-1; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Shekleton JA, 2014, SLEEP, V37, P107, DOI 10.5665/sleep.3318; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Sivertsen B, 2014, J SLEEP RES, V23, P124, DOI 10.1111/jsr.12102; Statistics Canada, LAB FORC SURV EST LF; Statistics Canada, OCC CLASS; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Vellante F, 2013, CLIN TER, V164, P429, DOI 10.7417/CT.2013.1609; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	74	27	27	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	APR	2016	20						157	166		10.1016/j.sleep.2015.09.008			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DO8RO	WOS:000378051400028	26790723				2022-02-06	
J	Rush, B; Rousseau, J; Sekhon, MS; Griesdale, DE				Rush, Barret; Rousseau, Justin; Sekhon, Mypinder S.; Griesdale, Donald E.			Craniotomy Versus Craniectomy for Acute Traumatic Subdural Hematoma in the United States: A National Retrospective Cohort Analysis	WORLD NEUROSURGERY			English	Article						Acute traumatic subdural; Craniectomy; Craniotomy	AXONAL STRETCH INJURY; DECOMPRESSIVE CRANIECTOMY; BRAIN-INJURY; SURGICAL-MANAGEMENT; PROPENSITY SCORE; MORTALITY; OUTCOMES; AXOTOMY; EXAMPLE; ADULTS	OBJECTIVE: The optimal surgical management of acute traumatic subdural hematoma (ASDH) is controversial; both craniectomy and craniotomy are performed. The purpose of this study was to determine the current management of ASDH in the United States. METHODS: This retrospective cohort study used the Nationwide Inpatient Sample from the years 2006-2011 to examine patients with a primary diagnosis of ASDH. All patients >= 18 years old with a primary diagnosis of ASDH were included in the analysis. Patients with procedure codes for craniectomy and craniotomy were isolated from the database. Propensity score matching based on logistic regression was used to match craniotomy to craniectomy in a 1: 1 fashion. RESULTS: There were 47,911,414 hospitalizations analyzed. Of 60,435 patients with ASDH identified, 1763 underwent craniotomy and 177 underwent craniectomy. The average age of patients who underwent craniectomy was 49.5 years (SD 20.8) compared with an average age of 68.9 years (SD 17.1) of patients who underwent craniotomy (P < 0.0001). Hospital mortality was significantly higher in patients who underwent craniectomy (35.0% vs. 10.9%, P < 0.0001). Patients who underwent craniectomy had longer hospital stays compared with patients who underwent craniotomy (median duration 14.3 days [interquartile range 25] for craniectomy vs. 10.9 days [interquartile range 9] for craniotomy, P < 0.0001). Patients who underwent craniectomy were also more likely to be discharged to a skilled nursing or rehabilitation facility (79.1% vs. 63.9%, P = 0.0011). CONCLUSIONS: Craniotomy is the preferred surgical technique for management of ASDH in the United States, being performed 10 times more frequently than craniectomy. Craniectomy was associated with significantly higher in hospital mortality after propensity score matched analysis.	[Rush, Barret; Sekhon, Mypinder S.; Griesdale, Donald E.] Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC V5Z 1M9, Canada; [Rush, Barret] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Rousseau, Justin] Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA USA; [Rousseau, Justin] Brigham & Womens Hosp, Ctr Evidence Based Imaging, 75 Francis St, Boston, MA 02115 USA; [Griesdale, Donald E.] Univ British Columbia, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Griesdale, Donald E.] Vancouver Coastal Hlth Res Inst, Ctr Clin Epidemiol & Evaluat, Vancouver, BC, Canada		Rush, B (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Med, Div Crit Care Med, Vancouver, BC V5Z 1M9, Canada.; Rush, B (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	bar890@mail.harvard.edu	Griesdale, Donald/AAT-7762-2021; Rousseau, Justin/ABG-4164-2021	Griesdale, Donald/0000-0001-5985-8624; Rousseau, Justin/0000-0002-2817-9124; Rush, Barret/0000-0001-9201-8352	National Library of MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007092]; VGH & UBC Hospital Foundation Best of Health Fund; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007092] Funding Source: NIH RePORTER	This study was funded in part by the National Library of Medicine Grant No. T15LM007092. D.G. is funded by the VGH & UBC Hospital Foundation Best of Health Fund. The remaining authors have no conflicts to report.	Averill Richard F, 2002, J AHIMA, V73, P46; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Cepeda MS, 2003, AM J EPIDEMIOL, V158, P280, DOI 10.1093/aje/kwg115; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faul M, 2010, TRAUMATIC BRAIN INJU; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Kolias AG, 2013, ACTA NEUROCHIR, V155, P187, DOI 10.1007/s00701-012-1531-x; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Marion DW, 2006, NEUROSURGERY, V58, P655; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; PATERNITI S, 1994, ACTA NEUROCHIR, V131, P207, DOI 10.1007/BF01808614; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Ryan CG, 2012, J TRAUMA ACUTE CARE, V73, P1348, DOI 10.1097/TA.0b013e31826fcb30; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Seeger JD, 2007, MED CARE, V45, pS143, DOI 10.1097/MLR.0b013e318074ce79; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Walcott BP, 2014, J CLIN NEUROSCI, V21, P2107, DOI 10.1016/j.jocn.2014.05.016; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019	31	27	27	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						25	31		10.1016/j.wneu.2015.12.034			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700006	26748175	Green Accepted			2022-02-06	
J	Wang, YN; Liu, Z; Li, Z; Shi, HN; Kang, YJ; Wang, JF; Huang, JQ; Jiang, L				Wang, Yanni; Liu, Zhe; Li, Zhen; Shi, Haina; Kang, Yujun; Wang, Jianfu; Huang, Jinqiang; Jiang, Li			Effects of heat stress on respiratory burst, oxidative damage and SERPINH1 (HSP47) mRNA expression in rainbow trout Oncorhynchus mykiss	FISH PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Heat stress; Respiratory burst; Oxidative stress; SERPINH1 (HSP47) expression; Oncorhynchus mykiss	SHOCK-PROTEIN EXPRESSION; HSP70 GENE-EXPRESSION; THERMAL TOLERANCE; ACCLIMATION TEMPERATURE; SUPEROXIDE-DISMUTASE; MOLECULAR CHAPERONE; OXYGEN LIMITATION; WATER TEMPERATURE; CLIMATE-CHANGE; TISSUE	For rainbow trout Oncorhynchus mykiss, high temperature is a major abiotic stress that limits its growth and productivity. In this study, spleen macrophage respiratory burst (RB), serum superoxide dismutase (SOD), serum malondialdehyde (MDA) and mRNA expression of the SERPINH1 (HSP47) gene in different tissues (liver, spleen, head kidney and heart) were measured in unstressed (18 A degrees C) and heat-stressed (25 A degrees C) fish. Spleen macrophage RB activity, serum SOD activity and MDA content all increased significantly (P < 0.05) during heat shock, and peaked at 8, 12 and 4 h, respectively. SERPINH1 mRNA expression responded in a time- and tissue-specific manner to heat stress, which was mainly reflected in the significant up-regulation in all tissues (P < 0.05) and greater expression in the liver than the other tissues (P < 0.05). During the heat-shock recovery period, the MDA content returned to the unstressed level. These results indicate that heat shock causes cell injury, induces oxidative damage and promotes SERPINH1 mRNA expression, which plays an important protective function during heat stress in O. mykiss. In practice, close attention should be given to temperature changes in O. mykiss production to reduce the effects of high temperature.	[Wang, Yanni; Liu, Zhe; Li, Zhen; Shi, Haina; Kang, Yujun; Wang, Jianfu; Huang, Jinqiang] Gansu Agr Univ, Coll Anim Sci & Technol, 1 Yingmencun, Lanzhou 730070, Gansu, Peoples R China; [Jiang, Li] Chinese Acad Fishery Sci, 150 Nanqingtacun, Beijing 100039, Peoples R China		Liu, Z (corresponding author), Gansu Agr Univ, Coll Anim Sci & Technol, 1 Yingmencun, Lanzhou 730070, Gansu, Peoples R China.	liuz@gsau.edu.cn	Kang, Yujun/F-2708-2010	Kang, Yujun/0000-0001-9696-5242	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31460687]; Fundamental Research Funds for the University of Gansu Province	This research was supported by the National Natural Science Foundation of China (No. 31460687) and the Fundamental Research Funds for the University of Gansu Province. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.	Amenomori M, 2010, RESP MED, V104, P895, DOI 10.1016/j.rmed.2010.01.011; Bagnyukova TV, 2007, J THERM BIOL, V32, P255, DOI 10.1016/j.jtherbio.2007.01.014; Bahrndorff S, 2009, FUNCT ECOL, V23, P233, DOI 10.1111/j.1365-2435.2009.01541.x; BANNISTER JV, 1987, CRC CR REV BIOCH MOL, V22, P111, DOI 10.3109/10409238709083738; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Burrells C, 1999, VET IMMUNOL IMMUNOP, V72, P277, DOI 10.1016/S0165-2427(99)00143-9; Cui YT, 2014, FISH PHYSIOL BIOCHEM, V40, P721, DOI 10.1007/s10695-013-9879-2; Currie S, 2000, J FISH BIOL, V56, P398, DOI 10.1111/j.1095-8649.2000.tb02114.x; DYER SD, 1991, CAN J ZOOL, V69, P2021, DOI 10.1139/z91-282; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Hamdoun AM, 2003, BIOL BULL-US, V205, P160, DOI 10.2307/1543236; Hidalgo MC, 2002, INT J BIOCHEM CELL B, V34, P183, DOI 10.1016/S1357-2725(01)00105-4; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Hochachka PW., 2002, BIOCH ADAPTATION MEC; Hofmann GE, 1999, AM ZOOL, V39, P889; HOKANSON KEF, 1977, J FISH RES BOARD CAN, V34, P639, DOI 10.1139/f77-100; Hori TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-72; Huber K, 2006, PROTOPLASMA, V229, P221, DOI 10.1007/s00709-006-0206-y; Kassahn KS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-358; Keefer ML, 2009, CAN J FISH AQUAT SCI, V66, P1734, DOI 10.1139/F09-131; Lele Z, 1997, DEV GENET, V21, P123, DOI 10.1002/(SICI)1520-6408(1997)21:2<123::AID-DVG2>3.3.CO;2-K; Lesser MP, 2004, COMP BIOCHEM PHYS A, V137, P495, DOI 10.1016/j.cbpb.2003.10.022; Li Da-Peng, 2008, Acta Hydrobiologica Sinica, V32, P327, DOI 10.3724/SP.J.1035.2008.00327; Lushchak VI, 2006, COMP BIOCHEM PHYS C, V143, P36, DOI 10.1016/j.cbpc.2005.11.018; Manchado M, 2008, GENE, V416, P77, DOI 10.1016/j.gene.2008.03.007; Mancino R, 2011, MOL VIS, V17, P1298; Matthews KR, 1997, J FISH BIOL, V50, P50, DOI 10.1111/j.1095-8649.1997.tb01339.x; Ming JH, 2010, FISH SHELLFISH IMMUN, V28, P407, DOI 10.1016/j.fsi.2009.11.018; Nagata K, 1996, TRENDS BIOCHEM SCI, V21, P23, DOI 10.1016/0968-0004(96)80881-4; Nagata K, 1998, MATRIX BIOL, V16, P379, DOI 10.1016/S0945-053X(98)90011-7; Nielsen F, 1997, CLIN CHEM, V43, P1209; Nikoskelainen S, 2004, DEV COMP IMMUNOL, V28, P581, DOI 10.1016/j.dci.2003.10.003; Ojima N, 2005, BIOCHEM BIOPH RES CO, V329, P51, DOI 10.1016/j.bbrc.2005.01.097; Parihar MS, 1997, J THERM BIOL, V22, P151, DOI 10.1016/S0306-4565(97)00006-5; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Patel S, 2009, FISH SHELLFISH IMMUN, V26, P385, DOI 10.1016/j.fsi.2008.11.018; Pearson DS, 1996, DNA CELL BIOL, V15, P263, DOI 10.1089/dna.1996.15.263; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Ranford J C, 2000, Expert Rev Mol Med, V2, P1, DOI 10.1017/S1462399400002015; Rebl A, 2013, MAR BIOTECHNOL, V15, P445, DOI 10.1007/s10126-013-9501-8; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Schmidt H, 1998, BIOL CHEM, V379, P1227, DOI 10.1515/bchm.1998.379.10.1227; Secombes C.J., 1990, TECH FISH IMMUNOL, V1, P137; Shi HN, 2015, GENET MOL RES, V14, P5280, DOI 10.4238/2015.May.18.20; Smith TR, 1999, FISH PHYSIOL BIOCHEM, V20, P279, DOI 10.1023/A:1007743329892; Tang Y, 2010, SHONG YI YAO, V50, P117, DOI DOI 10.3969/J.ISSN.1002-266X.2010.49.078; Taylor JF, 2007, GEN COMP ENDOCR, V152, P314, DOI 10.1016/j.ygcen.2007.02.029; Tian ZhaoHui, 2013, Acta Hydrobiologica Sinica, V37, P344; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Varfolomeeva EY, 2010, B EXP BIOL MED+, V149, P485, DOI 10.1007/s10517-010-0976-2; Wang YB, 2007, COMP BIOCHEM PHYS A, V148, P821, DOI 10.1016/j.cbpa.2007.08.009; Wood LA, 1999, COMP BIOCHEM PHYS A, V123, P35, DOI 10.1016/S1095-6433(99)00035-5; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; Zhang ChongYing, 2012, Journal of Fisheries of China, V36, P336	55	27	34	3	37	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-1742	1573-5168		FISH PHYSIOL BIOCHEM	Fish Physiol. Biochem.	APR	2016	42	2					701	710		10.1007/s10695-015-0170-6			10	Biochemistry & Molecular Biology; Fisheries; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Fisheries; Physiology	DH7GU	WOS:000372961400025	26614500				2022-02-06	
J	Rich, MC; Keene, CN; Neher, MD; Johnson, K; Yu, ZX; Ganivet, A; Holers, VM; Stahel, PF				Rich, Megan C.; Keene, Chesleigh N.; Neher, Miriam D.; Johnson, Krista; Yu, Zhao-Xue; Ganivet, Antoine; Holers, V. Michael; Stahel, Philip F.			Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Neuroinflammation; Site-targeted complement inhibition; CR2-conjugated pharmacological compounds; Secondary brain injury	CLOSED-HEAD INJURY; MEMBRANE ATTACK COMPLEX; ALTERNATIVE PATHWAY; MICE LACKING; FACTOR-B; ACTIVATION; SYSTEM; C3; INFLAMMATION; IMMUNITY	Intracerebral complement activation after severe traumatic brain injury (TBI) leads to a cascade of neuroinflammatory pathological sequelae that propagate host-mediated secondary brain injury and adverse outcomes. There are currently no specific pharmacological agents on the market to prevent or mitigate the development of secondary cerebral insults after TBI. A novel chimeric CR2-fH compound (mTT30) provides targeted inhibition of the alternative complement pathway at the site of tissue injury. This experimental study was designed to test the neuroprotective effects of mTT30 in a mouse model of closed head injury. The administration of 500 mu g mTT30 i.v. at 1 h, 4 h and 24 h after head injury attenuated complement C3 deposition in injured brains, reduced the extent of neuronal cell death, and decreased post-injury microglial activation, compared to vehicle-injected placebo controls. These data imply that site-targeted alternative pathway complement inhibition may represent a new promising therapeutic avenue for the future management of severe TBI. (C) 2016 Published by Elsevier Ireland Ltd.	[Rich, Megan C.; Keene, Chesleigh N.; Neher, Miriam D.; Ganivet, Antoine; Stahel, Philip F.] Denver Hlth Med Ctr, Dept Orthopaed Surg, Denver, CO 80204 USA; [Rich, Megan C.; Keene, Chesleigh N.; Neher, Miriam D.; Ganivet, Antoine; Stahel, Philip F.] Univ Colorado, Sch Med, 777 Bannock St, Denver, CO 80204 USA; [Johnson, Krista; Yu, Zhao-Xue] Alex Pharmaceut, Cheshire, CT 06410 USA; [Holers, V. Michael] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Holers, V. Michael] Univ Colorado, Sch Med, Dept Immunol, Aurora, CO 80045 USA; [Stahel, Philip F.] Univ Colorado, Sch Med, Dept Neurosurg, 777 Bannock St, Denver, CO 80204 USA; [Stahel, Philip F.] Univ Colorado, Sch Med, Denver Hlth Med Ctr, Dept Orthopaed Surg, 777 Bannock St, Denver, CO 80204 USA; [Stahel, Philip F.] Univ Colorado, Sch Med, Denver Hlth Med Ctr, Dept Neurosurg, 777 Bannock St, Denver, CO 80204 USA		Stahel, PF (corresponding author), Univ Colorado, Sch Med, Dept Neurosurg, 777 Bannock St, Denver, CO 80204 USA.; Stahel, PF (corresponding author), Univ Colorado, Sch Med, Denver Hlth Med Ctr, Dept Orthopaed Surg, 777 Bannock St, Denver, CO 80204 USA.; Stahel, PF (corresponding author), Univ Colorado, Sch Med, Denver Hlth Med Ctr, Dept Neurosurg, 777 Bannock St, Denver, CO 80204 USA.	philip.stahel@dhha.org			Colorado Traumatic Brain Injury Trust Fund	This study was supported by a project grant from the Colorado Traumatic Brain Injury Trust Fund to P.F.S.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Bellander BM, 2010, EXP BRAIN RES, V205, P103, DOI 10.1007/s00221-010-2342-z; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Elvington A, 2012, J IMMUNOL, V189, P4640, DOI 10.4049/jimmunol.1201904; Elvington M, 2015, CLIN EXP IMMUNOL, V179, P500, DOI 10.1111/cei.12464; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Gasque P, 1996, J IMMUNOL, V156, P2247; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Holers V.M., 2015, IMMUNOBIOLOGY; Holers VM, 2007, MOL IMMUNOL, V44, P64, DOI 10.1016/j.molimm.2006.07.003; Holers VM, 2013, ADV EXP MED BIOL, V735, P137, DOI 10.1007/978-1-4614-4118-2_9; Hu XZ, 2012, NEUROSCI LETT, V531, P35, DOI 10.1016/j.neulet.2012.10.012; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; KACZOROWSKI SL, 1995, J CEREBR BLOOD F MET, V15, P860, DOI 10.1038/jcbfm.1995.107; Keeling KL, 2000, J NEUROIMMUNOL, V105, P20, DOI 10.1016/S0165-5728(00)00183-1; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Nataf S, 1999, TRENDS NEUROSCI, V22, P397, DOI 10.1016/S0166-2236(98)01390-3; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2000, J NEUROIMMUNOL, V109, P164, DOI 10.1016/S0165-5728(00)00304-0; Stahel Philip F, 2006, Expert Rev Clin Immunol, V2, P445, DOI 10.1586/1744666X.2.3.445; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Woodruff TM, 2010, NEUROMOL MED, V12, P179, DOI 10.1007/s12017-009-8085-y	37	27	27	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAR 23	2016	617						188	194		10.1016/j.neulet.2016.02.025			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI5LB	WOS:000373539400032	26892188				2022-02-06	
J	Young, AMH; Donnelly, J; Czosnyka, M; Jalloh, I; Liu, XY; Aries, MJ; Fernandes, HM; Garnett, MR; Smielewski, P; Hutchinson, PJ; Agrawal, S				Young, Adam M. H.; Donnelly, Joseph; Czosnyka, Marek; Jalloh, Ibrahim; Liu, Xiuyun; Aries, Marcel J.; Fernandes, Helen M.; Garnett, Matthew R.; Smielewski, Peter; Hutchinson, Peter J.; Agrawal, Shruti			Continuous Multimodality Monitoring in Children after Traumatic Brain Injury-Preliminary Experience	PLOS ONE			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; BLOOD-FLOW; REACTIVITY	Introduction Multimodality monitoring is regularly employed in adult traumatic brain injury (TBI) patients where it provides physiologic and therapeutic insight into this heterogeneous condition. Pediatric studies are less frequent. Methods An analysis of data collected prospectively from 12 pediatric TBI patients admitted to Addenbrooke's Hospital, Pediatric Intensive Care Unit (PICU) between August 2012 and December 2014 was performed. Patients' intracranial pressure (ICP), mean arterial pressure (MAP), and cerebral perfusion pressure (CPP) were monitored continuously using brain monitoring software ICM+(R)) Pressure reactivity index (PRx) and 'Optimal CPP' (CPPopt) were calculated. Patient outcome was dichotomized into survivors and non-survivors. Results At 6 months 8/12 (66%) of the cohort survived the TBI. The median (+/- IQR) ICP was significantly lower in survivors 13.1 +/- 3.2 mm Hg compared to non-survivors 21.6 +/- 42.9 mm Hg (p = 0.003). The median time spent with ICP over 20 mm Hg was lower in survivors (9.7+ 9.8% vs 60.5 + 67.4% in non-survivors; p = 0.003). Although there was no evidence that CPP was different between survival groups, the time spent with a CPP close (within 10 mm Hg) to the optimal CPP was significantly longer in survivors (90.7 +/- 12.6%) compared with non-survivors (70.6 +/- 21.8%; p = 0.02). PRx provided significant outcome separation with median PRx in survivors being 0.02 +/- 0.19 compared to 0.39 +/- 0.62 in non-survivors (p = 0.02). Conclusion Our observations provide evidence that multi-modality monitoring may be useful in pediatric TBI with ICP, deviation of CPP from CPPopt, and PRx correlating with patient outcome.	[Young, Adam M. H.; Donnelly, Joseph; Czosnyka, Marek; Jalloh, Ibrahim; Liu, Xiuyun; Aries, Marcel J.; Fernandes, Helen M.; Garnett, Matthew R.; Smielewski, Peter; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Acad Neurosurg, Cambridge CB2 2QQ, England; [Agrawal, Shruti] Univ Cambridge, Addenbrookes Hosp, Dept Pediat Intens Care, Cambridge CB2 2QQ, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Aries, Marcel J.] Univ Groningen, Univ Med Ctr Groningen, Dept Intens Care, NL-9700 AB Groningen, Netherlands		Young, AMH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Acad Neurosurg, Cambridge CB2 2QQ, England.	ay276@cam.ac.uk	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018; Liu, Xiuyun/V-4427-2017	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Liu, Xiuyun/0000-0001-9540-4865; Smielewski, Peter/0000-0001-5096-3938	Medical Research Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986 ID79068, G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge; Peter J Hutchinson NIHR Research Professorship; Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; NIHR Cambridge BRC; Woolf Fisher Scholarship; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, ACF-2014-14-005, 12/35/57] Funding Source: researchfish	The authors gratefully acknowledge financial support as follows: Research support: the Medical Research Council (MRC, Grant Nos. G0600986 ID79068 and G1002277 ID98489) and the National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: Peter J Hutchinson NIHR Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and NIHR Cambridge BRC. Joseph Donnelly is supported by a Woolf Fisher Scholarship. MC-NIHR BRC. PS and MC have a financial interest in a part of the licensing fee for ICM+, a software licensed by Cambridge Enterprise Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Carlson JN, 2015, PEDIAT CRIT CARE MED; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2015, EXPERT REV NEUROTHER, V15, P169, DOI 10.1586/14737175.2015.996552; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Faul M, 2010, TRAUMATIC BRAIN INJU; GUILLAUME J, 1951, REV NEUROL, V84, P131; Haubrich C, 2015, MED ENG PHYS, V37, P175, DOI 10.1016/j.medengphy.2014.11.009; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Lang E W, 1995, New Horiz, V3, P400; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; MRC CRASH Trial Collaborators, 2008, BMJ-BRIT MED J, P336; Nordstrom C-H, 2013, CRIT CARE MED, V41, pe3; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Paulson O. B., 1990, BRAIN METAB REV, V2, P161; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Roux P Le, 2015, NEUROCRIT CARE; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165	24	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2016	11	3							e0148817	10.1371/journal.pone.0148817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1VK	WOS:000372572800013	26978532	Green Published, Green Submitted, gold			2022-02-06	
J	Kamper, JE; Garofano, J; Schwartz, DJ; Silva, MA; Zeitzer, J; Modarres, M; Barnett, SD; Nakase-Richardson, R				Kamper, Joel E.; Garofano, Jeffrey; Schwartz, Daniel J.; Silva, Marc A.; Zeitzer, Jamie; Modarres, Mo; Barnett, Scott D.; Nakase-Richardson, Risa			Concordance of Actigraphy With Polysomnography in Traumatic Brain Injury Neurorehabilitation Admissions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						rehabilitation; head injury; traumatic brain injury; actigraphy; polysomnography; sleep	MODIFIED ASHWORTH SCALE; SLEEP-APNEA; RELIABILITY; DISORDERS; REHABILITATION; CONSCIOUSNESS; PREVALENCE; SPASTICITY; VETERANS; COMA	Objective: To examine concordance of accelerometer-based actigraphy (ACG) with polysomnography (PSG) in the determination of sleep states in inpatients with traumatic brain injury (TBI), and examine the impact of injury severity and comorbid conditions (spasticity, apnea) on concordance. Participants: This was a convenience sample of 50 participants with primarily severe TBI. Design: This was a retrospective chart review of concurrent administration of PSG with ACG in nonconsecutive rehabilitation admissions with TBI. Main Measures: Total sleep time and sleep efficiency were measured by PSG and ACG. Results: Moderate to strong correlations between ACG and PSG were observed for total sleep time (r = 0.78, P < .01) and sleep efficiency (r = 0.66, P < .01). PSG and ACG estimates of total sleep time (316 minutes vs 325 minutes, respectively) and sleep efficiency (78% vs 77%, respectively) were statistically indistinguishable. Conclusions: Actigraphy is a valid proxy for monitoring of sleep in this population across injury severity and common comorbidity groups. However, further research with larger sample sizes to examine concordance in patients with TBI with disorder of consciousness and spasticity is recommended.	[Kamper, Joel E.; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Tampa, FL 33612 USA; [Schwartz, Daniel J.] James A Haley Vet Hosp, Med, Tampa, FL 33612 USA; [Barnett, Scott D.] James A Haley Vet Hosp, Res, Tampa, FL 33612 USA; [Garofano, Jeffrey] Univ S Florida, Dept Psychol & Social Fdn, Tampa, FL USA; [Schwartz, Daniel J.; Nakase-Richardson, Risa] Univ S Florida, Dept Med, Tampa, FL USA; [Zeitzer, Jamie] Stanford Univ, Stanford Ctr Sleep Sci & Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Zeitzer, Jamie] VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Palo Alto, CA USA; [Modarres, Mo] North Florida South Georgia Vet Hlth Syst, Brain Rehabil Res Ctr, Gainesville, FL USA; [Nakase-Richardson, Risa] HSR&D Ctr Innovat Disabil Rehabil & Res, Tampa, FL USA; [Silva, Marc A.; Nakase-Richardson, Risa] Def & Vet Brain Injury Ctr, Silver Spring, MD USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Risa.Richardson@va.gov	Kamper, Joel/V-2450-2019; Zeitzer, Jamie/AAO-2103-2020; Silva, Marc A./J-1874-2019; Zeitzer, Jamie M/A-1168-2007	Kamper, Joel/0000-0001-5098-5176; Zeitzer, Jamie/0000-0001-6174-5282; Silva, Marc A./0000-0002-3879-6054; Zeitzer, Jamie M/0000-0001-6174-5282	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U.S. Department of Veterans Affairs [W91YTZ-13-C-0015, I50 HX001233-01, W81XWH-13-2-0095]; General Dynamics Health Solutions from U.S. Department of Defense Congressionally Directed Medical Research Programs	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U.S. Department of Veterans Affairs grants (1 I50 HX001233-01, W81XWH-13-2-0095), and U.S. Department of Defense Congressionally Directed Medical Research Programs.	Allison SC, 1996, INT J REHABIL RES, V19, P67, DOI 10.1097/00004356-199603000-00007; ALLISON SC, 1995, J NEUROL, V242, P699, DOI 10.1007/BF00866923; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Baker FC, 1999, J PSYCHOSOM RES, V47, P335, DOI 10.1016/S0022-3999(99)00017-3; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cologan V, 2013, J NEUROTRAUM, V30, P339, DOI 10.1089/neu.2012.2654; Cruse D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-18; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; EDINGER JD, 1995, SLEEP, V18, P232, DOI 10.1093/sleep/18.4.232; Fischer J, 1997, RESPIRATION, V64, P39; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hagen C, 1979, REHABILITATION HEAD, P87; Holcomb E, 2016, EFFECTS SLEEP WAKE C, V31, P108; Holcomb E, 2015, J HEAD TRAU IN PRESS; IOM, 2006, SLEEP DISORDERS SLEE; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Madsen MT, 2013, J CLIN SLEEP MED, V9, P387, DOI 10.5664/jcsm.2598; Maglione JE, 2013, SLEEP, V36, P1209, DOI 10.5665/sleep.2888; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Martin JL, 2011, CHEST, V139, P1514, DOI 10.1378/chest.10-1872; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mccall C, 2012, J SLEEP RES, V21, P122, DOI 10.1111/j.1365-2869.2011.00917.x; Mehrholz J, 2005, CLIN REHABIL, V19, P751, DOI 10.1191/0269215505cr889oa; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Okifuji A, 2011, CLIN J PAIN, V27, P289, DOI 10.1097/AJP.0b013e31820485db; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Richardson A, 2007, J CLIN NURS, V16, P1660, DOI 10.1111/j.1365-2702.2005.01546.x; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Vallieres A, 2003, SLEEP, V26, P902, DOI 10.1093/sleep/26.7.902; van de Water ATM, 2011, J SLEEP RES, V20, P183, DOI 10.1111/j.1365-2869.2009.00814.x; Vaughn BV, 2015, AASM MANUAL SCORING; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	50	27	27	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		117	125		10.1097/HTR.0000000000000215			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NO	WOS:000372981100005	26959665				2022-02-06	
J	de Almeida, CER; de Sousa, JL; Dourado, JC; Gontijo, PAM; Dellaretti, MA; Costa, BS				Romeu de Almeida, Carlos Eduardo; de Sousa Filho, Jose Lopes; Dourado, Jules Carlos; Magalhaes Gontijo, Pollyana Anicio; Dellaretti, Marcos Antonio; Costa, Bruno Silva			Traumatic Brain Injury Epidemiology in Brazil	WORLD NEUROSURGERY			English	Article						Economics; Epidemiology; Head trauma; Prevention and control	HEAD-INJURY; MORTALITY; MORBIDITY; CITY	BACKGROUND: Traumatic brain injury (TBI) stands out as a grave social and economic problem. Emerging countries possess few epidemiologic studies on the range and impact of TBI. OBJECTIVE: Our study aimed to characterize the demographic, social, and economic profile of people suffering from TBI in Brazil. METHODS: Data on TBI cases in Brazil between 2008 and 2012 were collected through the website of the Information Technology Department of the Unified Health System (DATASUS) maintained by the Brazilian Ministry of Health. This database is fed by public hospital admission authorization forms provided nationwide. RESULTS: There were around 125,000 hospital admissions due to TBI a year, an incidence of 65.7 admissions per 100,000 inhabitants per year. Hospital mortality was 5.1/100,000/year, and the case fatality rate was 7.7%. The average annual cost of hospital expenses was US$70,960,000, with an average cost per admission of US$568. The age group 20-29, frequently admitted to the hospital due to TBI, presented the largest number of hospital deaths; however, the population >80 years of age showed the highest admission rate per age group, around 138/100,000/year, followed by the age group 70-79. CONCLUSIONS: TBI should be recognized as an important public health problem in Brazil because it is responsible for considerable social and economic costs. Besides the young adult age group (20-29 years old), the geriatric age group is especially vulnerable to the frequent and devastating consequences of TBI. The implementation of a system of effective epidemiologic vigilance for neurotrauma is urgent in Brazil and other countries worldwide.	[Romeu de Almeida, Carlos Eduardo; de Sousa Filho, Jose Lopes; Dourado, Jules Carlos; Magalhaes Gontijo, Pollyana Anicio; Dellaretti, Marcos Antonio; Costa, Bruno Silva] Santa Casa Belo Horizonte, Dept Neurosurg, Belo Horizonte, MG, Brazil		de Almeida, CER (corresponding author), Santa Casa Belo Horizonte, Dept Neurosurg, Belo Horizonte, MG, Brazil.	cadu_romeu@yahoo.com.br	Dellaretti, Marcos/G-4664-2012; Costa, Bruno/G-6500-2012	Costa, Bruno/0000-0003-0780-4709			Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Bener A, 2010, BRAIN INJURY, V24, P74, DOI 10.3109/02699050903508192; Brasure M, 2012, MULTIDISCIPLINARY PO; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; de Moura JC, 2011, BRAZ NEUROSURG, V30, P99; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Hu JH, 2013, J NEUROTRAUM, V30, P1755, DOI 10.1089/neu.2013.2857; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Maset A, 1993, ARQ BRAS NEUROCIRURG, V12, P293; Masini M, 1991, J BRAS NEUROCIR, V5, P61; Melo JRT, 2005, ARQ NEURO-PSIQUIAT, V63, P1054, DOI 10.1590/S0004-282X2005000600026; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ministry of Health of Brazil, 2008, EX SECR MOR HLTH RIG; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Fernandes RNR, 2013, BRAZ NEUROSURG, V32, P136; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thruman DJ, 1995, STANDARDS SURVEILLAN, P9; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418	23	27	31	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2016	87						540	547		10.1016/j.wneu.2015.10.020			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	DI3HR	WOS:000373390200076	26485419				2022-02-06	
J	Shah, FA; Gim, SA; Sung, JH; Jeon, SJ; Kim, MO; Koh, PO				Shah, Fawad-Ali; Gim, Sang-Ah; Sung, Jin-Hee; Jeon, Seong-Jun; Kim, Myeong-Ok; Koh, Phil-Ok			Identification of proteins regulated by curcumin in cerebral ischemia	JOURNAL OF SURGICAL RESEARCH			English	Article						Curcumin; Stroke; Proteomics	TRAUMATIC BRAIN-INJURY; C-TERMINAL HYDROLASE; SYNAPTIC PLASTICITY; REPERFUSION INJURY; OXIDATIVE STRESS; ARTERY OCCLUSION; UBIQUITIN; RATS; MECHANISMS; PYRIDOXAL	Background: Curcumin is known to have a neuroprotective effect against cerebral ischemia. The objective of this study was to identify various proteins that are differentially expressed by curcumin treatment in focal cerebral ischemia using a proteomic approach. Methods: Adult male rats were treated with vehicle or curcumin 1 h after middle cerebral artery occlusion. Brain tissues were collected 24 h after the onset of middle cerebral artery occlusion, and cerebral cortices proteins were identified by two-dimensional gel electrophoresis and mass spectrometry. Results: We detected several proteins with altered expression levels between vehicle- and curcumin-treated animals. Among these proteins, ubiquitin carboxy-terminal hydrolase L1, isocitrate dehydrogenase, adenosylhomocysteinase, and eukaryotic initiation factor 4A were decreased in the vehicle-treated animal, and curcumin treatment attenuated the injury-induced decreases of these proteins. Conversely, pyridoxal phosphate phosphatase was increased in the vehicle-treated animal, and curcumin treatment prevented decreases in this protein. The identified altered proteins are associated with cellular metabolism and differentiation. Conclusions: The results of this study suggest that curcumin exerts a neuroprotective effect by regulating the expression of various proteins in focal cerebral ischemia. (C) 2016 Elsevier Inc. All rights reserved.	[Shah, Fawad-Ali; Gim, Sang-Ah; Sung, Jin-Hee; Jeon, Seong-Jun; Koh, Phil-Ok] Gyeongsang Natl Univ, Life Sci Res Inst, Coll Vet Med, Dept Anat, Jinju, South Korea; [Shah, Fawad-Ali; Kim, Myeong-Ok] Gyeongsang Natl Univ, Div Life Sci & Appl Life Sci, Jinju, South Korea		Koh, PO (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Dept Anat, 900 Gajwa Dong, Jinju 660701, South Korea.	pokoh@gnu.ac.kr	Kim, Myeong Ok/AAS-1488-2021	Kim, Myeong Ok/0000-0003-4317-1072; Shah, Fawad Ali/0000-0002-5415-2179	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2007300]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2007300).	Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; BARNES LD, 1971, BIOCHEMISTRY-US, V10, P3939, DOI 10.1021/bi00797a022; Baxter P, 2003, BBA-PROTEINS PROTEOM, V1647, P36, DOI 10.1016/S1570-9639(03)00045-1; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Castillo J, 2000, STROKE, V31, P852, DOI 10.1161/01.STR.31.4.852; Chu KY, 2012, DIABETOLOGIA, V55, P128, DOI 10.1007/s00125-011-2323-1; Costa-Mattioli M, 2009, PROG MOL BIOL TRANSL, V90, P293, DOI 10.1016/S1877-1173(09)90008-4; Ge PF, 2007, STROKE, V38, P3230, DOI 10.1161/STROKEAHA.107.487108; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Guo LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070565; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hwang IK, 2007, EXP NEUROL, V206, P114, DOI 10.1016/j.expneurol.2007.04.005; Jang YM, 2003, J BIOL CHEM, V278, P50040, DOI 10.1074/jbc.M309619200; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Ouh In-Ohk, 2013, Lab Anim Res, V29, P156, DOI 10.5625/lar.2013.29.3.156; PALMER JL, 1979, J BIOL CHEM, V254, P1217; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PATEL BT, 1986, BRAIN RES, V370, P250, DOI 10.1016/0006-8993(86)90480-4; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; Sun JH, 2008, BIOCHEM BIOPH RES CO, V366, P539, DOI 10.1016/j.bbrc.2007.11.176; Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042; Tu XK, 2014, INFLAMMATION, V37, P1544, DOI 10.1007/s10753-014-9881-6; Wang Q, 2005, J NEUROSCI RES, V82, P138, DOI 10.1002/jnr.20610; Wardas J, 2002, POL J PHARMACOL, V54, P313; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Yamashima T, 2001, NUTR NEUROSCI, V4, P389, DOI 10.1080/1028415X.2001.11747375; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zhao J, 2008, BRAIN RES, V1229, P224, DOI 10.1016/j.brainres.2008.06.117; Zhao J, 2010, NEUROCHEM RES, V35, P374, DOI 10.1007/s11064-009-0065-y	34	27	28	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	MAR	2016	201	1					141	148		10.1016/j.jss.2015.10.025			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DD0GU	WOS:000369599200018	26850195				2022-02-06	
J	MacManus, DB; Pierrat, B; Murphy, JG; Gilchrist, MD				MacManus, David B.; Pierrat, Baptiste; Murphy, Jeremiah G.; Gilchrist, Michael D.			Mechanical characterization of the P56 mouse brain under large-deformation dynamic indentation	SCIENTIFIC REPORTS			English	Article							VISCOELASTIC PROPERTIES; IN-VIVO; TISSUE; HEAD; EPIDEMIOLOGY; VALIDATION; CELLS; SITU	The brain is a complex organ made up of many different functional and structural regions consisting of different types of cells such as neurons and glia, as well as complex anatomical geometries. It is hypothesized that the different regions of the brain exhibit significantly different mechanical properties, which may be attributed to the diversity of cells and anisotropy of neuronal fibers within individual brain regions. The regional dynamic mechanical properties of P56 mouse brain tissue in vitro and in situ at velocities of 0.71-4.28 mm/s, up to a deformation of 70 mu m are presented and discussed in the context of traumatic brain injury. The experimental data obtained from micro-indentation measurements were fit to three hyperelastic material models using the inverse Finite Element method. The cerebral cortex elicited a stiffer response than the cerebellum, thalamus, and medulla oblongata regions for all velocities. The thalamus was found to be the least sensitive to changes in velocity, and the medulla oblongata was most compliant. The results show that different regions of the mouse brain possess significantly different mechanical properties, and a significant difference also exists between the in vitro and in situ brain.	[MacManus, David B.; Pierrat, Baptiste; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland; [Murphy, Jeremiah G.] Dublin City Univ, Dept Mech & Mfg Engn, Dublin 9, Ireland		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland.	michael.gilchrist@ucd.ie		Pierrat, Baptiste/0000-0001-8064-8496; MacManus, David/0000-0003-2959-698X	Science Foundation IrelandScience Foundation IrelandEuropean Commission [12/IP/1732]	This work was supported by Science Foundation Ireland (Grant No. 12/IP/1732).	Atkin R. J., 2005, INTRO THEORY ELASTIC, P79; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Efremov YM, 2011, ACTA NATURAE, V3, P93, DOI 10.32607/20758251-2011-3-3-93-99; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elkin BS, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025386; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; England M. A., 1996, COLOUR ATLAS BRAIN S, P10; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrer I, 2007, J NEUROPATH EXP NEUR, V66, P35, DOI 10.1097/nen.0b013e31802c3e7d; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Iivarinen J. T., 2013, SKIN RES TECHNOL, P1; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; MacManus DB, 2015, J BIOMECH, V48, P3213, DOI 10.1016/j.jbiomech.2015.06.028; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Moerman KM, 2009, J BIOMECH, V42, P1150, DOI 10.1016/j.jbiomech.2009.02.016; Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sharp AA, 2009, IEEE T BIO-MED ENG, V56, P45, DOI 10.1109/TBME.2008.2003261; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Weissenberger C. A., 2010, EXPT TRANSLATIONAL M, V2; Willinger R, 1999, CR ACAD SCI II B, V327, P125, DOI 10.1016/S1287-4620(99)80021-0; Xu G, 2009, BIOMECH MODEL MECHAN, V8, P253, DOI 10.1007/s10237-008-0131-4; Zhang J, 2011, J BIOMECH, V44, P1909, DOI 10.1016/j.jbiomech.2011.04.034	43	27	27	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 22	2016	6								21569	10.1038/srep21569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DE3BJ	WOS:000370501500001	26898475	Green Published, Green Submitted, gold			2022-02-06	
J	Stergiou-Kita, M; Mansfield, E; Sokoloff, S; Colantonio, A				Stergiou-Kita, Mary; Mansfield, Elizabeth; Sokoloff, Sandra; Colantonio, Angela			Gender Influences on Return to Work After Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Employment; Rehabilitation; Return to work	HEALTH RESEARCH; UNITED-STATES; HELP-SEEKING; MENS HEALTH; WAGE GAP; MASCULINITY; SEX; WORKPLACE; PERSPECTIVE; DISABILITY	Objective: To examine the influence of gender on the return to work experience of workers who sustained a work-related mild traumatic brain injury (TBI). Design: Qualitative study using in-depth telephone interviews. Setting: Community. Participants: Purposive sampling was used to recruit participants. Participants were adults (N=12; males, n=6, females, n=6) with a diagnosis of mild TBI sustained through a workplace injury. Interventions: Not applicable. Main Outcome Measures: Not applicable. Results: Our findings suggest that gender impacts return to work experiences in multiple ways. Occupational and breadwinner roles were significant for both men and women after work -related mild TBI. Women in this study were more proactive than men in seeking and requesting medical and rehabilitation services; however, the workplace culture may contribute to whether and how health issues are discussed. Among our participants, those who worked in supportive, nurturing (eg, feminine) workplaces reported more positive return to work (RTW) experiences than participants employed in traditionally masculine work environments. For all participants, employer and coworker relations were critical elements in RTW outcomes. Conclusions: The application of a gender analysis in this preliminary exploratory study revealed that gender is implicated in the RTW process on many levels for men and women alike. Further examination of the work reintegration processes that takes gender into account is necessary for the development of successful policy and practice for RTW after work -related MTBI. (C) 2016 by the American Congress of Rehabilitation Medicine	[Stergiou-Kita, Mary; Sokoloff, Sandra; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Stergiou-Kita, Mary; Mansfield, Elizabeth; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Stergiou-Kita, Mary] Inst Work & Hlth, Toronto, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Dept Occupat Sci & Occupat Therapy, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	; Mansfield, Elizabeth/S-3426-2016	Colantonio, Angela/0000-0003-2094-4765; Mansfield, Elizabeth/0000-0003-1776-8641	Canadian Institutes of Health Research-Institute for Gender and HealthCanadian Institutes of Health Research (CIHR) [OGW-123786]; Toronto Rehabilitation Institute Foundation; Ontario Ministry of Health and Long Term Care, Provincial Rehabilitation Research Program to the Toronto Rehabilitation Institute, University Health Network; Canadian Institutes of Health Research Research Chair in Gender, Work and Health from the Institute of Gender and Health [CGW-126580]; Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute	Supported by the Canadian Institutes of Health Research-Institute for Gender and Health (grant no. OGW-123786); the Toronto Rehabilitation Institute Foundation and the Ontario Ministry of Health and Long Term Care, which provided funding under the Provincial Rehabilitation Research Program to the Toronto Rehabilitation Institute, University Health Network; the Canadian Institutes of Health Research Research Chair in Gender, Work and Health (grant no. CGW-126580) from the Institute of Gender and Health; and the Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute.	Armstrong P, 2014, POLICY PRACT HEALTH, V12, P3, DOI 10.1080/14774003.2014.11667794; Bauer GR, 2014, SOC SCI MED, V110, P10, DOI 10.1016/j.socscimed.2014.03.022; Bilsker D., 2010, ROADMAP MENS HLTH CU; Boudarbat B, 2013, CAN J ECON, V46, P1037, DOI 10.1111/caje.12036; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Breslin FC, 2007, SOC SCI MED, V64, P782, DOI 10.1016/j.socscimed.2006.10.024; Charles N, 2008, HEALTH RISK SOC, V10, P117, DOI 10.1080/13698570802160954; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Cote D, 2010, DISABIL REHABIL, V32, P87, DOI 10.3109/09638280903026572; Desmond Matthew, 2006, ETHNOGRAPHY, V7, P387, DOI DOI 10.1177/1466138106073142; Dolan A, 2011, SOCIOL HEALTH ILL, V33, P586, DOI 10.1111/j.1467-9566.2010.01300.x; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; Farrimond H, 2012, HEALTH-LONDON, V16, P208, DOI 10.1177/1363459311403943; Finnegan Alan, 2010, Br J Nurs, V19, P1355; Francis JJ, 2010, PSYCHOL HEALTH, V25, P1229, DOI 10.1080/08870440903194015; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gillespie BM, 2010, INT J NURS STUD, V47, P732, DOI 10.1016/j.ijnurstu.2009.11.001; Harkins C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-391; Hennessy M, 2014, INT J MED HLTH SCI R, V1, P13; Hilgert JA, 2012, AM J IND MED, V55, P506, DOI 10.1002/ajim.22023; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Hultin M, 2003, WORK OCCUPATION, V30, P30, DOI 10.1177/0730888402239326; Jensen SQ, 2014, SAFETY SCI, V64, P190, DOI 10.1016/j.ssci.2013.12.004; Johnson JL, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-14; Knaak S, 2004, SOCIOL INQ, V74, P302, DOI 10.1111/j.1475-682X.2004.00093.x; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Lips HM, 2013, SEX ROLES, V68, P223, DOI [10.1007/s11199-012-0245-0, 10.1007/s11199-012-0165-z]; Mackenzie CR, 2014, SOC SCI MED, V117, P96, DOI 10.1016/j.socscimed.2014.07.043; Marchant T, 2013, CONSTR MANAG ECON, V31, P845, DOI 10.1080/01446193.2013.808353; Menendez M, 2007, SOC SCI MED, V64, P776, DOI 10.1016/j.socscimed.2006.10.035; Messing K, 2003, AM J IND MED, V43, P618, DOI 10.1002/ajim.10225; Mikkonen J, 2010, SOCIAL DETERMINANTS; Miles M.B., 2013, QUALITATIVE DATA ANA; Misra J, 2014, SOCIOL COMPASS, V8, P1281, DOI 10.1111/soc4.12213; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; O'Brien R, 2005, SOC SCI MED, V61, P503, DOI 10.1016/j.socscimed.2004.12.008; O'Brien R, 2005, SIGNS, V30, P1529, DOI 10.1086/423350; Peerson A., 2009, Critical Public Health, V19, P441, DOI 10.1080/09581590902906229; Repta R, 2007, BETTER SCI SEX GENDE; Schofield T, 2000, J AM COLL HEALTH, V48, P247, DOI 10.1080/07448480009596266; Sharman Z, 2012, SOC SCI MED, V74, P1812, DOI 10.1016/j.socscimed.2011.08.039; Silva S., 2012, EPIDEMIOLOGY CURRENT, P63; Soeker MS, 2011, J OCCUP SCI, V18, P81, DOI 10.1080/14427591.2011.554155; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Stewart BJ, 2012, INT J NURS STUD, V49, P560, DOI 10.1016/j.ijnurstu.2011.11.004; Thorogood N, 2004, QUALITATIVE METHODS; WHO, 2008, CLOS GAP GEN HLTH EQ; Workplace Safety and Insurance Board (WSIB), 2013, NUMB 2012 WSIB STAT	48	27	27	1	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2016	97	2		1			S40	S45		10.1016/j.apmr.2015.04.008			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DC4RI	WOS:000369207600006	25921979	Green Accepted			2022-02-06	
J	Cristofori, I; Bulbulia, J; Shaver, JH; Wilson, M; Krueger, F; Grafman, J				Cristofori, Irene; Bulbulia, Joseph; Shaver, John H.; Wilson, Marc; Krueger, Frank; Grafman, Jordan			Neural correlates of mystical experience	NEUROPSYCHOLOGIA			English	Article						Mystical experience; Religious belief; Voxel-based lesion-symptom mapping; Penetrating traumatic brain injuries	COGNITIVE CONTROL; CORTICAL-LESIONS; HEAD-INJURY; RELIGION; EMOTION; CONSCIOUSNESS; INHIBITION; REGISTRATION; SYSTEMS; STATES	Mystical experiences, or subjectively believed encounters with a supernatural world, are widely reported across cultures and throughout human history. Previous theories speculate that executive brain functions underpin mystical experiences. To evaluate causal hypotheses, structural studies of brain lesion are required. Previous studies suffer from small samples or do not have valid measures of cognitive functioning prior to injury. We investigated mystical experience among participants from the Vietnam Head Injury Study and compared those who suffered penetrating traumatic brain injury (pTBI; n=116) with matched healthy controls (HC; n =32). Voxel-based lesion-symptom mapping analysis showed that lesions to frontal and temporal brain regions were linked with greater mystical experiences. Such regions included the dorsolateral prefrontal cortex (dIPFC) and middle/superior temporal cortex (TC). In a confirmatory analysis, we grouped pTBI patients by lesion location and compared mysticism experiences with the HC group. The dIPFC group presented markedly increased mysticism. Notably, longitudinal analysis of pre-injury data (correlating with general intelligence and executive performance) excludes explanations from individual differences. Our findings support previous speculation linking executive brain functions to mystical experiences, and reveal that executive functioning (d1PFC) causally contributes to the down regulation of mystical experiences. (C) 2015 Elsevier Ltd. All rights reserved.	[Cristofori, Irene; Grafman, Jordan] Rehabil Inst Chicago, Cognit Neurosci Lab, Brain Injury Res, Chicago, IL 60611 USA; [Cristofori, Irene; Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Bulbulia, Joseph; Shaver, John H.] Victoria Univ New Zealand, Sch Art Hist Class & Religious Studies, Wellington 6140, New Zealand; [Wilson, Marc] Victoria Univ New Zealand, Dept Psychol, Wellington 6012, New Zealand; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Grafman, Jordan] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA		Grafman, J (corresponding author), Rehabil Inst Chicago, Cognit Neurosci Lab, Brain Injury Res Program, 345 E Super St, Chicago, IL 60611 USA.	irene.cristofori@northwestern.edu; jgrafman@northwestern.edu		Wilson, Marc/0000-0002-3009-5229; Shaver, John/0000-0002-9522-4765; Bulbulia, Joseph/0000-0002-5861-2056; Cristofori, Irene/0000-0003-2339-1457	National Naval Medical Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); US Department of EducationUS Department of Education [H133F130009]; Templeton World Charity Foundation [0077]; Royal Society of New Zealand Marsden GrantRoyal Society of New ZealandMarsden Fund (NZ) [VUW1321]	We thank our dedicated Vietnam veterans for their invaluable participation in the study. We also thank G. J. Solomon for his assistance with ABLe, as well as V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for testing and evaluating participants. Lastly, we thank the National Naval Medical Center and the National Institute of Neurological Disorders and Stroke for their support and provision of their facilities. The US Department of Education (M. Switzer Research Fellowship: ID: H133F130009) supported IC. A Templeton World Charity Foundation Grant (ID: 0077) and a Royal Society of New Zealand Marsden Grant (ID: VUW1321) supported JB and JS. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, or the U.S. Government.	Alcorta CS, 2005, HUM NATURE-INT BIOS, V16, P323, DOI 10.1007/s12110-005-1014-3; Amting JM, 2010, J NEUROSCI, V30, P10039, DOI 10.1523/JNEUROSCI.6434-09.2010; Andersen M, 2014, METH THEORY STUD REL, V26, P217, DOI 10.1163/15700682-12341323; [Anonymous], 1960, AFQT7A DEP DEF; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Barrett JL, 1996, COGNITIVE PSYCHOL, V31, P219, DOI 10.1006/cogp.1996.0017; Beauregard M, 2006, NEUROSCI LETT, V405, P186, DOI 10.1016/j.neulet.2006.06.060; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; BEEMAN M, 1994, J COGNITIVE NEUROSCI, V6, P26, DOI 10.1162/jocn.1994.6.1.26; BENSON DF, 1990, SCHIZOPHRENIA BULL, V16, P403, DOI 10.1093/schbul/16.3.403; Botero CA, 2014, P NATL ACAD SCI USA, V111, P16784, DOI 10.1073/pnas.1408701111; Brugger P, 2008, CORTEX, V44, P1291, DOI 10.1016/j.cortex.2008.05.008; Bulbulia J., 2009, RELIGIOSITY MENTAL T; Bulbulia J, 2011, RELIG BRAIN BEHAV, V1, P220, DOI 10.1080/2153599X.2011.647851; Bulbulia J, 2013, CONT TOP COGN NEUROS, P169; Cassotti M, 2010, BRAIN COGNITION, V72, P378, DOI 10.1016/j.bandc.2009.11.004; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coruh BA, 2005, EXPLORE-NY, V1, P186, DOI 10.1016/j.explore.2005.02.001; Cristofori I, 2015, SOC COGN AFFECT NEUR, V10, P1038, DOI 10.1093/scan/nsu155; CUTTING J, 1987, BRIT J PSYCHIAT, V151, P324, DOI 10.1192/bjp.151.3.324; Dal Monte O, 2014, CORTEX, V58, P9, DOI 10.1016/j.cortex.2014.05.002; DAQUILI EG, 1993, ZYGON, V28, P177, DOI 10.1111/j.1467-9744.1993.tb01026.x; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; Deeley Q, 2014, CORTEX, V53, P107, DOI 10.1016/j.cortex.2014.01.004; Delis DC., 2001, DELIS KAPLAN EXECUTI; Devinsky O, 2003, EPILEPSY BEHAV, V4, pS2, DOI 10.1016/j.yebeh.2003.10.002; Devinsky O, 2008, EPILEPSY BEHAV, V12, P636, DOI 10.1016/j.yebeh.2007.11.011; DEWHURST K, 1970, BRIT J PSYCHIAT, V117, P497, DOI 10.1192/bjp.117.540.497; Dietrich A, 2003, CONSCIOUS COGN, V12, P231, DOI 10.1016/S1053-8100(02)00046-6; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GESCHWIND N, 1983, EPILEPSIA, V24, pS23, DOI 10.1111/j.1528-1157.1983.tb04640.x; Ghorbani N, 2007, PSYCHOL REP, V100, P451, DOI 10.2466/PR0.100.2.451-454; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Goldman-Rakic P. S., 1987, CIRCUITRY PRIMATE PR, V5; Gozzi M, 2009, NEUROPSYCHOLOGIA, V47, P2125, DOI 10.1016/j.neuropsychologia.2009.04.002; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; HOOD RW, 1975, J SCI STUD RELIG, V14, P29, DOI 10.2307/1384454; HOOD RW, 1981, J SCI STUD RELIG, V20, P261, DOI 10.2307/1385548; Hood RW., 2009, PSYCHOL RELIG EMPIRI; Inzlicht M, 2009, PSYCHOL SCI, V20, P385, DOI 10.1111/j.1467-9280.2009.02305.x; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Karlsgodt KH, 2009, SCHIZOPHR RES, V108, P143, DOI 10.1016/j.schres.2008.12.025; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kounios J, 2014, ANNU REV PSYCHOL, V65, P71, DOI 10.1146/annurev-psych-010213-115154; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lindeman M, 2013, SOC COGN AFFECT NEUR, V8, P943, DOI 10.1093/scan/nss096; LUDLOW CL, 1986, BRAIN, V109, P55, DOI 10.1093/brain/109.1.55; Luhrmann T.M., 2005, SPIRITUS, V5, P133, DOI [DOI 10.1353/SCS.2006.0014, https://doi.org/10.1353/scs.2006.0014]; Luhrmann Tanya M., 2012, GOD TALKS BACK UNDER; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; McCullough ME, 2009, PSYCHOL BULL, V135, P69, DOI 10.1037/a0014213; McNeil M., 1994, REVISED TOKEN TEST; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mizumori SJY, 2013, HIPPOCAMPUS, V23, P1103, DOI 10.1002/hipo.22176; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Newberg AB, 2006, PSYCHIAT RES-NEUROIM, V148, P67, DOI 10.1016/j.pscychresns.2006.07.001; Ng F, 2007, AUSTRALAS PSYCHIATRY, V15, P62, DOI 10.1080/10398560601083118; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Pena-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022812; Persinger MA, 2001, J NEUROPSYCH CLIN N, V13, P515, DOI 10.1176/appi.neuropsych.13.4.515; Previc FH, 2006, CONSCIOUS COGN, V15, P500, DOI 10.1016/j.concog.2005.09.009; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Saver JL, 1997, J NEUROPSYCH CLIN N, V9, P498; Schjoedt U, 2013, RELIG BRAIN BEHAV, V3, P39, DOI 10.1080/2153599X.2012.736714; Schjoedt U, 2011, SOC COGN AFFECT NEUR, V6, P119, DOI 10.1093/scan/nsq023; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stace W, 1960, MYSTICISM PHILOS; TEASDALE G, 1974, LANCET, V2, P81; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urgesi C, 2010, NEURON, V65, P309, DOI 10.1016/j.neuron.2010.01.026; Vivas AB, 2003, NEUROPSYCHOLOGIA, V41, P1531, DOI 10.1016/S0028-3932(03)00063-0; Warrington E. K., 1991, VISUAL OBJECT SPACE; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wildman WesleyJ., 2011, RELIG SPIRITUAL EXPE; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; [No title captured], DOI DOI 10.1353/PPP.2003.0095	86	27	27	0	25	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JAN 8	2016	80						212	220		10.1016/j.neuropsychologia.2015.11.021			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	DC1CB	WOS:000368953300022	26631541	Bronze			2022-02-06	
J	Du, GL; Zhao, ZM; Chen, YH; Li, ZH; Tian, YH; Liu, ZF; Liu, B; Song, JQ				Du, Guoliang; Zhao, Zongmao; Chen, Yonghan; Li, Zonghao; Tian, Yaohui; Liu, Zhifeng; Liu, Bin; Song, Jianqiang			Quercetin attenuates neuronal autophagy and apoptosis in rat traumatic brain injury model via activation of PI3K/Akt signaling pathway	NEUROLOGICAL RESEARCH			English	Article						Quercetin; Autophagy; Apoptosis; PI3K/Akt; Traumatic brain injury	INDUCED OXIDATIVE STRESS; CELL-DEATH; PATHOPHYSIOLOGY; NEUROPROTECTION; RESVERATROL; FLAVONOIDS; DAMAGE; EDEMA	Objective: Neuronal autophagy and apoptosis play an irreplaceable role in brain injury pathogenesis and may represent a hopeful target for treatment. Previous studies have demonstrated that administration of quercetin-attenuated brain damage in a variety of brain injury models including traumatic brain injury (TBI). However, whether PI3K/Akt signaling pathway mediates the neuroprotection of quercetin following TBI is not well clarified. We sought to propose a hypothesis that quercetin could attenuate neuronal autophagy and apoptosis via enhancing PI3K/Akt signaling. Methods: All rats were randomly arranged into four groups as follows: sham group (n = 25), TBI group (n = 25), TBI + quercetin group (n = 25), TBI + quercetin + LY294002 group (n = 25). Quercetin (Sigma, USA, dissolved in 0.9% saline solution) was administered intraperitoneally at a dose of 50 mg/kg at 30 min, 12 h, and 24 h after TBI. The neurological impairment and spatial cognitive function was assessed by the neurologic severity score and Morris water maze, respectively. Immunohistochemistry staining and western blotting was used to evaluate the expression of LC3, p-Akt, caspase-3, Bcl-2, and Bax. Results: Quercetin treatment significantly attenuated TBI-induced neurological impairment (1-3 days, p < 0.05) and improved cognitive function (5-8 days, p < 0.05). Double immunolabeling demonstrated that quercetin significantly reduced the LC3-positive cells co-labeled with NeuN, whereas significantly enhanced p-Akt-positive cells co-labeled with NeuN. Furthermore, quercetin treatment reduced the expression of LC3. caspase-3 and Bax levels induced following TBI (p < 0.05), and increased the expression of p-Akt and Bcl-2 at 48 h (p < 0.05). Conclusion: In conclusion, our observations indicate that post-injury treatment with quercetin could inhibit neuronal autophagy and apoptosis in the hippocampus in a rat model of TBI. The neuroprotective effects of quercetin may be related to modulation of PI3K/Akt signaling pathway.	[Du, Guoliang; Chen, Yonghan; Li, Zonghao; Tian, Yaohui; Liu, Zhifeng; Liu, Bin; Song, Jianqiang] Cent Hosp Cangzhou, Dept Neurosurg, Cangzhou 061001, Hebei, Peoples R China; [Zhao, Zongmao] Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang, Peoples R China		Du, GL (corresponding author), Cent Hosp Cangzhou, Dept Neurosurg, Cangzhou 061001, Hebei, Peoples R China.	guoliangdu2001@163.com					Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Bao HJ, 2015, NEUROCHEM RES, V40, P89, DOI 10.1007/s11064-014-1469-x; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Cao XJ, 2014, DEV PSYCHOBIOL, V56, P1102, DOI 10.1002/dev.21130; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Dajas F, 2012, J ETHNOPHARMACOL, V143, P383, DOI 10.1016/j.jep.2012.07.005; de Oliveira MR, 2016, BIOTECHNOL ADV, V34, P532, DOI 10.1016/j.biotechadv.2015.12.014; Dok-Go H, 2003, BRAIN RES, V965, P130, DOI 10.1016/S0006-8993(02)04150-1; Dong YS, 2014, INT J MED SCI, V11, P282, DOI 10.7150/ijms.7634; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Erlund I, 2004, NUTR RES, V24, P851, DOI 10.1016/j.nutres.2004.07.005; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Larson AJ, 2012, ADV NUTR, V3, P39, DOI 10.3945/an.111.001271; Li N, 2014, MOL MED REP, V10, P2299, DOI 10.3892/mmr.2014.2502; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Nabavi SF, 2015, FOOD CHEM, V179, P305, DOI 10.1016/j.foodchem.2015.02.006; Nabavi SF, 2012, FOOD FUNCT, V3, P437, DOI 10.1039/c2fo10264a; Nabavi SM, 2012, FOOD CHEM, V132, P931, DOI 10.1016/j.foodchem.2011.11.070; Nakamura M, 1999, J COMP NEUROL, V412, P681, DOI 10.1002/(SICI)1096-9861(19991004)412:4<681::AID-CNE9>3.0.CO;2-F; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Ossola B, 2009, EXPERT OPIN DRUG SAF, V8, P397, DOI 10.1517/14740330903026944; Pozuelo-Rubio M, 2011, AUTOPHAGY, V7, P240, DOI 10.4161/auto.7.2.14286; Singh P, 2003, NEUROL INDIA, V51, P215; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Wang JW, 2014, J SURG RES, V186, P328, DOI 10.1016/j.jss.2013.08.027; Wang XQ, 2011, BRAIN RES BULL, V86, P277, DOI 10.1016/j.brainresbull.2011.07.014; Yao RQ, 2012, NEUROCHEM RES, V37, P2777, DOI 10.1007/s11064-012-0871-5; Yousuf S, 2009, BRAIN RES, V1250, P242, DOI 10.1016/j.brainres.2008.10.068; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	35	27	29	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	11					1012	1019		10.1080/01616412.2016.1240393			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA1CQ	WOS:000386330500010	27690831				2022-02-06	
J	Heyer, GL; Fischer, A; Wilson, J; MacDonald, J; Cribbs, S; Ravindran, R; Pommering, TL; Cuff, S				Heyer, Geoffrey L.; Fischer, Anastasia; Wilson, Julie; MacDonald, James; Cribbs, Sarah; Ravindran, Reno; Pommering, Thomas L.; Cuff, Steven			Orthostatic Intolerance and Autonomic Dysfunction in Youth With Persistent Postconcussion Symptoms: A Head-Upright Tilt Table Study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						orthostatic; autonomic; tilt table; concussion; TBI; pediatric; adolescent; postconcussion; dizziness; POTS	TRAUMATIC BRAIN-INJURY; POSTURAL TACHYCARDIA SYNDROME; CONCUSSION SYMPTOMS; RATE-VARIABILITY; UNITED-STATES; CHILDREN; EPIDEMIOLOGY; PREDICTORS; RECOVERY; SEX	Objective:To explore head-upright tilt table (HUT) signs of autonomic dysfunction in a cohort of youth with persistent postconcussion symptoms (PCSs) that include light-headedness and to correlate repeat tilt table results with symptom improvements for those patients found to have postural tachycardia syndrome (POTS) on initial testing.Design:Prospective cohort design.Setting:Nationwide Children's Hospital, Neurology Clinic.Participants:Thirty-four patients (13-18 years of age) with persistent PCSs.Main Outcome Measures:All patients underwent at least 1 tilt table test. The PCS Interview (PCS-I) and patient ratings of light-headedness and vertigo were used to measure symptom burden. Patients found to have POTS were asked to repeat tilt table testing when PCSs improved or 3 to 6 months after the initial test if symptoms persisted.Results:Twenty-four of the 34 (70.6%) patients had abnormal tilt table results with patients categorized as normal (n = 10), isolated syncope (n = 10), and POTS (n = 14). Patients with POTS had higher PCS-I scores than normal patients (P < 0.001) and higher ratings of light-headedness than both normal patients (P = 0.015) and syncope patients (P = 0.04). Twelve POTS patients underwent repeat tilt table testing, and 9 of 12 (75%) no longer met POTS diagnostic criteria. All patients with resolution of POTS had corresponding improvements in PCSs, including light-headedness and vertigo.Conclusions:Our study demonstrates a high rate of tilt table abnormalities among youth with persistent PCSs. Several patients with POTS had normalization of tilt table testing when PCSs improved. These findings warrant further research of autonomic dysfunction related to concussion.	[Heyer, Geoffrey L.] Nationwide Childrens Hosp, Div Pediat Neurol, Columbus, OH 43205 USA; [Heyer, Geoffrey L.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Fischer, Anastasia; MacDonald, James; Ravindran, Reno; Pommering, Thomas L.; Cuff, Steven] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH 43205 USA; [Wilson, Julie] Childrens Hosp Colorado, Dept Orthoped, Aurora, CO USA; [Cribbs, Sarah] Childrens Alabama, Dept Pediat, Birmingham, AL USA; [Cribbs, Sarah] Childrens Alabama, Dept Orthoped, Birmingham, AL USA		Heyer, GL (corresponding author), Nationwide Childrens Hosp, Dept Pediat, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.	geoffrey.heyer@nationwidechildrens.org		MacDonald, James/0000-0002-0432-0808; Heyer, Geoffrey/0000-0001-9334-3739			Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kanjwal K, 2010, CARDIOL J, V17, P482; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kimpinski K, 2012, MAYO CLIN PROC, V87, P746, DOI 10.1016/j.mayocp.2012.02.020; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	29	27	27	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2016	26	1					40	45		10.1097/JSM.0000000000000183			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	DA2JB	WOS:000367620000006	25706664				2022-02-06	
J	Huang, MX; Risling, M; Baker, DG				Huang, Mingxiong; Risling, Marten; Baker, Dewleen G.			The role of biomarkers and MEG-based imaging markers in the diagnosis of post-traumatic stress disorder and blast-induced mild traumatic brain injury	PSYCHONEUROENDOCRINOLOGY			English	Article						Traumatic brain injury (TBI); Blast; Concussion; PTSD; Magnetoencephalogram; Diffusion tensor imaging (DTI); Military; Veteran	DIFFUSE AXONAL INJURY; OPERATION IRAQI FREEDOM; HEAD-INJURY; WAR VETERANS; DELTA WAVES; MILITARY PERSONNEL; BLOOD-FLOW; PTSD; ENCEPHALOPATHY; SYMPTOMS	Background: Pervasive use of improvised explosive devices (IEDs), rocket-propelled grenades, and land mines in the recent conflicts in Iraq and Afghanistan has brought traumatic brain injury (TBI) and its impact on health outcomes into public awareness. Blast injuries have been deemed signature wounds of these wars. War-related TBI is not new, having become prevalent during WWI and remaining medically relevant in WWII and beyond. Medicine's past attempts to accurately diagnose and disentangle the pathophysiology of war-related TBI parallels current lines of inquiry and highlights limitations in methodology and attribution of symptom etiology, be it organic, psychological, or behavioral. New approaches and biomarkers are needed. Preclinical: Serological biomarkers and biomarkers of injury obtained with imaging techniques represent cornerstones in the translation between experimental data and clinical observations. Experimental models for blast related TBI and PTSD can generate critical data on injury threshold, for example for white matter injury from acceleration. Carefully verified and validated models can be evaluated with gene expression arrays and proteomics to identify new candidates for serological biomarkers. Such models can also be analyzed with diffusion MRI and microscopy in order to identify criteria for detection of diffuse white matter injuries, such as DAI (diffuse axonal injury). The experimental models can also be analyzed with focus on injury outcome in brain stem regions, such as locus coeruleus or nucleus raphe magnus that can be involved in response to anxiety changes. Clinical: Mild (and some moderate) TBI can be difficult to diagnose because the injuries are often not detectable on conventional MRI or CT. There is accumulating evidence that injured brain tissues in TBI patients generate abnormal low-frequency magnetic activity (ALFMA, peaked at 1-4 Hz) that can be measured and localized by magnetoencephalography (MEG). MEG imaging detects TBI abnormalities at the rates of 87% for the mild TBI, group (blast-induced plus non-blast causes) and 100% for the moderate group. Among the mild TBI patients, the rates of abnormalities are 96% and 77% for the blast and non-blast TBI groups, respectively. There is emerging evidence based on fMRI and MEG studies showing hyper-activity in the amygdala and hypo-activity in prefrontal cortex in individuals with PTSD. MEG signal may serve as a sensitive imaging marker for mTBI, distinguishable from abnormalities generated in association with PTSD. More work is needed to fully describe physiological mechanisms of post-concussive symptoms. Published by Elsevier Ltd.	[Huang, Mingxiong] VA San Diego Healthcare Syst, Serv Radiol, San Diego, CA USA; [Huang, Mingxiong] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Huang, Mingxiong] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Baker, Dewleen G.] Vet Affairs Ctr Excellence Stress & Mental Hlth C, San Diego, CA USA; [Baker, Dewleen G.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA		Huang, MX (corresponding author), UCSD Radiol Imaging Lab, San Diego, CA 92121 USA.	mxhuang@ucsd.edu	Baker, Dewleen/O-4957-2019	Baker, Dewleen/0000-0002-1736-9838	Veterans Affairs Health Service Research and Development [SDR 09-0128]; Department of Veterans AffairsUS Department of Veterans Affairs [101-CX000499, NURC-022-10F]; VA Center of Excellence for Stress and Mental Health San Diego, CA, USA; Swedish Defense FoT Research; Veterans AffairsUS Department of Veterans Affairs [I01CX000499] Funding Source: NIH RePORTER	We gratefully acknowledge the fiscal support for our work. Acknowledgements include Veterans Affairs Health Service Research and Development project SDR 09-0128 (DGB), the Marine Corps (MXH, DGB), and the Navy Bureau of Medicine and Surgery (MXH, DGB), Merit Review Grants from the Department of Veterans Affairs (MXH, DGB, 101-CX000499, NURC-022-10F) as well as support of the VA Center of Excellence for Stress and Mental Health San Diego, CA, USA (DGB) and the Swedish Defense FoT Research funding program. We also thank the anonymous reviewers' constructive suggestions that substantially strengthen this study.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Agoston Denes V, 2012, Front Neurol, V3, P3, DOI 10.3389/fneur.2012.00003; Anderson AK, 2003, J NEUROSCI, V23, P5627; [Anonymous], 2007, LANCET, V370, P1879; Baayen JC, 2003, BRAIN TOPOGR, V16, P85, DOI 10.1023/B:BRAT.0000006332.71345.b7; Baker DG, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110134; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Bigler ED, 2004, STUD NEUROPSYCHOL DE, P71; Birnie M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-303; Bryant RA, 2005, BIOL PSYCHIAT, V58, P111, DOI 10.1016/j.biopsych.2005.03.021; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; CELANDER H, 1955, ACTA PHYSIOL SCAND, V33, P6, DOI 10.1111/j.1748-1716.1955.tb01188.x; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chung YA, 2006, CLIN NEUROPHYSIOL, V117, P637, DOI 10.1016/j.clinph.2005.10.020; Clemedson C.J., 1949, ACTA PHYSL SCAND S61, V18; CLEMEDSON CARL-JOHAN, 1955, JOUR AVIATION MED, V26, P373; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de Jongh A, 2003, NEUROIMAGE, V20, P2291, DOI 10.1016/j.neuroimage.2003.07.030; de Kloet CS, 2006, J PSYCHIATR RES, V40, P550, DOI 10.1016/j.jpsychires.2005.08.002; DECKER DA, 1972, ELECTROEN CLIN NEURO, V33, P303, DOI 10.1016/0013-4694(72)90157-5; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Eulion JF, 1942, NEW ENGL J MED, V226, P1; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Gunther M., 2015, ACTA NEUROCHIR WIEN; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2014, JAMA-J AM MED ASSOC, V312, P1685, DOI 10.1001/jama.2014.6670; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; Jacobo A-M, 2014, INT J AUTOMOTIVE ENG, V5, P31; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jin C, 2014, PSYCHOL MED, V44, P1927, DOI 10.1017/S003329171300250X; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kansagara D., 2013, COMPLICATIONS MILD T; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Krystal JH, 2009, BRAIN RES, V1293, P13, DOI 10.1016/j.brainres.2009.03.044; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lakis N, 2013, NEUROL RES, V35, P290, DOI 10.1179/1743132813Y.0000000177; Leahy RM, 1998, ELECTROEN CLIN NEURO, V107, P159, DOI 10.1016/S0013-4694(98)00057-1; Lee KYK, 2011, NEUROIMAGE, V54, pS30, DOI 10.1016/j.neuroimage.2010.05.042; Lewine J D, 1995, Neuroimaging Clin N Am, V5, P575; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; McFarlane AC, 2010, J AFFECT DISORDERS, V127, P365, DOI 10.1016/j.jad.2010.05.002; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Myers CS, 1915, LANCET, V1, P316; NAGATA K, 1985, NEUROSURGERY, V17, P613, DOI 10.1227/00006123-198510000-00014; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL., 1998, CNS SPECTRUMS, V3, P30, DOI [10. 1017/S1092852900007306, DOI 10.1017/S1092852900007306, 10.1017/S1092852900007306]; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Schaul N, 1998, ELECTROEN CLIN NEURO, V106, P101, DOI 10.1016/S0013-4694(97)00111-9; SCHAUL N, 1978, BRAIN RES, V143, P475, DOI 10.1016/0006-8993(78)90358-X; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Semple WE, 2000, PSYCHIATRY, V63, P65, DOI 10.1080/00332747.2000.11024895; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; TEASDALE G, 1974, LANCET, V2, P81; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; van Liempt S, 2013, PSYCHONEUROENDOCRINO, V38, P155, DOI 10.1016/j.psyneuen.2012.05.015; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vieth JB, 1996, BRAIN TOPOGR, V8, P215, DOI 10.1007/BF01184772; Walcott BP, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yan XD, 2013, NEUROSCI LETT, V547, P1, DOI 10.1016/j.neulet.2013.04.032; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	107	27	28	1	25	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4530			PSYCHONEUROENDOCRINO	Psychoneuroendocrinology	JAN	2016	63						398	409		10.1016/j.psyneuen.2015.02.008			12	Endocrinology & Metabolism; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology; Psychiatry	CZ9MT	WOS:000367422400050	25769625	Green Submitted			2022-02-06	
J	Di Leva, A; Lam, T; Alcaide-Leon, P; Bharatha, A; Montanera, W; Cusimano, MD				Di Leva, Antonio; Lam, Timothy; Alcaide-Leon, Paula; Bharatha, Aditya; Montanera, Walter; Cusimano, Michael D.			Magnetic resonance susceptibility weighted imaging in neurosurgery: current applications and future perspectives	JOURNAL OF NEUROSURGERY			English	Article						brain tumors; vascular neurosurgery; neurotrauma; functional neurosurgery; MRI; neuroradiology; SWI; susceptibility weighted imaging; diagnostic and operative techniques	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; CEREBRAL CAVERNOUS MALFORMATIONS; CHARACTERIZING IRON DEPOSITION; SUBTHALAMIC NUCLEUS; NECROTIC GLIOBLASTOMAS; RADIATION-THERAPY; HIGH-FIELD; IN-VIVO; MRI	Susceptibility weighted imaging (SWI) is a relatively new imaging technique. Its high sensitivity to hemorrhagic components and ability to depict microvasculature by means of susceptibility effects within the veins allow for the accurate detection, grading, and monitoring of brain tumors. This imaging modality can also detect changes in blood flow to monitor stroke recovery and reveal specific subtypes of vascular malformations. In addition, small punctate lesions can be demonstrated with SWI, suggesting diffuse axonal injury, and the location of these lesions can help predict neurological outcome in patients. This imaging technique is also beneficial for applications in functional neurosurgery given its ability to clearly depict and differentiate deep midbrain nuclei and close submillimeter veins, both of which are necessary for presurgical planning of deep brain stimulation. By exploiting the magnetic susceptibilities of substances within the body, such as deoxyhemoglobin, calcium, and iron, SWI can clearly visualize the vasculature and hemorrhagic components even without the use of contrast agents. The high sensitivity of SWI relative to other imaging techniques in showing tumor vasculature and microhemorrhages suggests that it is an effective imaging modality that provides additional information not shown using conventional MRI. Despite SWI's clinical advantages, its implementation in MRI protocols is still far from consistent in clinical usage. To develop a deeper appreciation for SWI, the authors here review the clinical applications in 4 major fields of neurosurgery: neurooncology, vascular neurosurgery, neurotraumatology, and functional neurosurgery. Finally, they address the limitations of and future perspectives on SWI in neurosurgery.	[Di Leva, Antonio; Lam, Timothy; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Dept Surg, Toronto, ON M5B 1W8, Canada; [Alcaide-Leon, Paula; Bharatha, Aditya; Montanera, Walter] Univ Toronto, St Michaels Hosp, Dept Radiol, Div Neuroradiol, Toronto, ON M5B 1W8, Canada		Di Leva, A (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	diieva@hotmail.com	Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650; Di Ieva, Antonio/0000-0002-5341-5416			Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Ashwal S, 2010, DEV NEUROSCI-BASEL, V32, P343, DOI 10.1159/000316801; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Bai QK, 2013, NEUROL RES, V35, P586, DOI 10.1179/1743132813Y.0000000179; Baik SK, 2012, CEREBROVASC DIS, V34, P206, DOI 10.1159/000342148; Bauer S, 2013, PHYS MED BIOL, V58, pR97, DOI 10.1088/0031-9155/58/13/R97; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Beggs CB, 2012, NEUROL RES, V34, P793, DOI 10.1179/1743132812Y.0000000048; Bian W, 2014, NEURORADIOLOGY, V56, P91, DOI 10.1007/s00234-013-1297-8; Butcher KS, 2003, STROKE, V34, pE215, DOI 10.1161/01.STR.0000099066.23627.24; Cai M, 2015, NEURORADIOLOGY, V57, P163, DOI 10.1007/s00234-014-1450-z; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Choi JI, 2014, CHILD NERV SYST, V30, P1011, DOI 10.1007/s00381-013-2349-4; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; CRAELIUS W, 1982, ARCH PATHOL LAB MED, V106, P397; de Champfleur NM, 2011, NEUROSURGERY, V68, P641, DOI 10.1227/NEU.0b013e31820773cf; de Souza JM, 2008, AM J NEURORADIOL, V29, P154, DOI 10.3174/ajnr.A0748; Deistung A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00710; Deistung A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057924; Di Ieva A, 2015, NEUROSCIENTIST, V21, P30, DOI 10.1177/1073858413513928; Di Ieva A, 2013, NEURORADIOLOGY, V55, P35, DOI 10.1007/s00234-012-1081-1; Di Ieva A, 2012, WORLD NEUROSURG, V77, DOI 10.1016/j.wneu.2011.09.006; Di Ieva A, 2011, NEUROIMAGE, V54, P74, DOI 10.1016/j.neuroimage.2010.07.045; El-Koussy M, 2012, AM J NEURORADIOL, V33, P715, DOI 10.3174/ajnr.A2893; Frischer JM, 2012, NEUROIMAGE-CLIN, V1, P116, DOI 10.1016/j.nicl.2012.09.005; Fu JH, 2015, EUR RADIOL, V25, P1413, DOI 10.1007/s00330-014-3518-x; Fujima N, 2010, RADIOLOGY, V254, P891, DOI 10.1148/radiol.09090286; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Go JL, 1998, NEUROIMAG CLIN N AM, V8, P541; Grabner G, 2014, J MAGN RESON IMAGING, V40, P655, DOI 10.1002/jmri.24393; Grabner G, 2012, MAGN RESON IMAGING, V30, P139, DOI 10.1016/j.mri.2011.08.004; Grabner G, 2011, J MAGN RESON IMAGING, V33, P543, DOI 10.1002/jmri.22452; Gramsch C, 2013, EUR RADIOL, V23, P2622, DOI 10.1007/s00330-013-2857-3; Gupta D, 2010, NEURORADIOLOGY, V52, P1087, DOI 10.1007/s00234-010-0677-6; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Haller S, 2013, EUR RADIOL, V23, P12, DOI 10.1007/s00330-012-2579-y; Han YH, 2013, J NEUROL SCI, V325, P29, DOI 10.1016/j.jns.2012.11.009; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hori M, 2010, MAGN RESON IMAGING, V28, P594, DOI 10.1016/j.mri.2010.01.002; Hu J, 2008, J MAGN RESON IMAGING, V28, P300, DOI 10.1002/jmri.21435; Huang PY, 2012, J NEUROL, V259, P1426, DOI 10.1007/s00415-011-6369-2; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; Jagadeesan BD, 2012, AM J NEURORADIOL, V33, P1747, DOI 10.3174/ajnr.A3058; Jagadeesan BD, 2011, STROKE, V42, P87, DOI 10.1161/STROKEAHA.110.584862; Jenkinson MD, 2006, BRAIN, V129, P1884, DOI 10.1093/brain/awl108; Jin L, 2012, EUR J NEUROL, V19, P969, DOI 10.1111/j.1468-1331.2011.03658.x; Kao HW, 2012, EUR RADIOL, V22, P1397, DOI 10.1007/s00330-012-2387-4; Kawabori M, 2009, NEUROL MED-CHIR, V49, P248, DOI 10.2176/nmc.49.248; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Kesavadas C, 2010, NEURORADIOLOGY, V52, P1047, DOI 10.1007/s00234-010-0733-2; Kim HS, 2009, AM J NEURORADIOL, V30, P1574, DOI 10.3174/ajnr.A1635; Kumar R, 1998, MOVEMENT DISORD, V13, P73; Letourneau-Guillon L, 2012, AM J NEURORADIOL, V33, P301, DOI 10.3174/ajnr.A2777; Li CT, 2010, EUR J RADIOL, V75, pE81, DOI 10.1016/j.ejrad.2009.08.003; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063013; Lobel U, 2010, NEURORADIOLOGY, V52, P1167, DOI 10.1007/s00234-010-0771-9; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; Lou X, 2009, AM J NEURORADIOL, V30, P1694, DOI 10.3174/ajnr.A1696; Lou X, 2012, J MAGN RESON IMAGING, V36, P92, DOI 10.1002/jmri.23624; Luo S, 2014, J NEURORADIOL; Lupo JM, 2013, NEURO-ONCOLOGY, V15, P480, DOI 10.1093/neuonc/nos325; Lupo JM, 2012, INT J RADIAT ONCOL, V82, pE493, DOI 10.1016/j.ijrobp.2011.05.046; Lupo JM, 2009, MAGN RESON IMAGING, V27, P480, DOI 10.1016/j.mri.2008.08.003; Maderwald S, 2012, NEUROIMAGE, V63, P1421, DOI 10.1016/j.neuroimage.2012.07.063; Mahvash M, 2014, CLIN NEUROL NEUROSUR, V124, P151, DOI 10.1016/j.clineuro.2014.06.041; MARTIN F, 1952, AM J PATHOL, V28, P1107; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Moenninghoff C, 2010, KOREAN J RADIOL, V11, P244, DOI 10.3348/kjr.2010.11.2.244; MORK SJ, 1985, J NEUROSURG, V63, P881, DOI 10.3171/jns.1985.63.6.0881; Nishiguchi T, 2013, EUR RADIOL, V23, P551, DOI 10.1007/s00330-012-2618-8; O'Gorman RL, 2011, EUR RADIOL, V21, P130, DOI 10.1007/s00330-010-1885-5; Ohmoto Y, 2002, NEUROL MED-CHIR, V42, P264, DOI 10.2176/nmc.42.264; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Park MJ, 2009, AM J NEURORADIOL, V30, P1402, DOI 10.3174/ajnr.A1593; Park SM, 2010, BRIT J RADIOL, V83, P466, DOI 10.1259/bjr/34304111; Patel NK, 2008, STEREOT FUNCT NEUROS, V86, P153, DOI 10.1159/000120427; Peters S, 2013, NEURORADIOLOGY, V55, P853, DOI 10.1007/s00234-013-1185-2; Peters S, 2012, ROFO-FORTSCHR RONTG, V184, P713, DOI 10.1055/s-0032-1312862; Pinker K, 2007, INVEST RADIOL, V42, P346, DOI 10.1097/01.rli.0000262744.85397.fc; Radbruch A, 2012, EUR J RADIOL, V81, P4064, DOI 10.1016/j.ejrad.2012.06.016; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Rossi M, 2010, INVEST RADIOL, V45, P795, DOI 10.1097/RLI.0b013e3181ec9c96; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Shimoda Y, 2011, MAGN RESON MED SCI, V10, P49, DOI 10.2463/mrms.10.49; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Starr PA, 2002, STEREOT FUNCT NEUROS, V79, P118, DOI 10.1159/000070828; Sun W, 2013, CEREBROVASC DIS, V35, P469, DOI 10.1159/000350203; Toh CH, 2012, AM J NEURORADIOL, V33, P1534, DOI 10.3174/ajnr.A2986; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tuleasca C, 2014, NEUROCHIRURGIE, V60, P347; Vossough A, 2012, PEDIATR RADIOL, V42, P481, DOI 10.1007/s00247-011-2330-x; WALTON JC, 1984, ARCH PATHOL LAB MED, V108, P755; Wang MY, 2011, MAGN RESON IMAGING, V29, P365, DOI 10.1016/j.mri.2010.10.016; Wang Y, 2012, AM J NEURORADIOL, V33, P266, DOI 10.3174/ajnr.A2765; Whitehead KJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006635; Wieczorek-Pastusiak J, 2013, POL J RADIOL, V78, P50, DOI 10.12659/PJR.883767; Willats L, 2013, NMR BIOMED, V26, P913, DOI 10.1002/nbm.2833; Wu JL, 2011, J MAGN RESON IMAGING, V34, P791, DOI 10.1002/jmri.22687; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Yamada N, 1996, RADIOLOGY, V198, P171, DOI 10.1148/radiology.198.1.8539373; ZABRAMSKI JM, 1994, J NEUROSURG, V80, P422, DOI 10.3171/jns.1994.80.3.0422; Zeng QS, 2011, ACTA RADIOL, V52, P115, DOI 10.1258/ar.2010.100220; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zhang W, 2009, J INT MED RES, V37, P1139, DOI 10.1177/147323000903700418; Zulfiqar M, 2012, AM J NEURORADIOL, V33, P858, DOI 10.3174/ajnr.A2862	118	27	28	2	25	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2015	123	6					1463	1475		10.3171/2015.1.JNS142349			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CX0FK	WOS:000365372100015	26207600	Bronze			2022-02-06	
J	Kroshus, E; Garnett, BR; Baugh, CM; Calzo, JP				Kroshus, Emily; Garnett, Bernice R.; Baugh, Christine M.; Calzo, Jerel P.			Social norms theory and concussion education	HEALTH EDUCATION RESEARCH			English	Article							SPORT-RELATED CONCUSSION; HIGH-SCHOOL; ICE HOCKEY; EPIDEMIOLOGY; INTERVENTION; COLLEGIATE; KNOWLEDGE; SYMPTOMS; DRINKING; RISK	Secondary prevention of harm from sport-related concussion is contingent on immediate removal from play post-injury. To-date, educational efforts to reduce the prevalent risk behavior of continued play while symptomatic have been largely ineffective. Social norms theory may hold promise as a foundation for more effective concussion education aimed at increasing concussion reporting. The primary objective of this study was to assess whether perceived team concussion reporting norms would be less supportive of an individual's safe concussion symptom reporting behavior than objective team norms. Participants were 328 male and female US collegiate athletes. Written surveys were completed in person during the spring of 2014. Among both male and female athletes, team concussion reporting norms were significantly misperceived, with athletes tending to think that they themselves have safer attitudes about concussion reporting than their teammates. Perceived norms were associated with symptom reporting intention, independent of the team's objective reporting norm. A social norms approach to concussion education, in which misperceived group norms are corrected and shifted in the direction of safety, is an important avenue for program development and evaluation research aimed at the secondary prevention of harm from concussion. Implications for the design of this type of educational programming are discussed.	[Kroshus, Emily] Univ Washington, Dept Pediat, Ctr Child Hlth Behav & Dev, Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Kroshus, Emily] Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Garnett, Bernice R.] Univ Vermont, Dept Educ, Coll Educ & Social Serv, Burlington, VT USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Baugh, Christine M.] Boston Childrens Hosp, Div Sports Med, Cambridge, MA USA; [Calzo, Jerel P.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Calzo, Jerel P.] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Boston, MA USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, Ctr Child Hlth Behav & Dev, Seattle Childrens Res Inst, Seattle, WA 98195 USA.	ekroshus@u.washington.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Calzo, Jerel/0000-0002-4656-1052	National Institute of Mental Health of National Institutes of Health [T32MH019733]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [K01DA034753] Funding Source: NIH RePORTER	Christine M. Baugh was supported by the National Institute of Mental Health of theNational Institutes of Health under Award Number T32MH019733. The content is solely theresponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson E, 2009, ROUTL RES GEND SOC, P1; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Berkowitz A. D., 2003, SOCIAL NORMS APPROAC, P259; Borsari B, 2003, J STUD ALCOHOL, V64, P331, DOI 10.15288/jsa.2003.64.331; Carey KB, 2007, ADDICT BEHAV, V32, P2469, DOI 10.1016/j.addbeh.2007.05.004; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; *CDCP, HEADS CONC HIGH SCH; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; EAGLEY AH, 1987, SEX DIFFERENCES SOCI; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gidycz CA, 2011, VIOLENCE AGAINST WOM, V17, P720, DOI 10.1177/1077801211409727; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hardy J, 2005, SMALL GR RES, V36, P166, DOI 10.1177/1046496404266715; HECKATHORN DD, 1988, AM J SOCIOL, V94, P535, DOI 10.1086/229029; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Horne C, 2001, SOC PSYCHOL QUART, V64, P253, DOI 10.2307/3090115; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2014, INT EPIDEMIOL, V1, P1; Kitts JA, 2006, AM SOCIOL REV, V71, P235, DOI 10.1177/000312240607100204; Kitts JA, 2003, SOC PSYCHOL QUART, V66, P222, DOI 10.2307/1519823; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, EAT DISORD, V22, P136, DOI 10.1080/10640266.2013.867744; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; LaBrie JW, 2010, ADDICT BEHAV, V35, P1094, DOI 10.1016/j.addbeh.2010.08.003; Lewis MA, 2006, J AM COLL HEALTH, V54, P213, DOI 10.3200/JACH.54.4.213-218; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MILLER DT, 1994, PERS SOC PSYCHOL B, V20, P541, DOI 10.1177/0146167294205011; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Moreira MT, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006748.pub2; National Collegiate Athletic Association, 1981 82 2012 13 NCAA; National Federation of High School Sports, 2014, HIGH SCH SPORT PART; NOELLENE.E, 1974, J COMMUN, V24, P43, DOI 10.1111/j.1460-2466.1974.tb00367.x; Perkins HW, 2011, GROUP PROCESS INTERG, V14, P703, DOI 10.1177/1368430210398004; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sandstrom MJ, 2010, BASIC APPL SOC PSYCH, V32, P217, DOI 10.1080/01973533.2010.495645; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	64	27	27	3	27	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0268-1153	1465-3648		HEALTH EDUC RES	Health Educ. Res.	DEC	2015	30	6					1004	1013		10.1093/her/cyv047			10	Education & Educational Research; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Education & Educational Research; Public, Environmental & Occupational Health	CZ5UG	WOS:000367166900015	26471918	Green Published, Bronze			2022-02-06	
J	Mayer, AR; Ling, JM; Dodd, AB; Gasparovic, C; Klimaj, SD; Meier, TB				Mayer, Andrew R.; Ling, Josef M.; Dodd, Andrew B.; Gasparovic, Charles; Klimaj, Stefan D.; Meier, Timothy B.			A Longitudinal Assessment of Structural and Chemical Alterations in Mixed Martial Arts Fighters	JOURNAL OF NEUROTRAUMA			English	Article						concussion; longitudinal; repetitive injury; spectroscopy; volumetrics	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; COLLEGIATE FOOTBALL PLAYERS; PROTON MR SPECTROSCOPY; NEUROCOGNITIVE PERFORMANCE; PROFESSIONAL FIGHTERS; N-ACETYLASPARTATE; NCAA CONCUSSION; HEAD TRAUMA; SYMPTOMS	Growing evidence suggests that temporally proximal acute concussions and repetitive subconcussive head injuries may lead to long-term neurological deficits. However, the underlying mechanisms of injury and their relative time-scales are not well documented in human injury models. The current study therefore investigated whether biomarkers of brain chemistry (magnetic resonance [MR] spectroscopy: N-acetylaspartate [NAA], combined glutamate and glutamine [Glx], total creatine [Cre], choline compounds [Cho], and myo-inositol [mI]) and structure (cortical thickness, white matter [WM]/subcortical volume) differed between mixed martial artists (MMA; n=13) and matched healthy controls (HC) without a history of contact sport participation (HC; n=14). A subset of participants (MMA=9; HC=10) returned for follow-up visits, with MMA (n=3) with clinician-documented acute concussions also scanned serially. As expected, MMA self-reported a higher incidence of previous concussions and significantly more cognitive symptoms during prior concussion recovery. Fighters also exhibited reduced memory and processing speed relative to controls on neuropsychological testing coupled with cortical thinning in the left posterior cingulate gyrus and right occipital cortex at baseline assessment. Over a 1-year follow-up period, MMA experienced a significant decrease in both WM volume and NAA concentration, as well as relative thinning in the left middle and superior frontal gyri. These longitudinal changes did not correlate with self-reported metrics of injury (i.e., fight diary). In contrast, HC did not exhibit significant longitudinal changes over a 4-month follow-up period (p>0.05). Collectively, current results provide preliminary evidence of progressive changes in brain chemistry and structure over a relatively short time period in individuals with high exposure to repetitive head hits. These findings require replication in independent samples.	[Mayer, Andrew R.; Ling, Josef M.; Dodd, Andrew B.; Gasparovic, Charles; Klimaj, Stefan D.; Meier, Timothy B.] Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA		Mayer, AR (corresponding author), Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org	Klimaj, Stefan/AAV-4060-2020				Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gasparovic C, 2001, NEUROSCI LETT, V301, P87, DOI 10.1016/S0304-3940(01)01616-0; Gasparovic C, 2006, MAGN RESON MED, V55, P1219, DOI 10.1002/mrm.20901; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; George EO, 2014, J NEUROTRAUM, V31, P1018, DOI 10.1089/neu.2013.3224; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heath CJ, 2013, RES SPORTS MED, V21, P195, DOI 10.1080/15438627.2013.792082; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Johnson B, 2012, J NEUROTRAUM, V29, P2297, DOI 10.1089/neu.2011.2294; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Schlaffke L, 2014, NEUROSCIENCE, V259, P35, DOI 10.1016/j.neuroscience.2013.11.046; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sivak S, 2014, BRAIN INJURY, V28, P341, DOI 10.3109/02699052.2013.865270; Sobell M. B., 1996, TIMELINE FOLLOWBACK; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2013, J HEAD TRAUMA REHAB, V28, P284, DOI 10.1097/HTR.0b013e3182795045; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; Walz NC, 2008, J NEUROTRAUM, V25, P94, DOI 10.1089/neu.2007.0362; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	61	27	27	1	29	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2015	32	22					1759	1767		10.1089/neu.2014.3833			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV6ST	WOS:000364401500006	26096140				2022-02-06	
J	Bock, S; Grim, R; Barron, TF; Wagenheim, A; Hu, YE; Hendell, M; Deitch, J; Deibert, E				Bock, Suzanne; Grim, Rod; Barron, Todd F.; Wagenheim, Andrew; Hu, Yaowen Eliot; Hendell, Matthew; Deitch, John; Deibert, Ellen			Factors associated with delayed recovery in athletes with concussion treated at a pediatric neurology concussion clinic	CHILDS NERVOUS SYSTEM			English	Article						Pediatric; Concussion; Recovery; Factors	SPORTS CONCUSSION; MANAGEMENT; EPIDEMIOLOGY	With the increase in knowledge and management of sport-related concussion over the last 15 years, there has been a shift from a grading scale approach to an individualized management approach. As a result, there is an increased need to better understand the factors involved in delayed recovery of concussion. The purpose of this retrospective study was to examine factors that may be associated with recovery from sport-related concussion in student athletes aged 11 to 18 years old. Of the 366 patients who met the inclusion criteria, 361 were included in our analysis. The primary dependent variable included days until athlete was able to return to play (RTP). Independent variables of interest included age, gender, academic performance, comorbid factors, sports, on-field markers, days until initial neurological evaluation, Immediate Post-Concussion Assessment and Cognitive Testing (ImPACTA (R)) scores, acute headache rescue medications, chronic headache medication, sleep medication, and referral to concussion rehabilitation program. Variables associated with longer median RTP were being female (35 days), having a referral to concussion rehabilitation program (53 days), being prescribed acute headache rescue therapy (34 days), and having chronic headache treatment (53 days) (all p < 0.05). Variables associated with shorter RTP were on-field marker of headache (23 days) and evaluation within 1 week of concussion by a concussion specialist (16 days) (Both p < 0.05). This study supports the need for a concussed athlete to have access to a provider trained in concussion management in a timely fashion in order to prevent delayed recovery and return to play.	[Bock, Suzanne; Grim, Rod] WellSpan Hlth, Emig Res Ctr, York Hosp, York, PA 17405 USA; [Barron, Todd F.; Hendell, Matthew; Deibert, Ellen] WellSpan Neurosci, York, PA 17402 USA; [Wagenheim, Andrew] Pinnacle Hlth Spine & Sports Med, Mechanicsburg, PA 17050 USA; [Hu, Yaowen Eliot] VCU Fairfax Family Practice Sports Med Fellowship, Richmond, VA USA; [Hu, Yaowen Eliot] George Mason Univ, Team Phys, Fairfax, VA 22030 USA; [Hu, Yaowen Eliot] Herndon High Sch, Team Phys, Herndon, VA 20170 USA; [Deitch, John] Sports Med WellSpan Hlth, York, PA 17403 USA; [Deibert, Ellen] Drexel Univ, Dept Neurol, Coll Med, Philadelphia, PA 19102 USA; [Barron, Todd F.] Penn Coll Med, Hershey, PA 17033 USA		Bock, S (corresponding author), WellSpan Hlth, Emig Res Ctr, York Hosp, 1001 S George St, York, PA 17405 USA.	markbock@comcast.net					Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; CDC, 2007, CDC ANN UPD INF HELP; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gordon KE, 2006, PEDIATR NEUROL, V34, P376, DOI 10.1016/j.pediatrneurol.2005.09.007; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Kelly JP, 1997, NEUROLOGY, V48, P581; Kinnaman KA, 2013, ACTA PAEDIATR, V102, pE424, DOI 10.1111/apa.12315; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell M, 2009, CLIN SPORT MED, V28, P95, DOI 10.1016/j.csm.2008.08.008; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; McCarthy Mark, 2010, Conn Med, V74, P485; McCrea M, 2012, CLIN NEUROPSYCHOL, V26, P1, DOI 10.1080/13854046.2012.658678; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	21	27	27	1	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	NOV	2015	31	11					2111	2116		10.1007/s00381-015-2846-8			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CU4FT	WOS:000363483300019	26243160				2022-02-06	
J	Kanninen, KM; Pomeshchik, Y; Leinonen, H; Malm, T; Koistinaho, J; Levonen, AL				Kanninen, Katja M.; Pomeshchik, Yuriy; Leinonen, Hanna; Malm, Tarja; Koistinaho, Jari; Levonen, Anna-Liisa			Applications of the Keap1-Nrf2 system for gene and cell therapy	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Nrf2; Transcription factor; Gene therapy; Stem cell therapy; Cancer; Spinal cord injury; Neurodegenerative diseases	SPINAL-CORD-INJURY; NEURAL STEM-CELLS; IMPROVE MEMORY DYSFUNCTION; TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; MOUSE MODEL; ISCHEMIC-STROKE; LENTIVIRAL VECTORS	Oxidative stress has been implicated to play a role in a number of acute and chronic diseases including acute injuries of the central nervous system, neurodegenerative and cardiovascular diseases, and cancer. The redox-activated transcription factor Nrf2 has been shown to protect many different cell types and organs from a variety of toxic insults, whereas in many cancers, unchecked Nrf2 activity increases the expression of cytoprotective genes and, consequently, provides growth advantage to cancerous cells. Herein, we discuss current preclinical gene therapy approaches to either increase or decrease Nrf2 activity with a special reference to neurological diseases and cancer. In addition, we discuss the role of Nrf2 in stem cell therapy for neurological disorders. (C) 2015 Elsevier Inc. All rights reserved.	[Kanninen, Katja M.; Pomeshchik, Yuriy; Malm, Tarja; Koistinaho, Jari] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Joensuu, Finland; [Leinonen, Hanna; Levonen, Anna-Liisa] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, Joensuu, Finland		Koistinaho, J (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, Joensuu, Finland.	jari.koistinaho@uef.fi; anna-liisa.levonen@uef.fi		Levonen, Anna-Liisa/0000-0002-6575-2137; Pomeshchik, Yuriy/0000-0002-1412-7403; Malm, Tarja/0000-0002-9530-7472			Akhter H, 2011, J ALZHEIMERS DIS, V26, P767, DOI 10.3233/JAD-2011-110512; Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bastani NE, 2012, ARCH PHYS MED REHAB, V93, P2223, DOI 10.1016/j.apmr.2012.06.021; Ben Menachem-Zidon O, 2014, NEUROPSYCHOPHARMACOL, V39, P401, DOI 10.1038/npp.2013.208; Benedict AL, 2012, J NEUROTRAUM, V29, P2576, DOI 10.1089/neu.2012.2474; Benraiss A, 2011, NEUROTHERAPEUTICS, V8, P577, DOI 10.1007/s13311-011-0075-8; Blurton-Jones M., 2009, P NATL ACAD SCI US; Bobkova NV, 2013, B EXP BIOL MED+, V156, P119, DOI 10.1007/s10517-013-2293-z; Bourdenx M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00050; Burger C, 2005, HUM GENE THER, V16, P781, DOI 10.1089/hum.2005.16.781; Cai G, 2006, J GENE MED, V8, P1369, DOI 10.1002/jgm.983; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Capasso C, 2014, VIRUSES-BASEL, V6, P832, DOI 10.3390/v6020832; Chang KA, 2014, J PHARMACOL SCI, V126, P293, DOI 10.1254/jphs.14R10CP; Chang KA, 2014, NEURODEGENER DIS, V13, P99, DOI 10.1159/000355261; Chen LJ, 2008, J NEUROCHEM, V107, P197, DOI 10.1111/j.1471-4159.2008.05603.x; Chen M, 2007, J NEUROCHEM, V103, P2015, DOI 10.1111/j.1471-4159.2007.04885.x; Chen SD, 2010, J BIOENERG BIOMEMBR, V42, P461, DOI 10.1007/s10863-010-9321-8; Chen Yuying, 2013, Top Spinal Cord Inj Rehabil, V19, P1, DOI 10.1310/sci1901-1; Chen ZC, 2014, NEUROSCI BULL, V30, P271, DOI 10.1007/s12264-013-1423-y; Choi BH, 2007, NEUROSCI LETT, V412, P118, DOI 10.1016/j.neulet.2006.11.015; Choi Sung S, 2014, Exp Neurobiol, V23, P45, DOI 10.5607/en.2014.23.1.45; Choudhry F, 2012, NEUROBIOL AGING, V33, P960, DOI 10.1016/j.neurobiolaging.2010.07.008; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cyranoski D, 2013, NATURE, V494, P413, DOI 10.1038/494413a; D'Amico E, 2013, FREE RADICAL BIO MED, V65, P509, DOI 10.1016/j.freeradbiomed.2013.06.029; Dachs GU, 1997, NAT MED, V3, P515, DOI 10.1038/nm0597-515; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Darlington D, 2013, STEM CELLS DEV, V22, P412, DOI 10.1089/scd.2012.0345; Dasari Venkata Ramesh, 2014, World J Stem Cells, V6, P120, DOI 10.4252/wjsc.v6.i2.120; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; Feron F, 2005, BRAIN, V128, P2951, DOI 10.1093/brain/awh657; Ferreira M.E., 2015, CELL MOL NEUROBIOL; Follenzi Antonia, 2002, Methods Mol Med, V69, P259; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fujimoto Y, 2012, STEM CELLS, V30, P1163, DOI 10.1002/stem.1083; Gaki GS, 2014, NEUROMOL MED, V16, P217, DOI 10.1007/s12017-014-8294-x; Gamblin TC, 2000, BIOCHEMISTRY-US, V39, P14203, DOI 10.1021/bi001876l; Genovese T, 2008, SHOCK, V29, P32, DOI 10.1097/shk.0b013e318059053a; Genovese T, 2009, J NEUROCHEM, V108, P1360, DOI 10.1111/j.1471-4159.2009.05899.x; Gu G, 2015, NEUROSCIENCE, V291, P81, DOI 10.1016/j.neuroscience.2015.01.073; Hall E.D., 2015, J BIOENERG BIOMEMBR; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hao L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/468748; Harvey TJ, 2011, CANCER GENE THER, V18, P773, DOI 10.1038/cgt.2011.43; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Hermann DM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00291; Hisahara S, 1997, J NEUROCHEM, V69, P10; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Hurttila H, 2008, GENE THER, V15, P1271, DOI 10.1038/gt.2008.75; Hwang DH, 2011, EXPERT OPIN BIOL TH, V11, P1599, DOI 10.1517/14712598.2011.631908; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Jin W, 2014, ANN CLIN LAB SCI, V44, P151; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Johnson DA, 2010, TOXICOL SCI, V114, P237, DOI 10.1093/toxsci/kfp274; Joshi G, 2015, NEUROBIOL AGING, V36, P664, DOI 10.1016/j.neurobiolaging.2014.09.004; Kalladka D, 2014, STEM CELLS CLONING, V7, P31, DOI 10.2147/SCCAA.S38003; Kanamaru T, 2015, NEUROSCI LETT, V587, P126, DOI 10.1016/j.neulet.2014.12.033; Kanninen K, 2008, MOL CELL NEUROSCI, V39, P302, DOI 10.1016/j.mcn.2008.07.010; Kanninen K, 2009, P NATL ACAD SCI USA, V106, P16505, DOI 10.1073/pnas.0908397106; Karkkainen V, 2014, STEM CELLS, V32, P1904, DOI 10.1002/stem.1666; Kazmerova Z, 2013, J ALZHEIMERS DIS, V37, P251, DOI 10.3233/JAD-130572; Kefalopoulou Z, 2014, JAMA NEUROL, V71, P83, DOI 10.1001/jamaneurol.2013.4749; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kim HV, 2013, AMYLOID, V20, P7, DOI 10.3109/13506129.2012.751367; Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052787; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; L'Episcopo F, 2013, J NEUROSCI, V33, P1462, DOI 10.1523/JNEUROSCI.3206-12.2013; Lacroix S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085916; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Lebkowski Jane, 2011, Regen Med, V6, P11, DOI 10.2217/rme.11.77; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee RJ, 2000, CIRCULATION, V102, P898; Leinonen HM, 2014, ADV CANCER RES, V122, P281, DOI 10.1016/B978-0-12-420117-0.00008-6; Leinonen HM, 2012, CANCER RES, V72, P6227, DOI 10.1158/0008-5472.CAN-12-1166; Leiser SF, 2010, MOL CELL BIOL, V30, P871, DOI 10.1128/MCB.01145-09; Lentz TB, 2012, NEUROBIOL DIS, V48, P179, DOI 10.1016/j.nbd.2011.09.014; Levonen AL, 2014, FREE RADICAL BIO MED, V71, P196, DOI 10.1016/j.freeradbiomed.2014.03.025; Lewis TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012672; Leyva FJ, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-13; Li J, 2005, TOXICOL SCI, V83, P313, DOI 10.1093/toxsci/kfi027; Li T, 2014, BRAIN RES, V1558, P90, DOI 10.1016/j.brainres.2014.02.036; Lindvall O, 2012, NAT BIOTECHNOL, V30, P56, DOI 10.1038/nbt.2077; Liu XF, 2014, PROG NEUROBIOL, V115, P92, DOI 10.1016/j.pneurobio.2013.11.007; Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014; Ma T, 2013, CELL TRANSPLANT, V22, pS113, DOI 10.3727/096368913X672181; Mackay-Sim A, 2008, BRAIN, V131, P2376, DOI 10.1093/brain/awn173; Malik YS, 2013, BIOCHEM BIOPH RES CO, V432, P355, DOI 10.1016/j.bbrc.2013.01.097; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009; Mao L, 2012, J TRAUMA ACUTE CARE, V72, P189, DOI 10.1097/TA.0b013e31821bf541; Mao L, 2011, J SURG RES, V170, pE105, DOI 10.1016/j.jss.2011.05.049; Mao L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/238321; Marei HES, 2015, J CELL PHYSIOL, V230, P116, DOI 10.1002/jcp.24688; Marignol L, 2009, J GENE MED, V11, P169, DOI 10.1002/jgm.1281; Mattis VB, 2011, LANCET NEUROL, V10, P383, DOI 10.1016/S1474-4422(11)70022-9; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000536; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Mendez-Armenta M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/293689; Merson TD, 2014, INT J BIOCHEM CELL B, V56, P4, DOI 10.1016/j.biocel.2014.08.003; Mielke MM, 2014, CLIN EPIDEMIOL, V6, P37, DOI 10.2147/CLEP.S37929; Mittal D, 2014, DRUG DELIV, V21, P75, DOI 10.3109/10717544.2013.838713; Mohamad O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064160; Morroni F, 2013, NEUROTOXICOLOGY, V36, P63, DOI 10.1016/j.neuro.2013.03.004; Mothe AJ, 2013, INT J DEV NEUROSCI, V31, P701, DOI 10.1016/j.ijdevneu.2013.07.004; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Namani A, 2014, BBA-MOL CELL RES, V1843, P1875, DOI 10.1016/j.bbamcr.2014.05.003; Negi G, 2011, CURR NEUROVASC RES, V8, P294, DOI 10.2174/156720211798120972; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Nowakowski A, 2013, ACTA NEUROBIOL EXP, V73, P1; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Pachori AS, 2004, P NATL ACAD SCI USA, V101, P12282, DOI 10.1073/pnas.0404616101; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Pan H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/217580; Park D, 2012, EXP NEUROL, V234, P521, DOI 10.1016/j.expneurol.2011.12.040; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Persson A, 2006, J NEURO-ONCOL, V78, P1, DOI 10.1007/s11060-005-9055-3; Persson T, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/427318; Petit GH, 2014, NEUROPATH APPL NEURO, V40, P60, DOI 10.1111/nan.12110; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Polentes J, 2012, CELL TRANSPLANT, V21, P2587, DOI 10.3727/096368912X653228; Policastro LL, 2009, MOL THER, V17, P1355, DOI 10.1038/mt.2009.103; Pollari E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00131; Pomeshchik Y, 2014, ANTIOXID REDOX SIGN, V20, P1313, DOI 10.1089/ars.2013.5453; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ramsey CP, 2007, J NEUROPATH EXP NEUR, V66, P75, DOI 10.1097/nen.0b013e31802d6da9; Reddy SA, 2015, INT IMMUNOPHARMACOL, V24, P440, DOI 10.1016/j.intimp.2014.12.037; Reeh M, 2013, BRIT J CANCER, V109, P1848, DOI 10.1038/bjc.2013.509; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Rinsch C, 1997, HUM GENE THER, V8, P1881, DOI 10.1089/hum.1997.8.16-1881; Roet KCD, 2014, EXP NEUROL, V261, P594, DOI 10.1016/j.expneurol.2014.05.007; Romanyuk N, 2014, CELL TRANSPLANT; Rooney GE, 2009, TISSUE ENG PT A, V15, P3049, DOI [10.1089/ten.tea.2009.0045, 10.1089/ten.TEA.2009.0045]; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Rowley S, 2013, FREE RADICAL BIO MED, V62, P121, DOI 10.1016/j.freeradbiomed.2013.02.002; Ruggieri S, 2014, THER CLIN RISK MANAG, V10, P229, DOI 10.2147/TCRM.S53285; Ruszkiewicz J., 2015, NEUROCHEM INT; Sabelstrom H, 2014, EXP NEUROL, V260, P44, DOI 10.1016/j.expneurol.2013.01.026; Saberi H, 2008, NEUROSCI LETT, V443, P46, DOI 10.1016/j.neulet.2008.07.041; Sakata H, 2012, J NEUROSCI, V32, P3462, DOI 10.1523/JNEUROSCI.5686-11.2012; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322; Shah ZA, 2007, NEUROSCIENCE, V147, P53, DOI 10.1016/j.neuroscience.2007.02.066; Shi QD, 2009, NEUROSCI LETT, V465, P220, DOI 10.1016/j.neulet.2009.08.049; Shibata T, 2002, NEOPLASIA, V4, P40, DOI 10.1038/sj.neo.7900189; Shih AY, 2005, J BIOL CHEM, V280, P22925, DOI 10.1074/jbc.M414635200; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Smith JG, 2010, CURR TOP MICROBIOL, V343, P195, DOI 10.1007/82_2010_16; Springer ML, 1998, MOL CELL, V2, P549, DOI 10.1016/S1097-2765(00)80154-9; Su H, 2004, P NATL ACAD SCI USA, V101, P16280, DOI 10.1073/pnas.0407449101; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Tabakow P, 2013, CELL TRANSPLANT, V22, P1591, DOI 10.3727/096368912X663532; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka N, 2011, BRAIN RES, V1370, P246, DOI 10.1016/j.brainres.2010.11.010; Tang J, 2008, NEUROSCI RES, V62, P86, DOI 10.1016/j.neures.2008.06.005; Tatarishvili J, 2014, RESTOR NEUROL NEUROS, V32, P547, DOI 10.3233/RNN-140404; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Tong LM, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.124; Tong LM, 2014, J NEUROSCI, V34, P9506, DOI 10.1523/JNEUROSCI.0693-14.2014; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vannucci L, 2013, NEW MICROBIOL, V36, P1; Vawda R, 2013, CURR STEM CELL RES T, V8, P25, DOI 10.2174/1574888X11308010005; Vehvilaainen P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00126; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wang CY, 2014, ANTIOXID REDOX SIGN, V21, P2208, DOI 10.1089/ars.2014.5845; Wang W, 2014, BRAIN RES, V1544, P54, DOI 10.1016/j.brainres.2013.12.004; Wang XL, 2012, J NEUROTRAUM, V29, P936, DOI 10.1089/neu.2011.1922; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097685; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Yang H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt227; Yla-Herttuala S, 2012, MOL THER, V20, P1831, DOI 10.1038/mt.2012.194; Yuan SH, 2013, AGEING RES REV, V12, P739, DOI 10.1016/j.arr.2013.04.002; Yuan X, 2011, STEM CELLS, V29, P549, DOI 10.1002/stem.594; Yun HM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.490; Zavattari P., 2015, HEPATOLOGY; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589; Zhang W, 2014, J NEUROSCI RES, V92, P185, DOI 10.1002/jnr.23299; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523	211	27	27	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	NOV	2015	88		B				350	361		10.1016/j.freeradbiomed.2015.06.037			12	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CV0TN	WOS:000363966300023	26164630				2022-02-06	
J	Matsushima, K; Inaba, K; Siboni, S; Skiada, D; Strumwasser, AM; Magee, GA; Sung, GY; Benjaminm, ER; Lam, L; Demetriades, D				Matsushima, Kazuhide; Inaba, Kenji; Siboni, Stefano; Skiada, Dimitra; Strumwasser, Aaron M.; Magee, Gregory A.; Sung, Gene Y.; Benjaminm, Elizabeth R.; Lam, Lydia; Demetriades, Demetrios			Emergent operation for isolated severe traumatic brain injury: Does time matter?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; emergency operation; time; prognosis	ACUTE SUBDURAL-HEMATOMA; COMATOSE PATIENTS; TO-TREATMENT; MORTALITY; GUIDELINES; MANAGEMENT; HOSPITALS; SURGERY; STROKE	BACKGROUND It remains unclear whether the timing of neurosurgical intervention impacts the outcome of patients with isolated severe traumatic brain injury (TBI). We hypothesized that a shorter time between emergency department (ED) admission to neurosurgical intervention would be associated with a significantly higher rate of patient survival. METHODS Our institutional trauma registry was queried for patients (2003-2013) who required an emergent neurosurgical intervention (craniotomy, craniectomy) for TBI within 300 minutes after the ED admission. We included patients with altered mental status upon presentation in the ED (Glasgow Coma Scale [GCS] score < 9). Patients with associated severe injuries (Abbreviated Injury Scale [AIS] score 2) in other body regions were excluded. In-hospital mortality of patients who underwent surgery in less than 200 minutes (early group) was compared with those who underwent surgery in 200 minutes or longer (late group) using univariate and multivariate analyses. RESULTS A total of 161 patients were identified during the study time frame. Head computed tomographic scan demonstrated subdural hematoma in 85.8%, subarachnoid hemorrhage in 55.5%, and equal numbers of epidural hematoma and intraparenchymal hemorrhage in 22.6%. Median time between ED admission and neurosurgical intervention was 133 minutes. In univariate analysis, a significantly lower in-hospital mortality rate was identified in the early group (34.5% vs. 59.1%, p = 0.03). After adjusting for clinically important covariates in a logistic regression model, early neurosurgical intervention was significantly associated with a higher odds of patient survival (odds ratio, 7.41; 95% confidence interval, 1.66-32.98; p = 0.009). CONCLUSION Our data suggest that the survival rate of isolated severe TBI patients who required an emergent neurosurgical intervention could be time dependent. These patients might benefit from expedited process (computed tomographic scan, neurosurgical consultation, etc.) to shorten the time to surgical intervention. LEVEL OF EVIDENCE Prognostic study, level IV.	[Matsushima, Kazuhide; Inaba, Kenji; Siboni, Stefano; Skiada, Dimitra; Strumwasser, Aaron M.; Magee, Gregory A.; Benjaminm, Elizabeth R.; Lam, Lydia; Demetriades, Demetrios] Univ So Calif, Div Acute Care Surg, Los Angeles, CA USA; [Sung, Gene Y.] Univ So Calif, Div Neurocrit Care & Stroke, Los Angeles, CA USA		Matsushima, K (corresponding author), 1200 N State St,Inpatient Tower C,Rm C5L100, Los Angeles, CA 90033 USA.	mkazu45@gmail.com	INABA, KENJI/AAC-8532-2020; Siboni, Stefano/AAF-5456-2019	Siboni, Stefano/0000-0003-0532-3135			American College of Surgeons, NAT TRAUM DAT STAND; American College of Surgeons, 2014, RESOURCES OPTIMAL CA, V6; American College of Surgeons, 2012, ADV TRAUM LIF SUPP S, V9th; Bradley EH, 2005, J AM COLL CARDIOL, V46, P1236, DOI 10.1016/j.jacc.2005.07.009; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY, V58, pS16; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Faul M, 2010, TRAUMATIC BRAIN INJU; Fung Kon Jin PH, 2009, EUR J RADIOL, V72, P134; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Rasouli MR, 2013, ANN SURG, V257, pE8, DOI 10.1097/SLA.0b013e318289f0c9; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Tien HCN, 2011, ANN SURG, V253, P1178, DOI 10.1097/SLA.0b013e318217e339; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Xian Y, 2014, STROKE, V45, P1387, DOI 10.1161/STROKEAHA.113.003898	23	27	27	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2015	79	5					838	842		10.1097/TA.0000000000000719			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	CV3XX	WOS:000364201100021	26317818				2022-02-06	
J	Zhang, B; Wang, B; Cao, SH; Wang, YQ				Zhang, Bo; Wang, Bing; Cao, Shuhua; Wang, Yongqiang			Epigallocatechin-3-Gallate (EGCG) Attenuates Traumatic Brain Injury by Inhibition of Edema Formation and Oxidative Stress	KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY			English	Article						Anti-oxidant; Edema; EGCG; NADPH; Traumatic brain injury	GREEN TEA POLYPHENOL; CEREBRAL-ISCHEMIA; DOWN-REGULATION; GALLATE; DAMAGE; ACTIVATION; EXPRESSION; PATHOPHYSIOLOGY; INVOLVEMENT; MECHANISMS	Traumatic brain injury (TBI) is a major cause of mortality and long-term disability, which can decrease quality of life. In spite of numerous studies suggesting that Epigallocatechin-3- gallate (EGCG) has been used as a therapeutic agent for a broad range of disorders, the effect of EGCG on TBI remains unknown. In this study, a weight drop model was established to evaluate the therapeutic potential of EGCG on TBI. Rats were administered with 100 mg/kg EGCG or PBS intraperitoneally. At different times following trauma, rats were sacrificed for analysis. It was found that EGCG (100 mg/kg, i.p.) treatment significantly reduced brain water content and vascular permeability at 12, 24, 48, 72 hour after TBI. Real-time PCR results revealed that EGCG inhibited TBI-induced IL-1 beta and TNF-alpha mRNA expression. Importantly, CD68 mRNA expression decreasing in the brain suggested that EGCG inhibited microglia activation. Western blotting and immunohistochemistry results showed that administering of EGCG significantly inhibited the levels of aquaporin-4 (AQP4) and glial fibrillary acidic protein (GFAP) expression. TBI-induced oxidative stress was remarkably impaired by EGCG treatment, which elevated the activities of SOD and GSH-PX. Conversely, EGCG significantly reduced the contents of MDA after TBI. In addition, EGCG decreased TBI-induced NADPH oxidase activation through inhibition of p47(phox) translocation from cytoplasm to plasma membrane. These data demonstrate that EGCG treatment may be an effective therapeutic strategy for TBI and the underlying mechanism involves inhibition of oxidative stress.	[Zhang, Bo] Tianjin Huanhu Hosp, Intens Care Unit, Tianjin Key Lab Cerebral Vasc & Neurodegenerat Di, Tianjin 300060, Peoples R China; [Zhang, Bo; Wang, Bing; Cao, Shuhua; Wang, Yongqiang] Tianjin First Ctr Hosp, Tianjin Inst Emergency Med, Intens Care Unit, Tianjin 300192, Peoples R China		Wang, YQ (corresponding author), Tianjin First Ctr Hosp, Tianjin Inst Emergency Med, Intens Care Unit, 24 Fukang Rd, Tianjin 300192, Peoples R China.	yongqiangwangdr@163.com			National Clinical Key Specialty Construction Project [2011873]	This work was supported by National Clinical Key Specialty Construction Project (2011873).	Adachi N, 2006, EUR J PHARMACOL, V531, P171, DOI 10.1016/j.ejphar.2005.12.024; Ahn HY, 2010, KOREAN J PHYSIOL PHA, V14, P325, DOI 10.4196/kjpp.2010.14.5.325; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Fang MZ, 2003, CANCER RES, V63, P7563; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ge R, 2013, BRAIN RES, V1527, P40, DOI 10.1016/j.brainres.2013.06.009; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Huang J, 2013, BRAIN RES, V1539, P61, DOI 10.1016/j.brainres.2013.09.022; Kim KC, 2014, KOREAN J PHYSIOL PHA, V18, P61, DOI 10.4196/kjpp.2014.18.1.61; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee H, 2004, J NEUROSCI RES, V77, P892, DOI 10.1002/jnr.20193; Lehmann GL, 2004, CURR NEUROVASC RES, V1, P293, DOI 10.2174/1567202043362081; Levites Y, 2002, J BIOL CHEM, V277, P30574, DOI 10.1074/jbc.M202832200; Li GX, 2015, KOREAN J PHYSIOL PHA, V19, P1, DOI 10.4196/kjpp.2015.19.1.1; Liu XB, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-187; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Rezai-Zadeh K, 2005, J NEUROSCI, V25, P8807, DOI 10.1523/JNEUROSCI.1521-05.2005; Schroeder EK, 2009, ANTIOXID REDOX SIGN, V11, P469, DOI [10.1089/ars.2008.2215, 10.1089/ARS.2008.2215]; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Tobi SE, 2002, INT J CANCER, V102, P439, DOI 10.1002/ijc.10730; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Yu JX, 2010, FEBS LETT, V584, P2921, DOI 10.1016/j.febslet.2010.05.011; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	38	27	29	0	19	KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY	SEOUL	C/O EDITORIAL OFFICE, 448-13 SEOKYO-DONG, SEOUL, SOUTH KOREA	1226-4512	2093-3827		KOREAN J PHYSIOL PHA	KOREAN J. PHYSIOL. PHARMACOL.	NOV	2015	19	6					491	497		10.4196/kjpp.2015.19.6.491			7	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	CU2LW	WOS:000363356000003	26557015	Green Published, Green Submitted			2022-02-06	
J	Boyd, BJ; Galle, A; Daglas, M; Rosenfeld, JV; Medcalf, R				Boyd, Ben J.; Galle, Adam; Daglas, Maria; Rosenfeld, Jeffrey V.; Medcalf, Robert			Traumatic brain injury opens blood-brain barrier to stealth liposomes via an enhanced permeability and retention (EPR)-like effect	JOURNAL OF DRUG TARGETING			English	Article						Albumin; blood-brain barrier; extravasation; stealth liposomes; traumatic brain injury	SERUM-ALBUMIN; MOLECULAR-WEIGHT; MICE; DENDRIMER; FASUDIL; EDEMA; MODEL	The opening of the tight junctions in the blood-brain barrier (BBB) following traumatic brain injury (TBI) is hypothesized to be sufficient to enable accumulation of large drug carriers, such as stealth liposomes, in a similar manner to the extravasation seen in tumor tissue via the enhanced permeability and retention (EPR) effect. The controlled cortical impact model of TBI was used to evaluate liposome accumulation in mice. Dual-radiolabeled PEGylated liposomes were administered either immediately after induction of TBI or at increasing times post-TBI to mimic the likely clinical scenario. The accumulation of radiolabel in the brain tissue ipsilateral and contralateral to the site of trauma, as well as in other organs, was evaluated. Selective influx of liposomes occurred at 0-8h after injury, while the barrier closed between 8 and 24hr after injury, consistent with reports on albumin infiltration. Significantly enhanced accumulation of liposomes occurred in mice subjected to TBI compared to anaesthetized controls, and accumulation was greater in the injured versus the contralateral side of the brain. Thus, stealth liposomes show potential to enhance drug delivery to the site of brain injury with a wide range of encapsulated therapeutic candidates.	[Boyd, Ben J.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, Parkville Campus,381 Royal Parade, Parkville, Vic 3052, Australia; [Boyd, Ben J.] Monash Univ, Monash Inst Pharmaceut Sci, ARC Ctr Excellence Convergent Bionano Sci & Techn, Parkville, Vic 3052, Australia; [Galle, Adam; Daglas, Maria; Medcalf, Robert] Monash Univ, Alfred Hosp, Australian Ctr Blood Dis, Melbourne, Vic, Australia; [Galle, Adam; Daglas, Maria; Medcalf, Robert] Monash Univ, Cent Clin Sch, Mol Neurotrauma & Haemostasis, Parkville, Vic 3052, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Alfred Hosp, Dept Surg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA; [Rosenfeld, Jeffrey V.] Monash Univ, Monash Inst Med Engn, Melbourne, Vic, Australia		Boyd, BJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, Parkville Campus,381 Royal Parade, Parkville, Vic 3052, Australia.	ben.boyd@monash.edu; robert.medcalf@monash.edu	Medcalf, Robert L/E-9632-2011	Boyd, Ben/0000-0001-5434-590X; Daglas, Maria/0000-0002-9356-4061	Faculty of Medicine, Nursing and Health Sciences, Monash UniversityMonash University [SPG-L 016]; John and Joan Power Charitable Trust; Australian Research CouncilAustralian Research Council	The authors report no declarations of interest. The authors acknowledge the Faculty of Medicine, Nursing and Health Sciences, Monash University for funding Strategic Grant (SPG-L 016) and the John and Joan Power Charitable Trust awarded to JVR. B.J.B. acknowledges the Australian Research Council for a Future Fellowship.	ALLEN TM, 1993, BIOCHIM BIOPHYS ACTA, V1150, P9, DOI 10.1016/0005-2736(93)90115-G; Boyd BJ, 2006, MOL PHARMACEUT, V3, P614, DOI 10.1021/mp060032e; Caraglia M, 2012, CURR DRUG METAB, V13, P4, DOI 10.2174/138920012798356871; Gillies ER, 2005, MOL PHARMACEUT, V2, P129, DOI 10.1021/mp049886u; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Ishida T, 2002, INT J PHARMACEUT, V232, P59, DOI 10.1016/S0378-5173(01)00896-1; Kaminskas LM, 2008, MOL PHARMACEUT, V5, P449, DOI 10.1021/mp7001208; Kaminskas LM, 2012, NANOMED-NANOTECHNOL, V8, P103, DOI 10.1016/j.nano.2011.05.013; Kaminskas LM, 2011, J PHARM SCI-US, V100, P5069, DOI 10.1002/jps.22682; Kaminskas LM, 2009, MOL PHARMACEUT, V6, P1190, DOI 10.1021/mp900049a; Kiselev MA, 2001, BIOFIZIKA+, V46, P423; KITAGAWA K, 1991, ACTA NEUROPATHOL, V82, P164, DOI 10.1007/BF00294441; Lee CC, 2006, P NATL ACAD SCI USA, V103, P16649, DOI 10.1073/pnas.0607705103; Liddelow SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106592; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; Rashid H, 1998, BIOCHEM MOL BIOL INT, V44, P165; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Sashindranath M, 2011, LAB INVEST, V91, P1079, DOI 10.1038/labinvest.2011.67; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Takanashi Y, 2001, NEUROL MED-CHIR, V41, P107, DOI 10.2176/nmc.41.107; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiao Guangqing, 2013, Int J Cell Biol, V2013, P703545, DOI 10.1155/2013/703545	26	27	28	1	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1061-186X	1029-2330		J DRUG TARGET	J. Drug Target.	OCT 21	2015	23	9					847	853		10.3109/1061186X.2015.1034280			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DD2RK	WOS:000369769700008	26079716	Green Submitted			2022-02-06	
J	Ansari, MA				Ansari, Mubeen A.			Temporal profile of M1 and M2 responses in the hippocampus following early 24 h of neurotrauma	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Neurotrauma; Neuroinflammation; Pro- and anti-inflammatory cytokines; Secondary injury cascades; M1 and M2 responses	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; TIME-COURSE; NEUROINFLAMMATORY PHENOTYPE	Traumatic brain injury (TBI) elicits complex inflammatory assets (M1 and M2 responses) in the brain that include the expression of various cytokines/chemokines and the recruitment of blood cells, contributing secondary injury cascades (SIC), and also recovery processes. The modulation of such inflammatory assets might be a therapeutic option following TBI. The present study assesses a temporal profile of various molecular markers of M1 and M2 response in the hippocampus after TBI. Following a unilateral controlled cortical impact (CCI) on young rats, hippocampal tissues of each brain were harvested at 2, 4, 6, 10, and 24 h post trauma. Including shams (craniotomy only), half of the rats were assessed for gene expression and half for the protein of various markers for M1 [interferon-gamma (IFN gamma), tumor necrosis factor-alpha (TNF alpha), interleukin (1L)-1-beta (IL-1 beta), and IL-6] and M2 [IL-4, IL-10, IL-13, arginase 1 (Arg1), YM1, FIZZ1, and mannose receptor C-1 (MRC1)] responses. Analysis revealed that molecular markers of M1 and M2 responses have heterogeneous injury effects in the hippocampus and that "time-post-injury" is an important factor in determining inflammation status. With the heterogeneous gene expression of pro-inflammatory cytokines, M1 response was significantly elevated at 2 hand declined at 24 h after TBI, however, their levels remained higher than the sham rats. Except IFN gamma, proteins of M1 cytokines were significantly elevated in the first 24 h, and peaked between 2-6 h [TNF alpha (2 h), IL-1 beta (6 h), and IL-6 (4-6 h)]. With the heterogeneous relative gene expression of Arg1, YM1, FIZZ1, and MRC1,levels of M2 cytokines were peaked at 24 h post TBI. IL-10 and IL-13 expression appeared biphasic in the first 24 h. Protein values of IL-4 and IL-13 peaked at 24 h and IL-10 at 6 h post injury. Results suggest that the M1 response rises rapidly after injury and overpowers the initial, comparatively smaller, or transient M2 response. A treatment that can modulate inflammation, reduce SIC, and improve recovery should be initiated early (within 10 h) after TBI. (C) 2015 Published by Elsevier B.V.	[Ansari, Mubeen A.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Ansari, Mubeen A.] Univ Kentucky, Spinal Cord Brain Injury Res Ctr, Lexington, KY 40536 USA		Ansari, MA (corresponding author), Univ Kentucky, Ctr Aging, 229A Sanders Brown, Lexington, KY 40536 USA.	mansa3@email.uky.edu		Ansari, Mubeen Ahmad/0000-0002-1132-5965	Kentucky Spinal Cord Head Injury Research Trust [12-16A]	This research was supported by the Kentucky Spinal Cord Head Injury Research Trust #12-16A.	Ajmone-Cat MA, 2013, GLIA, V61, P1698, DOI 10.1002/glia.22550; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Ansari MA, 2013, J NEUROTRAUM, V30, P1542, DOI 10.1089/neu.2013.2910; Anthony DC, 2013, MOL CELL NEUROSCI, V53, P1, DOI 10.1016/j.mcn.2012.11.005; Anthony DC, 2012, BRAIN BEHAV IMMUN, V26, P534, DOI 10.1016/j.bbi.2011.10.011; Babcock AA, 2003, J NEUROSCI, V23, P7922; Baron R, 2008, FASEB J, V22, P2843, DOI 10.1096/fj.08-105866; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; Benaroyo L, 1994, Praxis (Bern 1994), V83, P1343; Bialas AR, 2013, NAT NEUROSCI, V16, P1773, DOI 10.1038/nn.3560; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Blond D, 2002, BRAIN RES, V958, P89, DOI 10.1016/S0006-8993(02)03473-X; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Bonecchi R, 2000, J IMMUNOL, V164, P3862, DOI 10.4049/jimmunol.164.7.3862; Boulanger LM, 2001, CURR OPIN NEUROBIOL, V11, P568, DOI 10.1016/S0959-4388(00)00251-8; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cao L, 2013, NEUROSCI BULL, V29, P189, DOI 10.1007/s12264-013-1324-0; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Filiou MD, 2014, NEUROGENETICS, V15, P201, DOI 10.1007/s10048-014-0409-x; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Franco ECS, 2012, NEUROSCI RES, V73, P122, DOI 10.1016/j.neures.2012.03.006; Fumagalli S, 2013, GLIA, V61, P827, DOI 10.1002/glia.22474; GEHRMANN J, 1993, BRAIN PATHOL, V3, P11, DOI 10.1111/j.1750-3639.1993.tb00720.x; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Girard S, 2013, GLIA, V61, P813, DOI 10.1002/glia.22478; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hailer NP, 1999, EUR J NEUROSCI, V11, P3359, DOI 10.1046/j.1460-9568.1999.00808.x; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jang E, 2013, FASEB J, V27, P1176, DOI 10.1096/fj.12-222257; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johansson S, 2008, STEM CELLS, V26, P2444, DOI 10.1634/stemcells.2008-0116; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kodelja V, 1997, IMMUNOBIOLOGY, V197, P478, DOI 10.1016/S0171-2985(97)80080-0; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; Pathipati P, 2013, DEV NEUROSCI-BASEL, V35, P241, DOI 10.1159/000346159; Perego C, 2013, JOVE-J VIS EXP, DOI 10.3791/50605; Phani Sudarshan, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS207, DOI 10.1016/S1353-8020(11)70064-5; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao JS, 2012, NEUROCHEM RES, V37, P903, DOI 10.1007/s11064-012-0708-2; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Rocha e Silva M., 1994, AGENTS ACTIONS, V43, P86; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Scott A, 2004, BRIT J SPORT MED, V38, P248, DOI 10.1136/bjsm.2003.011221; Selenica MLB, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-86; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; SIESJO BK, 1994, ANN NY ACAD SCI, V747, P140; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stirling DP, 2014, BRAIN, V137, P707, DOI 10.1093/brain/awt341; Sudduth TL, 2013, J NEUROSCI, V33, P9684, DOI 10.1523/JNEUROSCI.1220-13.2013; Sudduth TL, 2013, NEUROBIOL AGING, V34, P1051, DOI 10.1016/j.neurobiolaging.2012.09.012; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Varnum MM, 2012, ARCH IMMUNOL THER EX, V60, P251, DOI 10.1007/s00005-012-0181-2; Walter J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-18; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Weekman EM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-127; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wilcock DM, 2011, ASN NEURO, V3, DOI 10.1042/AN20110018; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009; Wirjatijasa F, 2002, J NEUROSCI RES, V68, P579, DOI 10.1002/jnr.10254; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	94	27	27	0	25	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	OCT 15	2015	357	1-2					41	49		10.1016/j.jns.2015.06.062			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS5SQ	WOS:000362138800007	26148932				2022-02-06	
J	Sandhaug, M; Andelic, N; Langhammer, B; Mygland, A				Sandhaug, Maria; Andelic, Nada; Langhammer, Birgitta; Mygland, Aase			Functional level during the first 2 years after moderate and severe traumatic brain injury	BRAIN INJURY			English	Article						Level of function; rehabilitation; traumatic brain injury	EMPLOYMENT OUTCOME 2; INDEPENDENCE MEASURE; HEAD-INJURY; FOLLOW-UP; REHABILITATION; PREDICTORS; DISABILITY; SCALE; MULTICENTER; INTEGRATION	Background: Long-term outcomes after TBI are examined to a large extent, but longitudinal studies with more than 1-year follow-up time after injury have been fewer in number. The course of recovery may vary due to a number of factors and it is still somewhat unclear which factors are contributing.Aim: The aim of this study was to describe the functional level at four time points up to 24 months after traumatic brain injury (TBI) and to evaluate the predictive impact of pre-injury and injury-related factors.Design: A cohort study.Setting: Outpatient.Population: Sixty-five patients with moderate (n=21) or severe (n = 44) TBI.Methods: The patients with TBI were examined with Functional Independence Measure (FIM) and Glasgow Outcome Scale Extended (GOSE) at 3 months, 12 months and 24 months after injury. Possible predictors were analysed in a regression model using FIM total score at 24 months as the outcome measure.Results: FIM scores improved significantly from rehabilitation unit discharge to 24 months after injury, with peak levels at 3 and 24 months after injury (p<0.001), for the whole TBI group and the group with severe TBI. The moderate TBI group did not show significant FIM score improvement during this time period. GOSE scores for the whole group and the moderate group improved significantly over time, but the severe group did not. FIM at admission to the rehabilitation unit and GCS score at admission to the rehabilitation unit were closest to being significant predictors of FIM total scores 24 months after injury (B=0.265 and 2.883, R-2=0.39, p=0.073, p=0.081).Conclusion: FIM levels improved during the period from rehabilitation unit discharge to 3 months follow-up; thereafter, there was a plateauing' of recovery. In contrast, GOSE plateauing' of recovery was at 12 months.Clinical rehabilitation impact: The study results may indicate that two of the most used outcome measures in TBI research are more relevant for assessment of the functional recovery in a sub-acute phase than in later stages of TBI recovery.	[Sandhaug, Maria; Langhammer, Birgitta] Oslo & Akershus Univ Coll, Inst Physiotherapy, Oslo, Norway; [Sandhaug, Maria] Statped, Head Off, Oslo, Norway; [Sandhaug, Maria] Statped, Dept Acquired Brain Injury, Oslo, Norway; [Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Ulleval, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Oslo, Norway; [Langhammer, Birgitta] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Mygland, Aase] Sorlandet Hosp, Dept Habilitat, Kristiansand, Norway; [Mygland, Aase] Sorlandet Hosp, Dept Neurol, Kristiansand, Norway; [Mygland, Aase] Univ Bergen, Dept Clin Med, Bergen, Norway		Sandhaug, M (corresponding author), Statped Head Off, Acquired Brain Injury, Postbox 2814, N-0204 Oslo, Norway.	maria.sandhaug@statped.no	Langhammer, Birgitta/P-1765-2019	Langhammer, Birgitta/0000-0002-9639-0570; Andelic, Nada/0000-0002-3719-4406	Norwegian Foundation for Health and Rehabilitation	The authors report no conflicts of interest. This study has been financed with the aid of EXTRA funds from the Norwegian Foundation for Health and Rehabilitation.	Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bulletin of the World Health Organization, 2001, B WHO, P79; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Deutsch A, 2006, STROKE, V37, P1477, DOI 10.1161/01.STR.0000221172.99375.5a; Dijikers M., 1997, J HEAD TRAUMA REHAB, V12, P74; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dunn LT, 2000, BRIT J NEUROSURG, V14, P219; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Grimby G, 1996, SCAND J REHABIL MED, V28, P51; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kunik CL, 2008, ARCH PHYS MED REHAB, V89, pS3; Langhammer Birgitta, 2009, Physiotherapy Theory and Practice, V25, P55, DOI 10.1080/09593980802686938; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Ma YW, 2013, INT J MOL SCI, V14, P8570, DOI 10.3390/ijms14048570; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sandhaug M, 2011, J NEUROLOGICAL RES, V1, P48; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tennant KA, 2012, NEUROBIOL LEARN MEM, V98, P291, DOI 10.1016/j.nlm.2012.09.004; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; World Health Organization, 2007, INT CLASS FUNCT DIS; [No title captured]	42	27	27	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1431	1438		10.3109/02699052.2015.1063692			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200006	26361939				2022-02-06	
J	Su, EJ; Fredriksson, L; Kanzawa, M; Moore, S; Folestad, E; Stevenson, TK; Nilsson, I; Sashindranath, M; Schielke, GP; Warnock, M; Ragsdale, M; Mann, K; Lawrence, ALE; Medcalf, RL; Eriksson, U; Murphy, GG; Lawrence, DA				Su, Enming J.; Fredriksson, Linda; Kanzawa, Mia; Moore, Shannon; Folestad, Erika; Stevenson, Tamara K.; Nilsson, Ingrid; Sashindranath, Maithili; Schielke, Gerald P.; Warnock, Mark; Ragsdale, Margaret; Mann, Kris; Lawrence, Anna-Lisa E.; Medcalf, Robert L.; Eriksson, Ulf; Murphy, Geoffrey G.; Lawrence, Daniel A.			Imatinib treatment reduces brain injury in a murine model of traumatic brain injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						traumatic brain injury; TBI outcome; blood brain barrier; platelet derived growth factor-CC; platelet derived growth factor receptor alpha; Imatinib; cerebral edema; Morris water maze	TISSUE-PLASMINOGEN ACTIVATOR; CEREBRAL-BLOOD-FLOW; MORRIS WATER MAZE; GROWTH-FACTOR-CC; UNITED-STATES; HEAD-INJURY; ISCHEMIC-STROKE; CLINICAL-TRIAL; PDGF-CC; MICE	Current therapies for Traumatic brain injury (TBI) focus on stabilizing individuals and on preventing further damage from the secondary consequences of TBI. A major complication of TBI is cerebral edema, which can be caused by the loss of blood brain barrier (BBB) integrity. Recent studies in several CNS pathologies have shown that activation of latent platelet derived growth factor-CC (PDGF-CC) within the brain can promote BBB permeability through PDGF receptor alpha (PDGFR alpha) signaling, and that blocking this pathway improves outcomes. In this study we examine the efficacy for the treatment of TBI of an FDA approved antagonist of the PDGFR alpha, Imatinib. Using a murine model we show that Imatinib treatment, begun 45 min after TBI and given twice daily for 5 days, significantly reduces BBB dysfunction. This is associated with significantly reduced lesion size 24 h, 7 days, and 21 days after TBI, reduced cerebral edema, determined from apparent diffusion co-efficient (ADC) measurements, and with the preservation of cognitive function. Finally, analysis of cerebrospinal fluid (CSF) from human TBI patients suggests a possible correlation between high PDGF-CC levels and increased injury severity. Thus, our data suggests a novel strategy for the treatment of TBI with an existing FDA approved antagonist of the PDGFR alpha.	[Su, Enming J.; Fredriksson, Linda; Kanzawa, Mia; Schielke, Gerald P.; Warnock, Mark; Ragsdale, Margaret; Mann, Kris; Lawrence, Anna-Lisa E.; Lawrence, Daniel A.] Univ Michigan, Dept Internal Med, Sch Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Fredriksson, Linda; Folestad, Erika; Nilsson, Ingrid; Eriksson, Ulf] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, Stockholm, Sweden; [Moore, Shannon; Murphy, Geoffrey G.] Univ Michigan, Mol & Behav Neurosci Inst, Sch Med, Ann Arbor, MI 48109 USA; [Stevenson, Tamara K.; Murphy, Geoffrey G.; Lawrence, Daniel A.] Univ Michigan, Dept Mol & Integrat Physiol, Sch Med, Ann Arbor, MI 48109 USA; [Sashindranath, Maithili; Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Mol Neurotrauma & Haemostasis, Melbourne, Vic 3004, Australia		Lawrence, DA (corresponding author), Univ Michigan, Dept Internal Med, Sch Med, Div Cardiovasc Med, 7301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	dlawrenc@umich.edu	Sashindranath, Maithili/AAI-7408-2021; Medcalf, Robert L/E-9632-2011	Sashindranath, Maithili/0000-0002-9712-4784; Moore, Shannon/0000-0002-5874-6572; Fredriksson, Linda/0000-0003-4952-2742; Lawrence, Daniel/0000-0003-3126-1935	Massey Foundation TBI Innovation Fund at the University of Michigan; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL055374, NS079639, AG028488]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024986]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; Swedish Governmental Agency for Innovation SystemsVinnova [201103503]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [2012-1853]; Karolinska InstitutetKarolinska Institutet; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL125242, R01HL055374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG028488] Funding Source: NIH RePORTER	We wish to acknowledge Dr Amanda Au (Monash) for providing the positive control (platelet releasate) for the human CSF western blot data. We also wish to acknowledge Prof Richard MacDonnell, Dr Marion Simpson and Ms Jennifer Horvath (Austin Hospital, Heidelberg, Victoria, Australia) for providing control CSF samples. This research was supported by The Massey Foundation TBI Innovation Fund at the University of Michigan, by NIH Grants HL055374 (DAL), NS079639 (DAL) AG028488 (GGM), by the National Center for Research Resources, Grant UL1RR024986, and is now at the National Center for Advancing Translational Sciences, Grant UL1TR000433, and by the Swedish Governmental Agency for Innovation Systems, Grant 201103503 (LF), the Swedish Research Council, Grant 2012-1853 (LF) and Karolinska Institutet (LF).	Abrams MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038760; Adzemovic MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056586; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Finnie JW, 2014, VET RES COMMUN, V38, P297, DOI 10.1007/s11259-014-9616-z; Fredriksson L, 2005, J BIOL CHEM, V280, P26856, DOI 10.1074/jbc.M503388200; Fredriksson L, 2004, EMBO J, V23, P3793, DOI 10.1038/sj.emboj.7600397; Fredriksson L, 2015, ANN CLIN TRANSL NEUR, V2, P722, DOI 10.1002/acn3.209; Fridgeirsdottir GA, 2014, UPSALA J MED SCI, V119, P1, DOI 10.3109/03009734.2013.847511; Frieden T.R., 2014, C TRAUM BRAIN INJ US; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gilmer LK, 2008, J NEUROTRAUM, V25, P593, DOI 10.1089/neu.2007.0477; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hemphill J. C., 2013, TRAUMATIC BRAIN INJU; Hemphill J. C., 2013, MANAGEMENT ACUTE SEV; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Lescot T, 2010, J NEUROTRAUM, V27, P1069, DOI 10.1089/neu.2009.1188; Liu NK, 2013, BRAIN RES, V1499, P121, DOI 10.1016/j.brainres.2012.12.031; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Ma QY, 2011, ANN NEUROL, V70, P920, DOI 10.1002/ana.22549; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.004.2009; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKinney BC, 2008, GENES BRAIN BEHAV, V7, P629, DOI 10.1111/j.1601-183X.2008.00399.x; Mori T, 2001, NEUROREPORT, V12, P4117, DOI 10.1097/00001756-200112210-00051; Perkowski JJ, 2011, J NEUROSCI, V31, P46, DOI 10.1523/JNEUROSCI.2634-10.2011; Rau PR, 2006, LIFE SCI, V78, P1175, DOI 10.1016/j.lfs.2005.06.032; Rodriguez-Gonzalez R, 2013, ATHEROSCLEROSIS, V226, P165, DOI 10.1016/j.atherosclerosis.2012.10.072; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Shipton OA, 2014, P NATL ACAD SCI USA, V111, P15238, DOI 10.1073/pnas.1405648111; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Swartz BE, 2006, EPILEPSIA, V47, P1373, DOI 10.1111/j.1528-1167.2006.00602.x; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; White JA, 2008, LEARN MEMORY, V15, P1, DOI 10.1101/lm.773208; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2000, BLOOD, V96, P569; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; Zauner A, 1996, ACT NEUR S, V67, P40	60	27	27	0	10	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	OCT 7	2015	9								385	10.3389/fncel.2015.00385			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CT1CG	WOS:000362534300001	26500491	gold, Green Published			2022-02-06	
J	Babaee, A; Eftekhar-Vaghefi, SH; Asadi-shekaari, M; Shahrokhi, N; Soltani, SD; Malekpour-Afshar, R; Basiri, M				Babaee, Abdolreza; Eftekhar-Vaghefi, Seyed Hassan; Asadi-shekaari, Majid; Shahrokhi, Nader; Soltani, Samereh Dehghani; Malekpour-Afshar, Reza; Basiri, Mohsen			Melatonin treatment reduces astrogliosis and apoptosis in rats with traumatic brain injury	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Apoptosis; Astrogliosis; GFAP; Melatonin; Traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; WHITE-MATTER; PATHOPHYSIOLOGY; INFLAMMATION; DAMAGE; EDEMA; NEUROPROTECTION; DEGENERATION; HIPPOCAMPUS	Objective(s): Melatonin is known as an anti-inflammatory agent, and it has been proven to exert neuroprotection through inhibition of cell death (apoptosis) in several models of brain injury. Secondary injury following the primary traumatic brain injury (TBI) results in glial cells activation, especially astrocytes. In fact, astrocyte activation causes the production of pro-inflammatory cytokines that may lead to secondary injury. Since most TBI research studies have focused on injured neurons and paid little attention to glial cells, the aim of current study was to investigate the effects of melatonin against astrocytes activation (astrogliosis), as well as inhibition of apoptosis in brain tissue of male rats after TBI. Materials and Methods: The animals were randomly allocated into five groups: sham group, TBI+ vehicle group (1% ethanol in saline) and TBI+ melatonin groups (5 mg/kg, 10 mg/kg and 20 mg/kg). All rats were intubated and then exposed to diffuse TBI, except for the sham group. Immunohistochemical methods were conducted using glial fibrillary acidic protein (GFAP) marker and TUNEL assay to evaluate astrocyte reactivity and cell death, respectively. Results: The results showed that based on the number of GFAP positive astrocytes in brain cortex, astrogliosis was reduced significantly (P<0.05) in melatonin-treated groups (no dose dependent) compared to the vehicle group. Furthermore, based on TUNEL results, melatonin treatment considerably reduced the number of apoptotic cells (P<0.05). Conclusion: In total, the present findings suggest that melatonin treatment following TBI diminishes astrocyte reactivity and neuronal cells apoptosis in brain cortex in the rat model.	[Babaee, Abdolreza; Eftekhar-Vaghefi, Seyed Hassan; Soltani, Samereh Dehghani] Kerman Univ Med Sci, Afzalipour Sch Med, Dept Anat Sci, Kerman, Iran; [Asadi-shekaari, Majid; Basiri, Mohsen] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran; [Shahrokhi, Nader] Kerman Univ Med Sci, Afzalipour Sch Med, Dept Physiol, Kerman, Iran; [Malekpour-Afshar, Reza] Kerman Univ Med Sci, Afzalipour Sch Med, Dept Pathol, Kerman, Iran		Basiri, M (corresponding author), Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran.	m_basiri@kmu.ac.ir	Vaghefi, Seyed Hassan Eftekhar/AAW-9916-2020; Babaee, Abdolreza/AAB-1310-2021; Basiri, Mohsen/AAH-2438-2021; Shahrokhi, Nader/AAV-3747-2020; Dehghani, Samereh/ABC-1351-2020; Dehghani-Soltani, Samereh/AAR-7297-2021	Vaghefi, Seyed Hassan Eftekhar/0000-0002-5083-9563; Babaee, Abdolreza/0000-0002-9848-5442; Basiri, Mohsen/0000-0002-8372-3655; Shahrokhi, Nader/0000-0002-0149-7819; Dehghani-Soltani, Samereh/0000-0003-1074-3345	Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran	The present study was financially supported by Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran. This work was part of MSc thesis of Mr Babaee at the Department of Anatomical Sciences. The authors have no conflicts of interest to declare.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Aghakhani N, 2013, IRAN RED CRESCENT ME, V15, P173, DOI 10.5812/ircmj.2090; Ahmad molai Gh, 2008, KERMAN U MED SCI, V15, P47; Ahmadiasl N, 2013, IRAN J BASIC MED SCI, V16, P1209; Ananth C, 2003, HIPPOCAMPUS, V13, P375, DOI 10.1002/hipo.10090; Babaei-Balderlou F, 2010, IRAN J BASIC MED SCI, V13, P1; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Baydas G, 2003, FREE RADICAL BIO MED, V35, P797, DOI 10.1016/S0891-5849(03)00408-8; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Candace LF, 2007, PROG BRAIN RES, P161; Chern CM, 2012, FREE RADICAL BIO MED, V52, P1634, DOI 10.1016/j.freeradbiomed.2012.01.030; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Claustrat B, 2005, SLEEP MED REV, V9, P11, DOI 10.1016/j.smrv.2004.08.001; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Domowicz MS, 2011, BRAIN RES, V1389, P35, DOI 10.1016/j.brainres.2011.03.006; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kabadi SV, 2010, ANN NY ACAD SCI, V1199, P105, DOI 10.1111/j.1749-6632.2009.05352.x; Keshavarzi Z, 2014, IRAN J BASIC MED SCI, V17, P406; Keskin I, 2015, INT J DEV NEUROSCI, V41, P1, DOI 10.1016/j.ijdevneu.2014.12.002; Khorasani-Zavareh D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-486; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kunz A, 2010, BEST PRACT RES-CLIN, V24, P495, DOI 10.1016/j.bpa.2010.10.001; Lee MY, 2007, J PINEAL RES, V42, P297, DOI 10.1111/j.1600-079X.2007.00420.x; LI Y, 1995, STROKE, V26, P1252, DOI 10.1161/01.STR.26.7.1252; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; REITER RJ, 1991, MOL CELL ENDOCRINOL, V79, pC153, DOI 10.1016/0303-7207(91)90087-9; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; Skaper SD, 1999, ANN NY ACAD SCI, V890, P107, DOI 10.1111/j.1749-6632.1999.tb07985.x; Tsai MC, 2011, J PINEAL RES, V51, P233, DOI 10.1111/j.1600-079X.2011.00885.x; Welin AK, 2007, PEDIATR RES, V61, P153, DOI 10.1203/01.pdr.0000252546.20451.1a; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	39	27	30	1	4	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	SEP	2015	18	9					867	872					6	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	CV4DY	WOS:000364217400004	26523219				2022-02-06	
J	Hsu, HL; Chen, DYT; Tseng, YC; Kuo, YS; Huang, YL; Chiu, WT; Yan, FX; Wang, WS; Chen, CJ				Hsu, Hui-Ling; Chen, David Yen-Ting; Tseng, Ying-Chi; Kuo, Ying-Sheng; Huang, Yen-Lin; Chiu, Wen-Ta; Yan, Feng-Xian; Wang, Wei-Shuan; Chen, Chi-Jen			Sex Differences in Working Memory after Mild Traumatic Brain Injury: A Functional MR Imaging Study	RADIOLOGY			English	Article							GENDER-DIFFERENCES; ABNORMALITIES; METAANALYSIS; CONCUSSION; SYMPTOMS; MODERATE; FMRI	Purpose: To evaluate sex differences in mild traumatic brain injury (MTBI) with working memory functional magnetic resonance (MR) imaging. Materials and Methods: Research ethics committee approval and patient written informed consent were obtained. Working memory brain activation patterns were assessed with functional MR imaging in 30 patients (15 consecutive men and 15 consecutive women) with MTBI and 30 control subjects (15 consecutive men and 15 consecutive women). Two imaging studies were performed in patients: the initial study, which was performed within 1 month after the injury, and a follow-up study, which was performed 6 weeks after the first study. For each participant, digit span and continuous performance testing were performed before functional MR imaging. Clinical data were analyzed by using Kruskal-Wallis, Mann-Whitney U, Wilcoxon signed rank, and Fisher exact tests. Within-and between-group differences of functional MR imaging data were analyzed with one-and two-sample t tests, respectively. Results: Among female participants, the total digit span score was lower in the MTBI group than in the control group (P = .044). In initial working memory functional MR imaging studies, hyperactivation was found in the male MTBI group and hypoactivation was found in the female MTBI group compared with control male and female groups, respectively. At the 6-week follow-up study, the female MTBI group showed persistent hypoactivation, whereas the male MTBI group showed a regression of hyperactivation at visual comparison of activation maps. The male MTBI group was also found to have a higher initial ss value than the male control group (P = .040), and there was no significant difference between the male MTBI group and the male control group (P = .221) at follow-up evaluation, which was comparable to findings on activation maps. In the female MTBI group, average ss values at both initial and follow-up studies were lower compared with those in the female control group but were not statistically significant (P = .663 and P = .191, respectively). Conclusion: Female patients with MTBI had lower digit span scores than did female control subjects, and functional MR imaging depicted sex differences in working memory functional activation; hypoactivation with nonrecovery of activation change at follow-up studies may suggest a worse working memory outcome in female patients with MTBI. (C) RSNA, 2015	[Chen, Chi-Jen] Taipei Med Univ, Shuang Ho Hosp, Dept Diagnost Radiol, New Taipei, Taiwan; Taipei Med Univ, Shuang Ho Hosp, Brain & Consciousness Res Ctr, New Taipei, Taiwan		Chen, CJ (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Diagnost Radiol, 291 Jhong Jheng Rd,235 Jhonghe Dist, New Taipei, Taiwan.	ed100975@yahoo.com			National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC 101-2314-B-038-035-MY3]; Taipei Medical University, Taiwan [102TMU-SHH-20]	Supported by the National Science Council, Taiwan (grant NSC 101-2314-B-038-035-MY3), and Taipei Medical University, Taiwan (grant 102TMU-SHH-20).	Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farace E, 2000, Neurosurg Focus, V8, pe6; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Goldstein JM, 2005, NEUROPSYCHOLOGY, V19, P509, DOI 10.1037/0894-4105.19.4.509; Hill AC, 2014, BIOL PSYCHOL, V102, P18, DOI 10.1016/j.biopsycho.2014.06.008; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Speck O, 2000, NEUROREPORT, V11, P2581, DOI 10.1097/00001756-200008030-00046; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027	31	27	27	0	14	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	SEP	2015	276	3					828	835		10.1148/radiol.2015142549			8	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	CV6EM	WOS:000364363500022	25919663	Bronze			2022-02-06	
J	Zhang, Z; Saraswati, M; Koehler, RC; Robertson, C; Kannan, S				Zhang, Zhi; Saraswati, Manda; Koehler, Raymond C.; Robertson, Courtney; Kannan, Sujatha			A New Rabbit Model of Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						microglia; pediatric traumatic brain injury; motor; rabbit; cognition	CONTROLLED CORTICAL IMPACT; CENTRAL-NERVOUS-SYSTEM; PROTEIN 18 KDA; WHITE-MATTER; HEAD-INJURY; CEREBRAL-PALSY; POSTNATAL-DEVELOPMENT; COGNITIVE DEFICITS; MOTOR DEFICITS; AXONAL INJURY	Traumatic brain injury (TBI) is a common cause of disability in childhood, resulting in numerous physical, behavioral, and cognitive sequelae, which can influence development through the lifespan. The mechanisms by which TBI influences normal development and maturation remain largely unknown. Pediatric rodent models of TBI often do not demonstrate the spectrum of motor and cognitive deficits seen in patients. To address this problem, we developed a New Zealand white rabbit model of pediatric TBI that better mimics the neurological injury seen after TBI in children. On postnatal Day 5-7 (P5-7), rabbits were injured by a controlled cortical impact (6-mm impactor tip; 5.5 m/sec, 2-mm depth, 50-msec duration). Rabbits from the same litter served as naive (no injury) and sham (craniotomy alone) controls. Functional abilities and activity levels were measured 1 and 5 d after injury. Maturation level was monitored daily. We performed cognitive tests during P14-24 and sacrificed the animals at 1, 3, 7, and 21 d after injury to evaluate lesion volume and microglia. TBI kits exhibited delayed achievement of normal developmental milestones. They also demonstrated significant cognitive deficits, with lower percentage of correct alternation rate in the T-maze (n=9-15/group; p<0.001) and less discrimination between novel and old objects (p<0.001). Lesion volume increased from 16% at Day 3 to 30% at Day 7 after injury, indicating ongoing secondary injury. Activated microglia were noted at the injury site and also in white matter regions of the ipsilateral and contralateral hemispheres. The neurologic and histologic changes in this model are comparable to those reported clinically. Thus, this rabbit model provides a novel platform for evaluating neuroprotective therapies in pediatric TBI.	[Zhang, Zhi; Saraswati, Manda; Koehler, Raymond C.; Robertson, Courtney; Kannan, Sujatha] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care, Baltimore, MD USA		Kannan, S (corresponding author), Dept Anesthesiol & Crit Care Med, Bloomberg Childrens Bldg 6318D-C4,1800 Orleans St, Baltimore, MD 21287 USA.	skannan3@jhmi.edu		Kannan, Sujatha/0000-0002-9497-5786; Zhang, Zhi/0000-0001-6256-9516	NICHD, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069562]; Department of Anesthesiology and Critical Care Medicine; Brain Science Institute, Johns Hopkins University School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069562] Funding Source: NIH RePORTER	This work was funded in part by R01HD069562, NICHD, NIH; by the Department of Anesthesiology and Critical Care Medicine, and the Brain Science Institute, Johns Hopkins University School of Medicine.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bass WT, 1998, HISTOCHEM J, V30, P657, DOI 10.1023/A:1003597010707; Bauman Johnson WL, 2010, ARCH CLIN NEUROPSYCH, V25, P601, DOI 10.1093/arclin/acq049; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Billiards SS, 2006, J COMP NEUROL, V497, P199, DOI 10.1002/cne.20991; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chen CY, 2013, DEV NEUROSCI-BASEL, V35, P474, DOI 10.1159/000355874; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Conley YP, 2014, J NEUROTRAUM, V31, P34, DOI 10.1089/neu.2013.2855; Dapul HR, 2013, J NEUROTRAUM, V30, P382, DOI 10.1089/neu.2012.2536; de Graaf-Peters VB, 2006, EARLY HUM DEV, V82, P257, DOI 10.1016/j.earlhumdev.2005.10.013; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; DEGROOT D, 1978, BRAIN RES, V147, P362, DOI 10.1016/0006-8993(78)90846-6; DELHAYE-BOUCHAUD N, 1971, Developmental Psychobiology, V4, P375, DOI 10.1002/dev.420040410; Derrick M, 2004, J NEUROSCI, V24, P24, DOI 10.1523/JNEUROSCI.2816-03.2004; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; DIRESTA GR, 1990, ACT NEUR S, V51, P34; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; Drobyshevsky A, 2005, J NEUROSCI, V25, P5988, DOI 10.1523/JNEUROSCI.4983-04.2005; Drobyshevsky A, 2014, EXP NEUROL, V261, P76, DOI 10.1016/j.expneurol.2014.06.021; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Eixarch E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031497; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Georgiadis P, 2008, STROKE, V39, P3378, DOI 10.1161/STROKEAHA.107.510883; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; HAREL S, 1972, BIOL NEONATE, V21, P381; Huh JW, 2008, EXP NEUROL, V213, P84, DOI 10.1016/j.expneurol.2008.05.009; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Hutchison JS, 2001, J NEUROTRAUM, V18, P1333, DOI 10.1089/08977150152725632; Kannan S, 2007, J NUCL MED, V48, P946, DOI 10.2967/jnumed.106.038539; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Kannan S, 2011, DEV NEUROSCI-BASEL, V33, P231, DOI 10.1159/000328125; Kannan S, 2009, J CHILD NEUROL, V24, P1190, DOI 10.1177/0883073809338063; Kenk M., 2014, SCHIZOPHR B, V41, P85; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; MATHERS LH, 1979, BRAIN RES, V168, P21, DOI 10.1016/0006-8993(79)90125-2; Matsushima K, 2012, J CRIT CARE, V27, P125, DOI 10.1016/j.jcrc.2011.08.012; MCMULLEN NT, 1988, J COMP NEUROL, V278, P139, DOI 10.1002/cne.902780109; Mendez DR, 2004, J TRAUMA, V56, P1235, DOI 10.1097/01.TA.0000130759.62286.0E; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Mitchell RL, 2003, CLEFT PALATE-CRAN J, V40, P486, DOI 10.1597/1545-1569(2003)040<0486:ENBICR>2.0.CO;2; Morrison Gavin, 2013, Pathophysiology, V20, P49, DOI 10.1016/j.pathophys.2012.02.006; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; RICE FL, 1985, J COMP NEUROL, V236, P477, DOI 10.1002/cne.902360405; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Saadani-Makki F, 2009, J CHILD NEUROL, V24, P1179, DOI 10.1177/0883073809338213; Saadani-Makki F, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.090; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Tan S, 2005, J CHILD NEUROL, V20, P972, DOI 10.1177/08830738050200120801; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333	76	27	29	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2015	32	17					1369	1379		10.1089/neu.2014.3701			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CP0KP	WOS:000359564500010	25758339	Green Published			2022-02-06	
J	Kawa, L; Arborelius, UP; Yoshitake, T; Kehr, J; Hokfelt, T; Risling, M; Agoston, D				Kawa, Lizan; Arborelius, Ulf P.; Yoshitake, Takashi; Kehr, Jan; Hokfelt, Tomas; Risling, Marten; Agoston, Denes			Neurotransmitter Systems in a Mild Blast Traumatic Brain Injury Model: Catecholamines and Serotonin	JOURNAL OF NEUROTRAUMA			English	Article						anxiety; mood disorder; noradrenaline; PTSD; stress	POSTTRAUMATIC-STRESS-DISORDER; COERULEUS-NOREPINEPHRINE FUNCTION; CORTICOTROPIN-RELEASING-FACTOR; FORCED SWIMMING TEST; ELEVATED PLUS-MAZE; LOCUS-COERULEUS; TYROSINE-HYDROXYLASE; PREFRONTAL CORTEX; MESSENGER-RNA; RAT	Exposure to improvised explosive devices can result in a unique form of traumatic brain injuryblast-induced traumatic brain injury (bTBI). At the mild end of the spectrum (mild bTBI [mbTBI]), there are cognitive and mood disturbances. Similar symptoms have been observed in post-traumatic stress disorder caused by exposure to extreme psychological stress without physical injury. A role of the monoaminergic system in mood regulation and stress is well established but its involvement in mbTBI is not well understood. To address this gap, we used a rodent model of mbTBI and detected a decrease in immobility behavior in the forced swim test at 1d post-exposure, coupled with an increase in climbing behavior, but not after 14d or later, possibly indicating a transient increase in anxiety-like behavior. Using in situ hybridization, we found elevated messenger ribonucleic acid levels of both tyrosine hydroxylase and tryptophan hydroxylase 2 in the locus coeruleus and the dorsal raphe nucleus, respectively, as early as 2h post-exposure. High-performance liquid chromatography analysis 1d post-exposure primarily showed elevated noradrenaline levels in several forebrain regions. Taken together, we report that exposure to mild blast results in transient changes in both anxiety-like behavior and brain region-specific molecular changes, implicating the monoaminergic system in the pathobiology of mbTBI.	[Kawa, Lizan; Arborelius, Ulf P.; Hokfelt, Tomas; Risling, Marten] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden; [Yoshitake, Takashi; Kehr, Jan] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Stockholm, Sweden; [Agoston, Denes] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Kawa, L (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, SE-17177 Stockholm, Sweden.	lizan.kawa@ki.se		Kehr, Jan/0000-0002-2410-124X	Swedish Armed Forces RD; Swedish Research CouncilSwedish Research CouncilEuropean Commission [04X-2887]; Karolinska Institutet Funds	This study was supported by the Swedish Armed Forces R&D (MR), the Swedish Research Council (04X-2887) (TH) and Karolinska Institutet Funds (TH). The valuable contribution of Maria Angeria is gratefully acknowledged. We thank Ms. Alaa Kamnaksh for her advice on the statistical analysis and for read proofing the paper.	ABERCROMBIE ED, 1988, NEUROSCIENCE, V27, P897, DOI 10.1016/0306-4522(88)90192-3; Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; ASBERG M, 1976, ARCH GEN PSYCHIAT, V33, P1193; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Berridge CW, 2008, BRAIN RES REV, V58, P1, DOI 10.1016/j.brainresrev.2007.10.013; Bjorklund A., 1986, HDB PHYSL; BLANCHARD EB, 1991, J NERV MENT DIS, V179, P371, DOI 10.1097/00005053-199106000-00012; Blier P, 2001, J PSYCHIATR NEUROSCI, V26, pS3; Bogdanova OV, 2013, PHYSIOL BEHAV, V118, P227, DOI 10.1016/j.physbeh.2013.05.012; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P246; Bremner JD, 1996, SYNAPSE, V23, P28, DOI 10.1002/(SICI)1098-2396(199605)23:1<28::AID-SYN4>3.0.CO;2-J; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chamas FM, 2004, BIOL PSYCHIAT, V55, P278, DOI 10.1016/S0006-3223(03)00788-1; Chang MS, 2000, NEUROSCIENCE, V101, P131, DOI 10.1016/S0306-4522(00)00352-3; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; CLEMEDSON CARL-JOHAN, 1955, JOUR AVIATION MED, V26, P373; CLEMEDSON CJ, 1956, ACTA PHYSIOL SCAND, V37, P202; CLEMEDSON CJ, 1956, NATURE, V177, P380, DOI 10.1038/177380a0; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; Dahlstroem A., 1964, ACTA PHYSIOL SCAND S, V232, P1; Davis LL, 1997, J PSYCHIATR NEUROSCI, V22, P318; DEAKIN JFW, 1990, PSYCHOPHARMACOLOGY, V101, P85, DOI 10.1007/BF02253723; Detke MJ, 1996, BEHAV BRAIN RES, V73, P43; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Estanislau C, 2011, BEHAV PROCESS, V86, P46, DOI 10.1016/j.beproc.2010.08.008; Evans AK, 2009, NEUROSCI LETT, V455, P36, DOI 10.1016/j.neulet.2009.03.025; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FINKLESTEIN S, 1983, BRAIN RES, V271, P279, DOI 10.1016/0006-8993(83)90290-1; Flierl MA, 2008, MOL MED, V14, P195, DOI 10.2119/2007-00105.Flierl; Foote S., 1995, PHARM PHYSL CENTRAL; George SA, 2013, EUR J NEUROSCI, V37, P901, DOI 10.1111/ejn.12095; Goddard AW, 2010, DEPRESS ANXIETY, V27, P339, DOI 10.1002/da.20642; Goenjian AK, 2012, J AFFECT DISORDERS, V140, P244, DOI 10.1016/j.jad.2012.02.015; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; GRIMA B, 1987, NATURE, V326, P707, DOI 10.1038/326707a0; Harro J, 2001, BRAIN RES REV, V38, P79, DOI 10.1016/S0165-0173(01)00082-0; Harvey BH, 2006, PHYSIOL BEHAV, V87, P881, DOI 10.1016/j.physbeh.2006.01.033; Heim C, 2009, CNS SPECTRUMS, V14, P13; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kehr J., 2006, ENCY SENSORS, V6; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; KORF J, 1973, NEUROPHARMACOLOGY, V12, P933, DOI 10.1016/0028-3908(73)90024-5; Kuo JR, 2013, J NEUROTRAUM, V30, P1223, DOI 10.1089/neu.2012.2689; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Maes M, 1995, PSYCHOPHARMACOLOGY 4; Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364; Mathew SJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2080, DOI 10.1038/sj.npp.1301652; McDevitt RA, 2009, BRAIN RES, V1285, P109, DOI 10.1016/j.brainres.2009.06.017; McEwen BS, 2013, NEURON, V79, P16, DOI 10.1016/j.neuron.2013.06.028; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Ong LK, 2014, J NEUROCHEM, V128, P547, DOI 10.1111/jnc.12482; PAPPIUS HM, 1987, J NEUROCHEM, V49, P321, DOI 10.1111/j.1471-4159.1987.tb03433.x; Pardon MC, 2002, NEUROSCIENCE, V115, P229, DOI 10.1016/S0306-4522(02)00364-0; Paxinos G, 2007, RAT BRAIN STREOTAXIC, V6th; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Robbins T, 1995, CENTRAL NOREPINEPHRI; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Schatzberg AF, 1995, PSYCHOPHARMACOLOGY 4; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Shinba T, 2010, NEUROCHEM RES, V35, P412, DOI 10.1007/s11064-009-0070-1; Solovieff N, 2014, NEUROPSYCHOPHARMACOL, V39, P1872, DOI 10.1038/npp.2014.34; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Tanaka K, 1997, REGUL PEPTIDES, V70, P173, DOI 10.1016/S0167-0115(97)01013-6; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; TSUIKI K, 1995, J NEUROCHEM, V64, P1319; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; VALENTINO RJ, 1993, ANN NY ACAD SCI, V697, P173, DOI 10.1111/j.1749-6632.1993.tb49931.x; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wilson CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089104; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5	94	27	29	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2015	32	16					1190	1199		10.1089/neu.2014.3669			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CU9RU	WOS:000363883400002	25525686	Green Published			2022-02-06	
J	Abend, NS; Wagenman, KL; Blake, TP; Schultheis, MT; Radcliffe, J; Berg, RA; Topjian, AA; Dlugos, DJ				Abend, Nicholas S.; Wagenman, Katherine L.; Blake, Taylor P.; Schultheis, Maria T.; Radcliffe, Jerilynn; Berg, Robert A.; Topjian, Alexis A.; Dlugos, Dennis J.			Electrographic status epilepticus and neurobehavioral outcomes in critically ill children	EPILEPSY & BEHAVIOR			English	Article						EEG monitoring; Seizure; Status epilepticus; Pediatric; Outcome; Nonconvulsive seizure	NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; CONTINUOUS VIDEO-EEG; INTENSIVE-CARE-UNIT; COMATOSE CHILDREN; SEIZURES; PREDICTORS	Purpose: Electrographic seizures (ESs) and electrographic status epilepticus (ESE) are common in children with acute neurologic conditions in pediatric intensive care units (PICUs), and ESE is associated with worse functional and quality-of-life outcomes. As an exploratory study, we aimed to determine if ESE was associated with worse outcomes using more detailed neurobehavioral measures. Methods: Three hundred children with an acute neurologic condition and altered mental status underwent clinically indicated EEG monitoring and were enrolled in a prospective observational study. We obtained follow-up data from subjects who were neurodevelopmentally normal prior to PICU admission. We evaluated for associations between ESE and adaptive behavior (Adaptive Behavior Assessment System-II, ABAS-II), behavioral and emotional problems (Child Behavior Checklist, CBCL), and executive function (Behavior Rating Inventory of Executive Function, BRIEF) using linear regression analyses. A p-value of <0.05 was considered significant. Results: One hundred thirty-seven of 300 subjects were neurodevelopmentally normal prior to PICU admission. We obtained follow-up data from 36 subjects for the CBCL, 32 subjects for the ABAS-II, and 20 subjects for the BRIEF. The median duration from admission to follow-up was 2.6 years (IQR: 12-3.8). There were no differences in the acute care variables (age, sex, mental status category, intubation status, paralysis status, acute neurologic diagnosis category, seizure category, EEG background category, or short-term outcome) between subjects with and without follow-up data for any of the outcome measures. On univariate analysis, significant differences were not identified for CBCL total problem (ES coefficient: 4.1, p = 0.48; ESE coefficient: 8.9, p = 0.13) or BRIEF global executive function (ES coefficient: 2.1, p = 078; ESE coefficient: 14.1, p = 0.06) scores, although there were trends toward worse scores in subjects with ESE. On univariate analysis, ESs were not associated with worse scores (coefficient: -21.5, p = 0.051), while ESE (coefficient: -29.7, p = 0.013) was associated with worse ABAS-II adaptive behavioral global composite scores. On multivariate analysis, when compared to subjects with no seizures, both ESs (coefficient: 28, p = 0.014) and ESE (coefficient: -36, p = 0.003) were associated with worse adaptive behavioral global composite scores. Discussion: Among previously neuroclevelopmentally normal children with acute neurologic disorders, ESs and ESE were associated with worse adaptive behavior and trends toward worse behavioral emotional and executive function problems. This was a small exploratory study, and the impact of ESs and ESE on these neurobehavioral measures may be clarified by subsequent larger studies. (C) 2015 Elsevier Inc. All rights reserved.	[Berg, Robert A.; Topjian, Alexis A.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Anesthesia & Crit Care Med, Philadelphia, PA 19104 USA; [Abend, Nicholas S.; Wagenman, Katherine L.; Dlugos, Dennis J.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Abend, Nicholas S.; Dlugos, Dennis J.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Abend, Nicholas S.; Dlugos, Dennis J.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Blake, Taylor P.; Schultheis, Maria T.] Drexel Univ, Dept Psychol, Philadelphia, PA 19104 USA; [Radcliffe, Jerilynn] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA		Abend, NS (corresponding author), Childrens Hosp Philadelphia, Div Neurol, 3501 Civ Ctr Blvd,CTRC 10016, Philadelphia, PA 19104 USA.	abend@email.chop.edu		Schultheis, Maria/0000-0002-6558-548X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23NS076550]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD047349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL094345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS045911, U01NS077276, K23NS076550, K23NS075363] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM011124] Funding Source: NIH RePORTER	The study was supported by NIH (K23NS076550) to Dr. Abend.	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2007, PEDIATR NEUROL, V37, P165, DOI 10.1016/j.pediatrneurol.2007.05.012; Abend NS, 2013, LANCET NEUROL, V12, P1170, DOI 10.1016/S1474-4422(13)70246-1; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2013, SEIZURE-EUR J EPILEP, V22, P467, DOI 10.1016/j.seizure.2013.03.008; Abend NS, 2011, NEUROCRIT CARE, V15, P70, DOI 10.1007/s12028-010-9380-z; Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Abend NS, 2015, J CLIN NEUROPHYSIOL; Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gold JJ, 2014, PEDIATR NEUROL, V50, P318, DOI 10.1016/j.pediatrneurol.2013.12.014; Greiner HM, 2012, PEDIATRICS, V129, pE748, DOI 10.1542/peds.2011-2067; Gutierrez-Colina AM, 2012, PEDIATR NEUROL, V46, P158, DOI 10.1016/j.pediatrneurol.2011.12.009; Gwer S, 2012, ARCH DIS CHILD, V97, P343, DOI 10.1136/archdischild-2011-300935; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hauf M, 2009, AM J NEURORADIOL, V30, P693, DOI 10.3174/ajnr.A1456; Herman ST, 2015, J CLIN NEUROPHYSIOL; Hosain SA, 2005, PEDIATR NEUROL, V32, P162, DOI 10.1016/j.pediatrneurol.2004.09.008; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; Lambrechtsen FACP, 2008, EPILEPSIA, V49, P615, DOI 10.1111/j.1528-1167.2007.01465.x; McCoy B, 2011, EPILEPSIA, V52, P1973, DOI 10.1111/j.1528-1167.2011.03291.x; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Piantino JA, 2013, PEDIATR CRIT CARE ME, V14, P601, DOI 10.1097/PCC.0b013e318291755a; Sanchez SM, 2013, J CLIN NEUROPHYSIOL, V30, P156, DOI 10.1097/WNP.0b013e31827eda27; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Tay SKH, 2006, EPILEPSIA, V47, P1504, DOI 10.1111/j.1528-1167.2006.00623.x; Topjian AA, 2013, CRIT CARE MED, V41, P215, DOI 10.1097/CCM.0b013e3182668035; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Wagenman KL, 2014, NEUROLOGY, V82, P396, DOI 10.1212/WNL.0000000000000082; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x	39	27	27	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	AUG	2015	49						238	244		10.1016/j.yebeh.2015.03.013			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	CO7CK	WOS:000359314900044	25908325	Green Accepted			2022-02-06	
J	Horn, SD; Corrigan, JD; Beaulieu, CL; Bogner, J; Barrett, RS; Giuffrida, CG; Ryser, DK; Cooper, K; Carroll, DM; Deutscher, D				Horn, Susan D.; Corrigan, John D.; Beaulieu, Cynthia L.; Bogner, Jennifer; Barrett, Ryan S.; Giuffrida, Clare G.; Ryser, David K.; Cooper, Kelli; Carroll, Deborah M.; Deutscher, Daniel			Traumatic Brain Injury Patient, Injury, Therapy, and Ancillary Treatments Associated With Outcomes at Discharge and 9 Months Postdischarge	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Craniocerebral trauma; Outcome assessment (health care); Rehabilitation	LENGTH-OF-STAY; FUNCTIONAL INDEPENDENCE MEASURE; COGNITIVE REHABILITATION; INPATIENT REHABILITATION; STROKE REHABILITATION; THE-LITERATURE; RECOVERY; INTENSITY; HALOPERIDOL; IMPAIRMENT	Objective: To examine associations of patient and injury characteristics, inpatient rehabilitation therapy activities, and neurotropic medications with outcomes at discharge and 9 months postdischarge for patients with traumatic brain injury (TBI). Design: Prospective, longitudinal observational study. Setting: Inpatient rehabilitation centers. Participants: Consecutive patients (N=2130) enrolled between 2008 and 2011, admitted for inpatient rehabilitation after an index TBI injury. Interventions: Not applicable. Main Outcome Measures: Rehabilitation length of stay, discharge to home, and FIM at discharge and 9 months postdischarge. Results: The admission F114 cognitive score was used to create 5 relatively homogeneous subgroups for subsequent analysis of treatment outcomes. Within each subgroup, significant associations were found between outcomes and patient and injury characteristics, time spent in therapy activities, and medications used. Patient and injury characteristics explained on average 35.7% of the variation in discharge outcomes and 22.3% in 9-month outcomes. Adding time spent and level of effort in therapy activities and percentage of stay using specific medications explained approximately 20% more variation for discharge outcomes and 12.9% for 9-month outcomes. After patient, injury, and treatment characteristics were used to predict outcomes, center differences added only approximately 1.9% additional variance explained. Conclusions: At discharge, greater effort during therapy sessions, time spent in more complex therapy activities, and use of specific medications were associated with better outcomes for patients in all admission FIM cognitive subgroups. At 9 months postdischarge, similar but less pervasive associations were observed for therapy activities, but not classes of medications. Further research is warranted to examine more specific combinations of therapy activities and medications that are associated with better outcomes. (C) 2015 by the American Congress of Rehabilitation Medicine	[Horn, Susan D.; Barrett, Ryan S.] Int Sever Informat Syst, Inst Clin Outcomes Res, Salt Lake City, UT USA; [Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Beaulieu, Cynthia L.] Brooks Rehabil Hosp, Jacksonville, FL USA; [Giuffrida, Clare G.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Ryser, David K.; Cooper, Kelli; Carroll, Deborah M.] Intermt Med Ctr, Neuro Specialty Rehabil Unit, Salt Lake City, UT USA; [Deutscher, Daniel] Maccabi Healthcare Serv, Tel Aviv, Israel		Horn, SD (corresponding author), Univ Utah, Sch Med, Dept Populat Hlth Sci, Hlth Syst Innovat & Res Program, Williams Bdg,Rm 1N461,295 Chipeta Way, Salt Lake City, UT 84108 USA.	susan.horn@hsc.utah.edu			National Institutes of Health, National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01HD050439-01]; National Institute on Disability and Rehabilitation Research [H133A080023]; Ontario Neurotrauma Foundation [2007-ABI-ISIS-525]; American Congress of Rehabilitation Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD050439] Funding Source: NIH RePORTER	Supported by the National Institutes of Health, National Center for Medical Rehabilitation Research (grant no. 1R01HD050439-01); National Institute on Disability and Rehabilitation Research (grant no. H133A080023); and Ontario Neurotrauma Foundation (grant no. 2007-ABI-ISIS-525).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Baker E, 2012, INT J SPEECH-LANG PA, V14, P478, DOI 10.3109/17549507.2012.717967; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; Blicher JU, 2008, NEUROREHABILITATION, V23, P175; Bode RK, 2004, ARCH PHYS MED REHAB, V85, P1901, DOI 10.1016/j.apmr.2004.02.023; Breceda EY, 2013, CURR OPIN NEUROL, V26, P595, DOI 10.1097/WCO.0000000000000024; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Dumas Helene M, 2004, Pediatr Phys Ther, V16, P157, DOI 10.1097/01.PEP.0000136004.69289.01; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS178, DOI 10.1016/j.apmr.2014.09.042; Horn SD, 2012, ARCH PHYS MED REHAB, V93, pS127, DOI 10.1016/j.apmr.2011.10.031; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P1; Kortte KB, 2007, ARCH PHYS MED REHAB, V88, P877, DOI 10.1016/j.apmr.2007.03.030; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Leon-Carrion J, 2013, BRAIN INJURY, V27, P1119, DOI 10.3109/02699052.2013.804204; Lequerica AH, 2007, J HEAD TRAUMA REHAB, V22, P177, DOI 10.1097/01.HTR.0000271118.96780.bc; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Madeira G, 2007, LARYNGOL OTOL RHINOL, V128, P145; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS235, DOI 10.1016/j.apmr.2014.10.027; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Togher L, 2012, INT J SPEECH-LANG PA, V14, P438, DOI 10.3109/17549507.2012.689334; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3	44	27	27	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2015	96	8		3			S304	S329		10.1016/j.apmr.2014.11.030			26	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CO3CV	WOS:000359035100012	26212406	Green Accepted			2022-02-06	
J	Kram, BL; Kram, SJ; Brooks, KR				Kram, Bridgette L.; Kram, Shawn J.; Brooks, Kelli R.			Implications of atypical antipsychotic prescribing in the intensive care unit	JOURNAL OF CRITICAL CARE			English	Article						Delirium; Antipsychotic agents; Care transitions	TRAUMATIC BRAIN-INJURY; CRITICALLY-ILL PATIENTS; MECHANICALLY VENTILATED PATIENTS; CONFUSION ASSESSMENT METHOD; TERM COGNITIVE IMPAIRMENT; CAM-ICU; CLINICAL-OUTCOMES; CRITICAL ILLNESS; RISK-FACTORS; DOUBLE-BLIND	Purpose: The purpose of the study was to determine the downstream implications of atypical antipsychotic (AAP) prescribing in the intensive care unit (ICU), including discharge prescribing practices, monitoring, and attributable adverse drug events. Materials and methods: This retrospective cohort study included patients at least 18 years of age admitted to an ICU that received at least 2 doses of an AAP for documented delirium or avoidance of a deliriogenic medication. Exclusion criteria were documentation of an AAP as a home medication or initiation for a psychiatric indication unrelated to delirium (eg, schizophrenia). Results: During the 8-month study period, 156 patients were included and 133 (85.2%) patients survived to hospital discharge. Of the survivors, AAP therapy was continued for 112 (84.2%) patients upon ICU transfer and for 38 (28.6%) patients upon hospital discharge. A majority of these patients had evidence of delirium resolution or no indication for continuation documented at discharge. Of the 127 patients with an electrocardiogram ordered during AAP therapy, QTc prolongation occurred in 49 (31.4%) patients. An adverse drug event leading to drug discontinuation was documented in 16 (10.2%) patients. Conclusions: Because of significant patient-centered implications, AAPs initiated in the ICU require continued evaluation for indication to avoid prolonged and possibly unnecessary use. (C) 2015 Elsevier Inc. All rights reserved.	[Kram, Bridgette L.; Kram, Shawn J.; Brooks, Kelli R.] Duke Univ Hosp, Durham, NC 27710 USA		Kram, BL (corresponding author), Duke Univ Hosp, DUMC Box 3089, Durham, NC 27710 USA.	Bridgette.Kram@duke.edu; Shawn.Kram@duke.edu; Kelli.Brooks@dm.duke.edu					Agawal V, 2010, J BURN CARE RES, V31, P706; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Brummel N.E., 2013, CRIT CARE MED; Brummel NE, 2013, CRIT CARE MED, V41, P2196, DOI 10.1097/CCM.0b013e31829a6f1e; Cha DS, 2012, EXPERT OPIN PHARMACO, V13, P1587, DOI 10.1517/14656566.2012.656590; Devlin JW, 2007, CRIT CARE MED, V35, P2721, DOI 10.1097/01.CCM.0000292011.93074.82; Devlin JW, 2010, CRIT CARE MED, V38, P419, DOI 10.1097/CCM.0b013e3181b9e302; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, INTENS CARE MED, V27, P1892, DOI 10.1007/s00134-001-1132-2; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Girard TD, 2010, CRIT CARE MED, V38, P428, DOI 10.1097/CCM.0b013e3181c58715; Han CS, 2004, PSYCHOSOMATICS, V45, P297, DOI 10.1016/S0033-3182(04)70170-X; Huybrechts KF, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e977; Jasiak Karalea D, 2013, J Pharm Pract, V26, P253, DOI 10.1177/0897190012465987; Kim E, 2006, J NEUROPSYCH CLIN N, V18, P547, DOI 10.1176/appi.neuropsych.18.4.547; Lat I, 2009, CRIT CARE MED, V37, P1898, DOI 10.1097/CCM.0b013e31819ffe38; Lin SM, 2004, CRIT CARE MED, V32, P2254, DOI 10.1097/01.CCM.0000145587.16421.BB; Mizoguchi Y, 2002, J NEUROPSYCH CLIN N, V14, P87, DOI 10.1176/appi.neuropsych.14.1.87-a; Modrykamien AM, 2012, RESP CARE, V57, P764, DOI 10.4187/respcare.01461; Morandi A, 2013, J AM GERIATR SOC, V61, P1128, DOI 10.1111/jgs.12329; Noe E, 2007, BEHAV NEUROL, V18, P7, DOI 10.1155/2007/529076; Olafson K, 2012, ANN PHARMACOTHER, V46, P9, DOI 10.1345/aph.1Q446; Oster TJ, 2007, CNS SPECTRUMS, V12, P764, DOI 10.1017/S1092852900015455; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Patel RP, 2009, CRIT CARE MED, V37, P825, DOI 10.1097/CCM.0b013e31819b8608; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Schreiber S, 1998, INT CLIN PSYCHOPHARM, V13, P273, DOI 10.1097/00004850-199811000-00006; Silver BV, 2003, BRAIN INJURY, V17, P237, DOI 10.1080/0269905021000013192; Skrobik YK, 2004, INTENS CARE MED, V30, P444, DOI 10.1007/s00134-003-2117-0; Swan JT, 2012, CRIT CARE, V16, DOI 10.1186/cc11342; Thomason JWW, 2005, CRIT CARE, V9, pR375, DOI 10.1186/cc3729; Tomasi CD, 2012, J CRIT CARE, V27, P212, DOI 10.1016/j.jcrc.2011.05.015; van Eijk MMJ, 2010, AM J RESP CRIT CARE, V181, P419, DOI 10.1164/ajrccm.181.4.419b; van Eijk MM, 2010, AM J RESP CRIT CARE, V181; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Wilcox ME, 2013, CRIT CARE MED, V41, pS81, DOI 10.1097/CCM.0b013e3182a16946	40	27	27	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	AUG	2015	30	4					814	818		10.1016/j.jcrc.2015.03.030			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CK2TO	WOS:000356066100028	25887805				2022-02-06	
J	Amen, DG; Raji, CA; Willeumier, K; Taylor, D; Tarzwell, R; Newberg, A; Henderson, TA				Amen, Daniel G.; Raji, Cyrus A.; Willeumier, Kristen; Taylor, Derek; Tarzwell, Robert; Newberg, Andrew; Henderson, Theodore A.			Functional Neuroimaging Distinguishes Posttraumatic Stress Disorder from Traumatic Brain Injury in Focused and Large Community Datasets	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; TRANSCRANIAL MAGNETIC STIMULATION; EMISSION COMPUTED-TOMOGRAPHY; MENTAL-HEALTH PROBLEMS; PSYCHIATRIC-DISORDERS; PREFRONTAL CORTEX; POLICE OFFICERS; PTSD SYMPTOMS; PERFUSION; SPECT	Background Traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are highly heterogeneous and often present with overlapping symptomology, providing challenges in reliable classification and treatment. Single photon emission computed tomography (SPECT) may be advantageous in the diagnostic separation of these disorders when comorbid or clinically indistinct. Methods Subjects were selected from a multisite database, where rest and on-task SPECT scans were obtained on a large group of neuropsychiatric patients. Two groups were analyzed: Group 1 with TBI (n=104), PTSD (n=104) or both (n=73) closely matched for demographics and comorbidity, compared to each other and healthy controls (N=116); Group 2 with TBI (n=7,505), PTSD (n=1,077) or both (n=1,017) compared to n=11,147 without either. ROIs and visual readings (VRs) were analyzed using a binary logistic regression model with predicted probabilities inputted into a Receiver Operating Characteristic analysis to identify sensitivity, specificity, and accuracy. One-way ANOVA identified the most diagnostically significant regions of increased perfusion in PTSD compared to TBI. Analysis included a 10-fold cross validation of the protocol in the larger community sample (Group 2). Results For Group 1, baseline and on-task ROIs and VRs showed a high level of accuracy in differentiating PTSD, TBI and PTSD+TBI conditions. This carefully matched group separated with 100% sensitivity, specificity and accuracy for the ROI analysis and at 89% or above for VRs. Group 2 had lower sensitivity, specificity and accuracy, but still in a clinically relevant range. Compared to subjects with TBI, PTSD showed increases in the limbic regions, cingulum, basal ganglia, insula, thalamus, prefrontal cortex and temporal lobes. Conclusions This study demonstrates the ability to separate PTSD and TBI from healthy controls, from each other, and detect their co-occurrence, even in highly comorbid samples, using SPECT. This modality may offer a clinical option for aiding diagnosis and treatment of these conditions.	[Amen, Daniel G.; Willeumier, Kristen; Taylor, Derek] Amen Clin Inc, Dept Res, Costa Mesa, CA 92626 USA; [Raji, Cyrus A.] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA; [Tarzwell, Robert] Univ British Columbia, Lions Gate Hosp, Fac Med, Dept Psychiat, N Vancouver, BC, Canada; [Newberg, Andrew] Thomas Jefferson Univ, Dept Radiol, Philadelphia, PA 19107 USA; [Henderson, Theodore A.] Synapt Space, Denver, CO USA; [Henderson, Theodore A.] Int Soc Appl Neuroimaging, Denver, CO USA		Amen, DG (corresponding author), Amen Clin Inc, Dept Res, Costa Mesa, CA 92626 USA.	docamen@amenclinics.com		Willeumier, Kristen/0000-0002-1229-8516			Amen DG, 2008, J PSYCHOACTIVE DRUGS, V40, P139, DOI 10.1080/02791072.2008.10400623; Amen DG, 2008, J PSYCHOACTIVE DRUGS, V40, P131, DOI 10.1080/02791072.2008.10400622; Anderson RJ, 2008, MOL INTERV, V8, P204, DOI 10.1124/mi.8.5.2; [Anonymous], 2009, GULF AND WAR HEALTH; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Berlim MT, 2014, CAN J PSYCHIAT, V59, P487, DOI 10.1177/070674371405900905; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bonne O, 2003, BIOL PSYCHIAT, V54, P1077, DOI 10.1016/S0006-3223(03)00525-0; Bremner J D, 1999, Semin Clin Neuropsychiatry, V4, P249; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P246; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Castel-Lacanal E, 2014, ANN FR ANESTH, V33, P83, DOI 10.1016/j.annfar.2013.11.006; Centers for Disease Control and Prevention, INJURY PREVENTION AN; Centers for Disease Control and Prevention, EB BASED INJURY STAT; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; CHANG W, 1984, J NUCL MED, V25, P788; Chung YA, 2006, CLIN NEUROPHYSIOL, V117, P637, DOI 10.1016/j.clinph.2005.10.020; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Defense and Veterans Brain Injury Center, DOD WORLDWIDE NUMBER; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fischer H, 2014, U S MILITARY CASUALT; Francati V, 2007, DEPRESS ANXIETY, V24, P202, DOI 10.1002/da.20208; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Hastie TT, 2001, THE ELEMENTS OF STAT, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; Hermes E, 2014, EPIDEMIOL PSYCH SCI, V23, P281, DOI 10.1017/S2045796013000449; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; Jacobs A, 1996, J NUCL MED, V37, P1605; Jain S, 2012, PSYCHIAT SERV, V63, P154, DOI 10.1176/appi.ps.201100199; Jeyaraj JA, 2013, BRAIN INJURY, V27, P1338, DOI 10.3109/02699052.2013.823650; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kim J, 2012, NEUROREHAB NEURAL RE, V26, P870, DOI 10.1177/1545968311434553; Kim SY, 2012, PSYCHIAT RES-NEUROIM, V201, P214, DOI 10.1016/j.pscychresns.2011.08.007; Kinuya K, 2004, NUCL MED COMMUN, V25, P333, DOI 10.1097/00006231-200404000-00004; Kitayama N, 2006, J AFFECT DISORDERS, V90, P171, DOI 10.1016/j.jad.2005.11.006; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Krystal JH, 2014, CELL, V157, P201, DOI 10.1016/j.cell.2014.02.042; Krystal JH, 2011, JAMA-J AM MED ASSOC, V306, P493, DOI 10.1001/jama.2011.1080; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lee Bruce, 2005, NeuroRx, V2, P372; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lindauer RJL, 2008, PSYCHOL MED, V38, P543, DOI 10.1017/S0033291707001432; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P853, DOI 10.1016/j.biopsych.2004.08.003; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P356, DOI 10.1016/j.biopsych.2004.05.021; Lucey JV, 1997, BRIT J PSYCHIAT, V171, P346, DOI 10.1192/bjp.171.4.346; Macera CA, 2012, J REHABIL RES DEV, V49, P1197, DOI 10.1682/JRRD.2011.07.0131; Mai JK, 1997, ATLAS OF THE HUMAN B; Maroon JC, 2012, PHYSICIAN SPORTSMED, V40, P73, DOI 10.3810/psm.2012.11.1990; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Morgan M, 2012, PSYCHIAT SERV, V63, P182, DOI 10.1176/appi.ps.201000531; National Institute of Mental Health, POST TRAUMATIC STRES; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pavel D, 2006, BRAIN COGNITION, V60, P211; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peterson A, 2014, CAN J PSYCHIAT, V59, P294, DOI 10.1177/070674371405900602; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Sachinvala N, 2000, MIL MED, V165, P473, DOI 10.1093/milmed/165.6.473; Sartory G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058150; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seedat S, 2004, J AFFECT DISORDERS, V80, P45, DOI 10.1016/S0165-0327(03)00047-8; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Shin LM, 2004, ARCH GEN PSYCHIAT, V61, P168, DOI 10.1001/archpsyc.61.2.168; Silver JM, 2011, TEXTBOOK OF TRAUMATI, P609; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Stamatakis EA, 1999, BEHAV NEUROL, V12, P29, DOI 10.1155/2000/681916; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielan T, 2008, INVISIBLE WOUNDS OF; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; TEASDALE G, 1974, LANCET, V2, P81; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; The American College of Radiology, 2014, ACR SPR PRACTICE PAR; Thomas JT, 1964, J AM STAT ASSOC, V61, P852; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; Van Laere KJ, 2002, J NUCL MED, V43, P458; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Villarreal G, 2004, PSYCHIAT RES-NEUROIM, V131, P227, DOI 10.1016/j.pscychresns.2004.05.002; Wang HR, 2013, CLIN NEUROPHARMACOL, V36, P216, DOI 10.1097/WNF.0b013e3182aa365f; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225; Weniger G, 2008, ACTA PSYCHIAT SCAND, V118, P281, DOI 10.1111/j.1600-0447.2008.01246.x; Whipple E, 2014, ARCH CLIN NEUROPSYCH, V29; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Zaroya G., 2005, US TODAY; Zubieta JK, 1999, J PSYCHIAT RES, V33, P259, DOI 10.1016/S0022-3956(98)00060-0	114	27	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2015	10	7							e0129659	10.1371/journal.pone.0129659			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1CG	WOS:000358153000031	26132293	Green Published, gold, Green Submitted			2022-02-06	
J	Mautner, K; Sussman, WI; Axtman, M; Al-Farsi, Y; Al-Adawi, S				Mautner, Kenneth; Sussman, Walter I.; Axtman, Matthew; Al-Farsi, Yahya; Al-Adawi, Samir			Relationship of Attention Deficit Hyperactivity Disorder and Postconcussion Recovery in Youth Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sport-related concussion; mild traumatic brain injury; computerized neurocognitive testing; immediate postconcussion assessment and cognitive testing; attention deficit hyperactivity disorder	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; AMERICAN MEDICAL SOCIETY; STATES HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; FOOTBALL PLAYERS; ON-FIELD; COLLEGIATE; IMPACT; SENSITIVITY	Objective:To investigate whether attention deficit hyperactivity disorder (ADHD) influences postconcussion recovery, as measured by computerized neurocognitive testing.Design:This is a retrospective case control study.Setting:Computer laboratories across 10 high schools in the greater Atlanta, Georgia area.Participants:Immediate postconcussion assessment and cognitive testing (ImPACT) scores of 70 athletes with a self-reported diagnosis of ADHD and who sustained a sport-related concussion were compared with a randomly selected age-matched control group. Immediate postconcussion assessment and cognitive testing scores over a 5-year interval were reviewed for inclusion.Main Outcome Measures:Postconcussion recovery was defined as a return to equivalent baseline neurocognitive score on the ImPACT battery, and a concussion symptom score of 7.Results:Athletes with ADHD had on average a longer time to recovery when compared with the control group (16.5 days compared with 13.5 days), although not statistically significant. The number of previous concussions did not have any effect on the rate of recovery in the ADHD or the control group. In addition, baseline neurocognitive testing did not statistically differ between the 2 groups, except in verbal memory.Conclusions:Although not statistically significant, youth athletes with ADHD took on average 3 days longer to return to baseline neurocognitive testing compared with a control group without ADHD.Clinical Relevance:Youth athletes with ADHD may have a marginally prolonged recovery as indexed by neurocognitive testing and should be considered when prognosticating time to recovery in this subset of student athletes.	[Mautner, Kenneth] Emory Univ, Emory Sports Med Ctr, Dept Orthopaed, Atlanta, GA 30322 USA; [Mautner, Kenneth] Emory Univ, Emory Sports Med Ctr, Dept Rehabil, Atlanta, GA 30322 USA; [Sussman, Walter I.] Emory Univ, Dept Rehabil, Atlanta, GA 30322 USA; [Axtman, Matthew] Spectrum Hlth Med Grp, Orthopaed & Sports Med, Grand Rapids, MI USA; [Al-Farsi, Yahya] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Family Med & Publ Hlth, Muscat, Oman; [Al-Adawi, Samir] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Behav Med, Muscat, Oman		Mautner, K (corresponding author), Emory Orthopaed & Spine Ctr, Dept Orthopaed & Rehabil, 59 Execut Pk South, Atlanta, GA 30329 USA.	kmautne@emory.edu	sussman, walter/V-5191-2019; Al-Adawi, Samir/A-9663-2016; Meijer, Anna/K-5118-2016; Al-Farsi, Yahya/AAM-2181-2020	sussman, walter/0000-0002-3279-6029; Al-Adawi, Samir/0000-0002-9858-5582; Al-Farsi, Yahya/0000-0002-0302-7132			Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BEERS SR, 1994, J LEARN DISABIL, V27, P315, DOI 10.1177/002221949402700508; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Coppel DB, 2011, PHYS MED REH CLIN N, V22, P653, DOI 10.1016/j.pmr.2011.08.006; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; DiScala C, 1998, PEDIATRICS, V102, P1415, DOI 10.1542/peds.102.6.1415; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Grindel Scott H, 2006, Curr Sports Med Rep, V5, P9; Guskiewicz KM, 2011, PHYS MED REH CLIN N, V22, P603, DOI 10.1016/j.pmr.2011.08.003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Monaghan S, HIGH SCH SPORTS PART; Owens JS, 2007, CLIN CHILD FAM PSYCH, V10, P335, DOI 10.1007/s10567-007-0027-3; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Putukian M, 2011, CLIN J SPORT MED, V21, P392, DOI 10.1097/JSM.0b013e3182262eb1; Randolph C, 2001, J ATHL TRAINING, V36, P288; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Seidman LJ, 1995, J CHILD PSYCHOL PSYC, V36, P1459, DOI 10.1111/j.1469-7610.1995.tb01675.x; Slobounov S, 2007, NEUROSURGERY, V61, P338, DOI 10.1227/01.NEU.0000280001.03578.FF; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Wolraich ML, 2005, PEDIATRICS, V115, P1734, DOI 10.1542/peds.2004-1959; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	53	27	27	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2015	25	4					355	360		10.1097/JSM.0000000000000151			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	CM2EK	WOS:000357492400008	25353721				2022-02-06	
J	Midura, EF; Jernigan, PL; Kuethe, JW; Friend, LA; Veile, R; Makley, AT; Caldwell, CC; Goodman, MD				Midura, Emily F.; Jernigan, Peter L.; Kuethe, Joshua W.; Friend, Lou Ann; Veile, Rosalie; Makley, Amy T.; Caldwell, Charles C.; Goodman, Michael D.			Microparticles impact coagulation after traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Platelet function; Microparticles; TBI; Hypercoagulability; Thromboelastometry	PLATELET DYSFUNCTION; HYPERCOAGULABLE STATE; CEREBROSPINAL-FLUID; VENOUS THROMBOSIS; PROCOAGULANT; COAGULOPATHY; RESUSCITATION; PREDICTORS; GENERATION; MODEL	Background: The pathophysiology that drives the subacute hypercoagulable state commonly seen after traumatic brain injury (TBI) is not well understood. Alterations caused by TBI in platelet and microparticle (MP) numbers and function have been suggested as possible causes; however, the contributions of platelets and MPs are currently unknown. Materials and methods: A weight-drop technique of TBI using a murine model of moderate head injury was used. Blood was collected at intervals after injury. MP enumeration and characterization were performed using Nanoparticle Tracking Analysis, and platelet counts and coagulation parameters were determined using thromboelastometry. A MP procoagulant assay was used to compare activity between injured and sham mice. Results: At 24 h after injury, there were no changes in circulating platelet numbers. However, there was a decrease in platelet contribution to clot formation. In contrast, there was a decline in circulating total MP numbers. When MPs from sham mice were added to the blood from head-injured animals, there was a normalization of platelet contribution to clot formation. Conversely, when MPs from TBI mice were added to sham blood, there was a significant decrease in platelet contribution to clot formation. Notably, there was an increase in MP procoagulant activity in head-injured mice. Conclusions: MPs generated after TBI likely contribute to altered coagulation after head injury and may play a key role in the development of a posttraumatic hypercoagulable state in TBI patients. (C) 2015 Elsevier Inc. All rights reserved.	[Goodman, Michael D.] Univ Cincinnati, Dept Surg, Div Res, Cincinnati, OH 45267 USA; Univ Cincinnati, Inst Mil Med, Cincinnati, OH 45267 USA		Goodman, MD (corresponding author), Univ Cincinnati, Dept Surg, Div Res, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	goodmamd@ucmail.uc.edu		Caldwell, Charles/0000-0003-1692-4550; Veile, Rosalie/0000-0002-0139-7498; Midura, Emily/0000-0002-7659-316X; Goodman, Michael/0000-0001-7218-4855	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM100913] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM100913] Funding Source: NIH RePORTER		Brakenridge SC, 2013, J TRAUMA ACUTE CARE, V74, P1231, DOI 10.1097/TA.0b013e31828cc9a0; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Choudhry MA, 2007, INJURY, V38, P1382, DOI 10.1016/j.injury.2007.09.027; Cotton BA, 2012, J TRAUMA ACUTE CARE, V72, P1470, DOI 10.1097/TA.0b013e31824d56ad; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Epstein DS, 2015, BRIT J NEUROSURG, V29, P118, DOI 10.3109/02688697.2014.950632; Geddings JE, 2013, BLOOD, V122, P1873, DOI 10.1182/blood-2013-04-460139; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Haut ER, 2009, J TRAUMA, V66, P994, DOI 10.1097/TA.0b013e3181991adc; Huang M, 2009, SURG NEUROL, V72, P481, DOI 10.1016/j.surneu.2008.12.016; Kaptan K, 2008, INT J GYNECOL OBSTET, V102, P271, DOI 10.1016/j.ijgo.2008.04.007; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Lacroix R, 2012, THROMB RES, V129, pS27, DOI 10.1016/j.thromres.2012.02.025; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Matijevic N, 2014, THROMB RES, V134, P652, DOI 10.1016/j.thromres.2014.07.023; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nekludov M, 2007, J NEUROTRAUM, V24, P174, DOI 10.1089/neu.2006.0173; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Park MS, 2012, SURGERY, V151, P831, DOI 10.1016/j.surg.2011.12.022; Park MS, 2009, J TRAUMA, V67, P266, DOI 10.1097/TA.0b013e3181ae6f1c; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Prakash PS, 2012, J TRAUMA ACUTE CARE, V73, P401, DOI 10.1097/TA.0b013e31825a776d; Schiro A, 2014, ATHEROSCLEROSIS, V234, P295, DOI 10.1016/j.atherosclerosis.2014.03.019; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Schreiber M, 2009, J TRAUMA, V67, P275; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; VECHT CJ, 1975, J NEUROL NEUROSUR PS, V38, P567, DOI 10.1136/jnnp.38.6.567; Windelov NA, 2014, J TRAUMA ACUTE CARE, V77, P692, DOI 10.1097/TA.0000000000000437; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zhou L, 2014, ACTA PHARMACOL SIN, V35, P1103, DOI 10.1038/aps.2014.73	41	27	29	0	19	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUL	2015	197	1					25	31		10.1016/j.jss.2015.02.064			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CJ5UA	WOS:000355554900005	25846728	Green Accepted			2022-02-06	
J	Moore, RD; Pindus, DM; Drolette, ES; Scudder, MR; Raine, LB; Hillman, CH				Moore, Robert D.; Pindus, Dominika M.; Drolette, Eric S.; Scudder, Mark R.; Raine, Lauren B.; Hillman, Charles H.			The persistent influence of pediatric concussion on attention and cognitive control during flanker performance	BIOLOGICAL PSYCHOLOGY			English	Article						Child; Concussion; Brain function; Cognition	TRAUMATIC BRAIN-INJURY; SUSTAINED ATTENTION; RESPONSE CONFLICT; CHILDREN; ERP; QUESTIONNAIRE; ADOLESCENTS; POTENTIALS; ACTIVATION; COMPONENT	This study investigated the influence of concussion history on children's neurocognitive processing. Thirty-two children ages 8-10 years (16 with a concussion history, 16 controls) completed compatible and incompatible conditions of a flanker task while behavioral and neuroelectric data were collected. Relative to controls, children with a concussion history exhibited alterations in the sequential congruency effect, committed more omission errors, and exhibited decreased post-error accuracy. Children with a concussion history exhibited longer N2 latency across task conditions, increased N2 amplitude during the incompatible condition of the task, and decreased P3b amplitude across task conditions. Children with a history of concussion also exhibited decreased ERN and Pe amplitudes, with group difference increasing for the incompatible condition of the task. The current results indicate that pediatric concussion may lead to subtle, but pervasive deficits in attention and cognitive control. These results serve to inform a poorly understood but significant public health concern. (C) 2015 Elsevier B. V. All rights reserved.	[Moore, Robert D.; Drolette, Eric S.; Scudder, Mark R.; Raine, Lauren B.; Hillman, Charles H.] Univ Illinois, Dept Kinesiol, Urbana, IL 61801 USA; [Moore, Robert D.] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Pindus, Dominika M.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England		Moore, RD (corresponding author), 2100 Boul Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	robert.moore@umontreal.ca	Hillman, Charles/AAD-4828-2019	Pindus, Dominika M/0000-0001-7288-7921; Hillman, Charles/0000-0002-3722-5612	National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [RO1 HD055352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055352] Funding Source: NIH RePORTER	Partial support for this research and the preparation of this manuscript was provided by a grant from the National Institute of Child Health and Human Development (NICHD) to Charles Hillman (RO1 HD055352).	Alexander WH, 2010, TOP COGN SCI, V2, P658, DOI 10.1111/j.1756-8765.2010.01085.x; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Birnbaum AS, 2002, AM J HEALTH BEHAV, V26, P284, DOI 10.5993/AJHB.26.4.5; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Broglio S.P., 2009, J NEUROTRAUM, V23, P899; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Caggiano DM, 2004, PSYCHON B REV, V11, P932, DOI 10.3758/BF03196724; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; DuPaul G.J., 1998, ADHD RATING SCALE 4; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; FALKENSTEIN M, 1991, ELECTROEN CLIN NEURO, V78, P447, DOI 10.1016/0013-4694(91)90062-9; FISK AD, 1981, HUM FACTORS, V23, P737, DOI 10.1177/001872088102300610; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friedman D, 2009, COGN AFFECT BEHAV NE, V9, P91, DOI 10.3758/CABN.9.1.91; Gajewski PD, 2008, BRAIN RES, V1189, P127, DOI 10.1016/j.brainres.2007.10.076; Gajewski PD, 2013, INT J PSYCHOPHYSIOL, V87, P273, DOI 10.1016/j.ijpsycho.2012.08.007; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hajcak G, 2009, PSYCHOPHYSIOLOGY, V46, pS15; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hilti CC, 2013, BRAIN COGNITION, V81, P193, DOI 10.1016/j.bandc.2012.10.013; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Luna B, 2009, ADV CHILD DEV BEHAV, V37, P233, DOI 10.1016/S0065-2407(09)03706-9; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Moore R. D., 2015, PERSISTENT INF UNPUB; Moore RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00258; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Pontifex MB, 2012, NEUROPSYCHOLOGY, V26, P407, DOI 10.1037/a0028795; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Pontifex MB, 2010, PSYCHOPHYSIOLOGY, V47, P767, DOI 10.1111/j.1469-8986.2010.00974.x; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Spencer KM, 1999, PSYCHOPHYSIOLOGY, V36, P364, DOI 10.1017/S0048577299970749; Taylor SJC, 2001, PAEDIATR PERINAT EP, V15, P88; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	64	27	27	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0301-0511	1873-6246		BIOL PSYCHOL	Biol. Psychol.	JUL	2015	109						93	102		10.1016/j.biopsycho.2015.04.008			10	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	CN4XQ	WOS:000358434200011	25951782				2022-02-06	
J	Newell, E; Shellington, DK; Simon, DW; Bell, MJ; Kochanek, PM; Feldman, K; Bayir, H; Aneja, RK; Carcillo, JA; Clark, RSB				Newell, Elizabeth; Shellington, David K.; Simon, Dennis W.; Bell, Michael J.; Kochanek, Patrick M.; Feldman, Keri; Bayir, Huelya; Aneja, Rajesh K.; Carcillo, Joseph A.; Clark, Robert S. B.			Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						cluster of differentiation 163; ferritin; head injury; interleukin-2 receptor; macrophage activation syndrome; microglia	CONTROLLED CORTICAL IMPACT; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; CD163(+) MACROPHAGES/MICROGLIA; MULTIPLE-SCLEROSIS; IMMATURE RAT; FERRITIN; EXPRESSION; RESPONSES; ACCUMULATION; INTERLEUKIN-10	Objectives: The magnitude and role of the cellular immune response following pediatric traumatic brain injury remains unknown. We tested the hypothesis that macrophage/microglia and T-cell activation occurs following pediatric traumatic brain injury by measuring cerebrospinal fluid levels of soluble cluster of differentiation 163 and ferritin and soluble interleukin-2 receptor , respectively, and determined whether these biomarkers were associated with relevant clinical variables and outcome. Design: Retrospective analysis of samples from an established, single-center cerebrospinal fluid bank. Setting: PICU in a tertiary children's hospital. Patients: Sixty-six pediatric patients after severe traumatic brain injury (Glasgow Coma Scale score < 8) who were 1 month to 16 years old and 17 control patients who were 1 month to 14 years old. Interventions: None. Measurements and Main Results: Cerebrospinal fluid levels of soluble cluster of differentiation 163, ferritin, and soluble interleukin-2 receptor were determined by enzyme-linked immunosorbent assay at two time points (t(1) = 17 10 hr; t(2) = 72 +/- 15 hr) for each traumatic brain injury patient. Cerebrospinal fluid levels of soluble cluster of differentiation 163, ferritin, and soluble interleukin-2 receptor after traumatic brain injury were compared with controls and analyzed for associations with age, patient sex, initial Glasgow Coma Scale score, diagnosis of abusive head trauma, the presence of hemorrhage on CT scan, and Glasgow Outcome Scale score. Cerebrospinal fluid level of soluble cluster of differentiation 163 was increased in traumatic brain injury patients at t(2) versus t(1) and controls (median, 95.4 ng/mL [interquartile range, 21.8-134.0 ng/mL] vs 31.0 ng/mL [5.7-77.7 ng/mL] and 27.8 ng/mL [19.1-43.1 ng/mL], respectively; p < 0.05). Cerebrospinal fluid level of ferritin was increased in traumatic brain injury patients at t(2) and t(1) versus controls (8.3 ng/mL [<7.5-19.8 ng/mL] and 8.9 ng/mL [<7.5-26.7 ng/mL] vs <7.5 ng/mL below lower limit of detection, respectively; p < 0.05). Cerebrospinal fluid levels of soluble interleukin-2 receptor in traumatic brain injury patients at t(2) and t(1) were not different versus controls. Multivariate regression revealed associations between high ferritin and age 4 years or younger, lower Glasgow Coma Scale score, abusive head trauma, and unfavorable Glasgow Outcome Scale score. Conclusions: Children with traumatic brain injury demonstrate evidence for macrophage activation after traumatic brain injury, and in terms of cerebrospinal fluid ferritin, this appears more prominent with young age, initial injury severity, abusive head trauma, and unfavorable outcome. Further study is needed to determine whether biomarkers of macrophage activation may be used to discriminate between aberrant and adaptive immune responses and whether inflammation represents a therapeutic target after traumatic brain injury.	[Newell, Elizabeth] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Shellington, David K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Simon, Dennis W.; Bell, Michael J.; Kochanek, Patrick M.; Feldman, Keri; Bayir, Huelya; Aneja, Rajesh K.; Carcillo, Joseph A.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Bell, Michael J.; Bayir, Huelya; Aneja, Rajesh K.; Carcillo, Joseph A.; Clark, Robert S. B.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Bell, Michael J.; Kochanek, Patrick M.; Bayir, Huelya; Aneja, Rajesh K.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Kochanek, Patrick M.; Carcillo, Joseph A.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Bayir, Huelya] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA		Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu		Newell, Elizabeth/0000-0002-1476-033X	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 HD40686]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 GM098474, U01 NS081041, R01 GM108618, R01 NS38620]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM098474, R01GM108618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS081041, R01NS038620] Funding Source: NIH RePORTER	Dr. Simon was supported by grants from the National Institutes of Health (NIH; T32 HD40686). Dr. Bell was supported by grants from the NIH (R01 GM098474 and U01 NS081041). Dr. Carcillo was supported by grants from the NIH (R01 GM108618). Dr. Clark was supported by grants from the NIH (R01 NS38620). Dr. Clark is employed by the University of Pittsburgh, received royalties from Elsevier (textbook), and received support for article research from the NIH. His institution received grant support from the NIH (R01 NS38620). Dr. Bell's institution received grant support from the NIH. Dr. Kochanek is a co-provisional patent holder: Emergency preservation and resuscitation, A multiplex panel diagnostic aid for abusive head trauma, and RNA binding motif targeting agents as neuroprotectants. Dr. Bayir received support for article research from the NIH. Dr. Aneja received support for article research from the NIH and received royalties from Uptodate. His institution received grant support from the NIH. Dr. Carcillo disclosed other support (NICHD and NIHMS funding not related to this manuscript). His institution received grant support. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Bell MJ, 1997, ACT NEUR S, V70, P96; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Beschorner R, 2002, ACTA NEUROPATHOL, V103, P541, DOI 10.1007/s00401-001-0503-7; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Cernak I, 2010, DEV NEUROSCI-BASEL, V32, P442, DOI 10.1159/000320085; Chandrakasan S, 2013, J PEDIATR-US, V163, P1253, DOI 10.1016/j.jpeds.2013.06.053; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038400; Fitzgerald NE, 2003, PEDIATR RADIOL, V33, P392, DOI 10.1007/s00247-003-0894-9; Glanzer JG, 2007, J NEUROCHEM, V102, P627, DOI 10.1111/j.1471-4159.2007.04568.x; Hohnholt MC, 2013, BIOCHEM SOC T, V41, P1588, DOI 10.1042/BST20130114; Holfelder K, 2011, HISTOL HISTOPATHOL, V26, P1007, DOI 10.14670/HH-26.1007; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kamper JE, 2013, EXP NEUROL, V250, P8, DOI 10.1016/j.expneurol.2013.09.016; KANEKO Y, 1989, ACTA NEUROPATHOL, V79, P129, DOI 10.1007/BF00294369; KEIR G, 1993, CLIN CHIM ACTA, V216, P153, DOI 10.1016/0009-8981(93)90148-W; Kim YO, 2003, PEDIATR NEUROL, V28, P271, DOI 10.1016/S0887-8994(02)00625-2; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Meyron-Holtz EG, 2011, J NEURAL TRANSM, V118, P337, DOI 10.1007/s00702-011-0582-0; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Petzold A, 2002, BRAIN, V125, P1462, DOI 10.1093/brain/awf165; Potts Mathew B, 2006, NeuroRx, V3, P143; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Rooms L, 2003, PEDIATRICS, V111, pE636, DOI 10.1542/peds.111.5.e636; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Shein SL, 2012, J PEDIAT, V161; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Su LX, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/969875; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Todorich B, 2011, GLIA, V59, P927, DOI 10.1002/glia.21164; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Zhang ZR, 2012, BRAIN RES, V1461, P102, DOI 10.1016/j.brainres.2012.04.038; Zhang Z, 2011, J NEUROIMMUNOL, V237, P73, DOI 10.1016/j.jneuroim.2011.06.006	51	27	27	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUL	2015	16	6					549	557		10.1097/PCC.0000000000000400			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	CN2YQ	WOS:000358289700008	25850867	Green Accepted			2022-02-06	
J	Rosenberg, H; Dethier, M; Kessels, RPC; Westbrook, RF; McDonald, S				Rosenberg, Hannah; Dethier, Marie; Kessels, Roy P. C.; Westbrook, R. Frederick; McDonald, Skye			Emotion Perception After Moderate-Severe Traumatic Brain Injury: The Valence Effect and the Role of Working Memory, Processing Speed, and Nonverbal Reasoning	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; emotion recognition; valence; working memory; processing speed	FACIAL AFFECT RECOGNITION; BLUNT HEAD-INJURY; SOCIAL-PERCEPTION; STROKE PATIENTS; HUMAN AMYGDALA; WECHSLER TEST; EXPRESSIONS; DEFICITS; IMPAIRMENTS; PERFORMANCE	Objective: Traumatic brain injury (TBI) impairs emotion perception. Perception of negative emotions (sadness, disgust, fear, and anger) is reportedly affected more than positive (happiness and surprise) ones. It has been argued that this reflects a specialized neural network underpinning negative emotions that is vulnerable to brain injury. However, studies typically do not equate for differential difficulty between emotions. We aimed to examine whether emotion recognition deficits in people with TBI were specific to negative emotions, while equating task difficulty, and to determine whether perception deficits might be accounted for by other cognitive processes. Method: Twenty-seven people with TBI and 28 matched control participants identified 6 basic emotions at 2 levels of intensity (a) the conventional 100% intensity and (b) "equated intensity"-that is, an intensity that yielded comparable accuracy rates across emotions in controls. Results: (a) At 100% intensity, the TBI group was impaired in recognizing anger, fear, and disgust but not happiness, surprise, or sadness and performed worse on negative than positive emotions. (b) At equated intensity, the TBI group was poorer than controls overall but not differentially poorer in recognizing negative emotions. Although processing speed and nonverbal reasoning were associated with emotion accuracy, injury severity by itself was a unique predictor. Conclusions: When task difficulty is taken into account, individuals with TBI show impairment in recognizing all facial emotions. There was no evidence for a specific impairment for negative emotions or any particular emotion. Impairment was accounted for by injury severity rather than being a secondary effect of reduced neuropsychological functioning.	[Rosenberg, Hannah; McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia; [Dethier, Marie] Univ Liege, Dept Psychol Cognit & Behav, B-4000 Liege, Belgium; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Venray, Netherlands; [Kessels, Roy P. C.] Radboud Univ Nijmegen, Dept Med Psychol, Venray, Netherlands; [Kessels, Roy P. C.] Vincent van Gogh Inst Psychiat, Korsakoff Clin, Venray, Netherlands		Rosenberg, H (corresponding author), Univ New S Wales, Sch Psychol, Mathews Bldg, Sydney, NSW 2052, Australia.	hannah.rosenberg@unsw.edu.au	Kessels, Roy P.C./D-1902-2010	Kessels, Roy P.C./0000-0001-9500-9793	Australian Research CouncilAustralian Research Council [DP0988689]	This research was funded by Australian Research Council Discovery Project Grant DP0988689. We thank the individuals with brain injuries, their families, and community controls for their interest and participation in this study. We are also grateful to Jacob Rosenberg for assistance with data processing and technical support.	ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Adolphs R, 1999, PSYCHOL SCI, V10, P167, DOI 10.1111/1467-9280.00126; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Ammerlaan EJG, 2008, ACTA NEUROBIOL EXP, V68, P214; Anderson AK, 2000, PSYCHOL SCI, V11, P106, DOI 10.1111/1467-9280.00224; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; BENSON PJ, 1991, IMAGE VISION COMPUT, V9, P123, DOI 10.1016/0262-8856(91)90022-H; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bird KD, 2011, PSYCHOL METHODS, V16, P432, DOI 10.1037/a0024447; Bornhofen C., 2010, READING SMILES OTHER; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Braun C M, 1989, Brain Inj, V3, P5, DOI 10.3109/02699058909008068; Braun M, 2005, BRAIN COGNITION, V58, P193, DOI 10.1016/j.bandc.2004.11.003; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Callahan BL, 2011, BRAIN COGNITION, V77, P412, DOI 10.1016/j.bandc.2011.08.017; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P345, DOI 10.1080/13854049708400463; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Dethier M, 2013, J INT NEUROPSYCH SOC, V19, P367, DOI 10.1017/S1355617712001555; Dethier M, 2012, J CLIN EXP NEUROPSYC, V34, P936, DOI 10.1080/13803395.2012.702734; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; Ekman P., 1976, PICTURES FACIAL AFFE; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; ESLINGER PJ, 1995, NEUROREHABILITATION, V5, P161, DOI 10.3233/NRE-1995-5206; Fernandez-Duque D, 2005, NEUROPSYCHOLOGIA, V43, P1673, DOI 10.1016/j.neuropsychologia.2005.01.005; Freeman J, 2001, BRIT J CLIN PSYCHOL, V40, P221, DOI 10.1348/014466501163562; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Graham R, 2007, NEUROPSYCHOLOGIA, V45, P42, DOI 10.1016/j.neuropsychologia.2006.04.021; Grattan LM, 2002, NEUROPSYCHOLOGICAL INTERVENTIONS, P266; Gray John, 2006, Cogn Neuropsychiatry, V11, P505, DOI 10.1080/13546800544000028; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Harmer CJ, 2001, NAT NEUROSCI, V4, P17, DOI 10.1038/82854; Hennenlotter A, 2006, PROG BRAIN RES, V156, P443, DOI 10.1016/S0079-6123(06)56024-8; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Kessels RPC, 2007, BEHAV NEUROL, V18, P31, DOI 10.1155/2007/868431; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kohler CG, 2005, AM J GERIAT PSYCHIAT, V13, P926, DOI 10.1176/appi.ajgp.13.11.926; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Kucharska-Pietura K, 2003, NEUROPSYCHOLOGIA, V41, P1082, DOI 10.1016/S0028-3932(02)00294-4; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LOVIBOND PF, 1995, MANUAL DEPRESSION AN; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mandal MK, 1998, SCHIZOPHRENIA BULL, V24, P399, DOI 10.1093/oxfordjournals.schbul.a033335; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Montagne B, 2008, EUR PSYCHIAT, V23, P26, DOI 10.1016/j.eurpsy.2007.07.007; Montagne B, 2007, ACTA NEUROPSYCHIATR, V19, P279, DOI 10.1111/j.1601-5215.2007.00235.x; Montagne B, 2007, BRIT J PSYCHOL, V98, P517, DOI 10.1348/000712606X160669; Montagne Barbara, 2006, Cogn Neuropsychiatry, V11, P389, DOI 10.1080/13546800444000254; Montagne B, 2006, CORTEX, V42, P705, DOI 10.1016/S0010-9452(08)70408-8; Montagne B, 2006, EUR NEUROL, V55, P151, DOI 10.1159/000093215; Morris PG, 2005, BRIT J CLIN PSYCHOL, V44, P209, DOI 10.1348/014466505X34174; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Poljac E, 2011, CORTEX, V47, P974, DOI 10.1016/j.cortex.2010.10.002; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Sato W, 2002, CORTEX, V38, P727, DOI 10.1016/S0010-9452(08)70040-6; Scholten MRM, 2005, SCHIZOPHR RES, V78, P61, DOI 10.1016/j.schres.2005.06.019; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Smith MJL, 2010, NEUROPSYCHOLOGIA, V48, P2777, DOI 10.1016/j.neuropsychologia.2010.03.008; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tottenham N, 2002, J COGNITIVE NEUROSCI, P74; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408; Yim J, 2013, BRAIN INJURY, V27, P1155, DOI 10.3109/02699052.2013.804203; Ylvisaker M, 2000, APHASIOLOGY, V14, P407, DOI 10.1080/026870300401432; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6; Zupan B, 2014, BRAIN INJURY, V28, P1087, DOI 10.3109/02699052.2014.901560	101	27	29	2	39	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2015	29	4					509	521		10.1037/neu0000171			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CL5CA	WOS:000356976200002	25643220				2022-02-06	
J	Wade, SL; Taylor, HG; Cassedy, A; Zhang, NH; Kirkwood, MW; Brown, TM; Stancin, T				Wade, Shari L.; Taylor, H. Gerry; Cassedy, Amy; Zhang, Nanhua; Kirkwood, Michael W.; Brown, Tanya M.; Stancin, Terry			Long-Term Behavioral Outcomes after a Randomized, Clinical Trial of Counselor-Assisted Problem Solving for Adolescents with Complicated Mild-to-Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adolescent; behavior; brain injury; child; online; therapy	PSYCHIATRIC-DISORDERS; CHILD-BEHAVIOR; INTERVENTION; PREVALENCE; DEPRESSION; DEFICITS	Family problem-solving therapy (FPST) has been shown to reduce behavior problems after pediatric traumatic brain injury (TBI). It is unclear whether treatment gains are maintained. We sought to evaluate the maintenance of improvements in behavior problems after a Web-based counselor-assisted FPST (CAPS) intervention compared to an Internet resource comparison (IRC) intervention provided to adolescents within the initial year post-TBI. We hypothesized that family socioeconomic status, child educational status, and baseline levels of symptoms would moderate the efficacy of the treatment over time. Participants included 132 adolescents ages 12-17 years who sustained a complicated mild-to-severe TBI 1-6 months before study enrollment. Primary outcomes were the Child Behavior Checklist Internalizing and Externalizing Totals. Mixed-models analyses, using random intercepts and slopes, were conducted to examine group differences over time. There was a significant groupxtimexgrade interaction (F-(1,F-304)=4.42; p=0.03) for internalizing problems, with high school-age participants in CAPS reporting significantly lower symptoms at 18 months postbaseline than those in the IRC. Post-hoc analyses to elucidate the nature of effects on internalizing problems revealed significant groupxtimexgrade interactions for the anxious/depressed (p=0.03) and somatic complaints subscales (p=0.04). Results also indicated significant improvement over time for CAPS participants who reported elevated externalizing behavior problems at baseline (F-(1,F- 310)=7.17; p=0.008). Findings suggest that CAPS may lead to long-term improvements in behavior problems among older adolescents and those with pretreatment symptoms.	[Wade, Shari L.; Cassedy, Amy; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.; Cassedy, Amy; Zhang, Nanhua] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Aurora, CO USA; [Brown, Tanya M.] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Rochester, MN USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Zhang, Nanhua/L-7606-2015; Stancin, Terry/L-7993-2019	Zhang, Nanhua/0000-0001-5796-3404	National Institutes of Health from the National Institute of Mental Health [R01-MH073764]; Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; Department of Education's National Institute on Disability and Rehabilitation Research (Center on Interventions for Children and Youth with Traumatic Brain Injury) [H133B090010-10]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported, in part, by National Institutes of Health grant R01-MH073764 from the National Institute of Mental Health; a grant from the Colorado Traumatic Brain Injury Trust Fund Research Program, Colorado Department of Human Services, Division of Vocational Rehabilitation, Traumatic Brain Injury Program; and the Department of Education's National Institute on Disability and Rehabilitation Research (Center on Interventions for Children and Youth with Traumatic Brain Injury; grant no.: H133B090010-10). This material does not necessarily represent the policy of these agencies, nor is the material necessarily endorsed by the federal government. Clinical Trial Registration: NCT00409448.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Antonini TN, 2014, BEHAV THER, V45, P455, DOI 10.1016/j.beth.2014.02.003; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; D'Zurilla TJN A. M., 2010, HDB COGNITIVE BEHAV, P197; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Gan C, 2010, BRAIN INJURY, V24, P651, DOI 10.3109/02699051003692142; Hofer TP, 1998, HEALTH SERV RES, V33, P243; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Rath JF, 2011, REHABIL PSYCHOL, V56, P320, DOI 10.1037/a0025817; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2015, PEDIATRICS, V135, pE487, DOI 10.1542/peds.2014-1386; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Woods D, 2015, SOCIAL CARE NEURODIS, V5, P70, DOI [DOI 10.1108/SCN-01-2014-0001, 10.1108/SCN-01-2014-0001]	24	27	27	1	19	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2015	32	13					967	975		10.1089/neu.2014.3684			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	CV0SU	WOS:000363964200005	25738891	Green Published			2022-02-06	
J	Sours, C; Rosenberg, J; Kane, R; Roys, S; Zhuo, JC; Shanmuganathan, K; Gullapalli, RP				Sours, Chandler; Rosenberg, Joseph; Kane, Robert; Roys, Steve; Zhuo, Jiachen; Shanmuganathan, Kathirkamanthan; Gullapalli, Rao P.			Associations between interhemispheric functional connectivity and the Automated Neuropsychological Assessment Metrics (ANAM) in civilian mild TBI	BRAIN IMAGING AND BEHAVIOR			English	Article						Resting state fMRI; Mild TBI; Automated Neuropsychological Assessment Metrics; Functional connectivity	TRAUMATIC BRAIN-INJURY; COGNITIVE DEFICITS; HEAD-INJURY; PERFORMANCE; NETWORK; CONCUSSION; STATE; RELIABILITY; DISRUPTION; BATTERY	This study investigates cognitive deficits and alterations in resting state functional connectivity in civilian mild traumatic brain injury (mTBI) participants with high and low symptoms. Forty-one mTBI participants completed a resting state fMRI scan and the Automated Neuropsychological Assessment Metrics (ANAM) during initial testing (< 10 days of injury) and a 1 month follow up. Data were compared to 30 healthy control subjects. Results from the ANAM demonstrate that mTBI participants performed significantly worse than controls on the code substitution delayed subtest (p = 0.032) and weighted throughput score (p = 0.001). Among the mTBI patients, high symptom mTBI participants performed worse than those with low symptoms on the code substitution delayed (p = 0.017), code substitution (p = 0.012), repeated simple reaction time (p = 0.031), and weighted throughput score (p = 0.009). Imaging results reveal that during the initial visit, low symptom mTBI participants had reduced interhemispheric functional connectivity (IH-FC) within the lateral parietal lobe (p = 0.020); however, during follow up, high symptom mTBI participants showed reduced IH-FC compared to the control group within the dorsolateral prefrontal cortex (DLPFC) (p = 0.013). Reduced IH-FC within the DLPFC during the follow-up was associated with reduced cognitive performance. Together, these findings suggest that reduced rs-FC may contribute to the subtle cognitive deficits noted in high symptom mTBI participants compared to control subjects and low symptom mTBI participants.	[Sours, Chandler; Rosenberg, Joseph; Roys, Steve; Zhuo, Jiachen; Gullapalli, Rao P.] Univ Maryland, Sch Med, Magnet Resonance Res Ctr, Baltimore, MD 21201 USA; [Sours, Chandler; Rosenberg, Joseph; Roys, Steve; Zhuo, Jiachen; Shanmuganathan, Kathirkamanthan; Gullapalli, Rao P.] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Sours, Chandler; Gullapalli, Rao P.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Kane, Robert] Georgetown Univ, Sch Med, Washington, DC 20057 USA		Gullapalli, RP (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, 22 South Greene St, Baltimore, MD 21201 USA.	csour001@umaryland.edu; jrosenberg2@umm.edu; kaner@georgetown.edu; sroys@umm.edu; jzhuo@umm.edu; kshanmuganathan@umm.edu; rgullapalli@umm.edu			DODUnited States Department of Defense [W81XWH-08-1-0725, W81XWH- 12-1-0098]; NRSA Grant from the National Institute of Neurological Disorders and Stroke [1F31NS081984]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR019214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS081984, R03NS088014] Funding Source: NIH RePORTER	The authors would like to thank Joshua Betz, Jacqueline Janowich and Teodora Stoica for their help with participant recruitment and George Makris for his help with acquiring and processing the data. This study was supported by DOD award W81XWH-08-1-0725 and W81XWH- 12-1-0098. Chandler Sours was partly supported by an NRSA Grant from the National Institute of Neurological Disorders and Stroke (1F31NS081984).	Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bleiberg J, 1997, NEUROPSY NEUROPSY BE, V10, P247; Brown CN, 2007, J ATHL TRAINING, V42, P515; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Faul M, 2010, TRAUMATIC BRAIN INJU; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hawkins KA, 2012, PARKINSONISM RELAT D, V18, P864, DOI 10.1016/j.parkreldis.2012.04.021; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levinson D, 2005, ARCH CLIN NEUROPSYCH, V20, P403, DOI 10.1016/j.acn.2004.09.001; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrea M., 2000, STAND ASSESSMENT CON; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Pellicano C, 2013, J NEUROIMAGING, V23, P445, DOI 10.1111/j.1552-6569.2011.00687.x; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Reeves DL, 2006, MIL MED, V171, P982, DOI 10.7205/MILMED.171.10.982; Reich S, 2005, VALIDATION ANAM TEST; Roebuck-Spencer TM, 2012, CLIN NEUROPSYCHOL, V26, P473, DOI 10.1080/13854046.2011.650214; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; The World Health Organization, 2010, INT CLASS DIS; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	56	27	28	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2015	9	2					190	203		10.1007/s11682-014-9295-y			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CI7TB	WOS:000354966600005	24557591	Green Accepted			2022-02-06	
J	Urban, KJ; Barlow, KM; Jimenez, JJ; Goodyear, BG; Dunn, JF				Urban, Karolina J.; Barlow, Karen M.; Jimenez, Jon J.; Goodyear, Bradley G.; Dunn, Jeff F.			Functional Near-Infrared Spectroscopy Reveals Reduced Interhemispheric Cortical Communication after Pediatric Concussion	JOURNAL OF NEUROTRAUMA			English	Article						coherence; concussion; fNIRS; mild traumatic brain injury; near infrared spectroscopy	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; 4TH INTERNATIONAL-CONFERENCE; PROTON MR SPECTROSCOPY; DIFFUSE AXONAL INJURY; RESTING HUMAN BRAIN; WORKING-MEMORY; CONSENSUS STATEMENT; NOVEMBER 2012; MOTOR CORTEX	Concussion, or mild traumatic brain injury (mTBI), is a growing concern, especially among the pediatric population. By age 25, as many as 30% of the population are likely to have had a concussion. Many result in long-term disability, with some evolving to postconcussion syndrome. Treatments are being developed, but are difficult to assess given the lack of measures to quantitatively monitor concussion. There is no accepted quantitative imaging metric for monitoring concussion. We hypothesized that because cognitive function and fiber tracks are often impacted in concussion, interhemispheric brain communication may be impaired. We used functional near-infrared spectroscopy (fNIRS) to quantify functional coherence between the left and right motor cortex as a marker of interhemispheric communication. Studies were undertaken during the resting state and with a finger-tapping task to activate the motor cortex. Pediatric patients (ages 12-18) had symptoms for 31-473 days, compared to controls, who have not had reported a previous concussion. We detected differences between patients and controls in coherence between the contralateral motor cortices using measurements of total hemoglobin and oxy-hemoglobin with a p<0.01 (n=8, control; n=12mTBI). Given the critical need for a quantitative biomarker for recovery after a concussion, we present these data to highlight the potential of fNIRS coupled with interhemispheric coherence analysis as a biomarker of concussion injury.	[Urban, Karolina J.; Goodyear, Bradley G.; Dunn, Jeff F.] Univ Calgary, Dept Radiol, Calgary, AB T2N 4N1, Canada; [Urban, Karolina J.; Goodyear, Bradley G.; Dunn, Jeff F.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Urban, Karolina J.; Jimenez, Jon J.; Dunn, Jeff F.] Univ Calgary, Expt Imaging Ctr, Calgary, AB T2N 4N1, Canada; [Barlow, Karen M.] Univ Calgary, Dept Pediat & Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Barlow, Karen M.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 4N1, Canada		Dunn, JF (corresponding author), Univ Calgary, Dept Radiol, Fac Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	dunnj@ucalgary.ca	Barlow, Karen/C-1323-2014; Meijer, Anna/K-5118-2016; Barlow, Karen/I-6492-2019	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Urban, Karolina/0000-0003-1301-7891			Arfanakis K, 2000, MAGN RESON IMAGING, V18, P921, DOI 10.1016/S0730-725X(00)00190-9; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Chamard E, 2014, J NEUROTRAUM, V31, P339, DOI 10.1089/neu.2013.3083; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Ciuciu P, 2014, NEUROIMAGE, V95, P248, DOI 10.1016/j.neuroimage.2014.03.047; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Guio F, 2012, PEDIATR NEUROL, V46, P94, DOI 10.1016/j.pediatrneurol.2011.11.019; Emanuelson I, 2003, INT J REHABIL RES, V26, P257, DOI 10.1097/00004356-200312000-00002; Franceschini MA, 2003, PSYCHOPHYSIOLOGY, V40, P548, DOI 10.1111/1469-8986.00057; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Giza CC, 2001, J ATHL TRAINING, V36, P228; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jimenez JJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.076008; Johnson B, 2012, NEUROSCI LETT, V509, P5, DOI 10.1016/j.neulet.2011.11.013; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirov II, 2013, J NEUROTRAUM, V30, P1200, DOI 10.1089/neu.2012.2696; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mesquita RC, 2010, BIOMED OPT EXPRESS, V1, P324, DOI 10.1364/BOE.1.000324; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Newton AT, 2007, HUM BRAIN MAPP, V28, P663, DOI 10.1002/hbm.20294; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Pieper P, 2014, BRAIN INJURY, V28, P105, DOI 10.3109/02699052.2013.847208; Riedl V, 2014, J NEUROSCI, V34, P6260, DOI 10.1523/JNEUROSCI.0492-14.2014; Sasai S, 2011, NEUROIMAGE, V56, P252, DOI 10.1016/j.neuroimage.2010.12.075; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tallus J, 2013, J NEUROTRAUM, V30, P1270, DOI 10.1089/neu.2012.2760; Varshney VP, 2012, J EUR OPT SOC-RAPID, V7, DOI 10.2971/jeos.2012.12047; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	68	27	27	2	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					833	840		10.1089/neu.2014.3577			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700008	25387354	Green Published, Green Submitted			2022-02-06	
J	Xiao, Y; Faucherre, A; Pola-Morell, L; Heddleston, JM; Liu, TL; Chew, TL; Sato, F; Sehara-Fujisawa, A; Kawakami, K; Lopez-Schier, H				Xiao, Yan; Faucherre, Adele; Pola-Morell, Laura; Heddleston, John M.; Liu, Tsung-Li; Chew, Teng-Leong; Sato, Fuminori; Sehara-Fujisawa, Atsuko; Kawakami, Koichi; Lopez-Schier, Hernan			High-resolution live imaging reveals axon-glia interactions during peripheral nerve injury and repair in zebrafish	DISEASE MODELS & MECHANISMS			English	Article						High-resolution imaging; Neurotrauma; Regeneration; Schwann cells; Haptotaxis	SCHWANN-CELL DENERVATION; TARGETED GENE-EXPRESSION; BEAM PLANE ILLUMINATION; LATERAL-LINE; MYELINATED AXONS; EXPERIMENTAL STRATEGIES; FUNCTIONAL RECOVERY; REGENERATION; GROWTH; ADULT	Neural damage is a devastating outcome of physical trauma. The glia are one of the main effectors of neuronal repair in the nervous system, but the dynamic interactions between peripheral neurons and Schwann cells during injury and regeneration remain incompletely characterized. Here, we combine laser microsurgery, genetic analysis, high-resolution intravital imaging and lattice light-sheet microscopy to study the interaction between Schwann cells and sensory neurons in a zebrafish model of neurotrauma. We found that chronic denervation by neuronal ablation leads to Schwann-cell death, whereas acute denervation by axonal severing does not affect the overall complexity and architecture of the glia. Neuronal-circuit regeneration begins when Schwann cells extend bridging processes to close the injury gap. Regenerating axons grow faster and directionally after the physiological clearing of distal debris by the Schwann cells. This might facilitate circuit repair by ensuring that axons are guided through unoccupied spaces within bands of Bungner towards their original peripheral target. Accordingly, in the absence of Schwann cells, regenerating axons are misrouted, impairing the re-innervation of sensory organs. Our results indicate that regenerating axons use haptotaxis as a directional cue during the reconstitution of a neural circuit. These findings have implications for therapies aimed at neurorepair, which will benefit from preserving the architecture of the peripheral glia during periods of denervation.	[Xiao, Yan; Lopez-Schier, Hernan] Helmholtz Zentrum Munchen, Res Unit Sensory Biol Organogenesis, D-85764 Munich, Germany; [Faucherre, Adele; Pola-Morell, Laura; Lopez-Schier, Hernan] Ctr Genom Regulat, Cell & Dev Biol, Barcelona 08003, Spain; [Heddleston, John M.; Liu, Tsung-Li; Chew, Teng-Leong] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Sato, Fuminori; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan; [Kawakami, Koichi] Grad Univ Adv Studies Sokendai, Natl Inst Genet, Div Mol & Dev Biol, Mishima, Shizuoka 4118540, Japan; [Kawakami, Koichi] Grad Univ Adv Studies Sokendai, Dept Genet, Mishima, Shizuoka 4118540, Japan		Lopez-Schier, H (corresponding author), Helmholtz Zentrum Munchen, Res Unit Sensory Biol Organogenesis, D-85764 Munich, Germany.	hernan.lopez-schier@helmholtz-muenchen.de	Kawakami, Koichi/AAF-1380-2019; Liu, Tsung-li/M-4473-2015	Faucherre, Adele/0000-0002-6099-3898	HDC Diabetes Portfolio of the Helmholtz Gemeinschaft; Program Grant of the Human Frontier Science Program [RGP0033/2014]; National BioResource Project (NBRP)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Ministry of Education, Science, Sports and Technology (MEXT) of Japan [23241063]; Gordon and Betty Moore FoundationGordon and Betty Moore Foundation; Howard Hughes Medical InstituteHoward Hughes Medical Institute; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [22122007, 15K21745] Funding Source: KAKEN	This work was funded by the HDC Diabetes Portfolio of the Helmholtz Gemeinschaft, and by a Program Grant of the Human Frontier Science Program (RGP0033/2014) to H.L.-S.; and by the National BioResource Project (NBRP) and Grants-in-Aid for Scientific Research (23241063 to K.K. and 2212207 to A.F.-S.) from the Ministry of Education, Science, Sports and Technology (MEXT) of Japan. The AIC at Janelia is sponsored by the Gordon and Betty Moore Foundation and by the Howard Hughes Medical Institute.	Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; BASTMEYER M, 1994, GLIA, V11, P300, DOI 10.1002/glia.440110403; Beirowski B, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00256; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Brosamle C, 2002, GLIA, V39, P47, DOI 10.1002/glia.10088; BUETTNER HM, 1994, DEV BIOL, V163, P407, DOI 10.1006/dbio.1994.1158; Cashman C. R., 2015, NEUROSCI LETT; Chada S, 1997, J CELL SCI, V110, P1179; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Court FA, 2004, NATURE, V431, P191, DOI 10.1038/nature02841; Czopka T, 2011, METHOD CELL BIOL, V105, P25, DOI 10.1016/B978-0-12-381320-6.00002-3; David G, 1997, J PHYSIOL-LONDON, V498, P295, DOI 10.1113/jphysiol.1997.sp021858; Dedkov EI, 2002, ACTA NEUROPATHOL, V103, P565, DOI 10.1007/s00401-001-0504-6; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Faber C. G., 2015, NEUROSCI LETT; Faucherre A, 2014, METHODS MOL BIOL, V1082, P187, DOI 10.1007/978-1-62703-655-9_13; Faucherre A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016587; Faucherre A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004477; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; FENELEY MR, 1991, EXP NEUROL, V114, P275, DOI 10.1016/0014-4886(91)90153-4; Gao L, 2014, NAT PROTOC, V9, P1083, DOI 10.1038/nprot.2014.087; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Goessling W, 2014, DIS MODEL MECH, V7, P769, DOI 10.1242/dmm.016352; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Graciarena M, 2014, P NATL ACAD SCI USA, V111, P1610, DOI 10.1073/pnas.1319405111; Grant KA, 2005, NEURON, V45, P69, DOI 10.1016/j.neuron.2004.12.020; Hall SM, 1999, ANN NY ACAD SCI, V883, P215, DOI 10.1111/j.1749-6632.1999.tb08584.x; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jung SH, 2010, DEV DYNAM, V239, P592, DOI 10.1002/dvdy.22166; Kang H, 2014, J NEUROSCI, V34, P6323, DOI 10.1523/JNEUROSCI.4673-13.2014; Kang H, 2013, J NEUROSCI, V33, P19480, DOI 10.1523/JNEUROSCI.4067-13.2013; Kawakami K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-105; Kidd GJ, 2013, HAND CLINIC, V115, P55, DOI 10.1016/B978-0-444-52902-2.00005-9; LAFONT F, 1994, PERSPECT DEV NEUROBI, V2, P259; Lewis G. M., 2013, JOVE; Lombardo FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086405; Lopez-Schier H, 2005, P NATL ACAD SCI USA, V102, P1496, DOI 10.1073/pnas.0409361102; Lush ME, 2014, ELIFE, V3, DOI 10.7554/eLife.01832; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Martin SM, 2010, DEVELOPMENT, V137, P3985, DOI 10.1242/dev.053611; Meier C, 1999, J NEUROSCI, V19, P3847; Misgeld T, 2007, NAT PROTOC, V2, P263, DOI 10.1038/nprot.2007.24; Monk KR, 2013, DIS MODEL MECH, V6, P135, DOI 10.1242/dmm.009217; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Munzel EJ, 2012, GLIA, V60, P253, DOI 10.1002/glia.21260; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Painter MW, 2014, NEURON, V83, P331, DOI 10.1016/j.neuron.2014.06.016; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Patton EE, 2014, DIS MODEL MECH, V7, P731, DOI 10.1242/dmm.017004; Perlin JR, 2011, DEVELOPMENT, V138, P4639, DOI 10.1242/dev.068072; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/nmeth.1586, 10.1038/NMETH.1586]; Pogoda HM, 2006, DEV BIOL, V298, P118, DOI 10.1016/j.ydbio.2006.06.021; Pujol-Marti J, 2012, J NEUROSCI, V32, P2976, DOI 10.1523/JNEUROSCI.5157-11.2012; Raphael AR, 2011, CURR TOP DEV BIOL, V97, P1, DOI 10.1016/B978-0-12-385975-4.00007-3; Rodrigues F, 2011, CELL MOL LIFE SCI, V68, P55, DOI 10.1007/s00018-010-0512-6; Ruohonen S, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-26; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; Scherer SS, 2008, GLIA, V56, P1578, DOI 10.1002/glia.20751; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Sharghi-Namini S, 2006, J NEUROSCI, V26, P6364, DOI 10.1523/JNEUROSCI.0157-06.2006; SHEPPARD CJR, 1981, J MICROSC-OXFORD, V124, P107, DOI 10.1111/j.1365-2818.1981.tb00304.x; Shy ME, 2009, ADV EXP MED BIOL, V652, P171, DOI 10.1007/978-90-481-2813-6_11; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; Soares L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06199; SPIRA ME, 1993, J NEUROBIOL, V24, P300, DOI 10.1002/neu.480240304; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Sulaiman OAR, 2002, EXP NEUROL, V176, P342, DOI 10.1006/exnr.2002.7928; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Villegas R, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-19; WEINBERG HJ, 1978, J NEUROCYTOL, V7, P555, DOI 10.1007/BF01260889; Wuhr M, 2011, METHOD CELL BIOL, V101, P1, DOI 10.1016/B978-0-12-387036-0.00001-3; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861	81	27	27	0	31	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	JUN	2015	8	6					553	564		10.1242/dmm.018184			12	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	CJ5VD	WOS:000355559100004	26035865	Green Published, gold			2022-02-06	
J	Charolidi, N; Schilling, T; Eder, C				Charolidi, Nicoletta; Schilling, Tom; Eder, Claudia			Microglial Kv1.3 Channels and P2Y12 Receptors Differentially Regulate Cytokine and Chemokine Release from Brain Slices of Young Adult and Aged Mice	PLOS ONE			English	Article							NEURONAL NMDA RECEPTORS; POTASSIUM CHANNELS; INFLAMMATORY RESPONSES; ACTIVATED MICROGLIA; EXPRESSION; ASTROCYTES; CULTURE; MODEL	Brain tissue damage following stroke or traumatic brain injury is accompanied by neuroinflammatory processes, while microglia play a central role in causing and regulating neuroinflammation via production of proinflammatory substances, including cytokines and chemokines. Here, we used brain slices, an established in situ brain injury model, from young adult and aged mice to investigate cytokine and chemokine production with particular focus on the role of microglia. Twenty four hours after slice preparation, higher concentrations of proinflammatory cytokines, i.e. TNF-alpha and IL-6, and chemokines, i.e. CCL2 and CXCL1, were released from brain slices of aged mice than from slices of young adult mice. However, maximal microglial stimulation with LPS for 24 h did not reveal age-dependent differences in the amounts of released cytokines and chemokines. Mechanisms underlying microglial cytokine and chemokine production appear to be similar in young adult and aged mice. Inhibition of microglial Kv1.3 channels with margatoxin reduced release of IL-6, but not release of CCL2 and CXCL1. In contrast, blockade of microglial P2Y12 receptors with PSB0739 inhibited release of CCL2 and CXCL1, whereas release of IL-6 remained unaffected. Cytokine and chemokine production was not reduced by inhibitors of Kir2.1 K+ channels or adenosine receptors. In summary, our data suggest that brain tissue damage-induced production of cytokines and chemokines is age-dependent, and differentially regulated by microglial Kv1.3 channels and P2Y12 receptors.	[Charolidi, Nicoletta; Schilling, Tom; Eder, Claudia] Univ London, Inst Infect & Immun, London SW17 0RE, England		Eder, C (corresponding author), Univ London, Inst Infect & Immun, Cranmer Terrace, London SW17 0RE, England.	ceder@sgul.ac.uk		Schilling, Tom/0000-0002-0274-5482; Charolidi, Nicoletta/0000-0002-5721-5155	EU-FP7 grant "TargetBraIn" [279017]	Funding provided by EU-FP7 grant "TargetBraIn" (#279017).	Bartok A, 2014, TOXICON, V87, P6, DOI 10.1016/j.toxicon.2014.05.002; Benakis C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00461; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dissing-Olesen L, 2014, J NEUROSCI, V34, P10511, DOI 10.1523/JNEUROSCI.0405-14.2014; Duque A, 2013, DEV NEUROBIOL, V73, P841, DOI 10.1002/dneu.22105; Eder C, 2005, J NEUROSCI RES, V81, P314, DOI 10.1002/jnr.20476; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Huuskonen J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-25; Jaerve A, 2012, CELL TISSUE RES, V349, P229, DOI 10.1007/s00441-012-1427-3; Kawabori M, 2015, CURR MED CHEM, V22, P1258, DOI 10.2174/0929867322666150209154036; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Lyons SA, 2000, J CEREBR BLOOD F MET, V20, P1537, DOI 10.1097/00004647-200011000-00003; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Menteyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006770; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; NORENBERG W, 1994, J PHYSIOL-LONDON, V475, P15; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Orre M, 2014, NEUROBIOL AGING, V35, P1, DOI 10.1016/j.neurobiolaging.2013.07.008; Peng Y, 2014, NEURO-ONCOLOGY, V16, P528, DOI 10.1093/neuonc/not221; Quick ED, 2014, J VIROL, V88, P13005, DOI 10.1128/JVI.01994-14; Rangaraju S, 2015, J ALZHEIMERS DIS, V44, P797, DOI 10.3233/JAD-141704; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Schilling T, 2007, BRAIN RES, V1186, P21, DOI 10.1016/j.brainres.2007.10.027; Schilling T, 2015, GLIA, V63, P664, DOI 10.1002/glia.22776; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Stock C, 2006, J IMMUNOL, V177, P8560, DOI 10.4049/jimmunol.177.12.8560; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Streit WJ, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0142-6; Streit WJ, 2014, CURR OPIN IMMUNOL, V29, P93, DOI 10.1016/j.coi.2014.05.005; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; Wang HR, 2011, ACS CHEM BIOL, V6, P845, DOI 10.1021/cb200146a; Wong WT, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00022	43	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2015	10	5							e0128463	10.1371/journal.pone.0128463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ0QZ	WOS:000355183900237	26011191	Green Published, Green Submitted, gold			2022-02-06	
J	Wylie, GR; Freeman, K; Thomas, A; Shpaner, M; OKeefe, M; Watts, R; Naylor, MR				Wylie, Glenn R.; Freeman, Kalev; Thomas, Alex; Shpaner, Marina; OKeefe, Michael; Watts, Richard; Naylor, Magdalena R.			Cognitive Improvement after Mild Traumatic Brain Injury Measured with Functional Neuroimaging during the Acute Period	PLOS ONE			English	Article							WORKING-MEMORY LOAD; HEAD-INJURY; NETWORK; CONNECTIVITY; SYMPTOMS; RECOVERY; RETURN; TBI; ABNORMALITIES; RECRUITMENT	Functional neuroimaging studies in mild traumatic brain injury (mTBI) have been largely limited to patients with persistent post-concussive symptoms, utilizing images obtained months to years after the actual head trauma. We sought to distinguish acute and delayed effects of mild traumatic brain injury on working memory functional brain activation patterns < 72 hours after mild traumatic brain injury (mTBI) and again one-week later. We hypothesized that clinical and fMRI measures of working memory would be abnormal in symptomatic mTBI patients assessed < 72 hours after injury, with most patients showing clinical recovery (i.e., improvement in these measures) within 1 week after the initial assessment. We also hypothesized that increased memory workload at 1 week following injury would expose different cortical activation patterns in mTBI patients with persistent post-concussive symptoms, compared to those with full clinical recovery. We performed a prospective, cohort study of working memory in emergency department patients with isolated head injury and clinical diagnosis of concussion, compared to control subjects (both uninjured volunteers and emergency department patients with extremity injuries and no head trauma). The primary outcome of cognitive recovery was defined as resolution of reported cognitive impairment and quantified by scoring the subject's reported cognitive post-concussive symptoms at 1 week. Secondary outcomes included additional post-concussive symptoms and neurocognitive testing results. We enrolled 46 subjects: 27 with mild TBI and 19 controls. The time of initial neuroimaging was 48 (22 S.D.) hours after injury (time 1). At follow up (8.7, + 1.2 S.D., days after injury, time 2), 18 of mTBI subjects (64%) reported moderate to complete cognitive recovery, 8 of whom fully recovered between initial and follow-up imaging. fMRI changes from time 1 to time 2 showed an increase in posterior cingulate activation in the mTBI subjects compared to controls. Increases in activation were greater in those mTBI subjects without cognitive recovery. As workload increased in mTBI subjects, activation increased in cortical regions in the right hemisphere. In summary, we found neuroimaging evidence for working memory deficits during the first week following mild	[Wylie, Glenn R.] Kessler Fdn, Rocco Ortenzio Neuroimaging Ctr, W Orange, NJ USA; [Wylie, Glenn R.] Rutgers State Univ, Sch Med, Dept Phys Med & Rehabil, Newark, NJ 07102 USA; [Wylie, Glenn R.] War Related Illness & Injury Study Ctr, Dept Vet Affairs, E Orange, NJ USA; [Freeman, Kalev; Thomas, Alex; Shpaner, Marina; OKeefe, Michael; Watts, Richard; Naylor, Magdalena R.] Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA		Naylor, MR (corresponding author), Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA.	magdalena.naylor@uvm.edu			Department of Surgery at UVM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM098795] Funding Source: NIH RePORTER	This work was supported by an internal grant from the Department of Surgery at UVM to Dr. Freeman.	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Das A, 2012, NEUROLOGY, V79, P2146, DOI 10.1212/WNL.0b013e3182752cdb; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Faul M, 2010, TRAUMATIC BRAIN INJU; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006	38	27	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126110	10.1371/journal.pone.0126110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	WOS:000354542500063	25962067	gold, Green Published, Green Submitted			2022-02-06	
J	Halaweish, I; Bambakidis, T; He, W; Linzel, D; Chang, ZG; Srinivasan, A; Dekker, SE; Liu, BL; Li, YQ; Alam, HB				Halaweish, Ihab; Bambakidis, Ted; He, Wei; Linzel, Durk; Chang, Zhigang; Srinivasan, Ashok; Dekker, Simone E.; Liu, Baoling; Li, Yongqing; Alam, Hasan B.			Early Resuscitation with Fresh Frozen Plasma for Traumatic Brain Injury Combined with Hemorrhagic Shock Improves Neurologic Recovery	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							LARGE-ANIMAL-MODEL; EMERGENCY-DEPARTMENT THORACOTOMY; SEVERE HEAD-INJURY; NORMAL SALINE; ENDOTHELIAL PERMEABILITY; PLATELET DYSFUNCTION; INDUCED COAGULOPATHY; MASSIVE TRANSFUSION; INDUCED HYPOTHERMIA; LYOPHILIZED PLASMA	BACKGROUND: We have shown that early administration of fresh frozen plasma (FFP) reduces the size of brain lesions 6 hours after injury in a large animal model of traumatic brain injury (TBI) and hemorrhagic shock (HS). To examine long-term outcomes, we hypothesized that early treatment with FFP would result in faster neurologic recovery and better long-term outcomes in a combined TBI and HS model. STUDY DESIGN: Anesthetized Yorkshire swine underwent combined TBI and volume-controlled hemorrhage (40% blood volume). After 2 hours of shock, animals were randomized (n = 5/group) to normal saline (3 x shed blood) or FFP (1 x shed blood) treatment. A neurologic severity score was assessed for 30 days. Magnetic resonance imaging of the brain was performed at days 3, 10, and 24. Cognitive function was tested by training animals to retrieve food from color-coded boxes. RESULTS: Neurologic impairment was lower and speed of recovery was considerably faster in the FFPtreated animals. There was a trend toward a smaller lesion size in FFP-treated animal at days 3 and 10, but this did not reach statistical significance. Both groups reached baseline performance on the cognitive testing; however, FFP-treated animals were able to participate, on average, 8 days earlier due to quicker recovery. CONCLUSIONS: This is the first study to demonstrate the beneficial effects of FFP treatment in a long-term survival model of combined TBI and HS. Our data show that early treatment with FFP substantially attenuates the degree of neurologic impairment, improves the rate of recovery, and preserves the cognitive functions. (C) 2015 by the American College of Surgeons	[Halaweish, Ihab; Bambakidis, Ted; Liu, Baoling; Li, Yongqing; Alam, Hasan B.] Univ Michigan Hosp, Dept Surg, Ann Arbor, MI 48109 USA; [Srinivasan, Ashok] Univ Michigan Hosp, Neuroradiol Sect, Dept Radiol, Ann Arbor, MI 48109 USA; [He, Wei] Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiothorac Surg, Nanjing, Peoples R China; [Chang, Zhigang] Beijing Hosp Minist Hlth, Beijing, Peoples R China; [Linzel, Durk] Flevoziekenhuis Hosp, Dept Emergency Med, Almere, Netherlands; [Dekker, Simone E.] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Dept Anesthesiol, Amsterdam, Netherlands		Alam, HB (corresponding author), Univ Michigan Hosp, Dept Surg, 2920 Taubman Ctr 5331,1500 Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [GRANTT00521959]	Dr Alam received a grant from the US Army Medical Research and Materiel Command (GRANTT00521959).	Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; [Anonymous], 1999, JAMA, V282, P974; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Cao YN, 2014, J TRAUMA ACUTE CARE, V77, P28, DOI 10.1097/TA.0000000000000276; Cardenas JC, 2014, CURR OPIN HEMATOL, V21, P404, DOI 10.1097/MOH.0000000000000063; Centers for Disease Control and Prevention, INJ PREV CONTR LEAD; Centers for Disease Control and Prevention, INJ PREV CONTR WEB B; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Dardiotis E, 2012, BRAIN INJURYEPATHOGE; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Dekker SE, 2014, SURGERY, V156, P556, DOI 10.1016/j.surg.2014.04.016; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; Difede J, 2010, ANN NY ACAD SCI, V1208, P1, DOI 10.1111/j.1749-6632.2010.05795.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Gentilello L, 2000, J TRAUMA, V48, P447; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Gonzalez EA, 2006, J TRAUMA, V61, P66, DOI 10.1097/01.ta.0000224190.65542.e2; Hartog CS, 2011, ANESTH ANALG, V112, P156, DOI 10.1213/ANE.0b013e3181eaff91; HOFFMAN M, 1990, AM J CLIN PATHOL, V93, P694, DOI 10.1093/ajcp/93.5.694; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Hwabejire JO, 2013, J TRAUMA ACUTE CARE, V75, P968, DOI 10.1097/TA.0b013e31829a021a; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Matijevic N, 2013, J TRAUMA ACUTE CARE, V74, P84, DOI 10.1097/TA.0b013e3182788e32; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; Moore EE, 2014, SHOCK, V41, P35, DOI 10.1097/SHK.0000000000000110; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nichol AD, 2009, INJURY, V40, P471, DOI 10.1016/j.injury.2009.01.002; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Safar P, 1996, STROKE, V27, P105, DOI 10.1161/01.STR.27.1.105; Sailliol A, 2013, TRANSFUSION, V53, p65S, DOI 10.1111/trf.12038; Schenk S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-41; Schrieber M, 2007, J TRAUMA, V63, P1261; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P998, DOI 10.1097/TA.0000000000000193; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Spinella PC, 2009, J TRAUMA, V66, pS69, DOI 10.1097/TA.0b013e31819d85fb; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012	51	27	28	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	MAY	2015	220	5					809	819		10.1016/j.jamcollsurg.2015.01.057			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CG5OP	WOS:000353342200010	25907868				2022-02-06	
J	Sherer, M; Sander, AM; Nick, TG; Melguizo, MS; Tulsky, DS; Kisala, P; Hanks, R; Novack, TA				Sherer, Mark; Sander, Angelle M.; Nick, Todd G.; Melguizo, Maria S.; Tulsky, David S.; Kisala, Pamela; Hanks, Robin; Novack, Thomas A.			Key Dimensions of Impairment, Self-Report, and Environmental Supports in Persons With Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; cognitive function; self-report; environmental facilitators; outcome	FAMILY ASSESSMENT DEVICE; PARTICIPATION ASSESSMENT; SYMPTOMS; DISORDER; OUTCOMES	Purpose/Objectives: To determine key dimensions relevant to recovery in the postacute period for persons with traumatic brain injury (TBI) and to determine the ability of scores on these dimensions to predict participation outcomes for persons with TBI. Research Method/Design: This was a prospective cohort, observational study of 504 persons with medically documented TBI. Participants completed a comprehensive battery of measures including cognitive tests; questionnaires assessing self-report of physical, cognitive, and emotional symptoms and strengths; environmental supports; and a measure of participation outcome. Results: Participants were a predominantly male, ethnically/racially diverse sample of persons with complicated mild, moderate, and severe TBI. Variable cluster analysis identified 12 key dimensions of cognitive function, neurobehavioral complaints, personal strengths, physical symptoms and function, environmental supports, and performance validity. In unadjusted analyses, all 12 dimensions were predictive of participation outcome. In multivariable regression analysis with adjustment of all predictors for all other predictors, dimensions measuring memory, independence and self-esteem, resilience, emotional distress, physical functioning, and economic and family support made unique contributions to predicting participation outcome. Conclusions/Implications: Findings add to our understanding of key aspects of functioning and self-perception for persons with TBI. Knowledge of the profile of an individual patient on these 12 dimensions may assist with development of a treatment approach for the person with TBI.	[Sherer, Mark] TIRR Mem Hermann, Dept Res, Houston, TX 77030 USA; [Sander, Angelle M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Ctr Trauma Rehabil, Dept Phys Med & Rehabil, Houston, TX USA; [Nick, Todd G.; Melguizo, Maria S.] Univ Arkansas Med Sci, Dept Pediat & Biostat, Little Rock, AR 72205 USA; [Tulsky, David S.; Kisala, Pamela] Univ Delaware, Coll Hlth Sci, Dept Phys Therapy, Newark, DE 19716 USA; [Hanks, Robin] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Wayne, NJ USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA		Sherer, M (corresponding author), TIRR Mem Hermann, 1333 Moursund, Houston, TX 77030 USA.	mark.sherer@memorialhermann.org		Sherer, Mark/0000-0003-1784-7008; Tulsky, David/0000-0002-4335-4509	U.S. Department of Education National Institute on Disability and Rehabilitation ResearchUS Department of Education [H133B090023, H133A120020]	This research was supported by U.S. Department of Education National Institute on Disability and Rehabilitation Research Grants H133B090023 and H133A120020. This article was presented as the Leonard Diller Lecture at Rehabilitation Psychology's 16th Annual Conference, San Antonio, Texas, February-March, 2014.	Bertisch H, 2014, NEUROREHABILITATION, V34, P573, DOI 10.3233/NRE-141059; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cook KF, 2011, ARCH PHYS MED REHAB, V92, P818, DOI 10.1016/j.apmr.2010.12.008; D'Agostino R. B., 1992, P 5 ANN C NE SAS US; Dams-O'Connor K, 2013, BRAIN IMPAIR, V14, P51, DOI 10.1017/BrImp.2013.9; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green P., 1996, WORD MEMORY TEST USE; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harrell F, 2009, RMS S FUNCTIONS BIOS; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1958, EXAMIN CLINIQUE PSYC; Ridenour TA, 1999, FAM PROCESS, V38, P497, DOI 10.1111/j.1545-5300.1999.00497.x; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; SAS Institute Inc, 2008, SAS STAQT 9 2 US GUI; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; Tulsky D. S., J HEAD TRAUMA REHABI; Tulsky D. S., 2014, ARCH PHYS MED REHABI; Vickery CD, 2008, REHABIL PSYCHOL, V53, P101, DOI 10.1037/0090-5550.53.1.101; Wechsler D., 2008, WECHSLER ADULT INTEL; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	37	27	27	0	12	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2015	60	2					138	146		10.1037/rep0000030			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	CL5CG	WOS:000356976800005	26120740	Bronze			2022-02-06	
J	Sullivan, KA; Edmed, SL; Allan, AC; Smith, SS; Karlsson, LJE				Sullivan, Karen A.; Edmed, Shannon L.; Allan, Alicia C.; Smith, Simon S.; Karlsson, Lina J. E.			The Role of Psychological Resilience and mTBI as Predictors of Postconcussional Syndrome Symptomatology	REHABILITATION PSYCHOLOGY			English	Article						head injury; neurocognitive disorder; resilience; postconcussional syndrome; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; COGNITIVE RESERVE; HEAD-INJURY; SYMPTOMS; SCALE; RELIABILITY; COMPLAINTS; INVENTORY; RECOVERY; SAMPLE	Objective: Resilience is 1 of several factors that are thought to contribute to outcome following mild traumatic brain injury (mTBI). This study explored the predictors of the postconcussional syndrome (PCS) symptoms that can occur following mTBI. We hypothesized that a reported recent mTBI and lower psychological resilience would predict worse reported PCS symptomatology. Method: 233 participants completed the Neurobehavioral Symptom Inventory (NSI) and the Brief Resilience Scale (BRS). Three NSI scores were used to define PCS symptomatology. A total of 35 participants reported an mTBI (as operationally defined by the World Health Organization) that was sustained between 1 and 6 months prior to their participation (positive mTBI history); the remainder reported having never had an mTBI. Results: Regression analyses revealed that a positive reported recent mTBI history and lower psychological resilience were significant independent predictors of reported PCS symptomatology. These results were found for the 3 PCS scores from the NSI, including using a stringent caseness criterion, p<.05. Demographic variables (age and gender) were not related to outcome, with the exception of education in some analyses. Conclusion: The results demonstrate that: (a) both perceived psychological resilience and mTBI history play a role in whether or not PCS symptoms are experienced, even when demographic variables are considered, and (b) of these 2 variables, lower perceived psychological resilience was the strongest predictor of PCS-like symptomatology.	[Sullivan, Karen A.; Edmed, Shannon L.] Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, Kelvin Grove, Qld 4059, Australia; [Allan, Alicia C.; Smith, Simon S.] Queensland Univ Technol, Sch Psychol & Counselling, Inst Hlth & Biomed Innovat, Clin Neuropsychol Res Grp, Kelvin Grove, Qld 4059, Australia; [Allan, Alicia C.; Smith, Simon S.] Queensland Univ Technol, Ctr Accid Res & Rd Safety, Kelvin Grove, Qld 4059, Australia; [Karlsson, Lina J. E.] Queensland Univ Technol, Clin Neuropsychol Res Grp, Kelvin Grove, Qld 4059, Australia		Sullivan, KA (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	karen.sullivan@qut.edu.au	Smith, Simon/P-1859-2017	Smith, Simon/0000-0002-0362-9045	School of Psychology and Counselling, Queensland University of Technology	The Human Research Ethics Committee of Queensland University of Technology (QUT-HREC #1300000224) approved this research. This project was granted occupational workplace health and safety clearance. Funding for this project was provided by the School of Psychology and Counselling, Queensland University of Technology.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2013, J CHILD PSYCHOL PSYC, V54, P378, DOI 10.1111/jcpp.12021; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS278, DOI 10.1016/j.apmr.2013.08.295; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Hemphill JF, 2003, AM PSYCHOL, V58, P78, DOI 10.1037/0003-066X.58.1.78; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King P., 2011, THESIS; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Salmond CH, 2006, J NEUROTRAUM, V23, P1049, DOI 10.1089/neu.2006.23.1049; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sullivan K. A., 2015, J NEUROTRAUMA; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Windle G, 2011, REV CLIN GERONTOL, V21, P152, DOI 10.1017/S0959259810000420; World Health Organization, 2004, ICD 10 INT STAT CLAS	36	27	27	1	10	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2015	60	2					147	154		10.1037/rep0000037			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	CL5CG	WOS:000356976800006	25822180				2022-02-06	
J	Bachstetter, AD; Webster, SJ; Goulding, DS; Morton, JE; Watterson, DM; Van Eldik, LJ				Bachstetter, Adam D.; Webster, Scott J.; Goulding, Danielle S.; Morton, Jonathan E.; Watterson, D. Martin; Van Eldik, Linda J.			Attenuation of traumatic brain injury-induced cognitive impairment in mice by targeting increased cytokine levels with a small molecule experimental therapeutic	JOURNAL OF NEUROINFLAMMATION			English	Article						Cytokines; Glia; Interleukin; Neuroinflammation; Drug discovery; Microglia; Astrocytes; Traumatic brain injury; Closed head injury; Cognitive dysfunction	PROINFLAMMATORY CYTOKINE; ALZHEIMERS-DISEASE; UP-REGULATION; MOUSE MODEL; MICROGLIAL ACTIVATION; SYNAPTIC DYSFUNCTION; BEHAVIORAL DEFICITS; GLIAL ACTIVATION; NEUROINFLAMMATION; DRUG	Background: Evidence from clinical studies and preclinical animal models suggests that proinflammatory cytokine overproduction is a potential driving force for pathology progression in traumatic brain injury (TBI). This raises the possibility that selective targeting of the overactive cytokine response, a component of the neuroinflammation that contributes to neuronal dysfunction, may be a useful therapeutic approach. MW151 is a CNS-penetrant, small molecule experimental therapeutic that selectively restores injury-or disease-induced overproduction of proinflammatory cytokines towards homeostasis. We previously reported that MW151 administered post-injury (p.i.) is efficacious in a closed head injury (CHI) model of diffuse TBI in mice. Here we test dose dependence of MW151 to suppress the target mechanism (proinflammatory cytokine up-regulation), and explore the therapeutic window for MW151 efficacy. Methods: We examined suppression of the acute cytokine surge when MW151 was administered at different times post-injury and the dose-dependence of cytokine suppression. We also tested a more prolonged treatment with MW151 over the first 7 days post-injury and measured the effects on cognitive impairment and glial activation. Results: MW151 administered up to 6 h post-injury suppressed the acute cytokine surge, in a dose-dependent manner. Administration of MW151 over the first 7 days post-injury rescues the CHI-induced cognitive impairment and reduces glial activation in the focus area of the CHI. Conclusions: Our results identify a clinically relevant time window post-CHI during which MW151 effectively restores cytokine production back towards normal, with a resultant attenuation of downstream cognitive impairment.	[Bachstetter, Adam D.; Webster, Scott J.; Goulding, Danielle S.; Morton, Jonathan E.; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA; [Watterson, D. Martin] Northwestern Univ, Dept Pharmacol, Chicago, IL 60611 USA; [Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA		Van Eldik, LJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, 800 S Limestone St, Lexington, KY 40506 USA.	linda.vaneldik@uky.edu		Bachstetter, Adam/0000-0003-4646-6757; Watterson, Daniel/0000-0001-7605-5866	NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K99AG044445]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32 NS084605]; Kentucky Spinal Cord and Head Injury Research Trust [12-20A]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS084605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K99AG044445] Funding Source: NIH RePORTER	We thank Edgardo Dimayuga for his assistance with various aspects of this work. This research was supported in part by NIH/NIA (K99AG044445 to ADB), NIH/NINDS (F32 NS084605 to SJW), and the Kentucky Spinal Cord and Head Injury Research Trust (12-20A to LVE).	Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Chrzaszcz M, 2010, J NEUROTRAUM, V27, P1283, DOI 10.1089/neu.2009.1227; Craft JM, 2006, GLIA, V53, P484, DOI 10.1002/glia.20306; Craft JM, 2004, NEUROBIOL AGING, V25, P1283, DOI 10.1016/j.neurobiolaging.2004.01.006; Craft JM, 2004, J MOL NEUROSCI, V24, P115, DOI 10.1385/JMN:24:1:115; Faul M, 2010, TRAUMATIC BRAIN INJU; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; Jenrow KA, 2013, RADIAT RES, V179, P549, DOI 10.1667/RR3026.1; Jordan Barry D, 2014, Continuum (Minneap Minn), V20, P1588, DOI 10.1212/01.CON.0000458972.94013.e1; Karpus WJ, 2008, J NEUROIMMUNOL, V203, P73, DOI 10.1016/j.jneuroim.2008.06.039; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Macauley SL, 2014, J NEUROSCI, V34, P13077, DOI 10.1523/JNEUROSCI.2518-14.2014; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Shineman DW, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt90; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Somera-Molina KC, 2009, BRAIN RES, V1282, P162, DOI 10.1016/j.brainres.2009.05.073; Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	27	27	27	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	APR 10	2015	12								69	10.1186/s12974-015-0289-5			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CF7XG	WOS:000352769100001	25886256	Green Published, gold			2022-02-06	
J	Pham, H; Duy, AP; Pansiot, J; Bollen, B; Gallego, J; Charriaut-Marlangueu, C; Baud, O				Pham, Hoa; Duy, An Phan; Pansiot, Julien; Bollen, Bieke; Gallego, Jorge; Charriaut-Marlangueu, Christiane; Baud, Olivier			Impact of inhaled nitric oxide on white matter damage in growth-restricted neonatal rats	PEDIATRIC RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; FOR-GESTATIONAL-AGE; LOW-BIRTH-WEIGHT; INTRAUTERINE GROWTH; PERIVENTRICULAR LEUKOMALACIA; PREMATURE-INFANTS; STROKE MODEL; FETAL-GROWTH; NEUROPROTECTION; INFLAMMATION	BACKGROUND: Fetal growth restriction is the second leading cause of perinatal morbidity and mortality, and neonates with intrauterine growth retardation (IUGR) have increased neurocognitive and neuropsychiatric morbidity. These neurocognitive impairments are mainly related to injury of the developing brain associated with IUGR. Growing evidence from preclinical models of brain injury in both adult and neonatal rodents supports the view that nitric oxide can promote neuroprotection. METHODS: In a model of IUGR induced by protracted gestational hypoxia leading to diffuse white matter injury, we subjected neonatal rats to low dose (5 ppm) but long-lasting (7 d) exposure to inhaled NO (iNO). We used a combination of techniques, including immunohistochemistry, quantitative PCR, and cognitive assessment, to assess neuroprotection. RESULTS: Antenatal hypoxia-induced IUGR was associated with severe neuroinflammation and delayed myelination. iNO exposure during the first postnatal week significantly attenuated cell death and microglial activation, enhanced oligodendroglial proliferation and finally improved myelination. Remarkably, iNO was associated with the specific upregulation of P27kip1, which initiates oligodendrocytic differentiation. Finally, iNO counteracted the deleterious effects of hypoxia on learning abilities. CONCLUSION: This study provides new evidence that iNO could be effective in preventing brain damage and/or enhancing repair of the developing brain.	[Pham, Hoa; Duy, An Phan; Pansiot, Julien; Bollen, Bieke; Gallego, Jorge; Charriaut-Marlangueu, Christiane; Baud, Olivier] Univ Paris Diderot, INSERM, UMR1141, Paris, France; [Pham, Hoa; Duy, An Phan; Pansiot, Julien; Bollen, Bieke; Gallego, Jorge; Charriaut-Marlangueu, Christiane; Baud, Olivier] PremUP Fdn, Paris, France; [Baud, Olivier] Robert Debre Childrens Hosp, AP HP, Neonatal Intens Care Unit, Paris, France		Baud, O (corresponding author), Univ Paris Diderot, INSERM, UMR1141, Paris, France.	olivier.baud@rdb.aphp.fr		Bollen, Bieke/0000-0002-8457-9317	INSERM (Institut National de la Sante et de la Recherche Medicale)Institut National de la Sante et de la Recherche Medicale (Inserm); Premup Foundation	This study was funded by INSERM (Institut National de la Sante et de la Recherche Medicale), and Premup Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or Preparation of the manuscript. We have nothing to disclose.	Amarenco P, 2006, NEW ENGL J MED, V355, P549; Batalle D, 2012, NEUROIMAGE, V60, P1352, DOI 10.1016/j.neuroimage.2012.01.059; Baud O, 2004, BRAIN PATHOL, V14, P1; Bouslama M, 2005, BEHAV BRAIN RES, V161, P102, DOI 10.1016/j.bbr.2005.01.010; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Charriaut-Marlangue C, 2014, STROKE, V45, P850, DOI 10.1161/STROKEAHA.113.003606; Charriaut-Marlangue C, 2013, ANN NEUROL, V73, P442, DOI 10.1002/ana.23842; Charriaut-Marlangue C, 2012, STROKE, V43, P3078, DOI 10.1161/STROKEAHA.112.664243; Chen W, 2014, NEUROCHEM INT, V68, P28, DOI 10.1016/j.neuint.2014.01.015; Chhor V, 2012, ARCH PEDIATRIE, V19, P946, DOI 10.1016/j.arcped.2012.06.013; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Fontaine RH, 2008, P NATL ACAD SCI USA, V105, P16779, DOI 10.1073/pnas.0803004105; Gabbe SG, 1996, OBESTETRICS NORMAL P, P863; Geva R, 2006, BRAIN RES, V1117, P186, DOI 10.1016/j.brainres.2006.08.004; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Pham H, 2014, EXP NEUROL, V252, P114, DOI 10.1016/j.expneurol.2013.11.025; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Isaacs EB, 2000, PEDIATR RES, V47, P713, DOI 10.1203/00006450-200006000-00006; Jarvis S, 2003, LANCET, V362, P1106, DOI 10.1016/S0140-6736(03)14466-2; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Leviton A, 2013, PEDIATR RES, V73, P362, DOI 10.1038/pr.2012.188; Li YS, 2013, BRAIN RES, V1507, P134, DOI 10.1016/j.brainres.2013.02.031; McElrath TF, 2013, ACTA PAEDIATR, V102, pE439, DOI 10.1111/apa.12339; NEERHOF MG, 1995, CLIN PERINATOL, V22, P375; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; Olivier P, 2010, J NEUROPATH EXP NEUR, V69, P828, DOI 10.1097/NEN.0b013e3181ea5203; Ozanne SE, 2004, SEMIN PERINATOL, V28, P81, DOI 10.1053/j.semperi.2003.10.015; Pansiot J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010916; Rees S, 2011, INT J DEV NEUROSCI, V29, P551, DOI 10.1016/j.ijdevneu.2011.04.004; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2012, J CEREBR BLOOD F MET, V32, P1332, DOI 10.1038/jcbfm.2012.12; Terpolilli NA, 2012, CIRC RES, V110, P727, DOI 10.1161/CIRCRESAHA.111.253419; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wiles NJ, 2006, AM J EPIDEMIOL, V163, P829, DOI 10.1093/aje/kwj108; Yuen TJ, 2014, CELL, V158, P383, DOI 10.1016/j.cell.2014.04.052	39	27	27	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	APR	2015	77	4					563	569		10.1038/pr.2015.4			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	CD8HK	WOS:000351335600010	25580736	Bronze			2022-02-06	
J	Pham, N; Akonasu, H; Shishkin, R; Taghibiglou, C				Nam Pham; Akonasu, Hungbo; Shishkin, Rhonda; Taghibiglou, Changiz			Plasma Soluble Prion Protein, a Potential Biomarker for Sport-Related Concussions: A Pilot Study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; CELLULAR ISOFORM; EXPRESSION; EPIDEMIOLOGY; PRPC; PATHOPHYSIOLOGY; DIAGNOSIS; HEALTHY	Sport-related mild traumatic brain injury (mTBI) or concussion is a significant health concern to athletes with potential long-term consequences. The diagnosis of sport concussion and return to sport decision making is one of the greatest challenges facing health care clinicians working in sports. Blood biomarkers have recently demonstrated their potential in assisting the detection of brain injury particularly, in those cases with no obvious physical injury. We have recently discovered plasma soluble cellular prion protein (PrPC) as a potential reliable biomarker for blast induced TBI (bTBI) in a rodent animal model. In order to explore the application of this novel TBI biomarker to sport-related concussion, we conducted a pilot study at the University of Saskatchewan (U of S) by recruiting athlete and non-athlete 18 to 30 year-old students. Using a modified quantitative ELISA method, we first established normal values for the plasma soluble PrPC in male and female students. The measured plasma soluble PrPC in confirmed concussion cases demonstrated a significant elevation of this analyte in post-concussion samples. Data collected from our pilot study indicates that the plasma soluble PrPC is a potential biomarker for sport-related concussion, which may be further developed into a clinical diagnostic tool to assist clinicians in the assessment of sport concussion and return-to-play decision making.	[Nam Pham; Akonasu, Hungbo; Taghibiglou, Changiz] Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada; [Shishkin, Rhonda] Univ Saskatchewan, Coll Kinesiol & Huskies Athlet, Saskatoon, SK, Canada		Taghibiglou, C (corresponding author), Univ Saskatchewan, Coll Med, Dept Pharmacol, Saskatoon, SK S7N 0W0, Canada.	changiz.taghibiglou@usask.ca	Taghibiglou, Changiz/H-4590-2019				Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Breitling LP, 2012, EXP GERONTOL, V47, P919, DOI 10.1016/j.exger.2012.08.001; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Haddon DJ, 2009, J INFECT DIS, V200, P827, DOI 10.1086/605022; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Jeon Jae-Won, 2013, Immune Netw, V13, P148, DOI 10.4110/in.2013.13.4.148; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Krupinski J, 2008, ACTA NEUROPATHOL, V116, P537, DOI 10.1007/s00401-008-0427-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2011, CLIN SPORT MED, V30, pXVII, DOI 10.1016/j.csm.2010.09.008; Megra B, 2013, J NEUROIMMUNE PHARM, V8, P1159, DOI 10.1007/s11481-013-9458-4; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Meyne F, 2009, J ALZHEIMERS DIS, V17, P863, DOI 10.3233/JAD-2009-1110; Mitsios N, 2007, J NEUROSCI RES, V85, P602, DOI 10.1002/jnr.21142; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Parsons MP, 2014, NEURON, V82, P279, DOI 10.1016/j.neuron.2014.03.030; Pham N, 2015, J NEUROTRAUM, V32, P58, DOI 10.1089/neu.2014.3471; Pham N, 2014, BIOCHEM BIOPH RES CO, V448, P151, DOI 10.1016/j.bbrc.2014.04.071; Picard-Hagen N, 2006, J GEN VIROL, V87, P3723, DOI 10.1099/vir.0.81859-0; Politopoulou G, 2000, HAEMATOLOGICA, V85, P580; Ritchie AJ, 2013, BRIT J HAEMATOL, V163, P678, DOI 10.1111/bjh.12543; Roberts TK, 2010, AM J PATHOL, V177, P1848, DOI 10.2353/ajpath.2010.091006; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Simak J, 2002, TRANSFUSION, V42, P334, DOI 10.1046/j.1537-2995.2002.00072.x; Starke R, 2002, BRIT J HAEMATOL, V119, P863, DOI 10.1046/j.1365-2141.2002.03847.x; Stewart TC, 2013, J TRAUMA ACUTE CARE, V76, P736; Strathmann FG, 2014, CLIN BIOCHEM, DOI [10.1016/j.clinbiochem.2014.12.017, DOI 10.1016/J.CLINBIOCHEM.2014.12.017]; Torres M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036159; Volkel D, 2001, TRANSFUSION, V41, P441, DOI 10.1046/j.1537-2995.2001.41040441.x; Wang Kevin K W, 2012, Front Neurol, V3, P147, DOI 10.3389/fneur.2012.00147; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Yusa S, 2012, VIRUSES-BASEL, V4, P3109, DOI 10.3390/v4113109; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	48	27	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2015	10	2							e0117286	10.1371/journal.pone.0117286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA3QK	WOS:000348821200036	25643046	Green Published, gold, Green Submitted			2022-02-06	
J	Trotman, M; Vermehren, P; Gibson, CL; Fern, R				Trotman, Melissa; Vermehren, Philipp; Gibson, Claire L.; Fern, Robert			The dichotomy of memantine treatment for ischemic stroke: dose-dependent protective and detrimental effects	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						glutamate; ischemia; memantine; NMDA receptor; stroke	NMDA RECEPTOR ANTAGONIST; TRAUMATIC BRAIN-INJURY; NEURONAL CELL-DEATH; GLUTAMATE RECEPTORS; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; CLINICAL-TRIALS; CHANNEL BLOCK; WHITE-MATTER; RAT	Excitotoxicity is a major contributor to cell death during the acute phase of ischemic stroke but aggressive pharmacological targeting of excitotoxicity has failed clinically. Here we investigated whether pretreatment with low doses of memantine, within the range currently used and well tolerated for the treatment of Alzheimer's disease, produce a protective effect in stroke. A coculture preparation exposed to modeled ischemia showed cell death associated with rapid glutamate rises and cytotoxic Ca2+ influx. Cell death was significantly enhanced in the presence of high memantine concentrations. However, low memantine concentrations significantly protected neurons and glia via excitotoxic cascade interruption. Mice were systemically administered a range of memantine doses (0.02, 0.2, 2, 10, and 20 mg/kg/day) starting 24 hours before 60 minutes reversible focal cerebral ischemia and continuing for a 48-hour recovery period. Low dose (0.2 mg/kg/day) memantine treatment significantly reduced lesion volume (by 30% to 50%) and improved behavioral outcomes in stroke lesions that had been separated into either small/striatal or large/striatocortical infarcts. However, higher doses of memantine (20 mg/kg/day) significantly increased injury. These results show that clinically established low doses of memantine should be considered for patients 'at risk' of stroke, while higher doses are contraindicated.	[Trotman, Melissa; Vermehren, Philipp] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Gibson, Claire L.] Univ Leicester, Sch Psychol, Leicester, Leics, England; [Fern, Robert] Univ Plymouth, Peninsula Sch Med & Dent, Plymouth PL6 8BU, Devon, England		Fern, R (corresponding author), Univ Plymouth, Peninsula Sch Med & Dent, John Bull Bldg,Res Way, Plymouth PL6 8BU, Devon, England.	robert.fern@plymouth.ac.uk	trotman-lucas, melissa/Y-5096-2019	trotman-lucas, melissa/0000-0002-7735-7476; fern, robert/0000-0002-0625-3434; Gibson, Claire/0000-0002-3358-7341			Aarts MM, 2005, PFLUG ARCH EUR J PHY, V451, P243, DOI 10.1007/s00424-005-1439-x; Ahlgren H, 2011, CELL TISSUE RES, V345, P329, DOI 10.1007/s00441-011-1218-2; Allgaier M, 2014, FRONT BIOSCI-LANDMRK, V19, P1344; Bakiri Y, 2008, GLIA, V56, P233, DOI 10.1002/glia.20608; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Blanpied TA, 1997, J NEUROPHYSIOL, V77, P309, DOI 10.1152/jn.1997.77.1.309; Block F, 1996, NEUROSCI LETT, V208, P41, DOI 10.1016/0304-3940(96)12545-3; Bondarenko A, 2001, GLIA, V34, P134, DOI 10.1002/glia.1048; Bonde C, 2005, NEUROSCIENCE, V136, P779, DOI 10.1016/j.neuroscience.2005.07.020; Chen HSV, 1998, NEUROSCIENCE, V86, P1121, DOI 10.1016/S0306-4522(98)00163-8; CHEN HSV, 1992, J NEUROSCI, V12, P4427; Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909; Clark W, 1998, STROKE, V29, P2136, DOI 10.1161/01.STR.29.10.2136; Coull AJ, 2004, STROKE, V35, P1925, DOI 10.1161/01.STR.0000133129.58126.67; Creeley C, 2006, J NEUROSCI, V26, P3923, DOI 10.1523/JNEUROSCI.4883-05.2006; Culmsee C, 2004, STROKE, V35, P1197, DOI 10.1161/01.STR.0000125855.17686.6d; Dale N, 2005, TRENDS BIOTECHNOL, V23, P420, DOI 10.1016/j.tibtech.2005.05.010; Danysz W, 2012, BRIT J PHARMACOL, V167, P324, DOI 10.1111/j.1476-5381.2012.02057.x; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Elijovich L, 2010, CURR ATHEROSCLER REP, V12, P316, DOI 10.1007/s11883-010-0121-8; Fern R, 1998, J NEUROSCI, V18, P7232; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Ginsberg MD, 2009, STROKE, V40, pS111, DOI 10.1161/STROKEAHA.108.528877; Gorgulu A, 2000, ACTA NEUROCHIR, V142, P1287, DOI 10.1007/s007010070027; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Klyubin I, 2011, NEUROBIOL AGING, V32, P614, DOI 10.1016/j.neurobiolaging.2009.04.005; KORNHUBER J, 1995, NEUROSCI LETT, V195, P137, DOI 10.1016/0304-3940(95)11785-U; KRIEGSTEIN AR, 1983, J NEUROSCI, V3, P1634; Lapchak PA, 2006, BRAIN RES, V1088, P141, DOI 10.1016/j.brainres.2006.02.093; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lipton Stuart A, 2004, NeuroRx, V1, P101, DOI 10.1602/neurorx.1.1.101; Liu FD, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464701; Loihl AK, 1999, BRAIN RES, V830, P155, DOI 10.1016/S0006-8993(99)01388-8; Longuemare MC, 1996, AM J PHYSIOL-CELL PH, V270, pC1398; Lubitz SA, 2013, J AM GERIATR SOC, V61, P1798, DOI 10.1111/jgs.12456; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; Orgogozo JM, 2002, STROKE, V33, P1834, DOI 10.1161/01.STR.0000020094.08790.49; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Rammes G, 2001, NEUROSCI LETT, V306, P81, DOI 10.1016/S0304-3940(01)01872-9; REISER G, 1989, EUR J PHARM-MOLEC PH, V172, P199, DOI 10.1016/0922-4106(89)90011-4; Rogawski MA, 2003, CNS DRUG REV, V9, P275, DOI 10.1111/j.1527-3458.2003.tb00254.x; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Sperlagh B, 2007, NEUROSCIENCE, V149, P99, DOI 10.1016/j.neuroscience.2007.07.035; Sun HX, 2013, J STROKE, V15, P109, DOI 10.5853/jos.2013.15.2.109; Umegaki M, 2005, J NEUROSCI, V25, P1387, DOI 10.1523/JNEUROSCI.4182-04.2005; Yaksh TL, 2008, ANESTHESIOLOGY, V108, P938, DOI 10.1097/ALN.0b013e31816c902a	52	27	30	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2015	35	2					230	239		10.1038/jcbfm.2014.188			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CA2QS	WOS:000348753100010	25407270	Green Published, Bronze			2022-02-06	
J	Alexander, DG; Shuttleworth-Edwards, AB; Kidd, M; Malcolm, CM				Alexander, D. G.; Shuttleworth-Edwards, A. B.; Kidd, M.; Malcolm, C. M.			Mild traumatic brain injuries in early adolescent rugby players: Long-term neurocognitive and academic outcomes	BRAIN INJURY			English	Article						Academic performance; adolescence; concussion; mild traumatic brain injury; MTBI; neurocognitive; rugby	REPORTED CONCUSSIONS; EXECUTIVE FUNCTIONS; DIGIT SYMBOL; HEAD-INJURY; CHILDREN; SCHOOL; VULNERABILITY; PERFORMANCE; MANAGEMENT; SPEED	Background: Information is scant concerning enduring brain injury effects of participation in the contact sport of Rugby Union (hereafter rugby) on early adolescents. Objective: The objective was prospectively to investigate differences between young adolescent male rugby players and non-contact sports controls on neurocognitive test performance over 3 years and academic achievement over 6 years. Method: A sample of boys from the same school and grade was divided into three groups: rugby with seasonal concussions (n = 45), rugby no seasonal concussions (n = 21) and non-contact sports controls (n = 30). Baseline neurocognitive testing was conducted pre-season in Grade 7 and post-season in Grades 8 and 9. Year-end academic grades were documented for Grades 6-9 and 12 (pre-high school to year of school leaving). A mixed model repeated measures ANOVA was conducted to investigate comparative neurocognitive and academic outcomes between the three sub-groups. Results: Compared with controls, both rugby groups were significantly lower on the WISC-III Coding Immediate Recall sub-test. There was a significant interaction effect on the academic measure, with improved scores over time for controls, that was not in evidence for either rugby group. Conclusions: Tentatively, the outcome suggests cognitive vulnerability in association with school level participation in rugby.	[Alexander, D. G.] Univ Stellenbosch, Dept Psychiat, ZA-7600 Stellenbosch, South Africa; [Alexander, D. G.; Malcolm, C. M.] Univ Western Cape, Dept Psychol, Cape Town, South Africa; [Shuttleworth-Edwards, A. B.] Rhodes Univ, Dept Psychol, ZA-6140 Grahamstown, South Africa; [Kidd, M.] Univ Stellenbosch, Ctr Stat Consultat, ZA-7600 Stellenbosch, South Africa		Alexander, DG (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Psychiat, POB 19063, ZA-7505 Tygerberg, South Africa.	debalex@sun.ac.za	Meijer, Anna/K-5118-2016				Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1111/1469-8986.3710013; Baker JH, 1967, DETROIT TEST LEARNIN; Baker Robert J., 2000, Indian Journal of Pediatrics, V67, P317, DOI 10.1007/BF02820676; Baroff GS, 1998, J HEAD TRAUMA REHAB, V13, P45, DOI 10.1097/00001199-199804000-00007; Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BIJUR PE, 1990, PEDIATRICS, V86, P337; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy T., 2004, UNDERSTANDING SPORTS; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Farace E, 2003, J INT NEUROPSYCH SOC, V9, P207; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Golden C, 2000, NEUROPSYCHOLOGICAL I; HART RP, 1987, J CONSULT CLIN PSYCH, V55, P236; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Horton AM, 2010, APPL NEUROPSYCHOL, V17, P99, DOI 10.1080/09084281003708944; Kelly JP, 1997, NEUROLOGY, V48, P581; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; KOLB B, 2003, FUNDAMENTALS HUMAN N; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Macleod DAD, 1993, SOFT TISSUES TRAUMA, P371; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mira M. P., 1992, TRAUMATIC BRAIN INJU; Mitrushina MN, 1999, HDB NORMATIVE DATA N; NATHAN M, 1983, S AFR MED J, V64, P132; Newman BM, 2005, DEV LIFE PSYCHOL APP; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Pettersen JA, 2000, PSYCHOBIOLOGY, V28, P81; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Psychological Corporation, 1992, WECHSL IND ACH TEST; Sattler JM, 2001, COGNITIVE APPL; Satz P, 2001, CURR DIR PSYCHOL SCI, V10, P106, DOI 10.1111/1467-8721.00127; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shuttleworth-Edwards A, 2004, STUD NEUROPSYCHOL DE, P149; Shuttleworth-Edwards A, 2013, ARCH CLIN NEUROPSYCH, V129, P86; Shuttleworth-Edwards A. B., 2013, PSYCHOL ASSESSMENT S, P33; Shuttleworth-Edwards AB, 2004, J CLIN EXP NEUROPSYC, V26, P903, DOI 10.1080/13803390490510824; Shuttleworth-Edwards AB, 2008, J CLIN EXP NEUROPSYC, V30, P870, DOI 10.1080/13803390701846914; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Shuttleworth-Edwards AB, 2014, PROG NEUROL SURG, V28, P213, DOI 10.1159/000358785; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Shuttleworth-Jordan AB, 1993, P 5 NAT NEUR C S AFR, P38; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; SHUTTLEWORTHJORDAN AB, 1995, J CLIN EXP NEUROPSYC, V17, P439, DOI 10.1080/01688639508405135; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stephens R, 2005, CHILD NEUROPSYCHOL, V11, P513, DOI 10.1080/092970490959629; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd	69	27	27	3	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	9					1113	1125		10.3109/02699052.2015.1031699			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR1UG	WOS:000361110000012	26004752				2022-02-06	
J	An, F; Qu, YY; Liu, XM; Zhong, RT; Luo, Y				An, Fan; Qu, Yueyang; Liu, Xianming; Zhong, Runtao; Luo, Yong			Organ-on-a-Chip: New Platform for Biological Analysis	ANALYTICAL CHEMISTRY INSIGHTS			English	Article						organ-on-a-chip; tissue engineering; microenvironment; drug screening	TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; RAT HEPATOCYTES; CULTURE; LIVER; DIFFERENTIATION; SPHEROIDS; CONFIGURATION; NEUROGENESIS; STIMULATION	Direct detection and analysis of biomolecules and cells in physiological microenvironment is urgently needed for fast evaluation of biology and pharmacy. The past several years have witnessed remarkable development opportunities in vitro organs and tissues models with multiple functions based on microfluidic devices, termed as "organ-on-a-chip". Briefly speaking, it is a promising technology in rebuilding physiological functions of tissues and organs, featuring mammalian cell co-culture and artificial microenvironment created by microchannel networks. In this review, we summarized the advances in studies of heart-, vessel-, liver-, neuron-, kidney- and Multi-organs-on-a-chip, and discussed some noteworthy potential on-chip detection schemes.	[An, Fan; Qu, Yueyang; Luo, Yong] Dalian Univ Technol, Sch Pharmaceut Sci & Technol, Dalian, Peoples R China; [An, Fan; Qu, Yueyang; Luo, Yong] Dalian Univ Technol, Dept Chem Engn, State Key Lab Fine Chem, Dalian, Peoples R China; [Liu, Xianming; Zhong, Runtao] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Peoples R China		Zhong, RT (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Peoples R China.	rintozh@dicp.ac.cn; yluo@dlut.edu.cn	Zhong, Runtao/AAA-2687-2021				Abaci HE, 2015, INTEGR BIOL-UK, V7, P383, DOI 10.1039/c4ib00292j; [Anonymous], 2014, J SPINAL CORD MED, V37, P243; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Chen AA, 2011, P NATL ACAD SCI USA, V108, P11842, DOI 10.1073/pnas.1101791108; Chen HY, 2013, LAB CHIP, V13, P2999, DOI 10.1039/c3lc50123j; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Dvir-Ginzberg M, 2004, TISSUE ENG, V10, P1806, DOI 10.1089/ten.2004.10.1806; Ferrell N, 2012, BIOTECHNOL BIOENG, V109, P797, DOI 10.1002/bit.24339; Fraczek J, 2013, ARCH TOXICOL, V87, P577, DOI 10.1007/s00204-012-0983-3; Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2; Hald ES, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/4/045005; Hamilton G, 2001, IN VITRO CELL DEV-AN, V37, P656; Jagasia R, 2006, TRENDS MOL MED, V12, P400, DOI 10.1016/j.molmed.2006.07.006; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Kaufmann PM, 1997, CELL TRANSPLANT, V6, P463, DOI 10.1016/S0963-6897(97)00052-3; Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a; LeCluyse EL, 2001, EUR J PHARM SCI, V13, P343, DOI 10.1016/S0928-0987(01)00135-X; Lei KF, 2014, LANGMUIR, V30, P14241, DOI 10.1021/la5039238; Li CY, 2014, TISSUE ENG PT A, V20, P2200, DOI [10.1089/ten.tea.2013.0667, 10.1089/ten.TEA.2013.0667]; Nguyen MD, 2015, ANAL CHEM, V87, P2107, DOI 10.1021/ac503716z; Maschmeyer I, 2015, LAB CHIP, V15, P2688, DOI 10.1039/c5lc00392j; Maton A., 1993, HUMAN BIOL HLTH; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Nerya FC, 2015, J NEUROSCI METH, V239, P80, DOI 10.1016/j.jneumeth.2014.09.028; Nishikawa Y, 1996, EXP CELL RES, V223, P357, DOI 10.1006/excr.1996.0091; REINECKE M, 1985, PROG HISTOCHEM CYTOC, V16, P1; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Richert L, 2002, TOXICOL IN VITRO, V16, P89, DOI 10.1016/S0887-2333(01)00099-6; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Shamloo A, 2015, INTEGR BIOL-UK, V7, P335, DOI 10.1039/c4ib00144c; Sherafat MA, 2012, J MOL NEUROSCI, V48, P144, DOI 10.1007/s12031-012-9791-8; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Theberge AB, 2015, ANAL CHEM, V87, P3239, DOI 10.1021/ac503700f; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; TONG JZ, 1990, EXP CELL RES, V189, P87, DOI 10.1016/0014-4827(90)90260-H; Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043; Vinci B, 2011, BIOTECHNOL J, V6, P554, DOI 10.1002/biot.201000326; World Health Organization, 2017, CARD DIS CVDS; Xiao Y, 2014, LAB CHIP, V14, P869, DOI 10.1039/c3lc51123e; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yuan B, 2012, ADV MATER, V24, P890, DOI 10.1002/adma.201104589	44	27	28	13	81	LIBERTAS ACAD	AUCKLAND	PO BOX 300-874, ALBANY 0752, AUCKLAND, 00000, NEW ZEALAND	1177-3901			ANAL CHEM INSIGHTS	Anal. Chem. Insights		2015	10						39	45		10.4137/ACICI.S28905			7	Chemistry, Analytical	Emerging Sources Citation Index (ESCI)	Chemistry	CZ7NS	WOS:000367286700001	26640364				2022-02-06	
J	Bosco, FM; Angeleri, R; Sacco, K; Bara, BG				Bosco, Francesca M.; Angeleri, Romina; Sacco, Katiuscia; Bara, Bruno G.			Explaining pragmatic performance in traumatic brain injury: a process perspective on communicative errors	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article							CLOSED-HEAD INJURY; COMPREHENSION; DISCOURSE; INFORMATION; IMPAIRMENT; CHILDREN; REQUESTS; ADULTS; EXPRESSION; FAILURES	BackgroundThe purpose of this study is to investigate the pragmatic abilities of individuals with traumatic brain injury (TBI). Several studies in the literature have previously reported communicative deficits in individuals with TBI, however such research has focused principally on communicative deficits in general, without providing an analysis of the errors committed in understanding and expressing communicative acts. Within the theoretical framework of Cognitive Pragmatics theory and Cooperative principle we focused on intermediate communicative errors that occur in both the comprehension and the production of various pragmatic phenomena, expressed through both linguistic and extralinguistic communicative modalities. AimsTo investigate the pragmatic abilities of individuals with TBI. Methods & ProceduresA group of 30 individuals with TBI and a matched control group took part in the experiment. They were presented with a series of videotaped vignettes depicting everyday communicative exchanges, and were tested on the comprehension and production of various kinds of communicative acts (standard communicative act, deceit and irony). The participants' answers were evaluated as correct or incorrect. Incorrect answers were then further evaluated with regard to the presence of different intermediate errors. Outcomes & ResultsIndividuals with TBI performed worse than control participants on all the tasks investigated when considering correct versus incorrect answers. Furthermore, a series of logistic regression analyses showed that group membership (TBI versus controls) significantly predicted the occurrence of intermediate errors. This result holds in both the comprehension and production tasks, and in both linguistic and extralinguistic modalities. Conclusions & ImplicationsParticipants with TBI tend to have difficulty in managing different types of communicative acts, and they make more intermediate errors than the control participants. Intermediate errors concern the comprehension and production of the expression act, the comprehension of the actors' meaning, as well as the respect of the Cooperative principle.	[Bosco, Francesca M.; Angeleri, Romina; Sacco, Katiuscia; Bara, Bruno G.] Univ Turin, Dept Psychol, Ctr Cognit Sci, I-10123 Turin, Italy; [Bosco, Francesca M.; Sacco, Katiuscia; Bara, Bruno G.] Neurosci Inst Turin, Turin, Italy; [Sacco, Katiuscia] Koelliker Hosp, CCS fMRI Neuroradiol, Turin, Italy		Bosco, FM (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy.	francesca.bosco@unito.it	bosco, francesca marina/B-6746-2013	bosco, francesca marina/0000-0001-6101-8587	Regione Piemonte under IIINBEMA; Regione Piemonte under IIINBEMA	This research was supported by Regione Piemonte, under project title 'Institutions, Behaviour and Markets in Local and Global Settings' (Project IIINBEMA). The authors would like to thank Lorena Fonte, Viviana Leveratto and Elena Scarsoglio for their contribution to data collection, and Alessandra Ruzzini for assistance with selecting participants. They thank Marco Del Giudice for help with the revision of the manuscript. Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	AIRENTI G, 1993, J PRAGMATICS, V20, P303, DOI 10.1016/0378-2166(93)90055-T; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; Bara B. G., 2010, LINGUISTIC PHILOS IN, V9, P182; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; Bara Bruno, 2010, COGNITIVE PRAGMATICS; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Bogart E, 2012, BRAIN INJURY, V26, P221, DOI 10.3109/02699052.2011.648711; Bosco FM, 2004, J PRAGMATICS, V36, P467, DOI 10.1016/S0378-2166(03)00055-9; Bosco FM, 2008, J PRAGMATICS, V40, P583, DOI 10.1016/j.pragma.2007.05.004; Bosco FM, 2006, J PRAGMATICS, V38, P1398, DOI 10.1016/j.pragma.2005.06.011; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Bosco FM, 2009, CONSCIOUS COGN, V18, P306, DOI 10.1016/j.concog.2008.06.006; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bucciarelli M, 2003, J PRAGMATICS, V35, P207, DOI 10.1016/S0378-2166(02)00099-1; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Ciccia Angel H., 2002, ADV SPEECH LANGUAGE, V4, P1, DOI DOI 10.1080/14417040210001669181; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Cummings L., 2014, PRAGMATIC DISORDERS; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dardier V, 2011, J COMMUN DISORD, V44, P359, DOI 10.1016/j.jcomdis.2011.02.001; Dascal M., 1985, DIALOGUE INTERDISCIP, P441; Dennis M, 2001, J HEAD TRAUMA REHAB, V16, P456, DOI 10.1097/00001199-200110000-00005; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Evans K, 2011, BRAIN INJURY, V25, P767, DOI 10.3109/02699052.2011.576307; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Grice P., 1989, STUDIES WAY WORDS; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Huber W., 1983, AACHENER APHASIE TES; KREUZ RJ, 1993, J PRAGMATICS, V19, P239, DOI 10.1016/0378-2166(93)90030-S; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luzzatti C., 1996, AACHENER APHASIE TES, V2nd; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Marquardt TP, 2001, APHASIOLOGY, V15, P1091, DOI 10.1080/02687040143000429; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mondini S., 2004, ESAME NEUROPSICOLOGI; Pearce S, 1998, BRAIN COGNITION, V38, P150, DOI 10.1006/brcg.1998.1018; REITER R, 1980, ARTIF INTELL, V13, P81, DOI 10.1016/0004-3702(80)90014-4; Sacco K, 2008, J COGN SCI, V9, P111; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tirassa M, 2006, CONSCIOUS COGN, V15, P197, DOI 10.1016/j.concog.2005.06.005; Tirassa M, 2006, COGN SYST RES, V7, P128, DOI 10.1016/j.cogsys.2006.01.002; Tirassa M, 2008, EMERG COMMUN-STUD NE, V10, P81; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Turkstra L.S., 2006, BRAIN IMPAIR, V7, P234, DOI [DOI 10.1375/BRIM.7.3.234, 10.1375/brim.7.3.234]; Volden J, 2004, INT J LANG COMM DIS, V39, P171, DOI 10.1080/13682820410001663252; Weigand E, 1999, J PRAGMATICS, V31, P763, DOI 10.1016/S0378-2166(98)00068-X; WINNER E, 1977, BRAIN, V100, P717, DOI 10.1093/brain/100.4.717	60	27	27	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	JAN-FEB	2015	50	1					63	83		10.1111/1460-6984.12114			21	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	CA4AJ	WOS:000348846400005	25039503	Green Submitted			2022-02-06	
J	Chase, RP; Nevin, RL				Chase, Rachel P.; Nevin, Remington L.			Population Estimates of Undocumented Incident Traumatic Brain Injuries Among Combat-Deployed US Military Personnel	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Afghan war; Iraq war; late diagnosis; military; traumatic brain injury	IRAQ	Objective: To estimate the number of undocumented incident traumatic brain injuries (TBIs) among active component US military personnel serving in Iraq and Afghanistan prior to policy changes implemented in late 2006 and 2010 that improved TBI documentation. Methods: Negative binomial regression was used to model monthly incident TBI counts between December 2010 and June 2012 (N = 19) and then estimate expected monthly counts of incident TBIs during 2 periods: January 2003-October 2006 and November 2006-November 2010. Monthly amputation counts from Department of Defense surveillance data were used as a proxy for changing injury rates. Monthly active component deployment estimates derived from the Congressional Research Service, Brookings Institution, and Defense Manpower Data Center were used to estimate the size of the at-risk population each month. The difference between expected monthly incident TBI counts and reported counts is presented as the estimated number of undocumented incident TBIs. Results: The full model estimates that 21 257 active component military personnel experienced undocumented incident TBIs while deployed in Iraq or Afghanistan between January 2003 and October 2006, more than 4 times the 5272 incident TBIs documented during that period. Conclusions: A sizeable majority of Iraq and Afghanistan combat veterans who experienced incident TBI while deployed prior to November 2006 are likely to have had their injuries undocumented, creating challenges for clinical care, disability evaluation, and future research.	[Chase, Rachel P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Nevin, Remington L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA		Chase, RP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	rachel.chase@jhu.edu		Chase, Rachel/0000-0002-1503-4954; Nevin, Remington/0000-0002-0534-1889			Ader Melissa, 2012, CASTING TROOPS ASIDE; [Anonymous], 2010, Medical Surveillance Monthly Report, V17, P18; [Anonymous], 2009, Medical Surveillance Montly Report, V16, P2; Armed Forces Health Surveillance Center, 2007, MED SURVEILL MON REP, V14, P30; Armed Forces Health Surveillance Center, 2010, MED SURVEILL MON REP, V17, P21; Armed Forces Health Surveillance Center, 2012, MED SURVEILL MON REP, V19, P24; Army Medical Surveillance Activity, 2005, MED SURVEILL MON REP, V11, P22; Auerbach D., 2013, HLTH CARE SPENDING E; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; BELASCO A, 2011, COST IRAQ AFGHANISTA; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Casscells W, 2007, 0730 ASS SECR DEF HL; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Defense and Veterans Brain Injury Center, 2013, DOD WORLDW NUMB TRAU; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Edgar E., 2012, LOOK INSIDE CENTCOM; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Hampton T, 2011, JAMA-J AM MED ASSOC, V306, P477, DOI 10.1001/jama.2011.1092; Hicks MHR, 2011, AM J PSYCHIAT, V168, P341, DOI 10.1176/appi.ajp.2011.11010074; Kors J, 2007, NATION; Lechner R, 2010, UNFALLCHIRURG, V113, P106, DOI 10.1007/s00113-009-1732-9; Livingston IS, 2012, AFGHANISTAN INDEX AL; Lynn WJ, 2010, 0933 DEP SECR DEF; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Miller T.C., 2010, MILITARY STILL FAILI; Miller TC, 2010, SOLIDERS BRAIN TRAUM; Nevin RL, 2011, PSYCHIAT SERV, V62, P805, DOI 10.1176/ps.62.7.pss6207_0805a; O'Hanlon M. E., 2011, IRAQ INDEX TRACKING; O'Neil C., 2012, CHANGING GUARD LOOK; Panangala SV, 2011, VETERANS AFFAIRS PRE; Rauh MJ, 2013, J REHABIL RES DEV, V50, P161, DOI 10.1682/JRRD.2011.11.0212; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rooney JA, 2012, OFFICE SECRETARY DEF; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1; Snethen B, 2010, ARMY HOSP SAVES TIME; United States Central Command (USCENTCOM), 2010, AMPL MIN STAND FITN; US Department of Veterans Affairs, 2009, VET BEN TIM INF VET; US Department of Veterans Affairs, 2013, FED REGISTER, V78, P76196; *US GOV ACC OFF, 2008, GAO08615; *US GOV ACC OFF, 2008, GAO08276; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wallace D, 2009, AUSTRALAS PSYCHIATRY, V17, P218, DOI 10.1080/10398560902878679; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wojcik BE, 2010, J DEF MODEL SIMUL-AP, V7, P157, DOI 10.1177/1548512910371083; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	47	27	27	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2015	30	1					E57	E64		10.1097/HTR.0000000000000061			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AY8BW	WOS:000347780400007	24810487				2022-02-06	
J	Deutsch, MB; Mendez, MF; Teng, E				Deutsch, Mariel B.; Mendez, Mario F.; Teng, Edmond			Interactions between Traumatic Brain Injury and Frontotemporal Degeneration	DEMENTIA AND GERIATRIC COGNITIVE DISORDERS			English	Article						Brain injuries; Frontotemporal degeneration; Frontotemporal dementia; Frontotemporal lobar degeneration; Primary progressive aphasia; Neuropsychological features in subjects with dementia	ENVIRONMENTAL RISK-FACTORS; DATA SET UDS; HEAD-INJURY; FUNCTIONAL-ACTIVITIES; CLINICAL PHENOTYPE; LOBAR DEGENERATION; ALZHEIMERS-DISEASE; DEMENTIA	Background/Aims: Prior work in smaller cohorts suggests that traumatic brain injury (TBI) may be a risk factor for frontotemporal degeneration (FTD). We sought to confirm and extend these results using the National Alzheimer's Coordinating Center Uniform Data Set. Methods: We compared the TBI prevalence between FTD subjects and matched normal controls. Indices of cognitive, behavioral, functional, and global dementia severity were compared between FTD subjects with and without prior TBI. Results: Remote TBI with extended loss of consciousness (TBI-ext) was more common in individuals with FTD than in controls (OR: 1.67; 95% CI: 1.004-2.778). With TBI-ext, less functional and global impairment was seen in the behavioral variant of FTD, but more behavioral pathology was seen in the semantic variant. Conclusion: TBI may increase the FTD risk and influence clinical symptomatology and severity in FTD sub-types. (C) 2014 S. Karger AG, Basel	[Deutsch, Mariel B.; Mendez, Mario F.; Teng, Edmond] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol Sci, Los Angeles, CA 90095 USA; [Mendez, Mario F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Deutsch, Mariel B.; Mendez, Mario F.; Teng, Edmond] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA		Deutsch, MB (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Neurobehav Serv 116AF, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	mdeutsch@mednet.ucla.edu	Deutsch, Mariel/V-3876-2019	Deutsch, Mariel/0000-0003-1228-8868	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG16570, K08 AG34628, R01AG034499-05, U01 AG016976]; NIA (American Federation for Aging Research); NIA (John A. Hartford Foundation); NIA (Atlantic Philanthropies); NIA (Starr Foundation); Alzheimer's Disease Research Centers of California; Sidell-Kagan Foundation; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG016570, K08AG034628, R01AG034499, U01AG016976] Funding Source: NIH RePORTER	This study was supported by the NIA (P50 AG16570 and K08 AG34628 to E.T.; jointly sponsored by the NIA, the American Federation for Aging Research, the John A. Hartford Foundation, the Atlantic Philanthropies, the Starr Foundation, and an anonymous donor) and R01AG034499-05 (M. F. M., principle investigator), the Alzheimer's Disease Research Centers of California, and the Sidell-Kagan Foundation. The NACC database is funded by the NIA (U01 AG016976).	Bahia Valéria Santoro, 2013, Dement. neuropsychol., V7, P19, DOI 10.1590/S1980-57642013DN70100004; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; BUTTERS N, 1987, J CLIN EXP NEUROPSYC, V9, P479, DOI 10.1080/01688638708410764; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Dams-O'Connor K, 2013, NEUROREHABILITATION, V32, P199, DOI 10.3233/NRE-130838; Davies RR, 2005, BRAIN, V128, P1984, DOI 10.1093/brain/awh582; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Galimberti Daniela, 2012, Front Neurol, V3, P52, DOI 10.3389/fneur.2012.00052; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Grossman M, 2007, ARCH NEUROL-CHICAGO, V64, P1449, DOI 10.1001/archneur.64.10.1449; Hou CE, 2006, DEMENT GERIATR COGN, V22, P42, DOI 10.1159/000093217; Hsiao JJ, 2015, DEMENT GERIATR COGN, V39, P12, DOI 10.1159/000365587; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Jawaid A, 2009, NEURODEGENER DIS, V6, P219, DOI 10.1159/000258704; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Kaplan E, 1983, BOSTON NAMING TEST; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; Leger GC, 2014, DEMENT GERIATR COGN, V37, P104, DOI 10.1159/000354368; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendez MF, 2013, NEUROLOGY, V80, P561, DOI 10.1212/WNL.0b013e3182815547; Mesulam MM, 2001, ANN NEUROL, V49, P425, DOI 10.1002/ana.91; Mesulam MM, 2003, NEW ENGL J MED, V349, P1535, DOI 10.1056/NEJMra022435; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Onyike CU, 2013, INT REV PSYCHIATR, V25, P130, DOI 10.3109/09540261.2013.776523; Perry DC, 2013, SEMIN NEUROL, V33, P336, DOI 10.1055/s-0033-1359316; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Pressman PS, 2014, BIOL PSYCHIAT, V75, P574, DOI 10.1016/j.biopsych.2013.11.006; Reitan R, 1985, HALSTEAD REITAN NEUR; Rosen HJ, 2006, NEUROLOGY, V67, P1752, DOI 10.1212/01.wnl.0000247630.29222.34; Rosso SM, 2003, J NEUROL NEUROSUR PS, V74, P1574, DOI 10.1136/jnnp.74.11.1574; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Strickland D, 1996, ACTA NEUROL SCAND, V94, P45, DOI 10.1111/j.1600-0404.1996.tb00038.x; Teng E, 2010, ALZ DIS ASSOC DIS, V24, P348, DOI 10.1097/WAD.0b013e3181e2fc84; Teng E, 2010, DEMENT GERIATR COGN, V30, P189, DOI 10.1159/000313540; Wechsler D., 1987, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED	47	27	27	0	11	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1420-8008	1421-9824		DEMENT GERIATR COGN	Dement. Geriatr. Cogn. Disord.		2015	39	3-4					143	153		10.1159/000369787			11	Geriatrics & Gerontology; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology; Psychiatry	CB5UJ	WOS:000349692800003	25531628	Bronze, Green Accepted			2022-02-06	
J	Diwakar, M; Harrington, DL; Maruta, J; Ghajar, J; El-Gabalawy, F; Muzzatti, L; Corbetta, M; Huang, MX; Lee, RR				Diwakar, Mithun; Harrington, Deborah L.; Maruta, Jun; Ghajar, Jamshid; El-Gabalawy, Fady; Muzzatti, Laura; Corbetta, Maurizio; Huang, Ming-Xiong; Lee, Roland R.			Filling in the gaps: Anticipatory control of eye movements in chronic mild traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Mild traumatic brain injury; Visual tracking; Anticipatory control; Attention; Magnetoencephalography	SIGNAL SPACE SEPARATION; POST-CONCUSSION SYNDROME; DIFFUSION-TENSOR; SMOOTH-PURSUIT; IMAGING APPROACH; TARGET BLANKING; CORTICAL MECHANISMS; HEAD-INJURY; MEG; ATTENTION	A barrier in the diagnosis of mild traumatic brain injury (mTBI) stems from the lack of measures that are adequately sensitive in detecting mild head injuries. MRI and CT are typically negative in mTBI patients with persistent symptoms of post-concussive syndrome (PCS), and characteristic difficulties in sustaining attention often go undetected on neuropsychological testing, which can be insensitive to momentary lapses in concentration. Conversely, visual tracking strongly depends on sustained attention over time and is impaired in chronic mTBI patients, especially when tracking an occluded target. This finding suggests deficient internal anticipatory control in mTBI, the neural underpinnings of which are poorly understood. The present study investigated the neuronal bases for deficient anticipatory control during visual tracking in 25 chronic mTBI patients with persistent PCS symptoms and 25 healthy control subjects. The task was performed while undergoing magnetoencephalography (MEG), which allowed us to examine whether neural dysfunction associated with anticipatory control deficits was due to altered alpha, beta, and/or gamma activity. Neuropsychological examinations characterized cognition in both groups. During MEG recordings, subjects tracked a predictably moving target that was either continuously visible or randomly occluded (gap condition). MEG source-imaging analyses tested for group differences in alpha, beta, and gamma frequency bands. The results showed executive functioning, information processing speed, and verbal memory deficits in the mTBI group. Visual tracking was impaired in the mTBI group only in the gap condition. Patients showed greater error than controls before and during target occlusion, and were slower to resynchronize with the target when it reappeared. Impaired tracking concurred with abnormal beta activity, which was suppressed in the parietal cortex, especially the right hemisphere, and enhanced in left caudate and frontal-temporal areas. Regional beta-amplitude demonstrated high classification accuracy (92%) compared to eye-tracking (65%) and neuropsychological variables (80%). These findings show that deficient internal anticipatory control in mTBI is associated with altered beta activity, which is remarkably sensitive given the heterogeneity of injuries. Published by Elsevier Inc.	[Diwakar, Mithun; Harrington, Deborah L.; El-Gabalawy, Fady; Muzzatti, Laura; Huang, Ming-Xiong; Lee, Roland R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92121 USA; [Harrington, Deborah L.; Huang, Ming-Xiong; Lee, Roland R.] VA San Diego Healthcare Syst, Radiol & Res Serv, San Diego, CA USA; [Maruta, Jun; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY USA; [Ghajar, Jamshid] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Corbetta, Maurizio] Washington Univ, Dept Neurol, St Louis, MO USA		Huang, MX (corresponding author), Univ Calif San Diego, Radiol Imaging Lab, 3510 Dunhill St, San Diego, CA 92121 USA.	mxhuang@ucsd.edu; rrlee@ucsd.edu	Corbetta, Maurizio/AAZ-5219-2020; Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605; CORBETTA, MAURIZIO/0000-0001-8295-3304	McDonnell Foundation [220020185]; Department of Veterans AffairsUS Department of Veterans Affairs [NURC-022-10F, CX000146-05A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095741] Funding Source: NIH RePORTER	This work was supported by grants from the McDonnell Foundation (220020185 to JG) and the Department of Veterans Affairs (NURC-022-10F to MXH; CX000146-05A1 to DLH).	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assmus A, 2003, NEUROIMAGE, V20, pS82, DOI 10.1016/j.neuroimage.2003.09.025; Baayen JC, 2003, BRAIN TOPOGR, V16, P85, DOI 10.1023/B:BRAT.0000006332.71345.b7; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burgess PW, 2007, PHILOS T R SOC B, V362, P887, DOI 10.1098/rstb.2007.2095; Burke MR, 2008, CEREB CORTEX, V18, P126, DOI 10.1093/cercor/bhm038; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; de Jongh A, 2003, NEUROIMAGE, V20, P2291, DOI 10.1016/j.neuroimage.2003.07.030; de Xivry JJO, 2008, J VISION, V8, DOI 10.1167/8.15.6; Delis DC, 1987, CALIFORNIA VERBAL LE; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Ding JH, 2009, HUM BRAIN MAPP, V30, P3541, DOI 10.1002/hbm.20777; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Elsinger CL, 2006, NEUROIMAGE, V31, P1177, DOI 10.1016/j.neuroimage.2006.01.041; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Genovesio A, 2014, TRENDS COGN SCI, V18, P72, DOI 10.1016/j.tics.2013.11.007; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Gross J, 1999, PHYS MED BIOL, V44, P2081, DOI 10.1088/0031-9155/44/8/317; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Harrington DL, 1998, J NEUROSCI, V18, P1085; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2008, IEEE ENG MED BIO, P3570, DOI 10.1109/IEMBS.2008.4649977; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jakobs O, 2009, NEUROIMAGE, V47, P667, DOI 10.1016/j.neuroimage.2009.04.065; Kawawaki D, 2006, NEUROSCI RES, V54, P112, DOI 10.1016/j.neures.2005.10.015; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lencer R, 2004, EUR J NEUROSCI, V19, P1430, DOI 10.1111/j.1460-9568.2004.03229.x; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; Lewine J D, 1995, Neuroimaging Clin N Am, V5, P575; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Makin ADJ, 2009, NEUROPSYCHOLOGIA, V47, P1128, DOI 10.1016/j.neuropsychologia.2009.01.010; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; MIZUKI Y, 1992, INT J PSYCHOPHYSIOL, V12, P169, DOI 10.1016/0167-8760(92)90008-Y; MIZUKI Y, 1980, CLIN NEUROPHYSIOL, V49, P345; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Nagel M, 2006, NEUROIMAGE, V29, P1319, DOI 10.1016/j.neuroimage.2005.08.050; Nagel M, 2008, NEUROIMAGE, V41, P483, DOI 10.1016/j.neuroimage.2008.02.058; Niedermeyer E., 2005, ELECTROENCEPHALOGRAP; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; O'Driscoll GA, 2000, NEUROREPORT, V11, P1335, DOI 10.1097/00001756-200004270-00037; Pascual B, 2015, CEREB CORTEX, V25, P680, DOI 10.1093/cercor/bht260; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SMITH MB, 1995, AM PSYCHOL, V50, P393; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Takahashi N, 1997, CLIN ELECTROENCEPHAL, V28, P49, DOI 10.1177/155005949702800109; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Taulu S., 2004, NEUROL CLIN NEUROPHY, V2004; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vieth JB, 1996, BRAIN TOPOGR, V8, P215, DOI 10.1007/BF01184772; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; [No title captured]	97	27	27	0	15	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2015	8						210	223		10.1016/j.nicl.2015.04.011			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI0LE	WOS:000373187100022	26106545	Green Published, gold			2022-02-06	
J	Godbolt, AK; Stenberg, M; Jakobsson, J; Sorjonen, K; Krakau, K; Stalnacke, BM; DeBoussard, CN				Godbolt, Alison K.; Stenberg, Maud; Jakobsson, Jan; Sorjonen, Kimmo; Krakau, Karolina; Stalnacke, Britt-Marie; DeBoussard, Catharina Nygren			Subacute complications during recovery from severe traumatic brain injury: frequency and associations with outcome	BMJ OPEN			English	Article							PAROXYSMAL SYMPATHETIC HYPERACTIVITY; DEEP-VEIN THROMBOSIS; INPATIENT REHABILITATION; DIAGNOSTIC-CRITERIA; CONTINUOUS CHAIN; CONSCIOUSNESS; GUIDELINES; SCALE; DISORDERS; NUTRITION	Background: Medical complications after severe traumatic brain injury (S-TBI) may delay or prevent transfer to rehabilitation units and impact on long-term outcome. Objective: Mapping of medical complications in the subacute period after S-TBI and the impact of these complications on 1-year outcome to inform healthcare planning and discussion of prognosis with relatives. Setting: Prospective multicentre observational study. Recruitment from 6 neurosurgical centres in Sweden and Iceland. Participants and assessments: Patients aged 18-65 years with S-TBI and acute Glasgow Coma Scale 3-8, who were admitted to neurointensive care. Assessment of medical complications 3 weeks and 3 months after injury. Follow-up to 1 year. 114 patients recruited with follow-up at 1 year as follows: 100 assessed, 7 dead and 7 dropped out. Outcome measure: Glasgow Outcome Scale Extended. Results: 68 patients had >= 1 complication 3 weeks after injury. 3 weeks after injury, factors associated with unfavourable outcome at 1 year were: tracheostomy, assisted ventilation, on-going infection, epilepsy and nutrition via nasogastric tube or percutaneous endoscopic gastroscopy (PEG) tube (univariate logistic regression analyses). Multivariate analysis demonstrated that tracheostomy and epilepsy retained significance even after incorporating acute injury severity into the model. 3 months after injury, factors associated with unfavourable outcome were tracheostomy and heterotopic ossification (Fisher's test), infection, hydrocephalus, autonomic instability, PEG feeding and weight loss (univariate logistic regression). PEG feeding and weight loss at 3 months were retained in a multivariate model. Conclusions: Subacute complications occurred in two-thirds of patients. Presence of a tracheostomy or epilepsy at 3 weeks, and of PEG feeding and weight loss at 3 months, had robust associations with unfavourable outcome that were incompletely explained by acute injury severity.	[Godbolt, Alison K.; Krakau, Karolina; DeBoussard, Catharina Nygren] Karolinska Inst, Dept Clin Sci, Stockholm, Sweden; [Godbolt, Alison K.; Krakau, Karolina; DeBoussard, Catharina Nygren] Danderyd Hosp, Univ Dept Rehabil Med Stockholm, Stockholm, Sweden; [Godbolt, Alison K.] Univ Uppsala Hosp, Dept Rehabil Med, Uppsala, Sweden; [Godbolt, Alison K.] Uppsala Univ, Uppsala, Sweden; [Stenberg, Maud; Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, Rehabil Med, Umea, Sweden; [Jakobsson, Jan] Karolinska Inst, Danderyd Hosp, Inst Clin Sci, Natl Resp Ctr,Dept Anaesthesia & Intens Care, Stockholm, Sweden; [Sorjonen, Kimmo] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden		Godbolt, AK (corresponding author), Karolinska Inst, Dept Clin Sci, Stockholm, Sweden.	alison.godbolt@ki.se	Stenberg, Maud/AAX-4366-2021	Godbolt, Alison/0000-0003-4511-6181	AFA insurance [060833]; Uppsala University Hospital; Danderyd Hospital; Umea University Hospital	This study was supported by grant 060833 from AFA insurance (to Professor Jorgen Borg). AKG has received support from ALF-grants from Uppsala University Hospital and Danderyd Hospital. MS and B-MS have received ALF-grants from Umea University Hospital.	Andelic N, 2014, J NEUROTRAUM, V31, P1313, DOI 10.1089/neu.2013.3292; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; British Society of Rehabilitation Medicine, 2013, SPEC REH TRAUM PATHW; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Godbolt AK, 2014, J HEAD TRAUMA REHABI; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Loser C, 2005, CLIN NUTR, V24, P848, DOI 10.1016/j.clnu.2005.06.013; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Perkes IE, 2011, BRAIN INJURY, V25, P925, DOI 10.3109/02699052.2011.589797; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Praeger AJ, 2012, CRIT CARE RESUSC, V14, P10; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Scrimgeour AG, 2014, J NEUROTRAUM, V31, P989, DOI 10.1089/neu.2013.3234; Socialstyrelsen, 2012, REH PERS MED TRAUM H; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	26	27	29	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2015	5	4							e007208	10.1136/bmjopen-2014-007208			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI4GB	WOS:000354705000065	25941181	Green Published, gold			2022-02-06	
J	Ooi, YY; Dheen, ST; Tay, SSW				Ooi, Yin Yin; Dheen, S. Thameem; Tay, Samuel Sam Wah			Paracrine Effects of Mesenchymal Stem Cells-Conditioned Medium on Microglial Cytokines Expression and Nitric Oxide Production	NEUROIMMUNOMODULATION			English	Article						Mesenchymal stem cells; Microglia; Conditioned medium; Cytokines	TRAUMATIC BRAIN-INJURY; UMBILICAL-CORD BLOOD; BONE-MARROW; INTRACEREBRAL TRANSPLANTATION; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; BV2 MICROGLIA; SYNTHASE; MECHANISMS; LIPOPOLYSACCHARIDE	Background/Aim: Microglia, the resident macrophages in the central nervous system, secrete various proinflammatory cytokines and undergo proliferation upon activation in various neurodegenerative diseases. Activation of microglia has been implicated in exacerbation of various neurodegenerative diseases. Recently, it has been proposed that mesenchymal stem cells (MSC) have immunosuppressive properties and the potential to moderate inflammation. This study aimed to elucidate the effects of MSC-conditioned medium (MSC-CM) in modulating microglial activation by analyzing microglial proinflammatory and anti-inflammatory factors [interleukin (IL)-6, tumor necrosis factor (TNF)-alpha, inducible nitric oxide synthase (iNOS) and IL-10], signaling pathway molecules [NF kappa B, c-Jun N-terminal kinase (JNK) and MKP-1) and NO production. Methods: Immortalized murine microglia cell line, BV2 microglia and primary microglia isolated from C57BL/6 mouse pup brains were used in this study. Mouse MSC were isolated from the male C57BL/6 mouse tibia and fibula. The effects of MSC-CM on the expression of inflammatory cytokines and signaling molecules in microglia were elucidated using RT-PCR, immunofluorescence analysis and Western blot analysis. NO production in microglia was assessed using a Griess kit. Results: MSC-CM significantly reduced the mRNA and protein expression levels of proinflammatory cytokines (IL-6 and TNF-alpha) in microglia activated by lipopolysaccharide (LPS). In addition, MSC-CM significantly reduced the protein expression of NF kappa B, JNK and c-Jun, but increased the expression levels of IL-10 and MKP-1 in activated BV2 microglia. NO production and iNOS expression by BV2 microglia in MSC-CM were increased. Conclusions: Overall, our findings suggest that MSC immunomodulate microglial activities through paracrine effects. (C) 2014 S. Karger AG, Basel	[Ooi, Yin Yin; Dheen, S. Thameem; Tay, Samuel Sam Wah] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117594, Singapore		Tay, SSW (corresponding author), Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, MD10,4 Med Dr, Singapore 117594, Singapore.	samuel_tay@nuhs.edu.sg	Dheen, S. Thameem/AAU-8627-2020	Dheen, S. Thameem/0000-0001-9600-6789	Singapore Ministry of EducationMinistry of Education, Singapore [R-181-000-128-112]; Singapore National University Health System Seed Grant [R-181-000-151-750]	This study was supported by the Singapore Ministry of Education (R-181-000-128-112) and Singapore National University Health System Seed Grant (R-181-000-151-750). We thank Parakalan Rangarajan for providing critical comments about the manuscript.	Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Barker Roger A, 2004, NeuroRx, V1, P472, DOI 10.1007/BF03206631; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Cipriani R, 2011, J NEUROSCI, V31, P16327, DOI 10.1523/JNEUROSCI.3611-11.2011; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; DEMERLEPALLARDY C, 1993, LIFE SCI, V52, P1883, DOI 10.1016/0024-3205(93)90009-R; Emborg ME, 2013, CELL TRANSPLANT, V22, P831, DOI 10.3727/096368912X647144; Fouraschen SMG, 2012, STEM CELLS DEV, V21, P2410, DOI 10.1089/scd.2011.0560; Gaetani P, 2013, J NEUROSURG SCI, V57, P55; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Giunti D, 2012, STEM CELLS, V30, P2044, DOI 10.1002/stem.1174; Huo YQ, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-49; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Kim YJ, 2009, GLIA, V57, P13, DOI 10.1002/glia.20731; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lee HJ, 2012, NEUROBIOL AGING, V33, P588, DOI 10.1016/j.neurobiolaging.2010.03.024; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Ling E A, 2001, Prog Brain Res, V132, P61; Magnusson S, 1996, NEUROREPORT, V7, P2046, DOI 10.1097/00001756-199608120-00039; Muller I, 2008, CURR OPIN ORGAN TRAN, V13, P639, DOI 10.1097/MOT.0b013e328317a462; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Nikolic WV, 2008, STEM CELLS DEV, V17, P423, DOI 10.1089/scd.2008.0018; Ooi YY, 2010, INT IMMUNOPHARMACOL, V10, P1532, DOI 10.1016/j.intimp.2010.09.001; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Parekkadan B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000941; Peunova N, 1996, COLD SPRING HARB SYM, V61, P417; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Rahmat Z, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt160; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Sarojini H, 2008, J CELL BIOCHEM, V104, P1793, DOI 10.1002/jcb.21748; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; Sun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072926; Timmers L, 2011, STEM CELL RES, V6, P206, DOI 10.1016/j.scr.2011.01.001; Trounson A, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-52; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Waetzig V, 2005, GLIA, V50, P235, DOI 10.1002/glia.20173; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Wieseler-Frank J, 2005, NEUROSIGNALS, V14, P166, DOI 10.1159/000087655; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x; Zhu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035125	51	27	28	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2015	22	4					233	242		10.1159/000365483			10	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	CG8NE	WOS:000353564000003	25341618				2022-02-06	
J	Pokorna, P; Wildschut, ED; Vobruba, V; van den Anker, JN; Tibboel, D				Pokorna, P.; Wildschut, E. D.; Vobruba, V.; van den Anker, John N.; Tibboel, D.			The Impact of Hypothermia on the Pharmacokinetics of Drugs Used in Neonates and Young Infants	CURRENT PHARMACEUTICAL DESIGN			English	Article						Hypothermia; pharmacokinetics; pharmacodynamics; pharmacogenomics; developmental pharmacology; absorption; distribution; metabolism; and excretion; neonates; infants; covariates; asphyxia; sepsis; multiorgan dysfunction syndrome; cardiac arrest	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; WHOLE-BODY HYPOTHERMIA; TRAUMATIC BRAIN-INJURY; REGIONAL BLOOD-FLOW; MILD THERAPEUTIC HYPOTHERMIA; CEREBRAL ENERGY-METABOLISM; HOSPITAL CARDIAC-ARREST; CARDIOPULMONARY BYPASS; GENTAMICIN PHARMACOKINETICS; RENAL-FUNCTION	Therapeutic hypothermia (HT) is frequently used in neonates with hypoxic-ischemic encephalopathy and young infants during cardiopulmonary bypass (CPB). Hypothermia and CPB result in physiological changes contributing to pharmacokinetic (PK) and pharmacodynamic (PD) changes. Changes in the absorption, the volume of distribution (Vd) and the total body clearance (CL) of drugs used during hypothermia and CPB might lead to the interindividual PK variability resulting in either insufficient or toxic plasma concentrations and have an impact on the biodisposition and action of drugs. Both under-or overdosing of medicines in these critically ill patients may contribute to a worse overall outcome. Overall, hypothermia decreases CL but may decrease or increase Vd by changing intravascular blood volume, organ perfusion and enzymatic metabolic processes. In addition, maturational as well as organ specific changes may occur during hypothermia superimposed on the underlying disease and/or procedures such as extracorporeal membrane oxygenation (ECMO) or CPB. This paper will provide an overview of variables and potential covariates (e.g., asphyxia, sepsis, multiorgan dysfunction syndrome, cardiac arrest) determining the PK of frequently used drugs. In addition, the effects of hypothermia on individual drugs are described as well as alternative ways for future study designs such as the use of population PK-PD and opportunistic sampling. Ultimately, these investigations are warranted to obtain specific dosing nomograms of medicines for use in clinical practice and to improve the treatment results of this vulnerable group of pediatric patients.	[Pokorna, P.; Vobruba, V.; Tibboel, D.] Charles Univ Prague, Intens Care Unit, Dept Pediat, Gen Fac Hosp,Fac Med 1, Prague, Czech Republic; [Pokorna, P.; Wildschut, E. D.; van den Anker, John N.; Tibboel, D.] Erasmus MC Sophia Childrens Hosp, Intens Care, NL-3015 GJ Rotterdam, Netherlands; [Pokorna, P.; Wildschut, E. D.; van den Anker, John N.; Tibboel, D.] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, NL-3015 GJ Rotterdam, Netherlands; [Pokorna, P.; Vobruba, V.] Charles Univ Prague, Dept Pharmacol, Gen Univ Hosp, Fac Med 1, Prague 12800 2, Czech Republic; [van den Anker, John N.] Childrens Natl Med Ctr, Div Pediat Clin Pharmacol, Washington, DC 20010 USA; [van den Anker, John N.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [van den Anker, John N.] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20052 USA; [van den Anker, John N.] George Washington Univ, Sch Med & Hlth Sci, Dept Pharmacol, Washington, DC 20052 USA; [van den Anker, John N.] George Washington Univ, Sch Med & Hlth Sci, Dept Physiol, Washington, DC 20052 USA; [van den Anker, John N.] Univ Childrens Hosp Basel, Dept Paediat Pharmacol, Basel, Switzerland		Tibboel, D (corresponding author), Erasmus MC Sophia Childrens Hosp, Intens Care, Dr Molewaterplein 60, NL-3015 GJ Rotterdam, Netherlands.	d.tibboel@erasmusmc.nl	Pokorna, Pavla/N-3785-2017; Vobruba, Vaclav/N-6378-2017	Pokorna, Pavla/0000-0001-6803-7350; Vobruba, Vaclav/0000-0001-9148-8467; Vobruba, Vaclav/0000-0001-9476-0614	Erasmus Medical Center, Rotterdam the NetherlandsNetherlands Government	Dr. P. Pokorna is supported by an unrestricted research grant of Erasmus Medical Center, Rotterdam the Netherlands.	Abend NS, 2012, PEDIATR CRIT CARE ME, V13, P32, DOI 10.1097/PCC.0b013e3182196a7b; AKINBI H, 1994, J PEDIATR-US, V125, P625, DOI 10.1016/S0022-3476(94)70024-9; ALCARAZ C, 1989, CLIN EXP PHARMACOL P, V16, P367, DOI 10.1111/j.1440-1681.1989.tb01573.x; ALCARAZ C, 1989, ARCH INT PHARMACOD T, V297, P133; Allegaert K, 2007, BRIT J ANAESTH, V99, P864, DOI 10.1093/bja/aem294; Allegaert K, 2006, ARCH DIS CHILD, V91, P451; Allegaert K, 2004, BIOL NEONATE, V86, P207, DOI 10.1159/000079618; Allegaert K, 2010, NEONATAL PEDIAT PHAR, P194; Allegaert K, 2013, EUR J PEDIATR, V172, P429, DOI 10.1007/s00431-012-1734-4; Allegaert K, 2012, J MATERN-FETAL NEO M, V25, P1678, DOI 10.3109/14767058.2012.657277; Allegaert K, 2011, PEDIATR ANESTH, V21, P266, DOI 10.1111/j.1460-9592.2010.03389.x; Allegaert K, 2007, CURR CLIN PHARMACOL, V2, P23, DOI 10.2174/157488407779422294; Alonso-Spilsbury M, 2005, ANIM REPROD SCI, V90, P1, DOI 10.1016/j.anireprosci.2005.01.007; Alonso-Spilsbury M, 2004, ANIM REPROD SCI, V84, P157, DOI 10.1016/j.anireprosci.2003.11.002; Amaker RD, 1996, ANTIMICROB AGENTS CH, V40, P1139, DOI 10.1128/AAC.40.5.1139; Anand KJS, 2008, BRIT J ANAESTH, V101, P680, DOI 10.1093/bja/aen248; Anderson BJ, 2002, ANESTHESIOLOGY, V96, P1336, DOI 10.1097/00000542-200206000-00012; ARANDA JV, 1979, SCIENCE, V206, P1319, DOI 10.1126/science.515734; Arpino PA, 2008, PHARMACOTHERAPY, V28, P102, DOI 10.1592/phco.28.1.102; Askenazi DJ, 2012, J PEDIATR-US, V161, P270, DOI 10.1016/j.jpeds.2012.02.007; Atkins DL, 2009, CIRCULATION, V119, P1484, DOI 10.1161/CIRCULATIONAHA.108.802678; Atkins DL, 2006, PEDIATRICS, V117, pE1005, DOI 10.1542/peds.2006-0346; Azzopardi D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-17; Baltagi S, 2011, PEDIATR CRIT CARE ME, V12, P370, DOI 10.1097/PCC.0b013e3181e8b7ef; BANSINATH M, 1988, J CLIN PHARMACOL, V28, P860, DOI 10.1002/j.1552-4604.1988.tb03229.x; Barks JD, 2010, PEDIATR RES, V67, P532, DOI 10.1203/PDR.0b013e3181d4ff4d; Bartelink IH, 2006, CLIN PHARMACOKINET, V45, P1077, DOI 10.2165/00003088-200645110-00003; BEAUFORT AM, 1995, EUR J ANAESTH, V12, P95; Bell SG, 2012, NEONATAL NETW, V31, P48, DOI 10.1891/0730-0832.31.1.48; Berger R, 1999, BRAIN RES REV, V30, P107, DOI 10.1016/S0165-0173(99)00009-0; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bhagat H, 2006, J CLIN NEUROSCI, V13, P953, DOI 10.1016/j.jocn.2005.09.018; Bhalla T, 2012, PEDIATR ANESTH, V22, P627, DOI 10.1111/j.1460-9592.2012.03842.x; BHAT R, 1990, J PEDIATR-US, V117, P477, DOI 10.1016/S0022-3476(05)81102-3; Bisschops LLA, 2012, CRIT CARE MED, V40, P1136, DOI 10.1097/CCM.0b013e3182377050; Bjelland TW, 2013, DRUG METAB DISPOS, V41, P214, DOI 10.1124/dmd.112.045567; Blake MJ, 2005, SEMIN FETAL NEONAT M, V10, P123, DOI 10.1016/j.siny.2004.11.001; Bourdages M, 2010, PEDIATR CRIT CARE ME, V11, P408, DOI 10.1097/PCC.0b013e3181c51dea; Bouwmeester NJ, 2004, BRIT J ANAESTH, V92, P208, DOI 10.1093/bja/aeh042; Bouwmeester NJ, 2003, BRIT J ANAESTH, V90, P642, DOI 10.1093/bja/aeg121; Buck ML, 1998, PHARMACOTHERAPY, V18, P1082; Buonocore G, 2012, CURR PHARM DESIGN, V18, P3086, DOI 10.2174/1381612811209023086; Caldwell JE, 2000, ANESTHESIOLOGY, V92, P84, DOI 10.1097/00000542-200001000-00018; Capparelli E., 2010, NEONATAL PEDIAT PHAR, P819; Capparelli EV, 2001, J CLIN PHARMACOL, V41, P927, DOI 10.1177/00912700122010898; Ceelie I, 2013, JAMA-J AM MED ASSOC, V309, P149, DOI 10.1001/jama.2012.148050; Chambers D W, 2000, J Am Coll Dent, V67, P2; CHAY PCW, 1992, CLIN PHARMACOL THER, V51, P334, DOI 10.1038/clpt.1992.30; COHN HE, 1974, AM J OBSTET GYNECOL, V120, P817, DOI 10.1016/0002-9378(74)90587-0; COOMBS RC, 1990, ARCH DIS CHILD-FETAL, V65, P1067, DOI 10.1136/adc.65.10_Spec_No.1067; Corneli HM, 2012, PEDIATR EMERG CARE, V28, P475, DOI 10.1097/PEC.0b013e3182539098; Coskun KO, 2010, ARTIF ORGANS, V34, P1026, DOI 10.1111/j.1525-1594.2010.01156.x; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; De Cock RFW, 2011, EUR J CLIN PHARMACOL, V67, pS5, DOI 10.1007/s00228-009-0782-9; de Haan TR, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-45; De Paepe P, 2002, CLIN PHARMACOKINET, V41, P1135, DOI 10.2165/00003088-200241140-00002; de Toledo JS, 2010, PEDIATR CRIT CARE ME, V11, P439, DOI 10.1097/PCC.0b013e3181c510e9; de Wildt SN, 2001, CLIN PHARMACOL THER, V70, P525, DOI 10.1067/mcp.2001.120683; de Wildt SN, 1999, CLIN PHARMACOKINET, V37, P485, DOI 10.2165/00003088-199937060-00004; DELIN NA, 1965, J THORAC CARDIOV SUR, V49, P511, DOI 10.1016/S0022-5223(19)33287-8; Donoghue A, 2009, PEDIATRICS, V124, P1541, DOI 10.1542/peds.2009-0727; DRISCOLL DJ, 1987, CLIN PERINATOL, V14, P931, DOI 10.1016/S0095-5108(18)30741-3; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Empey PE, 2012, CRIT CARE MED, V40, P1221, DOI 10.1097/CCM.0b013e31823779f9; Faura CC, 1998, PAIN, V74, P43, DOI 10.1016/S0304-3959(97)00142-5; Field DJ, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-24; Filippi L, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-144; Filippi L, 2011, EPILEPSIA, V52, P794, DOI 10.1111/j.1528-1167.2011.02978.x; Filippi L, 2010, J PEDIATR-US, V157, P361, DOI 10.1016/j.jpeds.2010.04.019; Filippi L, 2009, EPILEPSIA, V50, P2355, DOI 10.1111/j.1528-1167.2009.02302.x; Fink EL, 2010, PEDIATR CRIT CARE ME, V11, P66, DOI 10.1097/PCC.0b013e3181c58237; Fox JL, 2010, CAN J EMERG MED, V12, P355; FRANK SM, 1995, ANESTHESIOLOGY, V82, P83, DOI 10.1097/00000542-199501000-00012; FRIEDMAN WF, 1985, J PEDIATR-US, V106, P697, DOI 10.1016/S0022-3476(85)80339-5; Fries M, 2012, CRIT CARE MED, V40, P1297, DOI 10.1097/CCM.0b013e31823c8ce7; Fritz HG, 2005, ANESTH ANALG, V100, P996, DOI 10.1213/01.ANE.0000146517.17910.54; Frymoyer A, 2013, J PERINATOL, V33, P778, DOI 10.1038/jp.2013.59; Frymoyer A, 2013, PHARMACOTHERAPY, V33, P718, DOI 10.1002/phar.1263; Fukuoka N, 2004, RESUSCITATION, V60, P225, DOI 10.1016/j.resuscitation.2003.09.017; Gebauer CM, 2006, PEDIATRICS, V117, P843, DOI 10.1542/peds.2004-1587; Geiduschek JM, 1997, CRIT CARE MED, V25, P360, DOI 10.1097/00003246-199702000-00027; Gluckman P D, 2001, Semin Neonatol, V6, P109, DOI 10.1053/siny.2001.0042; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Godambe S V, 1997, Indian Pediatr, V34, P927; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; GORODISCHER R, 1976, CLIN PHARMACOL THER, V19, P256; GUIGNARD JP, 1982, PEDIATR CLIN N AM, V29, P777; Guignard JP, 1997, ACTA PAEDIATR, V86, P1040, DOI 10.1111/j.1651-2227.1997.tb14802.x; Gupta BD, 2005, INDIAN PEDIATR, V42, P928; HAM J, 1978, ANESTHESIOLOGY, V49, P324, DOI 10.1097/00000542-197811000-00005; Hammerman C, 1998, CLIN PERINATOL, V25, P757, DOI 10.1016/S0095-5108(18)30110-6; Hartling L, 2011, CLIN PHARMACOL THER, V90, P727, DOI 10.1038/clpt.2011.212; Hofer N, 2012, J PERINAT MED, V0, P1; HOIE EB, 1990, CLIN PHARMACY, V9, P711; Holzer M, 2002, NEW ENGL J MED, V346, P549; Horan MR, 2004, J PEDIATR-US, V144, P301, DOI 10.1016/j.jpeds.2003.11.034; HORROW JC, 1983, ANESTHESIOLOGY, V58, P357, DOI 10.1097/00000542-198304000-00010; Hostler D, 2010, DRUG METAB DISPOS, V38, P781, DOI 10.1124/dmd.109.031377; Ichiba S, 2003, ARCH DIS CHILD-FETAL, V88, pF128, DOI 10.1136/fn.88.2.F128; Inder T E, 2000, Semin Neonatol, V5, P3, DOI 10.1053/siny.1999.0112; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; JONES JH, 1962, J PATHOL BACTERIOL, V84, P428, DOI 10.1002/path.1700840218; KADAR D, 1982, CAN ANAESTH SOC J, V29, P16, DOI 10.1007/BF03007942; KALSER SC, 1969, J PHARMACOL EXP THER, V170, P145; Kart T, 1997, PAEDIATR ANAESTH, V7, P5, DOI 10.1046/j.1460-9592.1997.d01-30.x; Kaufmann R., 2010, NEONATAL PEDIAT PHAR, P20; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; KERN FH, 1991, ANESTH ANALG, V72, P487; Kirkham F, 2011, EUR J PAEDIATR NEURO, V15, P379, DOI 10.1016/j.ejpn.2011.04.009; Kleinman ME, 2010, CIRCULATION, V122, P8466, DOI [10.1161/CIRCULATIONAHA.110.971093, 10.1542/peds.2010-2972A]; Knibbe CAJ, 2011, EXPERT OPIN DRUG MET, V7, P1, DOI 10.1517/17425255.2011.539201; Koren G, 1997, CLIN CHEM, V43, P222; KOREN G, 1985, CRIT CARE MED, V13, P844, DOI 10.1097/00003246-198510000-00014; KOREN G, 1987, EUR J CLIN PHARMACOL, V32, P373, DOI 10.1007/BF00543972; KOSKA AJ, 1981, CLIN PHARMACOL THER, V29, P100, DOI 10.1038/clpt.1981.16; Kramer C, 2012, NEUROLOGIST, V18, P173, DOI 10.1097/NRL.0b013e318253f8ef; Krekels EHJ, 2011, CLIN PHARMACOKINET, V50, P51, DOI 10.2165/11536750-000000000-00000; Kuppens M, 2012, J MATERN-FETAL NEO M, V25, P978, DOI 10.3109/14767058.2011.602144; Kussman BD, 2005, J CARDIOTHOR VASC AN, V19, P316, DOI 10.1053/j.jvca.2005.03.008; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; LAZENBY WD, 1992, ANN THORAC SURG, V53, P957, DOI 10.1016/0003-4975(92)90367-D; Lee CR, 2002, CLIN PHARMACOL THER, V72, P562, DOI 10.1067/mcp.2002.127913; Leeder J., 2010, NEONATAL PEDIAT PHAR, P46; LESLIE K, 1995, ANESTH ANALG, V80, P1007, DOI 10.1097/00000539-199505000-00027; Lingvall M, 2005, BRIT J CLIN PHARMACO, V59, P54, DOI 10.1111/j.1365-2125.2005.02260.x; Liu MZ, 2001, ANESTHESIOLOGY, V94, P429, DOI 10.1097/00000542-200103000-00011; Liu X, 2009, PEDIATRICS, V124, P310, DOI 10.1542/peds.2008-2942; Liu YQ, 2012, PEDIATR RES, V71, P559, DOI 10.1038/pr.2012.7; Lynn A, 1998, ANESTH ANALG, V86, P958, DOI 10.1097/00000539-199805000-00008; Madadi P, 2007, CAN FAM PHYSICIAN, V53, P33; Mallet ML, 2002, QJM-INT J MED, V95, P775, DOI 10.1093/qjmed/95.12.775; Mark LF, 2013, THER DRUG MONIT, V35, P872, DOI 10.1097/FTD.0b013e318299f660; Mark LF, 2013, THER DRUG MONIT, V35, P217, DOI 10.1097/FTD.0b013e3182834335; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; MARTINANCEL A, 1995, J PEDIATR-US, V127, P786, DOI 10.1016/S0022-3476(95)70174-5; Martinkova J, 2010, CLIN THER, V32, P2400, DOI 10.1016/j.clinthera.2011.01.013; Massaro A, 2010, J PEDIAT, V157; Massaro A, 2010, J PEDIATR-US, V157, P499, DOI 10.1016/j.jpeds.2010.04.011; Mathew PJ, 2009, PERFUSION-UK, V24, P27, DOI 10.1177/0267659109106071; Mathur N. B., 2006, Indian Journal of Pediatrics, V73, P499, DOI 10.1007/BF02759894; MCCANCE RA, 1954, COLD SPRING HARB SYM, V19, P161, DOI 10.1101/SQB.1954.019.01.022; MCCRACKEN GH, 1978, PEDIATRICS, V62, P738; Mercer JM, 2010, PHARMACOTHERAPY, V30, P654, DOI 10.1592/phco.30.7.654; MERETOJA OA, 1989, BRIT J ANAESTH, V62, P184, DOI 10.1093/bja/62.2.184; MERETOJA OA, 1989, ANESTH ANALG, V68, P20; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MILLER RD, 1978, J PHARMACOL EXP THER, V207, P532; Mommsen P, 2013, INJURY, V44, P86, DOI 10.1016/j.injury.2011.10.013; MOORE RD, 1984, J INFECT DIS, V149, P443, DOI 10.1093/infdis/149.3.443; Mulla H, 2005, BRIT J CLIN PHARMACO, V60, P265, DOI 10.1111/j.1365-2125.2005.02432.x; Newland M C, 1989, J Cardiothorac Anesth, V3, P407, DOI 10.1016/S0888-6296(89)97315-8; Ohri SK, 1997, ANN THORAC SURG, V64, P163, DOI 10.1016/S0003-4975(97)00290-7; OLSEN GD, 1975, CLIN PHARMACOL THER, V17, P31; Orozco-Gregorio H, 2010, AM J VET RES, V71, P1214, DOI 10.2460/ajvr.71.10.1214; Pacifici G, 2009, EUR J CLIN PHARMACOL, V65, P191, DOI 10.1007/s00228-008-0562-y; Pacifici GM, 2012, CLINICS, V67, P831, DOI 10.6061/clinics/2012(07)21; Pacifici G, 2009, EUR J CLIN PHARMACOL, V65, P419, DOI 10.1007/s00228-008-0599-y; PALMER CM, 1993, ANESTH ANALG, V76, P457; Perlman JM, 2006, CLIN PERINATOL, V33, P335, DOI 10.1016/j.clp.2006.03.004; Perrone S, 2012, J MATERN-FETAL NEO M, V25, P83, DOI 10.3109/14767058.2012.663168; PETITTI DB, 1985, J CHRON DIS, V38, P581, DOI 10.1016/0021-9681(85)90047-5; PETROS A, 1995, ANESTH ANALG, V81, P458, DOI 10.1097/00000539-199509000-00005; Pettifer GR, 2004, VET ANAESTH ANALG, V31, P109, DOI 10.1111/j.1467-2987.2004.00158.x; Pietrini D, 2012, CURR DRUG TARGETS, V13, P925, DOI 10.2174/138945012800675641; Poloyac SM, 2013, PEDIATR CRIT CARE ME, V14, P228, DOI 10.1097/PCC.0b013e31826775cd; Powell RW, 1999, J PEDIATR SURG, V34, P193, DOI 10.1016/S0022-3468(99)90255-5; PUIG MM, 1987, BRIT J ANAESTH, V59, P1459, DOI 10.1093/bja/59.11.1459; Quaedackers JS, 2004, J PHYSIOL-LONDON, V557, P1033, DOI 10.1113/jphysiol.2004.062554; Quaedackers JS, 2004, AM J PHYSIOL-REG I, V286, pR576, DOI 10.1152/ajpregu.00592.2003; Rajska-Neumann Agnieszka, 2004, Przegl Lek, V61, P401; Rakhmanina NY, 2006, ADV DRUG DELIVER REV, V58, P4, DOI 10.1016/j.addr.2005.12.001; Rane A., 2010, NEONATAL PEDIAT PHAR, P31; Reed MD, 2002, PEDIAT INFECT DIS PR, P147; Rocha Milagros, 2012, Infectious Disorders - Drug Targets, V12, P161; Roka A, 2008, PEDIATRICS, V121, pE844, DOI 10.1542/peds.2007-1987; Saarenmaa E, 2000, CLIN PHARMACOL THER, V68, P160, DOI 10.1067/mcp.2000.108947; Samiee S, 2013, THER DRUG MONIT, V35, P872, DOI 10.1097/FTD.0b013e318296bcfe; Sando Mitsuru, 2004, Journal of Infection and Chemotherapy, V10, P280, DOI 10.1007/s10156-004-0339-x; Sarkar S, 2012, J PERINATOL, V32, P15, DOI 10.1038/jp.2011.41; Satas S, 2000, BIOL NEONATE, V77, P50; SCHAIBLE DH, 1982, J PEDIATR-US, V100, P655, DOI 10.1016/S0022-3476(82)80780-4; Shah P, 2004, ARCH DIS CHILD-FETAL, V89, P152, DOI 10.1136/adc.2002.023093; Shah PS, 2010, SEMIN FETAL NEONAT M, V15, P238, DOI 10.1016/j.siny.2010.02.003; Shah Sachin, 2004, J Perinatol, V24, P16, DOI 10.1038/sj.jp.7211023; Shank RP, 2000, EPILEPSIA, V41, pS3, DOI 10.1111/j.1528-1157.2000.tb06045.x; Shankaran S, 2008, PEDIATRICS, V122, pE791, DOI 10.1542/peds.2008-0456; Shankaran S, 2012, NEW ENGL J MED, V366, P2085, DOI 10.1056/NEJMoa1112066; Shellhaas RA, 2013, PEDIATR CRIT CARE ME, V14, P194, DOI 10.1097/PCC.0b013e31825bbbc2; SIMANTOV R, 1976, MOL PHARMACOL, V12, P977; Simbruner G, 2010, PEDIATRICS, V126, pE771, DOI 10.1542/peds.2009-2441; Smits A, 2012, CURR PHARM DESIGN, V18, P3119, DOI 10.2174/1381612811209023119; Statler KD, 2010, PEDIATR CRIT CARE ME, V11, P151, DOI 10.1097/PCC.0b013e3181c0115a; Stravitz RT, 2009, CRIT CARE MED, V37, pS258, DOI 10.1097/CCM.0b013e3181aa5fb8; Thoresen M, 2000, PEDIATRICS, V106, P92, DOI 10.1542/peds.106.1.92; Thoresen M, 2008, CLIN PERINATOL, V35, P749, DOI 10.1016/j.clp.2008.07.018; THORNBERG E, 1995, ACTA PAEDIATR, V84, P927, DOI 10.1111/j.1651-2227.1995.tb13794.x; Ting JY, 2015, INDIAN J PEDIATR, V82, P119, DOI 10.1007/s12098-014-1527-z; Topjian A, 2011, PEDIATR CRIT CARE ME, V12, pE127, DOI 10.1097/PCC.0b013e3181e28717; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Touw DJ, 2009, CLIN PHARMACOKINET, V48, P71, DOI [10.2165/00003088-200948020-00001, 10.2165/0003088-200948020-00001]; Trentzsch H, 2012, SHOCK, V37, P131, DOI 10.1097/SHK.0b013e318245f6b2; UTLEY JR, 1982, ANN THORAC SURG, V33, P250, DOI 10.1016/S0003-4975(10)61920-0; van den Anker JN, 2012, CURR PHARM DESIGN, V18, P3114, DOI 10.2174/1381612811209023114; van den Anker Johannes N, 2011, Handb Exp Pharmacol, V205, P51, DOI 10.1007/978-3-642-20195-0_2; van den Broek MPH, 2012, CLIN PHARMACOKINET, V51, P671, DOI 10.1007/s40262-012-0004-y; van den Broek MPH, 2015, NEONATOLOGY, V107, P150, DOI 10.1159/000368180; van den Broek MPH, 2013, ARCH DIS CHILD-FETAL, V98, pF341, DOI 10.1136/archdischild-2012-302678; van den Broek MPH, 2010, CLIN PHARMACOKINET, V49, P277, DOI 10.2165/11319360-000000000-00000; van Saet A, 2013, CURR CLIN PHARMACOL, V8, P297, DOI 10.2174/15748847113089990067; VANDENANKER JN, 1995, PEDIATR RES, V38, P808, DOI 10.1203/00006450-199511000-00028; VANDENANKER JN, 1995, BRIT J CLIN PHARMACO, V40, P439; VandenAnker JN, 1997, CRIT CARE MED, V25, P1933, DOI 10.1097/00003246-199711000-00039; vandenAnker JN, 1996, ACTA PAEDIATR, V85, P1393, DOI 10.1111/j.1651-2227.1996.tb13942.x; Vargha R, 2012, INDIAN PEDIATR, V49, P60; Vergnano S, 2005, ARCH DIS CHILD-FETAL, V90, P220, DOI 10.1136/adc.2002.022863; Vet NJ, 2011, DRUG DISCOV TODAY, V16, P435, DOI 10.1016/j.drudis.2011.02.014; VOLPE JJ, 1976, PEDIATR CLIN N AM, V23, P383; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; von Tavel L, 2005, DEUT TIERARZTL WOCH, V112, P443; Wang CG, 2012, PHARM RES-DORDR, V29, P1570, DOI 10.1007/s11095-012-0668-x; Whitelaw A, 2001, LANCET, V358, P36, DOI 10.1016/S0140-6736(00)05269-7; Wildschut ED, 2010, INTENS CARE MED, V36, P2109, DOI 10.1007/s00134-010-2041-z; Wildschut ED, 2012, PEDIATR CLIN N AM, V59, P1183, DOI 10.1016/j.pcl.2012.07.013; WILLIAMS CE, 1993, CLIN PERINATOL, V20, P305, DOI 10.1016/S0095-5108(18)30395-6; Williams GD, 1997, PEDIATR RES, V42, P700, DOI 10.1203/00006450-199711000-00024; Withington D, 2000, CAN J ANAESTH, V47, P1188, DOI 10.1007/BF03019867; Withington D, 2011, PEDIATR ANESTH, V21, P341, DOI 10.1111/j.1460-9592.2010.03514.x; Yager JY, 1996, STROKE, V27, P919, DOI 10.1161/01.STR.27.5.919; Yoshitani K, 2003, BRIT J ANAESTH, V90, P122, DOI 10.1093/bja/aeg010; Yu RG, 2001, BRIT J ANAESTH, V86, P338, DOI 10.1093/bja/86.3.338; Zalzstein E., 2010, NEONATAL PEDIAT PHAR, P610; Zanelli S, 2011, J PERINATOL, V31, P377, DOI 10.1038/jp.2010.146; Zhao W, 2013, BRIT J CLIN PHARMACO, V75, P1068, DOI 10.1111/j.1365-2125.2012.04406.x; Zhou JQ, 2011, DRUG METAB DISPOS, V39, P2209, DOI 10.1124/dmd.111.040642; Zhou JQ, 2011, EXPERT OPIN DRUG MET, V7, P803, DOI 10.1517/17425255.2011.574127; Zhou JX, 2002, CHINESE MED J-PEKING, V115, P1014; Zhou JX, 2001, ANESTH ANALG, V93, P234	237	27	28	1	9	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2015	21	39					5705	5724		10.2174/1381612821666150901110929			20	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CW5OF	WOS:000365044900012	26323408				2022-02-06	
J	Salgado, ASI; Zangaro, RA; Parreira, RB; Kerppers, II				Salgado, Afonso S. I.; Zangaro, Renato A.; Parreira, Rodolfo B.; Kerppers, Ivo I.			The effects of transcranial LED therapy (TCLT) on cerebral blood flow in the elderly women	LASERS IN MEDICAL SCIENCE			English	Article						Cerebrovascular blood flow; Elderly people; Light emitting diode; Transcranial Doppler ultrasound	TRAUMATIC BRAIN-INJURY; LEVEL LASER THERAPY; NEAR-INFRARED LIGHT; DOPPLER ULTRASOUND; PERFORMANCE; STROKE; INDEX; MICE; DEPRESSION; PRESSURE	During aging processes, there is a range of functional changes, where we can highlight the disease related to the central nervous system, such as Alzheimer disease and others forms of dementia. This study investigated the effects of transcranial light emitting diode (LED) on cerebral blood flow in healthy elderly women analyzed by transcranial Doppler ultrasound (TCD) of the right and left middle cerebral artery and basilar artery. Twenty-five noninstitutionalized elderly women (mean age 72 years old), with a cognitive status > 24, were assessed using transcranial Doppler ultrasound on two separate occasions: pre-irradiation and post-transcranial LED therapy (TCLT). Prior to this, they answered two questionnaires: the perceived stress scale and the general health questionnaire. TCLT (627 nm, 70 mW/cm(2), 10 J/cm(2)) was performed at four points of the frontal and parietal region for 30 s each, totaling 120 s two times per week for 4 weeks. Paired t-test results showed that there was a significant improvement after TCLT with increase in the systolic and diastolic velocity of the left middle cerebral artery (25 and 30 %, respectively) and basilar artery (up to 17 and 25 %), as well as a decrease in the pulsatility index and resistance index values of the three cerebral arteries analyzed (p < 0.05). TCD parameters showed improvement in the blood flow on the arteries analyzed. TCLT promoted a blood and vasomotor behavior of the basilar and middle cerebral arteries in healthy elderly women.	[Salgado, Afonso S. I.; Zangaro, Renato A.] Univ Camilo Castelo Branco, Inst Biomed Engn, Unicastelo, BR-12247004 Sao Paulo, Brazil; [Salgado, Afonso S. I.; Parreira, Rodolfo B.] Sch Postural & Manual Therapy, BR-86015300 Londrina, Parana, Brazil; [Zangaro, Renato A.] CITE, BR-12245650 Sao Paulo, Brazil; [Kerppers, Ivo I.] Univ Estadual Centro Oeste, Physiotherapy Course, Lab Neuroanat & Neurophysiol, BR-85040080 Guarapuava, Parana, Brazil		Salgado, ASI (corresponding author), Univ Camilo Castelo Branco, Inst Biomed Engn, Unicastelo, BR-12247004 Sao Paulo, Brazil.	afonsosisalgado@yahoo.com.br	Kerppers, Ivo Ilvan/ABF-8157-2020; Parreira, Rodolfo/AAH-6459-2019; Parreira, Rodolfo B/L-9793-2016; Kerppers, Ivo Ilvan/AAF-2075-2019; Zangaro, Renato/K-5961-2015	Parreira, Rodolfo/0000-0003-2597-1172; Parreira, Rodolfo B/0000-0003-2597-1172; Zangaro, Renato/0000-0001-6962-3001			Akinyemi RO, 2013, CURR ALZHEIMER RES, V10, P642; Akiyama H, 1997, J NEUROL SCI, V152, P39, DOI 10.1016/S0022-510X(97)00141-X; Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; Ball KA, 2011, J PHOTOCH PHOTOBIO B, V102, P182, DOI 10.1016/j.jphotobiol.2010.12.002; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Chen JJ, 2011, NEUROIMAGE, V55, P468, DOI 10.1016/j.neuroimage.2010.12.032; Demidova-Rice TN, 2007, LASER SURG MED, V39, P706, DOI 10.1002/lsm.20549; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; ELIAS MF, 1995, EXP AGING RES, V21, P369, DOI 10.1080/03610739508253991; FARMER ME, 1990, J CLIN EPIDEMIOL, V43, P475, DOI 10.1016/0895-4356(90)90136-D; Gouveia Valdiney V., 2003, Psic.: Teor. e Pesq., V19, P241, DOI 10.1590/S0102-37722003000300006; Gsell W, 2000, J CHEM NEUROANAT, V20, P215, DOI 10.1016/S0891-0618(00)00095-8; Hutsler J, 2003, TRENDS NEUROSCI, V26, P429, DOI 10.1016/S0166-2236(03)00198-X; Jagdeo JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047460; KAY DWK, 1985, PSYCHOL MED, V15, P771, DOI 10.1017/S0033291700005006; KELLEY RE, 1992, STROKE, V23, P9, DOI 10.1161/01.STR.23.1.9; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lane N, 2006, NATURE, V443, P901, DOI 10.1038/443901a; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Li M, 2014, NEUROSCI RES, V84, P19, DOI 10.1016/j.neures.2014.02.009; Lim MH, 2009, STROKE, V40, P3216, DOI 10.1161/STROKEAHA.109.558403; Luft CD, 2007, REV SAUDE PUBL, V41, P606, DOI 10.1590/S0034-89102007000400015; Michalikova S, 2008, NEUROBIOL LEARN MEM, V89, P480, DOI 10.1016/j.nlm.2007.07.014; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P443, DOI 10.1089/pho.2011.9908; Nawashiro H, 2012, PHOTOMED LASER SURG, V30, P231, DOI 10.1089/pho.2011.3044; Okamoto Y, 2012, ACTA NEUROPATHOL, V123, P381, DOI 10.1007/s00401-011-0925-9; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; ROBERTSON LC, 1991, COGNITIVE PSYCHOL, V23, P299, DOI 10.1016/0010-0285(91)90012-D; Roher AE, 2011, ALZHEIMERS DEMENT, V7, P445, DOI 10.1016/j.jalz.2010.09.002; Samoilova KA, 2004, PHOTOCH PHOTOBIO SCI, V3, P96, DOI 10.1039/b305738k; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Sejdic E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055405; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; SPERRY R, 1982, SCIENCE, V217, P1223, DOI 10.1126/science.7112125; Staub D, 2006, STROKE, V37, P800, DOI 10.1161/01.STR.0000202589.47401.c6; Suter OC, 2002, STROKE, V33, P1986, DOI 10.1161/01.STR.0000024523.82311.77; Tanaka Kortaro, 1996, Keio Journal of Medicine, V45, P14; Uozumi Y, 2010, LASER SURG MED, V42, P566, DOI 10.1002/lsm.20938; Vicenzini E, 2007, EUR NEUROL, V58, P84, DOI 10.1159/000103642; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003	44	27	29	0	12	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	JAN	2015	30	1					339	346		10.1007/s10103-014-1669-2			8	Engineering, Biomedical; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Surgery	AZ5ZS	WOS:000348297900045	25277249				2022-02-06	
J	Westfall, DR; West, JD; Bailey, JN; Arnold, T; Kersey, PA; Saykin, AJ; McDonald, BC				Westfall, Daniel R.; West, John D.; Bailey, Jessica N.; Arnold, Toddw.; Kersey, Patrick A.; Saykin, Andrew J.; McDonald, Brenna C.			Increased brain activation during working memory processing after pediatric mild traumatic brain injury (mTBI)	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Concussion; mild traumatic brain injury; mTBI; pediatric; functional magnetic resonance imaging; fMRI; working memory	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; FUNCTIONAL MRI; RECOVERY; DYSFUNCTION; INHIBITION; CHALLENGE; FOOTBALL; CHILDREN; IMPACT	PURPOSE: The neural substrate of post-concussive symptoms following the initial injury period after mild traumatic brain injury (mTBI) in pediatric populations remains poorly elucidated. This study examined neuropsychological, behavioral, and brain functioning in adolescents post-mTBI to assess whether persistent differences were detectable up to a year post-injury. METHODS: Nineteen adolescents on average 7.5 months post-mTBI completed neuropsychological testing and an fMRI auditory-verbal N-back working memory task. Parents completed behavioral ratings. The comparison group included 19 healthy controls matched to the mTBI group for demographic variables and N-back task performance. RESULTS: There were no between-group differences for cognition or behavior ratings. The expected decreased accuracy and increased reaction time as N-back task difficulty increased were apparent. The mTBI group showed significantly greater brain activation than controls during the most difficult working memory load condition. CONCLUSION: Greater working memory task-related activation was found in adolescents up to one year post-mTBI relative to controls, potentially indicating compensatory activation to support normal task performance. Differences in brain activation in the mTBI group so long after injury may indicate residual alterations in brain function much later than would be expected based on the typical pattern of symptom recovery, which could have important clinical implications.	[Westfall, Daniel R.; West, John D.; Bailey, Jessica N.; Saykin, Andrew J.; McDonald, Brenna C.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Ctr Neuroimaging, 355 W 16th St,GH Suite 4100, Indianapolis, IN 46202 USA; [Arnold, Toddw.; Kersey, Patrick A.] St Vincent Sports Performance, Carmel, IN USA		McDonald, BC (corresponding author), Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Ctr Neuroimaging, 355 W 16th St,GH Suite 4100, Indianapolis, IN 46202 USA.	mcdonalb@iupui.edu	Saykin, Andrew/A-1318-2007	Saykin, Andrew/0000-0002-1376-8532	Indiana State Department of Health Spinal Cord and Brain Injury Fund Research Grant Program; Project Development Team within the ICTSI NIH/NCRR Grant [RR025761]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG010133] Funding Source: NIH RePORTER	The authors thank our MRI technologist colleagues at the Indiana Institute for Biomedical Imaging Sciences for their assistance in assuring successful MRI scans, and also thank Lindsey Shine and Kimberly Campbell for their contributions to this project. We are also very grateful to our participants and their families for their time and effort. This work was supported by a grant from the Indiana State Department of Health Spinal Cord and Brain Injury Fund Research Grant Program and by a Project Development Team within the ICTSI NIH/NCRR Grant Number RR025761.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Ahles TA, 2008, BREAST CANCER RES TR, V110, P143, DOI 10.1007/s10549-007-9686-5; Ahles TA, 2010, J CLIN ONCOL, V28, P4434, DOI 10.1200/JCO.2009.27.0827; Aylward, 1996, GORDON DIAGNOSTIC SY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Brett M., 2002, NEUROIMAGE, DOI 10.1016/S1053-8119(02)90010-8; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; CDC, 2010, TRAUM BRAIN INJ US; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Conroy SK, 2013, BRAIN IMAGING BEHAV, V7, P491, DOI 10.1007/s11682-013-9240-5; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gioia G.A., 2000, BRIEF BEHAV RATING I; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kearney-Ramos TE, 2014, J INT NEUROPSYCH SOC, P1; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Lafayette Instrument, 1989, GROOV PEGB INSTR OWN; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2011, INT J PSYCHOPHYSIOL, V82, P107, DOI 10.1016/j.ijpsycho.2011.06.022; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Meyers JE., 1995, REY COMPLEX FIGURE T; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Sahler CS, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/659652; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Yang Z, 2012, J NEUROTRAUM, V29, P2124, DOI 10.1089/neu.2012.2395	56	27	28	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2015	8	4					297	308		10.3233/PRM-150348			12	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7LK	WOS:000448290900004	26684070	Green Accepted, Green Submitted			2022-02-06	
J	Zhang, X; Jiang, XY				Zhang, Xuan; Jiang, Xiaoying			Effects of Enteral Nutrition on the Barrier Function of the Intestinal Mucosa and Dopamine Receptor Expression in Rats With Traumatic Brain Injury	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article						enteral nutrition; traumatic brain injury; intestinal mucosa; dopamine receptor; bacterial translocation	BLOOD-FLOW; D1; SUPPLEMENTATION; PERMEABILITY; DOPEXAMINE; GLUTAMINE; AMYGDALA; SEPSIS; IMMUNE	Background: Impaired intestinal mucosal barrier (IMB) function is common in traumatic brain injury (TBI), but dopamine receptors (DRs) change in intestinal mucosa after TBI, and effects of enteral nutrition (EN) and supplements on IMB function remain unclear. Our purpose was to study the effects of EN and supplements on intestinal mucosal permeability (IMPB) and the expression of DRs DRD1 and DRD2 in the intestinal mucosa of rats with TBI. Methods: Forty-eight rats were divided into 8 groups; control, animals with TBI, dopamine group, animals with TBI treated with dopamine antagonist, EN alone, or EN combined with glutamine, probiotics, or a combination of probiotics and glutamine daily after TBI. Results: The IMPB was improved in the glutamine, probiotics, and combination groups. Including probiotics improved IMPB more than adding glutamine, and bacterial translocation in the intestines after TBI was reduced in the probiotics and combination groups (all Ps < .01). TBI led to elevated DRD1 and DRD2 mRNA and protein levels, which were reduced in the DA antagonist, glutamine, probiotics, and combination groups. DRD2 mRNA and protein levels in the probiotics and combination groups were decreased more than in the DA antagonist group (all Ps < .01). The increased IMPB after TBI correlated with increased DRD1 and DRD2 levels in the rat intestinal mucosa. Conclusion: EN supplemented with probiotics or combining glutamine and probiotics lowers the increased IMPB, bacterial translocation, and DRD1 and DRD2 mRNA and protein expression in rat intestinal mucosa caused by TBI.	[Zhang, Xuan; Jiang, Xiaoying] Fujian Med Univ, Sch Nursing, Fuzhou 350108, Peoples R China		Jiang, XY (corresponding author), Fujian Med Univ, Sch Nursing, 1 Xueyuan Rd Shangjie Zhen Minhou Cty, Fuzhou 350108, Peoples R China.	zhangxuan1203@163.com			Natural Science Foundation of Fujian Province of ChinaNatural Science Foundation of Fujian Province [2009J01151]	This project was supported by the Natural Science Foundation of Fujian Province of China (No. 2009J01151).	Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bernal S, 2009, BEHAV BRAIN RES, V205, P183, DOI 10.1016/j.bbr.2009.06.032; Birnbaum J, 2006, CRIT CARE, V10, DOI 10.1186/cc5011; Briassoulis G, 2005, INTENS CARE MED, V31, P851, DOI 10.1007/s00134-005-2631-3; dos Santos RDC, 2010, JPEN-PARENTER ENTER, V34, P408, DOI 10.1177/0148607110362530; Chaiseha Y, 2003, NEUROENDOCRINOLOGY, V77, P105, DOI 10.1159/000068649; Charrueau C, 2009, J NEUROTRAUM, V26, P1911, DOI 10.1089/neu.2008.0737; Eizaguirre I, 2010, Cir Pediatr, V23, P118; Feng D, 2007, J INT MED RES, V35, P644, DOI 10.1177/147323000703500509; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Garcia-Rodenas CL, 2006, J PEDIATR GASTR NUTR, V43, P16, DOI 10.1097/01.mpg.0000226376.95623.9f; Gu Rong-min, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P468; Guerin JP, 2005, SHOCK, V23, P18, DOI 10.1097/01.shk.0000150549.45338.6c; Gun F, 2005, SURG TODAY, V35, P760, DOI 10.1007/s00595-005-3023-6; Guzman JA, 2003, AM J PHYSIOL-HEART C, V284, pH668, DOI 10.1152/ajpheart.00636.2002; Guzman JA, 2001, J APPL PHYSIOL, V91, P596, DOI 10.1152/jappl.2001.91.2.596; Hiltebrand LB, 2004, ANESTHESIOLOGY, V100, P1188, DOI 10.1097/00000542-200405000-00022; Le Foll B, 2009, BEHAV PHARMACOL, V20, P1, DOI 10.1097/FBP.0b013e3283242f05; Louin G, 2004, J NEUROSCI METH, V138, P73, DOI 10.1016/j.jneumeth.2004.03.010; Mcvay MR, 2008, J PEDIATR SURG, V43, P25, DOI 10.1016/j.jpedsurg.2007.09.013; Nahidi L, 2012, J GASTROENTEROL, V47, P107, DOI 10.1007/s00535-011-0471-1; Ozturk H, 2006, DIGEST DIS SCI, V51, P1454, DOI 10.1007/s10620-005-9060-6; Peng Xi, 2002, Zhonghua Shao Shang Za Zhi, V18, P339; Pinto A, 2008, BRAIN STRUCT FUNCT, V213, P159, DOI 10.1007/s00429-008-0180-6; Schmidt H, 1996, BRIT J ANAESTH, V76, P707, DOI 10.1093/bja/76.5.707; Schwarz A, 2004, J BIOL CHEM, V279, P5641, DOI 10.1074/jbc.M309317200; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Takahashi H, 2010, J NEUROSCI, V30, P3043, DOI 10.1523/JNEUROSCI.5689-09.2010; TIBERI M, 1991, P NATL ACAD SCI USA, V88, P7491, DOI 10.1073/pnas.88.17.7491; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Vaughan CJ, 2000, AM J PHYSIOL-REG I, V279, pR599, DOI 10.1152/ajpregu.2000.279.2.R599; Yang De-lin, 2007, Chin J Traumatol, V10, P145; Yasuda T, 2006, J SURG RES, V135, P18, DOI 10.1016/j.jss.2006.02.050; Zou XP, 2010, JPEN-PARENTER ENTER, V34, P554, DOI 10.1177/0148607110362691	35	27	30	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-6071	1941-2444		JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	JAN	2015	39	1					114	123		10.1177/0148607113501881			10	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	AZ3GF	WOS:000348114800012	24047867				2022-02-06	
J	Xiong, KL; Zhu, YS; Zhang, L; Yin, ZY; Zhang, JN; Qiu, MG; Zhang, WG				Xiong, Kunlin; Zhu, Yongshan; Zhang, Long; Yin, Zhiyong; Zhang, Jingna; Qiu, Mingguo; Zhang, Weiguo			White matter integrity and cognition in mild traumatic brain injury following motor vehicle accident	BRAIN RESEARCH			English	Article						Mild traumatic brain injury; Diffuse axonal injury; Cognitive impairment; Diffusion tensor imaging; Tract-based spatial statistics; Fractional anisotropy; Mean diffusivity	DIFFUSE AXONAL INJURY; MULTIPLE-SCLEROSIS; HEAD-INJURY; TENSOR; ADULTS; MEMORY; DAMAGE	The aim of this study is to explore the white matter structure integrity in patients with mild traumatic brain injury (mTBI) using diffusion tensor imaging (DTI), and to analyze the relationship between the white matter structure integrity and cognitive impairment of patients with mTBI. Twenty-five patients with mTBI and 25 healthy control subjects were studied with conventional MR imaging and diffusion tensor imaging. Fractional anisotropy (FA) and mean diffusivity (MD) maps of patients with mTBI were calculated and compared, with these control maps using tract-based spatial statistics (TBSS). Significantly lower fractional anisotropy was found in patients in the uncinate fasciculus, superior longitudinal fasciculus, inferior longitudinal fasciculus, and internal capsule. Mean diffusivity was significantly elevated in the body of corpus callosum, uncinate fasciculus, superior longitudinal fasciculus, and internal capsule in the mTBI group compared with the control group (P<0.05). The mTBI group showed a significant negative correlation between the elevated mean diffusivity of the uncinate fasciculus and the working memory index (WMI) (R-2=0.51, P<0.05), and the internal capsule of MD values was significantly negatively related to processing speed index (PSI) (R-2=0.45, P<0.05). There was a positive correlation between the FA value of the uncinate fasciculus and Mini Mental State Examination (MMSE) in the mTBI patient group (R-2=0.36, P<0.05). TBSS analysis of DTI suggests that patients with mTBI have focal axonal injury, and the pathophysiology is significantly related to the MMSE and IQ of mTBI patients. Diffusion tensor imaging can be a powerful technique for in vivo detection of mTBI, and can help in the diagnosis of patients with mTBI. (C) 2014 Elsevier B.V. All rights reserved.	[Xiong, Kunlin; Zhu, Yongshan; Zhang, Long; Zhang, Weiguo] Third Mil Med Univ, Daping Hosp, Dept Radiol, Chongqing 400042, Peoples R China; [Yin, Zhiyong] Third Mil Med Univ, Inst Surg Res, Dept 4, Chongqing 400042, Peoples R China; [Zhang, Jingna; Qiu, Mingguo] Third Mil Med Univ, Coll Biomed Engn, Dept Med Image, Chongqing 400038, Peoples R China		Qiu, MG (corresponding author), Third Mil Med Univ, Coll Biomed Engn, Dept Med Image, Chongqing 400038, Peoples R China.	jellyhuangsci2@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171866, 30870696]; Chongqing research [cstc2012gg-yyjs10059]	This study was sponsored by the National Natural Science Foundation of China (Grant numbers 81171866, 30870696), and supported in part by Chongqing research grant no. cstc2012gg-yyjs10059.	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Ceccarelli A, 2009, HUM BRAIN MAPP, V30, P3009, DOI 10.1002/hbm.20725; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gu L, 2013, J TRAUMA ACUTE CARE, V74, P242, DOI 10.1097/TA.0b013e3182684fe8; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lowenstein Daniel H, 2009, Ann Neurol, V66, pA7, DOI 10.1002/ana.21876; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Seo JP, 2012, NEUROREHABILITATION, V30, P323, DOI 10.3233/NRE-2012-0762; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	24	27	31	1	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 3	2014	1591						86	92		10.1016/j.brainres.2014.10.030			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU6QZ	WOS:000345728300008	25451093				2022-02-06	
J	Mansson, C; Nilsson, A; Karlson, BM				Mansson, Christopher; Nilsson, Anders; Karlson, Britt-Marie			Severe complications with irreversible electroporation of the pancreas in the presence of a metallic stent: a warning of a procedure that never should be performed	ACTA RADIOLOGICA OPEN			English	Article						IRE; irreversible electroporation; pancreatic cancer; metallic stent; bowel perforation; bleeding; artery injury		Irreversible electroporation (IRE) is an ablation technique that is being investigated as a potential treatment of pancreatic cancer. However, many of these patients have a metallic stent in the bile duct, which is recognized as a contraindication for IRE ablation. We report a case in which an IRE ablation in the region of the pancreatic head was performed on a patient with a metallic stent which led to severe complications. After the treatment, the patient suffered from several complications including perforation of the duodenum and transverse colon, and bleeding from a branch of the superior mesenteric artery which eventually lead to her death. Therefore, we believe it is important to be aware of this if an IRE ablation close to a metallic stent is considered.	[Mansson, Christopher; Karlson, Britt-Marie] Uppsala Univ, Dept Surg Sci, Uppsala 75185, Sweden; [Nilsson, Anders] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden		Mansson, C (corresponding author), Uppsala Univ, Dept Surg Sci, Uppsala 75185, Sweden.	christopher.mansson@surgsci.uu.se					Goldberg SN, 2001, J VASC INTERV RADIOL, V12, P1021, DOI 10.1016/S1051-0443(07)61587-5; Kasivisvanathan V, 2012, CARDIOVASC INTER RAD, V35, P1531, DOI 10.1007/s00270-012-0363-7; Mansson C, 2014, ANTICANCER RES, V34, P289; Maor E, 2010, J VASC INTERV RADIOL, V21, P1708, DOI 10.1016/j.jvir.2010.06.024; Martin RCG, 2013, ANN SURG ONCOL, V20, pS443, DOI 10.1245/s10434-012-2736-1; Narayanan G, 2012, J VASC INTERV RADIOL, V23, P1613, DOI 10.1016/j.jvir.2012.09.012; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Yu NC, 2008, J VASC INTERV RADIOL, V19, P1087, DOI 10.1016/j.jvir.2008.03.023	8	27	27	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2058-4601			ACTA RADIOL OPEN	Acta Radiol. Open	DEC	2014	3	11								10.1177/2047981614556409			3	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	V29WA	WOS:000215523900003	25535573	gold, Green Published			2022-02-06	
J	Munce, TA; Dorman, JC; Odney, TO; Thompson, PA; Valentine, VD; Bergeron, MF				Munce, Thayne A.; Dorman, Jason C.; Odney, Tryg O.; Thompson, Paul A.; Valentine, Verle D.; Bergeron, Michael F.			Effects of Youth Football on Selected Clinical Measures of Neurologic Function: A Pilot Study	JOURNAL OF CHILD NEUROLOGY			English	Article						balance; oculomotor; neurocognitive; subconcussive	SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; VISUAL SCREENING TOOL; HIGH-SCHOOL FOOTBALL; VOLLEYBALL PLAYERS; NCAA CONCUSSION; UNITED-STATES; COLLEGIATE; IMPACT; BALANCE	We assessed 10 youth football players (13.4 +/- 0.7 y) immediately before and after their season to explore the effects of football participation on selected clinical measures of neurologic function. Postseason postural stability in a closed-eye condition was improved compared to preseason (P = .017). Neurocognitive testing with the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) battery revealed that reaction time was significantly faster at postseason (P = .015). There were no significant preseason versus postseason differences in verbal memory (P = .507), visual memory (P = .750), or visual motor speed (P = .087). Oculomotor performance assessed by the King-Devick test was moderately to significantly improved (P = .047-.115). A 12-week season of youth football did not impair the postural stability, neurocognitive function, or oculomotor performance measures of the players evaluated. Though encouraging, continued and more comprehensive investigations of this at-risk population are warranted.	[Munce, Thayne A.; Dorman, Jason C.; Valentine, Verle D.; Bergeron, Michael F.] Sanford Hlth, Natl Inst Athlet Hlth & Performance, Sioux Falls, SD 57104 USA; [Munce, Thayne A.; Bergeron, Michael F.] Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA; [Munce, Thayne A.; Dorman, Jason C.; Valentine, Verle D.; Bergeron, Michael F.] Sanford Res, Sioux Falls, SD USA; [Odney, Tryg O.; Valentine, Verle D.] Sanford Hlth, Sanford Orthoped & Sports Med, Sioux Falls, SD 57104 USA; [Thompson, Paul A.] Sanford Res, Methodol & Data Anal Div, Sioux Falls, SD USA; [Valentine, Verle D.] Univ S Dakota, Sanford Sch Med, Dept Family Med, Sioux Falls, SD USA		Munce, TA (corresponding author), Sanford Hlth, Natl Inst Athlet Hlth & Performance, 1210 W 18th St,Suite 204, Sioux Falls, SD 57104 USA.	thayne.munce@sanfordhealth.org			Sanford Research, Sioux Falls, South Dakota	The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The authors received financial support for this study from Sanford Research, Sioux Falls, South Dakota.	Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; HASCELIK Z, 1989, J SPORT MED PHYS FIT, V29, P234; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Jafarzadehpur E, 2007, SCAND J MED SCI SPOR, V17, P186, DOI 10.1111/j.1600-0838.2005.00535.x; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Nakamoto H, 2008, PERCEPT MOTOR SKILL, V106, P163, DOI 10.2466/PMS.106.1.163-170; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Talavage TM, 2013, J NEUROTRAUMA; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Valentine VD, 2012, MED SCI SPORTS EXERC, p[44, S264]	35	27	27	0	23	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	DEC	2014	29	12					1601	1607		10.1177/0883073813509887			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	AX4NB	WOS:000346908000011	24272520				2022-02-06	
J	Wang, X; Ding, XB; Tong, Y; Zong, JY; Zhao, X; Ren, H; Li, Q				Wang, Xin; Ding, Xibing; Tong, Yao; Zong, Jiaying; Zhao, Xiang; Ren, Hao; Li, Quan			Ketamine does not increase intracranial pressure compared with opioids: meta-analysis of randomized controlled trials	JOURNAL OF ANESTHESIA			English	Article						Ketamine; Opioids; Intracranial pressure; Hemodynamic instability; Brain injuries	CEREBROSPINAL-FLUID PRESSURE; CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; HYDROCEPHALIC CHILDREN; INTRAVENOUS KETAMINE; UNITED-KINGDOM; INTENSIVE-CARE; ANESTHESIA; SEDATION	Ketamine is traditionally avoided in sedation management of patients with risk of intracranial hypertension. However, results from many clinical trials contradict this concern. We critically analyzed the published data of the effects of ketamine on intracranial pressure (ICP) and other cerebral hemodynamics to determine whether ketamine was safe for patients with hemodynamic instability and brain injuries. We systematically searched the online databases of PubMed, Medline, Embase, Current Controlled Trials, and Cochrane Central (last search performed on January 15, 2014). Trial characteristics and outcomes were independently extracted by two assessors (Xin Wang, Xibing Ding). For continuous data, mean differences (MD) were formulated. If the P value of the chi-square test was > 0.10 or I (2) < 50 %, a fixed-effects model was used; otherwise, the random effects model was adopted. Five trials (n = 198) met the inclusion criteria. Using ICP levels within the first 24 h of ketamine administration as the main outcome, the use of ketamine leads to the same ICP levels as opioids [MD = 1.94; 95 % confidence interval (95 % CI), -2.35, 6.23; P = 0.38]. There were no significant differences in mean arterial pressure values between the two groups (MD = 0.99; 95 % CI, -2.24, 4.22; P = 0.55). Ketamine administration was also comparable with opioids in the maintenance of cerebral perfusion pressure (MD = -1.07; 95 % CI, -7.95, 5.8; P = 0.76). The results of this study suggest that ketamine does not increase ICP compared with opioids. Ketamine provides good maintenance of hemodynamic status. Clinical application of ketamine should not be discouraged on the basis of ICP-related concerns.	[Wang, Xin; Ding, Xibing; Tong, Yao; Zong, Jiaying; Zhao, Xiang; Ren, Hao; Li, Quan] Tongji Univ, Sch Med, Dept Anesthesiol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Wang, Xin; Zong, Jiaying] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China; [Li, Quan] Tongji Univ, Sch Med, Dept Anesthesiol, East Hosp, Shanghai 200072, Peoples R China		Li, Q (corresponding author), Tongji Univ, Sch Med, Dept Anesthesiol, Shanghai Peoples Hosp 10, 301 Yanchang Zhong Rd, Shanghai 200072, Peoples R China.	liquantongji@163.com			National Natural Science FoundationNational Natural Science Foundation of China (NSFC)	We are grateful for the support from the National Natural Science Foundation. We also thank all authors of the publications included in this study for contributing information as requested.	Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; BELOPAVLOVIC M, 1982, ACTA ANAESTH SCAND, V26, P458, DOI 10.1111/j.1399-6576.1982.tb01799.x; Bhutta AT, 2012, PEDIATR CRIT CARE ME, V13, P328, DOI 10.1097/PCC.0b013e31822f18f9; Bourgoin A, 2005, CRIT CARE MED, V33, P1109, DOI 10.1097/01.CCM.0000162491.26292.98; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Bowles Eric D, 2012, AANA J, V80, P445; Caricato A, 2013, CRIT CARE, V17, DOI 10.1186/cc13097; Chang LC, 2013, CNS NEUROSCI THER, V19, P390, DOI 10.1111/cns.12077; CHI OZ, 1994, ANESTH ANALG, V79, P860; Craven R, 2007, ANAESTHESIA, V62, P48, DOI 10.1111/j.1365-2044.2007.05298.x; CRUMRINE RS, 1975, ANESTHESIOLOGY, V42, P758, DOI 10.1097/00000542-197506000-00026; EVANS J, 1971, LANCET, V1, P40; Filanovsky Y, 2010, CAN J EMERG MED, V12, P154; Flower O, 2012, EMERG MED INT, V2012, DOI 10.1155/2012/637171; GARDNER AE, 1972, ANESTH ANAL CURR RES, V51, P741; GIBBS JM, 1972, BRIT J ANAESTH, V44, P1298, DOI 10.1093/bja/44.12.1298; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; KAUL HL, 1976, ANAESTHESIA, V31, P698, DOI 10.1111/j.1365-2044.1976.tb11853.x; Kolenda H, 1996, ACTA NEUROCHIR, V138, P1193, DOI 10.1007/BF01809750; Langsjo JW, 2003, ANESTHESIOLOGY, V99, P614, DOI 10.1097/00000542-200309000-00016; LIST WF, 1972, ANESTHESIOLOGY, V36, P98, DOI 10.1097/00000542-197201000-00023; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; MAYBERG TS, 1995, ANESTH ANALG, V81, P84, DOI 10.1097/00000539-199507000-00017; MCDONALD JW, 1989, EXP NEUROL, V106, P289, DOI 10.1016/0014-4886(89)90162-3; Mennella F, 1976, Minerva Anestesiol, V42, P418; Michalczyk K, 2013, PEDIATR CRIT CARE ME, V14, pE149, DOI 10.1097/PCC.0b013e3182720459; MIRSKI MA, 1995, CRIT CARE MED, V23, P2038, DOI 10.1097/00003246-199512000-00013; Miyamoto E, 2004, NEUROSCI LETT, V354, P26, DOI 10.1016/j.neulet.2003.09.058; Nagase K, 2003, J NEUROSURG ANESTH, V15, P98, DOI 10.1097/00008506-200304000-00006; Nimkoff L, 1997, J CRIT CARE, V12, P132, DOI 10.1016/S0883-9441(97)90042-3; Ohata H, 2001, ANESTH ANALG, V93, P697, DOI 10.1097/00000539-200109000-00032; PFENNINGER E, 1990, STATUS OF KETAMINE IN ANESTHESIOLOGY, P109; Polocki B, 1976, Anaesth Resusc Intensive Ther, V4, P121; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Schmittner MD, 2007, J NEUROSURG ANESTH, V19, P257, DOI 10.1097/ANA.0b013e31811f3feb; SCHULTEAMESCH J, 1978, ACTA NEUROCHIR, V45, P15, DOI 10.1007/BF01774380; Sehdev Rajesh S, 2006, Emerg Med Australas, V18, P37; SHAPIRO HM, 1972, BRIT J ANAESTH, V44, P1200, DOI 10.1093/bja/44.11.1200; STREBEL S, 1995, ANAESTHESIA, V50, P223, DOI 10.1111/j.1365-2044.1995.tb04561.x; TAKESHITA H, 1972, ANESTHESIOLOGY, V36, P69, DOI 10.1097/00000542-197201000-00013; Urwin SC, 2004, DRUG SAFETY, V27, P107, DOI 10.2165/00002018-200427020-00003; Wilson E, 1976, Acta Neurol Latinoam, V22, P10; WYTE SR, 1972, ANESTHESIOLOGY, V36, P174, DOI 10.1097/00000542-197202000-00021	47	27	27	0	5	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	DEC	2014	28	6					821	827		10.1007/s00540-014-1845-3			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	AW4GX	WOS:000346240300004	24859931				2022-02-06	
J	Garber, BG; Rusu, C; Zamorski, MA				Garber, Bryan G.; Rusu, Corneliu; Zamorski, Mark A.			Deployment-related mild traumatic brain injury, mental health problems, and post-concussive symptoms in Canadian armed forces personnel	BMC PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; OEF/OIF SERVICE MEMBERS; POSTCONCUSSION SYNDROME; DIAGNOSTIC-CRITERIA; NCAA CONCUSSION; PTSD CHECKLIST; NATIONAL-GUARD; WAR VETERANS; PRIMARY-CARE	Background: Up to 20% of US military personnel deployed to Iraq or Afghanistan experience mild traumatic brain injury (mTBI) while deployed; up to one-third will experience persistent post-concussive symptoms (PCS). The objective of this study was to examine the epidemiology of deployment-related mTBI and its relationship to PCS and mental health problems (MHPs) in Canadian Armed Forces (CAF) personnel. Methods: Participants were 16153 personnel who underwent post-deployment screening (median = 136 days after return) following deployment in support of the mission in Afghanistan from 2009 - 2012. The screening questionnaire assessed mTBI and other injuries while deployed, using the Brief Traumatic Brain Injury Screening Tool. Current MHPs and PCS were assessed using items from the Patient Health Questionnaire, the Patient Checklist for PTSD, and the Cognitive Failures Questionnaire. Log-binomial regression explored the association of mTBI, other injuries, and MHPs with PCS, using the presence of 3 or more of 7 PCS as the outcome. Results are expressed as adjusted prevalence ratios (PR). Results: mTBI while deployed was reported in 843 respondents (5.2%). Less severe forms of mTBI (associated only with having been dazed or confused or having "seen stars") predominated. Blast was reported as a mechanism of injury in half of those with mTBI. Multiple PCS were present in 21% of those with less severe forms of mTBI and in 27% of those with more severe forms of mTBI (i.e., mTBI associated with loss of consciousness or post-traumatic amnesia). After adjustment for confounding, mTBI had no statistically significant association with PCS relative to non-TBI injury. In contrast, MHPs had a strong association with reporting 3 or more PCS (adjusted prevalence ratio (PR) = 7.77). Conclusion: Deployment-related mTBI prevalence was lower than in many US reports; most of those who had had mTBI were free of multiple PCS. PCS was strongly associated with MHPs but not with mTBI. Careful assessment of MHPs is essential in personnel with a history of combat-related mTBI and PCS.	[Garber, Bryan G.; Rusu, Corneliu; Zamorski, Mark A.] Canadian Forces Hlth Serv Grp Headquarters, Deployment Hlth Sect, Directorate Mental Hlth, Ottawa, ON K1A 0K6, Canada		Garber, BG (corresponding author), Canadian Forces Hlth Serv Grp Headquarters, Deployment Hlth Sect, Directorate Mental Hlth, 1745 Alta Vista Dr, Ottawa, ON K1A 0K6, Canada.	bryan.garber@forces.gc.ca			Canadian Forces Surgeon General's Health Research Program [2012-08-089-003-001]	This study was funded by The Canadian Forces Surgeon General's Health Research Program Protocol# 2012-08-089-003-001. Role of Funders in the Study: The investigators developed the study protocol, which was accepted by the study sponsor without modification. The sponsor had no direct role in the collection, or analysis of the data. The sponsor did provide contextual information that assisted in the interpretation of the results. In accordance with Department of National Defence policy, the paper was reviewed and approved for submission without modification by the Canadian Forces Deputy Surgeon General. The authors can however attest that no undue influence on the part of the Department of National Defence, the Canadian Forces, or the Government of Canada occurred at any part of this research project.	Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; [Anonymous], 2012, VA DOD CLIN PRACTICE; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Black DW, 2004, EPIDEMIOLOGY, V15, P135, DOI 10.1097/01.EDE.0000103188.18059.21; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Boulos D, 2013, CAN MED ASSOC J, V185, pE545, DOI 10.1503/cmaj.122120; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Fann Jesse, 2013, Arch Phys Med Rehabil, V94, P801, DOI 10.1016/j.apmr.2012.04.001; Fear NT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-797; Ferrari R, 2003, CLIN NEUROL NEUROSUR, V105, P146, DOI 10.1016/S0303-8467(02)00108-7; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Garber B., 2008, CANADIAN FORCES HLTH; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hourani L, 2012, MIL MED, V177, P643, DOI 10.7205/MILMED-D-11-00421; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Kashluba S, 2006, J INT NEUROPSYCH SOC, V12, P111, DOI 10.1017/S1355617706060036; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lang AJ, 2005, BEHAV RES THER, V43, P585, DOI 10.1016/j.brat.2004.04.005; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McCauley SR, 2006, BRAIN INJURY, V20, P519, DOI 10.1080/02699050600676651; McCauley SR, 2005, J NERV MENT DIS, V193, P540, DOI 10.1097/01.nmd.0000172592.05801.71; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Office of the Surgeon General UAMC, 2006, FIN REP MENT HLTH AD; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ontario Neurotrauma Foundation, 2011, GUID MILD TRAUM BRAI; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P75, DOI 10.1097/HTR.0b013e31823029f6; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; *STAT CAN, 2003, DAIL CAN COMM HLTH S; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Zamorski M. A., 2011, REPORT FINDINGS ENHA; Zamorski MA, 2014, CAN J PSYCHIAT, V59, P319, DOI 10.1177/070674371405900605	71	27	27	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-244X			BMC PSYCHIATRY	BMC Psychiatry	NOV 20	2014	14								325	10.1186/s12888-014-0325-5			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	AW1EK	WOS:000346033100001	25410348	gold, Green Published			2022-02-06	
J	Lowing, JL; Susick, LL; Caruso, JP; Provenzano, AM; Raghupathi, R; Conti, AC				Lowing, Jennifer L.; Susick, Laura L.; Caruso, James P.; Provenzano, Anthony M.; Raghupathi, Ramesh; Conti, Alana C.			Experimental Traumatic Brain Injury Alters Ethanol Consumption and Sensitivity	JOURNAL OF NEUROTRAUMA			English	Article						alcohol; DARPP-32; loss of righting reflex; nucleus accumbens; traumatic brain injury	CONTROLLED CORTICAL IMPACT; SPINAL-CORD-INJURY; SUBSTANCE-ABUSE; SYNAPTIC PLASTICITY; NUCLEUS-ACCUMBENS; PSYCHIATRIC-DISORDERS; ADENYLYL CYCLASES; OXIDATIVE STRESS; AXONAL INJURY; RAT STRIATUM	Altered alcohol consumption patterns after traumatic brain injury (TBI) can lead to significant impairments in TBI recovery. Few preclinical models have been used to examine alcohol use across distinct phases of the post-injury period, leaving mechanistic questions unanswered. To address this, the aim of this study was to describe the histological and behavioral outcomes of a noncontusive closed-head TBI in the mouse, after which sensitivity to and consumption of alcohol were quantified, in addition to dopaminergic signaling markers. We hypothesized that TBI would alter alcohol consumption patterns and related signal transduction pathways that were congruent to clinical observations. After midline impact to the skull, latency to right after injury, motor deficits, traumatic axonal injury, and reactive astrogliosis were evaluated in C57BL/6J mice. Amyloid precursor protein (APP) accumulation was observed in white matter tracts at 6, 24, and 72 h post-TBI. Increased intensity of glial fibrillary acidic protein (GFAP) immunoreactivity was observed by 24 h, primarily under the impact site and in the nucleus accumbens, a striatal subregion, as early as 72 h, persisting to 7 days, after TBI. At 14 days post-TBI, when mice were tested for ethanol sensitivity after acute high-dose ethanol (4 g/kg, intraperitoneally), brain-injured mice exhibited increased sedation time compared with uninjured mice, which was accompanied by deficits in striatal dopamine-and cAMP-regulated neuronal phosphoprotein, 32 kDa (DARPP-32) phosphorylation. At 17 days post-TBI, ethanol intake was assessed using the Drinking-in-the-Dark paradigm. Intake across 7 days of consumption was significantly reduced in TBI mice compared with sham controls, paralleling the reduction in alcohol consumption observed clinically in the initial post-injury period. These data demonstrate that TBI increases sensitivity to ethanol-induced sedation and affects downstream signaling mediators of striatal dopaminergic neurotransmission while altering ethanol consumption. Examining TBI effects on ethanol responsitivity will improve our understanding of alcohol use post-TBI in humans.	[Lowing, Jennifer L.; Susick, Laura L.; Caruso, James P.; Provenzano, Anthony M.; Conti, Alana C.] Wayne State Univ, Sch Med, John D Dingell VA Med Ctr, Detroit, MI 48201 USA; [Lowing, Jennifer L.; Susick, Laura L.; Caruso, James P.; Provenzano, Anthony M.; Conti, Alana C.] Wayne State Univ, Sch Med, Dept Neurosurg, Detroit, MI 48201 USA; [Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA		Conti, AC (corresponding author), Wayne State Univ, Sch Med, John D Dingell VA Med Ctr, Dept Neurosurg, 4646 John R St 11R, Detroit, MI 48201 USA.	aconti@med.wayne.edu	Raghupathi, Ramesh/AAX-5538-2021	Susick, Laura/0000-0002-1389-837X	Wayne State University (WSU) Department of Neurosurgery; Children's Hospital of Michigan Foundation; WSU Office of the Vice President for Research (ACC)	This material is the result of work supported with resources and the use of facilities at the John D. Dingell VA Medical Center, Detroit, MI, and by funds from Wayne State University (WSU) Department of Neurosurgery, Children's Hospital of Michigan Foundation, and WSU Office of the Vice President for Research (ACC).	Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Baldo BA, 2007, PSYCHOPHARMACOLOGY, V191, P439, DOI 10.1007/s00213-007-0741-z; Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Chen G, 2011, ALCOHOL CLIN EXP RES, V35, P1739, DOI 10.1111/j.1530-0277.2011.01520.x; Conti AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005697; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; ELLERD DA, 1992, J APPL REHABILITATIO, V23, P48; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; KAKIHANA R, 1966, SCIENCE, V154, P1574, DOI 10.1126/science.154.3756.1574; KEIR WJ, 1990, J PHARMACOL EXP THER, V254, P831; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Lyons AM, 2008, ALCOHOL CLIN EXP RES, V32, P1962, DOI 10.1111/j.1530-0277.2008.00784.x; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; Maldve RE, 2002, NAT NEUROSCI, V5, P641, DOI 10.1038/nn877; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Papa M, 2014, NEUROSCI BIOBEHAV R, V42, P35, DOI 10.1016/j.neubiorev.2014.01.010; PENNARTZ CMA, 1991, J NEUROSCI, V11, P2838; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Ponomarev I, 2002, GENES BRAIN BEHAV, V1, P82, DOI 10.1034/j.1601-183X.2002.10203.x; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Rhodes JS, 2005, PHYSIOL BEHAV, V84, P53, DOI 10.1016/j.physbeh.2004.10.007; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Risinger FO, 2001, J NEUROSCI, V21, P340, DOI 10.1523/JNEUROSCI.21-01-00340.2001; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ron D, 2004, NEUROSCIENTIST, V10, P325, DOI 10.1177/1073858404263516; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; TABAKOFF B, 1979, DRUG ALCOHOL DEPEN, V4, P87, DOI 10.1016/0376-8716(79)90043-7; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wallsten S., 2005, AEI BROOKINGS JOINT, P5; Wilcox MV, 2014, NEUROPSYCHOPHARMACOL, V39, P579, DOI 10.1038/npp.2013.230; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087	67	27	27	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2014	31	20					1700	1710		10.1089/neu.2013.3286			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AP8BF	WOS:000342302200003	24934382	Green Published			2022-02-06	
J	Marhong, J; Fan, E				Marhong, Jonathan; Fan, Eddy			Carbon Dioxide in the Critically Ill: Too Much or Too Little of a Good Thing?	RESPIRATORY CARE			English	Article						hypercapnia; hypocapnia; intensive care units; respiration; artificial; respiratory acidosis; respiratory distress syndrome; adult	CEREBRAL-BLOOD-FLOW; PROVIDING PERMISSIVE HYPERCAPNIA; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; 6 ML/KG; LUNG; VENTILATION; ACIDOSIS; VOLUME; HYPOCAPNIA	Hypercapnia and hypocapnia commonly complicate conditions that are present in critically ill patients. Both conditions have important physiologic effects that may impact the clinical management of these patients. For instance, hypercapnia results in bronchodilation and enhanced hypoxic vasoconstriction, leading to improved ventilation/perfusion matching. Hypocapnia reduces cerebral blood volume through arterial vasoconstriction. These effects have also been exploited for therapeutic aims. In patients with traumatic brain injury (TB!), hypocapnia is often utilized to control intracranial pressure. However, this effect is not sustained, and prolonged hypocapnia increases the risk of mortality and severe disability in patients with TBI. Hypercapnia and hypercapnic acidosis are common consequences of lung-protective ventilation in ARDS. Hypercapnic acidosis reduces ischemic lung injury and preserves lung compliance, but concern has arisen over hypercapnia-induced immunosuppression and the potential for bacterial proliferation in sepsis. Experimental studies suggest that buffering hypercapnic acidosis attenuates these effects, whereas hypocapnia appears to potentiate lung injury through increased capillary permeability and decreased lung compliance. Several areas of uncertainty surround the role of hypercapnia/hypocapnia in treating TB! and ARDS. Current data support recommendations to avoid hypocapnia in treating TB!, with the exception of emergent treatment of elevated intracranial pressure, while awaiting definitive management. Permissive hypercapnia is commonly accepted as a consequence of lung-protective ventilation in ARDS, but there is insufficient evidence to support the induction of hypercapnic acidosis in clinical practice. Buffering hypercapnic acidosis should be considered only for a specific clinical indication (eg, hemodynamic instability). For clinicians choosing to buffer hypercapnic acidosis, tris-hydroxymethyl aminomethane is recommended over sodium bicarbonate, as it is more effective in correcting pH and is not associated with increased carbon dioxide production. Future studies should aim to address these areas of uncertainty to help guide clinicians in the therapeutic use and management of hypercapnia/hypocapnia in critically ill patients.	[Marhong, Jonathan; Fan, Eddy] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Marhong, Jonathan; Fan, Eddy] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Marhong, Jonathan; Fan, Eddy] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada		Fan, E (corresponding author), Toronto Gen Hosp, 585 Univ Ave,PMB 11-123, Toronto, ON M5G 2N2, Canada.	eddy.fan@uhn.ca					ALEXANDER SC, 1968, J APPL PHYSIOL, V24, P66, DOI 10.1152/jappl.1968.24.1.66; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Bein T, 2013, INTENS CARE MED, V39, P847, DOI 10.1007/s00134-012-2787-6; Beitler JR, 2013, J PHYSIOL-LONDON, V591, P2767, DOI 10.1113/jphysiol.2013.252619; Bor-Seng-Shu E, 2013, BIOMED RES INT, V2013, P750; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Coakley RJ, 2002, J LEUKOCYTE BIOL, V71, P603; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CULLEN DJ, 1974, ANESTHESIOLOGY, V41, P345, DOI 10.1097/00000542-197410000-00006; Curley G, 2010, CRIT CARE, V14, DOI 10.1186/cc8926; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Curley G, 2010, ANESTHESIOLOGY, V112, P462, DOI 10.1097/ALN.0b013e3181ca361f; Curley GF, 2013, J PHYSIOL-LONDON, V591, P2763, DOI 10.1113/jphysiol.2013.252601; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Del Sorbo L, 2014, LANCET RESP MED, V2, P154, DOI 10.1016/S2213-2600(13)70197-8; Doerr CH, 2005, AM J RESP CRIT CARE, V171, P1371, DOI 10.1164/rccm.200309-1223OC; DOMINO KB, 1993, J APPL PHYSIOL, V75, P1306, DOI 10.1152/jappl.1993.75.3.1306; Domino KB, 1998, RESP PHYSIOL, V111, P89, DOI 10.1016/S0034-5687(97)00103-5; Fee JP, 2004, PHYSL ANAESTHESIOLOG; Forsythe SM, 2000, CHEST, V117, P260, DOI 10.1378/chest.117.1.260; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Hall JE., 2006, TXB MED PHYSL; Ito H, 2005, J CEREBR BLOOD F MET, V25, P852, DOI 10.1038/sj.jcbfm.9600076; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Kregenow DA, 2006, CRIT CARE MED, V34, P1, DOI 10.1097/01.CCM.0000194533.75481.03; Kregenow DA, 2002, EUR RESPIR J, V20, P6, DOI 10.1183/09031936.02.00400802; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P2287, DOI 10.1164/ajrccm.162.6.2003066; Laffey JG, 2000, AM J RESP CRIT CARE, V162, P399, DOI 10.1164/ajrccm.162.2.9911026; Laffey JG, 2004, INTENS CARE MED, V30, P347, DOI 10.1007/s00134-003-2051-1; Laffey JG, 2003, CRIT CARE MED, V31, P2634, DOI 10.1097/01.CCM.0000089646.52395.BA; Laffey JG, 2000, AM J RESP CRIT CARE, V161, P141, DOI 10.1164/ajrccm.161.1.9905080; LAHIRI S, 1975, RESP PHYSIOL, V24, P267, DOI 10.1016/0034-5687(75)90018-3; Lee C, 2013, KOREAN J ANESTHESIOL, V65, P337, DOI 10.4097/kjae.2013.65.4.337; Mazzeo AT, 2004, PEDIATR ANESTH, V14, P596, DOI 10.1111/j.1460-9592.2004.01260.x; McCrimmon DR, 2003, AM J PHYSIOL-REG I, V285, pR1274, DOI 10.1152/ajpregu.00428.2003; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nahas GG, 1998, DRUGS, V55, P191, DOI 10.2165/00003495-199855020-00003; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Pugin J, 2008, AM J RESP CELL MOL, V38, P362, DOI 10.1165/rcmb.2007-0114OC; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; RAICHLE ME, 1970, ARCH NEUROL-CHICAGO, V23, P394, DOI 10.1001/archneur.1970.00480290014002; RICHARDSON DW, 1972, AM J PHYSIOL, V223, P1308, DOI 10.1152/ajplegacy.1972.223.6.1308; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SAMRA SK, 1989, ANESTHESIOLOGY, V70, P523, DOI 10.1097/00000542-198903000-00024; Shibata K, 1998, AM J RESP CRIT CARE, V158, P1578, DOI 10.1164/ajrccm.158.5.9804039; Smith CA, 2006, J APPL PHYSIOL, V100, P13, DOI 10.1152/japplphysiol.00926.2005; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Vadasz I, 2012, AM J RESP CELL MOL, V46, P417, DOI 10.1165/rcmb.2011-0395PS; Weber T, 2000, AM J RESP CRIT CARE, V162, P1361, DOI 10.1164/ajrccm.162.4.9808092; West JB, 1996, RESP PHYSL PEOPLE ID; Zwienenberg M, 1999, J NEUROTRAUM, V16, P937, DOI 10.1089/neu.1999.16.937	56	27	30	0	12	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	OCT	2014	59	10					1597	1605		10.4187/respcare.03405			9	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Respiratory System	CA8WB	WOS:000349200500018	25261559	Bronze			2022-02-06	
J	Prichep, LS; Dastidar, SG; Jacquin, A; Koppes, W; Miller, J; Radman, T; O'Neil, B; Naunheim, R; Huff, JS				Prichep, Leslie S.; Dastidar, Samanwoy Ghosh; Jacquin, Arnaud; Koppes, William; Miller, Jonathan; Radman, Thomas; O'Neil, Brian; Naunheim, Rosanne; Huff, J. Stephen			Classification algorithms for the identification of structural injury in TBI using brain electrical activity	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						TBI; Acute traumatic brain injury; Classifier algorithms; Genetic algorithms; Quantitative brain activity; Electrophysiology of TBI; TBI triage; Structural brain injury; CT plus TBI	NEW-ORLEANS CRITERIA; CT HEAD RULE; GENETIC ALGORITHMS; SEVERITY; SCALE; CONCUSSION; REDUCTION; RECOVERY	Background: There is an urgent need for objective criteria adjunctive to standard clinical assessment of acute Traumatic Brain Injury (TBI). Details of the development of a quantitative index to identify structural brain injury based on brain electrical activity will be described. Methods: Acute closed head injured and normal patients (n=1470) were recruited from 16 US Emergency Departments and evaluated using brain electrical activity (EEG) recorded from forehead electrodes. Patients had high GCS (median=15), and most presented with low suspicion of brain injury. Patients were divided into a CT positive (CT+) group and a group with CT negative findings or where CT scans were not ordered according to standard assessment (CT-/CT_NR). Three different classifier methodologies, Ensemble Harmony, Least Absolute Shrinkage and Selection Operator (LASSO), and Genetic Algorithm (GA), were utilized. Results: Similar performance accuracy was obtained for all three methodologies with an average sensitivity/specificity of 97.5%/59.5%, area under the curves (AUC) of 0.90 and average Negative Predictive Validity (NPV) > 99%. Sensitivity was highest for CT+ cases with potentially life threatening hematomas, where two of three classifiers were 100%. Conclusion: Similar performance of these classifiers suggests that the optimal separation of the populations was obtained given the overlap of the underlying distributions of features of brain activity. High sensitivity to CT+ injuries (highest in hematomas) and specificity significantly higher than that obtained using ED guidelines for imaging, supports the enhanced clinical utility of this technology and suggests the potential role in the objective, rapid and more optimal triage of TB! patients. Published by Elsevier Ltd.	[Prichep, Leslie S.] NYU, Sch Med, Dept Psychiat, Brain Res Labs, New York, NY USA; [Dastidar, Samanwoy Ghosh; Jacquin, Arnaud; Koppes, William; Miller, Jonathan; Radman, Thomas] BrainScope Co Inc, Algorithm Dev Dept, Bethesda, MD USA; [O'Neil, Brian] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Naunheim, Rosanne; Huff, J. Stephen] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA; [Huff, J. Stephen] Univ Virginia, Dept Emergency Med, Charlottesville, VA USA; [Huff, J. Stephen] Univ Virginia, Dept Neurol, Charlottesville, VA USA		Prichep, LS (corresponding author), Brain Res Labs, Old Bellevue Admin Bldg,8th Floor,462 First Ave, New York, NY 10016 USA.	Leslie.Prichep@nyumc.org			BrainScope Co., Inc., Bethesda Maryland	The authors acknowledge the contributions of those who made this research possible, including the primary investigators and research technicians at all the clinical sites and the patients who volunteered. The authors also acknowledge the contributions of Greg Mahowald and Julie Filipenko in support of the project. This research was supported by BrainScope Co., Inc., Bethesda Maryland who granted expenses related to data acquisition.	Baranauskas JA, 2003, KNOWL-BASED SYST, V16, P129, DOI 10.1016/S0950-7051(02)00021-7; Cantu RC, 2001, J ATHL TRAINING, V36, P244; DUDA OR, 2001, PATTERN CLASSIFICATI; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Faul M, 2010, TRAUMATIC BRAIN INJU; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Giza CC, 2001, J ATHL TRAINING, V36, P228; Hanley D.F., 2013, J NEUROTRAUMA; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; John E.R., 1987, HDB ELECTROENCEPHALO, P449; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Langlois J.A., 2006, J HEAD TRAUMA REHABI, V21; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mitchell M., 1996, INTRO GENETIC ALGORI; Molina DK, 2007, J TRAUMA, V63, P625, DOI 10.1097/01.ta.0000236055.33085.77; Naunheim RS, 2011, AM J EMERG MED, V29, P845, DOI 10.1016/j.ajem.2010.03.010; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; O'Neil B, 2012, WEST J EMERG MED, V13, P394, DOI 10.5811/westjem.2011.12.6815; Oh IS, 2004, IEEE T PATTERN ANAL, V26, P1424, DOI 10.1109/TPAMI.2004.105; Opitz D., 1999, J ARTIF INTELL RES, V11, P169, DOI [DOI 10.1613/JAIR.614, 10.1613/jair.614]; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Prichep LS, 2005, CLIN EEG NEUROSCI, V36, P82, DOI 10.1177/155005940503600207; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Raymer ML, 2000, IEEE T EVOLUT COMPUT, V4, P164, DOI 10.1109/4235.850656; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; SIEDLECKI W, 1989, PATTERN RECOGN LETT, V10, P335, DOI 10.1016/0167-8655(89)90037-8; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stiell I.G., 2000, ACAD EMERG MED, V7, P572; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Syswerda G, 1991, P 4 INT C GEN ALG, P502; TEASDALE G, 1974, LANCET, V2, P81; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; Thakor NV, 2004, ANNU REV BIOMED ENG, V6, P453, DOI 10.1146/annurev.bioeng.5.040202.121601; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tomassini Marco, 1999, EVOLUTIONARY ALGORIT; Turner K., 1996, P 13 INT C PATT REC, P25; Yang JH, 1998, IEEE INTELL SYST APP, V13, P44, DOI 10.1109/5254.671091	47	27	27	1	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	OCT 1	2014	53						125	133		10.1016/j.compbiomed.2014.07.011			9	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	AR5HY	WOS:000343617000014	25137412				2022-02-06	
J	Kilcoyne, KG; Dickens, JF; Svoboda, SJ; Owens, BD; Cameron, KL; Sullivan, RT; Rue, JP				Kilcoyne, Kelly G.; Dickens, Jonathan F.; Svoboda, Steven J.; Owens, Brett D.; Cameron, Kenneth L.; Sullivan, Robert T.; Rue, John-Paul			Reported Concussion Rates for Three Division I Football Programs: An Evaluation of the New NCAA Concussion Policy	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; mild traumatic brain injury; incidence; NCAA	UNITED-STATES; EPIDEMIOLOGY; INJURY; SPORTS	Background: There has been increased interest in the number of concussions occurring in college football over the past year. In April 2010, the National Collegiate Athletic Association (NCAA) published new guidelines for the diagnosis and treatment of concussions in student athletes. Purpose: To determine the number of concussions that occurred on 3 collegiate Division I military academy football teams prior to and following recent changes in the NCAA concussion management policy. Study Design: Descriptive epidemiology study. Methods: Injury reports were reviewed from 3 Division I military academy football teams. The number of concussions that occurred over the 2009-2010 and 2010-2011 seasons, including those sustained in practice and game situations, was determined for each team. Incidence rates were compared using the exact binomial method. Results: The combined concussion incidence rate doubled from 0.57 per 1000 athlete exposures in the 2009-2010 season to 1.16 per 1000 athlete exposures in the 2010-2011 season (incidence rate ratio, 2.04; 95% CI, 1.2-3.55; P = 0.01). The combined numbers of concussions for the 2009-2010 and 2010-2011 seasons were 23 (40,481 exposures) and 42 (36,228), respectively. Conclusion: The combined incidence rate of concussions for the 2010-2011 season doubled from the previous season after the implementation of new NCAA policies on concussion management. While the institution of a more formalized concussion plan on the part of medical staff is one possible factor, another may have been the increased recognition and reporting on the part of players and coaches after the rule change.	[Kilcoyne, Kelly G.; Dickens, Jonathan F.] Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA; [Svoboda, Steven J.; Owens, Brett D.; Cameron, Kenneth L.] US Mil Acad, Keller Army Hosp, John Feagin, West Point, NY 10996 USA; [Sullivan, Robert T.] US Air Force Acad, Colorado Springs, CO 80840 USA; [Rue, John-Paul] US Naval Acad, Annapolis, MD 21402 USA		Kilcoyne, KG (corresponding author), Walter Reed Natl Mil Med Ctr, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	Kelly.g.kilcoyne@us.army.mil		Cameron, Kenneth/0000-0002-6276-4482			[Anonymous], 2009, NY TIMES; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Booher MA, 2003, CLIN J SPORT MED, V13, P93, DOI 10.1097/00042752-200303000-00005; Cantu RC, 2006, NEUROSURG FOCUS, V21, P1, DOI [10.3171/foc.2006.21.4.4, DOI 10.3171/FOC.2006.21.4.4]; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Dick R, 2007, J ATHL TRAINING, V42, P221; Dunkle D., 2010, CONCUSSION MANAGEMEN, P1; Ellenbogen RG, 2010, WORLD NEUROSURG, V74, P560, DOI 10.1016/j.wneu.2010.11.016; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Klossner D., 2009, NCAA SPORTS MED HDB, P52; Klossner D., 2010, NCAA SPORTS MED HDB; Knowles SB, 2006, J ATHL TRAINING, V41, P207; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; Standaert CJ, 2007, ARCH PHYS MED REHAB, V88, P1077, DOI 10.1016/j.apmr.2007.06.002; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003	19	27	27	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP-OCT	2014	6	5					402	405		10.1177/1941738113491545			4	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V20FU	WOS:000214873300004	25177415	Green Published			2022-02-06	
J	Maestas, KL; Sander, AM; Clark, AN; van Veldhoven, LM; Struchen, MA; Sherer, M; Hannay, HJ				Maestas, Kacey Little; Sander, Angelle M.; Clark, Allison N.; van Veldhoven, Laura M.; Struchen, Margaret A.; Sherer, Mark; Hannay, H. Julia			Preinjury Coping, Emotional Functioning, and Quality of Life Following Uncomplicated and Complicated Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anxiety; cluster analysis; coping behavior; coping skills; depression; emotional disturbances; quality of life; rehabilitation; traumatic brain injury	CLUSTER-ANALYTIC APPROACH; SPINAL-CORD-INJURY; BREAST-CANCER; HEAD-INJURY; STRESS-DISORDER; SOCIAL SUPPORT; RISK-FACTORS; MONTE-CARLO; DEPRESSION; ADJUSTMENT	Objective: To identify preinjury coping profiles among adults with uncomplicated mild traumatic brain injury (mTBI) and complicated mTBI and to determine whether preinjury coping profiles contribute to the prediction of emotional functioning and quality of life (QOL) 3 months post-mTBI. Participants: One hundred eighty-seven persons with medically documented mTBI (uncomplicated mTBI, n = 89; complicated mTBI, n = 98) were recruited from the emergency center of a level I trauma center and followed in community 3 months post-mTBI. Measures: The Ways of Coping Questionnaire was administered within 2 weeks of injury. Cluster analysis was used to group participants on basis of their preinjury use of problem-focused and avoidant coping strategies. The Brief Symptom Inventory and the 36-item Short-Form Health Survey were administered 3 months postinjury. Results: Cluster analysis distinguished 3 distinct preinjury coping profiles that were differentially associated with outcomes. Participants who used avoidant coping showed the worse emotional functioning and QOL outcomes, although this cluster also reported high usage of problem-focused strategies. Preinjury coping profiles explained a significant proportion of the variance in depression, anxiety, and mental health QOL at 3 months postinjury beyond that accounted for by demographic characteristics andmTBI severity. Conclusions: Cluster analysis holds practical value in illustrating the pattern of coping strategies used by person with uncomplicated and complicated mTBI. It appears worthwhile to address coping in future trials of interventions that are aimed at improving emotional functioning after mTBI.	[Maestas, Kacey Little; Clark, Allison N.; van Veldhoven, Laura M.; Struchen, Margaret A.; Sherer, Mark] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77019 USA; [Maestas, Kacey Little; Sander, Angelle M.; Clark, Allison N.; van Veldhoven, Laura M.; Struchen, Margaret A.; Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Sander, Angelle M.] Univ Houston, Dept Phys Med & Rehabil, Houston, TX USA; [Hannay, H. Julia] Univ Houston, Dept Neurosurg, Houston, TX USA; [Hannay, H. Julia] Univ Houston, Baylor Coll Med Harris Hlth Syst, Houston, TX USA; [Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX USA		Maestas, KL (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 2323 S Shepherd Dr,Ste 907, Houston, TX 77019 USA.	kacey.maestas@memorialhermann.org		Hannay, H. Julia/0000-0001-7023-912X	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133P080007, H133B990014, H133B090023, H133A070043]	This work was supported in part by grants from the National Institute on Disability and Rehabilitation Research, US Department of Education (grant nos. H133P080007, H133B990014, H133B090023, and H133A070043).	Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; BOMBARDIER CH, 1990, BEHAV RES THER, V28, P297, DOI 10.1016/0005-7967(90)90081-S; Broomhall LGJ, 2009, J NERV MENT DIS, V197, P178, DOI 10.1097/NMD.0b013e318199fe7f; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, NAT CTR INJ PREV CON; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; Clatworthy J, 2007, PSYCHOL HEALTH, V22, P123, DOI 10.1080/14768320600774496; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Finset A, 2000, BRAIN INJURY, V14, P887; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Folkman S., 1984, STRESS; Folkman S., 1988, MANUAL WAYS COPING Q; FRANK RG, 1987, J CONSULT CLIN PSYCH, V55, P727; Hack TF, 1999, BREAST CANCER RES TR, V54, P185, DOI 10.1023/A:1006145504850; Hack TF, 2004, PSYCHO-ONCOL, V13, P235, DOI 10.1002/pon.739; Hamilton JB, 2011, J PAIN SYMPTOM MANAG, V41, P79, DOI 10.1016/j.jpainsymman.2010.04.013; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Krpan KM, 2011, BRAIN INJURY, V25, P989, DOI 10.3109/02699052.2011.597045; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; MILLIGAN GW, 1981, MULTIVAR BEHAV RES, V16, P379, DOI 10.1207/s15327906mbr1603_7; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rutskij R, 2010, PSYCHOL HEALTH MED, V15, P146, DOI 10.1080/13548501003623955; Shapiro DE, 1997, J PSYCHOSOM RES, V43, P143, DOI 10.1016/S0022-3999(97)80001-3; SHAPIRO DE, 1994, J PSYCHOSOM RES, V38, P151, DOI 10.1016/0022-3999(94)90088-4; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Strom TQ, 2007, BRAIN INJURY, V21, P1137, DOI 10.1080/02699050701687334; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Trask PC, 2004, J PSYCHOSOM RES, V57, P287, DOI 10.1016/j.jpsychores.2004.01.005; van Leeuwen CMC, 2012, SPINAL CORD, V50, P174, DOI 10.1038/sc.2011.120; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Ware J.E., 1994, SF 36 PHYS MENTAL SU; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Willebrand M, 2002, BURNS, V28, P549, DOI 10.1016/S0305-4179(02)00064-5; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolters G, 2011, J HEAD TRAUMA REHAB, V26, P150, DOI 10.1097/HTR.0b013e3181e421dc; Zasler N., 2007, BRAIN INJURY MED PRI	64	27	27	1	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					407	417		10.1097/HTR.0b013e31828654b4			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700009	23535388				2022-02-06	
J	Moster, S; Wilson, JA; Galetta, SL; Balcer, LJ				Moster, Stephen; Wilson, James A.; Galetta, Steven L.; Balcer, Laura J.			The King-Devick (K-D) test of rapid eye movements: A bedside correlate of disability and quality of life in MS	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						King-Devick; Quality of life; Visual acuity; Low-contrast letter acuity; Optical coherence tomography; Retinal nerve fiber layer	MULTIPLE-SCLEROSIS; VISION; CONCUSSION	Objective: We investigated the King-Devick (K-D) test of rapid number naming as a visual performance measure in a cohort of patients with multiple sclerosis (MS). Methods: In this cross-sectional study, 81 patients with MS and 20 disease-free controls from an ongoing study of visual outcomes underwent K-D testing. A test of rapid number naming, K-D requires saccadic eye movements as well as intact vision, attention and concentration. To perform the K-D test, participants are asked to read numbers aloud as quickly as possible from three test cards; the sum of the three test card times in seconds constitutes the summary score. High-contrast visual acuity (VA), low-contrast letter acuity (1.25% and 25% levels), retinal nerve fiber layer (RNFL) thickness by optical coherence tomography (OCT), MS Functional Composite (MSFC) and vision-specific quality of life (QOL) measures (25-Item NEI Visual Functioning Questionnaire [NEI-VFQ-25] and 10-Item Neuro-Ophthalmic Supplement) were also assessed. Results: K-D time scores in the MS cohort (total time to read the three test cards) were significantly higher (worse) compared to those for disease-free controls (P = 0.003, linear regression, accounting for age). Within the MS cohort, higher K-D scores were associated with worse scores for the NEI-VFQ-25 composite (P < 0.001), 10-Item Neuro-Ophthalmic Supplement (P < 0.001), binocular low-contrast acuity (25%, 1.25%, P < 0.001, and high-contrast VA (P = 0.003). Monocular low-contrast vision scores (P = 0.001-0.009) and RNFL thickness (P = 0.001) were also reduced in eyes of patients with worse K-D scores (GEE models accounting for age and within-patient, inter-eye correlations). Patients with a history of optic neuritis (ON) had increased (worse) K-D scores. Patients who classified their work disability status as disabled (receiving disability pension) did worse on K-D testing compared to those working full-time (P = 0.001, accounting for age). Conclusions: The K-D test, a <2 minute bedside test of rapid number naming, is associated with visual dysfunction, neurologic impairment, and reduced vision-specific QOL in patients with MS. Scores reflect work disability as well as structural changes as measured by OCT imaging. History of ON and abnormal binocular acuities were associated with worse K-D scores, suggesting that abnormalities detected by K-D may go along with afferent dysfunction in MS patients. A brief test that requires saccadic eye movements, K-D should be considered for future MS trials as a rapid visual performance measure. (C), 2014 Elsevier B.V. All rights reserved.	[Moster, Stephen; Wilson, James A.; Galetta, Steven L.; Balcer, Laura J.] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA		Balcer, LJ (corresponding author), NYU, Sch Med, 240 East 38th St,15th Floor, New York, NY 10016 USA.	laura.balcer@nyumc.org					Baumstarck K, 2013, MULT SCLER INT, V2013, P1; BLAKE R, 1973, PERCEPT PSYCHOPHYS, V14, P161, DOI 10.3758/BF03198631; BLAKE R, 1981, PERCEPT PSYCHOPHYS, V30, P266, DOI 10.3758/BF03214282; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Kulp MT, 1997, OPTOMETRY VISION SCI, V74, P37, DOI 10.1097/00006324-199701000-00018; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mowry EM, 2009, J NEUROL NEUROSUR PS, V80, P767, DOI 10.1136/jnnp.2008.165449; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Pineles SL, 2011, AM J OPHTHALMOL, V152, P133, DOI 10.1016/j.ajo.2011.01.023; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Raphael BA, 2006, AM J OPHTHALMOL, V142, P1026, DOI 10.1016/j.ajo.2006.06.060; Rudick RA, 2009, MULT SCLER J, V15, P984, DOI 10.1177/1352458509106212; Sakai RE, 2011, J NEURO-OPHTHALMOL, V31, P362, DOI 10.1097/WNO.0b013e318238937f; Talman LS, 2010, ANN NEUROL, V67, P749, DOI 10.1002/ana.22005; Wu GF, 2007, NEUROLOGY, V69, P2128, DOI 10.1212/01.wnl.0000278387.15090.5a	20	27	27	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	AUG 15	2014	343	1-2					105	109		10.1016/j.jns.2014.05.047			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN0WE	WOS:000340303900021	24954088				2022-02-06	
J	Ignatowski, TA; Spengler, RN; Dhandapani, KM; Folkersma, H; Butterworth, RF; Tobinick, E				Ignatowski, Tracey A.; Spengler, Robert N.; Dhandapani, Krishnan M.; Folkersma, Hedy; Butterworth, Roger F.; Tobinick, Edward			Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence	CNS DRUGS			English	Article							TUMOR-NECROSIS-FACTOR; TRAUMATIC BRAIN-INJURY; TRANSFORAMINAL EPIDURAL ETANERCEPT; VERTEBRAL VENOUS PLEXUS; FACTOR-ALPHA EXPRESSION; PAIN-RELATED BEHAVIOR; OFF-LABEL USE; TNF-ALPHA; ALZHEIMERS-DISEASE; INTRACEREBRAL HEMORRHAGE	There is increasing recognition of the involvement of the immune signaling molecule, tumor necrosis factor (TNF), in the pathophysiology of stroke and chronic brain dysfunction. TNF plays an important role both in modulating synaptic function and in the pathogenesis of neuropathic pain. Etanercept is a recombinant therapeutic that neutralizes pathologic levels of TNF. Brain imaging has demonstrated chronic intracerebral microglial activation and neuroinflammation following stroke and other forms of acute brain injury. Activated microglia release TNF, which mediates neurotoxicity in the stroke penumbra. Recent observational studies have reported rapid and sustained improvement in chronic post-stroke neurological and cognitive dysfunction following perispinal administration of etanercept. The biological plausibility of these results is supported by independent evidence demonstrating reduction in cognitive dysfunction, neuropathic pain, and microglial activation following the use of etanercept, as well as multiple studies reporting improvement in stroke outcome and cognitive impairment following therapeutic strategies designed to inhibit TNF. The causal association between etanercept treatment and reduction in post-stroke disability satisfy all of the Bradford Hill Criteria: strength of the association; consistency; specificity; temporality; biological gradient; biological plausibility; coherence; experimental evidence; and analogy. Recognition that chronic microglial activation and pathologic TNF concentration are targets that may be therapeutically addressed for years following stroke and other forms of acute brain injury provides an exciting new direction for research and treatment.	[Ignatowski, Tracey A.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA; [Ignatowski, Tracey A.] SUNY Buffalo, Sch Med & Biomed Sci, Program Neurosci, Buffalo, NY 14260 USA; [Spengler, Robert N.] NanoAxis LLC, Clarence, NY USA; [Dhandapani, Krishnan M.] Georgia Regents Univ, Med Coll Georgia, Dept Neurosurg, Augusta, GA USA; [Folkersma, Hedy] Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands; [Butterworth, Roger F.] Univ Montreal, Hop St Luc CHUM, Neurosci Res Unit, Montreal, PQ, Canada; [Tobinick, Edward] Inst Neurol Recovery, Boca Raton, FL 33431 USA		Tobinick, E (corresponding author), Inst Neurol Recovery, 2300 Glades Rd Suite 305E, Boca Raton, FL 33431 USA.	nrimed@gmail.com	Ignatowski, Tracey/ABG-8740-2020	Ignatowski, Tracey/0000-0002-8033-4566; Dhandapani, Krishnan/0000-0001-7044-1117; Tobinick, Edward/0000-0001-7614-499X			American Psychiatric Association, 2001, PRINC MED ETH ANN ES, P46; ANDERSON R, 1951, J NEUROSURG, V8, P411, DOI 10.3171/jns.1951.8.4.0411; [Anonymous], 2008, LANCET NEUROL, V7, P285, DOI 10.1016/S1474-4422(08)70050-4; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Aronson JK, 2006, BMJ-BRIT MED J, V333, P1267, DOI 10.1136/bmj.39036.666389.94; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bacher M, 2009, NEUROSCI LETT, V449, P240, DOI 10.1016/j.neulet.2008.08.083; Bains JS, 2007, TRENDS NEUROSCI, V30, P417, DOI 10.1016/j.tins.2007.06.007; BANKS WA, 1995, NEUROIMMUNOMODULAT, V2, P161, DOI 10.1159/000096887; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Bassi E, 2010, AM J CLIN DERMATOL, V11, P44, DOI 10.2165/1153423-S0-000000000-00000; Batson OV, 1940, ANN SURG, V112, P138, DOI 10.1097/00000658-194007000-00016; BATSON OV, 1957, AMER J ROENTGENOL RA, V78, P195; Bauer HH, 2012, DOGMATISM SCI MED DO, Vvii, P293; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Beattie MS, 2010, EUR J NEUROSCI, V32, P290, DOI 10.1111/j.1460-9568.2010.07343.x; Beck JM, 1998, FOOD DRUG LAW J, V53, P71; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Bemeur C, 2010, NEUROCHEM INT, V56, P213, DOI 10.1016/j.neuint.2009.11.010; Blaylock Russell L, 2013, Surg Neurol Int, V4, P118, DOI 10.4103/2152-7806.118349; Bohac D., 2002, NEUROBIOL AGING S1, V23, pS1; Brambilla L, 2013, PRION, V7, P28, DOI 10.4161/pri.22512; Breschet G, 1819, THESIS F MED PARIS; Breschet G., 1829, RECHERCHES ANATOMIQU, P48; Buchhave P, 2010, NEUROBIOL AGING, V31, P1877, DOI 10.1016/j.neurobiolaging.2008.10.012; Butchart J, 2012, CNS NEUROSCI THER, V18, P64, DOI 10.1111/j.1755-5949.2011.00245.x; Butterworth RF, 2013, NAT REV GASTRO HEPAT, V10, P522, DOI 10.1038/nrgastro.2013.99; Butterworth RF, 2011, NEUROCHEM INT, V59, P830, DOI 10.1016/j.neuint.2011.07.014; Butterworth RF, 2011, HEPATOLOGY, V53, P1372, DOI 10.1002/hep.24228; Camara ML, 2013, PSYCHONEUROENDOCRINO, V38, P3102, DOI 10.1016/j.psyneuen.2013.09.010; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Cavanagh C, 2011, FUTUR NEUROL, V6, P757, DOI 10.2217/FNL.11.50; Chastre A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049670; Chen YM, 2010, JOINT BONE SPINE, V77, P366, DOI 10.1016/j.jbspin.2010.01.017; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Chou RC, AM COLL RHEUM ANN M; Clark IA, 2009, PARASITOLOGY, V136, P1457, DOI 10.1017/S0031182009006088; Clark I A, 1992, Immunol Ser, V56, P365; CLARK IA, 1989, T ROY SOC TROP MED H, V83, P436, DOI 10.1016/0035-9203(89)90240-X; CLARK IA, 1990, IMMUNOL LETT, V25, P195, DOI 10.1016/0165-2478(90)90114-6; CLARK IA, 1991, LANCET, V337, P302, DOI 10.1016/0140-6736(91)90915-C; CLARK IA, 1993, Q J MED, V86, P217; Clark I, 2012, CNS DRUGS, V26, P1071, DOI 10.1007/s40263-012-0014-1; Clark I, 2012, PHARMACOL REV, V64, P1004, DOI 10.1124/pr.112.005850; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; Clark IA, 2013, BIOCHEM PHARMACOL, V86, P862, DOI 10.1016/j.bcp.2013.07.030; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Coelho SC, 2014, EUR J PAIN; Cohen SP, 2009, ANESTHESIOLOGY, V110, P1116, DOI 10.1097/ALN.0b013e3181a05aa0; Covey WC, 2002, REGION ANESTH PAIN M, V27, P357, DOI 10.1053/rapm.2002.31930; Covey WC, 2000, BRAIN RES, V859, P113, DOI 10.1016/S0006-8993(00)01965-X; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Dabus G, 2012, WORLD NEUROSURG, V77, DOI 10.1016/j.wneu.2011.01.031; Dacks PA, 2014, JAMA NEUROL, V71, P137, DOI 10.1001/jamaneurol.2013.5376; De Sanctis JB, 2010, RECENT PATENTS INFLA, V4, P144, DOI 10.2174/187221310791163026; De Wyngaert R, 2009, NEURORADIOLOGY, V51, P385, DOI 10.1007/s00234-009-0505-z; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; DeMonaco HJ, 2006, PHARMACOTHERAPY, V26, P323, DOI 10.1592/phco.26.3.323; Detrait ER, 2014, NEUROCHEM INT, V72, P10, DOI 10.1016/j.neuint.2014.04.001; Di Bona D, 2009, BRAIN RES REV, V61, P60, DOI 10.1016/j.brainresrev.2009.05.001; Dogrul A, 2011, ACTA DIABETOL, V48, P135, DOI 10.1007/s00592-010-0237-x; DUBOIS A, 1988, BRAIN RES, V445, P77, DOI 10.1016/0006-8993(88)91076-1; Dumont TM, 2010, SPINE, V35, pE1238, DOI 10.1097/BRS.0b013e3181f62600; Dziedzic T, 2002, STROKE, V33, P2334, DOI 10.1161/01.STR.0000027211.73567.FA; Elfferich MD, 2010, RESPIRATION, V80, P212, DOI 10.1159/000314225; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Etz CD, 2008, J THORAC CARDIOV SUR, V135, P324, DOI 10.1016/j.jtcvs.2007.11.002; Faingold C. L., 2014, NEURONAL NETWORKS BR; Fang HY, 2007, J CLIN NEUROSCI, V14, P435, DOI 10.1016/j.jocn.2005.12.022; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Folkersma H, 2011, J NUCL MED, V52, P1235, DOI 10.2967/jnumed.110.084061; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Frattarelli DAC, 2014, PEDIATRICS, V133, P563, DOI 10.1542/peds.2013-4060; Freeman BJC, 2013, SPINE, V38, P1986, DOI 10.1097/01.brs.0000435140.61593.4c; Friedman P J, 1990, Int Disabil Stud, V12, P119; Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Galustian C, 2004, EXPERT OPIN BIOL TH, V4, P1963, DOI 10.1517/14712598.4.12.1963; Gasco J, 2009, SKULL BASE-INTERD AP, V19, P425, DOI 10.1055/s-0029-1224774; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Ghaemi S Nassir, 2007, Philos Ethics Humanit Med, V2, P26, DOI 10.1186/1747-5341-2-26; Giuliani F, 2009, BRAIN RES BULL, V80, P302, DOI 10.1016/j.brainresbull.2009.07.009; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Grant GJ, 2005, OBSTET GYNECOL, V106, P384, DOI 10.1097/01.AOG.0000168452.10067.27; Gray H, 1866, ANATOMY DESCRIPTIVE; Griessenauer CJ, 2014, CLIN ANAT; Griessenauer CJ, 2014, VENOUS DRAINAGE SPIN; Griffin WST, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-3; Groen RJM, 1997, ANAT REC, V249, P285, DOI 10.1002/(SICI)1097-0185(199710)249:2<285::AID-AR16>3.0.CO;2-K; Groen RJM, 2004, SPINE, V29, P1465, DOI 10.1097/01.BRS.0000128758.64381.75; Gururaja TL, 2007, CHEM BIOL, V14, P1105, DOI 10.1016/j.chembiol.2007.08.012; Hachinski V, 2010, STROKE, V41, P1084, DOI 10.1161/STROKEAHA.110.586156; HERLIHY W F, 1947, Med J Aust, V1, P661; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hojlund J, 2012, ANESTHESIOL RES PRAC, V2012, DOI 10.1155/2012/647258; Horrobin DF, 2002, LANCET, V359, P1857, DOI 10.1016/S0140-6736(02)08707-X; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; Hughes JL, 2010, NEUROIMAGE, V49, P19, DOI 10.1016/j.neuroimage.2009.08.047; Ignatowski TA, 2013, 4TH INTERNATIONAL CONGRESS ON NEUROPATHIC PAIN, P29; Ignatowski TA, 1999, BRAIN RES, V841, P70, DOI 10.1016/S0006-8993(99)01782-5; Ignatowski TA, 2008, NEUROIMMUNE, V6, P111; Jiang WL, 2009, J CEREBR BLOOD F MET, V29, P944, DOI 10.1038/jcbfm.2009.18; Jiang WL, 2009, J NEUROCHEM, V109, P485, DOI 10.1111/j.1471-4159.2009.05981.x; John CC, 2008, AM J TROP MED HYG, V78, P198, DOI 10.4269/ajtmh.2008.78.198; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P27, DOI 10.1016/S0003-9993(95)80038-7; Kaplan BJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-65; Kato K, 2009, NEUROSCIENCE, V160, P492, DOI 10.1016/j.neuroscience.2009.02.038; Kaufman EL, 2013, OPEN SPINE J, V5, P12; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim JS, 1996, STROKE, V27, P1553, DOI 10.1161/01.STR.27.9.1553; King MD, 2014, INT J CELL BIOL; King MD, 2013, NEUROSCI LETT, V542, P92, DOI 10.1016/j.neulet.2013.02.051; Kirschner KL, 2013, PM&R, V5, P882, DOI 10.1016/j.pmrj.2013.08.601; Kitanaka C, 1999, CELL DEATH DIFFER, V6, P508, DOI 10.1038/sj.cdd.4400526; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Kooijman E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090584; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kuhn TS, 1962, STRUCTURE SCI REVOLU, Vxv, P172; Kuhn TS, 2000, ROAD STRUCTURE PHILO, Vviii, P335; LaBan MM, 1998, AM J PHYS MED REHAB, V77, P553, DOI 10.1097/00002060-199811000-00021; LaBan MM, 1997, AM J PHYS MED REHAB, V76, P517, DOI 10.1097/00002060-199711000-00016; Laird MD, 2008, FREE RADICAL BIO MED, V45, P1103, DOI 10.1016/j.freeradbiomed.2008.07.003; Laws SM, 2005, HUM MUTAT, V26, P29, DOI 10.1002/humu.20180; Lei BL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-103; Li SR, 2011, BLOOD, V117, P5157, DOI 10.1182/blood-2010-10-314278; Lindenlaub T, 2000, BRAIN RES, V866, P15, DOI 10.1016/S0006-8993(00)02190-9; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Low PC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4450; Lu AG, 2006, J CEREBR BLOOD F MET, V26, P230, DOI 10.1038/sj.jcbfm.9600183; Marchand F, 2009, EUR J PAIN, V13, P673, DOI 10.1016/j.ejpain.2008.08.001; Martuscello RT, 2012, PAIN, V153, P1871, DOI 10.1016/j.pain.2012.05.028; Maudsley S, 2012, CURR ALZHEIMER RES, V9, P1; Mayhan WG, 2002, BRAIN RES, V927, P144, DOI 10.1016/S0006-8993(01)03348-0; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; McNaull BBA, 2010, GERONTOLOGY, V56, P3, DOI 10.1159/000237873; Medeiros R, 2007, J NEUROSCI, V27, P5394, DOI 10.1523/JNEUROSCI.5047-06.2007; Mendis S, 2013, INT J STROKE, V8, P3, DOI 10.1111/j.1747-4949.2012.00969.x; Miklossy J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-90; Miller ZA, 2013, J NEUROL NEUROSUR PS, V84, P956, DOI 10.1136/jnnp-2012-304644; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Morimoto Akira, 2009, Legal Medicine, V11, P10, DOI 10.1016/j.legalmed.2008.07.006; MYERS R, 1991, NEUROSCI LETT, V133, P20, DOI 10.1016/0304-3940(91)90047-W; Nathoo N, 2011, NEUROSURGERY, V69, P1007, DOI 10.1227/NEU.0b013e3182274865; Nawashiro H, 1997, BRAIN RES, V778, P265, DOI 10.1016/S0006-8993(97)00981-5; Netter FH, 1958, CIBA COLLECTION MED; Neurex, 2012, M ROL TNF BRAIN DYSF; Nygard M, 2009, NEUROREPORT, V20, P213, DOI 10.1097/WNR.0b013e32831f1ca2; OCEBM Levels of Evidence Working Group, 2011, OXF 2011 LEV EV; Ohtori S, 2012, SPINE, V37, P439, DOI 10.1097/BRS.0b013e318238af83; Oka T, 1996, NEUROIMMUNOMODULAT, V3, P135, DOI 10.1159/000097238; Pan WH, 2007, PROG NEUROBIOL, V83, P363, DOI 10.1016/j.pneurobio.2007.07.008; Pappata S, 2000, NEUROLOGY, V55, P1052, DOI 10.1212/WNL.55.7.1052; Pearce JMS, 2006, EUR NEUROL, V56, P136, DOI 10.1159/000095706; Perry RT, 2001, NEUROBIOL AGING, V22, P873, DOI 10.1016/S0197-4580(01)00291-3; Pettygrove S, 2008, ENCY EPIDEMIOL, V1, P282; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Price CJS, 2006, STROKE, V37, P1749, DOI 10.1161/01.STR.0000226980.95389.0b; Puri AS, 2014, J NEUROINTERV SURG, V6, P150, DOI 10.1136/neurintsurg-2012-010589; Quain J, 1867, ELEMENTS ANATOMY; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ramos EM, 2006, ARCH NEUROL-CHICAGO, V63, P1165, DOI 10.1001/archneur.63.8.1165; Reynolds JL, 2005, J NEUROSCI RES, V79, P779, DOI 10.1002/jnr.20407; Riggs JE, 1996, ARCH NEUROL-CHICAGO, V53, P1306, DOI 10.1001/archneur.1996.00550120118026; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; Romanic AM, 1998, STROKE, V29, P1020, DOI 10.1161/01.STR.29.5.1020; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Rossi D, 2011, CNS DRUGS, V25, P641, DOI 10.2165/11593090-000000000-00000; Rubenstein JL, 2003, BLOOD, V101, P466, DOI 10.1182/blood-2002-06-1636; Sainoh T, 2013, INT SOC STUD LUMB SP; Santello M, 2012, TRENDS NEUROSCI, V35, P638, DOI 10.1016/j.tins.2012.06.001; Sarajarvi T, 2010, J ALZHEIMERS DIS, V21, P763, DOI 10.3233/JAD-2010-100597; See Andrew, 2000, DEFENCE COUNSEL J, V67, P478; Shen CH, 2011, ANESTH ANALG, V112, P454, DOI 10.1213/ANE.0b013e3182025b15; Sheridan C, 2009, NAT BIOTECHNOL, V27, P679, DOI 10.1038/nbt0809-679; SHERMAN ML, 1988, J CLIN ONCOL, V6, P344, DOI 10.1200/JCO.1988.6.2.344; Shi JQ, 2011, J AM GERIATR SOC, V59, P1142, DOI 10.1111/j.1532-5415.2011.03445.x; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Siniscalchi Antonio, 2014, Journal of Basic and Clinical Physiology and Pharmacology, V25, P131, DOI 10.1515/jbcpp-2013-0121; Sjogren M, 2004, J NEUROL NEUROSUR PS, V75, P1107, DOI 10.1136/jnnp.2003.019422; Skolarus LE, 2014, STROKE, V45, P224, DOI 10.1161/STROKEAHA.113.002874; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Sommer C, 2001, BRAIN RES, V913, P86, DOI 10.1016/S0006-8993(01)02743-3; Sommer C, 2001, J PERIPHER NERV SYST, V6, P67, DOI 10.1046/j.1529-8027.2001.01010.x; Sommer C, 1998, EXP NEUROL, V151, P138, DOI 10.1006/exnr.1998.6797; SPRIGGS DR, 1988, J NATL CANCER I, V80, P1039, DOI 10.1093/jnci/80.13.1039; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Strong C, 2013, J CLIN NEUROSCI, V20, P1546, DOI 10.1016/j.jocn.2013.02.014; Sumbria RK, 2012, J CEREBR BLOOD F MET, V32, P1933, DOI 10.1038/jcbfm.2012.97; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Tarkowski E, 1999, J CLIN IMMUNOL, V19, P223, DOI 10.1023/A:1020568013953; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tobinick E, 2004, CURR MED RES OPIN, V20, P1075, DOI 10.1185/030079903125004286; Tobinick E, 2007, CURR ALZHEIMER RES, V4, P550, DOI 10.2174/156720507783018217; Tobinick Edward, 2006, MedGenMed, V8, P25; Tobinick Edward, 2006, MedGenMed, V8, P53; Tobinick E, 2014, CLIN DRUG INVEST, V34, P361, DOI 10.1007/s40261-014-0186-1; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tobinick E, 2012, CURR ALZHEIMER RES, V9, P99, DOI 10.2174/156720512799015073; Tobinick E, 2011, CNS DRUGS, V25, P145, DOI 10.2165/11588400-000000000-00000; Tobinick E, 2010, EXPERT REV NEUROTHER, V10, P985, DOI 10.1586/ERN.10.52; Tobinick E, 2009, CNS DRUGS, V23, P713, DOI 10.2165/11310810-000000000-00000; Tobinick Edward, 2008, Medscape J Med, V10, P135; Tobinick E, 2009, DRUG DISCOV TODAY, V14, P168, DOI 10.1016/j.drudis.2008.10.005; Tobinick EL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-27; Tobinick EL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-2; Tobinick Edward L, 2009, BMC Res Notes, V2, P28; Tobinick EL, 2003, CLIN THER, V25, P2279, DOI 10.1016/S0149-2918(03)80219-9; Tobinick EL, 2003, SWISS MED WKLY, V133, P170; Tobinick EL, 2003, CLIN THER, V25, P1211, DOI 10.1016/S0149-2918(03)80077-2; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Trollor JN, 2010, DEMENT GERIATR COGN, V30, P569, DOI 10.1159/000322092; Tubbs RS, 2007, CLIN ANAT, V20, P755, DOI 10.1002/ca.20494; Tweedie D, 2007, CURR ALZHEIMER RES, V4, P378, DOI 10.2174/156720507781788873; WADE DT, 1987, SCAND J REHABIL MED, V19, P25; Wagner KR, 2006, ACTA NEUROCHIR SUPPL, V96, P177; Walsh N., 2010, MEDPAGE TODAY, V9, P2010; Wang QW, 2005, EUR J NEUROSCI, V22, P2827, DOI 10.1111/j.1460-9568.2005.04457.x; Wang Y, 2008, ALZHEIMER DEMENT S, V4, pT749; Wasserman JK, 2007, BRAIN RES, V1180, P140, DOI 10.1016/j.brainres.2007.08.058; Watanabe K, 2011, EUR SPINE J, V20, P1877, DOI 10.1007/s00586-011-1854-y; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Williams M, 2012, TRANSLATIONAL NEUROSCIENCE: APPLICATIONS IN PSYCHIATRY, NEUROLOGY, AND NEURODEVELOPMENTAL DISORDERS, P129; Winkelstein BA, 2014, INTERVERTEBRAL DISC; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Wolinsky H, 2008, EMBO REP, V9, P416, DOI 10.1038/embor.2008.65; Works MG, 2013, J CEREBR BLOOD F MET, V33, P1376, DOI 10.1038/jcbfm.2013.100; Xi GH, 2001, STROKE, V32, P162, DOI 10.1161/01.STR.32.1.162; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Yoon JS, 2013, J NEUROSCI RES, V91, P671, DOI 10.1002/jnr.23190; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zanella JM, 2008, SPINE, V33, P227, DOI 10.1097/BRS.0b013e318162340a; Zaremba J, 2000, Folia Morphol (Warsz), V59, P137; Zaremba J, 2001, BIOMED PHARMACOTHER, V55, P258, DOI 10.1016/S0753-3322(01)00058-0; Zaremba J, 2001, ACTA NEUROL SCAND, V104, P288, DOI 10.1034/j.1600-0404.2001.00053.x; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhu XX, 2003, J MED CHEM, V46, P5222, DOI 10.1021/jm030152f; Zivin JA, 2010, TPA STROKE STORY CON	253	27	29	0	10	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1172-7047	1179-1934		CNS DRUGS	CNS Drugs	AUG	2014	28	8					679	697		10.1007/s40263-014-0174-2			19	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AT0FX	WOS:000344613600001	24861337	Green Published, hybrid			2022-02-06	
J	Kerr, ZY; DeFreese, JD; Marshall, SW				Kerr, Zachary Y.; DeFreese, J. D.; Marshall, Stephen W.			Current Physical and Mental Health of Former Collegiate Athletes	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						physical health; mental health; injury; epidemiology; traumatic brain injury		Background: There is a dearth of research on the current health of former collegiate athletes. Purpose: To examine the current health and related correlates in a cohort of former collegiate athletes who played in a diverse range of men's and women's sports with various levels of contact. Study Design: Cross-sectional study; Level of evidence, 3. Methods: Former collegiate athletes (N = 3657) were asked to complete an online questionnaire addressing sports history, medical history, and demographics. The questionnaire also included the Veterans RAND 12-Item Health Survey (VR-12), which yielded 2 composite scores for physical (PCS) and mental (MCS) health. The VR-12 PCS and MCS scores were compared with published US normative data using t tests and analyses of variance. Results: Mean PCS and MCS scores of the 797 respondents with complete data (21.9% of target sample; average, 14.5 years since last played collegiate sport) were 53.0 +/- 6.1 and 51.7 +/- 9.4, respectively. When stratified by age and sex, PCS and MCS scores were similar to normative scores in the United States. Lower PCS scores were associated with sustaining >= 3 concussions, playing in collision sports during college, and sustaining a career-ending injury (all, P < .001). No association was found between concussion and MCS scores (P >= .06). Among former collegiate athletes, prevalent medical conditions included anxiety (16.2%), hypercholesterolemia/high cholesterol (10.6%), and depression (10.4%). Additionally, 5.8% screened positive for alcohol dependence, and 5.8% screened positive for disordered eating (eg, binge eating, purging). These findings were more prevalent than those reported by the World Health Organization as representative of the US population. Conversely, there was a lower prevalence of depression, bipolar disorders, and attention deficit disorder, with or without hyperactivity (ADD/ADHD), than in the World Health Organization US population data sample. Conclusion: Former collegiate athletes appear similar to the general US population on many aspects of mental and physical health. However, observed health deficits associated with previous sports injuries warrant ongoing monitoring of the health and well-being of former collegiate athletes.	[Kerr, Zachary Y.; DeFreese, J. D.; Marshall, Stephen W.] Univ North Carolina Chapel Hill, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Marshall, Stephen W.] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [DeFreese, J. D.] Univ North Carolina Chapel Hill, Ctr Study Retired Athletes, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA		Marshall, SW (corresponding author), Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Gillings Sch Global Publ Hlth, Dept Epidemiol, Suite 500,Bank Amer Bldg,CB 7505, Chapel Hill, NC 27599 USA.			Kerr, Zachary/0000-0003-1423-1259			Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; [Anonymous], 2013, BMI CLASSIFICATION; Atchley R. C., 2004, SOCIAL FORCES AGING; BERNADT MW, 1982, LANCET, V1, P325; Dave D, 2008, SOUTH ECON J, V75, P497; DeFreese JD, 2013, PSYCHOL SPORT EXERC, V14, P258, DOI 10.1016/j.psychsport.2012.10.009; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Golightly YM, 2009, J PHYS ACT HEALTH, V6, P638, DOI 10.1123/jpah.6.5.638; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Holcomb TF, 2010, HANDBOOK OF STRESSFUL TRANSITIONS ACROSS THE LIFESPAN, P133, DOI 10.1007/978-1-4419-0748-6_7; Kallus K. W., 2000, EMOTIONS SPORT, P209; Kazis L.E., 2008, VETERANS RAND 12 ITE; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2013, BIOL PSYCHIAT, V73, P904, DOI 10.1016/j.biopsych.2012.11.020; KITCHENS JM, 1994, JAMA-J AM MED ASSOC, V272, P1782, DOI 10.1001/jama.272.22.1782; Lavallee D, 1997, J PERS INTERPERS LOS, V2, P129, DOI 10.1080/10811449708414411; Malina RM, 2010, CURR SPORT MED REP, V9, P364, DOI 10.1249/JSR.0b013e3181fe3166; National Collegiate Athletic Association, 2012, EST PROB COMP ATHL H; National Collegiate Athletic Association, 2013, NCAA STUD ATHL PART; National Federation of State High School Associations, 2013, HIGH SCH SPORTS PART; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Pihl E, 2001, INT J OBESITY, V25, P1057, DOI 10.1038/sj.ijo.0801642; Reider B, 2012, AM J SPORT MED, V40, P2197, DOI 10.1177/0363546512462362; Richman JM., 1989, J APPL SPORT PSYCHOL, V1, P150, DOI DOI 10.1080/10413208908406411; Saarni SE, 2006, INT J OBESITY, V30, P1639, DOI 10.1038/sj.ijo.0803325; Schwenk TL, 2007, MED SCI SPORT EXER, V39, P599, DOI 10.1249/mss.0b013e31802fa679; Simon JE, 2014, AM J SPORT MED, V42, P423, DOI 10.1177/0363546513510393; Strand V, 2007, AM J MANAG CARE, V13, pS237; Taylor J., 2010, APPL SPORT PSYCHOL P, V6th, P542; Ware J.E., 1994, SF 36 PHYS MENTAL SU; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 1998, SF 12 PHYS MENTAL HL; Woods R., 2011, SOCIAL ISSUES SPORTS	37	27	27	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	AUG	2014	2	8							2325967114544107	10.1177/2325967114544107			9	Orthopedics; Sport Sciences	Emerging Sources Citation Index (ESCI)	Orthopedics; Sport Sciences	V0R5C	WOS:000216492700005	26535354	Green Published, gold			2022-02-06	
J	Leon, I; Garcia-Garcia, J; Roldan-Tapia, L				Leon, Irene; Garcia-Garcia, Juan; Roldan-Tapia, Lola			Estimating Cognitive Reserve in Healthy Adults Using the Cognitive Reserve Scale	PLOS ONE			English	Article							NEURONORMA PROJECT NORMS; TRAUMATIC BRAIN-INJURY; LEISURE ACTIVITIES; NEUROPSYCHOLOGICAL PERFORMANCE; INTERINDIVIDUAL VARIABILITY; VISUOSPATIAL SPAN; ALZHEIMER-DISEASE; NEURAL BASIS; VERBAL SPAN; LIFE-STYLE	The concept of cognitive reserve emerged from observed disparities between brain pathology and clinical symptoms. It may explain better neuropsychological performance in healthy individuals. The objectives of this study were to measure reserve in healthy subjects using a new Cognitive Reserve Scale (CRS), analyze the internal consistency of the CRS, and analyze validity evidence. A total of 117 healthy individuals were divided into two groups: 87 adults (aged 18-64 years) and 30 elderly adults (>= 65 years). All subjects completed the CRS and a comprehensive neuropsychological battery. The internal consistency of the scale was satisfactory (alpha = 0.77). No significant differences were observed between genders (t = 0.51, p = 0.611), and age was corrected by averaging the CRS score. The study of validity evidence showed that education affected the CRS (t = -2.98, p = 0.004, partial eta(2) = 0.07) and there was no significant relationship between the CRS and IQ (r = 0.09, p = 0.33). Occupational attainment and the CRS were not related (F-2,F-116 = 0.11, p = 0.898). In line with previous studies on reserve, heterogeneity was observed in the analyses of relationships between the CRS and cognitive performance. There were significant relationships between CRS score and the Verbal Learning Spanish-Complutense Test last trial (r = 0.24, p = 0.009), sum (r = 0.32, p = 0.000), short-term (r = 0.29, p = 0.002) and long-term memory (r = 0.22, p = 0.018), Matrix Reasoning subtest (r = 0.20, p = 0.027) and Block Design subtest (r = 0.20, p = 0.029). No other neuropsychological variables correlated with the CRS (p > 0.05). The CRS is a reliable instrument that reflects the frequency of participation in brain-stimulating activities across the lifetime. The associations between the CRS and education and neuropsychological performance support validity evidence.	[Leon, Irene; Garcia-Garcia, Juan; Roldan-Tapia, Lola] Univ Almeria, Dept Psychol, Almeria, Spain		Roldan-Tapia, L (corresponding author), Univ Almeria, Dept Psychol, Almeria, Spain.	mdroldan@ual.es	Garcia-Garcia, Juan/L-7116-2014; Leon, Irene/AAJ-6829-2020	Garcia-Garcia, Juan/0000-0002-0123-8497; Leon, Irene/0000-0002-3558-8831	Ministry of Economy and Competitiveness (Spain) [PSI2011-26985]; Plan Propio de Investigacion Grant	This work was supported by the Ministry of Economy and Competitiveness (Spain) [PSI2011-26985] and Plan Propio de Investigacion Grant to IL (University of Almeria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Alosco ML, 2012, J CLIN EXP NEUROPSYC, V34, P1, DOI 10.1080/13803395.2011.614596; Apolinario D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060084; Bartres-Faz D, 2011, BRAIN TOPOGR, V24, P340, DOI 10.1007/s10548-011-0195-9; Bastin C, 2012, NEUROIMAGE, V63, P713, DOI 10.1016/j.neuroimage.2012.06.074; Benedet M., 1998, TEST APRENDIZAJE VER; Borenstein AR, 2006, ALZ DIS ASSOC DIS, V20, P63, DOI 10.1097/01.wad.0000201854.62116.d7; Brayne C, 2010, BRAIN, V133, P2210, DOI 10.1093/brain/awq185; Brickman AM, 2011, NEUROBIOL AGING, V32, P1588, DOI 10.1016/j.neurobiolaging.2009.10.013; Carnero-Pardo C, 2007, NEUROLOGIA, V22, P860; Casals-Coll M, 2013, NEUROLOGIA, V28, P33, DOI 10.1016/j.nrl.2012.02.010; Chao S, 2012, NEUROIMAGE, V63, P1542; Chtistensen H, 2009, AM J GERIAT PSYCHIAT, V17, P218, DOI 10.1097/JGP.0b013e3181961a84; Coffey CE, 1999, NEUROLOGY, V53, P189, DOI 10.1212/WNL.53.1.189; de la Serna E, 2013, SCHIZOPHR RES, V143, P125, DOI 10.1016/j.schres.2012.10.026; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foubert-Samier A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.09.023; Fratiglioni L, 2007, J ALZHEIMERS DIS, V12, P11; Garcia-Molina A, 2013, MED CLIN-BARCELONA, V140, P527, DOI 10.1016/j.medcli.2012.09.047; Ghaffar O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047206; Golden CJ, 2010, STOOP TEST COLORES P; Instituto Nacional de Estadistica (INE), 2011, CLAS NAC OC CNO; Jones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748; Kemppainen NM, 2008, ANN NEUROL, V63, P112, DOI 10.1002/ana.21212; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Le Carret N, 2003, DEV NEUROPSYCHOL, V23, P317, DOI 10.1207/S15326942DN2303_1; Lee JM, 2007, CER ORTHO, P187, DOI 10.1007/978-3-7985-1783-7_26; Leon I, 2011, REV NEUROLOGIA, V52, P653, DOI 10.33588/rn.5211.2010704; Liu YY, 2013, J CLIN NEUROSCI, V20, P548, DOI 10.1016/j.jocn.2012.04.020; Lobo A, 1979, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V7, P189; Sanchez JL, 2011, J CLIN EXP NEUROPSYC, V33, P874, DOI 10.1080/13803395.2011.567976; Marioni RE, 2012, J ALZHEIMERS DIS, V28, P223, DOI 10.3233/JAD-2011-110377; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Nelson H.E., 1982, NATL ADULT READING T; Nucci Massimo, 2012, Aging Clin Exp Res, V24, P218, DOI 10.3275/7800; Palomo R, 2013, NEUROLOGIA, V28, P226, DOI 10.1016/j.nrl.2012.03.008; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P413, DOI 10.1093/arclin/acp043; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P395, DOI 10.1093/arclin/acp042; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P371, DOI 10.1093/arclin/acp041; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Perneczky R, 2008, DEMENT GERIATR COGN, V26, P475, DOI 10.1159/000167791; Rami L, 2011, REV NEUROLOGIA, V52, P195, DOI 10.33588/rn.5204.2010478; Reed BR, 2011, J INT NEUROPSYCH SOC, V17, P615, DOI 10.1017/S1355617711000014; Rey A., 2009, TEST COPIA FIGURA CO; Richards M, 2003, J CLIN EXP NEUROPSYC, V25, P614, DOI 10.1076/jcen.25.5.614.14581; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Rognoni T, 2013, NEUROLOGIA, V28, P73, DOI 10.1016/j.nrl.2012.02.009; Roldan-Tapia L, 2012, APPL NEUROPSYCH-ADUL, V19, P2, DOI 10.1080/09084282.2011.595458; Perez PS, 2009, MED CLIN-BARCELONA, V132, P459, DOI 10.1016/j.medcli.2008.04.012; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Scarmeas N, 2003, ARCH NEUROL-CHICAGO, V60, P359, DOI 10.1001/archneur.60.3.359; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schwartz CE, 2013, MULT SCLER J, V19, P87, DOI 10.1177/1352458512444914; Sole-Padulles C, 2009, NEUROBIOL AGING, V30, P1114, DOI 10.1016/j.neurobiolaging.2007.10.008; Soto-Anari M, 2013, REV NEUROLOGIA, V56, P79, DOI 10.33588/rn.5602.2012402; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; Stern, 2007, COGNITIVE RESERVE TH, P187; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P691, DOI 10.1076/jcen.25.5.691.14573; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Stern Y, 2008, CEREB CORTEX, V18, P959, DOI 10.1093/cercor/bhm134; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Tamayo F, 2012, NEUROLOGIA, V27, P319, DOI 10.1016/j.nrl.2011.12.020; Valenzuela M, 2006, PSYCHOL MED, V52, P195; Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; Van Dijk KRA, 2008, PSYCHOL AGING, V23, P119, DOI 10.1037/0882-7974.23.1.119; Vemuri P, 2011, BRAIN, V134, P1479, DOI 10.1093/brain/awr049; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; WECHSLER D, 1999, ESCALA INTELIGENCIA, V3; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Yaffe K, 2011, JAMA-J AM MED ASSOC, V305, P261, DOI 10.1001/jama.2010.1995; Zahodne LB, 2011, J INT NEUROPSYCH SOC, V17, P1039, DOI 10.1017/S1355617711001044	76	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e102632	10.1371/journal.pone.0102632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0QO	WOS:000339551100045		gold, Green Submitted, Green Published			2022-02-06	
J	Karalija, A; Novikova, LN; Kingham, PJ; Wiberg, M; Novikov, LN				Karalija, A.; Novikova, L. N.; Kingham, P. J.; Wiberg, M.; Novikov, L. N.			THE EFFECTS OF N-ACETYL-CYSTEINE AND ACETYL-L-CARNITINE ON NEURAL SURVIVAL, NEUROINFLAMMATION AND REGENERATION FOLLOWING SPINAL CORD INJURY	NEUROSCIENCE			English	Article						adult rats; spinal cord; motoneurons; antioxidants; apoptosis	PERIPHERAL-NERVE INJURY; AXONAL REGENERATION; FUNCTIONAL RECOVERY; OXIDATIVE STRESS; NEURONAL RESCUE; ADULT RATS; ACETYLCYSTEINE; APOPTOSIS; CASPASE-3; BRAIN	Traumatic spinal cord injury induces a long-standing inflammatory response in the spinal cord tissue, leading to a progressive apoptotic death of spinal cord neurons and glial cells. We have recently demonstrated that immediate treatment with the antioxidants N-acetyl-cysteine (NAC) and acetyl-L-carnitine (ALC) attenuates neuroinflammation, induces axonal sprouting, and reduces the death of motoneurons in the vicinity of the trauma zone 4 weeks after initial trauma. The objective of the current study was to investigate the effects of long-term antioxidant treatment on the survival of descending rubrospinal neurons after spinal cord injury in rats. It also examines the short-and long-term effects of treatment on apoptosis, inflammation, and regeneration in the spinal cord trauma zone. Spinal cord hemisection performed at the level C3 induced a significant loss of rubrospinal neurons 8 weeks after injury. At 2 weeks, an increase in the expression of the apoptosis-associated markers BCL-2-associated X protein (BAX) and caspase 3, as well as the microglial cell markers OX42 and ectodermal dysplasia 1 (ED1), was seen in the trauma zone. After 8 weeks, an increase in immunostaining for OX42 and the serotonin marker 5HT was detected in the same area. Antioxidant therapy reduced the loss of rubrospinal neurons by approximately 50%. Treatment also decreased the expression of BAX, caspase 3, OX42 and ED1 after 2 weeks. After 8 weeks, treatment decreased immunoreactivity for OX42, whereas it was increased for 5HT. In conclusion, this study provides further insight in the effects of treatment with NAC and ALC on descending pathways, as well as short-and long-term effects on the spinal cord trauma zone. (C) 2014 IBRO. Published by Elsevier Ltd. All rights reserved.	[Karalija, A.; Novikova, L. N.; Kingham, P. J.; Wiberg, M.; Novikov, L. N.] Umea Univ, Dept Integrat Med Biol, Sect Anat, SE-90187 Umea, Sweden; [Karalija, A.; Wiberg, M.] Umea Univ, Dept Surg & Perioperat Sci, Sect Hand & Plast Surg, SE-90187 Umea, Sweden		Karalija, A (corresponding author), Umea Univ, Dept Integrat Med Biol, SE-90187 Umea, Sweden.	amar.karalija@anatomy.umu.se		Novikov, Lev/0000-0001-5520-3890; Kingham, Paul/0000-0003-2596-5936	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission; European UnionEuropean Commission; Umea University, County of Vasterbotten; Ake Wibergs Stiftelse; Clas Groschinskys Minnesfond; Gunvor and Josef Aner Foundation; Magn. Bergvalls Stiftelse	We would like to thank Mrs G Folkesson and Mrs G Hellstrom for their excellent technical assistance. This study was supported by the Swedish Medical Research Council, European Union, Umea University, County of Vasterbotten, Ake Wibergs Stiftelse, Magn. Bergvalls Stiftelse, Clas Groschinskys Minnesfond and the Gunvor and Josef Aner Foundation.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Atkuri KR, 2007, CURR OPIN PHARMACOL, V7, P355, DOI 10.1016/j.coph.2007.04.005; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d; Bydon M, 2013, WORLD NEUROSURG, V11, P12; Charriaut-Marlangue C, 2004, THERAPIE, V59, P185, DOI 10.2515/therapie:2004035; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Fan LZ, 2006, J FUTURES MARKETS, V26, P153, DOI 10.1002/fut.20191; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Hagberg H, 2004, J BIOENERG BIOMEMBR, V36, P369, DOI 10.1023/B:JOBB.0000041770.00567.4f; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hart AM, 2002, EXP BRAIN RES, V145, P182, DOI 10.1007/s00221-002-1100-2; Heard KJ, 2008, NEW ENGL J MED, V359, P285, DOI 10.1056/NEJMct0708278; Hou Q, 2003, APOPTOSIS, V8, P617, DOI 10.1023/A:1026187526113; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Karalija A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041086; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Kullberg S, 2001, BRAIN RES, V899, P169, DOI 10.1016/S0006-8993(01)02222-3; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Ma JJ, 2001, EXP BRAIN RES, V139, P216, DOI 10.1007/s002210100769; Malaguarnera M, 2012, CURR OPIN GASTROEN, V28, P166, DOI 10.1097/MOG.0b013e3283505a3b; Maragos WF, 2004, J NEUROCHEM, V91, P257, DOI 10.1111/j.1471-4159.2004.02736.x; McEwen ML, 2011, NEUROTHERAPEUTICS, V8, P168, DOI 10.1007/s13311-011-0031-7; Novikov L, 1997, NEUROSCIENCE, V79, P765, DOI 10.1016/S0306-4522(96)00665-3; Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6; Novikova LN, 2000, EUR J NEUROSCI, V12, P776, DOI 10.1046/j.1460-9568.2000.00978.x; Palacio JR, 2011, INFLAMM RES, V60, P695, DOI 10.1007/s00011-011-0323-8; PARNETTI L, 1992, EUR J CLIN PHARMACOL, V42, P89, DOI 10.1007/BF00314926; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Patel SP, 2010, J NEUROCHEM, V114, P291, DOI 10.1111/j.1471-4159.2010.06764.x; Paxinos G, 1995, RAT NERVOUS SYSTEM; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Priestley John V, 2012, Handb Clin Neurol, V109, P463, DOI 10.1016/B978-0-444-52137-8.00029-2; Rabchevsky AG, 2011, PHARMACOL THERAPEUT, V132, P15, DOI 10.1016/j.pharmthera.2011.05.001; Ribas GS, 2014, GENE, V533, P469, DOI 10.1016/j.gene.2013.10.017; Rudel T, 1999, HERZ, V24, P236, DOI 10.1007/BF03044967; Sadowska AM, 2012, THER ADV RESPIR DIS, V6, P127, DOI 10.1177/1753465812437563; Santos RO, 2011, ACTA MEDICA PORT, V 24, P809; Sayer Faisal T, 2006, Spine J, V6, P335, DOI 10.1016/j.spinee.2005.11.001; Short DJ, 2000, SPINAL CORD, V38, P273, DOI 10.1038/sj.sc.3100986; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5; Song Y, 2012, NEUROCHEM RES, P610; Springer JE, 2001, CLIN CHEM LAB MED, V39, P299, DOI 10.1515/CCLM.2001.046; Vukojevic K, 2008, J MOL HISTOL, V39, P339, DOI 10.1007/s10735-008-9171-4; Waring WS, 2012, EXPERT REV CLIN PHAR, V5, P311, DOI [10.1586/ecp.12.15, 10.1586/ECP.12.15]; Welin D, 2009, BRAIN RES, V1287, P58, DOI 10.1016/j.brainres.2009.06.038; Wilson ADH, 2007, J PLAST RECONSTR AES, V60, P114, DOI 10.1016/j.bjps.2006.04.017; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051853, 10.1371/journal.pone.0038381]; Zhang CG, 2005, BRIT J PLAST SURG, V58, P765, DOI 10.1016/j.bjps.2005.04.012; Zhang N, 2012, INDIAN J MED RES, V135, P287; ZIMENT I, 1988, BIOMED PHARMACOTHER, V42, P513	54	27	29	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 6	2014	269						143	151		10.1016/j.neuroscience.2014.03.042			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AH1TL	WOS:000335903900014	24680856				2022-02-06	
J	Carl, RL; Kinsella, SB				Carl, Rebecca L.; Kinsella, Sarah B.			Pediatricians' Knowledge of Current Sports Concussion Legislation and Guidelines and Comfort With Sports Concussion Management: A Cross-Sectional Study	CLINICAL PEDIATRICS			English	Article						sports medicine; concussion; legislation	INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; POSTURAL CONTROL; HIGH-SCHOOL; SOCCER; RECOVERY; PLAYERS; ZURICH	Background. Sports-related concussions disproportionately affect young athletes. The primary objective of our study was to determine Illinois pediatricians' level of familiarity with state concussion legislation and with published consensus guidelines for sports concussion diagnosis and treatment. We also sought to determine pediatricians' knowledge regarding concussion management and comfort treating sports concussion patients. Methods. This was a cross-sectional survey of pediatrician members of the Illinois Chapter of the American Academy of Pediatrics. Results. Few general pediatricians (26.6%, n = 42) were "very familiar" or "somewhat familiar" with the recently passed Illinois state concussion legislation. Only 14.6% (n = 23) of general pediatrician respondents use concussion consensus guidelines in their practice. Pediatricians were generally very knowledgeable about concussions; only 5 out of 19 knowledge-based items were answered incorrectly by more than 25% of the study participants. Conclusions. General pediatricians are knowledgeable about concussions but most are not well aware of state concussion legislation and concussion consensus guidelines.	[Carl, Rebecca L.; Kinsella, Sarah B.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Carl, Rebecca L.; Kinsella, Sarah B.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA		Carl, RL (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave,Box 69, Chicago, IL 60611 USA.	rcarl@luriechildrens.org			Ann & Robert H. Lurie Children's Hospital Department of Pediatrics	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by the Ann & Robert H. Lurie Children's Hospital Department of Pediatrics.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; Broglio SP, 2004, BRIT J SPORT MED, V38, P561, DOI 10.1136/bjsm.2003.004887; Broshek DK, 2014, J CHILD NEUROL, V29, P17, DOI 10.1177/0883073812464525; Center for Sports Concussion at Idaho State University, 2012, KNOW CONC CONC LEG U; Centers for Disease Control and Prevention, HEADS CLIN ADDR CONC; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Delaney J Scott, 2005, Clin J Sport Med, V15, P216, DOI 10.1097/01.jsm.0000168077.74497.a4; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Illinois Chapter of the American Academy of Pediatrics, ICAAP COMM SPORTS ME; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Koutures CG, 2010, PEDIATRICS, V125, P410, DOI 10.1542/peds.2009-3009; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Pickett W, 2005, BRIT J SPORT MED, V39, P226, DOI 10.1136/bjsm.2004.013169; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Putukian Margot, 2004, Curr Sports Med Rep, V3, P9; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	25	27	27	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JUN	2014	53	7					689	697		10.1177/0009922814526979			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AJ4GM	WOS:000337631200011	24634428				2022-02-06	
J	Daoud, H; Alharfi, I; Alhelali, I; Stewart, TC; Qasem, H; Fraser, DD				Daoud, Hani; Alharfi, Ibrahim; Alhelali, Ibrahim; Stewart, Tanya Charyk; Qasem, Hadiah; Fraser, Douglas D.			Brain Injury Biomarkers as Outcome Predictors in Pediatric Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Pediatric; Severe traumatic brain injury; Biomarker; Outcome; Systematic review	NERVE GROWTH-FACTOR; FIBRILLARY ACIDIC PROTEIN; CEREBROSPINAL-FLUID; HEAD-INJURY; TRANSLATIONAL RESEARCH; FACTOR EXPRESSION; CHILDREN; SERUM; PERFORMANCE; RECLASSIFICATION	To systematically review the literature on brain injury biomarkers, defined as any injury biomarker detected in cerebrospinal fluid (CSF) or blood injury biomarkers primarily expressed in the brain parenchyma, to determine outcome prediction in pediatric severe traumatic brain injury (sTBI). A search of MEDLINEA (R), EMBASE(A (R)), PsycINFO(A (R)), Pubmed(A (R)), and the Cochrane Database, as well as grey literature sources, personal contacts, hand searches, and reference lists. The search terms used were traumatic brain injury, biomarkers, prognosis, and children. No language, publication type, or publication date restrictions were imposed. All articles were critically reviewed by two clinicians independently. A total of 7,150 articles were identified initially with 16 studies identified for review. Eighteen different biomarkers were examined; 11 in CSF and 7 in blood. Outcomes assessed included either in-hospital mortality or functional state (hospital discharge, 3-months or 6-months; Glasgow Outcome Scale or Pediatric Cerebral Performance Category). Significant correlations were established between sTBI outcomes and various biomarkers in CSF (IL-6, IL-8, IL-1 beta, S100 beta, NGF, NSE, DCX, ET-1, HMGB-1, cytochrome C) and blood (GFAP, NF-H, UCH-L1, SBDP-145, leptin). Mixed results were obtained for blood S100 beta. Outcome did not correlate with several biomarkers in either CSF (BDNF, GDNF, alpha-Syn) or blood (NSE, MBP). The Class of Evidence was considered II in 1 study and III in the remaining 15 studies. Based on the status of current sTBI biomarker research, we recommend that future research should be directed at both novel biomarker discovery and validation of biomarker panels in large, well-designed longitudinal studies.	[Daoud, Hani; Alharfi, Ibrahim; Alhelali, Ibrahim; Qasem, Hadiah; Fraser, Douglas D.] Univ Western Ontario, Dept Paediat, London, ON, Canada; [Alharfi, Ibrahim] King Fahad Med City, Dept Pediat Crit Care, Riyadh, Saudi Arabia; [Stewart, Tanya Charyk] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Stewart, Tanya Charyk; Fraser, Douglas D.] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; [Fraser, Douglas D.] Translat Res Ctr, London, ON, Canada; [Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, London, ON, Canada; [Fraser, Douglas D.] Childrens Hosp, London Hlth Sci Ctr, London N6A 5W9, England		Fraser, DD (corresponding author), Childrens Hosp, London Hlth Sci Ctr, Room C2-C82,800 Commissioners Rd East, London N6A 5W9, England.	douglas.fraser@lhsc.on.ca					Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Au AK, 2012, J NEUROTRAUM, V29, P2013, DOI 10.1089/neu.2011.2171; Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Brisson AR, 2012, PEDIATRICS, V129, P153, DOI 10.1542/peds.2011-0134; Charyk Stewart T, 2013, J TRAUMA AC IN PRESS; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chiaretti A, 2008, J TRAUMA, V65, P80, DOI 10.1097/TA.0b013e31805f7036; Chiaretti A, 2008, EUR J PAEDIATR NEURO, V12, P195, DOI 10.1016/j.ejpn.2007.07.016; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Gillio-Meina C, 2013, PEDIATRICS, V131, P754, DOI 10.1542/peds.2012-1181; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Houser B, 2012, ARCH PHYSIOL BIOCHEM, V118, P192, DOI 10.3109/13813455.2012.705301; JENNETT B, 1975, LANCET, V1, P480; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Kaska M, 2002, Rozhl Chir, V81, P22; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS7, DOI 10.1097/PCC.0b013e31823f43df; Lin C, 2012, PEPTIDES, V35, P166, DOI 10.1016/j.peptides.2012.03.024; Morrison G., 2012, PATHOPHYSIOLOGY, V20, P49; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Pickering A, 2008, EMERG MED J, V25, P88, DOI 10.1136/emj.2007.046631; Salonia R, 2010, J NEUROTRAUM, V27, P1819, DOI 10.1089/neu.2010.1402; Sangha GS, 2012, INJURY, V43, P2046, DOI 10.1016/j.injury.2011.10.034; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Shaw G, 2004, BIOCHEM BIOPH RES CO, V325, P619, DOI 10.1016/j.bbrc.2004.09.223; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Spinella PC, 2003, CRIT CARE MED, V31, P939, DOI 10.1097/01.CCM.0000053644.16336.52; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Zurek J, 2011, J TRAUMA, V71, P854, DOI 10.1097/TA.0b013e3182140c8c; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	42	27	27	2	18	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2014	20	3					427	435		10.1007/s12028-013-9879-1			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AI7RH	WOS:000337092900011	23943317				2022-02-06	
J	Kolias, AG; Bulters, DO; Cowie, CJ; Wilson, MH; Afshari, FT; Helmy, A; Broughton, E; Joannides, AJ; Zebian, B; Harrisson, SE; Hill, CS; Ahmed, AI; Barone, DG; Thakur, B; McMahon, CJ; Adlam, DM; Bentley, RP; Tolias, CM; Mitchell, PM; Whitfield, PC; Critchley, GR; Belli, A; Brennan, PM; Hutchinson, PJ				Kolias, Angelos G.; Bulters, Diederik O.; Cowie, Christopher J.; Wilson, Mark H.; Afshari, Fardad T.; Helmy, Adel; Broughton, Ellie; Joannides, Alexis J.; Zebian, Bassel; Harrisson, Stuart E.; Hill, Ciaran S.; Ahmed, Animul I.; Barone, Damiano G.; Thakur, Bhaskar; McMahon, Catherine J.; Adlam, David M.; Bentley, Robert P.; Tolias, Christos M.; Mitchell, Patrick M.; Whitfield, Peter C.; Critchley, Giles R.; Belli, Antonio; Brennan, Paul M.; Hutchinson, Peter J.		British Neurosurgical Trainee Res; British Neurotrauma Grp; UKCRR Collaborative Grp	Proposal for establishment of the UK Cranial Reconstruction Registry (UKCRR)	BRITISH JOURNAL OF NEUROSURGERY			English	Article						cranioplasty; decompressive craniectomy; stroke; surveillance; traumatic brain injury	DEATH FOLLOWING CRANIOPLASTY; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; TITANIUM CRANIOPLASTY; CLINICAL ARTICLE; HEAD-INJURY; COMPLICATIONS; HEMICRANIECTOMY; STROKE; SCALE	Background. The increasing utilisation of decompressive craniectomy for traumatic brain injury and stroke has led to an increase in the number of cranioplasties undertaken. Cranioplasty is also undertaken following excision of tumours originating from or invading the skull vault, removal of bone flaps due to post-operative infection, and decompressive craniectomy for the management of rarer causes of brain oedema and/or refractory intracranial hypertension. The existing literature which mainly consists of single-centre, retrospective studies, shows a significant variation in practice patterns and a wide range of morbidity. There also exists a need to measure the outcome as perceived by the patients themselves with patient reported outcome measures (PROMs; functional outcome, quality of life, satisfaction with cosmesis). In the UK, the concept of long-term surveillance of neurosurgical implants is well established with the UK shunt registry. Based on this background, we propose to establish the UK Cranial Reconstruction Registry (UKCRR). Aim. The overarching aim of the UKCRR is to collect high-quality data about cranioplasties undertaken across the UK and Ireland in order to improve outcomes for patients. Methods. Any patient undergoing reconstruction of the skull vault with autologous bone, titanium, or synthetic material in participating units will be eligible for inclusion. Data will be submitted directly by participating units to the Outcome Registry Intervention and Operation Network secure platform. A Steering Committee will be responsible for overseeing the strategic direction and running of the UKCRR. Outcome measures. These will include re-operation due to a cranioplasty-related issue, surgical site infection, re-admission due to a cranioplasty-related issue, unplanned post-operative escalation of care, adverse events, length of stay in admitting unit, destination at discharge from admitting unit, mortality at discharge from admitting unit, neurological status and PROMs during routine follow-up. Conclusion. The UKCRR will be an important pillar in the ongoing efforts to optimise the outcomes of patients undergoing cranioplasty.	[Kolias, Angelos G.; Helmy, Adel; Joannides, Alexis J.; Hutchinson, Peter J.] Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Kolias, Angelos G.; Helmy, Adel; Joannides, Alexis J.; Hutchinson, Peter J.] Univ Cambridge, Cambridge CB2 0QQ, England; [Bulters, Diederik O.; Ahmed, Animul I.] Southampton Univ Hosp, Div Neurosurg, Southampton, Hants, England; [Bulters, Diederik O.; Ahmed, Animul I.] Univ Southampton, Southampton, Hants, England; [Cowie, Christopher J.; Mitchell, Patrick M.] Royal Victoria Infirm, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England; [Cowie, Christopher J.; Mitchell, Patrick M.] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Wilson, Mark H.] St Marys Hosp, Div Neurosurg, London, England; [Wilson, Mark H.] Univ London Imperial Coll Sci Technol & Med, London, England; [Afshari, Fardad T.] Frenchay Hosp, Dept Neurosurg, Bristol BS16 1LE, Avon, England; [Broughton, Ellie; Whitfield, Peter C.] Derriford Hosp, South West Neurosurg Ctr, Plymouth PL6 8DH, Devon, England; [Zebian, Bassel; Thakur, Bhaskar; Tolias, Christos M.] Kings Coll Hosp London, Dept Neurosurg, London, England; [Harrisson, Stuart E.; Belli, Antonio] Queen Elizabeth Hosp, Dept Neurosurg, Birmingham, AL USA; [Hill, Ciaran S.] Royal London Hosp, Dept Neurosurg, London E1 1BB, England; [Barone, Damiano G.; McMahon, Catherine J.] Walton Ctr, Dept Neurosurg, Liverpool, Merseyside, England; [Adlam, David M.] Addenbrookes Hosp, Dept Oral & Maxillofacial Surg, Cambridge CB2 0QQ, England; [Bentley, Robert P.] Kings Coll Hosp London, Dept Oral & Craniofacial Surg, London, England; [Critchley, Giles R.] Hurstwood Pk Neurol Ctr, Dept Neurosurg, Haywards Heath, England; [Belli, Antonio] Queen Elizabeth Hosp, NIHR Ctr Surg Reconstruct & Microbiol, Birmingham B15 2TH, W Midlands, England; [Belli, Antonio] Univ Birmingham, Birmingham, W Midlands, England; [Brennan, Paul M.] Western Gen Hosp, Dept Clin Neurosci, Div Neurosurg, Edinburgh EH4 2XU, Midlothian, Scotland; [Brennan, Paul M.] Univ Edinburgh, Edinburgh, Midlothian, Scotland		Hutchinson, PJ (corresponding author), Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Box 167, Cambridge CB2 0QQ, England.	pjah2@cam.ac.uk	Bulters, Diederik/ABH-3573-2020; Barone, Damiano Giuseppe/O-5728-2018; Helmy, Adel/AAS-3084-2020; Belli, Antonio/I-3799-2015; Whitfield, Peter/ABA-4471-2020	Barone, Damiano Giuseppe/0000-0002-0091-385X; Helmy, Adel/0000-0002-0531-0556; Belli, Antonio/0000-0002-3211-9933; Ahmed, Aminul/0000-0001-6670-0438; Cowie, Christopher/0000-0003-0439-2278; Bulters, Diederik/0000-0001-9884-9050; Whitfield, Peter/0000-0003-0566-1820; Wilson, Mark/0000-0002-2346-4911; Harrisson, Stuart/0000-0003-4995-4270; Hill, Ciaran/0000-0002-4488-4034; Kolias, Angelos/0000-0003-3992-0587	Royal College of Surgeons of England Research Fellowship - Freemasons and the Rosetrees Trust; National Institute of Health Research (NIHR)National Institute for Health Research (NIHR); Raymond and Beverly Sackler Studentship; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); Codman UK; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [12/35/57, NIHR-RP-R3-12-013] Funding Source: researchfish	Angelos Kolias is supported by a Royal College of Surgeons of England Research Fellowship (funded by the Freemasons and the Rosetrees Trust), a National Institute of Health Research (NIHR) Academic Clinical Fellowship, and a Raymond and Beverly Sackler Studentship. Antonio Belli is supported by the NIHR and heads the neurotrauma research theme of the NIHR Surgical Reconstruction and Micro biology Research Centre. Paul Brennan holds a Clinical Lectureship, Edinburgh Clinical Academic Training Programme. Peter Hutchinson is supported by an NIHR Research Professorship, the NIHR Cambridge Biomedical Research Centre and has been appointed as the Surgical Specialty Lead for Neurosurgery, Royal College of Surgeons of England Clinical Research Initiative.; Mark Wilson and Peter Hutchinson have delivered lectures sponsored by Codman. Mark Wilson has co-ordinated London Neurotrauma Group meetings sponsored by Codman. The launch meeting of the British Neurosurgical Trainee Research Collaborative was supported by an educational grant from Codman UK.	Al-Tamimi YZ, 2012, BRIT J NEUROSURG, V26, P510, DOI 10.3109/02688697.2011.633640; Archavlis E, 2012, ACTA NEUROCHIR, V154, P1055, DOI 10.1007/s00701-012-1333-1; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Broughton E, 2011, BRIT J NEUROSURG, V25, P544; Broughton E, 2014, BRIT J NEUROSURG, V28, P34, DOI 10.3109/02688697.2013.815319; Bruno A, 2011, STROKE, V42, P2276, DOI 10.1161/STROKEAHA.111.613273; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Coulter IC, 2014, BRIT J NEUROSURG, V28, P199, DOI 10.3109/02688697.2013.835378; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Hill CS, 2012, BRIT J NEUROSURG, V26, P832, DOI 10.3109/02688697.2012.692839; Honeybul S, 2011, BRIT J NEUROSURG, V25, P343, DOI 10.3109/02688697.2011.568643; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Kolias AG, 2013, BRIT J NEUROSURG, V27, P307, DOI 10.3109/02688697.2013.781122; Mohan A, 2013, INT J SURG, V11, P4, DOI 10.1016/j.ijsu.2012.11.016; Richards HK, 2009, J NEUROSURG-PEDIATR, V4, P389, DOI 10.3171/2009.4.PEDS09210; Sarov M, 2010, STROKE, V41, P560, DOI 10.1161/STROKEAHA.109.568543; Saver JL, 2012, STROKE, V43, P967, DOI 10.1161/STROKEAHA.111.634352; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Surgical Site Infection Surveillance Service, 2013, PROT SURV SURG SIT I; Walcott BP, 2013, J NEUROSURG, V118, P757, DOI 10.3171/2013.1.JNS121626; Wiggins A, 2013, NEUROSURGERY, V72, P248, DOI 10.1227/NEU.0b013e31827b98f3; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zebian B, 2011, BRIT J NEUROSURG, V25, P785, DOI 10.3109/02688697.2011.623801	25	27	27	0	9	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	JUN	2014	28	3					310	314		10.3109/02688697.2013.859657			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AI6LT	WOS:000336986900005	24237069				2022-02-06	
J	Steppacher, I; Kaps, M; Kissler, J				Steppacher, Inga; Kaps, Michael; Kissler, Johanna			Will time heal? A long-term follow-up of severe disorders of consciousness	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; PROLONGED UNCONSCIOUS STATE; VEGETATIVE STATE; PREDICTS RECOVERY; SEX-DIFFERENCES; YOUNG-ADULTS; OUTCOMES; REHABILITATION; CHILDREN; DISABILITY	Objective: Little is known about the long-term outcome of patients with disorders of consciousness (DOCs) such as unresponsive wakefulness syndrome (UWS) or minimally conscious state (MCS). We describe the disease course of a large group of DOC patients 2-14 years after brain damage. Methods: In 102 patients (59 UWS, 43 MCS), clinical and demographic variables from disorder onset were related to the patients' outcomes 2-14 years after discharge. Etiology, age at event, time since onset, gender, and home care versus institutional care were assessed as predictors and similarities and differences between UWS and MCS determined. Results: Seventy-one percent of the patients had passed away or showed no improvement in condition. Twenty-nine percent regained consciousness and developed some communicative capacities. The time a syndrome persisted did not predict clinical outcome in either condition. Six patients regained consciousness after more than 3 years. Of these, five had been UWS (42% of recovered UWS, three traumatic origins, one tumor, one hypoxia) and one MCS (5% of recovered MCS, traumatic origin). In UWS, younger patients, those cared for at home, and in tendency those with traumatic origins, were more likely to recover. In MCS, no reliable outcome predictors were found. Interpretation: Current predictors are too vague for single patient predictions. This study identifies a subgroup of late-recovering patients, casting doubt on the 12-month boundary, after which UWS is stated to be permanent. Routine reexamination, use of more reliable outcome predictors and research determining optimal care settings are needed to inform the crucial decisions made for these patients.	[Steppacher, Inga; Kissler, Johanna] Univ Bielefeld, Dept Psychol, D-33615 Bielefeld, Germany; [Kaps, Michael] Kliniken Schmieder Allensbach, Lurija Inst, Early Rehabil Unit, D-78476 Allensbach, Germany		Steppacher, I (corresponding author), Univ Bielefeld, Univ Str 25, D-33615 Bielefeld, Germany.	Inga.Steppacher@Uni-Bielefeld.de	Kissler, Johanna/B-7361-2019	Kissler, Johanna/0000-0002-4567-1997			Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Cavinato M, 2009, BRAIN INJURY, V23, P973, DOI 10.3109/02699050903373493; Childs NL, 1996, BRIT MED J, V313, P944; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cranford R, 1996, BRIT MED J, V313, P5, DOI 10.1136/bmj.313.7048.5; Deakin CD, 2010, NOTFALL RETTUNGSMED, V13, P559, DOI 10.1007/s10049-010-1370-3; Eilander HJ, 2007, BRAIN INJURY, V21, P53, DOI 10.1080/02699050601151795; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Glader EL, 2003, STROKE, V34, P1970, DOI 10.1161/01.STR.0000083534.81284.C5; Guerit JM, 1999, CLIN NEUROPHYSIOL, V110, P1260, DOI 10.1016/S1388-2457(99)00061-9; Holzer M, 2002, NEW ENGL J MED, V346, P549; JENNETT B, 1975, LANCET, V1, P480; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Martinez-Sanchez P, 2011, CEREBROVASC DIS, V31, P455, DOI 10.1159/000323851; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; PAGNI CA, 1977, ACTA NEUROCHIR, V36, P37, DOI 10.1007/BF01405985; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; Roquer J, 2003, STROKE, V34, P1581, DOI 10.1161/01.STR.0000078562.82918.F6; Steppacher I, 2013, ANN NEUROL, V73, P594, DOI 10.1002/ana.23835; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; Strens LHA, 2004, BRAIN INJURY, V18, P213, DOI 10.1080/0269905031000149533; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Voss A, 1993, SPECTRUM NEUROREHABI, P112; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020	37	27	27	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	JUN	2014	1	6					401	408		10.1002/acn3.63			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V45KI	WOS:000209815100003	25356410	Green Published, gold			2022-02-06	
J	Montani, V; De Grazia, MD; Zorzi, M				Montani, Veronica; De Grazia, Michele De Filippo; Zorzi, Marco			A new adaptive videogame for training attention and executive functions: design principles and initial validation	FRONTIERS IN PSYCHOLOGY			English	Article						videogames; attention; attention deficits; executive functions; cognitive enhancement	DUAL-TASK PERFORMANCE; TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; COGNITIVE CONTROL; GAME EXPERIENCE; TIME; PLASTICITY; DEFICITS; SPEED; AWARENESS	A growing body of evidence suggests that action videogames could enhance a variety of cognitive skills and more specifically attention skills. The aim of this study was to develop a novel adaptive videogame to support the rehabilitation of the most common consequences of traumatic brain injury (TBI), that is the impairment of attention and executive functions. TBI patients can be affected by psychomotor slowness and by difficulties in dealing with distraction, maintain a cognitive set for a long time, processing different simultaneously presented stimuli, and planning purposeful behavior. Accordingly, we designed a videogame that was specifically conceived to activate those functions. Playing involves visuospatial planning and selective attention, active maintenance of the cognitive set representing the goal, and error monitoring. Moreover, different game trials require to alternate between two tasks (i.e., task switching) or to perform the two tasks simultaneously (i.e., divided attention/dual-tasking). The videogame is controlled by a multidimensional adaptive algorithm that calibrates task difficulty on-line based on a model of user performance that is updated on a trial-by-trial basis. We report simulations of user performance designed to test the adaptive game as well as a validation study with healthy participants engaged in a training protocol. The results confirmed the involvement of the cognitive abilities that the game is supposed to enhance and suggested that training improved attentional control during play.	[Montani, Veronica; De Grazia, Michele De Filippo; Zorzi, Marco] Univ Padua, Dept Gen Psychol, I-35131 Padua, Italy; [Zorzi, Marco] Univ Padua, Ctr Cognit Neurosci, I-35131 Padua, Italy; [Zorzi, Marco] IRCCS San Camillo Neurorehabil Hosp, Venice Lido, Italy		Zorzi, M (corresponding author), Univ Padua, Dept Gen Psychol, Via Venezia 8, I-35131 Padua, Italy.	marco.zorzi@unipd.it	De Filippo De Grazia, Michele/AAA-3054-2021; Zorzi, Marco/B-7863-2008	De Filippo De Grazia, Michele/0000-0003-3682-8582; Zorzi, Marco/0000-0002-4651-6390			Achtman RL, 2008, RESTOR NEUROL NEUROS, V26, P435; Andreadis N, 2010, ATTEN PERCEPT PSYCHO, V72, P1776, DOI 10.3758/APP.72.7.1776; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baayen R.H., 2008, ANAL LINGUISTIC DATA, DOI 10.1017/CBO9780511801686; Baniqued PL, 2013, ACTA PSYCHOL, V142, P74, DOI 10.1016/j.actpsy.2012.11.009; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Basso D, 2001, BRAIN COGNITION, V46, P38, DOI 10.1016/S0278-2626(01)80029-4; Bates D., 2013, LME4 LINEARMIXED EFF; Bavelier D, 2012, VISION RES, V61, P132, DOI 10.1016/j.visres.2011.08.007; Bherer L, 2005, PSYCHOL AGING, V20, P695, DOI 10.1037/0882-7974.20.4.695; Bonato M, 2013, BEHAV NEUROL, V26, P179, DOI [10.1155/2013/139812, 10.3233/BEN-2012-129005]; Bonato M, 2012, NEUROPSYCHOLOGY, V26, P20, DOI 10.1037/a0025306; Bonato M, 2010, NEUROPSYCHOLOGIA, V48, P3934, DOI 10.1016/j.neuropsychologia.2010.08.022; Boot WR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00226; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Cain MS, 2012, ATTEN PERCEPT PSYCHO, V74, P641, DOI 10.3758/s13414-012-0284-1; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Chiappe D, 2013, APPL ERGON, V44, P278, DOI 10.1016/j.apergo.2012.08.002; Chisholm JD, 2010, ATTEN PERCEPT PSYCHO, V72, P667, DOI 10.3758/APP.72.3.667; CLARK JE, 1987, J GERONTOL, V42, P82, DOI 10.1093/geronj/42.1.82; Clark K, 2011, ACTA PSYCHOL, V136, P67, DOI 10.1016/j.actpsy.2010.10.003; Colzato LS, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00008; Cutini S, 2008, COGN NEUROPSYCHOL, V25, P194, DOI 10.1080/02643290701606408; Dell'Acqua R, 2006, PSYCHOL RES-PSYCH FO, V70, P553, DOI 10.1007/s00426-005-0016-4; Donohue SE, 2012, ATTEN PERCEPT PSYCHO, V74, P803, DOI 10.3758/s13414-012-0323-y; Drew B., 1986, COGN REHABIL, V4, P26; Dux PE, 2009, NEURON, V63, P127, DOI 10.1016/j.neuron.2009.06.005; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Dye MWG, 2009, CURR DIR PSYCHOL SCI, V18, P321, DOI 10.1111/j.1467-8721.2009.01660.x; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Foley JA, 2010, BRAIN INJURY, V24, P851, DOI 10.3109/02699051003789278; Franceschini S, 2013, CURR BIOL, V23, P462, DOI 10.1016/j.cub.2013.01.044; Gehring K, 2008, LANCET NEUROL, V7, P548, DOI 10.1016/S1474-4422(08)70111-X; GOPHER D, 1994, HUM FACTORS, V36, P387, DOI 10.1177/001872089403600301; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Hubert-Wallander B, 2011, ATTEN PERCEPT PSYCHO, V73, P2399, DOI 10.3758/s13414-011-0194-7; Hubert-Wallander B, 2011, WIRES COGN SCI, V2, P222, DOI 10.1002/wcs.116; Irons JL, 2011, AUST J PSYCHOL, V63, P224, DOI 10.1111/j.1742-9536.2011.00001.x; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kamke MR, 2012, J NEUROSCI, V32, P7001, DOI 10.1523/JNEUROSCI.1028-12.2012; Karle JW, 2010, ACTA PSYCHOL, V134, P70, DOI 10.1016/j.actpsy.2009.12.007; Krainik A, 2004, NEUROLOGY, V62, P1323, DOI 10.1212/01.WNL.0000120547.83482.B1; Kristjansson A, 2013, ATTEN PERCEPT PSYCHO, V75, P667, DOI 10.3758/s13414-013-0427-z; Kuznetsova A., 2013, lmerTest: tests for random and fixed effects for linear mixed effect models (lmer objects of lme4 package) R package version 2-6; Latham AJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00629; Lawrence MA, 2012, EZ EASY ANAL VISUALI; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Mathewson KE, 2012, PSYCHOPHYSIOLOGY, V49, P1558, DOI 10.1111/j.1469-8986.2012.01474.x; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mattioli F., 1992, NEUROPSYCHOL REHABIL, V2, P169, DOI [10.1080/09602019208401406, DOI 10.1080/09602019208401406]; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Murphy K., 2009, J ARTICLES SUPPORT N; Nelson RA, 2009, PERCEPTION, V38, P1678, DOI 10.1068/p6324; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prigatano G. P., 1991, AWARENESS DEFICIT BR; R Development Core Team, 2012, R LANG ENV STAT COMP; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rosenberg BH, 2005, J ENDOUROL, V19, P372, DOI 10.1089/end.2005.19.372; Schumacher EH, 2001, PSYCHOL SCI, V12, P101, DOI 10.1111/1467-9280.00318; Serino A, 2006, BRAIN INJURY, V20, P23, DOI 10.1080/02699050500309627; Singmann H, 2013, AFEX ANAL FACTORIAL; Sohlberg M., 2001, COGNITIVE REHABILITA; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; Strobach T, 2012, ACTA PSYCHOL, V140, P13, DOI 10.1016/j.actpsy.2012.02.001; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Tombu M, 2004, J EXP PSYCHOL HUMAN, V30, P795, DOI 10.1037/0096-1523.30.5.795; Van Selst M, 1999, J EXP PSYCHOL HUMAN, V25, P1268, DOI 10.1037/0096-1523.25.5.1268; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Vikki Juhani, 1994, Journal of Clinical and Experimental Neuropsychology, V16, P325; West GL, 2008, J VISION, V8, DOI 10.1167/8.16.13; Wilson Anna J, 2006, Behav Brain Funct, V2, P19, DOI 10.1186/1744-9081-2-19; Wu SJ, 2012, J COGNITIVE NEUROSCI, V24, P1286, DOI 10.1162/jocn_a_00192	84	27	29	3	67	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	MAY 13	2014	5								409	10.3389/fpsyg.2014.00409			12	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	AH3OG	WOS:000336033000001	24860529	Green Published, gold			2022-02-06	
J	Liang, JM; Luan, YX; Lu, B; Zhang, HB; Luo, YN; Ge, PF				Liang, Jianmin; Luan, Yongxin; Lu, Bin; Zhang, Hongbo; Luo, Yi-nan; Ge, Pengfei			Protection of Ischemic Postconditioning against Neuronal Apoptosis Induced by Transient Focal Ischemia Is Associated with Attenuation of NF-kappa B/p65 Activation	PLOS ONE			English	Article							NF-KAPPA-B; CEREBRAL ISCHEMIA/REPERFUSION INJURY; SIGNALING PATHWAY CONTRIBUTES; TRAUMATIC BRAIN-INJURY; CELL-DEATH; REPERFUSION INJURY; STATUS EPILEPTICUS; INFARCT SIZE; RATS; INHIBITION	Background and Purpose: Accumulating evidences have demonstrated that nuclear factor kappa B/p65 plays a protective role in the protection of ischemic preconditioning and detrimental role in lethal ischemia-induced programmed cell death including apoptosis and autophagic death. However, its role in the protection of ischemic postconditioning is still unclear. Methods: Rat MCAO model was used to produce transient focal ischemia. The procedure of ischemic postconditioning consisted of three cycles of 30 seconds reperfusion/reocclusion of MCA. The volume of cerebral infarction was measured by TTC staining and neuronal apoptosis was detected by TUNEL staining. Western blotting was used to analyze the changes in protein levels of Caspase-3, NF-kappa B/p65, phosphor-NF-kappa B/p65, IkB alpha, phosphor-IkB alpha, Noxa, Bim and Bax between rats treated with and without ischemic postconditioning. Laser scanning confocal microscopy was used to examine the distribution of NF-kappa B/p65 and Noxa. Results: Ischemic postconditioning made transient focal ischemia-induced infarct volume decrease obviously from 38.6% +/- 65.8% to 23.5% +/- 64.3%, and apoptosis rate reduce significantly from 46.5% +/- 66.2 to 29.6% +/- 65.3% at reperfusion 24 h following 2 h focal cerebral ischemia. Western blotting analysis showed that ischemic postconditioning suppressed markedly the reduction of NF-kappa B/p65 in cytoplasm, but elevated its content in nucleus either at reperfusion 6 h or 24 h. Moreover, the decrease of IkBa and the increase of phosphorylated IkB alpha and phosphorylated NF-kappa B/p65 at indicated reperfusion time were reversed by ischemic postconditioning. Correspondingly, proapoptotic proteins Caspase-3, cleaved Caspase-3, Noxa, Bim and Bax were all mitigated significantly by ischemic postconditioning. Confocal microscopy revealed that ischemic postconditioning not only attenuated ischemia-induced translocation of NF-kappa B/p65 from neuronal cytoplasm to nucleus, but also inhibited the abnormal expression of proapoptotic protein Noxa within neurons. Conclusions: We demonstrated in this study that the protection of ischemic postconditioning on neuronal apoptosis caused by transient focal ischemia is associated with attenuation of the activation of NF-kappa B/p65 in neurons.	[Liang, Jianmin; Zhang, Hongbo] Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China; [Luan, Yongxin; Lu, Bin; Luo, Yi-nan; Ge, Pengfei] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China; [Liang, Jianmin; Luo, Yi-nan; Ge, Pengfei] Jilin Univ, Hosp 1, Neurosci Res Ctr, Changchun 130023, Peoples R China		Ge, PF (corresponding author), Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China.	pengfeige@gmail.com			National Nature and Science FoundationNational Natural Science Foundation of China (NSFC) [30973110, 81171234]; Science and Technology Department of Jilin Province [20080139]	This work was supported by National Nature and Science Foundation (30973110) and (81171234), the Outstanding Youth Grant (20080139) from the Science and Technology Department of Jilin Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Chuang YC, 2010, J NEUROSCI RES, V88, P1898, DOI 10.1002/jnr.22369; Clemens JA, 1997, MOL BRAIN RES, V48, P187, DOI 10.1016/S0169-328X(97)00092-2; Danielisova V, 2006, CELL MOL NEUROBIOL, V26, P1181, DOI 10.1007/s10571-006-9034-z; Darling CE, 2005, AM J PHYSIOL-HEART C, V289, pH1618, DOI 10.1152/ajpheart.00055.2005; Ding ZM, 2012, INT J MOL SCI, V13, P6089, DOI 10.3390/ijms13056089; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Engel T, 2011, J CEREBR BLOOD F MET, V31, P1196, DOI 10.1038/jcbfm.2011.26; Feng XD, 2013, MOL MED REP, V7, P1516, DOI 10.3892/mmr.2013.1392; Fischer Uwe M, 2006, Interact Cardiovasc Thorac Surg, V5, P531, DOI 10.1510/icvts.2006.130765; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Hu J, 2005, MOL CARCINOGEN, V44, P274, DOI 10.1002/mc.20142; Hu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050764; Inta I, 2006, J NEUROSCI, V26, P12896, DOI 10.1523/JNEUROSCI.3670-06.2006; Ishihara Y, 2012, J PHARMACOL SCI, V119, P251, DOI 10.1254/jphs.12079FP; Jang ER, 2011, NEUROCHEM INT, V58, P52, DOI 10.1016/j.neuint.2010.10.012; Kim EJ, 2010, TRANSL STROKE RES, V1, P40, DOI 10.1007/s12975-009-0006-8; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kin H, 2008, SHOCK, V29, P761, DOI 10.1097/SHK.0b013e31815cfd5a; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kong YH, 2013, NEUROCHEM RES, V38, P815, DOI 10.1007/s11064-013-0984-5; Li L, 2013, INFLAMM RES, V62, P387, DOI 10.1007/s00011-013-0590-7; Li WL, 2013, NEUROSCIENCE, V244, P16, DOI 10.1016/j.neuroscience.2013.03.045; Li ZY, 2012, J INT MED RES, V40, P954, DOI 10.1177/147323001204000314; Liang JM, 2013, J INT MED RES, V41, P618, DOI 10.1177/0300060513476587; Liang JM, 2012, INT J MED SCI, V9, P923, DOI 10.7150/ijms.4878; Liu KX, 2009, INTENS CARE MED, V35, P933, DOI 10.1007/s00134-009-1428-1; Loukogeorgakis SP, 2006, CIRCULATION, V113, P1015, DOI 10.1161/CIRCULATIONAHA.105.590398; Nakai M, 2000, J NEUROCHEM, V74, P647, DOI 10.1046/j.1471-4159.2000.740647.x; Pignataro Giuseppe, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P1; Pizzi M, 2009, FEBS J, V276, P27, DOI 10.1111/j.1742-4658.2008.06767.x; Qian YS, 2012, NEUROCHEM INT, V60, P759, DOI 10.1016/j.neuint.2012.03.011; Ren CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003851; Ryu HJ, 2011, NEUROSCIENCE, V187, P93, DOI 10.1016/j.neuroscience.2011.04.048; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Shen WH, 2003, ACTA PHARMACOL SIN, V24, P1125; Song YS, 2010, J CEREBR BLOOD F MET, V30, P1265, DOI 10.1038/jcbfm.2010.6; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Wang Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/124614; Xing BZ, 2008, STROKE, V39, P2362, DOI 10.1161/STROKEAHA.107.507939; Xiong J, 2011, INFLAMM RES, V60, P547, DOI 10.1007/s00011-010-0303-4; Xu L, 2002, BIOCHEM BIOPH RES CO, V299, P14, DOI 10.1016/S0006-291X(02)02573-1; Xu M, 2012, BRAIN RES, V1454, P48, DOI 10.1016/j.brainres.2012.03.020; Yin LL, 2012, INT J NEUROSCI, V122, P748, DOI 10.3109/00207454.2012.721827; You WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060290; Yuan YJ, 2011, BRAIN RES, V1367, P85, DOI 10.1016/j.brainres.2010.10.017; Zeng M, 2013, BIOCHEM BIOPH RES CO, V436, P180, DOI 10.1016/j.bbrc.2013.05.070; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhou XL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-251	57	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96734	10.1371/journal.pone.0096734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	WOS:000338029800116	24800741	Green Published, gold, Green Submitted			2022-02-06	
J	Doulames, V; Lee, S; Shea, TB				Doulames, Vanessa; Lee, Sangmook; Shea, Thomas B.			Environmental enrichment and social interaction improve cognitive function and decrease reactive oxidative species in normal adult mice	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						cognitive performance; social; isolation; environment; enriched environment; dementia; novel object recognition; Y Maze	TRAUMATIC BRAIN-INJURY; INTERVENING TOO LATE; ALZHEIMERS-DISEASE; HIPPOCAMPAL NEUROGENESIS; TRANSGENIC MICE; TG2576 MICE; STRESS; DEMENTIA; RATS; CORTEX	Environmental stimulation and increased social interactions stimulate cognitive performance, while decrease in these parameters can exacerbate cognitive decline as a function of illness, injury, or age. We examined the impact of environmental stimulation and social interactions on cognitive performance in healthy adult C57B1/6J mice. Mice were housed for 1 month individually or in groups of three (to prevent or allow social interaction) in either a standard environment (SE) or an enlarged cage containing nesting material and items classically utilized to stimulate exploration and activity ("enriched environment"; EE). Cognitive performance was tested by Y maze navigation and Novel Object Recognition (NOR; which compares the relative amount of time mice spent investigating a novel vs. a familiar object). Mice maintained for 1 month under isolated conditions in the SE statistically declined in performance versus baseline in the Y maze (p < 0.02; ANOVA). Performance under all other conditions did not change from baseline. Maintenance in groups in the SE statistically improved NOR (p < 0.01), whereas maintenance in isolation in the SE did not alter performance from baseline. Maintenance in the EE statistically improved performance in NOR for mice housed in groups and individually (p < 0.01). Maintenance under isolated conditions slightly increased reactive oxygen/nitrogen species (ROS/RNS) in brain. Environmental enrichment did not influence ROS/RNS. These findings indicate that environmental and social enrichment can positively influence cognitive performance in healthy adult mice, and support the notion that proactive approaches may delay age-related cognitive decline.	[Doulames, Vanessa; Lee, Sangmook; Shea, Thomas B.] Univ Massachusetts, Dept Biol Sci, Ctr Cellular Neurobiol & Neurodegenerat Res, Lowell, MA 01854 USA		Shea, TB (corresponding author), Univ Massachusetts, Dept Biol Sci, Ctr Cellular Neurobiol & Neurodegenerat Res, Lowell, MA 01854 USA.	Thomas_Shea@uml.edu	Doulames, Vanessa/AAG-8828-2021				Anderson-Hanley C, 2012, AM J PREV MED, V42, P109, DOI 10.1016/j.amepre.2011.10.016; Andrew MK, 2010, ALZHEIMERS DEMENT, V6, P319, DOI 10.1016/j.jalz.2009.11.001; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Barone I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050726; Bonsang E, 2012, J HEALTH ECON, V31, P490, DOI 10.1016/j.jhealeco.2012.03.005; Briones TL, 2004, BRAIN RES, V1018, P130, DOI 10.1016/j.brainres.2004.06.001; Chan A, 2008, J NUTR HEALTH AGING, V12, P252, DOI 10.1007/BF02982630; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Conroy RM, 2010, PSYCHOL HEALTH MED, V15, P463, DOI 10.1080/13548506.2010.487103; Crooks VC, 2008, AM J PUBLIC HEALTH, V98, P1221, DOI 10.2105/AJPH.2007.115923; Cuadrado-Tejedor M, 2012, J ALZHEIMERS DIS, V28, P567, DOI 10.3233/JAD-2011-110572; Cutuli D, 2011, NEUROBIOL DIS, V42, P9, DOI 10.1016/j.nbd.2010.12.007; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Emery VOB, 2011, J NEURAL TRANSM, V118, P1361, DOI 10.1007/s00702-011-0663-0; Ertel KA, 2008, AM J PUBLIC HEALTH, V98, P1215, DOI 10.2105/AJPH.2007.113654; Fernandez CI, 2004, ANN NY ACAD SCI, V1019, P53, DOI 10.1196/annals.1297.012; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; GREENOUGH WT, 1973, EXP NEUROL, V40, P491, DOI 10.1016/0014-4886(73)90090-3; Gresack JE, 2004, NEUROSCIENCE, V128, P459, DOI 10.1016/j.neuroscience.2004.06.011; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; HARLOW HF, 1965, SCIENCE, V148, P666, DOI 10.1126/science.148.3670.666-a; Huang HJ, 2011, BRAIN RES, V1371, P150, DOI 10.1016/j.brainres.2010.11.043; JACOBS B, 1993, J COMP NEUROL, V327, P97, DOI 10.1002/cne.903270108; Jeong YH, 2011, J NEUROCHEM, V119, P1282, DOI 10.1111/j.1471-4159.2011.07514.x; Kalev-Zylinska ML, 2007, J NEUROSCI, V27, P10456, DOI 10.1523/JNEUROSCI.2789-07.2007; Karp A, 2006, DEMENT GERIATR COGN, V21, P65, DOI 10.1159/000089919; KATZMAN R, 1995, J AM GERIATR SOC, V43, P583, DOI 10.1111/j.1532-5415.1995.tb06112.x; KONDO K, 1994, DEMENTIA, V5, P314, DOI 10.1159/000106741; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lee S, 2012, J ALZHEIMERS DIS, V28, P497, DOI 10.3233/JAD-2011-111562; Lehmann ML, 2011, J NEUROSCI, V31, P6159, DOI 10.1523/JNEUROSCI.0577-11.2011; Mattson MP, 2001, MECH AGEING DEV, V122, P757, DOI 10.1016/S0047-6374(01)00226-3; Miura H, 2002, SYNAPSE, V46, P116, DOI 10.1002/syn.10133; Mulero J, 2011, J NUTR HEALTH AGING, V15, P756, DOI 10.1007/s12603-011-0130-5; Munetsuna E, 2009, BIOCHEM BIOPH RES CO, V379, P480, DOI 10.1016/j.bbrc.2008.12.076; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Rogers E J, 2004, J Nutr Health Aging, V8, P92; SCHAPIRO S, 1970, SCIENCE, V167, P292, DOI 10.1126/science.167.3916.292; Schrijver NCA, 2002, PHARMACOL BIOCHEM BE, V73, P209, DOI 10.1016/S0091-3057(02)00790-6; Shankar A, 2013, PSYCHOSOM MED, V75, P161, DOI 10.1097/PSY.0b013e31827f09cd; Shea TB, 2004, J ALZHEIMERS DIS, V6, P269; Shea TB, 2007, NEUROMOL MED, V9, P264, DOI 10.1007/s12017-007-8005-y; Shea TB, 2012, J NEURAL TRANSM, V119, P1529, DOI 10.1007/s00702-012-0849-0; SIREVAAG AM, 1987, BRAIN RES, V424, P320, DOI 10.1016/0006-8993(87)91477-6; Smith MA, 2000, BBA-MOL BASIS DIS, V1502, P139, DOI 10.1016/S0925-4439(00)00040-5; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; van der Borght K, 2006, BEHAV BRAIN RES, V167, P36, DOI 10.1016/j.bbr.2005.08.012; Van der Borght K, 2007, BEHAV NEUROSCI, V121, P324, DOI 10.1037/0735-7044.121.2.324; van der Ploeg ES, 2013, INT PSYCHOGERIATR, V25, P565, DOI 10.1017/S1041610212002128; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454	53	27	27	0	32	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	MAY	2014	124	5					369	376		10.3109/00207454.2013.848441			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF0KS	WOS:000334403300008	24102158				2022-02-06	
J	Le, C; Guppy, KH; Axelrod, YV; Hawk, MW; Silverthorn, J; Inacio, MC; Akins, PT				Le, Catherine; Guppy, Kern H.; Axelrod, Yekaterina V.; Hawk, Mark W.; Silverthorn, James; Inacio, Maria C.; Akins, Paul T.			Lower complication rates for cranioplasty with pen-operative bundle	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Craniectomy; Cranioplasty; MRSA infection; Surgical site infection; Care bundles	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; HEMICRANIECTOMY; INFECTIONS; MANAGEMENT; SERIES; DEFECT	Background: The overall benefits of craniectomy must include procedural risks from cranioplasty. Cranioplasty carries a high risk of surgical site infections (SSI) particularly with antibiotic resistant bacteria. The goal of this study was to measure the effect of a cranioplasty bundle on pen-operative complications. Methods: The authors queried a prospective, inpatient neurosurgery database at Kaiser Sacramento Medical Center for craniectomy and cranioplasty over a 7 year period. 57 patients who underwent cranioplasties were identified. A retrospective chart review was completed for complications, including surgical complications such as SSI, wound dehiscence, and re-do cranioplasty. We measured cranioplasty complication rates before and after implementation of a pen-operative bundle, which consisted of peri-operative vancomycin (4 doses), a barrier dressing through post-operative day (POD) 3, and de-colonization of the surgical incision using topical chlorhexidine from POD 4 to 7. Results: The rate of MRSA colonization in cranioplasty patients is three times higher than the average seen on ICU admission screening (19% vs. 6%). The cranioplasty surgical complication rate was 22.8% and SSI rate was 10.5%. The concurrent SSI rate for craniectomy was 1.9%. Organisms isolated were methicillin-resistant Staphylococcus aureus (4), methicillin-sensitive S. aureus (1), Propionibacterium acnes (1), and Escherichia coli (1). Factors associated with SSI were pen-operative vancomycin (68.6% vs. 16.7%, p = 0.0217). Complication rates without (n = 21) and with (n = 36) the bundle were: SSI (23.8% vs. 2.8%, p = 0.0217) and redo cranioplasty (19% vs. 0%, p = 0.0152). Bundle use did not affect rates for superficial wound dehiscence, seizures, or hydrocephalus. Conclusions: The cranioplasty bundle was associated with reduced SSI rates and the need for re-do cranioplasties. (C) 2014 Elsevier B.V. All rights reserved.	[Le, Catherine] Univ Calif Los Angeles, Neurocrit Care Dept, Los Angeles, CA USA; [Guppy, Kern H.; Axelrod, Yekaterina V.; Hawk, Mark W.; Silverthorn, James; Akins, Paul T.] Kaiser Sacramento Neurosurg Dept, Sacramento, CA 95825 USA; [Inacio, Maria C.] Kaiser Surg Implant Registry, San Diego, CA 92108 USA		Akins, PT (corresponding author), Kaiser Sacramento Neurosurg Dept, 2025 Morse Ave, Sacramento, CA 95825 USA.	paul.t.akins@kp.org	Inacio, Maria/ABD-6778-2021; Inacio, Maria C/G-9593-2018; Axelrod, Katia/AAN-6454-2020	Inacio, Maria/0000-0001-8261-2665; Inacio, Maria C/0000-0001-8261-2665; 			Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Akins PT, 2010, J NEUROSURG, V112, P354, DOI 10.3171/2009.5.JNS081589; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lavu H, 2012, J SURG RES, V174, P215, DOI 10.1016/j.jss.2011.09.028; Liao CC, 2002, J CLIN NEUROSCI, V9, P553, DOI 10.1054/jocn.2002.1116; Moreira-Gonzalez A, 2003, J CRANIOFAC SURG, V14, P144, DOI 10.1097/00001665-200303000-00003; Park JS, 2007, J KOREAN NEUROSURG S, V42, P89; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Stephens FL, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1026; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Sughrue ME, 2011, J CLIN NEUROSCI, V18, P1201, DOI 10.1016/j.jocn.2011.01.016; Thavarajah D, 2012, BRIT J NEUROSURG, V26, P78, DOI 10.3109/02688697.2011.603850; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yadla S, 2011, NEUROSURGERY, V68, P1124, DOI 10.1227/NEU.0b013e31820a5470; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	23	27	27	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAY	2014	120						41	44		10.1016/j.clineuro.2014.02.009			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AG7UB	WOS:000335623200009	24731574				2022-02-06	
J	Osterstock, G; El Yandouzi, T; Romano, N; Carmignac, D; Langlet, F; Coutry, N; Guillou, A; Schaeffer, M; Chauvet, N; Vanacker, C; Galibert, E; Dehouck, B; Robinson, ICAF; Prevot, V; Mollard, P; Plesnila, N; Mery, PF				Osterstock, Guillaume; El Yandouzi, Taoufik; Romano, Nicola; Carmignac, Danielle; Langlet, Fanny; Coutry, Nathalie; Guillou, Anne; Schaeffer, Marie; Chauvet, Norbert; Vanacker, Charlotte; Galibert, Evelyne; Dehouck, Benedicte; Robinson, Iain C. A. F.; Prevot, Vincent; Mollard, Patrice; Plesnila, Nikolaus; Mery, Pierre-Franois			Sustained Alterations of Hypothalamic Tanycytes During Posttraumatic Hypopituitarism in Male Mice	ENDOCRINOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; GROWTH-HORMONE-SECRETION; PROTEIN TRANSGENIC MICE; QUALITY-OF-LIFE; ARCUATE NUCLEUS; GHRH NEURONS; INFLAMMATORY RESPONSE; GENE-EXPRESSION; IN-VIVO	Traumatic brain injury is a leading cause of hypopituitarism, which compromises patients' recovery, quality of life, and life span. To date, there are no means other than standardized animal studies to provide insights into the mechanisms of posttraumatic hypopituitarism. We have found that GH levels were impaired after inducing a controlled cortical impact (CCI) in mice. Furthermore, GHRH stimulation enhanced GH to lower level in injured than in control or sham mice. Because many characteristics were unchanged in the pituitary glands of CCI mice, we looked for changes at the hypothalamic level. Hypertrophied astrocytes were seen both within the arcuate nucleus and the median eminence, two pivotal structures of the GH axis, spatially remote to the injury site. In the arcuate nucleus, GHRH neurons were unaltered. In the median eminence, injured mice exhibited unexpected alterations. First, the distributions of claudin-1 and zonula occludens-1 between tanycytes were disorganized, suggesting tight junction disruptions. Second, endogenous IgG was increased in the vicinity of the third ventricle, suggesting abnormal barrier properties after CCI. Third, intracerebroventricular injection of a fluorescent-dextran derivative highly stained the hypothalamic parenchyma only after CCI, demonstrating an increased permeability of the third ventricle edges. This alteration of the third ventricle might jeopardize the communication between the hypothalamus and the pituitary gland. In conclusion, the phenotype of CCI mice had similarities to the posttraumatic hypopituitarism seen in humans with intact pituitary gland and pituitary stalk. It is the first report of a pathological status in which tanycyte dysfunctions appear as a major acquired syndrome.	[Osterstock, Guillaume; El Yandouzi, Taoufik; Romano, Nicola; Coutry, Nathalie; Guillou, Anne; Schaeffer, Marie; Chauvet, Norbert; Galibert, Evelyne; Mollard, Patrice; Mery, Pierre-Franois] Inst Genom Fonct, INSERM U661, F-34094 Montpellier, France; [Osterstock, Guillaume; El Yandouzi, Taoufik; Romano, Nicola; Coutry, Nathalie; Guillou, Anne; Schaeffer, Marie; Chauvet, Norbert; Galibert, Evelyne; Mollard, Patrice; Mery, Pierre-Franois] Inst Genom Fonct, Ctr Natl Rech Sci, Unite Mixte Rech 5203, F-34094 Montpellier, France; [Osterstock, Guillaume; El Yandouzi, Taoufik; Romano, Nicola; Coutry, Nathalie; Guillou, Anne; Schaeffer, Marie; Chauvet, Norbert; Galibert, Evelyne; Mollard, Patrice; Mery, Pierre-Franois] Univ Montpellier I, F-34967 Montpellier, France; [Carmignac, Danielle; Robinson, Iain C. A. F.] Natl Inst Med Res, Med Res Council, Div Mol Neuroendocrinol, London NW7 1AA, England; [Osterstock, Guillaume; El Yandouzi, Taoufik; Schaeffer, Marie; Plesnila, Nikolaus] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Langlet, Fanny; Vanacker, Charlotte; Dehouck, Benedicte; Prevot, Vincent] Jean Pierre Aubert Res Ctr, Dept Dev & Plast Postnatal Brain, INSERM U837, F-59045 Lille, France; [Langlet, Fanny; Vanacker, Charlotte; Dehouck, Benedicte; Prevot, Vincent] Univ Lille 2, F-59000 Lille, France		Mery, PF (corresponding author), Inst Genom Fonct, Dept Endocrinol, 141 Rue Cardonille, F-34094 Montpellier, France.	pierre-francois.mery@igf.cnrs.fr	Schaeffer, Marie/C-9815-2019; Plesnila, Nikolaus/T-7522-2019; COUTRY, Nathalie/O-9352-2017; Romano, Nicola/F-3688-2010; MERY, Pierre-Francois/C-5903-2019; Prevot, Vincent/E-5720-2016; Chauvet, Norbert/D-7333-2016	Schaeffer, Marie/0000-0002-2063-5324; COUTRY, Nathalie/0000-0001-5830-4013; Romano, Nicola/0000-0002-1316-8940; Prevot, Vincent/0000-0001-7185-3615; Chauvet, Norbert/0000-0003-4388-6422; Mery, Pierre-Francois/0000-0001-6214-5422	Royal College of Surgeons in Ireland; Institut National de la Sante et de la Recherche MedicaleInstitut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche ScientifiqueCentre National de la Recherche Scientifique (CNRS); Universities of Montpellier; National Biophotonics and Imaging Platform of Ireland; Institut Federatif de Recherches; Region Languedoc RoussillonRegion OccitanieRegion Ile-de-France; Agence Nationale de la RechercheFrench National Research Agency (ANR)European Commission; Ministere Delegue a la Recherche et aux Nouvelles Technologies; Medical Research Council of the United KingdomUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	This work was supported by grants from The Royal College of Surgeons in Ireland, the Institut National de la Sante et de la Recherche Medicale; the Centre National de la Recherche Scientifique; the Universities of Montpellier 1 and 2; the National Biophotonics and Imaging Platform of Ireland; the Institut Federatif de Recherches 3; the Region Languedoc Roussillon; the Agence Nationale de la Recherche (Gliodiabesity project); the Ministere Delegue a la Recherche et aux Nouvelles Technologies; and a core funding from the Medical Research Council of the United Kingdom.	Aberg ND, 2006, THESCIENTIFICWORLDJO, V6, P53, DOI 10.1100/tsw.2006.22; Addison ML, 2012, ENDOCRINOLOGY, V153, P1898, DOI 10.1210/en.2011-1982; Alonso G, 2007, AGING CELL, V6, P197, DOI 10.1111/j.1474-9726.2007.00276.x; Baccam N, 2007, J NEUROSCI, V27, P1631, DOI 10.1523/JNEUROSCI.2693-06.2007; Balthasar N, 2003, ENDOCRINOLOGY, V144, P2728, DOI 10.1210/en.2003-0006; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Briard N, 1998, ENDOCRINOLOGY, V139, P2662, DOI 10.1210/en.139.6.2662; Budry L, 2011, P NATL ACAD SCI USA, V108, P12515, DOI 10.1073/pnas.1105929108; Carraway Coralie A Carothers, 2007, Sci STKE, V2007, pre3, DOI 10.1126/stke.3812007re3; Carretero J, 2007, FOLIA MORPHOL WARSZ, V61, P209; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Chauvet N, 1998, EXP NEUROL, V151, P1, DOI 10.1006/exnr.1998.6784; Ciofi P, 2011, NEUROSCI LETT, V487, P187, DOI 10.1016/j.neulet.2010.10.019; CLARK RG, 1985, J ENDOCRINOL, V106, P281, DOI 10.1677/joe.0.1060281; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Cordoba-Chacon J, 2011, AM J PHYSIOL-ENDOC M, V300, pE46, DOI 10.1152/ajpendo.00514.2010; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; DANIEL PM, 1959, LANCET, V2, P927; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Flavell DM, 1996, EMBO J, V15, P3871, DOI 10.1002/j.1460-2075.1996.tb00761.x; Fleiss B, 2012, LANCET NEUROL, V11, P556, DOI 10.1016/S1474-4422(12)70058-3; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Giustina A, 1998, ENDOCR REV, V19, P717, DOI 10.1210/er.19.6.717; Gordon GRJ, 2009, NEURON, V64, P391, DOI 10.1016/j.neuron.2009.10.021; Hanchate NK, 2012, J NEUROSCI, V32, P932, DOI 10.1523/JNEUROSCI.4765-11.2012; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Hurley DL, 1998, NEUROENDOCRINOLOGY, V68, P201, DOI 10.1159/000054367; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Lafont C, 2010, P NATL ACAD SCI USA, V107, P4465, DOI 10.1073/pnas.0902599107; Langlet F, 2013, CELL METAB, V17, P607, DOI 10.1016/j.cmet.2013.03.004; Le Tissier PR, 2005, MOL ENDOCRINOL, V19, P1251, DOI 10.1210/me.2004-0223; LECHAN RM, 1981, ENDOCRINOLOGY, V109, P1950, DOI 10.1210/endo-109-6-1950; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Low MJ, 2001, J CLIN INVEST, V107, P1571, DOI 10.1172/JCI11941; Luque RM, 2006, ENDOCRINOLOGY, V147, P2754, DOI 10.1210/en.2005-1549; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Mantamadiotis T, 2006, MOL ENDOCRINOL, V20, P204, DOI 10.1210/me.2005-0195; McGuinness L, 2003, ENDOCRINOLOGY, V144, P720, DOI 10.1210/en.2002-220847; Mullier A, 2010, J COMP NEUROL, V518, P943, DOI 10.1002/cne.22273; Murray RD, 1999, CLIN ENDOCRINOL, V51, P565, DOI 10.1046/j.1365-2265.1999.00838.x; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pan WH, 2005, ENDOCRINOLOGY, V146, P4898, DOI 10.1210/en.2005-0587; Phelps CJ, 2003, J NEUROENDOCRINOL, V15, P280, DOI 10.1046/j.1365-2826.2003.01009.x; Prevot V, 2010, FRONT NEUROENDOCRIN, V31, P241, DOI 10.1016/j.yfrne.2010.05.003; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sanders NM, 2004, DIABETES, V53, P1230, DOI 10.2337/diabetes.53.5.1230; SATO M, 1993, ENDOCRINOLOGY, V133, P793, DOI 10.1210/en.133.2.793; Scheepens A, 2000, J PEDIATR ENDOCR MET, V13, P1483; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schwab JM, 2002, J NEUROSURG, V96, P892, DOI 10.3171/jns.2002.96.5.0892; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Steyn FJ, 2011, ENDOCRINOLOGY, V152, P3165, DOI 10.1210/en.2011-0253; Sumi N, 2010, CELL MOL NEUROBIOL, V30, P247, DOI 10.1007/s10571-009-9446-7; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Treip C S, 1970, J Clin Pathol Suppl (R Coll Pathol), V4, P178; Waite E, 2010, ENDOCRINOLOGY, V151, P234, DOI 10.1210/en.2009-0539; Wettschureck N, 2005, MOL CELL BIOL, V25, P1942, DOI 10.1128/MCB.25.5.1942-1948.2005; Witt CM, 2005, PLOS BIOL, V3, P1062, DOI 10.1371/journal.pbio.0030160; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zheng H, 1997, MOL ENDOCRINOL, V11, P1709, DOI 10.1210/me.11.11.1709; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	76	27	27	0	13	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	MAY	2014	155	5					1887	1898		10.1210/en.2013-1336			12	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	AP8PY	WOS:000342342200030	24601879				2022-02-06	
J	Smith, JE; Kehoe, A; Harrisson, SE; Russell, R; Midwinter, M				Smith, J. E.; Kehoe, A.; Harrisson, S. E.; Russell, R.; Midwinter, M.			Outcome of penetrating intracranial injuries in a military setting	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Military; Multiple trauma; Traumatic brain injury	CRANIOCEREBRAL INJURIES; SEVERITY SCORE; CARE; BRAIN; CONSCIOUSNESS; MANAGEMENT; SCALE; COMA; WAR	Background: Penetrating intracranial injuries are common in the deployed military medical environment. Early assessment of prognosis includes initial conscious level. There has been no previous identification of different outcomes depending on mechanism of penetrating injury. The aim of this study was to define outcome from penetrating head injury in our population, and to compare outcome between gunshot wound (GSW) and blast fragment injury, in order to detect a difference in survival. Methods: A retrospective database review was undertaken using the UK Joint Theatre Trauma Registry (JTTR) between the dates 2003 and 2011 to identify all cases of penetrating head injury. Data collected included mechanism of injury, first recorded GCS, injury severity score (ISS), abbreviated injury scale (AIS) head score, concomitant extracranial injury, surgical intervention, hospital length of stay, and survival. Results: 813 patients sustained a penetrating head injury, of whom 625 were injured by blast fragmentation and 188 were injured by GSW; overall 336 patients (41.3%) died. There was a significant difference between survival from GSW (41.5%) and blast fragment (63.8%; p < 0.001). In addition, the GCS in patients injured by GSW was significantly lower than that in patients injured by blast fragment. 157 cases sustained isolated head injury (79 GSW, 78 blast). The difference in injury severity between these groups was marked; median AIS was higher in the GSW group, survival lower (42% vs. 88%; p < 0.001) and distribution of GCS categories less favourable (p < 0.001). 338 of 343 patients (98.5%) with a best recorded GCS > 5, survived to discharge. Conclusion: Most patients who present following penetrating intracranial injury, who have a GCS > 5, survive to discharge. There is a significant difference in survival to hospital discharge following penetrating injury caused by blast fragment compared to those caused by GSW, partly attributable to a difference in injury severity. This is the first study to specifically highlight and define this difference. (C) 2013 Elsevier Ltd. All rights reserved.	[Smith, J. E.; Russell, R.] Royal Ctr Def Med Res & Acad, Acad Dept Mil Emergency Med, Med Directorate, Joint Med Command, Birmingham, W Midlands, England; [Smith, J. E.; Kehoe, A.] Derriford Hosp, Emergency Dept, Plymouth PL6 8DH, Devon, England; [Harrisson, S. E.; Midwinter, M.] Royal Ctr Def Med Res & Acad, Acad Dept Mil Surg & Trauma, Med Directorate, Joint Med Command, Birmingham, W Midlands, England; [Harrisson, S. E.] Wessex Neurol Ctr, Dept Neurosurg, Southampton, Hants, England		Smith, JE (corresponding author), Royal Ctr Def Med, Inst Res & Dev, Acad Dept Mil Emergency Med, Vincent Dr, Birmingham B15 2SQ, W Midlands, England.	jasonesmith@doctors.org.uk	Midwinter, Mark/AAB-6527-2019; Midwinter, Mark J/P-6264-2015; Smith, Jason Edward/H-9380-2013	Midwinter, Mark/0000-0003-1836-7137; Midwinter, Mark J/0000-0003-1836-7137; Smith, Jason Edward/0000-0002-6143-0421; Harrisson, Stuart/0000-0003-4995-4270			AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; Aarabi B, 2005, HEAD INJURY PATHOPHY, P384; Armonda RA, 2009, NEUROTRAUMA CRITICAL, P238; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2008; Balogh ZJ, 2003, J ORTHOP TRAUMA, V17, P508, DOI 10.1097/00005131-200308000-00006; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAIRNS H, 1947, Br J Surg, V55, P9; CAREY ME, 1987, MIL MED, V152, P6; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; LEVI L, 1990, ISRAEL J MED SCI, V26, P548; Mackay CA, 2000, PREHOSPITAL IMMEDIAT, V4, P17; Marcikic M, 1998, INJURY, V29, P613, DOI 10.1016/S0020-1383(98)00146-6; McNarry AF, 2004, ANAESTHESIA, V59, P34, DOI 10.1111/j.1365-2044.2004.03526.x; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; POLIN RS, 1995, NEUROSURG CLIN N AM, V6, P689; Roberts P, 2004, BRIT MILITARY SURG P; Russell RJ, 2011, PHILOS T R SOC B, V366, P171, DOI 10.1098/rstb.2010.0232; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; TEASDALE G, 1974, LANCET, V2, P81; Wani AA, 2012, NEUROSURG QUART, V22, P94, DOI 10.1097/WNQ.0b013e3182001874; Weisbrod AB, 2012, J TRAUMA ACUTE CARE, V73, P1525, DOI 10.1097/TA.0b013e318270e179	24	27	27	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2014	45	5					874	878		10.1016/j.injury.2013.12.004			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AD2AS	WOS:000333035500013	24398079				2022-02-06	
J	Macolino, CM; Daiutolo, BV; Albertson, BK; Elliott, MB				Macolino, Christine M.; Daiutolo, Brittany V.; Albertson, Brad K.; Elliott, Melanie B.			Mechanical alloydnia induced by traumatic brain injury is independent of restraint stress	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Traumatic brain injury; Headache; Mechanical allodynia; Stress; Corticosterone; Species	CORTICAL IMPACT INJURY; POSTTRAUMATIC HEADACHE; MOUSE STRAINS; NEUROPATHIC PAIN; RATS; ALLODYNIA; MODEL; NEURONS; MIGRAINE; CONCUSSION	Background: This study identifies the relationship between a test for post-traumatic headache and a marker for acute stress in rodent models of traumatic brain injury. New method: C57BL/6 mice and Sprague Dawley rats were divided into Controlled Cortical Impact (CCI) injury, craniotomy (CR), and incision groups. Periorbital and paw allodynia were evaluated using the von Frey test prior to injury and up to four weeks post-operatively. Serum corticosterone was evaluated in groups with and without mild restraint. Results: Periorbital and forepaw thresholds, but not hindpaw thresholds, were reduced in CCI and CR mice compared to incision (p < 0.0001 and p < 0.01). In contrast to mice, reduced periorbital and forepaw periorbital thresholds were found in CCI rats but not CR rats compared to incision (p < 0.0001). Right periorbital thresholds were reduced compared to left thresholds for both rat and mouse at one week (p < 0.01), but there were no side differences for forepaw thresholds. Hindpaw thresholds did not change from baseline values for any groups of mice or rats. In mice serum corticosterone levels were increased at one, two and four weeks post-CCI and CR, while the levels for rats were not different from incision (p < 0.0001). Corticosterone levels were not different in mice subjected to restraint compared to no restraint. Comparison with existing methods: This study presents novel data for allodynia in a rat model of TBI, and differences among mouse and rat species. Conclusions: Mechanical allodynia occurs independent of evoked restraint stress, while hypothalamic pituitary adrenal axis activity is dependent on head trauma and species. (c) 2014 Elsevier B.V. All rights reserved.	[Macolino, Christine M.; Daiutolo, Brittany V.] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Albertson, Brad K.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Elliott, Melanie B.] Jefferson Hosp Neurosci, Dept Neurosci, Chairs Off, Philadelphia, PA 19107 USA		Elliott, MB (corresponding author), Jefferson Hosp Neurosci, Dept Neurosci, Chairs Off, 900 Walnut St, Philadelphia, PA 19107 USA.	Christine.macolino@jefferson.edu; Brittany.Daiutolo@jefferson.edu; Bradley.alberston@jefferson.edu; Melanie.elliott@jefferson.edu			DoDUnited States Department of Defense [PR110389]; Merck Investigator Initiated Program Award	This research was supported by DoD PR110389 to MBE and Merck Investigator Initiated Program Award to MBE. Thank you to Drs. Michael Oshinsky and Stephen Silberstein, as well as the Thomas Jefferson University Headache Center for their continued feedback on this ongoing research. Thank you to Mason Love and Ashley Tyburski for assistance with behavioral testing.	Amenta PS, 2012, J NEUROSCI RES, V90, P2293, DOI 10.1002/jnr.23114; Atkinson HC, 1997, ENDOCRINOLOGY, V138, P3842, DOI 10.1210/en.138.9.3842; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Babb JA, 2013, NEUROSCIENCE, V234, P40, DOI 10.1016/j.neuroscience.2012.12.051; Bates EA, 2010, CEPHALALGIA, V30, P170, DOI 10.1111/j.1468-2982.2009.01864.x; Bernstein C, 2012, J CLIN NEUROL, V8, P89, DOI 10.3988/jcn.2012.8.2.89; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Burstein R, 2000, ANN NEUROL, V47, P614, DOI 10.1002/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N; Burstein R, 1998, J NEUROPHYSIOL, V79, P964, DOI 10.1152/jn.1998.79.2.964; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; Buse DC, 2013, J NEUROL, V260, P1960, DOI 10.1007/s00415-012-6725-x; Cernak I, 1999, BRAIN INJURY, V13, P1005; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Edelmayer RM, 2009, ANN NEUROL, V65, P184, DOI 10.1002/ana.21537; Elliott MB, 2010, NEUROSCIENCE, V170, P929, DOI 10.1016/j.neuroscience.2010.07.041; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Elliott MB, 2011, J NEUROTRAUM, V28, P973, DOI 10.1089/neu.2010.1672; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; Elliott MB, 2009, NEUROSCI LETT, V454, P34, DOI 10.1016/j.neulet.2009.01.037; Gibson CA, 2012, J REHABIL RES DEV, V49, P753, DOI 10.1682/JRRD.2011.09.0158; Gwak YS, 2010, J PHYSIOL SCI, V60, P59, DOI 10.1007/s12576-009-0066-2; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Imbe H, 2012, NEUROSCIENCE, V223, P209, DOI 10.1016/j.neuroscience.2012.08.007; Ising Marcus, 2006, Dialogues Clin Neurosci, V8, P433; Kerman IA, 2012, PSYCHONEUROENDOCRINO, V37, P256, DOI 10.1016/j.psyneuen.2011.06.010; Kerr BJ, 2007, EXP NEUROL, V206, P240, DOI 10.1016/j.expneurol.2007.04.014; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Martelli MF, 2004, J HEAD TRAUMA REHAB, V19, P10, DOI 10.1097/00001199-200401000-00003; Maxwell CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015963; McLean SA, 2005, PSYCHOSOM MED, V67, P783, DOI 10.1097/01.psy.0000181276.49204.bb; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Narita M, 2005, J NEUROSCI, V25, P10000, DOI 10.1523/JNEUROSCI.2507-05.2005; Newson MJF, 2013, J ENDOCRINOL, V216, P99, DOI 10.1530/JOE-12-0375; O'Malley D, 2010, STRESS, V13, P114, DOI 10.3109/10253890903067418; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Oshinsky ML, 2012, HEADACHE, V52, P1336, DOI 10.1111/j.1526-4610.2012.02247.x; Oshinsky ML, 2006, HEADACHE, V46, pS39, DOI 10.1111/j.1526-4610.2006.00489.x; Ray B, 2011, NEUROSCIENCE, V184, P139, DOI 10.1016/j.neuroscience.2011.03.067; Schwedt TJ, 2011, CEPHALALGIA, V31, P6, DOI 10.1177/0333102410365108; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Sotres-Bayon F, 2008, J NEUROSCI, V28, P12147, DOI 10.1523/JNEUROSCI.4373-08.2008; Sullivan RM, 2002, PSYCHONEUROENDOCRINO, V27, P99, DOI 10.1016/S0306-4530(01)00038-5; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; van Gaalen MM, 2000, BEHAV BRAIN RES, V115, P95, DOI 10.1016/S0166-4328(00)00240-0; Vargas BB, 2009, CURR PAIN HEADACHE R, V13, P64, DOI 10.1007/s11916-009-0013-1; Winkelstein BA, 2004, J BIOMECH ENG-T ASME, V126, P258, DOI 10.1115/1.1695571; Winner P, 2013, CEPHALALGIA, V33, P37; Woolf CJ, 2004, LIFE SCI, V74, P2605, DOI 10.1016/j.lfs.2004.01.003; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Zasler ND, 2011, J HEAD TRAUMA REHAB, V26, P397, DOI 10.1097/HTR.0b013e31822721f8	65	27	27	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	APR 15	2014	226						139	146		10.1016/j.jneumeth.2014.01.008			8	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AE4IR	WOS:000333946600014	24486873				2022-02-06	
J	Crenn, P; Hamchaoui, S; Bourget-Massari, A; Hanachi, M; Melchior, JC; Azouvi, P				Crenn, Pascal; Hamchaoui, Sabrina; Bourget-Massari, Aliette; Hanachi, Mouna; Melchior, Jean-Claude; Azouvi, Philippe			Changes in weight after traumatic brain injury in adult patients: A longitudinal study	CLINICAL NUTRITION			English	Article						Traumatic brain injury; Weight change; Behavioral dysexecutive syndrome; Eating disorders	HEAD-INJURY; FOOD-INTAKE; HYPOPITUITARISM; OBESITY; GAIN	Background & aims: Although changes in weight have been reported after traumatic brain injury (TBI), their frequency and underlying factors are little known. Our aim was to determine the prevalence of weight changes and the associated factors during the recovery phase after TBI. Methods: Longitudinal follow-up of adults with TBI. Multivariate analysis was carried out on weight change, demographic data, dysexecutive syndrome, eating behavior, physical activity, therapeutic classes and metabolic complications. Results: 107 patients (81 males/26 females), age 36 +/- 13 yrs, baseline BMI 23.3 +/- 3.9, followed for 38 (8-66) months, were included. In intensive care, patients lost a mean 11 +/- 6 kg. End of follow-up, mean BMI was not different to pre-TBI BMI, but patients could be categorized in 3 groups: stable (30%), loss (28%, -8 +/- 7 kg) and gain (42%, +9 +/- 6 kg). Sex, age, severity of TBI, intensive care weight loss, physical activity, therapeutic classes and the occurrence of metabolic syndrome did not differ between the groups. Factors related to weight gain were hyperphagia, OR 4.5 (IC95%, 1.6-12.1) and presence of a dysexecutive syndrome, OR 2.5 (IC95%, 1.03-6.3). Factors related to weight loss were hypophagia, OR 4.1 (IC95%, 1.5-10.9) and higher pre-TBI BMI, OR 4.9 (IC95%, 1.7-14.0). Conclusions: Over a median period of 38 months, 42% of TBI patients gained and 28% lost weight. Factors associated with these changes were the presence of a behavioral dysexecutive syndrome for weight gain, oral food intake and initial BMI, which were inversely associated with weight at end of follow-up. These findings highlight the importance of evaluating the time course of weight changes and providing specific nutritional care. (C) 2013 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.	[Crenn, Pascal; Hanachi, Mouna; Melchior, Jean-Claude; Azouvi, Philippe] Univ Versailles St Quentin En Yvelines, EA 4497, Versailles, France; [Crenn, Pascal; Hamchaoui, Sabrina; Bourget-Massari, Aliette; Hanachi, Mouna; Melchior, Jean-Claude; Azouvi, Philippe] Hop Raymond Poincare, AP HP, F-92380 Garches, France		Crenn, P (corresponding author), Hop Raymond Poincare, Dept Med Aigue Specialisee, 104 Blvd Raymond Poincare, F-92380 Garches, France.	pascal.crenn@rpc.aphp.fr		CRENN, Pascal/0000-0002-8213-2319			Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Brooke M, 1989, NEUROREHAB NEURAL RE, V3, P27; Castano B, 2010, NEUROREHABILITATION, V27, P113, DOI 10.3233/NRE-2010-0586; Denes Z, 2004, DISABIL REHABIL, V26, P1163, DOI 10.1080/09638280412331270380; Dolberg OT, 2005, PSYCHOPHARMACOLOGY, V179, P838, DOI 10.1007/s00213-004-2117-y; Fujii M, 1998, BRAIN INJURY, V12, P709, DOI 10.1080/026990598122278; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Henson Martha B., 1993, Brain Injury, V7, P169, DOI 10.3109/02699059309008170; Jourdan C, 2012, DEV MED CHILD NEUROL, V54, P624, DOI 10.1111/j.1469-8749.2012.04291.x; Klose M, 2007, CLIN ENDOCRINOL OXF, V67; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; LEWIN J, 1992, Brain Injury, V6, P199, DOI 10.3109/02699059209029660; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MIYASAKI K, 1972, ACTA PATHOL JAPON, V22, P779; Ogura K, 2008, BRAIN DEV-JPN, V30, P469, DOI 10.1016/j.braindev.2007.12.011; Perel P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001530.pub2; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Tagliaferri F, 2009, J TRAUMA, V66, P727, DOI 10.1097/TA.0b013e31815edefd; *WHO, 2002, MOV HLTH; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	26	27	27	1	13	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	APR	2014	33	2					348	353		10.1016/j.clnu.2013.06.003			6	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	AF8SI	WOS:000334985500026	23810396	Green Submitted			2022-02-06	
J	Miguel-Hidalgo, JJ; Whittom, A; Villarreal, A; Soni, M; Meshram, A; Pickett, JC; Rajkowska, G; Stockmeier, CA				Miguel-Hidalgo, Jose J.; Whittom, Angela; Villarreal, Ashley; Soni, Madhav; Meshram, Ashish; Pickett, Jason C.; Rajkowska, Grazyna; Stockmeier, Craig A.			Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Depression; Prefrontal cortex; Comorbidity; Vulnerability; Postmortem	FIBRILLARY ACIDIC PROTEIN; TRAUMATIC BRAIN-INJURY; CELL-PROLIFERATION; PREFRONTAL CORTEX; MOOD DISORDERS; TNF-ALPHA; ANTIDEPRESSANT DRUGS; COGNITIVE DEFICITS; CASPASE ACTIVATION; POSTMORTEM DELAY	Background: In major depressive disorder (MDD), lowered neural activity and significant reductions of markers of cell resiliency to degeneration occur in the prefrontal cortex (PFC). It is still unclear whether changes in other relevant markers of cell vulnerability to degeneration and markers of cell proliferation are associated with MDD. Methods: Levels of caspase 8 (C8), X-linked inhibitor of apoptosis protein (XIAP), direct IAP binding protein with low pI (DIABLO), proliferating cell nuclear antigen (PCNA) and density of cells immunoreactive (-IR) for proliferation marker Ki-67 were measured in postmortem samples of the left orbitofrontal cortex (OFC) of subjects with MDD, and psychiatrically-normal comparison subjects. Results: There was significant increase in C8, a higher ratio of DIABLO to XIAP, lower packing density of Ki-67-IR cells, and an unexpected age-dependent increase in PCNA in subjects with MDD vs. controls. PCNA levels were significantly higher in MDD subjects unresponsive to antidepressants or untreated with antidepressants. The DIABLO/XIAP ratio was higher in MDD subjects without antidepressants than in comparison subjects. Limitations: Qualitative nature of responsiveness assessments; definition of resistance to antidepressant treatment is still controversial; and unclear role of PCNA. Conclusions: Markers of cell vulnerability to degeneration are increased and density of Ki67-positive cells is low MDD, but accompanied by normal MAP levels. The results suggest increased vulnerability to cell pathology in depression that is insufficient to cause morphologically conspicuous cell death. Persistent but low-grade vulnerability to cell degeneration coexisting with reduced proliferation readiness may explain age-dependent reductions in neuronal densities in the OFC of depressed subjects. (C) 2014 Elsevier B.V. All rights reserved.	[Miguel-Hidalgo, Jose J.; Whittom, Angela; Villarreal, Ashley; Soni, Madhav; Meshram, Ashish; Pickett, Jason C.; Rajkowska, Grazyna; Stockmeier, Craig A.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Stockmeier, Craig A.] Case Western Reserve Univ, Cleveland, OH 44106 USA		Miguel-Hidalgo, JJ (corresponding author), Univ Mississippi, Dept Psychiat & Human Behav, Med Ctr, 2500 N State St,Box 127, Jackson, MS 39216 USA.	jmiguel-bidalgo@umc.edu		Miguel-Hidalgo, Jose/0000-0002-4094-1249	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH82297, P30 GM103328]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH082297] Funding Source: NIH RePORTER	Funding for this study was provided by NIH grants MH82297 and P30 GM103328. The NIH had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Austin MP, 2001, BRIT J PSYCHIAT, V178, P200, DOI 10.1192/bjp.178.3.200; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Banasr M, 2007, BIOL PSYCHIAT, V62, P496, DOI 10.1016/j.biopsych.2007.02.006; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Berthold-Losleben M, 2008, CURR NEUROPHARMACOL, V6, P193, DOI 10.2174/157015908785777238; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Brasnjevic I, 2008, DNA REPAIR, V7, P1087, DOI 10.1016/j.dnarep.2008.03.010; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Chiou SH, 2006, BIOCHEM BIOPH RES CO, V343, P391, DOI 10.1016/j.bbrc.2006.02.180; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Choi C, 1999, J IMMUNOL, V162, P1889; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cotter DR, 2001, BRAIN RES BULL, V55, P585, DOI 10.1016/S0361-9230(01)00527-5; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; Dejong TM, 2009, SUICIDE LIFE-THREAT, V39, P38, DOI 10.1521/suli.2009.39.1.38; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Drapeau E, 2008, AGING CELL, V7, P569, DOI 10.1111/j.1474-9726.2008.00369.x; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Epp JR, 2009, HIPPOCAMPUS, V19, P1040, DOI 10.1002/hipo.20546; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Honer WG, 1999, NEUROSCIENCE, V91, P1247, DOI 10.1016/S0306-4522(98)00679-4; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Khundakar AA, 2009, INT PSYCHOGERIATR, V21, P844, DOI 10.1017/S104161020999007X; Koski CL, 2004, ENDOCRINOLOGY, V145, P95, DOI 10.1210/en.2003-0803; Kubitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076882; Kulmatycki KM, 2006, J PHARM PHARM SCI, V9, P292, DOI 10.18433/J36P47; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; KURKI P, 1986, EXP CELL RES, V166, P209, DOI 10.1016/0014-4827(86)90520-3; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lucassen PJ, 2010, NEUROPHARMACOLOGY, V58, P940, DOI 10.1016/j.neuropharm.2010.01.012; LUCASSEN PJ, 1995, J HISTOCHEM CYTOCHEM, V43, P1163, DOI 10.1177/43.11.7560899; Lucassen PJ, 2001, AM J PATHOL, V158, P453, DOI 10.1016/S0002-9440(10)63988-0; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Manev H, 2001, EUR J PHARMACOL, V411, P67, DOI 10.1016/S0014-2999(00)00904-3; Manji HK, 2000, MOL PSYCHIATR, V5, P578, DOI 10.1038/sj.mp.4000811; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Merkl A, 2011, BIOL PSYCHIAT, V69, P772, DOI 10.1016/j.biopsych.2010.08.009; Miguel-Hidalgo JJ, 2000, BIOL PSYCHIAT, V48, P861, DOI 10.1016/S0006-3223(00)00999-9; Muskhelishvili L, 2003, J HISTOCHEM CYTOCHEM, V51, P1681, DOI 10.1177/002215540305101212; Niizuma K, 2010, BBA-MOL BASIS DIS, V1802, P92, DOI 10.1016/j.bbadis.2009.09.002; Olesen BT, 2008, NEUROTOXICOLOGY, V29, P13, DOI 10.1016/j.neuro.2007.08.010; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Rajkowska G, 2005, BIOL PSYCHIAT, V58, P297, DOI 10.1016/j.biopsych.2005.04.013; Riddle DR, 2007, BRAIN AGING MODELS M; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Saito A, 2003, J CEREBR BLOOD F MET, V23, P1010, DOI 10.1097/01.WCB.0000080702.47016.FF; Scarabelli TM, 2004, J AM COLL CARDIOL, V43, P865, DOI 10.1016/j.jacc.2003.09.050; Schallock K, 1997, CLIN NEUROPATHOL, V16, P133; Schamberger CJ, 2005, EXP CELL RES, V302, P115, DOI 10.1016/j.yexcr.2004.08.026; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Scott RJ, 1997, NEUROPATH APPL NEURO, V23, P307; Segura MF, 2007, J NEUROSCI, V27, P11228, DOI 10.1523/JNEUROSCI.3462-07.2007; Si XH, 2004, NEUROPSYCHOPHARMACOL, V29, P2088, DOI 10.1038/sj.npp.1300525; Souery D, 1999, EUR NEUROPSYCHOPHARM, V9, P83, DOI 10.1016/S0924-977X(98)00004-2; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Uranova NA, 2004, SCHIZOPHR RES, V67, P269, DOI 10.1016/S0920-9964(03)00181-6; Uylings HBM, 2010, PSYCHIAT RES-NEUROIM, V183, P1, DOI 10.1016/j.pscychresns.2010.04.012; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vostrikov V, 2011, SCHIZOPHR RES TREAT, V2011, DOI 10.1155/2011/174689; Wang XY, 2004, NEUROBIOL DIS, V16, P179, DOI 10.1016/j.nbd.2004.01.014	70	27	31	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	APR	2014	158						62	70		10.1016/j.jad.2014.02.010			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	AD4ZB	WOS:000333259500010	24655767	Green Accepted			2022-02-06	
J	Shafi, S; Barnes, SA; Millar, D; Sobrino, J; Kudyakov, R; Berryman, C; Rayan, N; Dubiel, R; Coimbra, R; Magnotti, LJ; Vercruysse, G; Scherer, LA; Jurkovich, GJ; Nirula, R				Shafi, Shahid; Barnes, Sunni A.; Millar, D.; Sobrino, Justin; Kudyakov, Rustam; Berryman, Candice; Rayan, Nadine; Dubiel, Rosemary; Coimbra, Raul; Magnotti, Louis J.; Vercruysse, Gary; Scherer, Lynette A.; Jurkovich, Gregory J.; Nirula, Raminder			Suboptimal compliance with evidence-based guidelines in patients with traumatic brain injuries	JOURNAL OF NEUROSURGERY			English	Article						evidence-based management; quality of care; traumatic brain injury; quality chasm; variations in care	UNITED-STATES; HEALTH-CARE; QUALITY; MORTALITY; CENTERS	Object. Evidence-based management (EBM) guidelines for severe traumatic brain injuries (TBIs) were promulgated decades ago. However, the extent of their adoption into bedside clinical practices is not known. The purpose of this study was to measure compliance with EBM guidelines for management of severe TBI and its impact on patient outcome. Methods. This was a retrospective study of blunt TBI (11 Level I trauma centers, study period 2008-2009, n = 2056 patients). Inclusion criteria were an admission Glasgow Coma Scale score s 8 and a CT scan showing TBI, excluding patients with nonsurvivable injuries-that is, head Abbreviated Injury Scale score of 6. The authors measured compliance with 6 nonoperative EBM processes (endotracheal intubation, resuscitation, correction of coagulopathy, intracranial pressure monitoring, maintaining cerebral perfusion pressure >= 50 cm H2O, and discharge to rehabilitation). Compliance rates were calculated for each center using multivariate regression to adjust for patient demographics, physiology, injury severity, and TBI severity. Results. The overall compliance rate was 73%, and there was wide variation among centers. Only 3 centers achieved a compliance rate exceeding 80%. Risk-adjusted compliance was worse than average at 2 centers, better than average at 1, and the remainder were average. Multivariate analysis showed that increased adoption of EBM was associated with a reduced mortality rate (OR 0.88; 95% CI 0.81-0.96, p < 0.005). Conclusions. Despite widespread dissemination of EBM guidelines, patients with severe TBI continue to receive inconsistent care. Barriers to adoption of EBM need to be identified and mitigated to improve patient outcomes.	[Shafi, Shahid; Barnes, Sunni A.; Sobrino, Justin; Kudyakov, Rustam; Berryman, Candice; Rayan, Nadine] Baylor Hlth Care Syst, Inst Hlth Care Res & Improvement, Dallas, TX 75206 USA; [Dubiel, Rosemary] Baylor Hlth Care Syst, Baylor Inst Rehabil, Dallas, TX 75206 USA; [Coimbra, Raul] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Magnotti, Louis J.] Univ Tennessee, Ctr Hlth Sci, Dept Gen Surg, Memphis, TN 38163 USA; [Vercruysse, Gary] Emory Univ, Div Trauma Surg Crit Care, Atlanta, GA 30322 USA; [Scherer, Lynette A.] Univ Calif Davis, Dept Surg, Sacramento, CA 95817 USA; [Jurkovich, Gregory J.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Millar, D.; Nirula, Raminder] Univ Utah, Dept Surg, Salt Lake City, UT USA		Shafi, S (corresponding author), Baylor Hlth Care Syst, Inst Hlth Care Res & Improvement, 8080 N Cent Expressway,Ste 500, Dallas, TX 75206 USA.	shahid.shafi@baylorhealth.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851	National Institute on Disability and Rehabilitation Research [H133A070027-11]; American Recovery and Reinvestment Act/National Institute of Neurological Disorders and Stroke [1RC1NS069066-01, 5RC1NS069066-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RC1NS069066] Funding Source: NIH RePORTER	Support was provided in part by a grant from the National Institute on Disability and Rehabilitation Research (no. H133A070027-11) and by the American Recovery and Reinvestment Act/National Institute of Neurological Disorders and Stroke (nos. 1RC1NS069066-01 and 5RC1NS069066-02).	Brain Injury Association of America, BRAIN INJ; Brain Trauma Foundation, AB BTF; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Fleming NS, 2009, JT COMM J QUAL PATIE, V35, P414, DOI 10.1016/S1553-7250(09)35058-8; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Rayan N, 2012, J TRAUMA ACUTE CARE, V72, P585, DOI 10.1097/TA.0b013e318243da4d; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shafi S, 2012, J TRAUMA ACUTE CARE, V72, P870, DOI 10.1097/TA.0b013e3182463e20; Shafi S, 2010, J TRAUMA, V68, P771, DOI 10.1097/TA.0b013e3181d03a20; Sucher JF, 2008, J TRAUMA, V64, P520, DOI 10.1097/TA.0b013e3181601812	12	27	27	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2014	120	3					773	777		10.3171/2013.12.JNS132151			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AB8OB	WOS:000332048800028	24438538				2022-02-06	
J	Lapp, DW; Zhang, SS; Barnstable, CJ				Lapp, Daniel W.; Zhang, Samuel S.; Barnstable, Colin J.			Stat3 Mediates LIF-Induced Protection of Astrocytes Against Toxic ROS by Upregulating the UPC2 mRNA Pool	GLIA			English	Article						glia; oxidative stress; uncoupling protein 2	MITOCHONDRIAL UNCOUPLING PROTEIN-2; LEUKEMIA INHIBITORY FACTOR; FOCAL CEREBRAL-ISCHEMIA; RETINAL GANGLION-CELLS; TRAUMATIC BRAIN-INJURY; EMBRYONIC STEM-CELLS; REACTIVE OXYGEN; IN-VITRO; OXIDATIVE STRESS; NERVOUS-SYSTEM	Reactive oxygen species (ROS) have been implicated in various types of CNS damage, including stroke. We used a cultured astrocyte model to explore mechanisms of survival of CNS cells following ROS damage. We found that pretreatment with leukemia inhibitory factor (LIF) preserves astrocytes exposed to toxic levels of t-BHP by inhibiting an increase in intracellular ROS following t-BHP treatment. Astrocytes lacking functional Stat3 did not benefit from the pro-survival or antioxidant effects of LIF. Inhibition of mitochondrial uncoupling protein 2 (UCP2) using a chemical inhibitor or siRNA abrogates the prosurvival effects of LIF, indicating a critical role for UCP2 in modulation of mitochondrial ROS production in survival following ROS exposure. LIF treatment of astrocytes results in increased UCP2 mRNA that is accompanied by an increase in Stat3 binding to the UCP2 promoter region. Although treatment with LIF alone did not increase UCP2 protein, a combination of LIF treatment and ROS stress led to increased UCP2 protein levels. We conclude that LIF protects astrocytes from ROS-induced death by increasing UCP2 mRNA, allowing cells to respond to ROS stress by rapidly producing UCP2 protein that ultimately decreases endogenous mitochondrial ROS production. GLIA 2014;62:159-170	[Lapp, Daniel W.; Zhang, Samuel S.; Barnstable, Colin J.] Penn State Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Zhang, Samuel S.; Barnstable, Colin J.] Penn State Coll Med, Penn State Hershey Eye Ctr, Hershey, PA USA		Barnstable, CJ (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Neural & Behav Sci, 500 Univ Dr, Hershey, PA 17033 USA.	cjb30@psu.edu	Barnstable, Colin/ABB-4822-2021	Barnstable, Colin/0000-0002-7011-4068			Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Banner LR, 1997, EXP NEUROL, V147, P1, DOI 10.1006/exnr.1997.6536; Barreto GE, 2011, NEUROSCI RES, V71, P107, DOI 10.1016/j.neures.2011.06.004; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; CHAN PH, 1994, BRAIN PATHOL, V4, P59; Chan SHH, 2009, CIRC RES, V105, P886, DOI 10.1161/CIRCRESAHA.109.199018; Choi JS, 2003, GLIA, V41, P237, DOI 10.1002/glia.10186; Craig R, 2001, J BIOL CHEM, V276, P37621, DOI 10.1074/jbc.M103276200; Cui Y, 2006, EXP EYE RES, V83, P807, DOI 10.1016/j.exer.2006.03.024; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Desagher S, 1996, J NEUROSCI, V16, P2553; Dienel GA, 2005, GLIA, V50, P362, DOI 10.1002/glia.20157; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Fang XX, 2013, CELL MOL NEUROBIOL, V33, P241, DOI 10.1007/s10571-012-9891-6; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Horvath TL, 2003, BIOCHEM PHARMACOL, V65, P1917, DOI 10.1016/S0006-2952(03)00143-6; Hurtaud C, 2006, CELL MOL LIFE SCI, V63, P1780, DOI 10.1007/s00018-006-6129-0; Ibarretxe G, 2006, GLIA, V53, P201, DOI 10.1002/glia.20267; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Ji JZ, 2004, EUR J NEUROSCI, V19, P265, DOI 10.1111/j.0953-816X.2003.03107.x; Jung JE, 2009, J NEUROSCI, V29, P7003, DOI 10.1523/JNEUROSCI.1110-09.2009; Kondrikov D, 2011, FREE RADICAL BIO MED, V50, P1689, DOI 10.1016/j.freeradbiomed.2011.03.020; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Liang QH, 2005, BIOCHEM PHARMACOL, V70, P1371, DOI 10.1016/j.bcp.2005.04.011; Lucius R, 1996, BRAIN RES, V743, P56, DOI 10.1016/S0006-8993(96)01029-3; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Mronga T, 2004, GLIA, V46, P446, DOI 10.1002/glia.20022; Naha PC, 2010, TOXICOL APPL PHARM, V246, P91, DOI 10.1016/j.taap.2010.04.014; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; OTERO GC, 1994, GLIA, V11, P117, DOI 10.1002/glia.440110207; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; PARK CK, 1994, BRAIN RES, V645, P157; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Peterson WM, 2000, J NEUROSCI, V20, P4081; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rousset S, 2007, FEBS LETT, V581, P479, DOI 10.1016/j.febslet.2007.01.010; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Schulz R., CURR PHARM IN PRESS; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Sofroniew MV, 2000, MOL PSYCHIATR, V5, P230, DOI 10.1038/sj.mp.4000753; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Tanaka J, 1999, GLIA, V28, P85, DOI 10.1002/(SICI)1098-1136(199911)28:2<85::AID-GLIA1>3.0.CO;2-Y; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Wang DT, 2010, J IMMUNOL, V184, P582, DOI 10.4049/jimmunol.0902352; Zhang SSM, 2004, INVEST OPHTH VIS SCI, V45, P2407, DOI 10.1167/iovs.04-0003; Zheng Z, 2010, INVEST OPHTH VIS SCI, V51, P64, DOI 10.1167/iovs.09-3511; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	52	27	31	0	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	FEB	2014	62	2					159	170		10.1002/glia.22594			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	268ZL	WOS:000328209300001	24307565				2022-02-06	
J	Nwachuku, EL; Puccio, AM; Fetzick, A; Scruggs, B; Chang, YF; Shutter, LA; Okonkwo, DO				Nwachuku, Enyinna L.; Puccio, Ava M.; Fetzick, Anita; Scruggs, Bobby; Chang, Yue-Fang; Shutter, Lori A.; Okonkwo, David O.			Intermittent Versus Continuous Cerebrospinal Fluid Drainage Management in Adult Severe Traumatic Brain Injury: Assessment of Intracranial Pressure Burden	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; External ventricular drain; Intracranial pressure; Neuromonitoring; Adults	SUBARACHNOID HEMORRHAGE; PEDIATRIC-PATIENTS; CHILDREN	There is clinical equipoise regarding whether neurointensive care unit management of external ventricular drains (EVD) in severe traumatic brain injury (TBI) should involve an open EVD, with continuous drainage of cerebrospinal fluid (CSF), versus a closed EVD, with intermittent opening as necessary to drain CSF. In a matched cohort design, we assessed the relative impact of continuous versus intermittent CSF drainage on intracranial pressure in the management of adult severe TBI. Sixty-two severe TBI patients were assessed. Thirty-one patients managed by open EVD drainage were matched by age, sex, and injury severity (initial Glasgow Coma Scale (GCS) score) to 31 patients treated with a closed EVD drainage. Patients in the open EVD group also had a parenchymal intracranial pressure (ICP) monitor placed through an adjacent burr hole, allowing real-time recording of ICP. Hourly ICP and other pertinent data, such as length of stay in intensive care unit (LOS-ICU), Injury Severity Score, and survival status, were extracted from our prospective database. With age, injury severity (initial GCS score), and neurosurgical intervention adjusted for, there was a statistically significant difference of 5.66 mmHg in mean ICP (p < 0.0001) between the open and the closed EVD groups, with the closed EVD group exhibiting greater mean ICP. ICP burden (ICP a parts per thousand yen 20 mmHg) was shown to be significantly higher in the intermittent EVD group (p = 0.0002) in comparison with the continuous EVD group. Continuous CSF drainage via an open EVD seemed to be associated with more effective ICP control in the management of adult severe TBI.	[Nwachuku, Enyinna L.; Puccio, Ava M.; Fetzick, Anita; Scruggs, Bobby; Chang, Yue-Fang; Shutter, Lori A.; Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA 15260 USA; [Shutter, Lori A.] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Pittsburgh, PA USA; [Shutter, Lori A.] Univ Pittsburgh, Dept Neurol, Med Ctr, Pittsburgh, PA 15260 USA		Okonkwo, DO (corresponding author), Univ Pittsburgh, Med Ctr, Dept Neurosurg, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15260 USA.	okonkwodo@upmc.edu	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [2R25MH054318]; Brain Trauma Research Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS030318]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25MH054318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318] Funding Source: NIH RePORTER	Mr. Nwachuku was supported by the National Institute of Mental Health (2R25MH054318) and the Brain Trauma Research Center was supported by the National Institute of Neurological Disorders and Stroke (P01 NS030318).	Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Exo J, 2011, PEDIATR CRIT CARE ME, V12, P560, DOI 10.1097/PCC.0b013e3181e8b3ee; Gigante P, 2010, BRIT J NEUROSURG, V24, P625, DOI 10.3109/02688697.2010.505989; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kim GS, 2011, NEUROCRIT CARE, V14, P68, DOI 10.1007/s12028-010-9401-y; Mehta A, 2010, DEV NEUROSCI-BASEL, V32, P413, DOI 10.1159/000316804; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Shore PM, 2004, NEUROSURGERY, V54, P605, DOI 10.1227/01.NEU.0000108642.88724.DB; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6	11	27	28	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2014	20	1					49	53		10.1007/s12028-013-9885-3			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AB2RI	WOS:000331639400007	23943318				2022-02-06	
J	Shehadah, A; Chen, JL; Pal, A; He, SY; Zeitlin, A; Cui, X; Zacharek, A; Cui, YS; Roberts, C; Lu, M; Hariri, R; Chopp, M				Shehadah, Amjad; Chen, Jieli; Pal, Ajai; He, Shuyang; Zeitlin, Andrew; Cui, Xu; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Lu, Mei; Hariri, Robert; Chopp, Michael			Human Placenta-Derived Adherent Cell Treatment of Experimental Stroke Promotes Functional Recovery after Stroke in Young Adult and Older Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; SENSORIMOTOR CORTEX LESIONS; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; STEM-CELLS; SYNAPTIC PLASTICITY; EMBOLIC STROKE; GENE-EXPRESSION; INFARCT VOLUME; AGED RATS	Background: Human Placenta-Derived Adherent Cells (PDAC (R)) are a novel mesenchymal-like cell population derived from normal human placental tissue. PDA-001 is a clinical formulation of PDAC (R) developed for intravenous administration. In this study, we investigated the efficacy of PDA-001 treatment in a rat model of transient middle cerebral artery occlusion (MCAo) in young adult (2-3 month old) and older rats (10-12 months old). Methods: To evaluate efficacy and determine the optimal number of transplanted cells, young adult Wistar rats were subjected to MCAo and treated 1 day post MCAo with 1x10(6), 4x10(6) or 8x10(6) PDA-001 cells (i. v.), vehicle or cell control. 4x10(6) or 8x10(6) PDA-001 cells were also tested in older rats after MCAo. Treatment response was evaluated using a battery of functional outcome tests, consisting of adhesive-removal test, modified Neurological Severity Score (mNSS) and foot-fault test. Young adult rats were sacrificed 56 days after MCAo, older rats were sacrificed 29 days after MCAo, and lesion volumes were measured using H& E. Immunohistochemical stainings for bromodeoxyuridine (BrdU) and von Willebrand Factor (vWF), and synaptophysin were performed. Results: In young adult rats, treatment with 4x10(6) PDA-001 cells significantly improved functional outcome after stroke (p<0.05). In older rats, significant functional improvement was observed with PDA-001 cell therapy in both of the 4x10(6) and 8x10(6) treatment groups. Functional benefits in young adult and older rats were associated with significant increases in the number of BrdU immunoreactive endothelial cells, vascular density and perimeter in the ischemic brain, as well as significantly increased synaptophysin expression in the ischemic border zone (p<0.05). Conclusion: PDA-001 treatment significantly improved functional outcome after stroke in both young adult and older rats. The neurorestorative effects induced by PDA-001 treatment may be related to increased vascular density and synaptic plasticity.	[Shehadah, Amjad; Chen, Jieli; Cui, Xu; Zacharek, Alex; Cui, Yisheng; Roberts, Cynthia; Chopp, Michael] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Pal, Ajai; He, Shuyang; Zeitlin, Andrew; Hariri, Robert] Celgene Cellular Therapeut, Warren, NJ USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	jieli@neuro.hfh.edu		Shehadah, Amjad/0000-0001-8679-3774; Cui, Xu/0000-0002-6937-6191	Celgene Cellular Therapeutics, New Jersey, USA	This work was funded by Celgene Cellular Therapeutics, New Jersey, USA. The funders had no role in study design, data collection, analysis or preparation of the manuscript. Study design and decision to publish were approved by the funders.	Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; BARTH TM, 1990, STROKE, V21, P153; Bohotin Catalina Roxana, 2004, Rom J Physiol, V41, P99; CHEN H, 1991, NEUROLOGY, V41, P1133, DOI 10.1212/WNL.41.7.1133; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Chen J, 2012, CELL TRANSPLANT; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2002, J NEUROL SCI, V199, P17, DOI 10.1016/S0022-510X(02)00075-8; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cramer SC, 2000, TRENDS NEUROSCI, V23, P265, DOI 10.1016/S0166-2236(00)01562-9; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cui X, 2010, STROKE, V41, P2044, DOI 10.1161/STROKEAHA.110.589333; Ding GL, 2011, STROKE, V42, P3537, DOI 10.1161/STROKEAHA.111.622092; FUTRELL N, 1991, STROKE, V22, P1582, DOI 10.1161/01.STR.22.12.1582; GARCIA JH, 1971, ACTA NEUROPATHOL, V18, P273, DOI 10.1007/BF00688441; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; He SY, 2013, BRAIN BEHAV IMMUN, V27, P185, DOI 10.1016/j.bbi.2012.10.015; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Kranz A, 2010, BRAIN RES, V1315, P128, DOI 10.1016/j.brainres.2009.12.001; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Li X, 2011, STEM CELLS, V29, P263, DOI 10.1002/stem.572; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Mayer L, 2013, INFLAMM BOWEL DIS, V19, P754, DOI 10.1097/MIB.0b013e31827f27df; Mochizuki N, 2008, EXP NEUROL, V211, P194, DOI 10.1016/j.expneurol.2008.01.027; Nichols RC, 2011, CLIN LUNG CANCER, V12, P252, DOI 10.1016/j.cllc.2011.03.027; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pratt Phillip F, 2004, Curr Opin Investig Drugs, V5, P952; Rao MS, 2001, MECH AGEING DEV, V122, P713, DOI 10.1016/S0047-6374(01)00224-X; Rempe DA, 2002, NEUROLOGY, V59, P486, DOI 10.1212/WNL.59.4.486; Risau W, 1998, KIDNEY INT, V54, pS3, DOI 10.1046/j.1523-1755.1998.06701.x; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Stroemer RP, 1998, STROKE, V29, P2381, DOI 10.1161/01.STR.29.11.2381; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Yoon YS, 2005, BIOL CELL, V97, P253, DOI 10.1042/BC20040099; Yu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076329; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	47	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2014	9	1							e86621	10.1371/journal.pone.0086621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297GT	WOS:000330244500266	24466174	Green Submitted, Green Published, gold			2022-02-06	
J	van Klaveren, D; Steyerberg, EW; Perel, P; Vergouwe, Y				van Klaveren, David; Steyerberg, Ewout W.; Perel, Pablo; Vergouwe, Yvonne			Assessing discriminative ability of risk models in clustered data	BMC MEDICAL RESEARCH METHODOLOGY			English	Article						Clustered data; Concordance; Discrimination; Meta-analysis; Prediction; Risk model	TRAUMATIC BRAIN-INJURY; PREDICTION MODELS; HETEROGENEITY; METAANALYSIS; INDEX; AREA	Background: The discriminative ability of a risk model is often measured by Harrell's concordance-index (c-index). The c-index estimates for two randomly chosen subjects the probability that the model predicts a higher risk for the subject with poorer outcome (concordance probability). When data are clustered, as in multicenter data, two types of concordance are distinguished: concordance in subjects from the same cluster (within-cluster concordance probability) and concordance in subjects from different clusters (between-cluster concordance probability). We argue that the within-cluster concordance probability is most relevant when a risk model supports decisions within clusters (e.g. who should be treated in a particular center). We aimed to explore different approaches to estimate the within-cluster concordance probability in clustered data. Methods: We used data of the CRASH trial (2,081 patients clustered in 35 centers) to develop a risk model for mortality after traumatic brain injury. To assess the discriminative ability of the risk model within centers we first calculated cluster-specific c-indexes. We then pooled the cluster-specific c-indexes into a summary estimate with different meta-analytical techniques. We considered fixed effect meta-analysis with different weights (equal; inverse variance; number of subjects, events or pairs) and random effects meta-analysis. We reflected on pooling the estimates on the log-odds scale rather than the probability scale. Results: The cluster-specific c-index varied substantially across centers (IQR = 0.70-0.81; I-2 = 0.76 with 95% confidence interval 0.66 to 0.82). Summary estimates resulting from fixed effect meta-analysis ranged from 0.75 (equal weights) to 0.84 (inverse variance weights). With random effects meta- analysis - accounting for the observed heterogeneity in c-indexes across clusters - we estimated a mean of 0.77, a between-cluster variance of 0.0072 and a 95% prediction interval of 0.60 to 0.95. The normality assumptions for derivation of a prediction interval were better met on the probability than on the log-odds scale. Conclusion: When assessing the discriminative ability of risk models used to support decisions at cluster level we recommend meta- analysis of cluster-specific c-indexes. Particularly, random effects meta- analysis should be considered.	[van Klaveren, David; Steyerberg, Ewout W.; Vergouwe, Yvonne] Erasmus MC, Dept Publ Hlth, NL-3015 GE Rotterdam, Netherlands; [Perel, Pablo] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1E 7HT, England		van Klaveren, D (corresponding author), Erasmus MC, Dept Publ Hlth, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.	d.vanklaveren.1@erasmusmc.nl		/0000-0002-2342-301X	Netherlands Organisation for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [917.11.383]	This work was supported by the Netherlands Organisation for Scientific Research (grant 917.11.383).	Bouwmeester W, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-19; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Duchateau L, 2008, STAT BIOL HEALTH, P1; Edwards P, 2005, LANCET, V365, P1957; Efron B., 1993, INTRO BOOTSTRAP; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Hill A, 2007, DATA ANAL USING REGR; JENNETT B, 1975, LANCET, V1, P480; Lumley T, 2009, RMETA METAANALYSIS R; Nam BH, 2002, STAT IND TECHNOL, P267; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Quade D, 1967, NONPARAMETRIC UNPUB, V526; R Development Core Team, 2011, R LANG ENV STAT COMP; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Therneau T., 2011, SURVIVAL SURVIVAL AN; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Van Oirbeek R, 2012, COMPUT STAT DATA AN, V56, P1966, DOI 10.1016/j.csda.2011.11.023; Van Oirbeek R, 2010, STAT MED, V29, P3160, DOI 10.1002/sim.4058; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223	31	27	27	1	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2288			BMC MED RES METHODOL	BMC Med. Res. Methodol.	JAN 15	2014	14								5	10.1186/1471-2288-14-5			10	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	AB5LR	WOS:000331830600001	24423445	Green Published, gold, Green Accepted			2022-02-06	
J	Tohme, S; Delhumeau, C; Zuercher, M; Haller, G; Walder, B				Tohme, Sophia; Delhumeau, Cecile; Zuercher, Mathias; Haller, Guy; Walder, Bernhard			Prehospital risk factors of mortality and impaired consciousness after severe traumatic brain injury: an epidemiological study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Out-of-hospital emergency medical services; Prehospital emergency medicine; Head injury; Short term outcome	GLASGOW COMA SCALE; PROGNOSTIC VALUE; HEAD-INJURY; CARE; CATECHOLAMINES; ASPIRATION; MANAGEMENT; OUTCOMES; FAILURE; SYSTEM	Background: Severe traumatic brain injury (TBI) is a significant health concern and a major burden for society. The period between trauma event and hospital admission in an emergency department (ED) could be a determinant for secondary brain injury and early survival. The aim was to investigate the relationship between prehospital factors associated with secondary brain injury (arterial hypotension, hypoxemia, hypothermia) and the outcomes of mortality and impaired consciousness of survivors at 14 days. Methods: A multicenter, prospective cohort study was performed in dedicated trauma centres of Switzerland. Adults with severe TBI (Abbreviated Injury Scale score of head region (HAIS) >3) were included. Main outcome measures were death and impaired consciousness (Glasgow Coma Scale (GCS) <= 13) at 14 days. The associations between risk factors and outcome were assessed with univariate and multivariate regression models. Results: 589 patients were included, median age was 55 years (IQR 33, 70). The median GCS in ED was 4 (IQR 3-14), with abnormal pupil reaction in 167 patients (29.2%). Median ISS was 25 (IQR 21, 34). Three hundred seven patients sustained their TBI from falls (52.1%) and 190 from a road traffic accidents (32.3%). Median time from Out-of-hospital Emergency Medical Service (OHEMS) departure on scene to arrival in ED was 50 minutes (IQR 37-72); 451 patients had a direct admission (76.6%). Prehospital hypotension was observed in 24 (4.1%) patients, hypoxemia in 73 (12.6%) patients and hypothermia in 146 (24.8%). Prehospital hypotension and hypothermia (apart of age and trauma severity) was associated with mortality. Prehospital hypoxemia (apart of trauma severity) was associated with impaired consciousness; indirect admission was a protective factor. Conclusion: Mortality and impaired consciousness at 14 days do not have the same prehospital risk factors; prehospital hypotension and hypothermia is associated with mortality, and prehospital hypoxemia with impaired consciousness.	[Tohme, Sophia; Delhumeau, Cecile; Haller, Guy; Walder, Bernhard] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland; [Zuercher, Mathias] Univ Basel Hosp, Dept Anaesthesia & Intens Care Med, CH-4031 Basel, Switzerland; [Haller, Guy] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland		Walder, B (corresponding author), Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland.	bernhard.walder@hcuge.ch		haller, guy/0000-0001-7367-7029	Swiss Accident Company; Bangerter-Rhyner Foundation, Switzerland	The authors declare no conflicts of interest. B. W. received support from the Swiss Accident Company and the Bangerter-Rhyner Foundation, Switzerland, for this project. The founding agencies had no role in the preparation, review or approval of the manuscript.	Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; de Ribaupierre S, 2011, NEUROL CLIN, V29, P883, DOI 10.1016/j.ncl.2011.07.012; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Franschman G, 2011, J TRAUMA, V71, P826, DOI 10.1097/TA.0b013e31820cebf0; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Haut ER, 2011, ANN SURG, V253, P371, DOI 10.1097/SLA.0b013e318207c24f; Hellal F, 2004, NEUROSCI LETT, V357, P21, DOI 10.1016/j.neulet.2003.12.036; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; Kool B, 2012, NEUROEPIDEMIOLOGY, V38, P179, DOI 10.1159/000337261; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Leon-Carrion J, 2012, BRAIN RES, V1476, P22, DOI 10.1016/j.brainres.2012.03.055; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; Lundgren P, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-59; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mosconi P, 2011, PATIENT, V4, P55, DOI 10.2165/11535550-000000000-00000; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Vadeboncoeur TF, 2006, J EMERG MED, V30, P131, DOI 10.1016/j.jemermed.2005.04.019; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	39	27	30	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JAN 7	2014	22								1	10.1186/1757-7241-22-1			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AB3VO	WOS:000331718500001	24393519	Green Published, gold			2022-02-06	
J	Beurskens, CJ; Horn, J; de Boer, AMT; Schultz, MJ; van Leeuwen, EMM; Vroom, MB; Juffermans, NP				Beurskens, Charlotte J.; Horn, Janneke; de Boer, Anita M. Tuip; Schultz, Marcus J.; van Leeuwen, Ester M. M.; Vroom, Margreeth B.; Juffermans, Nicole P.			Cardiac arrest patients have an impaired immune response, which is not influenced by induced hypothermia	CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; INDUCED LUNG INJURY; THERAPEUTIC HYPOTHERMIA; CARDIOPULMONARY-RESUSCITATION; MILD HYPOTHERMIA; SEPTIC SHOCK; REDUCES EXPRESSION; RISK-FACTORS; RATS; FEVER	Introduction: Induced hypothermia is increasingly applied as a therapeutic intervention in ICUs. One of the underlying mechanisms of the beneficial effects of hypothermia is proposed to be reduction of the inflammatory response. However, a fear of reducing the inflammatory response is an increased infection risk. Therefore, we studied the effect of induced hypothermia on immune response after cardiac arrest. Methods: A prospective observational cohort study in a mixed surgical-medical ICU. Patients admitted at the ICU after surviving cardiac arrest were included and during 24 hours body temperature was strictly regulated at 33 degrees C or 36 degrees C. Blood was drawn at three time points: after reaching target temperature, at the end of the target temperature protocol and after rewarming to 37 degrees C. Plasma cytokine levels and response of blood leucocytes to stimulation with toll-like receptor (TLR) ligands lipopolysaccharide (LPS) from Gram-negative bacteria and lipoteicoic acid (LTA) from Gram-positive bacteria were measured. Also, monocyte HLA-DR expression was determined. Results: In total, 20 patients were enrolled in the study. Compared to healthy controls, cardiac arrest patients kept at 36 degrees C (n = 9) had increased plasma cytokines levels, which was not apparent in patients kept at 33 degrees C (n = 11). Immune response to TLR ligands in patients after cardiac arrest was generally reduced and associated with lower HLA-DR expression. Patients kept at 33 degrees C had preserved ability of immune cells to respond to LPS and LTA compared to patients kept at 36 degrees C. These differences disappeared over time. HLA-DR expression did not differ between 33 degrees C and 36 degrees C. Conclusions: Patients after cardiac arrest have a modest systemic inflammatory response compared to healthy controls, associated with lower HLA-DR expression and attenuated immune response to Gram-negative and Gram-positive antigens, the latter indicative of an impaired immune response to bacteria. Patients with a body temperature of 33 degrees C did not differ from patients with a body temperature of 36 degrees C, suggesting induced hypothermia does not affect immune response in patients with cardiac arrest.	[Beurskens, Charlotte J.; de Boer, Anita M. Tuip; Schultz, Marcus J.; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anaesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Beurskens, Charlotte J.; Horn, Janneke; Schultz, Marcus J.; Vroom, Margreeth B.; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care, NL-1105 AZ Amsterdam, Netherlands; [van Leeuwen, Ester M. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Beurskens, Charlotte J.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, LEICA, NL-1105 AZ Amsterdam, Netherlands		Beurskens, CJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anaesthesiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.beurskens@amc.nl	Schultz, Marcus/AAB-6379-2021	Schultz, Marcus/0000-0003-3969-7792	NWO ZonMW Clinical Fellowship [90700269]	NWO ZonMW Clinical Fellowship to Dr. N. P. Juffermans. (Project number: 90700269). Funding did not influence the design, data collection, analysis, data interpretation, writing or the decision to submit the manuscript for publication.	Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Arts D, 2002, INTENS CARE MED, V28, P656, DOI 10.1007/s00134-002-1272-z; Bekeredjian-Ding I, 2009, IMMUNOLOGY, V128, P311, DOI 10.1111/j.1365-2567.2009.03173.x; BERNHEIM HA, 1976, SCIENCE, V193, P237, DOI 10.1126/science.935867; Beurskens CJ, 2012, CRIT CARE MED, V40, P319; BIGGAR WD, 1986, J APPL PHYSIOL, V60, P1186, DOI 10.1152/jappl.1986.60.4.1186; BIGGAR WD, 1984, INFECT IMMUN, V46, P857, DOI 10.1128/IAI.46.3.857-859.1984; Bisschops LLA, 2012, CRIT CARE MED, V40, P1136, DOI 10.1097/CCM.0b013e3182377050; Chin JY, 2007, ANESTH ANALG, V104, P1171, DOI 10.1213/01.ane.0000260316.95836.1c; Chu SJ, 2005, CHEST, V128, P327, DOI 10.1378/chest.128.1.327; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Fumeaux T, 2002, AM J RESP CRIT CARE, V166, P1475, DOI 10.1164/rccm.200203-217OC; Geurts M, 2014, CRIT CARE MED, V42, P231, DOI 10.1097/CCM.0b013e3182a276e8; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jiang QQ, 2000, INFECT IMMUN, V68, P1265, DOI 10.1128/IAI.68.3.1265-1270.2000; Kamps M, 2011, CRIT CARE, V15, DOI 10.1186/cc10012; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Kira S, 2005, ACTA ANAESTH SCAND, V49, P351, DOI 10.1111/j.1399-6576.2005.00593.x; KLASTERS.J, 1970, J INFECT DIS, V121, P81, DOI 10.1093/infdis/121.1.81; Kluger MJ, 1996, INFECT DIS CLIN N AM, V10, P1, DOI 10.1016/S0891-5520(05)70282-8; L'Her E, 2006, CRIT CARE MED, V34, P2621, DOI 10.1097/01.CCM.0000240231.76837.DC; Lim CM, 2003, INTENS CARE MED, V29, P453, DOI 10.1007/s00134-002-1529-6; Lukaszewicz AC, 2009, CRIT CARE MED, V37, P2746, DOI 10.1097/CCM.0b013e3181ab858a; Meybohm P, 2010, CRIT CARE, V14, DOI 10.1186/cc8879; Monneret G, 2002, CLIN CHEM, V48, P1589; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Perbet S, 2011, AM J RESP CRIT CARE, V184, P1048, DOI 10.1164/rccm.201102-0331OC; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Qadan M, 2009, ANN SURG, V250, P134, DOI 10.1097/SLA.0b013e3181ad85f7; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; RAO V, 1995, J CARDIAC SURG, V10, P468, DOI 10.1111/j.1540-8191.1995.tb00679.x; Rees K, 2001, COCHRANE DB SYST REV, V1; RELLO J, 1995, CLIN INFECT DIS, V21, P310, DOI 10.1093/clinids/21.2.310; Sarcia PJ, 2003, SHOCK, V20, P41, DOI 10.1097/01.shk.0000071080.50028.f2; Schortgen F, 2012, AM J RESP CRIT CARE, V185, P1088, DOI 10.1164/rccm.201110-1820OC; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Su FH, 2005, SHOCK, V23, P516, DOI 10.1097/01.shk.000161390.46688.da; Taniguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P940, DOI 10.1128/CDLI.10.5.940-943.2003; Torossian A, 2004, CRIT CARE MED, V32, P1899, DOI 10.1097/01.CCM.0000139608.34486.FD; Tsai MS, 2005, INTENS CARE MED, V31, P621, DOI 10.1007/s00134-005-2612-6; Zeiner A, 2001, ARCH INTERN MED, V161, P2007, DOI 10.1001/archinte.161.16.2007	46	27	28	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care		2014	18	4							R162	10.1186/cc14002			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA4MJ	WOS:000348878200046	25078879	gold, Green Published			2022-02-06	
J	Cook, LG; Chapman, SB; Elliott, AC; Evenson, NN; Vinton, K				Cook, Lori G.; Chapman, Sandra B.; Elliott, Alan C.; Evenson, Nellie N.; Vinton, Kami			Cognitive gains from gist reasoning training adolescents with chronic-stage traumatic brain injury	FRONTIERS IN NEUROLOGY			English	Article						adolescence; brain injury; cognitive plasticity; cognitive training; complex information; executive function; frontal lobe; reasoning		Adolescents with traumatic brain injury (TBI) typically demonstrate good recovery of previously acquired skills. However, higher-order and later emergent cognitive functions are often impaired and linked to poor outcomes in academic and social/behavioral domains. Few control trials exist that test cognitive treatment effectiveness at chronic recovery stages. The current pilot study compared the effects of two forms of cognitive training, gist reasoning (top-down) versus rote memory learning (bottom-up), on ability to abstract meanings, recall facts, and utilize core executive functions (i.e., working memory, inhibition) in 20 adolescents (ages 12-20) who were 6 months or longer post-TBI. Participants completed eight 45-min sessions over 1 month. After training, the gist reasoning group (n = 10) exhibited significant improvement in ability to abstract meanings and increased fact recall. This group also showed significant generalizations to untrained executive functions of working memory and inhibition. The memory training group (n = 10) failed to show significant gains in ability to abstract meaning or on other untrained specialized executive functions, although improved fact recall approached significance. These preliminary results suggest that relatively short-term training (6 h) utilizing a top-down reasoning approach is more effective than a bottom-up rote learning approach in achieving gains in higher-order cognitive abilities in adolescents at chronic stages of TBI. These findings need to be replicated in a larger study; nonetheless, the preliminary data suggest that traditional cognitive intervention schedules need to extend to later-stage training opportunities. Chronic-stage, higher-order cognitive trainings may serve to elevate levels of cognitive performance in adolescents with TBI.	[Cook, Lori G.; Chapman, Sandra B.; Evenson, Nellie N.; Vinton, Kami] Univ Texas Dallas, Ctr Brain Hlth, 2200 West,Mockingbird Lane, Dallas, TX 75235 USA; [Cook, Lori G.; Chapman, Sandra B.] Univ Texas Dallas, Sch Behav & Brain Sci, Dallas, TX 75235 USA; [Elliott, Alan C.] So Methodist Univ, Dept Stat Sci, Dallas, TX 75275 USA		Cook, LG (corresponding author), Univ Texas Dallas, Ctr Brain Hlth, 2200 West,Mockingbird Lane, Dallas, TX 75235 USA.	lori.cook@utdallas.edu			National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21-HD062835]; Crystal Charity Ball Foundation	This work was supported by funding from the National Institute of Child Health and Human Development (R21-HD062835). We would also like to acknowledge the generous support from the Crystal Charity Ball Foundation.	Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Beller S, 2007, THINK REASONING, V13, P426, DOI 10.1080/13546780701319122; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; Blosser JL, 2003, PEDIAT TRAUMATIC BRA; Brainerd CJ, 1996, DEV PSYCHOL, V32, P467, DOI 10.1037/0012-1649.32.3.467; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; BROWN AL, 1983, J VERB LEARN VERB BE, V22, P1, DOI 10.1016/S0022-5371(83)80002-4; Brown AL., 1981, EDUC RESEARCHER, V10, P14, DOI [DOI 10.3102/0013189X010002014, 10.3102/0013189X010002014]; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Chapman S.B., 2006, BRAIN INJ PROF, V3, P10; Chapman SB, 2015, CEREB CORTEX, V25, P396, DOI 10.1093/cercor/bht234; Chapman SB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00069; Chapman Sandra B., 2012, ADOLESCENT BRAIN LEA, P123, DOI DOI 10.1037/13493-005; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Chapman SB, TEST STRATEGIC LEARN; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cohen J., 2013, STAT POWER ANAL BEHA; Cook L. G., 2013, SOCIAL COMMUNICATION, P258; Cook L. G., 2011, SIG 2 PERSPECTIVES N, V21, P33, DOI DOI 10.1044/NNSLD21.1.33; Cook LG, 2007, CHILDRENS COMPREHENS, P218; Cook LG, 2008, NEUROREHABILITATION, V23, P467; COX BD, 1989, DEV PSYCHOL, V25, P619, DOI 10.1037/0012-1649.25.4.619; Delis DC., 2001, DELIS KAPLAN EXECUTI; Faul M, 2010, TRAUMATIC BRAIN INJU; Gabrieli John D E, 2004, Cerebrum, V6, P39; Gamino JF, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00188; Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; Gamino JF, 2009, INT NEUR SOC ANN M A; Garcia-Madruga JA, 2007, THINK REASONING, V13, P370, DOI [10.1080/13546780701203813, DOI 10.1080/13546780701203813]; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P1; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Marschark M., 1989, EUROPEAN J COGNITIVE, V1, P251, DOI DOI 10.1080/09541448908403084; Mayer R., 1984, EDUC PSYCHOL-US, V19, P30, DOI DOI 10.1080/00461528409529279; MAYER RE, 1989, REV EDUC RES, V59, P43, DOI 10.2307/1170446; Motes MA, 2014, BRAIN COGNITION, V84, P44, DOI 10.1016/j.bandc.2013.10.007; PALINCSAR AS, 1988, REM SPEC EDUC, V9, P53, DOI 10.1177/074193258800900110; Reyna VF, 2008, MED DECIS MAKING, V28, P850, DOI 10.1177/0272989X08327066; Reyna VF, 2009, PSYCHOL LEARN MOTIV, V50, P207, DOI 10.1016/S0079-7421(08)00407-6; REYNA VF, 1994, DEV PSYCHOL, V30, P178, DOI 10.1037/0012-1649.30.2.178; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Tuthill S, 2013, COGN NEUR SOC C SAN; Ulatowska H. K., 1994, DISCOURSE ANAL APPL, P29; Van Dijk TA., 1983, STRATEGIES DISCOURSE; VANDIJK TA, 1995, DISCOURSE COMPREHENSION, P383; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Verhaeghen P, 1996, PSYCHOL AGING, V11, P164, DOI 10.1037/0882-7974.11.1.164; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	65	27	27	0	10	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								87	10.3389/fneur.2014.00087			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QW	WOS:000209629300086	24966850	Green Published, gold			2022-02-06	
J	Joseph, B; Sadoun, M; Aziz, H; Tang, A; Wynne, JL; Pandit, V; Kulvatunyou, N; O'Keeffe, T; Friese, RS; Rhee, P				Joseph, Bellal; Sadoun, Moutamn; Aziz, Hassan; Tang, Andrew; Wynne, Julie L.; Pandit, Viraj; Kulvatunyou, Narong; O'Keeffe, Terence; Friese, Randall S.; Rhee, Peter			Repeat Head Computed Tomography in Anticoagulated Traumatic Brain Injury Patients: Still Warranted	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Scientific Meeting of the Trauma-Association-of-Canada	APR 12-13, 2012	Toronto, CANADA	Trauma Assoc Canada			INTRACRANIAL HEMORRHAGE; PREINJURY WARFARIN; THERAPY; UTILITY	Anticoagulation agents are proven risk factors for intracranial hemorrhage (ICH) in traumatic brain injury (TBI). The aim of our study is to describe the epidemiology of prehospital coumadin, aspirin, and Plavix (CAP) patients with ICH and evaluate the use of repeat head computed tomography (CT) in this group. We performed a retrospective study from our trauma registry. All patients with intracranial hemorrhage on initial CTwith prehospital CAP therapy were included. Demographics, CT scan findings, number of repeat CT scans, progressive findings, and neurosurgical intervention were abstracted. A comparison between prehospital CAP and no-CAP patients was done using chi(2) and Mann-Whitney U test. A total of 1606 patients with blunt TBI charts were reviewed of whom 508 patients had intracranial bleeding on initial CT scan and 72 were on prehospital CAP therapy. CAP patients were older (P < 0.001), had higher Injury Severity Score and head Abbreviated Injury Scores on admission (P < 0.001), were more likely to present with an abnormal neurologic examination (P = 0.004), and had higher hospital and intensive care unit lengths of stay (P < 0.005). Eighty-four per cent of patients were on antiplatelet therapy and 27 per cent were on warfarin. The CAP patients have a threefold increase in the rate of worsening repeat head CT (26 vs 9%, P < 0.05). Prehospital CAP therapy is high risk for progression of bleeding on repeat head CT. Routine repeat head CT remains an important component in this patient population and can provide useful information.	[Joseph, Bellal; Sadoun, Moutamn; Aziz, Hassan; Tang, Andrew; Wynne, Julie L.; Pandit, Viraj; Kulvatunyou, Narong; O'Keeffe, Terence; Friese, Randall S.; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu	Aziz, Hassan/ABA-5681-2021	Aziz, Hassan/0000-0003-0406-1946			Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; Hirsh J, 1995, J TRAUMA, V108, p231S; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Saab M, 1996, J ACCID EMERG MED, V13, P208; Smith JS, 2007, J TRAUMA, V63, P75, DOI 10.1097/01.ta.0000245991.42871.87; SREERAMA V, 1973, CAN MED ASSOC J, V108, P305; Wahl WL, 2001, J TRAUMA, V51, P1151; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	16	27	27	0	3	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JAN	2014	80	1					43	47					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	AJ5PQ	WOS:000337738000023	24401514				2022-02-06	
J	Kopczak, A; Kilimann, I; von Rosen, F; Krewer, C; Schneider, HJ; Stalla, GK; Schneider, M				Kopczak, Anna; Kilimann, Ingo; von Rosen, Friedrich; Krewer, Carmen; Schneider, Harald Joern; Stalla, Guenter Karl; Schneider, Manfred			Screening for Hypopituitarism in 509 Patients with Traumatic Brain Injury or Subarachnoid Hemorrhage	JOURNAL OF NEUROTRAUMA			English	Article						hypopituitarism; rehabilitation; subarachnoid hemorrhage; traumatic brain injury	ANTERIOR-PITUITARY INSUFFICIENCY; ACUTE-PHASE; PREVALENCE; DYSFUNCTION; HYPOGONADISM; COGNITION	We performed a screening on patients with traumatic brain injury (TBI) or subarachnoid hemorrhage (SAH) to determine the prevalence of post-traumatic hypopituitarism in neurorehabilitation in a cross-sectional, observational single-center study. In addition, the therapeutic consequences of our screening were analyzed retrospectively. From February 2006 to August 2009, patients between 18 and 65 years (n=509) with the diagnosis of TBI (n=340) or SAH (n=169) were screened within two weeks of admittance to neurorehabilitation as clinical routine. Blood was drawn to determine fasting cortisol, free thyroxine (fT4), prolactin, testosterone or estradiol, and insulin-like growth factor I (IGF-I). Patients with abnormalities in the screening or clinical signs of hypopituitarism received further stimulation tests: growth hormone releasing hormone -L-arginine-test and adrenocorticotrophic hormone (ACTH)-test (n=36); ACTH-test alone (n=26); or insulin tolerance test (n=56). In our screening of 509 patients, 28.5% showed lowered values in at least one hormone of the hypothalamus-pituitary axis and 4.5% in two or more axes. The most common disturbance was a decrease of testosterone in 40.7% of all men (in the following 13/131 men were given substitution therapy). Low fT4 was detected in 5.9% (n=3 were given substitution therapy). Low IGF-I was detected in 5.8%, low cortisol in 1.4%, and low prolactin in 0.2%; none were given substitution therapy. Further stimulation tests revealed growth hormone deficiency in 20.7% (n=19/92) and hypocortisolism in 23.7% (n=28/118). Laboratory values possibly indicating hypopituitarism (33%) were common but did not always implicate post-traumatic hypopituitarism. Laboratory values possibly indicating hypopituitarism were common in our screening but most patients were clinically not diagnosed as pituitary insufficient and did not receive hormone replacement therapy. A routine screening of all patients in neurorehabilitation without considering the time since injury, the severity of illness and therapeutic consequences seems not useful.	[Kopczak, Anna; Stalla, Guenter Karl] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Kilimann, Ingo] German Ctr Neurodegenerat Dis, DZNE, Rostock, Germany; [von Rosen, Friedrich] Schon Klin Staffelstein, Dept Neurol, Bad Staffelstein, Germany; [Krewer, Carmen; Schneider, Manfred] Schon Klin, Bad Aibling, Bad Aibling, Germany; [Schneider, Harald Joern] Univ Munich, Med Klin Innenstadt, D-80539 Munich, Germany		Kopczak, A (corresponding author), Max Planck Inst Psychiat, Clin Neuroendocrinol Grp, Kraepelinstr 2-10, D-80804 Munich, Germany.	anna_kopczak@mpipsykl.mpg.de	Krewer, Carmen/H-2845-2019	Krewer, Carmen/0000-0002-4153-0791; Kopczak, Anna/0000-0002-5037-2342	PfizerPfizer; NovartisNovartis; LillyEli Lilly; NovoNordiskNovo Nordisk; Pfizer GmbH, Germany [NRA 6280051]	H.J.S. received research grants from Pfizer, travel grants from Novartis, Pfizer, and Lilly, speaker fees from NovoNordisk, Pfizer, and Lilly, and is a member of the German KIMS (Pfizer International Metabolic Survey) board. M. S. received research grants and travel grants from Pfizer and Novo Nordisk. The other authors report that no competing financial interests exist.; This screening program and the stimulation tests were part of the project "Patients after traumatic brain injury or subarachnoid hemorrhage - screening for hypopituitarism" (project number NRA 6280051) which was supported by an unrestricted grant from Pfizer GmbH, Germany.	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Bondanelli M, 2002, METABOLISM, V51, P1363, DOI 10.1053/meta.2002.34714; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Cherrier MM, 2009, FRONT HORM RES, V37, P150, DOI 10.1159/000176051; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Fuck SP, 2009, FRONT HORM RES, V37, P123, DOI 10.1159/000176049; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Isidori A M, 2005, J Endocrinol Invest, V28, P73; Kaufman JM, 2005, ENDOCR REV, V26, P833, DOI 10.1210/er.2004-0013; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kopczak A, 2011, EUR J ENDOCRINOL, V164, P31, DOI 10.1530/EJE-10-0821; Kreitschmann-Andermahr I, 2011, EXP CLIN ENDOCR DIAB, V119, P15, DOI 10.1055/s-0030-1253414; MAHONEY F I, 1965, Md State Med J, V14, P61; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2009, CLIN ENDOCRINOL, V70, P446, DOI 10.1111/j.1365-2265.2008.03370.x; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601; Zitzmann M, 2009, NAT REV ENDOCRINOL, V5, P673, DOI 10.1038/nrendo.2009.212	34	27	27	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2014	31	1					99	107		10.1089/neu.2013.3002			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	302WJ	WOS:000330635500009	23980725				2022-02-06	
J	Middleton, A; Fritz, SL; Liuzzo, DM; Newman-Norlund, R; Herter, TM				Middleton, Addie; Fritz, Stacy L.; Liuzzo, Derek M.; Newman-Norlund, Roger; Herter, Troy M.			Using clinical and robotic assessment tools to examine the feasibility of pairing tDCS with upper extremity physical therapy in patients with stroke and TBI: A consideration-of-concept pilot study	NEUROREHABILITATION			English	Article						tDCS; stroke; TBI; upper extremity; rehabilitation	DIRECT-CURRENT STIMULATION; INDUCED MOVEMENT THERAPY; FUGL-MEYER ASSESSMENT; BRAIN-STIMULATION; IMPACT SCALE-16; MOTOR RECOVERY; REHABILITATION; PEOPLE; RELIABILITY; NORMS	BACKGROUND: Transcranial direct current stimulation (tDCS) may provide a safe, non-invasive technique for modulating neural excitability during neurorehabilitation. OBJECTIVE: 1) Assess feasibility and potential effectiveness of tDCS as an adjunct to standard upper extremity (UE) physical therapy (PT) for motor impairments resulting from neurological insult. 2) Determine sustainability of improvements over a six month period. METHODS: Five participants with chronic neurologic insult (stroke or traumatic brain injury > 6 months prior) completed 24 sessions (40 minutes, three times/week) of UE-PT combined with bihemispheric tDCS delivered at 1.5 mA over the motor cortex during the first 15 minutes of each PT session. Outcomes were assessed using clinical (UE Fugl-Meyer, Purdue Pegboard, Box and Block, Stroke Impact Scale) and robotic (unimanual and bimanual motor control) measures. Change in scores and associated effects sizes from Pre-test to Post-test and a six month Follow-up were calculated for each participant and group as a whole. RESULTS: Scores on UE Fugl-Meyer, Box and Block, Purdue Pegboard, Stroke Impact Scale, and robotic measures improved from Pre- to Post-test. Improvements on UE Fugl-Meyer, Box and Block, and robotic measures were largely sustained at six months. CONCLUSIONS: Combining bihemispheric tDCS with UE-PT in individuals with neurological insult warrants further investigation.	[Middleton, Addie; Fritz, Stacy L.; Liuzzo, Derek M.; Newman-Norlund, Roger; Herter, Troy M.] Univ S Carolina, Dept Exercise Sci, Div Rehabil Sci, Columbia, SC 29208 USA		Middleton, A (corresponding author), Univ S Carolina, Dept Exercise Sci, Phys Therapy Program, 921 Assembly St,3rd Floor PHRC, Columbia, SC 29208 USA.	middletj@email.sc.edu	LUO, JINGJING/AAZ-6697-2021	LUO, JINGJING/0000-0002-3222-1276; Middleton, Addie/0000-0001-8970-3703	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM081740, T32 GM081740] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM081740] Funding Source: NIH RePORTER		Ang KK, 2012, IEEE ENG MED BIO, P4128, DOI 10.1109/EMBC.2012.6346875; Balasubramanian Sivakumar, 2012, Am J Phys Med Rehabil, V91, pS255, DOI 10.1097/PHM.0b013e31826bcdc1; Birkenmeier RL, 2010, NEUROREHAB NEURAL RE, V24, P620, DOI 10.1177/1545968310361957; Bolognini N, 2011, NEUROREHAB NEURAL RE, V25, P819, DOI 10.1177/1545968311411056; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; Chang JJ, 2007, ARCH PHYS MED REHAB, V88, P1332, DOI 10.1016/j.apmr.2007.07.016; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Coderre AM, 2010, NEUROREHAB NEURAL RE, V24, P528, DOI 10.1177/1545968309356091; Debert CT, 2012, J NEUROL PHYS THER, V36, P58, DOI 10.1097/NPT.0b013e318254bd4f; DESROSIERS J, 1995, DISABIL REHABIL, V17, P217, DOI 10.3109/09638289509166638; DICKSTEIN R, 1986, PHYS THER, V66, P1233, DOI 10.1093/ptj/66.8.1233; Dobkin BH, 2009, NEUROREHAB NEURAL RE, V23, P197, DOI 10.1177/1545968309331863; Duncan PW, 2003, NEUROLOGY, V60, P291, DOI 10.1212/01.WNL.0000041493.65665.D6; DUNCAN PW, 1983, PHYS THER, V63, P1606, DOI 10.1093/ptj/63.10.1606; Einav O, 2011, TOP STROKE REHABIL, V18, P587, DOI 10.1310/tsr18s01-587; Feng WW, 2013, TOP STROKE REHABIL, V20, P68, DOI 10.1310/tsr2001-68; Fulk GD, 2010, TOP STROKE REHABIL, V17, P477, DOI 10.1310/tsr1706-477; Fusco A, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/837595; Giacobbe V, 2013, NEUROREHABILITATION, V33, P49, DOI 10.3233/NRE-130927; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; HOMAN RW, 1987, ELECTROEN CLIN NEURO, V66, P376, DOI 10.1016/0013-4694(87)90206-9; Khedr EM, 2013, NEUROREHAB NEURAL RE, V27, P592, DOI 10.1177/1545968313484808; Kidgell DJ, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-64; Kimberley TJ, 2010, J REHABIL RES DEV, V47, P851, DOI 10.1682/JRRD.2010.02.0019; Lang Catherine E, 2007, J Neurol Phys Ther, V31, P3; Lefebvre S, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00343; Lefebvre S, 2014, NEUROREHAB NEURAL RE, V28, P100, DOI 10.1177/1545968313478485; Lin JH, 2009, PHYS THER, V89, P840, DOI 10.2522/ptj.20080285; Lin KC, 2010, J REHABIL RES DEV, V47, P563, DOI 10.1682/JRRD.2009.09.0155; Lindenberg R, 2010, NEUROLOGY, V75, P2176, DOI 10.1212/WNL.0b013e318202013a; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nair DG, 2011, RESTOR NEUROL NEUROS, V29, P411, DOI 10.3233/RNN-2011-0612; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nowak DA, 2009, NEUROREHAB NEURAL RE, V23, P641, DOI 10.1177/1545968309336661; O'Shea J, 2014, NEUROIMAGE, V85, P924, DOI 10.1016/j.neuroimage.2013.05.096; Ochi M, 2013, J REHABIL MED, V45, P137, DOI 10.2340/16501977-1099; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Page SJ, 2012, PHYS THER, V92, P791, DOI 10.2522/ptj.20110009; Pellicciari MC, 2013, NEUROIMAGE, V83, P569, DOI 10.1016/j.neuroimage.2013.06.076; Russo R, 2013, BRAIN STIMUL, V6, P946, DOI 10.1016/j.brs.2013.05.009; Scott SH, 2011, J REHABIL RES DEV, V48, P335, DOI 10.1682/JRRD.2010.04.0057; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Tyryshkin K, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-47; Vines BW, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-103; Wang Q, 2011, J REHABIL MED, V43, P619, DOI 10.2340/16501977-0819; Wu DY, 2013, ARCH PHYS MED REHAB, V94, P1, DOI 10.1016/j.apmr.2012.07.022; Zollo L, 2011, EUR J PHYS REHAB MED, V47, P223	48	27	28	1	12	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	4					741	754		10.3233/NRE-141178			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW4HK	WOS:000346241600012	25323084	Green Accepted			2022-02-06	
J	Wu, AG; Ying, Z; Gomez-Pinilla, F				Wu, Aiguo; Ying, Zhe; Gomez-Pinilla, Fernando			Dietary Strategy to Repair Plasma Membrane After Brain Trauma: Implications for Plasticity and Cognition	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; BDNF; curcumin; DHA	OXIDATIVE STRESS; CORTICAL IMPACT; FATTY-ACIDS; INJURY; CURCUMIN; RATS; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; DHA; ADOLESCENTS	Background. Damage to the plasma membrane is a prevalent but often neglected aspect of traumatic brain injury (TBI), which can impair neuronal signaling and hamper neurological recovery. Objective. This study was performed to assess a new noninvasive intervention to counteract peroxidative damage to the phospholipids in the membrane using the powerful action of foods. Although dietary docosahexaenoic acid (C22:6n-3; DHA) provides protection against TBI, the pervasive effects of TBI that cause phospholipid damage, including to DHA, raises concerns about how to preserve DHA in the brain for optimal functional recovery. Methods. Rats were maintained on curcumin and/or DHA-enriched diets for 2 weeks postinjury, and their brains were subjected to analyses. Results. Fluid percussion injury reduced DHA levels as well as levels of enzymes involved in the metabolism of DHA such as FADS2 and 17-HSD4 and elevated levels of markers of lipid peroxidation such as 4-hydroxy-2-nonenal (4-HNE) and 4-hydroxy-2-hexenal (4-HHE). These effects were counteracted by DHA or curcumin, whereas the combination of curcumin and DHA had an enhanced effect on DHA and 4-HNE. The combination of curcumin and DHA was also efficient in counteracting reductions in the plasticity markers, brain-derived neurotrophic factor and its receptor p-trkB, and learning ability, which had been lessened after TBI. Conclusions. Curcumin complements the action of DHA on TBI pathology, and this property appears to be a viable strategy to counteract neuronal dysfunction after TBI and complement the application of rehabilitative interventions to foster functional recovery.	[Wu, Aiguo; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Los Angeles, CA USA; [Gomez-Pinilla, Fernando] UCLA Brain Injury Res Ctr, Los Angeles, CA USA		Gomez-Pinilla, F (corresponding author), Dept Integrat Biol & Physiol, 621 Charles E Young Dr, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu			NIH awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS50465]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by NIH award NS50465.	Cartagena CM, 2010, BRAIN RES, V1319, P1, DOI 10.1016/j.brainres.2009.12.080; Chytrova G, 2010, BRAIN RES, V1341, P32, DOI 10.1016/j.brainres.2009.05.018; Farooqui AA, 2004, NEUROCHEM RES, V29, P1961, DOI 10.1007/s11064-004-6871-3; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hua F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-42; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Kaur G, 2010, BRIT J NUTR, V103, P32, DOI 10.1017/S0007114509991334; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Long EK, 2008, J NEUROCHEM, V105, P714, DOI 10.1111/j.1471-4159.2007.05175.x; Ma QL, 2009, J NEUROSCI, V29, P9078, DOI 10.1523/JNEUROSCI.1071-09.2009; Mehla J, 2010, LIFE SCI, V87, P596, DOI 10.1016/j.lfs.2010.09.006; O'Connor SS, 2012, J TRAUMA STRESS, V25, P264, DOI 10.1002/jts.21704; Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Saw CLL, 2010, BIOCHEM PHARMACOL, V79, P421, DOI 10.1016/j.bcp.2009.08.030; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Sharma S, 2010, EXP NEUROL, V226, P191, DOI 10.1016/j.expneurol.2010.08.027; Thiyagarajan M, 2004, LIFE SCI, V74, P969, DOI 10.1016/j.lfs.2003.06.042; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872	25	27	27	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JAN	2014	28	1					75	84		10.1177/1545968313498650			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	274HW	WOS:000328598400009	23911971				2022-02-06	
J	Grulova, I; Slovinska, L; Nagyova, M; Cizek, M; Cizkova, D				Grulova, Ivana; Slovinska, Lucia; Nagyova, Miriam; Cizek, Milan; Cizkova, Dasa			The effect of hypothermia on sensory-motor function and tissue sparing after spinal cord injury	SPINE JOURNAL			English	Article						Spinal cord injury; Hypothermia; Urinary bladder; Sensory outcome; Functional recovery	TRAUMATIC BRAIN-INJURY; SYSTEMIC HYPOTHERMIA; COMPRESSION INJURY; MODERATE HYPOTHERMIA; ELECTRICAL-STIMULATION; RAT; TEMPERATURE; CONTUSION; RECOVERY; EXPRESSION	BACKGROUND CONTEXT: In recent years, hypothermia has been described as a therapeutic approach that leads to potential protective effects via minimization of secondary damage consequences, reduction of neurologic deficit, and increase of motor performance after spinal cord injury (SCI) in animal models and humans. PURPOSE: The objective of this study was to determine the therapeutic efficacy of hypothermia treatment on sensory-motor function and bladder activity outcome correlated with the white and gray matter sparing and neuronal survival after SCI in adult rats. STUDY DESIGN: A standardized animal model of compression SCI was used to test the hypothesis that hypothermia could have a neuroprotective effect on neural cell death and loss of white and/or gray matter. METHODS: Animals underwent spinal cord compression injury at the Th8-Th9 level followed by systemic hypothermia of 32.0 degrees C with gradual re-warming to 37.0 degrees C. Motor function of hind limbs (BBB score) and mechanical allodynia (von Frey hair filaments) together with function of urinary bladder was monitored in all experimental animals throughout the whole survival period. RESULTS: Present results showed that hypothermia had beneficial effects on urinary bladder activity and on locomotor function recovery at Days 7 and 14 post-injury. Furthermore, significant increase of NeuN-positive neuron survival within dorsal and ventral horns at Days 7, 14, and 21 were documented. CONCLUSIONS: Our conclusions suggest that hypothermia treatment may not only promote survival of neurons, which can have a significant impact on the improvement of motor and vegetative functions, but also induce mechanical allodynia. (C) 2013 Elsevier Inc. All rights reserved.	[Grulova, Ivana; Slovinska, Lucia; Nagyova, Miriam; Cizkova, Dasa] Slovak Acad Sci, Inst Neurobiol, Ctr Excellence Brain Res, Kosice, Slovakia; [Cizek, Milan; Cizkova, Dasa] Univ Vet Med & Pharm, Kosice, Slovakia		Grulova, I (corresponding author), Slovak Acad Sci, Inst Neurobiol, Ctr Excellence Brain Res, Soltesovej 4, Kosice, Slovakia.	novotna@saske.sk	Cizkova, Dasa/AAF-8976-2019	Cizek, Milan/0000-0003-2623-9194; cizkova, dasa/0000-0002-2504-3993			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Amar AP, 1999, J AM COLL SURGEONS, V188, P550, DOI 10.1016/S1072-7515(99)00013-7; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BERIC A, 1992, J UROLOGY, V148, P1845, DOI 10.1016/S0022-5347(17)37047-7; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BOVOLENTA P, 1993, EUR J NEUROSCI, V5, P454, DOI 10.1111/j.1460-9568.1993.tb00512.x; Casas CE, 2005, J NEUROSURG-SPINE, V2, P308, DOI 10.3171/spi.2005.2.3.0308; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Christensen MD, 1996, PAIN, V68, P97, DOI 10.1016/S0304-3959(96)03224-1; CHUONG CM, 1991, AM J PATHOL, V138, P427; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; DEGROAT WC, 1990, J AUTONOM NERV SYST, V30, pS71, DOI 10.1016/0165-1838(90)90105-R; Detloff MR, 2010, EXP NEUROL, V225, P366, DOI 10.1016/j.expneurol.2010.07.009; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; EBNER A, 1992, J UROLOGY, V148, P920, DOI 10.1016/S0022-5347(17)36778-2; Fukui O, 2006, BRAIN RES, V1121, P35, DOI 10.1016/j.brainres.2006.08.121; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Ha KY, 2008, SPINE, V33, P2059, DOI 10.1097/BRS.0b013e31818018f6; HALL ED, 1993, STROKE, V24, P711, DOI 10.1161/01.STR.24.5.711; Hutchinson KJ, 2004, BRAIN, V127, P1403, DOI 10.1093/brain/awh160; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Jou IM, 2000, SPINE, V25, P1878, DOI 10.1097/00007632-200008010-00004; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Kumar K, 1997, METAB BRAIN DIS, V12, P21, DOI 10.1007/BF02676351; Kwon BK, 2008, SPINE J, V8, P859, DOI 10.1016/j.spinee.2007.12.006; LIESI P, 1984, EMBO J, V3, P683, DOI 10.1002/j.1460-2075.1984.tb01867.x; LIGHT JK, 1992, J UROLOGY, V148, P355, DOI 10.1016/S0022-5347(17)36595-3; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; MAGASI P, 1986, UROL INT, V41, P241, DOI 10.1159/000281209; MARTINEZARIZALA A, 1992, J NEUROTRAUM, V9, pS497; Morino T, 2008, SPINAL CORD, V46, P425, DOI 10.1038/sj.sc.3102163; Morochovic R, 2008, INT J NEUROSCI, V118, P555, DOI 10.1080/00207450601123456; Nagel Simon, 2008, Expert Rev Neurother, V8, P1255, DOI 10.1586/14737175.8.8.1255; Park WB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-119; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Shibuya S, 2004, SPINAL CORD, V42, P29, DOI 10.1038/sj.sc.3101516; Sirimanne ES, 1996, PEDIATR RES, V39, P591, DOI 10.1203/00006450-199604000-00005; Steinberg GK, 2004, NEUROSURGERY, V55, P307, DOI 10.1227/01.NEU.0000129683.99430.8C; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; Strauch JT, 2004, EUR J CARDIO-THORAC, V25, P708, DOI 10.1016/j.ejcts.2004.01.007; STRONG MJ, 1967, ANESTHESIOLOGY, V28, P920, DOI 10.1097/00000542-196709000-00032; Svensson LG, 2003, ARCH SURG-CHICAGO, V138, P175, DOI 10.1001/archsurg.138.2.175; TABAYASHI K, 1993, ANN THORAC SURG, V56, P494, DOI 10.1016/0003-4975(93)90885-L; Tetik O, 2002, EUR J VASC ENDOVASC, V24, P540, DOI 10.1053/ejvs.2002.1753; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wakamatsu H, 1999, ANESTH ANALG, V88, P56, DOI 10.1097/00000539-199901000-00011; Westergren H, 2000, ACTA NEUROCHIR, V142, P567, DOI 10.1007/s007010050471; Westergren H, 1999, SPINAL CORD, V37, P696, DOI 10.1038/sj.sc.3100920; Westergren H, 1998, J NEUROTRAUM, V15, P943, DOI 10.1089/neu.1998.15.943; Westergren H, 2001, SPINAL CORD, V39, P74, DOI 10.1038/sj.sc.3101127; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; Yu WR, 1999, ACTA NEUROPATHOL, V98, P15, DOI 10.1007/s004010051046; Yu WR, 2000, ACTA NEUROPATHOL, V100, P546, DOI 10.1007/s004010000206; ZARZECKI P, 1982, EXP BRAIN RES, V48, P28	68	27	27	2	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC	2013	13	12					1881	1891		10.1016/j.spinee.2013.06.073			11	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	272XG	WOS:000328495800029	24012427				2022-02-06	
J	Jiang, JY				Jiang, Ji-yao		Chinese Head Trauma Study Collabor	Head trauma in China	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Head trauma; Data bank; Outcome; China	BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; GENDER; COMA; AGE	Objective: The Chinese Head Trauma Data Bank (CHTDB) has been established, which includes 7145 hospitalised cases with acute head trauma patients in 47 hospitals. Methods: We explored factors that might affect the outcome of acute traumatic brain injury. Results: There was no statistical difference in the mortality rate between male (7.5%) and female (7.2%) patients (P > 0.05). The mortality rate in children (< 18 years), adults (18-65 years) and elderly (> 65 years) was 7.3%, 7.2% and 9.0%, respectively (P > 0.05). The mortality rate of patients with mild (2.7%), moderate (5.0%) and severe (21.8%) head trauma was significantly different (P < 0.001). The mortality rate of patients with unilateral tentorial herniation, bilateral tentorial herniation and tonsillar herniation was 24.2%, 60.2% and 78.8% respectively (P < 0.001). The mortality rate of patients with intracranial pressure (ICP) < 20 mmHg, 20-40 mmHg and >40 mmHg was 6.3%, 21.4% and 93.1%, respectively (P < 0.001). The mortality rate of patients with no cerebral contusion, single cerebral contusion and multiple cerebral contusions was 3.9%, 7.8% and 14.8%, respectively (P < 0.001). The mortality rate of patients with and without traumatic subarachnoid haemorrhage (tSAH) was 9.5% and 5.4%, respectively (P < 0.001). The mortality rate of patients with no intracranial haematomas, single intracranial haematoma and multiple intracranial haematomas was 5.8%, 8.4% and 20.6%, respectively (P < 0.001). Conclusion: The CHTDB, the first head trauma data bank in China, has one of the largest numbers of cases of any head trauma data bank in the world. Our major findings on mortality may be helpful to neurosurgeons for predicting the outcome of acute head trauma patients. (c) 2012 Elsevier Ltd. All rights reserved.	[Jiang, Ji-yao; Chinese Head Trauma Study Collabor] Shanghai Jiao Tong Univ, Shanghai Renji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Renji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China.	jiyaojiang@126.com			National Health Science Grant [200802093]; National Key Basic Research ProjectNational Basic Research Program of China [2012CB518100]; Science and Technology committee of ShanghaiShanghai Science & Technology Committee [10JC1409800, 08411951900]; Program for Shanghai Outstanding Medical Academic Leader	This work was supported by grants from National Health Science Grant (No. 200802093), National Key Basic Research Project (No. 2012CB518100), Science and Technology committee of Shanghai (Nos. 10JC1409800, 08411951900) and Program for Shanghai Outstanding Medical Academic Leader.	Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bullock MR, 2006, NEUROSURGERY, V58, pS1; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Lu J, 2005, ACT NEUR S, V95, P281; Maas AI, 2003, LANCET NEUROL, V7, P728; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Otani N, 2010, ACTA NEUROCHIR SUPPL, V106, P257, DOI 10.1007/978-3-211-98811-4_48; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; von Wild KRH, 2005, ACTA NEUROCHIR SUPPL, V93, P15	24	27	39	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	NOV	2013	44	11					1453	1457		10.1016/j.injury.2012.08.045			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	227ZT	WOS:000325155000013	23068139				2022-02-06	
J	Li, AH; Sun, XL; Ni, YH; Chen, X; Guo, AS				Li, Aihong; Sun, Xiaolei; Ni, Yaohui; Chen, Xin; Guo, Aisong			HIF-1 alpha Involves in Neuronal Apoptosis after Traumatic Brain Injury in Adult Rats	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; HIF-1 alpha; Neuronal apoptosis; Rat	HYPOXIA-INDUCIBLE FACTOR-1; SECONDARY INSULTS; CORTICAL IMPACT; UP-REGULATION; BCL-2 FAMILY; EXPRESSION; P53; GLUTAMATE; PROTEIN; DEATH	Hypoxia-inducible factor-1 alpha (HIF-1 alpha), a well-identified hypoxia-related protein, is involved in regulating the biological functions of various cell types including neurons. The traditional biological function of HIF-1 alpha is promoting the transcription of some pro-survival genes when exposing to low oxygen conditions. Meanwhile, some studies also point out that HIF-1 alpha shows the detrimental role in several central nervous system (CNS) disorders. Up to now, the knowledge of HIF-1 alpha function in CNS is still limited. To investigate whether HIF-1 alpha is involved in CNS impairment and repair, we employed a traumatic brain injury model in adult rats. Upregulation of HIF-1 alpha was observed in the injured brain cortex by western blot analysis and immunohistochemistry staining. Terminal deoxynucleotidyl transferase deoxy-UTP nick-end labeling (TUNEL) and 4',6-diamidino-2-phenylindole (DAPI) staining suggested that HIF-1 alpha was relevant to neuronal apoptosis after brain injury. In addition, glutamate excitotoxic model of primary cortex neurons was introduced to further investigate the role of HIF-1 alpha in neuronal apoptosis; the result implied HIF-1 alpha was associated with the regulation of p53 and BNIP3 in the apoptotic neurons. Based on our data, we suggested that HIF-1 alpha might play an important role in neuronal apoptosis after traumatic brain injury in rat, which might also provide a basis for the further study on its role in regulating the transcription of target genes in apoptotic neurons, and might gain a novel strategy for the clinical therapy for traumatic brain injury.	[Li, Aihong; Ni, Yaohui; Chen, Xin] Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong 226002, Jiangsu, Peoples R China; [Sun, Xiaolei] Nantong Univ, Coll Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China; [Guo, Aisong] Nantong Univ, Dept Rehabil Med, Affiliated Hosp, Nantong 226002, Jiangsu, Peoples R China		Guo, AS (corresponding author), Nantong Univ, Dept Rehabil Med, Affiliated Hosp, Nantong 226002, Jiangsu, Peoples R China.	AisongGuo@hotmail.com			Open Science Foundation of the Jiangsu Province [KF200953]	The project was funded by the Open Science Foundation of the Jiangsu Province (KF200953).	Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Badawi Y, 2012, ASN NEURO, V4, P231, DOI 10.1042/AN20120006; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cregan SP, 1999, J NEUROSCI, V19, P7860; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Endo H, 2006, J NEUROSCI, V26, P7974, DOI 10.1523/JNEUROSCI.0897-06.2006; Feng JF, 2012, BRAIN RES, V1469, P144, DOI 10.1016/j.brainres.2012.06.021; Ha YM, 2012, APOPTOSIS, V17, P463, DOI 10.1007/s10495-011-0688-8; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Hota KB, 2012, J CEREBR BLOOD F MET, V32, P1046, DOI 10.1038/jcbfm.2012.21; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Mangat Halinder S, 2012, Continuum (Minneap Minn), V18, P532, DOI 10.1212/01.CON.0000415426.76524.e1; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mellergard P, 2012, J NEUROTRAUM, V29, P112, DOI 10.1089/neu.2010.1732; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Prabhakaran K, 2007, NEUROSCIENCE, V150, P159, DOI 10.1016/j.neuroscience.2007.07.033; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tedeschi A, 2009, CELL DEATH DIFFER, V16, P543, DOI 10.1038/cdd.2008.175; Trollmann R, 2009, BRAIN DEV-JPN, V31, P503, DOI 10.1016/j.braindev.2009.03.007; Vazquez-Valls E, 2011, J NEUROIMMUNOL, V238, P12, DOI 10.1016/j.jneuroim.2011.06.001; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Zhang HM, 2003, APOPTOSIS, V8, P229, DOI 10.1023/A:1023616620970; Zhang ZF, 2011, FEBS J, V278, P134, DOI 10.1111/j.1742-4658.2010.07939.x	38	27	29	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	NOV	2013	51	3					1052	1062		10.1007/s12031-013-0084-7			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	235IH	WOS:000325710500048	23979836				2022-02-06	
J	Stewart, TC; Alharfi, IM; Fraser, DD				Stewart, Tanya Charyk; Alharfi, Ibrahim M.; Fraser, Douglas D.			The role of serious concomitant injuries in the treatment and outcome of pediatric severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; concomitant injury; children and adolescents; outcome; mortality	SYSTEMIC CYTOKINE EXPRESSION; HEAD-INJURY; MORTALITY; CHILDREN; VOLUME	BACKGROUND: The study objective was to describe the epidemiology of serious concomitant injuries and their effects on outcome in pediatric severe traumatic brain injury (sTBI). METHODS: A retrospective cohort of all severely injured (Injury Severity Score [ISS] >= 12) pediatric patients (<18 years) admitted to our pediatric intensive care unit, between 2000 and 2011, after experiencing an sTBI (Glasgow Coma Scale [GCS] score <= 8 and head Abbreviated Injury Scale [AIS] >= 4) were included. Two groups were compared based on the presence of serious concomitant injuries (maximum AIS score >= 3). Multivariate logistic regression was undertaken to determine variable associations with mortality. RESULTS: Of the 180 patients with sTBI, 113 (63%) sustained serious concomitant injuries. Chest was the most commonly injured extracranial body region (84%), with lung being the most often injured. Patients with serious concomitant injuries had increased age, weight, and injury severity (p < 0.001) and were more likely injured in a motor vehicle collision (91% vs. 48%, p < 0.001). Those with serious concomitant injuries had worse sTBI, based on lower presedation GCS (p = 0.031), higher frequency of fixed pupils (p = 0.006), and increased imaging abnormalities (SAH and DAI, p <= 0.01). Non-neurosurgical operations and blood transfusions were more frequent in the serious concomitant injury group (p < 0.01). The differences in mortality for the two groups failed to reach statistical significant (p = 0.053), but patients with serious concomitant injuries had higher rates of infection and acute central diabetes insipidus, fewer ventilator-free days, and greater length of stays (p < 0.05). Multivariate analyses revealed fixed pupillary response (odd ratio [OR], 63.58; p < 0.001), presedation motor GCS (OR, 0.23; p = 0.001), blood transfusion (OR, 5.80; p = 0.008), and hypotension (OR, 4.82; p = 0.025) were associated with mortality, but serious concomitant injuries was not (p = 0.283). CONCLUSION: Head injury is the most important prognostic factor in mortality for sTBI pediatric patients, but the presence of serious concomitant injuries does contribute to greater morbidity, including longer stays, more infections, fewer ventilator-free days, and a higher level of care required on discharge from hospital. (J Trauma Acute Care Surg. 2013;75:836-842. Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Stewart, Tanya Charyk] Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; [Fraser, Douglas D.] Univ Western Ontario, Dept Pediat, London, ON N6A 3K7, Canada; [Fraser, Douglas D.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Stewart, Tanya Charyk] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; [Fraser, Douglas D.] Translat Res Ctr, London, ON, Canada; [Fraser, Douglas D.] Childrens Hlth Res Inst, London, ON, Canada; [Fraser, Douglas D.] Ctr Crit Illness Res, London, ON, Canada; [Alharfi, Ibrahim M.] King Fahad Med City, Dept Pediat Crit Care, Riyadh, Saudi Arabia		Stewart, TC (corresponding author), Childrens Hosp, LHSC, Trauma Program, Room E1-129,800 Commissioners Rd E, London, ON N6A 5W9, Canada.	Tanya.CharykStewart@lhsc.on.ca					Al-Sharif A, 2012, INJURY, V43, P2078, DOI 10.1016/j.injury.2012.01.012; Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; Alharfi IM, 2013, PEDIATR CRIT CARE ME, V14, P203, DOI 10.1097/PCC.0b013e31827127b5; [Anonymous], 2012, INJ PREV CONTR TRAUM; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Association for the Advancement of Automotive Medicine European Vehicle Passive Safety Network. International Research Council on the Biomechanics of Impact, 1999, CHILD OCC PROT MOT V; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Ballesteros MF, 2003, INJURY PREV, V9, P173, DOI 10.1136/ip.9.2.173; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Croce MA, 2012, J AM COLL SURGEONS, V214, P486; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Hosmer D, 1989, APPL LOGISTIC REGRES; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LaPar DJ, 2012, J AM COLL SURGEONS, V214, P478, DOI 10.1016/j.jamcollsurg.2011.12.015; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac	24	27	29	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2013	75	5					836	842		10.1097/TA.0b013e3182a685b0			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	300IP	WOS:000330457900013	24158203				2022-02-06	
J	Borlongan, CV; Burns, J; Tajiri, N; Stahl, CE; Weinbren, NL; Shojo, H; Sanberg, PR; Emerich, DF; Kaneko, Y; van Loveren, HR				Borlongan, Cesar V.; Burns, Jack; Tajiri, Naoki; Stahl, Christine E.; Weinbren, Nathan L.; Shojo, Hideki; Sanberg, Paul R.; Emerich, Dwaine F.; Kaneko, Yuji; van Loveren, Harry R.			Epidemiological Survey-Based Formulae to Approximate Incidence and Prevalence of Neurological Disorders in the United States: a Meta-Analysis	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; HUNTINGTONS-DISEASE; POPULATION; DURATION; DEMENTIA; COUNTY; AGE	Background: This study aims to create a convenient reference for both clinicians and researchers so that vis-a-vis comparisons between brain disorders can be made quickly and accurately. We report here the incidence and prevalence of the major adult-onset brain disorders in the United States using a meta-analysis approach. Material and Methods: Epidemiological figures were collected from the most recent, reliable data available in the research literature. Population statistics were based on the most recent census from the US Census Bureau. Extrapolations were made only when necessary. The most current epidemiological studies for each disorder were chosen. All effort was made to use studies based on national cohorts. Studies reviewed were conducted between 1950 and 2009. The data of the leading studies for several neurological studies was compiled in order to obtain the most accurate extrapolations. Results were compared to commonly accepted values in order to evaluate validity. Results: It was found that 6.75% of the American adult population is afflicted with brain disorders. This number was eclipsed by the 8.02% of Floridians with brain disorders, which is due to the large aged population residing in the state. Conclusions: There was a noticeable lack of epidemiological data concerning adult-onset brain disorders. Since approximately 1 out of every 7 households is affected by brain disorders, increased research into this arena is warranted.	[Borlongan, Cesar V.; Burns, Jack; Tajiri, Naoki; Stahl, Christine E.; Weinbren, Nathan L.; Shojo, Hideki; Sanberg, Paul R.; Emerich, Dwaine F.; Kaneko, Yuji; van Loveren, Harry R.] Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA		Borlongan, CV (corresponding author), Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Borlongan, Cesar/I-5696-2012; Kaneko, Yuji/J-6447-2012	Borlongan, Cesar/0000-0002-2966-9782; 	University of South Florida Department of Neurosurgery and Brain Repair; James and Esther King Biomedical Research Foundation [1KG01-33966]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5U01NS055914-04, 1R01NS071956-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956, U01NS055914] Funding Source: NIH RePORTER	Financial support for this study was through the University of South Florida Department of Neurosurgery and Brain Repair funds. CVB is funded by the James and Esther King Biomedical Research Foundation 1KG01-33966, NIH 5U01NS055914-04 and NIH 1R01NS071956-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNEGERS JF, 1991, ARCH NEUROL-CHICAGO, V48, P589, DOI 10.1001/archneur.1991.00530180041015; Brain Central Tumor Registry of the United States, 2009, CENTR BRAIN TUM REG; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Centers for Disease Control (CDC), 2008, MMWR-MORBID MORTAL W, V56, P469; Cronin S, 2007, NEUROLOGY, V68, P1002, DOI 10.1212/01.wnl.0000258551.96893.6f; Day JC, 1996, CURRENT POPULATION R; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; EISEN A, 1993, MUSCLE NERVE, V16, P27, DOI 10.1002/mus.880160107; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN SE, 1987, AM J HUM GENET, V41, P168; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hebert LE, 2004, NEUROLOGY, V62, P1645, DOI 10.1212/01.WNL.0000123018.01306.10; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; KOKMEN E, 1994, ARCH NEUROL-CHICAGO, V51, P696, DOI 10.1001/archneur.1994.00540190076018; KURLAND L T, 1958, J Chronic Dis, V8, P378, DOI 10.1016/0021-9681(58)90002-X; Kurtzke JF, 1983, CLIN NEUROLOGY, V3, P1; Lobo A, 2000, NEUROLOGY, V54, pS4; Myrianthopoulos N., 1973, ADV NEUROL, V1, P150; PEARSON JS, 1955, P STAFF M MAYO CLIN, V30, P349; Population Estimates Program, 2009, SCEST200801 US CENS; Population Estimates Program, 2009, NCEST200902 US CENS; Population Estimates Program, 2009, NSTEST200901 US CENS; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; U.S. Census Bureau Population Division, 2009, STAT COUNT QUICKFACT; Williams G R, 2001, BMC Neurol, V1, P2, DOI 10.1186/1471-2377-1-2; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	29	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2013	8	10							e78490	10.1371/journal.pone.0078490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	241FR	WOS:000326152300063	24205243	gold, Green Submitted, Green Published			2022-02-06	
J	Zhang, L; Yan, R; Zhang, Q; Wang, HN; Kang, XK; Li, J; Yang, SY; Zhang, JN; Liu, ZL; Yang, XY				Zhang, Lin; Yan, Rong; Zhang, Qi; Wang, Haining; Kang, Xiaokui; Li, Jia; Yang, Shuyuan; Zhang, Jianning; Liu, Zhenlin; Yang, Xinyu			Survivin, a key component of the Wnt/beta-catenin signaling pathway, contributes to traumatic brain injury-induced adult neurogenesis in the mouse dentate gyrus	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						survivin; dentate gyrus; adult neurogenesis; traumatic brain injury	CENTRAL-NERVOUS-SYSTEM; CELL-PROLIFERATION; ALZHEIMERS-DISEASE; UP-REGULATION; APOPTOSIS; EXPRESSION; PROTEIN; DIFFERENTIATION; CANCER; RATS	The enhancement of endogenous neurogenesis has been suggested in the treatment of traumatic brain injury (TBI); however, the factors that trigger the process of adult neurogenesis following TBI remain elusive. In the adult mammalian central nervous system, there are 2 neurogenic regions: the subgranular zone (SGZ) of the hippocampus and the subventricular zone (SVZ) of the lateral ventricles, both of which maintain relatively quiescent states in a stable microenvironment. However, once stimulated by intrinsic and extrinsic events, relevant signals are activated in these 2 regions. In this study, in order to explore the mechanisms behind endogenous neurogenesis following TBI, we investigated potential factors regulating this process. We observed that the expression of survivin, an anti-apoptotic protein, increased in a time-dependent manner in the hippocampus in a mouse model of TBI. In addition, the number of survivin (+) cells, as well as that of BrdU (+) cells increased in the SGZ of the dentate gyrus (DG) in the hippocampus following TBI, as shown by immunofluorescence double staining; the co-localization of survivin and BrdU was shown in the merged images. The expression of survivin was also significantly increased in the doublecortin (DCX) (+) immature neurons in the DG of the hippocampus soon after the induction of TBI. Taken together, these data confirm the connection between the expression of survivin and adult neurogenesis following TBI; our data also suggest the therapeutic potential of upregulating survivin expression as a novel strategy for the effective treatment of TBI.	[Zhang, Lin; Yan, Rong; Zhang, Qi; Wang, Haining; Kang, Xiaokui; Li, Jia; Yang, Shuyuan; Zhang, Jianning; Yang, Xinyu] Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Zhang, Lin; Yan, Rong; Liu, Zhenlin] Tianjin 5th Cent Hosp, Dept Neurosurg, Tianjin 300450, Peoples R China		Yang, XY (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	wjzhenlin817@sina.com; yangxinyu@tijmu.edu.cn			Science and Technology Foundation of Tianjin [10JCYBJC25700]; Health-System Science Foundation of Binhai New Area in Tianjin [2011BHKL002]	We thank Linchun Huan, Wangmiao Zhao and Zhen Zhang for their helpful comments on the manuscript. This study was supported by grants from the Science and Technology Foundation of Tianjin (no. 10JCYBJC25700) and the Health-System Science Foundation of Binhai New Area in Tianjin (no. 2011BHKL002).	Adida C, 1998, AM J PATHOL, V152, P43; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Baratchi S, 2010, CRIT REV BIOCHEM MOL, V45, P535, DOI 10.3109/10409238.2010.516740; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chen J, 2003, J BIOL CHEM, V278, P486, DOI 10.1074/jbc.M211119200; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Conway EM, 2003, AM J PATHOL, V163, P935, DOI 10.1016/S0002-9440(10)63453-0; Coremans V, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-2; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; HIROKAWA N, 1994, CURR OPIN CELL BIOL, V6, P74, DOI 10.1016/0955-0674(94)90119-8; Inestrosa NC, 2000, ACTA NEUROL SCAND, V102, P53, DOI 10.1034/j.1600-0404.2000.00308.x; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Johnson EA, 2004, J NEUROTRAUM, V21, P1183, DOI 10.1089/neu.2004.21.1183; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Li FZ, 2006, AM J PATHOL, V169, P1, DOI 10.2353/ajpath.2006.060121; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lovestone S, 2007, TRENDS NEUROSCI, V30, P142, DOI 10.1016/j.tins.2007.02.002; Lu Na, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P1856; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; Okazaki T, 2008, NEUROSCI LETT, V430, P109, DOI 10.1016/j.neulet.2007.10.046; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; RAY J, 1993, P NATL ACAD SCI USA, V90, P3602, DOI 10.1073/pnas.90.8.3602; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Skoufias DA, 2000, J CELL BIOL, V151, P1575, DOI 10.1083/jcb.151.7.1575; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Tamm I, 1998, CANCER RES, V58, P5315; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhang L, 2011, EUR J NEUROSCI, V33, P1, DOI 10.1111/j.1460-9568.2010.7483.x; Zhang T, 2001, CANCER RES, V61, P8664; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006; Zhao WM, 2010, NEURAL REGEN RES, V5, P645, DOI 10.3969/j.issn.1673-5374.2010.09.001; Zhu HX, 2010, CANCER SCI, V101, P1156, DOI 10.1111/j.1349-7006.2010.01528.x; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	56	27	30	0	17	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1107-3756	1791-244X		INT J MOL MED	Int. J. Mol. Med.	OCT	2013	32	4					867	875		10.3892/ijmm.2013.1456			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	209AL	WOS:000323725200016	23900556	Bronze			2022-02-06	
J	Boulet, T; Kelso, ML; Othman, SF				Boulet, Thomas; Kelso, Matthew L.; Othman, Shadi F.			Long-Term In Vivo Imaging of Viscoelastic Properties of the Mouse Brain after Controlled Cortical Impact	JOURNAL OF NEUROTRAUMA			English	Article						inverse problem; MRE; MRI; TBI; viscoelasticity	MAGNETIC-RESONANCE ELASTOGRAPHY; MR ELASTOGRAPHY; TISSUE ELASTICITY; INJURY; MICE; CONTUSION; BARRIER; EDEMA; RAT; INDENTATION	Traumatic brain injury (TBI) presents a variety of causes and symptoms, thus making the development of reliable diagnostic methods and therapeutic treatments challenging. Magnetic resonance elastography (MRE) is a technique that allows for a noninvasive assessment of the mechanical properties of soft biological tissue, such as tissue stiffness, storage modulus, and loss modulus. Importantly, by quantifying the changes in the stiffness of tissue that is often associated with disease, MRE is able to detect tissue pathologies at early stages. Recent improvements in instrumentation have allowed for the investigation of small samples with microscopic resolution (mu MRE). We hypothesize that mu MRE can sensitively detect variations in micromechanical properties in the brain caused by the compressive and shearing forces sustained during TBI. To test this hypothesis, we randomized 13 C57BL mice to receive a controlled cortical impact at a 0.5 mm or 0.75 mm depth, with both sham and naive mice as controls. Our objective was to propagate mechanical shear waves throughout the brain for in vivo TBI mu MRE imaging. The mechanical properties of the injured brain tissue were determined at days 0, 1, 7, and 28 post-injury. For both groups, we observed a significant drop in the stiffness of the impacted region immediately following the injury; the 0.75 mm animals experienced increased tissue softness that lasted longer than that for the 0.5 mm group. Although the shear stiffness, storage modulus, and loss modulus parameters all followed the same trend, the tissue stiffness yielded the most statistically significant results. Overall, this article introduces a transformative technique for mechanically mapping the brain and detecting brain diseases and injury.	[Boulet, Thomas] Univ Nebraska, Dept Engn Mech, Lincoln, NE 68583 USA; [Othman, Shadi F.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68583 USA; [Kelso, Matthew L.] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharm Practice, Omaha, NE USA		Othman, SF (corresponding author), Univ Nebraska, Translat & Regenerat Med TREM Imaging Lab, 249 LW Chase Hall, Lincoln, NE 68583 USA.	sothman2@unl.edu			University of Nebraska-Lincoln (UNL)/University of Nebraska Medical Center (UNMC) Engineering for Medicine Research Collaboration Seed Grant; National Institutes of Health (NIH) COBRE grant [RR021937]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR021937] Funding Source: NIH RePORTER	The authors thank Vahid Khalilzad-Sharghi for his technical assistance with the MRE pulse sequence, as well as the publishers and authors mentioned in Table 2 for providing their permission to replicate a figure. The authors also thank Melody Montgomery for help in editing this manuscript. This research was supported in part by University of Nebraska-Lincoln (UNL)/University of Nebraska Medical Center (UNMC) Engineering for Medicine Research Collaboration Seed Grant and National Institutes of Health (NIH) COBRE grant RR021937 (Nebraska Center for Nanomedicine).	Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bitner BR, 2010, J CEREBR BLOOD F MET, V30, P1105, DOI 10.1038/jcbfm.2010.47; Boulet T, 2011, J NEUROSCI METH, V201, P296, DOI 10.1016/j.jneumeth.2011.08.019; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Engel DC, 2008, J NEUROTRAUM, V25, P739, DOI 10.1089/neu.2007.0480; Faul M, 2010, TRAUMATIC BRAIN INJU; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fung Y. C., 1993, BIOMECHANICS MECH PR; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hamhaber U, 2010, J MAGN RESON IMAGING, V32, P577, DOI 10.1002/jmri.22294; Johnson C.L., 2012, MAGN RESON MED; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kuroiwa T, 1997, ACT NEUR S, V70, P87; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Manduca A, 2003, MED IMAGE ANAL, V7, P465, DOI 10.1016/S1361-8415(03)00038-0; Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006; Murphy MC, 2012, MAGN RESON IMAGING, V30, P535, DOI 10.1016/j.mri.2011.12.019; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Oliphant TE, 2001, MAGNET RESON MED, V45, P299, DOI 10.1002/1522-2594(200102)45:2<299::AID-MRM1039>3.0.CO;2-O; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Othman SF, 2005, MAGN RESON MED, V54, P605, DOI 10.1002/mrm.20584; Othman SF, 2012, NMR BIOMED, V25, P452, DOI 10.1002/nbm.1663; Prevost TP, 2011, ACTA BIOMATER, V7, P4090, DOI 10.1016/j.actbio.2011.06.032; Rnjak J, 2011, TISSUE ENG PART B-RE, V17, P81, DOI [10.1089/ten.teb.2010.0452, 10.1089/ten.TEB.2010.0452]; Romano AJ, 1998, IEEE T ULTRASON FERR, V45, P751, DOI 10.1109/58.677725; Schuhmann MU, 2002, ACTA NEUROCHIR SUPPL, V81, P213; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shire NJ, 2011, J MAGN RESON IMAGING, V34, P947, DOI 10.1002/jmri.22716; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Warner L, 2011, INVEST RADIOL, V46, P509, DOI 10.1097/RLI.0b013e3182183a95	41	27	28	0	23	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2013	30	17					1512	1520		10.1089/neu.2012.2788			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	202HX	WOS:000323205800007	23534701	Green Published			2022-02-06	
J	Gorsuch, J; Long, J; Miller, K; Primeau, K; Rutledge, S; Sossong, A; Durocher, JJ				Gorsuch, Joshua; Long, Janey; Miller, Katie; Primeau, Kyle; Rutledge, Sarah; Sossong, Andrew; Durocher, John J.			The Effect of Squat Depth on Multiarticular Muscle Activation in Collegiate Cross-Country Runners	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						concurrent training; EMG; resistance training; running; strength	RUNNING ECONOMY; DISTANCE RUNNERS; LOWER-EXTREMITY; CONCURRENT ENDURANCE; TRAINING EXERCISES; PERFORMANCE; BIOMECHANICS	Gorsuch, J, Long, J, Miller K, Primeau, K, Rutledge, S, Sossong, A, and Durocher, JJ. The effect of squat depth on multiarticular muscle activation in collegiate cross-country runners. J Strength Cond Res 27(9): 2619-2625, 2013The squat is a closed-chain lower body exercise commonly performed by many athletes. Muscle activity has been examined during partial and parallel squats in male weightlifters, but not in male and female runners. Therefore, this study measured muscle activity with surface electromyography (EMG) during partial and parallel squats in 20 Division I collegiate cross-country runners (10 males and 10 females) in a randomized crossover design. We hypothesized the parallel squat would increase extensor muscle activitation (i.e. hamstrings and erector spinae). Furthermore, we sought to determine if changes in muscle activity were different between males and females. Participants performed 6 repetitions using their 10 repetition maximum loads for each condition during EMG testing. EMG was performed on the right rectus femoris, biceps femoris, lumbar erector spinae, and lateral head of the gastrocnemius. Rectus femoris activity (0.18 +/- 0.01 vs. 0.14 +/- 0.01 mV) and erector spinae activity (0.16 +/- 0.01 vs. 0.13 +/- 0.01 mV) were significantly higher (p < 0.05) during the parallel squat than during the partial squat condition. This increase in muscle activity may be attributed to greater ranges of motion at the hip and knee joints. Biceps femoris and gastrocnemius activity were similar between conditions. No significant differences existed between males and females (squat condition x gender; p > 0.05). During preliminary isokinetic testing, both male and female runners demonstrated deficient hamstrings-to-quadriceps ratios, which would not likely improve by performing parallel squats based on our EMG findings. Despite the reduced load of the parallel squat, rectus femoris and erector spinae activity were elevated. Thus, parallel squats may help runners to train muscles vital for uphill running and correct posture, while preventing injury by using lighter weights through a larger range of motion.	[Gorsuch, Joshua; Long, Janey; Miller, Katie; Primeau, Kyle; Rutledge, Sarah; Sossong, Andrew; Durocher, John J.] St Francis Univ, Dept Phys Therapy, DiSepio Inst Human Performance Lab, Loretto, PA USA; [Durocher, John J.] Michigan Technol Univ, Dept Biol Sci, Clin & Appl Human Physiol Lab, Houghton, MI 49931 USA		Durocher, JJ (corresponding author), St Francis Univ, Dept Phys Therapy, DiSepio Inst Human Performance Lab, Loretto, PA USA.	jjduroch@mtu.edu			Saint Francis University Department of Physical Therapy	The authors are grateful to the Saint Francis University cross-country runners who volunteered for testing, and appreciate the assistance of Gordon Thomson, Jesse Webber, and Dr John Miko during data collection and analyses. The authors also thank Dr Kay Malek and the Saint Francis University Department of Physical Therapy for providing funding to support this project. Finally, the authors appreciate the contributions of Freya Moran, Jenna Edwards, and Marie Mets towards revisions of this manuscript.	Behm DG, 2009, APPL PHYSIOL NUTR ME, V34, P1008, DOI 10.1139/H09-102; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Caterisano A, 2002, J STRENGTH COND RES, V16, P428; Ebben WP, 2009, INT J SPORT PHYSIOL, V4, P84, DOI 10.1123/ijspp.4.1.84; Escamilla RF, 2001, MED SCI SPORT EXER, V33, P127; Esteve-Lanao J, 2008, J STRENGTH COND RES, V22, P1176, DOI 10.1519/JSC.0b013e31816a861f; Hamlyn N, 2007, J STRENGTH COND RES, V21, P1108; Hanon C, 2005, EUR J APPL PHYSIOL, V94, P118, DOI 10.1007/s00421-004-1276-1; Hoskins W, 2005, MANUAL THER, V10, P96, DOI 10.1016/j.math.2005.03.006; Isear JA, 1997, MED SCI SPORT EXER, V29, P532, DOI 10.1097/00005768-199704000-00016; Johnston RE, 1997, J STRENGTH COND RES, V11, P224; Kelly CM, 2008, J STRENGTH COND RES, V22, P396, DOI 10.1519/JSC.0b013e318163534a; MANN RA, 1980, AM J SPORT MED, V8, P345, DOI 10.1177/036354658000800510; MANN RA, 1986, AM J SPORT MED, V14, P501, DOI 10.1177/036354658601400614; Mikkola J, 2007, INT J SPORTS MED, V28, P602, DOI 10.1055/s-2007-964849; Millet GP, 2002, MED SCI SPORT EXER, V34, P1351, DOI 10.1097/00005768-200208000-00018; Nummela AT, 2006, EUR J APPL PHYSIOL, V97, P1, DOI 10.1007/s00421-006-0147-3; Nuzzo JL, 2008, J STRENGTH COND RES, V22, P95, DOI 10.1519/JSC.0b013e31815ef8cd; Paavolainen L, 1999, J APPL PHYSIOL, V86, P1527; Sloniger MA, 1997, J APPL PHYSIOL, V83, P2073, DOI 10.1152/jappl.1997.83.6.2073; Storen O, 2008, MED SCI SPORT EXER, V40, P1087, DOI 10.1249/MSS.0b013e318168da2f; Wright GA, 1999, J STRENGTH COND RES, V13, P168; Yamamoto LM, 2008, J STRENGTH COND RES, V22, P2036, DOI 10.1519/JSC.0b013e318185f2f0	23	27	27	2	42	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1064-8011			J STRENGTH COND RES	J. Strength Cond. Res.	SEP	2013	27	9					2619	2625		10.1519/JSC.0b013e31828055d5			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	210NB	WOS:000323839400033	23254544				2022-02-06	
J	Kramer, ME; Suskauer, SJ; Christensen, JR; DeMatt, EJ; Trovato, MK; Salorio, CF; Slomine, BS				Kramer, Megan E.; Suskauer, Stacy J.; Christensen, James R.; DeMatt, Ellen J.; Trovato, Melissa K.; Salorio, Cynthia F.; Slomine, Beth S.			Examining Acute Rehabilitation Outcomes for Children With Total Functional Dependence After Traumatic Brain Injury: A Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children and adolescents; functional independence measure; outcome; rehabilitation; traumatic brain injury	INPATIENT REHABILITATION; DEVELOPMENTAL-DISABILITIES; INDEPENDENCE MEASURE; WEEFIM; CONSCIOUSNESS; PREDICTORS; DISORDERS; RECOVERY; SAMPLE; SCALE	Objective: To examine in a pilot cohort factors associated with functional outcome at discharge and 3-month follow-up after discharge from inpatient rehabilitation in children with severe traumatic brain injury (TBI) who entered rehabilitation with the lowest level of functional skills. Participants: Thirty-nine children and adolescents (3-18 years old) who sustained a severe TBI and had the lowest possible rating at rehabilitation admission on the Functional Independence Measure for Children (total score = 18). Methods: Retrospective review of data collected as part of routine clinical care. Results: At discharge, 59% of the children were partially dependent for basic activities, while 41% remained dependent for basic activities. Initial Glasgow Coma Scale score, time to follow commands, and time from injury to rehabilitation admission were correlated with functional status at discharge. Time to follow commands and time from injury to rehabilitation admission were correlated with functional status at 3-month follow-up. Changes in functional status during the first few weeks of admission were associated with functional status at discharge and follow-up. Conclusions: Even children with the most severe brain injuries, who enter rehabilitation completely dependent for all daily activities, have the potential to make significant gains in functioning by discharge and in the following few months. Assessment of functional status early in the course of rehabilitation contributes to the ability to predict outcome from severe TBI.	[Kramer, Megan E.; Suskauer, Stacy J.; Christensen, James R.; DeMatt, Ellen J.; Trovato, Melissa K.; Salorio, Cynthia F.] Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Salorio, Cynthia F.; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Suskauer, Stacy J.; Christensen, James R.; Trovato, Melissa K.; Salorio, Cynthia F.; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.; Christensen, James R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, 707 North Broadway, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org		Kramer, Megan/0000-0002-8813-7217	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Eunice Kennedy Shriver National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD061611] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health and award K23HD061611 (Dr Suskauer) from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health.	Ashwal Stephen, 2002, Semin Pediatr Neurol, V9, P19, DOI 10.1053/spen.2002.30334; Azaula M, 2000, ARCH PHYS MED REHAB, V81, P307, DOI 10.1016/S0003-9993(00)90076-5; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P266, DOI 10.1136/adc.2008.147926; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Msall ME, 1999, AM J MED GENET, V89, P62, DOI 10.1002/(SICI)1096-8628(19990625)89:2<62::AID-AJMG3>3.0.CO;2-T; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; Niedzwecki CM, 2008, J HEAD TRAUMA REHAB, V23, P209, DOI 10.1097/01.HTR.0000327253.61751.29; Ottenbacher KJ, 1997, ARCH PHYS MED REHAB, V78, P1309, DOI 10.1016/S0003-9993(97)90302-6; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Slomine B, 2008, J HEAD TRAUMA REHAB, V23, P286, DOI 10.1097/01.HTR.0000336841.53338.2f; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Ziviani Jenny, 2001, Physical and Occupational Therapy in Pediatrics, V21, P91	25	27	27	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					361	370		10.1097/HTR.0b013e31824da031			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600082	22613944	Green Accepted			2022-02-06	
J	Larsson, J; Bjorkdahl, A; Esbjornsson, E; Sunnerhagen, KS				Larsson, Jerry; Bjorkdahl, Ann; Esbjornsson, Eva; Sunnerhagen, Katharina. S.			FACTORS AFFECTING PARTICIPATION AFTER TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						social participation; brain injury; depression; self-centring; cognitive	MINOR DEPRESSION; IMPACT; SCALE; MODEL; LIFE	Objective: The aim of this work was to explore the extent to which social, cognitive, emotional and physical aspects influence participation after a traumatic brain injury. Design/subjects: An explorative study of the patient perspective of participation 4 years after traumatic brain injury. The cohort consisted of all patients (age range 18-65 years), presenting in 1999-2000, admitted to the hospital (n=129). Sixty-three patients responded; 46 males and 17 females, mean age 41 (range 19-60) years. Methods: Four years after the injury, the European Brain Injury Questionnaire (EBIQ), EuroQoI-5D, Swedish Stroke Register Questionnaire and Impact on Participation and Autonomy (IPA) questionnaire were sent to the sample. Data were analysed with logistic regression. Results: On the EBIQ, 40% of the sample reported problems in most questions. According to IPA, between 20% and 40% did not perceive that they had a good participation. The analyses gave 5 predictors reflecting emotional and social aspects, which could explain up to 70% of the variation in participation. Conclusion: It is not easy to find single predictors, as there seems to be a close interaction between several aspects. Motor deficits appear to have smaller significance for participation in this late state, while emotional and social factors play a major role.	[Larsson, Jerry; Bjorkdahl, Ann; Esbjornsson, Eva; Sunnerhagen, Katharina. S.] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Bjorkdahl, Ann] Ersta Skondal Univ Coll, Gothenburg, Sweden; [Sunnerhagen, Katharina. S.] Univ Oslo, Fac Med, Sunaas Rehabil Hosp, Oslo, Norway		Larsson, J (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden.	jerry.larsson@vgregion.se	Bjorkdahl, Ann/ABD-6197-2021; Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Bjorkdahl, Ann/0000-0002-2194-6773; Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400			Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; Bedard M, 2012, ADV MIND BODY MED, V26, P6; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cardol M, 1999, CLIN REHABIL, V13, P411, DOI 10.1191/026921599668601325; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cox DR, 1981, APPL STAT PRINCIPLES; Dykeman B, 2003, J INSTRUCTIONAL PSYC, P225; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Guillamondegui OD, 2011, 11EHC017EF AG HEALTH; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hoyle M, 2012, BRAIN IMPAIR, V13, P4, DOI 10.1017/BrImp.2012.9; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; Larsson J, 2010, SCAND J PUBLIC HEALT, V38, P541, DOI 10.1177/1403494810371143; Lemeshow S, 2000, APPL LOGISTIC REGRES; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Nagelkerke N. D, 1992, MAXIMUM LIKELIHOOD E; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Truelle JL, 2010, CURR OPIN NEUROL, V23, P688, DOI 10.1097/WCO.0b013e3283404258; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; World Health Organization, 2007, INT CLASS FUNCT DIS	28	27	29	0	13	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					765	770		10.2340/16501977-1184			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500011	24002312	Green Published, gold, Green Submitted			2022-02-06	
